PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Savaskan, NE; Seufert, S; Hauke, J; Trankle, C; Eyupoglu, IY; Hahnen, E				Savaskan, N. E.; Seufert, S.; Hauke, J.; Traenkle, C.; Eyuepoglu, I. Y.; Hahnen, E.			Dissection of mitogenic and neurodegenerative actions of cystine and glutamate in malignant gliomas	ONCOGENE			English	Article						glioma; tumor microenvironment; ionotropic glutamate signaling; glutamate/cystine transporter; excitotoxicity; xCT (SLC7A11)	X(C)(-) CYSTINE/GLUTAMATE ANTIPORTER; PRIMARY BRAIN-TUMORS; AMPA RECEPTORS; CELL-PROLIFERATION; IN-VIVO; GROWTH; RNA; TRANSPORT; CANCER; MICE	Malignant glioma represents one of the most aggressive and lethal human neoplasias. A hallmark of gliomas is their rapid proliferation and destruction of vital brain tissue, a process in which excessive glutamate release by glioma cells takes center stage. Pharmacologic antagonism with glutamate signaling through ionotropic glutamate receptors attenuates glioma progression in vivo, indicating that glutamate release by glioma cells is a prerequisite for rapid glioma growth. Glutamate has been suggested to promote glioma cell proliferation in an autocrine or paracrine manner, in particular by activation of the (RS)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid hydrate (AMPA) subtype of glutamate receptors. Here, we dissect the effects of glutamate secretion on glioma progression. Glioma cells release glutamate through the amino-acid antiporter system X-c(-), a process that is mechanistically linked with cystine incorporation. We show that disrupting glutamate secretion by interfering with the system X-c(-) activity attenuates glioma cell proliferation solely cystine dependently, whereas glutamate itself does not augment glioma cell growth in vitro. Neither AMPA receptor agonism nor antagonism affects glioma growth in vitro. On a molecular level, AMPA insensitivity is concordant with a pronounced transcriptional downregulation of AMPA receptor subunits or overexpression of the fully edited GluR2 subunit, both of which block receptor activity. Strikingly, AMPA receptor inhibition in tumor-implanted brain slices resulted in markedly reduced tumor progression associated with alleviated neuronal cell death, suggesting that the ability of glutamate to promote glioma progression strictly requires the tumor microenvironment. Concerning a potential pharmacotherapy, targeting system X-c(-) activity disrupts two major pathophysiological properties of glioma cells, that is, the induction of excitotoxic neuronal cell death and incorporation of cystine required for rapid proliferation. Oncogene (2011) 30, 43-53; doi: 10.1038/onc.2010.391; published online 30 August 2010	[Savaskan, N. E.] Charite, Inst Cell Biol & Neurobiol, D-10117 Berlin, Germany; [Seufert, S.; Hauke, J.; Hahnen, E.] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Seufert, S.; Hauke, J.; Hahnen, E.] Univ Cologne, Ctr Mol Med Cologne, Inst Genet, D-50931 Cologne, Germany; [Traenkle, C.] Univ Bonn, Inst Pharm, Dept Pharmacol & Toxicol, D-5300 Bonn, Germany; [Eyuepoglu, I. Y.] Univ Erlangen Nurnberg, Dept Neurosurg, Erlangen, Germany; [Hahnen, E.] Univ Hosp Erlangen, Inst Neuropathol, Erlangen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; University of Cologne; University of Bonn; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Savaskan, NE (corresponding author), Charite, Inst Cell Biol & Neurobiol, Philippstr 12, D-10117 Berlin, Germany.	savaskan@gmx.net; eric.hahnen@uk-koeln.de	; Savaskan, Nicolai/D-2923-2018	Hauke, Jan/0000-0001-8236-4075; Savaskan, Nicolai/0000-0003-1348-094X	Wilhelm Sander-Stiftung; Institut Danone; International Human Frontiers Science Program; ELAN-Programm; Koln Fortune Programm; Center for Molecular Medicine Cologne (CMMC)	Wilhelm Sander-Stiftung; Institut Danone(Danone Nutricia); International Human Frontiers Science Program(Human Frontier Science Program); ELAN-Programm; Koln Fortune Programm; Center for Molecular Medicine Cologne (CMMC)	We thank Nadine Scheufler and Philip Rummel (both Erlangen) for experimental support. Jan Csupor (Berlin) is acknowledged for technical assistance. This study was supported by the 'Wilhelm Sander-Stiftung' (to EH), the 'Institut Danone' (to NES, IYE and EH), the 'International Human Frontiers Science Program' (to NES), the 'ELAN-Programm' (to IYE), the 'Koln Fortune Programm' (to EH) and the 'Center for Molecular Medicine Cologne (CMMC)' (to EH).	Behrens PF, 2000, J NEURO-ONCOL, V47, P11, DOI 10.1023/A:1006426917654; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Chung WJ, 2009, J NEUROCHEM, V110, P182, DOI 10.1111/j.1471-4159.2009.06129.x; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; De Groot JF, 2008, J NEURO-ONCOL, V88, P121, DOI 10.1007/s11060-008-9552-2; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; DONEVAN SD, 1993, NEURON, V10, P51, DOI 10.1016/0896-6273(93)90241-I; Eyupoglu IY, 2005, J NEUROSURG, V102, P738, DOI 10.3171/jns.2005.102.4.0738; Eyupoglu IY, 2005, J NEUROCHEM, V93, P992, DOI 10.1111/j.1471-4159.2005.03098.x; Eyupoglu LY, 2006, MOL CANCER THER, V5, P1248, DOI 10.1158/1535-7163.MCT-05-0533; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Huang Y, 2005, CANCER RES, V65, P7446, DOI 10.1158/0008-5472.CAN-04-4267; Ishiuchi S, 2002, NAT MED, V8, P971, DOI 10.1038/nm746; Jones DP, 2004, FASEB J, V18, P1246, DOI 10.1096/fj.03-0971fje; Liu RR, 2007, BIOCHEM BIOPH RES CO, V364, P528, DOI 10.1016/j.bbrc.2007.10.036; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Marcus HJ, 2010, J NEURO-ONCOL, V97, P11, DOI 10.1007/s11060-009-9990-5; Mawatari C, 1996, NEUROSCIENCE, V73, P201, DOI 10.1016/0306-4522(96)00025-5; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Patel SA, 2004, NEUROPHARMACOLOGY, V46, P273, DOI 10.1016/j.neuropharm.2003.08.006; Pham AN, 2010, J PHARMACOL EXP THER, V332, P949, DOI 10.1124/jpet.109.162248; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Robe PA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-372; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; Savaskan NE, 2007, CELL MOL LIFE SCI, V64, P230, DOI 10.1007/s00018-006-6412-0; Savaskan NE, 2009, J CELL PHYSIOL, V220, P531, DOI 10.1002/jcp.21795; Savaskan NE, 2008, NAT MED, V14, P629, DOI 10.1038/nm1772; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Turski L, 1998, P NATL ACAD SCI USA, V95, P10960, DOI 10.1073/pnas.95.18.10960; van Vuurden DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005953; Vanhoutte N, 2009, EXP NEUROL, V218, P56, DOI 10.1016/j.expneurol.2009.04.004; Ye ZC, 1999, CANCER RES, V59, P4383; Ye ZC, 1999, J NEUROSCI, V19, P10767, DOI 10.1523/JNEUROSCI.19-24-10767.1999; Yoshida Y, 2006, PATHOL INT, V56, P262, DOI 10.1111/j.1440-1827.2006.01954.x; Zhuge J, 2006, FREE RADICAL BIO MED, V40, P63, DOI 10.1016/j.freeradbiomed.2005.08.012	42	28	31	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	1					43	53		10.1038/onc.2010.391	http://dx.doi.org/10.1038/onc.2010.391			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	703EQ	20802520				2022-12-25	WOS:000285959300004
J	Chen, YW; Qiao, SJ; Tuckermann, J; Okret, S; Jondal, M				Chen, Yongwen; Qiao, Shengjun; Tuckermann, Jan; Okret, Sam; Jondal, Mikael			Thymus-derived glucocorticoids mediate androgen effects on thymocyte homeostasis	FASEB JOURNAL			English	Article						testosterone; corticosterone; local glucocorticoid synthesis; glucocorticoid receptor-knockout mice; metyrapone	IMMUNE-SYSTEM; AGE; THYMOPOIESIS; EXPRESSION; RECONSTITUTION; RECEPTORS; MICE	Androgens contribute to the involution process of the aging thymus gland. However, molecular mechanisms behind this effect remain largely unknown. We have investigated the influence of testosterone on the ectopic synthesis of glucocorticoids (GCs) in thymocytes, an activity recently shown by us to be important for the homeostatic regulation of these cells. Castration, which leads to a strong increase in thymus tissue and function, was associated with a reduced GC release from thymocytes caused by down-regulated expression of several enzymes involved in GC synthesis, without affecting GC synthesis in the adrenals. Testosterone treatment of castrated male mice reversed these effects, also without affecting adrenal GC synthesis. The effects of testosterone in castrated mice on thymocyte homeostasis and GC release were strongly reduced in mice pretreated with the CYP11B1 enzyme inhibitor metyrapone, acting on the last step in the corticosterone synthesis. The androgen-induced thymic involution was dependent on GC action, because this was completely absent in mice lacking GC receptor (GR) expression specifically in thymocytes. We provide here an unrecognized mechanism how androgens contribute to thymic involution by stimulating local synthesis and release of GCs in the thymus.-Chen, Y., Qiao, S., Tuckermann, J., Okret, S., Jondal, M. Thymus-derived glucocorticoids mediate androgen effects on thymocyte homeostasis. FASEB J. 24, 5043-5051 (2010). www.fasebj.org	[Chen, Yongwen; Qiao, Shengjun; Okret, Sam] Karolinska Inst, Dept Biosci & Nutr, SE-14183 Stockholm, Sweden; [Chen, Yongwen; Qiao, Shengjun; Jondal, Mikael] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-14183 Stockholm, Sweden; [Tuckermann, Jan] FLI, Leibnitz Inst Age Res, Jena, Germany	Karolinska Institutet; Karolinska Institutet; Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Chen, YW (corresponding author), Karolinska Inst, Dept Biosci & Nutr, SE-14183 Stockholm, Sweden.	yongwen.chen@ki.se			Swedish Cancer Society; European Union [HEALTH-F4-2008-202156]	Swedish Cancer Society(Swedish Cancer Society); European Union(European Commission)	This work was supported by grants from the Swedish Cancer Society and the European Union FP7 project TOLERAGE (HEALTH-F4-2008-202156).	Baschant U, 2010, J STEROID BIOCHEM, V120, P69, DOI 10.1016/j.jsbmb.2010.03.058; DASILVA JAP, 1993, J ENDOCRINOL, V136, P389, DOI 10.1677/joe.0.1360389; Dorshkind K, 2009, NAT REV IMMUNOL, V9, P57, DOI 10.1038/nri2471; Dudakov JA, 2010, TRENDS IMMUNOL, V31, P191, DOI 10.1016/j.it.2010.02.002; Dulos GJ, 2001, INT IMMUNOPHARMACOL, V1, P321, DOI 10.1016/S1567-5769(00)00029-1; Guevara Patino JA, 2000, EUR J IMMUNOL, V30, P2586; IZQUIERDO M, 1989, J IMMUNOL, V143, P2185; Jondal M, 2004, TRENDS IMMUNOL, V25, P595, DOI 10.1016/j.it.2004.09.003; Leposavic G, 2008, NEUROIMMUNOMODULAT, V15, P290, DOI 10.1159/000156473; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Lynch HE, 2009, TRENDS IMMUNOL, V30, P366, DOI 10.1016/j.it.2009.04.003; Morrhaye G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005668; Noti M, 2010, FASEB J, V24, P1340, DOI 10.1096/fj.09-140913; Olsen NJ, 2001, ENDOCRINOLOGY, V142, P1278, DOI 10.1210/en.142.3.1278; Olsen NJ, 1998, ENDOCRINOLOGY, V139, P748, DOI 10.1210/en.139.2.748; OLSEN NJ, 1993, J STEROID BIOCHEM, V45, P327, DOI 10.1016/0960-0760(93)90001-D; Page DM, 1998, J IMMUNOL, V160, P120; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Pazirandeh A, 2005, ENDOCRINOLOGY, V146, P2501, DOI 10.1210/en.2004-0943; Pfister G, 2008, NEUROIMMUNOMODULAT, V15, P351, DOI 10.1159/000156477; Pido-Lopez J, 2001, CLIN EXP IMMUNOL, V125, P409, DOI 10.1046/j.1365-2249.2001.01640.x; Qiao SJ, 2008, EXP CELL RES, V314, P3027, DOI 10.1016/j.yexcr.2008.06.014; Qiao SJ, 2009, ENDOCRINOLOGY, V150, P4163, DOI 10.1210/en.2009-0195; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269; Schmidt KL, 2008, GEN COMP ENDOCR, V157, P266, DOI 10.1016/j.ygcen.2008.03.025; Scott HM, 2009, ENDOCR REV, V30, P883, DOI 10.1210/er.2009-0016; Semposski GD, 2002, MOL IMMUNOL, V38, P841, DOI 10.1016/S0161-5890(01)00122-5; Sempowski GD, 2000, J IMMUNOL, V164, P2180, DOI 10.4049/jimmunol.164.4.2180; Sutherland JS, 2005, J IMMUNOL, V175, P2741, DOI 10.4049/jimmunol.175.4.2741; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; VACCHIO MS, 1994, J EXP MED, V179, P1835, DOI 10.1084/jem.179.6.1835; van den Brink MRM, 2004, NAT REV IMMUNOL, V4, P856, DOI 10.1038/nri1484; Wiegers GJ, 2001, EUR J IMMUNOL, V31, P2293, DOI 10.1002/1521-4141(200108)31:8<2293::AID-IMMU2293>3.0.CO;2-I; Williams KA, 2007, SEMIN IMMUNOL, V19, P318, DOI 10.1016/j.smim.2007.10.004; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140	36	35	35	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					5043	5051		10.1096/fj.10-168724	http://dx.doi.org/10.1096/fj.10-168724			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20798244	Green Published			2022-12-25	WOS:000284824400042
J	Yamazaki, H; Chan, J; Ikura, M; Michikawa, T; Mikoshiba, K				Yamazaki, Haruka; Chan, Jenny; Ikura, Mitsuhiko; Michikawa, Takayuki; Mikoshiba, Katsuhiko			Tyr-167/Trp-168 in Type 1/3 Inositol 1,4,5-Trisphosphate Receptor Mediates Functional Coupling between Ligand Binding and Channel Opening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EMBRYOS; MICE LACKING; MONOCLONAL-ANTIBODIES; ENDOPLASMIC-RETICULUM; MOLECULAR-CLONING; CALCIUM RELEASE; DOMAINS; SITE; AFFINITY; COMPLEX	The N-terminal similar to 220-amino acid region of the inositol 1,4,5-trisphosphate (IP3) receptor (IP3R)/Ca2+ release channel has been referred to as the suppressor/coupling domain because it is required for both IP3 binding suppression and IP3-induced channel gating. Measurements of IP3-induced Ca2+ fluxes of mutagenized mouse type 1 IP3R (IP(3)R1) showed that the residues responsible for IP3 binding suppression in this domain were not essential for channel opening. On the other hand, a single amino acid substitution of Tyr-167 to alanine completely impaired IP3-induced Ca2+ release without reducing the IP3 binding activity. The corresponding residue in type 3 IP3R (IP3R3), Trp-168, was also critical for channel opening. Limited trypsin digestion experiments showed that the trypsin sensitivities of the C-terminal gatekeeper domain differed markedly between the wild-type channel and the Tyr-167 mutant under the optimal conditions for channel opening. These results strongly suggest that the Tyr/Trp residue (Tyr-167 in IP(3)R1 and Trp-168 in IP3R3) is critical for the functional coupling between IP3 binding and channel gating by maintaining the structural integrity of the C-terminal gatekeeper domain at least under activation gating.	[Yamazaki, Haruka; Michikawa, Takayuki; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Yamazaki, Haruka; Michikawa, Takayuki; Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, Calcium Oscillat Project, Kawaguchi, Saitama 3320012, Japan; [Chan, Jenny; Ikura, Mitsuhiko] Univ Toronto, Ontario Canc Inst, Div Signaling Biol, Toronto, ON M5G 1L7, Canada; [Chan, Jenny; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada	RIKEN; Japan Science & Technology Agency (JST); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Michikawa, T (corresponding author), RIKEN, Brain Sci Inst, Dev Neurobiol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	t-michikawa@brain.riken.jp; mikosiba@brain.riken.jp	Mikoshiba, Katsuhiko/N-7943-2015	Ikura, Mitsuhiko/0000-0002-9524-1303	Ministry of Education, Science, Sports, and Culture of Japan [20370054, 20220007]; Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by grants from the Special Postdoctoral Researchers Program in RIKEN (to H. Y.), Ministry of Education, Science, Sports, and Culture of Japan Grants 20370054 (to T. M.) and 20220007 (to K. M.), a Canadian Institutes of Health Research doctoral award (to J. C.), and a grant from the Heart and Stroke Foundation of Ontario (to M. I.).	Akiyama H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000196; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Boehning D, 2000, EMBO J, V19, P5450, DOI 10.1093/emboj/19.20.5450; Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Chan J, 2007, J MOL BIOL, V373, P1269, DOI 10.1016/j.jmb.2007.08.057; Chan J, 2010, J BIOL CHEM, V285, P36092, DOI 10.1074/jbc.M110.140160; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; FERRIS CD, 1989, NATURE, V342, P87, DOI 10.1038/342087a0; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; Fukuda N, 2008, EUR J NEUROSCI, V27, P2665, DOI 10.1111/j.1460-9568.2008.06240.x; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; Furuichi Teiichi, 1994, Current Opinion in Neurobiology, V4, P294, DOI 10.1016/0959-4388(94)90089-2; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Galvan DL, 1999, J BIOL CHEM, V274, P29483, DOI 10.1074/jbc.274.41.29483; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hisatsune C, 2007, J BIOL CHEM, V282, P37225, DOI 10.1074/jbc.M705641200; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Iwai M, 2007, J BIOL CHEM, V282, P12755, DOI 10.1074/jbc.M609833200; JOSEPH SK, 1995, BIOCHEM J, V307, P859, DOI 10.1042/bj3070859; Kaftan EJ, 1997, J GEN PHYSIOL, V110, P529, DOI 10.1085/jgp.110.5.529; Kume S, 1997, SCIENCE, V278, P1940, DOI 10.1126/science.278.5345.1940; MAEDA N, 1990, EMBO J, V9, P61, DOI 10.1002/j.1460-2075.1990.tb08080.x; Mak DOD, 1998, P NATL ACAD SCI USA, V95, P15821, DOI 10.1073/pnas.95.26.15821; Matsu-ura T, 2006, J CELL BIOL, V173, P755, DOI 10.1083/jcb.200512141; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; Michikawa T, 1999, NEURON, V23, P799, DOI 10.1016/S0896-6273(01)80037-4; MICHIKAWA T, 1994, J BIOL CHEM, V269, P9184; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; Miyakawa T, 2001, EMBO J, V20, P1674, DOI 10.1093/emboj/20.7.1674; MIYAWAKI A, 1991, P NATL ACAD SCI USA, V88, P4911, DOI 10.1073/pnas.88.11.4911; MIYAWAKI A, 1990, NEURON, V5, P11, DOI 10.1016/0896-6273(90)90029-F; MIYAZAKI S, 1992, SCIENCE, V257, P251, DOI 10.1126/science.1321497; MONKAWA T, 1995, J BIOL CHEM, V270, P14700, DOI 10.1074/jbc.270.24.14700; Muto A, 1996, J CELL BIOL, V135, P181, DOI 10.1083/jcb.135.1.181; NAKADE S, 1991, BIOCHEM J, V277, P125, DOI 10.1042/bj2770125; Nakayama T, 2004, BIOCHEM J, V377, P299, DOI 10.1042/BJ20030599; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Ramos-Franco J, 1999, J GEN PHYSIOL, V114, P243, DOI 10.1085/jgp.114.2.243; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Shah PK, 2001, PROTEIN ENG, V14, P867, DOI 10.1093/protein/14.11.867; Sienaert I, 1997, J BIOL CHEM, V272, P25899, DOI 10.1074/jbc.272.41.25899; Sienaert I, 1996, J BIOL CHEM, V271, P27005, DOI 10.1074/jbc.271.43.27005; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; SUGIYAMA T, 1994, FEBS LETT, V354, P149, DOI 10.1016/0014-5793(94)01099-4; Tu HP, 2005, BIOPHYS J, V88, p269A; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; WATRAS J, 1991, J NEUROSCI, V11, P3239; Yoneshima H, 1997, BIOCHEM J, V322, P591, DOI 10.1042/bj3220591; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316; Yoshikawa F, 1999, BIOCHEM BIOPH RES CO, V257, P792, DOI 10.1006/bbrc.1999.0498; YOSHIKAWA S, 1992, J BIOL CHEM, V267, P16613	57	47	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36081	36091		10.1074/jbc.M110.140129	http://dx.doi.org/10.1074/jbc.M110.140129			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20813840	Green Published, hybrid			2022-12-25	WOS:000283845300084
J	Ivanov, SS; Charron, G; Hang, HC; Roy, CR				Ivanov, Stanimir S.; Charron, Guillaume; Hang, Howard C.; Roy, Craig R.			Lipidation by the Host Prenyltransferase Machinery Facilitates Membrane Localization of Legionella pneumophila Effector Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; LEGIONNAIRES-DISEASE; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; PHAGOSOME TRAFFICKING; INTRACELLULAR GROWTH; TERMINAL PROTEOLYSIS; FATTY-ACYLATION; HUMAN-MONOCYTES; S-ACYLATION	The intracellular human pathogen Legionella pneumophila translocates multiple proteins in the host cytosol known as effectors, which subvert host cellular processes to create a membrane-bound organelle that supports bacterial replication. It was observed that several Legionella effectors encode a prototypical eukaryotic prenylation CAAX motif (where C represents a cysteine residue and A denotes an aliphatic amino acid). These bacterial motifs mediated posttranslational modification of effector proteins resulting in the addition of either a farnesyl or geranylgeranyl isoprenyl lipid moiety to the cysteine residue of the CAAX tetrapeptide. Lipidation enhanced membrane affinity for most Legionella CAAX motif proteins and facilitated the localization of these effector proteins to host organelles. Host farnesyltransferase and class I geranylgeranyl transferase were both involved in the lipidation of the Legionella CAAX motif proteins. Perturbation of the host prenylation machinery during infection adversely affected there modeling of the Legionella-containing vacuole. Thus, these data indicate that Legionella utilize the host prenylation machinery to facilitate targeting of effector proteins to membrane-bound organelles during intracellular infection.	[Roy, Craig R.] Yale Univ, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, Sch Med, New Haven, CT 06536 USA; [Charron, Guillaume; Hang, Howard C.] Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, New York, NY 10065 USA	Yale University; Rockefeller University	Roy, CR (corresponding author), Yale Univ, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, Sch Med, 295 Congress Ave, New Haven, CT 06536 USA.	craig.roy@yale.edu	Ivanov, Stanimir/J-4289-2019	Ivanov, Stanimir/0000-0002-3294-7595; Roy, Craig/0000-0003-4490-440X	National Institutes of Health [F32-GM084485, R01-AI048770, R01-AI041699, R01-GM087544]; Rockefeller/Sloan-Kettering/Cornell Tri-Institutional Program in Chemical Biology; Irma T. Hirschl/Monique Weill-Caulier Trust; Ellison Medical Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048770, R01AI041699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM084485, R01GM087544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller/Sloan-Kettering/Cornell Tri-Institutional Program in Chemical Biology; Irma T. Hirschl/Monique Weill-Caulier Trust; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant F32-GM084485 (to S. S. I.), R01-AI048770 (to C. R. R.), R01-AI041699 (to C. R. R.), and R01-GM087544 (to G. C.).; Supported by the Rockefeller/Sloan-Kettering/Cornell Tri-Institutional Program in Chemical Biology.; Supported by the Irma T. Hirschl/Monique Weill-Caulier Trust and the Ellison Medical Foundation.	Archer KA, 2006, INFECT IMMUN, V74, P3325, DOI 10.1128/IAI.02049-05; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Cambronne ED, 2007, PLOS PATHOG, V3, P1837, DOI 10.1371/journal.ppat.0030188; Campodonico EM, 2005, MOL MICROBIOL, V56, P918, DOI 10.1111/j.1365-2958.2005.04595.x; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; Dorer MS, 2006, PLOS PATHOG, V2, P315, DOI 10.1371/journal.ppat.0020034; Dowen RH, 2009, J BIOL CHEM, V284, P15867, DOI 10.1074/jbc.M900519200; ENDO A, 1976, FEBS LETT, V72, P323, DOI 10.1016/0014-5793(76)80996-9; Ensminger AW, 2010, INFECT IMMUN, V78, P3905, DOI 10.1128/IAI.00344-10; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; FEELEY JC, 1979, J CLIN MICROBIOL, V10, P437, DOI 10.1128/JCM.10.4.437-441.1979; Franco IS, 2009, CELL MICROBIOL, V11, P1435, DOI 10.1111/j.1462-5822.2009.01351.x; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; HRYCYNA CA, 1991, EMBO J, V10, P1699, DOI 10.1002/j.1460-2075.1991.tb07694.x; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Ivanov SS, 2009, CELL MICROBIOL, V11, P261, DOI 10.1111/j.1462-5822.2008.01251.x; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kho Y, 2004, P NATL ACAD SCI USA, V101, P12479, DOI 10.1073/pnas.0403413101; Kim E, 1999, J BIOL CHEM, V274, P8383, DOI 10.1074/jbc.274.13.8383; Law BK, 2000, J BIOL CHEM, V275, P10796, DOI 10.1074/jbc.275.15.10796; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; MARRA A, 1992, P NATL ACAD SCI USA, V89, P9607, DOI 10.1073/pnas.89.20.9607; Maurer-Stroh S, 2007, PLOS COMPUT BIOL, V3, P634, DOI 10.1371/journal.pcbi.0030066; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; Ninio S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000278; Ragaz C, 2008, CELL MICROBIOL, V10, P2416, DOI 10.1111/j.1462-5822.2008.01219.x; Reinicke AT, 2005, J BIOL CHEM, V280, P14620, DOI 10.1074/jbc.M500076200; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x; SCHAFER WR, 1992, ANNU REV GENET, V26, P209, DOI 10.1146/annurev.ge.26.120192.001233; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Tilney LG, 2001, J CELL SCI, V114, P4637; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Wiater LA, 1998, INFECT IMMUN, V66, P4450; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhang MM, 2010, P NATL ACAD SCI USA, V107, P8627, DOI 10.1073/pnas.0912306107; Zuckman DM, 1999, MOL MICROBIOL, V32, P990, DOI 10.1046/j.1365-2958.1999.01410.x	64	83	83	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34686	34698		10.1074/jbc.M110.170746	http://dx.doi.org/10.1074/jbc.M110.170746			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20813839	hybrid, Green Published			2022-12-25	WOS:000283659100044
J	Orru, R; Pazmino, DET; Fraaije, MW; Mattevi, A				Orru, Roberto; Pazmino, Daniel E. Torres; Fraaije, Marco W.; Mattevi, Andrea			Joint Functions of Protein Residues and NADP(H) in Oxygen Activation by Flavin-containing Monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HALF-REACTION; FMO3; MUTATIONS; MECHANISM; GENE	The reactivity of flavoenzymes with dioxygen is at the heart of a number of biochemical reactions with far reaching implications for cell physiology and pathology. Flavin-containing monooxygenases are an attractive model system to study flavin-mediated oxygenation. In these enzymes, the NADP(H) cofactor is essential for stabilizing the flavin intermediate, which activates dioxygen and makes it ready to react with the substrate undergoing oxygenation. Our studies combine site-directed mutagenesis with the usage of NADP(+) analogues to dissect the specific roles of the cofactors and surrounding protein matrix. The highlight of this "double-engineering" approach is that subtle alterations in the hydrogen bonding and stereochemical environment can drastically alter the efficiency and outcome of the reaction with oxygen. This is illustrated by the seemingly marginal replacement of an Asn to Ser in the oxygen-reacting site, which inactivates the enzyme by effectively converting it into an oxidase. These data rationalize the effect of mutations that cause enzyme deficiency in patients affected by the fish odor syndrome. A crucial role of NADP(+) in the oxygenation reaction is to shield the reacting flavin N5 atom by H-bond interactions. A Tyr residue functions as backdoor that stabilizes this crucial binding conformation of the nicotinamide cofactor. A general concept emerging from this analysis is that the two alternative pathways of flavoprotein-oxygen reactivity (oxidation versus monooxygenation) are predicted to have very similar activation barriers. The necessity of fine tuning the hydrogen-bonding, electrostatics, and accessibility of the flavin will represent a challenge for the design and development of oxidases and monoxygenases for biotechnological applications.	[Pazmino, Daniel E. Torres; Fraaije, Marco W.] Univ Groningen, Biochem Lab, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Orru, Roberto; Mattevi, Andrea] Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy	University of Groningen; University of Pavia	Fraaije, MW (corresponding author), Univ Groningen, Biochem Lab, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	m.w.fraaije@rug.nl; andrea.mattevi@unipv.it	mattevi, andrea/K-5464-2012; Mattevi, Andrea/R-4469-2019; Orru, Roberto/E-9779-2013; Fraaije, Marco/E-8421-2014	mattevi, andrea/0000-0002-9523-7128; Mattevi, Andrea/0000-0002-9523-7128; Fraaije, Marco/0000-0001-6346-5014	Italian Ministry of Science; Fondazione Cariplo; American Chemical Society [46271-C4]; EU	Italian Ministry of Science(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo(Fondazione Cariplo); American Chemical Society(American Chemical Society); EU(European Commission)	This work was supported by the Italian Ministry of Science (PRIN08 program), Fondazione Cariplo, EU-FP7 (Oxygreen), and the American Chemical Society Petroleum Research Fund (46271-C4).	Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; ALWAIZ M, 1987, LANCET, V1, P634; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEATY NB, 1980, J BIOL CHEM, V255, P3817; BEATY NB, 1981, J BIOL CHEM, V256, P4619; BEATY NB, 1981, J BIOL CHEM, V256, P4611; CASHMAN JR, 2006, J ANNU REV PHARM TOX, P65; Choi HS, 2003, BIOCHEM BIOPH RES CO, V306, P930, DOI 10.1016/S0006-291X(03)01087-8; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Dolphin CT, 1997, NAT GENET, V17, P491, DOI 10.1038/ng1297-491; Dolphin CT, 2000, PHARMACOGENETICS, V10, P799, DOI 10.1097/00008571-200012000-00005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Forneris F, 2009, FEBS J, V276, P2833, DOI 10.1111/j.1742-4658.2009.07006.x; Imada Y, 2005, ANGEW CHEM INT EDIT, V44, P1704, DOI 10.1002/anie.200462429; KEMAL C, 1977, J AM CHEM SOC, V99, P7272, DOI 10.1021/ja00464a030; Koukouritaki SB, 2007, J PHARMACOL EXP THER, V320, P266, DOI 10.1124/jpet.106.112268; KRUEGER SK, 2005, PHARMACOL THERAPEUT, V106, P3573; Macheroux Peter, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091/6/26; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; PAI EF, 1983, J BIOL CHEM, V258, P1752; Phillips IR, 2008, TRENDS PHARMACOL SCI, V29, P294, DOI 10.1016/j.tips.2008.03.004; POULSEN LL, 1979, J BIOL CHEM, V254, P6449; Schlaich NL, 2007, TRENDS PLANT SCI, V12, P412, DOI 10.1016/j.tplants.2007.08.009; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Yeung CK, 2007, ARCH BIOCHEM BIOPHYS, V464, P251, DOI 10.1016/j.abb.2007.04.014; Ziegler DM, 2002, DRUG METAB REV, V34, P503, DOI 10.1081/DMR-120005650	28	41	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35021	35028		10.1074/jbc.M110.161372	http://dx.doi.org/10.1074/jbc.M110.161372			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20807767	Green Published, hybrid			2022-12-25	WOS:000283659100076
J	Pointon, JA; Smith, WD; Saalbach, G; Crow, A; Kehoe, MA; Banfield, MJ				Pointon, Jonathan A.; Smith, Wendy D.; Saalbach, Gerhard; Crow, Allister; Kehoe, Michael A.; Banfield, Mark J.			A Highly Unusual Thioester Bond in a Pilus Adhesin Is Required for Efficient Host Cell Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; STREPTOCOCCUS-PYOGENES; ISOPEPTIDE BONDS; STABILIZING ISOPEPTIDE; INTERNAL THIOESTER; STRUCTURAL BASIS; COMPLEMENT; PROTEIN; SURFACE; C3	Many bacterial pathogens present adhesins at the tips of long macromolecular filaments known as pili that are often important virulence determinants. Very little is known about how pili presented by Gram-positive pathogens mediate host cell binding. The crystal structure of a pilus adhesin from the important human pathogen Streptococcus pyogenes reveals an internal thioester bond formed between the side chains of a cysteine and a glutamine residue. The presence of the thioester was verified using UV-visible spectroscopy and mass spectrometry. This unusual bond has only previously been observed in thioester domains of complement and complement-like proteins where it is used to form covalent attachment to target molecules. The structure also reveals two intramolecular isopeptide bonds, one of these formed through a Lys/Asp residue pair, which are strategically positioned to confer protein stability. Removal of the internal thioester by allele-replacement mutagenesis in S. pyogenes severely compromises bacterial adhesion to model host cells. Although current paradigms of bacterial/host cell interaction envisage strong non-covalent interactions, the present study suggests cell adhesion could also involve covalent bonds.	[Pointon, Jonathan A.; Smith, Wendy D.; Kehoe, Michael A.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Saalbach, Gerhard; Crow, Allister; Banfield, Mark J.] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England	Newcastle University - UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Kehoe, MA (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	mike.kehoe@ncl.ac.uk; mark.banfield@bbsrc.ac.uk	Banfield, Mark/C-7453-2013; Crow, Allister/F-2147-2018	Banfield, Mark/0000-0001-8921-3835; Crow, Allister/0000-0001-6856-5962	Royal Society; Medical Research Council (United Kingdom) [G0400849, G0600309]; MRC [G0500367, G0400849] Funding Source: UKRI; Medical Research Council [G0400849, G0500367] Funding Source: researchfish	Royal Society(Royal Society of London); Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work has been funded by the Royal Society (to M.J.B.) and Medical Research Council (United Kingdom) Grant G0400849 (to M.A.K.) and Studentship G0600309 (to J.A.P.).	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P11235, DOI 10.1074/jbc.M110.102962; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Budzik JM, 2009, J BIOL CHEM, V284, P12989, DOI 10.1074/jbc.M900927200; Cherry S, 2006, NAT IMMUNOL, V7, P911, DOI 10.1038/ni1388; CHU CT, 1994, LAB INVEST, V71, P792; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dodds AW, 1996, NATURE, V379, P177, DOI 10.1038/379177a0; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fontaine MC, 2003, INFECT IMMUN, V71, P3857, DOI 10.1128/IAI.71.7.3857-3865.2003; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; KLEYWEGT GJ, 2001, INT TABLES CRYSTALLO, VF; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; Law SKA, 1997, PROTEIN SCI, V6, P263; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Linke C, 2010, J BIOL CHEM, V285, P20381, DOI 10.1074/jbc.M109.089680; Mandlik A, 2008, P NATL ACAD SCI USA, V105, P14147, DOI 10.1073/pnas.0806350105; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PANGBURN MK, 1992, FEBS LETT, V308, P280, DOI 10.1016/0014-5793(92)81293-U; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Quigley BR, 2009, MOL MICROBIOL, V72, P1379, DOI 10.1111/j.1365-2958.2009.06727.x; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; SIM RB, 1981, BIOCHEM J, V193, P129, DOI 10.1042/bj1930129; Smith WD, 2010, J BACTERIOL, V192, P4651, DOI 10.1128/JB.00071-10; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220	51	69	73	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33858	33866		10.1074/jbc.M110.149385	http://dx.doi.org/10.1074/jbc.M110.149385			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729215	Green Published, hybrid			2022-12-25	WOS:000283354000032
J	Chittenden, CM; Jensen, JLA; Ewart, D; Anderson, S; Balfry, S; Downey, E; Eaves, A; Saksida, S; Smith, B; Vincent, S; Welch, D; McKinley, RS				Chittenden, Cedar M.; Jensen, Jenny L. A.; Ewart, David; Anderson, Shannon; Balfry, Shannon; Downey, Elan; Eaves, Alexandra; Saksida, Sonja; Smith, Brian; Vincent, Stephen; Welch, David; McKinley, R. Scott			Recent Salmon Declines: A Result of Lost Feeding Opportunities Due to Bad Timing?	PLOS ONE			English	Article							WILD COHO SALMON; ONCORHYNCHUS-KISUTCH; MARINE SURVIVAL; INTERANNUAL VARIABILITY; ATLANTIC SALMON; CLIMATE-CHANGE; WEST-COAST; HATCHERY; SMOLTS; MIGRATION	As the timing of spring productivity blooms in near-shore areas advances due to warming trends in global climate, the selection pressures on out-migrating salmon smolts are shifting. Species and stocks that leave natal streams earlier may be favoured over later-migrating fish. The low post-release survival of hatchery fish during recent years may be in part due to static release times that do not take the timing of plankton blooms into account. This study examined the effects of release time on the migratory behaviour and survival of wild and hatchery-reared coho salmon (Oncorhynchus kisutch) using acoustic and coded-wire telemetry. Plankton monitoring and near-shore seining were also conducted to determine which habitat and food sources were favoured. Acoustic tags (n = 140) and coded-wire tags (n = 266,692) were implanted into coho salmon smolts at the Seymour and Quinsam Rivers, in British Columbia, Canada. Differences between wild and hatchery fish, and early and late releases were examined during the entire lifecycle. Physiological sampling was also carried out on 30 fish from each release group. The smolt-to-adult survival of coho salmon released during periods of high marine productivity was 1.5- to 3-fold greater than those released both before and after, and the fish's degree of smoltification affected their downstream migration time and duration of stay in the estuary. Therefore, hatchery managers should consider having smolts fully developed and ready for release during the peak of the near-shore plankton blooms. Monitoring chlorophyll a levels and water temperature early in the spring could provide a forecast of the timing of these blooms, giving hatcheries time to adjust their release schedule.	[Chittenden, Cedar M.; Jensen, Jenny L. A.] Univ Tromso, Dept Arct & Marine Biol, Tromso, Norway; [Ewart, David; Anderson, Shannon] Fisheries & Oceans Canada, Campbell River, BC, Canada; [Chittenden, Cedar M.; Balfry, Shannon; McKinley, R. Scott] Univ British Columbia, Ctr Aquaculture & Environm Res, W Vancouver, BC, Canada; [Chittenden, Cedar M.; Balfry, Shannon; McKinley, R. Scott] Fisheries & Oceans Canada, W Vancouver, BC, Canada; [Downey, Elan; Eaves, Alexandra; Saksida, Sonja] British Columbia Ctr Aquat Hlth Sci, Campbell River, BC, Canada; [Smith, Brian; Vincent, Stephen] Seymour Salmonid Soc, N Vancouver, BC, Canada; [Welch, David] Kintama Res Corp, Nanaimo, BC, Canada	UiT The Arctic University of Tromso; Fisheries & Oceans Canada; University of British Columbia; Fisheries & Oceans Canada	Chittenden, CM (corresponding author), Univ Tromso, Dept Arct & Marine Biol, Tromso, Norway.	Cedar.M.Chittenden@uit.no			Census of Marine Life; Gordon and Betty Moore Foundation; Pacific Salmon Foundation; Natural Sciences and Engineering Research Council	Census of Marine Life; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Pacific Salmon Foundation; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this work was provided by Census of Marine Life, the Gordon and Betty Moore Foundation, the Pacific Salmon Foundation and a grant from Natural Sciences and Engineering Research Council to RSM. The Pacific Ocean Shelf Tracking project (POST) acoustic receiver arrays were designed and deployed by Kintama Research Corp. None of the first three organizations were directly involved in the study design, analysis, or writing of the paper, nor the decision to submit the manuscript for publication. This work is a contribution to the Census of Marine Life.	Alvarez D, 2003, J FISH BIOL, V63, P1565, DOI 10.1111/j.1095-8649.2003.00267.x; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Beamish RJ, 2008, T AM FISH SOC, V137, P503, DOI 10.1577/T07-080.1; Beamish RJ, 2000, FISH OCEANOGR, V9, P114; Beamish RJ, 2004, T AM FISH SOC, V133, P26, DOI 10.1577/T03-028; Beamish RJ, 2004, PROG OCEANOGR, V60, P355, DOI 10.1016/j.pocean.2004.02.009; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; Berejikian BA, 1995, CAN J FISH AQUAT SCI, V52, P2476, DOI 10.1139/f95-838; Bilton H. T, 1984, CAN TECH REP FISH AQ, V1306, P1; BOHLIN T, 1993, CAN J FISH AQUAT SCI, V50, P224, DOI 10.1139/f93-025; Carruth LL, 2002, INTEGR COMP BIOL, V42, P574, DOI 10.1093/icb/42.3.574; Chittenden CM, 2008, J FISH BIOL, V72, P614, DOI 10.1111/j.1095-8649.2007.01729.x; Chittenden CM, 2009, T AM FISH SOC, V138, P1220, DOI 10.1577/T09-037.1; Chittenden CM, 2009, ICES J MAR SCI, V66, P2195, DOI 10.1093/icesjms/fsp174; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Daly EA, 2009, T AM FISH SOC, V138, P1420, DOI 10.1577/T08-226.1; DORN MW, 1989, THESIS U WASHINGTON; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; *ENV CAN, 2008, ARCH HYDR DAT; Eslinger DL, 2001, FISH OCEANOGR, V10, P81, DOI 10.1046/j.1054-6006.2001.00036.x; GOEDE RW, 1990, AM FISHERIES SOC S, V8, P93; Hendrick L.J., 1952, COPEIA, V4, P265; HOLTBY LB, 1989, CAN J FISH AQUAT SCI, V46, P1396, DOI 10.1139/f89-179; Houston A.H., 1990, P273; HVIDSTEN NA, 1988, J FISH BIOL, V33, P121, DOI 10.1111/j.1095-8649.1988.tb05453.x; Jepsen N, 2006, FISHERIES MANAG ECOL, V13, P341, DOI 10.1111/j.1365-2400.2006.00509.x; JONSSON B, 1985, CAN J FISH AQUAT SCI, V42, P593, DOI 10.1139/f85-076; Li M, 2000, ESTUAR COAST SHELF S, V50, P467, DOI 10.1006/ecss.2000.0593; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; Nichols T.L., 1990, MANUAL CODED WIRE TA; *NOAA PUBL AFF, 2007, NOAA REP 2006 WARM Y; Quinn TP, 1997, CAN J FISH AQUAT SCI, V54, P1349, DOI 10.1139/f97-038; SHRIMPTON JM, 1994, CAN J FISH AQUAT SCI, V51, P2179, DOI 10.1139/f94-219; Sweeting R. M., 2009, North Pacific Anadromous Fish Commission Bulletin, V5, P255; Tanasichuk RW, 2002, FISH OCEANOGR, V11, P18, DOI 10.1046/j.1365-2419.2002.00185.x	36	34	34	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12423	10.1371/journal.pone.0012423	http://dx.doi.org/10.1371/journal.pone.0012423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805978	Green Published, gold, Green Submitted			2022-12-25	WOS:000281301500006
J	Harewood, L; Liu, M; Keeling, J; Howatson, A; Whiteford, M; Branney, P; Evans, M; Fantes, J; FitzPatrick, DR				Harewood, Louise; Liu, Monica; Keeling, Jean; Howatson, Alan; Whiteford, Margo; Branney, Peter; Evans, Margaret; Fantes, Judy; FitzPatrick, David R.			Bilateral Renal Agenesis/Hypoplasia/Dysplasia (BRAHD): Postmortem Analysis of 45 Cases with Breakpoint Mapping of Two De Novo Translocations	PLOS ONE			English	Article							VACTERL-ASSOCIATION; NERVOUS-SYSTEM; MULLERIAN-DUCT; MICE LACKING; MUTATIONS; AGENESIS; DISEASE; KIDNEY; GENE; RET	Background: Bilateral renal agenesis/hypoplasia/dysplasia (BRAHD) is a relatively common, lethal malformation in humans. Established clinical risk factors include maternal insulin dependent diabetes mellitus and male sex of the fetus. In the majority of cases, no specific etiology can be established, although teratogenic, syndromal and single gene causes can be assigned to some cases. Methodology/Principal Findings: 45 unrelated fetuses, stillbirths or infants with lethal BRAHD were ascertained through a single regional paediatric pathology service (male:female 34:11 or 3.1:1). The previously reported phenotypic overlaps with VACTERL, caudal dysgenesis, hemifacial microsomia and Mullerian defects were confirmed. A new finding is that 16/45 (35.6%; m:f 13:3 or 4.3:1) BRAHD cases had one or more extrarenal malformations indicative of a disoder of laterality determination including; incomplete lobulation of right lung (seven cases), malrotation of the gut (seven cases) and persistence of the left superior vena cava (five cases). One such case with multiple laterality defects and sirelomelia was found to have a de novo apparently balanced reciprocal translocation 46, XY, t(2;6)(p22.3;q12). Translocation breakpoint mapping was performed by interphase fluorescent in-situ hybridization (FISH) using nuclei extracted from archival tissue sections in both this case and an isolated bilateral renal agenesis case associated with a de novo 46, XY, t(1;2)(q41;p25.3). Both t(2; 6) breakpoints mapped to gene-free regions with no strong evidence of cis-regulatory potential. Ten genes localized within 500 kb of the t(1;2) breakpoints. Wholemount in-situ expression analyses of the mouse orthologs of these genes in embryonic mouse kidneys showed strong expression of Esrrg, encoding a nuclear steroid hormone receptor. Immunohistochemical analysis showed that Esrrg was restricted to proximal ductal tissue within the embryonic kidney. Conclusions/Significance: The previously unreported association of BRAHD with laterality defects suggests that renal agenesis may share a common etiology with heterotaxy in some cases. Translocation breakpoint mapping identified ESRRG as a plausible candidate gene for BRAHD.	[Harewood, Louise; Branney, Peter; Fantes, Judy; FitzPatrick, David R.] Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Liu, Monica] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Keeling, Jean; Evans, Margaret] New Royal Infirm, Dept Paediat Pathol, Edinburgh, Midlothian, Scotland; [Howatson, Alan] Royal Hosp Sick Children, Dept Paediat Pathol, Glasgow G3 8SJ, Lanark, Scotland; [Whiteford, Margo] Royal Hosp Sick Children, Dept Clin Genet, Glasgow G3 8SJ, Lanark, Scotland; [FitzPatrick, David R.] Western Gen Hosp, SE Scotland Reg Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Glasgow; University of Glasgow; University of Edinburgh	Harewood, L (corresponding author), Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland.	david.fitzpatrick@hgu.mrc.ac.uk	FitzPatrick, David R/C-7301-2013	Harewood, Louise/0000-0002-6398-6714; FitzPatrick, David R./0000-0003-4861-969X	National Institutes of Health (NIH) [P50 DE16215]; Medical Research Council [MC_U127561093] Funding Source: researchfish; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016215] Funding Source: NIH RePORTER; MRC [MC_U127561093] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded by an intramural program grant in the name of David FitzPatrick and by a grant from the National Institutes of Health (NIH) P50 DE16215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Alazami AM, 2009, AM J HUM GENET, V85, P414, DOI 10.1016/j.ajhg.2009.08.010; Avni FE, 2010, PEDIATR RADIOL, V40, P939, DOI 10.1007/s00247-010-1599-5; BANKIER A, 1985, J MED GENET, V22, P104, DOI 10.1136/jmg.22.2.104; Biason-Lauber A, 2004, NEW ENGL J MED, V351, P792, DOI 10.1056/NEJMoa040533; Bruce JH, 2009, FETAL PEDIATR PATHOL, V28, P109, DOI 10.1080/15513810902772383; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; CARTER CO, 1981, J MED GENET, V18, P158, DOI 10.1136/jmg.18.2.158; CHEN A, 1995, AM J MED GENET, V58, P365, DOI 10.1002/ajmg.1320580413; Chong SS, 1997, HUM MOL GENET, V6, P147, DOI 10.1093/hmg/6.2.147; CORSELLO G, 1992, AM J MED GENET, V44, P813, DOI 10.1002/ajmg.1320440619; Costantini F, 2006, DIFFERENTIATION, V74, P402, DOI 10.1111/j.1432-0436.2006.00106.x; CURRY CJR, 1984, AM J MED GENET, V19, P679, DOI 10.1002/ajmg.1320190408; Davies JA, 2004, HUM MOL GENET, V13, P235, DOI 10.1093/hmg/ddh015; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Fantes JA, 2008, AM J HUM GENET, V82, P916, DOI 10.1016/j.ajhg.2008.02.007; FITCH N, 1977, CAN MED ASSOC J, V116, P381; Gebbia M, 1997, NAT GENET, V17, P305, DOI 10.1038/ng1197-305; Gell JS, 2003, SEMIN REPROD MED, V21, P375; Goldmuntz E, 2002, AM J HUM GENET, V70, P776, DOI 10.1086/339079; Gotoh I, 2007, GENES CELLS, V12, P105, DOI 10.1111/j.1365-2443.2006.01035.x; Guan XY, 1996, NAT GENET, V12, P10, DOI 10.1038/ng0196-10; HACK M, 1974, CLIN GENET, V5, P173; Harewood L, 2010, CLIN DYSMORPHOL, V19, P5, DOI 10.1097/MCD.0b013e328331ddbe; Hiruma T, 2003, J ANAT, V203, P539, DOI 10.1046/j.1469-7580.2003.00245.x; Jacob M, 1999, CELLS TISSUES ORGANS, V164, P63, DOI 10.1159/000016644; Joss S, 2003, CLIN GENET, V63, P239; Kanwar YS, 2005, PEDIATR NEPHROL, V20, P858, DOI 10.1007/s00467-005-1888-7; Katoh M, 2002, INT J MOL MED, V10, P11; KHOURY MJ, 1983, PEDIATRICS, V71, P815; Kibar Z, 2007, NEW ENGL J MED, V356, P1432, DOI 10.1056/NEJMoa060651; Kosaki R, 1999, AM J MED GENET, V82, P70, DOI 10.1002/(SICI)1096-8628(19990101)82:1<70::AID-AJMG14>3.0.CO;2-Y; KOVACS T, 1991, Acta Paediatrica Hungarica, V31, P13; Ludwig KS, 1998, ARCH GYNECOL OBSTET, V262, P27, DOI 10.1007/s004040050225; MCPHERSON E, 1987, AM J MED GENET, V26, P863, DOI 10.1002/ajmg.1320260413; Nielsen GL, 2005, DIABETIC MED, V22, P693, DOI 10.1111/j.1464-5491.2005.01477.x; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Oram SW, 2007, NEOPLASIA, V9, P643, DOI 10.1593/neo.07415; POTTER EL, 1946, J PEDIATR, V29, P68, DOI 10.1016/S0022-3476(46)80241-5; POTTER EL, 1946, AM J OBSTET GYNECOL, V51, P885, DOI 10.1016/S0002-9378(16)39968-9; PRAMANIK AK, 1977, AM J DIS CHILD, V131, P672, DOI 10.1001/archpedi.1977.02120190066013; RITCHEY ML, 1994, UROLOGY, V43, P88, DOI 10.1016/S0090-4295(94)80273-4; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; ROODHOOFT M, 1984, NEW ENGL J MED, V310, P1341, DOI 10.1056/NEJM198405243102101; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Sellick GS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh163; Shaul D B, 1997, Semin Pediatr Surg, V6, P187; Skinner MA, 2008, AM J HUM GENET, V82, P344, DOI 10.1016/j.ajhg.2007.10.008; Slavotinek AM, 2002, J MED GENET, V39, P623, DOI 10.1136/jmg.39.9.623; Tasse C, 2007, CLIN DYSMORPHOL, V16, P1, DOI 10.1097/MCD.0b013e328010d313; Wheeler PG, 2001, AM J MED GENET, V103, P99, DOI 10.1002/ajmg.1510; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178; ZELOP CM, 1993, OBSTET GYNECOL, V81, P412	56	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12375	10.1371/journal.pone.0012375	http://dx.doi.org/10.1371/journal.pone.0012375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811621	Green Submitted, Green Published, gold			2022-12-25	WOS:000281234700011
J	Garcia-Arriaza, J; Najera, JL; Gomez, CE; Sorzano, COS; Esteban, M				Garcia-Arriaza, Juan; Luis Najera, Jose; Gomez, Carmen E.; Sorzano, Carlos Oscar S.; Esteban, Mariano			Immunogenic Profiling in Mice of a HIV/AIDS Vaccine Candidate (MVA-B) Expressing Four HIV-1 Antigens and Potentiation by Specific Gene Deletions	PLOS ONE			English	Article							T-CELL RESPONSES; POXVIRUS VECTORS MVA; VIRUS ANKARA MVA; IMMUNE-RESPONSES; CLADE-C; PRECLINICAL EVALUATION; DNA PRIME; NYVAC; MEMORY; VIREMIA	Background: The immune parameters of HIV/AIDS vaccine candidates that might be relevant in protection against HIV-1 infection are still undefined. The highly attenuated poxvirus strain MVA is one of the most promising vectors to be use as HIV-1 vaccine. We have previously described a recombinant MVA expressing HIV-1 Env, Gag, Pol and Nef antigens from clade B (referred as MVA-B), that induced HIV-1-specific immune responses in different animal models and gene signatures in human dendritic cells (DCs) with immunoregulatory function. Methodology/Principal Findings: In an effort to characterize in more detail the immunogenic profile of MVA-B and to improve its immunogenicity we have generated a new vector lacking two genes (A41L and B16R), known to counteract host immune responses by blocking the action of CC-chemokines and of interleukin 1 beta, respectively (referred as MVA-B Delta A41L/Delta B16R). A DNA prime/MVA boost immunization protocol was used to compare the adaptive and memory HIV-1 specific immune responses induced in mice by the parental MVA-B and by the double deletion mutant MVA-B Delta A41L/Delta B16R. Flow cytometry analysis revealed that both vectors triggered HIV-1-specific CD4(+) and CD8(+) T cells, with the CD8(+) T-cell compartment responsible for >91.9% of the total HIV-1 responses in both immunization groups. However, MVA-B Delta A41L/Delta B16R enhanced the magnitude and polyfunctionality of the HIV-1-specific CD4(+) and CD8(+) T-cell immune responses. HIV-1specific CD4(+) T-cell responses were polyfunctional and preferentially Env-specific in both immunization groups. Significantly, while MVA-B induced preferentially Env-specific CD8(+) T-cell responses, MVA-B Delta A41L/Delta B16R induced more GPN-specific CD8(+) T-cell responses, with an enhanced polyfunctional pattern. Both vectors were capable of producing similar levels of antibodies against Env. Conclusions/Significance: These findings revealed that MVA-B and MVA-B Delta A41L/Delta B16R induced in mice robust, polyfunctional and durable T-cell responses to HIV-1 antigens, but the double deletion mutant showed enhanced magnitude and quality of HIV-1 adaptive and memory responses. Our observations are relevant in the immune evaluation of MVA-B and on improvements of MVA vectors as HIV-1 vaccines.	[Garcia-Arriaza, Juan; Luis Najera, Jose; Gomez, Carmen E.; Esteban, Mariano] CSIC, Dept Mol & Cellular Biol, Ctr Nacl Biotecnol, Madrid, Spain; [Sorzano, Carlos Oscar S.] CSIC, Biocomp Unit, Ctr Nacl Biotecnol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Garcia-Arriaza, J (corresponding author), CSIC, Dept Mol & Cellular Biol, Ctr Nacl Biotecnol, Madrid, Spain.	mesteban@cnb.csic.es	Sorzano, Carlos Oscar S S./F-2639-2016; GARCIA-ARRIAZA, JUAN/Q-6243-2017; Esteban, Mariano/ABG-5375-2020; S. Sorzano, Carlos Oscar/ABE-4884-2021; NAJERA, Jose Luis/W-8177-2019; Gomez, Carmen Elena/K-1940-2014	Sorzano, Carlos Oscar S S./0000-0002-9473-283X; GARCIA-ARRIAZA, JUAN/0000-0002-5167-5724; Esteban, Mariano/0000-0003-0846-2827; S. Sorzano, Carlos Oscar/0000-0002-9473-283X; Gomez, Carmen Elena/0000-0002-5414-7935; Najera, jose Luis/0000-0001-7798-3330	FIPSE (Fundacion para la Investigacion y la Prevencion del Sida en Espana) [36551/06, 360731/09]; Ministry of Science and Innovation [SAF2008-02036]; Foundation Botin of Spain	FIPSE (Fundacion para la Investigacion y la Prevencion del Sida en Espana); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Foundation Botin of Spain	This investigation was supported by grants from FIPSE (Fundacion para la Investigacion y la Prevencion del Sida en Espana)-36551/06 and 360731/09, the Ministry of Science and Innovation (SAF2008-02036) and Foundation Botin of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; Amara RR, 2005, VIROLOGY, V343, P246, DOI 10.1016/j.virol.2005.08.027; Amara RR, 2002, J VIROL, V76, P7625, DOI 10.1128/JVI.76.15.7625-7631.2002; Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Bahar MW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040005; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Clark RH, 2006, J GEN VIROL, V87, P29, DOI 10.1099/vir.0.81417-0; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Esteban M, 2009, HUM VACCINES, V5, P867, DOI 10.4161/hv.9693; FALKNER FG, 1990, J VIROL, V64, P3108, DOI 10.1128/JVI.64.6.3108-3111.1990; FENNER F, 1948, LANCET, V252, P915, DOI 10.1016/S0140-6736(48)91599-2; Flanagan K, 2004, CELL IMMUNOL, V231, P75, DOI 10.1016/j.cellimm.2004.12.006; Genesca Meritxell, 2010, Curr HIV/AIDS Rep, V7, P19, DOI 10.1007/s11904-009-0035-7; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Gomez CE, 2009, VACCINE, V27, P3165, DOI 10.1016/j.vaccine.2009.03.049; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; GUERRA S, 2010, J VIROL; Guerra S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000096; Guo ZH, 2003, BLOOD, V102, P4441, DOI 10.1182/blood-2002-11-3420; Harari A, 2005, J IMMUNOL, V174, P1037, DOI 10.4049/jimmunol.174.2.1037; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Im EJ, 2007, AIDS RES HUM RETROV, V23, P857, DOI 10.1089/aid.2007.0009; Khayyamian S, 2002, P NATL ACAD SCI USA, V99, P6198, DOI 10.1073/pnas.092576699; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; MIYAHIRA Y, 1995, J IMMUNOL METHODS, V181, P45, DOI 10.1016/0022-1759(94)00327-S; Mooij P, 2008, J VIROL, V82, P2975, DOI 10.1128/JVI.02216-07; Mooij P, 2009, J VIROL, V83, P5881, DOI 10.1128/JVI.02345-08; NAJERA JL, PLOS ONE, V5; Najera JL, 2006, J VIROL, V80, P6033, DOI 10.1128/JVI.02108-05; Ng A, 2001, J GEN VIROL, V82, P2095, DOI 10.1099/0022-1317-82-9-2095; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robinson HL, 2007, AIDS RES HUM RETROV, V23, P1555, DOI 10.1089/aid.2007.0165; Rouder JN, 2005, PSYCHON B REV, V12, P573, DOI 10.3758/BF03196750; Ruiz-Arguello MB, 2008, J VIROL, V82, P917, DOI 10.1128/JVI.02111-07; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Soldevila G, 2004, IMMUNOLOGY, V112, P191, DOI 10.1111/j.1365-2567.2004.01863.x; SPRIGGS MK, 1992, CELL, V71, P145, DOI 10.1016/0092-8674(92)90273-F; Staib C, 2005, J GEN VIROL, V86, P1997, DOI 10.1099/vir.0.80646-0; Wang W, 2000, J BIOL CHEM, V275, P22313, DOI 10.1074/jbc.M001461200; Wild J, 2009, VIRAL IMMUNOL, V22, P309, DOI 10.1089/vim.2009.0038; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	57	65	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12395	10.1371/journal.pone.0012395	http://dx.doi.org/10.1371/journal.pone.0012395			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20811493	Green Published, gold			2022-12-25	WOS:000281154300018
J	Vinuela, A; Snoek, LB; Riksen, JAG; Kammenga, JE				Vinuela, Ana; Snoek, L. Basten; Riksen, Joost A. G.; Kammenga, Jan E.			Genome-Wide Gene Expression Analysis in Response to Organophosphorus Pesticide Chlorpyrifos and Diazinon in C. elegans	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; BINARY-MIXTURE; MODEL; MECHANISM; BIOCONDUCTOR; TOXICITY; PATHWAYS	Organophosphorus pesticides (OPs) were originally designed to affect the nervous system by inhibiting the enzyme acetylcholinesterase, an important regulator of the neurotransmitter acetylcholine. Over the past years evidence is mounting that these compounds affect many other processes. Little is known, however, about gene expression responses against OPs in the nematode Caenorhabditis elegans. This is surprising because C. elegans is extensively used as a model species in toxicity studies. To address this question we performed a microarray study in C. elegans which was exposed for 72 hrs to two widely used Ops, chlorpyrifos and diazinon, and a low dose mixture of these two compounds. Our analysis revealed transcriptional responses related to detoxification, stress, innate immunity, and transport and metabolism of lipids in all treatments. We found that for both compounds as well as in the mixture, these processes were regulated by different gene transcripts. Our results illustrate intense, and unexpected crosstalk between gene pathways in response to chlorpyrifos and diazinon in C. elegans.	[Vinuela, Ana; Snoek, L. Basten; Riksen, Joost A. G.; Kammenga, Jan E.] Wageningen Univ, Nematol Lab, Wageningen, Netherlands	Wageningen University & Research	Vinuela, A (corresponding author), Wageningen Univ, Nematol Lab, Wageningen, Netherlands.	jan.kammenga@wur.nl	Viñuela, Ana/L-5015-2019; Snoek, Basten L/E-4713-2014	Viñuela, Ana/0000-0003-3771-8537; Snoek, Basten L/0000-0001-5321-2996	EU; Ecogenomics Consortium of the Netherlands Genomics Initiative	EU(European Commission); Ecogenomics Consortium of the Netherlands Genomics Initiative	This work was supported by the EU FP6 framework programme NoMiracle (http://nomiracle.jrc.ec.europa.eu/default.aspx) and Ecogenomics Consortium of the Netherlands Genomics Initiative (NGI)(http://www.ecogenomics.nl/) to AV and LBS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2005, P NATL ACAD SCI USA, V102, P16275, DOI 10.1073/pnas.0508105102; Boyd WA, 2010, NEUROTOXICOL TERATOL, V32, P68, DOI 10.1016/j.ntt.2008.12.004; Cole RD, 2004, TOXICOL APPL PHARM, V194, P248, DOI 10.1016/j.taap.2003.09.013; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Dong J, 2005, BBA-GENE STRUCT EXPR, V1727, P16, DOI 10.1016/j.bbaexp.2004.11.007; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Duysen EG, 2001, J PHARMACOL EXP THER, V299, P528; Evans EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000175; Ewbank JJ, 2006, SIGNALING IMMUNE RES; Hong FX, 2008, BIOINFORMATICS, V24, P374, DOI 10.1093/bioinformatics/btm620; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Lewis JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-202; Li Qing, 2007, Journal of Nippon Medical School, V74, P92, DOI 10.1272/jnms.74.92; Liang J, 2007, DEV BIOL, V305, P714, DOI 10.1016/j.ydbio.2007.02.038; Martin HL, 2009, ENVIRON TOXICOL CHEM, V28, P97, DOI 10.1897/07-215.1; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Menzel R, 2005, ARCH BIOCHEM BIOPHYS, V438, P93, DOI 10.1016/j.abb.2005.03.020; Moser VC, 2006, TOXICOL SCI, V92, P235, DOI 10.1093/toxsci/kfj189; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Oostingh GJ, 2009, J IMMUNOTOXICOL, V6, P136, DOI 10.1080/15476910902977407; Poet TS, 2004, NEUROTOXICOLOGY, V25, P1013, DOI 10.1016/j.neuro.2004.03.002; Poet TS, 2003, TOXICOL SCI, V72, P193, DOI 10.1093/toxsci/kfg035; Pope C, 2005, ENVIRON TOXICOL PHAR, V19, P433, DOI 10.1016/j.etap.2004.12.048; Pope CN, 1999, J TOXICOL ENV HEAL B, V2, P161, DOI 10.1080/109374099281205; Roh JY, 2008, ECOTOX ENVIRON SAFE, V71, P483, DOI 10.1016/j.ecoenv.2007.11.007; Roh JY, 2006, ENVIRON TOXICOL CHEM, V25, P2946, DOI 10.1897/05-676R.1; Ruan QL, 2009, J TOXICOL ENV HEAL A, V72, P746, DOI 10.1080/15287390902841532; Savage-Dunn C., 2005, TGF BETA SIGNALING; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Slotkin TA, 2008, BRAIN RES BULL, V76, P424, DOI 10.1016/j.brainresbull.2008.01.001; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Svendsen C, 2010, ENVIRON TOXICOL CHEM, V29, P1182, DOI 10.1002/etc.140; Taubert S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000021; TIM H, 2006, J EXPT ZOOLOGY A, V305, P720; Timchalk C, 2008, NEUROTOXICOLOGY, V29, P428, DOI 10.1016/j.neuro.2008.02.004; Timchalk C, 2005, TOXICOL APPL PHARM, V205, P31, DOI 10.1016/j.taap.2004.09.004; Timchalk C, 2002, TOXICOL SCI, V66, P34, DOI 10.1093/toxsci/66.1.34; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Yang YH, 2003, INST MATH S, V40, P403	41	36	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12145	10.1371/journal.pone.0012145	http://dx.doi.org/10.1371/journal.pone.0012145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808445	gold, Green Published, Green Submitted			2022-12-25	WOS:000280968000004
J	Wang, X; Zhao, JP; Tang, SX; Ye, ZP; Hewlett, I				Wang, Xue; Zhao, Jiangqin; Tang, Shixing; Ye, Zhiping; Hewlett, Indira			Viremia Associated with Fatal Outcomes in Ferrets Infected with Avian H5N1 Influenza Virus	PLOS ONE			English	Article							PATHOGENESIS	Avian H5N1 influenza viruses cause severe disease and high mortality in infected humans. However, tissue tropism and underlying pathogenesis of H5N1 virus infection in humans needs further investigation. The objective of this work was to study viremia, tissue tropism and disease pathogenesis of H5N1 virus infection in the susceptible ferret animal model. To evaluate the relationship of morbidity and mortality with virus loads, we performed studies in ferrets infected with the H5N1 strain A/VN/1203/04 to assess clinical signs after infection and virus load in lung, brain, ileum, nasal turbinate, nasal wash, and blood. We observed that H5N1 infection in ferrets is characterized by high virus load in the brain and and low levels in the ileum using real-time PCR. In addition, viral RNA was frequently detected in blood one or two days before death and associated with symptoms of diarrhea. Our observations further substantiate pathogenicity of H5N1 and further indicate that viremia may be a bio-marker for fatal outcomes in H5N1 infection.	[Wang, Xue; Zhao, Jiangqin; Tang, Shixing; Hewlett, Indira] US FDA, Mol Virol Lab, Div Emerging & Transfus Transmitted Dis, Bethesda, MD 20014 USA; [Ye, Zhiping] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Wang, X (corresponding author), US FDA, Mol Virol Lab, Div Emerging & Transfus Transmitted Dis, Bethesda, MD 20014 USA.	xue.wang@fda.hhs.gov; indira.hewlett@fda.hhs.gov		Zhao, Jiangqin/0000-0003-4672-0735				Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Barnard DL, 2009, ANTIVIR RES, V82, pA110, DOI 10.1016/j.antiviral.2008.12.014; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; REED LJ, 1938, AM J HYG, V27; Stanley E D, 1966, Trans Assoc Am Physicians, V79, P376; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Uiprasertkui M, 2007, EMERG INFECT DIS, V13, P708, DOI 10.3201/eid1305.060572; Zhou JJ, 2009, VIRUS GENES, V39, P76, DOI 10.1007/s11262-009-0365-y	16	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12099	10.1371/journal.pone.0012099	http://dx.doi.org/10.1371/journal.pone.0012099			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ZU	20730085	Green Published, Green Submitted, gold			2022-12-25	WOS:000280859700005
J	Olanich, ME; Moss, BL; Piwnica-Worms, D; Townsend, RR; Weber, JD				Olanich, M. E.; Moss, B. L.; Piwnica-Worms, D.; Townsend, R. R.; Weber, J. D.			Identification of FUSE-binding protein 1 as a regulatory mRNA-binding protein that represses nucleophosmin translation	ONCOGENE			English	Article						FBP1; Nucleophosmin; ribosome biogenesis; translation	RIBOSOME BIOGENESIS; STRESS GRANULES; PROCESSING BODIES; MAMMALIAN TARGET; P53 TRANSLATION; NUCLEAR EXPORT; C-MYC; PHOSPHORYLATION; EXPRESSION; RAPAMYCIN	Nucleophosmin (NPM/B23) is a multifunctional oncoprotein whose protein expression levels dictate cellular growth and proliferation rates. NPM is translationally responsive to hyperactive mammalian target of rapamycin (mTOR) signals, but the mechanism of this regulation is not understood. Using chimeric translational reporters, we found that the 30 untranslated region (UTR) of the NPM messenger (m) RNA is sufficient to mediate its translational modulation by mTOR signalling. We show that far upstream element (FUSE)-binding protein 1 (FBP1) interacts specifically with the 30 UTR of NPM to repress translation. Overexpression of FBP1 resulted in translational repression of NPM mRNAs, whereas depletion of FBP1 caused a dramatic increase in NPM translation and resulted in enhanced overall cell proliferation. Thus, we propose that FBP1 is a key regulator of cell growth and proliferation through its ability to selectively bind the NPM 30 UTR and repress NPM translation. Oncogene (2011) 30, 77-86; doi: 10.1038/onc.2010.404; published online 30 August 2010	[Olanich, M. E.; Weber, J. D.] Washington Univ, Sch Med, Div Mol Oncol, Dept Internal Med, St Louis, MO 63110 USA; [Olanich, M. E.; Moss, B. L.; Piwnica-Worms, D.; Weber, J. D.] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO 63110 USA; [Moss, B. L.; Piwnica-Worms, D.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Mol Imaging Ctr, St Louis, MO 63110 USA; [Townsend, R. R.] Washington Univ, Sch Med, Siteman Canc Ctr, Div Metab & Prote Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Weber, JD (corresponding author), Washington Univ, Sch Med, Div Mol Oncol, Dept Internal Med, 660 S Euclid Ave,Campus Box 8069, St Louis, MO 63110 USA.	jweber@dom.wustl.edu		Moss, Britney/0000-0002-1037-5717; Weber, Jason/0000-0002-1069-6983	Washington University Imaging Center; NIH [5T32 GM007067, P30 CA91842, P50 CA94056, CA128007]; National Center for Research Resources [P41RR000954, UL1 RR024992]; Era of Hope Scholar Award in Breast Cancer Research [BC007304]; NATIONAL CANCER INSTITUTE [R01CA127008, P30CA091842, P50CA094056] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992, P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	Washington University Imaging Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Era of Hope Scholar Award in Breast Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Weber, Townsend and Piwnica-Worms laboratories for their advice and technical assistance. The luciferase reporter work was initiated through a Pilot Grant from the Washington University Imaging Center. MEO was supported by NIH 5T32 GM007067. This research was supported with Grants from the National Institutes of Health, P30 CA91842 to the Siteman Comprehensive Cancer Center and P41RR000954 and UL1 RR024992 from the National Center for Research Resources to the Proteomics Center. DPW and BLM were supported by NIH P50 CA94056. This work was supported by NIH Grant CA128007 and an Era of Hope Scholar Award in Breast Cancer Research (BC007304) to JDW.	Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Brady SN, 2009, ONCOGENE, V28, P3209, DOI 10.1038/onc.2009.178; Brady SN, 2004, MOL CELL BIOL, V24, P9327, DOI 10.1128/MCB.24.21.9327-9338.2004; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Briata P, 2003, MOL CELL, V12, P1201, DOI 10.1016/S1097-2765(03)00407-6; Chung HJ, 2006, MOL CELL BIOL, V26, P6584, DOI 10.1128/MCB.00754-06; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Gross S, 2005, NAT METHODS, V2, P607, DOI 10.1038/NMETH779; Hamilton BJ, 2008, J BIOL CHEM, V283, P25606, DOI 10.1074/jbc.M802492200; He LS, 2000, EMBO J, V19, P1034, DOI 10.1093/emboj/19.5.1034; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; Irwin N, 1997, NUCLEIC ACIDS RES, V25, P1281, DOI 10.1093/nar/25.6.1281; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Jiang Y, 2006, MOL CELL BIOL, V26, P2419, DOI 10.1128/MCB.26.6.2419-2429.2006; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; King JB, 2006, ANAL CHEM, V78, P2171, DOI 10.1021/ac051520l; Kroll TT, 2002, DEVELOPMENT, V129, P5609, DOI 10.1242/dev.00160; Li H, 2009, J LIPID RES, V50, P820, DOI 10.1194/jlr.M800375-JLR200; Maggi LB, 2008, MOL CELL BIOL, V28, P7050, DOI 10.1128/MCB.01548-07; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mendez R, 1996, MOL CELL BIOL, V16, P2857; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Okuwaki M, 2002, MOL BIOL CELL, V13, P2016, DOI 10.1091/mbc.02-03-0036; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; Pelletier CL, 2007, CANCER RES, V67, P1609, DOI 10.1158/0008-5472.CAN-06-2875; Pontrelli L, 2004, BIOCHEMISTRY-US, V43, P6734, DOI 10.1021/bi049887s; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Proud CG, 2009, BIOCHEM SOC T, V37, P227, DOI 10.1042/BST0370227; Qi W, 2008, ONCOGENE, V27, P4210, DOI 10.1038/onc.2008.54; Sandsmark DK, 2007, HISTOL HISTOPATHOL, V22, P895, DOI 10.14670/HH-22.895; Sidiropoulos KG, 2007, ARCH BIOCHEM BIOPHYS, V459, P10, DOI 10.1016/j.abb.2006.11.003; Snee M, 2002, J CELL SCI, V115, P4661, DOI 10.1242/jcs.00137; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; TERADA N, 1994, P NATL ACAD SCI USA, V91, P11477, DOI 10.1073/pnas.91.24.11477; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang WH, 2006, RNA, V12, P547, DOI 10.1261/rna.2302706; Yu JH, 2005, RNA, V11, P1795, DOI 10.1261/rna.2142405; Yu Y, 2006, MOL CELL BIOL, V26, P3798, DOI 10.1128/MCB.26.10.3798-3809.2006; Zhang J, 2008, CANCER RES, V68, P1046, DOI 10.1158/0008-5472.CAN-07-1927; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952	57	33	34	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	1					77	86		10.1038/onc.2010.404	http://dx.doi.org/10.1038/onc.2010.404			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	703EQ	20802533	Green Accepted			2022-12-25	WOS:000285959300007
J	Kozlov, G; Bastos-Aristizabal, S; Maattanen, P; Rosenauer, A; Zheng, FL; Killikelly, A; Trempe, JF; Thomas, DY; Gehring, K				Kozlov, Guennadi; Bastos-Aristizabal, Sara; Maeaettaenen, Pekka; Rosenauer, Angelika; Zheng, Fenglin; Killikelly, April; Trempe, Jean-Francois; Thomas, David Y.; Gehring, Kalle			Structural Basis of Cyclophilin B Binding by the Calnexin/Calreticulin P-domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS-ISOMERASE; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; RIBONUCLEASE B; CALRETICULIN; CALNEXIN; PROTEIN; ERP57; ER; REFINEMENT	Little is known about how chaperones in the endoplasmic reticulum are organized into complexes to assist in the proper folding of secreted proteins. One notable exception is the complex of ERp57 and calnexin that functions as part the calnexin cycle to direct disulfide bond formation in N-glycoproteins. Here, we report three new complexes composed of the peptidyl prolyl cis-trans-isomerase cyclophilin B and any of the lectin chaperones: calnexin, calreticulin, or calmegin. The 1.7 angstrom crystal structure of cyclophilin with the proline-rich P-domain of calmegin reveals that binding is mediated by the same surface that binds ERp57. We used NMR titrations and mutagenesis to measure low micromolar binding of cyclophilin to all three lectin chaperones and identify essential interfacial residues. The immunosuppressant cyclosporin A did not affect complex formation, confirming the functional independence of the P-domain binding and proline isomerization sites of cyclophilin. Our results reveal the P-domain functions as a unique protein-protein interaction domain and implicate a peptidyl prolyl isomerase as a new element in the calnexin cycle.	McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University	Gehring, K (corresponding author), 3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019; Thomas, David/M-7661-2017	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184; Thomas, David/0000-0002-8854-762X	Canadian Institutes of Heath Research [81277, 74567]; National Science Foundation [DMR 0225180]; National Institutes of Health [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	Canadian Institutes of Heath Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Grants 81277 and 74567 from the Canadian Institutes of Heath Research (to D. Y. T. and K. G.).; Data acquisition at the Macromolecular Diffraction (MacCHESS) facility at the CHESS was supported by the National Science Foundation Award DMR 0225180 and the National Institutes of Health Award RR-01646. We thank Ali Fazel for liver microsomes and Daniel Tessier for anti-calreticulin serum.	ARBER S, 1992, J CELL BIOL, V116, P113, DOI 10.1083/jcb.116.1.113; Balbach J., 2000, MECH PROTEIN FOLDING, P212; Braakman I, 2008, SCIENCE, V321, P499, DOI 10.1126/science.1162125; Christis C, 2008, FEBS J, V275, P4700, DOI 10.1111/j.1742-4658.2008.06590.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ellgaard L, 2002, J MOL BIOL, V322, P773, DOI 10.1016/S0022-2836(02)00812-4; Ellgaard L, 2001, CURR OPIN CELL BIOL, V13, P431, DOI 10.1016/S0955-0674(00)00233-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Hanoulle X, 2007, J BIOL CHEM, V282, P34148, DOI 10.1074/jbc.M706353200; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P3813, DOI 10.1021/bi00468a001; HASEL KW, 1991, MOL CELL BIOL, V11, P3484, DOI 10.1128/MCB.11.7.3484; ISHIKAWA Y, 2009, J BIOL CHEM, V6, P6; Kay JE, 1996, BIOCHEM J, V314, P361, DOI 10.1042/bj3140361; Kim J, 2008, J CELL SCI, V121, P3636, DOI 10.1242/jcs.028654; Kozlov G, 2006, STRUCTURE, V14, P1331, DOI 10.1016/j.str.2006.06.019; Lavoie C, 1996, J CELL SCI, V109, P1415; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; LODISH HF, 1991, J BIOL CHEM, V266, P14835; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; MIKOL V, 1994, P NATL ACAD SCI USA, V91, P5183, DOI 10.1073/pnas.91.11.5183; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pollock S, 2004, EMBO J, V23, P1020, DOI 10.1038/sj.emboj.7600119; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zapun A, 1997, CELL, V88, P29, DOI 10.1016/S0092-8674(00)81855-3; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; Zhang LY, 2003, J BIOL CHEM, V278, P29344, DOI 10.1074/jbc.M300455200; Zhang Y, 2009, J BIOL CHEM, V284, P10160, DOI 10.1074/jbc.M808356200	35	72	78	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35551	35557		10.1074/jbc.M110.160101	http://dx.doi.org/10.1074/jbc.M110.160101			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20801878	Green Published, hybrid			2022-12-25	WOS:000283845300033
J	Tsuchiya, Y; Hatakeyama, H; Emoto, N; Wagatsuma, F; Matsushita, S; Kanzaki, M				Tsuchiya, Yo; Hatakeyama, Hiroyasu; Emoto, Natsumi; Wagatsuma, Fumie; Matsushita, Shinichi; Kanzaki, Makoto			Palmitate-induced Down-regulation of Sortilin and Impaired GLUT4 Trafficking in C2C12 Myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; SKELETAL-MUSCLE CELLS; PROTEIN-KINASE-C; ALPHA-CONVERTING-ENZYME; KAPPA-B ACTIVATION; FREE FATTY-ACIDS; TNF-ALPHA; PKC-THETA; GLUT4-CONTAINING VESICLES; 3T3-L1 ADIPOCYTES	Elevated saturated FFAs including palmitate (C16:0) are a primary trigger for peripheral insulin resistance characterized by impaired glucose uptake/disposal in skeletal muscle, resulting from impaired GLUT4 translocation in response to insulin. We herein demonstrate that palmitate induces down-regulation of sortilin, a sorting receptor implicated in the formation of insulin-responsive GLUT4 vesicles, via mechanisms involving PKC theta and TNF-alpha-converting enzyme, but not p38, JNK, or mitochondrial reactive oxygen species generation, leading to impaired GLUT4 trafficking in C2C12 myotubes. Intriguingly, unsaturated FFAs such as palmitoleate (C16:1) and oleate (C18:1) had no such detrimental effects, appearing instead to effectively reverse palmitate-induced impairment of insulin-responsive GLUT4 recycling along with restoration of sortilin abundance by preventing aberrant PKC theta activation. On the other hand, shRNA-mediated reduction of sortilin in intact C2C12 myotubes inhibited insulin-induced GLUT4 recycling without dampening Akt phosphorylation. We found that the peroxisome proliferator-activated receptor gamma agonist troglitazone prevented the palmitate-induced sortilin reduction and also ameliorated insulin-responsive GLUT4 recycling without altering the palmitate-evoked insults on signaling cascades; neither highly phosphorylated PKC theta states nor impaired insulin-responsive Akt phosphorylation was affected. Taken together, our data provide novel insights into the pathogenesis of PKC theta-dependent insulin resistance with respect to insulin-responsive GLUT4 translocation, which could occur not only through defects of insulin signaling but also via a reduction of sortilin, which directly controls trafficking/sorting of GLUT4 in skeletal muscle cells. In addition, our data suggest the insulin-sensitizing action of peroxisome proliferator-activated receptor gamma agonists to be at least partially mediated through the restoration of proper GLUT4 trafficking/sorting events governed by sortilin.	[Kanzaki, Makoto] Tohoku Univ, Grad Sch Biomed Engn, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kanzaki, Makoto] Japan Sci & Technol Agcy, Tokyo 1020075, Japan	Tohoku University; Japan Science & Technology Agency (JST)	Kanzaki, M (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	kanzaki@bme.tohoku.ac.jp	Kanzaki, Makoto/H-6680-2017	Kanzaki, Makoto/0000-0002-6884-2955	Ministry of Education, Science, Sports and Culture of Japan; New Energy and Industrial Technology Development Organization; Japan Society for the Promotion of Science for Young Scientists	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants from the Ministry of Education, Science, Sports and Culture of Japan and the New Energy and Industrial Technology Development Organization.; Supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists.	Alkhateeb H, 2007, AM J PHYSIOL-ENDOC M, V293, pE783, DOI 10.1152/ajpendo.00685.2006; Ariga M, 2008, J BIOL CHEM, V283, P10208, DOI 10.1074/jbc.M710604200; Boden Guenther, 2006, Curr Diab Rep, V6, P177, DOI 10.1007/s11892-006-0031-x; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Dimopoulos N, 2006, BIOCHEM J, V399, P473, DOI 10.1042/BJ20060244; Federici M, 2005, J CLIN INVEST, V115, P3494, DOI 10.1172/JCI26052; Felber JP, 2002, INT J OBESITY, V26, pS39, DOI 10.1038/sj.ijo.0802126; Fiorentino L, 2010, HEPATOLOGY, V51, P103, DOI 10.1002/hep.23250; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Fujita H, 2010, MOL BIOL CELL, V21, P2721, DOI 10.1091/mbc.E10-01-0029; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Granja AG, 2008, J IMMUNOL, V180, P2429, DOI 10.4049/jimmunol.180.4.2429; Griffin ME, 1999, DIABETES, V48, pA276; Haasch D, 2006, BIOCHEM BIOPH RES CO, V343, P361, DOI 10.1016/j.bbrc.2006.02.177; Hermey G, 2006, BIOCHEM J, V395, P285, DOI 10.1042/BJ20051364; Hirabara SM, 2007, J CELL PHYSIOL, V210, P7, DOI 10.1002/jcp.20811; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Hostamisligil GS, 1999, EXP CLIN ENDOCR DIAB, V107, P119, DOI 10.1055/s-0029-1212086; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Hoy AJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE67, DOI 10.1152/ajpendo.90945.2008; Ishaq M, 2003, J BIOL CHEM, V278, P39296, DOI 10.1074/jbc.M302767200; Jove M, 2006, ENDOCRINOLOGY, V147, P552, DOI 10.1210/en.2005-0440; Jove M, 2005, ENDOCRINOLOGY, V146, P3087, DOI 10.1210/en.2004-1560; Kaddai V, 2009, DIABETOLOGIA, V52, P932, DOI 10.1007/s00125-009-1273-3; Kadotani A, 2009, AM J PHYSIOL-ENDOC M, V297, pE1291, DOI 10.1152/ajpendo.00293.2009; Karlsson HKR, 2005, DIABETES, V54, P1459, DOI 10.2337/diabetes.54.5.1459; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kim YB, 2002, DIABETES, V51, P443, DOI 10.2337/diabetes.51.2.443; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Konrad D, 2005, DIABETOLOGIA, V48, P954, DOI 10.1007/s00125-005-1713-7; Lambe KG, 1996, EUR J BIOCHEM, V239, P1, DOI 10.1111/j.1432-1033.1996.0001u.x; Lessard SJ, 2007, DIABETES, V56, P1856, DOI 10.2337/db06-1065; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Manicassamy S, 2006, CELL MOL IMMUNOL, V3, P263; Meyer MM, 2002, DIABETES, V51, P2691, DOI 10.2337/diabetes.51.9.2691; Miyazaki Y, 2003, DIABETES, V52, P1943, DOI 10.2337/diabetes.52.8.1943; Monroy A, 2009, DIABETOLOGIA, V52, P2169, DOI 10.1007/s00125-009-1451-3; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Navarro V, 2002, BIOCHEM BIOPH RES CO, V298, P760, DOI 10.1016/S0006-291X(02)02564-0; Nedachi T, 2006, AM J PHYSIOL-ENDOC M, V291, pE817, DOI 10.1152/ajpendo.00194.2006; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Peterson JM, 2008, AM J PHYSIOL-ENDOC M, V295, pE1307, DOI 10.1152/ajpendo.00738.2007; Pimenta AS, 2008, J CELL PHYSIOL, V217, P478, DOI 10.1002/jcp.21520; Preininger K, 1999, BRIT J PHARMACOL, V126, P372, DOI 10.1038/sj.bjp.0702318; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; SchmitzPeiffer C, 1997, DIABETES, V46, P169, DOI 10.2337/diabetes.46.2.169; Serino M, 2007, DIABETES, V56, P2541, DOI 10.2337/db07-0360; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Shi J, 2008, J BIOL CHEM, V283, P30311, DOI 10.1074/jbc.M805182200; Shi J, 2007, J BIOL CHEM, V282, P9008, DOI 10.1074/jbc.M608971200; SHIBUKAWA A, 1995, J CHROMATOGR A, V697, P337, DOI 10.1016/0021-9673(94)00929-4; Storgaard H, 2004, J CLIN ENDOCR METAB, V89, P1301, DOI 10.1210/jc.2003-031243; Sugii S, 2006, J BIOL CHEM, V281, P23191, DOI 10.1074/jbc.M603215200; Tolosa L, 2005, CELL SIGNAL, V17, P1333, DOI 10.1016/j.cellsig.2005.02.001; Wang CH, 2009, J BIOL CHEM, V284, P2038, DOI 10.1074/jbc.M806336200; Watson P, 2006, J CELL SCI, V119, P2758, DOI 10.1242/jcs.02999; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	66	54	57	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34371	34381		10.1074/jbc.M110.128520	http://dx.doi.org/10.1074/jbc.M110.128520			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20805226	Green Published, hybrid			2022-12-25	WOS:000283659100011
J	Ingemarsdotter, CK; Baird, SK; Connell, CM; Oberg, D; Hallden, G; McNeish, IA				Ingemarsdotter, C. K.; Baird, S. K.; Connell, C. M.; Oeberg, D.; Hallden, G.; McNeish, I. A.			Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer	ONCOGENE			English	Article						oncolytic adenovirus; paclitaxel; mitosis; apoptosis; microtubule	CELL-CYCLE PROGRESSION; E4ORF4 PROTEIN; GROWTH ARREST; MICROTUBULE; INFECTION; MITOSIS; DEATH; BIOLUMINESCENCE; INSTABILITY; CHECKPOINTS	The microtubule-stabilizing drug paclitaxel has activity in relapsed ovarian cancer. dl922-947, an oncolytic adenovirus with a 24-bp deletion in E1A CR2, replicates selectively within and lyses cells with a dysregulated Rb pathway and has efficacy in ovarian cancer. In the aggressive A2780CP xenograft, combination treatment with weekly dl922-947 and paclitaxel has significantly greater efficacy than either treatment alone and can produce complete tumor eradication in some animals. We investigated the mechanisms of paclitaxel's synergy with dl922-947 in ovarian cancer. The host-cell microtubule network is grossly rearranged and stabilized following adenovirus infection, but paclitaxel does not increase this significantly. Paclitaxel does not synergize by increasing infectivity, viral protein expression or virus release. However, destabilizing the microtubule network with nocodazole reduces viral exit, revealing a novel microtubule-dependent pathway for non-lytic adenoviral exit. dl922-947 can override multiple cell cycle checkpoints but induces cell death by a non-apoptotic mechanism. In combination, dl922-947 and low-dose paclitaxel induces aberrant, multipolar mitoses, mitotic slippage and multinucleation, triggering an apoptotic cell death. Oncogene (2010) 29, 6051-6063; doi:10.1038/onc.2010.335; published online 23 August 2010	[McNeish, I. A.] Queen Mary Univ London, Barts & London Sch Med, John Vane Sci Ctr, Ctr Mol Oncol & Imaging,Inst Canc, London EC1M 6BQ, England	University of London; Queen Mary University London	McNeish, IA (corresponding author), Queen Mary Univ London, Barts & London Sch Med, John Vane Sci Ctr, Ctr Mol Oncol & Imaging,Inst Canc, Charterhouse Sq, London EC1M 6BQ, England.	i.a.mcneish@qmul.ac.uk		McNeish, Iain/0000-0002-9387-7586	Medical Research Council [G0601891] Funding Source: Medline; MRC [G0601891] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Baird SK, 2008, ONCOGENE, V27, P3081, DOI 10.1038/sj.onc.1210977; BELIN MT, 1987, J VIROL, V61, P2559, DOI 10.1128/JVI.61.8.2559-2566.1987; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Chen JG, 2002, CANCER RES, V62, P1935; Cheong SC, 2008, CANCER GENE THER, V15, P40, DOI 10.1038/sj.cgt.7701099; Cherubini G, 2006, CELL CYCLE, V5, P2244, DOI 10.4161/cc.5.19.3263; Connell CM, 2008, CANCER RES, V68, P7923, DOI 10.1158/0008-5472.CAN-08-0817; De Luca A, 2003, CANCER RES, V63, P1430; Decordier I, 2008, MUTAT RES-GEN TOX EN, V651, P30, DOI 10.1016/j.mrgentox.2007.10.016; Demidenko ZN, 2008, ONCOGENE, V27, P4402, DOI 10.1038/onc.2008.82; Felsani A, 2006, ONCOGENE, V25, P5277, DOI 10.1038/sj.onc.1209621; Flak MB, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-175; Gartner M, 2005, CHEMBIOCHEM, V6, P1173, DOI 10.1002/cbic.200500005; Giannakakou P, 1998, INT J CANCER, V75, P57, DOI 10.1002/(SICI)1097-0215(19980105)75:1<57::AID-IJC10>3.3.CO;2-V; Hassan MAIA, 2006, CANCER GENE THER, V13, P1105, DOI 10.1038/sj.cgt.7700984; Hecht JR, 2003, CLIN CANCER RES, V9, P555; Heise C, 2000, NAT MED, V6, P1134, DOI 10.1038/80474; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Katsumata N, 2009, LANCET, V374, P1331, DOI 10.1016/S0140-6736(09)61157-0; Kornitzer D, 2001, J CELL BIOL, V154, P331, DOI 10.1083/jcb.200104104; Le LP, 2004, MOL IMAGING, V3, P105, DOI 10.1162/1535350041464874; Le T, 2006, GYNECOL ONCOL, V102, P49, DOI 10.1016/j.ygyno.2005.11.025; Leopold PL, 2007, ADV DRUG DELIVER REV, V59, P810, DOI 10.1016/j.addr.2007.06.007; Leyton J, 2006, CANCER RES, V66, P9178, DOI 10.1158/0008-5472.CAN-06-1539; Li S, 2009, ONCOGENE, V28, P390, DOI 10.1038/onc.2008.393; Lockley M, 2006, CANCER RES, V66, P989, DOI 10.1158/0008-5472.CAN-05-2691; Markman M, 2002, J CLIN ONCOL, V20, P2365, DOI 10.1200/JCO.2002.09.130; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Meulenbroek RA, 2004, MOL THER, V9, P617, DOI 10.1016/j.ymthe.2004.01.012; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; MURRAY JD, 1982, J CELL PHYSIOL, V111, P89, DOI 10.1002/jcp.1041110114; Paoletti A, 1997, J CELL SCI, V110, P2403; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Reed JC, 2006, NAT CLIN PRACT ONCOL, V3, P388, DOI 10.1038/ncponc0538; Seidman MA, 2001, MOL THER, V4, P13, DOI 10.1006/mthe.2001.0414; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shtrichman R, 1999, P NATL ACAD SCI USA, V96, P10080, DOI 10.1073/pnas.96.18.10080; STAUFENBIEL M, 1986, J VIROL, V60, P1186, DOI 10.1128/JVI.60.3.1186-1191.1986; Tollefson AE, 1996, J VIROL, V70, P2296, DOI 10.1128/JVI.70.4.2296-2306.1996; Warren JC, 2006, MOL BIOL CELL, V17, P3557, DOI 10.1091/mbc.E05-09-0850; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; WHITE E, 1989, P NATL ACAD SCI USA, V86, P9886, DOI 10.1073/pnas.86.24.9886; Ying BL, 2003, VIROLOGY, V313, P224, DOI 10.1016/S0042-6822(03)00287-3	45	43	46	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	45					6051	6063		10.1038/onc.2010.335	http://dx.doi.org/10.1038/onc.2010.335			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	678VA	20729921	Green Published, hybrid			2022-12-25	WOS:000284108700007
J	Ogawa, H; Shionyu, M; Sugiura, N; Hatano, S; Nagai, N; Kubota, Y; Nishiwaki, K; Sato, T; Gotoh, M; Narimatsu, H; Shimizu, K; Kimata, K; Watanabe, H				Ogawa, Hiroyasu; Shionyu, Masafumi; Sugiura, Nobuo; Hatano, Sonoko; Nagai, Naoko; Kubota, Yukihiko; Nishiwaki, Kiyoji; Sato, Takashi; Gotoh, Masanori; Narimatsu, Hisashi; Shimizu, Katsuji; Kimata, Koji; Watanabe, Hideto			Chondroitin Sulfate Synthase-2/Chondroitin Polymerizing Factor Has Two Variants with Distinct Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN FOLD RECOGNITION; MOLECULAR-CLONING; HEPARAN-SULFATE; CHAIN-LENGTH; ARTICULAR-CARTILAGE; PROTEOGLYCANS; GLUCURONOSYLTRANSFERASE; EXPRESSION; BINDING; SYNTHASE-3	Chondroitin sulfate (CS) is a polysaccharide consisting of repeating disaccharide units of N-acetyl-D-galactosamine and D-glucuronic acid residues, modified with sulfated residues at various positions. To date six glycosyltransferases for chondroitin synthesis have been identified, and the complex of chondroitin sulfate synthase-1 (CSS1)/chondroitin synthase-1 (ChSy-1) and chondroitin sulfate synthase-2 (CSS2)/chondroitin polymerizing factor is assumed to play a major role in CS biosynthesis. We found an alternative splice variant of mouse CSS2 in a data base that lacks the N-terminal transmembrane domain, contrasting to the original CSS2. Here, we investigated the roles of CSS2 variants. Both the original enzyme and the splice variant, designated CSS2A and CSS2B, respectively, were expressed at different levels and ratios in tissues. Western blot analysis of cultured mouse embryonic fibroblasts confirmed that both enzymes were actually synthesized as proteins and were localized in both the endoplasmic reticulum and the Golgi apparatus. Pulldown assays revealed that either of CSS2A, CSS2B, and CSS1/ChSy-1 heterogeneously and homogeneously interacts with each other, suggesting that they form a complex of multimers. In vitro glycosyltransferase assays demonstrated a reduced glucuronyltransferase activity in CSS2B and no polymerizing activity in CSS2B co-expressed with CSS1, in contrast to CSS2A co-expressed with CSS1. Radiolabeling analysis of cultured COS-7 cells overexpressing each variant revealed that, whereas CSS2A facilitated CS biosynthesis, CSS2B inhibited it. Molecular modeling of CSS2A and CSS2B provided support for their properties. These findings, implicating regulation of CS chain polymerization by CSS2 variants, provide insight in elucidating the mechanisms of CS biosynthesis.	[Kimata, Koji] Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan; [Shionyu, Masafumi] Nagahama Inst Biosci & Technol, Fac Biosci, Dept Biosci, Nagahama 5260829, Japan; [Kubota, Yukihiko; Nishiwaki, Kiyoji] Kwansei Gakuin Univ, Sch Sci & Technol, Sanda 6691337, Japan; [Sato, Takashi; Gotoh, Masanori; Narimatsu, Hisashi] Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058568, Japan; [Ogawa, Hiroyasu; Shimizu, Katsuji] Gifu Univ, Dept Orthopaed Surg, Grad Sch Med, Gifu 5011194, Japan	Aichi Medical University; Kwansei Gakuin University; National Institute of Advanced Industrial Science & Technology (AIST); Gifu University	Watanabe, H (corresponding author), Karimata 21, Nagakute, Aichi 4801195, Japan.	wannabee@aichi-med-u.ac.jp	Sato, Takashi/M-2577-2018; Narimatsu, Hisashi/M-4757-2018	Sato, Takashi/0000-0002-9973-8923; Narimatsu, Hisashi/0000-0002-8402-133X; Kubota, Yukihiko/0000-0002-8151-9888; Shionyu, Masafumi/0000-0002-0431-3456; Ogawa, Hiroyasu/0000-0002-4737-6481; Watanabe, Hideto/0000-0001-5291-0696	Japan Society for the Promotion of Science [18370061]; New Energy and Industrial Technology Development Organization	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by a grant-in-aid for Scientific Research B (to H. W., and M. S.), by Japan Society for the Promotion of Science KAKENHI Grant 18370061, and by the New Energy and Industrial Technology Development Organization.	Bao XF, 2005, J BIOL CHEM, V280, P35318, DOI 10.1074/jbc.M507304200; BOLLET AJ, 1966, J CLIN INVEST, V45, P1170, DOI 10.1172/JCI105423; Brown MP, 2007, OSTEOARTHR CARTILAGE, V15, P1318, DOI 10.1016/j.joca.2007.04.005; Deepa SS, 2004, J BIOL CHEM, V279, P37368, DOI 10.1074/jbc.M403031200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Gotoh M, 2002, J BIOL CHEM, V277, P38179, DOI 10.1074/jbc.M202601200; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Jinek M, 2006, NAT STRUCT MOL BIOL, V13, P945, DOI 10.1038/nsmb1144; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Maeda N, 2006, J BIOL CHEM, V281, P4894, DOI 10.1074/jbc.M507750200; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MITCHELL D, 1982, BIOCHEM J, V202, P387, DOI 10.1042/bj2020387; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Oohira A, 2000, ARCH BIOCHEM BIOPHYS, V374, P24, DOI 10.1006/abbi.1999.1598; PAULSON JC, 1989, J BIOL CHEM, V264, P10931; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Prydz K, 2000, J CELL SCI, V113, P193; ROUGHLEY PJ, 1980, J BIOL CHEM, V255, P217; Sasai K, 2001, J BIOL CHEM, V276, P759, DOI 10.1074/jbc.M004972200; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugiura N, 2010, J BIOL CHEM, V285, P1597, DOI 10.1074/jbc.M109.023002; Suzuki N, 2006, DEV BIOL, V300, P635, DOI 10.1016/j.ydbio.2006.08.037; Tomii K, 2004, BIOINFORMATICS, V20, P594, DOI 10.1093/bioinformatics/btg474; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Yada T, 2003, J BIOL CHEM, V278, P39711, DOI 10.1074/jbc.M304421200; Yada T, 2003, J BIOL CHEM, V278, P30235, DOI 10.1074/jbc.M303657200	37	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34155	34167		10.1074/jbc.M110.109553	http://dx.doi.org/10.1074/jbc.M110.109553			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729547	Green Published, hybrid			2022-12-25	WOS:000283354000061
J	Buxton, ILO; Singer, CA; Tichenor, JN				Buxton, Iain L. O.; Singer, Cherie A.; Tichenor, Jennifer N.			Expression of Stretch-Activated Two-Pore Potassium Channels in Human Myometrium in Pregnancy and Labor	PLOS ONE			English	Article							DOMAIN K+-CHANNELS; PRETERM BIRTH; FUNCTIONAL-PROPERTIES; ARACHIDONIC-ACID; SPLICE VARIANTS; PROTEIN-KINASE; NITRIC-OXIDE; CYCLIC-GMP; TREK-1; PROGESTERONE	Background: We tested the hypothesis that the stretch-activated, four-transmembrane domain, two pore potassium channels (K2P), TREK-1 and TRAAK are gestationally-regulated in human myometrium and contribute to uterine relaxation during pregnancy until labor. Methodology: We determined the gene and protein expression of K2P channels in non-pregnant, pregnant term and preterm laboring myometrium. We employed both molecular biological and functional studies of K2P channels in myometrial samples taken from women undergoing cesarean delivery of a fetus. Principal Findings: TREK-1, but not TREK-2, channels are expressed in human myometrium and significantly up-regulated during pregnancy. Down-regulation of TREK-1 message was seen by Q-PCR in laboring tissues consistent with a role for TREK-1 in maintaining uterine quiescence prior to labor. The TRAAK channel was unregulated in the same women. Blockade of stretch-activated channels with a channel non-specific tarantula toxin (GsMTx-4) or the more specific TREK-1 antagonist L-methionine ethyl ester altered contractile frequency in a dose-dependent manner in pregnant myometrium. Arachidonic acid treatment lowered contractile tension an effect blocked by fluphenazine. Functional studies are consistent with a role for TREK-1 in uterine quiescence. Conclusions: We provide evidence supporting a role for TREK-1 in contributing to uterine quiescence during gestation and hypothesize that dysregulation of this mechanism may underlie certain cases of spontaneous pre-term birth.	[Buxton, Iain L. O.] Univ Nevada, Sch Med, Dept Pharmacol, Reno, NV 89557 USA; Univ Nevada, Sch Med, Dept Obstet & Gynecol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno	Buxton, ILO (corresponding author), Univ Nevada, Sch Med, Dept Pharmacol, Reno, NV 89557 USA.	ibuxton@medicine.nevada.edu			National Institutes of Health Child Health and Human Development [HD053028]; March of Dimes National Prematurity Initiative [21-FY06-576]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053028] Funding Source: NIH RePORTER	National Institutes of Health Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); March of Dimes National Prematurity Initiative(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health Child Health and Human Development grant HD053028 and March of Dimes National Prematurity Initiative Grant 21-FY06-576 to Dr. Buxton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Practice Bulletins--Obstetrics, 2003, Int J Gynaecol Obstet, V82, P127; Bai XL, 2005, REPRODUCTION, V129, P525, DOI 10.1530/rep.1.00442; Baker SA, 2008, BRIT J PHARMACOL, V153, P1259, DOI 10.1038/sj.bjp.0707690; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Behrman R.E, 2006, PRETERM BIRTH CAUSES; Benkusky NA, 2000, J BIOL CHEM, V275, P27712; Bowman CL, 2007, TOXICON, V49, P249, DOI 10.1016/j.toxicon.2006.09.030; Brainard AM, 2007, SEMIN CELL DEV BIOL, V18, P332, DOI 10.1016/j.semcdb.2007.05.008; Brainard AM, 2005, AM J PHYSIOL-CELL PH, V289, pC49, DOI 10.1152/ajpcell.00399.2004; Briery CM, 2009, SOUTH MED J, V102, P900, DOI 10.1097/SMJ.0b013e3181afee12; Buxton I L, 2000, AACN Clin Issues, V11, P271, DOI 10.1097/00044067-200005000-00010; Buxton ILO, 2001, BRIT J PHARMACOL, V134, P206, DOI 10.1038/sj.bjp.0704226; Cheng Longxian, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P31; Curley M, 2002, MOL HUM REPROD, V8, P941, DOI 10.1093/molehr/8.10.941; Curley Michael, 2004, Reprod Biol Endocrinol, V2, P67, DOI 10.1186/1477-7827-2-67; Dodd JM, 2008, OBSTET GYNECOL, V112, P127, DOI 10.1097/AOG.0b013e31817d0262; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gu WL, 2002, J PHYSIOL-LONDON, V539, P657, DOI 10.1113/jphysiol.2001.013432; Han J, 2003, AM J PHYSIOL-CELL PH, V285, pC529, DOI 10.1152/ajpcell.00601.2002; Helliwell RJA, 2006, J CLIN ENDOCR METAB, V91, P597, DOI 10.1210/jc.2005-1982; Higby K, 1999, DRUG SAFETY, V21, P35, DOI 10.2165/00002018-199921010-00004; Hogue CJR, 2005, AM J OBSTET GYNECOL, V192, pS47, DOI 10.1016/j.ajog.2005.01.073; Hu KL, 2003, NEURON, V38, P417, DOI 10.1016/S0896-6273(03)00256-3; HWANG SJ, 2008, JPHYSIOL; Jindal HK, 2008, AM J PHYSIOL-HEART C, V294, pH2012, DOI 10.1152/ajpheart.01374.2007; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; Kim D, 2003, TRENDS PHARMACOL SCI, V24, P648, DOI 10.1016/j.tips.2003.10.008; Koh SD, 2001, J BIOL CHEM, V276, P44338, DOI 10.1074/jbc.M108125200; Kuenzli KA, 1996, BRIT J PHARMACOL, V119, P737, DOI 10.1111/j.1476-5381.1996.tb15734.x; Li ZB, 2005, BIOCHEM BIOPH RES CO, V327, P1163, DOI 10.1016/j.bbrc.2004.12.124; Liu W, 2004, CLIN EXP PHARMACOL P, V31, P174, DOI 10.1111/j.1440-1681.2004.03964.x; MACDORMAN MF, 2008, RECENT TRENDS INFANT, P1; Mazzone J, 2003, P W PHARMACOL SOC, V46, P74; Mazzone JN, 2002, P W PHARMACOL SOC, V45, P184; Meadows HJ, 2000, PFLUG ARCH EUR J PHY, V439, P714, DOI 10.1007/s004240050997; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; Park KJ, 2005, BRIT J PHARMACOL, V144, P1126, DOI 10.1038/sj.bjp.0706154; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Patel AJ, 2001, ANESTHESIOLOGY, V95, P1013, DOI 10.1097/00000542-200110000-00034; Rittenberg C, 2009, J REPROD MED, V54, P47; Sakura H, 1999, J PHYSIOL-LONDON, V521, P337, DOI 10.1111/j.1469-7793.1999.00337.x; Sanders KM, 2006, J PHYSIOL-LONDON, V570, P37, DOI 10.1113/jphysiol.2005.098897; Smith V, 2009, EUR J OBSTET GYN R B, V142, P3, DOI 10.1016/j.ejogrb.2008.09.008; Steele DF, 2007, BIOCHEM SOC T, V35, P1069, DOI 10.1042/BST0351069; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Tan JHC, 2004, EXP PHYSIOL, V89, P237, DOI 10.1113/expphysiol.2003.027052; Thummler S, 2007, BIOCHEM BIOPH RES CO, V354, P284, DOI 10.1016/j.bbrc.2006.12.199; Tichenor JN, 2005, P W PHARMACOL SOC, V48, P44; *WHO, 2001, WHO REP; XIAN TL, 2006, CARDIOVASC RES, V69, P86, DOI DOI 10.1016/J.CARDIORES.2005.08.018	53	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12372	10.1371/journal.pone.0012372	http://dx.doi.org/10.1371/journal.pone.0012372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811500	Green Published, Green Submitted, gold			2022-12-25	WOS:000281234700009
J	Prasov, L; Brown, NL; Glaser, T				Prasov, Lev; Brown, Nadean L.; Glaser, Tom			A Critical Analysis of Atoh7 (Math5) mRNA Splicing in the Developing Mouse Retina	PLOS ONE			English	Article							PROGENITOR-CELL COMPETENCE; POLYMERASE CHAIN-REACTION; GANGLION-CELL; REVERSE-TRANSCRIPTASE; INTRONLESS GENES; PCR; SITE; AMPLIFICATION; EXPRESSION; ANTIBODIES	The Math5 (Atoh7) gene is transiently expressed during retinogenesis by progenitors exiting mitosis, and is essential for ganglion cell (RGC) development. Math5 contains a single exon, and its 1.7 kb mRNA encodes a 149-aa polypeptide. Mouse Math5 mutants have essentially no RGCs or optic nerves. Given the importance of this gene in retinal development, we thoroughly investigated the possibility of Math5 mRNA splicing by Northern blot, 3'RACE, RNase protection assays, and RT-PCR, using RNAs extracted from embryonic eyes and adult cerebellum, or transcribed in vitro from cDNA clones. Because Math5 mRNA contains an elevated G+C content, we used graded concentrations of betaine, an isostabilizing agent that disrupts secondary structure. Although similar to 10% of cerebellar Math5 RNAs are spliced, truncating the polypeptide, our results show few, if any, spliced Math5 transcripts exist in the developing retina (<1%). Rare deleted cDNAs do arise via RT-mediated RNA template switching in vitro, and are selectively amplified during PCR. These data differ starkly from a recent study (Kanadia and Cepko 2010), which concluded that the vast majority of Math5 and other bHLH transcripts are spliced to generate noncoding RNAs. Our findings clarify the architecture of the Math5 gene and its mechanism of action. These results have implications for all members of the bHLH gene family, for any gene that is alternatively spliced, and for the interpretation of all RT-PCR experiments.	[Prasov, Lev; Glaser, Tom] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Prasov, Lev; Glaser, Tom] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Brown, Nadean L.] Univ Cincinnati, Sch Med, Div Dev Biol, Dept Pediat & Ophthalmol,Cincinnati Childrens Res, Cincinnati, OH USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Prasov, L (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.	tglaser@umich.edu	Prasov, Lev/AAX-1642-2020; , Nadean/HCH-9314-2022	Prasov, Lev/0000-0002-6635-1116; 	National Institutes of Health (NIH) [EY14259, EY13612, GM07863, EY13934]; Glaucoma Foundation; NATIONAL EYE INSTITUTE [R01EY013612, T32EY013934, R01EY014259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glaucoma Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was funded by National Institutes of Health (NIH) R01 grants to TG (EY14259) and NLB (EY13612) and The Glaucoma Foundation (TG). LP was supported by NIH T32 grants to the University of Michigan Medical Scientist (GM07863) and Vision Research (EY13934) Training Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO S, 1986, J MOL EVOL, V23, P11, DOI 10.1007/BF02100994; ALTSHULER DM, 1991, P RET RES F, V3, P37; BAIM SB, 1985, MOL CELL BIOL, V5, P1839, DOI 10.1128/MCB.5.8.1839; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; BERGET SM, 1977, COLD SPRING HARB SYM, V42, P523; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; BERK AJ, 1977, CELL, V12, P721, DOI 10.1016/0092-8674(77)90272-0; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Blackburn DC, 2008, DEV DYNAM, V237, P2209, DOI 10.1002/dvdy.21634; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Brincat JL, 2002, J VIROL, V76, P88, DOI 10.1128/JVI.76.1.88-95.2002; Brown NL, 2002, MAMM GENOME, V13, P95, DOI 10.1007/s00335-001-2101-3; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brown NL, 2001, DEVELOPMENT, V128, P2497; Brzezinski JA, 2005, INVEST OPHTH VIS SCI, V46, P2540, DOI 10.1167/iovs.04-1123; Brzezinski JA, 2003, DEV BIOL, V259, P553; BRZEZINSKI JA, 2004, INVEST OPHTH VIS SCI, V45, P3422; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; Cho EA, 1998, MECH DEVELOP, V77, P9; Chooniedass-Kothari S, 2004, FEBS LETT, V566, P43, DOI 10.1016/j.febslet.2004.03.104; Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013; DERJAGUIN BV, 1973, NATURE, V244, P430, DOI 10.1038/244430a0; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Eisenstein M, 2005, NAT METHODS, V2, P396, DOI 10.1038/nmeth0505-396; ENGELBRECHT J, 1992, J MOL BIOL, V227, P108, DOI 10.1016/0022-2836(92)90685-D; Fedorov A, 2001, NUCLEIC ACIDS RES, V29, P1464, DOI 10.1093/nar/29.7.1464; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fox-Walsh KL, 2005, P NATL ACAD SCI USA, V102, P16176, DOI 10.1073/pnas.0508489102; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; Gentles AJ, 1999, TRENDS GENET, V15, P47, DOI 10.1016/S0168-9525(98)01648-5; GRAY NK, 1994, MOL BIOL REP, V19, P195, DOI 10.1007/BF00986961; Harlow E., 1988, ANTIBODIES LAB MANUA; Harrington ED, 2004, NAT GENET, V36, P916, DOI 10.1038/ng0904-916; Henke W, 1997, NUCLEIC ACIDS RES, V25, P3957, DOI 10.1093/nar/25.19.3957; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HUFNAGEL RB, 2010, DEV BIOL; Irimia M, 2008, TRENDS GENET, V24, P378, DOI 10.1016/j.tig.2008.05.007; Jaillon O, 2008, NATURE, V451, P359, DOI 10.1038/nature06495; JAMESON BA, 1988, COMPUT APPL BIOSCI, V4, P181; Jeffares DC, 2008, TRENDS GENET, V24, P375, DOI 10.1016/j.tig.2008.05.006; Kanadia RN, 2010, GENE DEV, V24, P229, DOI 10.1101/gad.1847110; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Kenneson A, 2001, HUM MOL GENET, V10, P1449, DOI 10.1093/hmg/10.14.1449; Kitabayashi M, 2003, BIOSCI BIOTECH BIOCH, V67, P2474, DOI 10.1271/bbb.67.2474; Leygue E, 1996, AM J PATHOL, V148, P1097; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; Mader RM, 2001, J LAB CLIN MED, V137, P422, DOI 10.1067/mlc.2001.115452; Maquat LE, 2001, RNA, V7, P445, DOI 10.1017/S1355838201002229; Margulies EH, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e60; Mastick GS, 2001, MOL CELL NEUROSCI, V17, P190, DOI 10.1006/mcne.2000.0924; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McCullough AJ, 2000, MOL CELL BIOL, V20, P9225, DOI 10.1128/MCB.20.24.9225-9235.2000; MELCHIOR WB, 1973, P NATL ACAD SCI USA, V70, P298, DOI 10.1073/pnas.70.2.298; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mitrovich QM, 2000, GENE DEV, V14, P2173, DOI 10.1101/gad.819900; Mu XQ, 2005, DEV BIOL, V280, P467, DOI 10.1016/j.ydbio.2005.01.028; Mytelka DS, 1996, NUCLEIC ACIDS RES, V24, P2774, DOI 10.1093/nar/24.14.2774; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Pfeiffer JK, 2001, J VIROL, V75, P11263, DOI 10.1128/JVI.75.23.11263-11274.2001; REES WA, 1993, BIOCHEMISTRY-US, V32, P137, DOI 10.1021/bi00052a019; Rhodes KJ, 2006, J NEUROSCI, V26, P8017, DOI 10.1523/JNEUROSCI.2728-06.2006; Roy SW, 2008, BIOESSAYS, V30, P601, DOI 10.1002/bies.20749; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Sakharkar MK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-67; Saper CB, 2003, J COMP NEUROL, V465, P161, DOI 10.1002/cne.10858; Saul SM, 2008, MOL CELL NEUROSCI, V37, P153, DOI 10.1016/j.mcn.2007.09.006; Schonbrunner NJ, 2006, BIOCHEMISTRY-US, V45, P12786, DOI 10.1021/bi0609117; Stolting KN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-565; Tabaska JE, 1999, GENE, V231, P77, DOI 10.1016/S0378-1119(99)00104-3; Telesnitsky A., 1997, P121; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Wallace VA, 1999, DEVELOPMENT, V126, P2901; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Weissensteiner T, 1996, BIOTECHNIQUES, V21, P1102; Wong LL, 2009, DEVELOPMENT, V136, P1707, DOI 10.1242/dev.027607; WU WM, 1995, J BIOL CHEM, V270, P325, DOI 10.1074/jbc.270.1.263; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; Zaphiropoulos PG, 2002, FEBS LETT, V527, P326, DOI 10.1016/S0014-5793(02)03239-8; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	87	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12315	10.1371/journal.pone.0012315	http://dx.doi.org/10.1371/journal.pone.0012315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808762	Green Published, Green Submitted, gold			2022-12-25	WOS:000281154300001
J	Thors, L; Bergh, A; Persson, E; Hammarsten, P; Stattin, P; Egevad, L; Granfors, T; Fowler, CJ				Thors, Lina; Bergh, Anders; Persson, Emma; Hammarsten, Peter; Stattin, Par; Egevad, Lars; Granfors, Torvald; Fowler, Christopher J.			Fatty Acid Amide Hydrolase in Prostate Cancer: Association with Disease Severity and Outcome, CB1 Receptor Expression and Regulation by IL-4	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CENTRAL-NERVOUS-SYSTEM; CANNABINOID RECEPTORS; TUMOR-GROWTH; TRANSCRIPTIONAL REGULATION; ANANDAMIDE HYDROLASE; CELL-PROLIFERATION; PANCREATIC-CANCER; INDUCED APOPTOSIS; T-LYMPHOCYTES	Background: Recent data have indicated that there may be a dysregulation of endocannabinoid metabolism in cancer. Here we have investigated the expression of the endocannabinoid metabolising enzyme fatty acid amide hydrolase (FAAH) in a well characterised tissue microarray from patients diagnosed with prostate cancer at transurethral resection for voiding problems. Methodology/Principal Findings: FAAH immunoreactivity (FAAH-IR) was assessed in formalin-fixed paraffin-embedded non-malignant and tumour cores from 412 patients with prostate cancer. CB1 receptor immunoreactivity (CB1IR) scores were available for this dataset. FAAH-IR was seen in epithelial cells and blood vessel walls but not in the stroma. Tumour epithelial FAAH-IR was positively correlated with the disease severity at diagnosis (Gleason score, tumour stage, % of the specimen that contained tumour) for cases with mid-range CB1IR scores, but not for those with high CB1IR scores. For the 281 cases who only received palliative therapy at the end stages of the disease, a high tumour epithelial FAAH-IR was associated with a poor disease-specific survival. Multivariate Cox proportional-hazards regression analyses indicated that FAAH-IR gave additional prognostic information to that provided by CB1IR when a midrange, but not a high CB1IR cutoff value was used. Interleukin-4 (IL-4) receptor IR was found on tumour epithelial cells and incubation of prostate cancer PC-3 and R3327 AT1 cells with IL-4 increased their FAAH activity. Conclusions/Significance: Tumour epithelial FAAH-IR is associated with prostate cancer severity and outcome at mid-range, but not high, CB1IR scores. The correlation with CB1IR in the tumour tissue may be related to a common local dysregulation by a component of the tumour microenvironment.	[Thors, Lina; Fowler, Christopher J.] Umea Univ, Pharmacol Unit, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Bergh, Anders; Hammarsten, Peter] Umea Univ, Pathol Unit, Dept Med Biosci, Umea, Sweden; [Persson, Emma] Umea Univ, Dept Oncol, Umea, Sweden; [Persson, Emma] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Stattin, Par] Umea Univ, Urol & Androl Unit, Dept Surg & Perioperat Sci, Umea, Sweden; [Egevad, Lars] Karolinska Univ Hosp, Dept Pathol & Cytol, Stockholm, Sweden; [Granfors, Torvald] Cent Hosp Vasteras, Dept Urol, Vasteras, Sweden	Umea University; Umea University; Umea University; Umea University; Umea University; Karolinska Institutet; Karolinska University Hospital; Vasteras Central Hospital	Thors, L (corresponding author), Umea Univ, Pharmacol Unit, Dept Pharmacol & Clin Neurosci, Umea, Sweden.	cf@pharm.umu.se	Fowler, Christopher J./M-6313-2019	Fowler, Christopher J./0000-0002-6658-7874; Thors, Lina/0000-0002-4948-6676; Egevad, Lars/0000-0001-8531-222X	Swedish Science Council [12158]; Swedish Cancer Society [CAN 2007/712]; Umea University/Cancer Research Fund Norrland; Medical Faculty, Umea University; NIH [DA11322]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011322] Funding Source: NIH RePORTER	Swedish Science Council; Swedish Cancer Society(Swedish Cancer Society); Umea University/Cancer Research Fund Norrland; Medical Faculty, Umea University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank the Swedish Science Council (Grant no. 12158, medicine, C.J. Fowler); the Swedish Cancer Society (Grant no. CAN 2007/712, Anders Bergh); the Lions Cancer Research Fund at Umea University/Cancer Research Fund Norrland and the Research Funds of the Medical Faculty, Umea University (C.J. Fowler) for financial support. The funding source for the antibody (to Dr. Mackie) was grant NIH DA11322. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Bifulco M, 2004, FASEB J, V18, P1606, DOI 10.1096/fj.04-1754fje; Borner C, 2008, MOL PHARMACOL, V73, P1013, DOI 10.1124/mol.107.042945; Borner C, 2007, J LEUKOCYTE BIOL, V81, P336, DOI 10.1189/jlb.0306224; Boldrup L, 2004, J BIOCHEM BIOPH METH, V60, P171, DOI 10.1016/j.jbbm.2004.04.020; Chung LWK, 2005, J UROLOGY, V173, P10, DOI 10.1097/01.ju.0000141582.15218.10; Chung SC, 2009, EUR J CANCER, V45, P174, DOI 10.1016/j.ejca.2008.10.010; Conticello C, 2004, J IMMUNOL, V172, P5467, DOI 10.4049/jimmunol.172.9.5467; COX DR, 1972, J R STAT SOC B, V34, P187; Cudaback E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008702; Czifra G, 2009, J CANCER RES CLIN, V135, P507, DOI 10.1007/s00432-008-0482-3; Egertova M, 1998, P ROY SOC B-BIOL SCI, V265, P2081, DOI 10.1098/rspb.1998.0543; Egevad L, 2002, BJU INT, V89, P538, DOI 10.1046/j.1464-410X.2002.02669.x; Endsley MP, 2008, INT J CANCER, V123, P1318, DOI 10.1002/ijc.23674; Endsley MP, 2007, INT J CANCER, V121, P984, DOI 10.1002/ijc.22761; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Fowler CJ, 2008, PHARMACOL RES, V58, P72, DOI 10.1016/j.phrs.2008.07.002; Fowler CJ, 2010, CURR TOP MED CHEM, V10, P814; Freimuth N, 2010, J PHARMACOL EXP THER, V332, P336, DOI 10.1124/jpet.109.157735; Galve-Roperh I, 2000, NAT MED, V6, P313, DOI 10.1038/73171; Gifford AN, 1999, J PHARMACOL EXP THER, V288, P478; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Goparaju SK, 1998, FEBS LETT, V422, P69, DOI 10.1016/S0014-5793(97)01603-7; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Harkany T, 2003, EUR J NEUROSCI, V18, P1979, DOI 10.1046/j.1460-9568.2003.02898.x; HARRINGTON CR, 1990, ANAL BIOCHEM, V186, P285, DOI 10.1016/0003-2697(90)90081-J; Hart S, 2004, CANCER RES, V64, P1943, DOI 10.1158/0008-5472.CAN-03-3720; HOEHE MR, 1991, NEW BIOL, V3, P880; Husain SR, 2003, MOL CANCER THER, V2, P245; Jhaveri MD, 2006, J NEUROSCI, V26, P13318, DOI 10.1523/JNEUROSCI.3326-06.2006; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Lee SO, 2008, PROSTATE, V68, P85, DOI 10.1002/pros.20691; Li ZG, 2008, CANCER RES, V68, P8687, DOI 10.1158/0008-5472.CAN-08-0449; Ligresti A, 2003, GASTROENTEROLOGY, V125, P677, DOI 10.1016/S0016-5085(03)00881-3; Lorente M, 2009, GLIA, V57, P1374, DOI 10.1002/glia.20856; Maccarrone M, 2001, J IMMUNOL, V166, P7183, DOI 10.4049/jimmunol.166.12.7183; Maccarrone M, 2000, J BIOL CHEM, V275, P31938, DOI 10.1074/jbc.M005722200; Maccarrone M, 2003, J BIOL CHEM, V278, P13318, DOI 10.1074/jbc.M211248200; McPartland JM, 2007, GENE, V397, P126, DOI 10.1016/j.gene.2007.04.017; Melck D, 2000, ENDOCRINOLOGY, V141, P118, DOI 10.1210/en.141.1.118; Michalski CW, 2008, INT J CANCER, V122, P742, DOI 10.1002/ijc.23114; Mimeault M, 2006, CARCINOGENESIS, V27, P1, DOI 10.1093/carcin/bgi229; Mimeault M, 2003, PROSTATE, V56, P1, DOI 10.1002/pros.10190; Nithipatikom K, 2004, CANCER RES, V64, P8826, DOI 10.1158/0008-5472.CAN-04-3136; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; OKADA H, 1992, VIRCHOWS ARCH A, V421, P157, DOI 10.1007/BF01607049; Olea-Herrero N, 2009, BRIT J CANCER, V101, P940, DOI 10.1038/sj.bjc.6605248; Olver S, 2007, TISSUE ANTIGENS, V69, P293, DOI 10.1111/j.1399-0039.2007.00831.x; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Pisanti S, 2009, PHARMACOL RES, V60, P107, DOI 10.1016/j.phrs.2009.03.011; Prokopchuk O, 2005, BRIT J CANCER, V92, P921, DOI 10.1038/sj.bjc.6602416; Rossi G, 2007, ENDOCRINOLOGY, V148, P1431, DOI 10.1210/en.2006-0969; Ruiz L, 1999, FEBS LETT, V458, P400, DOI 10.1016/S0014-5793(99)01073-X; SANCHEZ L, 2005, COMPREHENSIVE MOL IN, V1, P1; Sarfaraz S, 2005, CANCER RES, V65, P1635, DOI 10.1158/0008-5472.CAN-04-3410; Sarfaraz S, 2006, J BIOL CHEM, V281, P39480, DOI 10.1074/jbc.M603495200; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Tsou K, 1998, NEUROSCI LETT, V254, P137, DOI 10.1016/S0304-3940(98)00700-9; Waleh NS, 2002, GENE, V291, P203, DOI 10.1016/S0378-1119(02)00598-X; Wan MH, 1998, GENOMICS, V54, P408, DOI 10.1006/geno.1998.5597; Wang DZ, 2008, CANCER RES, V68, P6468, DOI 10.1158/0008-5472.CAN-08-0896; Wikstrom P, 2009, PROSTATE, V69, P799, DOI 10.1002/pros.20927; Wise GJ, 2000, J UROLOGY, V164, P722, DOI 10.1016/S0022-5347(05)67289-8; Xu XD, 2006, CANCER GENET CYTOGEN, V171, P31, DOI 10.1016/j.cancergencyto.2006.06.014; ZWEIG MH, 1993, CLIN CHEM, V39, P561	65	56	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12275	10.1371/journal.pone.0012275	http://dx.doi.org/10.1371/journal.pone.0012275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808855	Green Published, gold, Green Submitted			2022-12-25	WOS:000281075500010
J	Ryckman, KK; Fielding, K; Hill, AV; Mendy, M; Rayco-Solon, P; Sirugo, G; van der Sande, MA; Waight, P; Whittle, HC; Hall, AJ; Williams, SM; Hennig, BJ				Ryckman, Kelli K.; Fielding, Katherine; Hill, Adrian V.; Mendy, Maimuna; Rayco-Solon, Pura; Sirugo, Giorgio; van der Sande, Marianne A.; Waight, Pauline; Whittle, Hilton C.; Hall, Andrew J.; Williams, Scott M.; Hennig, Branwen J.			Host Genetic Factors and Vaccine-Induced Immunity to HBV Infection: Haplotype Analysis	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; DISEASE SUSCEPTIBILITY; SURFACE-ANTIGEN; IMMUNOGENETICS; RESPONSES; TWINS	Hepatitis B virus (HBV) infection remains a significant health burden world-wide, although vaccines help decrease this problem. We previously identified associations of single nucleotide polymorphisms in several candidate genes with vaccine-induced peak antibody level (anti-HBs), which is predictive of long-term vaccine efficacy and protection against infection and persistent carriage; here we report on a haplotype-based analysis. A total of 688 SNPs from 117 genes were examined for a two, three and four sliding window haplotype analysis in a Gambian cohort. Analysis was performed on 197 unrelated individuals, 454 individuals from 174 families, and the combined sample (N = 651). Global and individual haplotype association tests were carried out (adjusted for covariates), employing peak anti-HBs level as outcome. Five genes (CD44, CD58, CDC42, IL19 and IL1R1) had at least one significant haplotype in the unrelated or family analysis as well as the combined analysis. Previous single locus results were confirmed for CD44 (combined global p = 9.1 x 10(-5) for rs353644-rs353630-rs7937602) and CD58 (combined global p = 0.008 for rs1414275-rs11588376-rs1016140). Haplotypes in CDC42, IL19 and IL1R1 also associated with peak anti-HBs level. We have identified strong haplotype effects on HBV vaccine-induced antibody level in five genes, three of which, CDC42, IL19 and IL1R1, did not show evidence of association in a single SNP analyses and corroborated the majority of these effects in two datasets. The haplotype analysis identified associations with HBV vaccine-induced immunity in several new genes.	[Ryckman, Kelli K.; Williams, Scott M.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37203 USA; [Ryckman, Kelli K.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Rayco-Solon, Pura; Hennig, Branwen J.] London Sch Hyg & Trop Med, Med Res Council Int Nutr Grp, London WC1, England; [Hill, Adrian V.] Univ Oxford, Welcome Trust Ctr Human Genet, Oxford, England; [Hill, Adrian V.] Univ Oxford, Jenner Inst, Oxford, England; [Mendy, Maimuna; van der Sande, Marianne A.; Waight, Pauline; Whittle, Hilton C.] MRC Labs, Banjul, Gambia; [Rayco-Solon, Pura; Hennig, Branwen J.] MRC, Keneba, Gambia; [van der Sande, Marianne A.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Sirugo, Giorgio] Osped S Pietro FBF, Unita Genet Med, Rome, Italy	Vanderbilt University; University of Iowa; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Jenner Institute; MRC Laboratory Molecular Biology; University of London; London School of Hygiene & Tropical Medicine; Netherlands National Institute for Public Health & the Environment	Ryckman, KK (corresponding author), Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37203 USA.	smwilliams@chgr.mc.vanderbilt.edu	Sirugo, Giorgio/L-1628-2016; Williams, Scott/Q-4812-2019; Mendy, Maimuna/ABD-5038-2021; Hennig, Branwen/M-6444-2014; Sirugo, Giorgio/N-9056-2019; Williams, Scott/B-9491-2012	Williams, Scott/0000-0002-4835-9544; Fielding, Katherine/0000-0002-6524-3754; Ryckman, Kelli/0000-0002-9496-4147; Hennig, Branwen J./0000-0003-4127-8386; van der Sande, Marianne AB/0000-0002-4778-6739	Wellcome Trust [GR069267AIA]; MRC [MC_U123292699, MC_U123292700, MC_U190071516] Funding Source: UKRI; Medical Research Council [MC_U190071516, MC_U123292700, MC_U123292699] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by a Wellcome Trust Advanced Fellowship grant to BJH (grant number GR069267AIA, http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPER CA, 1995, EXP CLIN IMMUNOGENET, V12, P171; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brazzoli M, 2008, J VIROL, V82, P8316, DOI 10.1128/JVI.00665-08; Clark AG, 2004, GENET EPIDEMIOL, V27, P321, DOI 10.1002/gepi.20025; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; Davila S, 2010, GENES IMMUN, V11, P232, DOI 10.1038/gene.2010.1; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hennig BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001898; Hodge JW, 2005, J IMMUNOL, V174, P5994, DOI 10.4049/jimmunol.174.10.5994; Hohler T, 2002, J HEPATOL, V37, P387, DOI 10.1016/S0168-8278(02)00205-2; Kimman TG, 2007, COMMUNITY GENET, V10, P201, DOI 10.1159/000106559; Kimura K, 2009, J GASTROENTEROL, V44, P218, DOI 10.1007/s00535-008-2300-8; Kruger A, 2005, CLIN EXP IMMUNOL, V140, P325, DOI 10.1111/j.1365-2249.2005.02765.x; LIN TM, 1989, ANTICANCER RES, V9, P737; Milich DR, 2003, AUTOIMMUN REV, V2, P248, DOI 10.1016/S1568-9972(03)00031-4; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Newport MJ, 2004, GENES IMMUN, V5, P122, DOI 10.1038/sj.gene.6364051; Sirugo G, 2008, HUM GENET, V123, P557, DOI 10.1007/s00439-008-0511-y; Stanley SL, 2007, J INFECT DIS, V196, P212, DOI 10.1086/518794; Tan TL, 2008, BBA-MOL CELL RES, V1783, P360, DOI 10.1016/j.bbamcr.2007.10.024; Thursz M, 2001, QJM-MON J ASSOC PHYS, V94, P287, DOI 10.1093/qjmed/94.6.287; van der Sande MAB, 2006, J INFECT DIS, V193, P1528, DOI 10.1086/503433; Van LH, 2001, ENV HLTH PERSPECT, V109, P757; Wang CB, 2004, HEPATOLOGY, V39, P978, DOI 10.1002/hep.20142; Zuckerman JN, 2006, J MED VIROL, V78, P169, DOI 10.1002/jmv.20524; 2009, HEPATITIS B FACT SHE	29	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12273	10.1371/journal.pone.0012273	http://dx.doi.org/10.1371/journal.pone.0012273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20806065	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000281011600031
J	Voigt, A; Herholz, D; Fiesel, FC; Kaur, K; Muller, D; Karsten, P; Weber, SS; Kahle, PJ; Marquardt, T; Schulz, JB				Voigt, Aaron; Herholz, David; Fiesel, Fabienne C.; Kaur, Kavita; Mueller, Daniel; Karsten, Peter; Weber, Stephanie S.; Kahle, Philipp J.; Marquardt, Till; Schulz, Joerg B.			TDP-43-Mediated Neuron Loss In Vivo Requires RNA-Binding Activity	PLOS ONE			English	Article							NUCLEAR FACTOR TDP-43; MUTATIONS; DROSOPHILA; ALS; TOL2; GENE; ELEMENT; EXON-9	Alteration and/or mutations of the ribonucleoprotein TDP-43 have been firmly linked to human neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). The relative impacts of TDP-43 alteration, mutation, or inherent protein function on neural integrity, however, remain less clear-a situation confounded by conflicting reports based on transient and/or random-insertion transgenic expression. We therefore performed a stringent comparative investigation of impacts of these TDP-43 modifications on neural integrity in vivo. To achieve this, we systematically screened ALS/FTLD-associated and synthetic TDP-43 isoforms via same-site gene insertion and neural expression in Drosophila; followed by transposon-based motor neuron-specific transgenesis in a chick vertebrate system. Using this bi-systemic approach we uncovered a requirement of inherent TDP-43 RNA-binding function-but not ALS/FTLD-linked mutation, mislocalization, or truncation-for TDP-43-mediated neurotoxicity in vivo.	[Voigt, Aaron; Kaur, Kavita; Karsten, Peter; Schulz, Joerg B.] Rhein Westfal TH Aachen, Dept Neurol, Univ Med Ctr, D-5100 Aachen, Germany; [Herholz, David; Mueller, Daniel; Marquardt, Till] European Neurosci Inst Gottingen, Dev Neurobiol Lab, Gottingen, Germany; [Fiesel, Fabienne C.; Weber, Stephanie S.; Kahle, Philipp J.] Hertie Inst Clin Brain Res, Dept Neurodegenerat, Lab Funct Neurogenet, Tubingen, Germany; [Fiesel, Fabienne C.; Weber, Stephanie S.; Kahle, Philipp J.] German Ctr Neurodegenerat Dis, Tubingen, Germany; [Schulz, Joerg B.] JARA Brain Julich Aachen Res Alliance, Julich, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Voigt, A (corresponding author), Rhein Westfal TH Aachen, Dept Neurol, Univ Med Ctr, D-5100 Aachen, Germany.	T.Marquardt@eni-g.de; jschulz@ukaachen.de	Schulz, Jörg B/D-9786-2012	Schulz, Jörg B/0000-0002-8903-0593; Fiesel, Fabienne/0000-0002-1919-9676	START; German Competence Net Degenerative Dementias [01GI0703]; Gattingen graduate school for neurobiology fellowship	START(Austrian Science Fund (FWF)); German Competence Net Degenerative Dementias; Gattingen graduate school for neurobiology fellowship	This research project is supported by the START-Program of the Faculty of Medicine, RWTH Aachen and by the German Competence Net Degenerative Dementias, grant number 01GI0703, as well as an Emmy Noether Grant of the Deutsche Forschungsgemeinschaft. D.M. is supported by a Gattingen graduate school for neurobiology fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2009, ADV GENET, V66, P1, DOI 10.1016/S0065-2660(09)66001-6; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Gendron TF, 2010, NEUROPATH APPL NEURO, V36, P97, DOI [10.1111/j.1365-2990.2009.01060.x, 10.1111/j.1365-2990.2010.01060.x]; Giordana MT, 2010, BRAIN PATHOL, V20, P351, DOI 10.1111/j.1750-3639.2009.00284.x; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kawakami K, 2004, GENETICS, V166, P895, DOI 10.1534/genetics.166.2.895; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; LAGIERTOURENNE C, 2010, HUM MOL GENET; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Zhou HX, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000887	30	147	152	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12247	10.1371/journal.pone.0012247	http://dx.doi.org/10.1371/journal.pone.0012247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20806063	Green Published, gold, Green Submitted			2022-12-25	WOS:000281011600019
J	Vilceanu, D; Stucky, CL				Vilceanu, Daniel; Stucky, Cheryl L.			TRPA1 Mediates Mechanical Currents in the Plasma Membrane of Mouse Sensory Neurons	PLOS ONE			English	Article							CHANNEL; MECHANOTRANSDUCTION; TRANSDUCTION; EXPRESSION; ANKYRIN; COLD; A1	Mechanosensitive channels serve as essential sensors for cells to interact with their environment. The identity of mechanosensitive channels that underlie somatosensory touch transduction is still a mystery. One promising mechanotransduction candidate is the Transient Receptor Potential Ankyrin 1 (TRPA1) ion channel. To determine the role of TRPA1 in the generation of mechanically-sensitive currents, we used dorsal root ganglion (DRG) neuron cultures from adult mice and applied rapid focal mechanical stimulation (indentation) to the soma membrane. Small neurons (diameter, 27 mu m) were studied because TRPA1 is functionally present in these neurons which largely give rise to C-fiber afferents in vivo. Small neurons were classified by isolectin B4 binding. Mechanically-activated inward currents were classified into two subtypes: Slowly Adapting and Transient. First, significantly more IB4 negative neurons (84%) responded to mechanical stimulation than IB4 positive neurons (54%). Second, 89% of Slowly Adapting currents were present in IB4 negative neurons whereas only 11% were found in IB4 positive neurons. Third, Slowly Adapting currents were completely absent in IB4 negative neurons from TRPA1-/- mice. Consistent with this, Slowly Adapting currents were abolished in wild type IB4 negative neurons stimulated in the presence of a TRPA1 antagonist, HC-030031. In addition, the amplitude of Transient mechanically-activated currents in IB4 positive neurons from TRPA1-/- mice was reduced by over 60% compared to TRPA1+/+ controls; however, a similar reduction did not occur in wild-type neurons treated with HC-030031. Transfection of TRPA1 in HEK293 cells did not significantly alter the proportion or magnitude of mechanically-activated currents in HEK293 cells, indicating that TRPA1 alone is not sufficient to confer mechanical sensitivity. These parallel genetic and pharmacological data demonstrate that TRPA1 mediates the Slowly Adapting mechanically-activated currents in small-diameter IB4 negative neurons from adult mice. The TRPA1 protein may also contribute to a complex that mediates Transient mechanically-activated currents in small IB4 positive C fiber type neurons.	[Vilceanu, Daniel; Stucky, Cheryl L.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Vilceanu, D (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	cstucky@mcw.edu			National Institutes of Health [NS40538, NS070711]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040538, R01NS070711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health grant NS40538 and NS070711 to C.L.S.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Anand U, 2008, NEUROSCI LETT, V438, P221, DOI 10.1016/j.neulet.2008.04.007; Anishkin A, 2005, CURR OPIN NEUROBIOL, V15, P397, DOI 10.1016/j.conb.2005.06.002; Atoyan R, 2009, J INVEST DERMATOL, V129, P2312, DOI 10.1038/jid.2009.58; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Dirajlal S, 2003, J NEUROPHYSIOL, V89, P513, DOI 10.1152/jn.00371.2002; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Drew LJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-12-j0001.2002; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Inoue R, 2009, PHARMACOL THERAPEUT, V123, P371, DOI 10.1016/j.pharmthera.2009.05.009; Jaquemar D, 1999, J BIOL CHEM, V274, P7325, DOI 10.1074/jbc.274.11.7325; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kerstein PC, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-19; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lechner SG, 2009, EMBO J, V28, P1479, DOI 10.1038/emboj.2009.73; Martinac B, 2008, PHYSIOL REV, V88, P1449, DOI 10.1152/physrev.00005.2008; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; McCarter GC, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-28; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Rugiero F, 2009, NEUROPHARMACOLOGY, V56, P1138, DOI 10.1016/j.neuropharm.2009.03.012; Salas MM, 2009, EUR J NEUROSCI, V29, P1568, DOI 10.1111/j.1460-9568.2009.06702.x; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Stokes NR, 2003, P NATL ACAD SCI USA, V100, P15959, DOI 10.1073/pnas.2536607100; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stucky CL, 1999, J NEUROSCI, V19, P6497; Tsunozaki M, 2009, CURR OPIN NEUROBIOL, V19, P362, DOI 10.1016/j.conb.2009.07.008; Vilceanu D, 2010, J PAIN, V11, P588, DOI 10.1016/j.jpain.2009.09.018; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	31	105	107	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12177	10.1371/journal.pone.0012177	http://dx.doi.org/10.1371/journal.pone.0012177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808441	Green Published, Green Submitted, gold			2022-12-25	WOS:000280968000008
J	Zacchi, LF; Schulz, WL; Davis, DA				Zacchi, Lucia F.; Schulz, Wade L.; Davis, Dana A.			HOS2 and HDA1 Encode Histone Deacetylases with Opposing Roles in Candida albicans Morphogenesis	PLOS ONE			English	Article							FILAMENTOUS GROWTH; DISTINCT ROLES; PH RESPONSES; COMPLEX; RPD3; CELL; RECRUITMENT; REPRESSION; RESISTANCE; INHIBITORS	Epigenetic mechanisms regulate the expression of virulence traits in diverse pathogens, including protozoan and fungi. In the human fungal pathogen Candida albicans, virulence traits such as antifungal resistance, white-opaque switching, and adhesion to lung cells are regulated by histone deacetylases (HDACs). However, the role of HDACs in the regulation of the yeast-hyphal morphogenetic transitions, a critical virulence attribute of C. albicans, remains poorly explored. In this study, we wished to determine the relevance of other HDACs on C. albicans morphogenesis. We generated mutants in the HDACs HOS1, HOS2, RPD31, and HDA1 and determined their ability to filament in response to different environmental stimuli. We found that while HOS1 and RPD31 have no or a more limited role in morphogenesis, the HDACs HOS2 and HDA1 have opposite roles in the regulation of hyphal formation. Our results demonstrate an important role for HDACs on the regulation of yeast-hyphal transitions in the human pathogen C. albicans.	[Zacchi, Lucia F.; Schulz, Wade L.; Davis, Dana A.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Zacchi, LF (corresponding author), Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA.	zacch002@umn.edu	Zacchi, Lucia/N-6484-2019; Schulz, Wade/A-5737-2013; Zacchi, Lucia/F-7494-2016	Zacchi, Lucia/0000-0001-6217-1380; Schulz, Wade/0000-0002-2048-4028; Zacchi, Lucia/0000-0001-6217-1380	Burroughs Wellcome Fund; National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [R01-AI064054]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064054] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Investigators in Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund and by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases award R01-AI064054 to DD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Adams A, 1997, METHODS YEAST GENETI; Baillie GS, 1999, J MED MICROBIOL, V48, P671, DOI 10.1099/00222615-48-7-671; Bastidas RJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000294; Bauer J, 2007, EUKARYOT CELL, V6, P1736, DOI 10.1128/EC.00236-07; Biswas S, 2003, MICROBIOL-SGM, V149, P2597, DOI 10.1099/mic.0.26215-0; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Bockmuhl DP, 2001, MOL MICROBIOL, V42, P1243, DOI 10.1046/j.1365-2958.2001.02688.x; Braun BR, 2001, EMBO J, V20, P4753, DOI 10.1093/emboj/20.17.4753; Brown DH, 1999, MOL MICROBIOL, V34, P651, DOI 10.1046/j.1365-2958.1999.01619.x; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Davie JK, 2003, J BIOL CHEM, V278, P50158, DOI 10.1074/jbc.M309753200; Davis D, 2000, MOL CELL BIOL, V20, P971, DOI 10.1128/MCB.20.3.971-978.2000; Davis DA, 2002, GENETICS, V162, P1573; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Domergue R, 2005, SCIENCE, V308, P866, DOI 10.1126/science.1108640; Ernst JF, 2000, MICROBIOL-SGM, V146, P1763, DOI 10.1099/00221287-146-8-1763; Figueiredo LM, 2008, PLOS BIOL, V6, P1539, DOI 10.1371/journal.pbio.0060161; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Green SR, 2004, MOL BIOL CELL, V15, P4191, DOI 10.1091/mbc.E04-05-0412; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; HAWSER SP, 1995, ANTIMICROB AGENTS CH, V39, P2128, DOI 10.1128/AAC.39.9.2128; Hnisz D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000889; Hnisz D, 2009, MOL MICROBIOL, V74, P1, DOI 10.1111/j.1365-2958.2009.06772.x; Kadosh D, 1998, MOL CELL BIOL, V18, P5121, DOI 10.1128/MCB.18.9.5121; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Katan-Khaykovich Y, 2005, EMBO J, V24, P2138, DOI 10.1038/sj.emboj.7600692; Khalaf RA, 2001, GENETICS, V157, P1503; Klar AJS, 2001, GENETICS, V158, P919; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lu Y, 2008, MOL BIOL CELL, V19, P4260, DOI 10.1091/mbc.E08-02-0173; Mai A, 2007, BIOORG MED CHEM LETT, V17, P1221, DOI 10.1016/j.bmcl.2006.12.028; Mao XM, 2006, FEBS LETT, V580, P2615, DOI 10.1016/j.febslet.2006.04.009; Niimi M, 2010, ODONTOLOGY, V98, P15, DOI 10.1007/s10266-009-0118-3; Pfaller MA, 2009, J CLIN MICROBIOL, V47, P3797, DOI 10.1128/JCM.00618-09; Pfaller MA, 2001, J CLIN MICROBIOL, V39, P3254, DOI 10.1128/JCM.39.9.3254-3259.2001; Raman SB, 2006, MOL MICROBIOL, V60, P697, DOI 10.1111/j.1365-2958.2006.05121.x; Richard ML, 2005, EUKARYOT CELL, V4, P1493, DOI 10.1128/EC.4.8.1493-1502.2005; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Romani L, 2004, INT IMMUNOL, V16, P149, DOI 10.1093/intimm/dxh012; Romani L, 2003, CURR OPIN MICROBIOL, V6, P338, DOI 10.1016/S1369-5274(03)00081-X; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Saville SP, 2008, INFECT IMMUN, V76, P97, DOI 10.1128/IAI.00982-07; Sciascia QL, 2004, CAN J MICROBIOL, V50, P1081, DOI [10.1139/w04-095, 10.1139/W04-095]; Sellam A, 2009, MOL BIOL CELL, V20, P2389, DOI 10.1091/mbc.E08-11-1093; Simonetti G, 2007, FEMS YEAST RES, V7, P1371, DOI 10.1111/j.1567-1364.2007.00276.x; Smith WL, 2002, ANTIMICROB AGENTS CH, V46, P3532, DOI 10.1128/AAC.46.11.3532-3539.2002; Srikantha T, 2001, J BACTERIOL, V183, P4614, DOI 10.1128/JB.183.15.4614-4625.2001; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Tebarth B, 2003, J MOL BIOL, V329, P949, DOI 10.1016/S0022-2836(03)00505-9; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Watson AD, 2000, GENE DEV, V14, P2737, DOI 10.1101/gad.829100; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yang Y, 2003, NOVON, V13, P153, DOI 10.2307/3393581; Zordan RE, 2007, PLOS BIOL, V5, P2166, DOI 10.1371/journal.pbio.0050256	60	26	31	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12171	10.1371/journal.pone.0012171	http://dx.doi.org/10.1371/journal.pone.0012171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730094	Green Submitted, Green Published, gold			2022-12-25	WOS:000280862200023
J	Schwarzer, C; Wong, S; Shi, J; Matthes, E; Illek, B; Ianowski, JP; Arant, RJ; Isacoff, E; Vais, H; Foskett, JK; Maiellaro, I; Hofer, AM; Machen, TE				Schwarzer, Christian; Wong, Steven; Shi, James; Matthes, Elizabeth; Illek, Beate; Ianowski, Juan P.; Arant, Ryan J.; Isacoff, Ehud; Vais, Horia; Foskett, J. Kevin; Maiellaro, Isabella; Hofer, Aldebaran M.; Machen, Terry E.			Pseudomonas aeruginosa Homoserine Lactone Activates Store-operated cAMP and Cystic Fibrosis Transmembrane Regulator-dependent Cl- Secretion by Human Airway Epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MUCUS SECRETION; CA2+; CALCIUM; RESPONSES; RECEPTOR; EXPRESSION; TRANSPORT; MECHANISM; FLAGELLIN	The ubiquitous bacterium Pseudomonas aeruginosa frequently causes hospital-acquired infections. P. aeruginosa also infects the lungs of cystic fibrosis (CF) patients and secretes N-(3-oxo-dodecanoyl)-S-homoserine lactone (3O-C12) to regulate bacterial gene expression critical for P. aeruginosa persistence. In addition to its effects as a quorum-sensing gene regulator in P. aeruginosa, 3O-C12 elicits cross-kingdom effects on host cell signaling leading to both pro- or anti-inflammatory effects. We find that in addition to these slow effects mediated through changes in gene expression, 3O-C12 also rapidly increases Cl- and fluid secretion in the cystic fibrosis transmembrane regulator (CFTR)-expressing airway epithelia. 3O-C12 does not stimulate Cl- secretion in CF cells, suggesting that lactone activates the CFTR. 3O-C12 also appears to directly activate the inositol trisphosphate receptor and release Ca2+ from the endoplasmic reticulum (ER), lowering [Ca2+] in the ER and thereby activating the Ca2+ -sensitive ER signaling protein STIM1. 3O-C12 increases cytosolic [Ca2+] and, strikingly, also cytosolic [cAMP], the known activator of CFTR. Activation of Cl- current by 3O-C12 was inhibited by a cAMP antagonist and increased by a phosphodiesterase inhibitor. Finally, a Ca2+ buffer that lowers [Ca2+] in the ER similar to the effect of 3O-C12 also increased cAMP and I-C1. The results suggest that 3O-C12 stimulates CFTR-dependent Cl- and fluid secretion in airway epithelial cells by activating the inositol trisphosphate receptor, thus lowering [Ca2+] in the ER and activating STIM1 and store-operated cAMP production. In CF airways, where CFTR is absent, the adaptive ability to rapidly flush the bacteria away is compromised because the lactone cannot affect Cl- and fluid secretion.	[Schwarzer, Christian; Wong, Steven; Shi, James; Matthes, Elizabeth; Arant, Ryan J.; Isacoff, Ehud; Machen, Terry E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Illek, Beate] Childrens Hosp Oakland Res Inst, Ctr Nutr & Metab, Oakland, CA 94609 USA; [Ianowski, Juan P.] Univ Saskatchewan, Dept Physiol, Saskatoon, SK S7N 5E5, Canada; [Vais, Horia; Foskett, J. Kevin] Univ Penn, Dept Physiol, Sch Med, Philadelphia, PA 19104 USA; [Vais, Horia; Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Sch Med, Philadelphia, PA 19104 USA; [Maiellaro, Isabella; Hofer, Aldebaran M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg, W Roxbury, MA 02132 USA; [Maiellaro, Isabella; Hofer, Aldebaran M.] Vet Affairs Boston Healthcare Syst, W Roxbury, MA 02132 USA	University of California System; University of California Berkeley; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of Saskatchewan; University of Pennsylvania; University of Pennsylvania; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Machen, TE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 231 LSA, Berkeley, CA 94720 USA.	tmachen@berkeley.edu	isacoff, ehud/AAP-1459-2020; Foskett, Kevin/R-2549-2019	Foskett, J. Kevin/0000-0002-8854-0268; Maiellaro, Isabella/0000-0001-5595-8011; Isacoff, Ehud Y./0000-0003-4775-9359	National Institutes of Health [GM056328, MH059937, PN2 EY018241]; Cystic Fibrosis Foundation [MACHEN06, MACHEN07, ILLEK08]; Cystic Fibrosis Research, Inc.; Veterans Affairs; NATIONAL EYE INSTITUTE [PN2EY018241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK088197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056328, R37GM056328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Research, Inc.; Veterans Affairs(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM056328, MH059937, and PN2 EY018241. This work was also supported by Cystic Fibrosis Foundation Grants MACHEN06, MACHEN07, and ILLEK08, Cystic Fibrosis Research, Inc., and a Veterans Affairs Merit Review Award (to A. M. H.).	Bjarnsholt T, 2007, PHILOS T R SOC B, V362, P1213, DOI 10.1098/rstb.2007.2046; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Choi JY, 2007, J CLIN INVEST, V117, P3118, DOI 10.1172/JCI31992; Choi JY, 2009, J CLIN INVEST, V119, P1189, DOI 10.1172/JCI37284; Cooley M, 2008, CHEM BIOL, V15, P1141, DOI 10.1016/j.chembiol.2008.10.010; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DIMANGO E, 1995, J CLIN INVEST, V96, P2204, DOI 10.1172/JCI118275; Fu Z, 2007, AM J PHYSIOL-LUNG C, V292, pL353, DOI 10.1152/ajplung.00042.2006; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Gerbino A, 2005, J CELL BIOL, V171, P303, DOI 10.1083/jcb.200507054; Giorgi C, 2008, CURR MOL MED, V8, P119; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Hybiske K, 2007, AM J PHYSIOL-LUNG C, V293, pL1250, DOI 10.1152/ajplung.00231.2007; Illek B, 2008, AM J PHYSIOL-LUNG C, V295, pL531, DOI 10.1152/ajplung.90292.2008; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; Imamura Y, 2004, ANTIMICROB AGENTS CH, V48, P3457, DOI 10.1128/AAC.48.9.3457-3461.2004; Ionescu L, 2006, J PHYSIOL-LONDON, V573, P645, DOI 10.1113/jphysiol.2006.109504; Jahoor A, 2008, J BACTERIOL, V190, P4408, DOI 10.1128/JB.01444-07; Joo NS, 2001, AM J PHYSIOL-LUNG C, V281, pL458, DOI 10.1152/ajplung.2001.281.2.L458; Joo NS, 2002, J BIOL CHEM, V277, P28167, DOI 10.1074/jbc.M202712200; Kravchenko VV, 2008, SCIENCE, V321, P259, DOI 10.1126/science.1156499; Kravchenko VV, 2006, J BIOL CHEM, V281, P28822, DOI 10.1074/jbc.M606613200; Kunzelmann K, 2006, FASEB J, V20, P545, DOI 10.1096/fj.05-4454fje; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; Li HT, 2009, MED MICROBIOL IMMUN, V198, P113, DOI 10.1007/s00430-009-0111-z; Luik RM, 2007, TRENDS MOL MED, V13, P103, DOI 10.1016/j.molmed.2007.01.004; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; MAK DOD, 2005, METHODS CALCIUM SIGN, P203; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Schwarzer C, 2008, J BIOL CHEM, V283, P27144, DOI 10.1074/jbc.M709693200; Schwarzer C, 2008, FREE RADICAL BIO MED, V45, P1653, DOI 10.1016/j.freeradbiomed.2008.09.011; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; Shiner EK, 2006, CELL MICROBIOL, V8, P1601, DOI 10.1111/j.1462-5822.2006.00734.x; Smith RS, 2002, J IMMUNOL, V169, P2636, DOI 10.4049/jimmunol.169.5.2636; Smith RS, 2001, J IMMUNOL, V167, P366, DOI 10.4049/jimmunol.167.1.366; Taylor CW, 2009, IMMUNOL REV, V231, P23, DOI 10.1111/j.1600-065X.2009.00807.x; Thiagarajah JR, 2004, FASEB J, V18, P875, DOI 10.1096/fj.03-1248fje; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec	51	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34850	34863		10.1074/jbc.M110.167668	http://dx.doi.org/10.1074/jbc.M110.167668			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739289	Green Published, hybrid			2022-12-25	WOS:000283659100060
J	Sohn, J; Grant, RA; Sauer, RT				Sohn, Jungsan; Grant, Robert A.; Sauer, Robert T.			Allostery Is an Intrinsic Property of the Protease Domain of DegS IMPLICATIONS FOR ENZYME FUNCTION AND EVOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-SENSOR; HTRA FAMILY; MECHANISM; PROTEINS; BINDING; SIGNALS; RELIEF; SITE	DegS is a periplasmic Escherichia coli protease, which functions as a trimer to catalyze the initial rate-limiting step in a proteolytic cascade that ultimately activates transcription of stress response genes in the cytoplasm. Each DegS subunit consists of a protease domain and a PDZ domain. During protein folding stress, DegS is allosterically activated by peptides exposed in misfolded outer membrane porins, which bind to the PDZ domain and stabilize the active protease. It is not known whether allostery is conferred by the PDZ domains or is an intrinsic feature of the trimeric protease domain. Here, we demonstrate that free DegS(Delta PDZ) equilibrates between active and inactive trimers with the latter species predominating. Substrate binding stabilizes active DegS(Delta PDZ) in a positively cooperative fashion. Mutations can also stabilize active DegS(Delta PDZ) and produce an enzyme that displays hyperbolic kinetics and degrades substrate with a maximal velocity within error of that for fully activated, intact DegS. Crystal structures of multiple DegS(Delta PDZ) variants, in functional and non-functional conformations, support a two-state model in which allosteric switching is mediated by changes in specific elements of tertiary structure in the context of an invariant trimeric base. Overall, our results indicate that protein substrates must bind sufficiently tightly and specifically to the functional conformation of DegS(Delta PDZ) to assist their own degradation. Thus, substrate binding alone may have regulated the activities of ancestral DegS trimers with subsequent fusion of the protease domain to a PDZ domain, resulting in ligand-mediated regulation.	[Sohn, Jungsan; Grant, Robert A.; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu		Sauer, Robert/0000-0002-1719-5399	National Institutes of Health [F32AI-074245-03]; National Center for Research Resources [AI-16892, RR-15301]; United States Department of Defense Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892, F32AI074245] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Defense Office of Basic Energy Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Postdoctoral Fellowship F32AI-074245-03 (to J. S.), Grant AI-16892, and Award RR-15301 from the National Center for Research Resources. This work was also supported by the United States Department of Defense Office of Basic Energy Sciences under Contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ades SE, 2008, CURR OPIN MICROBIOL, V11, P535, DOI 10.1016/j.mib.2008.10.004; Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HAMMES GG, 1971, SCIENCE, V172, P1205, DOI 10.1126/science.172.3989.1205; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hardy JA, 2009, J BIOL CHEM, V284, P26063, DOI 10.1074/jbc.M109.001826; Hasselblatt H, 2007, GENE DEV, V21, P2659, DOI 10.1101/gad.445307; Kim DY, 2005, J BIOCHEM MOL BIOL, V38, P266; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Leskovac V, 2008, J SERB CHEM SOC, V73, P393, DOI 10.2298/JSC0804393L; Li XC, 2009, P NATL ACAD SCI USA, V106, P14837, DOI 10.1073/pnas.0903289106; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Nie GY, 2003, MOL HUM REPROD, V9, P279, DOI 10.1093/molehr/gag036; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; Sohn J, 2009, STRUCTURE, V17, P1411, DOI 10.1016/j.str.2009.07.017; Sohn J, 2009, MOL CELL, V33, P64, DOI 10.1016/j.molcel.2008.12.017; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Zeth K, 2004, FEBS LETT, V569, P351, DOI 10.1016/j.febslet.2004.06.012	26	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34039	34047		10.1074/jbc.M110.135541	http://dx.doi.org/10.1074/jbc.M110.135541			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20739286	hybrid, Green Published			2022-12-25	WOS:000283354000050
J	Weiss, T; Ricard-Blum, S; Moschcovich, L; Wineman, E; Mesilaty, S; Kessler, E				Weiss, Tali; Ricard-Blum, Sylvie; Moschcovich, Laura; Wineman, Eitan; Mesilaty, Shlomit; Kessler, Efrat			Binding of Procollagen C-Proteinase Enhancer-1 (PCPE-1) to Heparin/Heparan Sulfate PROPERTIES AND ROLE IN PCPE-1 INTERACTION WITH CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NETRIN-LIKE DOMAIN; BONE MORPHOGENETIC PROTEIN-1; HEPARAN-SULFATE; RAT-HEART; EXPRESSION; COLLAGEN; GLYCOPROTEIN; METALLOPROTEINASES; IDENTIFICATION; FIBROBLASTS	Procollagen C-proteinase enhancer-1 (PCPE-1) is an extracellular matrix (ECM) glycoprotein that can stimulate procollagen processing by procollagen C-proteinases (PCPs) such as bone morphogenetic protein-1 (BMP-1). The PCPs can process additional extracellular protein precursors and play fundamental roles in developmental processes and assembly of the ECM. The stimulatory activity of PCPE-1 is restricted to the processing of fibrillar procollagens, suggesting PCPE-1 is a specific regulator of collagen deposition. PCPE-1 consists of two CUB domains that bind to the procollagen C-propeptides and are required for PCP enhancing activity, and one NTR domain that binds heparin. To understand the biological role of the NTR domain, we performed surface plasmon resonance (SPR) binding assays, cell attachment assays as well as immunofluorescence and activity assays, all indicating that the NTR domain can mediate PCPE-1 binding to cell surface heparan sulfate proteoglycans (HSPGs). The SPR data revealed binding affinities to heparin/HSPGs in the high nanomolar range and dependence on calcium. Both 3T3 mouse fibroblasts and human embryonic kidney cells (HEK-293) attached to PCPE-1, an interaction that was inhibited by heparin. Cell attachment was also inhibited by an NTR-specific antibody and the NTR fragment. Immunofluorescence analysis revealed that PCPE-Flag binds to mouse fibroblasts and heparin competes for this binding. Cell-associated PCPE-Flag stimulated procollagen processing by BMP-1 several fold. Our data suggest that through interaction with cell surface HSPGs, the NTR domain can anchor PCPE-1 to the cell membrane, permitting pericellular enhancement of PCP activity. This points to the cell surface as a physiological site of PCPE-1 action.	[Weiss, Tali; Moschcovich, Laura; Wineman, Eitan; Mesilaty, Shlomit; Kessler, Efrat] Tel Aviv Univ, Sackler Fac Med, Maurice & Gabriela Goldschleger Eye Res Inst, Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Ricard-Blum, Sylvie] Univ Lyon 1, CNRS, Inst Biol & Chim Prot, UMR 5086, F-69367 Lyon 7, France	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Kessler, E (corresponding author), Tel Aviv Univ, Sackler Fac Med, Maurice & Gabriela Goldschleger Eye Res Inst, Sheba Med Ctr, IL-52621 Tel Hashomer, Israel.	ekessler@post.tau.ac.il		RICARD-BLUM, Sylvie/0000-0001-9263-1851	GIS Maladies Rares INSERM [A04115SP]; Israel Science Foundation [736/01, 1360/07]; European Commission [NMP2-CT-2003-504017]; Tel Aviv University Sackler Faculty of Medicine Maratier; Gothelf Foundations	GIS Maladies Rares INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); Israel Science Foundation(Israel Science Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Tel Aviv University Sackler Faculty of Medicine Maratier; Gothelf Foundations	This work was supported by the GIS Maladies Rares INSERM Grant A04115SP (to S. R.-B.), the Israel Science Foundation (Grants 736/01 and 1360/07), the European Commission (Contract No. NMP2-CT-2003-504017), and the Tel Aviv University Sackler Faculty of Medicine Maratier and Gothelf Foundations (to E. K.).	ADAR R, 1986, COLLAGEN REL RES, V6, P267; Banyai L, 1999, PROTEIN SCI, V8, P1636, DOI 10.1110/ps.8.8.1636; Bekhouche M, 2010, J BIOL CHEM, V285, P15950, DOI 10.1074/jbc.M109.086447; Bernocco S, 2003, J BIOL CHEM, V278, P7199, DOI 10.1074/jbc.M210857200; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Faye C, 2009, J BIOL CHEM, V284, P22029, DOI 10.1074/jbc.M109.002840; Gallagher JT, 2006, BIOCHEM SOC T, V34, P438, DOI 10.1042/BST0340438; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Humphries MJ, 2001, MOL BIOTECHNOL, V18, P57, DOI 10.1385/MB:18:1:57; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; Kanaki T, 2000, BIOCHEM BIOPH RES CO, V270, P1049, DOI 10.1006/bbrc.2000.2555; KESSLER E, 1989, EUR J BIOCHEM, V186, P115, DOI 10.1111/j.1432-1033.1989.tb15184.x; KESSLER E, 1990, BIOCHEM BIOPH RES CO, V173, P81, DOI 10.1016/S0006-291X(05)81024-1; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Kessler E., 2004, HDB PROTEOLYTIC ENZY, V1, P609; Kessler-Icekson G, 2006, INT J BIOCHEM CELL B, V38, P358, DOI 10.1016/j.biocel.2005.10.007; Kronenberg D, 2009, J BIOL CHEM, V284, P33437, DOI 10.1074/jbc.M109.046128; Liepinsh E, 2003, J BIOL CHEM, V278, P25982, DOI 10.1074/jbc.M302734200; Moali C, 2005, J BIOL CHEM, V280, P24188, DOI 10.1074/jbc.M501486200; Morimoto H, 2008, MATRIX BIOL, V27, P211, DOI 10.1016/j.matbio.2007.11.005; Moschcovich L, 2001, EUR J BIOCHEM, V268, P2991, DOI 10.1046/j.1432-1327.2001.02189.x; Mott JD, 2000, J BIOL CHEM, V275, P1384, DOI 10.1074/jbc.275.2.1384; Ogata I, 1997, HEPATOLOGY, V26, P611, DOI 10.1002/hep.510260312; Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051; Ricard-Blum S, 2005, TOP CURR CHEM, V247, P35, DOI 10.1007/b103819; Ricard-Blum S, 2004, J BIOL CHEM, V279, P2927, DOI 10.1074/jbc.M309868200; Ricard-Blum S, 2002, J BIOL CHEM, V277, P33864, DOI 10.1074/jbc.M205018200; Ricard-Blum S, 2006, J BIOL CHEM, V281, P25195, DOI 10.1074/jbc.M603096200; Shalitin N, 2003, J CELL BIOCHEM, V90, P397, DOI 10.1002/jcb.10646; Shao CH, 2006, J BIOL CHEM, V281, P31689, DOI 10.1074/jbc.M604502200; Steiglitz BM, 2002, J BIOL CHEM, V277, P49820, DOI 10.1074/jbc.M209891200; TAKAHARA K, 1994, J BIOL CHEM, V269, P26280; Unsold C, 2002, J BIOL CHEM, V277, P5596, DOI 10.1074/jbc.M110003200; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Williamson RA, 2008, MOL BIOSYST, V4, P417, DOI 10.1039/b717901d; WINEMAN E, 2008, FEDERATION EUROPEAN; Xu H, 2000, GENOMICS, V66, P264, DOI 10.1006/geno.2000.6229; Zhang G., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P5	38	31	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33867	33874		10.1074/jbc.M110.141366	http://dx.doi.org/10.1074/jbc.M110.141366			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729553	Green Published, hybrid			2022-12-25	WOS:000283354000033
J	Negishi, M; Saraya, A; Mochizuki, S; Helin, K; Koseki, H; Iwama, A				Negishi, Masamitsu; Saraya, Atsunori; Mochizuki, Shinobu; Helin, Kristian; Koseki, Haruhiko; Iwama, Atsushi			A Novel Zinc Finger Protein Zfp277 Mediates Transcriptional Repression of the Ink4a/Arf Locus through Polycomb Repressive Complex 1	PLOS ONE			English	Article							DEMETHYLASE JMJD3 CONTRIBUTES; HEMATOPOIETIC STEM-CELLS; ENHANCED SELF-RENEWAL; REPLICATIVE LIFE-SPAN; CELLULAR SENESCENCE; HISTONE H2A; INK4A-ARF LOCUS; BMI-1; MOUSE; CANCER	Background: Polycomb group (PcG) proteins play a crucial role in cellular senescence as key transcriptional regulators of the Ink4a/Arf tumor suppressor gene locus. However, how PcG complexes target and contribute to stable gene silencing of the Ink4a/Arf locus remains little understood. Methodology/Principal Findings: We examined the function of Zinc finger domain-containing protein 277 (Zfp277), a novel zinc finger protein that interacts with the PcG protein Bmi1. Zfp277 binds to the Ink4a/Arf locus in a Bmi1-independent manner and interacts with polycomb repressor complex (PRC) 1 through direct interaction with Bmi1. Loss of Zfp277 in mouse embryonic fibroblasts (MEFs) caused dissociation of PcG proteins from the Ink4a/Arf locus, resulting in premature senescence associated with derepressed p16(Ink4a) and p19(Arf) expression. Levels of both Zfp277 and PcG proteins inversely correlated with those of reactive oxygen species (ROS) in senescing MEFs, but the treatment of Zfp277(-/-) MEFs with an antioxidant restored the binding of PRC2 but not PRC1 to the Ink4a/Arf locus. Notably, forced expression of Bmi1 in Zfp277(-/-) MEFs did not restore the binding of Bmi1 to the Ink4a/Arf locus and failed to bypass cellular senescence. A Zfp277 mutant that could not bind Bmi1 did not rescue Zfp277(-/-) MEFs from premature senescence. Conclusions/Significance: Our findings implicate Zfp277 in the transcriptional regulation of the Ink4a/Arf locus and suggest that the interaction of Zfp277 with Bmi1 is essential for the recruitment of PRC1 to the Ink4a/Arf locus. Our findings also highlight dynamic regulation of both Zfp277 and PcG proteins by the oxidative stress pathways.	[Negishi, Masamitsu; Saraya, Atsunori; Iwama, Atsushi] Chiba Univ, Dept Cellular & Mol Med, Grad Sch Med, Chiba, Japan; [Mochizuki, Shinobu; Koseki, Haruhiko] RIKEN Res Ctr Allergy & Immunol, Lab Dev Genet, Yokohama, Kanagawa, Japan; [Helin, Kristian] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Helin, Kristian] Univ Copenhagen, Ctr Epigenet, Copenhagen, Denmark; [Negishi, Masamitsu; Saraya, Atsunori; Koseki, Haruhiko; Iwama, Atsushi] JST, CREST, Tokyo, Japan	Chiba University; RIKEN; University of Copenhagen; University of Copenhagen; Japan Science & Technology Agency (JST)	Negishi, M (corresponding author), Chiba Univ, Dept Cellular & Mol Med, Grad Sch Med, Chiba, Japan.	aiwama@faculty.chiba-u.jp	Koseki, Haruhiko/I-3825-2014; Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022	Koseki, Haruhiko/0000-0001-8424-5854; Helin, Kristian/0000-0003-1975-6097	MEXT, Japan [21390289]; Japan Science and Technology Corporation (JST); Takeda Science Foundation	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Grants-in-Aid for Scientific Research (#21390289) and for the Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan, a Grant-in-Aid for the Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Corporation (JST), and a grant from the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Akasaka T, 2001, DEVELOPMENT, V128, P1587; Atsuta T, 2001, HYBRIDOMA, V20, P43, DOI 10.1089/027245701300060427; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Chiba T, 2007, GASTROENTEROLOGY, V133, P937, DOI 10.1053/j.gastro.2007.06.016; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Fukamachi H, 2001, BIOCHEM BIOPH RES CO, V280, P1069, DOI 10.1006/bbrc.2001.4247; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Herz HM, 2010, GENE DEV, V24, P857, DOI 10.1101/gad.1921610; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kranc KR, 2003, MOL CELL BIOL, V23, P7658, DOI 10.1128/MCB.23.21.7658-7666.2003; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; Lennon PA, 2007, AM J MED GENET A, V143A, P791, DOI 10.1002/ajmg.a.31632; Liang H, 2000, GENOMICS, V66, P226, DOI 10.1006/geno.2000.6198; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; Miki J, 2007, GENES CELLS, V12, P1371, DOI 10.1111/j.1365-2443.2007.01135.x; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Negishi M, 2007, BIOCHEM BIOPH RES CO, V353, P992, DOI 10.1016/j.bbrc.2006.12.166; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Ren XJ, 2008, MOL CELL BIOL, V28, P2884, DOI 10.1128/MCB.00949-07; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022	60	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12373	10.1371/journal.pone.0012373	http://dx.doi.org/10.1371/journal.pone.0012373			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808772	Green Published, gold, Green Submitted			2022-12-25	WOS:000281154300011
J	Gulliksson, M; Carvalho, RFS; Ulleras, E; Nilsson, G				Gulliksson, Magdalena; Carvalho, Ricardo F. S.; Ulleras, Erik; Nilsson, Gunnar			Mast Cell Survival and Mediator Secretion in Response to Hypoxia	PLOS ONE			English	Article							CD30 LIGAND; EXPRESSION; IL-6; HIF-1-ALPHA; CYTOKINES; EFFECTOR	Tissue hypoxia is a consequence of decreased oxygen levels in different inflammatory conditions, many associated with mast cell activation. However, the effect of hypoxia on mast cell functions is not well established. Here, we have investigated the effect of hypoxia per se on human mast cell survival, mediator secretion, and reactivity. Human cord blood derived mast cells were subjected to three different culturing conditions: culture and stimulation in normoxia (21% O-2); culture and stimulation in hypoxia (1% O-2); or 24 hour culture in hypoxia followed by stimulation in normoxia. Hypoxia, per se, did not induce mast cell degranulation, but we observed an increased secretion of IL-6, where autocrine produced IL-6 promoted mast cell survival. Hypoxia did not have any effect on A23187 induced degranulation or secretion of cytokines. In contrast, cytokine secretion after LPS or CD30 treatment was attenuated, but not inhibited, in hypoxia compared to normoxia. Our data suggests that mast cell survival, degranulation and cytokine release are sustained under hypoxia. This may be of importance for host defence where mast cells in a hypoxic tissue can react to intruders, but also in chronic inflammations where mast cell reactivity is not inhibited by the inflammatory associated hypoxia.	[Gulliksson, Magdalena; Carvalho, Ricardo F. S.; Nilsson, Gunnar] Karolinska Inst, Clin Immunol & Allergy Unit, Dept Med, Stockholm, Sweden; [Ulleras, Erik] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden	Karolinska Institutet; Swedish University of Agricultural Sciences	Gulliksson, M (corresponding author), Karolinska Inst, Clin Immunol & Allergy Unit, Dept Med, Stockholm, Sweden.	Gunnar.P.Nilsson@ki.se		Nilsson, Gunnar/0000-0001-6795-5512	Swedish Research Council-Medicine; Swedish Cancer Foundation; Swedish Cancer and Allergy Fund; Consul Th C Berghs Foundation; Hans von Kantzows Foundation; Ollie and Elof Ericssons Foundation; King Gustav Vs 80-years Foundation; Ellen, Walter and Lennart Hesselmans foundation; Karolinska Institutet; European Union [504926]	Swedish Research Council-Medicine(Swedish Research Council); Swedish Cancer Foundation; Swedish Cancer and Allergy Fund; Consul Th C Berghs Foundation; Hans von Kantzows Foundation; Ollie and Elof Ericssons Foundation; King Gustav Vs 80-years Foundation; Ellen, Walter and Lennart Hesselmans foundation; Karolinska Institutet(Karolinska Institutet); European Union(European Commission)	This study was supported by grants to Gunnar Nilsson awarded by the following: The Swedish Research Council-Medicine, The Swedish Cancer Foundation, The Swedish Cancer and Allergy Fund, Consul Th C Berghs Foundation, Hans von Kantzows Foundation, Ollie and Elof Ericssons Foundation, King Gustav Vs 80-years Foundation, Ellen, Walter and Lennart Hesselmans foundation, and The Karolinska Institutet. Ricardo F. S. Carvalho was supported by a Marie Curie Early Stage Research Training Fellowship of the European Unions Sixth Framework Programme under contract number 504926. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Chan RK, 2003, BRIT J SURG, V90, P1470, DOI 10.1002/bjs.4408; Cruse G, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-2; Demasi M, 2003, J BIOL CHEM, V278, P38607, DOI 10.1074/jbc.M305944200; Endoh I, 2007, CLIN EXP IMMUNOL, V148, P161, DOI 10.1111/j.1365-2249.2007.03332.x; Fei PW, 2004, CANCER CELL, V6, P597, DOI 10.1016/j.ccr.2004.10.012; Fischer M, 2006, J CLIN INVEST, V116, P2748, DOI 10.1172/JCI24274; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Gulliksson M, 2006, ALLERGY, V61, P1473, DOI 10.1111/j.1398-9995.2006.01213.x; Gulliksson M, 2007, BBA-MOL CELL BIOL L, V1771, P1156, DOI 10.1016/j.bbalip.2007.06.001; Jeong HJ, 2003, BIOCHEM BIOPH RES CO, V306, P805, DOI 10.1016/S0006-291X(03)01073-8; Lee K, 2007, PHARMACOL THERAPEUT, V113, P229, DOI 10.1016/j.pharmthera.2006.08.001; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Matsui H, 1999, CARDIOVASC RES, V42, P104, DOI 10.1016/S0008-6363(98)00285-5; Metz M, 2007, TRENDS IMMUNOL, V28, P234, DOI 10.1016/j.it.2007.03.003; Molin D, 2001, BRIT J HAEMATOL, V114, P616, DOI 10.1046/j.1365-2141.2001.02977.x; Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257; NILSSON G, 1999, INFLAMMATION BASIC P, P97; Norrby K, 2002, APMIS, V110, P355, DOI 10.1034/j.1600-0463.2002.100501.x; Oskeritzian CA, 2004, J IMMUNOL, V172, P593, DOI 10.4049/jimmunol.172.1.593; Ribatti D, 2004, CLIN EXP ALLERGY, V34, P1660, DOI 10.1111/j.1365-2222.2004.02104.x; Saito H, 1996, J IMMUNOL, V157, P343; Singh Manjeet, 2003, Journal of Cardiovascular Pharmacology and Therapeutics, V8, P135, DOI 10.1177/107424840300800207; Soule BP, 2007, J IMMUNOL, V179, P3276, DOI 10.4049/jimmunol.179.5.3276; Steiner DRS, 2003, J APPL PHYSIOL, V94, P325, DOI 10.1152/japplphysiol.00637.2002; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Sundstrom M, 2003, IMMUNOLOGY, V108, P89, DOI 10.1046/j.1365-2567.2003.01559.x; Suzuki-Nishimura T, 1998, GEN PHARMACOL-VASC S, V31, P617, DOI 10.1016/S0306-3623(98)00066-4; Theoharides TC, 2004, TRENDS IMMUNOL, V25, P235, DOI 10.1016/j.it.2004.02.013; Walczak-Drzewiecka A, 2008, J IMMUNOL, V181, P1665, DOI 10.4049/jimmunol.181.3.1665; WASSERMAN SI, 1984, ARTHRITIS RHEUM, V27, P841, DOI 10.1002/art.1780270801; YANAGIDA M, 1995, BLOOD, V86, P3705, DOI 10.1182/blood.V86.10.3705.bloodjournal86103705; Zhang QZ, 2005, EXP CELL RES, V312, P145, DOI 10.1016/j.yexcr.2005.10.006	33	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12360	10.1371/journal.pone.0012360	http://dx.doi.org/10.1371/journal.pone.0012360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808808	Green Published, Green Submitted, gold			2022-12-25	WOS:000281153500032
J	Kimpel, J; Braun, SE; Qiu, G; Wong, FE; Conolle, M; Schmitz, JE; Brendel, C; Humeau, LM; Dropulic, B; Rossi, JJ; Berger, A; von Laer, D; Johnson, RP				Kimpel, Janine; Braun, Stephen E.; Qiu, Gang; Wong, Fay Eng; Conolle, Michelle; Schmitz, Joern E.; Brendel, Christian; Humeau, Laurent M.; Dropulic, Boro; Rossi, John J.; Berger, Annemarie; von Laer, Dorothee; Johnson, R. Paul			Survival of the Fittest: Positive Selection of CD4+T Cells Expressing a Membrane-Bound Fusion Inhibitor Following HIV-1 Infection	PLOS ONE			English	Article							MODIFIED T-CELLS; IMMUNODEFICIENCY-VIRUS; LENTIVIRAL VECTOR; GP41-DERIVED PEPTIDES; ANTIRETROVIRAL THERAPY; HEMATOPOIETIC-CELLS; GENE-EXPRESSION; LYMPHOCYTES; DELIVERY; CCR5	Although a variety of genetic strategies have been developed to inhibit HIV replication, few direct comparisons of the efficacy of these inhibitors have been carried out. Moreover, most studies have not examined whether genetic inhibitors are able to induce a survival advantage that results in an expansion of genetically-modified cells following HIV infection. We evaluated the efficacy of three leading genetic strategies to inhibit HIV replication: 1) an HIV-1 tat/rev-specific small hairpin (sh) RNA; 2) an RNA antisense gene specific for the HIV-1 envelope; and 3) a viral entry inhibitor, maC46. In stably transduced cell lines selected such that >95% of cells expressed the genetic inhibitor, the RNA antisense envelope and viral entry inhibitor maC46 provided the strongest inhibition of HIV-1 replication. However, when mixed populations of transduced and untransduced cells were challenged with HIV-1, the maC46 fusion inhibitor resulted in highly efficient positive selection of transduced cells, an effect that was evident even in mixed populations containing as few as 1% maC46-expressing cells. The selective advantage of the maC46 fusion inhibitor was also observed in HIV-1-infected cultures of primary T lymphocytes as well as in HIV-1-infected humanized mice. These results demonstrate robust inhibition of HIV replication with the fusion inhibitor maC46 and the antisense Env inhibitor, and importantly, a survival advantage of cells expressing the maC46 fusion inhibitor both in vitro and in vivo. Evaluation of the ability of genetic inhibitors of HIV-1 replication to confer a survival advantage on genetically-modified cells provides unique information not provided by standard techniques that may be important in the in vivo efficacy of these genes.	[Kimpel, Janine; Brendel, Christian; von Laer, Dorothee] Chemotherapeut Forschungsinst Georg Speyer Haus, Frankfurt, Germany; [Braun, Stephen E.; Qiu, Gang; Wong, Fay Eng; Conolle, Michelle; Johnson, R. Paul] Harvard Univ, Sch Med, Div Immunol, New England Primate Res Ctr, Southborough, MA 01772 USA; [Schmitz, Joern E.] Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Dept Med, Boston, MA 02215 USA; [Humeau, Laurent M.; Dropulic, Boro] VIRxSYS Corp, Gaithersburg, MD USA; [Rossi, John J.] Beckman Res Inst City Hope, Div Mol Biol, Duarte, CA USA; [Berger, Annemarie] JW Goethe Univ Hosp, Inst Med Virol, Frankfurt, Germany; [von Laer, Dorothee] Med Univ Innsbruck, Sekt Virol, Innsbruck, Austria; [Johnson, R. Paul] Massachusetts Gen Hosp, Ragon Inst MGH, Massachusetts Inst Technol & Harvard, Charlestown, MA USA; [Johnson, R. Paul] Massachusetts Gen Hosp, Infect Dis Unit, Charlestown, MA USA	Harvard University; Harvard University; Beth Israel Deaconess Medical Center; City of Hope; Beckman Research Institute of City of Hope; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Medical University of Innsbruck; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts General Hospital	Kimpel, J (corresponding author), Chemotherapeut Forschungsinst Georg Speyer Haus, Frankfurt, Germany.	paul_johnson@hms.harvard.edu	Brendel, Christian/HDN-6077-2022; Schmitz, Joern/A-4929-2018	Schmitz, Joern/0000-0001-8803-0922; Brendel, Christian/0000-0003-4081-4351; Kimpel, Janine/0000-0002-5210-7905; von Laer, Dorothee/0000-0001-5825-7237	National Institute of Health (NIH) [R01 CA73473, RR00168]; Partners/Fenway/Shattuck Center for AIDS Research (CFAR); NIH [AI 42851]; Deutsche Forschungsgemeinschaft, DFG [GRK1172]; NATIONAL CANCER INSTITUTE [R01CA073473] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR000168, P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI029329, P30AI042851] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Partners/Fenway/Shattuck Center for AIDS Research (CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by the National Institute of Health (NIH) Grants R01 CA73473, RR00168 and by a developmental award from the Partners/Fenway/Shattuck Center for AIDS Research (CFAR), an NIH-funded program (AI 42851). JK and CB were supported by a scholarship from the Deutsche Forschungsgemeinschaft, DFG, GRK1172. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2004, HUM GENE THER, V15, P251, DOI 10.1089/104303404322886101; An DS, 2007, P NATL ACAD SCI USA, V104, P13110, DOI 10.1073/pnas.0705474104; Beyer WR, 2002, J VIROL, V76, P1488, DOI 10.1128/JVI.76.3.1488-1495.2002; Braun SE, 2005, MOL THER, V12, P1157, DOI 10.1016/j.ymthe.2005.07.698; Braun SE, 2006, FRONT BIOSCI-LANDMRK, V11, P838, DOI 10.2741/1841; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Dropulic B, 2006, HUM GENE THER, V17, P577, DOI 10.1089/hum.2006.17.577; Egelhofer M, 2004, J VIROL, V78, P568, DOI 10.1128/JVI.78.2.568-575.2004; Estes JD, 2008, SEMIN IMMUNOL, V20, P181, DOI 10.1016/j.smim.2008.04.002; Hermann FG, 2009, HUM GENE THER, V20, P325, DOI 10.1089/hum.2006.158; HIGGINS JR, 1992, J MED PRIMATOL, V21, P265; Hildinger M, 2001, J VIROL, V75, P3038, DOI 10.1128/JVI.75.6.3038-3042.2001; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Humeau LM, 2004, MOL THER, V9, P902, DOI 10.1016/j.ymthe.2004.03.005; John V.B, 1990, THERMALLY ACTIVATED, P92, DOI [10.1007/978-1-349-10185-65, DOI 10.1007/978-1-349-10185-65]; Kozal MJ, 2009, CLIN MICROBIOL INFEC, V15, P69, DOI 10.1111/j.1469-0691.2008.02687.x; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103; Li MJ, 2005, MOL THER, V12, P900, DOI 10.1016/j.ymthe.2005.07.524; Lohrengel S, 2005, J VIROL, V79, P10237, DOI 10.1128/JVI.79.16.10237-10246.2005; Lu XB, 2004, J GENE MED, V6, P963, DOI 10.1002/jgm.593; Lu XB, 2004, J VIROL, V78, P7079, DOI 10.1128/JVI.78.13.7079-7088.2004; Macpherson JL, 2005, J GENE MED, V7, P552, DOI 10.1002/jgm.705; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Montessori V, 2004, CAN MED ASSOC J, V170, P229; Morgan RA, 2005, HUM GENE THER, V16, P1065, DOI 10.1089/hum.2005.16.1065; Mukherjee R, 2010, MOL THER, V18, P803, DOI 10.1038/mt.2009.316; Patel AK, 2006, J POSTGRAD MED, V52, P197; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Podsakoff GM, 2005, MOL THER, V12, P77, DOI 10.1016/j.ymthe.2005.02.024; Rossi JJ, 2007, NAT BIOTECHNOL, V25, P1444, DOI 10.1038/nbt1367; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Swan CH, 2006, GENE THER, V13, P1480, DOI 10.1038/sj.gt.3302801; van Lunzen J, 2007, MOL THER, V15, P1024, DOI 10.1038/mt.sj.6300124; von Laer D, 2006, J THEOR BIOL, V238, P60, DOI 10.1016/j.jtbi.2005.05.005; Woffendin C, 1996, P NATL ACAD SCI USA, V93, P2889, DOI 10.1073/pnas.93.7.2889; Zahn RC, 2008, GENE THER, V15, P1210, DOI 10.1038/gt.2008.73; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	39	42	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12357	10.1371/journal.pone.0012357	http://dx.doi.org/10.1371/journal.pone.0012357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808813	gold, Green Published, Green Submitted			2022-12-25	WOS:000281153500030
J	Lee, HJ; Kim, SA; Lee, HJ; Jeong, SJ; Han, I; Jung, JH; Lee, EO; Zhu, SD; Chen, CY; Kim, SH				Lee, Hyo-Jeong; Kim, Seung-Ae; Lee, Hyo-Jung; Jeong, Soo-Jin; Han, Ihn; Jung, Ji Hoon; Lee, Eun-Ok; Zhu, Shudong; Chen, Chang-Yan; Kim, Sung-Hoon			Paeonol Oxime Inhibits bFGF-Induced Angiogenesis and Reduces VEGF Levels in Fibrosarcoma Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SOFT-TISSUE SARCOMAS; MATRIX METALLOPROTEINASES; MELANOMA-CELLS; CANCER-THERAPY; ACTIVATION; EXPRESSION; APOPTOSIS; PATHWAYS; INACTIVATION	Background: We previously reported the anti-angiogenic activity of paeonol isolated from Moutan Cortex. In the present study, we investigated the negative effect of paeonol oxime (PO, a paeonol derivative) on basic fibroblast growth factor (bFGF)-mediated angiogenesis in human umbilical vein endothelial cells (HUVECs) (including tumor angiogenesis) and pro-survival activity in HT-1080 fibrosarcoma cell line. Methodology/Principal Findings: We showed that PO (IC50 = 17.3 mu g/ml) significantly inhibited bFGF-induced cell proliferation, which was achieved with higher concentrations of paeonol (IC50 over 200 mu g). The treatment with PO blocked bFGF-stimulated migration and in vitro capillary differentiation (tube formation) in a dose-dependent manner. Furthermore, PO was able to disrupt neovascularization in vivo. Interestingly, PO (25 mu g/ml) decreased the cell viability of HT-1080 fibrosarcoma cells but not that of HUVECs. The treatment with PO at 12.5 mu g/ml reduced the levels of phosphorylated AKT and VEGF expression (intracellular and extracelluar) in HT-1080 cells. Consistently, immunefluorescence imaging analysis revealed that PO treatment attenuated AKT phosphorylation in HT-1080 cells. Conclusions/Significance: Taken together, these results suggest that PO inhibits bFGF-induced angiogenesis in HUVECs and decreased the levels of PI3K, phospho-AKT and VEGF in HT-1080 cells.	[Lee, Hyo-Jeong; Kim, Seung-Ae; Lee, Hyo-Jung; Jeong, Soo-Jin; Han, Ihn; Jung, Ji Hoon; Lee, Eun-Ok; Kim, Sung-Hoon] Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea; [Zhu, Shudong; Chen, Chang-Yan] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Kyung Hee University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Lee, HJ (corresponding author), Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea.	sungkim7@khu.ac.kr	Lee, Eun-Ok/AAH-9116-2020; Han, Ihn/ABH-6275-2020	Han, Ihn/0000-0002-1372-7319; kim, sunghoon/0000-0002-1570-3230	Korea government (MEST) [2009-0063466]	Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) (No. 2009-0063466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelmann I, 2010, RECENT RESULTS CANC, V180, P51, DOI 10.1007/978-3-540-78281-0_5; Arbiser JL, 2007, BLOOD, V109, P560, DOI 10.1182/blood-2006-06-029934; BICKNELL R, 1994, ANN ONCOL, V5, pS45, DOI 10.1093/annonc/5.suppl_4.S45; Borthwick GM, 2006, FASEB J, V20, P2009, DOI 10.1096/fj.06-5987com; Cezar-de-Mello PFT, 2006, ONCOGENE, V25, P122, DOI 10.1038/sj.onc.1209002; Chao C, 2001, ANN SURG ONCOL, V8, P260, DOI 10.1007/s10434-001-0260-9; Chen PN, 2005, CHEM-BIOL INTERACT, V156, P141, DOI 10.1016/j.cbi.2005.08.005; Chou TC, 2003, BRIT J PHARMACOL, V139, P1146, DOI 10.1038/sj.bjp.0705360; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8; Hsieh CL, 2006, J ETHNOPHARMACOL, V106, P208, DOI 10.1016/j.jep.2005.12.027; Huang H, 2008, INFLAMM RES, V57, P189, DOI 10.1007/s00011-007-7190-3; Huh JE, 2005, CARCINOGENESIS, V26, P1436, DOI 10.1093/carcin/bgi097; Ito Y, 1996, INT J CANCER, V67, P148, DOI 10.1002/(SICI)1097-0215(19960703)67:1<148::AID-IJC24>3.3.CO;2-6; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Kim SA, 2009, BIOL PHARM BULL, V32, P1142, DOI 10.1248/bpb.32.1142; Kim SH, 2004, INT IMMUNOPHARMACOL, V4, P279, DOI 10.1016/j.intimp.2003.12.013; Lee HJ, 2005, BIOL PHARM BULL, V28, P27, DOI 10.1248/bpb.28.27; Lee HJ, 2007, INT J CANCER, V120, P2481, DOI 10.1002/ijc.22486; Lee HJ, 2006, CARCINOGENESIS, V27, P2455, DOI 10.1093/carcin/bgl104; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakashio A, 2002, INT J CANCER, V98, P36, DOI 10.1002/ijc.10166; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Shankar Sharmila, 2008, J Mol Signal, V3, P7, DOI 10.1186/1750-2187-3-7; Shi YH, 2005, J PATHOL, V205, P530, DOI 10.1002/path.1734; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Trisciuoglio D, 2005, MOL BIOL CELL, V16, P4153, DOI 10.1091/mbc.E04-12-1087; Yudoh K, 2001, BRIT J CANCER, V84, P1610, DOI 10.1054/bjoc.2001.1837; Zhang CH, 2008, ANTI-CANCER DRUG, V19, P401, DOI 10.1097/CAD.0b013e3282f7f4eb; Zhang G, 1997, Zhong Yao Cai, V20, P626	32	28	34	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12358	10.1371/journal.pone.0012358	http://dx.doi.org/10.1371/journal.pone.0012358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808805	Green Published, Green Submitted, gold			2022-12-25	WOS:000281153500031
J	Lee, JM; Sathish, P; Donaghy, DJ; Roche, JR				Lee, Julia M.; Sathish, Puthigae; Donaghy, Daniel J.; Roche, John R.			Plants Modify Biological Processes to Ensure Survival following Carbon Depletion: A Lolium perenne Model	PLOS ONE			English	Article							WATER-SOLUBLE CARBOHYDRATE; DACTYLIS-GLOMERATA L.; GENE-EXPRESSION; DEFOLIATION MANAGEMENT; ENERGY RESERVES; HERBAGE QUALITY; LEAF SHEATHS; ROOT-GROWTH; RYEGRASS; REGROWTH	Background: Plants, due to their immobility, have evolved mechanisms allowing them to adapt to multiple environmental and management conditions. Short-term undesirable conditions (e. g. moisture deficit, cold temperatures) generally reduce photosynthetic carbon supply while increasing soluble carbohydrate accumulation. It is not known, however, what strategies plants may use in the long-term to adapt to situations resulting in net carbon depletion (i.e. reduced photosynthetic carbon supply and carbohydrate accumulation). In addition, many transcriptomic experiments have typically been undertaken under laboratory conditions; therefore, long-term acclimation strategies that plants use in natural environments are not well understood. Methodology/Principal Findings: Perennial ryegrass (Lolium perenne L.) was used as a model plant to define whether plants adapt to repetitive carbon depletion and to further elucidate their long-term acclimation mechanisms. Transcriptome changes in both lamina and stubble tissues of field-grown plants with depleted carbon reserves were characterised using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). The RT-qPCR data for select key genes indicated that plants reduced fructan degradation, and increased photosynthesis and fructan synthesis capacities following carbon depletion. This acclimatory response was not sufficient to prevent a reduction (P<0.001) in net biomass accumulation, but ensured that the plant survived. Conclusions: Adaptations of plants with depleted carbon reserves resulted in reduced post-defoliation carbon mobilization and earlier replenishment of carbon reserves, thereby ensuring survival and continued growth. These findings will help pave the way to improve plant biomass production, for either grazing livestock or biofuel purposes.	[Lee, Julia M.; Roche, John R.] DairyNZ Ltd, Hamilton, New Zealand; [Sathish, Puthigae] ViaLactia Biosci NZ Ltd, Pastoral Genom, Auckland, New Zealand; [Donaghy, Daniel J.] Univ Tasmania, Burnie, Tas 7320, Australia	DairyNZ; University of Tasmania	Lee, JM (corresponding author), DairyNZ Ltd, Hamilton, New Zealand.	julia.lee@dairynz.co.nz	Roche, John/ABG-1722-2020	Roche, John/0000-0002-4165-9253; Puthigae, Sathish/0000-0001-8704-437X	DairyNZ; Pastoral Genomics; Foundation for Research, Science and Technology; T.R. Ellett Agricultural Research Trust; University of Tasmania	DairyNZ; Pastoral Genomics; Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); T.R. Ellett Agricultural Research Trust; University of Tasmania	This study was funded by DairyNZ, Pastoral Genomics, the Foundation for Research, Science and Technology, the T.R. Ellett Agricultural Research Trust and a Tasmanian Graduate Research Scholarship from the University of Tasmania. None of the authors were involved in the decision by the funding companies to fund the project, nor did those involved in the decision to fund the study have any role in study design, data collection and analysis, decision to publish or preparation of the manuscript. JML and JRR (DairyNZ) had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Amiard V, 2003, J EXP BOT, V54, P1231, DOI 10.1093/jxb/erg125; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Berthier A, 2009, PLANT CELL PHYSIOL, V50, P1329, DOI 10.1093/pcp/pcp081; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Braun DM, 2009, PLANT PHYSIOL, V149, P71, DOI 10.1104/pp.108.129049; Callow MN, 2005, GRASS FORAGE SCI, V60, P59, DOI 10.1111/j.1365-2494.2005.00451.x; Chalmers J, 2003, J PLANT PHYSIOL, V160, P1385, DOI 10.1078/0176-1617-01107; Chalmers J, 2005, PLANT BIOTECHNOL J, V3, P459, DOI 10.1111/j.1467-7652.2005.00148.x; deVisser R, 1997, PLANT CELL ENVIRON, V20, P37, DOI 10.1046/j.1365-3040.1997.d01-9.x; Donaghy DJ, 2008, AGRON J, V100, P122, DOI 10.2134/agronj2007.0016; Donaghy DJ, 1997, GRASS FORAGE SCI, V52, P401, DOI 10.1111/j.1365-2494.1997.tb02372.x; Donaghy DJ, 1998, GRASS FORAGE SCI, V53, P211, DOI 10.1046/j.1365-2494.1998.00129.x; FULKERSON WJ, 1995, GRASS FORAGE SCI, V50, P16, DOI 10.1111/j.1365-2494.1995.tb02289.x; Fulkerson WJ, 2001, AUST J EXP AGR, V41, P261, DOI 10.1071/EA00062; Graham Ian A., 2000, VVolume 9, P233; Hisano H, 2008, NEW PHYTOL, V178, P766, DOI 10.1111/j.1469-8137.2008.02409.x; KRAPP A, 1993, PLANT J, V3, P817, DOI 10.1111/j.1365-313X.1993.00817.x; LAMP CA, 1990, SPECIES DESCRIPTIONS, P57; Lasseur B, 2007, FUNCT PLANT BIOL, V34, P418, DOI 10.1071/FP06286; Lee JM, 2009, GRASS FORAGE SCI, V64, P266, DOI 10.1111/j.1365-2494.2009.00692.x; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Lytovchenko A, 2007, CURR OPIN PLANT BIOL, V10, P227, DOI 10.1016/j.pbi.2007.04.002; Morvan-Bertrand A, 1999, PLANT CELL ENVIRON, V22, P1097, DOI 10.1046/j.1365-3040.1999.00485.x; Morvan-Bertrand A, 1999, J EXP BOT, V50, P1817, DOI 10.1093/jexbot/50.341.1817; Morvan-Bertrand A, 2001, PLANTA, V213, P109, DOI 10.1007/s004250000478; Paul MJ, 2003, J EXP BOT, V54, P539, DOI 10.1093/jxb/erg052; PRUDHOMME MP, 1992, J PLANT PHYSIOL, V140, P282, DOI 10.1016/S0176-1617(11)81080-1; Rasmussen S., 2009, Proceedings of the New Zealand Grassland Association, V71, P167; Rensink WA, 2004, PLANT PHYSIOL, V135, P622, DOI 10.1104/pp.104.040170; Roche JR, 2009, ANIM PROD SCI, V49, P200, DOI 10.1071/EA07308; Rozen S, 2000, Methods Mol Biol, V132, P365; Sathish P, 2007, PLANT BIOTECHNOL J, V5, P146, DOI 10.1111/j.1467-7652.2006.00228.x; Sawbridge T, 2003, PLANT SCI, V165, P1089, DOI 10.1016/S0168-9452(03)00304-2; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; SMITH D, 1969, REMOVING ANAL TOTAL, P1; Strand A, 1997, PLANT J, V12, P605, DOI 10.1046/j.1365-313X.1997.00605.x; Turner LR, 2006, GRASS FORAGE SCI, V61, P164, DOI 10.1111/j.1365-2494.2006.00523.x; Turner LR, 2006, AUST J AGR RES, V57, P243, DOI 10.1071/AR05130; VSN International Ltd, 2008, GENSTAT REL 11 REF 3; Wissel K, 2003, PLANT PHYSIOL, V133, P1190, DOI 10.1104/pp.103.028191; Xu ZZ, 2006, PLANTA, V224, P1080, DOI 10.1007/s00425-006-0281-5; Xue GP, 2008, PLANT MOL BIOL, V67, P197, DOI 10.1007/s11103-008-9311-y	44	18	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12306	10.1371/journal.pone.0012306	http://dx.doi.org/10.1371/journal.pone.0012306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808836	Green Submitted, gold, Green Published			2022-12-25	WOS:000281077000012
J	Tanabe, H; Takayama, I; Nishiyama, T; Shimazaki, M; Kii, I; Li, MQ; Amizuka, N; Katsube, K; Kudo, A				Tanabe, Hideyuki; Takayama, Issei; Nishiyama, Takashi; Shimazaki, Masashi; Kii, Isao; Li, Minqi; Amizuka, Norio; Katsube, Ken-ichi; Kudo, Akira			Periostin Associates with Notch1 Precursor to Maintain Notch1 Expression under a Stress Condition in Mouse Cells	PLOS ONE			English	Article							OSTEOBLAST-SPECIFIC FACTOR; PERIODONTAL-LIGAMENT; EXTRACELLULAR-MATRIX; RESIDENT PROTEINS; SIGNALING PATHWAY; OXIDATIVE STRESS; RECEPTOR; DIFFERENTIATION; MATURATION; RETICULUM	Background: Matricellular proteins, including periostin, modulate cell-matrix interactions and cell functions by acting outside of cells. Methods and Findings: In this study, however, we reported that periostin physically associates with the Notch1 precursor at its EGF repeats in the inside of cells. Moreover, by using the periodontal ligament of molar from periostin-deficient adult mice (Pn(-/-) molar PDL), which is a constitutively mechanically stressed tissue, we found that periostin maintained the site-1 cleaved 120-kDa transmembrane domain of Notch1 (N1 (TM)) level without regulating Notch1 mRNA expression. N1 (TM) maintenance in vitro was also observed under such a stress condition as heat and H(2)O(2) treatment in periostin overexpressed cells. Furthermore, we found that the expression of a downstream effector of Notch signaling, Bcl-xL was decreased in the Pn(-)(-/) molar PDL, and in the molar movement, cell death was enhanced in the pressure side of Pn(-/-) molar PDL. Conclusion: These results suggest the possibility that periostin inhibits cell death through up-regulation of Bcl-xL expression by maintaining the Notch1 protein level under the stress condition, which is caused by its physical association with the Notch1 precursor.	[Tanabe, Hideyuki; Takayama, Issei; Nishiyama, Takashi; Shimazaki, Masashi; Kii, Isao; Kudo, Akira] Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 227, Japan; [Li, Minqi; Amizuka, Norio] Hokkaido Univ, Grad Sch Dent Med, Dept Dev Biol Hard Tissue, Div Oral Hlth Sci, Sapporo, Hokkaido, Japan; [Katsube, Ken-ichi] Tokyo Med & Dent Univ, Grad Sch, Dept Mol Pathol, Tokyo, Japan	Tokyo Institute of Technology; Hokkaido University; Tokyo Medical & Dental University (TMDU)	Tanabe, H (corresponding author), Tokyo Inst Technol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 227, Japan.	akudo@bio.titech.ac.jp	Amizuka, Norio/G-1397-2012; Kudo, Akira/C-7340-2015; KII, Isao/C-4117-2017; Nishiyama, Takashi/ABC-8965-2021	Kudo, Akira/0000-0001-6289-3391; KII, Isao/0000-0002-6153-6250; Nishiyama, Takashi/0000-0002-4496-240X	Ministry of Education, Science, Culture, and Sports of Japan; Ground-based Research Program for Space Utilization promoted by Japan Space Forum	Ministry of Education, Science, Culture, and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ground-based Research Program for Space Utilization promoted by Japan Space Forum	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Culture, and Sports of Japan, and by grants from the Ground-based Research Program for Space Utilization promoted by Japan Space Forum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Gillan L, 2002, CANCER RES, V62, P5358; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; Gude NA, 2008, CIRC RES, V102, P1025, DOI 10.1161/CIRCRESAHA.107.164749; Hecht JT, 2006, J HISTOCHEM CYTOCHEM, V54, P269, DOI 10.1369/jhc.5C6834.2005; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Karlstrom H, 2002, P NATL ACAD SCI USA, V99, P17119, DOI 10.1073/pnas.252624099; Kessler CB, 2007, ENDOCRINOLOGY, V148, P1666, DOI 10.1210/en.2006-0443; Kii I, 2006, BIOCHEM BIOPH RES CO, V342, P766, DOI 10.1016/j.bbrc.2006.02.016; Kim BY, 2009, J BIOL CHEM, V284, P19580, DOI 10.1074/jbc.M109.013607; Kruzynska-Frejtag A, 2001, MECH DEVELOP, V103, P183, DOI 10.1016/S0925-4773(01)00356-2; Lindner V, 2005, ARTERIOSCL THROM VAS, V25, P77, DOI 10.1161/01.ATV.0000149141.81230.c6; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Morrow D, 2005, CIRC RES, V96, P567, DOI 10.1161/01.RES.0000159182.98874.43; Norris RA, 2008, ANN NY ACAD SCI, V1123, P30, DOI 10.1196/annals.1420.005; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Paravicini TM, 2006, CARDIOVASC RES, V71, P247, DOI 10.1016/j.cardiores.2006.05.001; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Sakamoto K, 2005, EXP CELL RES, V302, P281, DOI 10.1016/j.yexcr.2004.09.016; Sakamoto K, 2002, J BIOL CHEM, V277, P29399, DOI 10.1074/jbc.M203727200; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Tkatchenko TV, 2009, PHYSIOL GENOMICS, V39, P160, DOI 10.1152/physiolgenomics.00078.2009; Van Der Vlies D, 2003, ANTIOXID REDOX SIGN, V5, P381, DOI 10.1089/152308603768295113; van der Vlies D, 2002, BIOCHEM J, V366, P825, DOI 10.1042/BJ20020618	29	44	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12234	10.1371/journal.pone.0012234	http://dx.doi.org/10.1371/journal.pone.0012234			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805882	Green Submitted, Green Published, gold			2022-12-25	WOS:000281011600013
J	Dumas, F; Byrne, RD; Vincent, B; Hobday, TMC; Poccia, DL; Larijani, B				Dumas, Fabrice; Byrne, Richard D.; Vincent, Ben; Hobday, Tina M. C.; Poccia, Dominic L.; Larijani, Banafshe			Spatial Regulation of Membrane Fusion Controlled by Modification of Phosphoinositides	PLOS ONE			English	Article							PHOSPHOLIPASE-C; PHOSPHATIDYLINOSITOL; BINDING; VESICLES	Membrane fusion plays a central role in many cell processes from vesicular transport to nuclear envelope reconstitution at mitosis but the mechanisms that underlie fusion of natural membranes are not well understood. Studies with synthetic membranes and theoretical considerations indicate that accumulation of lipids characterised by negative curvature such as diacylglycerol (DAG) facilitate fusion. However, the specific role of lipids in membrane fusion of natural membranes is not well established. Nuclear envelope (NE) assembly was used as a model for membrane fusion. A natural membrane population highly enriched in the enzyme and substrate needed to produce DAG has been isolated and is required for fusions leading to nuclear envelope formation, although it contributes only a small amount of the membrane eventually incorporated into the NE. It was postulated to initiate and regulate membrane fusion. Here we use a multidisciplinary approach including subcellular membrane purification, fluorescence spectroscopy and Forster resonance energy transfer (FRET)/two-photon fluorescence lifetime imaging microscopy (FLIM) to demonstrate that initiation of vesicle fusion arises from two unique sites where these vesicles bind to chromatin. Fusion is subsequently propagated to the endoplasmic reticulum-derived membranes that make up the bulk of the NE to ultimately enclose the chromatin. We show how initiation of multiple vesicle fusions can be controlled by localised production of DAG and propagated bidirectionally. Phospholipase C (PLC gamma), GTP hydrolysis and (phosphatidylinsositol-(4,5)-bisphosphate (PtdIns(4,5)P-2) are required for the latter process. We discuss the general implications of membrane fusion regulation and spatial control utilising such a mechanism.	[Dumas, Fabrice; Byrne, Richard D.; Hobday, Tina M. C.; Larijani, Banafshe] Canc Res UK, Cell Biophys Lab, Lincolns Inn Fields Labs, London, England; [Dumas, Fabrice] CNRS, IPBS, Toulouse, France; [Dumas, Fabrice] Univ Toulouse, UPS, IPBS, Toulouse, France; [Vincent, Ben; Poccia, Dominic L.] Amherst Coll, Dept Biol, Amherst, MA 01002 USA	Cancer Research UK; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Amherst College	Dumas, F (corresponding author), Canc Res UK, Cell Biophys Lab, Lincolns Inn Fields Labs, London, England.	dlpoccia@amherst.edu; banafshe.larijani@cancer.org.uk	Larijani, Banafshe/H-3909-2015	Larijani, Banafshe/0000-0003-4735-1169; Dumas, Fabrice/0000-0002-9164-4527	Cancer Research UK; Amherst College	Cancer Research UK(Cancer Research UK); Amherst College	This work was funded by the core funding of Cancer Research UK and Amherst College FRAP award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott B, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.181103; Barona T, 2005, J BIOL CHEM, V280, P41171, DOI 10.1074/jbc.M412863200; Byrne RD, 2005, BIOCHEM J, V387, P393, DOI 10.1042/BJ20040947; Byrne RD, 2007, CELL SIGNAL, V19, P913, DOI 10.1016/j.cellsig.2006.10.011; Byrne RD, 2009, CLIN LIPIDOL, V4, P103, DOI 10.2217/17584299.4.1.103; Byrne RD, 2009, ADV ENZYME REGUL, V49, P148, DOI 10.1016/j.advenzreg.2008.12.010; Byrne Richard D., 2008, V464, P207; CAMERON LA, 1994, DEV BIOL, V162, P568, DOI 10.1006/dbio.1994.1110; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; COLLAS P, 1995, DEV BIOL, V169, P123, DOI 10.1006/dbio.1995.1132; Collas P, 1998, METHOD CELL BIOL, V53, P417; Collas P, 1996, J CELL SCI, V109, P1275; Collas P, 1996, EUR J CELL BIOL, V71, P22; COTHREN CC, 1993, EXP CELL RES, V205, P126, DOI 10.1006/excr.1993.1066; Garnier-Lhomme M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004255; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Larijani B, 2001, BIOCHEM J, V356, P495, DOI 10.1042/0264-6021:3560495; Larijani B., 2007, SIGNAL TRANSDUCT, V7, P142, DOI [10.1002/sita.200600128, DOI 10.1002/SITA.200600128]; Larijani B, 2009, ANNU REV BIOPHYS, V38, P107, DOI 10.1146/annurev.biophys.050708.133625; Poccia D, 2009, BIOCHEM J, V418, P233, DOI 10.1042/BJ20082105; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; TERASAKI M, 1991, J CELL BIOL, V114, P929, DOI 10.1083/jcb.114.5.929; Villar AV, 2000, BIOCHEMISTRY-US, V39, P14012, DOI 10.1021/bi992515c	24	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12208	10.1371/journal.pone.0012208	http://dx.doi.org/10.1371/journal.pone.0012208			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808914	Green Published, gold, Green Submitted			2022-12-25	WOS:000280968100012
J	Schaller, MA; Logue, H; Mukherjee, S; Lindell, DM; Coelho, AL; Lincoln, P; Carson, WF; Ito, T; Cavassani, KA; Chensue, SW; Hogaboam, CM; Lukacs, NW; Kunkel, SL				Schaller, Matthew A.; Logue, Hannah; Mukherjee, Sumanta; Lindell, Dennis M.; Coelho, Ana Lucia; Lincoln, Pamela; Carson, William F.; Ito, Toshihiro; Cavassani, Karen A.; Chensue, Stephen W.; Hogaboam, Cory M.; Lukacs, Nicholas W.; Kunkel, Steven L.			Delta-Like 4 Differentially Regulates Murine CD4(+) T Cell Expansion via BMI1	PLOS ONE			English	Article							IN-VIVO; GATA3 EXPRESSION; DENDRITIC CELLS; NOTCH LIGANDS; MEMORY; ACTIVATION; ANTIGEN; RESPONSES; SUBSETS; GENE	Background: Studies have shown that Notch is essential for the maintenance of a T cell Th2 phenotype in vivo. It has also been shown that Notch ligands have diverse functions during T cell activation. We chose to investigate the role of Notch ligands during the Th2 response. Principal Findings: We studied the relationship of two Notch ligands, delta-like 4 and jagged-1, to T cell proliferation in C57 Bl/6 mice. Our findings indicate that jagged-1 does not affect the rate of T cell proliferation in any subset examined. However, delta-like 4 causes an increase in the expansion of Th2 memory cells and a decrease in effector cell proliferation. Our in vivo studies indicate that the Notch system is dynamically regulated, and that blocking one Notch ligand increases the effective concentration of other Notch ligands, thus altering the response. Examination of genes related to the Notch pathway revealed that the Notch receptors were increased in memory T cells. Expression of BMI1, a gene involved in T cell proliferation, was also higher in memory T cells. Further experiments demonstrated that Notch directly regulates the expression of the BMI1 gene in T cells and may govern T cell proliferation through this pathway. Conclusions: From these experiments we can make several novel conclusions about the role of Notch ligands in T cell biology. The first is that delta-like 4 suppresses effector cell proliferation and enhances Th2 memory cell proliferation. The second is that blocking one Notch ligand in vivo effectively increases the concentration of other Notch ligands, which can then alter the response.	[Schaller, Matthew A.; Logue, Hannah; Mukherjee, Sumanta; Coelho, Ana Lucia; Lincoln, Pamela; Carson, William F.; Ito, Toshihiro; Cavassani, Karen A.; Chensue, Stephen W.; Hogaboam, Cory M.; Lukacs, Nicholas W.; Kunkel, Steven L.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Lindell, Dennis M.] Seattle Childrens Hosp, Ctr Immun & Immunotherapies, Seattle, WA USA	University of Michigan System; University of Michigan; Seattle Children's Hospital	Schaller, MA (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	mschalle@umich.edu	hogaboam, cory/M-3578-2014; Hogaboam, Cory M./AAI-1433-2021; Lukacs, Nicholas W/ABH-5583-2020; Schaller, Matthew/AAL-7640-2020	Hogaboam, Cory M./0000-0003-3366-4850; Carson, William F/0000-0001-9459-3924	National Institutes of Health [HL092853, HL089210, HL031963, HL031237]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031237, R01HL089216, R33HL092853, P01HL031963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI077712, R01AI043460, R01AI073876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by National Institutes of Health grants HL092853, HL089210, HL031963, and HL031237. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Carter LL, 1998, J IMMUNOTHER, V21, P181, DOI 10.1097/00002371-199805000-00003; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; GOH F, 2008, IMMUNOLOGY; Hosokawa H, 2006, J IMMUNOL, V177, P7656, DOI 10.4049/jimmunol.177.11.7656; Ito T, 2009, J CLIN INVEST, V119, P33, DOI 10.1172/JCI35647; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; JOSHI I, 2008, BLOOD; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Matsukawa A, 2000, J IMMUNOL, V164, P1699, DOI 10.4049/jimmunol.164.4.1699; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; McKinstry KK, 2007, J EXP MED, V204, P2199, DOI 10.1084/jem.20070041; Miyazaki M, 2008, IMMUNITY, V28, P231, DOI 10.1016/j.immuni.2007.12.013; Mukherjee S, 2009, J IMMUNOL, V182, P7381, DOI 10.4049/jimmunol.0804322; Nakayama T, 2009, SEMIN IMMUNOL, V21, P78, DOI 10.1016/j.smim.2009.02.001; Okamoto M, 2009, J IMMUNOL, V183, P2995, DOI 10.4049/jimmunol.0900692; Page K, 2008, J IMMUNOL, V180, P6317, DOI 10.4049/jimmunol.180.9.6317; Raaphorst FM, 2001, J IMMUNOL, V166, P5925, DOI 10.4049/jimmunol.166.10.5925; Rudd BD, 2007, J IMMUNOL, V178, P5820, DOI 10.4049/jimmunol.178.9.5820; Rutz S, 2005, EUR J IMMUNOL, V35, P2443, DOI 10.1002/eji.200526294; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schaller MA, 2007, J EXP MED, V204, P2925, DOI 10.1084/jem.20070661; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Tan AM, 2010, J IMMUNOL, V184, P3535, DOI 10.4049/jimmunol.0900340; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Wen HT, 2008, BLOOD, V111, P1797, DOI 10.1182/blood-2007-08-106443; Yamashita M, 2008, J EXP MED, V205, P1109, DOI 10.1084/jem.20072000; Zhou L, 2008, BLOOD, V112, P308, DOI 10.1182/blood-2007-11-115204	35	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12172	10.1371/journal.pone.0012172	http://dx.doi.org/10.1371/journal.pone.0012172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808960	Green Submitted, gold, Green Published			2022-12-25	WOS:000280968100007
J	Remels, AHV; Gosker, HR; Schrauwen, P; Hommelberg, PPH; Sliwinski, P; Polkey, M; Galdiz, J; Wouters, EFM; Langen, RCJ; Schols, AMWJ				Remels, A. H. V.; Gosker, H. R.; Schrauwen, P.; Hommelberg, P. P. H.; Sliwinski, P.; Polkey, M.; Galdiz, J.; Wouters, E. F. M.; Langen, R. C. J.; Schols, A. M. W. J.			TNF-alpha impairs regulation of muscle oxidative phenotype: implications for cachexia?	FASEB JOURNAL			English	Article						inflammation; nuclear factor kappa B; peroxisome proliferator-activated receptors; mitochondrial transcription factor A	OBSTRUCTIVE PULMONARY-DISEASE; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; SKELETAL-MUSCLE; MITOCHONDRIAL-FUNCTION; SYSTEMIC INFLAMMATION; NUTRITIONAL DEPLETION; VASTUS LATERALIS; COPD; EXPRESSION	Chronic obstructive pulmonary disease (COPD) is characterized by weight loss, muscle wasting (in advanced disease ultimately resulting in cachexia), and loss of muscle oxidative phenotype (oxphen). This study investigates the effect of inflammation (as a determinant of muscle wasting) on muscle oxphen by using cell studies combined with analyses of muscle biopsies of patients with COPD and control participants. We analyzed markers (citrate synthase, beta-hydroxya-cyl-CoA dehydrogenase, and cytochrome c oxidase IV) and regulators (PGC-1 alpha, PPAR-alpha, and Tfam) of oxphen in vastus lateralis muscle biopsies of patients with advanced COPD and healthy smoking control participants. Here 17 of 73 patients exhibited elevated muscle TNF-alpha mRNA levels. In these patients, significantly lower mRNA levels of all oxidative markers/regulators were found. Interestingly, these patients also had a significantly lower body mass index and tended to have less muscle mass. In cultured muscle cells, mitochondrial protein content and myosin heavy chain isoform I (but not II) protein and mRNA levels were reduced on chronic TNF-alpha stimulation. TNF-alpha also reduced mitochondrial respiration in a nuclear factor kappaB (NF kappa B) -dependent manner. Importantly, TNF-alpha-induced NF-kappa B activation decreased promoter transactivation and transcriptional activity of regulators of mitochondrial biogenesis and muscle oxphen. In conclusion, these results demonstrate that TNF-alpha impairs muscle oxphen in a NF-kappa B-dependent manner.-Remels, A. H. V., Gosker, H. R., Schrauwen, P., Hommelberg, P. P. H., Sliwinski, P., Polkey, M., Galdiz, J., Wouters, E. F. M., Langen, R. C. J., Schols, A. M. W. J. TNF-alpha impairs regulation of muscle oxidative phenotype: implications for cachexia? FASEB J. 24, 5052-5062 (2010). www.fasebj.org	[Remels, A. H. V.; Gosker, H. R.; Wouters, E. F. M.; Langen, R. C. J.; Schols, A. M. W. J.] Maastricht Univ Med Ctr, Dept Resp Med, NUTRIM Sch Nutr Toxicol & Metab, NL-6202 AZ Maastricht, Netherlands; [Schrauwen, P.; Hommelberg, P. P. H.] Maastricht Univ Med Ctr, Dept Human Biol, NUTRIM Sch Nutr Toxicol & Metab, NL-6202 AZ Maastricht, Netherlands; [Sliwinski, P.] Inst TB & Lung Dis, Dept Resp Med, Warsaw, Poland; [Polkey, M.] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Dept Resp Med, London, England; [Galdiz, J.] Univ Basque Country, Cruces Hosp, Dept Pneumol, Baracaldo, Spain; [Galdiz, J.] Univ Basque Country, Cruces Hosp, Res Unit, Baracaldo, Spain; [Wouters, E. F. M.] Ctr Integrated Rehabil Organ Failure CIRO, Horn, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Imperial College London; Royal Brompton Hospital; Hospital Universitario Cruces; University of Basque Country; Hospital Universitario Cruces; University of Basque Country	Schols, AMWJ (corresponding author), Maastricht Univ Med Ctr, Dept Resp Med, NUTRIM Sch Nutr Toxicol & Metab, POB 5800, NL-6202 AZ Maastricht, Netherlands.	a.schols@pul.unimaas.nl	Dispositivos, Desarrollo/E-5176-2012; Galdiz, Juan Bautista/G-4977-2012; Wouters, Emiel/ABD-6200-2021	schrauwen, patrick/0000-0002-0973-847X; Gosker, Harry/0000-0002-7659-0225	Netherlands Asthma Foundation (NAF) [3.4.05.038, 3.2.08.061]; Royal Netherlands Academy of Arts and Sciences; VENI [VENI 916.56.112]; ENIGMA [QLK6-CT-2002-02285]	Netherlands Asthma Foundation (NAF); Royal Netherlands Academy of Arts and Sciences; VENI(Netherlands Organization for Scientific Research (NWO)); ENIGMA(European Commission)	The authors thank Dr. S. Wagers for critical and careful reviewing of the content of the paper and assistance with English. The authors also thank Dr. Marc van Bilsen (Maastricht University, Maastricht, The Netherlands) for delivering constructs encoding PPAR isoforms and PGC-1 alpha. The authors acknowledge E. Phielix for excellent technical support in cellular respiration measurements and M. Kelders for practical help in carrying out QPCR procedures. The authors have no conflicting financial interests. Funding sources had no involvement in collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. The research of H. R. G. is supported by a grant from the Netherlands Asthma Foundation (NAF 3.4.05.038). The research of P. Schrauwen has been made possible by fellowships of the Royal Netherlands Academy of Arts and Sciences. R.C.J.L. was sponsored by a VENI grant (VENI 916.56.112). A. H. V. R. is supported by a grant from Numico Research and a travel fellowship from the Netherlands Asthma Foundation (NAF 3.2.08.061). The ENIGMA study was sponsored by ENIGMA grant QLK6-CT-2002-02285.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; ALTMAN DG, 1983, BRIT MED J, V286, P1489, DOI 10.1136/bmj.286.6376.1489; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Barreiro E, 2008, THORAX, V63, P100, DOI 10.1136/thx.2007.078030; Broekhuizen R, 2005, THORAX, V60, P376, DOI 10.1136/thx.2004.030858; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; CERAMI A, 1985, IMMUNOL LETT, V11, P173, DOI 10.1016/0165-2478(85)90165-8; Chabi B, 2009, J APPL PHYSIOL, V107, P1730, DOI 10.1152/japplphysiol.91451.2008; Couillard A, 2005, EUR RESPIR J, V26, P703, DOI 10.1183/09031936.05.00139904; Crul T, 2007, EUR J CLIN INVEST, V37, P897, DOI 10.1111/j.1365-2362.2007.01867.x; de Oca MM, 2005, EUR RESPIR J, V26, P390, DOI 10.1183/09031936.05.00107404; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Fabbri Leonardo, 2004, COPD, V1, P105; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Gosker HR, 2007, THORAX, V62, P944, DOI 10.1136/thx.2007.078980; Gosker HR, 2009, AM J RESP CELL MOL, V40, P710, DOI 10.1165/rcmb.2008-0312OC; Gosker HR, 2006, AM J PHYSIOL-ENDOC M, V290, pE976, DOI 10.1152/ajpendo.00336.2005; Gosker HR, 2002, EUR RESPIR J, V19, P617, DOI 10.1183/09031936.02.00762001; Gosker HR, 2002, AM J CLIN NUTR, V76, P113, DOI 10.1093/ajcn/76.1.113; Gugneja S, 1996, MOL CELL BIOL, V16, P5708; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jia L, 1996, BLOOD, V87, P2401, DOI 10.1182/blood.V87.6.2401.bloodjournal8762401; LANCASTER JR, 1989, FEBS LETT, V248, P169, DOI 10.1016/0014-5793(89)80454-5; Langen RCJ, 2006, AM J RESP CELL MOL, V35, P689, DOI 10.1165/rcmb.2006-0103OC; Langen RCJ, 2001, FASEB J, V15, pA1080; Lanza IR, 2010, ACTA PHYSIOL, V199, P529, DOI 10.1111/j.1748-1716.2010.02124.x; LEE MD, 1987, P NATL ACAD SCI USA, V84, P2590, DOI 10.1073/pnas.84.9.2590; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Lyons CN, 2004, BIOCHEM CELL BIOL, V82, P391, DOI 10.1139/O04-040; Marin-Garcia J, 2001, CARDIOVASC RES, V52, P103, DOI 10.1016/S0008-6363(01)00368-6; Mensink M, 2007, INT J OBESITY, V31, P1302, DOI 10.1038/sj.ijo.0803567; Pajak B, 2008, J PHYSIOL PHARMACOL, V59, P251; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Petersen AM, 2009, J CLIN ENDOCR METAB, V94, P294, DOI 10.1210/jc.2008-1110; Puente-Maestu L, 2009, EUR RESPIR J, V33, P1045, DOI 10.1183/09031936.00112408; Rabinovich RA, 2007, EUR RESPIR J, V29, P643, DOI 10.1183/09031936.00086306; Remels AH, 2007, EUR RESPIR J, V30, P245, DOI 10.1183/09031936.00144106; Remels AHV, 2009, AM J PHYSIOL-ENDOC M, V297, pE174, DOI 10.1152/ajpendo.90632.2008; Safdar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010778; Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53; SCHOLS AMWJ, 1993, AM REV RESPIR DIS, V147, P1151, DOI 10.1164/ajrccm/147.5.1151; SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317; Sin DD, 2007, CAN J PHYSIOL PHARM, V85, P141, DOI 10.1139/Y06-093; Tang K, 2010, J CELL PHYSIOL, V222, P320, DOI 10.1002/jcp.21955; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; TRACEY KJ, 1988, J EXP MED, V167, P1211, DOI 10.1084/jem.167.3.1211; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; van der Velden JLJ, 2007, AM J PHYSIOL-CELL PH, V292, pC1636, DOI 10.1152/ajpcell.00504.2006; van Wetering CR, 2010, J AM MED DIR ASSOC, V11, P179, DOI 10.1016/j.jamda.2009.12.083; Vermeeren MAP, 2006, RESP MED, V100, P1349, DOI 10.1016/j.rmed.2005.11.023; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wust Rob C I, 2007, Int J Chron Obstruct Pulmon Dis, V2, P289; Zhao Cai-Yan, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P96	55	96	97	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					5052	5062		10.1096/fj.09-150714	http://dx.doi.org/10.1096/fj.09-150714			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20807714				2022-12-25	WOS:000284824400043
J	Uberti, B; Dentelli, P; Rosso, A; Defilippi, P; Brizzi, MF				Uberti, B.; Dentelli, P.; Rosso, A.; Defilippi, P.; Brizzi, M. F.			Inhibition of beta 1 integrin and IL-3R beta common subunit interaction hinders tumour angiogenesis	ONCOGENE			English	Article						IL-3; IL-3 receptor; beta 1 integrin; endothelial progenitor cells; tumour angiogenesis	ENDOTHELIAL PROGENITOR CELLS; GROWTH-FACTOR; INTERLEUKIN-3; IL-3; RECRUITMENT; VASCULATURE; EXPRESSION; RECEPTORS; SURVIVAL; PROTEIN	Integrin/cytokine receptor interaction provides permissive signals leading to neoangiogenesis, and integrins are crucial for differentiation of endothelial progenitor cells (EPCs). It is known that the inflammatory interleukin-3 (IL-3), released in the tumoral microenvironment, contributes to both angiogenesis and vasculogenic processes. Herein, we generated IL-3 receptor beta common (IL-3R beta c) extracellular domain-derived fusion proteins (Fc) to elucidate the molecular mechanisms regulating these processes. Three different Fc were generated, containing the entire extracellular domain of IL-3R beta c (Fc1.4), a fragment corresponding to domains 1-3 (Fc1.3) and a fragment corresponding to domain 4 (Fc4), respectively. The ability of the fusion proteins to interfere with IL-3R beta c/beta 1 integrin interaction was assessed on endothelial cells (ECs), EPCs and murine-derived ECs. Pull-down experiments showed that Fc1.4 and Fc4 fusion proteins specifically interacted with beta 1 integrin. Fc4 and Fc1.4 fragments prevented IL-3-mediated EPC expansion, arterial morphogenesis and tumour-derived EC migration, without affecting cell adhesion. Fc4 in vivo inhibited the IL-3-mediated vasculogenic process, as well as inflammatory and tumour vascular growth. In conclusion, these data identify the b1 integrin-interacting domain in the juxta-membrane IL-3Rbc extracellular domain, and provide the rational for targeting this interaction to impair vascular growth. Oncogene (2010) 29, 6581-6590; doi:10.1038/onc.2010.384; published online 30 August 2010	[Uberti, B.; Dentelli, P.; Rosso, A.; Brizzi, M. F.] Univ Turin, Dept Internal Med, I-10126 Turin, Italy; [Defilippi, P.] Univ Turin, Ctr Mol Biotechnol, I-10126 Turin, Italy; [Defilippi, P.] Univ Turin, Ctr Expt Res & Med Studies, I-10126 Turin, Italy	University of Turin; University of Turin; University of Turin	Brizzi, MF (corresponding author), Univ Turin, Dept Internal Med, Corso Dogliotti 14, I-10126 Turin, Italy.	mariafelice.brizzi@unito.it	DEFILIPPI, Paola/L-2232-2014; Brizzi, Maria Felice/J-7882-2016	Defilippi, Paola/0000-0001-6427-4906	Italian Association for Cancer Research (AIRC); Association for International Cancer Research (AICR); Regione Piemonte (OncoProt, Druidi, PIStem); EU	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Association for International Cancer Research (AICR); Regione Piemonte (OncoProt, Druidi, PIStem)(Regione Piemonte); EU(European Commission)	This work was supported by grants from the Italian Association for Cancer Research (AIRC) to MFB and PD, Association for International Cancer Research (AICR), Regione Piemonte (OncoProt, Druidi, PIStem) and EU FP7 Metafight to PD We thank Dr Alessandra Baragli and Dr Natalie Lassen for critical reading and final editing of the paper.	Ahn GO, 2009, ANGIOGENESIS, V12, P159, DOI 10.1007/s10456-009-9135-7; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; Bellik L, 2005, FEBS LETT, V579, P2731, DOI 10.1016/j.febslet.2005.04.003; Biancone L, 1999, J IMMUNOL, V162, P5263; Brizzi MF, 1999, CIRC RES, V84, P785; Buitenhuis M, 2004, INT J BIOCHEM CELL B, V36, P2120, DOI 10.1016/j.biocel.2003.11.008; Bussolati B, 2003, FASEB J, V17, P1159, DOI 10.1096/fj.02-0557fje; Carr PD, 2001, CELL, V104, P291, DOI 10.1016/S0092-8674(01)00213-6; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Defilippi P, 2005, J CELL BIOL, V168, P1099, DOI 10.1083/jcb.200405116; Dentelli P, 2005, ONCOGENE, V24, P6394, DOI 10.1038/sj.onc.1208786; Dentelli P, 2004, ONCOGENE, V23, P1681, DOI 10.1038/sj.onc.1207290; Dentelli P, 1999, J IMMUNOL, V163, P2151; Dentelli P, 2007, BLOOD, V109, P4264, DOI 10.1182/blood-2006-06-029603; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Furuya M, 2009, CURR PHARM DESIGN, V15, P1854, DOI 10.2174/138161209788453275; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gao DC, 2009, BBA-REV CANCER, V1796, P33, DOI 10.1016/j.bbcan.2009.05.001; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Giraudo E, 1996, J IMMUNOL, V157, P2618; Groger M, 2004, J IMMUNOL, V173, P7161, DOI 10.4049/jimmunol.173.12.7161; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hutchings H, 2003, FASEB J, V17, P1520, DOI 10.1096/fj.02-0691fje; KIBBEY MC, 1992, J NATL CANCER I, V84, P1633, DOI 10.1093/jnci/84.21.1633; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; MUI ALF, 1995, J LEUKOCYTE BIOL, V57, P799, DOI 10.1002/jlb.57.5.799; Naldini Antonella, 2005, Current Drug Targets - Inflammation and Allergy, V4, P3, DOI 10.2174/1568010053622830; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; PEOPLES GE, 1995, P NATL ACAD SCI USA, V92, P6547, DOI 10.1073/pnas.92.14.6547; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Reddy EP, 2000, ONCOGENE, V19, P2532, DOI 10.1038/sj.onc.1203594; Schroeter MR, 2008, CIRC RES, V103, P536, DOI 10.1161/CIRCRESAHA.107.169375; Shaked Y, 2008, CANCER CELL, V14, P263, DOI 10.1016/j.ccr.2008.08.001; Shaked Y, 2007, CANCER RES, V67, P7055, DOI 10.1158/0008-5472.CAN-07-0905; Shojaei F, 2008, DRUG RESIST UPDATE, V11, P219, DOI 10.1016/j.drup.2008.09.001; Silva RAGD, 2008, ARTERIOSCL THROM VAS, V28, pE64; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; Togliatto G, 2010, DIABETES, V59, P1016, DOI 10.2337/db09-0858; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Zeoli A, 2008, BLOOD, V112, P350, DOI 10.1182/blood-2007-12-128215	45	22	22	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2010	29	50					6581	6590		10.1038/onc.2010.384	http://dx.doi.org/10.1038/onc.2010.384			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	695OA	20802515				2022-12-25	WOS:000285380200007
J	Xu, K; Rajagopal, S; Klebba, I; Dong, S; Ji, Y; Liu, J; Kuperwasser, C; Garlick, JA; Naber, SP; Buchsbaum, RJ				Xu, K.; Rajagopal, S.; Klebba, I.; Dong, S.; Ji, Y.; Liu, J.; Kuperwasser, C.; Garlick, J. A.; Naber, S. P.; Buchsbaum, R. J.			The role of fibroblast Tiam1 in tumor cell invasion and metastasis	ONCOGENE			English	Article						Tiam1; Rac; tumor-associated fibroblasts; invasion; metastasis	RAC ACTIVATOR TIAM1; NUCLEOTIDE-EXCHANGE FACTORS; RHO-GTPASES; GENETIC ALTERATIONS; ACTIN CYTOSKELETON; CANCER METASTASIS; EPITHELIAL-CELLS; PROGRESSION; SKIN; PROTEINS	The co-evolution of tumors and their microenvironment involves bidirectional communication between tumor cells and tumor-associated stroma. Various cell types are present in tumor-associated stroma, of which fibroblasts are the most abundant. The Rac exchange factor Tiam1 is implicated in multiple signaling pathways in epithelial tumor cells and lack of Tiam1 in tumor cells retards tumor growth in Tiam1 knockout mouse models. Conversely, tumors arising in Tiam1 knockout mice have increased invasiveness. We have investigated the role of Tiam1 in tumor-associated fibroblasts as a modulator of tumor cell invasion and metastasis, using retroviral delivery of short hairpin RNA to suppress Tiam1 levels in three different experimental models. In spheroid co-culture of mammary epithelial cells and fibroblasts, Tiam1 silencing in fibroblasts led to increased epithelial cell outgrowth into matrix. In tissue-engineered human skin, Tiam1 silencing in dermal fibroblasts led to increased invasiveness of epidermal keratinocytes with pre-malignant features. In a model of human breast cancer in mice, co-implantation of mammary fibroblasts inhibited tumor invasion and metastasis, which was reversed by Tiam1 silencing in co-injected fibroblasts. These results suggest that stromal Tiam1 may have a role in modulating the effects of the tumor microenvironment on malignant cell invasion and metastasis. This suggests a set of pathways for further investigation, with implications for future therapeutic targets. Oncogene (2010) 29, 6533-6542; doi:10.1038/onc.2010.385; published online 30 August 2010	[Xu, K.; Rajagopal, S.; Dong, S.; Ji, Y.; Liu, J.; Buchsbaum, R. J.] Tufts Univ, Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Dong, S.; Kuperwasser, C.; Garlick, J. A.; Buchsbaum, R. J.] Tufts Univ, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; [Naber, S. P.] Tufts Univ, Tufts Med Ctr, Dept Pathol, Boston, MA 02111 USA; [Buchsbaum, R. J.] Tufts Univ, Tufts Med Ctr, Dept Med, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University; Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University	Buchsbaum, RJ (corresponding author), Tufts Univ, Tufts Med Ctr, Mol Oncol Res Inst, 800 Washington St,Box 245, Boston, MA 02111 USA.	rbuchsbaum@tuftsmedicalcenter.org			NIH [CA 095559, CA12555]; Vermont Community Foundation; Breast Cancer Research Foundation; Diane Connolly-Zaniboni Research Scholarship in Breast Cancer; Tufts Medical Center GRASP Digestive Disease Center [P30-DK34928]; Design and Data Resource Center of the Tufts Clinical; Translational Science Institute (National Center for Research Resources) [UL1 RR025752]; NATIONAL CANCER INSTITUTE [R01CA095559, R01CA125554] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vermont Community Foundation; Breast Cancer Research Foundation; Diane Connolly-Zaniboni Research Scholarship in Breast Cancer; Tufts Medical Center GRASP Digestive Disease Center; Design and Data Resource Center of the Tufts Clinical; Translational Science Institute (National Center for Research Resources)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH (RB: CA 095559 and CK: CA12555), the Landmann Family Fund of the Vermont Community Foundation (RB), the Breast Cancer Research Foundation (CK), the Diane Connolly-Zaniboni Research Scholarship in Breast Cancer (RB), the Tufts Medical Center GRASP Digestive Disease Center (RB, P30-DK34928) and the Design and Data Resource Center of the Tufts Clinical and Translational Science Institute (National Center for Research Resources: UL1 RR025752).	Andriani F, 2004, INT J CANCER, V108, P348, DOI 10.1002/ijc.11525; Baines AT, 2006, METHOD ENZYMOL, V407, P556, DOI 10.1016/S0076-6879(05)07045-X; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOUKAMP P, 1990, CANCER RES, V50, P2840; Buchsbaum RJ, 2007, J CELL SCI, V120, P1149, DOI 10.1242/jcs.03428; Connolly BA, 2005, MOL CELL BIOL, V25, P4602, DOI 10.1128/MCB.25.11.4602-4614.2005; Cruz-Monserrate Z, 2008, NEOPLASIA, V10, P408, DOI 10.1593/neo.07868; Cunha G R, 1989, Cancer Treat Res, V46, P159; Debnath J, 2003, J CELL BIOL, V163, P315, DOI 10.1083/jcb.200304159; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Fusenig NE, 1998, MOL CARCINOGEN, V23, P144, DOI 10.1002/(SICI)1098-2744(199811)23:3<144::AID-MC3>3.0.CO;2-U; Garlick JA, 2007, ADV BIOCHEM ENG BIOT, V103, P207; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hou M, 2004, ACTA BIOCH BIOPH SIN, V36, P537, DOI 10.1093/abbs/36.8.537; JUE SF, 1992, MOL CELL BIOL, V12, P321, DOI 10.1128/MCB.12.1.321; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Kuperwasser C, 2005, CANCER RES, V65, P6130, DOI 10.1158/0008-5472.CAN-04-1408; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; Liu L, 2006, NEOPLASIA, V8, P917, DOI 10.1593/neo.06364; Liu L, 2005, WORLD J GASTROENTERO, V11, P705, DOI 10.3748/wjg.v11.i5.705; Malliri A, 2006, J BIOL CHEM, V281, P543, DOI 10.1074/jbc.M507582200; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Margulis A, 2005, CANCER RES, V65, P1783, DOI 10.1158/0008-5472.CAN-04-3399; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Minard ME, 2005, ONCOGENE, V24, P2568, DOI 10.1038/sj.onc.1208503; Moinfar F, 2000, CANCER RES, V60, P2562; Patocs A, 2007, NEW ENGL J MED, V357, P2543, DOI 10.1056/NEJMoa071825; Rajagopal S, 2010, J BIOL CHEM, V285, P18060, DOI 10.1074/jbc.M109.051490; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rygiel TP, 2008, J CELL SCI, V121, P1183, DOI 10.1242/jcs.017194; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Segal N, 2008, MATRIX BIOL, V27, P163, DOI 10.1016/j.matbio.2007.09.002; Strumane K, 2008, LEUKEMIA RES, V32, P113, DOI 10.1016/j.leukres.2007.03.034; Supriatno, 2003, ONCOL REP, V10, P527; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Willhauck MJ, 2007, CARCINOGENESIS, V28, P595, DOI 10.1093/carcin/bgl188; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006	46	41	44	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2010	29	50					6533	6542		10.1038/onc.2010.385	http://dx.doi.org/10.1038/onc.2010.385			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	695OA	20802514	Green Accepted			2022-12-25	WOS:000285380200003
J	Jamros, MA; Oliveira, LC; Whitford, PC; Onuchic, JN; Adams, JA; Blumenthal, DK; Jennings, PA				Jamros, Michael A.; Oliveira, Leandro C.; Whitford, Paul C.; Onuchic, Jose N.; Adams, Joseph A.; Blumenthal, Donald K.; Jennings, Patricia A.			Proteins at Work A COMBINED SMALL ANGLE X-RAY SCATTERING AND THEORETICAL DETERMINATION OF THE MULTIPLE STRUCTURES INVOLVED ON THE PROTEIN KINASE FUNCTIONAL LANDSCAPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL SRC KINASE; TYROSINE KINASE; ENERGY LANDSCAPE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SH2 DOMAIN; C-SRC; CSK; CONFORMATION; RECOGNITION	C-terminal Src kinase (Csk) phosphorylates and down-regulates the Src family tyrosine kinases (SFKs). Crystallographic studies of Csk found an unusual arrangement of the SH2 and SH3 regulatory domains about the kinase core, forming a compact structure. However, recent structural studies of mutant Csk in the presence of an inhibitor indicate that the enzyme accesses an expanded structure. To investigate whether wt-Csk may also access open conformations we applied small angle x-ray scattering (SAXS). We find wt-Csk frequently occupies an extended conformation where the regulatory domains are removed from the kinase core. In addition, all-atom structure-based simulations indicate Csk occupies two free energy basins. These basins correspond to ensembles of distinct global conformations of Csk: a compact structure and an extended structure. The transitions between these structures are entropically driven and accessible via thermal fluctuations that break local interactions. We further characterized the ensemble by generating theoretical scattering curves for mixed populations of conformations from both basins and compared the predicted scattering curves to the experimental profile. This population-combination analysis is more consistent with the experimental data than any rigid model. It suggests that Csk adopts a broad ensemble of conformations in solution, populating extended conformations not observed in the crystal structure that may play an important role in the regulation of Csk. The methodology developed here is broadly applicable to biological macromolecules and will provide useful information about what ensembles of conformations are consistent with the experimental data as well as the ubiquitous dynamic reversible assembly processes inherent in biology.	[Jennings, Patricia A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Oliveira, Leandro C.; Whitford, Paul C.; Onuchic, Jose N.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Oliveira, Leandro C.; Whitford, Paul C.; Onuchic, Jose N.] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Adams, Joseph A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Whitford, Paul C.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Blumenthal, Donald K.] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; United States Department of Energy (DOE); Los Alamos National Laboratory; Utah System of Higher Education; University of Utah	Jennings, PA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pajennin@ucsd.edu	Oliveira, Leandro Cristante de/F-8638-2012	Oliveira, Leandro Cristante de/0000-0002-6932-6792; Blumenthal, Donald/0000-0002-8614-1167	National Institutes of Health [5T32GM008326, DK54441, GM67969]; National Science Foundation [PHY-0822283];  [NSF-MCB-0543906]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008326, R01GM054038, R01GM067969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5T32GM008326, DK54441, and GM67969. Support was also provided by the Center for Theoretical Biological Physics sponsored by National Science Foundation Grant PHY-0822283 with additional support from NSF-MCB-0543906.	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Bernado P, 2008, J MOL BIOL, V376, P492, DOI 10.1016/j.jmb.2007.11.066; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; BOUGERET C, 1993, ONCOGENE, V8, P1241; BRAUNINGER A, 1992, GENE, V110, P205, DOI 10.1016/0378-1119(92)90649-A; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; BRYNGELSON JD, 1989, J PHYS CHEM-US, V93, P6902, DOI 10.1021/j100356a007; Chavez LL, 2004, J AM CHEM SOC, V126, P8426, DOI 10.1021/ja049510+; Chen J, 2008, PHYS CHEM CHEM PHYS, V10, P471, DOI 10.1039/b714141f; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cole PA, 2003, CURR OPIN CHEM BIOL, V7, P580, DOI 10.1016/j.cbpa.2003.08.009; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; Doniach S, 2001, CHEM REV, V101, P1763, DOI 10.1021/cr990071k; Forster F, 2008, J MOL BIOL, V382, P1089, DOI 10.1016/j.jmb.2008.07.074; Grubisic I, 2010, J STRUCT BIOL, V169, P95, DOI 10.1016/j.jsb.2009.09.010; Hegler JA, 2008, HFSP J, V2, P307, DOI 10.2976/1.3003931; Jiang LQ, 2006, ONCOGENE, V25, P5495, DOI 10.1038/sj.onc.1209554; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kim SJ, 2008, BIOPHYS J, V94, P4924, DOI 10.1529/biophysj.107.123240; Kouza M, 2006, J PHYS CHEM A, V110, P671, DOI 10.1021/jp053770b; Lammert H, 2009, PROTEINS, V77, P881, DOI 10.1002/prot.22511; Lee SS, 2006, J BIOL CHEM, V281, P8183, DOI 10.1074/jbc.M508120200; Levinson NM, 2008, CELL, V134, P124, DOI 10.1016/j.cell.2008.05.051; Levinson NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007683; Lieser SA, 2006, J BIOL CHEM, V281, P38004, DOI 10.1074/jbc.M607824200; Lin XF, 2006, J MOL BIOL, V357, P1263, DOI 10.1016/j.jmb.2006.01.046; Lin XF, 2003, J BIOL CHEM, V278, P24072, DOI 10.1074/jbc.M210596200; Lu Q, 2009, J PHYS CHEM B, V113, P1517, DOI 10.1021/jp808923a; Marquez JA, 2003, EMBO J, V22, P4616, DOI 10.1093/emboj/cdg448; Mills JE, 2007, J MOL BIOL, V365, P1460, DOI 10.1016/j.jmb.2006.10.076; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; NOEL JK, NUCL ACIDS RES S, V38, pW657; Ogawa A, 2002, J BIOL CHEM, V277, P14351, DOI 10.1074/jbc.C200086200; Oliveira LC, 2008, J PHYS CHEM B, V112, P6131, DOI 10.1021/jp0769835; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Roy M, 2005, J MOL BIOL, V348, P335, DOI 10.1016/j.jmb.2005.02.059; Schug A, 2009, P NATL ACAD SCI USA, V106, P22124, DOI 10.1073/pnas.0912100106; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Sondhi D, 1999, BIOCHEMISTRY-US, V38, P11147, DOI 10.1021/bi990827+; Sun GQ, 1999, ARCH BIOCHEM BIOPHYS, V367, P167, DOI 10.1006/abbi.1999.1253; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Takeuchi S, 2000, J BIOL CHEM, V275, P29183, DOI 10.1074/jbc.C000326200; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang DX, 2001, BIOCHEMISTRY-US, V40, P2004, DOI 10.1021/bi002342n; Whitford PC, 2007, J MOL BIOL, V366, P1661, DOI 10.1016/j.jmb.2006.11.085; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; Wong L, 2005, J MOL BIOL, V351, P131, DOI 10.1016/j.jmb.2005.05.042; Wong L, 2004, J MOL BIOL, V341, P93, DOI 10.1016/j.jmb.2004.05.060; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yang SC, 2009, BIOPHYS J, V96, P4449, DOI 10.1016/j.bpj.2009.03.036	58	26	26	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36121	36128		10.1074/jbc.M110.116947	http://dx.doi.org/10.1074/jbc.M110.116947			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20801888	Green Published, hybrid			2022-12-25	WOS:000283845300088
J	Berlin, I; Schwartz, H; Nash, PD				Berlin, Ilana; Schwartz, Heather; Nash, Piers D.			Regulation of Epidermal Growth Factor Receptor Ubiquitination and Trafficking by the USP8.STAM Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC HOMOLOGY-3 DOMAIN; TERMINAL SH3 DOMAIN; DOWN-REGULATION; BINDING MOTIF; HIGH-AFFINITY; TYROSINE KINASES; STRUCTURAL BASIS; LIGASE NRDP1; UBPY; HRS	Reversible ubiquitination of activated receptor complexes signals their sorting between recycling and degradation and thereby dictates receptor fate. The deubiquitinating enzyme ubiquitin-specific protease 8 (USP8/UBPy) has been previously implicated in the regulation of the epidermal growth factor receptor (EGFR); however, the molecular mechanisms governing its recruitment and activity in this context remain unclear. Herein, we investigate the role of USP8 in countering ligand-induced ubiquitination and down-regulation of EGFR and characterize a subset of protein-protein interaction determinants critical for this function. USP8 depletion accelerates receptor turnover, whereas loss of hepatocyte growth factor-regulated substrate (Hrs) rescues this phenotype, indicating that USP8 protects EGFR from degradation via an Hrs-dependent pathway. Catalytic inactivation of USP8 incurs EGFR hyperubiquitination and promotes receptor localization to endosomes marked by high ubiquitin content. These phenotypes require the central region of USP8, containing three extended Arg-X-X-Lys (RXXK) motifs that specify direct low affinity interactions with the SH3 domain(s) of ESCRT-0 proteins, STAM1/2. The USP8.STAM complex critically impinges on receptor ubiquitination status and modulates ubiquitin dynamics on EGFR-positive endosomes. Consequently, USP8-mediated deubiquitination slows progression of EGFR past the early-to-recycling endosome circuit in a manner dependent upon the RXXK motifs. Collectively, these findings demonstrate a role for the USP8.STAM complex as a protective mechanism regulating early endosomal sorting of EGFR between pathways destined for lysosomal degradation and recycling.	[Berlin, Ilana; Schwartz, Heather; Nash, Piers D.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	University of Chicago	Nash, PD (corresponding author), 929 E 57th St W432, Chicago, IL 60637 USA.	pdnash@uchicago.edu			American Cancer Society, Illinois Division; Concern Foundation; V Foundation; Department of Defense	American Cancer Society, Illinois Division(American Cancer Society); Concern Foundation; V Foundation; Department of Defense(United States Department of Defense)	This work was supported by the American Cancer Society, Illinois Division, the Concern Foundation, and the V Foundation Scholars Program (to P. D. N.).; Recipient of a Department of Defense (Congressionally Directed Medical Research Programs) Breast Cancer pre-doctoral fellowship.	Alwan HAJ, 2007, J BIOL CHEM, V282, P1658, DOI 10.1074/jbc.M604711200; Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Berry DM, 2002, CURR BIOL, V12, P1336, DOI 10.1016/S0960-9822(02)01038-2; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Harkiolaki M, 2003, EMBO J, V22, P2571, DOI 10.1093/emboj/cdg258; Hasdemir B, 2009, J BIOL CHEM, V284, P28453, DOI 10.1074/jbc.M109.025692; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Hu C. D., 2005, CURR PROTOC PROTEIN, P19101; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Kanazawa C, 2003, BIOCHEM BIOPH RES CO, V309, P848, DOI 10.1016/j.bbrc.2003.08.078; Kaneko T, 2003, J BIOL CHEM, V278, P48162, DOI 10.1074/jbc.M306677200; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Kim MS, 2006, BIOCHEM BIOPH RES CO, V351, P612, DOI 10.1016/j.bbrc.2006.10.068; Komada M, 2005, J BIOCHEM, V137, P1, DOI 10.1093/jb/mvi001; Lewitzky M, 2004, J BIOL CHEM, V279, P28724, DOI 10.1074/jbc.M402745200; Lewitzky M, 2001, ONCOGENE, V20, P1052, DOI 10.1038/sj.onc.1204202; Liu Q, 2003, MOL CELL, V11, P471, DOI 10.1016/S1097-2765(03)00046-7; Lock LS, 2000, J BIOL CHEM, V275, P31536, DOI 10.1074/jbc.M003597200; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Mizuno E, 2007, EXP CELL RES, V313, P3624, DOI 10.1016/j.yexcr.2007.07.028; Mizuno E, 2006, TRAFFIC, V7, P1017, DOI 10.1111/j.1600-0854.2006.00452.x; Morino C, 2004, EXP CELL RES, V297, P380, DOI 10.1016/j.yexcr.2004.03.038; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Naviglio S, 1998, EMBO J, V17, P3241, DOI 10.1093/emboj/17.12.3241; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Pennock S, 2008, MOL CELL BIOL, V28, P3020, DOI 10.1128/MCB.01809-07; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; Ren XF, 2009, STRUCTURE, V17, P406, DOI 10.1016/j.str.2009.01.012; Row PE, 2007, J BIOL CHEM, V282, P30929, DOI 10.1074/jbc.M704009200; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Shields SB, 2009, J CELL BIOL, V185, P213, DOI 10.1083/jcb.200811130; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Sierra MI, 2010, J BIOL CHEM, V285, P13990, DOI 10.1074/jbc.M109.061309; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004	52	63	66	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34909	34921		10.1074/jbc.M109.016287	http://dx.doi.org/10.1074/jbc.M109.016287			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20736164	Green Published, hybrid			2022-12-25	WOS:000283659100065
J	Deshmukh, L; Gorbatyuk, V; Vinogradova, O				Deshmukh, Lalit; Gorbatyuk, Vitaliy; Vinogradova, Olga			Integrin beta(3) Phosphorylation Dictates Its Complex with the Shc Phosphotyrosine-binding (PTB) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; PROTEIN SHC; CYTOPLASMIC TAILS; NMR-SPECTROSCOPY; ACTIVATION; MEMBRANE; TALIN; ALPHA(IIB)BETA(3); IDENTIFICATION; RECOGNITION	Adaptor protein Shc plays a key role in mitogen-activated protein kinase (MAPK) signaling pathway, which can be mediated through a number of different receptors including integrins. By specifically recognizing the tyrosine-phosphorylated integrin beta(3), Shc has been shown to trigger integrin outside-in signaling, although the structural basis of this interaction remains nebulous. Here we present the detailed structural analysis of Shc phosphotyrosine-binding (PTB) domain in complex with the bi-phosphorylated beta(3)integrin cytoplasmic tail (CT). We show that this complex is primarily defined by the phosphorylation state of the integrin C-terminal Tyr(759), which fits neatly into the classical PTB pocket of Shc. In addition, we have identified a novel binding interface which concurrently accommodates phosphorylated Tyr(747) of the highly conserved NPXY motif of beta(3). The structure represents the first snapshot of an integrin cytoplasmic tail bound to a target for mediating the outside-in signaling. Detailed comparison with the known Shc PTB structure bound to a target TrkA peptide revealed some significant differences, which shed new light upon the PTB domain specificity.	[Deshmukh, Lalit; Vinogradova, Olga] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Gorbatyuk, Vitaliy] Univ Connecticut, Biotechnol Bioserv Ctr, BioNMR Facil, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Vinogradova, O (corresponding author), Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, 69 N Eagleville Rd,Unit 3092, Storrs, CT 06269 USA.	olga.vinogradova@uconn.edu	Deshmukh, Lalit/C-5073-2015; Vinogradova, Olga/ABE-8367-2020	Vinogradova, Olga/0000-0001-5101-7361	AHA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL098777] Funding Source: NIH RePORTER	AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported in part by AHA grants (to O. V.).	Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Cowan KJ, 2000, J BIOL CHEM, V275, P36423, DOI 10.1074/jbc.M004068200; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; De S, 2005, P NATL ACAD SCI USA, V102, P7589, DOI 10.1073/pnas.0502935102; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Farooq A, 2003, STRUCTURE, V11, P905, DOI 10.1016/S0969-2126(03)00134-5; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Higashi T, 2004, BIOCHEM BIOPH RES CO, V322, P700, DOI 10.1016/j.bbrc.2004.07.177; Hoch JC, 1996, NMR DATA PROCESSING; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Jenkins AL, 1998, J BIOL CHEM, V273, P13878, DOI 10.1074/jbc.273.22.13878; Kirk RI, 2000, J BIOL CHEM, V275, P30901, DOI 10.1074/jbc.M001908200; KOSEN P, 1989, METHODS ENZYMOLOGY B, P86; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Mahoney NM, 2000, J AM CHEM SOC, V122, P7851, DOI 10.1021/ja001240h; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Oxley CL, 2008, J BIOL CHEM, V283, P5420, DOI 10.1074/jbc.M709435200; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips DR, 2001, THROMB HAEMOSTASIS, V86, P246; Phillips DR, 2001, CURR OPIN CELL BIOL, V13, P546, DOI 10.1016/S0955-0674(00)00250-7; Porollo AA, 2004, BIOINFORMATICS, V20, P2460, DOI 10.1093/bioinformatics/bth248; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Ravichandran KS, 1997, MOL CELL BIOL, V17, P5540, DOI 10.1128/MCB.17.9.5540; Schaffner-Reckinger E, 1998, J BIOL CHEM, V273, P12623, DOI 10.1074/jbc.273.20.12623; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; ZHOU MM, 1995, P NATL ACAD SCI USA, V92, P7784, DOI 10.1073/pnas.92.17.7784; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	43	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34875	34884		10.1074/jbc.M110.159087	http://dx.doi.org/10.1074/jbc.M110.159087			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739287	hybrid, Green Published			2022-12-25	WOS:000283659100062
J	Jin, ZG; Wallace, L; Harper, SQ; Yang, J				Jin, Zhigang; Wallace, Lindsay; Harper, Scott Q.; Yang, Jing			PP2A:B56 epsilon, a Substrate of Caspase-3, Regulates p53-dependent and p53-independent Apoptosis during Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; T-LYMPHOCYTE STIMULATION; A-ALPHA SUBUNIT; TUMOR-SUPPRESSOR; CELL-DEATH; CYCLIN-G; SERINE/THREONINE PHOSPHATASES; XENOPUS EMBRYOS; PP2A; P53	Protein phosphatase 2A (PP2A) is one of the most abundantly expressed serine/threonine protein phosphatases. A large body of evidence suggests that PP2A is a tumor suppressor and plays critical roles in regulating apoptosis. PP2A is a heterotrimeric protein complex. Its substrate specificity, localization, and activity are regulated by regulatory subunits of PP2A. A recent study has demonstrated that single nucleotide polymorphism in B56 epsilon (PPP2R5E), a B56 family regulatory subunit of PP2A, is associated with human soft tissue sarcoma. This raises the possibility that B56 epsilon is involved in tumorigenesis and plays important roles in regulating apoptosis. However, this hypothesis has not been tested experimentally. Our previous studies revealed that B56 epsilon regulates a number of developmental signaling pathways during early embryonic patterning. Here we report novel functions of B56 epsilon in regulating apoptosis. We provide evidence that B56 epsilon has both anti-and pro-apoptotic functions. B56 epsilon suppresses p53-independent apoptosis during neural development, but triggers p53-dependent apoptosis. Mechanistically, B56 epsilon regulates the p53-dependent apoptotic pathway solely through controlling the stability of p53 protein. In addition to its function in regulating apoptosis, we show that B56 epsilon undergoes proteolytic cleavage. The cleavage of B56 epsilon is mediated by caspase-3 and occurs on the carboxyl side of an evolutionarily conserved N-terminal "DKXD" motif. These results demonstrate that B56 epsilon, a substrate of caspase-3, is an essential regulator of apoptosis. So far, we have identified an alternative translation isoform and a caspase cleavage product of B56 epsilon. The significance of post-transcriptional regulation of B56 epsilon is discussed.	[Jin, Zhigang; Wallace, Lindsay; Harper, Scott Q.; Yang, Jing] Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Dept Pediat, Columbus, OH 43205 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Yang, J (corresponding author), Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Dept Pediat, Columbus, OH 43205 USA.	Jing.Yang@nationwidechildrens.org	Jin, Zhigang/T-7125-2019; Harper, Scott/E-3205-2011	Jin, Zhigang/0000-0001-7557-2968; 	National Institutes of Health, NIGMS [1R01GM093217-01A1]; Nationwide Children's Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093217] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Nationwide Children's Hospital(Ohio State University); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01GM093217-01A1 from NIGMS (to J. Y.).; Supported by the Nationwide Children's Hospital internal fund.	Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Algeciras-Schimnich A, 2002, CURR OPIN CELL BIOL, V14, P721, DOI 10.1016/S0955-0674(02)00384-8; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Bertoli C, 2009, ONCOGENE, V28, P721, DOI 10.1038/onc.2008.425; CHEN JY, 1993, ONCOGENE, V8, P2159; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Cho US, 2007, PLOS BIOL, V5, P1810, DOI 10.1371/journal.pbio.0050202; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Colella S, 2001, INT J CANCER, V93, P798, DOI 10.1002/ijc.1423; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; de Botton S, 2002, BLOOD, V100, P1310, DOI 10.1182/blood-2002-03-0686; DEMETRICK DJ, 1995, CYTOGENET CELL GENET, V69, P190, DOI 10.1159/000133960; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Giaime E, 2006, J BIOL CHEM, V281, P11515, DOI 10.1074/jbc.M508619200; Giaime E, 2010, CELL DEATH DIFFER, V17, P158, DOI 10.1038/cdd.2009.116; Gjoerup O, 2001, J VIROL, V75, P9142, DOI 10.1128/JVI.75.19.9142-9155.2001; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Grochola LF, 2009, CLIN CANCER RES, V15, P6301, DOI 10.1158/1078-0432.CCR-09-0797; Hensey C, 1998, DEV BIOL, V203, P36, DOI 10.1006/dbio.1998.9028; HENSEY C, 1997, J MECH DEV */* Mech, V69, P183; HOWE JA, 1995, GENE DEV, V9, P1164, DOI 10.1101/gad.9.10.1164; JANSSENS V, 2001, J BIOCH J */* BIOCH, V353, P417; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jin Z, 2009, J BIOL CHEM, V284, P7190, DOI 10.1074/jbc.M807907200; Kateneva AV, 2009, DEV CELL, V17, P303, DOI 10.1016/j.devcel.2009.08.016; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kimura SH, 2002, GENES CELLS, V7, P869, DOI 10.1046/j.1365-2443.2002.00564.x; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Lin SS, 2006, J BIOL CHEM, V281, P23003, DOI 10.1074/jbc.M602648200; Liu W, 2007, MOL CELL PROTEOMICS, V6, P319, DOI 10.1074/mcp.M600272-MCP200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; Miossec C, 1997, J BIOL CHEM, V272, P13459, DOI 10.1074/jbc.272.21.13459; MOODY SA, 1987, DEV BIOL, V119, P560, DOI 10.1016/0012-1606(87)90059-5; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Nojima H, 2006, GENOME DYN, V1, P131, DOI 10.1159/000092505; Okamoto K, 1996, MOL CELL BIOL, V16, P6593; Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X; Peng AM, 2008, CELL CYCLE, V7, P3, DOI 10.4161/cc.7.1.5157; Posmantur R, 1998, EXP CELL RES, V244, P302, DOI 10.1006/excr.1998.4214; Rivera T, 2006, BIOESSAYS, V28, P775, DOI 10.1002/bies.20448; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Rorick AM, 2007, DEV BIOL, V302, P477, DOI 10.1016/j.ydbio.2006.10.011; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Ruvolo VR, 2008, J BIOL CHEM, V283, P35474, DOI 10.1074/jbc.M800951200; Sablina AA, 2008, CANCER METAST REV, V27, P137, DOI 10.1007/s10555-008-9116-0; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Sablina AA, 2007, CELL ADHES MIGR, V1, P140, DOI 10.4161/cam.1.3.4986; Saraf A, 2007, J BIOL CHEM, V282, P573, DOI 10.1074/jbc.M607407200; Schwerk C, 2003, BIOCHEM PHARMACOL, V66, P1453, DOI 10.1016/S0006-2952(03)00497-0; Shen Y, 2001, ADV CANCER RES, V82, P55, DOI 10.1016/S0065-230X(01)82002-9; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shouse GP, 2008, MOL CELL BIOL, V28, P448, DOI 10.1128/MCB.00983-07; Sible JC, 1997, DEV BIOL, V189, P335, DOI 10.1006/dbio.1997.8683; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Stack JH, 1997, DEVELOPMENT, V124, P3185; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; Trinkle-Mulcahy L, 2006, CURR OPIN CELL BIOL, V18, P623, DOI 10.1016/j.ceb.2006.09.001; Tsao CC, 2007, CELL CYCLE, V6, P2377, DOI 10.4161/cc.6.19.4737; VASEVA AV, 2009, BIOCHIM BIOPHYS ACTA, P414; Veenstra GJC, 1998, CELL DEATH DIFFER, V5, P774, DOI 10.1038/sj.cdd.4400416; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yan XX, 2001, J COMP NEUROL, V433, P4, DOI 10.1002/cne.1121; Yang J, 2003, DEVELOPMENT, V130, P5569, DOI 10.1242/dev.00762; ZAUBERMAN A, 1995, ONCOGENE, V10, P2361	78	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34493	34502		10.1074/jbc.M110.169581	http://dx.doi.org/10.1074/jbc.M110.169581			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20807766	Green Published, hybrid			2022-12-25	WOS:000283659100024
J	Ouimet, T; Orng, SV; Poras, H; Gagnidze, K; Devi, LA; Fournie-Zaluski, MC; Roques, BP				Ouimet, Tanja; Orng, Sou-Vinh; Poras, Herve; Gagnidze, Khatuna; Devi, Lakshmi A.; Fournie-Zaluski, Marie-Claude; Roques, Bernard P.			Identification of an Endothelin-converting Enzyme-2-specific Fluorigenic Substrate and Development of an in Vitro and ex Vivo Enzymatic Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRAL ENDOPEPTIDASE ENKEPHALINASE; MEMBRANE-BOUND METALLOPROTEASE; ALZHEIMERS-DISEASE; POTENT INHIBITORS; MOLECULAR-CLONING; ACTIVE-SITE; A-BETA; NEPRILYSIN; ENZYME-1; EXPRESSION	Endothelin-converting enzyme-2 (ECE-2) is a membrane-bound zinc-dependent metalloprotease that shares a high degree of sequence homology with ECE-1, but displays an acidic pH optimum characteristic of maturing enzymes acting late in the secretory pathway. Although ECE-2, like ECE-1, can cleave the big endothelin intermediate to produce the vasoconstrictive endothelin peptide, its true physiological function remains to be elucidated, a task that is hampered by the lack of specific tools to study and discriminate ECE-2 from ECE-1, i.e. specific substrates and/or specific inhibitors. To fill this gap, we searched for novel ECE-specific peptide substrates. To this end, peptides derived from the big endothelin intermediate were tested using ECE-1 and ECE-2, leading to the identification of an ECE-1-specific substrate. Moreover, screening of our proprietary fluorigenic peptide Fluofast(R) libraries using ECE-1 and ECE-2 allowed the identification of Ac-SKG-Pya-F-W-Nop-GGK-NH2 (PL405), as a specific and high affinity ECE-2 substrate. Indeed, ECE-2 cleaved PL405 at the Pya-F amide bond with a specificity constant (k(cat)/K-m) of 8.1 +/- 0.9 x 10(3) M-1 s(-1). Using this novel substrate, we also characterized the first potent (K-i = 7.7 +/- 0.3 nM) and relatively selective ECE-2 inhibitor and developed a quantitative fluorigenic ECE-2 assay. The assay was used to study the ex vivo ECE-2 activity in wild type and ECE-2 knockout tissues and was found to truly reflect ECE-2 expression patterns. The PL405 assay is thus the first tool to study ECE-2 inhibition using high throughput screening or for ex vivo ECE-2 quantification.	[Ouimet, Tanja; Orng, Sou-Vinh; Poras, Herve; Fournie-Zaluski, Marie-Claude; Roques, Bernard P.] Pharmaleads, F-75013 Paris, France; [Gagnidze, Khatuna; Devi, Lakshmi A.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Roques, BP (corresponding author), Pharmaleads, Paris BioPk,11 Rue Watt, F-75013 Paris, France.	bernard.roques@pharmaleads.com	Devi P, Lakshmi/GXM-5982-2022; PORAS, Hervé/ABE-1773-2020	Devi P, Lakshmi/0000-0001-9274-4776; PORAS, Herve/0000-0002-3329-7432	National Institutes of Health [NS26880, DA19521]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA019521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS26880 and DA19521 (to L. A. D.).	Ahn K, 1998, ARCH BIOCHEM BIOPHYS, V359, P258, DOI 10.1006/abbi.1998.0913; AUBRY M, 1987, BIOCHEM CELL BIOL, V65, P398, DOI 10.1139/o87-050; BACK SA, 1989, J NEUROSCI, V9, P4439; Daull P, 2005, AM J HYPERTENS, V18, P1606, DOI 10.1016/j.amjhyper.2005.06.022; DEVAULT A, 1988, J BIOL CHEM, V263, P4033; Du L, 1996, GENOMICS, V36, P22, DOI 10.1006/geno.1996.0421; Eckman EA, 2003, J BIOL CHEM, V278, P2081, DOI 10.1074/jbc.C200642200; Eckman EA, 2006, J BIOL CHEM, V281, P30471, DOI 10.1074/jbc.M605827200; EMOTO N, 1995, J BIOL CHEM, V270, P15262, DOI 10.1074/jbc.270.25.15262; Fahnoe DC, 2000, J CARDIOVASC PHARM, V36, pS22, DOI 10.1097/00005344-200036051-00009; FOURNIEZALUSKI MC, 1994, P NATL ACAD SCI USA, V91, P4072, DOI 10.1073/pnas.91.9.4072; Funalot B, 2004, MOL PSYCHIATR, V9, P1122, DOI 10.1038/sj.mp.4001584; Gagnidze K, 2008, J MED CHEM, V51, P3378, DOI 10.1021/jm7015478; Ghaddar G, 2000, BIOCHEM J, V347, P419, DOI 10.1042/0264-6021:3470419; Ikeda K, 1999, J BIOL CHEM, V274, P32469, DOI 10.1074/jbc.274.45.32469; Inguimbert N, 2002, J MED CHEM, V45, P1477, DOI 10.1021/jm0005454; Inguimbert N, 2002, BIOORG MED CHEM LETT, V12, P2001, DOI 10.1016/S0960-894X(02)00248-2; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Johnson GD, 2000, ANAL BIOCHEM, V286, P112, DOI 10.1006/abio.2000.4772; Johnson GD, 1999, J BIOL CHEM, V274, P4053, DOI 10.1074/jbc.274.7.4053; Kiryu-Seo S, 2000, P NATL ACAD SCI USA, V97, P4345, DOI 10.1073/pnas.070509897; LEE S, 1991, P NATL ACAD SCI USA, V88, P6353, DOI 10.1073/pnas.88.14.6353; Luciani N, 2001, BIOCHEM J, V356, P813, DOI 10.1042/0264-6021:3560813; Mzhavia N, 2003, J BIOL CHEM, V278, P14704, DOI 10.1074/jbc.M211242200; Oefner C, 2004, ACTA CRYSTALLOGR D, V60, P392, DOI 10.1107/S0907444903027410; OHNAKA K, 1993, J BIOL CHEM, V268, P26759; Palmer JC, 2009, AM J PATHOL, V175, P262, DOI 10.2353/ajpath.2009.081054; PIQUILLO.Y, 1970, BIOCHIM BIOPHYS ACTA, V206, P136, DOI 10.1016/0005-2744(70)90090-2; RODERICK SL, 1989, BIOCHEMISTRY-US, V28, P1493, DOI 10.1021/bi00430a011; Rodriguiz RM, 2008, GENES BRAIN BEHAV, V7, P418, DOI 10.1111/j.1601-183X.2007.00365.x; Roques BP, 2000, TRENDS PHARMACOL SCI, V21, P475, DOI 10.1016/S0165-6147(00)01571-6; ROQUES BP, 1980, NATURE, V288, P286, DOI 10.1038/288286a0; ROQUES BP, 1993, BIOCHEM SOC T, V21, P678, DOI 10.1042/bst0210678; ROQUES BP, 1993, PHARMACOL REV, V45, P87; Rose C, 2002, BIOCHEM J, V363, P697, DOI 10.1042/0264-6021:3630697; Schulz H, 2009, J MOL BIOL, V385, P178, DOI 10.1016/j.jmb.2008.10.052; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Tanja O, 2000, BIOCHEM BIOPH RES CO, V271, P565, DOI 10.1006/bbrc.2000.2664; Valdenaire O, 1999, MOL BRAIN RES, V64, P211, DOI 10.1016/S0169-328X(98)00321-0; Valeur B., 2004, INVITATION FLUORESCE; Weeraratna AT, 2007, EXP CELL RES, V313, P450, DOI 10.1016/j.yexcr.2006.10.028; XU D, 1994, CELL, V78, P473, DOI 10.1016/0092-8674(94)90425-1; Yanagisawa H, 2000, J CLIN INVEST, V105, P1373, DOI 10.1172/JCI7447	43	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34390	34400		10.1074/jbc.M110.120576	http://dx.doi.org/10.1074/jbc.M110.120576			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20807771	Green Published, hybrid			2022-12-25	WOS:000283659100013
J	Zheng, ZQ; Sabirzhanov, B; Keifer, J				Zheng, Zhaoqing; Sabirzhanov, Boris; Keifer, Joyce			Oligomeric Amyloid-beta Inhibits the Proteolytic Conversion of Brain-derived Neurotrophic Factor (BDNF), AMPA Receptor Trafficking, and Classical Conditioning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL SLICE CULTURES; PROTEIN-KINASE-II; IN-VITRO; ALZHEIMERS-DISEASE; SYNAPTIC DELIVERY; SILENT SYNAPSES; MESSENGER-RNA; ACQUISITION; ACTIVATION	Amyloid-beta (A beta) peptide is thought to have a significant role in the progressive memory loss observed in patients with Alzheimer disease and inhibits synaptic plasticity in animal models of learning. We previously demonstrated that brain-derived neurotrophic factor (BDNF) is critical for synaptic AMPA receptor delivery in an in vitro model of eyeblink classical conditioning. Here, we report that acquisition of conditioned responses was significantly attenuated by bath application of oligomeric (200 nM), but not fibrillar, A beta peptide. Western blotting revealed that BDNF protein expression during conditioning is significantly reduced by treatment with oligomeric A beta, as were phosphorylation levels of cAMP-response element-binding protein (CREB), Ca2+/calmodulin-dependent protein kinase II (CaMKII), Ca2+/calmodulin-dependent protein kinase IV (CaMKIV), and ERK. However, levels of PKA and PKC zeta/lambda were unaffected, as was PDK-1. Protein localization studies using confocal imaging indicate that oligomeric A beta, but not fibrillar or scrambled forms, suppresses colocalization of GluR1 and GluR4 AMPA receptor subunits with synaptophysin, indicating that trafficking of these subunits to synapses during the conditioning procedure is blocked. In contrast, coapplication of BDNF with oligomeric A beta significantly reversed these findings. Interestingly, a tolloid-like metalloproteinase in turtle, tTLLs (turtle tolloid-like protein), which normally processes the precursor proBDNF into mature BDNF, was found to degrade oligomeric A beta into small fragments. These data suggest that an A beta-induced reduction in BDNF, perhaps due to interference in the proteolytic conversion of proBDNF to BDNF, results in inhibition of synaptic AMPA receptor delivery and suppression of the acquisition of conditioning.	[Zheng, Zhaoqing; Sabirzhanov, Boris; Keifer, Joyce] Univ S Dakota, Neurosci Grp, Div Basic Biomed Sci, Sanford Sch Med, Vermillion, SD 57069 USA	University of South Dakota	Zheng, ZQ (corresponding author), Univ S Dakota, Neurosci Grp, Div Basic Biomed Sci, Sanford Sch Med, 414 E Clark St, Vermillion, SD 57069 USA.	zzheng@usd.edu		Keifer, Joyce/0000-0002-5900-0414	National Institutes of Health [NS051187, P20 RR015567]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS051187 and P20 RR015567, which is designated as a Center of Biomedical Research Excellence (to J. K.).	Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Anderson CW, 1999, J NEUROPHYSIOL, V81, P1242, DOI 10.1152/jn.1999.81.3.1242; Bell KA, 2004, J NEUROCHEM, V91, P349, DOI 10.1111/j.1471-4159.2004.02722.x; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Chang EH, 2006, P NATL ACAD SCI USA, V103, P3410, DOI 10.1073/pnas.0507313103; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Garzon DJ, 2007, J NEUROSCI, V27, P2628, DOI 10.1523/JNEUROSCI.5053-06.2007; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Holsinger RMD, 2000, MOL BRAIN RES, V76, P347, DOI 10.1016/S0169-328X(00)00023-1; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Itami C, 2003, P NATL ACAD SCI USA, V100, P13069, DOI 10.1073/pnas.2131948100; KEIFER J, 1995, J NEUROSCI, V15, P5036; Keifer J, 2001, J NEUROSCI, V21, P2434, DOI 10.1523/JNEUROSCI.21-07-02434.2001; Keifer J, 2009, J NEUROSCI, V29, P14956, DOI 10.1523/JNEUROSCI.3649-09.2009; Komulainen P, 2008, NEUROBIOL LEARN MEM, V90, P596, DOI 10.1016/j.nlm.2008.07.014; Li W, 2008, NEUROSCIENCE, V155, P686, DOI 10.1016/j.neuroscience.2008.06.043; Li W, 2009, NEUROBIOL LEARN MEM, V91, P243, DOI 10.1016/j.nlm.2008.10.002; Lu CB, 2006, J NEUROCHEM, V97, P1104, DOI 10.1111/j.1471-4159.2006.03800.x; Minogue AM, 2003, J BIOL CHEM, V278, P27971, DOI 10.1074/jbc.M302530200; Mokin M, 2007, J NEUROPHYSIOL, V98, P1278, DOI 10.1152/jn.00212.2007; Mokin M, 2006, J NEUROSCI METH, V157, P218, DOI 10.1016/j.jneumeth.2006.04.016; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Nakata H, 2007, FEBS LETT, V581, P2047, DOI 10.1016/j.febslet.2007.04.041; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Trommer BL, 2005, NEUROBIOL DIS, V18, P75, DOI 10.1016/j.nbd.2004.08.011; Tucker HM, 2000, J NEUROSCI, V20, P3937; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yu MS, 2004, INT J MOL MED, V14, P917; Zhao DY, 2004, J NEUROPHYSIOL, V92, P2853, DOI 10.1152/jn.00485.2004; Zheng Z, 2008, NEUROSCIENCE, V156, P872, DOI 10.1016/j.neuroscience.2008.08.042; Zheng ZQ, 2009, J NEUROPHYSIOL, V101, P2539, DOI 10.1152/jn.91282.2008	38	40	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34708	34717		10.1074/jbc.M110.150821	http://dx.doi.org/10.1074/jbc.M110.150821			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20807770	Green Published, hybrid			2022-12-25	WOS:000283659100046
J	Burnett, LA; Blais, EM; Unadkat, JD; Hille, B; Tilley, SL; Babcock, DF				Burnett, Lindsey A.; Blais, Edik M.; Unadkat, Jashvant D.; Hille, Bertil; Tilley, Stephen L.; Babcock, Donner F.			Testicular Expression of Adora3i2 in Adora3 Knockout Mice Reveals a Role of Mouse A3Ri2 and Human A3Ri3 Adenosine Receptors in Sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE ADENYLYL-CYCLASE; NUCLEOSIDE TRANSPORTER FAMILY; HAMSTER OVARY CELLS; SIGNALING PATHWAYS; GENE-EXPRESSION; MALE-FERTILITY; HYPERACTIVATED MOTILITY; CATECHOLAMINE AGONISTS; MAMMALIAN SPERMATOZOA; IDENTIFICATION	Adenosine is a candidate modulator of sperm motility in the female reproductive tract that increases sperm flagellar beat frequency in vitro. Past work suggested that this acceleration may involve equilibrative (ENT) and concentrative (CNT) nucleoside transporters. Here we show that Slc29a1 (ENT-1) is the predominant nucleoside transporter expressed in the mouse testis. Unexpectedly, the beat of Slc29a1-null sperm still accelerates in response to 2-chloro-2'-deoxyadenosine (Cl-dAdo). Moreover, in wild-type sperm neither blockade of CNTs by removal of external Na+, nor inhibition of ENTs with nitrobenzylthioionosine, prevents acceleration of the sperm beat by Cl-dAdo. In contrast, pertussis toxin produces strong blockade, indicating involvement of a G alpha(i/o)-coupled adenosine receptor. Although agonists selective for adenosine receptors A1R, A2aR, and A2bR are ineffective, A3R-selective agonists Cl-IB-MECA and IB-MECA do accelerate the beat. Consistent with this pharmacological profile, the predominant Adora transcripts in the testis are products of the nested Adora3i1 and Adora3i2 genes. Surprisingly, Cl-IB-MECA and Cl-dAdo still accelerate the beat of Adora3i1-null sperm indicating that the remaining Adora3i2 transcript produces an A3R that functions in sperm. When cloned Adora3i2 is heterologously expressed in tsA-201 cells, Cl-dAdo decreases forskolin-evoked accumulation of cAMP, indicating that Adora3i2 specifies a functional A3Ri2 adenosine receptor that couples through G alpha(i). Database mining reveals that mouse Adora3i2 is expressed primarily in testis, almost exclusively in spermatids. Expression of the orthologous ADORA3i3 transcript also is most prominent in human testis; presumably producing an A3Ri3 receptor that is functional in sperm and that may be a target for development of male-directed contraceptives.	[Burnett, Lindsey A.; Blais, Edik M.; Hille, Bertil; Babcock, Donner F.] Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Unadkat, Jashvant D.] Univ Washington, Sch Med, Dept Pharmaceut, Seattle, WA 98195 USA; [Tilley, Stephen L.] Univ N Carolina, Dept Med, Div Pulm & Crit Care Med, Chapel Hill, NC 27599 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill	Babcock, DF (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.	donner@u.washington.edu		Babcock, Donner/0000-0002-4461-4544; Burnett, Lindsey/0000-0002-6430-4498; Unadkat, Jashvant/0000-0002-4820-8455	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [HD12629-27, U54];  [5T32-HD007453];  [NS08174];  [GM54447];  [HL071802]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD012629, T32HD007453, P50HD012629] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS008174, R37NS008174] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by Grant HD12629-27 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health through cooperative agreement U54 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research (to L. A. B., E. M. B., J. D. U., B. H., and D. F. B.) and Grants 5T32-HD007453 and NS08174 (to L. A. B.), GM54447 (to J. D. U.), NS08174 (to B. H. and D. F. B.), and HL071802 (to S. L. T.).	Adeoya-Osiguwa SA, 2002, MOL REPROD DEV, V63, P245, DOI 10.1002/mrd.90009; Alexander SPH, 2006, BRIT J PHARMACOL, V147, pS1; Almog T, 2008, J BIOL CHEM, V283, P14479, DOI 10.1074/jbc.M710492200; Aouadi M, 2006, BIOCHIMIE, V88, P1091, DOI 10.1016/j.biochi.2006.06.003; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Baram D, 2010, J IMMUNOL, V184, P3677, DOI 10.4049/jimmunol.0901333; BERSE B, 1995, J BIOL CHEM, V270, P22101, DOI 10.1074/jbc.270.38.22101; Carlson AE, 2005, J BIOL CHEM, V280, P32238, DOI 10.1074/jbc.M501430200; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Carlson AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006844; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Choi DS, 2004, NAT NEUROSCI, V7, P855, DOI 10.1038/nn1288; de Lamirande E, 2002, MOL HUM REPROD, V8, P124, DOI 10.1093/molehr/8.2.124; Fredholm BB, 2000, N-S ARCH PHARMACOL, V362, P364, DOI 10.1007/s002100000313; Govindarajan R, 2009, AM J PHYSIOL-GASTR L, V296, pG910, DOI 10.1152/ajpgi.90672.2008; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Jaiswal BS, 2001, J BIOL CHEM, V276, P31698, DOI 10.1074/jbc.M011698200; Jha KN, 2006, MOL HUM REPROD, V12, P781, DOI 10.1093/molehr/gal085; Jin JL, 2007, BIOL REPROD, V77, P37, DOI 10.1095/biolreprod.107.060186; Johnston DS, 2008, P NATL ACAD SCI USA, V105, P8315, DOI 10.1073/pnas.0709854105; Johnston DS, 2007, ANN NY ACAD SCI, V1120, P36, DOI 10.1196/annals.1411.014; KOPF GS, 1986, J BIOL CHEM, V261, P7327; Minelli A, 2000, J HISTOCHEM CYTOCHEM, V48, P1163, DOI 10.1177/002215540004800901; Minelli A, 2008, BIOCHEM PHARMACOL, V75, P931, DOI 10.1016/j.bcp.2007.10.024; Nixon B, 2010, J CELL PHYSIOL, V224, P71, DOI 10.1002/jcp.22090; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Quill TA, 2001, P NATL ACAD SCI USA, V98, P12527, DOI 10.1073/pnas.221454998; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Salvatore CA, 2000, J BIOL CHEM, V275, P4429, DOI 10.1074/jbc.275.6.4429; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schuh SM, 2006, BIOL REPROD, V74, P492, DOI 10.1095/biolreprod.105.047837; Schuh SM, 2007, BIOL REPROD, V77, P960, DOI 10.1095/biolreprod.107.062562; Schulte G, 2000, MOL PHARMACOL, V58, P477, DOI 10.1124/mol.58.3.477; Schulte G, 2002, MOL PHARMACOL, V62, P1137, DOI 10.1124/mol.62.5.1137; SHEN MR, 1993, CLIN EXP PHARMACOL P, V20, P527, DOI 10.1111/j.1440-1681.1993.tb01736.x; SHEN MR, 1993, J PHARM PHARMACOL, V45, P650, DOI 10.1111/j.2042-7158.1993.tb05671.x; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Wennemuth G, 2003, DEVELOPMENT, V130, P1317, DOI 10.1242/dev.00353; Westenbroek RE, 1999, DEV BIOL, V207, P457, DOI 10.1006/dbio.1998.9172; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; Yu P, 2005, GENOMICS, V86, P414, DOI 10.1016/j.ygeno.2005.06.008	45	17	17	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33662	33670		10.1074/jbc.M110.156075	http://dx.doi.org/10.1074/jbc.M110.156075			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20732875	Green Published, hybrid			2022-12-25	WOS:000283354000011
J	Drake, JM; Barnes, JM; Madsen, JM; Domann, FE; Stipp, CS; Henry, MD				Drake, Justin M.; Barnes, J. Matthew; Madsen, Joshua M.; Domann, Frederick E.; Stipp, Christopher S.; Henry, Michael D.			ZEB1 Coordinately Regulates Laminin-332 and beta 4 Integrin Expression Altering the Invasive Phenotype of Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-MESENCHYMAL TRANSITION; CARCINOMA-CELLS; TRANSCRIPTIONAL REPRESSOR; DIFFERENTIAL EXPRESSION; ALPHA-6-BETA-4 INTEGRIN; BASEMENT-MEMBRANES; TUMOR-GROWTH; E-CADHERIN; METASTASIS; MIGRATION	Metastasis involves the invasion of cancer cells across both the extracellular matrix and cellular barriers, and an evolving theme is that epithelial-to-mesenchymal transition (EMT) may mediate invasive cellular behavior. Previously, we isolated and analyzed a subpopulation of PC-3 prostate cancer cells, TEM4-18, and found that these cells both invaded an endothelial barrier more efficiently and exhibited enhanced metastatic colonization in vivo. Transendothelial migration of these cells depended on expression of ZEB1, a known regulator of EMT. Surprisingly, these cells were much less invasive than parental PC-3 cells in assays that involve matrix barriers. Here, we report that TEM4-18 cells express significantly reduced levels of two subunits of laminin-332 (beta 3 and gamma 2) and that exogenous laminin-332, or co-culture with laminin-332-expressing cells, rescues the in vitro invasion phenotype in these cells. Stable knockdown of ZEB1 in prostate cancer cells up-regulated LAMC2 and ITGB4 mRNA and protein and resulted in a concomitant increase in Transwell migration. Using chromatin immunopre-cipitation (ChIP), we show that ZEB1 directly interacts with the promoters of LAMC2 and ITGB4. These results provide a novel molecular basis for reduced laminin-332 observed in clinical prostate cancer specimens and demonstrate a context-dependent role for EMT in invasive cellular behavior.	[Drake, Justin M.; Barnes, J. Matthew; Henry, Michael D.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Henry, Michael D.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Madsen, Joshua M.; Domann, Frederick E.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Stipp, Christopher S.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Domann, Frederick E.; Stipp, Christopher S.; Henry, Michael D.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Henry, MD (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, 6-510 Bowen Sci Bldg, Iowa City, IA 52242 USA.	michael-henry@uiowa.edu		Domann, Frederick/0000-0002-0489-2179; Henry, Michael/0000-0002-7871-245X; Drake, Justin/0000-0002-8329-7748	National Institutes of Health [R01 CA130916, R01 CA136664, R01 CA115438]; American Heart Association [0610074Z]; NATIONAL CANCER INSTITUTE [R01CA115438, R01CA136664, R01CA130916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA130916 (to M. D. H.), R01 CA136664 (to C. S. S.), and R01 CA115438 (to F. E. D.). This work was also supported by American Heart Association Predoctoral Fellowship 0610074Z (to J. M. D.).	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Allen MV, 1998, HUM PATHOL, V29, P311, DOI 10.1016/S0046-8177(98)90109-5; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; Chao C, 1996, CANCER RES, V56, P4811; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Costantino ME, 2002, BIOCHEM BIOPH RES CO, V296, P368, DOI 10.1016/S0006-291X(02)00880-X; CRESS AE, 1995, CANCER METAST REV, V14, P219, DOI 10.1007/BF00690293; DELWEL GO, 1994, MOL BIOL CELL, V5, P203, DOI 10.1091/mbc.5.2.203; Drake JM, 2005, CLIN EXP METASTAS, V22, P674, DOI 10.1007/s10585-006-9011-4; Drake JM, 2009, MOL BIOL CELL, V20, P2207, DOI 10.1091/mbc.E08-10-1076; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hao JS, 2001, AM J PATHOL, V158, P1129, DOI 10.1016/S0002-9440(10)64060-6; Hao JS, 1996, AM J PATHOL, V149, P1341; Haraguchi M, 2008, J BIOL CHEM, V283, P23514, DOI 10.1074/jbc.M801125200; HEMLER ME, 1984, J IMMUNOL, V132, P3011; Hlubek F, 2001, CANCER RES, V61, P8089; LEE RT, 1995, CIRC RES, V76, P209, DOI 10.1161/01.RES.76.2.209; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; MIYAZAKI K, 1993, P NATL ACAD SCI USA, V90, P11767, DOI 10.1073/pnas.90.24.11767; NAGLE RB, 1995, AM J PATHOL, V146, P1498; Nishiuchi R, 2003, J BIOCHEM, V134, P497, DOI 10.1093/jb/mvg185; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pena C, 2006, INT J CANCER, V119, P2098, DOI 10.1002/ijc.22083; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; PYKE C, 1995, CANCER RES, V55, P4132; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sordat I, 1998, J PATHOL, V185, P44, DOI 10.1002/(SICI)1096-9896(199805)185:1<44::AID-PATH46>3.0.CO;2-A; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Takkunen M, 2006, J HISTOCHEM CYTOCHEM, V54, P1263, DOI 10.1369/jhc.6A6958.2006; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tripathi M, 2008, J BIOL CHEM, V283, P30576, DOI 10.1074/jbc.M802312200; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Udayakumar TS, 2003, CANCER RES, V63, P2292; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; WEITZMAN JB, 1993, J BIOL CHEM, V268, P8651; Winterwood NE, 2006, MOL BIOL CELL, V17, P2707, DOI 10.1091/mbc.E05-11-1042; Yang XF, 2009, J CELL SCI, V122, P2473, DOI 10.1242/jcs.049148; Yu HM, 2004, MOL CARCINOGEN, V41, P85, DOI 10.1002/mc.20041	46	60	61	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33940	33948		10.1074/jbc.M110.136044	http://dx.doi.org/10.1074/jbc.M110.136044			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729552	Green Published, hybrid			2022-12-25	WOS:000283354000041
J	Sansregret, L; Gallo, D; Santaguida, M; Leduy, L; Harada, R; Nepveu, A				Sansregret, Laurent; Gallo, David; Santaguida, Marianne; Leduy, Lam; Harada, Ryoko; Nepveu, Alain			Hyperphosphorylation by Cyclin B/CDK1 in Mitosis Resets CUX1 DNA Binding Clock at Each Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR HINF-D; CDP/CUX TRANSCRIPTION FACTOR; CUT HOMEODOMAIN PROTEINS; RIBOSOMAL-RNA GENES; S-PHASE; MITOTIC CHROMATIN; ACTIVE GENES; HISTONE MODIFICATIONS; CATHEPSIN-L; KINASE	The p110 CUX1 homeodomain protein participates in the activation of DNA replication genes in part by increasing the affinity of E2F factors for the promoters of these genes. CUX1 expression is very weak in quiescent cells and increases during G(1). Biochemical activities associated with transcriptional activation by CUX1 are potentiated by post-translational modifications in late G(1), notably a proteolytic processing event that generates p110 CUX1. Constitutive expression of p110 CUX1, as observed in some transformed cells, leads to accelerated entry into the S phase. In this study, we investigated the post-translation regulation of CUX1 during mitosis and the early G(1) phases of proliferating cells. We observed a major electrophoretic mobility shift and a complete inhibition of DNA binding during mitosis. We show that cyclin B/CDK1 interacts with CUX1 and phosphorylates it at multiple sites. Serine to alanine replacement mutations at 10 SP dipeptide sites were required to restore DNA binding in mitosis. Passage into G(1) was associated with the degradation of some p110 CUX1 proteins, and the remaining proteins were gradually dephosphorylated. Indirect immunofluorescence and subfractionation assays using a phospho-specific antibody showed that most of the phosphorylated protein remained in the cytoplasm, whereas the dephosphorylated protein was preferentially located in the nucleus. Globally, our results indicate that the hyperphosphorylation of CUX1 by cyclin B/CDK1 inhibits its DNA binding activity in mitosis and interferes with its nuclear localization following cell division and formation of the nuclear membrane, whereas dephosphorylation and de novo synthesis contribute to gradually restore CUX1 expression and activity in G(1).	[Nepveu, Alain] McGill Univ, Goodman Canc Ctr, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Nepveu, Alain] McGill Univ, Dept Oncol, Montreal, PQ H3A 1A3, Canada; [Nepveu, Alain] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; McGill Univ Canc Pavil, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; McGill University	Nepveu, A (corresponding author), McGill Univ, Goodman Canc Ctr, Dept Biochem, 1160 Pine Ave W,Rm 410, Montreal, PQ H3A 1A3, Canada.	alain.nepveu@mcgill.ca	/AAB-8315-2020		Canadian Cancer Society [019389]	Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported in part by Grant 019389 from the Canadian Cancer Society (to A. N.).	Ali SA, 2008, P NATL ACAD SCI USA, V105, P6632, DOI 10.1073/pnas.0800970105; Ali SA, 2010, P NATL ACAD SCI USA, V107, P4165, DOI 10.1073/pnas.1000620107; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Blobel GA, 2009, MOL CELL, V36, P970, DOI 10.1016/j.molcel.2009.12.001; BODMER R, 1987, CELL, V51, P293, DOI 10.1016/0092-8674(87)90156-5; Booher RN, 1997, J BIOL CHEM, V272, P22300, DOI 10.1074/jbc.272.35.22300; Brandeis M, 1998, P NATL ACAD SCI USA, V95, P4344, DOI 10.1073/pnas.95.8.4344; CAELLES C, 1995, MOL CELL BIOL, V15, P6694; Chen DY, 2002, MOL BIOL CELL, V13, P276, DOI 10.1091/mbc.01-10-0523; Chow CM, 2005, EMBO REP, V6, P354, DOI 10.1038/sj.embor.7400366; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; Coqueret O, 1996, J BIOL CHEM, V271, P24862, DOI 10.1074/jbc.271.40.24862; Coqueret O, 1998, EMBO J, V17, P4680, DOI 10.1093/emboj/17.16.4680; Coqueret O, 1998, J BIOL CHEM, V273, P2561, DOI 10.1074/jbc.273.5.2561; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; GAUTHIERROUVIERE C, 1991, CELL REGUL, V2, P575, DOI 10.1091/mbc.2.7.575; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; GOTTESFELD JM, 1994, SCIENCE, V263, P81, DOI 10.1126/science.8272869; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; HOLTHUIS J, 1990, SCIENCE, V247, P1454, DOI 10.1126/science.2321007; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; JACK J, 1991, DEVELOPMENT, V113, P735; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; LIU S, 1992, DEV BIOL, V150, P133, DOI 10.1016/0012-1606(92)90013-7; Long JJ, 1998, MOL CELL BIOL, V18, P1467, DOI 10.1128/MCB.18.3.1467; Ludlow C, 1996, DEV BIOL, V178, P149, DOI 10.1006/dbio.1996.0205; LUSCHER B, 1992, J CELL BIOL, V118, P775, DOI 10.1083/jcb.118.4.775; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; Michelotti EF, 1997, NATURE, V388, P895, DOI 10.1038/42282; Michl P, 2006, J BIOL CHEM, V281, P15138, DOI 10.1074/jbc.M600908200; Moon NS, 2000, J BIOL CHEM, V275, P31325, DOI 10.1074/jbc.M002912200; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; O'Farrell PH, 2001, TRENDS CELL BIOL, V11, P512, DOI 10.1016/S0962-8924(01)02142-0; PRESCOTT DM, 1962, EXP CELL RES, V26, P260, DOI 10.1016/0014-4827(62)90176-3; Rizkallah R, 2009, MOL BIOL CELL, V20, P4766, DOI 10.1091/mbc.E09-04-0264; Sansregret L, 2006, MOL CELL BIOL, V26, P2441, DOI 10.1128/MCB.26.6.2441-2455.2006; Santaguida M, 2005, J BIOL CHEM, V280, P32712, DOI 10.1074/jbc.M505417200; Santaguida M, 2001, J BIOL CHEM, V276, P45780, DOI 10.1074/jbc.M107978200; Sarge KD, 2005, TRENDS BIOCHEM SCI, V30, P605, DOI 10.1016/j.tibs.2005.09.004; SEGIL N, 1991, SCIENCE, V254, P1814, DOI 10.1126/science.1684878; Segil N, 1996, GENE DEV, V10, P2389, DOI 10.1101/gad.10.19.2389; Timofeev O, 2010, J BIOL CHEM, V285, P16978, DOI 10.1074/jbc.M109.096552; Truscott M, 2007, J BIOL CHEM, V282, P30216, DOI 10.1074/jbc.M702328200; Valls E, 2005, J BIOL CHEM, V280, P42592, DOI 10.1074/jbc.M507407200; VANWIJNEN AJ, 1989, J BIOL CHEM, V264, P15034; vanWijnen AJ, 1996, P NATL ACAD SCI USA, V93, P11516, DOI 10.1073/pnas.93.21.11516; VANWIJNEN AJ, 1991, J CELL PHYSIOL, V148, P174, DOI 10.1002/jcp.1041480120; Verdeguer F, 2010, NAT MED, V16, P106, DOI 10.1038/nm.2068; WRIGHT KL, 1992, BIOCHEMISTRY-US, V31, P2812, DOI 10.1021/bi00125a023; Xin L, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-31; Xing HY, 2008, NAT CELL BIOL, V10, P1318, DOI 10.1038/ncb1790; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Zaidi SK, 2010, NAT REV GENET, V11, P583, DOI 10.1038/nrg2827	60	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32834	32843		10.1074/jbc.M110.156406	http://dx.doi.org/10.1074/jbc.M110.156406			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729212	Green Published, hybrid			2022-12-25	WOS:000283048200020
J	Close, DM; Patterson, SS; Ripp, S; Baek, SJ; Sanseverino, J; Sayler, GS				Close, Dan M.; Patterson, Stacey S.; Ripp, Steven; Baek, Seung J.; Sanseverino, John; Sayler, Gary S.			Autonomous Bioluminescent Expression of the Bacterial Luciferase Gene Cassette (lux) in a Mammalian Cell Line	PLOS ONE			English	Article							IN-VIVO; CODON OPTIMIZATION; SACCHAROMYCES-CEREVISIAE; FIREFLY LUCIFERASES; FUSION; ALDEHYDE; LUMINESCENCE; EFFICIENCY; YEAST	Background: The bacterial luciferase (lux) gene cassette consists of five genes (luxCDABE) whose protein products synergistically generate bioluminescent light signals exclusive of supplementary substrate additions or exogenous manipulations. Historically expressible only in prokaryotes, the lux operon was re-synthesized through a process of multi-bicistronic, codon-optimization to demonstrate for the first time self-directed bioluminescence emission in a mammalian HEK293 cell line in vitro and in vivo. Methodology/Principal Findings: Autonomous in vitro light production was shown to be 12-fold greater than the observable background associated with untransfected control cells. The availability of reduced riboflavin phosphate (FMNH2) was identified as the limiting bioluminescence substrate in the mammalian cell environment even after the addition of a constitutively expressed flavin reductase gene (frp) from Vibrio harveyi. FMNH2 supplementation led to a 151-fold increase in bioluminescence in cells expressing mammalian codon-optimized luxCDE and frp genes. When injected subcutaneously into nude mice, in vivo optical imaging permitted near instantaneous light detection that persisted independently for the 60 min length of the assay with negligible background. Conclusions/Significance: The speed, longevity, and self-sufficiency of lux expression in the mammalian cellular environment provides a viable and powerful alternative for real-time target visualization not currently offered by existing bioluminescent and fluorescent imaging technologies.	[Close, Dan M.; Patterson, Stacey S.; Ripp, Steven; Sanseverino, John; Sayler, Gary S.] Univ Tennessee, Ctr Environm Biotechnol, Knoxville, TN 37932 USA; [Baek, Seung J.] Univ Tennessee, Coll Vet Med, Dept Pathobiol, Knoxville, TN 37932 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Close, DM (corresponding author), Univ Tennessee, Ctr Environm Biotechnol, Knoxville, TN 37932 USA.	sayler@utk.edu	Close, Dan/A-4417-2012; Ripp, Steven/B-2305-2008; Ripp, Steven/AAU-1225-2021	Ripp, Steven/0000-0002-6836-1764; Ripp, Steven/0000-0002-6836-1764; Sanseverino, John/0000-0002-2693-9521; Close, Dan/0000-0003-4790-4448	National Institutes of Health, National Cancer Institute [CA127745-01]; National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET) [CBET-0853780]; Army Defense University; NATIONAL CANCER INSTITUTE [R21CA127745] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET)(National Science Foundation (NSF)); Army Defense University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health, National Cancer Institute, Cancer Imaging Program, award number CA127745-01, the National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET) under award number CBET-0853780, and the Army Defense University Research Instrumentation Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMASHANU S, 1990, J BIOLUM CHEMILUM, V5, P89, DOI 10.1002/bio.1170050204; Baggett B, 2004, MOL IMAGING, V3, P324, DOI 10.1162/1535350042973553; Barrett JW, 2006, VIRUS GENES, V33, P15, DOI 10.1007/s11262-005-0035-7; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; Bloch S, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2070148; COLEPICOLO P, 1989, APPL ENVIRON MICROB, V55, P2601, DOI 10.1128/AEM.55.10.2601-2606.1989; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336; DUNN DK, 1973, BIOCHEMISTRY-US, V12, P4911, DOI 10.1021/bi00748a016; ESCHER A, 1989, P NATL ACAD SCI USA, V86, P6528, DOI 10.1073/pnas.86.17.6528; Gupta RK, 2003, FEMS YEAST RES, V4, P305, DOI 10.1016/S1567-1356(03)00174-0; Hollis RP, 2001, FEBS LETT, V506, P140, DOI 10.1016/S0014-5793(01)02905-2; Inoue Y, 2009, EUR J NUCL MED MOL I, V36, P771, DOI 10.1007/s00259-008-1022-8; Kalchenko V, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2364903; Kim CH, 1997, GENE, V199, P293, DOI 10.1016/S0378-1119(97)00384-3; Kim JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009364; KIRCHNER G, 1989, GENE, V81, P349, DOI 10.1016/0378-1119(89)90195-9; KONCZ C, 1987, P NATL ACAD SCI USA, V84, P131, DOI 10.1073/pnas.84.1.131; Mechold U, 2005, J BIOTECHNOL, V116, P245, DOI 10.1016/j.jbiotec.2004.12.003; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; MEIGHEN EA, 1976, BIOCHEM BIOPH RES CO, V69, P423, DOI 10.1016/0006-291X(76)90539-8; OLSSON O, 1989, GENE, V81, P335, DOI 10.1016/0378-1119(89)90194-7; Oshiro M, 1998, METHOD CELL BIOL, V56, P45, DOI 10.1016/S0091-679X(08)60420-3; Patterson SS, 2005, J IND MICROBIOL BIOT, V32, P115, DOI 10.1007/s10295-005-0211-8; PAZZAGLI M, 1992, ANAL BIOCHEM, V204, P315, DOI 10.1016/0003-2697(92)90245-3; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Slimko EM, 2003, J NEUROSCI METH, V124, P75, DOI 10.1016/S0165-0270(02)00362-X; Szittner R, 2003, BIOCHEM BIOPH RES CO, V309, P66, DOI 10.1016/S0006-291X(03)01530-4; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vo-Dinh T, 2014, BIOMED PHOTONICS, DOI 10.1201/9780203008997-38; Welham PA, 2009, MOL BIOSYST, V5, P68, DOI 10.1039/b812094c; Westerlund-Karlsson A, 2002, BIOCHEM BIOPH RES CO, V296, P1072, DOI 10.1016/S0006-291X(02)02052-1; Zhao H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032388	33	95	98	6	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12441	10.1371/journal.pone.0012441	http://dx.doi.org/10.1371/journal.pone.0012441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805991	Green Published, gold			2022-12-25	WOS:000281301500010
J	Egger, JR; Konty, KJ; Borrelli, JM; Cummiskey, J; Blank, S				Egger, Joseph R.; Konty, Kevin J.; Borrelli, Jessica M.; Cummiskey, Julia; Blank, Susan			Monitoring Temporal Changes in the Specificity of an Oral HIV Test: A Novel Application for Use in Postmarketing Surveillance	PLOS ONE			English	Article							NEW-YORK-CITY	Background: Postmarketing surveillance is routinely conducted to monitor performance of pharmaceuticals and testing devices in the marketplace. However, these surveillance methods are often done retrospectively and, as a result, are not designed to detect issues with performance in real-time. Methods and Findings: Using HIV antibody screening test data from New York City STD clinics, we developed a formal, statistical method of prospectively detecting temporal clusters of poor performance of a screening test. From 2005 to 2008, New York City, as well as other states, observed unexpectedly high false-positive (FP) rates in an oral fluid-based rapid test used for screening HIV. We attempted to formally assess whether the performance of this HIV screening test statistically deviated from both local expectation and the manufacturer's claim for the test. Results indicate that there were two significant temporal clusters in the FP rate of the oral HIV test, both of which exceeded the manufacturer's upper limit of the 95% CI for the product. Furthermore, the FP rate of the test varied significantly by both STD clinic and test lot, though not by test operator. Conclusions: Continuous monitoring of surveillance data has the benefit of providing information regarding test performance, and if conducted in real-time, it can enable programs to examine reasons for poor test performance in close proximity to the occurrence. Techniques used in this study could be a valuable addition for postmarketing surveillance of test performance and may become particularly important with the increase in rapid testing methods.	[Egger, Joseph R.; Konty, Kevin J.] New York City Dept Hlth & Mental Hyg, Bur Epidemiol Serv, New York, NY USA; [Borrelli, Jessica M.; Cummiskey, Julia; Blank, Susan] New York City Dept Hlth & Mental Hyg, Bur STD Prevent & Control, New York, NY USA; [Blank, Susan] US Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA USA	New York City Department of Health & Mental Hygiene; New York City Department of Health & Mental Hygiene; Centers for Disease Control & Prevention - USA	Egger, JR (corresponding author), New York City Dept Hlth & Mental Hyg, Bur Epidemiol Serv, New York, NY USA.	jegger@health.nyc.gov						[Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P826; *CDCP, 2007, QUAL ASS GUID TEST U; ELMORE JG, 1994, NEW ENGL J MED, V331, P1493, DOI 10.1056/NEJM199412013312206; Gottlieb S, 2005, HEALTH AFFAIR, V24, P938, DOI 10.1377/hlthaff.24.4.938; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Henning Kelly J, 2004, MMWR Suppl, V53, P5; Jafa K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000185; Jelinek T, 1999, J CLIN MICROBIOL, V37, P721, DOI 10.1128/JCM.37.3.721-723.1999; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; *ORASURE TECHN 1, 2009, ORAQUICK ADV RAP HIV; U.S. Food and Drug Administration, 2009, POSTM SURV PROGR; Wesolowski LG, 2006, AIDS, V20, P1661, DOI 10.1097/01.aids.0000238413.13442.ed; 2008, MMWR MORB MORTAL WKL, V57, P660	13	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12231	10.1371/journal.pone.0012231	http://dx.doi.org/10.1371/journal.pone.0012231			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811502	Green Published, Green Submitted, gold			2022-12-25	WOS:000281234700003
J	Pairet, B; Jaenicke, E				Pairet, Bruno; Jaenicke, Elmar			Structure of the Altitude Adapted Hemoglobin of Guinea Pig in the R2-State	PLOS ONE			English	Article							HIGH OXYGEN-AFFINITY; QUATERNARY STRUCTURE; DEOXY HUMAN; DEER MOUSE; ADAPTATION; BINDING; 2,3-DIPHOSPHOGLYCERATE; OXYHEMOGLOBIN; RESPIRATION; MECHANISM	Background: Guinea pigs are considered to be genetically adapted to a high altitude environment based on the consistent finding of a high oxygen affinity of their blood. Methodology/Principal Findings: The crystal structure of guinea pig hemoglobin at 1.8 angstrom resolution suggests that the increased oxygen affinity of guinea pig hemoglobin can be explained by two factors, namely a decreased stability of the T-state and an increased stability of the R2-state. The destabilization of the T-state can be related to the substitution of a highly conserved proline (P44) to histidine (H44) in the alpha-subunit, which causes a steric hindrance with H97 of the beta-subunit in the switch region. The stabilization of the R2-state is caused by two additional salt bridges at the beta 1/beta 2 interface. Conclusions/Significance: Both factors together are supposed to serve to shift the equilibrium between the conformational states towards the high affinity relaxed states resulting in an increased oxygen affinity.	[Pairet, Bruno; Jaenicke, Elmar] Johannes Gutenberg Univ Mainz, Inst Mol Biophys, Mainz, Germany	Johannes Gutenberg University of Mainz	Pairet, B (corresponding author), Johannes Gutenberg Univ Mainz, Inst Mol Biophys, Mainz, Germany.	elmar.jaenicke@uni-mainz.de	Jaenicke, Elmar/A-5317-2010	Jaenicke, Elmar/0000-0002-5157-7219	International Graduate School of Immunotherapy (DFG) [1043]; Computational Science Mainz (CSM)	International Graduate School of Immunotherapy (DFG)(German Research Foundation (DFG)); Computational Science Mainz (CSM)	B.P. thanks the International Graduate School of Immunotherapy (Graduiertenkolleg 1043, DFG) and the Computational Science Mainz (CSM) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1968, J CRYST GROWTH, DOI [rg/10.1016/00220248(68)900717, DOI 10.1016/0022-0248(68)90071-7]; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALDWIN J, 1979, J MOL BIOL, V129, P175, DOI 10.1016/0022-2836(79)90277-8; BARD H, 1979, PEDIATR RES, V13, P167, DOI 10.1203/00006450-197903000-00006; BARTELS H, 1969, RESP PHYSIOL, V7, P278, DOI 10.1016/0034-5687(69)90011-5; BAUER C, 1980, J COMP PHYSIOL, V136, P67, DOI 10.1007/BF00688624; BRAUNITZER G, 1979, H-S Z PHYSIOL CHEM, V360, P1941; BUNN HF, 1971, SCIENCE, V172, P1049, DOI 10.1126/science.172.3987.1049; Dickerson R.E., 1983, HEMOGLOBIN STRUCTURE; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HARANO T, 1982, HEMOGLOBIN, V6, P43, DOI 10.3109/03630268208996932; HONIG GR, 1980, BIOCHIM BIOPHYS ACTA, V626, P424, DOI 10.1016/0005-2795(80)90138-5; Jaenicke E, 2009, PROTEIN PEPTIDE LETT, V16, P444, DOI 10.2174/092986609787847983; JESSEN TH, 1991, P NATL ACAD SCI USA, V88, P6519, DOI 10.1073/pnas.88.15.6519; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KLEINSCHMIDT T, 1986, BIOL CHEM H-S, V367, P153, DOI 10.1515/bchm3.1986.367.1.153; Lukin JA, 2003, P NATL ACAD SCI USA, V100, P517, DOI 10.1073/pnas.232715799; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Ostojic H, 2002, BIOL RES, V35, P27, DOI 10.4067/S0716-97602002000100005; Paoli M, 2004, HDB METALLOPROTEINS, P1; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; PERUTZ MF, 1968, NATURE, V219, P131, DOI 10.1038/219131a0; PICCININI M, 1990, BIOL CHEM H-S, V371, P641, DOI 10.1515/bchm3.1990.371.2.641; Rivera M, 1995, COMP BIOCHEM PHYS A, V112, P411, DOI 10.1016/0300-9629(95)02008-X; Schumacher MA, 1997, P NATL ACAD SCI USA, V94, P7841, DOI 10.1073/pnas.94.15.7841; SHAANAN B, 1983, J MOL BIOL, V171, P31, DOI 10.1016/S0022-2836(83)80313-1; SILVA MM, 1992, J BIOL CHEM, V267, P17248; SNYDER LRG, 1988, EVOLUTION, V42, P689, DOI 10.1111/j.1558-5646.1988.tb02487.x; SRINIVASAN R, 1994, P NATL ACAD SCI USA, V91, P11113, DOI 10.1073/pnas.91.23.11113; Storz JF, 2008, HIGH ALT MED BIOL, V9, P148, DOI 10.1089/ham.2007.1079; Storz JF, 2009, P NATL ACAD SCI USA, V106, P14450, DOI 10.1073/pnas.0905224106; Tame JRH, 2000, ACTA CRYSTALLOGR D, V56, P805, DOI 10.1107/S0907444900006387; TUREK Z, 1978, PFLUG ARCH EUR J PHY, V376, P7, DOI 10.1007/BF00585241; TUREK Z, 1980, PFLUG ARCH EUR J PHY, V384, P109, DOI 10.1007/BF00584425; Weber RE, 2007, RESP PHYSIOL NEUROBI, V158, P132, DOI 10.1016/j.resp.2007.05.001; Winslow RM, 2007, RESP PHYSIOL NEUROBI, V158, P121, DOI 10.1016/j.resp.2007.03.011; Yokoyama T, 2006, J MOL BIOL, V356, P790, DOI 10.1016/j.jmb.2005.12.018	37	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12389	10.1371/journal.pone.0012389	http://dx.doi.org/10.1371/journal.pone.0012389			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20811494	gold, Green Submitted, Green Published			2022-12-25	WOS:000281154300017
J	Dhami, P; Saffrey, P; Bruce, AW; Dillon, SC; Chiang, K; Bonhoure, N; Koch, CM; Bye, J; James, K; Foad, NS; Ellis, P; Watkins, NA; Ouwehand, WH; Langford, C; Andrews, RM; Dunham, I; Vetrie, D				Dhami, Pawandeep; Saffrey, Peter; Bruce, Alexander W.; Dillon, Shane C.; Chiang, Kelly; Bonhoure, Nicolas; Koch, Christoph M.; Bye, Jackie; James, Keith; Foad, Nicola S.; Ellis, Peter; Watkins, Nicholas A.; Ouwehand, Willem H.; Langford, Cordelia; Andrews, Robert M.; Dunham, Ian; Vetrie, David			Complex Exon-Intron Marking by Histone Modifications Is Not Determined Solely by Nucleosome Distribution	PLOS ONE			English	Article							HUMAN GENOME; TRANSCRIPTION ELONGATION; CHROMATIN SIGNATURES; CELL-LINE; IN-VITRO; ELEMENTS; REGIONS; GENES; POLYADENYLATION; METHYLATIONS	It has recently been shown that nucleosome distribution, histone modifications and RNA polymerase II (Pol II) occupancy show preferential association with exons ("exon-intron marking"), linking chromatin structure and function to co-transcriptional splicing in a variety of eukaryotes. Previous ChIP-sequencing studies suggested that these marking patterns reflect the nucleosomal landscape. By analyzing ChIP-chip datasets across the human genome in three cell types, we have found that this marking system is far more complex than previously observed. We show here that a range of histone modifications and Pol II are preferentially associated with exons. However, there is noticeable cell-type specificity in the degree of exon marking by histone modifications and, surprisingly, this is also reflected in some histone modifications patterns showing biases towards introns. Exon-intron marking is laid down in the absence of transcription on silent genes, with some marking biases changing or becoming reversed for genes expressed at different levels. Furthermore, the relationship of this marking system with splicing is not simple, with only some histone modifications reflecting exon usage/inclusion, while others mirror patterns of exon exclusion. By examining nucleosomal distributions in all three cell types, we demonstrate that these histone modification patterns cannot solely be accounted for by differences in nucleosome levels between exons and introns. In addition, because of inherent differences between ChIP-chip array and ChIP-sequencing approaches, these platforms report different nucleosome distribution patterns across the human genome. Our findings confound existing views and point to active cellular mechanisms which dynamically regulate histone modification levels and account for exon-intron marking. We believe that these histone modification patterns provide links between chromatin accessibility, Pol II movement and co-transcriptional splicing.	[Dhami, Pawandeep; Bruce, Alexander W.; Dillon, Shane C.; Koch, Christoph M.; Bye, Jackie; James, Keith; Ellis, Peter; Ouwehand, Willem H.; Langford, Cordelia; Andrews, Robert M.; Dunham, Ian; Vetrie, David] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Hinxton, England; [Saffrey, Peter; Chiang, Kelly; Bonhoure, Nicolas; Vetrie, David] Univ Glasgow, Inst Canc Sci, Glasgow G12 8QQ, Lanark, Scotland; [Foad, Nicola S.; Watkins, Nicholas A.; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England	Wellcome Trust Sanger Institute; University of Glasgow; University of Cambridge	Dhami, P (corresponding author), UCL, Inst Canc, London, England.	dlv1q@clinmed.gla.ac.uk	Bruce, Alexander W/H-4235-2014; Dillon, Shane/A-2280-2011	Bruce, Alexander W/0000-0003-4297-4412; Vetrie, David/0000-0003-2075-4662; Andrews, Robert/0000-0002-3491-2361; Koch, Christof/0000-0001-6482-8067; Dunham, Ian/0000-0003-2525-5598; Ouwehand, Willem/0000-0002-7744-1790	Wellcome Trust; National Institute for Health Research in England; National Human Genome Research Institute [U01HG003168]; Ministry of Education, Czech Republic [6007665801]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG003168] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research in England; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Ministry of Education, Czech Republic(Ministry of Education, Youth & Sports - Czech RepublicCzech Republic Government); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The Wellcome Trust (http://www.wellcome.ac.uk/); The National Institute for Health Research in England (http://www.nihr.ac.uk/Pages/default.aspx); The National Human Genome Research Institute (http://www.genome.gov/) Grant No: U01HG003168; Ministry of Education, Czech Republic Grant No. 6007665801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Auerbach RK, 2009, P NATL ACAD SCI USA, V106, P14926, DOI 10.1073/pnas.0905443106; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bruce AW, 2006, J NEUROCHEM, V98, P1828, DOI 10.1111/j.1471-4159.2006.04010.x; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; DHAMI P, PLOS ONE, V5, pE9059; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Forsberg EC, 2000, P NATL ACAD SCI USA, V97, P14494, DOI 10.1073/pnas.97.26.14494; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Howe KJ, 2003, RNA, V9, P993, DOI 10.1261/rna.5390803; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; LOZZIO BB, 1979, LEUKEMIA RES, V3, P363, DOI 10.1016/0145-2126(79)90033-X; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Nagy PL, 2003, P NATL ACAD SCI USA, V100, P6364, DOI 10.1073/pnas.1131966100; Nahkuri S, 2009, CELL CYCLE, V8, P3420, DOI 10.4161/cc.8.20.9916; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; Park NJ, 2004, MOL CELL BIOL, V24, P4092, DOI 10.1128/MCB.24.10.4092-4103.2004; Robson-Dixon ND, 2004, J BIOL CHEM, V279, P29075, DOI 10.1074/jbc.M312747200; Schor IE, 2009, P NATL ACAD SCI USA, V106, P4325, DOI 10.1073/pnas.0810666106; Schwartz S, 2010, EMBO J, V29, P1629, DOI 10.1038/emboj.2010.71; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Tyagi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000470; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Yonaha M, 1999, MOL CELL, V3, P593, DOI 10.1016/S1097-2765(00)80352-4	49	48	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12339	10.1371/journal.pone.0012339	http://dx.doi.org/10.1371/journal.pone.0012339			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808788	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000281153500019
J	Lawson, VA; Lumicisi, B; Welton, J; Machalek, D; Gouramanis, K; Klemm, HM; Stewart, JD; Masters, CL; Hoke, DE; Collins, SJ; Hill, AF				Lawson, Victoria A.; Lumicisi, Brooke; Welton, Jeremy; Machalek, Dorothy; Gouramanis, Katrina; Klemm, Helen M.; Stewart, James D.; Masters, Colin L.; Hoke, David E.; Collins, Steven J.; Hill, Andrew F.			Glycosaminoglycan Sulphation Affects the Seeded Misfolding of a Mutant Prion Protein	PLOS ONE			English	Article							UNIFYING ELECTROSTATIC MECHANISM; CREUTZFELDT-JAKOB-DISEASE; INTRAVENTRICULAR PENTOSAN POLYSULFATE; SPONGIFORM ENCEPHALOPATHY AGENT; CELL-FREE FORMATION; HEPARAN-SULFATE; LIPID-MEMBRANES; IN-VITRO; NUCLEOCAPSID PROTEIN; AMYLOID PLAQUES	Background: The accumulation of protease resistant conformers of the prion protein (PrP(res)) is a key pathological feature of prion diseases. Polyanions, including RNA and glycosaminoglycans have been identified as factors that contribute to the propagation, transmission and pathogenesis of prion disease. Recent studies have suggested that the contribution of these cofactors to prion propagation may be species specific. Methodology/Principal Finding: In this study a cell-free assay was used to investigate the molecular basis of polyanion stimulated PrP(res) formation using brain tissue or cell line derived murine PrP. Enzymatic depletion of endogenous nucleic acids or heparan sulphate (HS) from the PrP(C) substrate was found to specifically prevent PrP(res) formation seeded by mouse derived PrP(Sc). Modification of the negative charge afforded by the sulphation of glycosaminoglycans increased the ability of a familial PrP mutant to act as a substrate for PrP(res) formation, while having no effect on PrP(res) formed by wildtype PrP. This difference may be due to the observed differences in the binding of wild type and mutant PrP for glycosaminoglycans. Conclusions/Significance: Cofactor requirements for PrP(res) formation are host species and prion strain specific and affected by disease associated mutations of the prion protein. This may explain both species and strain dependent propagation characteristics and provide insights into the underlying mechanisms of familial prion disease. It further highlights the challenge of designing effective therapeutics against a disease which effects a range of mammalian species, caused by range of aetiologies and prion strains.	[Lawson, Victoria A.; Lumicisi, Brooke; Welton, Jeremy; Machalek, Dorothy; Gouramanis, Katrina; Klemm, Helen M.; Stewart, James D.; Collins, Steven J.; Hill, Andrew F.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Hill, Andrew F.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Lawson, Victoria A.; Masters, Colin L.; Collins, Steven J.; Hill, Andrew F.] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3052, Australia; [Hoke, David E.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University	Lawson, VA (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia.	vlawson@unimelb.edu.au; afhill@unimelb.edu.au	Hill, Andrew F/B-4527-2009; Hill, Andrew F./GZL-4124-2022; Lawson, Victoria/AAJ-7392-2021; Hill, Andrew F./AAH-2854-2020; Welton, Jeremy/AAH-4120-2019	Hill, Andrew F/0000-0001-5581-2354; Hill, Andrew F./0000-0001-5581-2354; Welton, Jeremy/0000-0002-9446-9162; Stewart, James/0000-0002-1774-8619; Lawson, Victoria/0000-0002-7362-7176; Machalek, Dorothy/0000-0002-4101-8085	National Health and Medical Research Council (NHMRC) [400229, 400183]; University of Melbourne Research Grant Scheme; University of Melbourne; Faculty of Medicine, University of Melbourne	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne Research Grant Scheme(University of Melbourne); University of Melbourne(University of Melbourne); Faculty of Medicine, University of Melbourne(University of Melbourne)	This work was supported by National Health and Medical Research Council (NHMRC) Project Grant #400229 and The University of Melbourne Research Grant Scheme. VAL is the recipient of an NHMRC Howard Florey Fellowship and University of Melbourne CR Roper Fellowship. AFH is the recipient of an NHMRC RD Wright Career Development Award, and SJC is a recipient of an NHMRC Practitioner Fellowship #400183. JW is the recipient of the Mary Stewart Bursary from the Faculty of Medicine, University of Melbourne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjou KT, 2003, J GEN VIROL, V84, P2595, DOI 10.1099/vir.0.19073-0; Adler V, 2003, J MOL BIOL, V332, P47, DOI 10.1016/S0022-2836(03)00919-7; BAEUERLE PA, 1986, BIOCHEM BIOPH RES CO, V141, P870, DOI 10.1016/S0006-291X(86)80253-4; Ben-Zaken O, 2003, J BIOL CHEM, V278, P40041, DOI 10.1074/jbc.M301152200; Bone I, 2008, EUR J NEUROL, V15, P458, DOI 10.1111/j.1468-1331.2008.02108.x; Brazier MW, 2006, BRAIN RES BULL, V68, P346, DOI 10.1016/j.brainresbull.2005.09.010; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Cappai R, 1999, BIOCHEMISTRY-US, V38, P3280, DOI 10.1021/bi982328z; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; CHRISTOFINIS GJ, 1968, J PATHOL BACTERIOL, V95, P377, DOI 10.1002/path.1700950204; Collins SJ, 2004, LANCET, V363, P51, DOI 10.1016/S0140-6736(03)15171-9; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; Critchley P, 2004, BIOCHEM BIOPH RES CO, V313, P559, DOI 10.1016/j.bbrc.2003.12.004; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; DELEAULT NR, BIOCHEMISTRY, V49, P3928; Derrington E, 2002, CR BIOL, V325, P17, DOI 10.1016/S1631-0691(02)01388-4; Doh-Ura K, 2004, J VIROL, V78, P4999, DOI 10.1128/JVI.78.10.4999-5006.2004; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; GABIZON R, 1993, J CELL PHYSIOL, V157, P319, DOI 10.1002/jcp.1041570215; Gabus C, 2001, J BIOL CHEM, V276, P19301, DOI 10.1074/jbc.M009754200; Gabus C, 2001, J MOL BIOL, V307, P1011, DOI 10.1006/jmbi.2001.4544; Gonzalez-Iglesias R, 2002, J MOL BIOL, V319, P527, DOI 10.1016/S0022-2836(02)00341-8; Hijazi N, 2005, J BIOL CHEM, V280, P17057, DOI 10.1074/jbc.M411314200; Horonchik L, 2005, J BIOL CHEM, V280, P17062, DOI 10.1074/jbc.M500122200; Kazlauskaite J, 2005, BIOCHEM SOC SYMP, V72, P211, DOI 10.1042/bss0720211; Kazlauskaite J, 2003, BIOCHEMISTRY-US, V42, P3295, DOI 10.1021/bi026872q; KIM JI, J BIOL CHEM, V285, P14087; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Kovacic P, 2008, J RECEPT SIG TRANSD, V28, P153, DOI [10.1080/10799890802084234, 10.1080/10799890802084234 ]; Kovacic P, 2007, J RECEPT SIG TRANSD, V27, P411, DOI 10.1080/10799890701699686; Kovacic P, 2007, J RECEPT SIG TRANSD, V27, P433, DOI 10.1080/10799890701699702; Lawson VA, 2008, INT J BIOCHEM CELL B, V40, P2793, DOI 10.1016/j.biocel.2008.05.024; Lawson VA, 2007, J GEN VIROL, V88, P2905, DOI 10.1099/vir.0.82961-0; Lee KS, 2007, P NATL ACAD SCI USA, V104, P9551, DOI 10.1073/pnas.0703910104; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lehmann S, 1996, J BIOL CHEM, V271, P1633, DOI 10.1074/jbc.271.3.1633; Lucassen R, 2003, BIOCHEMISTRY-US, V42, P4127, DOI 10.1021/bi027218d; Manson JC, 2000, ARCH VIROL, P95; Moore RA, 2006, PROTEIN SCI, V15, P609, DOI 10.1110/ps.051822606; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; Nandi PK, 2004, J MOL BIOL, V344, P827, DOI 10.1016/j.jmb.2004.09.080; Nandi PK, 2002, J MOL BIOL, V322, P153, DOI 10.1016/S0022-2836(02)00750-7; Nishina K, 2004, J BIOL CHEM, V279, P40788, DOI 10.1074/jbc.M406548200; Papakonstantinou E, 1999, ARCH BIOCHEM BIOPHYS, V370, P250, DOI 10.1006/abbi.1999.1405; Paquet S, 2007, J VIROL, V81, P10786, DOI 10.1128/JVI.01137-07; Parry A, 2007, J NEUROL NEUROSUR PS, V78, P733, DOI 10.1136/jnnp.2006.104505; Proske D, 2002, CHEMBIOCHEM, V3, P717, DOI 10.1002/1439-7633(20020802)3:8<717::AID-CBIC717>3.0.CO;2-C; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; SNOW AD, 1989, ACTA NEUROPATHOL, V77, P337, DOI 10.1007/BF00687367; SNOW AD, 1990, LAB INVEST, V63, P601; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; Tateishi J, 1996, SEMIN VIROL, V7, P175, DOI 10.1006/smvy.1996.0022; TATEISHI J, 1979, ANN NEUROL, V5, P581, DOI 10.1002/ana.410050616; TAUBNER LM, 2009, J MOL BIOL; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; WANG F, SCIENCE; WANG F, SCIENCE, V327, P1132; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Yin SM, 2007, P NATL ACAD SCI USA, V104, P7546, DOI 10.1073/pnas.0610827104	69	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12351	10.1371/journal.pone.0012351	http://dx.doi.org/10.1371/journal.pone.0012351			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808809	Green Published, gold			2022-12-25	WOS:000281153500027
J	Zhang, F; Hu, YH; Xu, QB; Ye, S				Zhang, Feng; Hu, Yanhua; Xu, Qingbo; Ye, Shu			Different Effects of Angiotensin II and Angiotensin-(1-7) on Vascular Smooth Muscle Cell Proliferation and Migration	PLOS ONE			English	Article							FOCAL ADHESION KINASE; EPIDERMAL-GROWTH-FACTOR; STIMULATED MIGRATION; NEOINTIMAL FORMATION; STENT IMPLANTATION; NITRIC-OXIDE; VEIN GRAFTS; IN-VITRO; RECEPTOR; INHIBITION	Background: Angiotensin (Ang) II and Ang-(1-7) are two of the bioactive peptides of the rennin-angiotensin system. Ang II is involved in the development of cardiovascular disease, such as hypertension and atherosclerosis, while Ang-(1-7) shows cardiovascular protection in contrast to Ang II. Methodology/Principal Findings: In this study, we investigated effects of Ang II and Ang-(1-7) on vascular smooth muscle cell (SMC) proliferation and migration, which are critical in the formation of atherosclerotic lesions. Treatment with Ang II resulted in an increase of SMC proliferation, whereas Ang-(1-7) alone had no effects. However, preincubation with Ang-(1-7) inhibited Ang II-induced SMC proliferation. Ang II promoted SMC migration, and this effect was abolished by pretreatment with Ang-(1-7). The stimulatory effects of Ang II on SMC proliferation and migration were blocked by the Ang II receptor antagonist lorsartan, while the inhibitory effects of Ang-(1-7) were abolished by the Ang-(1-7) receptor antagonist A-799. Ang II treatment caused activation of ERK1/2 mediated signaling, and this was inhibited by preincubation of SMCs with Ang-(1-7). Conclusion: These results suggest that Ang-(1-7) inhibits Ang II-induced SMC proliferation and migration, at least in part, through negative modulation of Ang II induced ERK1/2 activity.	[Zhang, Feng; Ye, Shu] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Zhang, Feng] Peking Univ, Dept Physiol & Pathophysiol, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Hu, Yanhua; Xu, Qingbo] Kings Coll London, Div Cardiovasc, Kings BHF Ctr, London WC2R 2LS, England	University of London; Queen Mary University London; Peking University; University of London; King's College London	Zhang, F (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.	s.ye@qmul.ac.uk	Ye, Shu/R-6384-2017; Ye, Shu/C-4067-2009	Ye, Shu/0000-0002-4126-4278; 	British Heart Foundation [PG/08/051/25141]; Chinese scholarship; National Institute of Health Research	British Heart Foundation(British Heart Foundation); Chinese scholarship; National Institute of Health Research(National Institute for Health Research (NIHR))	This work was supported by grants from the British Heart Foundation (PG/08/051/25141) and a Chinese scholarship. The work forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOVY PR, 1989, J MED CHEM, V32, P520, DOI 10.1021/jm00123a002; Brosnihan KB, 1996, HYPERTENSION, V27, P523, DOI 10.1161/01.HYP.27.3.523; BURSON JM, 1994, AM J PHYSIOL, V267, pE260, DOI 10.1152/ajpendo.1994.267.2.E260; Cho A, 2000, ARTERIOSCL THROM VAS, V20, P2527, DOI 10.1161/01.ATV.20.12.2527; Clark MA, 2001, HYPERTENSION, V37, P1141, DOI 10.1161/01.HYP.37.4.1141; DAEMEN MJAP, 1991, CIRC RES, V68, P450, DOI 10.1161/01.RES.68.2.450; dos Santos RAS, 2001, HYPERTENSION, V38, P660, DOI 10.1161/01.HYP.38.3.660; DUBEY RK, 1995, J CLIN INVEST, V96, P141, DOI 10.1172/JCI118014; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; Freeman EJ, 1996, HYPERTENSION, V28, P104, DOI 10.1161/01.HYP.28.1.104; Galis ZS, 2002, CIRC RES, V91, P852, DOI 10.1161/01.RES.0000041036.86977.14; Gallagher PE, 2004, CARCINOGENESIS, V25, P2045, DOI 10.1093/carcin/bgh236; Grobe JL, 2007, AM J PHYSIOL-HEART C, V292, pH736, DOI 10.1152/ajpheart.00937.2006; Heitsch H, 2001, HYPERTENSION, V37, P72, DOI 10.1161/01.HYP.37.1.72; Heringer-Walther S, 2009, HAEMATOL-HEMATOL J, V94, P857, DOI 10.3324/haematol.2008.000034; Hu YH, 1999, CIRCULATION, V100, P861, DOI 10.1161/01.CIR.100.8.861; Hu YH, 1997, ARTERIOSCL THROM VAS, V17, P2808, DOI 10.1161/01.ATV.17.11.2808; Hunger-Glaser I, 2003, J BIOL CHEM, V278, P22631, DOI 10.1074/jbc.M210876200; Izumi Y, 2001, CIRC RES, V88, P1120, DOI 10.1161/hh1101.091267; Keidar S, 2007, CARDIOVASC RES, V73, P463, DOI 10.1016/j.cardiores.2006.09.006; Kyaw M, 2004, MOL PHARMACOL, V65, P832, DOI 10.1124/mol.65.4.832; Langeveld B, 2005, HYPERTENSION, V45, P138, DOI 10.1161/01.HYP.0000149382.83973.c2; Lee HM, 2007, J PHARMACOL SCI, V105, P74, DOI 10.1254/jphs.FP0070770; Li CH, 2003, FASEB J, V17, P2106, DOI 10.1096/fj.03-0150fje; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mercure C, 2008, CIRC RES, V103, P1319, DOI 10.1161/CIRCRESAHA.108.184911; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mugabe BE, 2010, J PHARMACOL EXP THER, V332, P116, DOI 10.1124/jpet.109.157552; Ohtsu H, 2005, ARTERIOSCL THROM VAS, V25, P1831, DOI 10.1161/01.ATV.0000175749.41799.9b; Pan CH, 2008, EXP PHYSIOL, V93, P599, DOI 10.1113/expphysiol.2007.041830; Roks AJM, 1999, HYPERTENSION, V34, P296, DOI 10.1161/01.HYP.34.2.296; Sampaio WO, 2007, HYPERTENSION, V50, P1093, DOI 10.1161/HYPERTENSIONAHA.106.084848; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Sharony R, 2006, AM J PHYSIOL-HEART C, V290, pH1651, DOI 10.1152/ajpheart.00530.2005; Strawn WB, 1999, HYPERTENSION, V33, P207, DOI 10.1161/01.HYP.33.1.207; Su Z, 2006, KIDNEY INT, V69, P2212, DOI 10.1038/sj.ki.5001509; Tallant EA, 1999, HYPERTENSION, V34, P950, DOI 10.1161/01.HYP.34.4.950; Tallant EA, 2005, AM J PHYSIOL-HEART C, V289, pH1560, DOI 10.1152/ajpheart.00941.2004; Tallant EA, 2003, HYPERTENSION, V42, P574, DOI 10.1161/01.HYP.0000090322.55782.30; Touyz RM, 1999, J HYPERTENS, V17, P907, DOI 10.1097/00004872-199917070-00006; Touyz RM, 2000, PHARMACOL REV, V52, P639; Ueda S, 2000, HYPERTENSION, V35, P998, DOI 10.1161/01.HYP.35.4.998; Ueda S, 2001, J HYPERTENS, V19, P2001, DOI 10.1097/00004872-200111000-00010; WANG Y, CIRC HEART FAIL; Weiss D, 2001, AM J CARDIOL, V87, p25C; Xi XP, 1999, ARTERIOSCL THROM VAS, V19, P73, DOI 10.1161/01.ATV.19.1.73; Yang XP, 2005, MOL CELLS, V20, P263; Yoshida O, 2005, AM HEART J, V149, DOI 10.1016/j.ahj.2004.08.006; Zeng WT, 2009, BIOCHEM BIOPH RES CO, V389, P138, DOI 10.1016/j.bbrc.2009.08.112; ZHANG J, 1979, AM J PHYSIOL-RENAL, V298, pF579	52	62	72	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12323	10.1371/journal.pone.0012323	http://dx.doi.org/10.1371/journal.pone.0012323			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808802	Green Published, gold, Green Submitted			2022-12-25	WOS:000281153500009
J	Cox, CL; Gotimer, K; Roy, AK; Castellanos, FX; Milham, MP; Kelly, C				Cox, Christine L.; Gotimer, Kristin; Roy, Amy K.; Castellanos, F. Xavier; Milham, Michael P.; Kelly, Clare			Your Resting Brain CAREs about Your Risky Behavior	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; ANTERIOR CINGULATE CORTEX; STATE FUNCTIONAL CONNECTIVITY; DECISION-MAKING; PREFRONTAL CORTEX; OUTCOME EXPECTANCIES; TAKING BEHAVIOR; YOUNG-ADULTS; REWARD ANTICIPATION; NEURAL MECHANISMS	Background: Research on the neural correlates of risk-related behaviors and personality traits has provided insight into mechanisms underlying both normal and pathological decision-making. Task-based neuroimaging studies implicate a distributed network of brain regions in risky decision-making. What remains to be understood are the interactions between these regions and their relation to individual differences in personality variables associated with real-world risk-taking. Methodology/Principal Findings: We employed resting state functional magnetic resonance imaging (R-fMRI) and resting state functional connectivity (RSFC) methods to investigate differences in the brain's intrinsic functional architecture associated with beliefs about the consequences of risky behavior. We obtained an individual measure of expected benefit from engaging in risky behavior, indicating a risk seeking or risk-averse personality, for each of 21 participants from whom we also collected a series of R-fMRI scans. The expected benefit scores were entered in statistical models assessing the RSFC of brain regions consistently implicated in both the evaluation of risk and reward, and cognitive control (i.e., orbitofrontal cortex, nucleus accumbens, lateral prefrontal cortex, dorsal anterior cingulate). We specifically focused on significant brain-behavior relationships that were stable across R-fMRI scans collected one year apart. Two stable expected benefit-RSFC relationships were observed: decreased expected benefit (increased risk-aversion) was associated with 1) stronger positive functional connectivity between right inferior frontal gyrus (IFG) and right insula, and 2) weaker negative functional connectivity between left nucleus accumbens and right parieto-occipital cortex. Conclusions/Significance: Task-based activation in the IFG and insula has been associated with risk-aversion, while activation in the nucleus accumbens and parietal cortex has been associated with both risk seeking and risk-averse tendencies. Our results suggest that individual differences in attitudes toward risk-taking are reflected in the brain's functional architecture and may have implications for engaging in real-world risky behaviors.	[Cox, Christine L.; Gotimer, Kristin; Roy, Amy K.; Castellanos, F. Xavier; Milham, Michael P.; Kelly, Clare] NYU, Phyllis Green & Randolph Cowen Inst Pediat Neuros, Ctr Child Study, Langone Med Ctr, New York, NY 10016 USA; [Castellanos, F. Xavier; Milham, Michael P.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA	New York University; NYU Langone Medical Center; Nathan Kline Institute for Psychiatric Research	Cox, CL (corresponding author), NYU, Phyllis Green & Randolph Cowen Inst Pediat Neuros, Ctr Child Study, Langone Med Ctr, New York, NY 10016 USA.	Clare.Kelly@nyumc.org	Milham, Michael P./Y-3160-2019; Roy, Amy K/J-7613-2013; Castellanos, Francisco Xavier/K-1892-2014; Milham, Michael P/K-9501-2014; Kelly, Clare/H-4629-2016	Castellanos, Francisco Xavier/0000-0001-9192-9437; Kelly, Clare/0000-0001-8253-357X	National Institute on Drug Abuse [2T32DA007254-16A2, R03DA024775, R01DA016979]; National Institute of Mental Health [R01MH083246, R01MH081218, K23MH074821]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081218, R01MH083246, K23MH074821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016979, T32DA007254, R03DA024775] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Financial support for this project was provided by grants from the National Institute on Drug Abuse (2T32DA007254-16A2, postdoctoral training support for CLC; R03DA024775, to CK; R01DA016979, to FXC), the National Institute of Mental Health (R01MH083246 and R01MH081218, to FXC and MPM; K23MH074821, to AKR), as well as gifts to the NYU Child Study Center from the Stavros Niarchos Foundation, Leon Levy Foundation, and an endowment provided by Phyllis Green and Randolph Cowen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L., 2007, FMRIB ANAL GROUP TEC; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Aron JL, 2007, ADDICTION, V102, P33, DOI 10.1111/j.1360-0443.2006.01778.x; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Castilla J, 1999, DRUG ALCOHOL DEPEN, V56, P47, DOI 10.1016/S0376-8716(99)00008-3; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Christopoulos GI, 2009, J NEUROSCI, V29, P12574, DOI 10.1523/JNEUROSCI.2614-09.2009; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Combs-Lane AM, 2002, J INTERPERS VIOLENCE, V17, P165, DOI 10.1177/0886260502017002004; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; d'Acremont M, 2009, NEUROIMAGE, V47, P1929, DOI 10.1016/j.neuroimage.2009.04.096; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Di Martino A, 2009, AM J PSYCHIAT, V166, P891, DOI 10.1176/appi.ajp.2009.08121894; Engelmann JB, 2009, BRAIN RES, V1290, P28, DOI 10.1016/j.brainres.2009.06.078; Ernst M, 2005, NEUROIMAGE, V25, P1279, DOI 10.1016/j.neuroimage.2004.12.038; Ernst M, 2005, BIOL PSYCHIAT, V58, P597, DOI 10.1016/j.biopsych.2005.06.004; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Floden D, 2008, NEUROPSYCHOLOGIA, V46, P213, DOI 10.1016/j.neuropsychologia.2007.07.020; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fromme K, 1997, COGNITIVE THER RES, V21, P421, DOI 10.1023/A:1021932326716; Galvan A, 2007, DEVELOPMENTAL SCI, V10, pF8, DOI 10.1111/j.1467-7687.2006.00579.x; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Garavan H, 2008, PHILOS T R SOC B, V363, P3267, DOI 10.1098/rstb.2008.0106; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; James GA, 2009, NEUROIMAGE, V45, P778, DOI 10.1016/j.neuroimage.2008.12.049; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kashdan TB, 2006, COGNITIVE THER RES, V30, P749, DOI 10.1007/s10608-006-9017-x; Katz EC, 2000, COGNITIVE THER RES, V24, P1, DOI 10.1023/A:1005460107337; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kelly C, 2009, J NEUROSCI, V29, P7364, DOI 10.1523/JNEUROSCI.0810-09.2009; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Krain AL, 2006, NEUROIMAGE, V32, P477, DOI 10.1016/j.neuroimage.2006.02.047; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Lawrence AJ, 2009, ADDICTION, V104, P1006, DOI 10.1111/j.1360-0443.2009.02533.x; Lee TMC, 2008, NEUROSCI LETT, V438, P138, DOI 10.1016/j.neulet.2008.04.061; Leigh BC, 1999, ADDICTION, V94, P371, DOI 10.1046/j.1360-0443.1999.9433717.x; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Maner JK, 2007, PERS INDIV DIFFER, V42, P665, DOI 10.1016/j.paid.2006.08.016; Mantyla T, 2012, J ATTEN DISORD, V16, P164, DOI 10.1177/1087054709360494; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Milham MP, 2005, HUM BRAIN MAPP, V25, P328, DOI 10.1002/hbm.20110; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Mohr PNC, 2010, J NEUROSCI, V30, P6613, DOI 10.1523/JNEUROSCI.0003-10.2010; Mohr PNC, 2010, NEUROIMAGE, V49, P2556, DOI 10.1016/j.neuroimage.2009.10.060; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; O'Doherty J, 2003, J NEUROSCI, V23, P7931; Paulus MP, 2007, SCIENCE, V318, P602, DOI 10.1126/science.1142997; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Peters J, 2010, BEHAV BRAIN RES, V213, P135, DOI 10.1016/j.bbr.2010.04.031; Plichta MM, 2009, BIOL PSYCHIAT, V65, P7, DOI 10.1016/j.biopsych.2008.07.008; Rauch SL, 1997, BIOL PSYCHIAT, V42, P446, DOI 10.1016/S0006-3223(97)00145-5; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Samanez-Larkin GR, 2008, PSYCHOL SCI, V19, P320, DOI 10.1111/j.1467-9280.2008.02087.x; Scheres A, 2007, BIOL PSYCHIAT, V61, P720, DOI 10.1016/j.biopsych.2006.04.042; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stark DE, 2008, J NEUROSCI, V28, P13754, DOI 10.1523/JNEUROSCI.4544-08.2008; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Strohle A, 2008, NEUROIMAGE, V39, P966, DOI 10.1016/j.neuroimage.2007.09.044; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Van Leijenhorst L, 2010, NEUROIMAGE, V51, P345, DOI 10.1016/j.neuroimage.2010.02.038; Venkatraman V, 2007, SLEEP, V30, P603, DOI 10.1093/sleep/30.5.603; Venkatraman V, 2009, NEURON, V62, P593, DOI 10.1016/j.neuron.2009.04.007; Weller JA, 2009, SOC NEUROSCI-UK, V4, P347, DOI 10.1080/17470910902934400; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037; [No title captured]	85	40	43	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12296	10.1371/journal.pone.0012296	http://dx.doi.org/10.1371/journal.pone.0012296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808870	Green Published			2022-12-25	WOS:000281075500023
J	Kandan-Kulangara, F; Shah, RG; Affar, E; Shah, GM				Kandan-Kulangara, Febitha; Shah, Rashmi G.; Affar, El Bachir; Shah, Girish M.			Persistence of Different Forms of Transient RNAi during Apoptosis in Mammalian Cells	PLOS ONE			English	Article							VECTOR-BASED RNAI	Gene silencing by transient or stable RNA-interference (RNAi) is used for the study of apoptosis with an assumption that apoptotic events will not influence RNAi. However, we recently reported that stable RNAi, i.e., a permanent gene-knockdown mediated by shRNA-generating DNA vectors that are integrated in the genome, fails rapidly after induction of apoptosis due to caspase-3-mediated cleavage and inactivation of the endoribonuclease Dicer-1 that is required for conversion of shRNA to siRNA. Since apoptosis studies also increasingly employ transient RNAi models in which apoptosis is induced immediately after a gene is temporarily knocked down within a few days of transfection with RNAi-inducing agents, we examined the impact of apoptosis on various models of transient RNAi. We report here that unlike the stable RNAi, all forms of transient RNAi, whether Dicer-1-independent (by 21mer dsRNA) or Dicer-1-dependent (by 27mer dsRNA or shRNA-generating DNA vector), whether for an exogenous gene GFP or an endogenous gene poly(ADP-ribose) polymerase-1, do not fail for 2-3 days after onset of apoptosis. Our results reflect the differences in dynamics of achieving and maintaining RNAi during the early phase after transfection in the transient RNAi model and the late steady-state phase of gene-knockdown in stable RNAi model. Our results also sound a cautionary note that RNAi status should be frequently validated in the studies involving apoptosis and that while stable RNAi can be safely used for the study of early apoptotic events, transient RNAi is more suitable for the study of both early and late apoptotic events.	[Kandan-Kulangara, Febitha; Shah, Rashmi G.; Shah, Girish M.] Univ Laval, Hosp Res Ctr Laval Univ CHUL CHUQ, Fac Med, Dept Mol Biol Med Biochem & Pathol,Lab Skin Canc, Quebec City, PQ, Canada; [Affar, El Bachir] Univ Montreal, Dept Med, Fac Med, Hop Maison Neuve Rosemont,Res Ctr, Montreal, PQ H3C 3J7, Canada	Laval University; Universite de Montreal	Kandan-Kulangara, F (corresponding author), Univ Laval, Hosp Res Ctr Laval Univ CHUL CHUQ, Fac Med, Dept Mol Biol Med Biochem & Pathol,Lab Skin Canc, Quebec City, PQ, Canada.	girish.shah@crchul.ulaval.ca		Shah, Girish/0000-0002-9291-1164	Natural Sciences and Engineering Research Council of Canada [155257-06]; NSERC; Fonds de la recherche en Sante du Quebec	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This study was supported by the research grant to G.M.S. from the Natural Sciences and Engineering Research Council of Canada (155257-06). F.K.K. was a recipient of the NSERC-Doctoral scholarship award. E.B.A. and G.M.S. were recipients of the FRSQ-Junior-1 and FRSQ-Senior Scholarship awards, respectively, from the Fonds de la recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp131; Dykxhoorn DM, 2006, CELL, V126, P231, DOI 10.1016/j.cell.2006.07.007; Ghodgaonkar MM, 2009, CELL DEATH DIFFER, V16, P858, DOI 10.1038/cdd.2009.15; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kurreck J, 2009, ANGEW CHEM INT EDIT, V48, P1378, DOI 10.1002/anie.200802092; Oikawa Y, 2008, J BIOL CHEM, V283, P14242, DOI 10.1074/jbc.M802257200; Shah RG, 2005, BIOCHEM BIOPH RES CO, V331, P167, DOI 10.1016/j.bbrc.2005.03.135; Shi Y, 2003, TRENDS GENET, V19, P9, DOI 10.1016/S0168-9525(02)00005-7; Zhang MS, 2006, CANCER LETT, V243, P38, DOI 10.1016/j.canlet.2005.11.020	9	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12263	10.1371/journal.pone.0012263	http://dx.doi.org/10.1371/journal.pone.0012263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805889	Green Submitted, Green Published, gold			2022-12-25	WOS:000281011600027
J	Benfield, CTO; Lyall, JW; Tiley, LS				Benfield, Camilla T. O.; Lyall, Jon W.; Tiley, Laurence S.			The Cytoplasmic Location of Chicken Mx Is Not the Determining Factor for Its Lack of Antiviral Activity	PLOS ONE			English	Article							INFLUENZA-VIRUS REPLICATION; THOGOTO-VIRUS; INTERFERON-ANTAGONIST; GENE-EXPRESSION; TRANSGENIC MICE; PROTEIN MX; V-PROTEIN; IN-VITRO; A VIRUS; RESISTANCE	Background: Chicken Mx belongs to the Mx family of interferon-induced dynamin-like GTPases, which in some species possess potent antiviral properties. Conflicting data exist for the antiviral capability of chicken Mx. Reports of anti-influenza activity of alleles encoding an Asn631 polymorphism have not been supported by subsequent studies. The normal cytoplasmic localisation of chicken Mx may influence its antiviral capacity. Here we report further studies to determine the antiviral potential of chicken Mx against Newcastle disease virus (NDV), an economically important cytoplasmic RNA virus of chickens, and Thogoto virus, an orthomyxovirus known to be exquisitely sensitive to the cytoplasmic MxA protein from humans. We also report the consequences of re-locating chicken Mx to the nucleus. Methodology/Principal Findings: Chicken Mx was tested in virus infection assays using NDV. Neither the Asn631 nor Ser631 Mx alleles (when transfected into 293T cells) showed inhibition of virus-directed gene expression when the cells were subsequently infected with NDV. Human MxA however did show significant inhibition of NDV-directed gene expression. Chicken Mx failed to inhibit a Thogoto virus (THOV) minireplicon system in which the cytoplasmic human MxA protein showed potent and specific inhibition. Relocalisation of chicken Mx to the nucleus was achieved by inserting the Simian Virus 40 large T antigen nuclear localisation sequence (SV40 NLS) at the N-terminus of chicken Mx. Nuclear re-localised chicken Mx did not inhibit influenza (A/PR/8/34) gene expression during virus infection in cell culture or influenza polymerase activity in A/PR/8/34 or A/Turkey/50-92/91 minireplicon systems. Conclusions/Significance: The chicken Mx protein (Asn631) lacks inhibitory effects against THOV and NDV, and is unable to suppress influenza replication when artificially re-localised to the cell nucleus. Thus, the natural cytoplasmic localisation of the chicken Mx protein does not account for its lack of antiviral activity.	[Benfield, Camilla T. O.; Lyall, Jon W.; Tiley, Laurence S.] Univ Cambridge, Dept Vet Med, Cambridge, England	University of Cambridge	Benfield, CTO (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Med, Sect Virol,Div Infect Dis, London, England.	c.benfield@imperial.ac.uk		Benfield, Camilla/0000-0001-7851-4181	Department for Environment, Food and Rural Affairs (DEFRA); Higher Education Funding Council for England (HEFCE); Veterinary Training Research Initiative (VTRI); Royal College of Veterinary Surgeons Trust [911]; Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/B/00239]; BBSRC [BB/G00479X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/00239, BB/G00479X/1] Funding Source: researchfish	Department for Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Veterinary Training Research Initiative (VTRI); Royal College of Veterinary Surgeons Trust; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Cambridge Infectious Diseases Consortium (CIDC), which is funded jointly by the Department for Environment, Food and Rural Affairs (DEFRA) and the Higher Education Funding Council for England (HEFCE) as part of the Veterinary Training Research Initiative (VTRI), a grant awarded to CB from the Royal College of Veterinary Surgeons Trust (Grant No. 911), and Biotechnology and Biological Sciences Research Council (BBSRC) Grant Nos. BBS/B/00239 and BB/G00479X/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNHEITER H, 1990, CELL, V62, P51, DOI 10.1016/0092-8674(90)90239-B; BAZZIGHER L, 1993, VIROLOGY, V195, P100, DOI 10.1006/viro.1993.1350; Benfield CTO, 2008, J VIROL, V82, P7533, DOI 10.1128/JVI.00185-08; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Berlin S, 2008, IMMUNOGENETICS, V60, P689, DOI 10.1007/s00251-008-0324-0; BERNASCONI D, 1995, J INTERF CYTOK RES, V15, P47, DOI 10.1089/jir.1995.15.47; Carlos TS, 2007, VIROLOGY, V363, P166, DOI 10.1016/j.virol.2007.01.014; Carrasco M, 2004, TRAFFIC, V5, P979, DOI 10.1111/j.1600-0854.2004.00237.x; Choudhary S, 2001, J VIROL, V75, P4823, DOI 10.1128/JVI.75.10.4823-4831.2001; DITTMANN J, 2008, J VIROL; DREIDING P, 1985, VIROLOGY, V140, P192, DOI 10.1016/0042-6822(85)90460-X; Engel-Herbert I, 2003, J VIROL METHODS, V108, P19, DOI 10.1016/S0166-0934(02)00247-1; Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7; FRESE M, 1995, J VIROL, V69, P3904, DOI 10.1128/JVI.69.6.3904-3909.1995; Grimm D, 2007, P NATL ACAD SCI USA, V104, P6806, DOI 10.1073/pnas.0701849104; Holler O, 2009, REV SCI TECH OIE, V28, P219, DOI 10.20506/rst.28.1.1867; HORISBERGER MA, 1983, P NATL ACAD SCI-BIOL, V80, P1910, DOI 10.1073/pnas.80.7.1910; Howard W, 2007, AVIAN DIS, V51, P393, DOI 10.1637/7645-050906R1.1; Huang ZH, 2003, J VIROL, V77, P8676, DOI 10.1128/JVI.77.16.8676-8685.2003; Jatiani SS, 2004, BIOCHEM BIOPH RES CO, V323, P541, DOI 10.1016/j.bbrc.2004.08.134; JOHANNES L, 1993, J VIROL, V67, P1653, DOI 10.1128/JVI.67.3.1653-1657.1993; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; King MC, 2004, P NATL ACAD SCI USA, V101, P8957, DOI 10.1073/pnas.0403167101; Ko JH, 2004, ANIM GENET, V35, P119, DOI 10.1111/j.1365-2052.2004.01096.x; Ko JH, 2002, GENOME RES, V12, P595, DOI 10.1101/gr.210702. Article published online before print in March ; KRUG RM, 1985, J VIROL, V56, P201, DOI 10.1128/JVI.56.1.201-206.1985; Leroy MPP, 2007, AM J VET RES, V68, P988, DOI 10.2460/ajvr.68.9.988; LINDENMANN J, 1964, P SOC EXP BIOL MED, V116, P506, DOI 10.3181/00379727-116-29292; LINDENMANN J, 1962, VIROLOGY, V16, P203, DOI 10.1016/0042-6822(62)90297-0; Lussier MP, 2005, J BIOL CHEM, V280, P19393, DOI 10.1074/jbc.M500391200; MAHY BWJ, 1977, VIROLOGY, V83, P150, DOI 10.1016/0042-6822(77)90218-5; MEIER E, 1990, J VIROL, V64, P6263, DOI 10.1128/JVI.64.12.6263-6269.1990; Mibayashi M, 2002, MICROBIOL IMMUNOL, V46, P29, DOI 10.1111/j.1348-0421.2002.tb02673.x; Mullin AE, 2004, J GEN VIROL, V85, P3689, DOI 10.1099/vir.0.80518-0; Mundt E, 2007, J GEN VIROL, V88, P1319, DOI 10.1099/vir.0.82526-0; Mushinski JF, 2009, J BIOL CHEM, V284, P15206, DOI 10.1074/jbc.M806324200; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; PAVLOVIC J, 1995, J VIROL, V69, P4506, DOI 10.1128/JVI.69.7.4506-4510.1995; PAVLOVIC J, 1990, J VIROL, V64, P3370, DOI 10.1128/JVI.64.7.3370-3375.1990; PAVLOVIC J, 1992, J VIROL, V66, P2564, DOI 10.1128/JVI.66.4.2564-2569.1992; PITOSSI F, 1993, J VIROL, V67, P6726, DOI 10.1128/JVI.67.11.6726-6732.1993; Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997; SCHNEIDERSCHAULIES S, 1994, J VIROL, V68, P6910, DOI 10.1128/JVI.68.11.6910-6917.1994; SCHNORR JJ, 1993, J VIROL, V67, P4760, DOI 10.1128/JVI.67.8.4760-4768.1993; Sironi L, 2008, VIROLOGY, V380, P152, DOI 10.1016/j.virol.2008.07.022; STAEHELI P, 1985, MOL CELL BIOL, V5, P2150, DOI 10.1128/MCB.5.8.2150; STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9; Stertz S, 2007, J INTERF CYTOK RES, V27, P847, DOI 10.1089/jir.2006.0176; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; Tumpey TM, 2007, J VIROL, V81, P10818, DOI 10.1128/JVI.01116-07; Turan K, 2004, NUCLEIC ACIDS RES, V32, P643, DOI 10.1093/nar/gkh192; Wagner E, 2001, J VIROL, V75, P9282, DOI 10.1128/JVI.75.19.9282-9286.2001; Weber F, 2000, J VIROL, V74, P560, DOI 10.1128/JVI.74.1.560-563.2000; Zhao H, 1996, VIROLOGY, V220, P330, DOI 10.1006/viro.1996.0321; ZURCHER T, 1992, EMBO J, V11, P1657, DOI 10.1002/j.1460-2075.1992.tb05212.x	56	20	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12151	10.1371/journal.pone.0012151	http://dx.doi.org/10.1371/journal.pone.0012151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808435	Green Published, Green Submitted, gold			2022-12-25	WOS:000280968000006
J	Bu, WY; Lim, KB; Yu, YH; Chou, AM; Sudhaharan, T; Ahmed, S				Bu, Wenyu; Lim, Kim Buay; Yu, Yuan Hong; Chou, Ai Mei; Sudhaharan, Thankiah; Ahmed, Sohail			Cdc42 Interaction with N-WASP and Toca-1 Regulates Membrane Tubulation, Vesicle Formation and Vesicle Motility: Implications for Endocytosis	PLOS ONE			English	Article							BAR-DOMAIN; ACTIN DYNAMICS; PLASMA-MEMBRANE; MEDIATED ENDOCYTOSIS; RHO-GTPASES; PROTEINS; COMPLEX; IRSP53; CELLS; INVAGINATIONS	Transducer of Cdc42-dependent actin assembly (Toca-1) consists of an F-BAR domain, a Cdc42 binding site and an SH3 domain. Toca-1 interacts with N-WASP, an activator of actin nucleation that binds Cdc42. Cdc42 may play an important role in regulating Toca-1 and N-WASP functions. We report here that the cellular expression of Toca-1 and N-WASP induces membrane tubulation and the formation of motile vesicles. Marker and uptake analysis suggests that the tubules and vesicles are associated with clathrin-mediated endocytosis. Forster resonance energy transfer (FRET) and Fluorescence Lifetime Imaging Microscopy (FLIM) analysis shows that Cdc42, N-WASP and Toca-1 form a trimer complex on the membrane tubules and vesicles and that Cdc42 interaction with N-WASP is critical for complex formation. Modulation of Cdc42 interaction with Toca-1 and/or N-WASP affects membrane tubulation, vesicle formation and vesicle motility. Thus Cdc42 may influence endocytic membrane trafficking by regulating the formation and activity of the Toca-1/N-WASP complex.	[Bu, Wenyu; Lim, Kim Buay; Yu, Yuan Hong; Chou, Ai Mei; Sudhaharan, Thankiah; Ahmed, Sohail] Inst Med Biol, Neural Stem Cell Lab, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Bu, WY (corresponding author), Inst Med Biol, Neural Stem Cell Lab, Singapore, Singapore.	sohail.ahmed@imb.a-star.edu.sg			Agency for Science, Technology and Research, Singapore	Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR))	This work was funded by Agency for Science, Technology and Research, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; Burton EA, 2005, MOL CELL BIOL, V25, P8834, DOI 10.1128/MCB.25.20.8834-8843.2005; Casal E, 2006, BIOCHEMISTRY-US, V45, P12917, DOI 10.1021/bi060717k; Chapple JP, 2002, INVEST OPHTH VIS SCI, V43, P2015; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Ellis S, 2000, TRENDS CELL BIOL, V10, P85, DOI 10.1016/S0962-8924(99)01710-9; Fares H, 2001, GENETICS, V159, P133; Fricke R, 2009, CURR BIOL, V19, P1429, DOI 10.1016/j.cub.2009.07.058; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Futterer K, 2007, CELL, V129, P655, DOI 10.1016/j.cell.2007.05.006; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091	34	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12153	10.1371/journal.pone.0012153	http://dx.doi.org/10.1371/journal.pone.0012153			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730103	Green Published, Green Submitted, gold			2022-12-25	WOS:000280862200012
J	Ma, WL; Kantarjian, H; Zhang, X; Wang, XQ; Zhang, Z; Yeh, CH; O'Brien, S; Giles, F; Bruey, JM; Albitar, M				Ma, Wanlong; Kantarjian, Hagop; Zhang, Xi; Wang, Xiuqiang; Zhang, Zhong; Yeh, Chen-Hsiung; O'Brien, Susan; Giles, Francis; Bruey, Jean Marie; Albitar, Maher			JAK2 Exon 14 Deletion in Patients with Chronic Myeloproliferative Neoplasms	PLOS ONE			English	Article							PSEUDOKINASE DOMAIN; MUTATIONS; ACTIVATION; V617F	Background: The JAK2 V617F mutation in exon 14 is the most common mutation in chronic myeloproliferative neoplasms (MPNs); deletion of the entire exon 14 is rarely detected. In our previous study of >10,000 samples from patients with suspected MPNs tested for JAK2 mutations by reverse transcription-PCR (RT-PCR) with direct sequencing, complete deletion of exon 14 (Delta exon14) constituted <1% of JAK2 mutations. This appears to be an alternative splicing mutation, not detectable with DNA-based testing. Methodology/Principal Findings: We investigated the possibility that MPN patients may express the JAK2 Delta exon14 at low levels (<15% of total transcript) not routinely detectable by RT-PCR with direct sequencing. Using a sensitive RT-PCR-based fluorescent fragment analysis method to quantify JAK2 Delta exon14 mRNA expression relative to wild-type, we tested 61 patients with confirmed MPNs, 183 with suspected MPNs (93 V617F-positive, 90 V617F-negative), and 46 healthy control subjects. The Delta exon14 variant was detected in 9 of the 61 (15%) confirmed MPN patients, accounting for 3.96% to 33.85% (mean = 12.04%) of total JAK2 transcript. This variant was also detected in 51 of the 183 patients with suspected MPNs (27%), including 20 of the 93 (22%) with V617F (mean [ range] expression = 5.41% [ 2.13%-26.22%]) and 31 of the 90 (34%) without V617F (mean [ range] expression = 3.88% [ 2.08%-12.22%]). Immunoprecipitation studies demonstrated that patients expressing Delta exon14 mRNA expressed a corresponding truncated JAK2 protein. The Delta exon14 variant was not detected in the 46 control subjects. Conclusions/Significance: These data suggest that expression of the JAK2 Delta exon14 splice variant, leading to a truncated JAK2 protein, is common in patients with MPNs. This alternatively spliced transcript appears to be more frequent in MPN patients without V617F mutation, in whom it might contribute to leukemogenesis. This mutation is missed if DNA rather than RNA is used for testing.	[Ma, Wanlong; Zhang, Xi; Wang, Xiuqiang; Zhang, Zhong; Yeh, Chen-Hsiung; Bruey, Jean Marie; Albitar, Maher] Quest Diagnost Nichols Inst, Dept Hematol Oncol, San Juan Capistrano, CA USA; [Kantarjian, Hagop; O'Brien, Susan] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Giles, Francis] Univ Texas Hlth Sci Ctr, Canc Treatment & Res Ctr CTRC, San Antonio, TX USA	Nichols Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health San Antonio	Ma, WL (corresponding author), Quest Diagnost Nichols Inst, Dept Hematol Oncol, San Juan Capistrano, CA USA.	maher.x.albitar@questdiagnostics.com						Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Dusa A, 2008, J BIOL CHEM, V283, P12941, DOI 10.1074/jbc.M709302200; Funakoshi-Tago M, 2008, MOL CELL BIOL, V28, P1792, DOI 10.1128/MCB.01447-07; Giordanetto F, 2002, PROTEIN ENG, V15, P727, DOI 10.1093/protein/15.9.727; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lee TS, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-58; Ma W, 2006, BRIT J HAEMATOL, V134, P341, DOI 10.1111/j.1365-2141.2006.06174.x; Ma WL, 2007, HAEMATOLOGICA, V92, P170, DOI 10.3324/haematol.10360; Ma WL, 2009, J MOL DIAGN, V11, P49, DOI 10.2353/jmoldx.2009.080114; Morgani KJ, 2008, ANNU REV MED, V59, P213, DOI 10.1146/annurev.med.59.061506.154159; Nelson ME, 2006, LEUKEMIA LYMPHOMA, V47, P177, DOI 10.1080/10428190500301348; Pietra D, 2008, BLOOD, V111, P1686, DOI 10.1182/blood-2007-07-101576; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Zhao LQ, 2010, BIOCHEM J, V426, P91, DOI 10.1042/BJ20090615	15	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12165	10.1371/journal.pone.0012165	http://dx.doi.org/10.1371/journal.pone.0012165			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730051	gold, Green Submitted, Green Published			2022-12-25	WOS:000280862200020
J	Park, HD; Lee, Y; Oh, YK; Jung, JG; Park, YW; Myung, K; Kim, KH; Koh, SS; Lim, DS				Park, H. D.; Lee, Y.; Oh, Y. K.; Jung, J. G.; Park, Y. W.; Myung, K.; Kim, K-H; Koh, S. S.; Lim, D-S			Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR/CXCR4 activation	ONCOGENE			English	Article						PAUF; TLR; CXCR4; TPL2; ERK; NF-kappa B	TOLL-LIKE RECEPTORS; TUMOR-GROWTH; CARBOHYDRATE SPECIFICITIES; STRUCTURAL BASIS; BINDING LECTINS; CANCER-CELLS; ANGIOGENESIS; LIPOPOLYSACCHARIDE; INFLAMMATION; PROGRESSION	Pancreatic adenocarcinoma upregulated factor (PAUF) is overproduced in certain types of cancer. However, little is known of the tumorigenic function of PAUF. In this study, we report the X-ray crystal structure of PAUF and reveal that PAUF is a mammalian lectin normally found in plant lectins. We also identify PAUF as an endogenous ligand of Toll-like receptor 2 (TLR2) and TLR4 by screening extracellular domain receptor pools. We further confirmed the specificity of the PAUF-TLR2 interaction. PAUF induces extracellular signal-regulated kinase (ERK) phosphorylation and activates the IKK-beta-mediated TPL2/MEK/ERK signaling pathway through TLR2. In agreement with the result of TLR2-mediated ERK activation by PAUF, PAUF induces increased expression of the protumorigenic cytokines RANTES and MIF in THP-1 cells. However, PAUF does not fully activate I kappa-B-alpha signaling pathways in THP-1 cells, and fails to translocate the p65 subunit of the nuclear factor-kappa B (NF-kappa B) complex into the nucleus, resulting in no NF-kappa B activation. Surprisingly, we found that PAUF also associated with the CXC chemokine receptor (CXCR4)-TLR2 complex and inhibited CXCR4-dependent, TLR2-mediated NF-kappa B activation. Together, these findings suggest that the new cancer-associated ligand, PAUF, may activate TLR-mediated ERK signaling to produce the protumorigenic cytokines, but inhibits TLR-mediated NF-kappa B signaling, thereby facilitating tumor growth and escape from innate immune surveillance. Oncogene (2011) 30, 201-211; doi:10.1038/onc.2010.401; published online 30 August 2010	[Lee, Y.; Jung, J. G.; Park, Y. W.; Kim, K-H; Koh, S. S.] Korea Res Inst Biosci & Biotechnol, Therapeut Antibody Res Ctr, Taejon, South Korea; [Park, H. D.; Lee, Y.; Lim, D-S] Natl Creat Res Initiat Ctr Cell Div & Differentia, Dept Biol Sci, Taejon, South Korea; [Park, H. D.; Oh, Y. K.] LG Life Sci, Dept Pharmacol, Taejon, South Korea; [Myung, K.] NHGRI, NIH, Bethesda, MD 20892 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); LG Life Sciences Ltd; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Koh, SS (corresponding author), Korea Res Inst Biosci & Biotechnol, Therapeut Antibody Res Ctr, Taejon, South Korea.	sskoh@kribb.re.kr; daesiklim@kaist.ac.kr	Lim, Dae-Sik/C-1599-2011	Lim, Dae-Sik/0000-0003-2356-7555	National Creative Research Initiative Center; World Class University (WCU); Ministry of Education, Science and Technology in Korea; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG012003] Funding Source: NIH RePORTER	National Creative Research Initiative Center; World Class University (WCU); Ministry of Education, Science and Technology in Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by grants from the National Creative Research Initiative Center Program, World Class University (WCU) program and the 21st Century Frontier Functional Human Genome Project of the Ministry of Education, Science and Technology in Korea. We thank Sang Yong Hong for technical support with the cloning work. We thank the staff of Beamline 4A at the Pohang Accelerator Laboratory, Korea, for assistance in data collection and Dr Hyun Kyu Song of Korea University for help with MAD data analysis.	Adachi H, 2003, ACTA CRYSTALLOGR D, V59, P194, DOI 10.1107/S0907444902019741; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Azenshtein E, 2002, CANCER RES, V62, P1093; Bach JP, 2008, ONCOLOGY-BASEL, V75, P127, DOI 10.1159/000155223; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; Barre A, 2001, BIOCHIMIE, V83, P645, DOI 10.1016/S0300-9084(01)01315-3; Bourne Y, 1999, STRUCTURE, V7, P1473, DOI 10.1016/S0969-2126(00)88338-0; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Cho J, 2005, J BIOL CHEM, V280, P20442, DOI 10.1074/jbc.M413554200; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hajishengallis G, 2008, P NATL ACAD SCI USA, V105, P13532, DOI 10.1073/pnas.0803852105; Huang B, 2005, CANCER RES, V65, P5009, DOI 10.1158/0008-5472.CAN-05-0784; Huang B, 2007, CANCER RES, V67, P4346, DOI 10.1158/0008-5472.CAN-06-4067; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jeyaprakash AA, 2004, J MOL BIOL, V338, P757, DOI 10.1016/j.jmb.2004.03.040; Jeyaprakash AA, 2003, J MOL BIOL, V332, P217, DOI 10.1016/S0022-2836(03)00901-X; Jouault T, 2006, J IMMUNOL, V177, P4679, DOI 10.4049/jimmunol.177.7.4679; JU G, 1991, P NATL ACAD SCI USA, V88, P2658, DOI 10.1073/pnas.88.7.2658; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Kim SA, 2009, CANCER SCI, V100, P828, DOI 10.1111/j.1349-7006.2009.01106.x; Lee Y, 2010, ONCOGENE, V29, P56, DOI 10.1038/onc.2009.298; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Li Y, 2008, J IMMUNOL, V181, P2781, DOI 10.4049/jimmunol.181.4.2781; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Miettinen M, 2008, J LEUKOCYTE BIOL, V84, P1092, DOI 10.1189/jlb.1206737; Morse RJ, 2001, STRUCTURE, V9, P409, DOI 10.1016/S0969-2126(01)00601-3; Nishihira J, 2003, ANN NY ACAD SCI, V995, P171, DOI 10.1111/j.1749-6632.2003.tb03220.x; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; RAZ A, 1987, CANCER METAST REV, V6, P433, DOI 10.1007/BF00144274; SHIMIZU T, 1994, EMBO J, V13, P1003, DOI 10.1002/j.1460-2075.1994.tb06348.x; Singh S, 2007, CANCER METAST REV, V26, P453, DOI 10.1007/s10555-007-9068-9; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Triantafilou M, 2008, EUR J IMMUNOL, V38, P192, DOI 10.1002/eji.200636821	34	72	77	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2011	30	2					201	211		10.1038/onc.2010.401	http://dx.doi.org/10.1038/onc.2010.401			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709LG	20802527	Green Accepted			2022-12-25	WOS:000286438900008
J	Desai, TM; Cerminara, M; Sadqi, M; Munoz, V				Desai, Tanay M.; Cerminara, Michele; Sadqi, Mourad; Munoz, Victor			The Effect of Electrostatics on the Marginal Cooperativity of an Ultrafast Folding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLTEN GLOBULE STATE; ACID DENATURATION; ENERGY LANDSCAPE; CYTOCHROME-C; DOWNHILL; DYNAMICS; THERMODYNAMICS; KINETICS; 2-STATE; MODELS	Proteins fold up by coordinating the different segments of their polypeptide chain through a network of weak cooperative interactions. Such cooperativity results in unfolding curves that are typically sigmoidal. However, we still do not know what factors modulate folding cooperativity or the minimal amount that ensures folding into specific three-dimensional structures. Here, we address these issues on BBL, a small helical protein that folds in microseconds via a marginally cooperative downhill process (Li, P., Oliva, F. Y., Naganathan, A. N., and Munoz, V. (2009) Proc. Natl. Acad. Sci. USA. 106, 103-108). Particularly, we explore the effects of salt-induced screening of the electrostatic interactions in BBL at neutral pH and in acid-denatured BBL. Our results show that electrostatic screening stabilizes the native state of the neutral and protonated forms, inducing complete refolding of acid-denatured BBL. Furthermore, without net electrostatic interactions, the unfolding process becomes much less cooperative, as judged by the broadness of the equilibrium unfolding curve and the relaxation rate. Our experiments show that the marginally cooperative unfolding of BBL can still be made twice as broad while the protein retains its ability to fold into the native three-dimensional structure in microseconds. This result demonstrates experimentally that efficient folding does not require cooperativity, confirming predictions from theory and computer simulations and challenging the conventional biochemical paradigm. Furthermore, we conclude that electrostatic interactions are an important factor in determining folding cooperativity. Thus, electrostatic modulation by pH-salt and/or mutagenesis of charged residues emerges as an attractive tool for tuning folding cooperativity.	[Munoz, Victor] CSIC, Ctr Invest Biol, CIB CSIC, Madrid 28040, Spain; [Desai, Tanay M.; Munoz, Victor] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University System of Maryland; University of Maryland College Park	Munoz, V (corresponding author), CSIC, Ctr Invest Biol, CIB CSIC, Calle Ramiro de Maeztu 9, Madrid 28040, Spain.	vmunoz@cib.csic.es	Sadqi, Mourad/J-3180-2018	Sadqi, Mourad/0000-0003-3553-3408; Cerminara, Michele/0000-0002-2131-395X	Marie Curie Excellence [MEXT-CT-2006-042334]; Spanish Ministry of Science and Innovation [BFU2008-03237, CSD2009-00088]	Marie Curie Excellence(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Marie Curie Excellence Grant MEXT-CT-2006-042334 and Grants BFU2008-03237 and CONSOLIDER CSD2009-00088 from the Spanish Ministry of Science and Innovation.	ABKEVICH VI, 1995, J MOL BIOL, V252, P460, DOI 10.1006/jmbi.1995.0511; ALEXANDRESCU AT, 1993, BIOCHEMISTRY-US, V32, P1707, DOI 10.1021/bi00058a003; ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Arbely E, 2009, J MOL BIOL, V387, P986, DOI 10.1016/j.jmb.2008.12.055; AUNE KC, 1969, BIOCHEMISTRY-US, V8, P4586, DOI 10.1021/bi00839a053; BARRICK D, 1994, J MOL BIOL, V237, P588, DOI 10.1006/jmbi.1994.1257; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Callender R, 2002, CURR OPIN STRUC BIOL, V12, P628, DOI 10.1016/S0959-440X(02)00370-6; CAMACHO CJ, 1993, P NATL ACAD SCI USA, V90, P6369, DOI 10.1073/pnas.90.13.6369; CHAN HS, 1995, PHILOS T R SOC B, V348, P61, DOI 10.1098/rstb.1995.0046; COLLINS KD, 1985, Q REV BIOPHYS, V18, P323, DOI 10.1017/S0033583500005369; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Ejtehadi MR, 2004, P NATL ACAD SCI USA, V101, P15088, DOI 10.1073/pnas.0403486101; Fersht A., 1999, STRUCTURE MECH PROTE; FINK AL, 1993, PROTEIN SCI, V2, P1155, DOI 10.1002/pro.5560020710; FINK AL, 1994, BIOCHEMISTRY-US, V33, P12504, DOI 10.1021/bi00207a018; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Garcia-Mira MM, 2002, SCIENCE, V298, P2191, DOI 10.1126/science.1077809; GOTO Y, 1991, J MOL BIOL, V222, P679, DOI 10.1016/0022-2836(91)90504-Y; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; Halskau O, 2008, P NATL ACAD SCI USA, V105, P8625, DOI 10.1073/pnas.0709881105; HAMADA D, 1994, P NATL ACAD SCI USA, V91, P10325, DOI 10.1073/pnas.91.22.10325; Huang CY, 2002, P NATL ACAD SCI USA, V99, P2788, DOI 10.1073/pnas.052700099; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Jamin M, 2001, P NATL ACAD SCI USA, V98, P6127, DOI 10.1073/pnas.111157998; Kaya H, 2003, J MOL BIOL, V326, P911, DOI 10.1016/S0022-2836(02)01434-1; Klimov DK, 1998, FOLD DES, V3, P127, DOI 10.1016/S1359-0278(98)00018-2; Klimov DK, 2002, J COMPUT CHEM, V23, P161, DOI 10.1002/jcc.10005; Knott M, 2004, CHEM PHYS, V307, P187, DOI 10.1016/j.chemphys.2004.06.014; Kouza M, 2006, J PHYS CHEM A, V110, P671, DOI 10.1021/jp053770b; Li MS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268107; Li P, 2009, P NATL ACAD SCI USA, V106, P103, DOI 10.1073/pnas.0802986106; Mao SD, 2009, INT J THERMOPHYS, V30, P1510, DOI 10.1007/s10765-009-0646-7; MUN OZV, 2008, HFSP J */* D HFSP J, V2, P342; MUN OZV, 2002, INT J QUANTUM CHEM *, V90, P1522; MUN OZV, 2007, Annu Rev Biophys Bio, V36, P395; Naganathan AN, 2005, BIOCHEMISTRY-US, V44, P7435, DOI 10.1021/bi050118y; Naganathan AN, 2005, J AM CHEM SOC, V127, P480, DOI 10.1021/ja044449u; Naganathan AN, 2008, BIOCHEMISTRY-US, V47, P6752, DOI 10.1021/bi800336x; Naganathan AN, 2007, J AM CHEM SOC, V129, P5673, DOI 10.1021/ja0689740; Naganathan AN, 2006, BIOCHEMISTRY-US, V45, P8466, DOI 10.1021/bi060643c; Neuweiler H, 2009, J MOL BIOL, V390, P1060, DOI 10.1016/j.jmb.2009.05.011; Oliva FY, 2004, J AM CHEM SOC, V126, P8596, DOI 10.1021/ja048309w; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; POLAND DC, 1965, BIOPOLYMERS, V3, P401, DOI 10.1002/bip.1965.360030405; POLAND DC, 1965, J CHEM PHYS, V43, P2071, DOI 10.1063/1.1697076; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Sadqi M, 2007, NATURE, V445, pE17, DOI 10.1038/nature05645; Sadqi M, 2006, NATURE, V442, P317, DOI 10.1038/nature04859; Sanchez-Ruiz JM, 2001, TRENDS BIOTECHNOL, V19, P132, DOI 10.1016/S0167-7799(00)01548-1; Settanni G, 2009, J MOL BIOL, V387, P993, DOI 10.1016/j.jmb.2009.02.014; Suzuki Y, 2005, J PHYS CHEM B, V109, P16503, DOI 10.1021/jp0512863; WIMBY JM, 1994, J CHEM ENG DATA, V39, P68, DOI 10.1021/je00013a019	54	15	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34549	34556		10.1074/jbc.M110.154021	http://dx.doi.org/10.1074/jbc.M110.154021			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20729560	Green Published, hybrid			2022-12-25	WOS:000283659100030
J	Neumann, S; Schneider, M; Daugherty, RL; Gottardi, CJ; Eming, SA; Beijer, A; Noegel, AA; Karakesisoglou, I				Neumann, Sascha; Schneider, Maria; Daugherty, Rebecca L.; Gottardi, Cara J.; Eming, Sabine A.; Beijer, Asa; Noegel, Angelika A.; Karakesisoglou, Iakowos			Nesprin-2 Interacts with alpha-Catenin and Regulates Wnt Signaling at the Nuclear Envelope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; MEMBRANE PROTEIN; N-CATENIN; EMERIN; CELLS; LOCALIZATION; ACTIVATION; ANCHORAGE; ISOFORMS; DOMAINS	Nesprins and emerin are structural nuclear envelope proteins that tether nuclei to the cytoskeleton. In this work, we identified the cytoskeleton-associated alpha-N/E-catenins as novel nesprin-2-binding partners. The association involves the C termini of nesprin-2 giant and alpha-N/E-catenins. alpha-E/T/N-catenins are known primarily for their roles in cadherin-mediated cell-cell adhesion. Here, we show that, in addition, alpha-catenin forms complexes with nesprin-2 that include beta-catenin and emerin. We demonstrate that the depletion of nesprin-2 reduces both the amount of active beta-catenin inside the nucleus and T-cell factor/lymphoid-enhancing factor-dependent transcription. Taken together, these findings suggest novel nesprin-2 functions in cellular signaling. Moreover, we propose that, in contrast to emerin, nesprin-2 is a positive regulator of the Wnt signaling pathway.	[Neumann, Sascha; Schneider, Maria; Beijer, Asa; Noegel, Angelika A.] Univ Cologne, Fac Med, Inst Biochem 1, Ctr Mol Med, D-50931 Cologne, Germany; [Eming, Sabine A.] Univ Cologne, Dept Dermatol, D-50931 Cologne, Germany; [Daugherty, Rebecca L.; Gottardi, Cara J.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Karakesisoglou, Iakowos] Univ Durham, Sch Biol & Biomed Sci, Dept Biol Sci, Durham DH1 3LE, England	University of Cologne; University of Cologne; Northwestern University; Feinberg School of Medicine; Durham University	Noegel, AA (corresponding author), Univ Cologne, Fac Med, Inst Biochem 1, Ctr Mol Med, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	noegel@uni-koeln.de; iakowos.karakesisoglou@durham.ac.uk	Gottardi, Cara J./AAU-4691-2021	Gottardi, Cara J./0000-0003-0912-7617; Karakesisoglou, Iakowos (Akis)/0000-0002-8549-0728	Center for Molecular Medicine, University of Cologne; Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases; Bundesministerium fur Bildung und Forschung-Deutsches Zentrum fur Luft- und Raumfahrt [MD-NET R23]; National Institutes of Health [GMS076561]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076561] Funding Source: NIH RePORTER	Center for Molecular Medicine, University of Cologne; Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases; Bundesministerium fur Bildung und Forschung-Deutsches Zentrum fur Luft- und Raumfahrt(Helmholtz AssociationGerman Aerospace Centre (DLR)Federal Ministry of Education & Research (BMBF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the Center for Molecular Medicine, University of Cologne, the Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases, and Bundesministerium fur Bildung und Forschung-Deutsches Zentrum fur Luft- und Raumfahrt Grant MD-NET R23 (to A. A. N. and I. K.), National Institutes of Health Grant GMS076561 (to C. J. G.), and an American Heart Association predoctoral award (to R. L. D.).	BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Inge LJ, 2008, MOL CANCER THER, V7, P1386, DOI 10.1158/1535-7163.MCT-07-2029; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Libotte T, 2005, MOL BIOL CELL, V16, P3411, DOI 10.1091/mbc.E04-11-1009; LU KEY, 2008, J CELL SCI */* A A J, V121, P1887; Markiewicz E, 2006, EMBO J, V25, P3275, DOI 10.1038/sj.emboj.7601230; Mejat A, 2010, NUCLEUS-PHILA, V1, P40, DOI 10.4161/nucl.1.1.10530; Mexal S, 2008, AM J MED GENET B, V147B, P759, DOI 10.1002/ajmg.b.30679; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Pokutta S, 2008, BIOCHEM SOC T, V36, P141, DOI 10.1042/BST0360141; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Salpingidou G, 2007, J CELL BIOL, V178, P897, DOI 10.1083/jcb.200702026; Simpson JG, 2008, BIOCHEM SOC T, V36, P1359, DOI 10.1042/BST0361359; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; UCHIDA N, 1994, DEV BIOL, V163, P75, DOI 10.1006/dbio.1994.1124; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Wheeler MA, 2007, EXP CELL RES, V313, P2845, DOI 10.1016/j.yexcr.2007.03.025; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783; Zhen YY, 2002, J CELL SCI, V115, P3207	28	59	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34932	34938		10.1074/jbc.M110.119651	http://dx.doi.org/10.1074/jbc.M110.119651			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801886	Green Published, hybrid			2022-12-25	WOS:000283659100067
J	Noma, A; Ishitani, R; Kato, M; Nagao, A; Nureki, O; Suzuki, T				Noma, Akiko; Ishitani, Ryuichiro; Kato, Megumi; Nagao, Asuteka; Nureki, Osamu; Suzuki, Tsutomu			Expanding Role of the Jumonji C Domain as an RNA Hydroxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RIBONUCLEIC-ACID; Y BASE; WYBUTOSINE; NUCLEOSIDE; IDENTIFICATION; ENZYME; PHE	JmjC (Jumonji C) domain-containing proteins are known to be an extensive family of Fe(II)/2-oxoglutarate-dependent oxygenases involved in epigenetic regulation of gene expression by catalyzing oxidative demethylation of methylated histones. We report here that a human JmjC protein named Tyw5p (TYW5) unexpectedly acts in the biosynthesis of a hypermodified nucleoside, hydroxywybutosine, in tRNA(Phe) by catalyzing hydroxylation. The finding provides an insight into the expanding role of JmjC protein as an RNA hydroxylase.	[Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Ishitani, Ryuichiro; Kato, Megumi; Nureki, Osamu] Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Div Struct Biol,Minato Ku, Tokyo 1088639, Japan	University of Tokyo; University of Tokyo	Suzuki, T (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	ts@chembio.t.u-tokyo.ac.jp	NUREKI, OSAMU/G-4960-2014; Suzuki, Tsutomu/J-1776-2015	Suzuki, Tsutomu/0000-0002-9731-1731	Ministry of Education, Science, Sports, and Culture of Japan; Japan Society for the Promotion of Science; New Energy and Industrial Technology Development Organization	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by grants-in-aid for scientific research on priority areas from the Ministry of Education, Science, Sports, and Culture of Japan (to T. S. and O. N.), by Japan Society for the Promotion of Science fellowship for Japanese junior scientists (to A. N.), and by a grant from the New Energy and Industrial Technology Development Organization (to T. S.).	BLOBSTEIN SH, 1975, ARCH BIOCHEM BIOPHYS, V167, P668, DOI 10.1016/0003-9861(75)90510-X; BLOBSTEIN SH, 1973, BIOCHEMISTRY-US, V12, P188, DOI 10.1021/bi00726a002; Ikeuchi Y, 2010, NAT CHEM BIOL, V6, P277, DOI [10.1038/NCHEMBIO.323, 10.1038/nchembio.323]; Iyer LM, 2010, NUCLEIC ACIDS RES, V38, P5261, DOI 10.1093/nar/gkq265; Kalhor HR, 2005, BIOCHEM BIOPH RES CO, V334, P433, DOI 10.1016/j.bbrc.2005.06.111; Kaneko T, 2003, EMBO J, V22, P657, DOI 10.1093/emboj/cdg066; KASAI H, 1979, NUCLEIC ACIDS RES, V6, P993, DOI 10.1093/nar/6.3.993; Katoh T, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1120; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Miyauchi K, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1129; NAKANISHI K, 1971, NATURE-NEW BIOL, V234, P107, DOI 10.1038/newbio234107b0; Noma A, 2006, EMBO J, V25, P2142, DOI 10.1038/sj.emboj.7601105; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; SUZUKI T, 2005, TOPICS CURRENT GENET; Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8; Suzuki Y, 2009, NUCLEIC ACIDS RES, V37, P2910, DOI 10.1093/nar/gkp158; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; Waas WF, 2005, J BIOL CHEM, V280, P37616, DOI 10.1074/jbc.M506939200; Waas WF, 2007, J BIOL CHEM, V282, P26026, DOI 10.1074/jbc.M703391200	23	54	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34503	34507		10.1074/jbc.M110.156398	http://dx.doi.org/10.1074/jbc.M110.156398			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739293	hybrid, Green Published			2022-12-25	WOS:000283659100025
J	Park, YD; Panepinto, J; Shin, S; Larsen, P; Giles, S; Williamson, PR				Park, Yoon-Dong; Panepinto, John; Shin, Soowan; Larsen, Peter; Giles, Steven; Williamson, Peter R.			Mating Pheromone in Cryptococcus neoformans Is Regulated by a Transcriptional/Degradative "Futile" Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNGAL PATHOGEN CRYPTOCOCCUS; MESSENGER-RNA; PROTEIN-KINASE; SEXUAL REPRODUCTION; GENE-EXPRESSION; STRESS-RESPONSE; VIRULENCE; DIFFERENTIATION; HELICASE; YEAST	Sexual reproduction in fungi requires induction of signaling pheromones within environments that are conducive to mating. The fungus Cryptococcus neoformans is currently the fourth greatest cause of infectious death in regions of Africa and undergoes mating in phytonutrient-rich environments to create spores with infectious potential. Here we show that under conditions where sexual development is inhibited, a similar to 17-fold excess of MF alpha pheromone transcript is synthesized and then degraded by a DEAD box protein, Vad1, resulting in low steady state transcript levels. Transfer to mating medium or deletion of the VAD1 gene resulted in high level accumulation of MF alpha transcripts and enhanced mating, acting in concert with the mating-related HOG1 pathway. We then investigated whether the high metabolic cost of this apparently futile transcriptional cycle could be justified by a more rapid induction of mating. Maintenance of Vad1 activity on inductive mating medium by constitutive expression resulted in repressed levels of MF alpha that did not prevent but rather prolonged the time to successful mating from 5-6 h to 15 h (p < 0.0001). In sum, these data suggest that VAD1 negatively regulates the sexual cell cycle via degradation of constitutive high levels of MF alpha transcripts in a synthetic/degradative cycle, providing a mechanism of mRNA induction for time-critical cellular events, such as mating induction.	NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Panepinto, John] SUNY Buffalo, Dept Microbiol & Immunol, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14214 USA; [Shin, Soowan; Williamson, Peter R.] Univ Illinois, Infect Dis Sect, Dept Med, Chicago, IL 60612 USA; [Larsen, Peter] Argonne Natl Lab, Biosci Div, Lemont, IL 60439 USA; [Giles, Steven] Univ Wisconsin, Dept Bacteriol, Madison, WI 53701 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; United States Department of Energy (DOE); Argonne National Laboratory; University of Wisconsin System; University of Wisconsin Madison	Williamson, PR (corresponding author), 9000 Rockville Pike,Bldg 10,Rm 11N234,MSC 1888, Bethesda, MD 20892 USA.	williamsonpr@mail.nih.gov			National Institutes of Health [AI45995, AI49371]; National Institutes of Health, NIAID; American Heart Association [0725736Z]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049371, ZIAAI001123, R01AI045995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI45995 and AI49371 and by the Intramural Research Program of the National Institutes of Health, NIAID. This work was also supported by American Heart Association Grant 0725736Z.	Alonso-Monge R, 2003, EUKARYOT CELL, V2, P351, DOI 10.1128/EC.2.2.351-361.2003; Bahn YS, 2005, MOL BIOL CELL, V16, P2285, DOI 10.1091/mbc.E04-11-0987; Bahn YS, 2004, EUKARYOT CELL, V3, P1476, DOI 10.1128/EC.3.6.1476-1491.2004; Beckham C, 2008, MOL BIOL CELL, V19, P984, DOI 10.1091/mbc.E07-09-0954; Butler G, 2004, P NATL ACAD SCI USA, V101, P1632, DOI 10.1073/pnas.0304170101; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; D'Souza CA, 2001, MOL CELL BIOL, V21, P3179, DOI 10.1128/MCB.21.9.3179-3191.2001; Davidson RC, 2003, MOL MICROBIOL, V49, P469, DOI 10.1046/j.1365-2958.2003.03563.x; Davidson RC, 2000, MOL MICROBIOL, V38, P1017, DOI 10.1046/j.1365-2958.2000.02213.x; Del Poeta M, 1999, INFECT IMMUN, V67, P1812; Duttagupta R, 2005, MOL CELL BIOL, V25, P5499, DOI 10.1128/MCB.25.13.5499-5513.2005; ELION EA, 1986, MOL CELL BIOL, V6, P2089, DOI 10.1128/MCB.6.6.2089; Erickson T, 2001, MOL MICROBIOL, V42, P1121, DOI 10.1046/j.1365-2958.2001.02712.x; Fischer N, 2002, EMBO J, V21, P2788, DOI 10.1093/emboj/21.11.2788; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2004, PLOS BIOL, V2, P2243, DOI 10.1371/journal.pbio.0020384; Giles SS, 2009, INFECT IMMUN, V77, P3491, DOI 10.1128/IAI.00334-09; Goeres DC, 2007, PLANT CELL, V19, P1549, DOI 10.1105/tpc.106.047621; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hata H, 1998, GENETICS, V148, P571; Hicks JK, 2004, EUKARYOT CELL, V3, P14, DOI 10.1128/EC.3.1.14-26.2004; HORSTHEMKE W, 1977, PHYS LETT A, V64, P19, DOI 10.1016/0375-9601(77)90512-6; Hsueh YP, 2007, MOL BIOL CELL, V18, P3237, DOI 10.1091/mbc.E07-02-0133; Hu GW, 2008, J CLIN INVEST, V118, P1186, DOI 10.1172/JCI32053; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Kebaara B, 2003, NUCLEIC ACIDS RES, V31, P3157, DOI 10.1093/nar/gkg430; Kraus PR, 2004, EUKARYOT CELL, V3, P1249, DOI 10.1128/EC.3.5.1249-1260.2004; KWONCHUNG KJ, 1975, MYCOLOGIA, V67, P1197, DOI 10.2307/3758842; KWONCHUNG KJ, 1976, MYCOLOGIA, V68, P821, DOI 10.2307/3758800; KWONCHUNG KJ, 1994, MOL BIOL PATHOGENIC, P341; Lengeler KB, 2002, EUKARYOT CELL, V1, P704, DOI 10.1128/EC.1.5.704-718.2002; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; Liu X, 2006, MOL MICROBIOL, V61, P1132, DOI 10.1111/j.1365-2958.2006.05299.x; Mao HY, 1999, NAT STRUCT BIOL, V6, P1139; MOORE TDE, 1993, MOL CELL BIOL, V13, P1962, DOI 10.1128/MCB.13.3.1962; Morrow CA, 2009, FEMS YEAST RES, V9, P161, DOI 10.1111/j.1567-1364.2008.00475.x; Nielsen K, 2007, ADV GENET, V57, P143, DOI 10.1016/S0065-2660(06)57004-X; Nielsen K, 2007, EUKARYOT CELL, V6, P949, DOI 10.1128/EC.00097-07; Panepinto J, 2005, J CLIN INVEST, V115, P632, DOI 10.1172/JCI200523048; Panepinto JC, 2007, INFECT IMMUN, V75, P4769, DOI 10.1128/IAI.00536-07; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Sakuno T, 2004, J BIOCHEM, V136, P805, DOI 10.1093/jb/mvh190; Salas SD, 1996, J EXP MED, V184, P377, DOI 10.1084/jem.184.2.377; Shen WC, 2002, EUKARYOT CELL, V1, P366, DOI 10.1128/EC.1.3.366-377.2002; Suh SH, 2007, MOL CELLS, V23, P272; Sunnarborg SW, 2001, YEAST, V18, P1505; Takizawa PA, 2000, P NATL ACAD SCI USA, V97, P5273, DOI 10.1073/pnas.080585897; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; Velagapudi R, 2009, INFECT IMMUN, V77, P4345, DOI 10.1128/IAI.00542-09; Wang P, 1999, CURR OPIN MICROBIOL, V2, P358, DOI 10.1016/S1369-5274(99)80063-0; Wichroski Michael J., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020041; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005; YOAV B, 1995, H J R Stat Soc Ser B, V57, P289; Zhu XD, 2003, MOL MICROBIOL, V50, P1271, DOI 10.1046/j.1365-2958.2003.03752.x	59	12	12	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34746	34756		10.1074/jbc.M110.136812	http://dx.doi.org/10.1074/jbc.M110.136812			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801870	Green Published, hybrid			2022-12-25	WOS:000283659100050
J	Fresquet, M; Jowitt, TA; Stephen, LA; Ylostalo, J; Briggs, MD				Fresquet, Maryline; Jowitt, Thomas A.; Stephen, Louise A.; Yloestalo, Joni; Briggs, Michael D.			Structural and Functional Investigations of Matrilin-1 A-domains Reveal Insights into Their Role in Cartilage ECM Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX PROTEIN; EXTRACELLULAR-MATRIX; SKELETAL DEVELOPMENT; MOLECULAR-BASIS; COLLAGEN-VI; FORMS; MICE; BIGLYCAN; INTEGRIN; FIBRIL	Matrilin-1 is expressed predominantly in cartilage and co-localizes with matrilin-3 with which it can form hetero-oligomers. We recently described novel structural and functional features of the matrilin-3 A-domain (M3A) and demonstrated that it bound with high affinity to type II and IX collagens. Interactions preferentially occurred in the presence of Zn2+ suggesting that matrilin-3 has acquired a requirement for specific metal ions for activation and/or molecular associations. To understand the interdependence of matrilin-1/-3 hetero-oligomers in extracellular matrix (ECM) interactions, we have extended these studies to include the two matrilin-1 A-domains (i.e. M1A1 and M1A2 respectively). In this study we have identified new characteristics of the matrilin-1 A-domains by describing their glycosylation state and the effect of N-glycan chains on their structure, thermal stability, and protein-protein interactions. Initial characterization revealed that N-glycosylation did not affect secretion of these two proteins, nor did it alter their folding characteristics. However, removal of the glycosylation decreased their thermal stability. We then compared the effect of different cations on binding between both M1A domains and type II and IX collagens and showed that Zn2+ also supports their interactions. Finally, we have demonstrated that both M1A1 domains and biglycan are essential for the association of the type II.VI collagen complex. We predict that a potential role of the matrilin-1/-3 hetero-oligomer might be to increase multivalency, and therefore the ability to connect various ECM components. Differing affinities could act to regulate the integrated network, thus coordinating the organization of the macromolecular structures in the cartilage ECM.	[Fresquet, Maryline; Jowitt, Thomas A.; Stephen, Louise A.; Briggs, Michael D.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Yloestalo, Joni] Tulane Univ Hlth Sci, Ctr Gene Therapy, New Orleans, LA 70123 USA	University of Manchester; Tulane University	Briggs, MD (corresponding author), Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	mike.briggs@manchester.ac.uk	Ylostalo, Joni/AAH-9457-2019	Ylostalo, Joni/0000-0001-9746-1994; Fresquet, Maryline/0000-0001-9530-6392; Stephen, Louise/0000-0001-6795-0383; Jowitt, Thomas/0000-0002-4045-0933	Wellcome Trust [071161/Z/03/Z, 084353/Z/07/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by Grants 071161/Z/03/Z and 084353/Z/07/Z from the Wellcome Trust.	Aszodi A, 1999, MOL CELL BIOL, V19, P7841; Budde B, 2005, MOL CELL BIOL, V25, P10465, DOI 10.1128/MCB.25.23.10465-10478.2005; Chen Q, 1999, MOL BIOL CELL, V10, P2149, DOI 10.1091/mbc.10.7.2149; Deak F, 1999, MATRIX BIOL, V18, P55, DOI 10.1016/S0945-053X(98)00006-7; Dixon Matthew C, 2008, J Biomol Tech, V19, P151; DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; DWEK RA, 1995, BIOCHEM SOC T, V23, P1; Ehlen HWA, 2009, J BIOL CHEM, V284, P21545, DOI 10.1074/jbc.M109.016568; Frank S, 2002, J BIOL CHEM, V277, P19071, DOI 10.1074/jbc.M202146200; Fresquet M, 2007, J BIOL CHEM, V282, P34634, DOI 10.1074/jbc.M705301200; GRENNAN DM, 1980, NEW ZEAL MED J, V91, P47; Huang XM, 1999, DEV DYNAM, V216, P434, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<434::AID-DVDY11>3.3.CO;2-O; Johansson JA, 2005, BIOMACROMOLECULES, V6, P1353, DOI 10.1021/bm0493741; Klatt AR, 2000, J BIOL CHEM, V275, P3999, DOI 10.1074/jbc.275.6.3999; Kleemann-Fischer D, 2001, ARCH BIOCHEM BIOPHYS, V387, P209, DOI 10.1006/abbi.2000.2256; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; Nicolae C, 2007, J BIOL CHEM, V282, P22163, DOI 10.1074/jbc.M610994200; PAULSSON M, 1979, BIOCHEM J, V183, P539, DOI 10.1042/bj1830539; PAULSSON M, 1981, BIOCHEM J, V197, P367, DOI 10.1042/bj1970367; Rich RL, 1999, J BIOL CHEM, V274, P24906, DOI 10.1074/jbc.274.35.24906; Romijn RA, 2003, J BIOL CHEM, V278, P15035, DOI 10.1074/jbc.M208977200; Springer TA, 2006, STRUCTURE, V14, P1611, DOI 10.1016/j.str.2006.10.001; Tams JW, 2001, BIOCHEM BIOPH RES CO, V286, P701, DOI 10.1006/bbrc.2001.5455; Ueda T, 1996, J BIOCHEM-TOKYO, V119, P157; Wagener R, 2005, FEBS LETT, V579, P3323, DOI 10.1016/j.febslet.2005.03.018; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; Wiberg C, 2002, J BIOL CHEM, V277, P49120, DOI 10.1074/jbc.M206891200; WINTERBOTTOM N, 1992, DEV DYNAM, V193, P266, DOI 10.1002/aja.1001930307; Wu JJ, 1998, J BIOL CHEM, V273, P17433, DOI 10.1074/jbc.273.28.17433; Zhang Y, 2000, J BIOL CHEM, V275, P32628, DOI 10.1074/jbc.M002594200; Zhang Yue, 2008, J Orthop Surg Res, V3, P21, DOI 10.1186/1749-799X-3-21	32	14	16	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34048	34061		10.1074/jbc.M110.154443	http://dx.doi.org/10.1074/jbc.M110.154443			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729554	Green Published, hybrid			2022-12-25	WOS:000283354000051
J	Plasari, G; Edelmann, S; Hogger, F; Dusserre, Y; Mermod, N; Calabrese, A				Plasari, Genta; Edelmann, Simone; Hoegger, Florence; Dusserre, Yves; Mermod, Nicolas; Calabrese, Alessandra			Nuclear Factor I-C Regulates TGF-beta-dependent Hair Follicle Cycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL STEM-CELLS; GAMMA-GLUTAMYL-TRANSPEPTIDASE; TOOTH ROOT DEVELOPMENT; SONIC-HEDGEHOG; COLORIMETRIC ASSAY; ANAGEN INDUCTION; SKIN APPENDAGE; LEF-1 PROMOTER; BINDING SITES; GROWTH-PHASE	Skin appendages such as teeth and hair share several common signaling pathways. The nuclear factor IC(NFI-C) transcription factor has been implicated in tooth development, but a potential role in hair growth had not been assessed. In this study we found that NFI-C regulates the onset of the hair growth cycle. NFIC-/- mice were delayed in the transition from the telogen to anagen phase of the hair follicle cycle after either experimental depilation or spontaneous hair loss. Lack of NFI-C resulted in delayed induction of the sonic hedgehog, Wnt5a, and Lef1 gene expression, which are key regulators of the hair follicle growth initiation. NFI-C-/- mice also showed elevated levels of transforming growth factor beta 1 (TGF-beta 1), an inhibitor of keratinocyte proliferation, and of the cell cycle inhibitor p21 at telogen. Reduced expression of Ki67, a marker of cell proliferation, was noted at the onset of anagen, indicating impaired activation of the hair progenitor cells. These findings implicate NFI-C in the repression of TGF-beta 1 signaling during telogen stage, resulting in the delay of progenitor cell proliferation and hair follicle regeneration in NFI-C-deficient mice. Taken together with prior observations, these findings also designate NFI-C as a regulator of adult progenitor cell proliferation and of postnatal tissue growth or regeneration.	[Mermod, Nicolas] Univ Lausanne, Inst Biotechnol, Mol Biotechnol Lab, Stn 6, CH-1015 Lausanne, Switzerland	University of Lausanne	Mermod, N (corresponding author), Univ Lausanne, Inst Biotechnol, Mol Biotechnol Lab, Stn 6, CH-1015 Lausanne, Switzerland.	Nicolas.Mermod@unil.ch			University of Lausanne	University of Lausanne	This work was supported by the University of Lausanne.	Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Argyris T S, 1968, Adv Morphog, V7, P1; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Botchkarev VA, 2002, J INVEST DERMATOL, V118, P3, DOI 10.1046/j.1523-1747.2002.01645.x; Botchkarev VA, 2001, FASEB J, V15, P2205, DOI 10.1096/fj.01-0207com; Botchkarev VA, 2003, J INVEST DERM SYMP P, V8, P46, DOI 10.1046/j.1523-1747.2003.12171.x; Budd PS, 1997, MAMM GENOME, V8, P631, DOI 10.1007/s003359900527; CAMERON R, 1978, CANCER RES, V38, P823; Campbell CE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-52; Chaudhry AZ, 1997, DEV DYNAM, V208, P313; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Cotsarelis G, 1999, EXP DERMATOL, V8, P80, DOI 10.1111/j.1600-0625.1999.tb00351.x; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; das Neves L, 1999, P NATL ACAD SCI USA, V96, P11946, DOI 10.1073/pnas.96.21.11946; DasGupta R, 1999, DEVELOPMENT, V126, P4557; DEYOUNG LM, 1978, CANCER RES, V38, P3697; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Foitzik K, 2000, FASEB J, V14, P752, DOI 10.1096/fasebj.14.5.752; GRONOSTAJSKI RM, 1985, MOL CELL BIOL, V5, P964, DOI 10.1128/MCB.5.5.964; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Grunder A, 2002, MECH DEVELOP, V112, P69, DOI 10.1016/S0925-4773(01)00640-2; HANDJISKI BK, 1994, BRIT J DERMATOL, V131, P303, DOI 10.1111/j.1365-2133.1994.tb08515.x; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; JACOBS WLW, 1971, CLIN CHIM ACTA, V31, P175, DOI 10.1016/0009-8981(71)90375-5; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; KAWABE TT, 1994, J INVEST DERMATOL, V103, P122, DOI 10.1111/1523-1747.ep12391894; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; Kralovics R, 2002, EXP HEMATOL, V30, P229, DOI 10.1016/S0301-472X(01)00789-5; Lavker RM, 2003, J INVEST DERM SYMP P, V8, P28, DOI 10.1046/j.1523-1747.2003.12169.x; Lee DS, 2009, J BIOL CHEM, V284, P17293, DOI 10.1074/jbc.M109.009084; Lefever T, 2010, J CELL SCI, V123, P128, DOI 10.1242/jcs.053835; Liu XM, 2004, J INVEST DERMATOL, V123, P264, DOI 10.1111/j.0022-202X.2004.23201.x; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Matsuo K, 2003, ARCH DERMATOL RES, V295, P33, DOI 10.1007/s00403-003-0384-9; Mikkola ML, 2006, J MAMMARY GLAND BIOL, V11, P187, DOI 10.1007/s10911-006-9029-x; Mikkola ML, 2007, CELL CYCLE, V6, P285, DOI 10.4161/cc.6.3.3798; Muller-Rover S, 1999, EXP DERMATOL, V8, P237; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; NEBL G, 1994, J BIOL CHEM, V269, P7371; Nordlund JJ, 2007, DERMATOL CLIN, V25, P271, DOI 10.1016/j.det.2007.04.001; Ouellet S, 2006, NUCLEIC ACIDS RES, V34, P6472, DOI 10.1093/nar/gkl861; Park JC, 2007, J PERIODONTOL, V78, P1795, DOI 10.1902/jop.2007.060363; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; PERSIJN JP, 1971, CLIN CHIM ACTA, V35, P239, DOI 10.1016/0009-8981(71)90318-4; Plasari G, 2009, MOL CELL BIOL, V29, P6006, DOI 10.1128/MCB.01921-08; Qiao W, 2006, ONCOGENE, V25, P207, DOI 10.1038/sj.onc.1209029; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Roulet E, 2000, J MOL BIOL, V297, P833, DOI 10.1006/jmbi.2000.3614; Sano S, 2000, P NATL ACAD SCI USA, V97, P13824, DOI 10.1073/pnas.240303097; Sato N, 1999, J CLIN INVEST, V104, P855, DOI 10.1172/JCI7691; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Steele-Perkins G, 2003, MOL CELL BIOL, V23, P1075, DOI 10.1128/MCB.23.3.1075-1084.2003; Tomita Y, 2006, J DERMATOL SCI, V43, P105, DOI 10.1016/j.jdermsci.2006.03.012; Viallard J F, 2001, Cancer Radiother, V5, P109, DOI 10.1016/S1278-3218(01)00087-7; Werner S, 2000, EXP CELL RES, V254, P80, DOI 10.1006/excr.1999.4726; Yang LL, 2005, CANCER RES, V65, P8671, DOI 10.1158/0008-5472.CAN-05-0800; Yue JB, 2001, PHARMACOL THERAPEUT, V91, P1, DOI 10.1016/S0163-7258(01)00143-7; Zhang JW, 2006, STEM CELLS, V24, P2826, DOI 10.1634/stemcells.2005-0544	62	19	22	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34115	34125		10.1074/jbc.M110.120659	http://dx.doi.org/10.1074/jbc.M110.120659			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729551	hybrid, Green Published			2022-12-25	WOS:000283354000057
J	Acevedo, JM; Centanin, L; Dekanty, A; Wappner, P				Acevedo, Julieta M.; Centanin, Lazaro; Dekanty, Andres; Wappner, Pablo			Oxygen Sensing in Drosophila: Multiple Isoforms of the Prolyl Hydroxylase Fatiga Have Different Capacity to Regulate HIF alpha/Sima	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; TRANSCRIPTIONAL RESPONSE; DOMAIN PROTEINS; HIF-1-ALPHA; CELLS; PHD2; O-2; FACTOR-1-ALPHA; LOCALIZATION; INHIBITION	Background: The Hypoxia Inducible Factor (HIF) mediates cellular adaptations to low oxygen. Prolyl-4-hydroxylases are oxygen sensors that hydroxylate the HIF alpha-subunit, promoting its proteasomal degradation in normoxia. Three HIFprolyl hydroxylases, encoded by independent genes, PHD1, PHD2, and PHD3, occur in mammals. PHD2, the longest PHD isoform includes a MYND domain, whose biochemical function is unclear. PHD2 and PHD3 genes are induced in hypoxia to shut down HIF dependent transcription upon reoxygenation, while expression of PHD1 is oxygen-independent. The physiologic significance of the diversity of the PHD oxygen sensors is intriguing. Methodology and Principal Findings: We have analyzed the Drosophila PHD locus, fatiga, which encodes 3 isoforms, FgaA, FgaB and FgaC that are originated through a combination of alternative initiation of transcription and alternative splicing. FgaA includes a MYND domain and is homologous to PHD2, while FgaB and FgaC are shorter isoforms most similar to PHD3. Through a combination of genetic experiments in vivo and molecular analyses in cell culture, we show that fgaB but not fgaA is induced in hypoxia, in a Sima-dependent manner, through a HIF-Responsive Element localized in the first intron of fgaA. The regulatory capacity of FgaB is stronger than that of FgaA, as complete reversion of fga loss-of-function phenotypes is observed upon transgenic expression of the former, and only partial rescue occurs after expression of the latter. Conclusions and Significance: Diversity of PHD isoforms is a conserved feature in evolution. As in mammals, there are hypoxia-inducible and non-inducible Drosophila PHDs, and a fly isoform including a MYND domain co-exists with isoforms lacking this domain. Our results suggest that the isoform devoid of a MYND domain has stronger regulatory capacity than that including this domain.	[Acevedo, Julieta M.; Centanin, Lazaro; Dekanty, Andres; Wappner, Pablo] Inst Leloir, Buenos Aires, DF, Argentina; [Wappner, Pablo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Acevedo, Julieta M.; Wappner, Pablo] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	Leloir Institute; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Acevedo, JM (corresponding author), Inst Leloir, Buenos Aires, DF, Argentina.	pwappner@leloir.org.ar	Dekanty, Andres/C-3925-2018	Dekanty, Andres/0000-0002-0587-0449; Centanin, Lazaro/0000-0003-3889-4524; Wappner, Pablo/0000-0003-1517-0742; Acevedo, Julieta/0000-0003-2572-6222	Agencia de Promocion Cientifica y Tecnologica [PICT 0665]; Howard Hughes Medical Institute [55005973]; Wellcome Trust [WT087675MA]	Agencia de Promocion Cientifica y Tecnologica(ANPCyT); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Agencia de Promocion Cientifica y Tecnologica grant PICT 0665, the Howard Hughes Medical Institute grant Nu 55005973 and the Wellcome Trust grant WT087675MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansieau S, 2002, J BIOL CHEM, V277, P4906, DOI 10.1074/jbc.M110078200; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Barth S, 2009, J BIOL CHEM, V284, P23046, DOI 10.1074/jbc.M109.032631; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Centanin L, 2005, EMBO REP, V6, P1070, DOI 10.1038/sj.embor.7400528; Centanin L, 2008, DEV CELL, V14, P547, DOI 10.1016/j.devcel.2008.01.020; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Choi KO, 2005, MOL PHARMACOL, V68, P1803, DOI 10.1124/mol.105.015271; Dekanty A, 2005, J CELL SCI, V118, P5431, DOI 10.1242/jcs.02648; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Frei C, 2004, DEV CELL, V6, P241, DOI 10.1016/S1534-5807(03)00409-X; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; MAXWELL PH, 1993, P NATL ACAD SCI USA, V90, P2423, DOI 10.1073/pnas.90.6.2423; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Ozer A, 2005, P NATL ACAD SCI USA, V102, P7481, DOI 10.1073/pnas.0502716102; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; To KKW, 2005, J BIOL CHEM, V280, P38102, DOI 10.1074/jbc.M504342200; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12	31	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12390	10.1371/journal.pone.0012390	http://dx.doi.org/10.1371/journal.pone.0012390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811646	Green Published, gold, Green Submitted			2022-12-25	WOS:000281234700015
J	Nyirenda, M; Zaba, B; Barnighausen, T; Hosegood, V; Newell, ML				Nyirenda, Makandwe; Zaba, Basia; Baernighausen, Till; Hosegood, Victoria; Newell, Marie-Louise			Adjusting HIV Prevalence for Survey Non-Response Using Mortality Rates: An Application of the Method Using Surveillance Data from Rural South Africa	PLOS ONE			English	Article							HIGH-RISK GROUPS; POPULATION; PREVENTION; BEHAVIORS; BIAS	Background: The main source of HIV prevalence estimates are household and population-based surveys; however, high refusal rates may hinder the interpretation of such estimates. The study objective was to evaluate whether population HIV prevalence estimates can be adjusted for survey non-response using mortality rates. Methodology/Principal Findings: Data come from the longitudinal Africa Centre Demographic Information System (ACDIS), in rural South Africa. Mortality rates for persons tested and not tested in the 2005 HIV surveillance were available from routine household surveillance. Assuming HIV status among individuals contacted but who refused to test (non-response) is missing at random and mortality among non-testers can be related to mortality of those tested a mathematical model was developed. Non-parametric bootstrapping was used to estimate the 95% confidence intervals around the estimates. Mortality rates were higher among untested (16.9 per thousand person-years) than tested population (11.6 per thousand person-years), suggesting higher HIV prevalence in the former. Adjusted HIV prevalence for females (15-49 years) was 31.6% (95% CI 26.1-37.1) compared to observed 25.2% (95% CI 24.0-26.4). For males (15-49 years) adjusted HIV prevalence was 19.8% (95% CI 14.8-24.8), compared to observed 13.2% (95% CI 12.1-14.3). For both sexes (15-49 years) combined, adjusted prevalence was 27.5% (95% CI 23.6-31.3), and observed prevalence was 19.7% (95% CI 19.6-21.3). Overall, observed prevalence underestimates the adjusted prevalence by around 7 percentage points (37% relative difference). Conclusions/Significance: We developed a simple approach to adjust HIV prevalence estimates for survey non-response. The approach has three features that make it easy to implement and effective in adjusting for selection bias than other approaches. Further research is needed to assess this approach in populations with widely available HIV treatment (ART).	[Nyirenda, Makandwe; Baernighausen, Till; Hosegood, Victoria; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Kwa Zulu, South Africa; [Baernighausen, Till] Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA; [Zaba, Basia; Hosegood, Victoria] London Sch Hyg & Trop Med, Ctr Populat Studies, London WC1, England; [Newell, Marie-Louise] UCL Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England	University of Kwazulu Natal; Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Nyirenda, M (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Kwa Zulu, South Africa.	mnyirenda@africacentre.ac.za	Newell, Marie-Louise/AAE-8222-2019; Nyirenda, Makandwe/B-2963-2015; Nyirenda, Makandwe/R-4080-2018; Bärnighausen, Till/Y-2388-2019	Newell, Marie-Louise/0000-0002-1074-7699; Nyirenda, Makandwe/0000-0002-1839-877X; Hosegood, Victoria/0000-0002-2244-2518	Wellcome Trust, UK [GR082384/Z/07/Z, WT082599MA, WT075886]; National Institute of Child Health and Human Development (NICHD) [1R01-HD058482-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058482] Funding Source: NIH RePORTER	Wellcome Trust, UK(Wellcome Trust); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The Wellcome Trust, UK, provided funding support through grants to the Africa Centre Demographic and HIV surveillance (#GR082384/Z/07/Z), Victoria Hosegood (#WT082599MA) and the ALPHA-Network (#WT075886). Till Barnighausen was supported by grant 1R01-HD058482-01 from the National Institute of Child Health and Human Development (NICHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2008, J HUM HYPERTENS, V22, P236, DOI 10.1038/sj.jhh.1002308; Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Barnighausen T, 2010, AIDS RES HUM RETROV, V26, P401, DOI 10.1089/aid.2009.0236; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Boerma JT, 2003, LANCET, V362, P1929, DOI 10.1016/S0140-6736(03)14967-7; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Garcia-Calleja JM, 2006, SEX TRANSM INFECT, V82, pIII64, DOI 10.1136/sti.2006.019901; Gregson S, 2002, AIDS, V16, P643, DOI 10.1097/00002030-200203080-00017; HOULIHAN CF, 2010, INT J EPIDEMIOLOGY; Islam MM, 2008, INT J INFECT DIS, V12, P363, DOI 10.1016/j.ijid.2007.12.002; Joint United Nations Program on AIDS/ World Health Organization (UNAIDS/WHO), 2003, GUID COND HIV SENT S; MARSTON M, 2008, SEX TRANSM INFECT S1, V84, P71; Mishra V, 2008, SEX TRANSM INFECT, V84, pI63, DOI 10.1136/sti.2008.030411; Nardone A, 1999, J PUBLIC HEALTH MED, V21, P208, DOI 10.1093/pubmed/21.2.208; Nyirenda M, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000299413.82893.2b; Reniers G, 2009, AIDS, V23, P621, DOI 10.1097/QAD.0b013e3283269e13; Shisana O, 2009, S AFRICAN NATL HIV P; UNAIDS, 2008, REP GLOB AIDS EP; Walker N, 2003, AIDS, V17, P2215, DOI 10.1097/00002030-200310170-00010; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; World Health Organization, 2007, WORLD HLTH STAT 2007	21	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12370	10.1371/journal.pone.0012370	http://dx.doi.org/10.1371/journal.pone.0012370			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811499	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000281234700007
J	Zavadil, J; Ye, HH; Liu, ZJ; Wu, JJ; Lee, P; Hernando, E; Soteropoulos, P; Toruner, GA; Wei, JJ				Zavadil, Jiri; Ye, Huihui; Liu, Zhaojian; Wu, JingJing; Lee, Peng; Hernando, Eva; Soteropoulos, Patricia; Toruner, Gokce A.; Wei, Jian-Jun			Profiling and Functional Analyses of MicroRNAs and Their Target Gene Products in Human Uterine Leiomyomas	PLOS ONE			English	Article							EXPRESSION PROFILE; TUMORIGENIC FACTORS; TUMOR SIZE; TUBERIN; CANCER; LET-7; DIFFERENTIATION; PATHOGENESIS; SIGNATURES; FIBROIDS	Background: Human uterine leiomyomas (ULM) are characterized by dysregulation of a large number of genes and non-coding regulatory microRNAs. In order to identify microRNA:: mRNA associations relevant to ULM pathogenesis, we examined global correlation patterns between the altered microRNA expression and the predicted target genes in ULMs and matched myometria. Methodology/Principal Findings: Patterns of inverse association of microRNA with mRNA expression in ULMs revealed an involvement of multiple candidate pathways, including extensive transcriptional reprogramming, cell proliferation control, MAP kinase, TGF-beta, WNT, JAK/STAT signaling, remodeling of cell adhesion, and cell-cell and cell-matrix contacts. We further examined the correlation between the expression of the selected target gene protein products and microRNAs in thirty-six paired sets of leiomyomas and matched myometria. We found that a number of dysregulated microRNAs were inversely correlated with their targets at the protein level. The comparative genomic hybridization (CGH) in eight ULM patients revealed that partially shared deletions of two distinct chromosomal regions might be responsible for loss of cancer-associated microRNA expression and could thus contribute to the ULM pathogenesis via deregulation of target mRNAs. Last, we functionally tested the repressor effects of selected cancer-related microRNAs on their predicted target genes in vitro. Conclusions/Significance: We found that some but not all of the predicted and inversely correlated target genes in ULMs can be directly regulated by microRNAs in vitro. Our findings provide a broad overview of molecular events underlying the tumorigenesis of uterine ULMs and identify select genetic and regulatory events that alter microRNA expression and may play important roles in ULM pathobiology by positively regulating tumor growth while maintaining the non-invasive character of ULMs.	[Zavadil, Jiri; Ye, Huihui; Lee, Peng; Hernando, Eva] NYU, Sch Med, Dept Pathol, New York, NY 10012 USA; [Zavadil, Jiri] NYU, Inst Canc, New York, NY USA; [Zavadil, Jiri] NYU, Ctr Hlth Informat & Bioinformat, New York, NY USA; [Liu, Zhaojian; Wu, JingJing; Wei, Jian-Jun] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Soteropoulos, Patricia] Univ Med & Dent New Jersey, Dept Microbiol & Mol Genet, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Toruner, Gokce A.] Univ Med & Dent New Jersey, Dept Pediat, Inst Genom Med, Newark, NJ 07103 USA	New York University; New York University; New York University; Northwestern University; Feinberg School of Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Zavadil, J (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10012 USA.	jianjun-wei@northwestern.edu	WEI, JJ/AAN-2638-2020; Toruner, Gokce A/J-5665-2015; Zavadil, Jiri/ABG-1780-2020; Toruner, Gokce/AAD-8412-2019	Zavadil, Jiri/0000-0003-0640-5562; Toruner, Gokce/0000-0002-5305-6337; Hernando, Eva/0000-0003-1023-0312	Department of Defence [W81XWH-09-1-0166]; National Institutes of Health [R03HD057380]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD057380] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER	Department of Defence; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by Department of Defence Tuberous Sclerosis Complex Research Program (TSCRP) award W81XWH-09-1-0166 and National Institutes of Health Small Grant Program (NIH RO3) grant R03HD057380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Arslan AA, 2005, HUM REPROD, V20, P852, DOI 10.1093/humrep/deh698; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Carney SA, 2002, LAB INVEST, V82, P719, DOI 10.1097/01.LAB.0000017499.51216.3E; Catherino WH, 2004, GENE CHROMOSOME CANC, V40, P204, DOI 10.1002/gcc.20035; Chegini N, 2003, J SOC GYNECOL INVEST, V10, P161, DOI 10.1016/S1071-5576(03)00004-2; Cochrane DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/821717; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Flake GP, 2003, ENVIRON HEALTH PERSP, V111, P1037, DOI 10.1289/ehp.5787; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hoffman PJ, 2004, FERTIL STERIL, V82, P639, DOI 10.1016/j.fertnstert.2004.01.047; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kim VN, 2005, MOL CELLS, V19, P1; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Liu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000804; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo XP, 2005, ENDOCRINOLOGY, V146, P1097, DOI 10.1210/en.2004-1377; Marsh EE, 2008, FERTIL STERIL, V89, P1771, DOI 10.1016/j.fertnstert.2007.05.074; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Mizuguchi M, 1996, ANN NEUROL, V40, P941, DOI 10.1002/ana.410400621; Mizuguchi M, 1997, ACTA NEUROPATHOL, V94, P525, DOI 10.1007/s004010050746; Pan Q, 2008, J CELL MOL MED, V12, P227, DOI 10.1111/j.1582-4934.2007.00207.x; Peng Y, 2008, MOL CANCER RES, V6, P663, DOI 10.1158/1541-7786.MCR-07-0370; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wang TS, 2007, GENE CHROMOSOME CANC, V46, P336, DOI 10.1002/gcc.20415; Wei JJ, 2005, FERTIL STERIL, V84, P474, DOI 10.1016/j.fertnstert.2005.01.142; Wei JJ, 2006, HUM REPROD, V21, P57, DOI 10.1093/humrep/dei309; Wei JJ, 2005, MODERN PATHOL, V18, P179, DOI 10.1038/modpathol.3800283; Weston G, 2003, MOL HUM REPROD, V9, P541, DOI 10.1093/molehr/gag066; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P152, DOI 10.1093/nar/gkl1032; Zavadil J, 2007, CELLS TISSUES ORGANS, V185, P157, DOI 10.1159/000101316; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036	45	55	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12362	10.1371/journal.pone.0012362	http://dx.doi.org/10.1371/journal.pone.0012362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808773	Green Published, Green Submitted, gold			2022-12-25	WOS:000281154300005
J	Qian, J; Gao, HJ				Qian, Jin; Gao, Huajian			Soft Matrices Suppress Cooperative Behaviors among Receptor-Ligand Bonds in Cell Adhesion	PLOS ONE			English	Article							MEMBRANE ADHESION; PATTERN-FORMATION; MOLECULAR-BOND; FORCE; MECHANICS; DYNAMICS; LIFETIME; ELASTICITY; STRENGTH; CLUSTERS	The fact that biological tissues are stable over prolonged periods of time while individual receptor-ligand bonds only have limited lifetime underscores the critical importance of cooperative behaviors of multiple molecular bonds, in particular the competition between the rate of rupture of closed bonds (death rate) and the rate of rebinding of open bonds (birth rate) in a bond cluster. We have recently shown that soft matrices can greatly increase the death rate in a bond cluster by inducing severe stress concentration near the adhesion edges. In the present paper, we report a more striking effect that, irrespective of stress concentration, soft matrices also suppress the birth rate in a bond cluster by increasing the local separation distance between open bonds. This is shown by theoretical analysis as well as Monte Carlo simulations based on a stochastic-elasticity model in which stochastic descriptions of molecular bonds and elastic descriptions of interfacial force/separation are unified in a single modeling framework. Our findings not only are important for understanding the role of elastic matrices in cell adhesion, but also have general implications on adhesion between soft materials.	[Qian, Jin; Gao, Huajian] Brown Univ, Sch Engn, Providence, RI 02912 USA	Brown University	Qian, J (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	huajian_gao@brown.edu	Qian, Jin/C-6115-2008; Gao, Huajian/F-9360-2010	Gao, Huajian/0000-0002-8656-846X	National Science Foundation (NSF) [CMMI-1028530]	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea)	Financial support from the National Science Foundation (NSF: CMMI-1028530) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL; ALON R, 1995, NATURE, V374, P539, DOI 10.1038/374539a0; Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Buehler MJ, 2006, MODEL SIMUL MATER SC, V14, P799, DOI 10.1088/0965-0393/14/5/001; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Chang KC, 2000, P NATL ACAD SCI USA, V97, P11262, DOI 10.1073/pnas.200240897; Chen X, 2006, CURR OPIN CELL BIOL, V18, P572, DOI 10.1016/j.ceb.2006.07.002; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Erdmann T, 2007, EUR PHYS J E, V22, P123, DOI 10.1140/epje/e2007-00019-8; Erdmann T, 2004, J CHEM PHYS, V121, P8997, DOI 10.1063/1.1805496; Erdmann T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.108102; Erdmann T, 2006, BIOPHYS J, V91, pL60, DOI 10.1529/biophysj.106.090209; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; EVANS EA, 1985, BIOPHYS J, V48, P175, DOI 10.1016/S0006-3495(85)83770-X; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Freund LB, 2009, P NATL ACAD SCI USA, V106, P8818, DOI 10.1073/pnas.0903003106; Freund LB, 2004, J MECH PHYS SOLIDS, V52, P2455, DOI 10.1016/j.jmps.2004.05.004; Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102; Gao HJ, 2005, MECH MATER, V37, P275, DOI 10.1016/j.mechmat.2004.03.008; Gao HJ, 2004, P NATL ACAD SCI USA, V101, P7851, DOI 10.1073/pnas.0400757101; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goel N., 1974, STOCHASTIC MODELS BI; Johnson K. L., 1985, CONTACT MECH, DOI 10.1201/b17110-2; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Lin Y, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.021909; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Qian J, 2008, LANGMUIR, V24, P1262, DOI 10.1021/la702401b; Qian J, 2009, BIOPHYS J, V97, P2438, DOI 10.1016/j.bpj.2009.08.027; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Schwarz US, 2004, P NATL ACAD SCI USA, V101, P6940, DOI 10.1073/pnas.0305822101; Seifert U, 2000, PHYS REV LETT, V84, P2750, DOI 10.1103/PhysRevLett.84.2750; Shenoy VB, 2005, P NATL ACAD SCI USA, V102, P3213, DOI 10.1073/pnas.0500368102; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Tada H., 2000, STRESS ANAL CRACKS H; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Walcott S, 2010, P NATL ACAD SCI USA, V107, P7757, DOI 10.1073/pnas.0912739107; Weikl TR, 2004, BIOPHYS J, V87, P3665, DOI 10.1529/biophysj.104.045609; Zamir E, 2001, J CELL SCI, V114, P3583; Zhu C, 2000, ANNU REV BIOMED ENG, V2, P189, DOI 10.1146/annurev.bioeng.2.1.189	56	35	35	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12342	10.1371/journal.pone.0012342	http://dx.doi.org/10.1371/journal.pone.0012342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808789	Green Published, gold, Green Submitted			2022-12-25	WOS:000281153500022
J	Wengenroth, M; Blatow, M; Bendszus, M; Schneider, P				Wengenroth, Martina; Blatow, Maria; Bendszus, Martin; Schneider, Peter			Leftward Lateralization of Auditory Cortex Underlies Holistic Sound Perception in Williams Syndrome	PLOS ONE			English	Article							HESCHLS GYRUS; PLANUM TEMPORALE; HEARING-LOSS; NEURAL BASIS; INDIVIDUALS; ABNORMALITIES; ASYMMETRY; PHENOTYPE; CHILDREN; PITCH	Background: Individuals with the rare genetic disorder Williams-Beuren syndrome (WS) are known for their characteristic auditory phenotype including strong affinity to music and sounds. In this work we attempted to pinpoint a neural substrate for the characteristic musicality in WS individuals by studying the structure-function relationship of their auditory cortex. Since WS subjects had only minor musical training due to psychomotor constraints we hypothesized that any changes compared to the control group would reflect the contribution of genetic factors to auditory processing and musicality. Methodology/Principal Findings: Using psychoacoustics, magnetoencephalography and magnetic resonance imaging, we show that WS individuals exhibit extreme and almost exclusive holistic sound perception, which stands in marked contrast to the even distribution of this trait in the general population. Functionally, this was reflected by increased amplitudes of left auditory evoked fields. On the structural level, volume of the left auditory cortex was 2.2-fold increased in WS subjects as compared to control subjects. Equivalent volumes of the auditory cortex have been previously reported for professional musicians. Conclusions/Significance: There has been an ongoing debate in the neuroscience community as to whether increased gray matter of the auditory cortex in musicians is attributable to the amount of training or innate disposition. In this study musical education of WS subjects was negligible and control subjects were carefully matched for this parameter. Therefore our results not only unravel the neural substrate for this particular auditory phenotype, but in addition propose WS as a unique genetic model for training-independent auditory system properties.	[Wengenroth, Martina; Blatow, Maria; Bendszus, Martin; Schneider, Peter] Univ Heidelberg, Dept Neuroradiol, Sch Med, Heidelberg, Germany; [Schneider, Peter] Univ Heidelberg, Dept Neurol, Sch Med, Sect Biomagnetism, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Wengenroth, M (corresponding author), Univ Heidelberg, Dept Neuroradiol, Sch Med, Heidelberg, Germany.	martina.wengenroth@med.uni-heidelberg.de		Blatow, Maria/0000-0003-3371-5697; Schneider, Peter/0000-0002-1920-0438	University of Heidelberg Medical Faculty	University of Heidelberg Medical Faculty	M. Blatow was supported by the Olympia-Morata-Program of the University of Heidelberg Medical Faculty. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonell A, 2010, J MED GENET, V47, P312, DOI 10.1136/jmg.2009.071712; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Campbell LE, 2009, BRAIN RES, V1258, P96, DOI 10.1016/j.brainres.2008.11.101; Chiang MC, 2007, NEUROIMAGE, V36, P1096, DOI 10.1016/j.neuroimage.2007.04.024; Dykens EM, 2005, AM J MENT RETARD, V110, P346, DOI 10.1352/0895-8017(2005)110[346:MAAIWS]2.0.CO;2; Eckert MA, 2006, NEUROIMAGE, V33, P39, DOI 10.1016/j.neuroimage.2006.05.062; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Galaburda AM, 2000, J COGNITIVE NEUROSCI, V12, P74, DOI 10.1162/089892900561995; Gao MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010292; Gaser C, 2003, ANN NY ACAD SCI, V999, P514, DOI 10.1196/annals.1284.062; Gaser C, 2006, NEUROIMAGE, V33, P46, DOI 10.1016/j.neuroimage.2006.06.018; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; Gothelf D, 2006, NEUROLOGY, V66, P390, DOI 10.1212/01.wnl.0000196643.35395.5f; Holinger DP, 2005, BRAIN RES, V1037, P35, DOI 10.1016/j.brainres.2004.11.038; Hyde KL, 2008, NEUROPSYCHOLOGIA, V46, P632, DOI 10.1016/j.neuropsychologia.2007.09.004; Jarvinen-Pasley A, 2010, NEUROPSYCHOLOGIA, V48, P1047, DOI 10.1016/j.neuropsychologia.2009.12.002; Leonard CM, 2006, GENES BRAIN BEHAV, V5, P64, DOI 10.1111/j.1601-183X.2006.00196.x; LEONARD CM, 1993, ARCH NEUROL-CHICAGO, V50, P461, DOI 10.1001/archneur.1993.00540050013008; Levitin DJ, 1998, MUSIC PERCEPT, V15, P357; Levitin DJ, 2004, CHILD NEUROPSYCHOL, V10, P223, DOI 10.1080/09297040490909288; Levitin DJ, 2003, NEUROIMAGE, V18, P74, DOI 10.1006/nimg.2002.1297; LIEGEOISCHAUVEL C, 1991, BRAIN, V114, P139; Marler JA, 2005, AM J MED GENET A, V138A, P318, DOI 10.1002/ajmg.a.30970; Marler JA, 2010, AM J MED GENET C, V154C, P249, DOI 10.1002/ajmg.c.30262; Martens MA, 2008, J CHILD PSYCHOL PSYC, V49, P576, DOI 10.1111/j.1469-7610.2008.01887.x; Martens MA, 2010, NEUROPSYCHOLOGIA, V48, P2602, DOI 10.1016/j.neuropsychologia.2010.05.007; Meyer-Lindenberg A, 2004, NEURON, V43, P623, DOI 10.1016/j.neuron.2004.08.014; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Pantev C, 2000, J CLIN NEUROPHYSIOL, V17, P130, DOI 10.1097/00004691-200003000-00003; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Peoples R, 2000, AM J HUM GENET, V66, P47, DOI 10.1086/302722; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Reiss AL, 2000, J COGNITIVE NEUROSCI, V12, P65, DOI 10.1162/089892900561986; Reiss AL, 2004, J NEUROSCI, V24, P5009, DOI 10.1523/JNEUROSCI.5272-03.2004; SCHEUERMAN GL, 1993, FUEL PROCESS TECHNOL, V35, P39, DOI 10.1016/0378-3820(93)90084-H; Schmitt JE, 2002, DEV MED CHILD NEUROL, V44, P292; Schmitt JE, 2001, ARCH NEUROL-CHICAGO, V58, P283, DOI 10.1001/archneur.58.2.283; Schneider P, 2005, NAT NEUROSCI, V8, P1241, DOI 10.1038/nn1530; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Schneider P, 2009, CONTEMP MUSIC REV, V28, P315, DOI 10.1080/07494460903404402; Seifritz E, 2002, SCIENCE, V297, P1706, DOI 10.1126/science.1074355; Steinmetz H, 1996, NEUROSCI BIOBEHAV R, V20, P587, DOI 10.1016/0149-7634(95)00071-2; Thompson PM, 2005, J NEUROSCI, V25, P4146, DOI 10.1523/JNEUROSCI.0165-05.2005; THORTONWELLS TA, 2010, J INTELLECT DEV DIS, V115, P172; Van Essen DC, 2006, J NEUROSCI, V26, P5470, DOI 10.1523/JNEUROSCI.4154-05.2006; Warrier C, 2009, J NEUROSCI, V29, P61, DOI 10.1523/JNEUROSCI.3489-08.2009; Westbury CF, 1999, CEREB CORTEX, V9, P392, DOI 10.1093/cercor/9.4.392; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946	48	32	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12326	10.1371/journal.pone.0012326	http://dx.doi.org/10.1371/journal.pone.0012326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808792	Green Published, gold, Green Submitted			2022-12-25	WOS:000281153500011
J	Wilbe, M; Ziener, ML; Aronsson, A; Harlos, C; Sundberg, K; Norberg, E; Andersson, L; Lindblad-Toh, K; Hedhammar, A; Andersson, G; Lingaas, F				Wilbe, Maria; Ziener, Martine Lund; Aronsson, Anita; Harlos, Charlotte; Sundberg, Katarina; Norberg, Elin; Andersson, Lisa; Lindblad-Toh, Kerstin; Hedhammar, Ake; Andersson, Goran; Lingaas, Frode			DLA Class II Alleles Are Associated with Risk for Canine Symmetrical Lupoid Onychodystropy (SLO)	PLOS ONE			English	Article							IMMUNE PRIVILEGE; NAIL APPARATUS; DOGS; COMPLEX; SUSCEPTIBILITY; ONYCHOMADESIS; IMMUNOLOGY; DISORDERS; HAPLOTYPE; SEQUENCE	Symmetrical lupoid onychodystrophy (SLO) is an immune-mediated disease in dogs affecting the claws with a suggested autoimmune aethiology. Sequence-based genotyping of the polymorphic exon 2 from DLA-DRB1, -DQA1, and -DQB1 class II loci were performed in a total of 98 SLO Gordon setter cases and 98 healthy controls. A risk haplotype (DRB1*01801/DQA1*00101/DQB1*00802) was present in 53% of cases and 34% of controls and conferred an elevated risk of developing SLO with an odds ratio (OR) of 2.1. When dogs homozygous for the risk haplotype were compared to all dogs not carrying the haplotype the OR was 5.4. However, a stronger protective haplotype (DRB1*02001/DQA1*00401/DQB1*01303, OR = 0.03, 1/OR = 33) was present in 16.8% of controls, but only in a single case (0.5%). The effect of the protective haplotype was clearly stronger than the risk haplotype, since 11.2% of the controls were heterozygous for the risk and protective haplotypes, whereas this combination was absent from cases. When the dogs with the protective haplotype were excluded, an OR of 2.5 was obtained when dogs homozygous for the risk haplotype were compared to those heterozygous for the risk haplotype, suggesting a co-dominant effect of the risk haplotype. In smaller sample sizes of the bearded collie and giant schnauzer breeds we found the same or similar haplotypes, sharing the same DQA1 allele, over-represented among the cases suggesting that the risk is associated primarily with DLA-DQ. We obtained conclusive results that DLA class II is significantly associated with risk of developing SLO in Gordon setters, thus supporting that SLO is an immune-mediated disease. Further studies of SLO in dogs may provide important insight into immune privilege of the nail apparatus and also knowledge about a number of inflammatory disorders of the nail apparatus like lichen planus, psoriasis, alopecia areata and onycholysis.	[Wilbe, Maria; Harlos, Charlotte; Sundberg, Katarina; Andersson, Lisa; Andersson, Goran] Swedish Univ Agr Sci SLU, Biomed Ctr, Dept Anim Breeding & Genet, Uppsala, Sweden; [Ziener, Martine Lund] Fredrikstad Dyrehosp, Gamle Fredrikstad, Norway; [Aronsson, Anita] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden; [Norberg, Elin; Hedhammar, Ake] Swedish Univ Agr Sci SLU, Dept Clin Sci, Uppsala, Sweden; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Lindblad-Toh, Kerstin] Broad Inst, Cambridge, MA USA; [Lingaas, Frode] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway	Swedish University of Agricultural Sciences; Karolinska Institutet; Swedish University of Agricultural Sciences; Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Norwegian University of Life Sciences	Wilbe, M (corresponding author), Swedish Univ Agr Sci SLU, Biomed Ctr, Dept Anim Breeding & Genet, Uppsala, Sweden.	Maria.Wilbe@hgen.slu.se; Frode.Lingaas@nvh.no	Andersson, Goran/AAK-6564-2020	Andersson, Goran/0000-0001-5131-3144; Hedhammar, Ake/0000-0001-7048-3851	European Commission [GA-201370]; FORMAS; Norwegian Gordon Setter Breed Club; Legacy of Veterinary Edvard Smidt; EURYI award	European Commission(European CommissionEuropean Commission Joint Research Centre); FORMAS(Swedish Research Council Formas); Norwegian Gordon Setter Breed Club; Legacy of Veterinary Edvard Smidt; EURYI award(European Science Foundation (ESF))	This work was supported by LUPA (part of the 7th Research Framework Programme of the European Commission), GA-201370, FORMAS and the Norwegian Gordon Setter Breed Club and the Legacy of Veterinary Edvard Smidt. KLT is a EURYI award recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arin MJ, 2009, HUM GENET, V125, P355, DOI 10.1007/s00439-009-0646-5; Bergvall K, 1998, VET DERMATOL, V9, P263, DOI 10.1046/j.1365-3164.1998.00094.x; Bohnhorst JO, 2001, ACTA VET SCAND, V42, P323, DOI 10.1186/1751-0147-42-323; Debenham SL, 2005, GENOMICS, V85, P48, DOI 10.1016/j.ygeno.2004.09.009; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Greer KA, 2010, TISSUE ANTIGENS, V76, P110, DOI 10.1111/j.1399-0039.2010.01484.x; Haneke E, 2009, J DTSCH DERMATOL GES, V7, P787, DOI 10.1111/j.1610-0387.2009.07037.x; HEAD JR, 1985, PERSPECT BIOL MED, V29, P115; Ito T, 2005, J INVEST DERMATOL, V125, P1139, DOI 10.1111/j.0022-202X.2005.23927.x; Ito Taisuke, 2008, V10, P27, DOI 10.1159/000131412; Kennedy LJ, 2007, TISSUE ANTIGENS, V69, P269, DOI 10.1111/j.1399-0039.2006.00778.x; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P502, DOI 10.1111/j.1399-0039.2006.00715.x; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P467, DOI 10.1111/j.1399-0039.2006.00716.x; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P82, DOI 10.1111/j.1399-0039.2006.00614.x; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Mariani Sara M, 2004, MedGenMed, V6, P18; Mueller RS, 1999, VET DERMATOL, V10, P55, DOI 10.1046/j.1365-3164.1999.00120.x; Mueller RS, 2003, J AM ANIM HOSP ASSOC, V39, P139, DOI 10.5326/0390139; Mueller RS, 2000, VET DERMATOL, V11, P133, DOI 10.1046/j.1365-3164.2000.00174.x; Ollier WER, 2001, IMMUNOGENETICS, V53, P669, DOI 10.1007/s002510100372; SCOTT DW, 1995, J AM ANIM HOSP ASSOC, V31, P194, DOI 10.5326/15473317-31-3-194; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; Wilbe M, 2010, TISSUE ANTIGENS, V75, P712, DOI 10.1111/j.1399-0039.2010.01449.x; Wilbe M, 2010, NAT GENET, V42, P250, DOI 10.1038/ng.525; Wilbe M, 2009, IMMUNOGENETICS, V61, P557, DOI 10.1007/s00251-009-0387-6; Ziener ML, 2008, VET DERMATOL, V19, P88, DOI 10.1111/j.1365-3164.2008.00650.x	26	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12332	10.1371/journal.pone.0012332	http://dx.doi.org/10.1371/journal.pone.0012332			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808798	Green Published, Green Submitted, gold			2022-12-25	WOS:000281153500014
J	Chen, XF; Li, XL; Wang, P; Liu, Y; Zhang, ZG; Zhao, GP; Xu, HM; Zhu, J; Qin, XY; Chen, SC; Hu, LD; Kong, XY				Chen, Xianfeng; Li, Xinlei; Wang, Ping; Liu, Yang; Zhang, Zhenguo; Zhao, Guoping; Xu, Haiming; Zhu, Jun; Qin, Xueying; Chen, Suchao; Hu, Landian; Kong, Xiangyin			Novel Association Strategy with Copy Number Variation for Identifying New Risk Loci of Human Diseases	PLOS ONE			English	Article							BIPOLAR-DISORDER; ENHANCER DETECTION; BREAST-CANCER; HUMAN GENOME; SCHIZOPHRENIA; NUCLEOTIDE; EXPRESSION; CHANNELS; MATTERS; CYP2D6	Background: Copy number variations (CNV) are important causal genetic variations for human disease; however, the lack of a statistical model has impeded the systematic testing of CNVs associated with disease in large-scale cohort. Methodology/Principal Findings: Here, we developed a novel integrated strategy to test CNV-association in genome-wide case-control studies. We converted the single-nucleotide polymorphism (SNP) signal to copy number states using a well-trained hidden Markov model. We mapped the susceptible CNV-loci through SNP site-specific testing to cope with the physiological complexity of CNVs. We also ensured the credibility of the associated CNVs through further window-based CNV-pattern clustering. Genome-wide data with seven diseases were used to test our strategy and, in total, we identified 36 new susceptible loci that are associated with CNVs for the seven diseases: 5 with bipolar disorder, 4 with coronary artery disease, 1 with Crohn's disease, 7 with hypertension, 9 with rheumatoid arthritis, 7 with type 1 diabetes and 3 with type 2 diabetes. Fifteen of these identified loci were validated through genotype-association and physiological function from previous studies, which provide further confidence for our results. Notably, the genes associated with bipolar disorder converged in the phosphoinositide/calcium signaling, a well-known affected pathway in bipolar disorder, which further supports that CNVs have impact on bipolar disorder. Conclusions/Significance: Our results demonstrated the effectiveness and robustness of our CNV-association analysis and provided an alternative avenue for discovering new associated loci of human diseases.	[Chen, Xianfeng; Li, Xinlei; Wang, Ping; Liu, Yang; Zhang, Zhenguo; Hu, Landian; Kong, Xiangyin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Chen, Xianfeng; Li, Xinlei; Wang, Ping; Liu, Yang; Zhang, Zhenguo; Hu, Landian; Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Zhao, Guoping] Chinese Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China; [Xu, Haiming; Zhu, Jun] Zhejiang Univ, Coll Agr & Biotechnol, Inst Bioinformat, Hangzhou 310003, Zhejiang, Peoples R China; [Qin, Xueying; Chen, Suchao] Zhejiang Univ, State Key Lab Comp Aided Design & Comp Graph, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Landian; Kong, Xiangyin] Shanghai Jiao Tong Univ, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Zhejiang University; Zhejiang University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Chen, XF (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China.	xykong@sibs.ac.cn	Zhang, Zhenguo/C-9960-2016; Xu, Haiming/AAF-8067-2019	Zhang, Zhenguo/0000-0002-9444-9604; Zhao, Guo-Ping/0000-0002-7621-6620	National High Technology Research and Development Program of China [2006AA02Z330]; National Basic Research Program of China [2007CB512202, 2007CB512100, 2004CB518603]; National Natural Science Foundation of China [30530450]; Chinese Academy of Sciences [KSCX1-YW-R-74]; Wellcome Trust [076113]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000073] Funding Source: NIH RePORTER	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National High Technology Research and Development Program of China (No. 2006AA02Z330), the National Basic Research Program of China (Nos. 2007CB512202, 2007CB512100 and 2004CB518603), the National Natural Science Foundation of China, Key Program (No. 30530450) and the Knowledge Innovation Program of the Chinese Academy of Sciences (No. KSCX1-YW-R-74). This study uses data generated by the Wellcome Trust Case-Control Consortium; funding for the project was provided by the Wellcome Trust (Award 076113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], 2007, NATURE, V447, P661; Barnes C, 2008, NAT GENET, V40, P1245, DOI 10.1038/ng.206; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Borsotto M, 2007, PHARMACOGENOMICS J, V7, P123, DOI 10.1038/sj.tpj.6500400; Carter CJ, 2007, NEUROCHEM INT, V50, P461, DOI 10.1016/j.neuint.2006.11.009; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Witte MA, 2008, J IMMUNOL, V180, P6365, DOI 10.4049/jimmunol.180.9.6365; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Ellingsen S, 2005, DEVELOPMENT, V132, P3799, DOI 10.1242/dev.01951; Fedorenko O, 2008, PSYCHOPHARMACOLOGY, V199, P47, DOI 10.1007/s00213-008-1095-x; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Graves TD, 2005, POSTGRAD MED J, V81, P20, DOI 10.1136/pgmj.2004.022012; Hahn CG, 2005, AM J PSYCHIAT, V162, P616, DOI 10.1176/appi.ajp.162.3.616; Hauck CR, 2006, EUR J CELL BIOL, V85, P235, DOI 10.1016/j.ejcb.2005.08.002; Hoskins JM, 2009, NAT REV CANCER, V9, P576, DOI 10.1038/nrc2683; Ilia M, 2004, INT REV NEUROBIOL, V59, P471; Kikuta H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S4; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; LEWANDOWSKI ED, 1995, CIRCULATION, V91, P2071, DOI 10.1161/01.CIR.91.7.2071; Lui WWY, 2003, MOL BIOL CELL, V14, P2385, DOI 10.1091/mbc.e02-11-0735; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Moberg PJ, 1999, NEUROPSYCHOPHARMACOL, V21, P325, DOI 10.1016/S0893-133X(99)00019-6; Mudge J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003625; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rodovicius Hiliaras, 2003, Medicina (Kaunas), V39, P62; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Servin AL, 2005, CLIN MICROBIOL REV, V18, P264, DOI 10.1128/CMR.18.2.264-292.2005; Stopkova P, 2004, BIOL PSYCHIAT, V55, P981, DOI 10.1016/j.biopsych.2004.01.014; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Umbach JA, 2004, CLIN NEUROSCI RES, V4, P253, DOI 10.1016/j.cnr.2004.09.002; Vergani L, 2007, MOL CELL ENDOCRINOL, V263, P29, DOI 10.1016/j.mce.2006.08.010; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yu KD, 2009, NAT REV CANCER, V9, P842, DOI 10.1038/nrc2683-c1	36	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12185	10.1371/journal.pone.0012185	http://dx.doi.org/10.1371/journal.pone.0012185			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808825	Green Published, gold, Green Submitted			2022-12-25	WOS:000281077000001
J	Fischer, W; Ganusov, VV; Giorgi, EE; Hraber, PT; Keele, BF; Leitner, T; Han, CS; Gleasner, CD; Green, L; Lo, CC; Nag, A; Wallstrom, TC; Wang, SY; McMichael, AJ; Haynes, BF; Hahn, BH; Perelson, AS; Borrow, P; Shaw, GM; Bhattacharya, T; Korber, BT				Fischer, Will; Ganusov, Vitaly V.; Giorgi, Elena E.; Hraber, Peter T.; Keele, Brandon F.; Leitner, Thomas; Han, Cliff S.; Gleasner, Cheryl D.; Green, Lance; Lo, Chien-Chi; Nag, Ambarish; Wallstrom, Timothy C.; Wang, Shuyi; McMichael, Andrew J.; Haynes, Barton F.; Hahn, Beatrice H.; Perelson, Alan S.; Borrow, Persephone; Shaw, George M.; Bhattacharya, Tanmoy; Korber, Bette T.			Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; IN-VIVO; RHESUS-MONKEYS; INFECTION; EVOLUTION; RESPONSES; VARIANTS; VACCINES; MUTATIONS; PHENOTYPE	We used ultra-deep sequencing to obtain tens of thousands of HIV-1 sequences from regions targeted by CD8+ T lymphocytes from longitudinal samples from three acutely infected subjects, and modeled viral evolution during the critical first weeks of infection. Previous studies suggested that a single virus established productive infection, but these conclusions were tempered because of limited sampling; now, we have greatly increased our confidence in this observation through modeling the observed earliest sample diversity based on vastly more extensive sampling. Conventional sequencing of HIV-1 from acute/early infection has shown different patterns of escape at different epitopes; we investigated the earliest escapes in exquisite detail. Over 3-6 weeks, ultradeep sequencing revealed that the virus explored an extraordinary array of potential escape routes in the process of evading the earliest CD8 T-lymphocyte responses - using 454 sequencing, we identified over 50 variant forms of each targeted epitope during early immune escape, while only 2-7 variants were detected in the same samples via conventional sequencing. In contrast to the diversity seen within epitopes, non-epitope regions, including the Envelope V3 region, which was sequenced as a control in each subject, displayed very low levels of variation. In early infection, in the regions sequenced, the consensus forms did not have a fitness advantage large enough to trigger reversion to consensus amino acids in the absence of immune pressure. In one subject, a genetic bottleneck was observed, with extensive diversity at the second time point narrowing to two dominant escape forms by the third time point, all within two months of infection. Traces of immune escape were observed in the earliest samples, suggesting that immune pressure is present and effective earlier than previously reported; quantifying the loss rate of the founder virus suggests a direct role for CD8 T-lymphocyte responses in viral containment after peak viremia. Dramatic shifts in the frequencies of epitope variants during the first weeks of infection revealed a complex interplay between viral fitness and immune escape.	[Fischer, Will; Ganusov, Vitaly V.; Giorgi, Elena E.; Hraber, Peter T.; Leitner, Thomas; Han, Cliff S.; Gleasner, Cheryl D.; Green, Lance; Lo, Chien-Chi; Nag, Ambarish; Wallstrom, Timothy C.; Perelson, Alan S.; Bhattacharya, Tanmoy; Korber, Bette T.] Los Alamos Natl Lab, Los Alamos, NM USA; [Ganusov, Vitaly V.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Giorgi, Elena E.] Univ Massachusetts, Dept Math & Stat, Amherst, MA 01003 USA; [Keele, Brandon F.] NCI, SAIC Frederick, Frederick, MD 21701 USA; [Wang, Shuyi; Hahn, Beatrice H.; Shaw, George M.] Univ Alabama, Dept Med, Birmingham, AL 35294 USA; [McMichael, Andrew J.] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Haynes, Barton F.] Duke Univ, Med Ctr, Durham, NC USA; [Borrow, Persephone] Univ Oxford, Jenner Inst, Compton, England; [Bhattacharya, Tanmoy; Korber, Bette T.] Santa Fe Inst, Santa Fe, NM 87501 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Massachusetts System; University of Massachusetts Amherst; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Alabama System; University of Alabama Birmingham; University of Oxford; Duke University; University of Oxford; Jenner Institute; The Santa Fe Institute	Fischer, W (corresponding author), Los Alamos Natl Lab, Los Alamos, NM USA.	btk@lanl.gov	Wallstrom, Timothy/J-9234-2017; Perelson, Alan S/Z-1959-2019; Bhattacharya, Tanmoy/J-8956-2013; Fischer, Will/AAD-2807-2019; Fischer, Will/B-1323-2013	Wallstrom, Timothy/0000-0002-9295-2441; Perelson, Alan S/0000-0002-2455-0002; Bhattacharya, Tanmoy/0000-0002-1060-652X; Fischer, Will/0000-0003-4579-4062; Fischer, Will/0000-0003-4579-4062; Borrow, Persephone/0000-0002-3877-9780; Lo, Chien-Chi/0000-0003-3470-1078; Han, Cliff/0000-0003-1972-0692; Korber, Bette/0000-0002-2026-5757; Hahn, Beatrice/0000-0002-9400-9887; Hraber, Peter/0000-0002-2920-4897; Nag, Ambarish/0000-0001-5174-4673; Ganusov, Vitaly/0000-0001-6572-1691	Los Alamos National Laboratory; National Institutes of Health (NIH) [AI-0678501]; Bill and Melinda Gates Foundation [37874]; MRC [MC_U137884177] Funding Source: UKRI; Medical Research Council [MC_U137884177, G1000800a] Funding Source: researchfish	Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding for this work was supplied by a Los Alamos National Laboratory Directed Research grant, National Institutes of Health (NIH) grant AI-0678501 (CHAVI), and the Bill and Melinda Gates Foundation (#37874). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Asquith B, 2006, PLOS BIOL, V4, P583, DOI 10.1371/journal.pbio.0040090; Bar KJ, 2010, J VIROL, V84, P6241, DOI 10.1128/JVI.00077-10; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Bimber BN, 2009, J VIROL, V83, P8247, DOI 10.1128/JVI.00897-09; Borroto R J, 1997, Rev Panam Salud Publica, V1, P3; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Crawford H, 2009, J EXP MED, V206, P909, DOI 10.1084/jem.20081984; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Ganusov VV, 2006, PLOS COMPUT BIOL, V2, P182, DOI 10.1371/journal.pcbi.0020024; Gasper-Smith N, 2008, J VIROL, V82, P7700, DOI 10.1128/JVI.00605-08; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KORBER BTM, 1994, J VIROL, V68, P7467, DOI 10.1128/JVI.68.11.7467-7481.1994; Lavreys L, 2006, CLIN INFECT DIS, V42, P1333, DOI 10.1086/503258; Lee HY, 2009, J THEOR BIOL, V261, P341, DOI 10.1016/j.jtbi.2009.07.038; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Love TMT, 2010, J VIROL, V84, P5802, DOI 10.1128/JVI.00117-10; Luria SE, 1943, GENETICS, V28, P491; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Navarro G, 2001, ACM COMPUT SURV, V33, P31, DOI 10.1145/375360.375365; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Peut V, 2006, CURR HIV RES, V4, P191, DOI 10.2174/157016206776055110; Pillai S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; R Development Core Team, 2009, R FDN STAT COMP; Rousseau CM, 2009, AIDS RES HUM RETROV, V25, P297, DOI 10.1089/aid.2008.0208; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Schneidewind A, 2009, J VIROL, V83, P3993, DOI 10.1128/JVI.01108-08; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Turnbull EL, 2006, J IMMUNOL, V176, P6130, DOI 10.4049/jimmunol.176.10.6130; Wang GP, 2010, J VIROL, V84, P6218, DOI 10.1128/JVI.02271-09; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Wood N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000414	45	200	201	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12303	10.1371/journal.pone.0012303	http://dx.doi.org/10.1371/journal.pone.0012303			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808830	Green Submitted, Green Published, gold			2022-12-25	WOS:000281077000010
J	Chittenden, CM; Biagi, CA; Davidsen, JG; Davidsen, AG; Kondo, H; McKnight, A; Pedersen, OP; Raven, PA; Rikardsen, AH; Shrimpton, JM; Zuehlke, B; McKinley, RS; Devlin, RH				Chittenden, Cedar M.; Biagi, Carlo A.; Davidsen, Jan Grimsrud; Davidsen, Anette Grimsrud; Kondo, Hidehiro; McKnight, Allison; Pedersen, Ole-Petter; Raven, Peter A.; Rikardsen, Audun H.; Shrimpton, J. Mark; Zuehlke, Brett; McKinley, R. Scott; Devlin, Robert H.			Genetic versus Rearing-Environment Effects on Phenotype: Hatchery and Natural Rearing Effects on Hatchery-and Wild-Born Coho Salmon	PLOS ONE			English	Article							ONCORHYNCHUS-KISUTCH; AGONISTIC BEHAVIOR; GROWTH; FITNESS; TROUT; POPULATIONS; SURVIVAL; DENSITY; RIVER; PRODUCTIVITY	With the current trends in climate and fisheries, well-designed mitigative strategies for conserving fish stocks may become increasingly necessary. The poor post-release survival of hatchery-reared Pacific salmon indicates that salmon enhancement programs require assessment. The objective of this study was to determine the relative roles that genotype and rearing environment play in the phenotypic expression of young salmon, including their survival, growth, physiology, swimming endurance, predator avoidance and migratory behaviour. Wild-and hatchery-born coho salmon adults (Oncorhynchus kisutch) returning to the Chehalis River in British Columbia, Canada, were crossed to create pure hatchery, pure wild, and hybrid offspring. A proportion of the progeny from each cross was reared in a traditional hatchery environment, whereas the remaining fry were reared naturally in a contained side channel. The resulting phenotypic differences between replicates, between rearing environments, and between cross types were compared. While there were few phenotypic differences noted between genetic groups reared in the same habitat, rearing environment played a significant role in smolt size, survival, swimming endurance, predator avoidance and migratory behaviour. The lack of any observed genetic differences between wild-and hatchery-born salmon may be due to the long-term mixing of these genotypes from hatchery introgression into wild populations, or conversely, due to strong selection in nature-capable of maintaining highly fit genotypes whether or not fish have experienced part of their life history under cultured conditions.	[Chittenden, Cedar M.; Biagi, Carlo A.; McKnight, Allison; Raven, Peter A.; Zuehlke, Brett; McKinley, R. Scott; Devlin, Robert H.] Univ British Columbia, Ctr Aquaculture & Environm Res, W Vancouver, BC, Canada; [Chittenden, Cedar M.; Biagi, Carlo A.; McKnight, Allison; Raven, Peter A.; Zuehlke, Brett; McKinley, R. Scott; Devlin, Robert H.] Fisheries & Oceans Canada, W Vancouver, BC, Canada; [Chittenden, Cedar M.; Davidsen, Jan Grimsrud; Davidsen, Anette Grimsrud; Pedersen, Ole-Petter; Rikardsen, Audun H.] Univ Tromso, Dept Arct & Marine Biol, Tromso, Norway; [Kondo, Hidehiro] Tokyo Univ Marine Sci & Technol, Lab Genome Sci, Tokyo, Japan; [Shrimpton, J. Mark] Univ No British Columbia, Prince George, BC V2L 5P2, Canada	University of British Columbia; Fisheries & Oceans Canada; UiT The Arctic University of Tromso; Tokyo University of Marine Science & Technology; University of Northern British Columbia	Chittenden, CM (corresponding author), Univ British Columbia, Ctr Aquaculture & Environm Res, W Vancouver, BC, Canada.	Cedar.M.Chittenden@uit.no	Biagi, Carlo/AAN-2030-2020; Kondo, Hidehiro/O-1954-2014; Davidsen, Jan Grimsrud/AAN-5974-2020	Biagi, Carlo/0000-0002-6345-9674; Kondo, Hidehiro/0000-0001-5102-6831; Davidsen, Jan Grimsrud/0000-0002-7253-2327	Census of Marine Life; Gordon and Betty Moore Foundation; Pacific Salmon Foundation; NSERC	Census of Marine Life; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Pacific Salmon Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this work was provided by Census of Marine Life, the Gordon and Betty Moore Foundation, the Pacific Salmon Foundation and a grant from NSERC to RSM. The Pacific Ocean Shelf Tracking project (POST) acoustic receiver arrays were designed and deployed by Kintama Research Corp. None of these organizations were directly involved in the study design, analysis, or writing of the paper, nor the decision to submit the manuscript for publication. This work is a contribution to the Census of Marine Life.	Araki H, 2008, EVOL APPL, V1, P342, DOI 10.1111/j.1752-4571.2008.00026.x; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Araki H, 2009, BIOL LETTERS, V5, P621, DOI 10.1098/rsbl.2009.0315; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; ARGUE AW, 1983, CANADIAN B FISHERIES, P211; BANKS JL, 1992, PROG FISH CULT, V54, P137, DOI 10.1577/1548-8640(1992)054<0137:EODALO>2.3.CO;2; BANKS JL, 1994, AQUACULTURE, V119, P201, DOI 10.1016/0044-8486(94)90176-7; Beamish RJ, 2008, T AM FISH SOC, V137, P503, DOI 10.1577/T07-080.1; Berejikian BA, 1996, CAN J FISH AQUAT SCI, V53, P2004, DOI 10.1139/cjfas-53-9-2004; Bradford MJ, 2000, CAN J FISH AQUAT SCI, V57, P13, DOI 10.1139/cjfas-57-1-13; BRAUNER CJ, 1994, CAN J FISH AQUAT SCI, V51, P2188, DOI 10.1139/f94-220; Brown C, 2002, FISH FISH, V3, P79, DOI 10.1046/j.1467-2979.2002.00077.x; Bryden CA, 2004, AQUACULTURE, V235, P249, DOI 10.1016/j.aquaculture.2004.01.027; BURROWS RE, 1969, T AM FISH SOC, V98, P777, DOI 10.1577/1548-8659(1969)98[777:TIOFQO]2.0.CO;2; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campbell B, 2006, T AM FISH SOC, V135, P164, DOI 10.1577/T05-115.1; Chittenden CM, 2008, J FISH BIOL, V72, P614, DOI 10.1111/j.1095-8649.2007.01729.x; Chittenden C, 2009, ENVIRON BIOL FISH, V84, P129, DOI 10.1007/s10641-008-9396-9; Coronado C, 1998, CAN J FISH AQUAT SCI, V55, P2067, DOI 10.1139/cjfas-55-9-2067; CRESSWELL RC, 1981, J FISH BIOL, V18, P429, DOI 10.1111/j.1095-8649.1981.tb03784.x; CROSS CL, 1991, CAN TECH REP FISH AQ, V1816, P48; Dannewitz J, 2004, J APPL ECOL, V41, P355, DOI 10.1111/j.0021-8901.2004.00895.x; Flagg TA, 1999, NMFSNWFSC38 US DEP C; Ford MJ, 2004, CONSERV GENET, V5, P797, DOI 10.1007/s10592-004-1983-5; GOEDE RW, 1990, AM FISHERIES SOC S, V8, P93; Goodman D, 2005, CAN J FISH AQUAT SCI, V62, P374, DOI 10.1139/F04-187; Greene C.W, 1952, T AM FISH SOC, V81, P43; Hanson RW, 2003, BIOCHIMIE, V85, P1199, DOI 10.1016/j.biochi.2003.10.022; Hendry AP, 2000, SCIENCE, V290, P516, DOI 10.1126/science.290.5491.516; HILBORN R, 1992, FISHERIES, V17, P5, DOI 10.1577/1548-8446(1992)017<0005:HATFOS>2.0.CO;2; LEON KA, 1986, PROG FISH CULT, V48, P43, DOI 10.1577/1548-8640(1986)48&lt;43:EOEOFC&gt;2.0.CO;2; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lynch M, 2001, CONSERV GENET, V2, P363, DOI 10.1023/A:1012550620717; MASON JW, 1967, T AM FISH SOC, V96, P313, DOI 10.1577/1548-8659(1967)96[313:CSOWAD]2.0.CO;2; Maynard DJ, 1996, PROG FISH CULT, V58, P187, DOI 10.1577/1548-8640(1996)058&lt;0187:EODSWL&gt;2.3.CO;2; MAYNARD DJ, 1998, P 48 ANN PAC NW FISH, P81; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; Miller R.B., 1952, T AM FISH SOC, V81, P35; Morita K, 2006, ICES J MAR SCI, V63, P1353, DOI 10.1016/j.icesjms.2006.03.024; MUNDIE JH, 1990, N AM J FISH MANAGE, V21, P327; Nickelson T, 2003, CAN J FISH AQUAT SCI, V60, P1050, DOI 10.1139/F03-091; Raven PA, 2008, GEN COMP ENDOCR, V159, P26, DOI 10.1016/j.ygcen.2008.07.011; REFSTIE T, 1977, AQUACULTURE, V11, P329, DOI 10.1016/0044-8486(77)90082-5; Reimers N., 1963, T AM FISH SOC, V92, P39, DOI [10.1577/1548-8659(1963)92[39:BCWTAO]2.0.CO;2., DOI 10.1577/1548-8659(1963)92[39:BCWTAO]2.0.CO;2]; Reisenbichler RR, 1999, ICES J MAR SCI, V56, P459, DOI 10.1006/jmsc.1999.0455; RIDDELL BE, 1991, AQUACULTURE, V98, P161, DOI 10.1016/0044-8486(91)90381-G; Rise ML, 2006, J MOL ENDOCRINOL, V37, P259, DOI 10.1677/jme.1.02031; SHRIMPTON JM, 1994, CAN J FISH AQUAT SCI, V51, P2179, DOI 10.1139/f94-219; Singer TD, 2003, AQUACULTURE, V222, P15, DOI 10.1016/S0044-8486(03)00099-1; SOSIAK AJ, 1978, THESIS U NEW BRUNSWI; Sundstrom LF, 2004, P ROY SOC B-BIOL SCI, V271, pS350, DOI 10.1098/rsbl.2004.0189; SWAIN DP, 1990, CAN J FISH AQUAT SCI, V47, P566, DOI 10.1139/f90-065; SWAIN DP, 1991, CAN J FISH AQUAT SCI, V48, P1783, DOI 10.1139/f91-210; Sweeting RM, 2004, REV FISH BIOL FISHER, V14, P361, DOI 10.1007/s11160-005-3793-3; Sweeting RM, 2003, N AM J FISH MANAGE, V23, P492, DOI 10.1577/1548-8675(2003)023<0492:ROWCSB>2.0.CO;2; Thompson RB., 1966, THESIS U WASHINGTON; TYMCHUK WE, 2006, ROLE GENOTYPE ENV PH, V4; Tymchuk WE, 2006, T AM FISH SOC, V135, P442, DOI 10.1577/T05-181.1; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Ward BR, 2000, CAN J FISH AQUAT SCI, V57, P298, DOI 10.1139/cjfas-57-2-298; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; *WORLD ORG AN HLTH, 2006, MAN DIAGN TESTS AQ A; ZHANG Z, 1995, CAN J FISH AQUAT SCI, V52, P344, DOI 10.1139/f95-035; [No title captured]	64	46	47	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12261	10.1371/journal.pone.0012261	http://dx.doi.org/10.1371/journal.pone.0012261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808853	Green Published, gold, Green Submitted			2022-12-25	WOS:000281075500006
J	Smits, SHJ; Meyer, T; Mueller, A; van Os, N; Stoldt, M; Willbold, D; Schmitt, L; Grieshaber, MK				Smits, Sander H. J.; Meyer, Tatu; Mueller, Andre; van Os, Nadine; Stoldt, Matthias; Willbold, Dieter; Schmitt, Lutz; Grieshaber, Manfred K.			Insights into the Mechanism of Ligand Binding to Octopine Dehydrogenase from Pecten maximus by NMR and Crystallography	PLOS ONE			English	Article							KINETIC MECHANISM; SCALLOP; ENZYME	Octopine dehydrogenase (OcDH) from the adductor muscle of the great scallop, Pecten maximus, catalyzes the NADH dependent, reductive condensation of L-arginine and pyruvate to octopine, NAD(+), and water during escape swimming and/or subsequent recovery. The structure of OcDH was recently solved and a reaction mechanism was proposed which implied an ordered binding of NADH, L-arginine and finally pyruvate. Here, the order of substrate binding as well as the underlying conformational changes were investigated by NMR confirming the model derived from the crystal structures. Furthermore, the crystal structure of the OcDH/NADH/agmatine complex was determined which suggests a key role of the side chain of L-arginine in protein cataylsis. Thus, the order of substrate binding to OcDH as well as the molecular signals involved in octopine formation can now be described in molecular detail.	[Smits, Sander H. J.; Meyer, Tatu; Schmitt, Lutz; Grieshaber, Manfred K.] Univ Dusseldorf, Inst Biochem, D-4000 Dusseldorf, Germany; [Mueller, Andre; van Os, Nadine; Grieshaber, Manfred K.] Univ Dusseldorf, Inst Zoophysiol, D-4000 Dusseldorf, Germany; [Stoldt, Matthias; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, D-4000 Dusseldorf, Germany; [Stoldt, Matthias; Willbold, Dieter] Res Ctr Julich, Inst Struct Biol & Biophys ISB 3, Julich, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich	Smits, SHJ (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, D-4000 Dusseldorf, Germany.	sander.smits@uni-duesseldorf.de	Willbold, Dieter/A-6280-2013; Stoldt, Matthias/G-5738-2013	Willbold, Dieter/0000-0002-0065-7366; Stoldt, Matthias/0000-0002-5060-4844; Mueller, Andre/0000-0001-7271-9303	Deutsche Forschungs Gemeinschaft [GR456/20-4]; North Rhein Westphalia graduate school Biostruct	Deutsche Forschungs Gemeinschaft(German Research Foundation (DFG)); North Rhein Westphalia graduate school Biostruct	This work was supported by the Deutsche Forschungs Gemeinschaft (grant GR456/20-4 to M.K.G.) and a stipendium of the North Rhein Westphalia graduate school Biostruct to T.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAICI A, 1974, EUR J BIOCHEM, V46, P59, DOI 10.1111/j.1432-1033.1974.tb03596.x; Baker PJ, 1998, NAT STRUCT BIOL, V5, P561, DOI 10.1038/817; Burk DL, 2007, J MOL BIOL, V373, P745, DOI 10.1016/j.jmb.2007.08.044; DOUBLET MO, 1975, EUR J BIOCHEM, V59, P185, DOI 10.1111/j.1432-1033.1975.tb02440.x; DOUBLET MO, 1975, EUR J BIOCHEM, V59, P175, DOI 10.1111/j.1432-1033.1975.tb02439.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GADE G, 1978, J COMP PHYSIOL, V124, P121; GORLACH M, 1992, EMBO J, V11, P3289, DOI 10.1002/j.1460-2075.1992.tb05407.x; GRIESHABER M, 1977, COMP BIOCHEM PHYS B, V58, P249, DOI 10.1016/0305-0491(77)90198-5; Grieshaber M K, 1994, Rev Physiol Biochem Pharmacol, V125, P43, DOI 10.1007/BFb0030909; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Keller R., 2004, THESIS SWISS FEDERAL; KREUTZER U, 1985, MOL PHYSIOL, V8, P371; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Muller A, 2007, FEBS J, V274, P6329, DOI 10.1111/j.1742-4658.2007.06151.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OLOMUCKI A, 1981, Biochemical Society Transactions, V9, P278; ORIOL C, 1972, EUR J BIOCHEM, V29, P288, DOI 10.1111/j.1432-1033.1972.tb01987.x; Peterson, 1998, ICRS NEWSLETTER, V1, P5; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; SCHRIMSHER JL, 1984, BIOCHEMISTRY-US, V23, P1348, DOI 10.1021/bi00302a002; Smits SHJ, 2008, ACTA CRYSTALLOGR F, V64, P836, DOI 10.1107/S1744309108025487; Smitst SHJ, 2008, J MOL BIOL, V381, P200, DOI 10.1016/j.jmb.2008.06.003; Stangler T, 2006, Z PHYS CHEM, V220, P567, DOI 10.1524/zpch.2006.220.5.567; SUBRAMANIAN S, 1979, TRENDS BIOCHEM SCI, V4, P102, DOI 10.1016/0968-0004(79)90392-X; THOAI NV, 1959, B SOC CHIM BIOL, V41, P735; THOAI NV, 1969, BIOCHIM BIOPHYS ACTA, V191, P46, DOI 10.1016/0005-2744(69)90313-1; THOMAS GE, 1971, MAR BIOL, V10, P87, DOI 10.1007/BF02026771	28	8	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12312	10.1371/journal.pone.0012312	http://dx.doi.org/10.1371/journal.pone.0012312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808820	Green Published, gold, Green Submitted			2022-12-25	WOS:000281075500029
J	Luo, LF; Ye, LZ; Liu, G; Shao, GC; Zheng, R; Ren, ZQ; Zuo, B; Xu, DQ; Lei, MG; Jiang, SW; Deng, CY; Xiong, YZ; Li, FG				Luo, Lifan; Ye, Lianzhi; Liu, Gang; Shao, Guochao; Zheng, Rong; Ren, Zhuqing; Zuo, Bo; Xu, Dequan; Lei, Minggang; Jiang, Siwen; Deng, Changyan; Xiong, Yuanzhu; Li, Fenge			Microarray-Based Approach Identifies Differentially Expressed MicroRNAs in Porcine Sexually Immature and Mature Testes	PLOS ONE			English	Article							GENE-EXPRESSION; BINDING-SITES; RNAS; POLYMORPHISM; ASSOCIATION; ENCODES; TISSUES; PIRNAS; RNF4	Background: MicroRNAs (miRNAs) are short non-coding RNA molecules which are proved to be involved in mammalian spermatogenesis. Their expression and function in the porcine germ cells are not fully understood. Methodology: We employed a miRNA microarray containing 1260 unique miRNA probes to evaluate the miRNA expression patterns between sexually immature (60-day) and mature (180-day) pig testes. One hundred and twenty nine miRNAs representing 164 reporter miRNAs were expressed differently (p<0.1). Fifty one miRNAs were significantly up-regulated and 78 miRNAs were down-regulated in mature testes. Nine of these differentially expressed miRNAs were validated using quantitative RT-PCR assay. Totally 15919 putative miRNA-target sites were detected by using RNA22 method to align 445 NCBI pig cDNA sequences with these 129 differentially expressed miRNAs, and seven putative target genes involved in spermatogenesis including DAZL, RNF4 gene were simply confirmed by quantitative RT-PCR. Conclusions: Overall, the results of this study indicated specific miRNAs expression in porcine testes and suggested that miRNAs had a role in regulating spermatogenesis.	[Luo, Lifan] Huazhong Agr Univ, Minist Agr, Key Lab Pig Genet & Breeding, Wuhan, Peoples R China; Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University	Luo, LF (corresponding author), Huazhong Agr Univ, Minist Agr, Key Lab Pig Genet & Breeding, Wuhan, Peoples R China.	lifener@mail.hzau.edu.cn			National Natural Science Foundation of China [30700571]; Trans-gene Key Project of China [2009ZX08009-148B]; National High Technology Development Project [2007AA10Z162]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Trans-gene Key Project of China; National High Technology Development Project(National High Technology Research and Development Program of China)	This work was supported financially by the National Natural Science Foundation of China (30700571), Trans-gene Key Project of China (2009ZX08009-148B), National High Technology Development Project (2007AA10Z162). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanai M, 2006, BIOL REPROD, V75, P877, DOI 10.1095/biolreprod.106.056499; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bouhallier F, 2010, RNA, V16, P720, DOI 10.1261/rna.1963810; Braun RE, 1998, SEMIN CELL DEV BIOL, V9, P483, DOI 10.1006/scdb.1998.0226; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; EGBUNIKE GN, 1976, ACTA ANAT, V104, P400; Feng Y, 2008, ANIM GENET, V39, P91, DOI 10.1111/j.1365-2052.2007.01685.x; Fernando MMA, 2007, PLOS GENET, V3, P2109, DOI 10.1371/journal.pgen.0030192; Fitzpatrick JM, 2005, MOL BIOCHEM PARASIT, V141, P1, DOI 10.1016/j.molbiopara.2005.01.007; Galili N, 2000, DEV DYNAM, V218, P102, DOI 10.1002/(SICI)1097-0177(200005)218:1<102::AID-DVDY9>3.3.CO;2-1; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Guo XJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-97; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Kleene KC, 2001, MECH DEVELOP, V106, P3, DOI 10.1016/S0925-4773(01)00413-0; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Niu BY, 2009, ANIM REPROD SCI, V110, P283, DOI 10.1016/j.anireprosci.2008.01.020; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Sawera M, 2005, MAMM GENOME, V16, P594, DOI 10.1007/s00335-005-0013-3; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Teng YN, 2002, J CLIN ENDOCR METAB, V87, P5258, DOI 10.1210/jc.2002-020016; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wester L, 2003, ARTHRITIS RES THER, V5, pR361, DOI 10.1186/ar993; Yan NH, 2007, REPRODUCTION, V134, P73, DOI 10.1530/REP-07-0056; Yan NH, 2009, J ASSIST REPROD GEN, V26, P179, DOI 10.1007/s10815-009-9305-y; Yan W, 2002, MECH DEVELOP, V118, P247, DOI 10.1016/S0925-4773(02)00261-7; Yu ZR, 2005, BIOL REPROD, V73, P427, DOI 10.1095/biolreprod.105.040998; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang YH, 2009, ANIM REPROD SCI, V112, P415, DOI 10.1016/j.anireprosci.2008.05.069	39	62	77	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e11744	10.1371/journal.pone.0011744	http://dx.doi.org/10.1371/journal.pone.0011744			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805883	Green Published, Green Submitted, gold			2022-12-25	WOS:000281011600002
J	Salazar, DL; Uchida, N; Hamers, FPT; Cummings, BJ; Anderson, AJ				Salazar, Desiree L.; Uchida, Nobuko; Hamers, Frank P. T.; Cummings, Brian J.; Anderson, Aileen J.			Human Neural Stem Cells Differentiate and Promote Locomotor Recovery in an Early Chronic Spinal coRd Injury NOD-scid Mouse Model	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; OLFACTORY ENSHEATHING CELLS; RESTRICTED PRECURSOR CELLS; TRAUMATIC BRAIN-INJURY; DELAYED TRANSPLANTATION; STEM/PROGENITOR CELLS; AXONAL REGENERATION; FUNCTIONAL RECOVERY; WHITE-MATTER; IN-VITRO	Background: Traumatic spinal cord injury (SCI) results in partial or complete paralysis and is characterized by a loss of neurons and oligodendrocytes, axonal injury, and demyelination/dysmyelination of spared axons. Approximately 1,250,000 individuals have chronic SCI in the U. S.; therefore treatment in the chronic stages is highly clinically relevant. Human neural stem cells (hCNS-SCns) were prospectively isolated based on fluorescence-activated cell sorting for a CD133(+) and CD24(-/lo) population from fetal brain, grown as neurospheres, and lineage restricted to generate neurons, oligodendrocytes and astrocytes. hCNS-SCns have recently been transplanted sub-acutely following spinal cord injury and found to promote improved locomotor recovery. We tested the ability of hCNS-SCns transplanted 30 days post SCI to survive, differentiate, migrate, and promote improved locomotor recovery. Methods and Findings: hCNS-SCns were transplanted into immunodeficient NOD-scid mice 30 days post spinal cord contusion injury. hCNS-SCns transplanted mice demonstrated significantly improved locomotor recovery compared to vehicle controls using open field locomotor testing and CatWalk gait analysis. Transplanted hCNS-SCns exhibited long-term engraftment, migration, limited proliferation, and differentiation predominantly to oligodendrocytes and neurons. Astrocytic differentiation was rare and mice did not exhibit mechanical allodynia. Furthermore, differentiated hCNS-SCns integrated with the host as demonstrated by co-localization of human cytoplasm with discrete staining for the paranodal marker contactin-associated protein. Conclusions: The results suggest that hCNS-SCns are capable of surviving, differentiating, and promoting improved locomotor recovery when transplanted into an early chronic injury microenvironment. These data suggest that hCNS-SCns transplantation has efficacy in an early chronic SCI setting and thus expands the "window of opportunity" for intervention.	[Salazar, Desiree L.; Anderson, Aileen J.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Salazar, Desiree L.; Cummings, Brian J.; Anderson, Aileen J.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA USA; [Salazar, Desiree L.; Cummings, Brian J.; Anderson, Aileen J.] Univ Calif Irvine, Reeve Irvine Res Ctr, Irvine, CA USA; [Uchida, Nobuko] StemCells Inc, Palo Alto, CA USA; [Hamers, Frank P. T.] Rehabil Hosp Tolbrug, sHertogenbosch, Netherlands; [Cummings, Brian J.; Anderson, Aileen J.] Univ Calif Irvine, Dept Phys Med & Rehabil, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Salazar, DL (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	aja@uci.edu	Anderson, Aileen J/H-5926-2012; Cummings, Brian J/C-9180-2012	Cummings, Brian J/0000-0003-3628-5290; Salazar, Desiree L./0000-0003-2912-6611	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [R43 NS046975, R01 NS049885]; CRF [AAC-2005]; CIRM [T1-00008]; NSF [HRD0450366]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049885, R43NS046975] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CRF; CIRM(California Institute for Regenerative Medicine); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) R43 NS046975, NIH/NINDS R01 NS049885, and CRF AAC-2005 to A.J. Anderson. D.L. Salazar was supported by CIRM stem cell training grant T1-00008 and UC AGEP fellowship NSF HRD0450366. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bambakidis Nicholas C, 2004, Spine J, V4, P16, DOI 10.1016/j.spinee.2003.07.004; Barakat DJ, 2005, CELL TRANSPLANT, V14, P225, DOI 10.3727/000000005783983106; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Blakemore WF, 2000, BRAIN, V123, P1543, DOI 10.1093/brain/123.8.1543; BLIGHT AR, 1989, BRAIN RES BULL, V22, P47, DOI 10.1016/0361-9230(89)90126-3; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exnr.2002.7981; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chow SY, 2000, BRAIN RES, V874, P87, DOI 10.1016/S0006-8993(00)02443-4; Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Cummings BJ, 2006, NEUROL RES, V28, P474, DOI 10.1179/016164106X115116; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Engesser-Cesar C, 2005, J NEUROTRAUM, V22, P157, DOI 10.1089/neu.2005.22.157; Engesser-Cesar C, 2007, EUR J NEUROSCI, V25, P1931, DOI 10.1111/j.1460-9568.2007.05469.x; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fitch MT, 1999, J NEUROSCI, V19, P8182; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Fraidakis MJ, 2004, EXP NEUROL, V188, P33, DOI 10.1016/j.expneurol.2004.01.032; Galvan MD, 2008, J NEUROSCI, V28, P13876, DOI 10.1523/JNEUROSCI.2823-08.2008; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Greiner DL, 1998, STEM CELLS, V16, P166, DOI 10.1002/stem.160166; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Heine W, 2004, EXP NEUROL, V189, P231, DOI 10.1016/j.expneurol.2004.06.014; Hill CE, 2004, EXP NEUROL, V190, P289, DOI 10.1016/j.expneurol.2004.05.043; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Hooshmand MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005871; Houle JD, 2003, EXP NEUROL, V182, P247, DOI 10.1016/S0014-4886(03)00029-3; Ishii K, 2006, J NEUROSCI RES, V84, P1669, DOI 10.1002/jnr.21079; Jakovcevski I, 2005, J NEUROSCI, V25, P10064, DOI 10.1523/JNEUROSCI.2324-05.2005; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Karimi-Abdolrezaee S, 2004, EUR J NEUROSCI, V19, P577, DOI 10.1111/j.0953-816X.2004.03164.x; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Keyvan-Fouladi N, 2003, J NEUROSCI, V23, P9428; Lasiene J, 2008, J NEUROSCI, V28, P3887, DOI 10.1523/JNEUROSCI.4756-07.2008; Liu Y, 1999, J NEUROSCI, V19, P4370; Liu Y, 2002, EXP NEUROL, V178, P150, DOI 10.1006/exnr.2002.7977; Llado J, 2004, MOL CELL NEUROSCI, V27, P322, DOI 10.1016/j.mcn.2004.07.010; Lu J, 2002, BRAIN, V125, P14, DOI 10.1093/brain/awf014; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Luchetti S, 2010, J NEUROTRAUM, V27, P411, DOI 10.1089/neu.2009.0930; Macias MY, 2006, EXP NEUROL, V201, P335, DOI 10.1016/j.expneurol.2006.04.035; Marsala M, 2004, EUR J NEUROSCI, V20, P2401, DOI 10.1111/j.1460-9568.2004.03702.x; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Mothe AJ, 2008, CELL TRANSPLANT, V17, P735, DOI 10.3727/096368908786516756; Nishi RA, 2007, J NEUROTRAUM, V24, P674, DOI 10.1089/neu.2006.0204; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Ogawa D, 2009, J NEUROSCI RES, V87, P307, DOI 10.1002/jnr.21843; Okano H, 2003, SEMIN CELL DEV BIOL, V14, P191, DOI 10.1016/S1084-9521(03)00011-9; Okano H, 2007, NEUROCHEM INT, V51, P68, DOI 10.1016/j.neuint.2007.04.013; Pallini R, 2005, NEUROSURGERY, V57, P1014, DOI 10.1227/01.NEU.0000180058.58372.4c; Parr AM, 2007, J NEUROTRAUM, V24, P835, DOI 10.1089/neu.2006.3771; Piao JH, 2006, J NEUROSCI RES, V84, P471, DOI 10.1002/jnr.20955; Plant GW, 2003, J NEUROTRAUM, V20, P1, DOI 10.1089/08977150360517146; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; PROCHAZKA M, 1992, DIABETES, V41, P98, DOI 10.2337/diabetes.41.1.98; Salazar DL, 2008, DEV DEGENERATION REG, P297; SERREZE DV, 1995, DIABETES, V44, P1392, DOI 10.2337/diabetes.44.12.1392; Shi R, 1997, NEUROSCIENCE, V77, P553, DOI 10.1016/S0306-4522(96)00477-0; Shi RY, 1997, EXP NEUROL, V148, P495, DOI 10.1006/exnr.1997.6706; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Smith PM, 2006, BRAIN PATHOL, V16, P99, DOI 10.1111/j.1750-3639.2006.00001.x; Su HX, 2007, EXP NEUROL, V206, P296, DOI 10.1016/j.expneurol.2007.05.018; Tan AM, 2007, EXP NEUROL, V206, P257, DOI 10.1016/j.expneurol.2007.05.013; Tarasenko YI, 2007, J NEUROSCI RES, V85, P47, DOI 10.1002/jnr.21098; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Tobias CA, 2003, EXP NEUROL, V184, P97, DOI 10.1016/S0014-4886(03)00394-7; Tripathi R, 2007, GLIA, V55, P698, DOI 10.1002/glia.20491; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vroemen M, 2003, EUR J NEUROSCI, V18, P743, DOI 10.1046/j.1460-9568.2003.02804.x; Wu P, 2002, GENE THER, V9, P245, DOI 10.1038/sj.gt.3301646; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039; Zurita M, 2001, SURG NEUROL, V55, P249, DOI 10.1016/S0090-3019(01)00442-6	80	160	167	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12272	10.1371/journal.pone.0012272	http://dx.doi.org/10.1371/journal.pone.0012272			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20806064	Green Published, gold			2022-12-25	WOS:000281011600030
J	Dumas, G; Nadel, J; Soussignan, R; Martinerie, J; Garnero, L				Dumas, Guillaume; Nadel, Jacqueline; Soussignan, Robert; Martinerie, Jacques; Garnero, Line			Inter-Brain Synchronization during Social Interaction	PLOS ONE			English	Article							PHASE SYNCHRONIZATION; BROCAS AREA; OSCILLATIONS; MOVEMENT; MEG; MECHANISMS; EEG; CONTINGENCY; IMITATION; AWARENESS	During social interaction, both participants are continuously active, each modifying their own actions in response to the continuously changing actions of the partner. This continuous mutual adaptation results in interactional synchrony to which both members contribute. Freely exchanging the role of imitator and model is a well-framed example of interactional synchrony resulting from a mutual behavioral negotiation. How the participants' brain activity underlies this process is currently a question that hyperscanning recordings allow us to explore. In particular, it remains largely unknown to what extent oscillatory synchronization could emerge between two brains during social interaction. To explore this issue, 18 participants paired as 9 dyads were recorded with dual-video and dual-EEG setups while they were engaged in spontaneous imitation of hand movements. We measured interactional synchrony and the turn-taking between model and imitator. We discovered by the use of nonlinear techniques that states of interactional synchrony correlate with the emergence of an interbrain synchronizing network in the alpha-mu band between the right centroparietal regions. These regions have been suggested to play a pivotal role in social interaction. Here, they acted symmetrically as key functional hubs in the interindividual brainweb. Additionally, neural synchronization became asymmetrical in the higher frequency bands possibly reflecting a top-down modulation of the roles of model and imitator in the ongoing interaction.	[Dumas, Guillaume; Martinerie, Jacques; Garnero, Line] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France; [Dumas, Guillaume; Martinerie, Jacques; Garnero, Line] INSERM, U975, Paris, France; [Dumas, Guillaume; Martinerie, Jacques; Garnero, Line] CNRS, UMR 7225, Paris, France; [Nadel, Jacqueline] Hop La Pitie Salpetriere, CNRS, USR 3246, Ctr Emot, Paris, France; [Soussignan, Robert] U B, Ctr Sci Gout Alimentat, UMR 6265, CNRS,INRA 1324, Dijon, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Dumas, G (corresponding author), Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France.	guillaume.dumas@upmc.fr	Dumas, Guillaume/E-3756-2012	Dumas, Guillaume/0000-0002-2253-1844; Lauwereyns, Jan/0000-0003-0551-2550	French National Center for Scientific Research; Direction generale de l'armement (DGA); Computer Neuroscience Program [070005IPAM]	French National Center for Scientific Research(Centre National de la Recherche Scientifique (CNRS)); Direction generale de l'armement (DGA); Computer Neuroscience Program	This work was supported in part by funds from the French National Center for Scientific Research (http://www.cnrs.fr/). This work was also supported by a PhD fellowship of the Direction generale de l'armement (DGA) (http://www.defense.gouv.fr/dga/) and the Computer Neuroscience Program no070005IPAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS S, 2010, NEUROIMAGE IN PRESS; ASTOLFI L, 2010, BRAIN TOPOGRAPHY, P1; Babiloni C, 2002, NEUROIMAGE, V17, P559, DOI 10.1006/nimg.2002.1192; BABILONI F, 2006, ANN INT C IEEE ENG M, P3666; Battelli L, 2007, TRENDS COGN SCI, V11, P204, DOI 10.1016/j.tics.2007.03.001; Battellil L, 2008, CURR OPIN NEUROBIOL, V18, P120, DOI 10.1016/j.conb.2008.08.004; Betti V, 2009, J NEUROSCI, V29, P12384, DOI 10.1523/JNEUROSCI.2759-09.2009; Bickford A., 2005, USING ELAN GETTING S; Blakemore SJ, 2003, CURR OPIN NEUROBIOL, V13, P219, DOI 10.1016/S0959-4388(03)00043-6; Bradberry TJ, 2010, J NEUROSCI, V30, P3432, DOI 10.1523/JNEUROSCI.6107-09.2010; Chavez M, 2006, J NEUROSCI METH, V154, P149, DOI 10.1016/j.jneumeth.2005.12.009; Decety J, 2002, NEUROIMAGE, V15, P265, DOI 10.1006/nimg.2001.0938; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fogel A., 1993, DEV RELATIONSHIPS OR; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; GALLESE V, 2007, J AM PSYCHOANAL ASS, V131, P176; GRYNSZPAN O, 2006, IST027574; Hamzei F, 2003, NEUROIMAGE, V19, P637, DOI 10.1016/S1053-8119(03)00087-9; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Harrington DL, 1998, J NEUROSCI, V18, P1085; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iizuka H, 2004, ARTIF LIFE, V10, P361, DOI 10.1162/1064546041766442; Ikegami T, 2007, INFANT BEHAV DEV, V30, P278, DOI 10.1016/j.infbeh.2007.02.002; Jackson PL, 2004, CURR OPIN NEUROBIOL, V14, P259, DOI 10.1016/j.conb.2004.01.020; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jerbi K, 2007, P NATL ACAD SCI USA, V104, P7676, DOI 10.1073/pnas.0609632104; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lindenberger U, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-22; Makuuchi M, 2005, CEREB CORTEX, V15, P563, DOI 10.1093/cercor/bhh157; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Maris E, 2007, J NEUROSCI METH, V163, P161, DOI 10.1016/j.jneumeth.2007.02.011; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Meltzoff A. N, 2002, THE IMITATIVE MIND D, V6; Molenberghs P, 2009, NEUROSCI BIOBEHAV R, V33, P975, DOI 10.1016/j.neubiorev.2009.03.010; Montague PR, 2002, NEUROIMAGE, V16, P1159, DOI 10.1006/nimg.2002.1150; Nadel J., 1999, IMITATION INFANCY; NADEL J, 1993, NEW PERSPECTIVES EAR; Nadel J, 1999, DEVELOPMENTAL SCI, V2, P164, DOI 10.1111/1467-7687.00065; NADELBRULFERT J, 1982, INT J BEHAV DEV, V5, P95, DOI 10.1177/016502548200500105; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Pantazis D, 2005, NEUROIMAGE, V25, P383, DOI 10.1016/j.neuroimage.2004.09.040; Pfurtscheller G, 2003, NEUROSCI LETT, V339, P111, DOI 10.1016/S0304-3940(02)01479-9; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Prepin K, 2007, ADV ROBOTICS, V21, P1709, DOI 10.1163/156855307782506192; Redcay E, 2010, NEUROIMAGE, V50, P1639, DOI 10.1016/j.neuroimage.2010.01.052; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Schippers MB, 2010, P NATL ACAD SCI USA, V107, P9388, DOI 10.1073/pnas.1001791107; Shannon C.E., 1963, MATH THEORY COMMUNIC; Soussignan R, 2006, INFANCY, V10, P123, DOI 10.1207/s15327078in1002_2; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; Thompson E, 2001, TRENDS COGN SCI, V5, P418, DOI 10.1016/S1364-6613(00)01750-2; Tognoli E, 2007, P NATL ACAD SCI USA, V104, P8190, DOI 10.1073/pnas.0611453104; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Waldert S, 2008, J NEUROSCI, V28, P1000, DOI 10.1523/JNEUROSCI.5171-07.2008; Wallstrom GL, 2004, INT J PSYCHOPHYSIOL, V53, P105, DOI 10.1016/j.ijpsycho.2004.03.007; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Wilson M, 2005, PSYCHON B REV, V12, P957, DOI 10.3758/BF03206432; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wyart V, 2008, J NEUROSCI, V28, P2667, DOI 10.1523/JNEUROSCI.4748-07.2008	66	447	458	5	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12166	10.1371/journal.pone.0012166	http://dx.doi.org/10.1371/journal.pone.0012166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808907	Green Published, gold, Green Submitted			2022-12-25	WOS:000280968100006
J	Gelin, A; Redrejo-Rodriguez, M; Laval, J; Fedorova, OS; Saparbaev, M; Ishchenko, AA				Gelin, Aurore; Redrejo-Rodriguez, Modesto; Laval, Jacques; Fedorova, Olga S.; Saparbaev, Murat; Ishchenko, Alexander A.			Genetic and Biochemical Characterization of Human AP Endonuclease 1 Mutants Deficient in Nucleotide Incision Repair Activity	PLOS ONE			English	Article							HUMAN APURINIC ENDONUCLEASE; HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE; BASE EXCISION-REPAIR; DNA-POLYMERASE-BETA; ESCHERICHIA-COLI; IONIZING-RADIATION; EXONUCLEASE-III; APYRIMIDINIC ENDONUCLEASE; ABASIC ENDONUCLEASE; ENZYME HAP1	Background: Human apurinic/apyrimidinic endonuclease 1 (APE1) is a key DNA repair enzyme involved in both base excision repair (BER) and nucleotide incision repair (NIR) pathways. In the BER pathway, APE1 cleaves DNA at AP sites and 3'-blocking moieties generated by DNA glycosylases. In the NIR pathway, APE1 incises DNA 59 to a number of oxidatively damaged bases. At present, physiological relevance of the NIR pathway is fairly well established in E. coli, but has yet to be elucidated in human cells. Methodology/Principal Finding: We identified amino acid residues in the APE1 protein that affect its function in either the BER or NIR pathway. Biochemical characterization of APE1 carrying single K98A, R185A, D308A and double K98A/R185A amino acid substitutions revealed that all mutants exhibited greatly reduced NIR and 3'-> 5' exonuclease activities, but were capable of performing BER functions to some extent. Expression of the APE1 mutants deficient in the NIR and exonuclease activities reduced the sensitivity of AP endonuclease-deficient E. coli xth nfo strain to an alkylating agent, methylmethanesulfonate, suggesting that our APE1 mutants are able to repair AP sites. Finally, the human NIR pathway was fully reconstituted in vitro using the purified APE1, human flap endonuclease 1, DNA polymerase beta and DNA ligase I proteins, thus establishing the minimal set of proteins required for a functional NIR pathway in human cells. Conclusion/Significance: Taken together, these data further substantiate the role of NIR as a distinct and separable function of APE1 that is essential for processing of potentially lethal oxidative DNA lesions.	[Gelin, Aurore] Univ Paris Sud, CNRS, UMR8126, Inst Cancerol Gustave Roussy, Villejuif, France; [Redrejo-Rodriguez, Modesto; Laval, Jacques; Saparbaev, Murat; Ishchenko, Alexander A.] Univ Paris Sud, CNRS, UMR8200, Inst Cancerol Gustave Roussy,Grp Reparat ADN, Villejuif, France; [Fedorova, Olga S.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Gelin, A (corresponding author), Univ Paris Sud, CNRS, UMR8126, Inst Cancerol Gustave Roussy, Villejuif, France.	ichtchen@igr.fr	Saparbaev, Murat K/N-3225-2015; Redrejo Rodríguez, Modesto/D-7247-2012; Fedorova, Olga S./E-1291-2013; Saparbaev, Murat/AAC-5478-2020; Fedorova, Olga/ABE-6637-2020; Ishchenko, Alexander/D-4133-2013	Saparbaev, Murat K/0000-0002-4630-1074; Redrejo Rodríguez, Modesto/0000-0003-0014-4162; Fedorova, Olga S./0000-0002-4001-7187; Saparbaev, Murat/0000-0002-4630-1074; Fedorova, Olga/0000-0002-4001-7187; Ishchenko, Alexander/0000-0002-0488-8858	Fondation pour la Recherche Medicale; Centre National de la Recherche Scientifique [PICS 5479-Russie]; Electricite de France [RB 2010]; Russian Foundation for Basic Research [10-04-00070]; Russian Ministry of Education and Science [02.740.11.0079, 02.740.11.5012]; Association pour la Recherche sur le Cancer; Fondation de France	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Electricite de France; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation de France(Fondation de France)	This work was supported by grants from Fondation pour la Recherche Medicale (http://www.frm.org) [EQUIPES FRM 2007 to MS]; Centre National de la Recherche Scientifique (http://www.cnrs.fr) [PICS 5479-Russie to MS]; Electricite de France (http://www.edf.fr) Contrat Radioprotection [RB 2010 to MS]; Russian Foundation for Basic Research (http://www.rfbr.ru) [10-04-00070 to OSF]; and Russian Ministry of Education and Science (http://mon.gov.ru) [02.740.11.0079 to OSF, 02.740.11.5012 to OSF and AAI]; Association pour la Recherche sur le Cancer (http://www.arc-cancer.net) [postdoctoral fellowships to MR-R]; Fondation de France (http://www.fondationdefrance.org) [to AAI]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN SA, 1994, MUTAT RES, V306, P35, DOI 10.1016/0027-5107(94)90165-1; Asagoshi K, 2010, DNA REPAIR, V9, P109, DOI 10.1016/j.dnarep.2009.11.002; Barnes T, 2009, NUCLEIC ACIDS RES, V37, P3946, DOI 10.1093/nar/gkp275; BARZILAY G, 1995, NUCLEIC ACIDS RES, V23, P1544, DOI 10.1093/nar/23.9.1544; Beernink PT, 2001, J MOL BIOL, V307, P1023, DOI 10.1006/jmbi.2001.4529; Bergeron F, 2010, P NATL ACAD SCI USA, V107, P5528, DOI 10.1073/pnas.1000193107; Berquist BR, 2008, J MOL BIOL, V379, P17, DOI 10.1016/j.jmb.2008.03.053; CHEN DS, 1994, ANN NY ACAD SCI, V726, P306, DOI 10.1111/j.1749-6632.1994.tb52834.x; Chou KM, 2003, J BIOL CHEM, V278, P18289, DOI 10.1074/jbc.M212143200; Chou KM, 2002, NATURE, V415, P655, DOI 10.1038/415655a; COUVEPRIVAT S, 2007, MOL B INT U, P54; CUNNINGHAM RP, 1986, J BACTERIOL, V168, P1120, DOI 10.1128/jb.168.3.1120-1127.1986; Daviet S, 2007, DNA REPAIR, V6, P8, DOI 10.1016/j.dnarep.2006.08.001; Demple B, 2005, DNA REPAIR, V4, P1442, DOI 10.1016/j.dnarep.2005.09.004; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; Fromme JC, 2004, CURR OPIN STRUC BIOL, V14, P43, DOI 10.1016/j.sbi.2004.01.003; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Golan G, 2010, MUTAT RES-FUND MOL M, V685, P70, DOI 10.1016/j.mrfmmm.2009.08.017; Gorman MA, 1997, EMBO J, V16, P6548, DOI 10.1093/emboj/16.21.6548; Gros L, 2004, NUCLEIC ACIDS RES, V32, P73, DOI 10.1093/nar/gkh165; Gros L, 2002, ONCOGENE, V21, P8905, DOI 10.1038/sj.onc.1206005; Guliaev AB, 2004, NUCLEIC ACIDS RES, V32, P2844, DOI 10.1093/nar/gkh594; Hang B, 1996, P NATL ACAD SCI USA, V93, P13737, DOI 10.1073/pnas.93.24.13737; Hang B, 1998, CARCINOGENESIS, V19, P1339, DOI 10.1093/carcin/19.8.1339; Harrison L, 1999, J MOL BIOL, V290, P667, DOI 10.1006/jmbi.1999.2892; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; IDE H, 1994, BIOCHEMISTRY-US, V33, P7842, DOI 10.1021/bi00191a011; Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; Ishchenko AA, 2006, P NATL ACAD SCI USA, V103, P2564, DOI 10.1073/pnas.0508582103; Ishchenko AA, 2004, BIOCHEMISTRY-US, V43, P15210, DOI 10.1021/bi049214+; Ishchenko AA, 2003, NUCLEIC ACIDS RES, V31, P6344, DOI 10.1093/nar/gkg812; Izumi T, 1998, CARCINOGENESIS, V19, P525, DOI 10.1093/carcin/19.3.525; Izumi T, 1999, J MOL BIOL, V287, P47, DOI 10.1006/jmbi.1999.2573; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Jiang L, 2001, SPECTROCHIM ACTA A, V57, P1711, DOI 10.1016/S1386-1425(01)00442-5; KANE CM, 1981, J BIOL CHEM, V256, P3405; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Lomax ME, 2004, BIOCHEMISTRY-US, V43, P11017, DOI 10.1021/bi049560r; Lowry DF, 2003, J MOL BIOL, V329, P311, DOI 10.1016/S0022-2836(03)00382-6; Lucas JA, 1999, BIOCHEMISTRY-US, V38, P4958, DOI 10.1021/bi982052v; Ludwig DL, 1998, MUTAT RES-DNA REPAIR, V409, P17, DOI 10.1016/S0921-8777(98)00039-1; Masuda Y, 1998, J BIOL CHEM, V273, P30360, DOI 10.1074/jbc.273.46.30360; Masuda Y, 1998, J BIOL CHEM, V273, P30352, DOI 10.1074/jbc.273.46.30352; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Muller E, 2003, NUCLEOS NUCLEOT NUCL, V22, P1563, DOI 10.1081/NCN-120023034; Nguyen LH, 2000, J MOL BIOL, V298, P447, DOI 10.1006/jmbi.2000.3653; Oezguen N, 2007, PROTEINS, V68, P313, DOI 10.1002/prot.21397; Podlutsky AJ, 2001, EMBO J, V20, P1477, DOI 10.1093/emboj/20.6.1477; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P5519, DOI 10.1093/nar/19.20.5519; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Tell G, 2010, MOL CELL BIOL, V30, P366, DOI 10.1128/MCB.01174-09; Vascotto C, 2009, MOL CELL BIOL, V29, P1834, DOI 10.1128/MCB.01337-08; WALKER LJ, 1994, NUCLEIC ACIDS RES, V22, P4884, DOI 10.1093/nar/22.23.4884; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Wong D, 2003, J BIOL CHEM, V278, P36242, DOI 10.1074/jbc.M306065200; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Yu E, 2010, BIOCHEMISTRY-US, V49, P3786, DOI 10.1021/bi901828t; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	62	37	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12241	10.1371/journal.pone.0012241	http://dx.doi.org/10.1371/journal.pone.0012241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808930	Green Published, Green Submitted, gold			2022-12-25	WOS:000280968100031
J	Novack, V; Pencina, M; Zahger, D; Fuchs, L; Nevzorov, R; Jotkowitz, A; Porath, A				Novack, Victor; Pencina, Michael; Zahger, Doron; Fuchs, Lior; Nevzorov, Roman; Jotkowitz, Allan; Porath, Avi			Routine Laboratory Results and Thirty Day and One-Year Mortality Risk Following Hospitalization with Acute Decompensated Heart Failure	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; MYOCARDIAL-INFARCTION; NATRIURETIC PEPTIDE; PREDICT SURVIVAL; VALIDATION; OUTCOMES; GLUCOSE; DEATH; MODEL	Introduction: Several blood tests are performed uniformly in patients hospitalized with acute decompensated heart failure and are predictive of the outcomes: complete blood count, electrolytes, renal function, glucose, albumin and uric acid. We sought to evaluate the relationship between routine admission laboratory tests results, patient characteristics and 30-day and one-year mortality of patients admitted for decompensated heart failure and to construct a simple mortality prediction tool. Methods: A retrospective population based study. Data from seven tertiary hospitals on all admissions with a principal diagnosis of heart failure during the years 2002-2005 throughout Israel were captured. Results: 8,246 patients were included in the study cohort. Thirty day mortality rate was 8.5% (701 patients) and one-year mortality rate was 28.7% (2,365 patients). Addition of five routine laboratory tests results (albumin, sodium, blood urea, uric acid and WBC) to a set of clinical and demographic characteristics improved c-statistics from 0.76 to 0.81 for 30-days and from 0.72 to 0.76 for one-year mortality prediction (both p-values <0.0001). Three dichotomized abnormal laboratory results with highest odds ratio for one-year mortality (hypoalbuminaemia, hyponatremia and elevated blood urea) were used to construct a simple prediction score, capable of discriminating from 1.1% to 21.4% in 30-day and from 11.6% to 55.6% in one-year mortality rates between patients with a score of 0 (1,477 patients) vs. score of 3 (544 patients). Discussion: A small set of abnormal routine laboratory results upon admission can risk-stratify and independently predict 30-day and one-year mortality in patients hospitalized with acute decompensated heart failure.	[Novack, Victor; Fuchs, Lior; Nevzorov, Roman; Jotkowitz, Allan; Porath, Avi] Soroka Univ, Med Ctr, Clin Res Ctr, Beer Sheva, Israel; [Novack, Victor; Pencina, Michael] Harvard Clin Res Inst, Boston, MA USA	Ben Gurion University; Soroka Medical Center; Harvard University; Harvard Medical School	Novack, V (corresponding author), Soroka Univ, Med Ctr, Clin Res Ctr, Beer Sheva, Israel.	VictorNo@clalit.org.il		Pencina, Michael/0000-0001-5798-8855				Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Anker SD, 2003, CIRCULATION, V107, P1991, DOI 10.1161/01.CIR.0000065637.10517.A0; Anker SD, 2002, INT J CARDIOL, V85, P51, DOI 10.1016/S0167-5273(02)00233-4; Battaglia M, 2006, ARCH INTERN MED, V166, P1073, DOI 10.1001/archinte.166.10.1073; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cooper HA, 1999, AM J CARDIOL, V84, P252, DOI 10.1016/S0002-9149(99)00272-6; De Denus S, 2006, J CARD FAIL, V12, P353, DOI 10.1016/j.cardfail.2006.02.014; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Gegenhuber A, 2007, J CARD FAIL, V13, P42, DOI 10.1016/j.cardfail.2006.09.004; Hastie TJ., 1990, GEN ADDITIVE MODELS; Horwich TB, 2008, AM HEART J, V155, P883, DOI 10.1016/j.ahj.2007.11.043; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Jotkowitz AB, 2006, ISRAEL MED ASSOC J, V8, P875; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Klein L, 2005, CIRCULATION, V111, P2454, DOI 10.1161/01.CIR.0000165065.82609.3D; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; MAISEL A, 2008, BIOMARKERS ASSESSMEN; METRA M, 2007, EUR J HEART FAIL; Mitchell JE, 2007, AM J CARDIOL, V99, p15D, DOI 10.1016/j.amjcard.2006.12.015; Oren RM, 2005, AM J CARDIOL, V95, p2B; Pascual-Figal DA, 2007, EUR J HEART FAIL, V9, P518, DOI 10.1016/j.ejheart.2006.09.001; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; SEWDARSEN M, 1989, Q J MED, V71, P461; Smith GL, 2006, ARCH INTERN MED, V166, P1134, DOI 10.1001/archinte.166.10.1134; Smith GL, 2006, J AM COLL CARDIOL, V47, P1987, DOI 10.1016/j.jacc.2005.11.084; Stranders I, 2004, ARCH INTERN MED, V164, P982, DOI 10.1001/archinte.164.9.982; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373	30	60	60	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12184	10.1371/journal.pone.0012184	http://dx.doi.org/10.1371/journal.pone.0012184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808904	Green Published, gold, Green Submitted			2022-12-25	WOS:000280968100010
J	Pullen, M; Clark, N; Zarinkamar, F; Topping, J; Lindsey, K				Pullen, Margaret; Clark, Nick; Zarinkamar, Fatemeh; Topping, Jennifer; Lindsey, Keith			Analysis of Vascular Development in the hydra Sterol Biosynthetic Mutants of Arabidopsis	PLOS ONE			English	Article							AUXIN BIOSYNTHESIS; CELL-DIVISION; TRANSCRIPTION FACTOR; GENE MONOPTEROS; ROOT-GROWTH; ETHYLENE; TRANSPORT; POLARITY; DIFFERENTIATION; ENDOCYTOSIS	Background: The control of vascular tissue development in plants is influenced by diverse hormonal signals, but their interactions during this process are not well understood. Wild-type sterol profiles are essential for growth, tissue patterning and signalling processes in plant development, and are required for regulated vascular patterning. Methodology/Principal Findings: Here we investigate the roles of sterols in vascular tissue development, through an analysis of the Arabidopsis mutants hydra1 and fackel/hydra2, which are defective in the enzymes sterol isomerase and sterol C-14 reductase respectively. We show that defective vascular patterning in the shoot is associated with ectopic cell divisions. Expression of the auxin-regulated AtHB8 homeobox gene is disrupted in mutant embryos and seedlings, associated with variably incomplete vascular strand formation and duplication of the longitudinal axis. Misexpression of the auxin reporter proIAA2:GUS and mislocalization of PIN proteins occurs in the mutants. Introduction of the ethylene-insensitive ein2 mutation partially rescues defective cell division, localization of PIN proteins, and vascular strand development. Conclusions: The results support a model in which sterols are required for correct auxin and ethylene crosstalk to regulate PIN localization, auxin distribution and AtHB8 expression, necessary for correct vascular development.	[Pullen, Margaret; Clark, Nick; Zarinkamar, Fatemeh; Topping, Jennifer; Lindsey, Keith] Univ Durham, Integrat Cell Biol Lab, Sch Biol & Biomed Sci, Durham, England	Durham University	Pullen, M (corresponding author), Univ Durham, Integrat Cell Biol Lab, Sch Biol & Biomed Sci, Durham, England.	keith.lindsey@durham.ac.uk	Lindsey, Keith/AAG-5228-2019	Lindsey, Keith/0000-0002-7992-6804; zarinkamar, fatemeh/0000-0002-2497-5131	Biotechnology and Biological Sciences Research Council [BBS/B/08418]; Durham University; BBSRC [BB/E006531/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E006531/1, BB/C512210/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Durham University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors gratefully acknowledge funding from the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk; BBS/B/08418) and Durham University (www.dur.ac.uk; studentship to MP) in support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1995, J MOL BIOL, V251, P533, DOI 10.1006/jmbi.1995.0454; Abel S, 1996, BIOESSAYS, V18, P647, DOI 10.1002/bies.950180808; Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Aloni R, 2001, J PLANT GROWTH REGUL, V20, P22, DOI 10.1007/s003440010001; Baima S, 1995, DEVELOPMENT, V121, P4171; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; BERLETH T, 1993, DEVELOPMENT, V118, P575; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Carland FM, 1999, PLANT CELL, V11, P2123, DOI 10.1105/tpc.11.11.2123; Carland FM, 2002, PLANT CELL, V14, P2045, DOI 10.1105/tpc.003939; Carland F, 2010, PLANT PHYSIOL, V153, P741, DOI 10.1104/pp.109.152587; Chilley PM, 2006, PLANT CELL, V18, P3058, DOI 10.1105/tpc.106.040790; Clouse SD, 2000, CURR BIOL, V10, pR601, DOI 10.1016/S0960-9822(00)00639-4; De Smet I, 2007, CURR OPIN GENET DEV, V17, P337, DOI 10.1016/j.gde.2007.04.012; Dengler NG, 2001, J PLANT GROWTH REGUL, V20, P1, DOI 10.1007/s003440010008; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Donner TJ, 2009, DEVELOPMENT, V136, P3235, DOI 10.1242/dev.037028; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Hardtke CS, 2004, DEVELOPMENT, V131, P1089, DOI 10.1242/dev.00925; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Hauser MT, 2000, PLANT SOIL, V226, P1, DOI 10.1023/A:1026421417979; Ikeda Y, 2009, NAT CELL BIOL, V11, P731, DOI 10.1038/ncb1879; Jang JC, 2000, GENE DEV, V14, P1485; Kazama H, 2004, PLANT PHYSIOL, V134, P1614, DOI 10.1104/pp.103.031088; Kehr J, 2008, J EXP BOT, V59, P85, DOI 10.1093/jxb/erm176; KENDE H, 1993, ANNU REV PLANT PHYS, V44, P283, DOI 10.1146/annurev.pp.44.060193.001435; Koizumi K, 2000, DEVELOPMENT, V127, P3197; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Lindsey K, 2003, TRENDS PLANT SCI, V8, P521, DOI 10.1016/j.tplants.2003.09.012; Liu JL, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.26; Mattsson J, 1999, DEVELOPMENT, V126, P2979; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; McHale NA, 2004, PLANT CELL, V16, P1730, DOI 10.1105/tpc.021816; Men SZ, 2008, NAT CELL BIOL, V10, P237, DOI 10.1038/ncb1686; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Ortega-Martinez O, 2007, SCIENCE, V317, P507, DOI 10.1126/science.1143409; Pan JW, 2009, PLANT CELL, V21, P568, DOI 10.1105/tpc.108.061465; Paponov IA, 2005, TRENDS PLANT SCI, V10, P170, DOI 10.1016/j.tplants.2005.02.009; Peng LC, 2002, SCIENCE, V295, P147, DOI 10.1126/science.1064281; Petricka JJ, 2008, PLANT J, V56, P251, DOI 10.1111/j.1365-313X.2008.03595.x; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Przemeck GKH, 1996, PLANTA, V200, P229, DOI 10.1007/BF00208313; Ruzicka K, 2007, PLANT CELL, V19, P2197, DOI 10.1105/tpc.107.052126; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sachs T, 2000, PLANT CELL PHYSIOL, V41, P649, DOI 10.1093/pcp/41.6.649; Sauer M, 2006, GENE DEV, V20, P2902, DOI 10.1101/gad.390806; Scarpella E, 2004, DEVELOPMENT, V131, P3445, DOI 10.1242/dev.01182; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Schrick K, 2000, GENE DEV, V14, P1471; Schrick K, 2004, PLANT J, V38, P227, DOI 10.1111/j.1365-313X.2004.02039.x; Schrick K, 2002, PLANT J, V31, P61, DOI 10.1046/j.1365-313X.2002.01333.x; Souter M, 2002, PLANT CELL, V14, P1017, DOI 10.1105/tpc.001248; Souter MA, 2004, PLANTA, V219, P773, DOI 10.1007/s00425-004-1280-z; Spencer MWB, 2007, PLANT PHYSIOL, V143, P924, DOI 10.1104/pp.106.087668; Stepanova AN, 2007, PLANT CELL, V19, P2169, DOI 10.1105/tpc.107.052068; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Swarup R, 2007, PLANT CELL, V19, P2186, DOI 10.1105/tpc.107.052100; Topping JF, 1997, DEVELOPMENT, V124, P4415; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Willemsen V, 2003, PLANT CELL, V15, P612, DOI 10.1105/tpc.008433	63	20	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12227	10.1371/journal.pone.0012227	http://dx.doi.org/10.1371/journal.pone.0012227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808926	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000280968100024
J	de Voer, RM; Mollema, L; Schepp, RM; de Greeff, SC; van Gageldonk, PGM; de Melker, HE; Sanders, EAM; Berbers, GAM; van der Klis, FRM				de Voer, Richarda M.; Mollema, Liesbeth; Schepp, Rutger M.; de Greeff, Sabine C.; van Gageldonk, Pieter G. M.; de Melker, Hester E.; Sanders, Elisabeth A. M.; Berbers, Guy A. M.; van der Klis, Fiona R. M.			Immunity against Neisseria meningitidis Serogroup C in the Dutch Population before and after Introduction of the Meningococcal C Conjugate Vaccine	PLOS ONE			English	Article							INFLUENZAE TYPE-B; SEROPREVALENCE; ANTIBODIES; PROTECTION; DIPHTHERIA; TETANUS; ABILITY; AGE	Background: In 2002 a Meningococcal serogroup C (MenC) conjugate vaccine, with tetanus toxoid as carrier protein, was introduced in the Netherlands as a single-dose at 14 months of age. A catch-up campaign was performed targeting all individuals aged 14 months to 18 years. We determined the MenC-specific immunity before and after introduction of the MenC conjugate (MenCC) vaccine. Methods and Findings: Two cross-sectional population-based serum banks, collected in 1995/1996 (n = 8539) and in 2006/2007 (n = 6386), were used for this study. The main outcome measurements were the levels of MenC polysaccharide(PS)specific IgG and serum bactericidal antibodies (SBA) after routine immunization, 4-5 years after catch-up immunization or by natural immunity. There was an increasing persistence of PS-specific IgG and SBA with age in the catch-up immunized cohorts 4-5 years after their MenCC immunization (MenC PS-specific IgG, 0.25 mu g/ml (95% CI: 0.19-0.31 mu g/ml) at age 6 years, gradually increasing to 2.34 mu g/ml,(95% CI: 1.70-3.32 mu g/ml) at age 21-22 years). A comparable pattern was found for antibodies against the carrier protein in children immunized above 9 years of age. In case of vaccination before the age of 5 years, PS-specific IgG was rapidly lost. For all age-cohorts together, SBA seroprevalence (>= 8) increased from 19.7% to 43.0% in the pre- and post-MenC introduction eras, respectively. In non-immunized adults the SBA seroprevalence was not significantly different between the pre- and post-MenC introduction periods, whereas PS-specific IgG was significantly lower in the post-MenC vaccination (GMT, age >= 25 years, 0.10 mu g/ml) era compared to the pre-vaccination (GMT, age >= 25 years, 0.43 mu g/ml) era. Conclusion: MenCC vaccination administered above 5 years of age induced high IgG levels compared to natural exposure, increasing with age. In children below 14 months of age and non-immunized cohorts lower IgG levels were observed compared to the pre-vaccination era, whereas functional levels remained similar in adults. Whether the lower IgG poses individuals at increased risk for MenC disease should be carefully monitored. Large-scale introduction of a MenCC vaccine has led to improved protection in adolescents, but in infants a single-dose schedule may not provide sufficient protection on the long-term and therefore a booster-dose early in adolescence should be considered.	[de Voer, Richarda M.; Schepp, Rutger M.; van Gageldonk, Pieter G. M.; Berbers, Guy A. M.; van der Klis, Fiona R. M.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands; [de Voer, Richarda M.] Univ Med Ctr, Dept Immunol, Utrecht, Netherlands; [Mollema, Liesbeth; de Greeff, Sabine C.; de Melker, Hester E.] Natl Inst Publ Hlth & Environm, Epidemiol & Surveillance Unit, NL-3720 BA Bilthoven, Netherlands; [Sanders, Elisabeth A. M.] Univ Med Ctr Utrecht, Dept Paediat Immunol & Infect Dis, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center	de Voer, RM (corresponding author), Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands.	Fiona.van.der.Klis@rivm.nl	de Voer, Richarda M/GSD-6097-2022; de Voer, Richarda M/ABD-1525-2021; de Voer, Richarda/P-5728-2015	de Voer, Richarda M/0000-0002-8222-0343; van Gageldonk, Pieter/0000-0003-2753-9674	Ministry of Health, Welfare and Sport, The Hague, The Netherlands	Ministry of Health, Welfare and Sport, The Hague, The Netherlands	This study was supported by the Ministry of Health, Welfare and Sport, The Hague, The Netherlands. The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	Backhouse JL, 2007, VACCINE, V25, P1310, DOI 10.1016/j.vaccine.2006.09.087; Borrow R, 2005, VACCINE, V23, P2222, DOI 10.1016/j.vaccine.2005.01.051; Borrow R, 2001, INFECT IMMUN, V69, P1568, DOI 10.1128/IAI.69.3.1568-1573.2001; Borrow R, 2010, CLIN VACCINE IMMUNOL, V17, P154, DOI 10.1128/CVI.00384-09; BREDIUS RGM, 1992, INFECT IMMUN, V60, P4838, DOI 10.1128/IAI.60.11.4838-4847.1992; Cameron C, 2006, EUROSURVEILLANCE, V11; Campbell H, 2010, CLIN VACCINE IMMUNOL, V17, P840, DOI 10.1128/CVI.00529-09; Ceyhan M, 2007, VACCINE, V25, P7233, DOI 10.1016/j.vaccine.2007.07.019; de Greeff SC, 2006, PEDIATR INFECT DIS J, V25, P79, DOI 10.1097/01.inf.0000195594.41449.c6; De Melker HE, 1998, EPIDEMIOL INFECT, V121, P637, DOI 10.1017/S0950268898001587; de Voer RM, 2009, VACCINE, V27, P6974, DOI 10.1016/j.vaccine.2009.09.082; de Voer RM, 2009, CLIN INFECT DIS, V49, P58, DOI 10.1086/599347; de Voer RM, 2009, CLIN VACCINE IMMUNOL, V16, P433, DOI 10.1128/CVI.00364-08; Diez-Domingo J, 2010, PEDIATR INFECT DIS J, V29, P148, DOI 10.1097/INF.0b013e3181b9a831; Feiring B, 2006, CLIN VACCINE IMMUNOL, V13, P790, DOI 10.1128/CVI.00047-06; *GEZ HLTH COUNC NE, 2002, 200127E GEZ HLTH COU; Goldblatt D, 1998, J INFECT DIS, V177, P1112, DOI 10.1086/517407; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327; Larrauri A, 2005, VACCINE, V23, P4097, DOI 10.1016/j.vaccine.2005.03.045; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156, DOI 10.1128/CDLI.4.2.156-167.1997; MYEROWITZ RL, 1973, INFECT IMMUN, V8, P896, DOI 10.1128/IAI.8.6.896-900.1973; NEPPELENBROEK SE, 2002, GOED GEDAAN WOORDVER; ODempsey TJD, 1996, ARCH DIS CHILD-FETAL, V74, pF43, DOI 10.1136/fn.74.1.F43; Pihlgren M, 2006, J IMMUNOL, V176, P165, DOI 10.4049/jimmunol.176.1.165; Richmond P, 2001, J INFECT DIS, V183, P160, DOI 10.1086/317646; Richmond P, 1999, J INFECT DIS, V179, P1569, DOI 10.1086/314753; ROBBINS JB, 1972, INFECT IMMUN, V6, P651, DOI 10.1128/IAI.6.5.651-656.1972; Rohner GB, 2008, J IMMUNOL, V180, P2165, DOI 10.4049/jimmunol.180.4.2165; Sakou II, 2009, VACCINE, V27, P4408, DOI 10.1016/j.vaccine.2009.05.047; Snape MD, 2006, CLIN INFECT DIS, V43, P1387, DOI 10.1086/508776; Snape MD, 2005, PEDIATR INFECT DIS J, V24, P128, DOI 10.1097/01.inf.0000151029.58752.27; SNAPE MD, 2008, BMJ-BRIT MED J, V7659, P1487; Southern J, 2009, CLIN VACCINE IMMUNOL, V16, P194, DOI 10.1128/CVI.00420-08; Trotter CL, 2008, CLIN VACCINE IMMUNOL, V15, P1694, DOI 10.1128/CVI.00279-08; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; Upham JW, 2002, INFECT IMMUN, V70, P6583, DOI 10.1128/IAI.70.12.6583-6588.2002; van der Klis FRM, 2009, NETH J MED, V67, P301; van Gageldonk PGM, 2008, J IMMUNOL METHODS, V335, P79, DOI 10.1016/j.jim.2008.02.018; VANN WF, 1976, INFECT IMMUN, V13, P1654, DOI 10.1128/IAI.13.6.1654-1662.1976; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607	42	61	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12144	10.1371/journal.pone.0012144	http://dx.doi.org/10.1371/journal.pone.0012144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730091	Green Submitted, Green Published, gold			2022-12-25	WOS:000280862200006
J	Liu, W; Xin, H; Eckert, DT; Brown, JA; Gnarra, JR				Liu, W.; Xin, H.; Eckert, D. T.; Brown, J. A.; Gnarra, J. R.			Hypoxia and cell cycle regulation of the von Hippel-Lindau tumor suppressor	ONCOGENE			English	Article						von Hippel-Lindau protein; renal cell carcinoma; anaphase-promoting complex/cyclosome; hypoxia; cell cycle	DNA-DAMAGE; GENE; ARREST; PROLIFERATION; TRANSLATION; EXPRESSION; COMPLEX; PROTEIN; GROWTH; DEGRADATION	Inactivation of von Hippel-Lindau tumor-suppressor protein (pVHL) is associated with von Hippel-Lindau disease, an inherited cancer syndrome, as well as the majority of patients with sporadic clear cell renal cell carcinoma (RCC). Although the involvement of pVHL in oxygen sensing through targeting hypoxia-inducible factor-alpha subunits to ubiquitin-dependent proteolysis has been well documented, less is known about pVHL regulation under both normoxic and hypoxic conditions. We found that pVHL levels decreased in hypoxia and that hypoxia-induced cell cycle arrest is associated with pVHL expression in RCC cells. pVHL levels fluctuate during the cell cycle, paralleling cyclin B1 levels, with decreased levels in mitosis and G1. pVHL contains consensus destruction (D) box sequences, and pVHL associates with Cdh1, an activator of the anaphase-promoting complex/cyclosome (APC/C) E3 ubiquitin ligase. We show that pVHL has a decreased half-life in G1, Cdh1 down-regulation results in increased pVHL expression, whereas Cdh1 overexpression results in decreased pVHL expression. Taken together, these results suggest that pVHL is a novel substrate of APC/C-Cdh1. D box-independent pVHL degradation was also detected, indicating that other ubiquitin ligases are also activated for pVHL degradation. Oncogene (2011) 30, 21-31; doi: 10.1038/onc.2010.395; published online 30 August 2010	[Gnarra, J. R.] Univ Pittsburgh, Sch Med, Dept Urol, Shadyside Med Ctr, Pittsburgh, PA 15232 USA; [Xin, H.; Brown, J. A.; Gnarra, J. R.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA USA; [Gnarra, J. R.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gnarra, JR (corresponding author), Univ Pittsburgh, Sch Med, Dept Urol, Shadyside Med Ctr, Suite G37,5200 Ctr Ave, Pittsburgh, PA 15232 USA.	gnarrajr@upmc.edu	Liu, Weijun/D-5291-2017; Liu, Weijun/B-5896-2008	Liu, Weijun/0000-0002-4426-6148; Gnarra, James/0000-0002-6369-3110	Cancer Association of Greater New Orleans; LSUHSC-NO; NIH [CA125930];  [T32DK007774]; NATIONAL CANCER INSTITUTE [R01CA125930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007774] Funding Source: NIH RePORTER	Cancer Association of Greater New Orleans; LSUHSC-NO; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr Arthur Haas, for support and discussions, Eric Hittle, Kimberlee Rankin, Mike Meyer, and Miki Katuwal for technical assistance, and the Cancer Association of Greater New Orleans for support to HX. This work was supported by the LSUHSC-NO Dean's Research Fund and NIH grant CA125930. DTE was supported by T32DK007774.	Baker DJ, 2007, CELL MOL LIFE SCI, V64, P589, DOI 10.1007/s00018-007-6443-1; Beroud C, 2000, HUM MUTAT, V15, P86, DOI 10.1002/(SICI)1098-1004(200001)15:1<86::AID-HUMU16>3.0.CO;2-4; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; de Paulsen N, 2001, P NATL ACAD SCI USA, V98, P1387, DOI 10.1073/pnas.031587498; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Fahling M, 2009, ACTA PHYSIOL, V195, P205, DOI 10.1111/j.1748-1716.2008.01894.x; Gardner LB, 2001, J BIOL CHEM, V276, P7919, DOI 10.1074/jbc.M010189200; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Hackenbeck T, 2009, CELL CYCLE, V8, P1386, DOI 10.4161/cc.8.9.8306; Harper Jane V., 2004, V296, P157; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Iliopoulos O, 1998, P NATL ACAD SCI USA, V95, P11661, DOI 10.1073/pnas.95.20.11661; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Jackson PK, 2004, TRENDS CELL BIOL, V14, P331, DOI 10.1016/j.tcb.2004.05.005; Jung CR, 2006, NAT MED, V12, P809, DOI 10.1038/nm1440; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kaelin WG, 2007, CLIN CANCER RES, V13, p680S, DOI 10.1158/1078-0432.CCR-06-1865; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Liu LP, 2004, CANCER BIOL THER, V3, P492, DOI 10.4161/cbt.3.6.1010; Liu WJ, 2008, CARCINOGENESIS, V29, P263, DOI 10.1093/carcin/bgm251; Liu WJ, 2007, MOL CELL BIOL, V27, P2967, DOI 10.1128/MCB.01830-06; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Pause A, 1998, P NATL ACAD SCI USA, V95, P993, DOI 10.1073/pnas.95.3.993; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Schmaltz C, 1998, MOL CELL BIOL, V18, P2845, DOI 10.1128/MCB.18.5.2845; Schoenfeld A, 1998, P NATL ACAD SCI USA, V95, P8817, DOI 10.1073/pnas.95.15.8817; Semenza GL, 2009, BLOOD, V114, P2015, DOI 10.1182/blood-2009-05-189985; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Stickle NH, 2005, MUTAT RES-FUND MOL M, V578, P23, DOI 10.1016/j.mrfmmm.2005.02.016; Sudo T, 2001, EMBO J, V20, P6499, DOI 10.1093/emboj/20.22.6499; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; Thoma CR, 2009, NAT CELL BIOL, V11, P994, DOI 10.1038/ncb1912; van Leuken R, 2008, BBA-REV CANCER, V1786, P49, DOI 10.1016/j.bbcan.2008.05.002; Wasch R, 2010, ONCOGENE, V29, P1, DOI 10.1038/onc.2009.325; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Warnecke C, 2008, EXP CELL RES, V314, P2016, DOI 10.1016/j.yexcr.2008.03.003; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wykoff CC, 2004, BRIT J CANCER, V90, P1235, DOI 10.1038/sj.bjc.6601657; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699	43	22	27	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	1					21	31		10.1038/onc.2010.395	http://dx.doi.org/10.1038/onc.2010.395			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	703EQ	20802534	Green Accepted			2022-12-25	WOS:000285959300002
J	Hong, JM; Huang, YY; Li, J; Yi, F; Zheng, J; Huang, HA; Wei, N; Shan, YQ; An, MR; Zhang, HY; Ji, JG; Zhang, PZ; Xi, Z; Du, QA; Liang, ZC				Hong, Junmei; Huang, Yuanyu; Li, Jun; Yi, Fan; Zheng, Jie; Huang, Huang; Wei, Na; Shan, Yongqiang; An, Mingrui; Zhang, Hongyan; Ji, Jianguo; Zhang, Peizhuo; Xi, Zhen; Du, Quan; Liang, Zicai			Comprehensive analysis of sequence-specific stability of siRNA	FASEB JOURNAL			English	Article						serum degradation; chemical modification; cleavage site; restrictive endonuclease	HUMAN PANCREATIC RIBONUCLEASE; DOUBLE-STRANDED-RNA; MAMMALIAN-CELLS; INTERFERENCE; TARGETS; DEGRADATION; DUPLEXES; SITES; SERUM	Double-stranded small interfering RNAs (siRNAs) are important modulators of biological processes and hold great promise for therapeutic applications. However, serum processing of synthetic siRNAs is still largely unknown. To address this issue, serum degradation assays of 125 siRNAs were first performed in this study. Four siRNA categories of distinct serum stability were identified, including a group of siRNAs that were stable in their native form for both in vitro and in vivo assays. Fine mapping of the cleavage events occurring in serum treatment demonstrated that most occurred at two vulnerable sites, leading to a speculation that rational modification of these sites might protect most siRNAs from serum degradation. For proof of concept, an exhaustive siRNA modification study was performed. In addition to the consistent stabilization pattern revealed at these sites, our study further showed that a single modification made at the cleavage site stabilized the siRNAs to a large extent, highlighting the importance of these sites in siRNA degradation. In summary, the present study provided a comprehensive picture of serum processing of siRNA as well as a starting point for a rational siRNA modification strategy, both of which are of great importance to in vivo and therapeutic applications of siRNA.-Hong, J., Huang, Y., Li, J., Yi, F., Zheng, J., Huang H., Wei, N., Shan, Y, An, M., Zhang, H., Ji J., Zhang, P., Xi, Z., Du, Q., Liang, Z. Comprehensive analysis of sequence-specific stability of small interfering RNA. FASEB J. 24, 4844-4855 (2010). www.fasebj.org	[Hong, Junmei; Huang, Yuanyu; Li, Jun; Yi, Fan; Zheng, Jie; Huang, Huang; Wei, Na; Shan, Yongqiang; Du, Quan; Liang, Zicai] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China; [An, Mingrui; Ji, Jianguo] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Zhang, Hongyan] Suzhou Ribo Life Sci Co Ltd, Kunshan, Jiangsu, Peoples R China; [Zhang, Peizhuo] Suzhou GenePharma Co Ltd, Suzhou, Peoples R China; [Xi, Zhen] Nankai Univ, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China	Peking University; Peking University; Nankai University	Du, QA (corresponding author), Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.	quan.du@pku.edu.cn; liangz@edu.pku.cn	Huang, Huang/AAG-6281-2019; Liang, Zicai/A-2646-2013; Huang, Yuanyu/H-8466-2014	Huang, Yuanyu/0000-0003-3935-7245; Huang, Huang/0000-0002-8377-4823	National Natural Science Foundation of China [30873187, 30771085, 30871385]; Beijing Natural Science Foundation [5092011]; National High-Tech R&D Program of China [2006AA02Z104, 2007AA02Z165, 2009ZX09503-022]; National Basic Research Program of China [2007CB512100]; National 985 Program; Department of Education of China [20070001011, 200800010019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National High-Tech R&D Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National 985 Program; Department of Education of China	The authors thank Dr. Iain C. Bruce for critically reading this manuscript. This work was supported by the National Natural Science Foundation of China (30873187, 30771085, and 30871385), the Beijing Natural Science Foundation (5092011), the National High-Tech R&D Program of China (2006AA02Z104, 2007AA02Z165, and 2009ZX09503-022), the National Basic Research Program of China (2007CB512100), the National 985 Program, and the Department of Education of China (grants 20070001011 and 200800010019).	Allerson CR, 2005, J MED CHEM, V48, P901, DOI 10.1021/jm049167j; BLACKBURN P, 1977, J BIOL CHEM, V252, P5904; Braasch DA, 2003, BIOCHEMISTRY-US, V42, P7967, DOI 10.1021/bi0343774; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Choung S, 2006, BIOCHEM BIOPH RES CO, V342, P919, DOI 10.1016/j.bbrc.2006.02.049; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, P2705, DOI 10.1093/nar/gkg393; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Dykxhoorn DM, 2006, P NATL ACAD SCI USA, V103, P5953, DOI 10.1073/pnas.0601309103; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Geary RS, 2001, J PHARMACOL EXP THER, V296, P890; Haupenthal J, 2006, BIOCHEM PHARMACOL, V71, P702, DOI 10.1016/j.bcp.2005.11.015; Huang HY, 2009, NUCLEIC ACIDS RES, V37, pD150, DOI 10.1093/nar/gkn852; KAWASAKI AM, 1993, J MED CHEM, V36, P831, DOI 10.1021/jm00059a007; KAZUNOBU F, 2008, ANAL BIOCHEM, V385, P386; Kurreck J, 2009, ANGEW CHEM INT EDIT, V48, P1378, DOI 10.1002/anie.200802092; Layzer JM, 2004, RNA, V10, P766, DOI 10.1261/rna.5239604; Lopez-Fraga M., 2008, Infectious Disorders - Drug Targets, V8, P262; Loverix S, 2003, CURR MED CHEM, V10, P779, DOI 10.2174/0929867033457845; MASSIMO L, 1992, MOL CELL BIOCHEM, V117, P139; Rodriguez M, 2008, ARCH BIOCHEM BIOPHYS, V471, P191, DOI 10.1016/j.abb.2007.12.016; Sorrentino S, 2003, BIOCHEMISTRY-US, V42, P10182, DOI 10.1021/bi030040q; Volkov AA, 2009, OLIGONUCLEOTIDES, V19, P191, DOI 10.1089/oli.2008.0162; Yakovlev G, 1997, J BIOMOL STRUCT DYN, V15, P243, DOI 10.1080/07391102.1997.10508189; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	25	33	37	2	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4844	4855		10.1096/fj.09-142398	http://dx.doi.org/10.1096/fj.09-142398			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20732955				2022-12-25	WOS:000284824400024
J	Nguyen, TN; Uemura, A; Shih, W; Yamada, S				Nguyen, Thuc Nghi; Uemura, Arisa; Shih, Wenting; Yamada, Soichiro			Zyxin-mediated Actin Assembly Is Required for Efficient Wound Closure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; CELL-CELL ADHESION; E-CADHERIN; ADHERENS JUNCTIONS; ENA/VASP PROTEINS; FOCAL ADHESIONS; ALPHA-ACTININ; POLYMERIZATION; VASP; CONTACTS	Cytoskeletal regulation of cell adhesion is vital to the organization of multicellular structures. The focal adhesion protein zyxin emerged as a key regulator of actin assembly because zyxin recruits Enabled/vasodilator-stimulated phospho-proteins (Ena/VASP) to promote actin assembly. Zyxin also localizes to the sites of cell-cell adhesion and is thought to promote actin assembly with Ena/VASP. Using shRNA targeted to zyxin, we analyzed the roles of zyxin at adhesive contacts. In zyxin-deficient cells, the actin assembly at both focal adhesion and cell-cell adhesion was limited, but their migration rate was unchanged. Cell spreading on E-cadherin-coated surfaces and the formation of cell clusters were slower for zyxin-deficient cells than wild type cells. By ablating a single cell within a cell monolayer, we quantified the rate of wound closure driven by a contractile circumferential actin ring. Zyxin-deficient cells failed to recruit VASP to cell-cell junctions at the wound edge and had a slower wound closure rate than wild type cells. Our results suggest that, by recruiting VASP, zyxin regulates actin assembly at the sites of force-bearing cell-cell adhesion.	[Nguyen, Thuc Nghi; Uemura, Arisa; Shih, Wenting; Yamada, Soichiro] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis	Yamada, S (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	syamada@ucdavis.edu	Yamada, Soichiro/B-7360-2019	Yamada, Soichiro/0000-0001-6413-0814; Nguyen, Thuc Nghi/0000-0002-6466-5883	Beckman Young Investigator Award; Hellman Family New Faculty Award; University of California Cancer Research Coordinating Committee; Achievement Rewards for College Scientists Award; Training Program in Biomolecular Technology [T32-GM08799]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094798, T32GM008799] Funding Source: NIH RePORTER	Beckman Young Investigator Award; Hellman Family New Faculty Award; University of California Cancer Research Coordinating Committee(University of California System); Achievement Rewards for College Scientists Award; Training Program in Biomolecular Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Beckman Young Investigator Award (to S. Y.), a Hellman Family New Faculty Award (to S. Y.), and by the University of California Cancer Research Coordinating Committee (S. Y.), the Achievement Rewards for College Scientists Award (to T. N. N.), and Training Program in Biomolecular Technology Fellowship T32-GM08799 (to T. N. N.).	Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Beckerle MC, 1997, BIOESSAYS, V19, P949, DOI 10.1002/bies.950191104; BEMENT WM, 1993, J CELL BIOL, V121, P565, DOI 10.1083/jcb.121.3.565; Brindle NPJ, 1996, BIOCHEM J, V318, P753, DOI 10.1042/bj3180753; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Castellano F, 2001, EMBO J, V20, P5603, DOI 10.1093/emboj/20.20.5603; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Colombelli J, 2009, J CELL SCI, V122, P1665, DOI 10.1242/jcs.042986; CRAWFORD AW, 1991, J BIOL CHEM, V266, P5847; CRAWFORD AW, 1992, J CELL BIOL, V116, P1381, DOI 10.1083/jcb.116.6.1381; Danjo Y, 1998, J CELL SCI, V111, P3323; Drees B, 2000, J BIOL CHEM, V275, P22503, DOI 10.1074/jbc.M001698200; Fradelizi J, 2001, NAT CELL BIOL, V3, P699, DOI 10.1038/35087009; Furman C, 2007, J CELL BIOL, V179, P761, DOI 10.1083/jcb.200705002; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Hansen MDH, 2006, J BIOL CHEM, V281, P16178, DOI 10.1074/jbc.M512771200; Hirata H, 2008, J CELL SCI, V121, P2795, DOI 10.1242/jcs.030320; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Hoffman LM, 2003, MOL CELL BIOL, V23, P70, DOI 10.1128/MCB.23.1.70-79.2003; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Lambert M, 2007, EXP CELL RES, V313, P4025, DOI 10.1016/j.yexcr.2007.07.035; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Nix DA, 2001, J BIOL CHEM, V276, P34759, DOI 10.1074/jbc.M102820200; Pasic L, 2008, J BIOL CHEM, V283, P9814, DOI 10.1074/jbc.M710475200; Petit MMR, 2000, MOL BIOL CELL, V11, P117, DOI 10.1091/mbc.11.1.117; Reinhard M, 1996, FEBS LETT, V399, P103, DOI 10.1016/S0014-5793(96)01295-1; REINHARD M, 1995, P NATL ACAD SCI USA, V92, P7956, DOI 10.1073/pnas.92.17.7956; Rottner K, 2001, MOL BIOL CELL, V12, P3103, DOI 10.1091/mbc.12.10.3103; Scott JA, 2006, MOL BIOL CELL, V17, P1085, DOI 10.1091/mbc.e05-07-0644; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Verma S, 2004, J BIOL CHEM, V279, P34062, DOI 10.1074/jbc.M404814200; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018	39	35	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35439	35445		10.1074/jbc.M110.119487	http://dx.doi.org/10.1074/jbc.M110.119487			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20801875	Green Published, hybrid			2022-12-25	WOS:000283845300021
J	Ayuso, MI; Hernandez-Jimenez, M; Martin, ME; Salinas, M; Alcazar, A				Ayuso, Maria I.; Hernandez-Jimenez, Macarena; Martin, Maria E.; Salinas, Matilde; Alcazar, Alberto			New Hierarchical Phosphorylation Pathway of the Translational Repressor eIF4E-binding Protein 1 (4E-BP1) in Ischemia-Reperfusion Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; MOLECULAR-MECHANISMS; MAMMALIAN TARGET; DOWN-REGULATION; PHAS-I; DEPENDENT PHOSPHORYLATION; 4E-BINDING PROTEIN-1; PHOSPHATASE 2A; RAPAMYCIN MTOR; (S/T)P SITES	Eukaryotic initiation factor (eIF) 4E-binding protein 1 (4E-BP1) is a translational repressor that is characterized by its capacity to bind specifically to eIF4E and inhibit its interaction with eIF4G. Phosphorylation of 4E-BP1 regulates eIF4E availability, and therefore, cap-dependent translation, in cell stress. This study reports a physiological study of 4E-BP1 regulation by phosphorylation using control conditions and a stress-induced translational repression condition, ischemia-reperfusion (IR) stress, in brain tissue. In control conditions, 4E-BP1 was found in four phosphorylation states that were detected by two-dimensional gel electrophoresis and Western blotting, which corresponded to Thr(69)-phosphorylated alone, Thr(69)- and Thr(36)/Thr(45)-phosphorylated, all these plus Ser(64) phosphorylation, and dephosphorylation of the sites analyzed. In control or IR conditions, no Thr(36)/Thr(45) phosphorylation alone was detected without Thr(69) phosphorylation, and neither was Ser(64) phosphorylation without Thr(36)/Thr(45)/Thr(69) phosphorylation detected. Ischemic stress induced 4E-BP1 dephosphorylation at Thr(69), Thr(36)/Thr(45), and Ser(64) residues, with 4E-BP1 remaining phosphorylated at Thr(69) alone or dephosphorylated. In the subsequent reperfusion, 4E-BP1 phosphorylation was induced at Thr(36)/Thr(45) and Ser(64), in addition to Thr(69). Changes in 4E-BP1 phosphorylation after IR were according to those found for Akt and mammalian target of rapamycin (mTOR) kinases. These results demonstrate a new hierarchical phosphorylation for 4E-BP1 regulation in which Thr(69) is phosphorylated first followed by Thr(36)/Thr(45) phosphorylation, and Ser(64) is phosphorylated last. Thr(69) phosphorylation alone allows binding to eIF4E, and subsequent Thr(36)/Thr(45) phosphorylation was sufficient to dissociate 4E-BP1 from eIF4E, which led to eIF4E-4G interaction. These data help to elucidate the physiological role of 4E-BP1 phosphorylation in controlling protein synthesis.	[Ayuso, Maria I.; Hernandez-Jimenez, Macarena; Martin, Maria E.; Salinas, Matilde; Alcazar, Alberto] Hosp Ramon & Cajal, Dept Invest, E-28034 Madrid, Spain	Hospital Universitario Ramon y Cajal	Alcazar, A (corresponding author), Hosp Ramon & Cajal, Dept Invest, Ctra Colmenar,Km 9-1, E-28034 Madrid, Spain.	alberto.alcazar@hrc.es	Ayuso, Maria Irene/C-9435-2015; Martín, María/HDL-9512-2022; Martín, María/ACU-3685-2022	Ayuso, Maria Irene/0000-0003-0046-3657; Martín, María/0000-0002-3204-1726; Hernandez Jimenez, Macarena/0000-0003-3329-3965; MARTIN, M. ELENA/0000-0003-2131-874X	Spanish Ministry of Science and Innovation [FIS08/0761, RETICS-RD06/0026/008]; Regional Government of Madrid	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government of Madrid	This work was supported by Institute of Health Carlos III (ISCIII) Grants FIS08/0761 and RETICS-RD06/0026/008 from the Spanish Ministry of Science and Innovation, including a predoctoral position for M. I. A.; A researcher from Fundacion de Investigacion Biomedica del Hospital Universitario Ramon y Cajal (FIBio-HRC) supported by the Regional Government of Madrid.	Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Beugnet A, 2003, J BIOL CHEM, V278, P40717, DOI 10.1074/jbc.M308573200; BURDA J, 1994, BIOCHEM J, V302, P335, DOI 10.1042/bj3020335; Cid C, 2003, FASEB J, V17, P409, DOI 10.1096/fj.03-0606fje; Cid C, 2007, PROTEOMICS, V7, P3207, DOI 10.1002/pmic.200700214; Clemens MJ, 1999, INT J BIOCHEM CELL B, V31, P1, DOI 10.1016/S1357-2725(98)00127-7; Clerkin JS, 2008, CANCER LETT, V266, P30, DOI 10.1016/j.canlet.2008.02.029; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Damjanac M, 2008, NEUROBIOL DIS, V29, P354, DOI 10.1016/j.nbd.2007.09.008; de la Vega CM, 2001, BIOCHEM J, V357, P819; Ermoian RP, 2009, J NEURO-ONCOL, V91, P19, DOI 10.1007/s11060-008-9683-5; Ferguson G, 2003, J BIOL CHEM, V278, P47459, DOI 10.1074/jbc.M307949200; Garcia-Bonilla L, 2007, J NEUROCHEM, V103, P1368, DOI 10.1111/j.1471-4159.2007.04844.x; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Harwood FC, 2008, J BIOL CHEM, V283, P2575, DOI 10.1074/jbc.M706173200; Heesom KJ, 1999, FEBS LETT, V457, P489, DOI 10.1016/S0014-5793(99)01094-7; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Kirino T, 2000, NEUROPATHOLOGY, V20, pS95; Li Q, 2007, EXP NEUROL, V204, P840, DOI 10.1016/j.expneurol.2007.01.005; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Lu AG, 2003, J CEREBR BLOOD F MET, V23, P786, DOI 10.1097/01.WCB.0000062340.80057.06; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin ME, 2000, BIOCHEM J, V351, P327, DOI 10.1042/0264-6021:3510327; Mothe-Satney I, 2000, J BIOL CHEM, V275, P33836, DOI 10.1074/jbc.M006005200; Mothe-Satney I, 2000, MOL CELL BIOL, V20, P3558, DOI 10.1128/MCB.20.10.3558-3567.2000; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Petroulakis E, 2006, BRIT J CANCER, V94, P195, DOI 10.1038/sj.bjc.6602902; Proud CG, 1997, BIOCHEM J, V328, P329; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Quevedo C, 2000, J BIOL CHEM, V275, P19192, DOI 10.1074/jbc.M000238200; Quevedo C, 2002, BIOCHEM BIOPH RES CO, V291, P560, DOI 10.1006/bbrc.2002.6479; Raghuraman G, 2009, ANTIOXID REDOX SIGN, V11, P1777, DOI [10.1089/ars.2008.2368, 10.1089/ARS.2008.2368]; Raught B., 2007, TRANSLATIONAL CONTRO, P369; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Rocic P, 2003, J BIOL CHEM, V278, P36973, DOI 10.1074/jbc.M302099200; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE74, DOI 10.1152/ajpendo.2000.279.1.E74; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; TsukiyamaKohara K, 1996, GENOMICS, V38, P353, DOI 10.1006/geno.1996.0638; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wang XM, 2003, MOL CELL BIOL, V23, P1546, DOI 10.1128/MCB.23.5.1546-1557.2003; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5	49	40	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34355	34363		10.1074/jbc.M110.135103	http://dx.doi.org/10.1074/jbc.M110.135103			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20736160	hybrid, Green Published			2022-12-25	WOS:000283659100009
J	Levesque, N; Leung, GP; Fok, AK; Schmidt, TI; Kobor, MS				Levesque, Nancy; Leung, Grace P.; Fok, Alexandra K.; Schmidt, Thorsten I.; Kobor, Michael S.			Loss of H3 K79 Trimethylation Leads to Suppression of Rtt107-dependent DNA Damage Sensitivity through the Translesion Synthesis Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION FORK RESTART; SACCHAROMYCES-CEREVISIAE; HISTONE H3; CHROMATIN MODIFICATIONS; PHOSPHATASE COMPLEX; BUDDING YEAST; METHYLATION; CHECKPOINT; REPAIR; DOT1	Genomic integrity is maintained by the coordinated interaction of many DNA damage response pathways, including checkpoints, DNA repair processes, and cell cycle restart. In Saccharomyces cerevisiae, the BRCA1 C-terminal domain-containing protein Rtt107/Esc4 is required for restart of DNA replication after successful repair of DNA damage and for cellular resistance to DNA-damaging agents. Rtt107 and its interaction partner Slx4 are phosphorylated during the initial phase of DNA damage response by the checkpoint kinases Mec1 and Tel1. Because the natural chromatin template plays an important role during the DNA damage response, we tested whether chromatin modifications affected the requirement for Rtt107 and Slx4 during DNA damage repair. Here, we report that the sensitivity to DNA-damaging agents of rtt107 Delta and slx4 Delta mutants was rescued by inactivation of the chromatin regulatory pathway leading to H3 K79 trimethylation. Further analysis revealed that lack of Dot1, the H3 K79 methyltransferase, led to activation of the translesion synthesis pathway, thereby allowing the survival in the presence of DNA damage. The DNA damage-induced phosphorylation of Rtt107 and Slx4, which was mutually dependent, was not restored in the absence of Dot1. The antagonistic relationship between Rtt107 and Dot1 was specific for DNA damage-induced phenotypes, whereas the genomic instability caused by loss of Rtt107 was not rescued. These data revealed a multifaceted functional relationship between Rtt107 and Dot1 in the DNA damage response and maintenance of genome integrity.	[Levesque, Nancy; Leung, Grace P.; Fok, Alexandra K.; Schmidt, Thorsten I.; Kobor, Michael S.] Univ British Columbia, Dept Med Genet, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada	Child & Family Research Institute; University of British Columbia	Kobor, MS (corresponding author), Univ British Columbia, Dept Med Genet, Child & Family Res Inst, Ctr Mol Med & Therapeut, 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	msk@cmmt.ubc.ca		Kobor, Michael/0000-0003-4140-1743	Michael Smith Foundation for Health Research; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported in part by a scholar award from the Michael Smith Foundation for Health Research.; Supported by a fellowship from the Canadian Institutes of Health Research.; Supported by a fellowship from the Natural Sciences and Engineering Research Council of Canada.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; AMBERG DC, 2005, METHODS YEAST GENETI, P155; Andrulis ED, 2004, GENETICS, V166, P631, DOI 10.1534/genetics.166.1.631; Bassal S, 2005, HUM MUTAT, V25, P101, DOI 10.1002/humu.20130; Bazzi M, 2010, MOL CELL BIOL, V30, P131, DOI 10.1128/MCB.01000-09; Biswas D, 2008, GENETICS, V178, P649, DOI 10.1534/genetics.107.084202; Chambers AL, 2007, BIOCHEM SOC T, V35, P1519, DOI 10.1042/BST0351519; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Chaudhuri S, 2009, NUCLEIC ACIDS RES, V37, P1690, DOI 10.1093/nar/gkp003; Chin JK, 2006, DNA REPAIR, V5, P618, DOI 10.1016/j.dnarep.2006.02.005; Conde F, 2008, GENETICS, V179, P1197, DOI 10.1534/genetics.108.089003; Conde F, 2009, GENETICS, V182, P437, DOI 10.1534/genetics.109.101899; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Foster ER, 2009, J CELL BIOL, V184, P631, DOI 10.1083/jcb.200812088; Game JC, 2005, GENETICS, V169, P51, DOI 10.1534/genetics.104.028613; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; GERRING SL, 1990, EMBO J, V9, P4347, DOI 10.1002/j.1460-2075.1990.tb07884.x; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; Grenon M, 2007, YEAST, V24, P105, DOI 10.1002/yea.1441; GRENSON M, 1966, BIOCHIM BIOPHYS ACTA, V127, P325, DOI 10.1016/0304-4165(66)90387-4; Haase SB, 1997, METHOD ENZYMOL, V283, P322; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Karagiannis TC, 2007, LEUKEMIA, V21, P195, DOI 10.1038/sj.leu.2404478; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Kunz BA, 2000, MUTAT RES-FUND MOL M, V451, P169, DOI 10.1016/S0027-5107(00)00048-8; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Lee KY, 2008, MOL CELLS, V26, P5; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Merkera JD, 2008, DNA REPAIR, V7, P1298, DOI 10.1016/j.dnarep.2008.04.009; Mohammad DH, 2009, DNA REPAIR, V8, P1009, DOI 10.1016/j.dnarep.2009.04.004; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; O'Neill BM, 2007, P NATL ACAD SCI USA, V104, P9290, DOI 10.1073/pnas.0703252104; Pages V, 2009, GENE DEV, V23, P1438, DOI 10.1101/gad.1793409; Putnam CD, 2009, DNA REPAIR, V8, P974, DOI 10.1016/j.dnarep.2009.04.021; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Roberts TM, 2008, MOL BIOL CELL, V19, P171, DOI 10.1091/mbc.E07-09-0961; Roberts TM, 2006, MOL BIOL CELL, V17, P539, DOI 10.1091/mbc.E05-08-0785; Rouse J, 2004, EMBO J, V23, P1188, DOI 10.1038/sj.emboj.7600129; Scholes DT, 2001, GENETICS, V159, P1449; Schulze JM, 2009, MOL CELL, V35, P626, DOI 10.1016/j.molcel.2009.07.017; Scott KL, 2003, MOL CELL BIOL, V23, P4522, DOI 10.1128/MCB.23.13.4522-4531.2003; Segurado M, 2009, BIOL CELL, V101, P617, DOI 10.1042/BC20090053; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Singer MS, 1998, GENETICS, V150, P613; Szyjka SJ, 2008, GENE DEV, V22, P1906, DOI 10.1101/gad.1660408; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Viggiani CJ, 2006, YEAST, V23, P1045, DOI 10.1002/yea.1406; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Yang B, 2008, J MOL BIOL, V381, P826, DOI 10.1016/j.jmb.2008.06.059; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104	63	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35113	35122		10.1074/jbc.M110.116855	http://dx.doi.org/10.1074/jbc.M110.116855			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810656	Green Published, hybrid			2022-12-25	WOS:000283659100085
J	Mollinedo, F; Janssen, H; de la Iglesia-Vicente, J; Villa-Pulgarin, JA; Calafat, J				Mollinedo, Faustino; Janssen, Hans; de la Iglesia-Vicente, Janis; Villa-Pulgarin, Janny A.; Calafat, Jero			Selective Fusion of Azurophilic Granules with Leishmania-containing Phagosomes in Human Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERTIARY GRANULES; POLYMORPHONUCLEAR LEUKOCYTES; ENDOPLASMIC-RETICULUM; CYTOCHROME-B; MEMBRANE; GELATINASE; DONOVANI; PHAGOCYTOSIS; INHIBITION; PROMASTIGOTES	Leishmania parasites use polymorphonuclear neutrophils as intermediate hosts before their ultimate delivery to macrophages following engulfment of parasite-infected neutrophils. This leads to a silent and unrecognized entry of Leishmania into the macrophage host cell. Neutrophil function depends on its cytoplasmic granules, but their mobilization and role in how Leishmania parasites evade intracellular killing in neutrophils remain undetermined. Here, we have found by ultrastructural approaches that neutrophils ingested Leishmania major promastigotes, and azurophilic granules fused in a preferential way with parasite-containing phagosomes, without promoting parasite killing. Azurophilic granules, identified by the granule marker myeloperoxidase, also fused with Leishmania donovani-engulfed vacuoles in human neutrophils. In addition, the azurophilic membrane marker CD63 was also detected in the vacuole surrounding the parasite, and in the fusion of azurophilic granules with the parasite-engulfed phagosome. Tertiary and specific granules, involved in vacuole acidification and superoxide anion generation, hardly fused with Leishmania-containing phagosomes. L. major interaction with neutrophils did not elicit production of reactive oxygen species or mobilization of tertiary and specific granules. By using immunogold electron microscopy approaches in the engulfment of L. major and L. donovani by human neutrophils, we did not find a significant contribution of endoplasmic reticulum to the formation of Leishmania-containing vacuoles. Live Leishmania parasites were required to be optimally internalized by neutrophils. Our data suggest that Leishmania promastigotes modulate their uptake by neutrophils, and regulate granule fusion processes in a rather selective way to favor parasite survival in human neutrophils.	CSIC Univ Salamanca, Inst Biol Mol & Celular Canc, Ctr Invest Canc, E-37007 Salamanca, Spain; [Janssen, Hans; Calafat, Jero] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands; [Villa-Pulgarin, Janny A.] Univ Salamanca, APOINTECH, Ctr Hispano Luso Invest Agr CIALE, E-37185 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); Netherlands Cancer Institute; University of Salamanca		fmollin@usal.es; j.calafat@nki.nl	IBSAL, Secretaría/H-3719-2011; Villa-Pulgarin, Janny A/AAW-4592-2020	Villa-Pulgarin, Janny A/0000-0002-9916-5977	Spanish Ministry of Science and Innovation [SAF2008-02251]; Junta de Castilla y Leon [CSI01A08]; Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III [RD06/0020/1037]; Fondo Europeo de Desarrollo Regional of the European Union	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional of the European Union	This work was supported by Spanish Ministry of Science and Innovation (Grant SAF2008-02251, and Grant RD06/0020/1037 from Red Tematica de Investigacion Cooperativa en Cancer, Instituto de Salud Carlos III, co-funded by the Fondo Europeo de Desarrollo Regional of the European Union), and Junta de Castilla y Leon (CSI01A08, GR15-Experimental Therapeutics and Translational Oncology Program, and Biomedicine Project 2009).	AL T, 1990, J MED MICROBIOL */*, V32, P189; BORREGAARD N, 1997, J B BLOOD */* BLOOD, V89, P3503; Calafat J, 1997, BLOOD, V90, P1255, DOI 10.1182/blood.V90.3.1255.1255_1255_1266; ELON J, 1990, PARASITE IMMUNOL, V12, P285, DOI 10.1111/j.1365-3024.1990.tb00955.x; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Gajate C, 2000, INT J CANCER, V86, P208, DOI 10.1002/(SICI)1097-0215(20000415)86:2<208::AID-IJC10>3.0.CO;2-E; Gueirard P, 2008, CELL MICROBIOL, V10, P100, DOI 10.1111/j.1462-5822.2007.01018.x; Iniesta V, 2001, J EXP MED, V193, P777, DOI 10.1084/jem.193.6.777; KJELDSEN L, 1992, EUR J HAEMATOL, V49, P180; KLEBANOFF SJ, 1986, J IMMUNOL, V136, P4220; KLEBANOFF SJ, 1982, PHAGOCYTIC CELLS, P111; KUIJPERS TW, 1991, BLOOD, V78, P1105; LACAL P, 1988, BIOCHEM BIOPH RES CO, V154, P641, DOI 10.1016/0006-291X(88)90187-8; LACAL P, 1988, J BIOL CHEM, V263, P9946; Laskay T, 2003, TRENDS MICROBIOL, V11, P210, DOI 10.1016/S0966-842X(03)00075-1; LILES WC, 1995, J IMMUNOL, V155, P2175; Lodge R, 2006, CELL MICROBIOL, V8, P1922, DOI 10.1111/j.1462-5822.2006.00758.x; Lodge R, 2006, EUR J IMMUNOL, V36, P2735, DOI 10.1002/eji.200636089; Martin-Martin B, 2000, BLOOD, V96, P2574; Matsubara S, 1999, PLACENTA, V20, P185, DOI 10.1053/plac.1998.0366; McGehee AM, 2009, J IMMUNOL, V183, P3690, DOI 10.4049/jimmunol.0900953; MOLLINEDO F, 1984, J BIOL CHEM, V259, P7143; MOLLINEDO F, 1987, FEBS LETT, V217, P158, DOI 10.1016/0014-5793(87)80655-5; Mollinedo F, 2003, J IMMUNOL, V170, P1034, DOI 10.4049/jimmunol.170.2.1034; Mollinedo F, 1999, IMMUNOL TODAY, V20, P535, DOI 10.1016/S0167-5699(99)01500-5; MOLLINEDO F, 1992, J IMMUNOL, V149, P323; MOLLINEDO F, 1991, SCAND J IMMUNOL, V34, P33, DOI 10.1111/j.1365-3083.1991.tb01518.x; MOLLINEDO F, 1991, MOL CELL BIOCHEM, V105, P49; MOLLINEDO F, 1989, MOL PHARMACOL, V36, P547; Mollinedo F, 1997, BIOCHEM J, V327, P917, DOI 10.1042/bj3270917; Mollinedo F., 2003, IMMUNOLOGIA, V22, P340; Mollinedo F, 2006, J IMMUNOL, V177, P2831, DOI 10.4049/jimmunol.177.5.2831; MU L, 2001, MED MICROBIOL IMMUN, V190, P73; Munder M, 2005, BLOOD, V105, P2549, DOI 10.1182/blood-2004-07-2521; NAUSEEF WM, 1995, J BIOL CHEM, V270, P4741, DOI 10.1074/jbc.270.9.4741; NICHOLS BA, 1984, J HISTOCHEM CYTOCHEM, V32, P165, DOI 10.1177/32.2.6319482; NOIVA R, 1992, J BIOL CHEM, V267, P3553; PEARSON RD, 1981, J IMMUNOL, V127, P1438; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Santos-Beneit AM, 2000, J LEUKOCYTE BIOL, V67, P712, DOI 10.1002/jlb.67.5.712; Staali L, 2006, CELL MICROBIOL, V8, P690, DOI 10.1111/j.1462-5822.2005.00662.x; STYRT B, 1988, J MED MICROBIOL, V25, P101, DOI 10.1099/00222615-25-2-101; Tapper H, 1997, J IMMUNOL, V159, P409; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; ULSAMER AG, 1971, J CELL BIOL, V51, P193, DOI 10.1083/jcb.51.1.193; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; Varela RE, 2009, EXP PARASITOL, V122, P134, DOI 10.1016/j.exppara.2009.02.012	47	48	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34528	34536		10.1074/jbc.M110.125302	http://dx.doi.org/10.1074/jbc.M110.125302			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801889	Green Published, hybrid			2022-12-25	WOS:000283659100028
J	Mori, T; Ono, K; Kariya, Y; Ogawa, T; Higashi, S; Miyazaki, K				Mori, Taizo; Ono, Kota; Kariya, Yoshinobu; Ogawa, Takashi; Higashi, Shouichi; Miyazaki, Kaoru			Laminin-3B11, a Novel Vascular-type Laminin Capable of Inducing Prominent Lamellipodial Protrusions in Microvascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-3B CHAIN; CELLULAR ADHESION; CARCINOMA CELLS; HUMAN TISSUES; EXPRESSION; MIGRATION; DOMAINS; CLONING; GROWTH; MORPHOGENESIS	The basement membrane (BM) proteins laminins, which consist of alpha, beta, and gamma chains, support tissue structures and cellular functions. To date only alpha 4 and alpha 5 types of laminins have been identified in the BMs of blood vessels. Our recent study suggested the presence of novel alpha 3B-containing laminins in vascular BMs. Here we identified and characterized the third member of vascular laminins, laminin-3B11 (Lm3B11). RT-PCR analysis showed that microvascular endothelial (MVE) cells and umbilical vein endothelial cells expressed the messages for the alpha 3B, beta 1, beta 2, and gamma 1 chains. In the culture of MVE cells, alpha 3B was associated with beta 1 and gamma 1, producing Lm3B11. Recombinant Lm3B11 was overexpressed by introducing the cDNAs of the three chains into HEK-293 cells and purified to homogeneity. Purified Lm3B11 exhibited relatively weak cell adhesion activity through both alpha 3 beta 1 and alpha 6 beta 1 integrins. Most characteristically, Lm3B11 strongly stimulated MVE cells to extend many lamellipodial protrusions. This pseudopodial branching was blocked by an inhibitor for Src or phosphatidylinositol 3-kinase. Consistently, Lm3B11 stimulated the phosphorylation of Src and Akt more strongly than other laminins, suggesting that the integrin-derived signaling is mediated by these factors. The unique activity of Lm3B11 appears to be favorable to the branching of capillaries and venules.	[Kariya, Yoshinobu; Ogawa, Takashi; Higashi, Shouichi; Miyazaki, Kaoru] Yokohama City Univ, Div Cell Biol, Kihara Inst Biol Res, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan; [Mori, Taizo; Ono, Kota; Higashi, Shouichi; Miyazaki, Kaoru] Yokohama City Univ, Grad Sch Integrated Sci, Totsuka Ku, Yokohama, Kanagawa 2440813, Japan	Yokohama City University; Yokohama City University	Miyazaki, K (corresponding author), Yokohama City Univ, Div Cell Biol, Kihara Inst Biol Res, Totsuka Ku, 641-12 Maioka Cho, Yokohama, Kanagawa 2440813, Japan.	miyazaki@yokohama-cu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [17014077]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Scientific Research on Priority Areas 17014077 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Baker SE, 1996, EXP CELL RES, V228, P262, DOI 10.1006/excr.1996.0325; Champliaud MF, 1996, J CELL BIOL, V132, P1189, DOI 10.1083/jcb.132.6.1189; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Connolly JO, 2002, MOL BIOL CELL, V13, P2474, DOI 10.1091/mbc.E02-01-0006; Doi M, 2002, J BIOL CHEM, V277, P12741, DOI 10.1074/jbc.M111228200; Doliana R, 1997, FEBS LETT, V417, P65, DOI 10.1016/S0014-5793(97)01251-9; Ferrigno O, 1997, J BIOL CHEM, V272, P20502, DOI 10.1074/jbc.272.33.20502; Fischer RS, 2009, CURR BIOL, V19, P260, DOI 10.1016/j.cub.2008.12.045; Frieser M, 1997, EUR J BIOCHEM, V246, P727, DOI 10.1111/j.1432-1033.1997.t01-1-00727.x; Fujiwara H, 2004, EXP CELL RES, V292, P67, DOI 10.1016/j.yexcr.2003.08.010; GALLIANO MF, 1995, J BIOL CHEM, V270, P21820, DOI 10.1074/jbc.270.37.21820; Garbe JHO, 2002, BIOCHEM J, V362, P213, DOI 10.1042/0264-6021:3620213; GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hirosaki T, 2000, J BIOL CHEM, V275, P22495, DOI 10.1074/jbc.M001326200; Hirosaki T, 2002, J BIOL CHEM, V277, P49287, DOI 10.1074/jbc.M111096200; Jakobsson L, 2008, FASEB J, V22, P1530, DOI 10.1096/fj.07-9617com; Kariya Y, 2002, J BIOCHEM, V132, P607, DOI 10.1093/oxfordjournals.jbchem.a003263; Kariya Y, 2004, J BIOL CHEM, V279, P24774, DOI 10.1074/jbc.M400670200; Kariya Y, 2008, J MOL HISTOL, V39, P435, DOI 10.1007/s10735-008-9183-0; Kikkawa Y, 1998, J BIOL CHEM, V273, P15854, DOI 10.1074/jbc.273.25.15854; KIVIRIKKO S, 1995, HUM MOL GENET, V4, P959, DOI 10.1093/hmg/4.5.959; Krasilnikov MA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P59; Liu YQ, 2004, FASEB J, V18, P457, DOI 10.1096/fj.03-0948com; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; MIYAZAKI K, 1993, P NATL ACAD SCI USA, V90, P11767, DOI 10.1073/pnas.90.24.11767; Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.2006.00150.x; Mizushima H, 1996, J BIOCHEM-TOKYO, V120, P1196; RYAN MC, 1994, J BIOL CHEM, V269, P22779; Sorokin LM, 1997, DEV BIOL, V189, P285, DOI 10.1006/dbio.1997.8668; Spessotto P, 2001, CANCER RES, V61, P339; Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002; Yamazaki D, 2003, NATURE, V424, P452, DOI 10.1038/nature01770	34	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35068	35078		10.1074/jbc.M110.146126	http://dx.doi.org/10.1074/jbc.M110.146126			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20805229	hybrid, Green Published			2022-12-25	WOS:000283659100081
J	Zhang, CY; Booth, JW				Zhang, Christine Y.; Booth, James W.			Divergent Intracellular Sorting of Fc gamma RIIA and Fc gamma RIIB2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; ANTIGEN PRESENTATION; DENDRITIC CELLS; IN-VIVO; IMMUNE-COMPLEXES; LIPID RAFTS; MDCK CELLS; B-CELLS; IGG; UBIQUITINATION	The human low affinity Fc gamma RII family includes both the activating receptor Fc gamma RIIA and the inhibitory receptor Fc gamma RIIB2. These receptors have opposing signaling functions but are both capable of internalizing IgG-containing immune complexes through clathrin-mediated endocytosis. We demonstrate that upon engagement by multivalent aggregated human IgG, Fc gamma RIIA expressed in ts20 Chinese hamster fibroblasts is delivered along with its ligand to lysosomal compartments for degradation, while Fc gamma RIIB2 dissociates from the ligand and is routed separately into the recycling pathway. Fc gamma RIIA sorting to lysosomes requires receptor multimerization, but does not require either Src family kinase activity or ubiquitylation of receptor lysine residues. The sorting of Fc gamma RIIB2 away from a degradative fate is not due to its lower affinity for IgG and occurs even upon persistent receptor aggregation. Upon co-engagement of Fc gamma RIIA and Fc gamma RIIB2, the receptors are sorted independently to distinct final fates after dissociation of co-clustering ligand. These results reveal fundamental differences in the trafficking behavior of different Fc gamma receptors.	[Zhang, Christine Y.; Booth, James W.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Zhang, Christine Y.; Booth, James W.] Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Booth, JW (corresponding author), Univ Toronto, Dept Immunol, Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	james.booth@utoronto.ca			Canadian Institutes of Health Research [MOP66961, MOP84475]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grants MOP66961 and MOP84475 from the Canadian Institutes of Health Research.	AMIGORENA S, 1992, SCIENCE, V256, P1808, DOI 10.1126/science.1535455; Antoniou AN, 2002, EUR J IMMUNOL, V32, P530, DOI 10.1002/1521-4141(200202)32:2<530::AID-IMMU530>3.0.CO;2-X; Bazin R, 2004, BRIT J HAEMATOL, V127, P90, DOI 10.1111/j.1365-2141.2004.05105.x; Beekman JM, 2004, P NATL ACAD SCI USA, V101, P10392, DOI 10.1073/pnas.0401217101; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Booth JW, 2002, EMBO J, V21, P251, DOI 10.1093/emboj/21.3.251; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; BUDDE P, 1994, EUR J CELL BIOL, V64, P45; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Dai XL, 2009, BLOOD, V114, P318, DOI 10.1182/blood-2008-10-184457; de Jong JMH, 2006, MOL IMMUNOL, V43, P2045, DOI 10.1016/j.molimm.2006.01.002; Desai DD, 2007, J IMMUNOL, V178, P6217, DOI 10.4049/jimmunol.178.10.6217; Floto RA, 2005, NAT MED, V11, P1056, DOI 10.1038/nm1288; Garcia-Garcia E, 2007, J IMMUNOL, V178, P3048, DOI 10.4049/jimmunol.178.5.3048; HARRISON PT, 1994, J BIOL CHEM, V269, P24396; Hunter S, 1998, BLOOD, V91, P1762, DOI 10.1182/blood.V91.5.1762.1762_1762_1768; HUNZIKER W, 1994, EMBO J, V13, P2963, DOI 10.1002/j.1460-2075.1994.tb06594.x; INDIK Z, 1991, J CLIN INVEST, V88, P1766, DOI 10.1172/JCI115496; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Maenaka K, 2001, J BIOL CHEM, V276, P44898, DOI 10.1074/jbc.M106819200; Marois L, 2009, J IMMUNOL, V182, P2374, DOI 10.4049/jimmunol.0801420; MATTER K, 1994, J CELL BIOL, V126, P991, DOI 10.1083/jcb.126.4.991; Mero P, 2006, J BIOL CHEM, V281, P33242, DOI 10.1074/jbc.M605372200; Mousavi SA, 2007, HEPATOLOGY, V46, P871, DOI 10.1002/hep.21748; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Sardjono CT, 2003, IMMUNOL CELL BIOL, V81, P374, DOI 10.1046/j.1440-1711.2003.01182.x; Siragam V, 2006, NAT MED, V12, P688, DOI 10.1038/nm1416; Stang E, 2004, MOL BIOL CELL, V15, P3591, DOI 10.1091/mbc.E04-01-0041; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Syam S, 2010, J IMMUNOL, V184, P2966, DOI 10.4049/jimmunol.0900016; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; VANDENHERIKOUDIJK IE, 1994, J IMMUNOL, V152, P574; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Yada A, 2003, CELL IMMUNOL, V225, P21, DOI 10.1016/j.cellimm.2003.09.008	39	28	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34250	34258		10.1074/jbc.M110.143834	http://dx.doi.org/10.1074/jbc.M110.143834			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20736173	Green Published, hybrid			2022-12-25	WOS:000283354000070
J	Tyssen, D; Henderson, SA; Johnson, A; Sterjovski, J; Moore, K; La, J; Zanin, M; Sonza, S; Karellas, P; Giannis, MP; Krippner, G; Wesselingh, S; McCarthy, T; Gorry, PR; Ramsland, PA; Cone, R; Paull, JRA; Lewis, GR; Tachedjian, G				Tyssen, David; Henderson, Scott A.; Johnson, Adam; Sterjovski, Jasminka; Moore, Katie; La, Jennifer; Zanin, Mark; Sonza, Secondo; Karellas, Peter; Giannis, Michael P.; Krippner, Guy; Wesselingh, Steve; McCarthy, Tom; Gorry, Paul R.; Ramsland, Paul A.; Cone, Richard; Paull, Jeremy R. A.; Lewis, Gareth R.; Tachedjian, Gilda			Structure Activity Relationship of Dendrimer Microbicides with Dual Action Antiviral Activity	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HERPES-SIMPLEX-VIRUS; CANDIDATE TOPICAL MICROBICIDES; RANDOMIZED CONTROLLED-TRIAL; HIV-INFECTION; SPL7013 GEL; VAGINAL MICROBICIDES; MACROPHAGE TROPISM; TYPE-1 REPLICATION; IN-VITRO	Background: Topical microbicides, used by women to prevent the transmission of HIV and other sexually transmitted infections are urgently required. Dendrimers are highly branched nanoparticles being developed as microbicides. However, the anti-HIV and HSV structure-activity relationship of dendrimers comprising benzyhydryl amide cores and lysine branches, and a comprehensive analysis of their broad-spectrum anti-HIV activity and mechanism of action have not been published. Methods and Findings: Dendrimers with optimized activity against HIV-1 and HSV-2 were identified with respect to the number of lysine branches (generations) and surface groups. Antiviral activity was determined in cell culture assays. Time-of-addition assays were performed to determine dendrimer mechanism of action. In vivo toxicity and HSV-2 inhibitory activity were evaluated in the mouse HSV-2 susceptibility model. Surface groups imparting the most potent inhibitory activity against HIV-1 and HSV-2 were naphthalene disulfonic acid (DNAA) and 3,5-disulfobenzoic acid exhibiting the greatest anionic charge and hydrophobicity of the seven surface groups tested. Their anti-HIV-1 activity did not appreciably increase beyond a second-generation dendrimer while dendrimers larger than two generations were required for potent anti-HSV-2 activity. Second (SPL7115) and fourth generation (SPL7013) DNAA dendrimers demonstrated broad-spectrum anti-HIV activity. However, SPL7013 was more active against HSV and blocking HIV-1 envelope mediated cell-to-cell fusion. SPL7013 and SPL7115 inhibited viral entry with similar potency against CXCR4-(X4) and CCR5-using (R5) HIV-1 strains. SPL7013 was not toxic and provided at least 12 h protection against HSV-2 in the mouse vagina. Conclusions: Dendrimers can be engineered with optimized potency against HIV and HSV representing a unique platform for the controlled synthesis of chemically defined multivalent agents as viral entry inhibitors. SPL7013 is formulated as VivaGel (R) and is currently in clinical development to provide protection against HIV and HSV. SPL7013 could also be combined with other microbicides.	[Tyssen, David; Johnson, Adam; Sterjovski, Jasminka; Moore, Katie; La, Jennifer; Zanin, Mark; Sonza, Secondo; Wesselingh, Steve; Gorry, Paul R.; Ramsland, Paul A.; Tachedjian, Gilda] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia; [Tyssen, David; Johnson, Adam; Sterjovski, Jasminka; Moore, Katie; La, Jennifer; Zanin, Mark; Sonza, Secondo; Wesselingh, Steve; Gorry, Paul R.; Ramsland, Paul A.; Tachedjian, Gilda] Burnet Inst, Ctr Immunol, Melbourne, Vic, Australia; [Henderson, Scott A.; Karellas, Peter; Giannis, Michael P.; Krippner, Guy; McCarthy, Tom; Paull, Jeremy R. A.; Lewis, Gareth R.] Starpharma Pty Ltd, Melbourne, Vic, Australia; [Wesselingh, Steve] Monash Univ, Fac Nursing & Hlth Sci, Clayton, Vic, Australia; [La, Jennifer] Monash Univ, Fac Pharm & Pharmaceut Sci, Parkville, Vic, Australia; [Sonza, Secondo; Tachedjian, Gilda] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Gorry, Paul R.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Gorry, Paul R.; Tachedjian, Gilda] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Ramsland, Paul A.] Univ Melbourne, Dept Surg Austin Hlth, Heidelberg, Vic, Australia; [Ramsland, Paul A.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Cone, Richard] Johns Hopkins Univ, Dept Biophys, Baltimore, MD USA	Burnet Institute; Burnet Institute; Monash University; Monash University; Monash University; University of Melbourne; Monash University; Austin Research Institute; University of Melbourne; Monash University; Johns Hopkins University	Tyssen, D (corresponding author), Burnet Inst, Ctr Virol, Melbourne, Vic, Australia.	gildat@burnet.edu.au	Tachedjian, Gilda/AAF-1327-2020	Tachedjian, Gilda/0000-0002-7733-7037; Zanin, Mark/0000-0003-3158-1744; Paull, Jeremy/0000-0002-9981-421X; Sterjovski, Jasminka/0000-0002-2471-3000; Ramsland, Paul/0000-0002-2107-2738	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200500042C, U19 AI060598]; NIAD, NIH [N01-AI-05420, N01-AI-25478]; National Health and Medical Research Council of Australia (NHMRC) [543105, 365209]; Australian Centre for HIV and Hepatitis Virology Research [ACH2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI060598, N01AI005420] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for HIV and Hepatitis Virology Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by US Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under Contract No. HHSN266200500042C and Grant No. U19 AI060598 awarded to Starpharma Pty Ltd. Southern Research Institute evaluation of dendrimer activity was supported by US funds NIAD, NIH contracts N01-AI-05420 (Principal Investigator: Dr Luke Pallansch) and N01-AI-25478 (Principal Investigator: Mr Roger Ptak), under the direction of Dr Steven Turk, Project Officer, NIAID, Division of AIDS. G. T. was supported by the National Health and Medical Research Council of Australia (NHMRC) Senior Research Fellowship 543105 and funding from the Australian Centre for HIV and Hepatitis Virology Research (ACH2). P. A. R. was supported by the NHMRC R. Douglas Wright Career Development Award 365209. The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The results and conclusions of this report are those of the authors and do not necessarily represent the views of NIH.	Abner SR, 2005, J INFECT DIS, V192, P1545, DOI 10.1086/462424; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Balzarini J, 2007, LANCET, V369, P787, DOI 10.1016/S0140-6736(07)60202-5; Bernstein DI, 2003, ANTIMICROB AGENTS CH, V47, P3784, DOI 10.1128/AAC.47.12.3784-3788.2003; BINDER D, 1987, J MED CHEM, V30, P678, DOI 10.1021/jm00387a017; BIRCH CJ, 1992, J INFECT DIS, V166, P108, DOI 10.1093/infdis/166.1.108; Bourne N, 2000, ANTIMICROB AGENTS CH, V44, P2471, DOI 10.1128/AAC.44.9.2471-2474.2000; Boyd BJ, 2006, MOL PHARMACEUT, V3, P614, DOI 10.1021/mp060032e; Brown JM, 2007, AIDS, V21, P1515, DOI 10.1097/QAD.0b013e3282004929; Butler DM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000447; Chen MY, 2009, JAIDS-J ACQ IMM DEF, V50, P375, DOI 10.1097/QAI.0b013e318198a7e6; CHISEMBELE M, 2010, 17 C RET OPP INF SAN; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Cummins JE, 2007, ANTIMICROB AGENTS CH, V51, P1770, DOI 10.1128/AAC.01129-06; Dezzutti CS, 2004, ANTIMICROB AGENTS CH, V48, P3834, DOI 10.1128/AAC.48.10.3834-3844.2004; Etemad-Moghadam B, 2000, J VIROL, V74, P4433, DOI 10.1128/JVI.74.9.4433-4440.2000; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; Fletcher PS, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-46; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gajbhiye V, 2009, J PHARM PHARMACOL, V61, P989, DOI 10.1211/jpp/61.08.0002; Galen BT, 2007, J INFECT DIS, V195, P1332, DOI 10.1086/513279; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; Gong E, 2005, ANTIVIR RES, V68, P139, DOI 10.1016/j.antiviral.2005.08.004; Gorry PR, 2001, J VIROL, V75, P10073, DOI 10.1128/JVI.75.21.10073-10089.2001; Gray L, 2005, VIROLOGY, V337, P384, DOI 10.1016/j.virol.2005.04.034; Hantson Anke, 2005, Antiviral Chemistry & Chemotherapy, V16, P253; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huskens D, 2009, ANTIVIR RES, V84, P38, DOI 10.1016/j.antiviral.2009.07.013; Jiang YH, 2005, AIDS RES HUM RETROV, V21, P207, DOI 10.1089/aid.2005.21.207; *JOINT UN PROGR HI, 2003, STIGMA DISCRIMINATIO; Kaminskas LM, 2007, MOL PHARMACEUT, V4, P949, DOI 10.1021/mp070047s; KARIM QA, 2010, SCIENCE         0719; Karim SA, 2009, 16 C RETR OPP INF MO; Ketas TJ, 2007, VIROLOGY, V364, P281, DOI 10.1016/j.virol.2007.02.022; Lacey CJN, 2006, AIDS, V20, P1027, DOI 10.1097/01.aids.0000222075.83490.ca; Lackman-Smith C, 2008, ANTIMICROB AGENTS CH, V52, P1768, DOI 10.1128/AAC.01328-07; LEVY JA, 1988, JAMA-J AM MED ASSOC, V259, P3037, DOI 10.1001/jama.259.20.3037; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; MATTHEWS BR, 2002, Patent No. 02079299; McCarthy TD, 2005, MOL PHARMACEUT, V2, P312, DOI 10.1021/mp050023q; McElrath MJ, 2010, ANTIMICROB AGENTS CH, V54, P763, DOI 10.1128/AAC.00891-09; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Moore JP, 2003, P NATL ACAD SCI USA, V100, P10598, DOI 10.1073/pnas.1932511100; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; Nanjwade BK, 2009, EUR J PHARM SCI, V38, P185, DOI 10.1016/j.ejps.2009.07.008; O'Loughlin J, 2010, SEX TRANSM DIS, V37, P100, DOI 10.1097/OLQ.0b013e3181bc0aac; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; PRICE CF, 2010, SPL7013 GEL VIVAGEL; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Roberts BP, 2009, MACROMOLECULES, V42, P2775, DOI 10.1021/ma802154e; Rusconi S, 1996, ANTIMICROB AGENTS CH, V40, P234, DOI 10.1128/AAC.40.1.234; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Scordi-Bello IA, 2005, ANTIMICROB AGENTS CH, V49, P3607, DOI 10.1128/AAC.49.9.3607-3615.2005; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Sonza S, 1996, J VIROL, V70, P3863, DOI 10.1128/JVI.70.6.3863-3869.1996; Sonza S, 2009, ANTIMICROB AGENTS CH, V53, P3565, DOI 10.1128/AAC.00102-09; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Springer CJ, 1995, J MED CHEM, V38, P5051, DOI 10.1021/jm00026a013; Sterjovski J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-89; Tao W, 2008, AIDS RES HUM RETROV, V24, P925, DOI 10.1089/aid.2008.0043; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Witvrouw M, 2000, MOL PHARMACOL, V58, P1100, DOI 10.1124/mol.58.5.1100; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335; Zhang YJ, 2002, J VIROL, V76, P6332, DOI 10.1128/JVI.76.12.6332-6343.2002	70	134	137	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12309	10.1371/journal.pone.0012309	http://dx.doi.org/10.1371/journal.pone.0012309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808791	gold, Green Published			2022-12-25	WOS:000281153500004
J	Wolford, JL; Chishti, Y; Jin, QL; Ward, J; Chen, LH; Vogt, S; Finney, L				Wolford, Janet L.; Chishti, Yasmin; Jin, Qiaoling; Ward, Jesse; Chen, Liaohai; Vogt, Stefan; Finney, Lydia			Loss of Pluripotency in Human Embryonic Stem Cells Directly Correlates with an Increase in Nuclear Zinc	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; FLUORESCENT SENSORS; DIFFERENTIATION; METALLOTHIONEIN; CHROMATIN; BIOLOGY; ACTIVATION; COPPER	The pluripotency of human embryonic stem cells (hESCs) is important to investigations of early development and to cell replacement therapy, but the mechanism behind pluripotency is incompletely understood. Zinc has been shown to play a key role in differentiation of non-pluripotent cell types, but here its role in hESCs is directly examined. By mapping the distribution of metals in hESCs at high resolution by x-ray fluorescence microprobe (XFM) and by analyzing subcellular metal content, we have found evidence that loss of pluripotency is directly correlated with an increase in nuclear zinc. Zinc elevation not only redefines our understanding of the mechanisms that support pluripotency, but also may act as a biomarker and an intervention point for stem cell differentiation.	[Wolford, Janet L.; Chishti, Yasmin; Jin, Qiaoling; Chen, Liaohai; Finney, Lydia] Argonne Natl Lab, Adv Photon Source, Biosci Div, Argonne, IL 60439 USA; [Ward, Jesse; Vogt, Stefan; Finney, Lydia] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory	Wolford, JL (corresponding author), Argonne Natl Lab, Adv Photon Source, Biosci Div, Argonne, IL 60439 USA.	lfinney@anl.gov	Jin, Qiaoling/D-2303-2016; Vogt, Stefan/B-9547-2009; Vogt, Stefan/J-7937-2013	Vogt, Stefan/0000-0002-8034-5513; Vogt, Stefan/0000-0002-8034-5513	Department of Energy Office of Science [DE-AC02-06CH11357]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	Department of Energy Office of Science(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work, including use of the Advanced Photon Source at Argonne National Laboratory, was supported by the Department of Energy Office of Science under contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Siva S. K. Dasa for support in the maintenance of our cell cultures. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357.	Adamczyk M, 2007, FEBS LETT, V581, P1409, DOI 10.1016/j.febslet.2007.02.063; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Bell SG, 2009, CHEMBIOCHEM, V10, P55, DOI 10.1002/cbic.200800511; Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Burdette SC, 2001, J AM CHEM SOC, V123, P7831, DOI 10.1021/ja010059l; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Chen LY, 2008, HUM MOL GENET, V17, pR23, DOI 10.1093/hmg/ddn050; CHERIAN MG, 1994, ENVIRON HEALTH PERSP, V102, P131, DOI 10.2307/3431776; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Domaille DW, 2008, NAT CHEM BIOL, V4, P168, DOI 10.1038/nchembio.69; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Finney L, 2007, P NATL ACAD SCI USA, V104, P2247, DOI 10.1073/pnas.0607238104; Finney L, 2010, ACS CHEM BIOL, V5, P577, DOI 10.1021/cb1000263; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; Gee KR, 2002, CELL CALCIUM, V31, P245, DOI 10.1016/S0143-4160(02)00053-2; Gee KR, 2002, J AM CHEM SOC, V124, P776, DOI 10.1021/ja011774y; Glesne D, 2006, J STRUCT BIOL, V155, P2, DOI 10.1016/j.jsb.2005.09.012; GRUMMT F, 1986, EXP CELL RES, V163, P191, DOI 10.1016/0014-4827(86)90572-0; Hirano T, 2000, J AM CHEM SOC, V122, P12399, DOI 10.1021/ja002467f; Huang HR, 2006, BIOCHEM BIOPH RES CO, V351, P321, DOI 10.1016/j.bbrc.2006.09.171; IDO A, 1994, DEV BIOL, V163, P184, DOI 10.1006/dbio.1994.1134; Keenen B, 2009, J CELL PHYSIOL, V219, P1, DOI 10.1002/jcp.21654; Kelleher SL, 2009, GENES NUTR, V4, P83, DOI 10.1007/s12263-009-0119-4; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kobrossy L, 2006, J BIOL CHEM, V281, P25926, DOI 10.1074/jbc.M602555200; Lee SJ, 2009, GLIA, V57, P1351, DOI 10.1002/glia.20854; Maret W, 2000, J NUTR, V130, p1455S, DOI 10.1093/jn/130.5.1455S; NAGEL WW, 1995, P NATL ACAD SCI USA, V92, P579, DOI 10.1073/pnas.92.2.579; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Park SW, 2005, J NEUROSCI, V25, P3350, DOI 10.1523/JNEUROSCI.0186-05.2005; Paunesku T, 2006, J CELL BIOCHEM, V99, P1489, DOI 10.1002/jcb.21047; PETRIE L, 1991, BIOCHEM J, V276, P109, DOI 10.1042/bj2760109; SAAVEDRA RA, 1986, SCIENCE, V234, P1589, DOI 10.1126/science.3787266; Schmidt C, 1999, ARCH BIOCHEM BIOPHYS, V364, P91, DOI 10.1006/abbi.1999.1107; Suhy DA, 1999, J BIOL CHEM, V274, P9183, DOI 10.1074/jbc.274.14.9183; Takahashi Y, 2005, J CELL PHYSIOL, V202, P563, DOI 10.1002/jcp.20158; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Vogt S, 2003, J PHYS IV, V104, P635, DOI 10.1051/jp4:20030160; Wang ZX, 2007, STEM CELLS, V25, P2173, DOI 10.1634/stemcells.2007-0085; Wang ZX, 2008, STEM CELLS, V26, P2791, DOI 10.1634/stemcells.2008-0443; Yang LC, 2005, P NATL ACAD SCI USA, V102, P11179, DOI 10.1073/pnas.0406547102; ZALEWSKI PD, 1994, J HISTOCHEM CYTOCHEM, V42, P877, DOI 10.1177/42.7.8014471; [No title captured]	45	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12308	10.1371/journal.pone.0012308	http://dx.doi.org/10.1371/journal.pone.0012308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808840	Green Published, Green Submitted, gold			2022-12-25	WOS:000281077000013
J	Sinkkonen, L; Hugenschmidt, T; Filipowicz, W; Svoboda, P				Sinkkonen, Lasse; Hugenschmidt, Tabea; Filipowicz, Witold; Svoboda, Petr			Dicer Is Associated with Ribosomal DNA Chromatin in Mammalian Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; POLYMERASE-I TRANSCRIPTION; RNA GENES; FISSION YEAST; INTERGENIC TRANSCRIPTS; METHYLATION; PROMOTER; HETEROCHROMATIN; INTERFERENCE; HYPERMETHYLATION	Background: RNA silencing is a common term for pathways utilizing small RNAs as sequence-specific guides to repress gene expression. Components of the RNA silencing machinery are involved in different aspects of chromatin function in numerous organisms. However, association of RNA silencing with chromatin in mammalian cells remains unclear. Methodology/Principal Findings: Immunostaining of mitotic chromosomes with antibodies visualizing either endogenous or ectopically expressed Dicer in mammalian cells revealed association of the protein with ribosomal DNA (rDNA) repeats. Chromatin immunoprecipitations and bisulfite sequencing experiments indicated that Dicer is associated with transcribed regions of both active and silenced genes in rDNA arrays of interphase chromosomes. Metabolic labeling of the mouse embryonic stem (ES) cells lacking Dicer did not reveal apparent defect in rRNA biogenesis though pre-rRNA synthesis in these cells was decreased, likely as a consequence of their slower growth caused by the loss of miRNAs. We analyzed in detail chromatin structure of rDNA but did not find any epigenetic changes at rDNA loci in Dicer(-/-) ES cells. Instead, we found that rDNA methylation is rather low in primary tissues, contrasting with rDNA methylation patterns in transformed cell lines. Conclusion/Significance: We found that Dicer, a key component of RNA silencing pathways, can be detected in association with rDNA chromatin in mammalian cells. The role of this particular localization of Dicer is not readily apparent since the enzyme is associated with rDNA genes regardless of their transcriptional activity. However, localization of Dicer to the transcribed region suggests that transcription may contribute to the Dicer deposition at rDNA chromatin. We hypothesize that Dicer functions in maintaining integrity of rDNA arrays.	[Sinkkonen, Lasse; Hugenschmidt, Tabea; Filipowicz, Witold; Svoboda, Petr] Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Sinkkonen, L (corresponding author), Univ Luxembourg, Life Sci Res Unit, Luxembourg, Luxembourg.	filipowi@fmi.ch; svobodap@img.cas.cz	Sinkkonen, Lasse/AAL-7906-2021; Svoboda, Petr/G-3890-2012	Sinkkonen, Lasse/0000-0002-4223-3027; Svoboda, Petr/0000-0002-4370-3705	Novartis Research Foundation; European Community; European Molecular Biology Organization (EMBO) [1488]; GACR [P305/10/2215]; Purkynje Fellowship	Novartis Research Foundation; European Community(European Commission); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); GACR(Grant Agency of the Czech Republic); Purkynje Fellowship	Friedrich Miescher Institute is supported by the Novartis Research Foundation. Work in WF laboratory is supported by the European Community FP7 Integrated Project "Sirocco". PS work is supported by the European Molecular Biology Organization Strategic Development Installation Grant (EMBO SDIG) program #1488, GACR P305/10/2215, and the Purkynje Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P268, DOI 10.1038/nsmb.1399; Brown SE, 2007, MOL CELL BIOL, V27, P4938, DOI 10.1128/MCB.01880-06; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Calabrese JM, 2006, RNA, V12, P2092, DOI 10.1261/rna.224606; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cecere G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-44; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Ciarmatori S, 2001, MOL CELL BIOL, V21, P5806, DOI 10.1128/MCB.21.17.5806-5814.2001; Emmerth S, 2010, DEV CELL, V18, P102, DOI 10.1016/j.devcel.2009.11.011; FRITZ J, 2009, MOL CELL BIOL; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Giles KE, 2010, NAT CELL BIOL, V12, P94, DOI 10.1038/ncb2010; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; Haussecker D, 2005, MOL CELL BIOL, V25, P9724, DOI 10.1128/MCB.25.21.9724-9733.2005; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kochanek S, 1996, FEBS LETT, V388, P192, DOI 10.1016/0014-5793(96)00506-6; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Li CH, 2006, MOL BIOL CELL, V17, P3848, DOI 10.1091/mbc.E06-03-0205; Mais C, 2005, GENE DEV, V19, P50, DOI 10.1101/gad.310705; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Mayer C, 2008, EMBO REP, V9, P774, DOI 10.1038/embor.2008.109; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nemeth A, 2008, EMBO J, V27, P1255, DOI 10.1038/emboj.2008.57; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; Oakes CC, 2003, P NATL ACAD SCI USA, V100, P1775, DOI 10.1073/pnas.0437971100; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Reddy KS, 1998, HUM GENET, V102, P653, DOI 10.1007/s004390050758; Riddle NC, 2008, CURR TOP MICROBIOL, V320, P185; ROUSSEL P, 1993, J CELL SCI, V104, P327; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Sinkkonen L, 2005, NUCLEIC ACIDS RES, V33, P2440, DOI 10.1093/nar/gki502; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Svoboda P, 2004, CYTOGENET GENOME RES, V105, P422, DOI 10.1159/000078215; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Wu HJ, 2000, J BIOL CHEM, V275, P36957, DOI 10.1074/jbc.M005494200; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zhou YG, 2005, CURR BIOL, V15, P1434, DOI 10.1016/j.cub.2005.06.057	51	59	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12175	10.1371/journal.pone.0012175	http://dx.doi.org/10.1371/journal.pone.0012175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730047	Green Submitted, gold, Green Published			2022-12-25	WOS:000280862200026
J	Alger, SE; Lau, HY; Fishbein, W				Alger, Sara E.; Lau, Hiuyan; Fishbein, William			Delayed Onset of a Daytime Nap Facilitates Retention of Declarative Memory	PLOS ONE			English	Article							SLOW-WAVE SLEEP; EYE-MOVEMENT SLEEP; SYNAPTIC HOMEOSTASIS; PARADOXICAL SLEEP; PROCEDURAL MEMORY; EMOTIONAL MEMORY; REM-SLEEP; CONSOLIDATION; HIPPOCAMPUS; INCREASES	Background: Learning followed by a period of sleep, even as little as a nap, promotes memory consolidation. It is now generally recognized that sleep facilitates the stabilization of information acquired prior to sleep. However, the temporal nature of the effect of sleep on retention of declarative memory is yet to be understood. We examined the impact of a delayed nap onset on the recognition of neutral pictorial stimuli with an added spatial component. Methodology/Principal Findings: Participants completed an initial study session involving 150 neutral pictures of people, places, and objects. Immediately following the picture presentation, participants were asked to make recognition judgments on a subset of "old'', previously seen, pictures versus intermixed "new'' pictures. Participants were then divided into one of four groups who either took a 90-minute nap immediately, 2 hours, or 4 hours after learning, or remained awake for the duration of the experiment. 6 hours after initial learning, participants were again tested on the remaining "old'' pictures, with "new'' pictures intermixed. Conclusions/Significance: Interestingly, we found a stabilizing benefit of sleep on the memory trace reflected as a significant negative correlation between the average time elapsed before napping and decline in performance from test to retest (p = .001). We found a significant interaction between the groups and their performance from test to retest (p = .010), with the 4-hour delay group performing significantly better than both those who slept immediately and those who remained awake (p = .044, p = .010, respectively). Analysis of sleep data revealed a significant positive correlation between amount of slow wave sleep (SWS) achieved and length of the delay before sleep onset (p = .048). The findings add to the understanding of memory processing in humans, suggesting that factors such as waking processing and homeostatic increases in need for sleep over time modulate the importance of sleep to consolidation of neutral declarative memories.	[Alger, Sara E.; Lau, Hiuyan; Fishbein, William] CUNY City Coll, Dept Psychol, Cognit Neurosci Subprogram, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Alger, SE (corresponding author), CUNY City Coll, Dept Psychol, Cognit Neurosci Subprogram, New York, NY 10031 USA.	sealger78@gmail.com		Alger, Sara/0000-0002-5078-6510	CUNY Research Foundation (PSC-CUNY) [PSCREG -38-661]	CUNY Research Foundation (PSC-CUNY)	This work was supported by the CUNY Research Foundation (PSC-CUNY) Grant #: PSCREG -38-661 to WF. http://www.rfcuny.org/rfwebsite/research/content.aspx?catID=1190. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhaus J, 2008, NEUROBIOL LEARN MEM, V89, P76, DOI 10.1016/j.nlm.2007.08.010; Backhaus J, 2006, SLEEP MED, V7, P508, DOI 10.1016/j.sleep.2006.04.002; Baran B, 2010, EXP BRAIN RES, V203, P471, DOI 10.1007/s00221-010-2242-2; Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; Behrens CJ, 2005, NAT NEUROSCI, V8, P1560, DOI 10.1038/nn1571; BENINGTON JH, 1995, BRAIN RES, V692, P79, DOI 10.1016/0006-8993(95)00590-M; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cohen DA, 2005, P NATL ACAD SCI USA, V102, P18237, DOI 10.1073/pnas.0506072102; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; EKSTRAND BR, 1967, J EXP PSYCHOL, V75, P64, DOI 10.1037/h0024907; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; Ellenbogen JM, 2006, CURR OPIN NEUROBIOL, V16, P716, DOI 10.1016/j.conb.2006.10.006; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; FISHBEIN W, 1977, BEHAV BIOL, V19, P425, DOI 10.1016/S0091-6773(77)91903-4; FISHBEIN W, 1971, SCIENCE, V172, P80, DOI 10.1126/science.172.3978.80; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; Gais S, 2002, J NEUROSCI, V22, P6830; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Hu P, 2006, PSYCHOL SCI, V17, P891, DOI 10.1111/j.1467-9280.2006.01799.x; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kali S, 2004, NAT NEUROSCI, V7, P286, DOI 10.1038/nn1202; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Nishida M, 2009, CEREB CORTEX, V19, P1158, DOI 10.1093/cercor/bhn155; Payne JD, 2008, PSYCHOL SCI, V19, P781, DOI 10.1111/j.1467-9280.2008.02157.x; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Racsmany M, 2010, PSYCHOL SCI, V21, P80, DOI 10.1177/0956797609354074; RADULOVACKI M, 1982, BRAIN RES, V246, P178, DOI 10.1016/0006-8993(82)90161-5; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Retey JV, 2005, P NATL ACAD SCI USA, V102, P15676, DOI 10.1073/pnas.0505414102; Ritchey M, 2008, CEREB CORTEX, V18, P2494, DOI 10.1093/cercor/bhm262; Schabus M, 2005, SOMNOLOGIE, V9, P148, DOI [DOI 10.1111/J.1439-054X.2005.00054.X, 10.1111/j.1439-054X.2005.00054, DOI 10.1111/J.1439-054X.2005.00054]; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; Smith C, 1996, BEHAV BRAIN RES, V78, P49, DOI 10.1016/0166-4328(95)00218-9; SMITH C, 1991, CAN J PSYCHOL, V45, P115, DOI 10.1037/h0084279; Sterpenich V, 2009, J NEUROSCI, V29, P5143, DOI 10.1523/JNEUROSCI.0561-09.2009; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Tucker MA, 2006, NEUROBIOL LEARN MEM, V86, P241, DOI 10.1016/j.nlm.2006.03.005; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	52	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12131	10.1371/journal.pone.0012131	http://dx.doi.org/10.1371/journal.pone.0012131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	637ZU	20808821	Green Published, gold			2022-12-25	WOS:000280859700020
J	Brekhman, V; Lugassie, J; Zaffryar-Eilot, S; Sabo, E; Kessler, O; Smith, V; Golding, H; Neufeld, G				Brekhman, Vera; Lugassie, Jennie; Zaffryar-Eilot, Shelly; Sabo, Edmond; Kessler, Ofra; Smith, Victoria; Golding, Hana; Neufeld, Gera			Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2	FASEB JOURNAL			English	Article						LOXL2; RAMP3; invasion; tumor progression	TUMOR PROGRESSION; CANCER-CELLS; CALCITONIN RECEPTOR; MOLECULAR ROLE; IN-VIVO; ADRENOMEDULLIN; AMYLIN; GROWTH; INVASION; ANGIOGENESIS	Lysyl oxidase-like protein-2 (LOXL2) induces epithelial to mesenchymal transition and promotes invasiveness. To understand the mechanisms involved, we examined the effect of LOXL2 overexpression in MCF-7 cells on gene expression. We found that LOXL2 up-regulated the expression of receptor activity modifying protein-3 (RAMP3). Expression of RAMP3 in MDA-MB-231 cells in which LOXL2 expression was inhibited restored vimentin expression, invasiveness, and tumor development. Inhibition of RAMP3 expression in MDA-MB-231 cells mimicked the effects produced by inhibition of LOXL2 expression and was accompanied by inhibition of p38 phosphorylation. LOXL2 overexpression in these cells did not restore invasiveness, suggesting that RAMP3 functions downstream to LOXL2. LOXL2 and RAMP3 are strongly coexpressed in human colon, breast, and gastric carcinomas but not in normal colon or gastric epithelial cells. RAMP3 associates with several G-protein-coupled receptors forming receptors for peptides, such as adrenomedullin and amylin. We hypothesized that RAMP3 could function as a transducer of autocrine signals induced by such peptides. However, the proinvasive effects of RAMP3 could not be abrogated following inhibition of the expression or activity of these peptides. Our experiments suggest that the protumorigenic effects of LOXL2 are partially mediated by RAMP3 and that RAMP3 inhibitors may function as antitumorigenic agents.-Brekhman, V., Lugassie, J., Zaffryar-Eilot, S., Sabo, E., Kessler, O., Smith, V., Golding, H., Neufeld, G. Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2. FASEB J. 25, 55-65 (2011). www.fasebj.org	[Brekhman, Vera; Lugassie, Jennie; Zaffryar-Eilot, Shelly; Sabo, Edmond; Kessler, Ofra; Neufeld, Gera] Technion Israel Inst Technol, Canc Res & Vasc Biol Ctr, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; [Sabo, Edmond] Rambam Med Ctr, Haifa, Israel; [Smith, Victoria] Arresto Biosci Inc, Palo Alto, CA USA; [Golding, Hana] Food & Drug Adm, Ctr Biol Evaluat & Res, Bethesda, MD USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Technion Israel Institute of Technology; US Food & Drug Administration (FDA)	Neufeld, G (corresponding author), Technion Israel Inst Technol, Canc Res & Vasc Biol Ctr, Bruce Rappaport Fac Med, POB 9679,1 Efron St, IL-31096 Haifa, Israel.	gera@tx.technion.ac.il	Neufeld, Gera/F-1524-2019		Arresto Biosciences Inc. (Palo Alto, CA, USA); U.S. Army [W81XWH-04-1-0430]	Arresto Biosciences Inc. (Palo Alto, CA, USA); U.S. Army(United States Department of DefenseUnited States Army)	This work was funded, in part, by a grant from Arresto Biosciences Inc. (Palo Alto, CA, USA; G.N.) and in part by a grant from the U.S. Army (W81XWH-04-1-0430; G.N. and H. G.). The authors thank Dr. Scott Ogg for critically reading the manuscript. The authors thank Dr. Robert Kerbel (Women's College Health Sciences Centre, Toronto, ON, Canada) and Dr. Israel Vlodavsky (Faculty of Medicine, Technion, Haifa, Israel) for gifts of cells.	Akiri G, 2003, CANCER RES, V63, P1657; Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; BAE SN, 1993, BREAST CANCER RES TR, V24, P241, DOI 10.1007/BF01833264; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Born W, 2002, RECEPTOR CHANNEL, V8, P201, DOI 10.1080/10606820213683; Bouschet T, 2005, J CELL SCI, V118, P4709, DOI 10.1242/jcs.02598; BOYER B, 1989, INT J CANCER, P69; Brekhman V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-415; DEEMS RO, 1991, BIOCHEM BIOPH RES CO, V181, P116, DOI 10.1016/S0006-291X(05)81389-0; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fernandez-Sauze S, 2004, INT J CANCER, V108, P797, DOI 10.1002/ijc.11663; Gibbons C, 2007, MOL ENDOCRINOL, V21, P783, DOI 10.1210/me.2006-0156; GITAYGOREN H, 1993, BIOCHEM BIOPH RES CO, V190, P702, DOI 10.1006/bbrc.1993.1106; Harikumar KG, 2009, BIOCHEMISTRY-US, V48, P11773, DOI 10.1021/bi901326k; Hornstra IK, 2003, J BIOL CHEM, V278, P14387, DOI 10.1074/jbc.M210144200; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kigel B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003287; Kirschmann DA, 2002, CANCER RES, V62, P4478; Kumar B, 2010, CANCER RES, V70, P832, DOI 10.1158/0008-5472.CAN-09-2918; Lerner U. H., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P87; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Matsushita A, 2007, CANCER RES, V67, P10309, DOI 10.1158/0008-5472.CAN-07-3256; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Muff R, 1999, ENDOCRINOLOGY, V140, P2924, DOI 10.1210/en.140.6.2924; Munoz R, 2006, CANCER RES, V66, P3386, DOI 10.1158/0008-5472.CAN-05-4411; Nakamura M, 2006, CURR CANCER DRUG TAR, V6, P635, DOI 10.2174/156800906778742442; Oehler MK, 2002, ONCOGENE, V21, P2815, DOI 10.1038/sj.onc.1205374; Oehler MK, 2001, ONCOGENE, V20, P2937, DOI 10.1038/sj.onc.1204422; Ouafik L, 2002, AM J PATHOL, V160, P1279, DOI 10.1016/S0002-9440(10)62555-2; Parameswaran N, 2006, TRENDS BIOCHEM SCI, V31, P631, DOI 10.1016/j.tibs.2006.09.006; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2008, CANCER RES, V68, P4541, DOI 10.1158/0008-5472.CAN-07-6345; Peng L, 2009, CARCINOGENESIS, V30, P1660, DOI 10.1093/carcin/bgp178; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Piao FL, 2004, REGUL PEPTIDES, V117, P159, DOI 10.1016/j.regpep.2003.10.005; Popa I, 2007, INT IMMUNOL, V19, P1249, DOI 10.1093/intimm/dxm092; Samonina G.E., 2004, Pathophysiology, V11, P1, DOI 10.1016/j.pathophys.2003.10.008; Schietke R. E., 2009, J BIOL CHEM; Varshavsky A, 2008, CANCER RES, V68, P6922, DOI 10.1158/0008-5472.CAN-07-5408; Wookey PJ, 2006, THESCIENTIFICWORLDJO, V6, P1642, DOI 10.1100/tsw.2006.263	43	35	36	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					55	65		10.1096/fj.10-162677	http://dx.doi.org/10.1096/fj.10-162677			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20802105				2022-12-25	WOS:000285869500006
J	Nevo, J; Mai, A; Tuomi, S; Pellinen, T; Pentikainen, OT; Heikkila, P; Lundin, J; Joensuu, H; Bono, P; Ivaska, J				Nevo, J.; Mai, A.; Tuomi, S.; Pellinen, T.; Pentikainen, O. T.; Heikkila, P.; Lundin, J.; Joensuu, H.; Bono, P.; Ivaska, J.			Mammary-derived growth inhibitor (MDGI) interacts with integrin alpha-subunits and suppresses integrin activity and invasion	ONCOGENE			English	Article						integrin; MDGI; breast cancer; adhesion; migration; invasion	FATTY-ACID-BINDING; BREAST-CANCER; PROXIMITY LIGATION; BETA(1) INTEGRIN; CELL-MIGRATION; IN-SITU; ACTIVATION; PROTEIN; ADHESION; TALIN	The majority of mortality associated with cancer is due to formation of metastases from the primary tumor. Adhesion mediated by different integrin heterodimers has an important role during cell migration and invasion. Protein interactions with the beta 1-integrin cytoplasmic tail are known to influence integrin affinity for extracellular ligands, but regulating binding partners for the alpha-subunit cytoplasmic tails have remained elusive. In this study, we show that mammary-derived growth inhibitor (MDGI) (also known as FABP-3 or H-FABP) binds directly to the cytoplasmic tail of integrin alpha-subunits and its expression inhibits integrin activity. In breast cancer cell lines, MDGI expression correlates with suppression of the active conformation of integrins. This results in reduced integrin adhesion to type I collagen and fibronectin and inhibition of cell migration and invasion. In tissue microarray of 1331 breast cancer patients, patients with MDGI-positive tumors had more favorable 10-year distant disease-free survival compared with patients with MDGI-negative tumors. Our data indicate that MDGI is a novel interacting partner for integrin alpha-subunits, and its expression modulates integrin activity and suppresses cell invasion in breast cancer patients. Retained MDGI expression is associated with favorable prognosis. Oncogene (2010) 29, 6452-6463; doi:10.1038/onc.2010.376; published online 30 August 2010	[Ivaska, J.] Univ Turku, VTT Med Biotechnol, Turku Ctr Biotechnol, FIN-20520 Turku, Finland; [Nevo, J.; Mai, A.; Tuomi, S.; Pellinen, T.; Ivaska, J.] VTT Tech Res Ctr Finland, Turku, Finland; [Nevo, J.; Mai, A.; Tuomi, S.; Pellinen, T.; Ivaska, J.] Abo Akad Univ, Turku, Finland; [Pentikainen, O. T.] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Pentikainen, O. T.] Univ Jyvaskyla, Nanosci Ctr, Jyvaskyla, Finland; [Heikkila, P.] Helsinki Univ Hosp, Dept Pathol, Helsinki, Finland; [Lundin, J.; Joensuu, H.; Bono, P.] Helsinki Univ Hosp, Dept Oncol, Helsinki, Finland; [Ivaska, J.] Univ Turku, Dept Biochem & Food Chem, FIN-20520 Turku, Finland	University of Turku; VTT Technical Research Center Finland; VTT Technical Research Center Finland; Abo Akademi University; University of Jyvaskyla; University of Jyvaskyla; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Turku	Ivaska, J (corresponding author), Univ Turku, VTT Med Biotechnol, Turku Ctr Biotechnol, Itainen Pitkakatu 4C, FIN-20520 Turku, Finland.	johanna.ivaska@vtt.fi	Lundin, Johan/I-1843-2018; Lundin, Johan/AAC-8510-2020; Pentikäinen, Olli T/E-1980-2012	Lundin, Johan/0000-0002-2681-4139; Lundin, Johan/0000-0002-2681-4139; Pentikäinen, Olli T/0000-0001-7188-4016; Joensuu, Heikki/0000-0003-0281-2507; Ivaska, Johanna/0000-0002-6295-6556	Academy of Finland; ERC; Sigrid Juselius Foundation; EMBO YIP Cancer Organization; Finnish Cancer Organization; Maud Kuistila Memorial Foundation; Turku University Foundation; Turku Graduate School of Biomedical Sciences; Drug Discovery Graduate School	Academy of Finland(Academy of Finland); ERC(European Research Council (ERC)European Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); EMBO YIP Cancer Organization; Finnish Cancer Organization; Maud Kuistila Memorial Foundation; Turku University Foundation; Turku Graduate School of Biomedical Sciences; Drug Discovery Graduate School	We thank Professor J Ylanne and Professor M Salmi for critically reviewing the paper; J Siivonen, H Marttila, O Levalampi and P Terho for the excellent technical assistance. This study has been supported by Academy of Finland, ERC Starting Grant, Sigrid Juselius Foundation, EMBO YIP and Finnish Cancer Organizations. JN has been supported by Maud Kuistila Memorial Foundation and Turku University Foundation. JN, ST and TP were supported by Turku Graduate School of Biomedical Sciences and AM by Drug Discovery Graduate School.	Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Bottcher RT, 2009, CURR OPIN CELL BIOL, V21, P670, DOI 10.1016/j.ceb.2009.05.008; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Bouvard D, 2003, J BIOL CHEM, V278, P6567, DOI 10.1074/jbc.M211258200; Brandt DT, 2009, NAT CELL BIOL, V11, P557, DOI 10.1038/ncb1862; Byron A, 2009, J CELL SCI, V122, P4009, DOI 10.1242/jcs.056770; Clark AJ, 2000, TRANSGENIC RES, V9, P439, DOI 10.1023/A:1026552629493; Czuchra A, 2006, J CELL BIOL, V174, P889, DOI 10.1083/jcb.200604060; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X; Huynh H, 1997, CLIN CANCER RES, V3, P2151; Huynh H, 1996, CANCER RES, V56, P4865; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Koistinen P, 1999, MATRIX BIOL, V18, P239, DOI 10.1016/S0945-053X(99)00022-0; KURTZ A, 1990, J CELL BIOL, V110, P1779, DOI 10.1083/jcb.110.5.1779; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Lucke C, 2001, BIOCHEM J, V354, P259, DOI 10.1042/0264-6021:3540259; Lundin J, 2001, J CLIN ONCOL, V19, P28, DOI 10.1200/JCO.2001.19.1.28; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142; Nevo J, 2009, CLIN CANCER RES, V15, P6570, DOI 10.1158/1078-0432.CCR-09-0773; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Tuomi S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000135; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Wang F, 2002, JNCI-J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494; Wang HL, 2000, ONCOGENE, V19, P2455, DOI 10.1038/sj.onc.1203575; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Yao ES, 2007, CANCER RES, V67, P659, DOI 10.1158/0008-5472.CAN-06-2768; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	47	35	38	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2010	29	49					6452	6463		10.1038/onc.2010.376	http://dx.doi.org/10.1038/onc.2010.376			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	692FP	20802519				2022-12-25	WOS:000285138900005
J	Foley, DA; Swartzentruber, KG; Thompson, MG; Mendiratta, SS; Colley, KJ				Foley, Deirdre A.; Swartzentruber, Kristin G.; Thompson, Matthew G.; Mendiratta, Shalu Shiv; Colley, Karen J.			Sequences from the First Fibronectin Type III Repeat of the Neural Cell Adhesion Molecule Allow O-Glycan Polysialylation of an Adhesion Molecule Chimera	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYSIALIC ACID SYNTHASE; IN-VIVO; HUMAN POLYSIALYLTRANSFERASE; NEURITE OUTGROWTH; NERVOUS-SYSTEM; LUNG-CANCER; WILMS TUMOR; N-CAM; NCAM; EXPRESSION	Polysialic acid is a developmentally regulated, anti-adhesive polymer that is added to N-glycans on the fifth immunoglobulin domain (Ig5) of the neural cell adhesion molecule (NCAM). We found that the first fibronectin type III repeat (FN1) of NCAM is required for the polysialylation of N-glycans on the adjacent Ig5 domain, and we proposed that the polysialyltransferases recognize specific sequences in FN1 to position themselves for Ig5 N-glycan polysialylation. Other studies identified a novel FN1 acidic surface patch and alpha-helix that play roles in NCAM polysialylation. Here, we characterize the contribution of two additional FN1 sequences, Pro(510)-Tyr(511)-Ser(512) (PYS) and Gln(516)-Val(517)-Gln(518) (QVQ). Replacing PYS or the acidic patch dramatically decreases the O-glycan polysialylation of a truncated NCAM protein, and replacing the alpha-helix or QVQ shifts polysialic acid to FN1 O-glycans in full-length NCAM. We also found that the FN1 domain of the olfactory cell adhesion molecule, a homologous but unpolysialylated protein, could partially replace NCAM FN1. Inserting Pro(510)-Tyr(511) eliminated N-glycan polysialylation and enhanced O-glycosylation of an NCAM-olfactory cell adhesion molecule chimera, and inserting other FN1 sequences unique to NCAM, predominantly the acidic patch, created a new polysialyltransferase recognition site. Taken together, our results highlight the role of the FN1 alpha-helix and QVQ sequences in N-glycan polysialylation and demonstrate that the acidic patch primarily functions in O-glycan polysialylation.	[Foley, Deirdre A.; Swartzentruber, Kristin G.; Thompson, Matthew G.; Mendiratta, Shalu Shiv; Colley, Karen J.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colley, KJ (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, 900 S Ash Land Ave,M-C 669, Chicago, IL 60607 USA.	karenc@uic.edu			National Institutes of Health [RO1 GM063843]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM063843 (to K. J. C.).	Alenius M, 1997, J BIOL CHEM, V272, P26083, DOI 10.1074/jbc.272.42.26083; Anderson AA, 2005, J NEUROCHEM, V95, P570, DOI 10.1111/j.1471-4159.2005.03417.x; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Asahina S, 2006, J BIOCHEM, V140, P687, DOI 10.1093/jb/mvj200; Campodonico PB, 2010, MOL CARCINOGEN, V49, P386, DOI 10.1002/mc.20611; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; Ditlevsen DK, 2008, J NEUROSCI RES, V86, P727, DOI 10.1002/jnr.21551; Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049; Drake PM, 2008, J IMMUNOL, V181, P6850, DOI 10.4049/jimmunol.181.10.6850; Drake PM, 2009, P NATL ACAD SCI USA, V106, P11995, DOI 10.1073/pnas.0905188106; Durbec P, 2001, MOL NEUROBIOL, V24, P53; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; FERNA N, 2010, ONCOLOGY */* E ONCOL, V78, P196; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; Foley DA, 2010, J BIOL CHEM, V285, P27360, DOI 10.1074/jbc.M110.140038; Francavilla C, 2009, J CELL BIOL, V187, P1101, DOI 10.1083/jcb.200903030; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Hamlin JA, 2004, J COMP NEUROL, V474, P438, DOI 10.1002/cne.20133; Hildebrandt H, 1998, CANCER RES, V58, P779; Hildebrandt H, 2009, BRAIN, V132, P2831, DOI 10.1093/brain/awp117; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; Kiss JZ, 2001, BRAIN RES REV, V36, P175, DOI 10.1016/S0165-0173(01)00093-5; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Martersteck CM, 1996, GLYCOBIOLOGY, V6, P289, DOI 10.1093/glycob/6.3.289; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; MU H, 1996, EMBO J */* R EMBO J, V15, P6943; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; PaoloniGiacobino A, 1997, GENOMICS, V43, P43, DOI 10.1006/geno.1997.4782; PELKONEN S, 1989, J VIROL, V63, P4409, DOI 10.1128/JVI.63.10.4409-4416.1989; ROTH J, 1988, AM J PATHOL, V133, P227; ROTH J, 1988, P NATL ACAD SCI USA, V85, P2999, DOI 10.1073/pnas.85.9.2999; ROTHBARD JB, 1982, J BIOL CHEM, V257, P1064; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; SCHEIDEGGER EP, 1994, LAB INVEST, V70, P95; Suzuki M, 2005, GLYCOBIOLOGY, V15, P887, DOI 10.1093/glycob/cwi071; Tanaka F, 2000, CANCER RES, V60, P3072; Walmod PS, 2004, NEUROCHEM RES, V29, P2015, DOI 10.1007/s11064-004-6875-z; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; Yoshida A, 1997, J BIOL CHEM, V272, P16884, DOI 10.1074/jbc.272.27.16884; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; ZUBER C, 1992, J BIOL CHEM, V267, P9965	55	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35056	35067		10.1074/jbc.M110.170209	http://dx.doi.org/10.1074/jbc.M110.170209			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20805222	hybrid, Green Published			2022-12-25	WOS:000283659100080
J	Schirmer, SH; Bot, PT; Fledderus, JO; van der Laan, AM; Volger, OL; Laufs, U; Bohm, M; de Vries, CJM; Horrevoets, AJG; Piek, JJ; Hoefer, IE; van Royen, N				Schirmer, Stephan H.; Bot, Pieter T.; Fledderus, Joost O.; van der Laan, A. M.; Volger, Oscar L.; Laufs, Ulrich; Boehm, Michael; de Vries, Carlie J. M.; Horrevoets, Anton J. G.; Piek, Jan J.; Hoefer, Imo E.; van Royen, Niels			Blocking Interferon beta Stimulates Vascular Smooth Muscle Cell Proliferation and Arteriogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATHEROSCLEROSIS; APOPTOSIS	Increased interferon (IFN)-beta signaling in patients with insufficient coronary collateralization and an inhibitory effect of IFN beta on collateral artery growth in mice have been reported. The mechanisms of IFN beta-induced inhibition of arteriogenesis are unknown. In stimulated monocytes from patients with chronic total coronary artery occlusion and decreased arteriogenic response, whole genome expression analysis showed increased expression of IFN beta-regulated genes. Immunohistochemically, the IFN beta receptor was localized in the vascular media of murine collateral arteries. Treatment of vascular smooth muscle cells (VSMC) with IFN beta resulted in an attenuated proliferation, cell-cycle arrest, and increased expression of cyclin-dependent kinase inhibitor-1A (p21). The growth inhibitory effect of IFN beta was attenuated by inhibition of p21 by RNA interference. IFN beta-treated THP1 monocytes showed enhanced apoptosis. Subsequently, we tested if collateral artery growth can be stimulated by inhibition of IFN beta-signaling. RNA interference of the IFN beta receptor-1 (IFNAR1) increased VSMC proliferation, cell cycle progression, and reduced p21 gene expression. IFN beta signaling and FAS and TRAIL expression were attenuated in monocytes from IFNAR1(-/-) mice, indicating reduced monocyte apoptosis. Hindlimb perfusion restoration 1 week after femoral artery ligation was improved in IFNAR1(-/-) mice compared with wild-type mice as assessed by infusion of fluorescent microspheres. These results demonstrate that IFN beta inhibits collateral artery growth and VSMC proliferation through p21-dependent cell cycle arrest and induction of monocyte apoptosis. Inhibition of IFN beta stimulates VSMC proliferation and collateral artery growth.	[Schirmer, Stephan H.; Bot, Pieter T.; van der Laan, A. M.; Piek, Jan J.; van Royen, Niels] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [de Vries, Carlie J. M.; Horrevoets, Anton J. G.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Boehm, Michael] Saarland Univ Hosp, Dept Cardiol, D-66421 Homburg, Germany; [Fledderus, Joost O.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, NL-3584 CX Utrecht, Netherlands; [Bot, Pieter T.; Hoefer, Imo E.] Univ Med Ctr Utrecht, Dept Expt Cardiol, NL-3584 CX Utrecht, Netherlands; [Volger, Oscar L.] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands; [van Royen, Niels] Vrije Univ Amsterdam Med Ctr, Dept Cardiol, NL-1081 BT Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Universitatsklinikum des Saarlandes; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Schirmer, SH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands.	stephan.schirmer@uks.eu	Fledderus, Joost O/D-5279-2011; Böhm, Michael/C-3638-2011; van Royen, Niels/Q-1097-2017	Fledderus, Joost O/0000-0002-7353-2572; 	Deutsche Forschungsgemeinschaft [SCHI 1012/1-1]; Netherlands Organisation for Scientific Research (NWO) [916-66-019, 050-10<SUP>-014</SUP>]; EU (European Vascular Genomics Network) [LSHM-CT-2003-503254]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); EU (European Vascular Genomics Network)(European Commission)	This study was supported by a grant from the Deutsche Forschungsgemeinschaft (to S. H. S.) (SCHI 1012/1-1), a VENI-grant by the Netherlands Organisation for Scientific Research (NWO) to N.v.R. (No. 916-66-019), and grants from the NWO (050-10<SUP>-014</SUP>) and the EU (European Vascular Genomics Network, LSHM-CT-2003-503254) (to A. J. G. H.).	ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; BENJAMINI Y, 1995, Y J Royal Statist So, V57, P289; BRU HLT, 2004, CIRC RES */* L CIRC, V94, P686; Celletti FL, 2001, NAT MED, V7, P425, DOI 10.1038/86490; Ehrlich S, 2003, CYTOKINE, V24, P244, DOI 10.1016/S1043-4666(03)00094-2; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Feau S, 2005, BLOOD, V105, P697, DOI 10.1182/blood-2004-03-1059; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008; Hoefer IE, 2002, CIRCULATION, V105, P1639, DOI 10.1161/01.CIR.0000014987.32865.8E; Katayama T, 2007, INT J ONCOL, V31, P613; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; MU L, 1994, SCIENCE */* M SCI, V264, P1918; Oehadian A, 2005, CANCER LETT, V225, P85, DOI 10.1016/j.canlet.2004.11.054; Rehman J, 2008, CIRC RES, V102, P1146, DOI 10.1161/CIRCRESAHA.108.177311; Schaper W, 2009, BASIC RES CARDIOL, V104, P5, DOI 10.1007/s00395-008-0760-x; Schirmer SH, 2004, CARDIOVASC RES, V64, P356, DOI 10.1016/j.cardiores.2004.06.022; Schirmer SH, 2008, CIRC RES, V102, P1286, DOI 10.1161/CIRCRESAHA.108.171827; Scholz D, 2000, VIRCHOWS ARCH, V436, P257, DOI 10.1007/s004280050039; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Van Weyenbergh J, 2001, J LEUKOCYTE BIOL, V70, P745; Zhang LN, 2008, ATHEROSCLEROSIS, V197, P204, DOI 10.1016/j.atherosclerosis.2007.03.019	24	36	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34677	34685		10.1074/jbc.M110.164350	http://dx.doi.org/10.1074/jbc.M110.164350			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20736166	hybrid, Green Published			2022-12-25	WOS:000283659100043
J	Tang, KH; Feng, XY; Zhuang, WQ; Alvarez-Cohen, L; Blankenship, RE; Tang, YJ				Tang, Kuo-Hsiang; Feng, Xueyang; Zhuang, Wei-Qin; Alvarez-Cohen, Lisa; Blankenship, Robert E.; Tang, Yinjie J.			Carbon Flow of Heliobacteria Is Related More to Clostridia than to the Green Sulfur Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL METABOLIC PATHWAYS; FLUX ANALYSIS; ISOTOPOMER; MODESTICALDUM; PROTEIN; ENZYME; NOV	The recently discovered heliobacteria are the only Gram-positive photosynthetic bacteria that have been cultured. One of the unique features of heliobacteria is that they have properties of both the photosynthetic green sulfur bacteria (containing the type I reaction center) and Clostridia (forming heat-resistant endospores). Most of the previous studies of heliobacteria, which are strict anaerobes and have the simplest known photosynthetic apparatus, have focused on energy and electron transfer processes. It has been assumed that like green sulfur bacteria, the major carbon flow in heliobacteria is through the (incomplete) reductive (reverse) tricarboxylic acid cycle, whereas the lack of CO2-enhanced growth has not been understood. Here, we report studies to fill the knowledge gap of heliobacterial carbon metabolism. We confirm that the CO2-anaplerotic pathway is active during phototrophic growth and that isoleucine is mainly synthesized from the citramalate pathway. Furthermore, to our surprise, our results suggest that the oxidative (forward) TCA cycle is operative and more active than the previously reported reductive (reverse) tricarboxylic acid cycle. Both isotopomer analysis and activity assays suggest that citrate is produced by a putative (Re)-citrate synthase and then enters the oxidative (forward) TCA cycle. Moreover, in contrast to (Si)citrate synthase, (Re)-citrate synthase produces a different isomer of 2-fluorocitrate that is not expected to inhibit the activity of aconitase.	[Tang, Kuo-Hsiang] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Tang, Kuo-Hsiang; Blankenship, Robert E.] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Feng, Xueyang; Tang, Yinjie J.] Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO 63130 USA; [Zhuang, Wei-Qin; Alvarez-Cohen, Lisa] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Berkeley	Tang, KH (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	j.tang@wustl.edu; yinjie.tang@seas.wustl.edu	Feng, Xueyang/G-1295-2015; Tang, Yinjie/AAI-5584-2020; ZHUANG, WEI-QIN/A-5235-2014	ZHUANG, WEI-QIN/0000-0001-9600-5225; Feng, Xueyang/0000-0003-4426-5732	National Science Foundation [MCB0954016]; NASA [NNX08AP62G]	National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	This work was supported by National Science Foundation Career Grant MCB0954016 (to Y. J. T.) and Exobiology Program of NASA Grant NNX08AP62G (to R. E. B.).	Asao M, 2010, PHOTOSYNTH RES, V104, P103, DOI 10.1007/s11120-009-9516-1; Baymann F, 2010, PHOTOSYNTH RES, V104, P177, DOI 10.1007/s11120-009-9524-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRYSCH K, 1987, ARCH MICROBIOL, V148, P264, DOI 10.1007/BF00456703; Feng XY, 2009, APPL ENVIRON MICROB, V75, P5001, DOI 10.1128/AEM.00715-09; Golbeck JH, 2010, PHOTOSYNTH RES, V104, P101, DOI 10.1007/s11120-010-9557-5; Heinnickel M, 2007, PHOTOSYNTH RES, V92, P35, DOI 10.1007/s11120-007-9162-4; Jahn U, 2007, J BACTERIOL, V189, P4108, DOI 10.1128/JB.00047-07; KIMBLE LK, 1995, ARCH MICROBIOL, V163, P259, DOI 10.1007/BF00393378; Lamzin VS, 1995, CURR OPIN STRUC BIOL, V5, P830, DOI 10.1016/0959-440X(95)80018-2; Lauble H, 1996, P NATL ACAD SCI USA, V93, P13699, DOI 10.1073/pnas.93.24.13699; Li FL, 2007, J BACTERIOL, V189, P4299, DOI 10.1128/JB.00198-07; Madigan MT, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P951, DOI 10.1007/0-387-30744-3_31; MARCUS A, 1956, J BIOL CHEM, V218, P823; Overmann J, 2006, PROKARYOTES, V7, P359, DOI DOI 10.1007/0-387-30747-8_13; PICKETT MW, 1994, PHOTOSYNTH RES, V41, P75, DOI 10.1007/BF02184147; Pingitore F, 2007, ANAL CHEM, V79, P2483, DOI 10.1021/ac061906b; Sattley WM, 2008, J BACTERIOL, V190, P4687, DOI 10.1128/JB.00299-08; Tang KH, 2010, J BIOL CHEM, V285, P35848, DOI 10.1074/jbc.M110.157834; Tang KH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-150; Tang KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007233; Tang KH, 2009, J BACTERIOL, V191, P3580, DOI 10.1128/JB.00110-09; Tang Y, 2007, J BACTERIOL, V189, P940, DOI 10.1128/JB.00948-06; Tang YJJ, 2007, APPL ENVIRON MICROB, V73, P718, DOI 10.1128/AEM.01532-06; Tang YJJ, 2009, J BACTERIOL, V191, P5224, DOI 10.1128/JB.00085-09; Wahl SA, 2004, BIOTECHNOL BIOENG, V85, P259, DOI 10.1002/bit.10909; Widdel F, 1984, BERGEYS MANUAL SYSTE, P663; WOLIN EA, 1963, J BIOL CHEM, V238, P2882	28	22	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35104	35112		10.1074/jbc.M110.163303	http://dx.doi.org/10.1074/jbc.M110.163303			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20807773	Green Published, hybrid			2022-12-25	WOS:000283659100084
J	Pan, J; Nakade, K; Huang, YC; Zhu, ZW; Masuzaki, S; Hasegawa, H; Murata, T; Yoshiki, A; Yamaguchi, N; Lee, CH; Yang, WC; Tsai, EM; Obata, Y; Yokoyama, KK				Pan, J.; Nakade, K.; Huang, Y-C; Zhu, Z-W; Masuzaki, S.; Hasegawa, H.; Murata, T.; Yoshiki, A.; Yamaguchi, N.; Lee, C-H; Yang, W-C; Tsai, E-M; Obata, Y.; Yokoyama, K. K.			Suppression of cell-cycle progression by Jun dimerization protein-2 (JDP2) involves downregulation of cyclin-A2	ONCOGENE			English	Article						cyclin-A2; cell proliferation; JDP2; epidermal thickness; cell-cycle arrest	INSERTIONAL MUTAGENESIS; AP-1 REPRESSOR; TRANSCRIPTION FACTOR; DIFFERENTIATION; IDENTIFICATION; TRANSFORMATION; FIBROBLASTS; ACTIVATION; INHIBITORS; DISTINCT	We report here a novel role for Jun dimerization protein-2 (JDP2) as a regulator of the progression of normal cells through the cell cycle. To determine the role of JDP2 in vivo, we generated Jdp2-knockout (Jdp2KO) mice by targeting exon-1 to disrupt the site of initiation of transcription. The epidermal thickening of skin from the Jdp2KO mice after treatment with 12-O-tetradecanoyl-phorbol 13-acetate (TPA) proceeded more rapidly than that of control mice, and more proliferating cells were found at the epidermis. Fibroblasts derived from embryos of Jdp2KO mice proliferated faster and formed more colonies than fibroblasts from wild-type mice. JDP2 was recruited to the promoter of the gene for cyclin-A2 (ccna2) at the AP-1 site. Cells lacking Jdp2 had elevated levels of cyclin-A2 mRNA. Furthermore, reintroduction of JDP2 resulted in the repression of transcription of ccna2 and of cell-cycle progression. Thus, transcription of the gene for cyclin-A2 appears to be a direct target of JDP2 in the suppression of cell proliferation. Oncogene (2010) 29, 6245-6256; doi:10.1038/onc.2010.355; published online 30 August 2010	[Huang, Y-C; Lee, C-H; Tsai, E-M; Yokoyama, K. K.] Kaohsiung Med Univ, Grad Inst Med, Ctr Excellence Environm Med, Kaohsiung 807, Taiwan; [Pan, J.; Nakade, K.; Masuzaki, S.; Murata, T.; Yoshiki, A.; Obata, Y.; Yokoyama, K. K.] RIKEN BioResource Ctr, Ibaraki, Japan; [Pan, J.; Zhu, Z-W] Zhejiang Acad Agr Sci, Inst Anim Husb & Vet, Hangzhou, Zhejiang, Peoples R China; [Hasegawa, H.; Yamaguchi, N.] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cell Biol, Chiba, Japan; [Lee, C-H] Kaohsiung Municipal Hsiaokang Hosp, Kaohsiung, Taiwan; [Yang, W-C] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Yokoyama, K. K.] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Tokyo, Japan	Kaohsiung Medical University; RIKEN; Zhejiang Academy of Agricultural Sciences; Chiba University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Academia Sinica - Taiwan; University of Tokyo	Yokoyama, KK (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Ctr Excellence Environm Med, Kaohsiung 807, Taiwan.	kazu@kmu.edu.tw	Lee, Chih-Hung/AAJ-5551-2020; Obata, Yuichi/A-5300-2016; Lee, Chih-Hung/B-4081-2010; Yoshiki, Atsushi/O-6162-2019; Yang, Wen-Chin/D-3441-2015	Lee, Chih-Hung/0000-0001-9804-3874; Obata, Yuichi/0000-0003-1839-4709; Yoshiki, Atsushi/0000-0002-9450-5151; Yang, Wen-Chin/0000-0001-6410-2581	RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan; Kaohsiung Medical University, Taiwan [KMU-EM-99-3]	RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kaohsiung Medical University, Taiwan	We thank S Itohara, C Jin, R Chiu, K Itakura, T Kondo, S Takahashi, P Kourilsky and G Gachelin for discussion, and L-H Lee, M Hirose and K Inabe for technical support. This work was supported by grants from the RIKEN Bioresource Project (to AY, YO and KKY), the Ministry of Education, Culture, Sports, Science and Technology of Japan (to KN, NY and KKY) and Kaohsiung Medical University, Taiwan (KMU-EM-99-3, to KKY, C-HL and ET).	Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Bitton-Worms K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-54; Blazek E, 2003, ONCOGENE, V22, P2151, DOI 10.1038/sj.onc.1206312; Broder YC, 1998, CURR BIOL, V8, P1121, DOI 10.1016/S0960-9822(98)70467-1; Caldon CE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-2; Chaudhry HW, 2004, J BIOL CHEM, V279, P35858, DOI 10.1074/jbc.M404975200; Cherasse Y, 2008, FEBS LETT, V582, P1537, DOI 10.1016/j.febslet.2008.03.050; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; GRANA X, 1995, ONCOGENE, V11, P211; Heinrich R, 2004, J BIOL CHEM, V279, P5708, DOI 10.1074/jbc.M307608200; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; Jin CY, 2006, NAT STRUCT MOL BIOL, V13, P331, DOI 10.1038/nsmb1063; Jin CY, 2002, MOL CELL BIOL, V22, P4815, DOI 10.1128/MCB.22.13.4815-4826.2002; Jin CY, 2001, FEBS LETT, V489, P34, DOI 10.1016/S0014-5793(00)02387-5; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Kawaida R, 2003, J EXP MED, V197, P1029, DOI 10.1084/jem.20021321; Lerdrup M, 2005, BBA-MOL CELL RES, V1745, P29, DOI 10.1016/j.bbamcr.2005.06.008; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mateo F, 2009, ONCOGENE, V28, P2654, DOI 10.1038/onc.2009.127; Nakade K, 2007, CELL DEATH DIFFER, V14, P1398, DOI 10.1038/sj.cdd.4402129; Nakade K, 2009, J BIOL CHEM, V284, P10808, DOI 10.1074/jbc.M808333200; Nakamura Y, 1998, CANCER RES, V58, P4832; Ostrovsky O, 2002, J BIOL CHEM, V277, P40043, DOI 10.1074/jbc.M205494200; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Piu F, 2001, MOL CELL BIOL, V21, P3012, DOI 10.1128/MCB.21.9.3012-3024.2001; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Polisetty N, 2008, MOL VIS, V14, P431; Rasmussen MH, 2009, NUCLEIC ACIDS RES, V37, P4657, DOI 10.1093/nar/gkp469; Rasmussen MH, 2005, VIROLOGY, V337, P353, DOI 10.1016/j.virol.2005.04.027; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stewart M, 2007, CANCER RES, V67, P5126, DOI 10.1158/0008-5472.CAN-07-0433; Sweeney C, 1996, DEVELOPMENT, V122, P53; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Weidenfeld-Baranboim K, 2008, NUCLEIC ACIDS RES, V36, P3608, DOI 10.1093/nar/gkn268; Weidenfeld-Baranboim K, 2009, NUCLEIC ACIDS RES, V37, P2194, DOI 10.1093/nar/gkp083	36	37	38	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	47					6245	6256		10.1038/onc.2010.355	http://dx.doi.org/10.1038/onc.2010.355			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	685CG	20802531	hybrid, Green Published			2022-12-25	WOS:000284601700006
J	Vogel, S; Wottawa, M; Farhat, K; Zieseniss, A; Schnelle, M; Le-Huu, S; von Ahlen, M; Malz, C; Camenisch, G; Katschinski, DM				Vogel, Sabine; Wottawa, Marieke; Farhat, Katja; Zieseniss, Anke; Schnelle, Moritz; Le-Huu, Sinja; von Ahlen, Melanie; Malz, Cordula; Camenisch, Gieri; Katschinski, Doerthe M.			Prolyl Hydroxylase Domain (PHD) 2 Affects Cell Migration and F-actin Formation via RhoA/Rho-associated Kinase-dependent Cofilin Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; MESSENGER-RNA; UP-REGULATION; HIF-ALPHA; HYPOXIA; PROTEIN; INHIBITION; BINDING; 4-HYDROXYLASES; FAMILY	Cells are responding to hypoxia via prolyl-4-hydroxylase domain (PHD) enzymes, which are responsible for oxygen-dependent hydroxylation of the hypoxia-inducible factor (HIF)-1 alpha subunit. To gain further insight into PHD function, we generated knockdown cell models for the PHD2 isoform, which is the main isoform regulating HIF-1 alpha hydroxylation and thus stability in normoxia. Induction of a PHD2 knockdown in tetracycline-inducible HeLa PHD2 knockdown cells resulted in increased F-actin formation as detected by phalloidin staining. A similar effect could be observed in the stably transfected PHD2 knockdown cell clones 1B6 and 3B7. F-actin is at least in part responsible for shaping cell morphology as well as regulating cell migration. Cell migration was impaired significantly as a consequence of PHD2 knockdown in a scratch assay. Mechanistically, PHD2 knockdown resulted in activation of the RhoA (Ras homolog gene family member A)/Rho-associated kinase pathway with subsequent phosphorylation of cofilin. Because cofilin phosphorylation impairs its actin-severing function, this may explain the F-actin phenotype, thereby providing a functional link between PHD2-dependent signaling and cell motility.	[Vogel, Sabine; Wottawa, Marieke; Farhat, Katja; Zieseniss, Anke; Schnelle, Moritz; Le-Huu, Sinja; von Ahlen, Melanie; Malz, Cordula; Katschinski, Doerthe M.] Univ Gottingen, Dept Cardiovasc Physiol, Univ Med Gottingen, D-37073 Gottingen, Germany; [Camenisch, Gieri] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Camenisch, Gieri] Univ Zurich, Zurich Ctr Integrat Human Physiol ZHIP, CH-8057 Zurich, Switzerland	University of Gottingen; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Katschinski, DM (corresponding author), Univ Gottingen, Dept Cardiovasc Physiol, Univ Med Gottingen, Humboldtallee 23, D-37073 Gottingen, Germany.	katschinski@physiol.med.uni-goettingen.de		Schnelle, Moritz/0000-0001-5134-8347	Deutsche Forschungsgemeinschaft [Ka1269/9-1]; Wilhelm Sander Stiftung [2008.062.1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm Sander Stiftung	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Ka1269/9-1) and the Wilhelm Sander Stiftung (Project 2008.062.1) (to D. M. K.). This work was performed as collaborative project within the COST Action TD0901 "HypoxiaNet."	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bailly M, 2003, CURR BIOL, V13, pR128, DOI 10.1016/S0960-9822(03)00072-1; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07; Brokers N, 2010, CANCER SCI, V101, P129, DOI 10.1111/j.1349-7006.2009.01367.x; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Cioffi CL, 2003, BIOCHEM BIOPH RES CO, V303, P947, DOI 10.1016/S0006-291X(03)00453-4; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Haffey WD, 2009, ADV ENZYME REGUL, V49, P121, DOI 10.1016/j.advenzreg.2008.12.004; Hewitson KS, 2003, BIOCHEM SOC T, V31, P510, DOI 10.1042/BST0310510; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Katschinski DM, 2009, ACTA PHYSIOL, V195, P407, DOI 10.1111/j.1748-1716.2008.01952.x; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Lieb ME, 2002, BIOCHEM CELL BIOL, V80, P421, DOI 10.1139/O02-115; Matozaki T, 2000, CELL SIGNAL, V12, P515, DOI 10.1016/S0898-6568(00)00102-9; Menzies K, 2004, BIOCHEM BIOPH RES CO, V317, P801, DOI 10.1016/j.bbrc.2004.03.115; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Mikhaylova O, 2008, MOL CELL BIOL, V28, P2701, DOI 10.1128/MCB.01231-07; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Myllyharju J, 2009, CURR PHARM DESIGN, V15, P3878, DOI 10.2174/138161209789649457; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Small JV, 1999, MICROSC RES TECHNIQ, V47, P3; Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thoms BL, 2010, J BIOL CHEM, V285, P20472, DOI 10.1074/jbc.M110.115238; Turcotte S, 2003, J CELL SCI, V116, P2247, DOI 10.1242/jcs.00427; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Winder SJ, 2003, CURR OPIN CELL BIOL, V15, P14, DOI 10.1016/S0955-0674(02)00002-9; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	49	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33756	33763		10.1074/jbc.M110.132985	http://dx.doi.org/10.1074/jbc.M110.132985			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20801873	Green Published, hybrid			2022-12-25	WOS:000283354000021
J	Setiadi, AF; Ray, NC; Kohrt, HE; Kapelner, A; Carcamo-Cavazos, V; Levic, EB; Yadegarynia, S; van der Loos, CM; Schwartz, EJ; Holmes, S; Lee, PP				Setiadi, A. Francesca; Ray, Nelson C.; Kohrt, Holbrook E.; Kapelner, Adam; Carcamo-Cavazos, Valeria; Levic, Edina B.; Yadegarynia, Sina; van der Loos, Chris M.; Schwartz, Erich J.; Holmes, Susan; Lee, Peter P.			Quantitative, Architectural Analysis of Immune Cell Subsets in Tumor-Draining Lymph Nodes from Breast Cancer Patients and Healthy Lymph Nodes	PLOS ONE			English	Article								Background: To date, pathological examination of specimens remains largely qualitative. Quantitative measures of tissue spatial features are generally not captured. To gain additional mechanistic and prognostic insights, a need for quantitative architectural analysis arises in studying immune cell-cancer interactions within the tumor microenvironment and tumor-draining lymph nodes (TDLNs). Methodology/Principal Findings: We present a novel, quantitative image analysis approach incorporating 1) multi-color tissue staining, 2) high-resolution, automated whole-section imaging, 3) custom image analysis software that identifies cell types and locations, and 4) spatial statistical analysis. As a proof of concept, we applied this approach to study the architectural patterns of T and B cells within tumor-draining lymph nodes from breast cancer patients versus healthy lymph nodes. We found that the spatial grouping patterns of T and B cells differed between healthy and breast cancer lymph nodes, and this could be attributed to the lack of B cell localization in the extrafollicular region of the TDLNs. Conclusions/Significance: Our integrative approach has made quantitative analysis of complex visual data possible. Our results highlight spatial alterations of immune cells within lymph nodes from breast cancer patients as an independent variable from numerical changes. This opens up new areas of investigations in research and medicine. Future application of this approach will lead to a better understanding of immune changes in the tumor microenvironment and TDLNs, and how they affect clinical outcomes.	[Setiadi, A. Francesca; Kohrt, Holbrook E.; Kapelner, Adam; Carcamo-Cavazos, Valeria; Levic, Edina B.; Yadegarynia, Sina; Lee, Peter P.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Ray, Nelson C.; Holmes, Susan] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [van der Loos, Chris M.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Schwartz, Erich J.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Stanford University	Setiadi, AF (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	ppl@stanford.edu		Lee, Peter P./0000-0002-2660-4377; Yadegarynia, Sina/0000-0002-8653-0146; Holmes, Susan/0000-0002-2208-8168	National Institutes of Health (NIH) [R01CA127947, R01GM086884]; Department of Defense [BC01560]; NATIONAL CANCER INSTITUTE [R01CA127947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086884] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (NIH) grant no. R01CA127947 and the Department of Defense Congressionally Directed Medical Research Programs grant no. BC01560 to PPL. SH was supported by NIH grant no. R01GM086884. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Besag J., 1977, J R STAT SOC SER C A, V26, P327, DOI [10.2307/2346974, DOI 10.2307/2346974]; BIVAND R, 2001, R NEWS, V1, P13; Diggle P., 2003, STAT ANAL SPATIAL PO; Dixon P.M., 2002, ENCY ENV, VVolume 3, P1796, DOI DOI 10.1002/9780470057339.VAR046; Domenech A, 2009, Q J NUCL MED MOL IM, V53, P422; Holmes S, 2009, J STAT SOFTW, V30, P1; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Kohrt HE, 2005, PLOS MED, V2, P904, DOI 10.1371/journal.pmed.0020284; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Quan ML, 2009, J SURG ONCOL, V99, P194, DOI 10.1002/jso.21201; Silverman B.W., 1986, DENSITY ESTIMATION S; van der Loos CM, 2008, J HISTOCHEM CYTOCHEM, V56, P313, DOI 10.1369/jhc.2007.950170	15	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12420	10.1371/journal.pone.0012420	http://dx.doi.org/10.1371/journal.pone.0012420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811638	Green Submitted, Green Published, gold			2022-12-25	WOS:000281234700034
J	Wang, P; Bai, HW; Zhu, BT				Wang, Pan; Bai, Hyoung-Woo; Zhu, Bao Ting			Structural Basis for Certain Naturally Occurring Bioflavonoids to Function as Reducing Co-Substrates of Cyclooxygenase I and II	PLOS ONE			English	Article							PROSTAGLANDIN-H SYNTHASE; ENDOPEROXIDE SYNTHASE-2; VESICULAR GLAND; PURIFICATION; ACETYLATION; ANTIOXIDANT; INHIBITION; RECEPTOR; SYNTHETASE; EXPRESSION	Background: Recent studies showed that some of the dietary bioflavonoids can strongly stimulate the catalytic activity of cyclooxygenase (COX) I and II in vitro and in vivo, presumably by facilitating enzyme re-activation. In this study, we sought to understand the structural basis of COX activation by these dietary compounds. Methodology/Principal Findings: A combination of molecular modeling studies, biochemical analysis and site-directed mutagenesis assay was used as research tools. Three-dimensional quantitative structure-activity relationship analysis (QSAR/CoMFA) predicted that the ability of bioflavonoids to activate COX I and II depends heavily on their B-ring structure, a moiety known to be associated with strong antioxidant ability. Using the homology modeling and docking approaches, we identified the peroxidase active site of COX I and II as the binding site for bioflavonoids. Upon binding to this site, bioflavonoid can directly interact with hematin of the COX enzyme and facilitate the electron transfer from bioflavonoid to hematin. The docking results were verified by biochemical analysis, which reveals that when the cyclooxygenase activity of COXs is inhibited by covalent modification, myricetin can still stimulate the conversion of PGG(2) to PGE(2), a reaction selectively catalyzed by the peroxidase activity. Using the site-directed mutagenesis analysis, we confirmed that Q189 at the peroxidase site of COX II is essential for bioflavonoids to bind and re-activate its catalytic activity. Conclusions/Significance: These findings provide the structural basis for bioflavonoids to function as high-affinity reducing co-substrates of COXs through binding to the peroxidase active site, facilitating electron transfer and enzyme re-activation.	[Wang, Pan; Bai, Hyoung-Woo; Zhu, Bao Ting] Univ Kansas, Med Ctr, Sch Med, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Wang, P (corresponding author), Univ Kansas, Med Ctr, Sch Med, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	BTZhu@kumc.edu			National Institutes of Health [ES015242]; NIH, National Center for Research Resources [P20RR021940]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study is supported in part by a grant from the National Institutes of Health (No. ES015242). Some of the analytical and imaging instruments employed in this study are part of the COBRE core facility that is supported by the NIH Grant P20RR021940 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amic D, 2003, CROAT CHEM ACTA, V76, P55; Bai HW, 2008, J LIPID RES, V49, P2557, DOI 10.1194/jlr.M800358-JLR200; Bai HW, 2010, PROSTAG LEUKOTR ESS, V82, P45, DOI 10.1016/j.plefa.2009.10.006; Bala M, 2008, BIOCHEM PHARMACOL, V75, P1472, DOI 10.1016/j.bcp.2007.12.005; Bambai B, 2000, J BIOL CHEM, V275, P27608; Bors W, 2002, ANN NY ACAD SCI, V957, P57, DOI 10.1111/j.1749-6632.2002.tb02905.x; Burda S, 2001, J AGR FOOD CHEM, V49, P2774, DOI 10.1021/jf001413m; Callan OH, 1996, J BIOL CHEM, V271, P3548; DIETZ R, 1988, EUR J BIOCHEM, V171, P321, DOI 10.1111/j.1432-1033.1988.tb13793.x; HAMBERG M, 1967, J BIOL CHEM, V242, P5344; HARVISON PJ, 1988, CHEM-BIOL INTERACT, V64, P251, DOI 10.1016/0009-2797(88)90101-9; HEMLER ME, 1980, J BIOL CHEM, V255, P6253; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; HSUANYU YC, 1992, J BIOL CHEM, V267, P17649; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; KULMACZ RJ, 1985, PROSTAGLANDINS, V29, P175, DOI 10.1016/0090-6980(85)90200-X; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Kurumbail RG, 2001, CURR OPIN STRUC BIOL, V11, P752, DOI 10.1016/S0959-440X(01)00277-9; Landino LM, 1997, J BIOL CHEM, V272, P21565, DOI 10.1074/jbc.272.34.21565; LECOMTE M, 1994, J BIOL CHEM, V269, P13207; Lee JL, 2005, J INVEST DERMATOL, V125, P818, DOI 10.1111/j.0022-202X.2005.23829.x; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; MIYAMOTO T, 1976, J BIOL CHEM, V251, P2629; OBANION MK, 1991, J BIOL CHEM, V266, P23261; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Silva MM, 2002, FREE RADICAL RES, V36, P1219, DOI 10.1080/198-1071576021000016472; SIROIS J, 1992, J BIOL CHEM, V267, P6382; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sung YM, 2005, CANCER RES, V65, P9304, DOI 10.1158/0008-5472.CAN-05-1015; THOMPSON D, 1989, MOL PHARMACOL, V36, P809; VANDEROUDERAA FJ, 1977, BIOCHIM BIOPHYS ACTA, V487, P315, DOI 10.1016/0005-2760(77)90008-X; WELLS I, 1992, BIOCHEMISTRY-US, V31, P9520, DOI 10.1021/bi00155a002; Wu G, 1999, J BIOL CHEM, V274, P9231, DOI 10.1074/jbc.274.14.9231; Zhu BT, 2006, ENDOCRINOLOGY, V147, P4132, DOI 10.1210/en.2006-0113	35	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12316	10.1371/journal.pone.0012316	http://dx.doi.org/10.1371/journal.pone.0012316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808785	Green Published, Green Submitted, gold			2022-12-25	WOS:000281153500005
J	TeKippe, EM; Allen, IC; Hulseberg, PD; Sullivan, JT; McCann, JR; Sandor, M; Braunstein, M; Ting, JPY				TeKippe, Erin McElvania; Allen, Irving C.; Hulseberg, Paul D.; Sullivan, Jonathan T.; McCann, Jessica R.; Sandor, Matyas; Braunstein, Miriam; Ting, Jenny P. -Y.			Granuloma Formation and Host Defense in Chronic Mycobacterium tuberculosis Infection Requires PYCARD/ASC but Not NLRP3 or Caspase-1	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; IMMUNE-RESPONSE; CELL-DEATH; INFLAMMASOME ACTIVATION; GENE FAMILY; T-CELLS; MICE; ASC; PROTEIN; INTERLEUKIN-1-BETA	The NLR gene family mediates host immunity to various acute pathogenic stimuli, but its role in chronic infection is not known. This paper addressed the role of NLRP3 (NALP3), its adaptor protein PYCARD (ASC), and caspase-1 during infection with Mycobacterium tuberculosis (Mtb). Mtb infection of macrophages in culture induced IL-1 beta secretion, and this requires the inflammasome components PYCARD, caspase-1, and NLRP3. However, in vivo Mtb aerosol infection of Nlrp3(-/-), Casp-1(-/-), and WT mice showed no differences in pulmonary IL-1b production, bacterial burden, or long-term survival. In contrast, a significant role was observed for Pycard in host protection during chronic Mtb infection, as shown by an abrupt decrease in survival of Pycard(-/-) mice. Decreased survival of Pycard(-/-) animals was associated with defective granuloma formation. These data demonstrate that PYCARD exerts a novel inflammasome-independent role during chronic Mtb infection by containing the bacteria in granulomas.	[TeKippe, Erin McElvania; Sullivan, Jonathan T.; McCann, Jessica R.; Braunstein, Miriam; Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA; [Allen, Irving C.; Ting, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Hulseberg, Paul D.; Sandor, Matyas] Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth, Madison, WI USA; [Hulseberg, Paul D.; Sandor, Matyas] Univ Wisconsin, Cellular & Mol Pathol Program, Sch Med & Publ Hlth, Madison, WI USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	TeKippe, EM (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.	panyun@med.unc.edu	, Pathology Services Core/CEZ-2246-2022; Ariel, Pablo/AGJ-4118-2022	McCann, Jessica/0000-0001-6139-7089; Allen, Irving/0000-0001-9573-5250	National Institutes of Health (NIH) [AI057157, AI063031, AI082895]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063031, U54AI057157, F32AI082895] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by grants from the National Institutes of Health (NIH) AI057157 (JT), AI063031 (JT and MB), and AI082895 (IA). IA was supported by a NIH postdoctoral training grant and is currently an American Cancer Society Postdoctoral fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Bean AGD, 1999, J IMMUNOL, V162, P3504; BLACK RA, 1988, J BIOL CHEM, V263, P9437; *CDC, 2009, TUB; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; IOERGER TR, 2010, J BACTERIOL, DOI DOI 10.4049/JIMMUNOL.0904189; IRMLER M, 1995, J EXP MED, V181, P1917, DOI 10.1084/jem.181.5.1917; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Kurtz S, 2006, INFECT IMMUN, V74, P6855, DOI 10.1128/IAI.01022-06; Ladel CH, 1997, INFECT IMMUN, V65, P4843, DOI 10.1128/IAI.65.11.4843-4849.1997; Leemans JC, 2001, J IMMUNOL, V166, P4604, DOI 10.4049/jimmunol.166.7.4604; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; MAYERBARBER KD, J IMMUNOL; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; MIZUTANI H, 1991, J EXP MED, V174, P821, DOI 10.1084/jem.174.4.821; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; ORME IM, 1994, MOUSE MODELS TUBERCU, P807; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Sugawara I, 1999, INFECT IMMUN, V67, P2585, DOI 10.1128/IAI.67.5.2585-2589.1999; Sugawara I, 2001, MICROBIOL IMMUNOL, V45, P743, DOI 10.1111/j.1348-0421.2001.tb01310.x; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Taxman DJ, 2006, J IMMUNOL, V177, P4252, DOI 10.4049/jimmunol.177.7.4252; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Yamada H, 2000, LAB INVEST, V80, P759, DOI 10.1038/labinvest.3780079; Ye ZM, 2008, CURR OPIN IMMUNOL, V20, P3, DOI 10.1016/j.coi.2008.01.003; [No title captured]	46	97	99	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12320	10.1371/journal.pone.0012320	http://dx.doi.org/10.1371/journal.pone.0012320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808838	Green Published, Green Submitted, gold			2022-12-25	WOS:000281077000014
J	Braithwaite, EK; Kedar, PS; Stumpo, DJ; Bertocci, B; Freedman, JH; Samson, LD; Wilson, SH				Braithwaite, Elena K.; Kedar, Padmini S.; Stumpo, Deborah J.; Bertocci, Barbara; Freedman, Jonathan H.; Samson, Leona D.; Wilson, Samuel H.			DNA Polymerases beta and lambda Mediate Overlapping and Independent Roles in Base Excision Repair in Mouse Embryonic Fibroblasts	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; DAMAGE; IOTA; HYPERMUTATION; GLYCOSYLASE; DEFICIENT; BYPASS; SITES	Base excision repair (BER) is a DNA repair pathway designed to correct small base lesions in genomic DNA. While DNA polymerase beta (pol beta) is known to be the main polymerase in the BER pathway, various studies have implicated other DNA polymerases in back-up roles. One such polymerase, DNA polymerase lambda (pol lambda), was shown to be important in BER of oxidative DNA damage. To further explore roles of the X-family DNA polymerases lambda and beta in BER, we prepared a mouse embryonic fibroblast cell line with deletions in the genes for both pol beta and pol lambda. Neutral red viability assays demonstrated that pol lambda and pol beta double null cells were hypersensitive to alkylating and oxidizing DNA damaging agents. In vitro BER assays revealed a modest contribution of pol lambda to single-nucleotide BER of base lesions. Additionally, using co-immunoprecipitation experiments with purified enzymes and whole cell extracts, we found that both pol lambda and pol beta interact with the upstream DNA glycosylases for repair of alkylated and oxidized DNA bases. Such interactions could be important in coordinating roles of these polymerases during BER.	[Braithwaite, Elena K.; Kedar, Padmini S.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Braithwaite, Elena K.; Freedman, Jonathan H.] NIEHS, Lab Toxicol & Pharmacol, NIH, Res Triangle Pk, NC 27709 USA; [Stumpo, Deborah J.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Bertocci, Barbara] INSERM, Fac Med Paris Descartes, U783, Paris, France; [Samson, Leona D.] MIT, Biol Engn Dept, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Massachusetts Institute of Technology (MIT)	Braithwaite, EK (corresponding author), NIEHS, Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019; Bertocci, Barbara/L-9115-2018	Wilson, Samuel H/0000-0002-1702-5293; 	National Institutes of Health (NIH) [ES050158, ES050159, CA055042, HHSN273200700046U]; NATIONAL CANCER INSTITUTE [R01CA055042, R01CA075576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102045, ZIAES050159, Z01ES050159, Z01ES050158, ZIAES050158] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health (NIH) grants ES050158 and ES050159 from the Intramural Research Program and by NIH grant CA055042 (to L.S.). P.K.'s contribution was supported in whole with funds from NIH, under delivery order HHSN273200700046U to Constella/SRA, LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard WA, 1995, METHOD ENZYMOL, V262, P98; Bertocci B, 2002, J IMMUNOL, V168, P3702, DOI 10.4049/jimmunol.168.8.3702; Braithwaite EK, 2005, J BIOL CHEM, V280, P31641, DOI 10.1074/jbc.C500256200; Braithwaite EK, 2005, J BIOL CHEM, V280, P18469, DOI 10.1074/jbc.M411864200; Crespan E, 2007, NUCLEIC ACIDS RES, V35, P5173, DOI 10.1093/nar/gkm568; Fortini P, 2000, NUCLEIC ACIDS RES, V28, P3040, DOI 10.1093/nar/28.16.3040; Harlow E., 1988, ANTIBODIES LAB MANUA; Horton JK, 2002, DNA REPAIR, V1, P317, DOI 10.1016/S1568-7864(02)00008-3; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; McDonald JP, 2003, J EXP MED, V198, P635, DOI 10.1084/jem.20030767; O'Brien PJ, 2003, BIOCHEMISTRY-US, V42, P12418, DOI 10.1021/bi035177v; Poltoratsky V, 2008, DNA REPAIR, V7, P830, DOI 10.1016/j.dnarep.2008.02.013; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Shimazaki N, 2005, GENES CELLS, V10, P705, DOI 10.1111/j.1365-2443.2005.00868.x; Sobol RW, 2007, DNA REPAIR, V6, P3, DOI 10.1016/j.dnarep.2006.08.005; Sobol RW, 2003, J BIOL CHEM, V278, P39951, DOI 10.1074/jbc.M306592200; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; SRIVASTAVA DK, 1995, J BIOL CHEM, V270, P16402, DOI 10.1074/jbc.270.27.16402; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; Tano K, 2007, DNA REPAIR, V6, P869, DOI 10.1016/j.dnarep.2007.01.011; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200	24	55	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12229	10.1371/journal.pone.0012229	http://dx.doi.org/10.1371/journal.pone.0012229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805875	Green Published, Green Submitted, gold			2022-12-25	WOS:000281011600011
J	Li, DD; Guo, JF; Huang, JJ; Wang, LL; Deng, R; Liu, JN; Feng, GK; Xiao, DJ; Deng, SZ; Zhang, XS; Zhu, XF				Li, Dan-Dan; Guo, Jing-Feng; Huang, Jia-Jia; Wang, Lin-Lin; Deng, Rong; Liu, Jian-Nan; Feng, Gong-Kan; Xiao, Ding-Jun; Deng, Song-Zhi; Zhang, Xiao-Shi; Zhu, Xiao-Feng			Rhabdastrellic Acid-A Induced Autophagy-Associated Cell Death through Blocking Akt Pathway in Human Cancer Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR FUNCTION; PI3K/AKT PATHWAY; TRITERPENOID SAPONINS; INDUCED APOPTOSIS; PROTEIN; EXPRESSION; BECLIN-1; GLOBOSTELLATA; ACTIVATION; MECHANISMS	Background: Autophagy is an evolutionarily conserved protein degradation pathway. A defect in autophagy may contribute to tumorigenesis. Autophagy inducers could have a potential function in tumor prevention and treatment. Methodology/Principal Findings: Our results showed that Rhabdastrellic acid-A, an isomalabaricane triterpenoid isolated from the sponge Rhabdastrella globostellata, inhibited proliferation of human cancer cell lines Hep3B and A549 and induced caspase-independent cell death in both the cell lines. Further investigation showed that Rhabdastrellic acid-A induced autophagy of cancer cells determined by YFP-LC3 punctation and increased LC3-II. The pretreatment with autophagy inhibitor 3-MA inhibited Rhabdastrellic acid-A-induced cell death. Knockdown of autophagy-related gene Atg5 inhibited Rhabdastrellic acid-A-induced cell death in A549 cells. Also, phospho-Akt and its downstream targets significantly decreased after treatment with Rhabdastrellic acid-A in both cancer cell lines. Transfection of constitutive active Akt plasmid abrogated autophagy and cell death induced by Rhabdastrellic acid-A. Conclusions/Significance: These results suggest that Rhabdastrellic acid-A could induce autophagy-associated cell death through blocking Akt pathway in cancer cells. It also provides the evidence that Rhabdastrellic acid-A deserves further investigation as a potential anticancer or cancer preventive agent.	[Li, Dan-Dan; Huang, Jia-Jia; Wang, Lin-Lin; Deng, Rong; Liu, Jian-Nan; Feng, Gong-Kan; Zhang, Xiao-Shi; Zhu, Xiao-Feng] Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Guo, Jing-Feng] So Med Univ, Affiliated He Xian Mem Hosp, Guangzhou, Guangdong, Peoples R China; [Xiao, Ding-Jun; Deng, Song-Zhi] Chinese Acad Sci, Guangzhou Inst Chem, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Southern Medical University - China; Chinese Academy of Sciences	Li, DD (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	zhuxfeng@mail.sysu.edu.cn			National Nature Science Foundation of China [30873085, 30972882]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by grants from the National Nature Science Foundation of China (30873085, 30972882) (http://www.nsfc.gov.cn/Portal0/default124.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani R, 2006, ONCOGENE, V25, P1743, DOI 10.1038/sj.onc.1209201; Bockbrader KM, 2005, ONCOGENE, V24, P7381, DOI 10.1038/sj.onc.1208888; Carroll J, 2001, J ORG CHEM, V66, P6847, DOI 10.1021/jo015784t; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chen Wong L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P575, DOI 10.2174/156801105774574649; Chu CT, 2007, AUTOPHAGY, V3, P663, DOI 10.4161/auto.4625; Cichy SB, 1998, J BIOL CHEM, V273, P6482, DOI 10.1074/jbc.273.11.6482; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Feng XZ, 2003, PLANTA MED, V69, P1036, DOI 10.1055/s-2003-45152; Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fu GM, 2005, PLANTA MED, V71, P666, DOI 10.1055/s-2005-871274; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Guo JF, 2008, CELL BIOL INT, V32, P48, DOI 10.1016/j.cellbi.2007.08.009; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; HIRON M, 1992, BIOCHEM J, V287, P255, DOI 10.1042/bj2870255; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim Donghwa, 2005, Curr Opin Investig Drugs, V6, P1250; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liang XH, 2001, CANCER RES, V61, P3443; Liu YH, 2003, J NAT PROD, V66, P1451, DOI 10.1021/np030268e; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Paglin S, 2006, AUTOPHAGY, V2, P291, DOI 10.4161/auto.2835; Parry R, 1997, BIOCHEM SOC T, V25, pS589, DOI 10.1042/bst025s589; Rao ZG, 1997, J NAT PROD, V60, P1163, DOI 10.1021/np960729e; Stephenson I, 2003, LANCET, V362, P1959, DOI 10.1016/S0140-6736(03)15014-3; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tan JH, 2003, CANCER RES, V63, P7663; Tasdemir D, 2002, J NAT PROD, V65, P210, DOI 10.1021/np0104020; Theodoropoulou M, 2006, CANCER RES, V66, P1576, DOI 10.1158/0008-5472.CAN-05-1189; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9	40	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12176	10.1371/journal.pone.0012176	http://dx.doi.org/10.1371/journal.pone.0012176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808909	Green Published, Green Submitted, gold			2022-12-25	WOS:000280968100008
J	Milanovich, JR; Peterman, WE; Nibbelink, NP; Maerz, JC				Milanovich, Joseph R.; Peterman, William E.; Nibbelink, Nathan P.; Maerz, John C.			Projected Loss of a Salamander Diversity Hotspot as a Consequence of Projected Global Climate Change	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; SPECIES DISTRIBUTION; DISTRIBUTION MODELS; FOOD WEBS; ECOLOGY; DESMOGNATHUS; POPULATIONS; NICHE; PLETHODONTIDAE; DISTRIBUTIONS	Background: Significant shifts in climate are considered a threat to plants and animals with significant physiological limitations and limited dispersal abilities. The southern Appalachian Mountains are a global hotspot for plethodontid salamander diversity. Plethodontids are lungless ectotherms, so their ecology is strongly governed by temperature and precipitation. Many plethodontid species in southern Appalachia exist in high elevation habitats that may be at or near their thermal maxima, and may also have limited dispersal abilities across warmer valley bottoms. Methodology/Principal Findings: We used a maximum-entropy approach (program Maxent) to model the suitable climatic habitat of 41 plethodontid salamander species inhabiting the Appalachian Highlands region (33 individual species and eight species included within two species complexes). We evaluated the relative change in suitable climatic habitat for these species in the Appalachian Highlands from the current climate to the years 2020, 2050, and 2080, using both the HADCM3 and the CGCM3 models, each under low and high CO2 scenarios, and using two-model thresholds levels (relative suitability thresholds for determining suitable/unsuitable range), for a total of 8 scenarios per species. Conclusion/Significance: While models differed slightly, every scenario projected significant declines in suitable habitat within the Appalachian Highlands as early as 2020. Species with more southern ranges and with smaller ranges had larger projected habitat loss. Despite significant differences in projected precipitation changes to the region, projections did not differ significantly between global circulation models. CO2 emissions scenario and model threshold had small effects on projected habitat loss by 2020, but did not affect longer-term projections. Results of this study indicate that choice of model threshold and CO2 emissions scenario affect short-term projected shifts in climatic distributions of species; however, these factors and choice of global circulation model have relatively small affects on what is significant projected loss of habitat for many salamander species that currently occupy the Appalachian Highlands.	[Milanovich, Joseph R.; Nibbelink, Nathan P.; Maerz, John C.] Univ Georgia, DB Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Peterman, William E.] Univ Missouri, Dept Biol Sci, Columbia, MO USA	University System of Georgia; University of Georgia; University of Missouri System; University of Missouri Columbia	Milanovich, JR (corresponding author), Univ Georgia, DB Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	milanovichj@warnell.uga.edu	Peterman, William/H-7809-2013	Peterman, William/0000-0001-5229-9268; Maerz, John/0000-0002-1592-5431	National Science Foundation; American Museum of Natural History; North Carolina Herpetological Society	National Science Foundation(National Science Foundation (NSF)); American Museum of Natural History; North Carolina Herpetological Society	The contributions of J. C. Maerz and J. R. Milanovich were partially supported by the Coweeta LTER (http://coweeta.uga.edu/), which is funded by the National Science Foundation and has among its current objectives to understand the role of climate change in patterns of species losses and gains in southern Appalachia. This study was also partially funded by the American Museum of Natural History (http://www.amnh.org/) and the North Carolina Herpetological Society (http://www.ncherps.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Beamer DA, 2008, MOL PHYLOGENET EVOL, V47, P143, DOI 10.1016/j.ympev.2008.01.015; Beaumont LJ, 2007, GLOBAL CHANGE BIOL, V13, P1368, DOI 10.1111/j.1365-2486.2007.01357.x; Bernardo J, 2007, BIOLOGY LETT, V3, P695, DOI 10.1098/rsbl.2007.0259; Bernardo J, 2006, BIOL LETTERS, V2, P135, DOI 10.1098/rsbl.2005.0417; BONETT RM, 2002, ANAL CONTACT ZONE DU, P344; Buckley LB, 2007, P ROY SOC B-BIOL SCI, V274, P1167, DOI 10.1098/rspb.2006.0436; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Cabe PR, 2007, HEREDITY, V98, P53, DOI 10.1038/sj.hdy.6800905; Camp CD, 2007, BIOL J LINN SOC, V91, P227, DOI 10.1111/j.1095-8312.2007.00793.x; Carr DE, 1996, HERPETOLOGICA, V52, P56; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chippindale PT, 2004, EVOLUTION, V58, P2809; Cramer J.S, 2003, LOGIT MODELS EC OTHE, DOI 10.1017/CBO9780511615412.002; Crespi EJ, 2003, MOL ECOL, V12, P969, DOI 10.1046/j.1365-294X.2003.01797.x; Cunningham HR, 2009, J ANIM ECOL, V78, P52, DOI 10.1111/j.1365-2656.2008.01468.x; Davic RD, 2004, ANNU REV ECOL EVOL S, V35, P405, DOI 10.1146/annurev.ecolsys.35.112202.130116; de Chazal J, 2009, GLOBAL ENVIRON CHANG, V19, P306, DOI 10.1016/j.gloenvcha.2008.09.007; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; FEDER ME, 1983, HERPETOLOGICA, V39, P291; Flato GM, 2001, GEOPHYS RES LETT, V28, P195, DOI 10.1029/2000GL012121; Fridley JD, 2009, J APPL METEOROL CLIM, V48, P1033, DOI 10.1175/2008JAMC2084.1; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gibbs JP, 2006, CONSERV BIOL, V20, P913, DOI 10.1111/j.1523-1739.2006.00375.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Highton R, 2000, BIOLOGY OF PLETHODONTID SALAMANDERS, P31; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Johns TC, 2003, CLIM DYNAM, V20, P583, DOI 10.1007/s00382-002-0296-y; Jones MT, 2006, MOL PHYLOGENET EVOL, V38, P280, DOI 10.1016/j.ympev.2005.05.007; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kettleborough JA, 2007, J CLIMATE, V20, P843, DOI 10.1175/JCLI4012.1; Kozak KH, 2010, AM NAT, V176, P40, DOI 10.1086/653031; Kozak KH, 2005, EVOLUTION, V59, P2000; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; Lawton J. H., 1995, EXTINCTION RATES; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Luoto M, 2005, GLOBAL ECOL BIOGEOGR, V14, P575, DOI 10.1111/j.1466-822x.2005.00186.x; Macey JR, 2005, CLADISTICS, V21, P194, DOI 10.1111/j.1096-0031.2005.00054.x; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Marshall JL, 2006, ACTA OECOL, V29, P33, DOI 10.1016/j.actao.2005.07.008; McCarthy J.J., 2001, CLIMATE CHANGE 2001; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; Mead LS, 2001, EVOLUTION, V55, P2287; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Mueller RL, 2004, P NATL ACAD SCI USA, V101, P13820, DOI 10.1073/pnas.0405785101; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Petranka, 1998, SALAMANDERS US CANAD; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Rissler LJ, 2004, AM NAT, V164, P201, DOI 10.1086/422200; Rissler LJ, 2003, MOL PHYLOGENET EVOL, V27, P197, DOI 10.1016/S1055-7903(02)00405-0; Robertson MP, 2003, ECOL MODEL, V164, P153, DOI 10.1016/S0304-3800(03)00028-0; Sokolov AP, 2009, J CLIMATE, V22, P5175, DOI 10.1175/2009JCLI2863.1; Stein B., 2000, PRECIOUS HERITAGE ST; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Titus TA, 1996, SYST BIOL, V45, P451, DOI 10.2307/2413525; Trotta-Moreu N, 2010, ENVIRON ENTOMOL, V39, P42, DOI 10.1603/EN08179; Vieites DR, 2007, P NATL ACAD SCI USA, V104, P19903, DOI 10.1073/pnas.0705056104; Walton BM, 2006, PEDOBIOLOGIA, V50, P313, DOI 10.1016/j.pedobi.2006.04.001; Walton BM, 2005, PEDOBIOLOGIA, V49, P51, DOI 10.1016/j.pedobi.2004.07.012; White EM, 2009, LANDSCAPE URBAN PLAN, V89, P37, DOI 10.1016/j.landurbplan.2008.09.004; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wyman RL, 1998, BIODIVERS CONSERV, V7, P641, DOI 10.1023/A:1008856402258	79	125	132	4	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12189	10.1371/journal.pone.0012189	http://dx.doi.org/10.1371/journal.pone.0012189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808442	Green Submitted, Green Published, gold			2022-12-25	WOS:000280968000016
J	Sharma, A; Bartell, SM; Baile, CA; Chen, B; Podolsky, RH; McIndoe, RA; She, JX				Sharma, Ashok; Bartell, Shoshana M.; Baile, Clifton A.; Chen, Bo; Podolsky, Robert H.; McIndoe, Richard A.; She, Jin-Xiong			Hepatic Gene Expression Profiling Reveals Key Pathways Involved in Leptin-Mediated Weight Loss in ob/ob Mice	PLOS ONE			English	Article							STEAROYL-COA DESATURASE-1; FACTOR BINDING PROTEIN-2; BODY-WEIGHT; INSULIN; LIVER; OVEREXPRESSION; GLUCOKINASE; MITONEET; PROTECTS; IGFBP-2	Background: Leptin, a cytokine-like protein, plays an important role in the regulation of body weight through inhibition of food intake and stimulation of energy expenditure. Leptin circulates in blood and acts on the brain, which sends downstream signals to regulate body weight. Leptin therapy has been successful in treating leptin deficient obese patients. However, high levels of leptin have been observed in more common forms of obesity indicating a state of leptin resistance which limits the application of leptin in the treatment of obesity. If the central effect of leptin could be by-passed and genes which respond to leptin treatment could be regulated directly, new therapeutic targets for the treatment of obesity may be possible. The purpose of this study was to identify genes and subsequent pathways correlated with leptin-mediated weight loss. Methodology/Principal Findings: We utilized microarray technology to compare hepatic gene expression changes after two types of leptin administration: one involving a direct stimulatory effect when administered peripherally (subcutaneous: SQ) and another that is indirect, involving a hypothalamic relay that suppresses food intake when leptin is administered centrally (intracerebroventricular: ICV). We identified 214 genes that correlate with leptin mediated weight loss. Several biological processes such as mitochondrial metabolic pathways, lipid metabolic and catabolic processes, lipid biosynthetic processes, carboxylic acid metabolic processes, iron ion binding and glutathione S-transferases were downregulated after leptin administration. In contrast, genes involved in the immune system inflammatory response and lysosomal activity were found to be upregulated. Among the cellular compartments mitochondrion (32 genes), endoplasmic reticulum (22 genes) and vacuole (8 genes) were significantly over represented. Conclusions/Significance: In this study we have identified key molecular pathways and downstream genes which respond to leptin treatment and are involved in leptin-mediated weight loss. Many of these genes have previously been shown to be associated with obesity; however, we have also identified a number of other novel target genes. Further investigation will be required to assess the possible use of these genes and their associated protein products as therapeutic targets for the treatment of obesity.	[Sharma, Ashok; Chen, Bo; Podolsky, Robert H.; McIndoe, Richard A.; She, Jin-Xiong] Med Coll Georgia, Sch Med, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Bartell, Shoshana M.; Baile, Clifton A.] Univ Georgia, Athens, GA 30602 USA; [Podolsky, Robert H.] Med Coll Georgia, Dept Med, Sch Med, Augusta, GA 30912 USA; [McIndoe, Richard A.; She, Jin-Xiong] Med Coll Georgia, Dept Pathol, Sch Med, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; University of Georgia; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Sharma, A (corresponding author), Med Coll Georgia, Sch Med, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA.	jshe@mail.mcg.edu	chen, bo/G-4522-2014; Podolsky, Robert/GRY-0740-2022	McIndoe, Richard/0000-0002-3040-3631; Sharma, Ashok/0000-0001-9597-4374	Georgia Research Alliance (GRA)	Georgia Research Alliance (GRA)	This study was supported by the Georgia Research Alliance (GRA, http://www.gra.org/) Eminent Scholar endowment and two GRA Challenge Grants to JXS and CAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RL, 2007, CANCER EPIDEM BIOMAR, V16, P593, DOI 10.1158/1055-9965.EPI-06-0775; Batra A, 2010, ENDOCRINOLOGY, V151, P56, DOI 10.1210/en.2009-0565; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boutilier RG, 2001, J EXP BIOL, V204, P3171; Caro JF, 1996, LANCET, V348, P159, DOI 10.1016/S0140-6736(96)03173-X; Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; Choi YH, 2003, PHYSIOL BEHAV, V79, P795, DOI 10.1016/S0031-9384(03)00205-1; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Elam MB, 2009, OBESITY, V17, P1563, DOI 10.1038/oby.2009.49; FAILLA ML, 1988, J NUTR, V118, P46, DOI 10.1093/jn/118.1.46; Ferre T, 2003, DIABETOLOGIA, V46, P1662, DOI 10.1007/s00125-003-1244-z; Friedman JM, 2009, AM J CLIN NUTR, V89, p973S, DOI 10.3945/ajcn.2008.26788B; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fukushima T, 2007, ANTICANCER RES, V27, P3685; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; Huang W, 2007, J APPL PHYSIOL, V102, P2260, DOI 10.1152/japplphysiol.01449.2006; Inoue Y, 2002, J BIOL CHEM, V277, P25257, DOI 10.1074/jbc.M203126200; Issandou M, 2009, EUR J PHARMACOL, V618, P28, DOI 10.1016/j.ejphar.2009.07.004; Jowsey IR, 2003, BIOCHEM BIOPH RES CO, V312, P1226, DOI 10.1016/j.bbrc.2003.11.068; Kerr KF, 2009, BIOINFORMATICS, V25, P2035, DOI 10.1093/bioinformatics/btp363; Lago F, 2007, NAT CLIN PRACT RHEUM, V3, P716, DOI 10.1038/ncprheum0674; LE GG, 2007, DIABETES RES CLIN PR, V77, P363; Li CS, 2009, BIOORG MED CHEM LETT, V19, P5214, DOI 10.1016/j.bmcl.2009.07.015; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Marucci G, 2008, VIRCHOWS ARCH, V453, P599, DOI 10.1007/s00428-008-0685-7; Munzberg H, 2010, FORUM NUTR, V63, P123, DOI 10.1159/000264400; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Prada PO, 2009, DIABETES, V58, P2910, DOI 10.2337/db08-0506; Ramani K, 2008, HEPATOLOGY, V47, P521, DOI 10.1002/hep.22064; Sharma A, 2009, BIOINFORMATICS, V25, P1152, DOI 10.1093/bioinformatics/btp123; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; So AI, 2008, CLIN CANCER RES, V14, P6944, DOI 10.1158/1078-0432.CCR-08-0408; Wang HM, 2008, BREAST J, V14, P261, DOI 10.1111/j.1524-4741.2008.00572.x; Warensjo E, 2007, OBESITY, V15, P1732, DOI 10.1038/oby.2007.206; Wheatcroft SB, 2007, DIABETES, V56, P285, DOI 10.2337/db06-0436; Wheatcroft SB, 2009, TRENDS ENDOCRIN MET, V20, P153, DOI 10.1016/j.tem.2009.01.002; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	45	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12147	10.1371/journal.pone.0012147	http://dx.doi.org/10.1371/journal.pone.0012147			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808936	gold, Green Published, Green Submitted			2022-12-25	WOS:000280968000005
J	Vanderelst, D; De Mey, F; Peremans, H; Geipel, I; Kalko, E; Firzlaff, U				Vanderelst, Dieter; De Mey, Fons; Peremans, Herbert; Geipel, Inga; Kalko, Elisabeth; Firzlaff, Uwe			What Noseleaves Do for FM Bats Depends on Their Degree of Sensorial Specialization	PLOS ONE			English	Article							BOUNDARY-ELEMENT METHOD; BIG BROWN BAT; EPTESICUS-FUSCUS; ECHOLOCATING BATS; EXTERNAL EAR; PHYLLOSTOMUS-DISCOLOR; SOUND LOCALIZATION; HORSESHOE BAT; EMISSION; SYSTEM	Background: Many bats vocalizing through their nose carry a prominent noseleaf that is involved in shaping the emission beam of these animals. To our knowledge, the exact role of these appendages has not been thoroughly investigated as for no single species both the hearing and the emission spatial sensitivities have been obtained. In this paper, we set out to evaluate the complete spatial sensitivity of two species of New World leaf-nosed bats: Micronycteris microtis and Phyllostomus discolor. From an ecological point of view, these species are interesting as they belong to the same family (Phyllostomidae) and their noseleaves are morphologically similar. They differ vastly in the niche they occupy. Comparing these species allows us to relate differences in function of the noseleaf to the ecological background of bat species. Methodology/Principal Findings: We simulate the spatial sensitivity of both the hearing and the emission subsystems of two species, M. microtis and P. discolor. This technique allows us to evaluate the respective roles played by the noseleaf in the echolocation system of these species. We find that the noseleaf of M. microtis focuses the radiated energy better and yields better control over the emission beam. Conclusions: From the evidence presented we conclude that the noseleaves serve quantitatively different functions for different bats. The main function of the noseleaf is to serve as an energy focusing mechanism that increases the difference between the reflected energy from objects in the focal area and objects in the periphery. However, despite the gross morphological similarities between the noseleaves of the two Phyllostomid species they focus the energy to a different extent, a capability that can be linked to the different ecological niches occupied by the two species.	[Vanderelst, Dieter; De Mey, Fons; Peremans, Herbert] Univ Antwerp, Act Percept Lab, B-2020 Antwerp, Belgium; [Geipel, Inga; Kalko, Elisabeth] Univ Ulm, Inst Expt Ecol, Ulm, Germany; [Kalko, Elisabeth] Smithsonian Trop Res Inst, Balboa, Panama; [Firzlaff, Uwe] Tech Univ Munich, Lehrstuhl Zool, D-8050 Freising Weihenstephan, Germany	University of Antwerp; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute; Technical University of Munich	Vanderelst, D (corresponding author), Univ Antwerp, Act Percept Lab, B-2020 Antwerp, Belgium.	dieter.vanderelst@ua.ac.be		Firzlaff, Uwe/0000-0003-2803-3587; Geipel, Inga/0000-0003-3118-2460	EU	EU(European Commission)	This work was funded by the EU CHIROPING (Chiroptera, Robots, Sonar) and CILIA (Customized Intelligent Life-inspired Arrays) projects. These projects are funded by the Seventh Framework Programme ICT Challenge 2: "Cognitive Systems, Interaction, Robotics" and the Future and Emergent Technologies arm of the IST Programme in the 6th Framework Programme respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTES RA, 1978, J ACOUST SOC AM, V63, P155, DOI 10.1121/1.381707; Arlettaz R, 2001, NATURE, V414, P742, DOI 10.1038/414742a; Aytekin M, 2004, J ACOUST SOC AM, V116, P3594, DOI 10.1121/1.1811412; AYTEKIN M, 2007, THESIS U MARYLAND; Chiu C, 2007, J ACOUST SOC AM, V121, P2227, DOI 10.1121/1.2434760; De Mey F, 2008, J ACOUST SOC AM, V124, P2123, DOI 10.1121/1.2968703; Firzlaff U, 2004, HEARING RES, V197, P74, DOI 10.1016/j.heares.2004.06.009; Firzlaff U, 2003, HEARING RES, V185, P109, DOI 10.1016/S0378-5955(03)00278-8; Fontaine B, 2009, J ACOUST SOC AM, V125, P3052, DOI 10.1121/1.3101485; FUZESSERY ZM, 1992, J COMP PHYSIOL A, V170, P57; GEIPEL I, 2007, THESIS GEORGAUGUST U; Giannini NP, 2004, OIKOS, V105, P209, DOI 10.1111/j.0030-1299.2004.12690.x; Grace SM, 2008, ACTA ACUST UNITED AC, V94, P310, DOI 10.3813/AAA.918034; Griffin D.R., 1958, LISTENING DARK ACOUS; HARTLEY DJ, 1987, J ACOUST SOC AM, V82, P1892, DOI 10.1121/1.395684; Hartmann WH, 1999, PHYS TODAY, V52, P24, DOI 10.1063/1.882727; Kalka M, 2006, J TROP ECOL, V22, P1, DOI 10.1017/S0266467405002920; Katz BFG, 2001, J ACOUST SOC AM, V110, P2449, DOI 10.1121/1.1412441; Kwiecinski Gary G., 2006, Mammalian Species, P1, DOI 10.1644/801.1; LAWRENCE BD, 1982, SCIENCE, V218, P481, DOI 10.1126/science.7123247; Muller R, 2004, J ACOUST SOC AM, V116, P3701, DOI 10.1121/1.1815133; Neuweiler G., 2000, BIOL BATS; OBRIST MK, 1993, J EXP BIOL, V180, P119; Otani M., 2003, Acoustical Science and Technology, V24, P259, DOI 10.1250/ast.24.259; Otani M, 2006, J ACOUST SOC AM, V119, P2589, DOI 10.1121/1.2191608; Pierce A. D., 1991, ACOUSTICS INTRO ITS; ROTHER G, 1982, Z SAUGETIERKD, V47, P324; SAILLANT PA, 1993, J ACOUST SOC AM, V94, P2691, DOI 10.1121/1.407353; SCHNITZLER HU, 1977, J COMP PHYSIOL, V116, P51, DOI 10.1007/BF00605516; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; SIMMONS JA, 1969, J ACOUST SOC AM, V46, P1054, DOI 10.1121/1.1911804; Skolnik M. I, 1990, RADAR HDB, Vsecond; STROTHER G K, 1970, Journal of the Acoustical Society of America, V48, P1430, DOI 10.1121/1.1912304; SUGA N, 1972, SCIENCE, V177, P82, DOI 10.1126/science.177.4043.82; Walsh T, 2004, J ACOUST SOC AM, V115, P1033, DOI 10.1121/1.1643360; Weinbeer M, 2007, BEHAV ECOL SOCIOBIOL, V61, P1337, DOI 10.1007/s00265-007-0364-8; Wotton JM, 1997, J ACOUST SOC AM, V101, P1723, DOI 10.1121/1.418271; Wotton JM, 1996, J ACOUST SOC AM, V100, P1764, DOI 10.1121/1.416073; Xiao T, 2003, J ACOUST SOC AM, V113, P2434, DOI 10.1121/1.1561495; Zhuang Q, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218701; Zhuang Q, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051902	42	71	72	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e11893	10.1371/journal.pone.0011893	http://dx.doi.org/10.1371/journal.pone.0011893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808438	Green Published, gold, Green Submitted			2022-12-25	WOS:000280968000001
J	Nogues, C; Leh, H; Langendorf, CG; Law, RHP; Buckle, AM; Buckle, M				Nogues, Claude; Leh, Herve; Langendorf, Christopher G.; Law, Ruby H. P.; Buckle, Ashley M.; Buckle, Malcolm			Characterisation of Peptide Microarrays for Studying Antibody-Antigen Binding Using Surface Plasmon Resonance Imagery	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; REAL-TIME; AUTOANTIBODY; EPITOPE; IDENTIFICATION; ADSORPTION; PROTEINS; OXIDE); GAD	Background: Non-specific binding to biosensor surfaces is a major obstacle to quantitative analysis of selective retention of analytes at immobilized target molecules. Although a range of chemical antifouling monolayers has been developed to address this problem, many macromolecular interactions still remain refractory to analysis due to the prevalent high degree of non-specific binding. We describe how we use the dynamic process of the formation of self assembling monolayers and optimise physical and chemical properties thus reducing considerably non-specific binding and allowing analysis of specific binding of analytes to immobilized target molecules. Methodology/Principal Findings: We illustrate this approach by the production of specific protein arrays for the analysis of interactions between the 65kDa isoform of human glutamate decarboxylase (GAD65) and a human monoclonal antibody. Our data illustrate that we have effectively eliminated non-specific interactions with the surface containing the immobilised GAD65 molecules. The findings have several implications. First, this approach obviates the dubious process of background subtraction and gives access to more accurate kinetic and equilibrium values that are no longer contaminated by multiphase non-specific binding. Second, an enhanced signal to noise ratio increases not only the sensitivity but also confidence in the use of SPR to generate kinetic constants that may then be inserted into van't Hoff type analyses to provide comparative Delta G, Delta S and Delta H values, making this an efficient, rapid and competitive alternative to ITC measurements used in drug and macromolecular-interaction mechanistic studies. Third, the accuracy of the measurements allows the application of more intricate interaction models than simple Langmuir monophasic binding. Conclusions: The detection and measurement of antibody binding by the type 1 diabetes autoantigen GAD65 represents an example of an antibody-antigen interaction where good structural, mechanistic and immunological data are available. Using SPRi we were able to characterise the kinetics of the interaction in greater detail than ELISA/RIA methods. Furthermore, our data indicate that SPRi is well suited to a multiplexed immunoassay using GAD65 proteins, and may be applicable to other biomarkers.	[Nogues, Claude; Leh, Herve; Buckle, Malcolm] Ecole Normale Super, Lab Biol & Pharmacol Appl, UMR 8113, CNRS,Inst Alembert, Cachan, France; [Langendorf, Christopher G.; Law, Ruby H. P.; Buckle, Ashley M.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Monash University	Nogues, C (corresponding author), Ecole Normale Super, Lab Biol & Pharmacol Appl, UMR 8113, CNRS,Inst Alembert, Cachan, France.	ashley.buckle@monash.edu; buckle@lbpa.ens-cachan.fr	Nogues, claude/B-7215-2012; Buckle, Ashley/P-8366-2016	Buckle, Ashley/0000-0003-2943-9044; Langendorf, Christopher/0000-0002-9049-5283; law, ruby/0000-0001-5432-5781	National Health & Medical Research Council (NHMRC, Australia); Australian Research Council; ANVAR/OSEO (National Agency for the Valorisation of Research) (specific biochemical platform for customised biosensor surfaces); ANR (National Research Agency); IMFOVIR (Structural and Functional Imagery of Retroviral Replication Complexes)	National Health & Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); ANVAR/OSEO (National Agency for the Valorisation of Research) (specific biochemical platform for customised biosensor surfaces); ANR (National Research Agency)(French National Research Agency (ANR)); IMFOVIR (Structural and Functional Imagery of Retroviral Replication Complexes)	The authors thank the National Health & Medical Research Council (NHMRC, Australia), and Australian Research Council for funding and support. AMB is an NHMRC Senior Research Fellow. CN and MB thank Eurotransbio (QUBIS) (Targeted functional genomics based on Mass Spectrometry (MS), Surface Plasmon Resonance imaging (SPRi) and Stable Isotope(SI)-labelling: Application towards the understanding of the function of PDZ-domains as switch board for signal transduction), ANVAR/OSEO (National Agency for the Valorisation of Research) (specific biochemical platform for customised biosensor surfaces) and ANR (National Research Agency) IMFOVIR (Structural and Functional Imagery of Retroviral Replication Complexes) for financial aid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arafat Y, 2009, MOL IMMUNOL, V47, P493, DOI 10.1016/j.molimm.2009.08.022; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Bouffartigues E, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm030; Buckle M, 1996, P NATL ACAD SCI USA, V93, P889, DOI 10.1073/pnas.93.2.889; Cherif B, 2006, CLIN CHEM, V52, P255, DOI 10.1373/clinchem.2005.085727; Fenalti G, 2008, DIABETES, V57, P1293, DOI 10.2337/db07-1461; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; Fenalti G, 2007, MOL IMMUNOL, V44, P1178, DOI 10.1016/j.molimm.2006.06.025; Fenalti G, 2010, AUTOIMMUN REV, V9, P148, DOI 10.1016/j.autrev.2009.05.003; Frederix F, 2004, J BIOCHEM BIOPH METH, V58, P67, DOI 10.1016/S0165-022X(03)00150-7; GOTTLIEB DI, 1986, P NATL ACAD SCI USA, V83, P8808, DOI 10.1073/pnas.83.22.8808; Lee JW, 2005, BIOSENS BIOELECTRON, V20, P1422, DOI 10.1016/j.bios.2004.04.017; Powell M, 1996, CLIN CHIM ACTA, V256, P175, DOI 10.1016/S0009-8981(96)06422-4; PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032; Primo ME, 2003, CLIN IMMUNOL, V108, P38, DOI 10.1016/S1521-6616(03)00061-5; Schwartz HL, 1999, J MOL BIOL, V287, P983, DOI 10.1006/jmbi.1999.2655; Teoh KL, 1998, AUTOIMMUNITY, V28, P259, DOI 10.3109/08916939808995374; TUOMILEHTO J, 1994, LANCET, V343, P1383, DOI 10.1016/S0140-6736(94)92521-6	18	17	18	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12152	10.1371/journal.pone.0012152	http://dx.doi.org/10.1371/journal.pone.0012152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730101	Green Submitted, Green Published, gold			2022-12-25	WOS:000280862200011
J	Yan, HD; Deshpande, DA; Misior, AM; Miles, MC; Saxena, H; Riemer, EC; Pascual, RM; Panettieri, RA; Penn, RB				Yan, Huandong; Deshpande, Deepak A.; Misior, Anna M.; Miles, Matthew C.; Saxena, Himansh; Riemer, Ellen C.; Pascual, Rodolfo M.; Panettieri, Reynold A.; Penn, Raymond B.			Anti-mitogenic effects of beta-agonists and PGE(2) on airway smooth muscle are PKA dependent	FASEB JOURNAL			English	Article						airway remodeling; asthma; cell proliferation; cyclic AMP; G protein-coupled receptor	PROTEIN-COUPLED RECEPTORS; CELL-PROLIFERATION; HUMAN BETA(2)-ADRENOCEPTOR; KINASE-A; CAMP; DESENSITIZATION; INHIBITION; MECHANISMS; PHOSPHORYLATION; ACTIVATION	Inhaled beta-agonists are effective airway smooth muscle (ASM)-relaxing agents that help reverse bronchoconstriction in asthma, but their ability to affect the aberrant ASM growth that also occurs with asthma is poorly understood. beta-Agonists exhibit PKA-dependent antimitogenic effects in several cell types. However, recent studies suggest that Epac, and not PKA, mediates the antimitogenic effect of cAMP in both ASM and fibroblasts. This study aims to clarify the role of PKA in mediating the effect of G(s)-coupled receptors on human ASM growth. Pretreatment of ASM cultures with beta-agonists albuterol, isoproterenol, or salmeterol (100 nM to 10 mu M) caused a significant (similar to 25-30%) inhibition of EGF-stimulated ASM thymidine incorporation and cell proliferation, whereas a much greater inhibition was observed from pretreatment with PGE(2) (75-80%). However, all agents were ineffective in cells expressing GFP chimeras of either PKI (a PKA inhibitor) or a mutant PKA regulatory subunit relative to the control cells expressing GFP. The antimitogenic efficacy of PGE(2) in inhibiting control cultures was associated with greater ability to stimulate sustained PKA activation and greater inhibition of late-phase promitogenic p42/p44 and PI3K activities. These findings suggest that therapeutic approaches enabling superior PKA activation in ASM will be most efficacious in deterring ASM growth.-Yan, H., Deshpande, D. A., Misior, A. M., Miles, M. C., Saxena, H., Riemer, E. C., Pascual, R. M., Panettieri, R. A., Penn. R. B. Anti-mitogenic effects of beta-agonists and PGE2 on airway smooth muscle are PKA dependent. FASEB J. 25, 389-397 (2011). www.fasebj.org	[Yan, Huandong; Deshpande, Deepak A.; Saxena, Himansh; Penn, Raymond B.] Univ Maryland, Sch Med, Dept Med, Cardiopulm Genom Program, Baltimore, MD 21201 USA; [Misior, Anna M.; Miles, Matthew C.; Pascual, Rodolfo M.] Wake Forest Univ Hlth Sci, Ctr Human Genom, Winston Salem, NC USA; [Misior, Anna M.; Miles, Matthew C.; Pascual, Rodolfo M.] Wake Forest Univ Hlth Sci, Dept Internal Med, Winston Salem, NC USA; [Riemer, Ellen C.] Med Univ S Carolina, Dept Pathol, Charleston, SC 29425 USA; [Panettieri, Reynold A.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA	University System of Maryland; University of Maryland Baltimore; Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine; Medical University of South Carolina; University of Pennsylvania	Penn, RB (corresponding author), Univ Maryland, Sch Med, Dept Med, Cardiopulm Genom Program, 20 Penn St,HSF II Rm 147, Baltimore, MD 21201 USA.	rpenn@medicine.umaryland.edu	panettieri, reynold/AAG-9485-2019	Miles, Matthew/0000-0003-4768-385X	National Institutes of Health Heart, Lung, and Blood Institute [HL58506, HL087560]; GlaxoSmithKline; Interdisciplinary Training Program in Muscle Biology [AR007592]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL058506, R01HL058506, K99HL087560, R00HL087560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041265] Funding Source: NIH RePORTER	National Institutes of Health Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); GlaxoSmithKline(GlaxoSmithKline); Interdisciplinary Training Program in Muscle Biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by National Institutes of Health Heart, Lung, and Blood Institute grants HL58506 (R.B.P.) and HL087560 (D.A.D.), and an independent investigator grant from GlaxoSmithKline (R.B.P.). M.C.M is a trainee in the Tinsley R. Harrison Translational Research Training Program. H.S. is supported by the Interdisciplinary Training Program in Muscle Biology training grant AR007592.	Baker JG, 2003, MOL PHARMACOL, V64, P1357, DOI 10.1124/mol.64.6.1357; Billington CK, 2005, BIOCHEMISTRY-US, V44, P14595, DOI 10.1021/bi0510734; BUTT E, 1994, J BIOL CHEM, V269, P14509; CORRELL LA, 1989, J BIOL CHEM, V264, P16672; Deshpande DA, 2008, FASEB J, V22, P2134, DOI 10.1096/fj.07-102459; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; Gosens R, 2003, AM J RESP CELL MOL, V28, P257, DOI 10.1165/rcmb.2002-0128OC; Grandoch M, 2009, BRIT J PHARMACOL, V159, P265; Guo MH, 2005, BIOCHEMISTRY-US, V44, P13771, DOI 10.1021/bi051255y; Haag S, 2008, N-S ARCH PHARMACOL, V378, P617, DOI 10.1007/s00210-008-0334-3; Hirst Stuart J, 2004, J Allergy Clin Immunol, V114, pS2, DOI 10.1016/j.jaci.2004.04.039; Huang SK, 2008, AM J RESP CELL MOL, V39, P482, DOI 10.1165/rcmb.2008-0080OC; January B, 1998, BRIT J PHARMACOL, V123, P701, DOI 10.1038/sj.bjp.0701658; Kassel KM, 2008, AM J PHYSIOL-LUNG C, V294, pL131, DOI 10.1152/ajplung.00381.2007; Kong KC, 2008, BIOCHEMISTRY-US, V47, P9279, DOI 10.1021/bi801056w; Kong KC, 2006, FASEB J, V20, P1558, DOI 10.1096/fj.05-5622fje; Krymskaya VP, 2000, AM J RESP CELL MOL, V23, P546, DOI 10.1165/ajrcmb.23.4.4115; Misior AM, 2008, MOL PHARMACOL, V73, P566, DOI 10.1124/mol.107.040519; Misior AM, 2009, AM J RESP CELL MOL, V41, P24, DOI 10.1165/rcmb.2008-0266OC; NOVERAL JP, 1994, AM J PHYSIOL, V267, pL291, DOI 10.1152/ajplung.1994.267.3.L291; Orsini MJ, 1999, AM J PHYSIOL-LUNG C, V277, pL479, DOI 10.1152/ajplung.1999.277.3.L479; Penn RB, 2008, N-S ARCH PHARMACOL, V378, P149, DOI 10.1007/s00210-008-0263-1; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Penn RB, 1999, J PHARMACOL EXP THER, V288, P428; Roscioni SS, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-88; Spicuzza L, 2001, BRIT J PHARMACOL, V133, P1201, DOI 10.1038/sj.bjp.0704213; Stewart AG, 1999, MOL PHARMACOL, V56, P1079, DOI 10.1124/mol.56.5.1079; Stewart AG, 1997, BRIT J PHARMACOL, V121, P361, DOI 10.1038/sj.bjp.0701128; TOMLINSON PR, 1995, BIOCHEM PHARMACOL, V49, P1809, DOI 10.1016/0006-2952(94)00532-Q; WALSH DA, 1971, J BIOL CHEM, V246, P1977	30	49	51	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2011	25	1					389	397		10.1096/fj.10-164798	http://dx.doi.org/10.1096/fj.10-164798			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20805374	Green Published			2022-12-25	WOS:000285869500035
J	Goldbourt, A; Day, LA; McDermott, AE				Goldbourt, Amir; Day, Loren A.; McDermott, Ann E.			Intersubunit Hydrophobic Interactions in Pf1 Filamentous Phage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAHN CROSS-POLARIZATION; FIBER DIFFRACTION DATA; ANGLE-SPINNING NMR; STRUCTURAL TRANSITION; COAT PROTEIN; CIRCULAR-DICHROISM; BACTERIAL-VIRUS; BACTERIOPHAGE; DNA; TEMPERATURE	Magic angle spinning solid-state NMR has been used to study the structural changes in the Pf1 filamentous bacteriophage, which occur near 10 degrees C. Comparisons of NMR spectra recorded above and below 10 degrees C reveal reversible perturbations in many NMR chemical shifts, most of which are assigned to atoms of hydrophobic side chains of the 46-residue subunit. The changes mainly involve groups located in patches on the interfaces between neighboring capsid subunits. The observations show that the transition adjusts the hydrophobic interfaces between fairly rigid subunits. The low temperature form has been generally more amenable to structure determination; spin diffusion experiments on this form revealed unambiguous contacts between side chains of neighboring subunits. These contacts are important constraints for structure modeling.	[McDermott, Ann E.] Columbia Univ, Dept Chem, New York, NY 10027 USA; Tel Aviv Univ, Sch Chem, IL-69978 Ramat Aviv, Israel; [Day, Loren A.] Univ Med & Dent New Jersey, Publ Hlth Res Inst, Newark, NJ 07103 USA	Columbia University; Tel Aviv University; Rutgers State University New Brunswick; Rutgers State University Medical Center	McDermott, AE (corresponding author), Columbia Univ, Dept Chem, 3000 Broadway,MC3113, New York, NY 10027 USA.	aem5@columbia.edu	Goldbourt, Amir/AAK-6625-2020	Goldbourt, Amir/0000-0002-7307-3417; McDermott, Ann/0000-0002-9249-1649	Public Health Research Institute; National Science Foundation [0316248]; European Union [IRG-FP7 224800]; National Institutes of Health, NIGMS [P41 GM66354]	Public Health Research Institute; National Science Foundation(National Science Foundation (NSF)); European Union(European Commission); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Research Institute (to L. A. D.), National Science Foundation MCB Grant 0316248 (to A. E. M.), and European Union, Marie Curie Action Grant IRG-FP7 224800 (to A. G.).; Member of the New York Structural Biology Center, which is supported by National Institutes of Health Grant P41 GM66354 from NIGMS.	ANDREW EB, 1995, J CHEM PHYS, V103, P6951; Baldus M, 1996, J MAGN RESON SER A, V118, P140, DOI 10.1006/jmra.1996.0022; Blanch EW, 1999, J MOL BIOL, V290, P1, DOI 10.1006/jmbi.1999.2871; CASADEVALL A, 1988, BIOCHEMISTRY-US, V27, P3599, DOI 10.1021/bi00410a010; DAY LA, 1988, ANNU REV BIOPHYS BIO, V17, P509; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; GODDARD TD, 2004, SPARKY VERSION 3 1 1; Goldbourt A, 2007, J AM CHEM SOC, V129, P2338, DOI 10.1021/ja066928u; GONZALEZ A, 1995, ACTA CRYSTALLOGR D, V51, P792, DOI 10.1107/S0907444995003027; HEDIGER S, 1995, CHEM PHYS LETT, V240, P449, DOI 10.1016/0009-2614(95)00505-X; HINZ HJ, 1980, J MOL BIOL, V144, P281, DOI 10.1016/0022-2836(80)90091-1; Jakeman DL, 1998, J BIOMOL NMR, V12, P417, DOI 10.1023/A:1008305118426; LIU DJ, 1994, SCIENCE, V265, P671, DOI 10.1126/science.8036516; MAHY BWJ, 2008, ENCY VIROLOGY, P117; Marvin DA, 1998, CURR OPIN STRUC BIOL, V8, P150, DOI 10.1016/S0959-440X(98)80032-8; MARVIN DA, 1990, INT J BIOL MACROMOL, V12, P125, DOI 10.1016/0141-8130(90)90064-H; MARVIN DA, 1992, PHASE TRANSIT, V39, P45, DOI 10.1080/01411599208203472; Morcombe CR, 2004, J AM CHEM SOC, V126, P7196, DOI 10.1021/ja047919t; NAKASHIMA Y, 1980, J MOL BIOL, V138, P493, DOI 10.1016/S0022-2836(80)80014-3; NAVE C, 1979, NATURE, V281, P232, DOI 10.1038/281232a0; Rice SA, 2009, ISME J, V3, P271, DOI 10.1038/ismej.2008.109; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; SPECTHRIE L, 1987, BIOPHYS J, V52, P199, DOI 10.1016/S0006-3495(87)83207-1; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; TAKEYA K, 1966, VIROLOGY, V28, P163, DOI 10.1016/0042-6822(66)90317-5; Thiriot DS, 2005, PROTEIN SCI, V14, P1064, DOI 10.1110/ps.041220305; Thiriot DS, 2004, J MOL BIOL, V341, P869, DOI 10.1016/j.jmb.2004.06.038; Tomar S, 2007, J AM CHEM SOC, V129, P3367, DOI 10.1021/ja068498d; TORBET J, 1981, BIOPOLYMERS, V20, P2657, DOI 10.1002/bip.1981.360201212; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; WACHTEL EJ, 1976, J MOL BIOL, V107, P379, DOI 10.1016/S0022-2836(76)80011-3; Webb JS, 2004, J BACTERIOL, V186, P8066, DOI 10.1128/JB.186.23.8066-8073.2004; Welsh LC, 1998, J MOL BIOL, V283, P155, DOI 10.1006/jmbi.1998.2081; Welsh LC, 2000, ACTA CRYSTALLOGR D, V56, P137, DOI 10.1107/S0907444999015334	34	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37051	37059		10.1074/jbc.M110.119339	http://dx.doi.org/10.1074/jbc.M110.119339			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20736177	Green Published, hybrid			2022-12-25	WOS:000284146100072
J	Yu, ASL; Cheng, MH; Coalson, RD				Yu, Alan S. L.; Cheng, Mary H.; Coalson, Rob D.			Calcium Inhibits Paracellular Sodium Conductance through Claudin-2 by Competitive Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-SELECTIVE CHANNELS; TIGHT JUNCTION; EPITHELIAL-CELLS; OCCLUDING JUNCTIONS; MEMBRANE-PROTEINS; ION PERMEATION; EXPRESSION; PERMEABILITY; GALLBLADDER; LOCALIZATION	Claudins form paracellular pores at the tight junction in epithelial cells. Profound depletion of extracellular calcium is well known to cause loosening of the tight junction with loss of transepithelial resistance. However, moderate variations in calcium concentrations within the physiological range can also regulate transepithelial permeability. To investigate the underlying molecular mechanisms, we studied the effects of calcium on the permeability of claudin-2, expressed in an inducible MDCK I cell line. We found that in the physiological range, calcium acts as a reversible inhibitor of the total conductance and Na+ permeability of claudin-2, without causing changes in tight junction structure. The effect of calcium is enhanced at low Na+ concentrations, consistent with a competitive effect. Furthermore, mutation of an intrapore negatively charged binding site, Asp-65, to asparagine partially abrogated the inhibitory effect of calcium. This suggests that calcium competes with Na+ for binding to Asp-65. Other polyvalent cations had similar effects, including La3+, which caused severe and irreversible inhibition of conductance. Brownian dynamics simulations demonstrated that such inhibition can be explained if Asp-65 has a relatively high charge density, thus favoring binding of Ca2+ over that of Na+, reducing Ca2+ permeation by inhibiting its dissociation from this site, and decreasing Na+ conductance through repulsive electrostatic interaction with Ca2+. These findings may explain why hypercalcemia inhibits Na+ reabsorption in the proximal tubule of the kidney.	Univ So Calif, Keck Sch Med, Div Nephrol, Dept Med, Los Angeles, CA 90089 USA; [Yu, Alan S. L.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA; [Cheng, Mary H.; Coalson, Rob D.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	University of Southern California; University of Southern California; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yu, ASL (corresponding author), 2025 Zonal Ave,RMR 406, Los Angeles, CA 90089 USA.	alanyu@usc.edu	Cheng, Mary Hongying/AAU-3768-2021; Yu, Alan/AID-7467-2022	Cheng, Mary Hongying/0000-0001-5833-8221; Yu, Alan/0000-0002-1776-2533	National Institutes of Health [DK062283, 1S10RR024754]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK062283 (to A. S. L. Y.) and 1S10RR024754 (shared instrumentation grant to the University of Southern California Multi-Photon Microscopy Core).	ALMERS W, 1984, J PHYSIOL-LONDON, V353, P585, DOI 10.1113/jphysiol.1984.sp015352; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; CEREIJIDO M, 1978, J CELL BIOL, V77, P853, DOI 10.1083/jcb.77.3.853; Cheng HY, 2005, J PHYS CHEM B, V109, P488, DOI 10.1021/jp047438w; Cheng MH, 2007, J PHYS CHEM B, V111, P5956, DOI 10.1021/jp063993h; Cheng MHY, 2005, BIOPHYS J, V89, P1669, DOI 10.1529/biophysj.105.060368; Colegio OR, 2002, AM J PHYSIOL-CELL PH, V283, pC142, DOI 10.1152/ajpcell.00038.2002; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; DIAMOND JM, 1966, J PHYSIOL-LONDON, V183, P37, DOI 10.1113/jphysiol.1966.sp007850; DIBONA GF, 1971, AM J PHYSIOL, V220, P49, DOI 10.1152/ajplegacy.1971.220.1.49; Enck AH, 2001, AM J PHYSIOL-RENAL, V281, pF966, DOI 10.1152/ajprenal.0021.2001; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; FIGUEROAQUINTANILLA D, 1993, NEW ENGL J MED, V328, P1653, DOI 10.1056/NEJM199306103282301; FROMM M, 1985, J MEMBRANE BIOL, V87, P141, DOI 10.1007/BF01870660; FROMTER E, 1972, NATURE-NEW BIOL, V235, P9, DOI 10.1038/newbio235009a0; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gillespie D, 2002, EUR BIOPHYS J BIOPHY, V31, P454, DOI 10.1007/s00249-002-0239-x; Gillespie D, 2008, BIOPHYS J, V95, P2658, DOI 10.1529/biophysj.107.127977; Graf P, 2000, J PHYS CHEM B, V104, P12324, DOI 10.1021/jp001282s; GREENBERG RN, 1982, INFECT IMMUN, V35, P483, DOI 10.1128/IAI.35.2.483-488.1982; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Hille B., 2001, ION CHANNELS EXCITAB, P309; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; KIMIZUKA H, 1964, J THEOR BIOL, V6, P290, DOI 10.1016/0022-5193(64)90035-9; Kiuchi-Saishin Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134875; Laurila JJ, 2007, J HISTOCHEM CYTOCHEM, V55, P567, DOI 10.1369/jhc.6A7155.2007; MACHEN TE, 1972, J CELL BIOL, V54, P302, DOI 10.1083/jcb.54.2.302; MARTINEZ.A, 1971, J CELL BIOL, V50, P277, DOI 10.1083/jcb.50.2.277; MARTINEZPALOMO A, 1980, J CELL BIOL, V87, P736, DOI 10.1083/jcb.87.3.736; MELDOLESI J, 1978, J CELL BIOL, V79, P156, DOI 10.1083/jcb.79.1.156; MORENO JH, 1975, J GEN PHYSIOL, V66, P97, DOI 10.1085/jgp.66.1.97; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Muto S, 2010, P NATL ACAD SCI USA, V107, P8011, DOI 10.1073/pnas.0912901107; Nemeth Z, 2009, J HISTOCHEM CYTOCHEM, V57, P113, DOI 10.1369/jhc.2008.952291; Rahner C, 2001, GASTROENTEROLOGY, V120, P411, DOI 10.1053/gast.2001.21736; Shaikh SA, 2008, BIOPHYS J, V95, P5153, DOI 10.1529/biophysj.108.141606; SILICIANO JD, 1988, J CELL BIOL, V107, P2389, DOI 10.1083/jcb.107.6.2389; Tang VW, 2003, BIOPHYS J, V84, P1660, DOI 10.1016/S0006-3495(03)74975-3; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Weber CR, 2008, LAB INVEST, V88, P1110, DOI 10.1038/labinvest.2008.78; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; WRIGHT EM, 1968, BIOCHIM BIOPHYS ACTA, V163, P57, DOI 10.1016/0005-2736(68)90033-3; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	46	30	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37060	37069		10.1074/jbc.M110.146621	http://dx.doi.org/10.1074/jbc.M110.146621			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20807759	Green Published, hybrid			2022-12-25	WOS:000284146100047
J	Fogel, AI; Li, Y; Giza, J; Wang, Q; Lam, TT; Modis, Y; Biederer, T				Fogel, Adam I.; Li, Yue; Giza, Joanna; Wang, Qing; Lam, TuKiet T.; Modis, Yorgo; Biederer, Thomas			N-Glycosylation at the SynCAM (Synaptic Cell Adhesion Molecule) Immunoglobulin Interface Modulates Synaptic Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYSIALIC ACID; NEUROLIGIN; NEUREXIN; BINDING; PROTEIN; SYNAPTOGENESIS; EXPRESSION; SYNAPSES; FAMILY; DOMAIN	Select adhesion molecules connect pre- and postsynaptic membranes and organize developing synapses. The regulation of these trans-synaptic interactions is an important neurobiological question. We have previously shown that the synaptic cell adhesion molecules (SynCAMs) 1 and 2 engage in homo- and heterophilic interactions and bridge the synaptic cleft to induce presynaptic terminals. Here, we demonstrate that site-specific N-glycosylation impacts the structure and function of adhesive SynCAM interactions. Through crystallographic analysis of SynCAM 2, we identified within the adhesive interface of its Ig1 domain an N-glycan on residue Asn(60). Structural modeling of the corresponding SynCAM 1 Ig1 domain indicates that its glycosylation sites Asn(70)/Asn(104) flank the binding interface of this domain. Mass spectrometric and mutational studies confirm and characterize the modification of these three sites. These site-specific N-glycans affect SynCAM adhesion yet act in a differential manner. Although glycosylation of SynCAM 2 at Asn(60) reduces adhesion, N-glycans at Asn(70)/Asn(104) of SynCAM 1 increase its interactions. The modification of SynCAM 1 with sialic acids contributes to the glycan-dependent strengthening of its binding. Functionally, N-glycosylation promotes the trans-synaptic interactions of SynCAM 1 and is required for synapse induction. These results demonstrate that N-glycosylation of SynCAM proteins differentially affects their binding interface and implicate post-translational modification as a mechanism to regulate trans-synaptic adhesion.	[Fogel, Adam I.; Li, Yue; Giza, Joanna; Wang, Qing; Modis, Yorgo; Biederer, Thomas] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Lam, TuKiet T.] Yale Univ, WM Keck Fdn Biotechnol Resource Lab, New Haven, CT 06520 USA	Yale University; Yale University	Biederer, T (corresponding author), 333 Cedar St, New Haven, CT 06520 USA.	thomas.biederer@yale.edu	Biederer, Thomas/AAZ-6133-2021	Biederer, Thomas/0000-0003-0912-1514; Modis, Yorgo/0000-0002-6084-0429; Wang, Qing/0000-0003-1138-4575	National Institutes of Health [R01 DA018928, T32 GM007223]; Burroughs Wellcome Investigator in the Pathogenesis of Infectious Disease; National Institute on Drug Abuse [P30 DA018343]; Offices of Biological and of Basic Energy Sciences of the U.S. Department of Energy; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223, T32GM007367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343, R01DA018928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Investigator in the Pathogenesis of Infectious Disease(Burroughs Wellcome Fund); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Offices of Biological and of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DA018928 (to T. B.). This work was also supported by a Burroughs Wellcome Investigator in the Pathogenesis of Infectious Disease grant (to Y.M.), National Institutes of Health Predoctoral Program in Cellular and Molecular Biology Grant T32 GM007223, and by National Institutes of Health Grant P30 DA018343 from the National Institute on Drug Abuse. Use of the National Synchrotron Light Source is supported by the Offices of Biological and of Basic Energy Sciences of the U.S. Department of Energy.	ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143; Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Bai Y, 2007, ACTA CRYSTALLOGR F, V63, P135, DOI 10.1107/S1744309107002904; Biederer T, 2006, GENOMICS, V87, P139, DOI 10.1016/j.ygeno.2005.08.017; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2008, CURR OPIN NEUROBIOL, V18, P261, DOI 10.1016/j.conb.2008.07.014; Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Bucior I, 2004, CURR OPIN STRUC BIOL, V14, P631, DOI 10.1016/j.sbi.2004.08.006; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Cooper CA, 2003, NUCLEIC ACIDS RES, V31, P511, DOI 10.1093/nar/gkg099; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Crocker PR, 2002, CURR OPIN STRUC BIOL, V12, P609, DOI 10.1016/S0959-440X(02)00375-5; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dong XH, 2006, J BIOL CHEM, V281, P10610, DOI 10.1074/jbc.M513459200; Dresbach T, 2004, MOL CELL NEUROSCI, V27, P227, DOI 10.1016/j.mcn.2004.06.013; Drescher B, 2003, IMMUNOLOGY, V110, P335, DOI 10.1046/j.1365-2567.2003.01743.x; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Giagtzoglou N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003079; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; GRAY EG, 1959, J ANAT, V93, P420; He YN, 2009, STRUCTURE, V17, P460, DOI 10.1016/j.str.2009.01.009; Huang ZJ, 2008, CURR OPIN NEUROBIOL, V18, P77, DOI 10.1016/j.conb.2008.05.008; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; KADMON G, 1990, J CELL BIOL, V110, P209, DOI 10.1083/jcb.110.1.209; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Koehnke J, 2008, STRUCTURE, V16, P410, DOI 10.1016/j.str.2007.12.024; Kwiatkowski AV, 2007, CURR OPIN CELL BIOL, V19, P551, DOI 10.1016/j.ceb.2007.08.005; Lim BK, 2008, NAT NEUROSCI, V11, P160, DOI 10.1038/nn2033; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; Lucic V, 2005, STRUCTURE, V13, P423, DOI 10.1016/j.str.2005.02.005; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Martin PT, 2002, GLYCOBIOLOGY, V12, p1R, DOI 10.1093/glycob/12.1.1R; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Maurel P, 2007, J CELL BIOL, V178, P861, DOI 10.1083/jcb.200705132; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morelle W, 2006, PROTEOMICS, V6, P3993, DOI 10.1002/pmic.200600129; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALAY SANFORD L., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P193, DOI 10.1083/jcb.2.4.193; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915; SU D, 2008, NATURE */* T C NATUR, V455, P903; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Thomas LA, 2008, J COMP NEUROL, V510, P47, DOI 10.1002/cne.21773; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279; Zaccai NR, 2007, J MOL BIOL, V365, P1469, DOI 10.1016/j.jmb.2006.10.084	56	45	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34864	34874		10.1074/jbc.M110.120865	http://dx.doi.org/10.1074/jbc.M110.120865			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739279	Green Published, hybrid			2022-12-25	WOS:000283659100061
J	Oleinik, NV; Krupenko, NI; Krupenko, SA				Oleinik, N. V.; Krupenko, N. I.; Krupenko, S. A.			ALDH1L1 inhibits cell motility via dephosphorylation of cofilin by PP1 and PP2A	ONCOGENE			English	Article						ALDH1L1; cofilin; phosphatases; actin; folate	ACTIN-BINDING PROTEINS; 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE; REGULATES COFILIN; GENE-EXPRESSION; CARCINOMA-CELLS; DIETARY-FOLATE; BREAST-CANCER; DYNAMICS; MIGRATION; INVASION	Here we report that ALDH1L1 (FDH, a folate enzyme with tumor suppressor-like properties) inhibits cell motility. The underlying mechanism involves F-actin stabilization, re-distribution of cytoplasmic actin toward strong preponderance of filamentous actin and formation of actin stress fibers. A549 cells expressing FDH showed a much slower recovery of green fluorescent protein-actin fluorescence in a fluorescence recovery after photobleaching assay, as well as an increase in G-actin polymerization and a decrease in F-actin depolymerization rates in pyren-actin fluorescence assays indicating the inhibition of actin dynamics. These effects were associated with robust dephosphorylation of the actin depolymerizing factor cofilin by PP1 and PP2A serine/threonine protein phosphatases, but not the cofilin-specific phosphatases slingshot and chronophin. In fact, the PP1/PP2A inhibitor calyculin prevented cofilin dephosphorylation and restored motility. Inhibition of FDH-induced apoptosis by the Jun N-terminal kinase inhibitor SP600125 or the pan-caspase inhibitor zVAD-fmk did not restore motility or levels of phosphor-cofilin, indicating that the observed effects are independent of FDH function in apoptosis. Interestingly, cofilin small interfering RNA or expression of phosphorylation-deficient S3A cofilin mutant resulted in a decrease of G-actin and the actin stress fiber formation, the effects seen upon FDH expression. In contrast, the expression of S3D mutant, mimicking constitutive phosphorylation, prevented these effects further supporting the cofilin-dependent mechanism. Dephosphorylation of cofilin and inhibition of motility in response to FDH can also be prevented by the increased folate in media. Furthermore, folate depletion itself, in the absence of FDH, resulted in cofilin dephosphorylation and inhibition of motility in several cell lines. Our experiments showed that these effects were folate specific and not a general response to nutrient starvation. Overall, this study shows the presence of distinct intracellular signaling pathways regulating motility in response to folate status and points toward mechanisms involving folates in promoting a malignant phenotype. Oncogene (2010) 29, 6233-6244; doi:10.1038/onc.2010.356; published online 23 August 2010	[Oleinik, N. V.; Krupenko, N. I.; Krupenko, S. A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Krupenko, SA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave,Room 512-B BSB, Charleston, SC 29425 USA.	krupenko@musc.edu			National Institutes of Health [DK054388, CA095030]; NATIONAL CANCER INSTITUTE [R01CA095030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The construct for expression of GFP/actin fusion was a kind gift from Dr Imhof. Vectors for expression of S3A and S3D cofilin mutants were generous gifts from Dr Shieh. The authors would like to thank Dr Condeelis for the helpful discussion. This work was supported by National Institutes of Health Grants DK054388 and CA095030.	Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Ananthakrishnan R, 2007, INT J BIOL SCI, V3, P303; Ballestrem C, 1998, J CELL SCI, V111, P1649; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Chanson A, 2005, J NUTR, V135, P2524, DOI 10.1093/jn/135.11.2524; Chhabra D, 2005, BIOPHYS J, V89, P1902, DOI 10.1529/biophysj.105.062083; Cohen PTW, 2002, J CELL SCI, V115, P241; Crott JW, 2008, J NUTR BIOCHEM, V19, P328, DOI 10.1016/j.jnutbio.2007.05.003; Crott JW, 2004, CARCINOGENESIS, V25, P69, DOI 10.1093/carcin/bgg150; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Franco C, 2006, AM J PATHOL, V168, P1697, DOI 10.2353/ajpath.2006.050613; Ghose S, 2009, MOL CANCER RES, V7, P99, DOI 10.1158/1541-7786.MCR-08-0309; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; HALL AL, 1989, DEV BIOL, V136, P517, DOI 10.1016/0012-1606(89)90277-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hsu FF, 2010, ONCOGENE, V29, P2864, DOI 10.1038/onc.2010.40; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jhaveri MS, 2001, MOL PHARMACOL, V60, P1288, DOI 10.1124/mol.60.6.1288; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; Krupenko SA, 2002, CELL GROWTH DIFFER, V13, P227; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Lewis CM, 1998, CANCER RES, V58, P2952; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Oleinik NV, 2007, ONCOGENE, V26, P7222, DOI 10.1038/sj.onc.1210526; Oleinik NV, 2006, BIOCHEM PHARMACOL, V72, P256, DOI 10.1016/j.bcp.2006.04.005; Oleinik NV, 2005, BIOCHEM J, V391, P503, DOI 10.1042/BJ20050533; Oleinik NV, 2003, MOL CANCER RES, V1, P577; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Roger L, 2006, BIOL CELL, V98, P141, DOI 10.1042/BC20050058; Song XY, 2006, J CELL SCI, V119, P2871, DOI 10.1242/jcs.03017; Turner DP, 2007, CANCER RES, V67, P1618, DOI 10.1158/0008-5472.CAN-06-2913; Tyagi SC, 1996, J CELL PHYSIOL, V167, P137, DOI 10.1002/(SICI)1097-4652(199604)167:1<137::AID-JCP16>3.0.CO;2-8; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; van Rheenen J, 2009, J CELL SCI, V122, P305, DOI 10.1242/jcs.031146; Wagner C, 1995, FOLATE HLTH DIS, P23; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Wiggan O, 2005, NAT CELL BIOL, V7, P8, DOI 10.1038/ncb0105-8; Williams MJ, 2006, J CELL SCI, V119, P2015, DOI 10.1242/jcs.02920; Winder SJ, 2005, J CELL SCI, V118, P651, DOI 10.1242/jcs.01670; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Zhan Q, 2003, CELL MOTIL CYTOSKEL, V54, P1, DOI 10.1002/cm.10079; Zhao RB, 2003, ONCOGENE, V22, P7431, DOI 10.1038/sj.onc.1206946; Zhao RB, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000969; Zhu HP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-128	56	57	62	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2010	29	47					6233	6244		10.1038/onc.2010.356	http://dx.doi.org/10.1038/onc.2010.356			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	685CG	20729910	Green Accepted			2022-12-25	WOS:000284601700005
J	Comunale, MA; Rodemich-Betesh, L; Hafner, J; Wang, MJ; Norton, P; Di Bisceglie, AM; Block, T; Mehta, A				Comunale, Mary Ann; Rodemich-Betesh, Lucy; Hafner, Julie; Wang, Mengjun; Norton, Pamela; Di Bisceglie, Adrian M.; Block, Timothy; Mehta, Anand			Linkage Specific Fucosylation of Alpha-1-Antitrypsin in Liver Cirrhosis and Cancer Patients: Implications for a Biomarker of Hepatocellular Carcinoma	PLOS ONE			English	Article							HIGHLY ENHANCED FUCOSYLATION; SERUM ALPHA-FETOPROTEIN; HEPATITIS-B-VIRUS; PROTEOMIC ANALYSIS; PH GRADIENTS; RISK-FACTORS; GLYCOPROTEINS; DIAGNOSIS; HEPATOMA	Background: We previously reported increased levels of protein-linked fucosylation with the development of liver cancer and identified many of the proteins containing the altered glycan structures. One such protein is alpha-1-antitrypsin (A1AT). To advance these studies, we performed N-linked glycan analysis on the five major isoforms of A1AT and completed a comprehensive study of the glycosylation of A1AT found in healthy controls, patients with hepatitis C-(HCV) induced liver cirrhosis, and in patients infected with HCV with a diagnosis of hepatocellular carcinoma (HCC). Methodology/Principal Findings: Patients with liver cirrhosis and liver cancer had increased levels of triantennary glycan-containing outer arm (alpha-1,3) fucosylation. Increases in core (alpha-1,6) fucosylation were observed only on A1AT from patients with cancer. We performed a lectin fluorophore-linked immunosorbent assay using Aleuria Aurantia lectin (AAL), specific for core and outer arm fucosylation in over 400 patients with liver disease. AAL-reactive A1AT was able to detect HCC with a sensitivity of 70% and a specificity of 86%, which was greater than that observed with the current marker of HCC, alpha-fetoprotein. Glycosylation analysis of the false positives was performed; results indicated that these patients had increases in outer arm fucosylation but not in core fucosylation, suggesting that core fucosylation is cancer specific. Conclusions/Significance: This report details the stepwise change in the glycosylation of A1AT with the progression from liver cirrhosis to cancer and identifies core fucosylation on A1AT as an HCC specific modification.	[Comunale, Mary Ann; Rodemich-Betesh, Lucy; Hafner, Julie; Wang, Mengjun; Norton, Pamela; Block, Timothy; Mehta, Anand] Drexel Univ, Coll Med, Drexel Inst Biotechnol & Virus Res, Dept Microbiol & Immunol, Doylestown, PA USA; [Di Bisceglie, Adrian M.] St Louis Univ, Sch Med, St Louis VA Med Ctr, Div Gastroenterol & Hepatol, St Louis, MO USA	Drexel University; Saint Louis University	Comunale, MA (corresponding author), Drexel Univ, Coll Med, Drexel Inst Biotechnol & Virus Res, Dept Microbiol & Immunol, Doylestown, PA USA.	anand.mehta@drexelmed.edu		Norton, Pamela/0000-0003-1327-9250	National Cancer Institute (NCI) [R01 CA120206-01]; NCI Early Research Detection Network (EDRN) [UO1 CA084951-06]; Hepatitis B Foundation; NATIONAL CANCER INSTITUTE [R01CA120206, U01CA084951] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Early Research Detection Network (EDRN); Hepatitis B Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant R01 CA120206-01 from the National Cancer Institute (NCI), grant UO1 CA084951-06 from the NCI Early Research Detection Network (EDRN), the Hepatitis B Foundation, and an appropriation from The Commonwealth of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Hamid UM, 2008, GLYCOBIOLOGY, V18, P1105, DOI 10.1093/glycob/cwn095; ALPERT ME, 1968, NEW ENGL J MED, V278, P984, DOI 10.1056/NEJM196805022781804; AOYAGI Y, 1993, CANCER-AM CANCER SOC, V72, P615, DOI 10.1002/1097-0142(19930715)72:2<615::AID-CNCR2820720246>3.0.CO;2-T; Aoyagi Y, 1998, CANCER, V83, P2076, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2076::AID-CNCR5>3.0.CO;2-L; Arnold JN, 2008, PROTEOMICS, V8, P3284, DOI 10.1002/pmic.200800163; Block TM, 2005, P NATL ACAD SCI USA, V102, P779, DOI 10.1073/pnas.0408928102; Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; BROOKS KP, 1985, CLIN BIOCHEM, V18, P280, DOI 10.1016/S0009-9120(85)80032-1; Comunale MA, 2006, J PROTEOME RES, V5, P308, DOI 10.1021/pr050328x; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; DIBISCEGLIE AM, 1989, MED CLIN N AM, V73, P985, DOI 10.1016/S0025-7125(16)30649-6; DIBISCEGLIE AM, 1989, CANCER, V64, P2117, DOI 10.1002/1097-0142(19891115)64:10<2117::AID-CNCR2820641024>3.0.CO;2-7; El-Serag HB, 2001, HEPATOLOGY, V33, P62, DOI 10.1053/jhep.2001.21041; Guile GR, 1996, ANAL BIOCHEM, V240, P210, DOI 10.1006/abio.1996.0351; JEPPSSON JO, 1992, CLIN CHEM, V38, P577; Kolarich D, 2006, PROTEOMICS, V6, P3369, DOI 10.1002/pmic.200500751; Liu XE, 2007, HEPATOLOGY, V46, P1426, DOI 10.1002/hep.21855; Lok ASF, 2001, HEPATOLOGY, V34, P1225, DOI 10.1053/jhep.2001.29401; Marrero JA, 2006, CURR OPIN GASTROEN, V22, P248, DOI 10.1097/01.mog.0000218961.86182.8c; Marrero JA, 2005, J HEPATOL, V43, P1007, DOI 10.1016/j.jhep.2005.05.028; Naitoh A, 1999, J GASTROEN HEPATOL, V14, P436, DOI 10.1046/j.1440-1746.1999.01882.x; Nakagawa T, 2006, J BIOL CHEM, V281, P29797, DOI 10.1074/jbc.M605697200; Noda K, 2003, CANCER RES, V63, P6282; PERACAULA R, 2010, PROTEOMICS IN PRESS; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; RUOSLAHTI E, 1974, BMJ-BRIT MED J, V2, P527, DOI 10.1136/bmj.2.5918.527; SALLIE R, 1994, GASTROENTEROL CLIN N, V23, P567; Sarbah SA, 2004, DIGEST DIS SCI, V49, P850, DOI 10.1023/B:DDAS.0000030098.75759.32; Sherman M, 2005, SEMIN LIVER DIS, V25, P143, DOI 10.1055/s-2005-871194	29	94	99	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12419	10.1371/journal.pone.0012419	http://dx.doi.org/10.1371/journal.pone.0012419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811639	Green Published, gold, Green Submitted			2022-12-25	WOS:000281234700033
J	Clark, J; Clore, EL; Zheng, KN; Adame, A; Masliah, E; Simon, DK				Clark, Joanne; Clore, Elizabeth L.; Zheng, Kangni; Adame, Anthony; Masliah, Eliezer; Simon, David K.			Oral N-Acetyl-Cysteine Attenuates Loss of Dopaminergic Terminals in alpha-Synuclein Overexpressing Mice	PLOS ONE			English	Article							GROWTH-FACTOR-B; PARKINSONS-DISEASE; OXIDATIVE STRESS; KAPPA-B; WILD-TYPE; NEURODEGENERATION; ACETYLCYSTEINE; GLUTATHIONE; MODEL; INDUCTION	Levels of glutathione are lower in the substantia nigra (SN) early in Parkinson's disease (PD) and this may contribute to mitochondrial dysfunction and oxidative stress. Oxidative stress may increase the accumulation of toxic forms of alpha-synuclein (SNCA). We hypothesized that supplementation with n-acetylcysteine (NAC), a source of cysteine - the limiting amino acid in glutathione synthesis, would protect against alpha-synuclein toxicity. Transgenic mice overexpressing wild-type human alpha-synuclein drank water supplemented with NAC or control water supplemented with alanine from ages 6 weeks to 1 year. NAC increased SN levels of glutathione within 5-7 weeks of treatment; however, this increase was not sustained at 1 year. Despite the transient nature of the impact of NAC on brain glutathione, the loss of dopaminergic terminals at 1 year associated with SNCA overexpression was significantly attenuated by NAC supplementation, as measured by immunoreactivity for tyrosine hydroxylase in the striatum (p = 0.007; unpaired, two-tailed t-test), with a similar but nonsignificant trend for dopamine transporter (DAT) immunoreactivity. NAC significantly decreased the levels of human SNCA in the brains of PDGFb-SNCA transgenic mice compared to alanine treated transgenics. This was associated with a decrease in nuclear NF kappa B localization and an increase in cytoplasmic localization of NF kappa B in the NAC-treated transgenics. Overall, these results indicate that oral NAC supplementation decreases SNCA levels in brain and partially protects against loss of dopaminergic terminals associated with overexpression of alpha-synuclein in this model.	[Clark, Joanne; Clore, Elizabeth L.; Zheng, Kangni; Simon, David K.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Clark, Joanne; Simon, David K.] Harvard Univ, Sch Med, Boston, MA USA; [Adame, Anthony; Masliah, Eliezer] Univ So Calif, Dept Neurosci, Sch Med, San Diego, CA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Southern California	Clark, J (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.	dsimon1@bidmc.harvard.edu			American Federation for Aging Research	American Federation for Aging Research	This project was supported by an 'Innovations in Aging Research Award' to Dr. Simon from the American Federation for Aging Research: http://afar.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair JC, 2001, NEUROLOGY, V57, P1515, DOI 10.1212/WNL.57.8.1515; Adams JD, 2001, CURR MED CHEM, V8, P809, DOI 10.2174/0929867013372995; Andreassen OA, 2000, NEUROREPORT, V11, P2491, DOI 10.1097/00001756-200008030-00029; Aoki E, 2009, EXP MOL PATHOL, V86, P57, DOI 10.1016/j.yexmp.2008.10.004; Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Balansky R, 1996, CANCER RES, V56, P1642; Banaclocha MM, 2001, MED HYPOTHESES, V56, P472, DOI 10.1054/mehy.2000.1194; Banaclocha MM, 2000, BRAIN RES, V859, P173, DOI 10.1016/S0006-8993(00)02005-9; Banaclocha MM, 1997, BRAIN RES, V762, P256, DOI 10.1016/S0006-8993(97)00493-9; Camandola S, 2007, EXPERT OPIN THER TAR, V11, P123, DOI 10.1517/14728222.11.2.123; Cassarino DS, 1997, BBA-MOL BASIS DIS, V1362, P77, DOI 10.1016/S0925-4439(97)00070-7; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chesselet Marie-Francoise, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS84, DOI 10.1016/j.parkreldis.2008.04.004; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; DEXTER DT, 1994, MOVEMENT DISORD, V9, P92, DOI 10.1002/mds.870090115; Dringen R, 1999, NEUROSCI LETT, V259, P79, DOI 10.1016/S0304-3940(98)00894-5; Duda JE, 2000, AM J PATHOL, V157, P1439, DOI 10.1016/S0002-9440(10)64781-5; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Greenamyre JT, 2003, PARKINSONISM RELAT D, V9, pS59, DOI 10.1016/S1353-8020(03)00023-3; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Gu XL, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-12; Gwinn-Hardy K, 2002, MOVEMENT DISORD, V17, P645, DOI 10.1002/mds.10173; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Hashimoto M, 2003, ANN NY ACAD SCI, V991, P171; Hashimoto M, 1999, NEUROREPORT, V10, P717, DOI 10.1097/00001756-199903170-00011; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; KHACHIGIAN LM, 1995, J CLIN INVEST, V96, P1169, DOI 10.1172/JCI118106; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Langston JW, 1996, NEUROLOGY, V47, pS153, DOI 10.1212/WNL.47.6_Suppl_3.153S; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Liu L, 2010, EXP NEUROL, V222, P25, DOI 10.1016/j.expneurol.2009.11.009; Martinez M, 1999, LIFE SCI, V64, P1253, DOI 10.1016/S0024-3205(98)00472-X; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsuura K, 1997, J NEUROSCI METH, V73, P45, DOI 10.1016/S0165-0270(96)02211-X; OGAWA N, 1985, RES COMMUN CHEM PATH, V50, P435; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1; PERRY TL, 1985, NEUROSCI LETT, V60, P109, DOI 10.1016/0304-3940(85)90229-0; Pocernich CB, 2000, NEUROCHEM INT, V36, P185, DOI 10.1016/S0197-0186(99)00126-6; Quilty MC, 2006, EXP NEUROL, V199, P249, DOI 10.1016/j.expneurol.2005.10.018; Ravina BM, 2003, NEUROLOGY, V60, P1234, DOI 10.1212/01.WNL.0000058760.13152.1A; Reliene R, 2004, CANCER RES, V64, P5148, DOI 10.1158/0008-5472.CAN-04-0442; Richfield EK, 2002, EXP NEUROL, V175, P35, DOI 10.1006/exnr.2002.7882; Rochet JC, 2004, J MOL NEUROSCI, V23, P23, DOI 10.1385/JMN:23:1-2:023; Rommelfanger KS, 2007, P NATL ACAD SCI USA, V104, P13804, DOI 10.1073/pnas.0702753104; Schapira AH, 2008, EUR J NEUROL, V15, P1, DOI 10.1111/j.1468-1331.2007.02036.x; SCHAPIRA AHV, 1992, ANN NEUROL, V32, pS116, DOI 10.1002/ana.410320720; Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501; Sharma A, 2007, CELL MOL BIOL, V53, P48, DOI 10.1170/T774; SHEFFNER AL, 1966, BIOCHEM PHARMACOL, V15, P1523, DOI 10.1016/0006-2952(66)90197-3; Sherer TB, 2002, J NEUROSCI, V22, P7006; Shi JR, 2004, J CARDIOVASC PHARM, V44, P26; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Thiruchelvam MJ, 2004, EUR J NEUROSCI, V19, P845, DOI 10.1111/j.0953-816X.2004.03139.x; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tillerson JL, 2002, EXP NEUROL, V178, P80, DOI 10.1006/exnr.2002.8021; VINA J, 1983, EXPERIENTIA, V39, P164; Vornov JJ, 1998, EXP NEUROL, V149, P109, DOI 10.1006/exnr.1997.6673; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zed PJ, 1999, AM J HEALTH-SYST PH, V56, P1081, DOI 10.1093/ajhp/56.11.1081	69	86	88	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12333	10.1371/journal.pone.0012333	http://dx.doi.org/10.1371/journal.pone.0012333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808797	Green Published, gold, Green Submitted			2022-12-25	WOS:000281153500015
J	Santini, E; Sgambato-Faure, V; Li, Q; Savasta, M; Dovero, S; Fisone, G; Bezard, E				Santini, Emanuela; Sgambato-Faure, Veronique; Li, Qin; Savasta, Marc; Dovero, Sandra; Fisone, Gilberto; Bezard, Erwan			Distinct Changes in cAMP and Extracellular Signal-Regulated Protein Kinase Signalling in L-DOPA-Induced Dyskinesia	PLOS ONE			English	Article							LEVODOPA-INDUCED DYSKINESIA; MEDIUM SPINY NEURONS; HEMIPARKINSONIAN MICE; PARKINSONS-DISEASE; PHOSPHORYLATION; SUBUNIT	Background: In rodents, the development of dyskinesia produced by L-DOPA in the dopamine-depleted striatum occurs in response to increased dopamine D1 receptor-mediated activation of the cAMP - protein kinase A and of the Ras-extracellular signal-regulated kinase (ERK) signalling pathways. However, very little is known, in non-human primates, about the regulation of these signalling cascades and their association with the induction, manifestation and/or maintenance of dyskinesia. Methodology/Results: We here studied, in the gold-standard non-human primate model of Parkinson's disease, the changes in PKA-dependent phosphorylation of DARPP-32 and GluR1 AMPA receptor, as well as in ERK and ribosomal protein S6 (S6) phosphorylation, associated to acute and chronic administration of L-DOPA. Increased phosphorylation of DARPP-32 and GluR1 was observed in both L-DOPA first-ever exposed and chronically-treated dyskinetic parkinsonian monkeys. In contrast, phosphorylation of ERK and S6 was enhanced preferentially after acute L-DOPA administration and decreased during the course of chronic treatment. Conclusion: Dysregulation of cAMP signalling is maintained during the course of chronic L-DOPA administration, while abnormal ERK signalling peaks during the initial phase of L-DOPA treatment and decreases following prolonged exposure. While cAMP signalling enhancement is associated with dyskinesia, abnormal ERK signalling is associated with priming.	[Santini, Emanuela] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Sgambato-Faure, Veronique; Savasta, Marc] Grenoble Inst Neurosci, INSERM, U836, Grenoble, France; [Sgambato-Faure, Veronique] Univ Lyon 1, CNRS, Ctr Neurosci Cognit, UMR 5229, Bron, France; [Li, Qin; Dovero, Sandra; Bezard, Erwan] Univ Bordeaux 2, CNRS, Bordeaux Inst Neurosci, UMR 5227, F-33076 Bordeaux, France; [Li, Qin; Bezard, Erwan] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100037, Peoples R China	Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS	Santini, E (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	erwan.bezard@u-bordeaux2.fr	Bezard, Erwan/A-8173-2008; Sgambato, Véronique/G-9062-2017; Bezard, Erwan/ABD-5153-2021; Savasta, Marc/M-4939-2017	Sgambato, Véronique/0000-0002-8792-8586; Fisone, Gilberto/0000-0002-0719-8000; Bezard, Erwan/0000-0002-0410-4638; DOVERO, Sandra/0000-0002-5781-1328	Agence Nationale de la Recherche; Swedish Research Council [20715, 13482]; Swedish Brain Foundation	Agence Nationale de la Recherche(French National Research Agency (ANR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation	This work was supported by an Agence Nationale de la Recherche grant (EB). GF was supported by Swedish Research Council grants 20715 and 13482 and by the Swedish Brain Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000664; Aubert I, 2005, ANN NEUROL, V57, P17, DOI 10.1002/ana.20296; Berton O, 2009, BIOL PSYCHIAT, V66, P554, DOI 10.1016/j.biopsych.2009.04.005; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; Bezard E, 2003, NAT MED, V9, P762, DOI 10.1038/nm875; Corvol JC, 2004, J NEUROSCI, V24, P7007, DOI 10.1523/JNEUROSCI.0676-04.2004; COTZIAS GC, 1969, NEW ENGL J MED, V280, P337, DOI 10.1056/NEJM196902132800701; FERNAGUT PO, 2010, DOPAMINE TRANS UNPUB; Gerfen CR, 2002, J NEUROSCI, V22, P5042, DOI 10.1523/JNEUROSCI.22-12-05042.2002; Jenner P, 2008, NAT REV NEUROSCI, V9, P665, DOI 10.1038/nrn2471; Kim DS, 2006, NEUROSCIENCE, V137, P1381, DOI 10.1016/j.neuroscience.2005.10.054; Nadjar A, 2006, J NEUROSCI, V26, P8653, DOI 10.1523/JNEUROSCI.2582-06.2006; Pavon N, 2006, BIOL PSYCHIAT, V59, P64, DOI 10.1016/j.biopsych.2005.05.044; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Santini E, 2007, J NEUROSCI, V27, P6995, DOI 10.1523/JNEUROSCI.0852-07.2007; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Santini E, 2009, J NEUROCHEM, V108, P621, DOI 10.1111/j.1471-4159.2008.05831.x; SNYDER GL, 1992, J NEUROSCI, V12, P3071, DOI 10.1523/JNEUROSCI.12-08-03071.1992; Westin JE, 2007, BIOL PSYCHIAT	21	94	94	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12322	10.1371/journal.pone.0012322	http://dx.doi.org/10.1371/journal.pone.0012322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808799	Green Published, gold			2022-12-25	WOS:000281153500008
J	Lorestani, A; Sheiner, L; Yang, K; Robertson, SD; Sahoo, N; Brooks, CF; Ferguson, DJP; Striepen, B; Gubbels, MJ				Lorestani, Alexander; Sheiner, Lilach; Yang, Kevin; Robertson, Seth D.; Sahoo, Nivedita; Brooks, Carrie F.; Ferguson, David J. P.; Striepen, Boris; Gubbels, Marc-Jan			A Toxoplasma MORN1 Null Mutant Undergoes Repeated Divisions but Is Defective in Basal Assembly, Apicoplast Division and Cytokinesis	PLOS ONE			English	Article							INNER MEMBRANE COMPLEX; FATTY-ACID SYNTHESIS; HOST-CELL INVASION; TETRAHYMENA-THERMOPHILA; GONDII; PROTEIN; MICROTUBULES; EXPRESSION; CYCLE; DIFFERENTIATION	The membrane occupation and recognition nexus protein 1 (MORN1) is highly conserved among apicomplexan parasites and is associated with several structures that have a role in cell division. Here we dissected the role of MORN1 using the relatively simple budding process of Toxoplasma gondii as a model. Ablation of MORN1 in a conditional null mutant resulted in pronounced defects suggesting a central role for MORN1 in apicoplast segregation and in daughter cell budding. Lack of MORN1 resulted in double-headed parasites. These Janus-headed parasites form two complete apical complexes but fail to assemble a basal complex. Moreover, these parasites were capable of undergoing several more budding rounds resulting in the formation of up to 16-headed parasites conjoined at the basal end. Despite this segregation defect, the mother's cytoskeleton was completely disassembled in every budding round. Overall this argues that successful completion of the budding is not required for cell cycle progression. None of the known basal complex components, including a set of recently identified inner membrane complex (IMC) proteins, localized correctly in these multi-headed parasites. These data suggest that MORN1 is essential for assembly of the basal complex, and that lack of the basal complex abolishes the contractile capacity assigned to the basal complex late in daughter formation. Consistent with this hypothesis we observe that MORN1 mutants fail to efficiently constrict and divide the apicoplast. We used the null background provided by the mutant to dissect the function of subdomains of the MORN1 protein. This demonstrated that deletion of a single MORN domain already prevented the function of MORN1 whereas a critical role for the short linker between MORN domains 6 and 7 was identified. In conclusion, MORN1 is required for basal complex assembly and loss of MORN1 results in defects in apicoplast division and daughter segregation.	[Lorestani, Alexander; Yang, Kevin; Robertson, Seth D.; Sahoo, Nivedita; Gubbels, Marc-Jan] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Sheiner, Lilach; Brooks, Carrie F.; Striepen, Boris] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Sheiner, Lilach; Brooks, Carrie F.; Striepen, Boris] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Ferguson, David J. P.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept, Clin Sci Lab, Oxford OX3 9DU, England	Boston College; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Oxford	Lorestani, A (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	gubbelsj@bc.edu		Gubbels, Marc-Jan/0000-0002-2769-8600; Robertson, Seth/0000-0003-0262-1276; Ferguson, David/0000-0001-5045-819X; Striepen, Boris/0000-0002-7426-432X	National Institutes of Health [AI081924, AI64671]; Smith Family Foundation through the Ludcke Foundation; Knights Templar Eye Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081924, R01AI064671] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smith Family Foundation through the Ludcke Foundation; Knights Templar Eye Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a National Institutes of Health grant (AI081924) and a Smith Family Foundation New Investigator research grant through the Ludcke Foundation to MJG, a Knights Templar Eye Foundation grant to NS and a National Institutes of Health grant (AI64671) to BS. Smith Family Foundation: www.smithfamilyfoundation.net; Ludcke Foundation: ludckefoundation.grantsmanagement08.com; NIH: www.nih.gov; Knights Templar Eye Association: www.knightstemplar.org/ktef. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agop-Nersesian C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000270; Agrawal S, 2009, J BIOL CHEM, V284, P33683, DOI 10.1074/jbc.M109.044024; ANDERSONWHITE BR, 2010, CELL MICROB IN PRESS; BROOKS CF, 2009, CELL HOST MICROBE; Brown JM, 1999, CELL BIOL INT, V23, P841, DOI 10.1006/cbir.1999.0480; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Cuttell L, 2008, CELL, V135, P524, DOI 10.1016/j.cell.2008.08.033; de Miguel N, 2008, BIOL CELL, V100, P479, DOI 10.1042/BC20080004; Ferguson DJP, 2007, INT J PARASITOL, V37, P33, DOI 10.1016/j.ijpara.2006.10.003; FERGUSON DJ, 2008, EUKARYOT CELL; Ferguson DJP, 1999, EXP PARASITOL, V91, P203, DOI 10.1006/expr.1998.4384; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gubbels MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040036; Gubbels MJ, 2006, J CELL SCI, V119, P2236, DOI 10.1242/jcs.02949; Gubbels MJ, 2004, MOL BIOCHEM PARASIT, V137, P99, DOI 10.1016/j.molbiopara.2004.05.007; Hadano S, 2007, NEUROCHEM INT, V51, P74, DOI 10.1016/j.neuint.2007.04.010; Hartmann J, 2006, MOL BIOCHEM PARASIT, V145, P125, DOI 10.1016/j.molbiopara.2005.09.015; Heaslip AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000754; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Hu K, 2006, PLOS PATHOG, V2, P121, DOI 10.1371/journal.ppat.0020013; Hu K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040010; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; JERKADZIADOSZ M, 1995, DEV BIOL, V171, P497, DOI 10.1006/dbio.1995.1299; Ju TK, 2004, BIOL REPROD, V71, P1419, DOI 10.1095/biolreprod.104.030346; Kakizawa S, 2008, CEREBELLUM, V7, P385, DOI 10.1007/s12311-008-0040-1; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Kunita R, 2004, J BIOL CHEM, V279, P38626, DOI 10.1074/jbc.M406120200; Kuroiwa T, 2010, J PLANT RES, V123, P207, DOI 10.1007/s10265-009-0306-9; Lai R, 2003, BIOTECHNIQUES, V34, P52, DOI 10.2144/03341bm07; Legesse-Miller A, 2003, MOL BIOL CELL, V14, P1953, DOI 10.1091/mbc.E02-10-0657; Lim L, 2010, PHILOS T R SOC B, V365, P749, DOI 10.1098/rstb.2009.0273; Ma H, 2006, CELL RES, V16, P466, DOI 10.1038/sj.cr.7310058; Maurer-Stroh S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r55; Mazumdar J, 2006, P NATL ACAD SCI USA, V103, P13192, DOI 10.1073/pnas.0603391103; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; Miyagishima SY, 2003, TRENDS PLANT SCI, V8, P432, DOI 10.1016/S1360-1385(03)00193-6; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Morrissette NS, 2002, J CELL SCI, V115, P1017; Morrissette NS, 1997, J CELL SCI, V110, P35; Nagamune K, 2007, EUKARYOT CELL, V6, P2147, DOI 10.1128/EC.00262-07; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; Pelletier L, 2002, NATURE, V418, P548, DOI 10.1038/nature00946; Radke JR, 2001, MOL BIOCHEM PARASIT, V115, P165, DOI 10.1016/S0166-6851(01)00284-5; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Satouh Y, 2005, MOL BIOL CELL, V16, P626, DOI 10.1091/mbc.e04-09-0784; Schweitzer JK, 2004, EXP CELL RES, V295, P1, DOI 10.1016/j.yexcr.2003.12.023; Shaw MK, 2000, J CELL SCI, V113, P1241; SHEFFIELD HG, 1968, J PARASITOL, V54, P209, DOI 10.2307/3276925; Striepen B, 2000, J CELL BIOL, V151, P1423, DOI 10.1083/jcb.151.7.1423; Striepen B, 2007, PLOS PATHOG, V3, P691, DOI 10.1371/journal.ppat.0030078; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Vaishnava S, 2005, J CELL SCI, V118, P3397, DOI 10.1242/jcs.02458; Vaishnava S, 2006, MOL MICROBIOL, V61, P1380, DOI 10.1111/j.1365-2958.2006.05343.x; van Dooren GG, 2008, P NATL ACAD SCI USA, V105, P13574, DOI 10.1073/pnas.0803862105; van Dooren GG, 2009, CURR BIOL, V19, P267, DOI 10.1016/j.cub.2008.12.048	57	70	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12302	10.1371/journal.pone.0012302	http://dx.doi.org/10.1371/journal.pone.0012302			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808817	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000281075500026
J	Nerandzic, MM; Donskey, CJ				Nerandzic, Michelle M.; Donskey, Curtis J.			Triggering Germination Represents a Novel Strategy to Enhance Killing of Clostridium difficile Spores	PLOS ONE			English	Article							BACTERIAL-SPORES; EPIDEMIC; EFFICACY; STRAINS; SPORULATION; INITIATION; RADIATION; OUTBREAK	Background: Clostridium difficile is an anaerobic, spore-forming bacterium that is the most common cause of healthcare-associated diarrhea in developed countries. Control of C. difficile is challenging because the spores are resistant to killing by alcohol-based hand hygiene products, antimicrobial soaps, and most disinfectants. Although initiation of germination has been shown to increase susceptibility of spores of other bacterial species to radiation and heat, it was not known if triggering of germination could be a useful strategy to increase susceptibility of C. difficile spores to radiation or other stressors. Principal Findings: Here, we demonstrated that exposure of dormant C. difficile spores to a germination solution containing amino acids, minerals, and taurocholic acid resulted in initiation of germination in room air. Germination of spores in room air resulted in significantly enhanced killing by ultraviolet-C (UV-C) radiation and heat. On surfaces in hospital rooms, application of germination solution resulted in enhanced eradication of spores by UV-C administered by an automated room decontamination device. Initiation of germination under anaerobic, but not aerobic, conditions resulted in increased susceptibility to killing by ethanol, suggesting that exposure to oxygen might prevent spores from progressing fully to outgrowth. Stimulation of germination also resulted in reduced survival of spores on surfaces in room air, possibly due to increased susceptibility to stressors such as oxygen and desiccation. Conclusions: Taken together, these data demonstrate that stimulation of germination could represent a novel method to enhance killing of spores by UV-C, and suggest the possible application of this strategy as a means to enhance killing by other agents.	[Nerandzic, Michelle M.; Donskey, Curtis J.] Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA; [Donskey, Curtis J.] Cleveland Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Cleveland, OH USA	Geriatric Research Education & Clinical Center	Nerandzic, MM (corresponding author), Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA.	curtisd123@yahoo.com			Department of Veterans Affairs; Geriatric Research, Education and Clinical Center, Cleveland Veterans Affairs Medical Center, Cleveland, Ohio	Department of Veterans Affairs(US Department of Veterans Affairs); Geriatric Research, Education and Clinical Center, Cleveland Veterans Affairs Medical Center, Cleveland, Ohio	This work was supported by a Merit Review Grant from the Department of Veterans Affairs to C.J.D. and by the Geriatric Research, Education and Clinical Center, Cleveland Veterans Affairs Medical Center, Cleveland, Ohio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2009, FOOD MICROBIOL, V26, P272, DOI 10.1016/j.fm.2008.12.011; Barbut F, 2009, INFECT CONT HOSP EP, V30, P507, DOI 10.1086/597232; Dumford DM, 2009, AM J INFECT CONTROL, V37, P15, DOI 10.1016/j.ajic.2008.07.009; DUNCAN CL, 1968, APPL MICROBIOL, V16, P82, DOI 10.1128/AEM.16.1.82-89.1968; DURBAN E, 1970, J BACTERIOL, V102, P590, DOI 10.1128/JB.102.2.590-592.1970; Fawley WN, 2007, INFECT CONT HOSP EP, V28, P920, DOI 10.1086/519201; Gerding DN, 2008, CLIN INFECT DIS, V46, pS43, DOI 10.1086/521861; Ghosh S, 2009, J BACTERIOL, V191, P1787, DOI 10.1128/JB.01668-08; GOULD GW, 1968, J APPL BACTERIOL, V31, P357, DOI 10.1111/j.1365-2672.1968.tb00378.x; GOULD GW, 1970, J APPL BACTERIOL, V33, P34, DOI 10.1111/j.1365-2672.1970.tb05232.x; Hamouda T, 2002, LETT APPL MICROBIOL, V34, P86, DOI 10.1046/j.1472-765x.2002.01047.x; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; MUNAKATA N, 1974, J BACTERIOL, V120, P59, DOI 10.1128/JB.120.1.59-65.1974; Nerandzic MM, 2009, J CLIN MICROBIOL, V47, P397, DOI 10.1128/JCM.01591-08; Owens MU, 2005, APPL BIOSAF, V10, P240, DOI DOI 10.1177/153567600501000406; Paidhungat M., 2002, BACILLUS SUBTILIS IT, P537, DOI DOI 10.1128/9781555817992.CH37; Popovich KJ, 2009, INFECT CONT HOSP EP, V30, P959, DOI 10.1086/605925; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; STUY J. H., 1956, ANTONIE VAN LEEUWENHOEK JOUR MICROBIOL AND SEROL, V22, P337, DOI 10.1007/BF02538347; STUY JH, 1956, BIOCHIM BIOPHYS ACTA, V22, P241, DOI 10.1016/0006-3002(56)90146-9; Wheeldon LJ, 2008, J ANTIMICROB CHEMOTH, V62, P522, DOI 10.1093/jac/dkn219; Wilcox MH, 2000, LANCET, V356, P1324, DOI 10.1016/S0140-6736(00)02819-1	24	46	47	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12285	10.1371/journal.pone.0012285	http://dx.doi.org/10.1371/journal.pone.0012285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808871	Green Published, Green Submitted, gold			2022-12-25	WOS:000281075500018
J	Halford, WP; Puschel, R; Rakowski, B				Halford, William P.; Pueschel, Ringo; Rakowski, Brandon			Herpes Simplex Virus 2 ICP0(-) Mutant Viruses Are Avirulent and Immunogenic: Implications for a Genital Herpes Vaccine	PLOS ONE			English	Article							IMMEDIATE-EARLY PROTEIN; WILD-TYPE; VARICELLA VACCINATION; TRIGEMINAL GANGLIA; UBIQUITIN LIGASE; GENE-EXPRESSION; TYPE-1; DISEASE; IMMUNIZATION; INFECTIONS	Herpes simplex virus 1 (HSV-1) ICP0(-) mutants are interferon-sensitive, avirulent, and elicit protective immunity against HSV-1 (Virol J, 2006, 3: 44). If an ICP0(-) mutant of herpes simplex virus 2 (HSV-2) exhibited similar properties, such a virus might be used to vaccinate against genital herpes. The current study was initiated to explore this possibility. Several HSV-2 ICP0(-) mutant viruses were constructed and evaluated in terms of three parameters: i. interferon-sensitivity; ii. virulence in mice; and iii. capacity to elicit protective immunity against HSV-2. One ICP0(-) mutant virus in particular, HSV-2 0 Delta NLS, achieved an optimal balance between avirulence and immunogenicity. HSV-2 0 Delta NLS was interferon-sensitive in cultured cells. HSV-2 0 Delta NLS replicated to low levels in the eyes of inoculated mice, but was rapidly repressed by an innate, Stat 1-dependent host immune response. HSV-2 0 Delta NLS failed to spread from sites of inoculation, and hence produced only inapparent infections. Mice inoculated with HSV-2 0 Delta NLS consistently mounted an HSV-specific IgG antibody response, and were consistently protected against lethal challenge with wild-type HSV-2. Based on their avirulence and immunogenicity, we propose that HSV-2 ICP0(-) mutant viruses merit consideration for their potential to prevent the spread of HSV-2 and genital herpes.	[Halford, William P.; Pueschel, Ringo; Rakowski, Brandon] So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL USA	Southern Illinois University System; Southern Illinois University	Halford, WP (corresponding author), So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL USA.	halford@siumed.edu			Central Research and Excellence in Academic Medicine Committees of the Southern Illinois University School of Medicine; National Institutes of Health [R01 AI51414, R21 AI81072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081072, R01AI051414] Funding Source: NIH RePORTER	Central Research and Excellence in Academic Medicine Committees of the Southern Illinois University School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Central Research and Excellence in Academic Medicine Committees of the Southern Illinois University School of Medicine, as well as grants from the National Institutes of Health to study the Role of the LAT-ICP0 locus in regulating HSV latency (R01 AI51414) and the Development of an Effective Genital Herpes Vaccine (R21 AI81072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Aurelian L, 1999, VACCINE, V17, P1951, DOI 10.1016/S0264-410X(98)00470-8; Bourne N, 2005, J INFECT DIS, V192, P2117, DOI 10.1086/498247; Bourne N, 2003, J INFECT DIS, V187, P542, DOI 10.1086/374002; Boutell C, 2002, J VIROL, V76, P841, DOI 10.1128/JVI.76.2.841-850.2002; Boutell C, 2008, J VIROL, V82, P10647, DOI 10.1128/JVI.01063-08; Canning M, 2004, J BIOL CHEM, V279, P38160, DOI 10.1074/jbc.M402885200; CENTIFANTOFITZGERALD YM, 1982, INFECT IMMUN, V35, P1125, DOI 10.1128/IAI.35.3.1125-1132.1982; CENTIFANTOFITZGERALD YM, 1985, P SOC EXP BIOL MED, V179, P55; CHEN JX, 1992, J VIROL, V66, P5598, DOI 10.1128/JVI.66.9.5598-5602.1992; CIUFO DM, 1994, J VIROL, V68, P3267, DOI 10.1128/JVI.68.5.3267-3282.1994; COREY L, 1983, ANN INTERN MED, V98, P958, DOI 10.7326/0003-4819-98-6-958; Da Costa XJ, 1999, P NATL ACAD SCI USA, V96, P6994, DOI 10.1073/pnas.96.12.6994; Davido DJ, 2005, J VIROL, V79, P1232, DOI 10.1128/JVI.79.2.1232-1243.2005; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Dudek T, 2006, VIROLOGY, V344, P230, DOI 10.1016/j.virol.2005.09.020; ELION GB, 1982, AM J MED, V73, P7, DOI 10.1016/0002-9343(82)90055-9; EVERETT R, 1995, J VIROL, V69, P7339, DOI 10.1128/JVI.69.11.7339-7344.1995; Galea SA, 2008, J INFECT DIS, V197, pS165, DOI 10.1086/522125; Gershon AA, 2001, INFECT DIS CLIN N AM, V15, P65, DOI 10.1016/S0891-5520(05)70268-3; Gottlieb SL, 2004, J INFECT DIS, V190, P1059, DOI 10.1086/423323; Green John, 2004, Herpes, V11, P60; Halford WP, 2007, FUTURE VIROL, V2, P1, DOI 10.2217/17460794.2.1.1; Halford WP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-44; Halford WP, 2005, J THEOR BIOL, V234, P439, DOI 10.1016/j.jtbi.2004.12.007; Halford WP, 1997, VIROLOGY, V238, P53, DOI 10.1006/viro.1997.8806; Halford WP, 2001, J VIROL, V75, P3240, DOI 10.1128/JVI.75.7.3240-3249.2001; Halford WP, 2000, J VIROL, V74, P5957, DOI 10.1128/JVI.74.13.5957-5967.2000; Harle P, 2002, VIROLOGY, V293, P295, DOI 10.1006/viro.2001.1280; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; Hoshino Y, 2008, VACCINE, V26, P4034, DOI 10.1016/j.vaccine.2008.05.022; Jacobs BL, 2009, ANTIVIR RES, V84, P1, DOI 10.1016/j.antiviral.2009.06.006; Janier M, 2006, INT J STD AIDS, V17, P44, DOI 10.1258/095646206775220531; Jones Cheryl A, 2004, Herpes, V11, P12; Jonsson MK, 2004, SCAND J INFECT DIS, V36, P93, DOI 10.1080/00365540310018905; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; KLEIN RJ, 1989, VACCINE, V7, P380, DOI 10.1016/0264-410X(89)90147-3; Krause PR, 2000, NAT MED, V6, P451, DOI 10.1038/74715; Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663; Liu MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010975; Liu MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008837; Lowhagen GB, 2000, SEX TRANSM INFECT, V76, P179, DOI 10.1136/sti.76.3.179; Mark H, 2009, JOGNN-J OBST GYN NEO, V38, P320, DOI 10.1111/j.1552-6909.2009.01026.x; Morrison LA, 1998, VIROLOGY, V243, P178, DOI 10.1006/viro.1998.9047; Mossman KL, 2000, J VIROL, V74, P2052, DOI 10.1128/JVI.74.4.2052-2056.2000; Nagashunmugam T, 1998, J VIROL, V72, P5351, DOI 10.1128/JVI.72.7.5351-5359.1998; Newton DC, 2008, J HEALTH PSYCHOL, V13, P864, DOI 10.1177/1359105308095058; Nicola AV, 1996, J VIROL, V70, P3815, DOI 10.1128/JVI.70.6.3815-3822.1996; Nieuwenhuis RF, 2006, ACTA DERM-VENEREOL, V86, P129, DOI 10.2340/00015555-0029; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Pasieka TJ, 2009, J VIROL, V83, P2075, DOI 10.1128/JVI.02007-08; Prichard MN, 2005, VACCINE, V23, P5424, DOI 10.1016/j.vaccine.2005.02.028; Reszka NJ, 2010, VACCINE, V28, P2754, DOI 10.1016/j.vaccine.2010.01.030; SABIN AB, 1985, J INFECT DIS, V151, P420, DOI 10.1093/infdis/151.3.420; Samaniego LA, 1998, J VIROL, V72, P3307, DOI 10.1128/JVI.72.4.3307-3320.1998; Sengupta N, 2008, EUR J PEDIATR, V167, P47, DOI 10.1007/s00431-007-0424-0; Singh M, 1998, VACCINE, V16, P1822, DOI 10.1016/S0264-410X(98)00179-0; Solomon L, 2003, SEX TRANSM INFECT, V79, P456, DOI 10.1136/sti.79.6.456; Stanberry Lawrence R, 2004, Herpes, V11 Suppl 3, p161A; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Stanberry LR, 2000, CLIN INFECT DIS, V30, P549, DOI 10.1086/313687; Straus SE, 1997, J INFECT DIS, V176, P1129, DOI 10.1086/514103; THOMPSON RL, 1986, MICROB PATHOGENESIS, V1, P409, DOI 10.1016/0882-4010(86)90072-0; VANEKDOM LTS, 1982, AM J MED, V73, P161, DOI 10.1016/0002-9343(82)90083-3; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; WATSON RJ, 1982, SCIENCE, V218, P381, DOI 10.1126/science.6289440; WATSON RJ, 1985, PROG MED VIROL, V31, P84; Wharton M, 1990, Infect Dis Clin North Am, V4, P47; Woolery WA, 2008, GERIATRICS-US, V63, P6; Xu F., 2010, Morbidity and Mortality Weekly Report, V59, P456; zur Hausen H, 1979, Dev Biol Stand, V43, P373	71	34	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12251	10.1371/journal.pone.0012251	http://dx.doi.org/10.1371/journal.pone.0012251			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808928	gold, Green Published, Green Submitted			2022-12-25	WOS:000280968100032
J	Kalb, SR; Garcia-Rodriguez, C; Lou, JL; Baudys, J; Smith, TJ; Marks, JD; Smith, LA; Pirkle, JL; Barr, JR				Kalb, Suzanne R.; Garcia-Rodriguez, Consuelo; Lou, Jianlong; Baudys, Jakub; Smith, Theresa J.; Marks, James D.; Smith, Leonard A.; Pirkle, James L.; Barr, John R.			Extraction of BoNT/A,/B,/E, and /F with a Single, High Affinity Monoclonal Antibody for Detection of Botulinum Neurotoxin by Endopep-MS	PLOS ONE			English	Article							CLOSTRIDIUM-BOTULINUM; TOXIN; SUBTYPES	Botulinum neurotoxins (BoNTs) are extremely potent toxins that are capable of causing respiratory failure leading to long-term intensive care or death. The best treatment for botulism includes serotype-specific antitoxins, which are most effective when administered early in the course of the intoxication. Early confirmation of human exposure to any serotype of BoNT is an important public health goal. In previous work, we focused on developing Endopep-MS, a mass spectrometry-based endopeptidase method for detecting and differentiating the seven serotypes (BoNT/A-G) in buffer and BoNT/A, /B, /E, and /F (the four serotypes that commonly affect humans) in clinical samples. We have previously reported the success of antibody-capture to purify and concentrate BoNTs from complex matrices, such as clinical samples. However, to check for any one of the four serotypes of BoNT/A, /B, /E, or /F, each sample is split into 4 aliquots, and tested for the specific serotypes separately. The discovery of a unique monoclonal antibody that recognizes all four serotypes of BoNT/A, /B, /E and /F allows us to perform simultaneous detection of all of them. When applied in conjunction with the Endopep-MS assay, the detection limit for each serotype of BoNT with this multi-specific monoclonal antibody is similar to that obtained when using other serotype-specific antibodies.	[Kalb, Suzanne R.; Pirkle, James L.; Barr, John R.] Ctr Dis Control & Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA; [Garcia-Rodriguez, Consuelo; Lou, Jianlong; Marks, James D.] Univ Calif San Francisco, Dept Anesthesia & Pharmaceut Chem, San Francisco, CA 94143 USA; [Baudys, Jakub] Ctr Dis Control & Prevent, Battelle Mem Inst, Atlanta, GA USA; [Smith, Theresa J.; Smith, Leonard A.] USAMRIID, Ft Detrick, MD USA	Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; United States Army Medical Research Institute of Infectious Diseases	Kalb, SR (corresponding author), Ctr Dis Control & Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30333 USA.	jbarr@cdc.gov	Baudys, Jakub/K-7643-2012	Kalb, Suzanne/0000-0002-8067-136X	Centers for Disease Control and Prevention; United States Army Medical Research Institute for Infectious Diseases	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Army Medical Research Institute for Infectious Diseases	Funding for this work was through the Centers for Disease Control and Prevention and the United States Army Medical Research Institute for Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amersdorfer P, 2002, VACCINE, V20, P1640, DOI 10.1016/S0264-410X(01)00482-0; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Barr JR, 2005, EMERG INFECT DIS, V11, P1578, DOI 10.3201/eid1110.041279; Boyer AE, 2005, ANAL CHEM, V77, P3916, DOI 10.1021/ac050485f; Carter AT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-115; Centers for Disease Control and Prevention, 1998, HDB EP CLIN LAB WORK; Chen Y, 2007, J BACTERIOL, V189, P8643, DOI 10.1128/JB.00784-07; Fischer A, 2008, J BIOL CHEM, V283, P3997, DOI 10.1074/jbc.M707917200; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; GARCIARODRIGUEZ D, PEDS UNPUB; Gaunt PS, 2007, J VET DIAGN INVEST, V19, P349, DOI 10.1177/104063870701900402; Kalb SR, 2006, ANAL BIOCHEM, V351, P84, DOI 10.1016/j.ab.2006.01.027; Kalb SR, 2005, ANAL CHEM, V77, P6140, DOI 10.1021/ac0511748; Kalb SR, 2008, INT J MASS SPECTROM, V278, P101, DOI 10.1016/j.ijms.2008.04.004; Kalb SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005355; KAUTTER DA, 1977, J ASSOC OFF ANA CHEM, V60, P541; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Lou J, 2010, PROTEIN ENG DES SEL, V23, P311, DOI 10.1093/protein/gzq001; Mah DCW, 2003, HYBRIDOMA HYBRIDOM, V22, P277, DOI 10.1089/153685903322538791; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; RAPHAEL BH, 2010, APPL ENV MI IN PRESS; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Umeda K, 2009, J CLIN MICROBIOL, V47, P2720, DOI 10.1128/JCM.00077-09; Wang XM, 2000, APPL ENVIRON MICROB, V66, P4992, DOI 10.1128/AEM.66.11.4992-4997.2000	24	44	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12237	10.1371/journal.pone.0012237	http://dx.doi.org/10.1371/journal.pone.0012237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808925	Green Published, gold, Green Submitted			2022-12-25	WOS:000280968100029
J	Kim, N; Goel, PK; Tivarus, ME; Hillier, A; Beversdorf, DQ				Kim, Namhee; Goel, Prem K.; Tivarus, Madalina E.; Hillier, Ashleigh; Beversdorf, David Q.			Independent Component Analysis of the Effect of L-dopa on fMRI of Language Processing	PLOS ONE			English	Article							INFERIOR PREFRONTAL CORTEX; RHESUS-MONKEY; PARKINSONS-DISEASE; BLIND SEPARATION; WORKING-MEMORY; FUNCTIONAL MRI; HUMAN BRAIN; RETRIEVAL; RECEPTORS; REGIONS	L-dopa, which is a precursor for dopamine, acts to amplify strong signals, and dampen weak signals as suggested by previous studies. The effect of L-dopa has been demonstrated in language studies, suggesting restriction of the semantic network. In this study, we aimed to examine the effect of L-dopa on language processing with fMRI using Independent Component Analysis (ICA). Two types of language tasks (phonological and semantic categorization tasks) were tested under two drug conditions (placebo and L-dopa) in 16 healthy subjects. Probabilistic ICA (PICA), part of FSL, was implemented to generate Independent Components (IC) for each subject for the four conditions and the ICs were classified into task-relevant source groups by a correlation threshold criterion. Our key findings include: (i) The highly task-relevant brain regions including the Left Inferior Frontal Gyrus (LIFG), Left Fusiform Gyrus (LFUS), Left Parietal lobe (LPAR) and Superior Temporal Gyrus (STG) were activated with both L-dopa and placebo for both tasks, and (ii) as compared to placebo, L-dopa was associated with increased activity in posterior regions, including the superior temporal area (BA 22), and decreased activity in the thalamus (pulvinar) and inferior frontal gyrus (BA 11/47) for both tasks. These results raise the possibility that L-dopa may exert an indirect effect on posterior regions mediated by the thalamus (pulvinar).	[Kim, Namhee; Goel, Prem K.] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Tivarus, Madalina E.] Univ Rochester, Dept Imaging Sci, Rochester, NY USA; [Tivarus, Madalina E.] Univ Rochester, Rochester Ctr Brain Imaging, Rochester, NY USA; [Hillier, Ashleigh] Univ Massachusetts, Dept Psychol, Lowell, MA USA; [Beversdorf, David Q.] Univ Missouri, Dept Radiol, Columbia, MO USA; [Beversdorf, David Q.] Univ Missouri, Dept Neurol, Columbia, MO USA; [Beversdorf, David Q.] Univ Missouri, Dept Psychol, Columbia, MO USA; [Beversdorf, David Q.] Univ Missouri, Thompson Ctr, Columbia, MO USA	University System of Ohio; Ohio State University; University of Rochester; University of Rochester; University of Massachusetts System; University of Massachusetts Lowell; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Kim, N (corresponding author), Ohio State Univ, Dept Stat, Columbus, OH 43210 USA.	beversdorfd@health.missouri.edu	Beversdorf, David Q./M-2786-2016; Tivarus, Madalina/ABB-4966-2021	Beversdorf, David Q./0000-0002-0298-0634; Tivarus, Madalina/0000-0001-7481-5913	National Alliance for Autism Research; National Institute of Neurological Disorders and Stroke (NINDS) [K23 NS43222]; Ohio State University (OSU); OSU Department of Statistics; Wright Center for Innovation; University of Missouri Department of Radiology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS043222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034977] Funding Source: NIH RePORTER	National Alliance for Autism Research; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Ohio State University (OSU)(Ohio State University); OSU Department of Statistics; Wright Center for Innovation; University of Missouri Department of Radiology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research is funded by a Pilot Grant from the National Alliance for Autism Research (now Autism Speaks, www.autismspeaks.org), and by grants from National Institute of Neurological Disorders and Stroke (NINDS) (K23 NS43222) (www.nih.gov), the Ohio State University (OSU) Research Investment Fund, the OSU Department of Statistics Release Time Fund, the Wright Center for Innovation, and the University of Missouri Department of Radiology Research Investment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASANUMA C, 1985, J COMP NEUROL, V241, P357, DOI 10.1002/cne.902410309; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Beversdorf DQ, 1997, CLIN NEUROPATHOL, V16, P328; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chalfin BP, 2007, J COMP NEUROL, V504, P265, DOI 10.1002/cne.21406; Cohen J, 2002, CURR OPIN NEUROBIOL, V12, P223, DOI 10.1016/S0959-4388(02)00314-8; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Dagher A, 2001, BRAIN, V124, P1020, DOI 10.1093/brain/124.5.1020; DEMB JB, 1995, J NEUROSCI, V15, P5870; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Devlin JT, 2003, J COGNITIVE NEUROSCI, V15, P71, DOI 10.1162/089892903321107837; Durstewitz D, 2002, NEURAL NETWORKS, V15, P561, DOI 10.1016/S0893-6080(02)00049-7; Eichele T, 2009, INT J PSYCHOPHYSIOL, V73, P53, DOI 10.1016/j.ijpsycho.2008.12.018; Floresco SB, 2006, NEUROPSYCHOPHARMACOL, V31, P297, DOI 10.1038/sj.npp.1300825; Gold BT, 2002, NEURON, V35, P803, DOI 10.1016/S0896-6273(02)00800-0; HALL H, 1994, NEUROPSYCHOPHARMACOL, V11, P245, DOI 10.1038/sj.npp.1380111; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Kastner Sabine, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P483, DOI 10.3758/CABN.4.4.483; Ketteler D, 2008, NEUROIMAGE, V39, P2002, DOI 10.1016/j.neuroimage.2007.10.023; KIEVIT J, 1977, EXP BRAIN RES, V29, P299; Kischka U, 1996, NEUROPSYCHOLOGIA, V34, P1107, DOI 10.1016/0028-3932(96)00024-3; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; LIDOW MS, 1991, NEUROSCIENCE, V40, P657, DOI 10.1016/0306-4522(91)90003-7; Markowitsch HJ, 1995, BRAIN RES REV, V21, P117, DOI 10.1016/0165-0173(95)00007-0; McDermott KB, 2003, NEUROPSYCHOLOGIA, V41, P293, DOI 10.1016/S0028-3932(02)00162-8; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Mehta MA, 2001, PSYCHOPHARMACOLOGY, V159, P10, DOI 10.1007/s002130100851; Mehta MA, 2004, PSYCHOPHARMACOLOGY, V176, P331, DOI 10.1007/s00213-004-1899-2; MINKA T, 2000, 514 TR MIT; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Rektorova I, 2008, MOVEMENT DISORD, V23, P1580, DOI 10.1002/mds.22158; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmithorst VJ, 2004, J MAGN RESON IMAGING, V19, P365, DOI 10.1002/jmri.20009; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Shivde G, 2004, COGN AFFECT BEHAV NE, V4, P10, DOI 10.3758/CABN.4.1.10; Svensen M, 2002, NEUROIMAGE, V16, P551, DOI 10.1006/nimg.2002.1122; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Tivarus ME, 2008, BRAIN LANG, V104, P42, DOI 10.1016/j.bandl.2007.02.007; TROJANOWSKI JQ, 1976, J COMP NEUROL, V169, P371, DOI 10.1002/cne.901690307; Winterer G, 2004, TRENDS NEUROSCI, V27, P683, DOI 10.1016/j.tins.2004.08.002; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	43	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e11933	10.1371/journal.pone.0011933	http://dx.doi.org/10.1371/journal.pone.0011933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808963	Green Published, gold, Green Submitted			2022-12-25	WOS:000280968100001
J	Tschopp, R; Aseffa, A; Schelling, E; Berg, S; Hailu, E; Gadisa, E; Habtamu, M; Argaw, K; Zinsstag, J				Tschopp, Rea; Aseffa, Abraham; Schelling, Esther; Berg, Stefan; Hailu, Elena; Gadisa, Endalamaw; Habtamu, Meseret; Argaw, Kifle; Zinsstag, Jakob			Bovine Tuberculosis at the Wildlife-Livestock-Human Interface in Hamer Woreda, South Omo, Southern Ethiopia	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; CATTLE; IDENTIFICATION; INFECTION; DIAGNOSIS; DIFFERENTIATION; PREVALENCE; DISEASE; REGIONS; GOATS	Bovine tuberculosis (BTB) is endemic in cattle in the Ethiopian Highlands but no studies have been done so far in pastoralists in South Omo. This study assessed the prevalence of bovine tuberculosis (BTB) at an intensive interface of livestock, wildlife and pastoralists in Hamer Woreda (South Omo), Ethiopia. A cross-sectional survey including a comparative intradermal skin testing (CIDT) was conducted in 499 zebu cattle and 186 goats in 12 settlements. Sputum samples from 26 symptomatic livestock owners were cultured for TB. Fifty-one wildlife samples from 13 different species were also collected in the same area and tested with serological (lateral flow assay) and bacteriological (culture of lymph nodes) techniques. Individual BTB prevalence in cattle was 0.8% (CI: 0.3%-2%) with the >4 mm cut-off and 3.4% (CI: 2.1%-5.4%) with the >2 mm cut-off. Herd prevalence was 33.3% and 83% when using the >4 and the >2 mm cut-off respectively. There was no correlation between age, sex, body condition and positive reactors upon univariate analysis. None of the goats were reactors for BTB. Acid fast bacilli (AFB) were detected in 50% of the wildlife cultures, 79.2% of which were identified as Mycobacterium terrae complex. No M. bovis was detected. Twenty-seven percent of tested wildlife were sero-positive. Four sputum cultures (15.4%) yielded AFB positive colonies among which one was M. tuberculosis and 3 non-tuberculous mycobacteria (NTM). The prevalence of M. avium-complex (MAC) was 4.2% in wildlife, 2.5% in cattle and 0.5% in goats. In conclusion, individual BTB prevalence was low, but herd prevalence high in cattle and BTB was not detected in goats, wildlife and humans despite an intensive contact interface. On the contrary, NTMs were highly prevalent and some Mycobacterium spp were more prevalent in specific species. The role of NTMs in livestock and co-infection with BTB need further research.	[Tschopp, Rea; Schelling, Esther; Zinsstag, Jakob] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Tschopp, Rea; Aseffa, Abraham; Hailu, Elena; Gadisa, Endalamaw; Habtamu, Meseret] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Berg, Stefan] Vet Labs Agcy, Addlestone, Surrey, England; [Argaw, Kifle] Ethiopian Wildlife Conservat Author, Addis Ababa, Ethiopia	University of Basel; Swiss Tropical & Public Health Institute; Veterinary Laboratories Agency	Tschopp, R (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	rea.tschopp@unibas.ch	Berg, Stefan/AAU-6463-2020; Schelling, Esther/K-7990-2015; Zinsstag, Jakob/A-8317-2008; Aseffa, Abraham/J-3248-2016; Berg, Stefan O/D-3847-2011	Berg, Stefan/0000-0002-3470-7579; Schelling, Esther/0000-0001-6444-0898; Zinsstag, Jakob/0000-0002-8899-6097; Aseffa, Abraham/0000-0002-8028-1150; 	Wellcome Trust (UK)	Wellcome Trust (UK)(Wellcome Trust)	Source of funding: Wellcome Trust (UK) under their Animal Health in the Developing World Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Wellcome Trust - Animal Health in the Developing World Initiative (UK) as well as AHRI/ALERT and Rift Valley Safaris for the logistic support. Many thanks go to the data management team in AHRI led by L. Yamuah. We thank Bamlaku Tilahun, Tesfaye Erenso, Girum Erenso and Jason Roussos for their valuable help in the field as well as the staff of Murulle lodge.	Alvarez J, 2008, VET MICROBIOL, V128, P72, DOI 10.1016/j.vetmic.2007.08.034; Ameni G, 2003, INT J APPL RES VET M, V1, P1; Ameni G, 2008, CLIN VACCINE IMMUNOL, V15, P1272, DOI 10.1128/CVI.00114-08; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; ASSEGED B, 2000, B ANIMAL HLTH PRODUC, V80, P67; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; BONGO NRN, 2009, PREV VET MED, V89, P81; Cleaveland S, 2005, J WILDLIFE DIS, V41, P446, DOI 10.7589/0090-3558-41.2.446; Coleman JD, 2001, TUBERCULOSIS, V81, P191, DOI 10.1054/tube.2001.0291; *CSA, 2007, STAT B CSA, V388; Demelash B, 2009, TROP ANIM HEALTH PRO, V41, P755, DOI 10.1007/s11250-008-9248-9; DONDE BG, 2009, THESIS SWISS TROPICA; El Hussein HA, 2009, TROP ANIM HEALTH PRO, V41, P617, DOI 10.1007/s11250-008-9232-4; Engeman RM, 2007, AFR J ECOL, V45, P184, DOI 10.1111/j.1365-2028.2006.00695.x; *EWD, 2008, COMP WILDL MAN DEP; Fetene T, 2009, TROP ANIM HEALTH PRO, V41, P273, DOI 10.1007/s11250-008-9186-6; GALLAGHER J, 1977, J HYG-CAMBRIDGE, V79, P155, DOI 10.1017/S0022172400052943; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; GUTIERREZ M, 1995, J CLIN MICROBIOL, V33, P2953; Gutierrez M, 1998, VET MICROBIOL, V62, P281, DOI 10.1016/S0378-1135(98)00217-X; Han XY, 2002, AM J CLIN PATHOL, V118, P796, DOI 10.1309/HN44-XQYM-JMAQ-2EDL; Javed MT, 2010, ACTA TROP, V113, P88, DOI 10.1016/j.actatropica.2009.08.026; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Liebana E, 1998, AUST VET J, V76, P50, DOI 10.1111/j.1751-0813.1998.tb15686.x; Lyashchenko KP, 2008, VET MICROBIOL, V132, P283, DOI 10.1016/j.vetmic.2008.05.029; Michel AL, 2007, BMC VET RES, V3, P23, DOI DOI 10.1186/1746-6148-3-23; Mostowy S, 2005, J BACTERIOL, V187, P6386, DOI 10.1128/JB.187.18.6386-6395.2005; Msangi B.S.J., 1999, P M TANZ SOC AN PROD; *OXF, 2009, BUILD BLOCKS PAST FE; Renwick AR, 2007, EPIDEMIOL INFECT, V135, P529, DOI 10.1017/S0950268806007205; Roberts GD, 1991, MANUAL CLIN MICROBIO, P304; Tschopp R, 2010, J WILDLIFE DIS, V46, P753, DOI 10.7589/0090-3558-46.3.753; TSCHOPP R, VET RECORD IN PRESS; Tschopp R, 2009, PREV VET MED, V89, P205, DOI 10.1016/j.prevetmed.2009.02.006; *WHO, 2007, NEW WHO POL; Wilton S, 1992, PCR Methods Appl, V1, P269; Zinsstag J., 2006, MYCOBACTERIUM BOVIS, P68, DOI DOI 10.1002/9780470344538.CH9	39	30	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12205	10.1371/journal.pone.0012205	http://dx.doi.org/10.1371/journal.pone.0012205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808913	Green Published, Green Submitted, gold			2022-12-25	WOS:000280968100011
J	Chen, TH; Chan, PC; Chen, CL; Chen, HC				Chen, T-H; Chan, P-C; Chen, C-L; Chen, H-C			Phosphorylation of focal adhesion kinase on tyrosine 194 by Met leads to its activation through relief of autoinhibition	ONCOGENE			English	Article						FAK; Met; RTK; FERM; autoinhibition	GROWTH-FACTOR; FERM DOMAIN; IN-VITRO; PROTEIN; IDENTIFICATION; PP125(FAK); CELLS; FAK; ASSOCIATION; PP60(SRC)	Focal adhesion kinase (FAK) has a crucial role in integration of signals from integrins and growth factor receptors. In this study, we demonstrate that growth factor receptors including hepatocyte growth factor receptor Met, epidermal growth factor receptor, and platelet-derived growth factor receptor directly phosphorylate FAK on Tyr194 in the FERM domain (band 4.1 and ezrin/radixin/moesin homology domain). Upon binding to Met or phosphoinositides, FAK may undergo conformational changes, which renders Tyr194 accessible for phosphorylation. Substitution of Tyr194 with Phe significantly suppresses the activation of FAK by Met. In contrast, substitution of Tyr194 with Glu (Y194E substitution) leads to constitutive activation of FAK. The phosphorylation of FAK on Tyr194 may cause conformational changes in the FERM domain, which disrupts the intramolecular inhibitory interaction between the FERM and kinase domains of FAK. Moreover, substitution of the basic residues in the (216)KAKTLRK(222) patch in the FERM domain with Ala antagonizes the effect of the Y194E substitution on FAK activation, thus suggesting that the interactions between the phosphorylated Tyr194 and the basic resides in the (216)KAKTLRK(222) patch may allow FAK to be activated through relief of its autoinhibition. Collectively, this study provides the first example to explain how FAK is activated by receptor tyrosine kinases. Oncogene (2011) 30, 153-166; doi:10.1038/onc.2010.398; published online 30 August 2010	[Chen, T-H; Chen, C-L; Chen, H-C] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Chan, P-C; Chen, H-C] Natl Chung Hsing Univ, Grad Inst Biomed Sci, Taichung 40227, Taiwan; [Chen, H-C] China Med Univ, Dept Nutr, Taichung, Taiwan	National Chung Hsing University; National Chung Hsing University; China Medical University Taiwan	Chen, HC (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, 250 Kuo Kuang Rd, Taichung 40227, Taiwan.	hcchen@nchu.edu.tw			National Science Council, Taiwan [NSC97-3112-B-005-001, NSC97-2628-B-005-001-MY3]; National Health Research Institutes, Taiwan [NHRI-EX97-9730BI]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work is supported by Grants NSC97-3112-B-005-001 and NSC97-2628-B-005-001-MY3 from the National Science Council, Taiwan and NHRI-EX97-9730BI from the National Health Research Institutes, Taiwan.	Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Chan PC, 2002, J BIOL CHEM, V277, P50373, DOI 10.1074/jbc.M204691200; Chen HC, 1998, J BIOL CHEM, V273, P25777, DOI 10.1074/jbc.273.40.25777; Chen LM, 2000, J NEUROSCI, V20, P3776, DOI 10.1523/JNEUROSCI.20-10-03776.2000; Chen RY, 2001, NAT CELL BIOL, V3, P439, DOI 10.1038/35074500; Chen SY, 2006, MOL CELL BIOL, V26, P5155, DOI 10.1128/MCB.02186-05; COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147; Cohen LA, 2005, J BIOL CHEM, V280, P8197, DOI 10.1074/jbc.M412021200; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; Dunty JM, 2004, MOL CELL BIOL, V24, P5353, DOI 10.1128/MCB.24.12.5353-5368.2004; EIDE BL, 1995, MOL CELL BIOL, V15, P2819; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; Jacamo RO, 2005, BIOCHEM BIOPH RES CO, V334, P1299, DOI 10.1016/j.bbrc.2005.07.034; Lai JF, 2000, J BIOL CHEM, V275, P7474, DOI 10.1074/jbc.275.11.7474; Lehr S, 1999, BIOCHEMISTRY-US, V38, P151, DOI 10.1021/bi9818265; Lehr S, 2000, BIOCHEMISTRY-US, V39, P10898, DOI 10.1021/bi000982k; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; MATSUMOTO K, 1994, J BIOL CHEM, V269, P31807; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Poullet P, 2001, J BIOL CHEM, V276, P37686, DOI 10.1074/jbc.M106175200; RANKIN S, 1994, J BIOL CHEM, V269, P704; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413	31	31	31	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	2					153	166		10.1038/onc.2010.398	http://dx.doi.org/10.1038/onc.2010.398			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709LG	20802513				2022-12-25	WOS:000286438900004
J	Mays, CE; Ryou, C				Mays, Charles E.; Ryou, Chongsuk			Plasminogen stimulates propagation of protease-resistant prion protein in vitro	FASEB JOURNAL			English	Article						cofactor; prion replication; protein misfolding	CYCLIC AMPLIFICATION; PRP ACCUMULATION; BINDING; CONVERSION; CELLS; MICE; ACTIVATION; GENERATION; COMPONENTS; THROMBOSIS	To clarify the role of plasminogen as a cofactor for prion propagation, we conducted functional assays using a cell-free prion protein (PrP) conversion assay termed protein misfolding cyclic amplification (PMCA) and prion-infected cell lines. Here, we report that plasminogen stimulates propagation of the protease-resistant scrapie PrP (PrPSc). Compared to control PMCA conducted without plasminogen, addition of plasminogen in PMCA using wild-type brain material significantly increased PrP conversion, with an EC50 = similar to 56 nM. PrP conversion in PMCA was substantially less efficient with plasminogen-deficient brain material than with wild-type material. The activity stimulating PrP conversion was specific for plasminogen and conserved in its kringle domains. Such activity was abrogated by modification of plasminogen structure and interference of PrP-plasminogen interaction. Kinetic analysis of PrPSc generation demonstrated that the presence of plasminogen in PMCA enhanced the PrPSc production rate to similar to 0.97U/mu l/h and reduced turnover time to similar to 1 h compared to those (similar to 0.4 U/mu l/h and similar to 2.5 h) obtained without supplementation. Furthermore, as observed in PMCA, plasminogen and kringles promoted PrPSc propagation in ScN2a and Elk 21(+) cells. Our results demonstrate that plasminogen functions in stimulating conversion processes and represents the first cellular protein cofactor that enhances the hypothetical mechanism of prion propagation.-Mays, C. E., Ryou, C. Plasminogen stimulates propagation of protease-resistant prion protein in vitro. FASEB J. 24, 5102-5112 (2010). www.fasebj.org	Univ Kentucky, Coll Med, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Ryou, C (corresponding author), 800 Rose St,HSRB 326, Lexington, KY 40536 USA.	cryou2@email.uky.edu			Sanders-Brown Center on Aging and College of Medicine, University of Kentucky	Sanders-Brown Center on Aging and College of Medicine, University of Kentucky	The authors thank Glenn Telling (University of Kentucky) for constructive discussion as well as for sharing experimental reagents and equipment. The authors are grateful to Jay Degen (Children's Hospital Research Foundation, Cincinnati, OH, USA) and Stanley Prusiner (University of California, San Francisco, CA, USA) for providing reagents. The authors also thank Paula Thomason for editing the manuscript. This work was supported in part by funds from the Sanders-Brown Center on Aging and College of Medicine, University of Kentucky.	Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Bian JF, 2010, J VIROL, V84, P8322, DOI 10.1128/JVI.00633-10; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Castellino FJ, 1997, CIBA F SYMP, V212, P46; CAUGHEY B, 1994, PHILOS T R SOC B, V343, P399, DOI 10.1098/rstb.1994.0035; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; CEDERHOLMWILLIAMS SA, 1981, J CLIN PATHOL, V34, P979, DOI 10.1136/jcp.34.9.979; Christen B, 2009, J MOL BIOL, V389, P833, DOI 10.1016/j.jmb.2009.04.040; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Cuccioloni M, 2005, PROTEINS, V58, P728, DOI 10.1002/prot.20346; Dandoy-Dron F, 2006, NEUROSCI LETT, V405, P181, DOI 10.1016/j.neulet.2006.05.066; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Degen JL, 2001, ANN NY ACAD SCI, V936, P276; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Ellis V, 2002, BIOCHEMISTRY-US, V41, P6891, DOI 10.1021/bi025676g; Epple G, 2004, J THROMB HAEMOST, V2, P962, DOI 10.1111/j.1538-7836.2004.00675.x; Epple G, 2004, THROMB HAEMOSTASIS, V91, P465, DOI 10.1160/TH03-06-0382; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; GORODINSKY A, 1995, J CELL BIOL, V129, P619, DOI 10.1083/jcb.129.3.619; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Kim Y, 2009, ANTIVIR RES, V84, P185, DOI 10.1016/j.antiviral.2009.09.002; Kim Y, 2009, MOL CELL BIOCHEM, V328, P177, DOI 10.1007/s11010-009-0087-4; KIMBERLIN RH, 1986, ANTIMICROB AGENTS CH, V30, P409, DOI 10.1128/AAC.30.3.409; Kornblatt JA, 2004, CELL MOL BIOL, V50, P387; Kornblatt JA, 2003, BIOCHEM BIOPH RES CO, V305, P518, DOI 10.1016/S0006-291X(03)00804-0; Kornblatt JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006196; Ledesma MD, 2000, EMBO REP, V1, P530; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lucassen R, 2003, BIOCHEMISTRY-US, V42, P4127, DOI 10.1021/bi027218d; Maissen M, 2001, LANCET, V357, P2026, DOI 10.1016/S0140-6736(00)05110-2; Mays CE, 2008, BRAIN RES, V1208, P170, DOI 10.1016/j.brainres.2008.02.103; Mays CE, 2009, BIOCHEM BIOPH RES CO, V388, P306, DOI 10.1016/j.bbrc.2009.07.163; Negredo C, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-43; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; PLOPLIS VA, 1995, CIRCULATION, V92, P2585, DOI 10.1161/01.CIR.92.9.2585; Praus M, 2003, THROMB HAEMOSTASIS, V89, P812, DOI 10.1055/s-0037-1613466; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; ROGERS M, 1993, P NATL ACAD SCI USA, V90, P3182, DOI 10.1073/pnas.90.8.3182; Ryou C, 2003, J MOL BIOL, V329, P323, DOI 10.1016/S0022-2836(03)00342-5; Ryou C, 2007, J MICROBIOL BIOTECHN, V17, P1059; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Salmona M, 2005, J VIROL, V79, P11225, DOI 10.1128/JVI.79.17.11225-11230.2005; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; Shaked Y, 2002, J NEUROCHEM, V82, P1, DOI 10.1046/j.1471-4159.2002.00995.x; Stathakis P, 1997, J BIOL CHEM, V272, P20641, DOI 10.1074/jbc.272.33.20641; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Vey M, 1996, P NATL ACAD SCI USA, V93, P14945, DOI 10.1073/pnas.93.25.14945; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; WHITELAW A, 1995, ACTA PAEDIATR, V84, P933, DOI 10.1111/j.1651-2227.1995.tb13795.x; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Xanthopoulos K, 2005, NEUROBIOL DIS, V20, P519, DOI 10.1016/j.nbd.2005.04.008; Zerr I, 2004, NEUROSCI LETT, V371, P163, DOI 10.1016/j.neulet.2004.08.063; Zhang L, 2002, THROMB HAEMOSTASIS, V87, P493; Zulianello L, 2000, J VIROL, V74, P4351, DOI 10.1128/JVI.74.9.4351-4360.2000	65	27	31	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					5102	5112		10.1096/fj.10-163600	http://dx.doi.org/10.1096/fj.10-163600			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20732953				2022-12-25	WOS:000284824400048
J	Yu, J; Ma, X; Cheung, KF; Li, X; Tian, L; Wang, S; Wu, CW; Wu, WKK; He, M; Wang, M; Ng, SSM; Sung, JJY				Yu, J.; Ma, X.; Cheung, K. F.; Li, X.; Tian, L.; Wang, S.; Wu, C. W.; Wu, W. K. K.; He, M.; Wang, M.; Ng, S. S. M.; Sung, J. J. Y.			Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer	ONCOGENE			English	Article						T-box transcription factor 5; colon cancer; tumor suppressor gene; epigenetic alteration; prognosis	SYNUCLEIN-GAMMA-GENE; COLORECTAL-CANCER; GASTRIC-CANCER; BREAST-CANCER; DNA METHYLATION; CPG ISLAND; APOPTOSIS; METASTASIS; EXPRESSION; SURVIVAL	T-box transcription factor 5 (TBX5) is a member of a phylogenetically conserved family of genes involved in the regulation of developmental processes. The function of TBX5 in cancer development is largely unclear. We identified that TBX5 was preferentially methylated in cancer using methylation-sensitive arbitrarily primed PCR. We aim to clarify the epigenetic inactivation, biological function and clinical significance of TBX5 in colon cancer. Promoter methylation was evaluated by combined bisulfite restriction analysis and bisulfite genomic sequencing. Cell proliferation was examined by cell viability assay and colony formation assay, apoptosis by flow cytometry and cell migration by wound-healing assay. TBX5 target genes were identified by cDNA microarray analysis. Cox regression model and log-rank test were used to identify independent predictors of prognosis. TBX5 was silenced or downregulated in 88% (7/8) colon cancer cell lines, but was expressed in normal colon tissues. Loss of gene expression was associated with promoter methylation. The biological function of TBX5 in human colon cancer cells was examined. Re-expression of TBX5 in silenced colon cancer cell lines suppressed colony formation (P<0.001), proliferation (P<0.001), migration and induced apoptosis (P<0.01). Induction of apoptosis was mediated through cross-talk of extrinsic apoptosis pathway, apoptotic BCL2-associated X protein and Granzyme A signaling cascades. TBX5 suppressed tumor cell proliferation and metastasis through the upregulation of cyclin-dependent kinase inhibitor 2A, metastasis suppressor 1 and downregulation of synuclein gamma and metastasis-associated protein 1 family member 2. TBX5 methylation was detected in 68% (71/105) of primary colon tumors. Multivariate analysis showed that patients with TBX5 methylation had a significantly poor overall survival (P=0.0007). In conclusion, we identified a novel functional tumor suppressor gene TBX5 inactivated by promoter methylation in colon cancer. Detection of methylated TBX5 may serve as a potential biomarker for the prognosis of this malignancy. Oncogene (2010) 29, 6464-6474; doi:10.1038/onc.2010.370; published online 30 August 2010	[Yu, J.; Ma, X.; Cheung, K. F.; Li, X.; Wang, S.; Wu, C. W.; Wu, W. K. K.; Sung, J. J. Y.] Chinese Univ Hong Kong, Dept Med & Therapeut, Inst Digest Dis, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; [Yu, J.; Ma, X.; Cheung, K. F.; Li, X.; Wang, S.; Wu, C. W.; Wu, W. K. K.; Sung, J. J. Y.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Ma, X.; Wang, M.] Hebei Med Univ, Dept Neurol, Hosp 1, Shijiazhuang, Peoples R China; [He, M.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Ng, S. S. M.] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Hebei Medical University; Chinese University of Hong Kong; Chinese University of Hong Kong	Yu, J (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Inst Digest Dis, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China.	junyu@cuhk.edu.hk	Pillay, Nischalan/F-9536-2012; Yu, Jun/D-8569-2015; Sung, Joseph J. Y./R-3203-2018; Tian, Linwei/A-9736-2009; HE, Ming-Liang/AAG-3397-2022; wu, william/HII-5817-2022; Ng, Simon S. M./M-1219-2018; HE, Ming-Liang/AFK-4738-2022; Li, Xiao-xing/B-9114-2008; Wu, William K.K./A-3277-2009	Yu, Jun/0000-0001-5008-2153; Sung, Joseph J. Y./0000-0003-3125-5199; Tian, Linwei/0000-0002-4739-1534; Ng, Simon S. M./0000-0002-5389-9297; Li, Xiao-xing/0000-0001-8791-7505; Wu, William K.K./0000-0002-5662-5240; Tian, Linwei/0000-0003-2240-8886; He, Ming-Liang/0000-0002-4317-2836; HE, Mingliang/0000-0002-9942-9151	Council Competitive Earmarked Research Grant CUHK [473008]	Council Competitive Earmarked Research Grant CUHK	This work was supported by research grant of Council Competitive Earmarked Research Grant CUHK (473008).	Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Barton CA, 2008, GYNECOL ONCOL, V109, P129, DOI 10.1016/j.ygyno.2007.12.017; Cai CL, 2005, DEVELOPMENT, V132, P2475, DOI 10.1242/dev.01832; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Cullen SP, 2010, CELL DEATH DIFFER, V17, P616, DOI 10.1038/cdd.2009.206; Finotto Susetta, 2008, V94, P83, DOI 10.1159/000154869; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Gupta A, 2003, ONCOGENE, V22, P7593, DOI 10.1038/sj.onc.1206880; Gupta A, 2003, CANCER RES, V63, P664; He ML, 2002, BIOCHEM BIOPH RES CO, V297, P185, DOI 10.1016/S0006-291X(02)02142-3; Hicks DG, 2006, CLIN CANCER RES, V12, P6702, DOI 10.1158/1078-0432.CCR-06-0635; Holoch PA, 2009, EUR J PHARMACOL, V625, P63, DOI 10.1016/j.ejphar.2009.06.066; Hu H, 2009, CLIN CANCER RES, V15, P5485, DOI 10.1158/1078-0432.CCR-08-2491; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Liu HY, 2005, CANCER RES, V65, P7635, DOI 10.1158/0008-5472.CAN-05-1089; Liu YE, 2007, ONCOGENE, V26, P2115, DOI 10.1038/sj.onc.1210000; Maitra M, 2009, DEV BIOL, V326, P368, DOI 10.1016/j.ydbio.2008.11.004; Mori AD, 2006, DEV BIOL, V297, P566, DOI 10.1016/j.ydbio.2006.05.023; Nemer M, 2008, CARDIOVASC PATHOL, V17, P48, DOI 10.1016/j.carpath.2007.06.005; NewburyEcob RA, 1996, J MED GENET, V33, P300, DOI 10.1136/jmg.33.4.300; Page D.L., 2002, TNM CLASSIFICATION M, V6th; Pan ZZ, 2002, J BIOL CHEM, V277, P35050, DOI 10.1074/jbc.M201650200; Papaioannou VE, 1998, BIOESSAYS, V20, P9, DOI 10.1002/(SICI)1521-1878(199801)20:1<9::AID-BIES4>3.0.CO;2-Q; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parr C, 2009, EUR J CANCER, V45, P1673, DOI 10.1016/j.ejca.2009.02.019; Plageman TF, 2006, DEV DYNAM, V235, P2868, DOI 10.1002/dvdy.20923; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Toh Y, 2009, CLIN EXP METASTAS, V26, P215, DOI 10.1007/s10585-008-9233-8; Yanagawa N, 2004, CLIN CANCER RES, V10, P2447, DOI 10.1158/1078-0432.CCR-03-0107; Yu J, 2009, CANCER-AM CANCER SOC, V115, P49, DOI 10.1002/cncr.23989; Yu J, 2009, GASTROENTEROLOGY, V136, P640, DOI 10.1053/j.gastro.2008.10.050; Zitt M, 2007, DIS MARKERS, V23, P51, DOI 10.1155/2007/891967	34	68	72	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC	2010	29	49					6464	6474		10.1038/onc.2010.370	http://dx.doi.org/10.1038/onc.2010.370			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	692FP	20802524				2022-12-25	WOS:000285138900006
J	Su, XY; Agarwal, V; Dodd, D; Bae, B; Mackie, RI; Nair, SK; Cann, IKO				Su, Xiaoyun; Agarwal, Vinayak; Dodd, Dylan; Bae, Brian; Mackie, Roderick I.; Nair, Satish K.; Cann, Isaac K. O.			Mutational Insights into the Roles of Amino Acid Residues in Ligand Binding for Two Closely Related Family 16 Carbohydrate Binding Modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMOANAEROBACTERIUM-POLYSACCHAROLYTICUM; CELLOBIOHYDROLASE I; MOLECULAR-CLONING; RECOGNITION; CELLULOSE; DOMAINS; PURIFICATION; SPECIFICITY; SELECTIVITY; EXPRESSION	Carbohydrate binding modules (CBMs) are specialized proteins that bind to polysaccharides and oligosaccharides. Caldanaerobius polysaccharolyticus Man5ACBM16-1/CBM16-2 bind to glucose-, mannose-, and glucose/mannose-configured substrates. The crystal structures of the two proteins represent the only examples in CBM family 16, and studies that evaluate the roles of amino acid residues in ligand binding in this family are lacking. In this study, we probed the roles of amino acids (selected based on CBM16-1/ligand co-crystal structures) on substrate binding. Two tryptophan (Trp-20 and Trp-125) and two glutamine (Gln-81 and Gln-93) residues are shown to be critical in ligand binding. Additionally, several polar residues that flank the critical residues also contribute to ligand binding. The CBM16-1 Q121E mutation increased affinity for all substrates tested, whereas the Q21G and N97R mutants exhibited decreased substrate affinity. We solved CBM/substrate co-crystal structures to elucidate the molecular basis of the increased substrate binding by CBM16-1 Q121E. The Gln-121, Gln-21, and Asn-97 residues can be manipulated to fine-tune ligand binding by the Man5A CBMs. Surprisingly, none of the eight residues investigated was absolutely conserved in CBM family 16. Thus, the critical residues in the Man5A CBMs are either not essential for substrate binding in the other members of this family or the two CBMs are evolutionarily distinct from the members available in the current protein database. Man5A is dependent on its CBMs for robust activity, and insights from this study should serve to enhance our understanding of the interdependence of its catalytic and substrate binding modules.	[Su, Xiaoyun; Dodd, Dylan; Mackie, Roderick I.; Nair, Satish K.; Cann, Isaac K. O.] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA; [Su, Xiaoyun; Dodd, Dylan; Mackie, Roderick I.; Nair, Satish K.; Cann, Isaac K. O.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Dodd, Dylan; Cann, Isaac K. O.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Bae, Brian; Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Agarwal, Vinayak; Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Mackie, Roderick I.; Cann, Isaac K. O.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nair, SK (corresponding author), Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA.	snair@uiuc.edu; icann@illinois.edu	Nair, Satish/AAY-2510-2021; Agarwal, Vinayak/L-5688-2017	Dodd, Dylan/0000-0001-6210-6239	Energy Biosciences Institute; NIDDK [1F30DK084726]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK084726] Funding Source: NIH RePORTER	Energy Biosciences Institute; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the Energy Biosciences Institute and in part by National Institutes of Health Fellowship 1F30DK084726 from NIDDK (to D. D.).	Bae B, 2008, J BIOL CHEM, V283, P12415, DOI 10.1074/jbc.M706513200; Barbeyron T, 1998, MOL BIOL EVOL, V15, P528, DOI 10.1093/oxfordjournals.molbev.a025952; BLAAK H, 1993, EUR J BIOCHEM, V214, P659, DOI 10.1111/j.1432-1033.1993.tb17966.x; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2003, J MOL BIOL, V327, P659, DOI 10.1016/S0022-2836(03)00152-9; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRU N, 1992, NATURE */* A T NATUR, V355, P472; Cann IKO, 1999, J BACTERIOL, V181, P1643, DOI 10.1128/JB.181.5.1643-1651.1999; Carvalho AL, 2004, J BIOL CHEM, V279, P34785, DOI 10.1074/jbc.M405867200; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P14077, DOI 10.1073/pnas.212516199; COUGHLAN MP, 1985, BIOTECHNOL GENET ENG, V3, P39, DOI 10.1080/02648725.1985.10647809; Czjzek M, 2001, J BIOL CHEM, V276, P48580, DOI 10.1074/jbc.M109142200; DIN N, 1994, P NATL ACAD SCI USA, V91, P11383, DOI 10.1073/pnas.91.24.11383; Flint J, 2005, J BIOL CHEM, V280, P23718, DOI 10.1074/jbc.M501551200; Flint J, 2004, J MOL BIOL, V337, P417, DOI 10.1016/j.jmb.2003.12.081; Gao PJ, 2001, ACTA BIOCH BIOPH SIN, V33, P13; Han YJ, 2010, J BACTERIOL, V192, P4111, DOI 10.1128/JB.00257-10; Henshaw JL, 2004, J BIOL CHEM, V279, P21552, DOI 10.1074/jbc.M401620200; Henshaw J, 2006, J BIOL CHEM, V281, P17099, DOI 10.1074/jbc.M600702200; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee YJ, 2008, INT J SYST EVOL MICR, V58, P666, DOI 10.1099/ijs.0.65329-0; Leng L, 1998, GENE, V222, P187, DOI 10.1016/S0378-1119(98)00496-X; Matsushima R, 2010, APPL MICROBIOL BIOT, V86, P567, DOI 10.1007/s00253-009-2278-z; Mattinen ML, 1997, PROTEIN SCI, V6, P294; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Notenboom V, 2001, J MOL BIOL, V314, P797, DOI 10.1006/jmbi.2001.5153; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Pell G, 2003, BIOCHEMISTRY-US, V42, P9316, DOI 10.1021/bi0347510; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; TAKEO K, 1984, ELECTROPHORESIS, V5, P187, DOI 10.1002/elps.1150050402; Tomme P, 1996, BIOCHEMISTRY-US, V35, P13885, DOI 10.1021/bi961185i; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Xie HF, 2001, BIOCHEMISTRY-US, V40, P5700, DOI 10.1021/bi010034z; Xie HF, 2001, BIOCHEMISTRY-US, V40, P9167, DOI 10.1021/bi0106742; Yamagishi K, 2003, J BIOL CHEM, V278, P25766, DOI 10.1074/jbc.M212183200	41	8	9	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34665	34676		10.1074/jbc.M110.168302	http://dx.doi.org/10.1074/jbc.M110.168302			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739280	hybrid, Green Published			2022-12-25	WOS:000283659100042
J	Morton, MJ; Farr, GA; Hull, M; Capendeguy, O; Horisberger, JD; Caplan, MJ				Morton, Michael J.; Farr, Glen A.; Hull, Michael; Capendeguy, Oihana; Horisberger, Jean-Daniel; Caplan, Michael J.			Association with beta-COP Regulates the Trafficking of the Newly Synthesized Na,K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM RETENTION; SODIUM-POTASSIUM PUMP; NA-K-ATPASE; ALPHA-SUBUNIT; CELL-SURFACE; CRYSTAL-STRUCTURE; XENOPUS OOCYTES; PROTEINS; RAT; TRANSCRIPTION	Plasma membrane expression of the Na,K-ATPase requires assembly of its alpha- and beta-subunits. Using a novel labeling technique to identify Na,K-ATPase partner proteins, we detected an interaction between the Na,K-ATPase alpha-subunit and the coat protein, beta-COP, a component of the COP-I complex. When expressed in the absence of the Na,K-ATPase beta-subunit, the Na,K-ATPase alpha-subunit interacts with beta-COP, is retained in the endoplasmic reticulum, and is targeted for degradation. In the presence of the Na,K-ATPase beta-subunit, the alpha-subunit does not interact with beta-COP and traffics to the plasma membrane. Pulse-chase experiments demonstrate that in cells expressing both the Na,K-ATPase alpha- and beta-subunits, newly synthesized alpha-subunit associates with beta-COP immediately after its synthesis but that this interaction does not constitute an obligate intermediate in the assembly of the alpha- and beta-subunits to form the pump holoenzyme. The interaction with beta-COP was reduced by mutating a dibasic motif at Lys(54) in the Na,K-ATPase alpha-subunit. This mutant alpha-subunit is not retained in the endoplasmic reticulum and reaches the plasma membrane, even in the absence of Na,K-ATPase alpha-subunit expression. Although the Lys(54) alpha-subunit reaches the cell surface without need for beta-subunit assembly, it is only functional as an ion-transporting ATPase in the presence of the beta-subunit.	[Caplan, Michael J.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Capendeguy, Oihana; Horisberger, Jean-Daniel] Univ Lausanne, Dept Pharmacol & Toxicol, Fac Biol & Med, CH-1005 Lausanne, Switzerland	Yale University; University of Lausanne	Caplan, MJ (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, POB 208026, New Haven, CT 06520 USA.	michael.caplan@yale.edu		Farr, Glen/0000-0002-5651-7995; Caplan, Michael/0000-0001-5768-4405	National Institutes of Health [DK 072614]; Leducq Foundation Transatlantic Network for Hypertension; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK072614, R01DK072614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation Transatlantic Network for Hypertension(Leducq Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 072614 (to M. J. C.). This work was also supported by funds from the Leducq Foundation Transatlantic Network for Hypertension (to M. J. C. and J.-D. H.).	Beggah A, 1996, J BIOL CHEM, V271, P20895, DOI 10.1074/jbc.271.34.20895; Chang XB, 1999, MOL CELL, V4, P137, DOI 10.1016/S1097-2765(00)80196-3; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; Espineda CE, 2004, MOL BIOL CELL, V15, P1364, DOI 10.1091/mbc.E03-09-0646; Farr GA, 2009, J CELL BIOL, V186, P269, DOI 10.1083/jcb.200901021; GEERING K, 1990, J MEMBRANE BIOL, V115, P109, DOI 10.1007/BF01869450; GEERING K, 1989, AM J PHYSIOL, V257, pC851, DOI 10.1152/ajpcell.1989.257.5.C851; GEERING K, 1991, FEBS LETT, V285, P189, DOI 10.1016/0014-5793(91)80801-9; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; GOTTARDI CJ, 1993, J BIOL CHEM, V268, P14342; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; Horisberger JD, 2002, J PHYSIOL-LONDON, V539, P669, DOI 10.1113/jphysiol.2001.013201; Jain S, 1997, GENE, V190, P37, DOI 10.1016/S0378-1119(96)00746-9; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; JORGENSEN PL, 1980, PHYSIOL REV, V60, P864; KATZ AI, 1979, AM J PHYSIOL, V237, pF114, DOI 10.1152/ajprenal.1979.237.2.F114; Keller SH, 2001, J BIOL CHEM, V276, P18384, DOI 10.1074/jbc.M100691200; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; LEMAS MV, 1994, J BIOL CHEM, V269, P8255; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Tirat A, 2006, INT J BIOL MACROMOL, V39, P66, DOI 10.1016/j.ijbiomac.2006.01.012; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Zatti A, 2005, MOL BIOL CELL, V16, P5087, DOI 10.1091/mbc.E05-03-0200; Zhuang Y, 2000, J BIOL CHEM, V275, P24173, DOI 10.1074/jbc.M002953200	29	9	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33737	33746		10.1074/jbc.M110.141119	http://dx.doi.org/10.1074/jbc.M110.141119			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20801885	Green Published, hybrid			2022-12-25	WOS:000283354000019
J	Rampersad, SN; Ovens, JD; Huston, E; Umana, MB; Wilson, LS; Netherton, SJ; Lynch, MJ; Baillie, GS; Houslay, MD; Maurice, DH				Rampersad, Sarah N.; Ovens, Jeffrey D.; Huston, Elaine; Umana, M. Bibiana; Wilson, Lindsay S.; Netherton, Stuart J.; Lynch, Martin J.; Baillie, George S.; Houslay, Miles D.; Maurice, Donald H.			Cyclic AMP Phosphodiesterase 4D (PDE4D) Tethers EPAC1 in a Vascular Endothelial Cadherin (VE-Cad)-based Signaling Complex and Controls cAMP-mediated Vascular Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; TYROSINE PHOSPHORYLATION; BARRIER FUNCTION; EXCHANGE FACTOR; CELL JUNCTIONS; VE-CADHERIN; PKA; ACTIVATION; ADHESION; INTEGRITY	Vascular endothelial cell (VEC) permeability is largely dependent on the integrity of vascular endothelial cadherin (VE-cadherin or VE-Cad)-based intercellular adhesions. Activators of protein kinase A (PKA) or of exchange protein activated by cAMP (EPAC) reduce VEC permeability largely by stabilizing VE-Cad-based intercellular adhesions. Currently, little is known concerning the nature and composition of the signaling complexes that allow PKA or EPAC to regulate VE-Cad-based structures and through these actions control permeability. Using pharmacological, biochemical, and cell biological approaches we identified and determined the composition and functionality of a signaling complex that coordinates cAMP-mediated control of VE-Cad-based adhesions and VEC permeability. Thus, we report that PKA, EPAC1, and cyclic nucleotide phosphodiesterase 4D (PDE4D) enzymes integrate into VE-Cad-based signaling complexes in human arterial endothelial cells. Importantly, we show that protein-protein interactions between EPAC1 and PDE4D serve to foster their integration into VE-Cad-based complexes and allow robust local regulation of EPAC1-based stabilization of VE-Cad-based adhesions. Of potential translational importance, we mapped the EPAC1 peptide motif involved in binding PDE4D and show that a cell-permeable variant of this peptide antagonizes EPAC1-PDE4D binding and directly alters VEC permeability. Collectively, our data indicate that PDE4D regulates both the activity and subcellular localization of EPAC1 and identify a novel mechanism for regulated EPAC1 signaling in these cells.	[Umana, M. Bibiana; Netherton, Stuart J.; Maurice, Donald H.] Queens Univ, Dept Pharmacol & Toxicol, Kingston, ON K7L 3N6, Canada; [Rampersad, Sarah N.; Ovens, Jeffrey D.; Wilson, Lindsay S.; Maurice, Donald H.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada; [Huston, Elaine; Lynch, Martin J.; Baillie, George S.; Houslay, Miles D.] Univ Glasgow, Inst Biomed & Life Sci, Mol Pharmacol Grp, Glasgow, Lanark, Scotland	Queens University - Canada; McMaster University; Queens University - Canada; University of Glasgow	Maurice, DH (corresponding author), Queens Univ, Dept Pharmacol & Toxicol, Botterell Hall,A208, Kingston, ON K7L 3N6, Canada.	mauriced@queensu.ca	Houslay, Miles/AAM-5281-2020; Maurice, Donald/AAE-9332-2019; Houslay, Miles D/A-6825-2011	Houslay, Miles/0000-0002-3826-8091	Canadian Institutes for Health Sciences [MOP-57699]; Medical Research Council (UK) [G0600765]; European Union [LSHB-CT-2006-037189]; Fondation Leducq [06CVD02]; MRC [G0600765] Funding Source: UKRI; Medical Research Council [G0600765] Funding Source: researchfish	Canadian Institutes for Health Sciences(Canadian Institutes of Health Research (CIHR)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Fondation Leducq(Leducq Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Grants MOP-57699 from the Canadian Institutes for Health Sciences, G0600765 from the Medical Research Council (UK), LSHB-CT-2006-037189 from the European Union, and 06CVD02 from the Fondation Leducq (to M. D. H.).	Andriopoulou P, 1999, ARTERIOSCL THROM VAS, V19, P2286, DOI 10.1161/01.ATV.19.10.2286; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Baillie GS, 2007, BIOCHEM J, V404, P71, DOI 10.1042/BJ20070005; Birukova AA, 2008, J CELL PHYSIOL, V215, P715, DOI 10.1002/jcp.21354; Birukova AA, 2007, EXP CELL RES, V313, P2504, DOI 10.1016/j.yexcr.2007.03.036; Borland G, 2009, BRIT J PHARMACOL, V158, P70, DOI 10.1111/j.1476-5381.2008.00087.x; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Moya EMG, 2009, CELL SIGNAL, V21, P1727, DOI 10.1016/j.cellsig.2009.08.006; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Gavard J, 2009, FEBS LETT, V583, P1, DOI 10.1016/j.febslet.2008.11.032; Gorski JA, 2005, MOL BIOL CELL, V16, P3574, DOI 10.1091/mbc.E05-02-0134; Hoffmann R, 1999, EMBO J, V18, P893, DOI 10.1093/emboj/18.4.893; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Hudry-Clergeon H, 2005, FASEB J, V19, P512, DOI 10.1096/fj.04-2202com; Kiely PA, 2009, J BIOL CHEM, V284, P20263, DOI 10.1074/jbc.M109.017640; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Liu F, 2001, AM J PHYSIOL-LUNG C, V280, pL1309, DOI 10.1152/ajplung.2001.280.6.L1309; Liu HG, 1999, J BIOL CHEM, V274, P10557, DOI 10.1074/jbc.274.15.10557; Lorenowicz MJ, 2008, EUR J CELL BIOL, V87, P779, DOI 10.1016/j.ejcb.2008.05.004; Mauban JRH, 2009, PHYSIOLOGY, V24, P78, DOI 10.1152/physiol.00041.2008; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; Moore TM, 1998, AM J PHYSIOL-LUNG C, V275, pL203, DOI 10.1152/ajplung.1998.275.2.L203; Netherton SJ, 2007, CIRC RES, V101, P768, DOI 10.1161/CIRCRESAHA.106.146159; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002; Qiao J, 2008, AM J PHYSIOL-CELL PH, V295, pC1161, DOI 10.1152/ajpcell.00139.2008; Raymond DR, 2007, CELL SIGNAL, V19, P2507, DOI 10.1016/j.cellsig.2007.08.005; Rich TC, 2007, AM J PHYSIOL-CELL PH, V292, pC319, DOI 10.1152/ajpcell.00121.2006; Sage EH, 2003, J BIOL CHEM, V278, P37849, DOI 10.1074/jbc.M302946200; Schlegel N, 2009, AM J PHYSIOL-CELL PH, V296, pC453, DOI 10.1152/ajpcell.00360.2008; Sehrawat S, 2008, MOL BIOL CELL, V19, P1261, DOI 10.1091/mbc.E06-10-0972; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909	40	74	78	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33614	33622		10.1074/jbc.M110.140004	http://dx.doi.org/10.1074/jbc.M110.140004			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20732872	Green Published, hybrid			2022-12-25	WOS:000283354000006
J	Pessiot, JF; Chiba, H; Hyakkoku, H; Taniguchi, T; Fujibuchi, W				Pessiot, Jean-Francois; Chiba, Hirokazu; Hyakkoku, Hiroto; Taniguchi, Takeaki; Fujibuchi, Wataru			PeakRegressor Identifies Composite Sequence Motifs Responsible for STAT1 Binding Sites and Their Potential rSNPs	PLOS ONE			English	Article								How to identify true transcription factor binding sites on the basis of sequence motif information (e.g., motif pattern, location, combination, etc.) is an important question in bioinformatics. We present "PeakRegressor," a system that identifies binding motifs by combining DNA-sequence data and ChIP-Seq data. PeakRegressor uses L1-norm log linear regression in order to predict peak values from binding motif candidates. Our approach successfully predicts the peak values of STAT1 and RNA Polymerase II with correlation coefficients as high as 0.65 and 0.66, respectively. Using PeakRegressor, we could identify composite motifs for STAT1, as well as potential regulatory SNPs (rSNPs) involved in the regulation of transcription levels of neighboring genes. In addition, we show that among five regression methods, L1-norm log linear regression achieves the best performance with respect to binding motif identification, biological interpretability and computational efficiency.	[Pessiot, Jean-Francois; Chiba, Hirokazu; Hyakkoku, Hiroto; Fujibuchi, Wataru] Adv Ind Sci & Technol AIST, Computat Biol Res Ctr, Tokyo, Japan; [Hyakkoku, Hiroto] Waseda Univ, Tokyo, Japan; [Taniguchi, Takeaki] Mitsubishi Res Inst Inc, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Waseda University; Mitsubishi Research Institute	Pessiot, JF (corresponding author), Adv Ind Sci & Technol AIST, Computat Biol Res Ctr, Tokyo, Japan.	w.fujibuchi@aist.go.jp			National Institute of Advanced Industrial Science and Technology, Japan; Mitsubishi Research Institute, Inc.	National Institute of Advanced Industrial Science and Technology, Japan; Mitsubishi Research Institute, Inc.	This work was supported by general subsidies from the National Institute of Advanced Industrial Science and Technology, Japan. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Takeaki Taniguchi is employed by the Mitsubishi Research Institute, Inc. His wages were funded by the company and he participated in performing the computational experiments. This funder also had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameur A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp381; Bishop C.M., 2006, PATTERN RECOGNITION; BUSSEMAKER HJ, 2001, RECOMB 01; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; CONLON EM, 2003, INTEGRATING REGULATO; Das D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000269; EFRON B, 2004, LEAST ANGLE REGRESSI; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; FRANK IE, 1993, TECHNOMETRICS; Gao F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-31; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x	13	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e11881	10.1371/journal.pone.0011881	http://dx.doi.org/10.1371/journal.pone.0011881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20806061	Green Submitted, Green Published, gold			2022-12-25	WOS:000281301500001
J	Mateo-Tomas, P; Olea, PP				Mateo-Tomas, Patricia; Olea, Pedro P.			Anticipating Knowledge to Inform Species Management: Predicting Spatially Explicit Habitat Suitability of a Colonial Vulture Spreading Its Range	PLOS ONE			English	Article							GYPS-FULVUS; DISTRIBUTION MODELS; NEOPHRON-PERCNOPTERUS; DISTRIBUTIONS; SPAIN; CONSERVATION; PERFORMANCE; SELECTION; RAPTORS	Background: The knowledge of both potential distribution and habitat suitability is fundamental in spreading species to inform in advance management and conservation planning. After a severe decline in the past decades, the griffon vulture (Gyps fulvus) is now spreading its breeding range towards the northwest in Spain and Europe. Because of its key ecological function, anticipated spatial knowledge is required to inform appropriately both vulture and ecosystem management. Methodology/Findings: Here we used maximum entropy (Maxent) models to determine the habitat suitability of potential and current breeding distribution of the griffon vulture using presence-only data (N = 124 colonies) in north-western Spain. The most relevant ecological factors shaping this habitat suitability were also identified. The resulting model had a high predictive performance and was able to predict species' historical distribution. 7.5% (similar to 1,850 km(2)) of the study area resulted to be suitable breeding habitat, most of which (similar to 70%) is already occupied by the species. Cliff availability and livestock density, especially of sheep and goats, around 10 km of the colonies were the fundamental factors determining breeding habitat suitability for this species. Conclusions/Significance: Griffon vultures could still spread 50-60 km towards the west, increasing their breeding range in 1,782 km(2). According to our results, 7.22% of the area suitable for griffon vulture will be affected by wind farms, so our results could help to better plan wind farm locations. The approach here developed could be useful to inform management of reintroductions and recovery programmes currently being implemented for both the griffon vulture and other threatened vulture species.	[Mateo-Tomas, Patricia; Olea, Pedro P.] IE Univ, Sch Biol, Segovia, Spain	IE University	Mateo-Tomas, P (corresponding author), IE Univ, Sch Biol, Segovia, Spain.	rktespejos@gmail.com	Mateo-Tomás, Patricia/L-8471-2014; Olea, Pedro P/M-1502-2014	Mateo-Tomás, Patricia/0000-0001-6762-9514; Olea, Pedro P/0000-0001-5387-9598	Spanish Ministerio de Educacion y Ciencia	Spanish Ministerio de Educacion y Ciencia(Spanish Government)	P. M. T. was partially supported by a PhD scholarship of the Spanish Ministerio de Educacion y Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; BALWIN RA, 2009, ENTROPY, V11, P854; BirdLife International, 2009, IUCN 2010 IUCN RED L; C?lix M., 2018, EUROPEAN RED LIST SA; Camina A, 2006, ACTA ORNITHOL, V41, P7, DOI 10.3161/068.041.0106; Cramp S., 1992, BIRDS W PALEARCTIC, VVI; Creel S, 2001, CONSERV BIOL, V15, P271, DOI 10.1046/j.1523-1739.2001.99534.x; *DBG, 2007, TERC INV FOR NAC BAN; de Frutos A, 2007, ECOL MODEL, V200, P33, DOI 10.1016/j.ecolmodel.2006.07.007; de Lucas M, 2008, J APPL ECOL, V45, P1695, DOI 10.1111/j.1365-2664.2008.01549.x; DELMORAL JC, 2009, BUITRE LEVADO ESPANA; Deygout C, 2009, ECOL MODEL, V220, P1826, DOI 10.1016/j.ecolmodel.2009.04.030; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; DONAZAR JA, 1990, BIOL CONSERV, V53, P83, DOI 10.1016/0006-3207(90)90001-6; Donazar JA, 2010, EUR J WILDLIFE RES, V56, P613, DOI 10.1007/s10344-009-0358-0; Donazar JA, 2009, SCIENCE, V326, P664, DOI 10.1126/science.326_664a; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; ELITH J, 2010, METHODS ECOLOGY EVOL, DOI DOI 10.1111/J.2041-210X.2010.00036.X; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; *FAPAS, 1991, BUITR AST EV CENS 19; FERNANDEZ C, 1991, BIRD STUDY, V38, P42, DOI 10.1080/00063659109477065; Franklin J, 2009, MAPPING SPECIES DIST; Garcia-Ripolles C, 2005, ARDEOLA, V52, P287; Garza V., 1990, 2 CENSO NACL BUITRE; Gavashelishvili A, 2006, ANIM CONSERV, V9, P159, DOI 10.1111/j.1469-1795.2005.00017.x; GENERO F, 2006, P INT C CONS MAN VUL; Gibson L, 2007, DIVERS DISTRIB, V13, P704, DOI 10.1111/j.1472-4642.2007.00365.x; GRUBAC B, 1997, ACT 2 C INT AV CARR; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2003, J BIOGEOGR, V30, P1233, DOI 10.1046/j.1365-2699.2003.00914.x; Heikkinen RK, 2004, J APPL ECOL, V41, P824, DOI 10.1111/j.0021-8901.2004.00938.x; *INE, INE POBL EN 2009; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Kadoya T, 2009, BIOL CONSERV, V142, P1011, DOI 10.1016/j.biocon.2009.01.012; Krebs CJ, 2001, ECOLOGY EXPT ANAL DI; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; Telleria JL, 2009, BIRD STUDY, V56, P268, DOI 10.1080/00063650902792056; Marti R., 2001, BUITRE LEONADO PENIN; Mateo-Tomas P, 2010, ORYX, V44, P424, DOI 10.1017/S0030605310000189; Mateo-Tomas P, 2010, ORYX, V44, P434, DOI 10.1017/S0030605310000505; Mateo-Tomas P, 2010, EUR J WILDLIFE RES, V56, P519, DOI 10.1007/s10344-009-0341-9; Mateo-Tomas P, 2009, ACTA OECOL, V35, P489, DOI 10.1016/j.actao.2009.03.004; MATEOTOMAS P, 2009, THESIS U LEON LEON; Millspaugh JJ, 2009, MODELS FOR PLANNING WILDLIFE CONSERVATION IN LARGE LANDSCAPES, P1; Olea Pedro P., 1999, Ardeola, V46, P81; Olea PP, 2009, BIOL CONSERV, V142, P1844, DOI 10.1016/j.biocon.2009.03.024; Rodriguez JP, 2007, DIVERS DISTRIB, V13, P243, DOI 10.1111/j.1472-4642.2007.00356.x; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Prakash V, 2003, BIOL CONSERV, V109, P381, DOI 10.1016/S0006-3207(02)00164-7; R Development Core Team, 2009, R FDN STAT COMP; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Rebelo H, 2010, J APPL ECOL, V47, P410, DOI 10.1111/j.1365-2664.2009.01765.x; Rhodes JR, 2006, CONSERV BIOL, V20, P449, DOI 10.1111/j.1523-1739.2006.00330.x; Sarrazin F, 1996, IBIS, V138, P315, DOI 10.1111/j.1474-919X.1996.tb04344.x; Sekercioglu C. H., 2006, HDB BIRDS WORLD, V11, P15; SEO, 1981, ARDEOLA, V26, p165 312; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Wilmers CC, 2003, J ANIM ECOL, V72, P909, DOI 10.1046/j.1365-2656.2003.00766.x; *WWF AD, 2006, VEN ESP 1990 2005 AN; Xirouchakis SM, 2005, ACTA ORNITHOL, V40, P155, DOI 10.3161/068.040.0211	65	30	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12374	10.1371/journal.pone.0012374	http://dx.doi.org/10.1371/journal.pone.0012374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811501	Green Published, gold, Green Submitted			2022-12-25	WOS:000281234700010
J	Champion, C; Guianvarc'h, D; Senamaud-Beaufort, C; Jurkowska, RZ; Jeltsch, A; Ponger, L; Arimondo, PB; Guieysse-Peugeot, AL				Champion, Christine; Guianvarc'h, Dominique; Senamaud-Beaufort, Catherine; Jurkowska, Renata Z.; Jeltsch, Albert; Ponger, Loic; Arimondo, Paola B.; Guieysse-Peugeot, Anne-Laure			Mechanistic Insights on the Inhibition of C5 DNA Methyltransferases by Zebularine	PLOS ONE			English	Article							EPIGENETIC THERAPY; METHYLATION INHIBITOR; CYTIDINE DEAMINASE; MOLECULAR ENZYMOLOGY; RIBOSIDE ZEBULARINE; HHAI METHYLASE; IN-VITRO; CANCER; 5-AZACYTIDINE; 5-AZA-2'-DEOXYCYTIDINE	In mammals DNA methylation occurs at position 5 of cytosine in a CpG context and regulates gene expression. It plays an important role in diseases and inhibitors of DNA methyltransferases (DNMTs)-the enzymes responsible for DNA methylation-are used in clinics for cancer therapy. The most potent inhibitors are 5-azacytidine and 5-azadeoxycytidine. Zebularine (1-(beta-D-ribofuranosyl)-2(1H)-pyrimidinone) is another cytidine analog described as a potent inhibitor that acts by forming a covalent complex with DNMT when incorporated into DNA. Here we bring additional experiments to explain its mechanism of action. First, we observe an increase in the DNA binding when zebularine is incorporated into the DNA, compared to deoxycytidine and 5-fluorodeoxycytidine, together with a strong decrease in the dissociation rate. Second, we show by denaturing gel analysis that the intermediate covalent complex between the enzyme and the DNA is reversible, differing thus from 5-fluorodeoxycytidine. Third, no methylation reaction occurs when zebularine is present in the DNA. We confirm that zebularine exerts its demethylation activity by stabilizing the binding of DNMTs to DNA, hindering the methylation and decreasing the dissociation, thereby trapping the enzyme and preventing turnover even at other sites.	[Champion, Christine; Senamaud-Beaufort, Catherine; Ponger, Loic; Arimondo, Paola B.; Guieysse-Peugeot, Anne-Laure] MNHN CNRS, UMR7196, Paris, France; [Champion, Christine; Senamaud-Beaufort, Catherine; Ponger, Loic; Arimondo, Paola B.; Guieysse-Peugeot, Anne-Laure] INSERM, U565, Paris, France; [Guianvarc'h, Dominique] Univ Paris 06, Lab Biomol, CNRS, ENS,FR, Paris, France; [Jurkowska, Renata Z.; Jeltsch, Albert] Univ Bremen, Sch Sci & Engn, Bremen, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Museum National d'Histoire Naturelle (MNHN); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; University of Bremen	Champion, C (corresponding author), MNHN CNRS, UMR7196, Paris, France.	arimondo@mnhn.fr; guieysse@mnhn.fr	Arimondo, Paola B/R-9095-2017; Jeltsch, Albert/O-7404-2014; Guianvarc'h, Dominique/AAE-5806-2022; Jurkowska, Renata/AAE-2504-2020	Arimondo, Paola B/0000-0001-5175-4396; Jeltsch, Albert/0000-0001-6113-9290; Guianvarc'h, Dominique/0000-0002-7722-370X; Jurkowska, Renata/0000-0002-4507-2222; Ponger, Loic/0000-0001-9222-8907	Agence National de la Recherche [JCJC06_134774]; DeutscheForschungsgemeinschaft [JE 252/6]	Agence National de la Recherche(French National Research Agency (ANR)); DeutscheForschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Agence National de la Recherche JCJC06_134774 grant to PBA and by DeutscheForschungsgemeinschaft grant JE 252/6 to AJ.CC was recipient of an INSERM-CNRS Bourse de Docteur Ingenieur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch C, 2005, MOL CANCER THER, V4, P1505, DOI 10.1158/1535-7163.MCT-05-0216; Cheng JC, 2003, J NATL CANCER I, V95, P399, DOI 10.1093/jnci/95.5.399; Cheng JC, 2004, MOL CELL BIOL, V24, P1270, DOI 10.1128/MCB.24.3.1270-1278.2004; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Clark J, 2003, ANAL BIOCHEM, V321, P50, DOI 10.1016/S0003-2697(03)00402-0; CREUSOT F, 1982, J BIOL CHEM, V257, P2041; Darii MV, 2009, BBA-PROTEINS PROTEOM, V1794, P1654, DOI 10.1016/j.bbapap.2009.07.016; DOERFLER W, 1983, ANNU REV BIOCHEM, V52, P93, DOI 10.1146/annurev.bi.52.070183.000521; Dote H, 2005, CLIN CANCER RES, V11, P4571, DOI 10.1158/1078-0432.CCR-05-0050; DRISCOLL JS, 1991, J MED CHEM, V34, P3280, DOI 10.1021/jm00115a017; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; FLOTHO C, 2009, LEUKEMIA; FRIEDMAN S, 1992, NUCLEIC ACIDS RES, V20, P3241, DOI 10.1093/nar/20.12.3241; GABBARA S, 1995, BIOCHEM J, V307, P87, DOI 10.1042/bj3070087; Gore SD, 2006, NAT REV DRUG DISCOV, V5, P891, DOI 10.1038/nrd2180; Gowher H, 2002, J BIOL CHEM, V277, P20409, DOI 10.1074/jbc.M202148200; Hellebrekers DMEI, 2006, MOL CANCER THER, V5, P467, DOI 10.1158/1535-7163.MCT-05-0417; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Hurd PJ, 1999, J MOL BIOL, V286, P389, DOI 10.1006/jmbi.1998.2491; Issa JPJ, 2005, NAT REV DRUG DISCOV, V4, P275, DOI 10.1038/nrd1698; Jeltsch A, 2006, CURR TOP MICROBIOL, V301, P203; Jeltsch A, 2006, EPIGENETICS-US, V1, P63, DOI 10.4161/epi.1.2.2767; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; JONES PA, 1985, CELL, V40, P485, DOI 10.1016/0092-8674(85)90192-8; KIM CH, 1986, J MED CHEM, V29, P1374, DOI 10.1021/jm00158a009; Laird PW, 2005, HUM MOL GENET, V14, pR65, DOI 10.1093/hmg/ddi113; LALIBERTE J, 1992, CANCER CHEMOTH PHARM, V30, P7, DOI 10.1007/BF00686478; Lee G, 2004, DNA REPAIR, V3, P155, DOI 10.1016/j.dnarep.2003.10.010; Lemaire M, 2009, CANCER CHEMOTH PHARM, V63, P411, DOI 10.1007/s00280-008-0750-6; LIN KT, 1981, J PHARM SCI, V70, P1228, DOI 10.1002/jps.2600701112; Liu K, 2003, MOL CELL BIOL, V23, P2709, DOI 10.1128/MCB.23.8.2709-2719.2003; Marquez VE, 2005, ANN NY ACAD SCI, V1058, P246, DOI 10.1196/annals.1359.037; Marquez VE, 2003, ANN NY ACAD SCI, V1002, P154, DOI 10.1196/annals.1281.014; MI S, 1993, NUCLEIC ACIDS RES, V21, P2459, DOI 10.1093/nar/21.10.2459; NOTARI RE, 1975, J PHARM SCI, V64, P1148, DOI 10.1002/jps.2600640704; OGara M, 1996, J MOL BIOL, V261, P634, DOI 10.1006/jmbi.1996.0489; OSTERMAN DG, 1988, BIOCHEMISTRY-US, V27, P5204, DOI 10.1021/bi00414a039; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Reither S, 2003, J MOL BIOL, V329, P675, DOI 10.1016/S0022-2836(03)00509-6; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Scott SA, 2007, EXP HEMATOL, V35, P263, DOI 10.1016/j.exphem.2006.10.005; Shigdel UK, 2008, J AM CHEM SOC, V130, P17634, DOI 10.1021/ja8064304; Song LG, 2005, ANAL CHEM, V77, P504, DOI 10.1021/ac0489420; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Suzuki M, 2009, CANCER CHEMOTH PHARM, V64, P223, DOI 10.1007/s00280-008-0833-4; TAYLOR C, 1993, BIOCHEM J, V291, P493, DOI 10.1042/bj2910493; TAYLOR SM, 1982, J MOL BIOL, V162, P679, DOI 10.1016/0022-2836(82)90395-3; van Bemmel DM, 2009, BIOCHEM PHARMACOL, V78, P633, DOI 10.1016/j.bcp.2009.05.017; Yokochi T, 2002, J BIOL CHEM, V277, P11735, DOI 10.1074/jbc.M106590200; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yoo CB, 2004, BIOCHEM SOC T, V32, P910, DOI 10.1042/BST0320910; Yoo CB, 2008, CANCER PREV RES, V1, P233, DOI 10.1158/1940-6207.CAPR-07-0008; Zhang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000438; Zhou L, 2002, J MOL BIOL, V321, P591, DOI 10.1016/S0022-2836(02)00676-9	56	77	80	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12388	10.1371/journal.pone.0012388	http://dx.doi.org/10.1371/journal.pone.0012388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808780	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000281154300016
J	Flynn, BP; Bhole, AP; Saeidi, N; Liles, M; DiMarzio, CA; Ruberti, JW				Flynn, Brendan P.; Bhole, Amit P.; Saeidi, Nima; Liles, Melody; DiMarzio, Charles A.; Ruberti, Jeffrey W.			Mechanical Strain Stabilizes Reconstituted Collagen Fibrils against Enzymatic Degradation by Mammalian Collagenase Matrix Metalloproteinase 8 (MMP-8)	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; DERMAL FIBROBLASTS; TENDON COLLAGEN; CROSS-LINKS; I COLLAGEN; TISSUE; EXPRESSION; STRESS; BONE; DIFFUSION	Background: Collagen, a triple-helical, self-organizing protein, is the predominant structural protein in mammals. It is found in bone, ligament, tendon, cartilage, intervertebral disc, skin, blood vessel, and cornea. We have recently postulated that fibrillar collagens (and their complementary enzymes) comprise the basis of a smart structural system which appears to support the retention of molecules in fibrils which are under tensile mechanical strain. The theory suggests that the mechanisms which drive the preferential accumulation of collagen in loaded tissue operate at the molecular level and are not solely cell-driven. The concept reduces control of matrix morphology to an interaction between molecules and the most relevant, physical, and persistent signal: mechanical strain. Methodology/Principal Findings: The investigation was carried out in an environmentally-controlled microbioreactor in which reconstituted type I collagen micronetworks were gently strained between micropipettes. The strained micronetworks were exposed to active matrix metalloproteinase 8 (MMP-8) and relative degradation rates for loaded and unloaded fibrils were tracked simultaneously using label-free differential interference contrast (DIC) imaging. It was found that applied tensile mechanical strain significantly increased degradation time of loaded fibrils compared to unloaded, paired controls. In many cases, strained fibrils were detectable long after unstrained fibrils were degraded. Conclusions/Significance: In this investigation we demonstrate for the first time that applied mechanical strain preferentially preserves collagen fibrils in the presence of a physiologically-important mammalian enzyme: MMP-8. These results have the potential to contribute to our understanding of many collagen matrix phenomena including development, adaptation, remodeling and disease. Additionally, tissue engineering could benefit from the ability to sculpt desired structures from physiologically compatible and mutable collagen.	[Flynn, Brendan P.; Bhole, Amit P.; Saeidi, Nima; Liles, Melody; DiMarzio, Charles A.; Ruberti, Jeffrey W.] Northeastern Univ, Boston, MA 02115 USA; [Saeidi, Nima] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Engn & Med, Boston, MA USA; [Liles, Melody] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales	Northeastern University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Cardiff University	Flynn, BP (corresponding author), Northeastern Univ, Boston, MA 02115 USA.	j.ruberti@neu.edu			National Institutes of Health National Institute of Arthritis and Musculoskeletal Skin Dieseases (NIH NIAMS) [R21 AR053551-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR053551] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Arthritis and Musculoskeletal Skin Dieseases (NIH NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The research was funded by National Institutes of Health National Institute of Arthritis and Musculoskeletal Skin Dieseases (NIH NIAMS) R21 AR053551-01 (PI Jeff W. Ruberti). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKESON WH, 1987, CLIN ORTHOP RELAT R, P28; Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje; Arokoski JPA, 2000, SCAND J MED SCI SPOR, V10, P186, DOI 10.1034/j.1600-0838.2000.010004186.x; BAILEY AJ, 1968, BIOCHIM BIOPHYS ACTA, V160, P447, DOI 10.1016/0005-2795(68)90216-X; BAROCAS VH, 1995, J BIOMECH ENG-T ASME, V117, P161, DOI 10.1115/1.2795998; Bass EC, 2004, J BIOMECH, V37, P233, DOI 10.1016/j.jbiomech.2003.07.002; Basser PJ, 1998, ARCH BIOCHEM BIOPHYS, V351, P207, DOI 10.1006/abbi.1997.0507; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; BELLOWS CG, 1981, J CELL SCI, V50, P299; Bhole AP, 2009, PHILOS T R SOC A, V367, P3339, DOI 10.1098/rsta.2009.0093; Bishop JE, 1999, CARDIOVASC RES, V42, P27, DOI 10.1016/S0008-6363(99)00021-8; Blain EJ, 2001, ARCH BIOCHEM BIOPHYS, V396, P49, DOI 10.1006/abbi.2001.2575; Bruel A, 1998, ATHEROSCLEROSIS, V140, P135, DOI 10.1016/S0021-9150(98)00130-0; Cawston TE, 2006, BEST PRACT RES CL RH, V20, P983, DOI 10.1016/j.berh.2006.06.007; CHAMAY A, 1972, J BIOMECH, V5, P173, DOI 10.1016/0021-9290(72)90053-X; COMPER WD, 1977, BIOPOLYMERS, V16, P2113, DOI 10.1002/bip.1977.360161004; Cowin SC, 2000, J BIOMECH ENG-T ASME, V122, P553, DOI 10.1115/1.1324665; COWIN SC, 1983, ANN BIOMED ENG, V11, P263, DOI 10.1007/BF02363288; Cowin SC, 2004, ANNU REV BIOMED ENG, V6, P77, DOI 10.1146/annurev.bioeng.6.040803.140250; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Delaisse JM, 2000, CLIN CHIM ACTA, V291, P223, DOI 10.1016/S0009-8981(99)00230-2; Ellsmere JC, 1999, BIOMATERIALS, V20, P1143, DOI 10.1016/S0142-9612(99)00013-7; Fredberg JJ, 2006, ANNU REV PHYSIOL, V68, P507, DOI 10.1146/annurev.physiol.68.072304.114110; Giraud-Guille MM, 2003, J BIOMECH, V36, P1571, DOI 10.1016/S0021-9290(03)00134-9; Goldring SR, 2004, CLIN ORTHOP RELAT R, pS27, DOI 10.1097/01.blo.0000144854.66565.8f; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Hannafin JA, 2006, J ORTHOP RES, V24, P149, DOI 10.1002/jor.20018; HORMANN H, 1982, KLIN WOCHENSCHR, V60, P1265, DOI 10.1007/BF01727483; HUANG C, 1977, J BIOMED MATER RES, V11, P137, DOI 10.1002/jbm.820110113; Humphrey JD, 2001, J BIOMECH ENG-T ASME, V123, P638, DOI 10.1115/1.1406131; Jeffrey JJ, 1998, BIOL EXTRAC, P15; JONAS M, 2008, BIOPHYS J; Jung JC, 2009, CELL TISSUE RES, V336, P79, DOI 10.1007/s00441-009-0755-4; Karamichos D, 2007, INVEST OPHTH VIS SCI, V48, P5030, DOI 10.1167/iovs.07-0443; Koskinen SOA, 2004, J APPL PHYSIOL, V96, P861, DOI 10.1152/japplphysiol.00489.2003; Krishnan L, 2004, TISSUE ENG, V10, P241, DOI 10.1089/107632704322791880; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; LAURENT GJ, 1987, AM J PHYSIOL, V252, pC1, DOI 10.1152/ajpcell.1987.252.1.C1; Lee SE, 2007, J BIOMECH, V40, P2096, DOI 10.1016/j.jbiomech.2007.04.006; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; LIU X, 1995, J CELL BIOL, V130, P227, DOI 10.1083/jcb.130.1.227; Lotz JC, 2008, EUR SPINE J, V17, P1149, DOI 10.1007/s00586-008-0721-y; LYUBIMOV AV, 1982, CELL BIOL INT REP, V6, P105, DOI 10.1016/0309-1651(82)90086-8; MICHAELI Y, 1994, J PERIODONTAL RES, V29, P25, DOI 10.1111/j.1600-0765.1994.tb01087.x; MICHNA H, 1989, INT ORTHOP, V13, P161, DOI 10.1007/BF00268040; Mudera VC, 2000, CELL MOTIL CYTOSKEL, V45, P1, DOI 10.1002/(SICI)1097-0169(200001)45:1<1::AID-CM1>3.0.CO;2-J; Murray JD, 2003, CR BIOL, V326, P239, DOI 10.1016/S1631-0691(03)00065-9; Nabeshima Y, 1996, J ORTHOP RES, V14, P123, DOI 10.1002/jor.1100140120; Ozerdem B, 1995, J BIOMECH ENG-T ASME, V117, P397, DOI 10.1115/1.2794198; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; Parsons M, 1999, EXP CELL RES, V252, P319, DOI 10.1006/excr.1999.4618; PEARCE RH, 1987, J ORTHOP RES, V5, P198, DOI 10.1002/jor.1100050206; PEPPAS NA, 1983, J MEMBRANE SCI, V15, P275, DOI 10.1016/S0376-7388(00)82304-2; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Petroll WM, 2004, INVEST OPHTH VIS SCI, V45, P3466, DOI 10.1167/iovs.04-0361; Prajapati RT, 2000, WOUND REPAIR REGEN, V8, P226, DOI 10.1046/j.1524-475x.2000.00226.x; RAEBER GP, 2007, BIOMECH MODEL MECHAN; Ragan PM, 1999, J ORTHOPAED RES, V17, P836, DOI 10.1002/jor.1100170608; Robbins JR, 1997, ARCH BIOCHEM BIOPHYS, V342, P203, DOI 10.1006/abbi.1997.0102; Ruberti JW, 2005, BIOCHEM BIOPH RES CO, V336, P483, DOI 10.1016/j.bbrc.2005.08.128; Sander EA, 2009, P NATL ACAD SCI USA, V106, P17675, DOI 10.1073/pnas.0903716106; STOPAK D, 1982, DEV BIOL, V90, P383, DOI 10.1016/0012-1606(82)90388-8; Tarbell JM, 2005, ANN BIOMED ENG, V33, P1719, DOI 10.1007/s10439-005-8775-z; TYN MT, 1990, BIOTECHNOL BIOENG, V35, P327, DOI 10.1002/bit.260350402; Tzafriri AR, 2002, BIOPHYS J, V83, P776, DOI 10.1016/S0006-3495(02)75208-9; WALTON RS, J MAT SCI MAT MED, V21, P451; Wong M, 2003, BONE, V33, P685, DOI 10.1016/S8756-3282(03)00242-4; WU H, 1990, P NATL ACAD SCI USA, V87, P5888, DOI 10.1073/pnas.87.15.5888; Wyatt KEK, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3078177; Zareian R, 2010, LANGMUIR, V26, P9917, DOI 10.1021/la100384e	70	121	122	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12337	10.1371/journal.pone.0012337	http://dx.doi.org/10.1371/journal.pone.0012337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808784	Green Published, Green Submitted, gold			2022-12-25	WOS:000281153500018
J	Abdullaev, IF; Rudkouskaya, A; Mongin, AA; Kuo, YH				Abdullaev, Iskandar F.; Rudkouskaya, Alena; Mongin, Alexander A.; Kuo, Yu-Hung			Calcium-Activated Potassium Channels BK and IK1 Are Functionally Expressed in Human Gliomas but Do Not Regulate Cell Proliferation	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; BREAST-CANCER CELLS; INTERMEDIATE-CONDUCTANCE; BRAIN-TUMOR; GROWTH; CYCLE; EPIDEMIOLOGY; CLOTRIMAZOLE; MODULATION; INHIBITION	Gliomas are morbid brain tumors that are extremely resistant to available chemotherapy and radiology treatments. Some studies have suggested that calcium-activated potassium channels contribute to the high proliferative potential of tumor cells, including gliomas. However, other publications demonstrated no role for these channels or even assigned them antitumorogenic properties. In this work we characterized the expression and functional contribution to proliferation of Ca2+-activated K+ channels in human glioblastoma cells. Quantitative RT-PCR detected transcripts for the big conductance (BK), intermediate conductance (IK1), and small conductance (SK2) K+ channels in two glioblastoma-derived cell lines and a surgical sample of glioblastoma multiforme. Functional expression of BK and IK1 in U251 and U87 glioma cell lines and primary glioma cultures was verified using whole-cell electrophysiological recordings. Inhibitors of BK (paxilline and penitrem A) and IK1 channels (clotrimazole and TRAM-34) reduced U251 and U87 proliferation in an additive fashion, while the selective blocker of SK channels UCL1848 had no effect. However, the antiproliferative properties of BK and IK1 inhibitors were seen at concentrations that were higher than those necessary to inhibit channel activity. To verify specificity of pharmacological agents, we downregulated BK and IK1 channels in U251 cells using gene-specific siRNAs. Although siRNA knockdowns caused strong reductions in the BK and IK1 current densities, neither single nor double gene silencing significantly affected rates of proliferation. Taken together, these results suggest that Ca2+-activated K+ channels do not play a critical role in proliferation of glioma cells and that the effects of pharmacological inhibitors occur through their off-target actions.	[Abdullaev, Iskandar F.; Rudkouskaya, Alena; Mongin, Alexander A.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Kuo, Yu-Hung] Albany Med Coll, Div Neurosurg, Albany, NY 12208 USA	Albany Medical College; Albany Medical College	Abdullaev, IF (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA.	mongina@mail.amc.edu	Mongin, Alexander A./A-5526-2008; Abdullaev, Iskandar/AAH-2478-2021	Mongin, Alexander A./0000-0002-2501-3778; Rudkouskaya, Alena/0000-0002-3632-9743	AMC [206-465247]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061953] Funding Source: NIH RePORTER	AMC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by AMC grant 206-465247 (to AAM and YHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova OA, 2006, CELL MOL BIOL, V52, P71, DOI 10.1170/T763; AMIGORENA S, 1990, J IMMUNOL, V144, P2038; Barnholtz-Sloan JS, 2003, J NEUROSURG, V99, P458, DOI 10.3171/jns.2003.99.3.0458; Basrai D, 2002, NEUROREPORT, V13, P403, DOI 10.1097/00001756-200203250-00008; BENZAQUEN LR, 1995, NAT MED, V1, P534, DOI 10.1038/nm0695-534; Bianchi L, 1998, CANCER RES, V58, P815; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; BRISMAR T, 1995, GLIA, V15, P231, DOI 10.1002/glia.440150305; BRISMAR T, 1989, BRAIN RES, V480, P259, DOI 10.1016/0006-8993(89)90191-1; Cambien B, 2008, INT J CANCER, V123, P365, DOI 10.1002/ijc.23511; Camphausen K, 2005, P NATL ACAD SCI USA, V102, P8287, DOI 10.1073/pnas.0502887102; Chen JQ, 2000, J MED CHEM, V43, P3478, DOI 10.1021/jm000904v; Chin LS, 1997, J NEUROSCI RES, V48, P122, DOI 10.1002/(SICI)1097-4547(19970415)48:2<122::AID-JNR4>3.0.CO;2-E; Coiret G, 2007, MOL PHARMACOL, V71, P843, DOI 10.1124/mol.106.028290; Fioretti B, 2004, EUR J PHARMACOL, V497, P1, DOI 10.1016/j.ejphar.2004.06.034; Fioretti B, 2006, CELL PHYSIOL BIOCHEM, V18, P47, DOI 10.1159/000095135; Gessner G, 2005, J MEMBRANE BIOL, V208, P229, DOI 10.1007/s00232-005-0830-z; Grgic I, 2005, ARTERIOSCL THROM VAS, V25, P704, DOI 10.1161/01.ATV.0000156399.12787.5c; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Han XB, 2008, BIOCHEM BIOPH RES CO, V375, P205, DOI 10.1016/j.bbrc.2008.07.161; Han XB, 2007, APOPTOSIS, V12, P1837, DOI 10.1007/s10495-007-0101-9; Hayashi M, 2004, AM J PHYSIOL-CELL PH, V286, pC635, DOI 10.1152/ajpcell.00283.2003; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Jager H, 2004, MOL PHARMACOL, V65, P630, DOI 10.1124/mol.65.3.630; Khalid MH, 2005, J NEUROSURG, V103, P79, DOI 10.3171/jns.2005.103.1.0079; Khalid MH, 1999, J NEUROSURG, V90, P918, DOI 10.3171/jns.1999.90.5.0918; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; KNAUS HG, 1994, BIOCHEMISTRY-US, V33, P5819, DOI 10.1021/bi00185a021; Lang F, 2000, CELL PHYSIOL BIOCHEM, V10, P417, DOI 10.1159/000016367; Liu XJ, 2002, J NEUROSCI, V22, P1840, DOI 10.1523/JNEUROSCI.22-05-01840.2002; NILIUS B, 1992, J PHYSIOL-LONDON, V445, P537, DOI 10.1113/jphysiol.1992.sp018938; Ouadid-Ahidouch H, 2004, AM J PHYSIOL-CELL PH, V287, pC125, DOI 10.1152/ajpcell.00488.2003; Ouadid-Ahidouch H, 2004, BIOCHEM BIOPH RES CO, V316, P244, DOI 10.1016/j.bbrc.2004.02.041; Parihar AS, 2003, EUR J PHARMACOL, V471, P157, DOI 10.1016/S0014-2999(03)01825-9; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Sciaccaluga M, 2010, AM J PHYSIOL-CELL PH, V299, pC175, DOI 10.1152/ajpcell.00344.2009; Si H, 2006, BRIT J PHARMACOL, V148, P909, DOI 10.1038/sj.bjp.0706793; Tao R, 2008, AM J PHYSIOL-CELL PH, V295, pC1409, DOI 10.1152/ajpcell.00268.2008; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Wang ZH, 2007, ONCOGENE, V26, P5107, DOI 10.1038/sj.onc.1210308; Wang ZG, 2004, PFLUG ARCH EUR J PHY, V448, P274, DOI 10.1007/s00424-004-1258-5; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Weaver AK, 2006, GLIA, V54, P223, DOI 10.1002/glia.20364; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; WOODFORK KA, 1995, J CELL PHYSIOL, V162, P163, DOI 10.1002/jcp.1041620202; Wrensch M, 2002, NEURO-ONCOLOGY, V4, P278, DOI 10.1093/neuonc/4.4.278; Wulf A, 2002, J MEMBRANE BIOL, V187, P71, DOI 10.1007/s00232-001-0149-3; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758	54	61	63	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12304	10.1371/journal.pone.0012304	http://dx.doi.org/10.1371/journal.pone.0012304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808839	Green Published, gold, Green Submitted			2022-12-25	WOS:000281077000011
J	Joyce, KE; Laurienti, PJ; Burdette, JH; Hayasaka, S				Joyce, Karen E.; Laurienti, Paul J.; Burdette, Jonathan H.; Hayasaka, Satoru			A New Measure of Centrality for Brain Networks	PLOS ONE			English	Article							SMALL-WORLD; ANATOMICAL NETWORKS; IDENTIFICATION; CONNECTIVITY; ORGANIZATION	Recent developments in network theory have allowed for the study of the structure and function of the human brain in terms of a network of interconnected components. Among the many nodes that form a network, some play a crucial role and are said to be central within the network structure. Central nodes may be identified via centrality metrics, with degree, betweenness, and eigenvector centrality being three of the most popular measures. Degree identifies the most connected nodes, whereas betweenness centrality identifies those located on the most traveled paths. Eigenvector centrality considers nodes connected to other high degree nodes as highly central. In the work presented here, we propose a new centrality metric called leverage centrality that considers the extent of connectivity of a node relative to the connectivity of its neighbors. The leverage centrality of a node in a network is determined by the extent to which its immediate neighbors rely on that node for information. Although similar in concept, there are essential differences between eigenvector and leverage centrality that are discussed in this manuscript. Degree, betweenness, eigenvector, and leverage centrality were compared using functional brain networks generated from healthy volunteers. Functional cartography was also used to identify neighborhood hubs (nodes with high degree within a network neighborhood). Provincial hubs provide structure within the local community, and connector hubs mediate connections between multiple communities. Leverage proved to yield information that was not captured by degree, betweenness, or eigenvector centrality and was more accurate at identifying neighborhood hubs. We propose that this metric may be able to identify critical nodes that are highly influential within the network.	[Joyce, Karen E.] Wake Forest Univ, Sch Med, Sch Biomed Engn & Sci, Winston Salem, NC 27109 USA; [Laurienti, Paul J.; Burdette, Jonathan H.; Hayasaka, Satoru] Wake Forest Univ, Sch Med, Dept Radiol, Winston Salem, NC 27109 USA; [Hayasaka, Satoru] Wake Forest Univ, Sch Med, Dept Biostat Sci, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest University; Wake Forest University	Joyce, KE (corresponding author), Wake Forest Univ, Sch Med, Sch Biomed Engn & Sci, Winston Salem, NC 27109 USA.	kajoyce@wfubmc.edu			Translational Science Institute of Wake Forest University; National Institute of Neurological Disorders and Stroke [NS070917]; National Institutes of Health [NS042658]; Roena Kulynych Memory and Cognition Research Center; General Clinical Research Center of Wake Forest University [RR07122]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR007122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070917] Funding Source: NIH RePORTER	Translational Science Institute of Wake Forest University; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roena Kulynych Memory and Cognition Research Center; General Clinical Research Center of Wake Forest University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Translational Science Institute of Wake Forest University (Translational Scholar Award, URL: http://www.wfubmc.edu/TSI.htm) and by the National Institute of Neurological Disorders and Stroke (NS070917, URL: http://www.ninds.nih.gov/). Data collection for this work was supported by the National Institutes of Health (NS042658, URL: http://www.nih.gov/), as well as the Roena Kulynych Memory and Cognition Research Center (URL: http://www.wfubmc.edu/krc/) and the General Clinical Research Center (RR07122, URL: http://www.wfubmc.edu/Research/TSI/Clinical-Research-Unit.htm) of Wake Forest University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Blondel VD, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036114; BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; GONG G, 2009, CEREBRAL CORETEX, V17, P2407; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Huxham M, 1996, OIKOS, V76, P284, DOI 10.2307/3546201; LIN TY, 2008, DATA MINING FDN PRAC; Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Meunier David, 2009, Front Neuroinform, V3, P37, DOI 10.3389/neuro.11.037.2009; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; NIEMINEN J, 1974, SCAND J PSYCHOL, V15, P332, DOI 10.1111/j.1467-9450.1974.tb00598.x; Peiffer AM, 2009, HUM BRAIN MAPP, V30, P228, DOI 10.1002/hbm.20497; RUAN J, 2007, SUPPLEMENTARY MAT ID; Ruan JH, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016104; Ruhnau B, 2000, SOC NETWORKS, V22, P357, DOI 10.1016/S0378-8733(00)00031-9; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Schmitt JE, 2008, CEREB CORTEX, V18, P1737, DOI 10.1093/cercor/bhm211; Shaw ME, 1954, J PSYCHOL, V38, P139, DOI 10.1080/00223980.1954.9712925; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; VALENCIA M, 2009, MODULAR ORG BASIS FU; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	48	177	180	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12200	10.1371/journal.pone.0012200	http://dx.doi.org/10.1371/journal.pone.0012200			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808943	Green Published, Green Submitted, gold			2022-12-25	WOS:000280968000023
J	Smyth, AM; Rickman, C; Duncan, RR				Smyth, Annya M.; Rickman, Colin; Duncan, Rory R.			Vesicle Fusion Probability Is Determined by the Specific Interactions of Munc18	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SNARE COMPLEX-FORMATION; PC12 CELLS; REGULATED EXOCYTOSIS; SECRETORY VESICLES; SYNTAXIN; PROTEINS; DOCKING; BINDING; ACTIVATION; MEMBRANE	Mammalian-regulated secretion is absolutely dependent on four evolutionarily conserved proteins: three SNARE proteins and munc18. Dissecting the functional outcomes of the spatially organized protein interactions between these factors has been difficult because of the close interrelationship between different binding modes. Here, we investigated the spatial distribution of single munc18 molecules at the plasma membrane of cells and the underlying interactions between syntaxin and munc18. Disruption of munc18 binding to the N-terminal peptide motif of syntaxin did not alter munc18 localization on the plasma membrane but had a pronounced influence on the behavior of secretory vesicles and their likelihood to undergo fusion. We therefore conclude that interaction with the syntaxin N-peptide can confer differential release probabilities to secretory vesicles and may contribute to the delineation of secretory vesicle pools.	Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Rickman, Colin] Heriot Watt Univ, Sch Engn & Phys Sci, Dept Chem, Edinburgh EH14 4AS, Midlothian, Scotland	University of Edinburgh; Heriot Watt University		rory.duncan@ed.ac.uk		Duncan, Rory/0000-0003-0693-910X; Rickman, Colin/0000-0001-8938-524X	Wellcome Trust; Medical Research Council	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Wellcome Trust and Medical Research Council project grant awards (to R.R.D. and C.R.).	Arunachalam L, 2008, MOL BIOL CELL, V19, P722, DOI 10.1091/mbc.E07-07-0662; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Bryant NJ, 2001, EMBO J, V20, P3380, DOI 10.1093/emboj/20.13.3380; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; de Wit H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000126; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Degtyar VE, 2007, P NATL ACAD SCI USA, V104, P15929, DOI 10.1073/pnas.0705406104; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; Graham ME, 1997, J NEUROCHEM, V69, P2369; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Madabushi S, 2002, J MOL BIOL, V316, P139, DOI 10.1006/jmbi.2001.5327; Malintan NT, 2009, J BIOL CHEM, V284, P21637, DOI 10.1074/jbc.M109.013508; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Medine CN, 2007, J CELL SCI, V120, P4407, DOI 10.1242/jcs.020230; Medine CN, 2007, MICROSC RES TECHNIQ, V70, P420, DOI 10.1002/jemt.20425; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Rickman C, 2005, CHEM BIOL, V12, P545, DOI 10.1016/j.chembiol.2005.03.004; Rickman C, 2003, J BIOL CHEM, V278, P5501, DOI 10.1074/jbc.C200692200; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Rickman C, 2010, J BIOL CHEM, V285, P13535, DOI 10.1074/jbc.M109.091058; Rickman C, 2010, J BIOL CHEM, V285, P3965, DOI 10.1074/jbc.M109.040402; Rowe J, 2001, J CELL SCI, V114, P3323; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330	47	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38141	38148		10.1074/jbc.M110.164038	http://dx.doi.org/10.1074/jbc.M110.164038			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20801887	Green Published, hybrid			2022-12-25	WOS:000284625600021
J	Butler, JA; Ventura, N; Johnson, TE; Rea, SL				Butler, Jeffrey A.; Ventura, Natascia; Johnson, Thomas E.; Rea, Shane L.			Long-lived mitochondrial (Mit) mutants of Caenorhabditis elegans utilize a novel metabolism	FASEB JOURNAL			English	Article						aging; metabolomics; isp-1; mev-1; hif-1	SYSTEMATIC RNAI SCREEN; LIFE-SPAN; C-ELEGANS; HYPOXIA; STRESS; MODEL; INTERFERENCE; ANAEROBIOSIS; RESTRICTION; MUTATIONS	The Caenorhabditis elegans mitochondrial (Mit) mutants have disrupted mitochondrial electron transport chain (ETC) functionality, yet, surprisingly, they are long lived. We have previously proposed that Mit mutants supplement their energy needs by exploiting alternate energy production pathways normally used by wild-type animals only when exposed to hypoxic conditions. We have also proposed that longevity in the Mit mutants arises as a property of their new metabolic state. If longevity does arise as a function of metabolic state, we would expect to find a common metabolic signature among these animals. To test these predictions, we established a novel approach monitoring the C. elegans exometabolism as a surrogate marker for internal metabolic events. Using HPLC-ultraviolet-based metabolomics and multivariate analyses, we show that long-lived clk-1(qm30) and isp-1(qm150) Mit mutants have a common metabolic profile that is distinct from that of aerobically cultured wild-type animals and, unexpectedly, wild-type animals cultured under severe oxygen deprivation. Moreover, we show that 2 short-lived mitochondrial ETC mutants, mev-1(kn1) and ucr-2.3(pk732), also share a common metabolic signature that is unique. We show that removal of soluble fumarate reductase unexpectedly increases health span in several genetically defined Mit mutants, identifying at least 1 alternate energy production pathway, malate dismutation, that is operative in these animals. Our study suggests long-lived, genetically specified Mit mutants employ a novel metabolism and that life span may well arise as a function of metabolic state.-Butler, J. A., Ventura, N., Johnson, T. E., Rea, S. L. Long-lived mitochondrial (Mit) mutants of Caenorhabditis elegans utilize a novel metabolism. FASEB J. 24, 4977-4988 (2010). www.fasebj.org	[Butler, Jeffrey A.; Rea, Shane L.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Butler, Jeffrey A.; Rea, Shane L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Butler, Jeffrey A.; Johnson, Thomas E.; Rea, Shane L.] Univ Colorado, Inst Behav Genet, Dept Integrat Physiol, Boulder, CO 80309 USA; [Ventura, Natascia] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Colorado System; University of Colorado Boulder; University of Rome Tor Vergata	Rea, SL (corresponding author), 15355 Lambda Dr,STCBM Bldg,Rm 2-200-04,Texas Res, San Antonio, TX 78245 USA.	reas3@uthscsa.edu	Ventura, Natascia/ABF-4279-2020; Rea, Shane/F-4073-2014	ventura, natascia/0000-0001-8718-4321; /0000-0001-7147-8237	National Institute on Aging; Polis Foundation; Ellison Medical Foundation; National Ataxia Foundation	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Polis Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); National Ataxia Foundation	The authors thank Elizabeth Glasser, Justin Springett, Yvonne Penrod, and William Swan for technical assistance. The authors also thank Milena Girotti, Shylesh Bhaskaran, and Chris Link for critically reading the manuscript, as well as the anonymous reviewer who provided insightful feedback. Financial support was provided by the National Institute on Aging (to T.E.J. and S. L. R.), the Polis Foundation (to T.E.J. and S. L. R.), the Ellison Medical Foundation (to T.E.J. and S. L. R.), and the National Ataxia Foundation (to N.V.). The nematode strain GR1371 was provided by the Caenorhabditis Genetics Centre (University of Minnesota, Minneapolis, MN, USA). NL1832 was a gift from Ron Plasterk (Utrecht University, Utrecht, Holland).	Anderson LL, 2009, SCIENCE, V323, P630, DOI 10.1126/science.1166175; Burgess J, 2003, J BIOL CHEM, V278, P49555, DOI 10.1074/jbc.M308507200; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dingley S, 2010, MITOCHONDRION, V10, P125, DOI 10.1016/j.mito.2009.11.003; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Enomoto K, 2002, FEMS MICROBIOL LETT, V215, P103; Falk MJ, 2008, MOL GENET METAB, V93, P388, DOI 10.1016/j.ymgme.2007.11.007; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Foll RL, 1999, COMP BIOCHEM PHYS B, V124, P269, DOI 10.1016/S0305-0491(99)00130-3; Fuchs S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-14; Ghafouri S, 2007, NEMATOLOGY, V9, P87, DOI 10.1163/156854107779969718; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hartman PS, 2001, MECH AGEING DEV, V122, P1187, DOI 10.1016/S0047-6374(01)00259-7; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; ISHII N, 1990, MUTAT RES, V237, P165, DOI 10.1016/0921-8734(90)90022-J; Jazwinski SM, 2005, GENE, V354, P22, DOI 10.1016/j.gene.2005.03.040; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; LI WB, 1993, BIOCHEMISTRY-US, V32, P1833, DOI 10.1021/bi00058a018; Link CD, 2002, METHOD ENZYMOL, V353, P497; Mehta R, 2009, SCIENCE, V324, P1196, DOI 10.1126/science.1173507; Mendenhall AR, 2006, GENETICS, V174, P1173, DOI 10.1534/genetics.106.061390; Mendenhall AR, 2009, PHYSIOL GENOMICS, V36, P167, DOI 10.1152/physiolgenomics.90278.2008; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Nomura H, 2006, J BIOCHEM, V139, P967, DOI 10.1093/jb/mvj114; Powell-Coffman JA, 2010, TRENDS ENDOCRIN MET, V21, P435, DOI 10.1016/j.tem.2010.02.006; Rea S, 2003, DEV CELL, V5, P197, DOI 10.1016/S1534-5807(03)00242-9; Rea S, 2001, FEBS LETT, V509, P389, DOI 10.1016/S0014-5793(01)03099-X; Rea SL, 2007, PLOS BIOL, V5, P2312, DOI 10.1371/journal.pbio.0050259; Rea SL, 2005, EXP GERONTOL, V40, P841, DOI 10.1016/j.exger.2005.06.015; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; REA SL, 2010, DEV DISABIL IN PRESS; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Samara C, 2008, CELL DEATH DIFFER, V15, P105, DOI 10.1038/sj.cdd.4402231; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Senoo-Matsuda N, 2003, J BIOL CHEM, V278, P22031, DOI 10.1074/jbc.M211377200; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Van Voorhies WA, 2000, J EXP BIOL, V203, P2467; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI 10.1016/s0960-9822(03)00539-6; Ventura Natascia, 2007, Biotechnology Journal, V2, P584, DOI 10.1002/biot.200600248; Ventura N, 2006, EXP GERONTOL, V41, P974, DOI 10.1016/j.exger.2006.06.060; Ventura N, 2009, AGING CELL, V8, P380, DOI 10.1111/j.1474-9726.2009.00482.x; WONG A, 1995, GENETICS, V139, P1247; Wood WB, 1988, NEMATODE CAENORHABDI; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006348	54	54	54	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4977	4988		10.1096/fj.10-162941	http://dx.doi.org/10.1096/fj.10-162941			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20732954	Green Published			2022-12-25	WOS:000284824400036
J	Hsia, MM; Callis, J				Hsia, Mon Mandy; Callis, Judy			BRIZ1 and BRIZ2 Proteins Form a Heteromeric E3 Ligase Complex Required for Seed Germination and Post-germination Growth in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; RING-RING COMPLEX; CRYSTAL-STRUCTURE; BINDING PROTEINS; GENE; DEGRADATION; PLANTS; DOMAIN; CANCER; BRCA1	Ubiquitin pathway E3 ligases are an important component conferring specificity and regulation in ubiquitin attachment to substrate proteins. The Arabidopsis thaliana RING (Really Interesting New Gene) domain-containing proteins BRIZ1 and BRIZ2 are essential for normal seed germination and post-germination growth. Loss of either BRIZ1 (At2g42160) or BRIZ2 (At2g26000) results in a severe phenotype. Heterozygous parents produce progeny that segregate 3: 1 for wild-type: growth-arrested seedlings. Homozygous T-DNA insertion lines are recovered for BRIZ1 and BRIZ2 after introduction of a transgene containing the respective coding sequence, demonstrating that disruption of BRIZ1 or BRIZ2 in the T-DNA insertion lines is responsible for the observed phenotype. Both proteins have multiple predicted domains in addition to the RING domain as follows: a BRAP2 (BRCA1-Associated Protein 2), a ZnF UBP (Zinc Finger Ubiquitin Binding protein), and a coiled-coil domain. In vitro, both BRIZ1 and BRIZ2 are active as E3 ligases but only BRIZ2 binds ubiquitin. In vitro synthesized and purified recombinant BRIZ1 and BRIZ2 preferentially form hetero-oligomers rather than homo-oligomers, and the coiled-coil domain is necessary and sufficient for this interaction. BRIZ1 and BRIZ2 co-purify after expression in tobacco leaves, which also requires the coiled-coil domain. BRIZ1 and BRIZ2 coding regions with substitutions in the RING domain are inactive in vitro and, after introduction, fail to complement their respective mutant lines. In our current model, BRIZ1 and BRIZ2 together are required for formation of a functional ubiquitin E3 ligase in vivo, and this complex is required for germination and early seedling growth.	[Callis, Judy] Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, Davis, CA 95616 USA; Univ Calif Davis, Biochem & Mol Biol Grad Program, Coll Biol Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Callis, J (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, 1 Shields Ave, Davis, CA 95616 USA.	jcallis@ucdavis.edu		Callis, Judy/0000-0002-0622-078X	National Science Foundation [MCB-0929100]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Arabidopsis 2010 Program Grant MCB-0929100 (to J. C.) and by the Paul K. and Ruth R. Stumpf Endowed Professorship in Plant Biochemistry (to J. C.).	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Andersen P, 2004, J BIOL CHEM, V279, P40053, DOI 10.1074/jbc.M405057200; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Bellon SF, 1997, NAT STRUCT BIOL, V4, P586, DOI 10.1038/nsb0797-586; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Brzovic PS, 2001, J BIOL CHEM, V276, P41399, DOI 10.1074/jbc.M106551200; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Clegg HV, 2008, CELL CYCLE, V7, P287, DOI 10.4161/cc.7.3.5358; Dasgupta A, 2004, J BIOL CHEM, V279, P26830, DOI 10.1074/jbc.M400894200; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Hardtke CS, 2002, PLANT J, V30, P385, DOI 10.1046/j.1365-313X.2002.01298.x; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Liu JJ, 2008, PLANT CELL, V20, P1538, DOI 10.1105/tpc.108.059741; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Ma QH, 2007, J PLANT GROWTH REGUL, V26, P369, DOI 10.1007/s00344-007-9022-7; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Matheny SA, 2009, J BIOL CHEM, V284, P11007, DOI 10.1074/jbc.R800082200; Mazzucotelli E, 2006, CURR GENOMICS, V7, P509, DOI 10.2174/138920206779315728; Meza JE, 1999, J BIOL CHEM, V274, P5659, DOI 10.1074/jbc.274.9.5659; Mita S, 1997, PLANT PHYSIOL, V114, P575, DOI 10.1104/pp.114.2.575; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Potuschak T, 1998, P NATL ACAD SCI USA, V95, P7904, DOI 10.1073/pnas.95.14.7904; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Scheich C, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-12; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Stone SL, 2006, PLANT CELL, V18, P3415, DOI 10.1105/tpc.106.046532; Vander Kooi CW, 2006, BIOCHEMISTRY-US, V45, P121, DOI 10.1021/bi051787e; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Vinatzer BA, 2006, MOL MICROBIOL, V62, P26, DOI 10.1111/j.1365-2958.2006.05350.x; Vlachostergios PJ, 2009, J CELL MOL MED, V13, P3006, DOI 10.1111/j.1582-4934.2009.00824.x; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Yang YL, 2009, CANCER SCI, V100, P24, DOI 10.1111/j.1349-7006.2008.01013.x; Zeng LR, 2006, CELL RES, V16, P413, DOI 10.1038/sj.cr.7310053; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488	56	18	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					37070	37081		10.1074/jbc.M110.168021	http://dx.doi.org/10.1074/jbc.M110.168021			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20810661	hybrid, Green Published			2022-12-25	WOS:000284146100075
J	Mellgren, RL				Mellgren, Ronald L.			A Plasma Membrane Wound Proteome REVERSIBLE EXTERNALIZATION OF INTRACELLULAR PROTEINS FOLLOWING REPARABLE MECHANICAL DAMAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCULAR-DYSTROPHY; A-TYPE; RHEUMATOID-ARTHRITIS; VIMENTIN EXPRESSION; SURFACE PROTEIN; SKELETAL-MUSCLE; CELL; DYSFERLIN; INJURY; MACROMOLECULES	Cells in mechanically active tissues undergo constant plasma membrane damage that must be repaired to allow survival. To identify wound-associated proteins, a cell-impermeant, thiol-reactive biotinylation reagent was used to label and subsequently isolate intracellular proteins that become exposed on the surface of cultured cells after plasma membrane damage induced by scraping from substratum or crushing with glass beads. Scrape-damaged cells survived injury and were capable of forming viable colonies. Proteins that were exposed to the cell surface were degraded or internalized a few seconds to several minutes after damage, except for vimentin, which was detectable on the cell surface for at least an hour after injury. Seven major biotinylated protein bands were identified on SDS-PAGE gels. Mass spectrometric studies identified cytoskeletal proteins (caldesmon-1 and vimentin), endoplasmic reticulum proteins (ERp57, ERp5, and HSP47), and nuclear proteins (lamin C, heterogeneous nuclear ribonucleoprotein F, and nucleophosmin-1) as major proteins exposed after injury. Although caldesmon was a major wound-associated protein in calpain small subunit knock-out fibroblasts, it was rapidly degraded in wildtype cells, probably by calpains. Lamin C exposure after wounding was most likely the consequence of nuclear envelope damage. These studies document major intracellular proteins associated with the cell surface of reversibly damaged somatic cells. The studies also show that externalization of some proteins reported to have physiologic or pathologic roles on the cell surface can occur in cells undergoing plasma membrane damage and subsequent repair.	[Mellgren, Ronald L.] Univ Toledo, Dept Physiol & Pharmacol, Coll Med, Toledo, OH 43614 USA	University System of Ohio; University of Toledo	Mellgren, RL (corresponding author), Block Hlth Sci Bldg,3000 Arlington Ave, Toledo, OH 43614 USA.	ronald.mellgren@utoledo.edu						Alderton JM, 2000, TRENDS CARDIOVAS MED, V10, P268, DOI 10.1016/S1050-1738(00)00075-X; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bement WM, 2007, CURR OPIN CELL BIOL, V19, P95, DOI 10.1016/j.ceb.2006.12.001; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Bryant AE, 2006, J INFECT DIS, V193, P1685, DOI 10.1086/504261; Deng M, 2007, CELL MOTIL CYTOSKEL, V64, P951, DOI 10.1002/cm.20236; El-Gabalawy HS, 2004, ARTHRITIS RES THER, V6, P86, DOI 10.1186/ar1171; Ellerman DA, 2006, DEV CELL, V10, P831, DOI 10.1016/j.devcel.2006.03.011; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Goldberg MW, 2008, J CELL SCI, V121, P215, DOI 10.1242/jcs.022020; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hamilton SM, 2008, J INFECT DIS, V198, P1692, DOI 10.1086/593016; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; HARLOW E, 1999, USING ANTIBODIES LAB, P85; Higuchi I, 2007, NEUROMUSCULAR DISORD, V17, P221, DOI 10.1016/j.nmd.2006.11.008; Idone V, 2008, TRENDS CELL BIOL, V18, P552, DOI 10.1016/j.tcb.2008.09.001; Iwaki-Egawa S, 2004, J RHEUMATOL, V31, P17; Jordan PA, 2005, BLOOD, V105, P1500, DOI 10.1182/blood-2004-02-0608; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; Khanal RC, 2007, CURR MED CHEM, V14, P1087, DOI 10.2174/092986707780362871; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; Koudelka KJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000417; KURKINEN M, 1984, J BIOL CHEM, V259, P5915; Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Marmiroli S, 2009, J CELL PHYSIOL, V220, P553, DOI 10.1002/jcp.21807; McNeil A, 2005, J CELL SCI, V118, P4701, DOI 10.1242/jcs.02593; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; MCNEIL PL, 1987, J CELL SCI, V88, P669; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; MCNEIL PL, 1992, AM J PATHOL, V140, P1097; MCNEIL PL, 1984, J CELL BIOL, V98, P1556, DOI 10.1083/jcb.98.4.1556; Mellgren RL, 2007, J BIOL CHEM, V282, P35868, DOI 10.1074/jbc.M706929200; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Mellgren RL, 2009, BBA-MOL CELL RES, V1793, P1886, DOI 10.1016/j.bbamcr.2009.09.013; Miyake K, 2001, J CELL SCI, V114, P3487; Moisan E, 2006, J LEUKOCYTE BIOL, V79, P489, DOI 10.1189/jlb.0405190; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mukhopadhyay UK, 2009, MOL CELL BIOL, V29, P3088, DOI 10.1128/MCB.01816-08; Sauk JJ, 2005, FRONT BIOSCI-LANDMRK, V10, P107, DOI 10.2741/1513; Shen SS, 2005, J BIOL CHEM, V280, P1652, DOI 10.1074/jbc.M410136200; Starr DA, 2009, J CELL SCI, V122, P577, DOI 10.1242/jcs.037622; Steinhardt RA, 2005, ANN NY ACAD SCI, V1066, P152, DOI 10.1196/annals.1363.017; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Togo T, 2003, MOL BIOL CELL, V14, P93, DOI 10.1091/mbc.E02-01-0056; Weisleder Noah, 2009, Commun Integr Biol, V2, P225; Zou YM, 2006, BIOCHEM BIOPH RES CO, V351, P625, DOI 10.1016/j.bbrc.2006.10.091	50	27	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36597	36607		10.1074/jbc.M110.110015	http://dx.doi.org/10.1074/jbc.M110.110015			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20810652	Green Published, hybrid			2022-12-25	WOS:000284146100009
J	Grigg, JC; Cheung, J; Heinrichs, DE; Murphy, MEP				Grigg, Jason C.; Cheung, Johnson; Heinrichs, David E.; Murphy, Michael E. P.			Specificity of Staphyloferrin B Recognition by the SirA Receptor from Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PERIPLASMIC-BINDING PROTEIN; IRON-HYDROXAMATE UPTAKE; ESCHERICHIA-COLI; SIDEROPHORE BINDING; CRYSTAL-STRUCTURE; TRANSPORT; HEME; IDENTIFICATION; ALIGNMENT	Many organisms use sophisticated systems to acquire growth-limiting iron. Iron limitation is especially apparent in bacterial pathogens of mammalian hosts where free iron concentrations are physiologically negligible. A common strategy is to secrete low molecular weight iron chelators, termed siderophores, and express high affinity receptors for the siderophore-iron complex. Staphylococcus aureus, a widespread pathogen, produces two siderophores, staphyloferrin A (SA) and staphyloferrin B (SB). We have determined the crystal structure of the staphyloferrin B receptor, SirA, at high resolution in both the apo and Fe(III)-SB (FeSB)-bound forms. SirA, a member of the class III binding protein family of metal receptors, has N- and C-terminal domains, each composed of mainly a beta-stranded core and alpha-helical periphery. The domains are bridged by a single alpha-helix and together form the FeSB binding site. SB coordinates Fe(III) through five oxygen atoms and one nitrogen atom in distorted octahedral geometry. SirA undergoes conformational change upon siderophore binding, largely securing two loops from the C-terminal domain to enclose FeSB with a low nanomolar dissociation constant. The staphyloferrin A receptor, HtsA, homologous to SirA, also encloses its cognate siderophore (FeSA); however, the largest conformational rearrangements involve a different region of the C-terminal domain. FeSB is uniquely situated in the binding pocket of SirA with few of the contacting residues being conserved with those of HtsA interacting with FeSA. Although both SirA and HtsA bind siderophores from the same alpha-hydroxycarboxylate class, the unique structural features of each receptor provides an explanation for their distinct specificity.	[Cheung, Johnson; Heinrichs, David E.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada	Western University (University of Western Ontario); University of British Columbia		Michael.Murphy@ubc.ca	Heinrichs, David/ABD-5702-2021; Murphy, Michael/R-6805-2017	Murphy, Michael/0000-0003-2589-0014; Heinrichs, David/0000-0002-7217-2456	Canadian Institutes of Health Research [MOP-102596, MOP-38002]; Michael Smith Foundation for Health Research; Natural Sciences and Engineering Research Council Canada; Department of Energy Office of Biological and Environmental Research; National Institutes of Health National Center for Research Resources, Biomedical Technology; NIGMS	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health National Center for Research Resources, Biomedical Technology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by Canadian Institutes of Health Research Grants MOP-102596 (to M. E. P. M.) and MOP-38002 (to D. E. H.).; Supported by a Michael Smith Foundation for Health Research Junior Graduate Trainee Award.; Supported by a Natural Sciences and Engineering Research Council Canada Graduate Scholarship.; We thank Angele Arrieta for technical assistance, John Cooper for providing staphyloferrin A, Michael Tiedemann for help with atomic absorption spectroscopy, Suya Liu for performing mass spectrometry, and Stephanie Pfaffen for critical reading of the manuscript. Portions of the research described in this paper were performed at the Stanford Synchrotron Radiation Light Source, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health National Center for Research Resources, Biomedical Technology Program, and NIGMS.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beasley FC, 2010, J INORG BIOCHEM, V104, P282, DOI 10.1016/j.jinorgbio.2009.09.011; Beasley FC, 2009, MOL MICROBIOL, V72, P947, DOI 10.1111/j.1365-2958.2009.06698.x; Bhatt G, 2004, J BACTERIOL, V186, P7896, DOI 10.1128/JB.186.23.7896-7904.2004; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; Braun V, 2007, J BACTERIOL, V189, P6913, DOI 10.1128/JB.00884-07; Cabrera G, 2001, APPL ENVIRON MICROB, V67, P1001, DOI 10.1128/AEM.67.2.1001-1003.2001; Carter DM, 2006, J BIOL CHEM, V281, P35413, DOI 10.1074/jbc.M607611200; Cheung J, 2009, MOL MICROBIOL, V74, P594, DOI 10.1111/j.1365-2958.2009.06880.x; Clarke TE, 2000, NAT STRUCT BIOL, V7, P287; Clarke TE, 2002, J BIOL CHEM, V277, P13966, DOI 10.1074/jbc.M109385200; Cobessi D, 2005, J MOL BIOL, V352, P893, DOI 10.1016/j.jmb.2005.08.004; Cotton JL, 2009, BIOCHEMISTRY-US, V48, P1025, DOI 10.1021/bi801844c; Dale SE, 2004, INFECT IMMUN, V72, P29, DOI 10.1128/IAI.72.1.29-37.2004; Dale SE, 2004, J BACTERIOL, V186, P8356, DOI 10.1128/JB.186.24.8356-8362.2004; DeLano WL., 2020, PYMOL MOL GRAPHICS S; DRECHSEL H, 1993, BIOMETALS, V6, P185; Einsle O, 1999, NATURE, V400, P476, DOI 10.1038/22802; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; GOBIN J, 1995, P NATL ACAD SCI USA, V92, P5189, DOI 10.1073/pnas.92.11.5189; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2010, J BIOL CHEM, V285, P11162, DOI 10.1074/jbc.M109.097865; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; HAAG H, 1994, FEMS MICROBIOL LETT, V115, P125; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Ho WW, 2007, J BIOL CHEM, V282, P35796, DOI 10.1074/jbc.M706761200; Hoegy FO, 2005, J BIOL CHEM, V280, P20222, DOI 10.1074/jbc.M500776200; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; HOUGH E, 1974, BIOCHEM BIOPH RES CO, V57, P73, DOI 10.1016/S0006-291X(74)80358-X; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Kandt C, 2006, BIOCHEMISTRY-US, V45, P13284, DOI 10.1021/bi061280j; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans JAJW, 2005, INFECTION, V33, P3, DOI 10.1007/s15010-005-4012-9; KONETSCHNYRAPP S, 1990, EUR J BIOCHEM, V191, P65, DOI 10.1111/j.1432-1033.1990.tb19094.x; Krewulak KD, 2005, BIOMETALS, V18, P375, DOI 10.1007/s10534-005-3712-z; Liu M, 2008, BIOPHYS CHEM, V138, P42, DOI 10.1016/j.bpc.2008.09.001; Liu M, 2008, BIOPHYS CHEM, V135, P19, DOI 10.1016/j.bpc.2008.02.017; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; MEIWES J, 1990, FEMS MICROBIOL LETT, V67, P201, DOI 10.1111/j.1574-6968.1990.tb13863.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Peuckert F, 2009, ANGEW CHEM INT EDIT, V48, P7924, DOI 10.1002/anie.200902495; ROHRBACH MR, 1995, J BACTERIOL, V177, P7186, DOI 10.1128/jb.177.24.7186-7193.1995; Sebulsky MT, 2000, J BACTERIOL, V182, P4394, DOI 10.1128/JB.182.16.4394-4400.2000; Sebulsky MT, 2004, J BIOL CHEM, V279, P53152, DOI 10.1074/jbc.M409793200; Sebulsky MT, 2003, J BIOL CHEM, V278, P49890, DOI 10.1074/jbc.M305073200; Sebulsky MT, 2001, J BACTERIOL, V183, P4994, DOI 10.1128/JB.183.17.4994-5000.2001; Shi R, 2009, PROTEINS, V75, P598, DOI 10.1002/prot.22272; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Speziali CD, 2006, J BACTERIOL, V188, P2048, DOI 10.1128/JB.188.6.2048-2055.2006; Stojiljkovic I, 2002, DNA CELL BIOL, V21, P281, DOI 10.1089/104454902753759708; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; TERWILLIGER TC, 2000, ACTA CRYSTALLOGR D *, V59, P38; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tseng CF, 2006, J BIOL INORG CHEM, V11, P419, DOI 10.1007/s00775-006-0088-7; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VAN D, 1993, J J MOL BIOL */* J M, V229, P105; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weems JJ, 2001, POSTGRAD MED, V110, P24, DOI 10.3810/pgm.2001.10.1042; Winkelmann G, 2002, BIOCHEM SOC T, V30, P691, DOI 10.1042/BST0300691	71	51	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34579	34588		10.1074/jbc.M110.172924	http://dx.doi.org/10.1074/jbc.M110.172924			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810662	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000283659100033
J	Verma, V; Hasbi, A; O'Dowd, BF; George, SR				Verma, Vaneeta; Hasbi, Ahmed; O'Dowd, Brian F.; George, Susan R.			Dopamine D1-D2 Receptor Heteromer-mediated Calcium Release Is Desensitized by D1 Receptor Occupancy with or without Signal Activation DUAL FUNCTIONAL REGULATION BY G PROTEIN-COUPLED RECEPTOR KINASE 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; RESONANCE ENERGY-TRANSFER; BETA-ARRESTIN RECRUITMENT; LIVING CELLS; ERK1/2 ACTIVATION; HOMOLOGY DOMAIN; D-1 RECEPTOR; D2 RECEPTOR; NEURONS; KINASE-2	We identified that activation of the G(q)-linked dopamine D1-D2 receptor hetero-oligomer generates a PLC-dependent intracellular calcium signal. Confocal FRET between endogenous dopamine D1 and D2 receptors in striatal neurons confirmed a physical interaction between them. Pretreatment with SKF 83959, which selectively activates the D1-D2 receptor heteromer, or SKF 83822, which only activates the D1 receptor homo-oligomer, led to rapid desensitization of the D1-D2 receptor heteromer-mediated calcium signal in both heterologous cells and striatal neurons. This desensitization response was mediated through selective occupancy of the D1 receptor binding pocket. Although SKF 83822 was unable to activate the D1-D2 receptor heteromer, it still permitted desensitization of the calcium signal. This suggested that occupancy of the D1 receptor binding pocket by SKF 83822 resulted in conformational changes sufficient for desensitization without heteromer activation. Bioluminescence resonance energy transfer and co-immunoprecipitation studies indicated an agonist-induced physical association between the D1-D2 receptor heteromeric complex and GRK2. Increased expression of GRK2 led to a decrease in the calcium signal with or without prior exposure to either SKF 83959 or SKF 83822. GRK2 knockdown by siRNA led to an increase in the signal after pretreatment with either agonist. Expression of the catalytically inactive and RGS (regulator of G protein signaling)-mutated GRK2 constructs each led to a partial recovery of the GRK2-attenuated calcium signal. These results indicated that desensitization of the dopamine D1-D2 receptor heteromer-mediated signal can occur by agonist occupancy even without activation and is dually regulated by both the catalytic and RGS domains of GRK2.	Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON M5S 1A8, Canada; [Verma, Vaneeta; Hasbi, Ahmed; O'Dowd, Brian F.; George, Susan R.] Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A8, Canada; [George, Susan R.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto	George, SR (corresponding author), Med Sci Bldg,Rm 4358,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	s.george@utoronto.ca	George, Susan R/P-9669-2018; George, Susan/W-7494-2019		National Institutes of Health (National Institute on Drug Abuse) [DA007223]; Natural Sciences and Engineering Research Council; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007223] Funding Source: NIH RePORTER	National Institutes of Health (National Institute on Drug Abuse)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA007223 (from the National Institute on Drug Abuse).; Supported by a Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council.	Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Chen Y, 2005, MOL IMAGING FRET MIC; Cheng ZJ, 2001, J BIOL CHEM, V276, P48040, DOI 10.1074/jbc.M105668200; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Dhami GK, 2004, J BIOL CHEM, V279, P16614, DOI 10.1074/jbc.M314090200; Dinger MC, 2003, J BIOL CHEM, V278, P10562, DOI 10.1074/jbc.M205747200; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; George SR, 1998, J BIOL CHEM, V273, P30244, DOI 10.1074/jbc.273.46.30244; Gerfen CR, 1995, J NEUROSCI, V15, P8167; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gines S, 2000, P NATL ACAD SCI USA, V97, P8606, DOI 10.1073/pnas.150241097; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Iwata K, 2005, J BIOL CHEM, V280, P2197, DOI 10.1074/jbc.M408834200; Jackson A, 2002, J NEUROCHEM, V82, P683, DOI 10.1046/j.1471-4159.2002.01001.x; Kim OJ, 2004, J BIOL CHEM, V279, P7999, DOI 10.1074/jbc.M308281200; Kita K, 1999, EUR NEUROPSYCHOPHARM, V9, P1, DOI 10.1016/S0924-977X(97)00098-9; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lamey M, 2002, J BIOL CHEM, V277, P9415, DOI 10.1074/jbc.M111811200; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Lee SP, 2000, MOL PHARMACOL, V58, P120, DOI 10.1124/mol.58.1.120; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; O'Dowd BF, 2005, J BIOL CHEM, V280, P37225, DOI 10.1074/jbc.M504562200; Pivonello R, 2007, EUR J ENDOCRINOL, V156, pS13, DOI 10.1530/eje.1.02353; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Ryman-Rasmussen JP, 2005, MOL PHARMACOL, V68, P1039, DOI 10.1124/mol.105.012153; Sachpatzidis A, 2003, J BIOL CHEM, V278, P896, DOI 10.1074/jbc.M204667200; Schachter JB, 1996, BRIT J PHARMACOL, V118, P167, DOI 10.1111/j.1476-5381.1996.tb15381.x; So CH, 2005, MOL PHARMACOL, V68, P568, DOI 10.1124/mol.105.012229; So CH, 2007, MOL PHARMACOL, V72, P450, DOI 10.1124/mol.107.034884; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Svenningsson P, 2000, NEUROSCIENCE, V98, P749, DOI 10.1016/S0306-4522(00)00155-X; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Tong JC, 2001, NEUROCHEM INT, V39, P117, DOI 10.1016/S0197-0186(01)00016-X; Truong K, 2001, NAT STRUCT BIOL, V8, P1069, DOI 10.1038/nsb728; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100	44	40	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35092	35103		10.1074/jbc.M109.088625	http://dx.doi.org/10.1074/jbc.M109.088625			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20807772	Green Published, hybrid			2022-12-25	WOS:000283659100083
J	Chen, KF; Liu, CY; Lin, YC; Yu, HC; Liu, TH; Hou, DR; Chen, PJ; Cheng, AL				Chen, K-F; Liu, C-Y; Lin, Y-C; Yu, H-C; Liu, T-H; Hou, D-R; Chen, P-J; Cheng, A-L			CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells	ONCOGENE			English	Article						HCC; CIP2A; bortezomib; proteasome inhibitor; PP2A; apoptosis	PROTEASOME INHIBITORS; CANCER; PP2A; PHOSPHATASES; MECHANISMS; SORAFENIB; MYC	Previously, we reported that Akt inactivation determines the sensitivity of hepatocellular carcinoma (HCC) cells to bortezomib. In this study, we report that cancerous inhibitor of protein phosphatase 2A (CIP2A), a cellular inhibitor of protein phosphatase 2A (PP2A), mediates the apoptotic effect of bortezomib in HCC. Silencing PP2A by small interference RNA (siRNA) abolishes bortezomib-induced down-regulation of phospho-Akt and apoptosis. Bortezomib increases PP2A activity in sensitive HCC cells, including Sk-Hep1, Hep3B and Huh-7, but not in resistant PLC5 cells. Bortezomib down-regulates CIP2A in a dose-and time-dependent manner in all sensitive HCC cells, whereas no alterations in CIP2A were found in resistant PLC5 cells. Knockdown of CIP2A by siRNA restored bortezomib's effects on apoptosis and PP2A activity in PLC5 cells. Moreover, over-expression of CIP2A up-regulated phospho-Akt and protected Sk-Hep1 cells from bortezomib-induced apoptosis. It is significant that, ectopic expression of CIP2A decreased Akt-related PP2A activity, whereas silencing CIP2A increased this activity, indicating that CIP2A negatively regulates Akt-related PP2A activity in HCC cells, furthermore, our in vivo data showed that bortezomib down-regulates CIP2A and up-regulates PP2A activity in Huh-7 tumors, but not in PLC5 tumors. In conclusion, inhibition of CIP2A determines the effects of bortezomib on apoptosis and PP2A-dependent Akt inactivation in HCC. Oncogene (2010) 29, 6257-6266; doi:10.1038/onc.2010.357; published online 23 August 2010	[Cheng, A-L] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 10016, Taiwan; [Cheng, A-L] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Chen, K-F; Yu, H-C; Liu, T-H; Chen, P-J] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 10016, Taiwan; [Chen, K-F; Yu, H-C; Liu, T-H; Chen, P-J] Natl Taiwan Univ, Coll Med, Dept Med Res, Taipei 10764, Taiwan; [Chen, K-F; Yu, H-C; Liu, T-H; Chen, P-J; Cheng, A-L] Natl Taiwan Univ Hosp, Natl Ctr Excellence Clin Trial & Res, Taipei 10016, Taiwan; [Liu, C-Y] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Liu, C-Y] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Lin, Y-C] Far Eastern Mem Hosp, Dept Internal Med, Taipei, Taiwan; [Hou, D-R] Natl Cent Univ, Dept Chem, Tao Yuan, Taiwan; [Cheng, A-L] Natl Taiwan Univ Hosp, Dept Oncol, Taipei 10016, Taiwan; [Cheng, A-L] Natl Taiwan Univ, Coll Med, Dept Oncol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Far Eastern Memorial Hospital; National Central University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Cheng, AL (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, 7 Chung Shan S Rd, Taipei 10016, Taiwan.	alcheng@ntu.edu.tw	Liu, Tsung-Hao/D-3357-2016	Liu, Tsung-Hao/0000-0002-8891-4426; Chen, Kuen-Feng/0000-0002-4686-7019; Cheng, Ann-Lii/0000-0002-9152-6512; Chen, Pei-Jer/0000-0001-8316-3785; HOU, Duen-Ren/0000-0003-1072-2915	National Taiwan University Hospital [NTUH98P03, NTUH98FTN21]; National Science Council, Taiwan [NSC97-2314-B-002-182, NSC98-2314-B-002-067-MY3, NSC98-3112-B-002-037]	National Taiwan University Hospital(National Taiwan University); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Supported by NTUH98P03, NTUH98FTN21 from National Taiwan University Hospital and NSC97-2314-B-002-182, NSC98-2314-B-002-067-MY3, NSC98-3112-B-002-037 from the National Science Council, Taiwan.	Bielinski VA, 2007, EXP CELL RES, V313, P3117, DOI 10.1016/j.yexcr.2007.05.008; Chen KF, 2008, CANCER RES, V68, P6698, DOI 10.1158/0008-5472.CAN-08-0257; Chen KF, 2010, J HEPATOL, V52, P88, DOI 10.1016/j.jhep.2009.10.011; Chen KF, 2009, J BIOL CHEM, V284, P11121, DOI 10.1074/jbc.M806268200; Come C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283; Davis NB, 2004, J CLIN ONCOL, V22, P115, DOI 10.1200/JCO.2004.07.165; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Hoo LS, 2002, ONCOGENE, V21, P5006, DOI 10.1038/sj.onc.1205625; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Khanna A, 2009, JNCI-J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103; Li WJ, 2008, CLIN CANCER RES, V14, P3722, DOI 10.1158/1078-0432.CCR-07-4137; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; McConkey DJ, 2008, DRUG RESIST UPDATE, V11, P164, DOI 10.1016/j.drup.2008.08.002; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Ocio EM, 2008, LANCET ONCOL, V9, P1157, DOI 10.1016/S1470-2045(08)70304-8; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Richardson P, 2008, ASH ANN M, V112, P870; Verslype C, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp281; Voorhees PM, 2006, ANNU REV PHARMACOL, V46, P189, DOI 10.1146/annurev.pharmtox.46.120604.141300; Yu CR, 2006, MOL CANCER THER, V5, P2378, DOI 10.1158/1535-7163.MCT-06-0235	24	133	143	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	47					6257	6266		10.1038/onc.2010.357	http://dx.doi.org/10.1038/onc.2010.357			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	685CG	20729919				2022-12-25	WOS:000284601700007
J	Mathias, A; Duc, M; Favre, L; Benyacoub, J; Blum, S; Corthesy, B				Mathias, Amandine; Duc, Melanie; Favre, Laurent; Benyacoub, Jalil; Blum, Stephanie; Corthesy, Blaise			Potentiation of Polarized Intestinal Caco-2 Cell Responsiveness to Probiotics Complexed with Secretory IgA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; EPITHELIAL-CELLS; DENDRITIC CELLS; IMMUNE-RESPONSE; IN-VIVO; COMMENSAL BACTERIA; MUCOSAL SURFACES; GUT; COMPONENT; HOMEOSTASIS	The precise mechanisms underlying the interaction between intestinal bacteria and the host epithelium lead to multiple consequences that remain poorly understood at the molecular level. Deciphering such events can provide valuable information as to the mode of action of commensal and probiotic microorganisms in the gastrointestinal environment. Potential roles of such microorganisms along the privileged target represented by the mucosal immune system include maturation prior, during and after weaning, and the reduction of inflammatory reactions in pathogenic conditions. Using human intestinal epithelial Caco-2 cell grown as polarized monolayers, we found that association of a Lactobacillus or a Bifidobacterium with nonspecific secretory IgA (SIgA) enhanced probiotic adhesion by a factor of 3.4-fold or more. Bacteria alone or in complex with SIgA reinforced transepithelial electrical resistance, a phenomenon coupled with increased phosphorylation of tight junction proteins zonula occludens-1 and occludin. In contrast, association with SIgA resulted in both enhanced level of nuclear translocation of NF-kappa B and production of epithelial polymeric Ig receptor as compared with bacteria alone. Moreover, thymic stromal lymphopoietin production was increased upon exposure to bacteria and further enhanced with SIgA-based complexes, whereas the level of pro-inflammatory epithelial cell mediators remained unaffected. Interestingly, SIgA-mediated potentiation of the Caco-2 cell responsiveness to the two probiotics tested involved Fab-independent interaction with the bacteria. These findings add to the multiple functions of SIgA and underscore a novel role of the antibody in interaction with intestinal bacteria.	[Mathias, Amandine; Duc, Melanie; Corthesy, Blaise] CHU Vaudois, R&D Lab, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland; [Favre, Laurent; Benyacoub, Jalil; Blum, Stephanie] Nestec Res Ctr, Dept Nutr & Hlth, CH-1000 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Nestle SA	Corthesy, B (corresponding author), Univ State Hosp CHUV, R&D Lab, Dept Immunol & Allergy, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	blaise.corthesy@chuv.ch			Swiss Science Research Foundation [3200-122039]; Nestec Research Center	Swiss Science Research Foundation(Swiss National Science Foundation (SNSF)); Nestec Research Center	This work was supported by Research Grant 3200-122039 from the Swiss Science Research Foundation and the Nestec Research Center.	Blumer N, 2007, CURR OPIN GASTROEN, V23, P655; Boullier S, 2009, J IMMUNOL, V183, P5879, DOI 10.4049/jimmunol.0901838; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Chirdo FG, 2005, EUR J IMMUNOL, V35, P1831, DOI 10.1002/eji.200425882; Cottet S, 2002, J BIOL CHEM, V277, P33978, DOI 10.1074/jbc.M201726200; Crottet P, 1999, BIOCHEM J, V341, P299, DOI 10.1042/0264-6021:3410299; Crottet P, 1998, J IMMUNOL, V161, P5445; Crottet P, 1999, J BIOL CHEM, V274, P31445, DOI 10.1074/jbc.274.44.31445; Favre L, 2005, J IMMUNOL, V175, P2793, DOI 10.4049/jimmunol.175.5.2793; Favre LI, 2003, J CHROMATOGR B, V786, P143, DOI 10.1016/S1570-0232(02)00723-7; Guarner F, 2006, DIGESTION, V73, P5, DOI 10.1159/000089775; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Kadaoui KA, 2007, J IMMUNOL, V179, P7751, DOI 10.4049/jimmunol.179.11.7751; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; KRAMER DR, 1995, J IMMUNOL, V154, P2051; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; MacKenzie DA, 2009, J BIOL CHEM, V284, P32444, DOI 10.1074/jbc.M109.040907; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2007, CURR OPIN GASTROEN, V23, P673, DOI 10.1097/MOG.0b013e3282f0d012; Matysiak-Budnik T, 2008, J EXP MED, V205, P143, DOI 10.1084/jem.20071204; MESTECKY J, 1987, ADV IMMUNOL, V40, P153, DOI 10.1016/S0065-2776(08)60240-0; MITSUOKA T, 1992, NUTR REV, V50, P438, DOI 10.1111/j.1753-4887.1992.tb02499.x; Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18; Pasparakis M, 2008, MUCOSAL IMMUNOL, V1, pS54, DOI 10.1038/mi.2008.53; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Philpott DJ, 2000, J IMMUNOL, V165, P903, DOI 10.4049/jimmunol.165.2.903; Resta-Lenert S, 2006, GASTROENTEROLOGY, V130, P731, DOI 10.1053/j.gastro.2005.12.015; RINDISBACHER L, 1995, J BIOL CHEM, V270, P14220, DOI 10.1074/jbc.270.23.14220; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Thierry AC, 2009, CLIN EXP ALLERGY, V39, P527, DOI 10.1111/j.1365-2222.2008.03185.x; vanderWaaij LA, 1996, GUT, V38, P348, DOI 10.1136/gut.38.3.348; Zeuthen LH, 2008, IMMUNOLOGY, V123, P197, DOI 10.1111/j.1365-2567.2007.02687.x	38	48	54	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33906	33913		10.1074/jbc.M110.135111	http://dx.doi.org/10.1074/jbc.M110.135111			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729211	Green Published, hybrid			2022-12-25	WOS:000283354000037
J	Tang, J; Bouyer, P; Mykoniatis, A; Buschmann, M; Matlin, KS; Matthews, JB				Tang, Jun; Bouyer, Patrice; Mykoniatis, Andreas; Buschmann, Mary; Matlin, Karl S.; Matthews, Jeffrey B.			Activated PKC delta and PKC epsilon Inhibit Epithelial Chloride Secretion Response to cAMP via Inducing Internalization of the Na+-K+-2Cl(-) Cotransporter NKCC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; MYRISTOYLATED PSEUDOSUBSTRATE PEPTIDE; CLATHRIN-DEPENDENT PATHWAY; MEDIATED RNA INTERFERENCE; NA-K-2CL COTRANSPORTER; MAMMALIAN-CELLS; APICAL MEMBRANE; CARDIAC MYOCYTES; TIGHT JUNCTIONS; ION SECRETION	The basolateral Na+-K+-2Cl(-)cotransporter (NKCC1) is a key determinant of transepithelial chloride secretion and dysregulation of chloride secretion is a common feature of many diseases including secretory diarrhea. We have previously shown that activation of protein kinase C (PKC) markedly reduces transepithelial chloride secretion in human colonic T84 cells, which correlates with both functional inhibition and loss of the NKCC1 surface expression. In the present study, we defined the specific roles of PKC isoforms in regulating epithelial NKCC1 and chloride secretion utilizing adenoviral vectors that express shRNAs targeting human PKC isoforms (alpha,delta,epsilon) (shPKCs) or LacZ (shLacZ, non-targeting control). After 72 h of adenoviral transduction, protein levels of the PKC isoforms in shPKCs-T84 cells were decreased by similar to 90% compared with the shLacZ-control. Activation of PKCs by phorbol 12-myristate 13-acetate (PMA) caused a redistribution of NKCC1 immuno-staining from the basolateral membrane to intracellular vesicles in both shLacZ- and shPKC alpha-T84 cells, whereas the effect of PMA was not observed in shPKC delta- and shPKC epsilon- cells. These results were further confirmed by basolateral surface biotinylation. Furthermore, activation of PKCs by PMA inhibited cAMP-stimulated chloride secretion in the uninfected, shLacZ- and shPKC alpha-T84 monolayers, but the inhibitory effect was significantly attenuated in shPKC delta- and shPKC epsilon-T84 monolayers. In conclusion, the activated novel isoforms PKC delta or PKC epsilon, but not the conventional isoform PKC alpha, inhibits transepithelial chloride secretion through inducing internalization of the basolateral surface NKCC1. Our study reveals that the novel PKC isoform-regulated NKCC1 surface expression plays an important role in the regulation of chloride secretion.	[Tang, Jun; Bouyer, Patrice; Mykoniatis, Andreas; Buschmann, Mary; Matlin, Karl S.; Matthews, Jeffrey B.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA	University of Chicago	Tang, J (corresponding author), 5841 S Maryland Ave,MC 5029, Chicago, IL 60637 USA.	juntang@uchicago.edu; jmatthews@uchicago.edu			National Institutes of Health, NIDDK [DK-48010]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK048010, R01DK048010] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-48010 from the NIDDK (to J. B. M.).	Abbas-Terki T, 2002, HUM GENE THER, V13, P2197, DOI 10.1089/104303402320987888; Alvi F, 2007, CELL MOL LIFE SCI, V64, P263, DOI 10.1007/s00018-006-6363-5; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bataille AM, 2008, AM J PHYSIOL-REG I, V295, pR2024, DOI 10.1152/ajpregu.90471.2008; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Broughman JR, 2006, AM J PHYSIOL-GASTR L, V291, pG318, DOI 10.1152/ajpgi.00355.2005; Broughman JR, 2006, AM J PHYSIOL-GASTR L, V291, pG331, DOI 10.1152/ajpgi.00356.2005; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chappe F, 2008, J PHARMACOL EXP THER, V327, P226, DOI 10.1124/jpet.108.141143; Chappell AE, 2008, FASEB J, V22, P2023, DOI 10.1096/fj.07-099697; Chen YF, 2006, HYPERTENSION, V47, P230, DOI 10.1161/01.HYP.0000200259.01947.bb; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Del Castillo IC, 2005, AM J PHYSIOL-CELL PH, V289, pC1332, DOI 10.1152/ajpcell.00580.2004; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204, DOI 10.1152/ajpgi.1984.246.2.G204; DHARMSATHAPHORN K, 1985, J CLIN INVEST, V75, P462, DOI 10.1172/JCI111721; EICHHOLTZ T, 1993, J BIOL CHEM, V268, P1982; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Farokhzad OC, 1999, J CELL PHYSIOL, V181, P489, DOI 10.1002/(SICI)1097-4652(199912)181:3<489::AID-JCP13>3.0.CO;2-7; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Geibel JP, 2005, ANNU REV PHYSIOL, V67, P471, DOI 10.1146/annurev.physiol.67.031103.153530; Ghadimi D, 2010, INFLAMM BOWEL DIS, V16, P410, DOI 10.1002/ibd.21057; Ghartey-Tagoe EB, 2006, INT J PHARMACEUT, V315, P122, DOI 10.1016/j.ijpharm.2006.02.022; Gonzalez MI, 2005, J NEUROCHEM, V94, P1180, DOI 10.1111/j.1471-4159.2005.03330.x; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; HALM DR, 1990, TXB SECRETORY DIARRH, P47; Harris TE, 1999, MOL CELL ENDOCRINOL, V155, P61, DOI 10.1016/S0303-7207(99)00114-8; Hassan HA, 2007, AM J PHYSIOL-CELL PH, V292, pC1485, DOI 10.1152/ajpcell.00447.2006; Huang B, 2005, HUM GENE THER, V16, P618, DOI 10.1089/hum.2005.16.618; HVALBY O, 1994, P NATL ACAD SCI USA, V91, P4761, DOI 10.1073/pnas.91.11.4761; Irnaten M, 2008, CELL CALCIUM, V44, P441, DOI 10.1016/j.ceca.2008.02.007; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Jobbagy Z, 1999, J BIOL CHEM, V274, P7067, DOI 10.1074/jbc.274.11.7067; Johnson JA, 2004, LIFE SCI, V74, P3153, DOI 10.1016/j.lfs.2003.11.016; Karatas-Wulf U, 2009, NEUROSCIENCE, V161, P794, DOI 10.1016/j.neuroscience.2009.04.017; Keely SJ, 2003, AM J PHYSIOL-CELL PH, V284, pC339, DOI 10.1152/ajpcell.00144.2002; Krotova K, 2006, BRIT J PHARMACOL, V148, P732, DOI 10.1038/sj.bjp.0706777; Kuwano Y, 2006, AM J PHYSIOL-CELL PH, V290, pC433, DOI 10.1152/ajpcell.00135.2005; LEBENTHAL E, 1990, TXB SECRETORY DIARRH; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Liedtke CM, 2002, AM J PHYSIOL-LUNG C, V282, pL1151, DOI 10.1152/ajplung.00143.2001; Lim S, 2008, LIFE SCI, V82, P733, DOI 10.1016/j.lfs.2008.01.005; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; Matthews JB, 1998, J CLIN INVEST, V101, P2072, DOI 10.1172/JCI1042; Matthews JB, 2002, WORLD J SURG, V26, P826, DOI 10.1007/s00268-002-4059-z; MATTHEWS JB, 1993, AM J PHYSIOL, V265, pC1109, DOI 10.1152/ajpcell.1993.265.4.C1109; McGovern SL, 2003, J MED CHEM, V46, P1478, DOI 10.1021/jm020427b; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Mykoniatis A, 2010, AM J PHYSIOL-CELL PH, V298, pC85, DOI 10.1152/ajpcell.00118.2009; OMAHONY F, 2008, M J PHYSL CELL PHYSL, V294, pC1362; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Perry C, 2009, AM J PHYSIOL-CELL PH, V297, pC1409, DOI 10.1152/ajpcell.00028.2009; Pitcher MH, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-17; Price TJ, 2005, CURR TOP MED CHEM, V5, P547, DOI 10.2174/1568026054367629; Rinne Andreas, 2009, V515, P107, DOI 10.1007/978-1-59745-559-6_7; Rotmann A, 2004, J BIOL CHEM, V279, P54185, DOI 10.1074/jbc.M409556200; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Sen A, 2007, EPILEPSY RES, V74, P220, DOI 10.1016/j.eplepsyres.2007.01.004; Shen CX, 2003, FEBS LETT, V539, P111, DOI 10.1016/S0014-5793(03)00209-6; Sheth P, 2007, AM J PHYSIOL-GASTR L, V293, pG308, DOI 10.1152/ajpgi.00582.2006; Smith L, 2008, J BIOL CHEM, V283, P22147, DOI 10.1074/jbc.M801752200; Song JC, 2001, AM J PHYSIOL-CELL PH, V281, pC649, DOI 10.1152/ajpcell.2001.281.2.C649; Song JC, 1999, AM J PHYSIOL-CELL PH, V277, pC1239, DOI 10.1152/ajpcell.1999.277.6.C1239; Spitzner M, 2007, FASEB J, V21, P35, DOI 10.1096/fj.06-6200com; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Suzuki T, 2008, J BIOL CHEM, V283, P3574, DOI 10.1074/jbc.M709141200; Suzuki T, 2009, P NATL ACAD SCI USA, V106, P61, DOI 10.1073/pnas.0802741106; Takeshita F, 2006, CANCER SCI, V97, P689, DOI 10.1111/j.1349-7006.2006.00234.x; Tiscornia G, 2006, NAT PROTOC, V1, P234, DOI 10.1038/nprot.2006.36; Yue W, 2009, MOL PHARMACEUT, V6, P134, DOI 10.1021/mp800100e; Zhang Q, 2008, J BIOL CHEM, V283, P32570, DOI 10.1074/jbc.M800298200	73	14	14	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34072	34085		10.1074/jbc.M110.137380	http://dx.doi.org/10.1074/jbc.M110.137380			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20732874	Green Published, hybrid			2022-12-25	WOS:000283354000053
J	Abdul-Nabi, AM; Yassin, ER; Varghese, N; Deshmukh, H; Yaseen, NR				Abdul-Nabi, Anmaar M.; Yassin, Enas R.; Varghese, Nobish; Deshmukh, Hrishikesh; Yaseen, Nabeel R.			In Vitro Transformation of Primary Human CD34+Cells by AML Fusion Oncogenes: Early Gene Expression Profiling Reveals Possible Drug Target in AML	PLOS ONE			English	Article							ACUTE-MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; HUMAN CD34(+) CELLS; ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; TUMOR-SUPPRESSOR; MALIGNANT HEMATOPOIESIS; MLL REARRANGEMENT; AML1-ETO	Different fusion oncogenes in acute myeloid leukemia (AML) have distinct clinical and laboratory features suggesting different modes of malignant transformation. Here we compare the in vitro effects of representatives of 4 major groups of AML fusion oncogenes on primary human CD34+ cells. As expected from their clinical similarities, MLL-AF9 and NUP98-HOXA9 had very similar effects in vitro. They both caused erythroid hyperplasia and a clear block in erythroid and myeloid maturation. On the other hand, AML1-ETO and PML-RARA had only modest effects on myeloid and erythroid differentiation. All oncogenes except PML-RARA caused a dramatic increase in long-term proliferation and self-renewal. Gene expression profiling revealed two distinct temporal patterns of gene deregulation. Gene deregulation by MLL-AF9 and NUP98-HOXA9 peaked 3 days after transduction. In contrast, the vast majority of gene deregulation by AML1-ETO and PML-RARA occurred within 6 hours, followed by a dramatic drop in the numbers of deregulated genes. Interestingly, the p53 inhibitor MDM2 was upregulated by AML1-ETO at 6 hours. Nutlin-3, an inhibitor of the interaction between MDM2 and p53, specifically inhibited the proliferation and self-renewal of primary human CD34+ cells transduced with AML1-ETO, suggesting that MDM2 upregulation plays a role in cell transformation by AML1-ETO. These data show that differences among AML fusion oncogenes can be recapitulated in vitro using primary human CD34+ cells and that early gene expression profiling in these cells can reveal potential drug targets in AML.	[Abdul-Nabi, Anmaar M.; Yassin, Enas R.; Varghese, Nobish; Deshmukh, Hrishikesh; Yaseen, Nabeel R.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Abdul-Nabi, AM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	nyaseen@wustl.edu		Yaseen, Nabeel/0000-0001-6902-5116	NIH [R01HL082549, K02HL084179, T32CA009547]; NCI Cancer Center [P30CA91842]; NATIONAL CANCER INSTITUTE [P30CA091842, T32CA009547] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL084179, R01HL082549] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants R01HL082549 and K02HL084179 (N.R. Yaseen), and T32CA009547 (A.M. Abdul-Nabi). The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant #P30CA91842. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banker DE, 1998, CLIN CANCER RES, V4, P3051; Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Brunning RD, 2008, WHO CLASSIFICATION T, P87; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Chi YQ, 2008, ARCH PATHOL LAB MED, V132, P1835, DOI 10.1043/1543-2165-132.11.1835; Choi YJ, 2006, CANCER RES, V66, P2990, DOI 10.1158/0008-5472.CAN-05-2944; CHOU WC, 2009, ACUTE MYELOID LEUKEM; Chung KY, 2006, CANCER RES, V66, P11781, DOI 10.1158/0008-5472.CAN-06-0706; Debernardi S, 2003, GENE CHROMOSOME CANC, V37, P149, DOI 10.1002/gcc.10198; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Eklund EA, 2007, CURR OPIN HEMATOL, V14, P85, DOI 10.1097/MOH.0b013e32801684b6; Elagib KE, 2007, CANCER LETT, V251, P179, DOI 10.1016/j.canlet.2006.10.010; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; Grignani F, 2000, BLOOD, V96, P1531, DOI 10.1182/blood.V96.4.1531.h8001531_1531_1537; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Haferlach T, 2005, BLOOD, V106, P1189, DOI 10.1182/blood-2004-12-4938; Isufi I, 2007, J INTERF CYTOK RES, V27, P543, DOI 10.1089/jir.2007.0009; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Krejci O, 2008, BLOOD, V111, P2190, DOI 10.1182/blood-2007-06-093682; Krug U, 2002, ONCOGENE, V21, P3475, DOI 10.1038/sj.onc.1205322; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lam DH, 2001, LEUKEMIA, V15, P1689, DOI 10.1038/sj.leu.2402269; Lee S, 2006, P NATL ACAD SCI USA, V103, P1030, DOI 10.1073/pnas.0509878103; Li ZJ, 2009, CANCER RES, V69, P1109, DOI 10.1158/0008-5472.CAN-08-3381; Lin HK, 2005, ONCOGENE, V24, P5693, DOI 10.1038/sj.onc.1208923; Linggi B, 2002, NAT MED, V8, P743, DOI 10.1038/nm726; Long JT, 2010, BLOOD, V116, P71, DOI 10.1182/blood-2010-01-261628; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; McCormack E, 2008, ONCOGENE, V27, P3765, DOI 10.1038/onc.2008.16; MEYER C, 2009, NEW INSIGHTS MLL REC; Mikesch JH, 2007, LEUKEMIA, V21, P1638, DOI 10.1038/sj.leu.2404732; Moll UM, 2003, MOL CANCER RES, V1, P1001; Mulloy JC, 2005, P NATL ACAD SCI USA, V102, P4016, DOI 10.1073/pnas.0404701102; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Romana SP, 2006, LEUKEMIA, V20, P696, DOI 10.1038/sj.leu.2404130; Rowley JD, 2002, GENE CHROMOSOME CANC, V33, P331, DOI 10.1002/gcc.10040; Schoch C, 2003, BLOOD, V102, P2395, DOI 10.1182/blood-2003-02-0434; Schoch C, 2002, P NATL ACAD SCI USA, V99, P10008, DOI 10.1073/pnas.142103599; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Shih LY, 2006, LEUKEMIA, V20, P218, DOI 10.1038/sj.leu.2404024; Slany RK, 2009, HAEMATOL-HEMATOL J, V94, P984, DOI 10.3324/haematol.2008.002436; SUTHERLAND HJ, 1990, P NATL ACAD SCI USA, V87, P3584, DOI 10.1073/pnas.87.9.3584; Takeda A, 2006, CANCER RES, V66, P6628, DOI 10.1158/0008-5472.CAN-06-0458; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tonks A, 2004, LEUKEMIA, V18, P1238, DOI 10.1038/sj.leu.2403396; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Van Vlierberghe P, 2008, BLOOD, V111, P4668, DOI 10.1182/blood-2007-09-111872; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vitoux D, 2007, INT J BIOCHEM CELL B, V39, P1063, DOI 10.1016/j.biocel.2007.01.028; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Westervelt P, 2003, BLOOD, V102, P1857, DOI 10.1182/blood-2002-12-3779; Wilson CS, 2006, BLOOD, V108, P685, DOI 10.1182/blood-2004-12-4633; Wunderlich M, 2006, BLOOD, V108, P1690, DOI 10.1182/blood-2005-12-012773; Wunderlich Mark, 2009, V538, P263, DOI 10.1007/978-1-59745-418-6_13; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	60	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12464	10.1371/journal.pone.0012464	http://dx.doi.org/10.1371/journal.pone.0012464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805992	Green Published, Green Submitted, gold			2022-12-25	WOS:000281301500028
J	Chaudhury, S; Igoshin, OA				Chaudhury, Srabanti; Igoshin, Oleg A.			Dynamic Disorder in Quasi-Equilibrium Enzymatic Systems	PLOS ONE			English	Article							SINGLE-MOLECULE KINETICS; PROTEIN	Conformations and catalytic rates of enzymes fluctuate over a wide range of timescales. Despite these fluctuations, there exist some limiting cases in which the enzymatic catalytic rate follows the macroscopic rate equation such as the Michaelis-Menten law. In this paper we investigate the applicability of macroscopic rate laws for fluctuating enzyme systems in which catalytic transitions are slower than ligand binding-dissociation reactions. In this quasi-equilibrium limit, for an arbitrary reaction scheme we show that the catalytic rate has the same dependence on ligand concentrations as obtained from mass-action kinetics even in the presence of slow conformational fluctuations. These results indicate that the timescale of conformational dynamics-no matter how slow-will not affect the enzymatic rate in quasi-equilibrium limit. Our numerical results for two enzyme-catalyzed reaction schemes involving multiple substrates and inhibitors further support our general theory.	[Chaudhury, Srabanti; Igoshin, Oleg A.] Rice Univ, Dept Bioengn, Houston, TX 77251 USA	Rice University	Chaudhury, S (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	igoshin@rice.edu	Igoshin, Oleg/P-3937-2014	Igoshin, Oleg/0000-0002-1449-4772	Rice University; National Science Foundation [MCB-0920463]; Div Of Molecular and Cellular Bioscience [0920463] Funding Source: National Science Foundation	Rice University; National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The research is supported by a start-up fund from Rice University and partially supported by National Science Foundation award and MCB-0920463. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5627, DOI 10.1021/bi00670a031; BENNER SA, 1989, CHEM REV, V89, P789, DOI 10.1021/cr00094a004; Cao JS, 2000, CHEM PHYS LETT, V327, P38, DOI 10.1016/S0009-2614(00)00809-5; Chaudhury S, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2768059; Chaudhury S, 2009, J PHYS CHEM B, V113, P13421, DOI 10.1021/jp907908d; English BP, 2006, NAT CHEM BIOL, V2, P87, DOI 10.1038/nchembio759; FERSHT A, 1982, ENZYME STRUCTURE MEC; Garrett R.H., 2009, BIOCHEMISTRY; Hanson SM, 2008, J PHYS CHEM A, V112, P8654, DOI 10.1021/jp8026226; HEINEKEN F. G., 1967, MATH BIOSCI, V1, P95, DOI 10.1016/0025-5564(67)90029-6; Kou SC, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.180603; LAIDLER KJ, 1955, CAN J CHEM, V33, P1614, DOI 10.1139/v55-195; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Michaelis L, 1913, BIOCHEM Z, V49, P333; Min W, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198302; Min W, 2006, J PHYS CHEM B, V110, P20093, DOI 10.1021/jp065187g; Segel IH., 1993, ENZYME KINETICS BEHA; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wang HY, 2003, J THEOR BIOL, V221, P491, DOI 10.1006/jtbi.2003.3200; Xing JH, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.168103; Xue X, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.030902; Yang H, 2003, SCIENCE, V302, P262, DOI 10.1126/science.1086911; Yang SL, 2002, J CHEM PHYS, V117, P10996, DOI 10.1063/1.1521155; ZWANZIG R, 1992, J CHEM PHYS, V97, P3587, DOI 10.1063/1.462993; ZWANZIG R, 1990, ACCOUNTS CHEM RES, V23, P148, DOI 10.1021/ar00173a005	25	4	5	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12364	10.1371/journal.pone.0012364	http://dx.doi.org/10.1371/journal.pone.0012364			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808776	gold, Green Submitted, Green Published			2022-12-25	WOS:000281154300007
J	Lussier, CR; Brial, F; Roy, SAB; Langlois, MJ; Verdu, EF; Rivard, N; Perreault, N; Boudreau, F				Lussier, Carine R.; Brial, Francois; Roy, Sebastien A. B.; Langlois, Marie-Josee; Verdu, Elena F.; Rivard, Nathalie; Perreault, Nathalie; Boudreau, Francois			Loss of Hepatocyte-Nuclear-Factor-1 alpha Impacts on Adult Mouse Intestinal Epithelial Cell Growth and Cell Lineages Differentiation	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-1-ALPHA; STEM-CELLS; TUMOR SUPPRESSION; GENE; MICE; AUTOPHAGY; TRANSCRIPTION; CDX2; METABOLISM; COMMITMENT	Background and Aims: Although Hnf1 alpha is crucial for pancreas and liver functions, it is believed to play a limited functional role for intestinal epithelial functions. The aim of this study was to assess the consequences of abrogating Hnf1 alpha on the maintenance of adult small intestinal epithelial functions. Methodology/Principal Findings: An Hnf1 alpha knockout mouse model was used. Assessment of histological abnormalities, crypt epithelial cell proliferation, epithelial barrier, glucose transport and signalling pathways were measured in these animals. Changes in global gene expression were also analyzed. Mice lacking Hnf1 alpha displayed increased crypt proliferation and intestinalomegaly as well as a disturbance of intestinal epithelial cell lineages production during adult life. This phenotype was associated with a decrease of the mucosal barrier function and lumen-to-blood glucose delivery. The mammalian target of rapamycin (mTOR) signalling pathway was found to be overly activated in the small intestine of adult Hnf1a mutant mice. The intestinal epithelium of Hnf1 alpha null mice displayed a reduction of the enteroendocrine cell population. An impact was also observed on proper Paneth cell differentiation with abnormalities in the granule exocytosis pathway. Conclusions/Significance: Together, these results unravel a functional role for Hnf1 alpha in regulating adult intestinal growth and sustaining the functions of intestinal epithelial cell lineages.	[Lussier, Carine R.; Brial, Francois; Roy, Sebastien A. B.; Langlois, Marie-Josee; Rivard, Nathalie; Perreault, Nathalie; Boudreau, Francois] Univ Sherbrooke, Dept Anat & Biol Cellulaire, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada; [Verdu, Elena F.] McMaster Univ, Div Gastroenterol, Hamilton, ON, Canada	University of Sherbrooke; McMaster University	Lussier, CR (corresponding author), Univ Sherbrooke, Dept Anat & Biol Cellulaire, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada.	francois.boudreau@usherbrooke.ca	Brial, Francois/ABF-2794-2020	Brial, Francois/0000-0002-2418-1614	Canadian Institute of Health Research (CIHR) [MOP-89770]; FRSQ; Natural Sciences and Engineering Research Council of Canada (NSERC); McMaster University Department of Medicine	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); McMaster University Department of Medicine	This work was supported by the Canadian Institute of Health Research (CIHR) (MOP-89770 to F.B.). F.B. is a Senior scholar from the Fonds de la recherche en sante du Quebec (FRSQ). F.B., N.P. and N.R. are members of the FRSQ-funded Centre de Recherche Clinique Etienne-Le Bel. N.R. is a recipient of a Canadian Research Chair in Signaling and Digestive Physiopathology. C.R.L. is a recipient of a Natural Sciences and Engineering Research Council of Canada (NSERC) fellowship. E. Verdu holds a McMaster University Department of Medicine Internal Career Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babeu JP, 2009, AM J PHYSIOL-GASTR L, V297, pG124, DOI 10.1152/ajpgi.90690.2008; Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Battle MA, 2008, GASTROENTEROLOGY, V135, P1676, DOI 10.1053/j.gastro.2008.07.074; BAUMHUETER S, 1990, GENE DEV, V4, P372, DOI 10.1101/gad.4.3.372; BLUMENFELD M, 1991, DEVELOPMENT, V113, P589; Bosse T, 2006, AM J PHYSIOL-GASTR L, V290, pG1016, DOI 10.1152/ajpgi.00359.2005; BOSSE T, 2007, AM J PHYSL GASTROINT; Boudreau F, 2002, J BIOL CHEM, V277, P31909, DOI 10.1074/jbc.M204622200; Boudreau F., 2007, FASEB J; Boulanger J, 2005, J BIOL CHEM, V280, P18095, DOI 10.1074/jbc.M502184200; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; CHENG H, 1985, ANAT REC, V211, P420, DOI 10.1002/ar.1092110408; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; D'Angelo A, 2010, DEVELOPMENT, V137, P1573, DOI 10.1242/dev.044420; Darsigny M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007609; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Gautier-Stein A, 2006, J BIOL CHEM, V281, P31268, DOI 10.1074/jbc.M603258200; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hiraiwa H, 2001, J BIOL CHEM, V276, P7963, DOI 10.1074/jbc.M010523200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Langlois MJ, 2009, FASEB J, V23, P1835, DOI 10.1096/fj.08-123125; Lee YH, 1998, MOL CELL BIOL, V18, P3059, DOI 10.1128/MCB.18.5.3059; Lussier CR, 2008, AM J PHYSIOL-GASTR L, V294, pG418, DOI 10.1152/ajpgi.00418.2007; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Menard D, 2006, CELL SIGNALING AND GROWTH FACTORS IN DEVELOPMENT: FROM MOLECULES TO ORGANOGENESIS, P755; Novak JP, 2002, GENOMICS, V79, P104, DOI 10.1006/geno.2001.6675; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; SEMENZA G, 1985, ANN NY ACAD SCI, V456, P83, DOI 10.1111/j.1749-6632.1985.tb14848.x; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Tamura A, 2008, GASTROENTEROLOGY, V134, P523, DOI 10.1053/j.gastro.2007.11.040; Traber Peter G., 1995, P21; Wasan HS, 1998, J PATHOL, V185, P246; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	43	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12378	10.1371/journal.pone.0012378	http://dx.doi.org/10.1371/journal.pone.0012378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808783	Green Published, Green Submitted, gold			2022-12-25	WOS:000281154300013
J	Rhein, V; Giese, M; Baysang, G; Meier, F; Rao, S; Schulz, KL; Hamburger, M; Eckert, A				Rhein, Virginie; Giese, Maria; Baysang, Ginette; Meier, Fides; Rao, Stefania; Schulz, Kathrin L.; Hamburger, Matthias; Eckert, Anne			Ginkgo Biloba Extract Ameliorates Oxidative Phosphorylation Performance and Rescues A beta-Induced Failure	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; TRANSGENIC MOUSE MODEL; CYTOCHROME-C-OXIDASE; ALZHEIMERS-DISEASE; MITOCHONDRIAL-FUNCTION; DOUBLE-BLIND; EGB 761; NEUROPSYCHIATRIC FEATURES; HIPPOCAMPAL-NEURONS; RESPIRATORY-CHAIN	Background: Energy deficiency and mitochondrial failure have been recognized as a prominent, early event in Alzheimer's disease (AD). Recently, we demonstrated that chronic exposure to amyloid-beta (A beta) in human neuroblastoma cells over-expressing human wild-type amyloid precursor protein (APP) resulted in (i) activity changes of complexes III and IV of the oxidative phosphorylation system (OXPHOS) and in (ii) a drop of ATP levels which may finally instigate loss of synapses and neuronal cell death in AD. Therefore, the aim of the present study was to investigate whether standardized Ginkgo biloba extract LI 1370 (GBE) is able to rescue A beta-induced defects in energy metabolism. Methodology/Principal Findings: We used a high-resolution respiratory protocol to evaluate OXPHOS respiratory capacity under physiological condition in control (stably transfected with the empty vector) and APP cells after treatment with GBE. In addition, oxygen consumption of isolated mitochondria, activities of mitochondrial respiratory enzymes, ATP and reactive oxygen species (ROS) levels as well as mitochondrial membrane mass and mitochondrial DNA content were determined. We observed a general antioxidant effect of GBE leading to an increase of the coupling state of mitochondria as well as energy homeostasis and a reduction of ROS levels in control cells and in APP cells. GBE effect on OXPHOS was even preserved in mitochondria after isolation from treated cells. Moreover, these functional data were paralleled by an up-regulation of mitochondrial DNA. Improvement of the OXPHOS efficiency was stronger in APP cells than in control cells. In APP cells, the GBE-induced amelioration of oxygen consumption most likely arose from the modulation and respective normalization of the A beta-induced disturbance in the activity of mitochondrial complexes III and IV restoring impaired ATP levels possibly through decreasing A beta and oxidative stress level. Conclusions/Significance: Although the underlying molecular mechanisms of the mode of action of GBE remain to be determined, our study clearly highlights the beneficial effect of GBE on the cellular OXPHOS performance and restoration of A beta-induced mitochondrial dysfunction.	[Rhein, Virginie; Giese, Maria; Baysang, Ginette; Meier, Fides; Rao, Stefania; Schulz, Kathrin L.; Eckert, Anne] Univ Basel, Neurobiol Lab Brain Aging & Mental Hlth, Psychiat Univ Clin, Basel, Switzerland; [Hamburger, Matthias] Univ Basel, Inst Pharmaceut Biol, Basel, Switzerland	University of Basel; University of Basel	Rhein, V (corresponding author), Univ Basel, Neurobiol Lab Brain Aging & Mental Hlth, Psychiat Univ Clin, Basel, Switzerland.	anne.eckert@upkbs.ch		Eckert, Anne/0000-0002-9341-3669	SNSF (Swiss National Science Foundation) [310000-108223]; Vifor SA, Switzerland	SNSF (Swiss National Science Foundation)(Swiss National Science Foundation (SNSF)); Vifor SA, Switzerland	This research was supported by a grant from the SNSF (Swiss National Science Foundation) #310000-108223 to A. E. and an unrestricted research grant from Vifor SA, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Kader R, 2007, PHARMACOL RES, V56, P493, DOI 10.1016/j.phrs.2007.09.011; Augustin S, 2009, ARCH BIOCHEM BIOPHYS, V481, P177, DOI 10.1016/j.abb.2008.10.032; Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8; Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029; Bastianetto S, 2000, EUR J NEUROSCI, V12, P1882, DOI 10.1046/j.1460-9568.2000.00069.x; Blass JP, 2003, NEUROL RES, V25, P556, DOI 10.1179/016164103101201995; Cardoso SM, 2004, J NEUROCHEM, V89, P1417, DOI 10.1111/j.1471-4159.2004.02438.x; Cardoso SM, 2004, NEUROBIOL AGING, V25, P105, DOI 10.1016/S0197-4580(03)00033-2; Carvalho C, 2009, J BIOENERG BIOMEMBR, V41, P433, DOI 10.1007/s10863-009-9247-1; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Colciaghi F, 2004, NEUROBIOL DIS, V16, P454, DOI 10.1016/j.nbd.2004.03.011; Cote HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035; D'Aurelio M, 2006, HUM MOL GENET, V15, P2157, DOI 10.1093/hmg/ddl141; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; David DC, 2005, J BIOL CHEM, V280, P23802, DOI 10.1074/jbc.M500356200; DeKosky ST, 2008, JAMA-J AM MED ASSOC, V300, P2253, DOI 10.1001/jama.2008.683; Devore EE, 2010, ARCH NEUROL-CHICAGO, V67, P819, DOI 10.1001/archneurol.2010.144; Djafarzadeh R, 2000, BBA-BIOENERGETICS, V1459, P230, DOI 10.1016/S0005-2728(00)00154-7; DOUSSIERE J, 1984, BIOCHIM BIOPHYS ACTA, V766, P492, DOI 10.1016/0005-2728(84)90265-2; Eckert A, 2005, ANN NY ACAD SCI, V1056, P474, DOI 10.1196/annals.1352.023; Eckert A, 2003, PHARMACOPSYCHIATRY, V36, pS15; Eckert A, 2008, J MOL MED, V86, P1255, DOI 10.1007/s00109-008-0391-6; Eckert A, 2010, MOL NEUROBIOL, V41, P107, DOI 10.1007/s12035-010-8109-5; Fernandez-Vizarra P, 2004, HISTOL HISTOPATHOL, V19, P823, DOI 10.14670/HH-19.823; Gibson GE, 1998, J NEURAL TRANSM, V105, P855, DOI 10.1007/s007020050099; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005; Hou Y, 2010, NEUROPHARMACOLOGY, V58, P911, DOI 10.1016/j.neuropharm.2009.11.002; Iijima-Ando K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008310; Janssens D, 1999, BIOCHEM PHARMACOL, V58, P109, DOI 10.1016/S0006-2952(99)00061-1; JANSSENS D, 1995, BIOCHEM PHARMACOL, V50, P991, DOI 10.1016/0006-2952(95)00227-Q; Kanowski S, 1996, PHARMACOPSYCHIATRY, V29, P47, DOI 10.1055/s-2007-979544; Keil U, 2004, J BIOL CHEM, V279, P50310, DOI 10.1074/jbc.M405600200; KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x; KUROIWA T, 1994, MICROSC RES TECHNIQ, V27, P220, DOI 10.1002/jemt.1070270304; Laurin D, 2004, AM J EPIDEMIOL, V159, P959, DOI 10.1093/aje/kwh124; LeBars PL, 1997, JAMA-J AM MED ASSOC, V278, P1327, DOI 10.1001/jama.278.16.1327; Leuner K, 2007, ANTIOXID REDOX SIGN, V9, P1659, DOI 10.1089/ars.2007.1763; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo Y, 2002, P NATL ACAD SCI USA, V99, P12197, DOI 10.1073/pnas.182425199; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; McCarney R, 2008, INT J GERIATR PSYCH, V23, P1222, DOI 10.1002/gps.2055; Mix JA, 2002, HUM PSYCHOPHARM CLIN, V17, P267, DOI 10.1002/hup.412; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P212, DOI 10.1016/j.bbadis.2009.10.007; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P2, DOI 10.1016/j.bbadis.2009.10.006; Napryeyenko O, 2007, ARZNEIMITTELFORSCH, V57, P4; Navarro A, 2005, AM J PHYSIOL-REG I, V289, pR1392, DOI 10.1152/ajpregu.00834.2004; Plecita-Hlavata L, 2009, INT J BIOCHEM CELL B, V41, P1697, DOI 10.1016/j.biocel.2009.02.015; Rhein V, 2009, CELL MOL NEUROBIOL, V29, P1063, DOI 10.1007/s10571-009-9398-y; Rhein Virginie, 2007, Archives of Physiology and Biochemistry, V113, P131, DOI 10.1080/13813450701572288; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Schindowski K, 2001, J NEURAL TRANSM, V108, P969, DOI 10.1007/s007020170016; Shi QL, 2007, ALZ DIS ASSOC DIS, V21, P276, DOI 10.1097/WAD.0b013e31815721c3; Smith JV, 2002, CELL MOL BIOL, V48, P699; Tchantchou F, 2007, FASEB J, V21, P2400, DOI 10.1096/fj.06-7649com; Tchantchou F, 2009, J ALZHEIMERS DIS, V18, P787, DOI 10.3233/JAD-2009-1189; Tendi EA, 2002, NEUROCHEM RES, V27, P319, DOI 10.1023/A:1014963313559; Trumbeckaite S, 2007, J ETHNOPHARMACOL, V111, P512, DOI 10.1016/j.jep.2006.12.028; Valla J, 2001, J NEUROSCI, V21, P4923, DOI 10.1523/JNEUROSCI.21-13-04923.2001; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Yancheva S, 2009, AGING MENT HEALTH, V13, P183, DOI 10.1080/13607860902749057; Yao ZX, 2001, BRAIN RES, V889, P181, DOI 10.1016/S0006-8993(00)03131-0	63	52	54	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12359	10.1371/journal.pone.0012359	http://dx.doi.org/10.1371/journal.pone.0012359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808761	Green Published, Green Submitted, gold			2022-12-25	WOS:000281154300003
J	Redemann, S; Pecreaux, J; Goehring, NW; Khairy, K; Stelzer, EHK; Hyman, AA; Howard, J				Redemann, Stefanie; Pecreaux, Jacques; Goehring, Nathan W.; Khairy, Khaled; Stelzer, Ernst H. K.; Hyman, Anthony A.; Howard, Jonathon			Membrane Invaginations Reveal Cortical Sites that Pull on Mitotic Spindles in One-Cell C. elegans Embryos	PLOS ONE			English	Article							ANTERIOR-POSTERIOR POLARITY; CAENORHABDITIS-ELEGANS; EARLY EMBRYOGENESIS; MOLECULAR MOTORS; FORCE GENERATORS; ERM PROTEINS; PAR PROTEINS; CYTOKINESIS; POSITION; ACTIN	Asymmetric positioning of the mitotic spindle in C. elegans embryos is mediated by force-generating complexes that are anchored at the plasma membrane and that pull on microtubules growing out from the spindle poles. Although asymmetric distribution of the force generators is thought to underlie asymmetric positioning of the spindle, the number and location of the force generators has not been well defined. In particular, it has not been possible to visualize individual force generating events at the cortex. We discovered that perturbation of the acto-myosin cortex leads to the formation of long membrane invaginations that are pulled from the plasma membrane toward the spindle poles. Several lines of evidence show that the invaginations, which also occur in unperturbed embryos though at lower frequency, are pulled by the same force generators responsible for spindle positioning. Thus, the invaginations serve as a tool to localize the sites of force generation at the cortex and allow us to estimate a lower limit on the number of cortical force generators within the cell.	[Redemann, Stefanie; Pecreaux, Jacques; Goehring, Nathan W.; Hyman, Anthony A.; Howard, Jonathon] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Khairy, Khaled; Stelzer, Ernst H. K.] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL)	Redemann, S (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	redemann@mpi-cbg.de; jacques.pecreaux@m4x.org; hyman@mpi-cbg.de; howard@mpi-cbg.de	Khairy, Khaled/T-4623-2018; Redemann, Stefanie/C-9256-2016; Goehring, Nathan/AAC-7310-2020; Howard, Jonathon/J-7492-2016; Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017; Stelzer, Ernst H K/A-7648-2011; Pecreaux, Jacques/A-4248-2008; Howard, Jonathon/D-4229-2011; Redemann, Stefanie/AAG-1683-2021	Goehring, Nathan/0000-0001-8710-4467; Howard, Jonathon/0000-0003-0086-1196; Hyman, Anthony A/0000-0003-3664-154X; Stelzer, Ernst H K/0000-0003-1545-0736; Pecreaux, Jacques/0000-0001-9998-4844; Howard, Jonathon/0000-0003-0086-1196; Redemann, Stefanie/0000-0003-2334-7309	Human Frontier Science Program [LT00563/2005-C]; Alexander von Humboldt Foundation; European Commission [219286]	Human Frontier Science Program(Human Frontier Science Program); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre)	JP was supported by the Human Frontier Science Program (LT00563/2005-C), NWG was supported by the Alexander von Humboldt Foundation and a Marie Curie Grant (219286) from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar K, 2010, DEVELOPMENT, V137, P237, DOI 10.1242/dev.042754; Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; BRENNER S, 1974, GENETICS, V77, P71; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bringmann H, 2007, CURR BIOL, V17, P185, DOI 10.1016/j.cub.2006.11.070; Brochard-Wyart F, 2006, P NATL ACAD SCI USA, V103, P7660, DOI 10.1073/pnas.0602012103; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Couwenbergs C, 2007, J CELL BIOL, V179, P15, DOI 10.1083/jcb.200707085; Derenyi I, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.238101; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gautreau A, 2002, CURR OPIN CELL BIOL, V14, P104, DOI 10.1016/S0955-0674(01)00300-3; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Goulding MB, 2007, J CELL BIOL, V178, P1177, DOI 10.1083/jcb.200703159; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Grill SW, 2005, DEV CELL, V8, P461, DOI 10.1016/j.devcel.2005.03.014; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; HOWARD J, 2001, MECH MOTOR PROTEINS, V16, P367; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Kachur TM, 2008, DEV BIOL, V314, P287, DOI 10.1016/j.ydbio.2007.11.028; Koster G, 2003, P NATL ACAD SCI USA, V100, P15583, DOI 10.1073/pnas.2531786100; Kozlowski C, 2007, CELL, V129, P499, DOI 10.1016/j.cell.2007.03.027; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Labbe JC, 2004, J CELL BIOL, V167, P245, DOI 10.1083/jcb.200406008; Leduc C, 2004, P NATL ACAD SCI USA, V101, P17096, DOI 10.1073/pnas.0406598101; Motegi F, 2006, NAT CELL BIOL, V8, P978, DOI 10.1038/ncb1459; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; Panbianco C, 2008, DEV CELL, V15, P198, DOI 10.1016/j.devcel.2008.06.002; PECREAUX J, 2006, TENSION BENDING, P1949; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Piekny AJ, 2002, J CELL SCI, V115, P2271; Portier N, 2007, DEV CELL, V12, P515, DOI 10.1016/j.devcel.2007.01.019; Praitis V, 2001, GENETICS, V157, P1217; Rappleye Chad A, 2003, BMC Dev Biol, V3, P8, DOI 10.1186/1471-213X-3-8; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Roux A, 2002, P NATL ACAD SCI USA, V99, P5394, DOI 10.1073/pnas.082107299; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Schonegg S, 2007, P NATL ACAD SCI USA, V104, P14976, DOI 10.1073/pnas.0706941104; Schonegg S, 2006, DEVELOPMENT, V133, P3507, DOI 10.1242/dev.02527; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Severson AF, 2002, CURR BIOL, V12, P2066, DOI 10.1016/S0960-9822(02)01355-6; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Snedecor GW, 1967, STAT METHODS, p[593, xiv]; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Tabdanov E, 2009, BIOPHYS J, V96, P2457, DOI 10.1016/j.bpj.2008.11.059; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tolic-Norrelykke IM, 2004, CURR BIOL, V14, P1181, DOI 10.1016/j.cub.2004.06.029; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Velarde N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-142; Zonies S, 2010, DEVELOPMENT, V137, P1669, DOI 10.1242/dev.045823	56	66	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12301	10.1371/journal.pone.0012301	http://dx.doi.org/10.1371/journal.pone.0012301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808841	Green Published, gold, Green Submitted			2022-12-25	WOS:000281077000009
J	Dasgupta, A; Sureka, K; Mitra, D; Saha, B; Sanyal, S; Das, AK; Chakrabarti, P; Jackson, M; Gicquel, B; Kundu, M; Basu, J				Dasgupta, Arunava; Sureka, Kamakshi; Mitra, Devrani; Saha, Baisakhee; Sanyal, Sourav; Das, Amit K.; Chakrabarti, Parul; Jackson, Mary; Gicquel, Brigitte; Kundu, Manikuntala; Basu, Joyoti			An Oligopeptide Transporter of Mycobacterium tuberculosis Regulates Cytokine Release and Apoptosis of Infected Macrophages	PLOS ONE			English	Article							BACILLUS-SUBTILIS; BINDING PROTEIN; SYSTEM; METHYLGLYOXAL; GLUTATHIONE; OPPA; ARCHITECTURE; MUTANT; CELLS	Background: The Mycobacterium tuberculosis genome encodes two peptide transporters encoded by Rv3665c-Rv3662c and Rv1280c-Rv1283c. Both belong to the family of ABC transporters containing two nucleotide-binding subunits, two integral membrane proteins and one substrate-binding polypeptide. However, little is known about their functions in M. tuberculosis. Here we report functional characterization of the Rv1280c-Rv1283c-encoded transporter and its substrate-binding polypeptide OppA(MTB). Methodology/Principal Findings: OppA(MTB) was capable of binding the tripeptide glutathione and the nonapeptide bradykinin, indicative of a somewhat broad substrate specificity. Amino acid residues G109, N110, N230, D494 and F496, situated at the interface between domains I and III of OppA, were required for optimal peptide binding. Complementaton of an oppA knockout mutant of M. smegmatis with OppA(MTB) confirmed the role of this transporter in importing glutathione and the importance of the aforesaid amino acid residues in peptide transport. Interestingly, this transporter regulated the ability of M. tuberculosis to lower glutathione levels in infected compared to uninfected macrophages. This ability was partly offset by inactivation of oppD. Concomitantly, inactivation of oppD was associated with lowered levels of methyl glyoxal in infected macrophages and reduced apoptosis-inducing ability of the mutant. The ability to induce the production of the cytokines IL-1 beta, IL-6 and TNF-alpha was also compromised after inactivation of oppD. Conclusions: Taken together, these studies uncover the novel observations that this peptide transporter modulates the innate immune response of macrophages infected with M. tuberculosis.	[Dasgupta, Arunava; Jackson, Mary; Gicquel, Brigitte] Inst Pasteur, Unite Genet Mycobacterienne, Paris, France; [Sureka, Kamakshi; Sanyal, Sourav; Chakrabarti, Parul; Kundu, Manikuntala; Basu, Joyoti] Bose Inst, Dept Chem, Kolkata, India; [Mitra, Devrani; Saha, Baisakhee; Das, Amit K.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Department of Science & Technology (India); Bose Institute; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Dasgupta, A (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.	joyoti@vsnl.com	Sureka, Kamakshi/ABE-4125-2021; Jackson, Mary/D-5345-2017	Sureka, Kamakshi/0000-0003-3093-5299; Jackson, Mary/0000-0002-9212-0258	Indo-French Centre for the Promotion of Advanced Research; Council of Scientific and Industrial Research; Indian Council of Medical Research	Indo-French Centre for the Promotion of Advanced Research(French National Research Agency (ANR)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported in part by grants from the Indo-French Centre for the Promotion of Advanced Research to B.G. and J.B., the Council of Scientific and Industrial Research to P.C. and the Indian Council of Medical Research to J.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abordo EA, 1997, IMMUNOL LETT, V58, P139, DOI 10.1016/S0165-2478(97)00080-1; Flores-Valdez MA, 2009, FASEB J, V23, P4091, DOI 10.1096/fj.09-132407; ALLOING G, 1994, J MOL BIOL, V241, P44, DOI 10.1006/jmbi.1994.1472; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Berntsson RPA, 2009, EMBO J, V28, P1332, DOI 10.1038/emboj.2009.65; Biemans-Oldehinkel E, 2006, FEBS LETT, V580, P1023, DOI 10.1016/j.febslet.2005.11.079; Davidson SD, 2002, UROL RES, V30, P116, DOI 10.1007/s00240-002-0244-7; Detmers FJM, 2000, P NATL ACAD SCI USA, V97, P12487, DOI 10.1073/pnas.220308797; Gaora PO, 1997, MED PRIN PRACT, V6, P91; Green RM, 2000, INFECT IMMUN, V68, P429, DOI 10.1128/IAI.68.2.429-436.2000; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Levdikov VM, 2005, J MOL BIOL, V345, P879, DOI 10.1016/j.jmb.2004.10.089; Mahenthiralingam E, 1998, INFECT IMMUN, V66, P3626, DOI 10.1128/IAI.66.8.3626-3634.1998; Nickitenko AV, 1995, BIOCHEMISTRY-US, V34, P16585, DOI 10.1021/bi00051a006; Nodwell JR, 1996, MOL MICROBIOL, V22, P881, DOI 10.1046/j.1365-2958.1996.01540.x; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pelicic V, 1996, MOL MICROBIOL, V20, P919, DOI 10.1111/j.1365-2958.1996.tb02533.x; PEREGO M, 1991, MOL MICROBIOL, V5, P173, DOI 10.1111/j.1365-2958.1991.tb01838.x; Prade L, 1997, BIOL CHEM, V378, P317; Rachman H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000029; RUDNER DZ, 1991, J BACTERIOL, V173, P1388, DOI 10.1128/jb.173.4.1388-1398.1991; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Tame JRH, 1995, STRUCTURE, V3, P1395, DOI 10.1016/S0969-2126(01)00276-3; Tanabe M, 2007, ACTA CRYSTALLOGR D, V63, P1185, DOI 10.1107/S0907444907048299; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; THORNALLEY PJ, 1988, BIOCHEM J, V254, P751, DOI 10.1042/bj2540751; TYNKKYNEN S, 1993, J BACTERIOL, V175, P7523, DOI 10.1128/JB.175.23.7523-7532.1993; Venketaraman V, 2008, MICROB PATHOGENESIS, V44, P255, DOI 10.1016/j.micpath.2007.09.002; Wang XG, 2004, J BACTERIOL, V186, P51, DOI 10.1128/JB.186.1.51-60.2004	32	34	36	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12225	10.1371/journal.pone.0012225	http://dx.doi.org/10.1371/journal.pone.0012225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808924	gold, Green Published, Green Submitted			2022-12-25	WOS:000280968100023
J	Hung, TH; Chen, SF; Li, MJ; Yeh, YL; Hsieh, TT				Hung, Tai-Ho; Chen, Szu-Fu; Li, Meng-Jen; Yeh, Yi-Lin; Hsieh, T'sang-T'ang			Differential Effects of Concomitant Use of Vitamins C and E on Trophoblast Apoptosis and Autophagy between Normoxia and Hypoxia-Reoxygenation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; OXIDATIVE STRESS; HUMAN PLACENTA; PREGNANT-WOMEN; CELL-DEATH; IN-VITRO; PREECLAMPSIA; EXPLANTS; RISK; RELEASE	Background: Concomitant supplementation of vitamins C and E during pregnancy has been reportedly associated with low birth weight, the premature rupture of membranes and fetal loss or perinatal death in women at risk for preeclampsia; however, the cause is unknown. We surmise that hypoxia-reoxygenation (HR) within the intervillous space due to abnormal placentation is the mechanism and hypothesize that concomitant administration of aforementioned vitamin antioxidants detrimentally affects trophoblast cells during HR. Methodology/Principal Findings: Using villous explants, concomitant administration of 50 mu M of vitamins C and E was observed to reduce apoptotic and autophagic changes in the trophoblast layer at normoxia (8% oxygen) but to cause more prominent apoptosis and autophagy during HR. Furthermore, increased levels of Bcl-2 and Bcl-xL in association with a decrease in the autophagy-related protein LC3-II were noted in cytotrophoblastic cells treated with vitamins C and E under standard culture conditions. In contrast, vitamin treatment decreased Bcl-2 and Bcl-xL as well as increased mitochondrial Bak and cytosolic LC3-II in cytotrophoblasts subjected to HR. Conclusions/Significance: Our results indicate that concomitant administration of vitamins C and E has differential effects on the changes of apoptosis, autophagy and the expression of Bcl-2 family of proteins in the trophoblasts between normoxia and HR. These changes may probably lead to the impairment of placental function and suboptimal growth of the fetus.	[Hung, Tai-Ho; Li, Meng-Jen; Yeh, Yi-Lin; Hsieh, T'sang-T'ang] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taipei 10591, Taiwan; [Hung, Tai-Ho] Chang Gung Univ, Coll Med, Dept Chinese Med, Tao Yuan, Taiwan; [Chen, Szu-Fu] Cheng Hsin Rehabil Med Ctr, Dept Phys Med & Rehabil, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Hung, TH (corresponding author), Chang Gung Mem Hosp, Dept Obstet & Gynecol, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	thh20@adm.cgmh.org.tw	Hung, Tai-Ho/C-7584-2011; Hung, Tai-Ho/ABD-1800-2020; Chen, Szu-Fu/K-5040-2012	Hung, Tai-Ho/0000-0003-2354-7060; 	National Science Council, Taiwan [NSC96-2314-B182A-061-MY3, NSC96-2314-B-182A-065-MY2]; Chang Gung Memorial Hospital [NMRPG166021]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by the National Science Council, Taiwan (NSC96-2314-B182A-061-MY3 to THH, NSC96-2314-B-182A-065-MY2 to TTH) and Chang Gung Memorial Hospital (NMRPG166021 to THH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almog B, 2002, PLACENTA, V23, P331, DOI 10.1053/plac.2002.0788; Aris A, 2008, J OBSTET GYNAECOL RE, V34, P504, DOI 10.1111/j.1447-0756.2008.00722.x; CHAN AC, 1993, CAN J PHYSIOL PHARM, V71, P725, DOI 10.1139/y93-109; Chappell LC, 1999, LANCET, V354, P810, DOI 10.1016/S0140-6736(99)80010-5; Cindrova-Davies T, 2007, AM J PATHOL, V170, P1511, DOI 10.2353/ajpath.2007.061035; Crocker IP, 2004, J PATHOL, V204, P11, DOI 10.1002/path.1610; Crocker IP, 2003, AM J PATHOL, V162, P637, DOI 10.1016/S0002-9440(10)63857-6; Hubel CA, 1999, P SOC EXP BIOL MED, V222, P222, DOI 10.1046/j.1525-1373.1999.d01-139.x; Humphrey RG, 2008, ENDOCRINOLOGY, V149, P2131, DOI 10.1210/en.2007-1253; Hung TH, 2008, PLACENTA, V29, P565, DOI 10.1016/j.placenta.2008.03.005; Hung TH, 2008, REPROD SCI, V15, P195, DOI 10.1177/1933719107310709; Hung Tai-Ho, 2006, Taiwan J Obstet Gynecol, V45, P189; Hung TH, 2002, CIRC RES, V90, P1274, DOI 10.1161/01.RES.0000024411.22110.AA; Hung TH, 2004, AM J PATHOL, V164, P1049, DOI 10.1016/S0002-9440(10)63192-6; Hung TH, 2001, AM J PATHOL, V159, P1031, DOI 10.1016/S0002-9440(10)61778-6; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kumar D, 2004, PLACENTA, V25, P573, DOI 10.1016/j.placenta.2003.12.005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Oh SY, 2008, REPROD SCI, V15, P912, DOI 10.1177/1933719108319159; Poston L, 2006, LANCET, V367, P1145, DOI 10.1016/S0140-6736(06)68433-X; Rumbold AR, 2006, NEW ENGL J MED, V354, P1796, DOI 10.1056/NEJMoa054186; Shen ZY, 2008, PLACENTA, V29, P956, DOI 10.1016/j.placenta.2008.09.001; Siman CM, 2001, AM J PHYSIOL-REG I, V280, pR1116, DOI 10.1152/ajpregu.2001.280.4.R1116; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P1395, DOI 10.1016/S0002-9378(97)70081-4; Spinnato JA, 2007, OBSTET GYNECOL, V110, P1311, DOI 10.1097/01.AOG.0000289576.43441.1f; Spinnato JA, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.011; Tanir H. Mete, 2005, Archives of Gynecology and Obstetrics, V273, P98, DOI 10.1007/s00404-005-0028-8; Tannetta DS, 2008, PLACENTA, V29, P680, DOI 10.1016/j.placenta.2008.04.009; Tjoa ML, 2006, AM J PATHOL, V169, P400, DOI 10.2353/ajpath.2006.060161; Villar J, 2009, BJOG-INT J OBSTET GY, V116, P780, DOI 10.1111/j.1471-0528.2009.02158.x; Xu HR, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.050	32	33	36	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12202	10.1371/journal.pone.0012202	http://dx.doi.org/10.1371/journal.pone.0012202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808946	Green Published, gold, Green Submitted			2022-12-25	WOS:000280968000025
J	Li, MD; Yoon, D; Lee, JY; Han, BG; Niu, T; Payne, TJ; Ma, JZ; Park, T				Li, Ming D.; Yoon, Dankyu; Lee, Jong-Young; Han, Bok-Ghee; Niu, Tianhua; Payne, Thomas J.; Ma, Jennie Z.; Park, Taesung			Associations of Variants in CHRNA5/A3/B4 Gene Cluster with Smoking Behaviors in a Korean Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LUNG-CANCER RISK; NICOTINE DEPENDENCE; RECEPTOR GENES; SUSCEPTIBILITY LOCUS; EUROPEAN-AMERICANS; TOBACCO INITIATION; CIGARETTE-SMOKING; LINKAGE ANALYSES; HEAVY SMOKING	Multiple genome-wide and targeted association studies reveal a significant association of variants in the CHRNA5-CHRNA3-CHRNB4 (CHRNA5/A3/B4) gene cluster on chromosome 15 with nicotine dependence. The subjects examined in most of these studies had a European origin. However, considering the distinct linkage disequilibrium patterns in European and other ethnic populations, it would be of tremendous interest to determine whether such associations could be replicated in populations of other ethnicities, such as Asians. In this study, we performed comprehensive association and interaction analyses for 32 single-nucleotide polymorphisms (SNPs) in CHRNA5/A3/B4 with smoking initiation (SI), smoking quantity (SQ), and smoking cessation (SC) in a Korean sample (N = 8,842). We found nominally significant associations of 7 SNPs with at least one smoking-related phenotype in the total sample (SI: P = 0.015 similar to 0.023; SQ: P = 0.008 similar to 0.028; SC: P = 0.018 similar to 0.047) and the male sample (SI: P = 0.001 similar to 0.023; SQ: P = 0.001 similar to 0.046; SC: P = 0.01). A spectrum of haplotypes formed by three consecutive SNPs located between rs16969948 in CHRNA5 and rs6495316 in the intergenic region downstream from the 5' end of CHRNB4 was associated with these three smoking-related phenotypes in both the total and the male sample. Notably, associations of these variants and haplotypes with SC appear to be much weaker than those with SI and SQ. In addition, we performed an interaction analysis of SNPs within the cluster using the generalized multifactor dimensionality reduction method and found a significant interaction of SNPs rs7163730 in LOC123688, rs6495308 in CHRNA3, and rs7166158, rs8043123, and rs11072793 in the intergenic region downstream from the 5' end of CHRNB4 to be influencing SI in the male sample. Considering that fewer than 5% of the female participants were smokers, we did not perform any analysis on female subjects specifically. Together, our detected associations of variants in the CHRNA5/A3/B4 cluster with SI, SQ, and SC in the Korean smoker samples provide strong evidence for the contribution of this cluster to the etiology of SI, ND, and SC in this Asian population.	[Li, Ming D.; Niu, Tianhua] Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22903 USA; [Yoon, Dankyu] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Lee, Jong-Young; Han, Bok-Ghee] Natl Inst Hlth, Ctr Genome Sci, Seoul, South Korea; [Payne, Thomas J.] Univ Mississippi, Med Ctr, Dept Otolaryngol & Communicat Sci, Jackson, MS 39216 USA; [Ma, Jennie Z.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Park, Taesung] Seoul Natl Univ, Coll Nat Sci, Dept Stat, Seoul 151742, South Korea	University of Virginia; Seoul National University (SNU); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; University of Mississippi; University of Mississippi Medical Center; University of Virginia; Seoul National University (SNU)	Li, MD (corresponding author), Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22903 USA.	Ming_Li@virginia.edu; tspark@stats.snu.ac.kr	Lee, Jong-Young/M-6319-2013; Payne, Thomas/R-4290-2019	Lee, Jong-Young/0000-0002-0092-9958; Payne, Thomas/0000-0002-9839-6255	Korea Science and Engineering Foundation [M10500000126]; National Institute of Health of Korea [2008-E00355-00]; National Institutes of Health [DA-12844, DA-13783]; Consortium for Large Scale Genome Wide Association Study [2008-E00355-00]; National Research Foundation [KRF-2008-313-C00086]; Ministry of Education; Korea National Institute of Health (Korea Center for Disease Control, Ministry for Health, Welfare and Family Affairs), Republic of Korea [4845-301]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012844, R01DA013783] Funding Source: NIH RePORTER	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); National Institute of Health of Korea; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Large Scale Genome Wide Association Study; National Research Foundation; Ministry of Education; Korea National Institute of Health (Korea Center for Disease Control, Ministry for Health, Welfare and Family Affairs), Republic of Korea; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the National Research Laboratory Program of the Korea Science and Engineering Foundation (M10500000126), a grant from the National Institute of Health of Korea (2008-E00355-00) to TP, and National Institutes of Health grants DA-12844 and DA-13783 to MDL. The work of TP was supported by the Consortium for Large Scale Genome Wide Association Study (2008-E00355-00), the National Research Foundation (KRF-2008-313-C00086) and the Brain Korea 21 Project of the Ministry of Education. The KARE data analyzed in this study were obtained from the Korean Genome Analysis Project (4845-301) which was funded by a grant from the Korea National Institute of Health (Korea Center for Disease Control, Ministry for Health, Welfare and Family Affairs), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; APA, 1994, DIAGN STAT MAN MENT; Baker TB, 2009, NICOTINE TOB RES, V11, P785, DOI 10.1093/ntr/ntp064; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bender R, 1997, J ROY COLL PHYS LOND, V31, P546; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Breitling LP, 2009, BIOL PSYCHIAT, V65, P691, DOI 10.1016/j.biopsych.2008.10.004; Broms U, 2006, TWIN RES HUM GENET, V9, P64, DOI 10.1375/183242706776403046; Caporaso N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004653; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Carter BL, 2004, NICOTINE TOB RES, V6, P221, DOI 10.1080/14622200410001676387; Chen XN, 2009, AM J MED GENET B, V150B, P926, DOI 10.1002/ajmg.b.30919; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Diaz FJ, 2005, AUST NZ J PSYCHIAT, V39, P161, DOI 10.1111/j.1440-1614.2005.01538.x; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gaimarri A, 2007, BRAIN RES REV, V55, P134, DOI 10.1016/j.brainresrev.2007.02.005; Ge YC, 2008, STAT SINICA, V18, P881; Greenbaum L, 2006, MOL PSYCHIATR, V11, P312, DOI 10.1038/sj.mp.4001774; HEATHERTON TF, 1989, BRIT J ADDICT, V84, P791; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jee SH, 2004, CANCER CAUSE CONTROL, V15, P341, DOI 10.1023/B:CACO.0000027481.48153.97; *KASH, 1991, SURV SMOK HAB KOR 19, P6; Kendler KS, 1999, PSYCHOL MED, V29, P299, DOI 10.1017/S0033291798008022; Keskitalo K, 2009, HUM MOL GENET, V18, P4007, DOI 10.1093/hmg/ddp322; Le Marchand L, 2008, CANCER RES, V68, P9137, DOI 10.1158/0008-5472.CAN-08-2271; Lerman C, 1998, CANCER EPIDEM BIOMAR, V7, P253; Lessov CN, 2004, PSYCHOL MED, V34, P865, DOI 10.1017/S0033291703001582; Lessov-Schlaggar CN, 2008, BIOCHEM PHARMACOL, V75, P178, DOI 10.1016/j.bcp.2007.08.018; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Li MD, 2008, HUM GENET, V123, P119, DOI 10.1007/s00439-008-0473-0; Li MD, 2010, AM J MED GENET B, V153B, P745, DOI 10.1002/ajmg.b.31043; Li MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007055; Li MD, 2009, NAT REV GENET, V10, P225, DOI 10.1038/nrg2536; Li MD, 2008, BIOL PSYCHIAT, V64, P951, DOI 10.1016/j.biopsych.2008.04.026; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Lips EH, 2010, INT J EPIDEMIOL, V39, P563, DOI 10.1093/ije/dyp288; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Maes HH, 2004, PSYCHOL MED, V34, P1251, DOI 10.1017/S0033291704002405; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Picciotto MR, 2000, NEUROPSYCHOPHARMACOL, V22, P451, DOI 10.1016/S0893-133X(99)00146-3; Piper ME, 2004, J CONSULT CLIN PSYCH, V72, P139, DOI 10.1037/0022-006X.72.2.139; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Saccone NL, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-58; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schlaelpfer IR, 2008, BIOL PSYCHIAT, V63, P1039, DOI 10.1016/j.biopsych.2007.10.024; Sherva R, 2008, ADDICTION, V103, P1544, DOI 10.1111/j.1360-0443.2008.02279.x; Shiffman S, 2004, NICOTINE TOB RES, V6, P327, DOI 10.1080/1462220042000202481; Shiraishi K, 2009, CARCINOGENESIS, V30, P65, DOI 10.1093/carcin/bgn257; Stevens VL, 2008, CANCER EPIDEM BIOMAR, V17, P3517, DOI 10.1158/1055-9965.EPI-08-0585; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; Vink JM, 2009, AM J HUM GENET, V84, P367, DOI 10.1016/j.ajhg.2009.02.001; Watkins S S, 2000, Nicotine Tob Res, V2, P19; Weiss RB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000125; Wipfli H, 2009, CLIN PHARMACOL THER, V86, P263, DOI 10.1038/clpt.2009.93; Wu C, 2009, CANCER RES, V69, P5065, DOI 10.1158/0008-5472.CAN-09-0081; Xian H, 2003, NICOTINE TOB RES, V5, P245, DOI 10.1080/1462220031000073667; Zhang H, 2003, RESPIROLOGY, V8, P17, DOI 10.1046/j.1440-1843.2003.00433.x; Zuo LJ, 2009, PHARMACOGENET GENOM, V19, P437, DOI 10.1097/FPC.0b013e32832b9cfc	64	96	98	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12183	10.1371/journal.pone.0012183	http://dx.doi.org/10.1371/journal.pone.0012183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808433	Green Submitted, Green Published, gold			2022-12-25	WOS:000280968000012
J	Sheridan, C; Brumatti, G; Elgendy, M; Brunet, M; Martin, SJ				Sheridan, C.; Brumatti, G.; Elgendy, M.; Brunet, M.; Martin, S. J.			An ERK-dependent pathway to Noxa expression regulates apoptosis by platinum-based chemotherapeutic drugs	ONCOGENE			English	Article						apoptosis; cisplatin; Noxa; BH3-only; ERK; Ras	CISPLATIN-INDUCED APOPTOSIS; BH3-ONLY PROTEINS; MITOCHONDRIAL APOPTOSIS; PROTEASOME INHIBITION; SIGNALING PATHWAY; BCL-2 FAMILY; HL-60 CELLS; CANCER; ACTIVATION; BIM	Cisplatin is a widely used cancer chemotherapeutic that promotes DNA damage-associated apoptosis. Although platinum compounds are known to form DNA adducts and provoke DNA damage, the molecular mechanism of cisplatin-induced cell death remains unclear. In this article, we show that the BH3-only protein Noxa is strongly transcriptionally upregulated in response to cisplatin and related platinum compounds. Cisplatin-induced Noxa expression was ERK dependent, but p53 independent, and inhibition of ERK activation markedly attenuated cisplatin-induced cell death, as well as Noxa expression. Furthermore, siRNA-mediated ablation of Noxa expression also inhibited cisplatin-induced cell death and permitted clonogenic survival. These observations reveal a novel ERK-regulated route to Noxa expression that is important for the cell killing activity of platinum-based chemotherapeutic drugs. Oncogene (2010) 29, 6428-6441; doi:10.1038/onc.2010.380; published online 30 August 2010	[Sheridan, C.; Brumatti, G.; Elgendy, M.; Brunet, M.; Martin, S. J.] Trinity Coll Dublin, Mol Cell Biol Lab, Dept Genet, Smurfit Inst, Dublin D2, Ireland	Trinity College Dublin	Martin, SJ (corresponding author), Trinity Coll Dublin, Mol Cell Biol Lab, Dept Genet, Smurfit Inst, Dublin D2, Ireland.	martinsj@tcd.ie		Martin, Seamus/0000-0002-8539-3143	Science Foundation Ireland [08/IN.1/B203]; Irish Cancer Society [CRP08MAR]; IRCSET	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Cancer Society; IRCSET(Irish Research Council for Science, Engineering and Technology)	We thank Dr Julian Downward, Dr Richard Marais and Dr Maria Soengas for provision of Ras, B-Raf and Bax/Bak shRNA expression plasmids, respectively; Dr Eric Eldering for provision of shRNA constructs against Noxa and Mcl-1; Dr Dean Fennell for provision of H460 cells and for very useful discussions; Dr Yihong Ye for provision of shRNA constructs against ATF4 and Dr Hans van Dam for provision of shRNA constructs against Fra1 and ATF3. We thank Science Foundation Ireland (08/IN.1/B203) and The Irish Cancer Society (CRP08MAR) for support of this work. GB was supported, in part, by an IRCSET post-doctoral fellowship. CS was supported, in part, by an IRCSET PhD studentship. SJM is a Science Foundation Ireland Principal Investigator.	Adrain C, 2006, SCIENCE, V311, P785, DOI 10.1126/science.1124154; Alves NL, 2006, IMMUNITY, V24, P703, DOI 10.1016/j.immuni.2006.03.018; Amran D, 2005, BBA-MOL CELL RES, V1743, P269, DOI 10.1016/j.bbamcr.2004.10.009; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; CHOI SS, 1995, ONCOGENE, V11, P1693; Cosaert J, 2002, BRIT J CANCER, V87, P825, DOI 10.1038/sj.bjc.6600540; Dhomen N, 2007, CURR OPIN GENET DEV, V17, P31, DOI 10.1016/j.gde.2006.12.005; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Gong JG, 1999, NATURE, V399, P806; Hao D, 2006, SEMIN RADIAT ONCOL, V16, P10, DOI 10.1016/j.semradonc.2005.08.002; Kim GP, 2007, EXPERT OPIN DRUG MET, V3, P281, DOI 10.1517/17425255.3.2.281; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kollmannsberger C, 2006, CANCER-AM CANCER SOC, V106, P1217, DOI 10.1002/cncr.21742; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; LENNON SV, 1991, CELL PROLIFERAT, V24, P203, DOI 10.1111/j.1365-2184.1991.tb01150.x; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Martin Seamus J., 1994, Current Opinion in Oncology, V6, P616, DOI 10.1097/00001622-199411000-00015; MARTIN SJ, 1990, CELL TISSUE KINET, V23, P545, DOI 10.1111/j.1365-2184.1990.tb01345.x; Muggia F, 2009, GYNECOL ONCOL, V112, P275, DOI 10.1016/j.ygyno.2008.09.034; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; O'Reilly LA, 2009, J IMMUNOL, V183, P261, DOI 10.4049/jimmunol.0803853; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Pectasides D, 2008, CANCER TREAT REV, V34, P603, DOI 10.1016/j.ctrv.2008.05.006; Petit T, 2003, MOL CANCER THER, V2, P165; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Schimmer AD, 2008, CLIN CANCER RES, V14, P8295, DOI 10.1158/1078-0432.CCR-08-0999; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schulze A, 2004, MOL BIOL CELL, V15, P3450, DOI 10.1091/mbc.E03-11-0807; Schweyer S, 2004, BRIT J CANCER, V91, P589, DOI 10.1038/sj.bjc.6601919; Sheridan C, 2008, J BIOL CHEM, V283, P22128, DOI 10.1074/jbc.M800271200; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; WOLF D, 1985, P NATL ACAD SCI USA, V82, P790, DOI 10.1073/pnas.82.3.790; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937	49	71	71	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2010	29	49					6428	6441		10.1038/onc.2010.380	http://dx.doi.org/10.1038/onc.2010.380			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	692FP	20802529				2022-12-25	WOS:000285138900003
J	Alvarado, JJ; Betts, L; Moroco, JA; Smithgall, TE; Yeh, JI				Alvarado, John J.; Betts, Laurie; Moroco, Jamie A.; Smithgall, Thomas E.; Yeh, Joanne I.			Crystal Structure of the Src Family Kinase Hck SH3-SH2 Linker Regulatory Region Supports an SH3-dominant Activation Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; C-SRC; SH3 DOMAINS; PROTEIN; ORIENTATION; DYNAMICS; RELEASE; COMPLEX; BINDING	Most mammalian cell types depend on multiple Src family kinases (SFKs) to regulate diverse signaling pathways. Strict control of SFK activity is essential for normal cellular function, and loss of kinase regulation contributes to several forms of cancer and other diseases. Previous x-ray crystal structures of the SFKs c-Src and Hck revealed that intramolecular association of their Src homology (SH) 3 domains and SH2 kinase linker regions has a key role in down-regulation of kinase activity. However, the amino acid sequence of the Hck linker represents a suboptimal ligand for the isolated SH3 domain, suggesting that it may form the polyproline type II helical conformation required for SH3 docking only in the context of the intact structure. To test this hypothesis directly, we determined the crystal structure of a truncated Hck protein consisting of the SH2 and SH3 domains plus the linker. Despite the absence of the kinase domain, the structures and relative orientations of the SH2 and SH3 domains in this shorter protein were very similar to those observed in near full-length, down-regulated Hck. However, the SH2 kinase linker adopted a modified topology and failed to engage the SH3 domain. This new structure supports the idea that these noncatalytic regions work together as a "conformational switch" that modulates kinase activity in a manner unique to the SH3 domain and linker topologies present in the intact Hck protein. Our results also provide fresh structural insight into the facile induction of Hck activity by HIV-1 Nef and other Hck SH3 domain binding proteins and implicate the existence of innate conformational states unique to individual Src family members that "fine-tune" their sensitivities to activation by SH3-based ligands.	[Alvarado, John J.; Betts, Laurie; Yeh, Joanne I.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Moroco, Jamie A.; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Smithgall, Thomas E.; Yeh, Joanne I.] Univ Pittsburgh, Sch Med, Pittsburgh Ctr Study HIV Prot Interact, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yeh, JI (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, 1036 BST3,3501 5th Ave, Pittsburgh, PA 15260 USA.	jiyeh@pitt.edu		Moroco, Jamie/0000-0001-8250-5923	National Institutes of Health (Pittsburgh Center for HIV-Protein Interactions) [AI077444, GM082251]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI077444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health (Pittsburgh Center for HIV-Protein Interactions)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants AI077444 and GM082251 (Pittsburgh Center for HIV-Protein Interactions).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arold ST, 2001, J BIOL CHEM, V276, P17199, DOI 10.1074/jbc.M011185200; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Briggs SD, 1999, J BIOL CHEM, V274, P26579, DOI 10.1074/jbc.274.37.26579; Chong YP, 2005, BBA-PROTEINS PROTEOM, V1754, P210, DOI 10.1016/j.bbapap.2005.07.027; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ECK MJ, 1994, NATURE, V368, P764, DOI 10.1038/368764a0; Emert-Sedlak L, 2009, ACS CHEM BIOL, V4, P939, DOI 10.1021/cb900195c; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; Fushman D, 1999, BIOCHEMISTRY-US, V38, P10225, DOI 10.1021/bi990897g; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Guiet R, 2008, EUR J CELL BIOL, V87, P527, DOI 10.1016/j.ejcb.2008.03.008; Hochrein JM, 2006, PROTEIN SCI, V15, P65, DOI 10.1110/ps.051782206; Hofmann G, 2005, BIOCHEMISTRY-US, V44, P13043, DOI 10.1021/bi050814y; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lerner EC, 2005, J BIOL CHEM, V280, P40832, DOI 10.1074/jbc.M508782200; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; RICKLES RJ, 1995, P NATL ACAD SCI USA, V92, P10909, DOI 10.1073/pnas.92.24.10909; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schreiner SJ, 2002, J BIOL CHEM, V277, P45680, DOI 10.1074/jbc.M204255200; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4	38	23	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35455	35461		10.1074/jbc.M110.145102	http://dx.doi.org/10.1074/jbc.M110.145102			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20810664	Green Published, hybrid			2022-12-25	WOS:000283845300023
J	Zeng, L; Akasaki, Y; Sato, K; Ouchi, N; Izumiya, Y; Walsh, K				Zeng, Ling; Akasaki, Yuichi; Sato, Kaori; Ouchi, Noriyuki; Izumiya, Yasuhiro; Walsh, Kenneth			Insulin-like 6 Is Induced by Muscle Injury and Functions as a Regenerative Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; RELAXIN-FAMILY PEPTIDES; STEM-CELL FUNCTION; SKELETAL-MUSCLE; FACTOR-I; IGF-I; EXPRESSION; HYPERTROPHY; DIFFERENTIATION; MICE	The insulin-like family of factors are involved in the regulation of a variety of physiological processes, but the function of the family member termed insulin-like 6 (Insl6) in skeletal muscle has not been reported. We show that Insl6 is a myokine that is up-regulated in skeletal muscle downstream of Akt signaling and in regenerating muscle in response to cardiotoxin (CTX)-induced injury. In the CTX injury model, myofiber regeneration was improved by the intramuscular or systemic delivery of an adenovirus expressing Insl6. Skeletal muscle-specific Insl6 transgenic mice exhibited normal muscle mass under basal conditions but elevated satellite cell activation and enhanced muscle regeneration in response to CTX injury. The Insl6-mediated regenerative response was associated with reductions in muscle cell apoptosis and reduced serum levels of creatine kinase M. Overexpression of Insl6 stimulated proliferation and reduced apoptosis in cultured myogenic cells. Conversely, knockdown of Insl6 reduced proliferation and increased apoptosis. These data indicate that Insl6 is an injury-regulated myokine that functions as a myogenic regenerative factor.	[Walsh, Kenneth] Boston Univ, Mol Cardiol Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Akasaki, Yuichi] Kagoshima Univ, Grad Sch Med, Dept Cardiovasc Resp & Metab Med, Kagoshima 8908520, Japan; [Izumiya, Yasuhiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan	Boston University; Kagoshima University; Kumamoto University	Walsh, K (corresponding author), Boston Univ, Mol Cardiol Whitaker Cardiovasc Inst, Med Campus,715 Albany St,W611, Boston, MA 02118 USA.	kxwalsh@bu.edu	OUCHI, Noriyuki/I-7306-2014		NATIONAL INSTITUTE ON AGING [R01AG034972] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG034972] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams GR, 1998, J APPL PHYSIOL, V84, P1716, DOI 10.1152/jappl.1998.84.5.1716; ALLEN RE, 1989, J CELL PHYSIOL, V138, P311, DOI 10.1002/jcp.1041380213; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Armand AS, 2003, DEV DYNAM, V227, P256, DOI 10.1002/dvdy.10306; Bathgate RA, 2005, ANN NY ACAD SCI, V1041, P61, DOI 10.1196/annals.1282.010; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Brack AS, 2007, STEM CELL REV, V3, P226, DOI 10.1007/s12015-007-9000-2; Brailoiu GC, 2005, BRAIN RES, V1040, P187, DOI 10.1016/j.brainres.2005.01.077; Burnicka-Turek O, 2009, ENDOCRINOLOGY, V150, P4348, DOI 10.1210/en.2009-0201; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen KC, 2008, TOXICON, V51, P624, DOI 10.1016/j.toxicon.2007.11.024; COLEMAN ME, 1995, J BIOL CHEM, V270, P12109, DOI 10.1074/jbc.270.20.12109; Collins CA, 2006, CURR OPIN PHARMACOL, V6, P301, DOI 10.1016/j.coph.2006.01.006; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Fujio Y, 1999, MOL CELL BIOL, V19, P5073; Garry DJ, 2000, P NATL ACAD SCI USA, V97, P5416, DOI 10.1073/pnas.100501197; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; Gonzalez-Cadavid NF, 2004, CURR OPIN CLIN NUTR, V7, P451, DOI 10.1097/01.mco.0000134365.99523.7f; Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x; Hayashi S, 2004, HISTOCHEM CELL BIOL, V122, P427, DOI 10.1007/s00418-004-0704-y; Hojman P, 2009, DIABETES, V58, P2797, DOI 10.2337/db09-0713; Hsu SYT, 2005, ANN NY ACAD SCI, V1041, P520, DOI 10.1196/annals.1282.078; Ivell R, 2009, ENDOCRINOLOGY, V150, P3986, DOI 10.1210/en.2009-0691; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Kasemkijwattana C, 1998, CELL TRANSPLANT, V7, P585, DOI 10.1016/S0963-6897(98)00037-2; Krzysik-Walker SM, 2008, ENDOCRINOLOGY, V149, P1543, DOI 10.1210/en.2007-1301; Li Y, 2005, ANN NY ACAD SCI, V1041, P395, DOI 10.1196/annals.1282.060; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Lok S, 2000, BIOL REPROD, V62, P1593, DOI 10.1095/biolreprod62.6.1593; Lu CX, 2006, ENDOCRINOLOGY, V147, P5611, DOI 10.1210/en.2006-0503; MacGregor J, 1996, Can J Appl Physiol, V21, P236; Machida S, 2006, ANN NY ACAD SCI, V1067, P349, DOI 10.1196/annals.1354.049; Mackey AL, 2009, MUSCLE NERVE, V40, P455, DOI 10.1002/mus.21369; McArdle A, 2006, EXP GERONTOL, V41, P497, DOI 10.1016/j.exger.2006.02.002; Menetrey J, 2000, J BONE JOINT SURG BR, V82B, P131, DOI 10.1302/0301-620X.82B1.8954; MILLER JB, 2003, SCI AGING KNOWLEDGE, pPE34; Miller KJ, 2000, AM J PHYSIOL-CELL PH, V278, pC174, DOI 10.1152/ajpcell.2000.278.1.C174; Mitchell CA, 1996, GROWTH FACTORS, V13, P37, DOI 10.3109/08977199609034565; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Negishi S, 2005, AM J SPORT MED, V33, P1816, DOI 10.1177/0363546505278701; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527; Patel K, 2005, NEUROMUSCULAR DISORD, V15, P117, DOI 10.1016/j.nmd.2004.10.018; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Pedersen BK, 2005, BRAIN BEHAV IMMUN, V19, P371, DOI 10.1016/j.bbi.2005.04.008; Peter AK, 2009, HUM MOL GENET, V18, P318, DOI 10.1093/hmg/ddn358; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sato K, 2003, MUSCLE NERVE, V28, P365, DOI 10.1002/mus.10436; Schiekofer S, 2008, ANGIOGENESIS, V11, P289, DOI 10.1007/s10456-008-9112-6; Schiekofer S, 2006, PHYSIOL GENOMICS, V27, P156, DOI 10.1152/physiolgenomics.00234.2005; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Shibata R, 2007, CARDIOVASC RES, V74, P471, DOI 10.1016/j.cardiores.2007.02.010; Sinha-Hikim I, 2007, APOPTOSIS, V12, P1965, DOI 10.1007/s10495-007-0120-6; STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896; Takahashi A, 2002, MOL CELL BIOL, V22, P4803, DOI 10.1128/MCB.22.13.4803-4814.2002; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; Wilkinson TN, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-14; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200	59	36	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36060	36069		10.1074/jbc.M110.160879	http://dx.doi.org/10.1074/jbc.M110.160879			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20807758	Green Published, hybrid			2022-12-25	WOS:000283845300082
J	Ohmine, S; Sakuma, R; Sakuma, T; Thatava, T; Solis, GP; Ikeda, Y				Ohmine, Seiga; Sakuma, Ryuta; Sakuma, Toshie; Thatava, Tayaramma; Solis, Gonzalo P.; Ikeda, Yasuhiro			Cytoplasmic Body Component TRIM5 alpha Requires Lipid-enriched Microdomains for Efficient HIV-1 Restriction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RETROVIRAL RESTRICTION; MEMBRANE MICRODOMAINS; ENDOCYTIC PATHWAY; OLD-WORLD; PROTEINS; DROPLETS; BODIES; ENTRY; FAMILY	TRIM5 alpha is a member of the tripartite motif (TRIM) family of proteins and affects both early and late phases of the retroviral life cycle. Although TRIM5 alpha multimerizes to form cytoplasmic bodies, which are thought to play an important role in viral restriction, the identity of TRIM5 alpha-containing cytoplasmic bodies remains elusive. To better understand TRIM5 alpha cytoplasmic body constituents and the cellular proteins that could be involved in the TRIM5 alpha-mediated antiviral activities, we sought TRIM5 alpha-binding factors. We identified a lipid microdomain protein flotillin-1/Reggie-2 as an interacting partner of TRIM5 alpha via co-immunoprecipitation. Immunohistochemistry studies confirmed the co-localization of rhesus monkey TRIM5 alpha (TRIM5 alpha rh) cytoplasmic bodies with flotillin-1/Reggie-2. Caveolin-1, another lipid microdomain-associated protein, also co-localized with TRIM5 alpha cytoplasmic bodies. Intriguingly, disruption of cellular cholesterol by cyclodextrin perturbed TRIM5 alpha cytoplasmic body formation. Furthermore, lipid starvation partially relieved the endogenous post-entry restriction of HIV-1 infection, which could be subsequently restored by lipid repletion. These observations indicate the involvement of cellular lipids in TRIM5 alpha-mediated antiviral activities. Given that many viruses utilize cellular lipid microdomains for viral entry and assembly, it is plausible that lipid-enriched domains provide microenvironments where TRIM5 alpha recognizes retroviral components.	Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Solis, Gonzalo P.] Univ Konstanz, Dept Biol, D-78457 Constance, Germany	Mayo Clinic; University of Konstanz	Ikeda, Y (corresponding author), 200 1st St SW, Rochester, MN 55905 USA.	ikeda.yasuhiro@mayo.edu	Solís Sánchez, Gonzalo/C-9088-2015	Solís Sánchez, Gonzalo/0000-0003-0363-831X; Solis, Gonzalo P./0000-0002-2359-3780	National Institutes of Health [1R56AI074363-01A1]; Mayo Foundation; Siebens Ph.D. training fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI074363] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; Siebens Ph.D. training fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R56AI074363-01A1 (to Y.I.). This work was also supported by the Mayo Foundation (to Y.I.).; Recipient of a Siebens Ph.D. training fellowship.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Beer C, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-21; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Campbell EM, 2008, J CELL BIOL, V180, P549, DOI 10.1083/jcb.200706154; Campbell EM, 2007, MOL BIOL CELL, V18, P2102, DOI 10.1091/mbc.E06-12-1075; Carter GC, 2009, VIROLOGY, V386, P192, DOI 10.1016/j.virol.2008.12.031; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Cicala C, 2002, P NATL ACAD SCI USA, V99, P9380, DOI 10.1073/pnas.142287999; del Real G, 2002, J EXP MED, V196, P293, DOI 10.1084/jem.20020308; Diaz-Griffero F, 2006, VIROLOGY, V351, P404, DOI 10.1016/j.virol.2006.03.023; Diaz-Griffero F, 2006, VIROLOGY, V349, P300, DOI 10.1016/j.virol.2005.12.040; Dremina ES, 2005, J NEUROCHEM, V93, P1262, DOI 10.1111/j.1471-4159.2005.03115.x; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Fujimoto T, 2001, J CELL BIOL, V152, P1079, DOI 10.1083/jcb.152.5.1079; Fujimoto T, 2006, ANN NY ACAD SCI, V1086, P104, DOI 10.1196/annals.1377.010; Fujimoto T, 2006, AUTOPHAGY, V2, P299, DOI 10.4161/auto.2904; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007; Gurer C, 2002, J VIROL, V76, P4666, DOI 10.1128/JVI.76.9.4666-4670.2002; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Hwang CY, 2010, J BIOL CHEM, V285, P7827, DOI 10.1074/jbc.M109.040618; Javanbakht H, 2005, J BIOL CHEM, V280, P26933, DOI 10.1074/jbc.M502145200; Javanbakht H, 2006, VIROLOGY, V353, P234, DOI 10.1016/j.virol.2006.05.017; Jiang HF, 2007, BBA-MOL CELL BIOL L, V1771, P66, DOI 10.1016/j.bbalip.2006.10.004; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kaumanns P, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-79; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Kim SY, 2009, PROTEOMICS, V9, P4321, DOI 10.1002/pmic.200900077; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lindwasser OW, 2001, J VIROL, V75, P7913, DOI 10.1128/JVI.75.17.7913-7924.2001; LUCIW PA, 1992, AIDS RES HUM RETROV, V8, P395, DOI 10.1089/aid.1992.8.395; Marchant D, 2005, J VIROL, V79, P9410, DOI 10.1128/JVI.79.15.9410-9418.2005; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martin S, 2005, SEMIN CELL DEV BIOL, V16, P163, DOI 10.1016/j.semcdb.2005.01.007; MO R, 1999, J VIROL */* E J VIRO, V73, P2343; NE GRED, 2000, Gene Ther */* F L GE, V7, P1613; Noser JA, 2006, J VIROL, V80, P7769, DOI 10.1128/JVI.02427-05; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Ostermeyer AG, 2001, J CELL BIOL, V152, P1071, DOI 10.1083/jcb.152.5.1071; Perez-Caballero D, 2005, J VIROL, V79, P15567, DOI 10.1128/JVI.79.24.15567-15572.2005; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Popik W, 2002, J VIROL, V76, P4709, DOI 10.1128/JVI.76.10.4709-4722.2002; Quirin K, 2008, VIROLOGY, V378, P21, DOI 10.1016/j.virol.2008.04.046; Rajendran L, 2007, BIOL CHEM, V388, P307, DOI 10.1515/BC.2007.034; Reuter A, 2004, CELL MOL LIFE SCI, V61, P2092, DOI 10.1007/s00018-004-4193-x; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rojek JM, 2008, J VIROL, V82, P1505, DOI 10.1128/JVI.01331-07; Rold CJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000074; Sakuma R, 2007, NAT MED, V13, P631, DOI 10.1038/nm1562; Sakuma R, 2007, J VIROL, V81, P10201, DOI 10.1128/JVI.00419-07; Sakuma R, 2010, J BIOL CHEM, V285, P3784, DOI 10.1074/jbc.M109.059063; Sastri J, 2010, VIROLOGY, V405, P259, DOI 10.1016/j.virol.2010.06.015; Schmitz C, 2004, J VIROL, V78, P2006, DOI 10.1128/JVI.78.4.2006-2016.2004; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Song B, 2005, VIROLOGY, V343, P201, DOI 10.1016/j.virol.2005.08.019; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Stuermer CAO, 2005, BIOCHEM SOC SYMP, V72, P109, DOI 10.1042/bss0720109; Waheed AA, 2008, J VIROL, V82, P9776, DOI 10.1128/JVI.00917-08; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Yap MW, 2004, P NATL ACAD SCI USA, V101, P10786, DOI 10.1073/pnas.0402876101; Yonezawa A, 2005, J VIROL, V79, P918, DOI 10.1128/JVI.79.2.918-926.2005; Zhang F, 2008, NAT MED, V14, P235, DOI 10.1038/nm0308-235; Zhang XF, 2010, MICROBES INFECT, V12, P768, DOI 10.1016/j.micinf.2010.05.004; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	73	5	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34508	34517		10.1074/jbc.M110.158188	http://dx.doi.org/10.1074/jbc.M110.158188			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810659	Green Published, hybrid			2022-12-25	WOS:000283659100026
J	Pascual, MB; Mata-Cabana, A; Florencio, FJ; Lindahl, M; Cejudo, FJ				Pascual, Maria B.; Mata-Cabana, Alejandro; Florencio, Francisco J.; Lindahl, Marika; Cejudo, Francisco J.			Overoxidation of 2-Cys Peroxiredoxin in Prokaryotes CYANOBACTERIAL 2-CYS PEROXIREDOXINS SENSITIVE TO OXIDATIVE STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; THIOL-SPECIFIC ANTIOXIDANT; OXYR TRANSCRIPTION FACTOR; HYDROGEN-PEROXIDE; ARABIDOPSIS-THALIANA; PHOTOOXIDATIVE STRESS; THIOREDOXIN; REDUCTASE; PLANTS; CYANOBACTERIA	In eukaryotic organisms, hydrogen peroxide has a dual effect; it is potentially toxic for the cell but also has an important signaling activity. According to the previously proposed floodgate hypothesis, the signaling activity of hydrogen peroxide in eukaryotes requires a transient increase in its concentration, which is due to the inactivation by overoxidation of 2-Cys peroxiredoxin (2-Cys Prx). Sensitivity to overoxidation depends on the structural GGLG and YF motifs present in eukaryotic 2-Cys Prxs and is believed to be absent from prokaryotic enzymes, thus representing a paradoxical gain of function exclusive to eukaryotic organisms. Here we show that 2-Cys Prxs from several prokaryotic organisms, including cyanobacteria, contain the GG(L/V/I) G and YF motifs characteristic of sensitive enzymes. In search of the existence of overoxidation-sensitive 2-Cys Prxs in prokaryotes, we have analyzed the sensitivity to overoxidation of 2-Cys Prxs from two cyanobacterial strains, Anabaena sp. PCC7120 and Synechocystis sp. PCC6803. In vitro analysis of wild type and mutant variants of the Anabaena 2-Cys Prx showed that this enzyme is overoxidized at the peroxidatic cysteine residue, thus constituting an exception among prokaryotes. Moreover, the 2-Cys Prx from Anabaena is readily and reversibly overoxidized in vivo in response to high light and hydrogen peroxide, showing higher sensitivity to overoxidation than the Synechocystis enzyme. These cyanobacterial strains have different strategies to cope with hydrogen peroxide. While Synechocystis has low content of less sensitive 2-Cys Prx and high catalase activity, Anabaena contains abundant and sensitive 2-Cys Prx, but low catalase activity, which is remarkably similar to the chloroplast system.	[Cejudo, Francisco J.] Univ Seville, Inst Bioquim Vegetal & Fotosintesis, Seville 41092, Spain; CSIC, Seville 41092, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); Consejo Superior de Investigaciones Cientificas (CSIC)	Cejudo, FJ (corresponding author), Univ Seville, Inst Bioquim Vegetal & Fotosintesis, Avda Amer Vespucio 49, Seville 41092, Spain.	fjcejudo@us.es	Cabana, Alejandro Mata/U-8388-2019; Pascual, Belén/H-5242-2015; Florencio, Francisco J/K-7716-2014; Cejudo, Francisco Javier/M-2749-2014; Lindahl, Marika/H-2259-2017	Cabana, Alejandro Mata/0000-0002-0179-2746; Florencio, Francisco J/0000-0002-2068-7861; Cejudo, Francisco Javier/0000-0002-3936-5491; Pascual/0000-0002-7988-1204; Lindahl, Marika/0000-0003-1627-0809	Ministerio de Educacion y Ciencia (Spain) [BIO2007-60644, BFU2007-60300]; Junta de Andalucia (Spain) [P06-CVI-01578, BIO-182, BIO-284]	Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Junta de Andalucia (Spain)(Junta de Andalucia)	This work was supported by Grants BIO2007-60644 and BFU2007-60300 from the Ministerio de Educacion y Ciencia (Spain) and Grants P06-CVI-01578, BIO-182, and BIO-284 from the Junta de Andalucia (Spain).	Aran M, 2008, FEBS J, V275, P1450, DOI 10.1111/j.1742-4658.2008.06299.x; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Baier M, 1997, PLANT J, V12, P179, DOI 10.1046/j.1365-313X.1997.12010179.x; Bernroitner M, 2009, J EXP BOT, V60, P423, DOI 10.1093/jxb/ern309; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Broin M, 2003, PLANT PHYSIOL, V132, P1335, DOI 10.1104/pp.103.021626; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7022, DOI 10.1073/pnas.91.15.7022; Deusch O, 2008, MOL BIOL EVOL, V25, P748, DOI 10.1093/molbev/msn022; Dietz KJ, 2006, J EXP BOT, V57, P1697, DOI 10.1093/jxb/erj160; Dietz KJ, 2002, J EXP BOT, V53, P1321, DOI 10.1093/jexbot/53.372.1321; Perez-Perez ME, 2009, J BACTERIOL, V191, P7477, DOI 10.1128/JB.00831-09; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Galvez-Valdivieso G, 2009, PLANT CELL, V21, P2143, DOI 10.1105/tpc.108.061507; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Huang CH, 2010, J BIOCHEM, V147, P661, DOI 10.1093/jb/mvp209; Iglesias-Baena I, 2010, J EXP BOT, V61, P1509, DOI 10.1093/jxb/erq016; Kirchsteiger K, 2009, MOL PLANT, V2, P298, DOI 10.1093/mp/ssn082; Laloi C, 2007, P NATL ACAD SCI USA, V104, P672, DOI 10.1073/pnas.0609063103; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Lindahl M, 2003, P NATL ACAD SCI USA, V100, P16107, DOI 10.1073/pnas.2534397100; Miller AG, 2000, PLANT PHYSIOL, V123, P625, DOI 10.1104/pp.123.2.625; Mimuro M, 2008, PHOTOSYNTH RES, V97, P167, DOI 10.1007/s11120-008-9311-4; Mullineaux PM, 2006, PLANT PHYSIOL, V141, P346, DOI 10.1104/pp.106.078162; Parsonage D, 2010, P NATL ACAD SCI USA, V107, P6240, DOI 10.1073/pnas.0910057107; PE R, 2006, PLANT CELL */* F J P, V18, P2356; PE R, 2009, FEBS LETT */* F J FE, V583, P1399; Pitzschke A, 2006, ANTIOXID REDOX SIGN, V8, P1757, DOI 10.1089/ars.2006.8.1757; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Rey P, 2007, PLANT J, V49, P505, DOI 10.1111/j.1365-313X.2006.02969.x; Serrato AJ, 2004, J BIOL CHEM, V279, P43821, DOI 10.1074/jbc.M404696200; Tichy M, 1999, J BACTERIOL, V181, P1875, DOI 10.1128/JB.181.6.1875-1882.1999; Vandenabeele S, 2003, P NATL ACAD SCI USA, V100, P16113, DOI 10.1073/pnas.2136610100; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Weber H, 2004, MOL MICROBIOL, V52, P133, DOI 10.1111/j.1365-2958.2004.03971.x; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	44	64	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34485	34492		10.1074/jbc.M110.160465	http://dx.doi.org/10.1074/jbc.M110.160465			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20736168	Green Published, hybrid			2022-12-25	WOS:000283659100023
J	Rey, M; Man, P; Clemencon, B; Trezeguet, V; Brandolin, G; Forest, E; Pelosi, L				Rey, Martial; Man, Petr; Clemencon, Benjamin; Trezeguet, Veronique; Brandolin, Gerard; Forest, Eric; Pelosi, Ludovic			Conformational Dynamics of the Bovine Mitochondrial ADP/ATP Carrier Isoform 1 Revealed by Hydrogen/Deuterium Exchange Coupled to Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE CARRIER; ADP ATP CARRIER; PHOSPHOLIPASE A(2); DEUTERIUM-EXCHANGE; HEART-MITOCHONDRIA; MEMBRANE-PROTEINS; CYSTEINE RESIDUES; N-ETHYLMALEIMIDE; LIPID-MEMBRANE; TRANSPORT	The mitochondrial adenine nucleotide carrier (Ancp) catalyzes the transport of ADP and ATP across the mitochondrial inner membrane, thus playing an essential role in cellular energy metabolism. During the transport mechanism the carrier switches between two different conformations that can be blocked by two toxins: carboxyatractyloside (CATR) and bongkrekic acid. Therefore, our understanding of the nucleotide transport mechanism can be improved by analyzing structural differences of the individual inhibited states. We have solved the three-dimensional structure of bovine carrier isoform 1 (bAnc1p) in a complex with CATR, but the structure of the carrier-bongkrekic acid complex, and thus, the detailed mechanism of transport remains unknown. Improvements in sample processing in the hydrogen/deuterium exchange technique coupled to mass spectrometry (HDX-MS) have allowed us to gain novel insights into the conformational changes undergone by bAnc1p. This paper describes the first study of bAnc1p using HDX-MS. Results obtained with the CATR-bAnc1p complex were fully in agreement with published results, thus, validating our approach. On the other hand, the HDX kinetics of the two complexes displays marked differences. The bongkrekic acid-bAnc1p complex exhibits greater accessibility to the solvent on the matrix side, whereas the CATR-bAnc1p complex is more accessible on the intermembrane side. These results are discussed with respect to the structural and biochemical data available on Ancp.	[Man, Petr; Forest, Eric] Univ Grenoble 1, CEA, CNRS, LSMP,IBS,UMR 5075, F-38027 Grenoble 1, France; [Rey, Martial; Clemencon, Benjamin; Brandolin, Gerard; Pelosi, Ludovic] Univ Grenoble 1, Lab Biochim & Biophys Syst Integres, Inst Rech Technol & Sci Vivant, CNRS Commissariat Energie Atom,UMR 5092, F-38054 Grenoble 9, France; [Man, Petr] Acad Sci Czech Republ, Vvi, Inst Microbiol, CZ-14220 Prague 4, Czech Republic; [Trezeguet, Veronique] Univ Bordeaux 2, CNRS, UMR 5095, Lab Physiol Mol,Inst Biochim & Genet Cellulaires, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Forest, E (corresponding author), Univ Grenoble 1, CEA, CNRS, LSMP,IBS,UMR 5075, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.	eric.forest@ibs.fr; ludovic.pelosi@cea.fr	Forest, Eric/E-9042-2012; Man, Petr/H-2451-2014; Pelosi, Ludovic/M-6406-2014; Pelosi, Ludovic/AAB-9832-2020	Man, Petr/0000-0002-1485-2197; Pelosi, Ludovic/0000-0002-4198-5681; Rey, Martial/0000-0002-7378-1106; Trezeguet, Veronique/0000-0003-2487-7571	University Joseph Fourier; CNRS; Commissariat a l'Energie Atomique; Institutional Research Concept of the Institute of Microbiology	University Joseph Fourier; CNRS(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique(French Atomic Energy Commission); Institutional Research Concept of the Institute of Microbiology	This work was supported by grants from the University Joseph Fourier, the CNRS, and the Commissariat a l'Energie Atomique (programme Signalisation et Transport Membranaires).; Supported by the Institutional Research Concept of the Institute of Microbiology and by a fellowship from the Commissariat a l'Energie Atomique.	AQUILA H, 1982, H-S Z PHYSIOL CHEM, V363, P345; BLOCK MR, 1984, BIOCHIM BIOPHYS ACTA, V767, P369, DOI 10.1016/0005-2728(84)90207-X; BOULAY F, 1984, BIOCHEMISTRY-US, V23, P4807, DOI 10.1021/bi00315a042; BRANDOLIN G, 1989, BIOCHEMISTRY-US, V28, P1093, DOI 10.1021/bi00429a025; BRANDOLIN G, 1980, BIOCHIM BIOPHYS ACTA, V592, P592, DOI 10.1016/0005-2728(80)90103-6; Burke JE, 2008, J BIOL CHEM, V283, P31227, DOI 10.1074/jbc.M804492200; Burke JE, 2008, BIOCHEMISTRY-US, V47, P6451, DOI 10.1021/bi8000962; Busenlehner LS, 2004, BIOCHEMISTRY-US, V43, P11145, DOI 10.1021/bi048716k; Chenal A, 2005, J MOL BIOL, V349, P890, DOI 10.1016/j.jmb.2005.04.036; Cravello L, 2003, RAPID COMMUN MASS SP, V17, P2387, DOI 10.1002/rcm.1207; Falconi M, 2006, PROTEINS, V65, P681, DOI 10.1002/prot.21102; Feng JH, 2008, CARDIOVASC RES, V80, P20, DOI 10.1093/cvr/cvn161; Feng JH, 2010, AM J PHYSIOL-CELL PH, V298, pC740, DOI 10.1152/ajpcell.00310.2009; Halskau O, 2002, J MOL BIOL, V321, P99, DOI 10.1016/S0022-2836(02)00565-X; Hamuro Y, 2008, RAPID COMMUN MASS SP, V22, P1041, DOI 10.1002/rcm.3467; Hebling CM, 2010, ANAL CHEM, V82, P5415, DOI 10.1021/ac100962c; Hsu YH, 2009, J BIOL CHEM, V284, P23652, DOI 10.1074/jbc.M109.021857; Iwahashi A, 2006, MITOCHONDRION, V6, P245, DOI 10.1016/j.mito.2006.07.007; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Kihira Y, 2005, BIOCHEMISTRY-US, V44, P184, DOI 10.1021/bi0488653; KLINGENBERG M, 1989, ARCH BIOCHEM BIOPHYS, V270, P1, DOI 10.1016/0003-9861(89)90001-5; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Krishna MMG, 2004, METHODS, V34, P51, DOI 10.1016/j.ymeth.2004.03.005; LAUQUIN GJM, 1976, BIOCHEMISTRY-US, V15, P2316, DOI 10.1021/bi00656a011; Lewandrowski U, 2008, FEBS LETT, V582, P1104, DOI 10.1016/j.febslet.2008.02.077; MAJIMA E, 1994, BIOCHEMISTRY-US, V33, P9530, DOI 10.1021/bi00198a019; MAJIMA E, 1993, J BIOL CHEM, V268, P22181; Man P, 2007, J MOL BIOL, V368, P464, DOI 10.1016/j.jmb.2007.02.014; MARTY I, 1992, BIOCHEMISTRY-US, V31, P4058, DOI 10.1021/bi00131a023; Mazon H, 2005, BIOCHIMIE, V87, P1101, DOI 10.1016/j.biochi.2005.05.012; Nury H, 2008, BIOCHEMISTRY-US, V47, P12319, DOI 10.1021/bi801053m; Palmieri F, 2010, FEBS LETT, V584, P1931, DOI 10.1016/j.febslet.2009.10.063; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Pinheiro TJT, 2000, J MOL BIOL, V303, P617, DOI 10.1006/jmbi.2000.4159; Redfield Christina, 2004, Methods Mol Biol, V278, P233; Rey M, 2010, ANAL CHEM, V82, P5107, DOI 10.1021/ac100171m; Rey M, 2009, RAPID COMMUN MASS SP, V23, P3431, DOI 10.1002/rcm.4260; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; SARASTE M, 1982, FEBS LETT, V144, P250, DOI 10.1016/0014-5793(82)80648-0; TREZE G, 2008, J Bioenerg Biomembr, V40, P435; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401; Wang Y, 2008, P NATL ACAD SCI USA, V105, P9598, DOI 10.1073/pnas.0801786105; Wu Y, 2006, ANAL CHEM, V78, P1719, DOI 10.1021/ac0518497; Zhang X, 2010, ANAL CHEM, V82, P1100, DOI 10.1021/ac902484p; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	46	32	32	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34981	34990		10.1074/jbc.M110.146209	http://dx.doi.org/10.1074/jbc.M110.146209			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20805227	Green Published, hybrid			2022-12-25	WOS:000283659100072
J	Park, UH; Kim, EJ; Um, SJ				Park, Ui-Hyun; Kim, Eun-Joo; Um, Soo-Jong			A Novel Cytoplasmic Adaptor for Retinoic Acid Receptor (RAR) and Thyroid Receptor Functions as a Derepressor of RAR in the Absence of Retinoic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR HORMONE-RECEPTORS; CO-REPRESSOR; STRUCTURAL BASIS; BINDING DOMAIN; P53 FAMILY; IN-VIVO; IDENTIFICATION; PROTEIN; LOCALIZATION; RECRUITMENT	In most mammalian cells, the retinoic acid receptor (RAR) is nuclear rather than cytoplasmic, regardless of its cognate ligand, retinoic acid (RA). In testis Sertoli cells, however, RAR is retained in the cytoplasm and moves to the nucleus only when RA is supplied. This led us to identify a protein that regulates the translocation of RAR. From yeast two-hybrid screening, we identified a novel RAR-interacting protein called CART1 (cytoplasmic adaptor for RAR and TR). Systematic interaction assays using deletion mutants showed that the C-terminal CoRNR box of CART1 was responsible for the interaction with the NCoR binding region of RAR and TR. Such interaction was impaired in the presence of ligand RA, as further determined by GST pull-down assays in vitro and immunoprecipitation assays in vivo. Fluorescence microscopy showed that unliganded RAR was captured by CART1 in the cytoplasm, whereas liganded RAR was liberated and moved to the nucleus. Overexpression of CART1 blocked the transcriptional repressing activity of unliganded apo RAR, mediated by corepressor NCoR in the nucleus. CART1 siRNA treatment in a mouse Sertoli cell line, TM4, allowed RAR to move to the nucleus and blocked the derepressing function of CART1, suggesting that CART1 might be a cytoplasmic, testis-specific derepressor of RAR.	[Kim, Eun-Joo] Dankook Univ, Dept Mol Biol, Yongin 448701, Gyeonggi Do, South Korea; [Park, Ui-Hyun; Um, Soo-Jong] Sejong Univ, Dept Biosci & Biotechnol, Seoul 143747, South Korea	Dankook University; Sejong University	Kim, EJ (corresponding author), Dankook Univ, Dept Mol Biol, Yongin 448701, Gyeonggi Do, South Korea.	nbrejk@dankook.ac.kr; umsj@sejong.ac.kr			NRF MEST, Republic of Korea [2007-0053438, 2008-0057731, 2009-0064593]	NRF MEST, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program through NRF MEST Grants 2007-0053438 and 2008-0057731 (to S.-J.U.) and 2009-0064593 (to E.-J.K.), Republic of Korea.	Akmal KM, 1998, ENDOCRINOLOGY, V139, P1239, DOI 10.1210/en.139.3.1239; BANIAHMAD A, 1992, EMBO J, V11, P1015, DOI 10.1002/j.1460-2075.1992.tb05140.x; Baumann CT, 2001, J BIOL CHEM, V276, P11237, DOI 10.1074/jbc.M011112200; Braun KW, 2000, J BIOL CHEM, V275, P4145, DOI 10.1074/jbc.275.6.4145; BRENT G A, 1989, New Biologist, V1, P329; Bunn CF, 2001, MOL ENDOCRINOL, V15, P512, DOI 10.1210/mend.15.4.0619; CHAMBON P, 1995, RECENT PROG HORM RES, V50, P317; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cho YS, 2006, J BIOL CHEM, V281, P17588, DOI 10.1074/jbc.M512616200; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; Davis PJ, 2008, STEROIDS, V73, P1013, DOI 10.1016/j.steroids.2007.12.030; DeFranco Donald B., 1999, Cell Biochemistry and Biophysics, V30, P1, DOI 10.1007/BF02737882; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Hager GL, 2000, J STEROID BIOCHEM, V74, P249, DOI 10.1016/S0960-0760(00)00100-X; Hales CM, 2001, J BIOL CHEM, V276, P39067, DOI 10.1074/jbc.M104831200; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Kim EJ, 2003, NUCLEIC ACIDS RES, V31, P5356, DOI 10.1093/nar/gkg741; Kim EJ, 2002, J BIOL CHEM, V277, P32020, DOI 10.1074/jbc.M200153200; Kumar S, 2006, MOL CELL ENDOCRINOL, V246, P147, DOI 10.1016/j.mce.2005.11.028; KUROKAWA R, 1995, NATURE, V377, P451, DOI 10.1038/377451a0; Mackem S, 2001, J BIOL CHEM, V276, P45501, DOI 10.1074/jbc.C100269200; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Maruvada P, 2003, J BIOL CHEM, V278, P12425, DOI 10.1074/jbc.M202752200; McKenna NJ, 1999, J STEROID BIOCHEM, V69, P3, DOI 10.1016/S0960-0760(98)00144-7; Moore JMR, 2005, MOL CELL PROTEOMICS, V4, P475, DOI 10.1074/mcp.R500001-MCP200; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Park JS, 2000, J BIOL CHEM, V275, P6764, DOI 10.1074/jbc.275.10.6764; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Prekeris R, 2001, J BIOL CHEM, V276, P38966, DOI 10.1074/jbc.M106133200; Schonteich E, 2007, EUR J CELL BIOL, V86, P417, DOI 10.1016/j.ejcb.2007.05.004; Shiba T, 2006, P NATL ACAD SCI USA, V103, P15416, DOI 10.1073/pnas.0605357103; Shin OH, 1999, J BIOL CHEM, V274, P36609, DOI 10.1074/jbc.274.51.36609; Tiwari AK, 2008, CELL BIOL INT, V32, P1158, DOI 10.1016/j.cellbi.2008.04.002; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wei LN, 2003, ANNU REV PHARMACOL, V43, P47, DOI 10.1146/annurev.pharmtox.43.100901.140301; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Wolgemuth D J, 2007, Soc Reprod Fertil Suppl, V63, P11; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Yamashita S, 1998, HISTOL HISTOPATHOL, V13, P255, DOI 10.14670/HH-13.255	42	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34269	34278		10.1074/jbc.M110.143008	http://dx.doi.org/10.1074/jbc.M110.143008			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20736163	hybrid, Green Published			2022-12-25	WOS:000283354000072
J	Zhang, QA; Li, YW; Tang, CM				Zhang, Qian; Li, Yanwen; Tang, Christoph M.			The Role of the Exopolyphosphatase PPX in Avoidance by Neisseria meningitidis of Complement-mediated Killing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM BACTERICIDAL ACTIVITY; INORGANIC POLYPHOSPHATE; MENINGOCOCCAL DISEASE; FACTOR-H; ESCHERICHIA-COLI; SEROGROUP-B; LIPOOLIGOSACCHARIDE; RESISTANCE; BINDING; KINASE	The complement system is critical for immunity against the important human pathogen Neisseria meningitidis. We describe the isolation of a meningococcal mutant lacking PPX, an exopolyphosphatase responsible for cleaving cellular polyphosphate, a polymer of tens to hundreds of orthophosphate residues found in virtually all living cells. Bacteria lacking PPX exhibit increased resistance to complement-mediated killing. By site directed mutagenesis, we define amino acids necessary for the biochemical activity of meningococcal PPX, including a conserved glutamate (Glu(117)) and residues in the Walker B box predicted to be involved in binding to phosphate. We show that the biochemical activity of PPX is necessary for interactions with the complement. The relative resistance of the ppx mutant does not result from changes in structures (such as capsule, lipopolysaccharide, and factor H-binding protein), which are known to be required for evasion of this key aspect of host immunity. Instead, expression of PPX modifies the interaction of N. meningitidis with the alternative pathway of complement activation.	[Zhang, Qian; Li, Yanwen; Tang, Christoph M.] Univ London Imperial Coll Sci Technol & Med, Dept Microbiol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Imperial College London	Tang, CM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Microbiol, Ctr Mol Microbiol & Infect, Flowers Bldg, London SW7 2AZ, England.	c.tang@imperial.ac.uk			MRC; Medical Research Council [G0900888] Funding Source: researchfish; MRC [G0900888] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to Dr. Robert Wall and Dr. Rachel Exley for their support and advice. Work in C.M.T.'s laboratory is supported by the MRC.	Ault-Riche D, 1998, J BACTERIOL, V180, P1841; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Darton T, 2009, CLIN INFECT DIS, V48, P587, DOI 10.1086/596707; Drogari-Apiranthitou M, 2002, INFECT IMMUN, V70, P3752, DOI 10.1128/IAI.70.7.3752-3758.2002; Estabrook MM, 1997, INFECT IMMUN, V65, P4436, DOI 10.1128/IAI.65.11.4436-4444.1997; Exley RM, 2005, J EXP MED, V201, P1637, DOI 10.1084/jem.20041548; FIGUEROA JE, 1991, CLIN MICROBIOL REV, V4, P359, DOI 10.1128/CMR.4.3.359-395.1991; Geoffroy MC, 2003, GENOME RES, V13, P391, DOI 10.1101/gr.664303; Gilbert M, 1996, J BIOL CHEM, V271, P28271, DOI 10.1074/jbc.271.45.28271; Haralambous E, 2006, SCAND J INFECT DIS, V38, P764, DOI 10.1080/00365540600643203; Herbert MA, 2002, MICROB PATHOGENESIS, V33, P211, DOI 10.1006/mpat.2002.0530; Hibberd ML, 1999, LANCET, V353, P1049, DOI 10.1016/S0140-6736(98)08350-0; Ishibashi Y, 2002, MICROB PATHOGENESIS, V33, P115, DOI 10.1006/mpat.2002.0517; JARVIS GA, 1987, INFECT IMMUN, V55, P174, DOI 10.1128/IAI.55.1.174-180.1987; Kim KS, 2002, P NATL ACAD SCI USA, V99, P7675, DOI 10.1073/pnas.112210499; Kristensen O, 2008, J MOL BIOL, V375, P1469, DOI 10.1016/j.jmb.2007.11.073; Lemercier G, 2004, J BIOL CHEM, V279, P3420, DOI 10.1074/jbc.M309974200; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156, DOI 10.1128/CDLI.4.2.156-167.1997; Mullan A, 2002, ANAL BIOCHEM, V308, P294, DOI 10.1016/S0003-2697(02)00249-X; NOEGEL A, 1983, J EXP MED, V157, P2049, DOI 10.1084/jem.157.6.2049; Ohtomo R, 2004, ANAL BIOCHEM, V328, P139, DOI 10.1016/j.ab.2004.03.004; Price-Carter M, 2005, J BACTERIOL, V187, P3088, DOI 10.1128/JB.187.9.3088-3099.2005; Rangarajan ES, 2006, J MOL BIOL, V359, P1249, DOI 10.1016/j.jmb.2006.04.031; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Shi XB, 2004, P NATL ACAD SCI USA, V101, P17061, DOI 10.1073/pnas.0407787101; Stephens DS, 2007, FEMS MICROBIOL REV, V31, P3, DOI 10.1111/j.1574-6976.2006.00051.x; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; TINSLEY CR, 1993, INFECT IMMUN, V61, P3703, DOI 10.1128/IAI.61.9.3703-3710.1993; TINSLEY CR, 1995, INFECT IMMUN, V63, P1624, DOI 10.1128/IAI.63.5.1624-1630.1995; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; Vogel U, 1996, MED MICROBIOL IMMUN, V185, P81, DOI 10.1007/s004300050018; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Winzer K, 2002, INFECT IMMUN, V70, P2245, DOI 10.1128/IAI.70.4.2245-2248.2002; YAMASAKI R, 1991, MOL IMMUNOL, V28, P1233, DOI 10.1016/0161-5890(91)90010-H; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	41	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34259	34268		10.1074/jbc.M110.154393	http://dx.doi.org/10.1074/jbc.M110.154393			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20736171	hybrid, Green Published			2022-12-25	WOS:000283354000071
J	Arana-Argaez, VE; Delgado-Rizo, V; Pizano-Martinez, OE; Martinez-Garcia, EA; Martin-Marquez, BT; Munoz-Gomez, A; Petri, MH; Armendariz-Borunda, J; Espinosa-Ramirez, G; Zuniga-Tamayo, DA; Herrera-Esparza, R; Vazquez-Del Mercado, M				Arana-Argaez, Victor E.; Delgado-Rizo, Vidal; Pizano-Martinez, Oscar E.; Martinez-Garcia, Erika A.; Martin-Marquez, Beatriz T.; Munoz-Gomez, Andrea; Petri, Marcelo H.; Armendariz-Borunda, Juan; Espinosa-Ramirez, Guillermo; Zuniga-Tamayo, Diego A.; Herrera-Esparza, Rafael; Vazquez-Del Mercado, Monica			Inhibitors of MAPK Pathway ERK1/2 or p38 Prevent the IL-1 beta-induced Up-regulation of SRP72 Autoantigen in Jurkat Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; ACTIVATED PROTEIN-KINASE; IDIOPATHIC INFLAMMATORY MYOPATHIES; SMOOTH-MUSCLE-CELLS; GENE-EXPRESSION; KAPPA-B; TRANSLOCATION; SEQUENCE; RECEPTOR; APOPTOSIS	Phosphorylation is the most important post-translational event at a cellular level that is regulated by protein kinases. MAPK is a key player in the important cellular signaling pathway. It has been hypothesized that phosphorylation might have a role in the induction of break tolerance against some autoantigens such as SRP72. The aim of this study was to explore the pathways of phosphorylation and overexpression of the SRP72 polypeptide, using an in vitro model of Jurkat cells stimulated by recombinant human (rh) IL-1 beta in the presence of MAPK inhibitors. We used Jurkat cells as a substrate stimulated with rhIL-1 beta in the presence of MAPK inhibitors at different concentrations in a time course in vitro experiment by immunoprecipitation, immunoprecipitation-Western blotting, and real time PCR. Our results showed that rhIL-1 beta causes up-regulation of protein expression and phosphorylation of SRP72 in Jurkat cells. Inhibitors of the MAPK pathway ERK1/2 or p38 alpha/beta down-regulate the expression of SRP72 autoantigen in Jurkat cells stimulated by rhIL-1 beta. Our results highlight the importance of studying the pathways of activation and overexpression of autoantigens. It will be necessary to perform careful research on various kinases pathways, including MAPK in dermatomyositis and other rheumatic diseases, to help to explain the routes of activation and inhibition of autoantigens. The understanding of this process may help to develop new therapies to prevent and control the loss of tolerance toward own normal proteins.	[Arana-Argaez, Victor E.; Martinez-Garcia, Erika A.; Martin-Marquez, Beatriz T.; Munoz-Gomez, Andrea; Petri, Marcelo H.; Espinosa-Ramirez, Guillermo; Zuniga-Tamayo, Diego A.; Vazquez-Del Mercado, Monica] Univ Guadalajara, Inst Invest Reumatol & Sistema Musculo Esquelet, Ctr Univ Ciencias Salud, Guadalajara 44340, Jalisco, Mexico; [Munoz-Gomez, Andrea] Univ Autonoma Guadalajara, Guadalajara 45129, Jalisco, Mexico; [Armendariz-Borunda, Juan] Univ Guadalajara, Inst Biol Mol Med, Ctr Univ Ciencias Salud, Dept Biol Mol & Genom, Guadalajara 44340, Jalisco, Mexico; [Herrera-Esparza, Rafael] Univ Autonoma Zacatecas, Zacatecas 98000, Mexico; [Vazquez-Del Mercado, Monica] Hosp Civil Dr Juan I Menchaca, Dept Reumatol, Div Med Interna, Guadalajara 44340, Jalisco, Mexico	Universidad de Guadalajara; Universidad Autonoma de Guadalajara; Universidad de Guadalajara; Universidad Autonoma de Zacatecas	Vazquez-Del Mercado, M (corresponding author), Univ Guadalajara, Inst Invest Reumatol & Sistema Musculo Esquelet, Ctr Univ Ciencias Salud, Sierra Mojada 950,Edificio P, Guadalajara 44340, Jalisco, Mexico.	dravme@hotmail.com	Armendáriz-Borunda, Juan/AAU-1471-2021; Arana-Argaez, Victor/AAT-3634-2020; Pizano, Oscar/AGR-5765-2022; Martínez-Garcia, Erika Aurora/V-4409-2017; del Mercado, Monica Vazquez/F-5856-2017	Martínez-Garcia, Erika Aurora/0000-0001-6486-1086; del Mercado, Monica Vazquez/0000-0002-3823-4676; PIZANO, OSCAR/0000-0003-3635-7071; Arana Argaez, Victor Ermilo/0000-0003-1434-1677; Espinosa-Ramirez, Guillermo/0000-0001-9573-8806; Martin-Marquez, Beatriz Teresita/0000-0002-6756-4316; Petri, Marcelo/0000-0002-6892-2680	COECyTJAL [PS-2009-420]	COECyTJAL	This work was supported by COECyTJAL Grant PS-2009-420 (to M. V.-D. M.).	Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; ARANAARGAEZ VE, 2009, BIOQUIMIA, V34, P77; Barksby HE, 2007, CLIN EXP IMMUNOL, V149, P217, DOI 10.1111/j.1365-2249.2007.03441.x; Barksby HE, 2006, ARTHRITIS RHEUM-US, V54, P540, DOI 10.1002/art.21574; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bui N, 1999, BIOL CHEM, V380, P135, DOI 10.1515/BC.1999.021; Buskiewicz IA, 2009, RNA, V15, P44, DOI 10.1261/rna.1285609; Casciola-Rosen L, 1999, J EXP MED, V190, P815, DOI 10.1084/jem.190.6.815; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; CONNOLLY T, 1993, J CELL BIOL, V123, P799, DOI 10.1083/jcb.123.4.799; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Paepe B, 2008, FRONT BIOSCI-LANDMRK, V13, P2548, DOI 10.2741/2866; De Paepe B, 2009, CURR OPIN RHEUMATOL, V21, P610, DOI 10.1097/BOR.0b013e3283317b31; Dodeller F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1905; Fulga TA, 2001, EMBO J, V20, P2338, DOI 10.1093/emboj/20.9.2338; Gerner C, 2002, MOL CELL PROTEOMICS, V1, P528, DOI 10.1074/mcp.M200026-MCP200; Giordano TJ, 2001, AM J PATHOL, V159, P1231, DOI 10.1016/S0002-9440(10)62509-6; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Imajo M, 2006, IUBMB LIFE, V58, P312, DOI 10.1080/15216540600746393; Inoue T, 2006, P NATL ACAD SCI USA, V103, P5484, DOI 10.1073/pnas.0509188103; Jiang Y, 2008, J CELL BIOL, V180, P1149, DOI 10.1083/jcb.200707196; Kamachi M, 2002, J EXP MED, V196, P1213, DOI 10.1084/jem.20021167; Lakkaraju AKK, 2008, CELL, V133, P440, DOI 10.1016/j.cell.2008.02.049; Liang KC, 2007, J CELL PHYSIOL, V211, P759, DOI 10.1002/jcp.20992; LINGAPPA VR, 1978, J BIOL CHEM, V253, P8667; LUTCKE H, 1995, EUR J BIOCHEM, V228, P531, DOI 10.1111/j.1432-1033.1995.0531m.x; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; MIGLIACCIO G, 1992, J CELL BIOL, V117, P15, DOI 10.1083/jcb.117.1.15; Mitchell MD, 2007, AM J PHYSIOL-HEART C, V292, pH1139, DOI 10.1152/ajpheart.00881.2005; Nagai K, 2003, EMBO J, V22, P3479, DOI 10.1093/emboj/cdg337; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; RAPIEJKO PJ, 1994, MOL BIOL CELL, V5, P887, DOI 10.1091/mbc.5.8.887; RAPIEJKO PJ, 1992, J CELL BIOL, V117, P493, DOI 10.1083/jcb.117.3.493; Romisch K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1895; Rutjes SA, 1999, CELL DEATH DIFFER, V6, P976, DOI 10.1038/sj.cdd.4400571; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shan SO, 2007, J CELL BIOL, V178, P611, DOI 10.1083/jcb.200702018; Sheryanna A, 2007, J AM SOC NEPHROL, V18, P1167, DOI 10.1681/ASN.2006010050; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; Siu FY, 2007, RNA, V13, P240, DOI 10.1261/rna.135407; Utz PJ, 2000, ARTHRITIS RES, V2, P101, DOI 10.1186/ar75; Utz PJ, 1998, ARTHRITIS RHEUM, V41, P1152, DOI 10.1002/1529-0131(199807)41:7<1152::AID-ART3>3.0.CO;2-L; Utz PJ, 1998, J BIOL CHEM, V273, P35362, DOI 10.1074/jbc.273.52.35362; Yang HT, 2008, CELL SIGNAL, V20, P375, DOI 10.1016/j.cellsig.2007.10.025; Yao YX, 2006, J IMMUNOL, V177, P70, DOI 10.4049/jimmunol.177.1.70	49	22	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32824	32833		10.1074/jbc.M110.121087	http://dx.doi.org/10.1074/jbc.M110.121087			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729213	Green Published, hybrid			2022-12-25	WOS:000283048200019
J	Tooley, LD; Zamurs, LK; Beecher, N; Baker, NL; Peat, RA; Adams, NE; Bateman, JF; North, KN; Baldock, C; Lamande, SR				Tooley, Leona D.; Zamurs, Laura K.; Beecher, Nicola; Baker, Naomi L.; Peat, Rachel A.; Adams, Naomi E.; Bateman, John F.; North, Kathryn N.; Baldock, Clair; Lamande, Shireen R.			Collagen VI Microfibril Formation Is Abolished by an alpha 2(VI) von Willebrand Factor Type A Domain Mutation in a Patient with Ullrich Congenital Muscular Dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETHLEM-MYOPATHY; VONWILLEBRAND-FACTOR; ALPHA-3(VI) CHAIN; LIGAND-BINDING; SEQUENCE-ANALYSIS; GLOBULAR DOMAINS; I-DOMAIN; DOMINANT; INTEGRIN; IDENTIFICATION	Collagen VI is an extracellular protein that most often contains the three genetically distinct polypeptide chains, alpha 1(VI), alpha 2(VI), and alpha 3(VI), although three recently identified chains, alpha 4(VI), alpha 5(VI), and alpha 6(VI), may replace alpha 3(VI) in some situations. Each chain has a triple helix flanked by N- and C-terminal globular domains that share homology with the von Willebrand factor type A (VWA) domains. During biosynthesis, the three chains come together to form triple helical monomers, which then assemble into dimers and tetramers. Tetramers are secreted from the cell and align end-to-end to form microfibrils. The precise molecular mechanisms responsible for assembly are unclear. Mutations in the three collagen VI genes can disrupt collagen VI biosynthesis and matrix organization and are the cause of the inherited disorders Bethlem myopathy and Ullrich congenital muscular dystrophy. We have identified a Ullrich congenital muscular dystrophy patient with compound heterozygous mutations in alpha 2(VI). The first mutation causes skipping of exon 24, and the mRNA is degraded by nonsense-mediated decay. The second mutation is a two-amino acid deletion in the C1 VWA domain. Recombinant C1 domains containing the deletion are insoluble and retained intracellularly, indicating that the mutation has detrimental effects on domain folding and structure. Despite this, mutant alpha 2(VI) chains retain the ability to associate into monomers, dimers, and tetramers. However, we show that secreted mutant tetramers containing structurally abnormal C1 VWA domains are unable to associate further into microfibrils, directly demonstrating the critical importance of a correctly folded alpha 2(VI) C1 domain in microfibril formation.	[Tooley, Leona D.; Zamurs, Laura K.; Baker, Naomi L.; Adams, Naomi E.; Bateman, John F.; Lamande, Shireen R.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Tooley, Leona D.; Lamande, Shireen R.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia; [Bateman, John F.] Univ Melbourne, Royal Childrens Hosp, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Beecher, Nicola; Baldock, Clair] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PL, Lancs, England; [Peat, Rachel A.; North, Kathryn N.] Univ Sydney, Childrens Hosp Westmead, Neurogenet Res Unit, Westmead, NSW 2145, Australia; [Peat, Rachel A.; North, Kathryn N.] Univ Sydney, Discipline Paediat & Child Hlth, Westmead, NSW 2145, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; University of Manchester; University of Sydney; University of Sydney	Lamande, SR (corresponding author), Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	shireen.lamande@mcri.edu.au	North, Kathryn N/K-6476-2012	North, Kathryn N/0000-0003-0841-8009; Baldock, Clair/0000-0003-3497-1959; Lamande, Shireen/0000-0003-2938-2711; Bateman, John/0000-0001-8542-0730	National Health and Medical Research Council of Australia [491252]; Biotechnology and Biological Sciences Research Council [BB/D008662/1]; Murdoch Childrens Research Institute; Melbourne University; BBSRC [BB/D008662/1] Funding Source: UKRI	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Murdoch Childrens Research Institute; Melbourne University(University of Melbourne); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by National Health and Medical Research Council of Australia Grant 491252 (to S. R. L. and J. F. B.), Biotechnology and Biological Sciences Research Council Grant BB/D008662/1 (to N. B.), and the Murdoch Childrens Research Institute.; Supported by a Melbourne University Research Scholarship.	BAJT ML, 1994, J BIOL CHEM, V269, P20913; Baker NL, 2007, ANN NEUROL, V62, P390, DOI 10.1002/ana.21213; Baker NL, 2005, HUM MOL GENET, V14, P279, DOI 10.1093/hmg/ddi025; Baldock C, 2003, J MOL BIOL, V330, P297, DOI 10.1016/S0022-2836(03)00585-0; Ball SG, 2001, J BIOL CHEM, V276, P7422, DOI 10.1074/jbc.M002816200; BONALDO P, 1989, J BIOL CHEM, V264, P5575; BRUNS RR, 1986, J CELL BIOL, V103, P393, DOI 10.1083/jcb.103.2.393; Camacho V.O., 2001, P NATL ACAD SCI USA, V98, P7516, DOI DOI 10.1073/PNAS.121027598; CHU ML, 1990, EMBO J, V9, P385, DOI 10.1002/j.1460-2075.1990.tb08122.x; CHU ML, 1988, J BIOL CHEM, V263, P18601; CHU ML, 1989, EMBO J, V8, P1939, DOI 10.1002/j.1460-2075.1989.tb03598.x; Cotterill SL, 2005, HUM MUTAT, V26, P557, DOI 10.1002/humu.20263; Demir E, 2002, AM J HUM GENET, V70, P1446, DOI 10.1086/340608; DOLIANA R, 1990, J CELL BIOL, V111, P2197, DOI 10.1083/jcb.111.5.2197; Doliana R, 1998, MATRIX BIOL, V16, P427, DOI 10.1016/S0945-053X(98)90015-4; Fitzgerald J, 2001, J BIOL CHEM, V276, P187, DOI 10.1074/jbc.M008173200; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Foley AR, 2009, NEUROMUSCULAR DISORD, V19, P813, DOI 10.1016/j.nmd.2009.09.010; FURTHMAYR H, 1983, BIOCHEM J, V211, P303, DOI 10.1042/bj2110303; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Giusti B, 2005, ANN NEUROL, V58, P400, DOI 10.1002/ana.20586; Gualandi F, 2009, NEUROLOGY, V73, P1883, DOI 10.1212/WNL.0b013e3181c3fd2a; Ishikawa H, 2004, NEUROLOGY, V62, P620, DOI 10.1212/01.WNL.0000113023.84421.00; Ishikawa H, 2002, NEUROLOGY, V59, P920, DOI 10.1212/WNL.59.6.920; Kamata T, 1999, J BIOL CHEM, V274, P32108, DOI 10.1074/jbc.274.45.32108; KAMATA T, 1994, J BIOL CHEM, V269, P9659; Kielty Cay M., 1993, P103; LAMANDE S, 2002, J BIOL CHEM, V277, P1848; Lamande SR, 2006, J BIOL CHEM, V281, P16607, DOI 10.1074/jbc.M510192200; Lamande SR, 1999, J BIOL CHEM, V274, P21817, DOI 10.1074/jbc.274.31.21817; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Lampe AK, 2005, J MED GENET, V42, P108, DOI 10.1136/jmg.2004.023754; Merlini L, 2008, NEUROLOGY, V71, P1245, DOI 10.1212/01.wnl.0000327611.01687.5e; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; Pace RA, 2008, ANN NEUROL, V64, P294, DOI 10.1002/ana.21439; Pan TC, 2003, AM J HUM GENET, V73, P355, DOI 10.1086/377107; Pan TC, 1998, HUM MOL GENET, V7, P807, DOI 10.1093/hmg/7.5.807; Peat RA, 2007, NEUROMUSCULAR DISORD, V17, P547, DOI 10.1016/j.nmd.2007.03.017; Sasaki T, 2000, FASEB J, V14, P761, DOI 10.1096/fasebj.14.5.761; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; SPISSINGER T, 1995, MATRIX BIOL, V14, P499, DOI 10.1016/0945-053X(95)90007-1; Vanegas OC, 2002, MUSCLE NERVE, V25, P513, DOI 10.1002/mus.10100; Wilson R, 2002, J BIOL CHEM, V277, P12516, DOI 10.1074/jbc.M112044200; Zhang RZ, 2010, J BIOL CHEM, V285, P10005, DOI 10.1074/jbc.M109.093666; Zhang RZ, 2002, J BIOL CHEM, V277, P43557, DOI 10.1074/jbc.M207696200	45	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33567	33576		10.1074/jbc.M110.152520	http://dx.doi.org/10.1074/jbc.M110.152520			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729548	hybrid, Green Published			2022-12-25	WOS:000283048200090
J	Bush, SL; Schul, J				Bush, Sarah L.; Schul, Johannes			Evolution of Novel Signal Traits in the Absence of Female Preferences in Neoconocephalus Katydids (Orthoptera, Tettigoniidae)	PLOS ONE			English	Article							NEBRASCENSIS ORTHOPTERA; SEXUAL SELECTION; CALL RECOGNITION; RECEIVER BIASES; SONG; POPULATION; PHONOTAXIS; FREQUENCY; PREDATION; TREEFROGS	Background Significance: Communication signals that function to bring together the sexes are important for maintaining reproductive isolation in many taxa. Changes in male calls are often attributed to sexual selection, in which female preferences initiate signal divergence. Natural selection can also influence signal traits if calls attract predators or parasitoids, or if calling is energetically costly. Neutral evolution is often neglected in the context of acoustic communication. Methodology/Principal Findings: We describe a signal trait that appears to have evolved in the absence of either sexual or natural selection. In the katydid genus Neoconocephalus, calls with a derived pattern in which pulses are grouped into pairs have evolved five times independently. We have previously shown that in three of these species, females require the double pulse pattern for call recognition, and hence the recognition system of the females is also in a derived state. Here we describe the remaining two species and find that although males produce the derived call pattern, females use the ancestral recognition mechanism in which no pulse pattern is required. Females respond equally well to the single and double pulse calls, indicating that the derived trait is selectively neutral in the context of mate recognition. Conclusions/Significance: These results suggest that 1) neutral changes in signal traits could be important in the diversification of communication systems, and 2) males rather than females may be responsible for initiating signal divergence.	[Bush, Sarah L.; Schul, Johannes] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Bush, SL (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	schulj@missouri.edu		Schul, Johannes/0000-0003-4059-7123	National Science Foundation [IOB-0445286]	National Science Foundation(National Science Foundation (NSF))	The work was funded by the National Science Foundation (www.nsf.gov) through one grant to JS & SLB (IOB-0445286). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander Richard D., 1997, P4, DOI 10.1017/CBO9780511721946.002; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; Beckers OM, 2008, P ROY SOC B-BIOL SCI, V275, P1243, DOI 10.1098/rspb.2007.1765; BENTLEY DR, 1972, ANIM BEHAV, V20, P478, DOI 10.1016/S0003-3472(72)80012-5; BURK T, 1982, FLA ENTOMOL, V65, P90, DOI 10.2307/3494148; Bush SL, 2009, J EXP BIOL, V212, P648, DOI 10.1242/jeb.024786; Bush SL, 2006, J COMP PHYSIOL A, V192, P113, DOI 10.1007/s00359-005-0053-x; Bush SL, 2002, ANIM BEHAV, V63, P7, DOI 10.1006/anbe.2001.1880; Deily JA, 2004, J EXP BIOL, V207, P3523, DOI 10.1242/jeb.01179; Deily JA, 2009, J COMP PHYSIOL A, V195, P31, DOI 10.1007/s00359-008-0379-2; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; ENQUIST M, 1993, NATURE, V361, P446, DOI 10.1038/361446a0; FORREST TG, 1994, AM ZOOL, V34, P644; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Gleason JM, 1998, EVOLUTION, V52, P1493, DOI [10.2307/2411319, 10.1111/j.1558-5646.1998.tb02031.x]; Greenfield M.D., 1990, P71; GREENFIELD MD, 1993, NATURWISSENSCHAFTEN, V80, P570, DOI 10.1007/BF01149275; Greenfield MD, 2005, ADV STUD BEHAV, V35, P1, DOI 10.1016/S0065-3454(05)35001-7; GREENFIELD MD, 1983, ANIM BEHAV, V31, P102, DOI 10.1016/S0003-3472(83)80178-X; Greenfield MD, 2002, SIGNALERS RECEIVERS; Groning J, 2008, Q REV BIOL, V83, P257, DOI 10.1086/590510; HELLER KG, 1988, BIOACOUSTICS EUROPEA; Henry CS, 1999, EVOLUTION, V53, P1165, DOI [10.2307/2640820, 10.1111/j.1558-5646.1999.tb04530.x]; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Lehmann GUC, 1998, BEHAV ECOL SOCIOBIOL, V43, P239, DOI 10.1007/s002650050488; LLOYD JE, 1984, FLA ENTOMOL, V67, P228, DOI 10.2307/3493942; MEIXNER AJ, 1986, ANN ENTOMOL SOC AM, V79, P554, DOI 10.1093/aesa/79.4.554; Otte D., 1989, P482; Roff DA, 1999, EVOLUTION, V53, P216, DOI 10.1111/j.1558-5646.1999.tb05347.x; Ryan MJ, 1998, SCIENCE, V281, P1999, DOI 10.1126/science.281.5385.1999; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; Schul J, 2003, J EXP BIOL, V206, P141, DOI 10.1242/jeb.00070; Schul J, 1998, J COMP PHYSIOL A, V183, P401, DOI 10.1007/s003590050266; Shaw KL, 1996, EVOLUTION, V50, P256, DOI 10.1111/j.1558-5646.1996.tb04489.x; SNYDER RL, 2009, THESIS U MISSOURI CO; Snyder RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007203; TALWAR M, 2007, THESIS U MISSOURI CO; von Helversen Otto, 1994, Progress in Zoology, V39, P253; Walker T.J., 1983, Transactions of the American Entomological Society (Philadelphia), V109, P357; WALKER TJ, 1975, J INSECT PHYSIOL, V21, P595, DOI 10.1016/0022-1910(75)90163-8; WALKER TJ, 1974, AM ZOOL, V14, P1137; WALKER TJ, 2008, SINGING INSECTS N AM; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412; Zuk M, 2006, BIOL LETTERS, V2, P521, DOI 10.1098/rsbl.2006.0539	46	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12457	10.1371/journal.pone.0012457	http://dx.doi.org/10.1371/journal.pone.0012457			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805980	gold, Green Submitted, Green Published			2022-12-25	WOS:000281301500023
J	Lubell, Y; Mills, AJ; Whitty, CJM; Staedke, SG				Lubell, Yoel; Mills, Anne J.; Whitty, Christopher J. M.; Staedke, Sarah G.			An Economic Evaluation of Home Management of Malaria in Uganda: An Interactive Markov Model	PLOS ONE			English	Article							UNCOMPLICATED FALCIPARUM-MALARIA; ARTEMETHER-LUMEFANTRINE; COMBINATION THERAPY; SULFADOXINE-PYRIMETHAMINE; COST-EFFECTIVENESS; VECTOR CONTROL; CHILDREN; TRANSMISSION; ARTESUNATE; BURDEN	Background: Home management of malaria (HMM), promoting presumptive treatment of febrile children in the community, is advocated to improve prompt appropriate treatment of malaria in Africa. The cost-effectiveness of HMM is likely to vary widely in different settings and with the antimalarial drugs used. However, no data on the cost-effectiveness of HMM programmes are available. Methods/Principal Findings: A Markov model was constructed to estimate the cost-effectiveness of HMM as compared to conventional care for febrile illnesses in children without HMM. The model was populated with data from Uganda, but is designed to be interactive, allowing the user to adjust certain parameters, including the antimalarials distributed. The model calculates the cost per disability adjusted life year averted and presents the incremental cost-effectiveness ratio compared to a threshold value. Model output is stratified by level of malaria transmission and the probability that a child would receive appropriate care from a health facility, to indicate the circumstances in which HMM is likely to be cost-effective. The model output suggests that the cost-effectiveness of HMM varies with malaria transmission, the probability of appropriate care, and the drug distributed. Where transmission is high and the probability of appropriate care is limited, HMM is likely to be cost-effective from a provider perspective. Even with the most effective antimalarials, HMM remains an attractive intervention only in areas of high malaria transmission and in medium transmission areas with a lower probability of appropriate care. HMM is generally not cost-effective in low transmission areas, regardless of which antimalarial is distributed. Considering the analysis from the societai perspective decreases the attractiveness of HMM. Conclusion: Syndromic HMM for children with fever may be a useful strategy for higher transmission settings with limited health care and diagnosis, but is not appropriate for all settings. HMM may need to be tailored to specific settings, accounting for local malaria transmission intensity and availability of health services.	[Lubell, Yoel] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Lubell, Yoel; Mills, Anne J.] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England; [Whitty, Christopher J. M.; Staedke, Sarah G.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Lubell, Y (corresponding author), Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand.	yoel@tropmedres.ac	Whitty, Christopher/C-7740-2012	Lubell, Yoel/0000-0002-0237-1070; Mills, Anne/0000-0001-9863-9950; Whitty, Christopher/0000-0002-6076-5027	Medical Research Council (UK); ACT Consortium; Bill & Melinda Gates Foundation	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ACT Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was carried out as a part of a PhD thesis funded by the Medical Research Council (UK) (http://www.mrc.ac.uk/index.htm). This research is supported by the ACT Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine (http://www.actconsortium.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi IO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-6; [Anonymous], 2004, SCAL HOM BAS MAN MAL; Ansah EK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c930; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Breman JG, 2001, AM J TROP MED HYG, V64, pIV, DOI 10.4269/ajtmh.2001.64.iv; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Briggs A, 1998, PHARMACOECONOMICS, V13, P397, DOI 10.2165/00019053-199813040-00003; Bukirwa H, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010007; Checchi F, 2004, TROP MED INT HEALTH, V9, P445, DOI 10.1111/j.1365-3156.2004.01217.x; Chinbuah AM, 2006, TROP MED INT HEALTH, V11, P1003, DOI 10.1111/j.1365-3156.2006.01654.x; Conteh L, 2004, TROP MED INT HEALTH, V9, P125, DOI 10.1046/j.1365-3156.2003.01150.x; D'Alessandro U, 2005, TROP MED INT HEALTH, V10, P1, DOI 10.1111/j.1365-3156.2004.01375.x; Dorsey G, 2002, LANCET, V360, P2031, DOI 10.1016/S0140-6736(02)12021-6; Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210; Drummond M.F., 2015, METHODS EC EVALUATIO; Edejer T, 2003, MAKING CHOICES HLTH; Fapohunda B, 2004, HOME BASED MANAGEMEN; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Hodel EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008184; Hopkins H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-134; Jensen TP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-213; Kager PA, 2002, TROP MED INT HEALTH, V7, P1042, DOI 10.1046/j.1365-3156.2002.00981.x; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; Kallander Karin, 2006, BMC Int Health Hum Rights, V6, P2, DOI 10.1186/1472-698X-6-2; Kamya Moses R, 2007, PLoS Clin Trials, V2, pe20, DOI 10.1371/journal.pctr.0020020; Kelly JM, 2001, AM J PUBLIC HEALTH, V91, P1617, DOI 10.2105/AJPH.91.10.1617; Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P986, DOI 10.1046/j.1365-3156.2001.00817.x; Kolaczinski JH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-40; LUBELL Y, LIKELY HLTH IN PRESS; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Lubell Y, 2007, AM J TROP MED HYG, V77, P128, DOI 10.4269/ajtmh.2007.77.128; Maiteki-Sebuguzi C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-106; Malik EM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-60; Malimbo M, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-124; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Mathers CD., 2002, GLOBAL BURDEN DIS 20; Moerman F, 2003, LANCET INFECT DIS, V3, P99, DOI 10.1016/S1473-3099(03)00518-8; Mutabingwa TK, 2005, ACTA TROP, V95, P305, DOI 10.1016/j.actatropica.2005.06.009; Nsabagasani X, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-11; Nsungwa-Sabiiti J, 2007, T ROY SOC TROP MED H, V101, P1199, DOI 10.1016/j.trstmh.2007.08.005; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Pagnoni F, 2005, TROP MED INT HEALTH, V10, P621; Priotto G, 2003, T ROY SOC TROP MED H, V97, P325, DOI 10.1016/S0035-9203(03)90161-1; Rafael Maria E, 2006, Nature, V444 Suppl 1, P39, DOI 10.1038/nature05445; ROCAFELTRER A, 2008, TROP MED INT HLTH, V13; Sachs J, 2002, MACROECONOMICS HLTH; Schellenberg DM, 2003, T ROY SOC TROP MED H, V97, P647, DOI 10.1016/S0035-9203(03)80096-2; Snow RW, 2003, TRENDS PARASITOL, V19, P363, DOI 10.1016/S1471-4922(03)00168-5; Staedke SG, 2009, LANCET, V373, P1623, DOI 10.1016/S0140-6736(09)60328-7; Staedke SG, 2004, LANCET, V364, P1950, DOI 10.1016/S0140-6736(04)17478-3; TRAPE JF, 1987, AM J EPIDEMIOL, V126, P193, DOI 10.1093/aje/126.2.193; Tren R, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-305; *UN STAT DIV, UN STAT DIV WORLD ST; WHO, 2010, GUID TREATM MAL, V2nd; *WHO STAT INF SYST, 2007, WORLD HLTH STAT 2007; Winch PJ, 2005, HEALTH POLICY PLANN, V20, P199, DOI 10.1093/heapol/czi027; Wiseman V, 2006, PLOS MED, V3, P1844, DOI 10.1371/journal.pmed.0030373; *WORLD BANK, 2007, GNI PER CAP 2005 ATL; Yeka A, 2005, PLOS MED, V2, P654, DOI 10.1371/journal.pmed.0020190	62	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12439	10.1371/journal.pone.0012439	http://dx.doi.org/10.1371/journal.pone.0012439			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805977	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000281301500008
J	Cernuda-Morollon, E; Millan, J; Shipman, M; Marelli-Berg, FM; Ridley, AJ				Cernuda-Morollon, Eva; Millan, Jaime; Shipman, Mark; Marelli-Berg, Federica M.; Ridley, Anne J.			Rac Activation by the T-Cell Receptor Inhibits T Cell Migration	PLOS ONE			English	Article							RHO-GTPASES; IMMUNOLOGICAL SYNAPSE; MICROTUBULE GROWTH; CRUCIAL ROLE; PHOSPHORYLATION; POLARITY; ERM; POLARIZATION; LYMPHOCYTES; SIGNALS	Background: T cell migration is essential for immune responses and inflammation. Activation of the T-cell receptor (TCR) triggers a migration stop signal to facilitate interaction with antigen-presenting cells and cell retention at inflammatory sites, but the mechanisms responsible for this effect are not known. Methodology/Principal Findings: Migrating T cells are polarized with a lamellipodium at the front and uropod at the rear. Here we show that transient TCR activation induces prolonged inhibition of T-cell migration. TCR pre-activation leads to cells with multiple lamellipodia and lacking a uropod even after removal of the TCR signal. A similar phenotype is induced by expression of constitutively active Rac1, and TCR signaling activates Rac1. TCR signaling acts via Rac to reduce phosphorylation of ezrin/radixin/moesin proteins, which are required for uropod formation, and to increase stathmin phosphorylation, which regulates microtubule stability. T cell polarity and migration is partially restored by inhibiting Rac or by expressing constitutively active moesin. Conclusions/Significance: We propose that transient TCR signaling induces sustained inhibition of T cell migration via Rac1, increased stathmin phosphorylation and reduced ERM phosphorylation which act together to inhibit T-cell migratory polarity.	[Cernuda-Morollon, Eva] Hosp Univ Cent Asturias, Histocompatibil & Transplantat Unit, Oviedo, Spain; [Millan, Jaime] Ctr Biol Mol Severo Ochoa, Dept Cell Biol & Immunol, Canto Blanco, Spain; [Shipman, Mark] Univ Oxford, Ludwig Inst Canc Res, Oxford, England; [Marelli-Berg, Federica M.] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England; [Ridley, Anne J.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	Central University Hospital Asturias; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Ludwig Institute for Cancer Research; University of Oxford; Imperial College London; University of London; King's College London	Cernuda-Morollon, E (corresponding author), Hosp Univ Cent Asturias, Histocompatibil & Transplantat Unit, Oviedo, Spain.	anne.ridley@kcl.ac.uk		Millan, Jaime/0000-0003-3107-147X; Ridley, Anne/0000-0001-8186-5708	British Heart Foundation Funding Source: Medline; MRC [G0901084] Funding Source: UKRI; British Heart Foundation [RG/09/002/26425] Funding Source: researchfish; Medical Research Council [G0901084] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Croker BA, 2002, IMMUNOL CELL BIOL, V80, P231, DOI 10.1046/j.1440-1711.2002.01077.x; del Pozo MA, 1999, EUR J IMMUNOL, V29, P3609; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gardiner EM, 2002, CURR BIOL, V12, P2029, DOI 10.1016/S0960-9822(02)01334-9; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Geisler C, 2004, CRIT REV IMMUNOL, V24, P67; Gomez TS, 2008, ADV IMMUNOL, V97, P1, DOI 10.1016/S0065-2776(08)00001-1; Guo F, 2008, BLOOD, V112, P1767, DOI 10.1182/blood-2008-01-132068; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kaminuma O, 2001, MOL CELL BIOL, V21, P3126, DOI 10.1128/MCB.21.9.3126-3136.2001; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lord GM, 2002, J LEUKOCYTE BIOL, V72, P330; Marelli-Berg FM, 1999, J IMMUNOL, V162, P696; Millan J, 2006, NAT CELL BIOL, V8, P113, DOI 10.1038/ncb1356; Mirenda V, 2007, BLOOD, V109, P2968, DOI 10.1182/blood-2006-10-050724; Mustelin T, 2006, SCIENCE, V313, P1902, DOI 10.1126/science.1133578; Nijhara R, 2004, J IMMUNOL, V173, P4985, DOI 10.4049/jimmunol.173.8.4985; Nishihara H, 2002, BIOCHEM BIOPH RES CO, V296, P716, DOI 10.1016/S0006-291X(02)00931-2; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Ratner S, 1997, J IMMUNOL, V159, P1063; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sanchez-Madrid F, 2009, NAT REV MOL CELL BIO, V10, P353, DOI 10.1038/nrm2680; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Stepanova T, 2003, J NEUROSCI, V23, P2655; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; STRAHLER JR, 1992, J IMMUNOL, V149, P1191; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Wells Claire M., 2004, V294, P31; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997; Westermann J, 2001, ANN INTERN MED, V135, P279, DOI 10.7326/0003-4819-135-4-200108210-00013; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yu H, 2001, J EXP MED, V194, P915, DOI 10.1084/jem.194.7.915	51	44	46	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12393	10.1371/journal.pone.0012393	http://dx.doi.org/10.1371/journal.pone.0012393			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811629	gold, Green Published, Green Submitted			2022-12-25	WOS:000281234700018
J	Yin, JX; Tu, JL; Lin, HJ; Shi, FD; Liu, RL; Zhao, CB; Coons, SW; Kuniyoshi, S; Shi, JO				Yin, Jun-xiang; Tu, Jiang-long; Lin, Hao-jie; Shi, Fu-dong; Liu, Ru-lan; Zhao, Chong-bo; Coons, Stephen W.; Kuniyoshi, Sandra; Shi, Jiong			Centrally Administered Pertussis Toxin Inhibits Microglia Migration to the Spinal Cord and Prevents Dissemination of Disease in an EAE Mouse Model	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; PROGRESSIVE MULTIPLE-SCLEROSIS; AUTOREACTIVE T-CELLS; SENSITIZED B6 MICE; IN-VITRO; INTRACEREBRAL INJECTION; ACTIVATION	Experimental autoimmune encephalomyelitis (EAE) models are important vehicles for studying the effect of infectious elements such as Pertussis toxin (PTx) on disease processes related to acute demyelinating encephalomyelitis (ADEM) or multiple sclerosis (MS). PTx has pleotropic effects on the immune system. This study was designed to investigate the effects of PTx administered intracerebroventricularly (icv) in preventing downstream immune cell infiltration and demyelination of the spinal cord. Methods and Findings: EAE was induced in C57BL/6 mice with MOG35-55. PTx icv at seven days post MOG immunization resulted in mitigation of clinical motor symptoms, minimal T cell infiltration, and the marked absence of axonal loss and demyelination of the spinal cord. Integrity of the blood brain barrier was compromised in the brain whereas spinal cord BBB integrity remained intact. PTx icv markedly increased microglia numbers in the brain preventing their migration to the spinal cord. An in vitro transwell study demonstrated that PTx inhibited migration of microglia. Conclusion: Centrally administered PTx abrogated migration of microglia in EAE mice, limiting the inflammatory cytokine milieu to the brain and prevented dissemination of demyelination. The effects of PTx icv warrants further investigation and provides an attractive template for further study regarding the pleotropic effects of infectious elements such as PTx in the pathogenesis of autoimmune disorders.	[Yin, Jun-xiang; Tu, Jiang-long; Lin, Hao-jie; Shi, Fu-dong; Liu, Ru-lan; Zhao, Chong-bo; Kuniyoshi, Sandra; Shi, Jiong] Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA; [Coons, Stephen W.] Barrow Neurol Inst, Dept Pathol, Phoenix, AZ 85013 USA	Barrow Neurological Institute; Barrow Neurological Institute	Yin, JX (corresponding author), Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA.	jiong.shi@chw.edu			NIAID NIH HHS [R01 AI083294] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083294] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahn M, 2001, NEUROSCI LETT, V308, P41, DOI 10.1016/S0304-3940(01)01979-6; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Bai B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007869; Bhasin M, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-10; Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307; Carson MJ, 2002, GLIA, V40, P218, DOI 10.1002/glia.10145; Chen X, 2006, EUR J IMMUNOL, V36, P671, DOI 10.1002/eji.200535353; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Floden AM, 2007, J NEUROSCI METH, V164, P218, DOI 10.1016/j.jneumeth.2007.04.018; GITIK M, 2010, FASEB J; Giuliani F, 2005, J NEUROIMMUNOL, V165, P83, DOI 10.1016/j.jneuroim.2005.04.020; Guo X, 2007, NEUROSCI RES, V59, P457, DOI 10.1016/j.neures.2007.08.014; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Herrero-Herranz E, 2008, NEUROBIOL DIS, V30, P162, DOI 10.1016/j.nbd.2008.01.001; Ho TS, 1997, J BIOMED SCI, V4, P300, DOI 10.1007/BF02258354; Hofstetter HH, 2002, J IMMUNOL, V169, P117, DOI 10.4049/jimmunol.169.1.117; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Imai Y, 2002, GLIA, V40, P164, DOI 10.1002/glia.10149; Jack C, 2005, J NEUROSCI RES, V81, P363, DOI 10.1002/jnr.20482; Kerfoot SM, 2004, J IMMUNOL, V173, P7070, DOI 10.4049/jimmunol.173.11.7070; Kuerten S, 2007, J NEUROIMMUNOL, V189, P31, DOI 10.1016/j.jneuroim.2007.06.016; Matyszak MK, 1999, EUR J IMMUNOL, V29, P3063, DOI 10.1002/(SICI)1521-4141(199910)29:10<3063::AID-IMMU3063>3.0.CO;2-G; Merodio M, 2000, J DRUG TARGET, V8, P289, DOI 10.3109/10611860008997907; Muller DM, 2005, J NEUROIMMUNOL, V160, P162, DOI 10.1016/j.jneuroim.2004.11.011; MUNOZ JJ, 1984, CELL IMMUNOL, V86, P541, DOI 10.1016/0008-8749(84)90410-6; Nolte C, 1996, NEUROSCIENCE, V73, P1091, DOI 10.1016/0306-4522(96)00106-6; Nutile-McMenemy N, 2007, J NEUROCHEM, V103, P2035, DOI 10.1111/j.1471-4159.2007.04889.x; Okuda Y, 1999, J NEUROIMMUNOL, V101, P188, DOI 10.1016/S0165-5728(99)00139-3; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Prineas JW, 2001, ANN NEUROL, V50, P646, DOI 10.1002/ana.1255; Raivich G, 1998, J NEUROSCI, V18, P5804; Raivich G, 2004, BRAIN RES REV, V46, P261, DOI 10.1016/j.brainresrev.2004.06.006; RAKIC LM, 1989, METAB BRAIN DIS, V4, P9, DOI 10.1007/BF00999488; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; Shi FD, 2000, J IMMUNOL, V165, P3099, DOI 10.4049/jimmunol.165.6.3099; STERNBERGER LA, 1986, J HISTOCHEM CYTOCHEM, V34, P599, DOI 10.1177/34.5.3517144; Tanuma N, 2006, ACTA NEUROPATHOL, V112, P195, DOI 10.1007/s00401-006-0083-7; Tonra JR, 2001, J COMP NEUROL, V430, P131; Tran EH, 1998, J IMMUNOL, V161, P3767; Tsai CY, 1997, CLIN EXP IMMUNOL, V109, P127, DOI 10.1046/j.1365-2249.1997.4251326.x	41	33	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12400	10.1371/journal.pone.0012400	http://dx.doi.org/10.1371/journal.pone.0012400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811645	Green Published, gold, Green Submitted			2022-12-25	WOS:000281234700024
J	Krueger, BJ; Varzavand, K; Cooper, JJ; Price, DH				Krueger, Brian J.; Varzavand, Katayoun; Cooper, Jeffrey J.; Price, David H.			The Mechanism of Release of P-TEFb and HEXIM1 from the 7SK snRNP by Viral and Cellular Activators Includes a Conformational Change in 7SK	PLOS ONE			English	Article							POLYMERASE-II TRANSCRIPTION; RNA-POLYMERASE; HIV-1 TAT; CYCLIN T1; POL-II; INTERACTING DOMAIN; ANDROGEN RECEPTOR; ELONGATION; PROTEIN; COMPLEX	Background: The positive transcription elongation factor, P-TEFb, is required for the production of mRNAs, however the majority of the factor is present in the 7SK snRNP where it is inactivated by HEXIM1. Expression of HIV-1 Tat leads to release of P-TEFb and HEXIM1 from the 7SK snRNP in vivo, but the release mechanisms are unclear. Methodology/Principal Findings: We developed an in vitro P-TEFb release assay in which the 7SK snRNP immunoprecipitated from HeLa cell lysates using antibodies to LARP7 was incubated with potential release factors. We found that P-TEFb was directly released from the 7SK snRNP by HIV-1 Tat or the P-TEFb binding region of the cellular activator Brd4. Glycerol gradient sedimentation analysis was used to demonstrate that the same Brd4 protein transfected into HeLa cells caused the release of P-TEFb and HEXIM1 from the 7SK snRNP in vivo. Although HEXIM1 binds tightly to 7SK RNA in vitro, release of P-TEFb from the 7SK snRNP is accompanied by the loss of HEXIM1. Using a chemical modification method, we determined that concomitant with the release of HEXIM1, 7SK underwent a major conformational change that blocks re-association of HEXIM1. Conclusions/Significance: Given that promoter proximally paused polymerases are present on most human genes, understanding how activators recruit P-TEFb to those genes is critical. Our findings reveal that the two tested activators can extract P-TEFb from the 7SK snRNP. Importantly, we found that after P-TEFb is extracted a dramatic conformational change occurred in 7SK concomitant with the ejection of HEXIM1. Based on our findings, we hypothesize that reincorporation of HEXIM1 into the 7SK snRNP is likely the regulated step of reassembly of the 7SK snRNP containing P-TEFb.	[Krueger, Brian J.; Price, David H.] Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA 52242 USA; [Varzavand, Katayoun; Cooper, Jeffrey J.; Price, David H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Krueger, BJ (corresponding author), Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA 52242 USA.	david-price@uiowa.edu	Price, David H/F-6173-2010	Price, David/0000-0002-5597-385X	National Institutes of Health [GM35500]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI074392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM35500 to D. H. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Bark-Jones SJ, 2006, ONCOGENE, V25, P1775, DOI 10.1038/sj.onc.1209205; Barrandon C, 2007, MOL CELL BIOL, V27, P6996, DOI 10.1128/MCB.00975-07; Bayfield MA, 2010, BBA-GENE REGUL MECH, V1799, P365, DOI 10.1016/j.bbagrm.2010.01.011; Belanger F, 2009, J MOL BIOL, V386, P1094, DOI 10.1016/j.jmb.2009.01.015; Bhattacharya R, 2002, GENE EXPRESSION, V10, P243, DOI 10.3727/000000002783992398; Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Byers SA, 2005, J BIOL CHEM, V280, P16360, DOI 10.1074/jbc.M500424200; Byun JS, 2009, P NATL ACAD SCI USA, V106, P19292, DOI 10.1073/pnas.0905469106; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen B, 2008, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2008/01/007; Chen YH, 2000, RNA, V6, P1277, DOI 10.1017/S1355838200000285; CHIN DJ, 1991, J VIROL, V65, P1758, DOI 10.1128/JVI.65.4.1758-1764.1991; Cho SY, 2009, EMBO J, V28, P1407, DOI 10.1038/emboj.2009.99; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Diribarne G, 2009, RNA BIOL, V6, P122, DOI 10.4161/rna.6.2.8115; DOW EC, 2010, J CELL; Durand LO, 2008, J VIROL, V82, P10591, DOI 10.1128/JVI.01242-08; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Egloff S, 2006, MOL CELL BIOL, V26, P630, DOI 10.1128/MCB.26.2.630-642.2006; Endo S, 1989, Virus Genes, V3, P99; Fan H, 1997, CELL, V88, P707, DOI 10.1016/S0092-8674(00)81913-3; Garber ME, 1998, COLD SPRING HARB SYM, V63, P371, DOI 10.1101/sqb.1998.63.371; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Giacinti C, 2006, J CELL PHYSIOL, V206, P807, DOI 10.1002/jcp.20523; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; He N, 2008, MOL CELL, V29, P588, DOI 10.1016/j.molcel.2008.01.003; Hogg JR, 2007, RNA, V13, P868, DOI 10.1261/rna.565207; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Kanamaru H, 2001, NEUROSCI LETT, V300, P9, DOI 10.1016/S0304-3940(01)01527-0; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; Krueger BJ, 2008, NUCLEIC ACIDS RES, V36, P2219, DOI 10.1093/nar/gkn061; KUPPUSWAMY M, 1989, NUCLEIC ACIDS RES, V17, P3551, DOI 10.1093/nar/17.9.3551; Lee DK, 2003, J STEROID BIOCHEM, V84, P41, DOI 10.1016/S0960-0760(03)00005-0; Lee DK, 2001, J BIOL CHEM, V276, P9978, DOI 10.1074/jbc.M002285200; Li QT, 2007, NUCLEIC ACIDS RES, V35, P2503, DOI 10.1093/nar/gkm150; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Markert A, 2008, EMBO REP, V9, P569, DOI 10.1038/embor.2008.72; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; MARZ M, 2009, MOL BIOL EVOL; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2008, CELL CYCLE, V7, P1539, DOI 10.4161/cc.7.11.6006; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; RUBEN S, 1989, J VIROL, V63, P1; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Simone C, 2002, ONCOGENE, V21, P4137, DOI 10.1038/sj.onc.1205493; Sinha KM, 1998, J BIOL CHEM, V273, P6853, DOI 10.1074/jbc.273.12.6853; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Urano E, 2008, FEBS LETT, V582, P4053, DOI 10.1016/j.febslet.2008.10.047; Van Herreweghe E, 2007, EMBO J, V26, P3570, DOI 10.1038/sj.emboj.7601783; WASSARMAN DA, 1991, MOL CELL BIOL, V11, P3432, DOI 10.1128/MCB.11.7.3432; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhou MS, 2006, J VIROL, V80, P4781, DOI 10.1128/JVI.80.10.4781-4791.2006; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	73	76	91	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12335	10.1371/journal.pone.0012335	http://dx.doi.org/10.1371/journal.pone.0012335			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808803	Green Published, Green Submitted, gold			2022-12-25	WOS:000281153500017
J	Bergmann-Leitner, ES; Mease, RM; De La Vega, P; Savranskaya, T; Polhemus, M; Ockenhouse, C; Angov, E				Bergmann-Leitner, Elke S.; Mease, Ryan M.; De La Vega, Patricia; Savranskaya, Tatyana; Polhemus, Mark; Ockenhouse, Christian; Angov, Evelina			Immunization with Pre-Erythrocytic Antigen CelTOS from Plasmodium falciparum Elicits Cross-Species Protection against Heterologous Challenge with Plasmodium berghei	PLOS ONE			English	Article							CIRCUMSPOROZOITE PROTEIN; MALARIA INFECTION; GENETIC DIVERSITY; IMMUNE-RESPONSES; VACCINE; SPOROZOITES; EFFICACY; PARASITES; CHILDREN; AFFINITY	Background: The Plasmodium protein Cell-traversal protein for ookinetes and sporozoites (CelTOS) plays an important role in cell traversal of host cells in both, mosquito and vertebrates, and is required for successful malaria infections. CelTOS is highly conserved among the Plasmodium species, suggesting an important functional role across all species. Therefore, targeting the immune response to this highly conserved protein and thus potentially interfering with its biological function may result in protection against infection even by heterologous species of Plasmodium. Methodology/Principal Findings: To test this hypothesis, we developed a recombinant codon-harmonized P. falciparum CelTOS protein that can be produced to high yields in the E. coli expression system. Inbred Balb/c and outbred CD-1 mice were immunized with various doses of the recombinant protein adjuvanted with Montanide ISA 720 and characterized using in vitro and in vivo analyses. Conclusions/Significance: Immunization with PfCelTOS resulted in potent humoral and cellular immune responses and most importantly induced sterile protection against a heterologous challenge with P. berghei sporozoites in a proportion of both inbred and outbred mice. The biological activity of CelTOS-specific antibodies against the malaria parasite is likely linked to the impairment of sporozoite motility and hepatocyte infectivity. The results underscore the potential of this antigen as a pre-erythrocytic vaccine candidate and demonstrate for the first time a malaria vaccine that is cross-protective between species.	[Bergmann-Leitner, Elke S.; Mease, Ryan M.; De La Vega, Patricia; Polhemus, Mark; Ockenhouse, Christian; Angov, Evelina] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, US Mil Malaria Vaccine Program, Silver Spring, MD USA; [Savranskaya, Tatyana] Walter Reed Army Inst Res, Div Entomol, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Bergmann-Leitner, ES (corresponding author), Walter Reed Army Inst Res, Div Malaria Vaccine Dev, US Mil Malaria Vaccine Program, Silver Spring, MD USA.	Elke.BergmannLeitner@us.army.mil	Bergmann-Leitner, Elke/I-5431-2019; Bergmann-Leitner, Elke S./B-3548-2011	Bergmann-Leitner, Elke/0000-0002-8571-8956; Bergmann-Leitner, Elke S./0000-0002-8571-8956	United States Agency for International Development [936-3118, GHA-T-00-08-00007-01]; United States Army Medical Research and Material Command	United States Agency for International Development(United States Agency for International Development (USAID)); United States Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by the United States Agency for International Development under project number 936-3118, award number GHA-T-00-08-00007-01, and by the United States Army Medical Research and Material Command. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Bergmann-Leitner ES, 2005, INT IMMUNOL, V17, P245, DOI 10.1093/intimm/dxh205; COCHRANE AH, 1976, J IMMUNOL, V116, P859; Darko CA, 2005, INFECT IMMUN, V73, P287, DOI 10.1128/IAI.73.1.287-297.2005; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Kaiser K, 2004, MOL MICROBIOL, V51, P1221, DOI 10.1046/j.1365-2958.2003.03909.x; Kariu T, 2006, MOL MICROBIOL, V59, P1369, DOI 10.1111/j.1365-2958.2005.05024.x; KIM YT, 1974, CLIN EXP IMMUNOL, V17, P329; Leitner WW, 1997, J IMMUNOL, V159, P6112; LEITNER WW, 2010, MAL J, V9, pE145; NUSSENZWEIG RS, 1969, NATURE, V222, P488, DOI 10.1038/222488a0; Ockenhouse EB, 2009, AM J TROP MED HYG, V81, P260; OZAKI LS, 1984, J PARASITOL, V70, P831, DOI 10.2307/3281779; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; Scheiblhofer S, 2001, EUR J IMMUNOL, V31, P692, DOI 10.1002/1521-4141(200103)31:3&lt;692::AID-IMMU692&gt;3.0.CO;2-Y; Sharma Shobhona, 2008, Journal of Vector Borne Diseases, V45, P1; SINA BJ, 1983, EXPT PARASITOL, V77, P122; STEWART MJ, 1988, J PROTOZOOL, V35, P389, DOI 10.1111/j.1550-7408.1988.tb04115.x; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Vulliet R, 1996, BIOTECHNIQUES, V20, P797; Weiss R, 2000, INFECT IMMUN, V68, P5914, DOI 10.1128/IAI.68.10.5914-5919.2000	23	81	92	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12294	10.1371/journal.pone.0012294	http://dx.doi.org/10.1371/journal.pone.0012294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808868	Green Submitted, gold, Green Published			2022-12-25	WOS:000281075500022
J	Teramoto, W; Hidaka, S; Sugita, Y				Teramoto, Wataru; Hidaka, Souta; Sugita, Yoichi			Sounds Move a Static Visual Object	PLOS ONE			English	Article							MOTION PERCEPTION; AUDITORY MOTION; INTEGRATION; DIRECTION; CAPTURE; VISION; CORTEX	Background: Vision provides the most salient information with regard to stimulus motion, but audition can also provide important cues that affect visual motion perception. Here, we show that sounds containing no motion or positional cues can induce illusory visual motion perception for static visual objects. Methodology/Principal Findings: Two circles placed side by side were presented in alternation producing apparent motion perception and each onset was accompanied by a tone burst of a specific and unique frequency. After exposure to this visual apparent motion with tones for a few minutes, the tones became drivers for illusory motion perception. When the flash onset was synchronized to tones of alternating frequencies, a circle blinking at a fixed location was perceived as lateral motion in the same direction as the previously exposed apparent motion. Furthermore, the effect lasted at least for a few days. The effect was well observed at the retinal position that was previously exposed to apparent motion with tone bursts. Conclusions/Significance: The present results indicate that strong association between sound sequence and visual motion is easily formed within a short period and that, after forming the association, sounds are able to trigger visual motion perception for a static visual object.	[Teramoto, Wataru] Tohoku Univ, Dept Psychol, Grad Sch Arts & Letters, Sendai, Miyagi 980, Japan; [Teramoto, Wataru] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi 980, Japan; [Hidaka, Souta] Rikkyo Univ, Dept Psychol, Niiza, Saitama, Japan; [Sugita, Yoichi] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki, Japan	Tohoku University; Tohoku University; Rikkyo University; National Institute of Advanced Industrial Science & Technology (AIST)	Teramoto, W (corresponding author), Tohoku Univ, Dept Psychol, Grad Sch Arts & Letters, Sendai, Miyagi 980, Japan.	y.sugita@aist.go.jp	Hidaka, Souta/L-6393-2019	Hidaka, Souta/0000-0001-6727-5322	Ministry of Education, Science, and Culture, JAPAN [19001004]	Ministry of Education, Science, and Culture, JAPAN(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Specially Promoted Research (19001004) of the Ministry of Education, Science, and Culture, JAPAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Alais D, 2004, COGNITIVE BRAIN RES, V19, P185, DOI 10.1016/j.cogbrainres.2003.11.011; Alink A, 2008, J NEUROSCI, V28, P2690, DOI 10.1523/JNEUROSCI.2980-07.2008; Backus BT, 2007, VISION RES, V47, P919, DOI 10.1016/j.visres.2006.12.008; Dong CJ, 1999, NAT NEUROSCI, V2, P863, DOI 10.1038/13161; FAVREAU OE, 1972, SCIENCE, V176, P78, DOI 10.1126/science.176.4030.78; Freeman E, 2008, CURR BIOL, V18, P1262, DOI 10.1016/j.cub.2008.07.066; Hidaka S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008188; Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873; Meyer GF, 2001, NEUROREPORT, V12, P2557, DOI 10.1097/00001756-200108080-00053; Qi HJ, 2006, P NATL ACAD SCI USA, V103, P483, DOI 10.1073/pnas.0506728103; Seitz AR, 2007, CURR OPIN NEUROBIOL, V17, P148, DOI 10.1016/j.conb.2007.02.004; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Shams L, 2008, TRENDS COGN SCI, V12, P411, DOI 10.1016/j.tics.2008.07.006; Shimojo S, 1997, VISION RES, V37, P1575, DOI 10.1016/S0042-6989(96)00313-6; Soto-Faraco S, 2004, J EXP PSYCHOL HUMAN, V30, P330, DOI 10.1037/0096-1523.30.2.330; TERAMOTO W, 2010, NEUROSCI LE IN PRESS; Vroomen J, 2003, PSYCHOL SCI, V14, P357, DOI 10.1111/1467-9280.24431; Watanabe K, 2001, PSYCHOL SCI, V12, P109, DOI 10.1111/1467-9280.00319	19	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12255	10.1371/journal.pone.0012255	http://dx.doi.org/10.1371/journal.pone.0012255			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	640TN	20808861	Green Published, Green Submitted, gold			2022-12-25	WOS:000281075500005
J	Charlton, NL; Houston, AI				Charlton, Nicholas L.; Houston, Alasdair I.			What Currency Do Bumble Bees Maximize?	PLOS ONE			English	Article							LIFE-SPAN; FLIGHT SPEED; ENERGY; TIME; EFFICIENCY; COLONY; SIZE; CONSTRAINTS; PERFORMANCE; COSTS	In modelling bumble bee foraging, net rate of energetic intake has been suggested as the appropriate currency. The foraging behaviour of honey bees is better predicted by using efficiency, the ratio of energetic gain to expenditure, as the currency. We re-analyse several studies of bumble bee foraging and show that efficiency is as good a currency as net rate in terms of predicting behaviour. We suggest that future studies of the foraging of bumble bees should be designed to distinguish between net rate and efficiency maximizing behaviour in an attempt to discover which is the more appropriate currency.	[Charlton, Nicholas L.; Houston, Alasdair I.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Bristol	Charlton, NL (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	Nic.Charlton@bristol.ac.uk			Biotechnology and Biological Sciences Research Council (BBSRC)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is part of a PhD studentship funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTON T, 2006, BUMBLEBEES NATURAL H, V11; BEST LS, 1982, EVOLUTION, V36, P70, DOI 10.1111/j.1558-5646.1982.tb05011.x; CARTAR RV, 1990, BEHAV ECOL SOCIOBIOL, V27, P377, DOI 10.1007/BF00164009; CARTAR RV, 1992, J ANIM ECOL, V61, P225, DOI 10.2307/5525; CRESSWELL JE, 1990, OECOLOGIA, V82, P450, DOI 10.1007/BF00319785; Cresswell JE, 2000, ECOL ENTOMOL, V25, P249, DOI 10.1046/j.1365-2311.2000.00264.x; Denny AJ, 2001, ANIM BEHAV, V62, P139, DOI 10.1006/anbe.2001.1718; Dyer AG, 2006, NATURE, V442, P525, DOI 10.1038/442525a; FEWELL JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P401, DOI 10.1007/BF00294977; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; HEDENSTROM A, 1995, PHILOS T ROY SOC B, V348, P471, DOI 10.1098/rstb.1995.0082; HEINRICH B, 1983, AM ZOOL, V23, P273; HODGES CM, 1981, ANIM BEHAV, V29, P1166, DOI 10.1016/S0003-3472(81)80068-1; HOUSTON A, 1988, AM NAT, V131, P107, DOI 10.1086/284776; HOUSTON AI, 1987, J THEOR BIOL, V124, P251, DOI 10.1016/S0022-5193(87)80115-7; Houston AI, 1995, BEHAV ECOL, V6, P393, DOI 10.1093/beheco/6.4.393; Houston AI, 2006, J AVIAN BIOL, V37, P545; KACELNIK A, 1986, BEHAV ECOL SOCIOBIOL, V19, P19, DOI 10.1007/BF00303838; KACELNIK A, 1984, ANIM BEHAV, V32, P609, DOI 10.1016/S0003-3472(84)80298-5; KACELNIK A, 1984, J ANIM ECOL, V53, P283, DOI 10.2307/4357; KAMMER AE, 1974, J EXP BIOL, V61, P219; McNamara JM, 1997, AM NAT, V150, P603, DOI 10.1086/286084; NEUKIRCH A, 1982, J COMP PHYSIOL, V146, P35, DOI 10.1007/BF00688714; Pelletier L, 2003, OIKOS, V103, P688, DOI 10.1034/j.1600-0706.2003.12592.x; PLOWRIGHT RC, 1968, INSECT SOC, V15, P171, DOI 10.1007/BF02223465; PYKE GH, 1979, ANIM BEHAV, V27, P1167, DOI 10.1016/0003-3472(79)90064-2; PYKE GH, 1980, THEOR POPUL BIOL, V17, P232, DOI 10.1016/0040-5809(80)90008-8; Rands SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002007; Schmid-Hempel R, 1998, FUNCT ECOL, V12, P22, DOI 10.1046/j.1365-2435.1998.00153.x; SCHMIDHEMPEL P, 1985, BEHAV ECOL SOCIOBIOL, V17, P61, DOI 10.1007/BF00299430; SCHMIDHEMPEL P, 1988, J ANIM ECOL, V57, P509, DOI 10.2307/4921; Shepard ELC, 2009, P ROY SOC B-BIOL SCI, V276, P3149, DOI 10.1098/rspb.2009.0683; Spaethe J, 2002, INSECT SOC, V49, P142, DOI 10.1007/s00040-002-8293-z; Stephens D.W., 1986, pi; Tofilski A, 2009, INSECT SOC, V56, P359, DOI 10.1007/s00040-009-0031-3; van Gils JA, 2006, ARDEA, V94, P409; WADDINGTON KD, 1989, J INSECT BEHAV, V2, P91, DOI 10.1007/BF01053620; WELHAM CVJ, 1988, BEHAV ECOL SOCIOBIOL, V23, P75, DOI 10.1007/BF00299890; WILSON EO, 1971, INSECT SOC, V11; WOLF TJ, 1989, J ANIM ECOL, V58, P943, DOI 10.2307/5134; YDENBERG RC, 1994, BEHAV ECOL, V5, P28, DOI 10.1093/beheco/5.1.28	41	19	19	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12186	10.1371/journal.pone.0012186	http://dx.doi.org/10.1371/journal.pone.0012186			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808437	gold, Green Published, Green Submitted			2022-12-25	WOS:000280968000013
J	Lao, QZ; Kobrinsky, E; Liu, Z; Soldatov, NM				Lao, Qi Zong; Kobrinsky, Evgeny; Liu, Zhuo; Soldatov, Nikolai M.			Oligomerization of Ca-v beta subunits is an essential correlate of Ca2+ channel activity	FASEB JOURNAL			English	Article						protein-protein interaction; high-order protein complexes; calcium channel regulation; calcium signaling	GATED CALCIUM-CHANNELS; ALKALINE-PHOSPHATASE; HEART; MODULATION; EXPRESSION; COMPLEX; HETEROGENEITY; MECHANISM; MODULE	Voltage-gated calcium channels conduct Ca2+ ions in response to membrane depolarization. The resulting transient increase in cytoplasmic free calcium concentration is a critical trigger for the initiation of such vital responses as muscle contraction and transcription. L-type Ca(v)1.2 calcium channels are complexes of the pore-forming alpha(1C) subunit associated with cytosolic Ca-v beta subunits. All major Ca-v beta s share a highly homologous membrane associated guanylate kinaselike (MAGUK) domain that binds to alpha(1C) at the alpha-interaction domain (AID), a short motif in the linker between transmembrane repeats I and II. In this study we show that Ca-v beta subunits form multimolecular homoand heterooligomeric complexes in human vascular smooth muscle cells expressing native calcium channels and in Cos7 cells expressing recombinant Ca(v)1.2 channel subunits. Ca-v beta s oligomerize at the alpha(1C) subunits residing in the plasma membrane and bind to the AID. However, Ca-v beta oligomerization occurs independently on the association with alpha(1C). Molecular structures responsible for Ca-v beta oligomerization reside in 3 regions of the guanylate kinase subdomain of MAGUK. An augmentation of Ca-v beta homooligomerization significantly increases the calcium current density, while heterooligomerization may also change the voltagedependence and inactivation kinetics of the channel. Thus, oligomerization of Ca-v beta subunits represents a novel and essential aspect of calcium channel regulation.-Lao, Q. Z., Kobrinsky, E., Liu, Z., Soldatov, N. M. Oligomerization of Ca-v beta subunits is an essential correlate of Ca2+ channel activity. FASEB J. 24, 5013-5023 (2010). www. fasebj. org	[Lao, Qi Zong; Kobrinsky, Evgeny; Liu, Zhuo; Soldatov, Nikolai M.] NIA, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Soldatov, NM (corresponding author), Humgenex Inc, 3105 Starner Court, Kensington, MD 20895 USA.	soldatovn.humgenex@verizon.net			National Institute on Aging [Z01 AG000294-08]; NATIONAL INSTITUTE ON AGING [Z01AG000294] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging Intramural Research Program (Z01 AG000294-08 to N.M.S.).	AKIYAMA Y, 1993, J BIOL CHEM, V268, P8146; Canti C, 2001, BIOPHYS J, V81, P1439, DOI 10.1016/S0006-3495(01)75799-2; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen XW, 2005, CIRC RES, V97, P1009, DOI 10.1161/01.RES.0000189270.72915.D1; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Foell JD, 2004, PHYSIOL GENOMICS, V17, P183, DOI 10.1152/physiolgenomics.00207.2003; Gonzalez-Gutierrez G, 2008, P NATL ACAD SCI USA, V105, P14198, DOI 10.1073/pnas.0806558105; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; Hullin R, 1999, CIRCULATION, V100, P155, DOI 10.1161/01.CIR.100.2.155; Hullin R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000292; Kobrinsky E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005587; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Lao QZ, 2008, J BIOL CHEM, V283, P15577, DOI 10.1074/jbc.M802035200; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; LIPSCOMBE D, 1988, P NATL ACAD SCI USA, V85, P2398, DOI 10.1073/pnas.85.7.2398; McGee AW, 2004, NEURON, V42, P89, DOI 10.1016/S0896-6273(04)00149-7; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Miriyala J, 2008, CIRC RES, V102, pE54, DOI 10.1161/CIRCRESAHA.108.171736; Navedo MF, 2010, CIRC RES, V106, P748, DOI 10.1161/CIRCRESAHA.109.213363; Navedo MF, 2005, P NATL ACAD SCI USA, V102, P11112, DOI 10.1073/pnas.0500360102; Neely A, 2004, J BIOL CHEM, V279, P21689, DOI 10.1074/jbc.M312675200; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Page KM, 2010, J BIOL CHEM, V285, P835, DOI 10.1074/jbc.M109.065045; POWERS PA, 1992, J BIOL CHEM, V267, P22967; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Ravindran A, 2008, P NATL ACAD SCI USA, V105, P8154, DOI 10.1073/pnas.0711624105; Swamy Mahima, 2006, Sci STKE, V2006, ppl4, DOI 10.1126/stke.3452006pl4; Tareilus E, 1997, P NATL ACAD SCI USA, V94, P1703, DOI 10.1073/pnas.94.5.1703; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Walsh CP, 2009, J BIOL CHEM, V284, P22310, DOI 10.1074/jbc.M109.017152; Wei S, 2000, CIRC RES, V86, P175, DOI 10.1161/01.RES.86.2.175; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WITCHER DR, 1993, SCIENCE, V261, P486, DOI 10.1126/science.8392754; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yasuda T, 2004, J GEN PHYSIOL, V123, P401, DOI 10.1085/jgp.200308967; YEH MF, 1976, J BIOL CHEM, V251, P3134; Zhang R, 2005, FASEB J, V19, P1153, DOI 10.1096/fj.04-3283fje	40	15	15	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					5013	5023		10.1096/fj.10-165381	http://dx.doi.org/10.1096/fj.10-165381			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20732952	Green Published			2022-12-25	WOS:000284824400039
J	Murakami, E; Tolstykh, T; Bao, HY; Niu, CR; Steuer, HMM; Bao, DH; Chang, W; Espiritu, C; Bansal, S; Lam, AM; Otto, MJ; Sofia, MJ; Furman, PA				Murakami, Eisuke; Tolstykh, Tatiana; Bao, Haiying; Niu, Congrong; Steuer, Holly M. Micolochick; Bao, Donghui; Chang, Wonsuk; Espiritu, Christine; Bansal, Shalini; Lam, Angela M.; Otto, Michael J.; Sofia, Michael J.; Furman, Phillip A.			Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE ANALOG INHIBITORS; C VIRUS-REPLICATION; HEPATITIS-C; PHOSPHORAMIDATE DERIVATIVES; CARBOXYLESTERASE ISOZYMES; SUBSTRATE-SPECIFICITY; RNA-POLYMERASE; HUMAN-LIVER; HYDROLYSIS; HIV	A phosphoramidate prodrug of 2'-deoxy-2'-alpha-fluoro-beta-C-methyluridine-5'-monophosphate, PSI-7851, demonstrates potent anti-hepatitis C virus (HCV) activity both in vitro and in vivo. PSI-7851 is a mixture of two diastereoisomers, PSI-7976 and PSI-7977, with PSI-7977 being the more active inhibitor of HCV RNA replication in the HCV replicon assay. To inhibit the HCV NS5B RNA-dependent RNA polymerase, PSI-7851 must be metabolized to the active triphosphate form. The first step, hydrolysis of the carboxyl ester by human cathepsin A (CatA) and/or carboxylesterase 1 (CES1), is a stereospecific reaction. Western blot analysis showed that CatA and CES1 are both expressed in primary human hepatocytes. However, expression of CES1 is undetectable in clone A replicon cells. Studies with inhibitors of CatA and/or CES1 indicated that CatA is primarily responsible for hydrolysis of the carboxyl ester in clone A cells, although in primary human hepatocytes, both CatA and CES1 contribute to the hydrolysis. Hydrolysis of the ester is followed by a putative nucleophilic attack on the phosphorus by the carboxyl group resulting in the spontaneous elimination of phenol and the production of an alaninyl phosphate metabolite, PSI-352707, which is common to both isomers. The removal of the amino acid moiety of PSI-352707 is catalyzed by histidine triad nucleotide-binding protein 1 (Hint1) to give the 5'-monophosphate form, PSI-7411. siRNA-mediated Hint1 knockdown studies further indicate that Hint1 is, at least in part, responsible for converting PSI-352707 to PSI-7411. PSI-7411 is then consecutively phosphorylated to the diphosphate, PSI-7410, and to the active triphosphate metabolite, PSI-7409, by UMP-CMP kinase and nucleoside diphosphate kinase, respectively.	[Murakami, Eisuke; Tolstykh, Tatiana; Bao, Haiying; Niu, Congrong; Steuer, Holly M. Micolochick; Bao, Donghui; Chang, Wonsuk; Espiritu, Christine; Bansal, Shalini; Lam, Angela M.; Otto, Michael J.; Sofia, Michael J.; Furman, Phillip A.] Pharmasset Inc, Princeton, NJ 08540 USA		Murakami, E (corresponding author), 303 A Coll Rd E, Princeton, NJ 08540 USA.	emurakami@pharmasset.com; pfurman@pharmasset.com		Chang, Wonsuk/0000-0003-4697-4663				Birkus G, 2007, ANTIMICROB AGENTS CH, V51, P543, DOI 10.1128/AAC.00968-06; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; BLOCK W, 1978, BIOCHIM BIOPHYS ACTA, V524, P85, DOI 10.1016/0005-2744(78)90106-7; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Carroll S. S., 2006, Infectious Disorders - Drug Targets, V6, P17, DOI 10.2174/187152606776056698; Chou TF, 2005, J BIOL CHEM, V280, P15356, DOI 10.1074/jbc.M500434200; Chou TF, 2007, J BIOL CHEM, V282, P15137, DOI 10.1074/jbc.M606972200; Chou TF, 2007, J MOL BIOL, V373, P978, DOI 10.1016/j.jmb.2007.08.023; Chou TF, 2007, MOL PHARMACEUT, V4, P208, DOI 10.1021/mp060070y; Crow JA, 2007, TOXICOL APPL PHARM, V221, P1, DOI 10.1016/j.taap.2007.03.002; De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P1001, DOI 10.1038/nrd2424; Derudas M, 2009, J MED CHEM, V52, P5520, DOI 10.1021/jm9007856; DUARTE MIS, 1989, J SUBMICR CYTOL PATH, V21, P275; FE RIRG, 2008, REV MED VIROL */* E, V18, P19; Forestier N, 2007, HEPATOLOGY, V46, P640, DOI 10.1002/hep.21774; Furman PA, 2009, FUTURE MED CHEM, V1, P1429, DOI 10.4155/FMC.09.88; Hewlett G, 2004, CURR OPIN PHARMACOL, V4, P453, DOI 10.1016/j.coph.2004.06.004; Hiraiwa M, 1999, CELL MOL LIFE SCI, V56, P894, DOI 10.1007/s000180050482; Huang HZ, 2005, CHEM RES TOXICOL, V18, P1371, DOI 10.1021/tx050072+; Imai T, 2006, DRUG METAB PHARMACOK, V21, P173, DOI 10.2133/dmpk.21.173; Imai T, 2006, DRUG METAB DISPOS, V34, P1734, DOI 10.1124/dmd.106.009381; Kwong AD, 2008, CURR OPIN PHARMACOL, V8, P522, DOI 10.1016/j.coph.2008.09.007; Liverton NJ, 2010, ANTIMICROB AGENTS CH, V54, P305, DOI 10.1128/AAC.00677-09; Ma H, 2007, J BIOL CHEM, V282, P29812, DOI 10.1074/jbc.M705274200; McGuigan C, 1998, ANTIVIR CHEM CHEMOTH, V9, P473, DOI 10.1177/095632029800900603; McGuigan C, 1998, ANTIVIR CHEM CHEMOTH, V9, P109, DOI 10.1177/095632029800900202; Murakami E, 2008, ANTIMICROB AGENTS CH, V52, P458, DOI 10.1128/AAC.01184-07; Murakami E, 2007, ANTIMICROB AGENTS CH, V51, P503, DOI 10.1128/AAC.00400-06; NAESENS L, 2001, E Herpes, V8, P12; Stuyver Lieven J., 2006, Antiviral Chemistry & Chemotherapy, V17, P79; Stuyver LJ, 2003, J VIROL, V77, P10689, DOI 10.1128/JVI.77.19.10689-10694.2003; Sun ZJ, 2004, J PHARMACOL EXP THER, V310, P469, DOI 10.1124/jpet.104.067116; Valette G, 1996, J MED CHEM, V39, P1981, DOI 10.1021/jm9507338; Vivet-Boudou V, 2006, CELL MOL LIFE SCI, V63, P163, DOI 10.1007/s00018-005-5367-x; Yang DF, 2009, BIOCHEM PHARMACOL, V77, P238, DOI 10.1016/j.bcp.2008.10.005; Yang J, 2007, MOL PHARMACOL, V72, P686, DOI 10.1124/mol.107.036889	36	210	257	3	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34337	34347		10.1074/jbc.M110.161802	http://dx.doi.org/10.1074/jbc.M110.161802			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801890	hybrid, Green Published			2022-12-25	WOS:000283659100007
J	Vigil, D; Martin, TD; Williams, F; Yeh, JJ; Campbell, SL; Der, CJ				Vigil, Dominico; Martin, Timothy D.; Williams, Falina; Yeh, Jen Jen; Campbell, Sharon L.; Der, Channing J.			Aberrant Overexpression of the Rgl2 Ral Small GTPase-specific Guanine Nucleotide Exchange Factor Promotes Pancreatic Cancer Growth through Ral-dependent and Ral-independent Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; FAMILY GTPASES; CELL-GROWTH; DISSOCIATION STIMULATOR; GENE INDUCTION; ACTIVATION; EFFECTOR; PROTEIN; CORTACTIN; RLF	Our recent studies established essential and distinct roles for RalA and RalB small GTPase activation in K-Ras mutant pancreatic ductal adenocarcinoma (PDAC) cell line tumorigencity, invasion, and metastasis. However, the mechanism of Ral GTPase activation in PDAC has not been determined. There are four highly related mammalian RalGEFs (RalGDS, Rgl1, Rgl2, and Rgl3) that can serve as Ras effectors. Whether or not they share distinct or overlapping functions in K-Ras-mediated growth transformation has not been explored. We found that plasma membrane targeting to mimic persistent Ras activation enhanced the growth-transforming activities of RalGEFs. Unexpectedly, transforming activity did not correlate directly with total cell steady-state levels of Ral activation. Next, we observed elevated Rgl2 expression in PDAC tumor tissue and cell lines. Expression of dominant negative Ral, which blocks RalGEF function, as well as interfering RNA suppression of Rgl2, reduced PDAC cell line steady-state Ral activity, growth in soft agar, and Matrigel invasion. Surprisingly, the effect of Rgl2 on anchorage-independent growth could not be rescued by constitutively activated RalA, suggesting a novel Ral-independent function for Rgl2 in transformation. Finally, we determined that Rgl2 and RalB both localized to the leading edge, and this localization of RalB was dependent on endogenous Rgl2 expression. In summary, our observations support nonredundant roles for RalGEFs in Ras-mediated oncogenesis and a key role for Rgl2 in Ral activation and Ral-independent PDAC growth.	[Martin, Timothy D.; Der, Channing J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Vigil, Dominico; Martin, Timothy D.; Williams, Falina; Yeh, Jen Jen; Campbell, Sharon L.; Der, Channing J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Yeh, Jen Jen] Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA; [Campbell, Sharon L.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Der, CJ (corresponding author), Univ N Carolina, Dept Pharmacol, 201CB 7295, Chapel Hill, NC 27599 USA.	cjder@med.unc.edu		campbell, sharon/0000-0003-0311-409X; Der, Channing/0000-0002-7751-2747	National Institutes of Health [CA042978, CA67771]; National Institutes of Health, NCI [CA106991]; Emerald Foundation; Kimmel Foundation; American College of Surgeon; North Carolina University; NATIONAL CANCER INSTITUTE [R01CA140424, R01CA042978, P50CA106991, U19CA067771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Emerald Foundation; Kimmel Foundation; American College of Surgeon; North Carolina University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA042978 and CA67771 (to C. J. D.) and National Institutes of Health, NCI, SPORE in Gastrointestinal Cancer P50 Grant CA106991 (to C. J. D. and J. J. Y.). This work was also supported by the Emerald Foundation, the Kimmel Foundation, the American College of Surgeons, and the North Carolina University Cancer Research Fund.	ALBRIGHT CF, 1993, EMBO J, V12, P339, DOI 10.1002/j.1460-2075.1993.tb05662.x; Baines AT, 2006, METHOD ENZYMOL, V407, P556, DOI 10.1016/S0076-6879(05)07045-X; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Boguslavsky S, 2007, P NATL ACAD SCI USA, V104, P10882, DOI 10.1073/pnas.0702731104; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; COX AD, 1994, METHOD ENZYMOL, V238, P277; DE R, 1997, J L ONCOGENE */* ONC, V14, P623; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Ehrhardt GRA, 2001, ONCOGENE, V20, P188, DOI 10.1038/sj.onc.1204053; Evelyn CR, 2009, J BIOMOL SCREEN, V14, P161, DOI 10.1177/1087057108328761; Falsetti SC, 2007, MOL CELL BIOL, V27, P8003, DOI 10.1128/MCB.00057-07; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Goi T, 1999, MOL CELL BIOL, V19, P1731; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Hao YS, 2008, MOL CELL BIOL, V28, P2851, DOI 10.1128/MCB.01917-07; Isomura M, 1996, CYTOGENET CELL GENET, V74, P263, DOI 10.1159/000134431; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kaksonen M, 2000, J CELL SCI, V113, P4421; KIKUCHI A, 1994, MOL CELL BIOL, V14, P7483, DOI 10.1128/MCB.14.11.7483; Lanigan TM, 2003, FASEB J, V17, P2048, DOI 10.1096/fj.02-1096com; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lim KH, 2010, MOL CELL BIOL, V30, P508, DOI 10.1128/MCB.00916-08; Lok W, 2010, ANTI-CANCER DRUG, V21, P339, DOI 10.1097/CAD.0b013e3283350dd1; Matsubara K, 1999, ONCOGENE, V18, P1303, DOI 10.1038/sj.onc.1202425; McGillicuddy LT, 2009, CANCER CELL, V16, P44, DOI 10.1016/j.ccr.2009.05.009; Murai H, 1997, J BIOL CHEM, V272, P10483; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Oxford G, 2005, CANCER RES, V65, P7111, DOI 10.1158/0008-5472.CAN-04-1957; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Reid TS, 2004, J MOL BIOL, V343, P417, DOI 10.1016/j.jmb.2004.08.056; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Rosse C, 2006, MOL CELL BIOL, V26, P727, DOI 10.1128/MCB.26.2.727-734.2006; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shao HP, 2000, J BIOL CHEM, V275, P26914; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Shirakawa R, 2009, J BIOL CHEM, V284, P21580, DOI 10.1074/jbc.M109.012112; Sood R, 2000, BBA-GENE STRUCT EXPR, V1491, P285, DOI 10.1016/S0167-4781(00)00031-2; Takaya A, 2004, MOL BIOL CELL, V15, P2549, DOI 10.1091/mbc.E03-11-0857; Takaya A, 2007, MOL BIOL CELL, V18, P1850, DOI 10.1091/mbc.E06-08-0765; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; Wolthuis RMF, 1997, EMBO J, V16, P6748, DOI 10.1093/emboj/16.22.6748; Wolthuis RMF, 1996, ONCOGENE, V13, P353; Yeh JJ, 2007, EXPERT OPIN THER TAR, V11, P673, DOI 10.1517/14728222.11.5.673; Yin JJ, 2007, MOL CELL BIOL, V27, P7538, DOI 10.1128/MCB.00955-07; Yoshizaki H, 2007, MOL BIOL CELL, V18, P119, DOI 10.1091/mbc.E06-05-0467	57	42	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34729	34740		10.1074/jbc.M110.116756	http://dx.doi.org/10.1074/jbc.M110.116756			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801877	Green Published, hybrid			2022-12-25	WOS:000283659100048
J	Zhang, J; Ravichandran, KS; Garrison, JC				Zhang, Jun; Ravichandran, Kodi S.; Garrison, James C.			A Key Role for the Phosphorylation of Ser(440) by the Cyclic AMP-dependent Protein Kinase in Regulating the Activity of the Src Homology 2 Domain-containing Inositol 5 '-Phosphatase (SHIP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE 3-KINASE PATHWAY; TYROSINE PHOSPHORYLATION; POLYPHOSPHATE 5-PHOSPHATASE; LIPID PHOSPHATASES; MASS-SPECTROMETRY; IN-VIVO; CELLS; ACTIVATION; SHC; PI3K	The Src homology 2 domain-containing inositol 5'-phosphatase 1 (SHIP1) dephosphorylates phosphatidylinositol 3,4,5-trisphosphate to phophatidylinositol 3,4-bisphosphate in hematopoietic cells to regulate multiple cell signaling pathways. SHIP1 can be phosphorylated by the cyclic AMP-dependent protein kinase (PKA), resulting in an increase in SHIP1 activity (Zhang, J., Walk, S. F., Ravichandran, K. S., and Garrison, J. C. (2009) J. Biol. Chem. 284, 20070-20078). Using a combination of approaches, we identified the serine residue regulating SHIP1 activity. After mass spectrometric identification of 17 serine and threonine residues on SHIP1 as being phosphorylated by PKA in vitro, studies with truncation mutants of SHIP1 narrowed the phosphorylation site to the catalytic region between residues 400 and 866. Of the two candidate phosphorylation sites located in this region (Ser(440) and Ser(774)), only mutation of Ser(440) to Ala abolished the ability of PKA to phosphorylate the purified, catalytic domain of SHIP1 (residues 401-866). Mutation of Ser(440) to Ala in full-length SHIP1 abrogated the ability of PKA to increase the activity of SHIP1 in mammalian cells. Using flow cytometry, we found that the PKA activator, Sp-adenosine 3',5'-cyclic monophosphorothioate triethylammonium salt hydrate (Sp-cAMPS) blunted the phosphorylation of Akt downstream of B cell antigen receptor engagement in SHIP1-null DT40 B lymphocytes expressing native mouse SHIP1. The inhibitory effect of Sp-cAMPS was absent in cells expressing the S440A mutant of SHIP1. These results suggest that activation of SHIP1 by PKA via phosphorylation on Ser(440) is an important regulatory event in hematopoietic cells.	[Zhang, Jun; Garrison, James C.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Garrison, JC (corresponding author), Univ Virginia, Dept Pharmacol, POB 800735, Charlottesville, VA 22908 USA.	jcg8w@virginia.edu		Ravichandran, Kodi/0000-0001-9049-1410; Zhang, Jun/0000-0002-3339-0346	Garrison laboratory; National Institutes of Health [R01 GM076236, DK199520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076236] Funding Source: NIH RePORTER	Garrison laboratory; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Susan Taylor for providing the expression vector containing the catalytic subunit of PKA and the purified PKA catalytic subunit. We thank Dr. Nicholas E. Sherman of the University of Virginia Biomolecular Research Facility for identification of phosphorylation sites. We thank Dr. Paul Trampont for discussions and suggestions for the flow cytometry experiments. We also thank all the members of the Garrison laboratory for advice and support on this project.; This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM076236 and DK199520.	Aman MJ, 2000, MOL CELL BIOL, V20, P3576, DOI 10.1128/MCB.20.10.3576-3589.2000; Artemenko Y, 2007, J CELL PHYSIOL, V211, P598, DOI 10.1002/jcp.20965; Backers K, 2003, ADV ENZYME REGUL, V43, P15, DOI 10.1016/S0065-2571(02)00043-2; Batty IH, 2007, BIOCHEM J, V407, P255, DOI 10.1042/BJ20070558; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Bruce JIE, 2002, J BIOL CHEM, V277, P1340, DOI 10.1074/jbc.M106609200; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Giuriato S, 1997, J BIOL CHEM, V272, P26857, DOI 10.1074/jbc.272.43.26857; Gronborg M, 2002, MOL CELL PROTEOMICS, V1, P517, DOI 10.1074/mcp.M200010-MCP200; Harris SJ, 2008, J BIOL CHEM, V283, P2465, DOI 10.1074/jbc.R700044200; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Kagawa S, 2005, J CLIN ENDOCR METAB, V90, P2911, DOI 10.1210/jc.2004-1724; Kennah M, 2009, EXP HEMATOL, V37, P1274, DOI 10.1016/j.exphem.2009.08.001; Kisseleva MV, 2000, J BIOL CHEM, V275, P20110, DOI 10.1074/jbc.M910119199; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Krystal G, 2000, SEMIN IMMUNOL, V12, P397, DOI 10.1006/smim.2000.0222; Lamkin TD, 1997, J BIOL CHEM, V272, P10396; LIU L, 1994, MOL CELL BIOL, V14, P6926, DOI 10.1128/MCB.14.10.6926; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Mandal A, 1999, BIOL REPROD, V61, P1184, DOI 10.1095/biolreprod61.5.1184; March ME, 2002, SEMIN IMMUNOL, V14, P37, DOI 10.1006/smim.2001.0340; O'Flaherty C, 2004, MOL HUM REPROD, V10, P355, DOI 10.1093/molehr/gah046; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Ong CJ, 2007, BLOOD, V110, P1942, DOI 10.1182/blood-2007-03-079699; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Osborne MA, 1996, J BIOL CHEM, V271, P29271, DOI 10.1074/jbc.271.46.29271; Phee H, 2000, J BIOL CHEM, V275, P19090, DOI 10.1074/jbc.M001093200; Pradhan M, 1997, J CELL BIOCHEM, V67, P32, DOI 10.1002/(SICI)1097-4644(19971001)67:1<32::AID-JCB4>3.0.CO;2-X; Prasad NK, 2009, BIOCHEMISTRY-US, V48, P6285, DOI 10.1021/bi900492d; Salomon AR, 2003, P NATL ACAD SCI USA, V100, P443, DOI 10.1073/pnas.2436191100; Sly LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2836, DOI 10.2741/2276; Sly LM, 2003, EXP HEMATOL, V31, P1170, DOI 10.1016/j.exphem.2003.09.011; Tsujishita Y, 2001, CELL, V105, P379, DOI 10.1016/S0092-8674(01)00326-9; Zhang J, 2009, J BIOL CHEM, V284, P20070, DOI 10.1074/jbc.M109.016865	36	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34839	34849		10.1074/jbc.M110.128827	http://dx.doi.org/10.1074/jbc.M110.128827			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810657	Green Published, hybrid			2022-12-25	WOS:000283659100059
J	Suzuki, R; Katayama, T; Kim, BJ; Wakagi, T; Shoun, H; Ashida, H; Yamamoto, K; Fushinobu, S				Suzuki, Ryuichiro; Katayama, Takane; Kim, Byung-Jun; Wakagi, Takayoshi; Shoun, Hirofumi; Ashida, Hisashi; Yamamoto, Kenji; Fushinobu, Shinya			Crystal Structures of Phosphoketolase THIAMINE DIPHOSPHATE-DEPENDENT DEHYDRATION MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XYLULOSE 5-PHOSPHATE; LACTOBACILLUS-PLANTARUM; TRANSKETOLASE; CRYSTALLOGRAPHY; CATALYSIS; CLEAVAGE; FRUCTOSE-6-PHOSPHATE; PURIFICATION; 6-PHOSPHATE; BACTERIAL	Thiamine diphosphate (ThDP)-dependent enzymes are ubiquitously present in all organisms and catalyze essential reactions in various metabolic pathways. ThDP-dependent phosphoketolase plays key roles in the central metabolism of heterofermentative bacteria and in the pentose catabolism of various microbes. In particular, bifidobacteria, representatives of beneficial commensal bacteria, have an effective glycolytic pathway called bifid shunt in which 2.5 mol of ATP are produced per glucose. Phosphoketolase catalyzes two steps in the bifid shunt because of its dual-substrate specificity; they are phosphorolytic cleavage of fructose 6-phosphate or xylulose 5-phosphate to produce aldose phosphate, acetyl phosphate, and H2O. The phosphoketolase reaction is different from other well studied ThDP-dependent enzymes because it involves a dehydration step. Although phosphoketolase was discovered more than 50 years ago, its three-dimensional structure remains unclear. In this study we report the crystal structures of xylulose 5-phosphate/ fructose 6-phosphate phosphoketolase from Bifidobacterium breve. The structures of the two intermediates before and after dehydration (alpha,beta-dihydroxyethyl ThDP and 2-acetylThDP) and complex with inorganic phosphate give an insight into the mechanism of each step of the enzymatic reaction.	[Suzuki, Ryuichiro; Wakagi, Takayoshi; Shoun, Hirofumi; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Katayama, Takane] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Kim, Byung-Jun; Ashida, Hisashi; Yamamoto, Kenji] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan	University of Tokyo; Ishikawa Prefecture University; Kyoto University	Fushinobu, S (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Ashida, Hisashi/HCI-0293-2022; Fushinobu, Shinya/E-4987-2011; Wakagi, Takayoshi/AAJ-4145-2021	Fushinobu, Shinya/0000-0003-1346-6435; Katayama, Takane/0000-0003-4009-7874; Ashida, Hisashi/0000-0001-5844-4075	Program for the Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) in Japan	Program for the Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) in Japan	This work was supported by the Program for the Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) in Japan.	Asztalos P, 2007, BIOCHEMISTRY-US, V46, P12037, DOI 10.1021/bi700844m; BRESLOW R, 1958, J AM CHEM SOC, V80, P3719, DOI 10.1021/ja01547a064; BURGI HB, 1983, ACCOUNTS CHEM RES, V16, P153, DOI 10.1021/ar00089a002; Duggleby RG, 2006, ACCOUNTS CHEM RES, V39, P550, DOI 10.1021/ar068022z; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiedler E, 2002, P NATL ACAD SCI USA, V99, P591, DOI 10.1073/pnas.022510999; FREY P A, 1989, Biofactors, V2, P1; GOLDBERG ML, 1962, J BIOL CHEM, V237, P3841; GRUYS KJ, 1987, BIOCHEMISTRY-US, V26, P7575, DOI 10.1021/bi00398a007; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; HEATH EC, 1958, J BIOL CHEM, V231, P1009; HURWITZ J, 1958, BIOCHIM BIOPHYS ACTA, V28, P599, DOI 10.1016/0006-3002(58)90526-2; Jordan F, 2003, NAT PROD REP, V20, P184, DOI 10.1039/b111348h; Kern D, 1997, SCIENCE, V275, P67, DOI 10.1126/science.275.5296.67; Kluger R, 2008, CHEM REV, V108, P1797, DOI 10.1021/cr068444m; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Meile L, 2001, J BACTERIOL, V183, P2929, DOI 10.1128/JB.183.9.2929-2936.2001; MULLER YA, 1993, SCIENCE, V259, P965, DOI 10.1126/science.8438155; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nilsson U, 1997, J BIOL CHEM, V272, P1864, DOI 10.1074/jbc.272.3.1864; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panagiotou G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003847; Pang SS, 2004, J BIOL CHEM, V279, P2242, DOI 10.1074/jbc.M304038200; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petrareanu G, 2010, ACTA CRYSTALLOGR F, V66, P805, DOI 10.1107/S174430911001732X; Rappleye J, 2002, J APPL CRYSTALLOGR, V35, P374, DOI 10.1107/S0021889802005782; Reed GH, 1996, CURR OPIN STRUC BIOL, V6, P736, DOI 10.1016/S0959-440X(96)80002-9; Sanchez B, 2010, J MOL MICROB BIOTECH, V18, P37, DOI 10.1159/000274310; Scardovi V., 1965, ANN MICROBIOL ENZ, V15, P19; SCARDOVI V, 1986, BERGEYS MANUAL SYSTE, V2, P1418; Schneider G, 1998, BBA-PROTEIN STRUCT M, V1385, P387, DOI 10.1016/S0167-4838(98)00082-X; SCHRAMM M, 1958, J BIOL CHEM, V233, P1283; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SGORBATI B, 1976, A VAN LEEUW J MICROB, V42, P49, DOI 10.1007/BF00399448; Suzuki R, 2010, ACTA CRYSTALLOGR F, V66, P941, DOI 10.1107/S1744309110023845; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tittmann K, 2003, BIOCHEMISTRY-US, V42, P7885, DOI 10.1021/bi034465o; Tittmann K, 2005, BIOCHEMISTRY-US, V44, P13291, DOI 10.1021/bi051058z; Tittmann K, 2009, J MOL CATAL B-ENZYM, V61, P93, DOI 10.1016/j.molcatb.2009.02.019; Tittmann K, 2009, FEBS J, V276, P2454, DOI 10.1111/j.1742-4658.2009.06966.x; Vlkova E, 2005, J MICROBIOL METH, V60, P365, DOI 10.1016/j.mimet.2004.10.012; Wikner C, 1997, BIOCHEMISTRY-US, V36, P15643, DOI 10.1021/bi971606b; Wille G, 2006, NAT CHEM BIOL, V2, P324, DOI 10.1038/nchembio788; Yevenes A, 2008, BIOORG CHEM, V36, P121, DOI 10.1016/j.bioorg.2008.03.002	45	39	40	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34279	34287		10.1074/jbc.M110.156281	http://dx.doi.org/10.1074/jbc.M110.156281			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20739284	hybrid, Green Published			2022-12-25	WOS:000283354000073
J	Katouli, AA; Komarova, NL				Katouli, Allen A.; Komarova, Natalia L.			Optimizing Combination Therapies with Existing and Future CML Drugs	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; CHROMOSOME-POSITIVE LEUKEMIAS; CHRONIC MYELOGENOUS LEUKEMIA; ABL INHIBITORS IMATINIB; BCR-ABL; GENE AMPLIFICATION; AURORA KINASES; DASATINIB BMS-354825; CANCER-CHEMOTHERAPY; MATHEMATICAL-MODELS	Small-molecule inhibitors imatinib, dasatinib and nilotinib have been developed to treat Chromic Myeloid Leukemia (CML). The existence of a triple-cross-resistant mutation, T315I, has been a challenging problem, which can be overcome by finding new inhibitors. Many new compounds active against T315I mutants are now at different stages of development. In this paper we develop an algorithm which can weigh different combination treatment protocols according to their cross-resistance properties, and find the protocols with the highest probability of treatment success. This algorithm also takes into account drug toxicity by minimizing the number of drugs used, and their concentration. Although our methodology is based on a stochastic model of CML microevolution, the algorithm itself does not require measurements of any parameters (such as mutation rates, or division/death rates of cells), and can be used by medical professionals without a mathematical background. For illustration, we apply this algorithm to the mutation data obtained in [1,2].	[Katouli, Allen A.; Komarova, Natalia L.] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA	University of California System; University of California Irvine	Katouli, AA (corresponding author), Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA.	komarova@uci.edu			National Institutes of Health [R01 CA129286]; NATIONAL CANCER INSTITUTE [R01CA129286] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to gratefully acknowledge the generous support of the National Institutes of Health grant R01 CA129286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apperley JF, 2007, LANCET ONCOL, V8, P1018, DOI 10.1016/S1470-2045(07)70342-X; Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580; Branford S, 2009, BLOOD, V114, P5426, DOI 10.1182/blood-2009-08-215939; BYRNE HM, 1995, MATH BIOSCI, V130, P151, DOI 10.1016/0025-5564(94)00117-3; Calabretta B, 2004, BLOOD, V103, P4010, DOI 10.1182/blood-2003-12-4111; Cohen RB, 2009, CLIN CANCER RES, V15, P6694, DOI 10.1158/1078-0432.CCR-09-1445; COJOCARU L, 1992, MATH BIOSCI, V109, P85, DOI 10.1016/0025-5564(92)90053-Y; COLDMAN AJ, 1983, MATH BIOSCI, V65, P291, DOI 10.1016/0025-5564(83)90066-4; COLDMAN AJ, 1986, B MATH BIOL, V48, P279, DOI 10.1016/S0092-8240(86)90028-5; COLDMAN AJ, 1985, CANCER TREAT REP, V69, P1041; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; de Pillis LG, 2007, MATH BIOSCI, V209, P292, DOI 10.1016/j.mbs.2006.05.003; Deguchi Y, 2008, LEUKEMIA RES, V32, P980, DOI 10.1016/j.leukres.2007.11.008; Deininger MWN, 2007, EXP HEMATOL, V35, P144, DOI 10.1016/j.exphem.2007.01.023; Deininger MWN, 2003, J CLIN ONCOL, V21, P1637, DOI 10.1200/JCO.2003.11.143; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Druker BJ, 2003, MOL CANCER THER, V2, P225; Gaffney EA, 2005, B MATH BIOL, V67, P563, DOI 10.1016/j.bulm.2004.09.002; Gaffney EA, 2004, J MATH BIOL, V48, P375, DOI 10.1007/s00285-003-0246-2; Gambacorti-Passerini CB, 2003, LANCET ONCOL, V4, P75, DOI 10.1016/S1470-2045(03)00979-3; Gardner SN, 2003, MOL CANCER THER, V2, P1079; Giles FJ, 2007, BLOOD, V109, P500, DOI 10.1182/blood-2006-05-025049; GOLDIE JH, 1983, CANCER TREAT REP, V67, P923; GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727; Gontarewicz A, 2008, BLOOD, V111, P4355, DOI 10.1182/blood-2007-09-113175; Gontarewicz A, 2010, RECENT RESULTS CANC, V184, P199, DOI 10.1007/978-3-642-01222-8_14; Hantschel O, 2008, LEUKEMIA LYMPHOMA, V49, P615, DOI 10.1080/10428190801896103; HARNEVO LE, 1993, MUTAT RES, V292, P17, DOI 10.1016/0165-1161(93)90004-J; HARNEVO LE, 1991, MATH BIOSCI, V103, P115, DOI 10.1016/0025-5564(91)90094-Y; Jackson TL, 2000, MATH BIOSCI, V164, P17, DOI 10.1016/S0025-5564(99)00062-0; JAFFREZOU JP, 1994, J NATL CANCER I, V86, P1152, DOI 10.1093/jnci/86.15.1152; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; KATOULI AA, 2009, THESIS U CALIFORNIA; Kendal W S, 1988, Adv Exp Med Biol, V233, P1; KIMMEL M, 1994, B MATH BIOL, V56, P337, DOI 10.1016/S0092-8240(05)80262-9; KIMMEL M, 1990, GENETICS, V125, P633; Komarova N, 2006, J THEOR BIOL, V239, P351, DOI 10.1016/j.jtbi.2005.08.003; Komarova NL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000990; Komarova NL, 2007, THEOR POPUL BIOL, V72, P523, DOI 10.1016/j.tpb.2007.08.003; Komarova NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004423; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Loriaux M, 2004, LEUKEMIA LYMPHOMA, V45, P2197, DOI 10.1080/10428190410001723278; McKinnell R. G., 1998, BIOL BASIS CANC; Melo Junia V, 2003, Hematology Am Soc Hematol Educ Program, P132; Michor F, 2006, CURR PHARM DESIGN, V12, P261, DOI 10.2174/138161206775201956; Modugno M, 2007, CANCER RES, V67, P7987, DOI 10.1158/0008-5472.CAN-07-1825; MOLONEY WC, 1987, BLOOD, V70, P905; MOOLGAVKAR SH, 1988, RISK ANAL, V8, P383, DOI 10.1111/j.1539-6924.1988.tb00502.x; MOOLGAVKAR SH, 1981, J NATL CANCER I, V66, P1037, DOI 10.1093/jnci/66.6.1037; MOOLGAVKAR SH, 1989, CELL BIOL TOXICOL, V5, P445, DOI 10.1007/BF00118413; Nardi V, 2004, CURR OPIN HEMATOL, V11, P35, DOI 10.1097/00062752-200401000-00006; Noronha G, 2008, CURR TOP MED CHEM, V8, P905, DOI 10.2174/156802608784911635; O'Hare T, 2008, P NATL ACAD SCI USA, V105, P5507, DOI 10.1073/pnas.0800587105; O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936; Quintas-Cardama A, 2007, BLOOD, V109, P497, DOI 10.1182/blood-2006-07-035493; Redaelli S, 2009, J CLIN ONCOL, V27, P469, DOI 10.1200/JCO.2008.19.8853; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Roeder I, 2008, J MOL MED, V86, P17, DOI 10.1007/s00109-007-0241-y; Shannon KM, 2002, CANCER CELL, V2, P99, DOI 10.1016/S1535-6108(02)00101-0; Shet AS, 2002, LEUKEMIA, V16, P1402, DOI 10.1038/sj.leu.2402577; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Weisberg E, 2007, NAT REV CANCER, V7, P345, DOI 10.1038/nrc2126; Weisberg E, 2007, BLOOD, V109, P2112, DOI 10.1182/BLOOD-2006-06-026377; Xie Y, 2003, CANCER-AM CANCER SOC, V97, P2229, DOI 10.1002/cncr.11316; Yoshida C, 2004, INT J HEMATOL, V79, P420, DOI 10.1532/IJH97.04032; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhou TJ, 2007, CHEM BIOL DRUG DES, V70, P171, DOI 10.1111/j.1747-0285.2007.00556.x	68	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12300	10.1371/journal.pone.0012300	http://dx.doi.org/10.1371/journal.pone.0012300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808800	Green Published, gold			2022-12-25	WOS:000281153500002
J	Yin, J; Hu, S; Jiang, W; Liu, LA; Lan, SM; Song, XG; Liu, CL				Yin, Jun; Hu, Si; Jiang, Wei; Liu, Liang; Lan, Shemin; Song, Xuegang; Liu, Changlin			DNA-Triggered Aggregation of Copper, Zinc Superoxide Dismutase in the Presence of Ascorbate	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ALS-LINKED SOD1; MUTANT CU,ZN-SUPEROXIDE DISMUTASE; MOTOR-NEURON DEGENERATION; FAMILIAL ALS; OXIDATIVE STRESS; WILD-TYPE; IN-VITRO; MUTATIONS; TOXICITY	The oxidative damage hypothesis proposed for the function gain of copper, zinc superoxide dismutase (SOD1) maintains that both mutant and wild-type (WT) SOD1 catalyze reactions with abnormal substrates that damage cellular components critical for viability of the affected cells. However, whether the oxidative damage of SOD1 is involved in the formation of aggregates rich in SOD1 or not remains elusive. Here, we sought to explore the oxidative aggregation of WT SOD1 exposed to environments containing both ascorbate (Asc) and DNA under neutral conditions. The results showed that the WT SOD1 protein was oxidized in the presence of Asc. The oxidation results in the higher affinity of the modified protein for DNA than that of the unmodified protein. The oxidized SOD1 was observed to be more prone to aggregation than the WT SOD1, and the addition of DNA can significantly accelerate the oxidative aggregation. Moreover, a reasonable relationship can be found between the oxidation, increased hydrophobicity, and aggregation of SOD1 in the presence of DNA. The crucial step in aggregation is neutralization of the positive charges on some SOD1 surfaces by DNA binding. This study might be crucial for understanding molecular forces driving the protein aggregation.	[Yin, Jun] Cent China Normal Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Wuhan, Peoples R China; Cent China Normal Univ, Sch Chem, Wuhan, Peoples R China	Central China Normal University; Central China Normal University	Yin, J (corresponding author), Cent China Normal Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Wuhan, Peoples R China.	liuchl@mail.ccnu.edu.cn			National Natural Science Foundation of China [20971049]; Key Laboratory of Pesticide and Chemical Biology, Ministry of Education, Central China Normal University [200601A04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Pesticide and Chemical Biology, Ministry of Education, Central China Normal University(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China (grant 20971049) and by Key Laboratory of Pesticide and Chemical Biology, Ministry of Education, Central China Normal University (200601A04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Barbosa LF, 2010, BBA-MOL BASIS DIS, V1802, P462, DOI 10.1016/j.bbadis.2010.01.011; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653; CHANG Y, 2008, PLOS ONE, V3, pE2489; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104; Cherny D, 2004, J MOL BIOL, V344, P929, DOI 10.1016/j.jmb.2004.09.096; Choi J, 2005, J BIOL CHEM, V280, P11648, DOI 10.1074/jbc.M414327200; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; Cozzolino M, 2009, ANTIOXID REDOX SIGN, V11, P1547, DOI 10.1089/ARS.2009.2545; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Ferri A, 2006, P NATL ACAD SCI USA, V103, P13860, DOI 10.1073/pnas.0605814103; FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Ge WW, 2005, J BIOL CHEM, V280, P118, DOI 10.1074/jbc.M405065200; Gros-Louis F, 2006, BBA-MOL BASIS DIS, V1762, P956, DOI 10.1016/j.bbadis.2006.01.004; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hart PJ, 2006, CURR OPIN CHEM BIOL, V10, P131, DOI 10.1016/j.cbpa.2006.02.034; Ihara Y, 2005, NEUROL RES, V27, P105, DOI 10.1179/016164105X18430; Jaarsma D, 2000, NEUROBIOL DIS, V7, P623, DOI 10.1006/nbdi.2000.0299; Jiang W, 2008, BIOPOLYMERS, V89, P1154, DOI 10.1002/bip.21067; Jiang W, 2007, BIOCHEMISTRY-US, V46, P5911, DOI 10.1021/bi062234m; Jiang W, 2006, J BIOL INORG CHEM, V11, P835, DOI 10.1007/s00775-006-0127-4; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kawamata H, 2008, HUM MOL GENET, V17, P3303, DOI 10.1093/hmg/ddn226; Khare SD, 2004, P NATL ACAD SCI USA, V101, P15094, DOI 10.1073/pnas.0406650101; Kim YJ, 2005, J BIOL CHEM, V280, P21515, DOI 10.1074/jbc.M502230200; Kinnula VL, 2004, FREE RADICAL BIO MED, V36, P718, DOI 10.1016/j.freeradbiomed.2003.12.010; Kurahashi T, 2001, J AM CHEM SOC, V123, P9268, DOI 10.1021/ja015953r; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Li XL, 2009, J NEUROCHEM, V108, P1032, DOI 10.1111/j.1471-4159.2008.05856.x; LIPPARD SJ, 1977, BIOCHEMISTRY-US, V16, P1136, DOI 10.1021/bi00625a017; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Ogusucu R, 2009, J BIOL CHEM, V284, P5546, DOI 10.1074/jbc.M805526200; PARDO CA, 1995, P NATL ACAD SCI USA, V92, P954, DOI 10.1073/pnas.92.4.954; Potter SZ, 2003, J BIOL INORG CHEM, V8, P373, DOI 10.1007/s00775-003-0447-6; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Shaw BF, 2008, J BIOL CHEM, V283, P8340, DOI 10.1074/jbc.M707751200; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Simpson CL, 2006, BBA-MOL BASIS DIS, V1762, P973, DOI 10.1016/j.bbadis.2006.08.001; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Tiwari A, 2005, J BIOL CHEM, V280, P29771, DOI 10.1074/jbc.M504039200; Valentine JS, 2002, FREE RADICAL BIO MED, V33, P1314, DOI 10.1016/S0891-5849(02)01080-8; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; WANG L, 2002, SCI STKE, V138, P1; Zhang FJ, 2006, BBA-GEN SUBJECTS, V1760, P404, DOI 10.1016/j.bbagen.2005.11.024	70	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12328	10.1371/journal.pone.0012328	http://dx.doi.org/10.1371/journal.pone.0012328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808835	gold, Green Published, Green Submitted			2022-12-25	WOS:000281077000017
J	Yu, ACL				Yu, Alan C. L.			Perceptual Compensation Is Correlated with Individuals' "Autistic" Traits: Implications for Models of Sound Change	PLOS ONE			English	Article							SPECTRUM QUOTIENT AQ; HIGH-FUNCTIONING AUTISM; ASPERGER-SYNDROME; COGNITIVE STYLES; SEX; POPULATION; DOMINANCE; GENDER; ADULTS	Variation is a ubiquitous feature of speech. Listeners must take into account context-induced variation to recover the interlocutor's intended message. When listeners fail to normalize for context-induced variation properly, deviant percepts become seeds for new perceptual and production norms. In question is how deviant percepts accumulate in a systematic fashion to give rise to sound change (i.e., new pronunciation norms) within a given speech community. The present study investigated subjects' classification of /s/ and /integral/ before /a/ or /u/ spoken by a male or a female voice. Building on modern cognitive theories of autism-spectrum condition, which see variation in autism-spectrum condition in terms of individual differences in cognitive processing style, we established a significant correlation between individuals' normalization for phonetic context (i.e., whether the following vowel is /a/ or /u/) and talker voice variation (i.e., whether the talker is male or female) in speech and their "autistic" traits, as measured by the Autism Spectrum Quotient (AQ). In particular, our mixed-effect logistic regression models show that women with low AQ (i.e., the least "autistic") do not normalize for phonetic coarticulation as much as men and high AQ women. This study provides first direct evidence that variability in human's ability to compensate for context-induced variations in speech perceptually is governed by the individual's sex and cognitive processing style. These findings lend support to the hypothesis that the systematic infusion of new linguistic variants (i.e., the deviant percepts) originate from a sub-segment of the speech community that consistently under-compensates for contextual variation in speech.	Univ Chicago, Dept Linguist, Phonol Lab, Chicago, IL 60637 USA	University of Chicago	Yu, ACL (corresponding author), Univ Chicago, Dept Linguist, Phonol Lab, Chicago, IL 60637 USA.	aclyu@uchicago.edu			National Science Foundation [BCS-0949754]; Direct For Social, Behav & Economic Scie [0949754] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work is partially funded by National Science Foundation grant BCS-0949754. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; *APA, 1994, DSM 4 DIAGN STAT MAN; AUSBURN LJ, 1978, ECTJ-EDUC COMMUN TEC, V26, P337; Austin EJ, 2005, PERS INDIV DIFFER, V38, P451, DOI 10.1016/j.paid.2004.04.022; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S., 2001, J DEV LEARNING DISOR, V5, P47, DOI DOI 10.1111/J.1467-7687.2008.00720.X; Baron-Cohen S, 2009, ANN NY ACAD SCI, V1156, P68, DOI 10.1111/j.1749-6632.2009.04467.x; Bates D., 2009, IME4 LINEAR MIXED EF; Beddor PS, 2009, LANGUAGE, V85, P785; Blevins Juliette, 2004, EVOLUTIONARY PHONOLO; Bonnel A, 2003, J COGNITIVE NEUROSCI, V15, P226, DOI 10.1162/089892903321208169; Chambers Jack K., 1995, SOCIOLINGUISTIC THEO; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524; COURCHESNE E, 1994, BEHAV NEUROSCI, V108, P848, DOI 10.1037/0735-7044.108.5.848; Deutsch, 1985, LEFT BRAIN RIGHT BRA; ECKERT P, 1988, LANG SOC, V17, P183, DOI 10.1017/S0047404500012756; ECKERT P, 1999, LINGUISTIC VARIATION; Eckert Penelope, 1989, LANG VAR CHANGE, V1, P245, DOI DOI 10.1017/S095439450000017X; Emberts Zachary, 2020, EVOLUTION, V74, P897, DOI [10.1111/evo.13948, DOI 10.1111/EVO.13580]; Gordon M, 1998, CURR ANTHROPOL, V39, P421, DOI 10.1086/204758; Groen W, 2008, J AUTISM DEV DISORD, V38, P1819, DOI 10.1007/s10803-008-0572-8; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; Hoekstra RA, 2008, J AUTISM DEV DISORD, V38, P1555, DOI 10.1007/s10803-008-0538-x; Hoekstra RA, 2007, ARCH PEDIAT ADOL MED, V161, P372, DOI 10.1001/archpedi.161.4.372; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Labov William, 1990, LANG VAR CHANGE, V2, P205, DOI [10. 1017/S09543945 00000338, DOI 10.1017/S0954394500000338]; Lindblom Bjorn E. F., 1995, RIV LINGUISTICA, V7, P5; MANN VA, 1980, PERCEPT PSYCHOPHYS, V28, P407, DOI 10.3758/BF03204884; Messick S., 1976, INDIVIDUALITY LEARNI; Mitterer H, 2006, PERCEPT PSYCHOPHYS, V68, P1227, DOI 10.3758/BF03193723; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Mufwene Salikoko S., 2008, LANGUAGE EVOLUTION C; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; OHala J.J., 1993, HIST LINGUISTICS PRO, P237; Schilling-Estes N., 2002, J ENGL LINGUIST, V30, P122, DOI DOI 10.1177/007242030002003; Soulieres I, 2007, J AUTISM DEV DISORD, V37, P481, DOI 10.1007/s10803-006-0172-4; SPERRY RW, 1964, SCI AM, V210, P42, DOI 10.1038/scientificamerican0164-42; Stewart ME, 2008, COGNITION, V109, P157, DOI 10.1016/j.cognition.2008.07.010; Strand EA, 1996, NATURAL LANGUAGE PROCESSING AND SPEECH TECHNOLOGY, P14; Strand EA, 1999, J LANG SOC PSYCHOL, V18, P86, DOI 10.1177/0261927X99018001006; Uskul AK, 2008, P NATL ACAD SCI USA, V105, P8552, DOI 10.1073/pnas.0803874105; Wakabayashi A, 2006, PERS INDIV DIFFER, V41, P873, DOI 10.1016/j.paid.2006.04.003; Wakabayashi A, 2006, J AUTISM DEV DISORD, V36, P263, DOI 10.1007/s10803-005-0061-2; Walenski M., 2006, UNDERSTANDING AUTISM, P175, DOI 10.1201/9781420004205.ch9; Walenski M, 2008, J AUTISM DEV DISORD, V38, P1395, DOI 10.1007/s10803-007-0513-y; Weinreich Uriel, 1968, DIRECTIONS HIST LING, P95; William Labov, 2001, PRINCIPLES LINGUISTI, V2; WITKIN HA, 1977, REV EDUC RES, V47, P1; World Health Organization, 2022, INT CLASS DIS, V11th; ZENHAUSERN R, 1979, B PSYCHONOMIC SOC, V14, P71; ZENHAUSERN R, 1978, B PSYCHONOMIC SOC, V12, P381; [No title captured]; [No title captured]; [No title captured]; [No title captured]	59	57	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e11950	10.1371/journal.pone.0011950	http://dx.doi.org/10.1371/journal.pone.0011950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	640TN	20808859	gold, Green Published, Green Submitted			2022-12-25	WOS:000281075500001
J	Degrange, FJ; Tambussi, CP; Moreno, K; Witmer, LM; Wroe, S				Degrange, Federico J.; Tambussi, Claudia P.; Moreno, Karen; Witmer, Lawrence M.; Wroe, Stephen			Mechanical Analysis of Feeding Behavior in the Extinct "Terror Bird'' Andalgalornis steulleti (Gruiformes: Phorusrhacidae)	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; MAXIMAL BITE FORCE; PREDATORY BEHAVIOR; CRANIAL MECHANICS; DARWINS FINCHES; PERFORMANCE; MORPHOLOGY; EVOLUTION; KINEMATICS; KINESIS	The South American phorusrhacid bird radiation comprised at least 18 species of small to gigantic terrestrial predators for which there are no close modern analogs. Here we perform functional analyses of the skull of the medium-sized (similar to 40 kg) patagornithine phorusrhacid Andalgalornis steulleti (upper Miocene-lower Pliocene, Andalgala Formation, Catamarca, Argentina) to assess its mechanical performance in a comparative context. Based on computed tomographic (CT) scanning and morphological analysis, the skull of Andalgalornis steulleti is interpreted as showing features reflecting loss of intracranial immobility. Discrete anatomical attributes permitting such cranial kinesis are widespread phorusrhacids outgroups, but this is the first clear evidence of loss of cranial kinesis in a gruiform bird and may be among the best documented cases among all birds. This apomorphic loss is interpreted as an adaptation for enhanced craniofacial rigidity, particularly with regard to sagittal loading. We apply a Finite Element approach to a three-dimensional (3D) model of the skull. Based on regression analysis we estimate the bite force of Andalgalornis at the bill tip to be 133 N. Relative to results obtained from Finite Element Analysis of one of its closest living relatives (seriema) and a large predatory bird (eagle), the phorusrhacid's skull shows relatively high stress under lateral loadings, but low stress where force is applied dorsoventrally (sagittally) and in "pullback'' simulations. Given the relative weakness of the skull mediolaterally, it seems unlikely that Andalgalornis engaged in potentially risky behaviors that involved subduing large, struggling prey with its beak. We suggest that it either consumed smaller prey that could be killed and consumed more safely (e. g., swallowed whole) or that it used multiple well-targeted sagittal strikes with the beak in a repetitive attack-and-retreat strategy.	[Degrange, Federico J.; Tambussi, Claudia P.] Univ Nacl La Plata, Fac Ciencias Nat & Museo, Museo La Plata, CONICET,Div Paleontol Vertebrados, La Plata, Buenos Aires, Argentina; [Moreno, Karen] Univ Austral Chile, Inst Geociencias, Lab Paleontol, Valdivia, Chile; [Moreno, Karen; Wroe, Stephen] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Witmer, Lawrence M.] Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Universidad Austral de Chile; University of New South Wales Sydney; University System of Ohio; Ohio University	Degrange, FJ (corresponding author), Univ Nacl La Plata, Fac Ciencias Nat & Museo, Museo La Plata, CONICET,Div Paleontol Vertebrados, La Plata, Buenos Aires, Argentina.	fjdegrange@fcnym.unlp.edu.ar	Wroe, Stephen/A-4462-2010; Moreno, Karen/B-6127-2009	Wroe, Stephen/0000-0002-5813-9182; Moreno, Karen/0000-0002-5949-133X; Witmer, Lawrence/0000-0002-7610-0118; Wroe, Stephen/0000-0002-6365-5915	Australian Research Council (ARC) [DP0666374, DP098785]; Australian Pacific Science Foundation (APSF); University of New South Wales; Agencia Nacional de Investigaciones Cientificas y Tecnicas [PICT 32617]; National Science Foundation (NSF) [IBN-0343744, IBN-0517257]	Australian Research Council (ARC)(Australian Research Council); Australian Pacific Science Foundation (APSF); University of New South Wales; Agencia Nacional de Investigaciones Cientificas y Tecnicas; National Science Foundation (NSF)(National Science Foundation (NSF))	Funding was provided by Australian Research Council (ARC) Discovery Grants (DP0666374, DP098785), an Australian Pacific Science Foundation (APSF) and a University of New South Wales Internal Strategic Grant (to S.W.), Agencia Nacional de Investigaciones Cientificas y Tecnicas PICT 32617 (to C.P.T.), and National Science Foundation (NSF) IBN-0343744 and NSF IBN-0517257 to L.M.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abourachid A, 2005, ORNITOL NEOTROP, V16, P471; Alvarenga Herculano M.F., 2003, Pap. Avulsos Zool. (São Paulo), V43, P55, DOI 10.1590/S0031-10492003000400001; Andrews C.W., 1901, T ZOOLOGICAL SOC LON, V15, P55; BAUMEL JJ, 1993, HDB AVIAN ANATOMY NO, P00133; Blanco RE, 2005, P ROY SOC B-BIOL SCI, V272, P1769, DOI 10.1098/rspb.2005.3133; Bout RG, 2001, COMP BIOCHEM PHYS A, V131, P197, DOI 10.1016/S1095-6433(01)00470-6; Campbell Kenneth E. Jr, 1992, Natural History Museum of Los Angeles County Science Series, V36, P395; Chiappe LM, 2006, NATURE, V443, P929, DOI 10.1038/443929a; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; DEGRANGE FJ, 2008, 3 C LAT PAL VERT S M, P76; Gussekloo SWS, 2005, J EXP BIOL, V208, P3409, DOI 10.1242/jeb.01768; Gussekloo SWS, 2001, J EXP BIOL, V204, P1735; Herrel A, 2005, FUNCT ECOL, V19, P43, DOI 10.1111/j.0269-8463.2005.00923.x; Herrel A, 2001, CAN J ZOOL, V79, P662, DOI 10.1139/cjz-79-4-662; Herrel A, 2002, J EVOLUTION BIOL, V15, P1083, DOI 10.1046/j.1420-9101.2002.00459.x; Herrel A, 2005, J EVOLUTION BIOL, V18, P669, DOI 10.1111/j.1420-9101.2004.00857.x; Hofling E., 1984, Gegenbaurs Morphologisches Jahrbuch, V130, P235; Holliday CM, 2008, J VERTEBR PALEONTOL, V28, P1073, DOI 10.1671/0272-4634-28.4.1073; JIMENEZ J E, 1990, Hornero, V13, P97; Kraglievich L., 1931, Physis Buenos Aires, V10, P304; Livezey BC, 1998, PHILOS T R SOC B, V353, P2077, DOI 10.1098/rstb.1998.0353; Mayr Gerald, 2002, Palaeontologische Zeitschrift, V76, P305; McDOWELL SAM, 1948, AUK, V65, P520; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Mchenry CR, 2006, ANAT REC PART A, V288A, P827, DOI 10.1002/ar.a.20360; Metzger K., 2002, TOPICS FUNCTIONAL EC, P15; Moazen M, 2009, P NATL ACAD SCI USA, V106, P8273, DOI 10.1073/pnas.0813156106; Moazen M, 2009, P ROY SOC B-BIOL SCI, V276, P39, DOI 10.1098/rspb.2008.0863; Moreno K, 2008, J ANAT, V212, P736, DOI 10.1111/j.1469-7580.2008.00899.x; Patterson B., 1960, Publ Mus Cienc nat Mar del Plata, V1, P1; Preuschoft Holger, 2002, Senckenbergiana Lethaea, V82, P207; Rayfield EJ, 2005, ANAT REC PART A, V283A, P349, DOI 10.1002/ar.a.20168; Rayfield EJ, 2004, P ROY SOC B-BIOL SCI, V271, P1451, DOI 10.1098/rspb.2004.2755; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Reid JR., 1835, P ZOOL SOC LOND, V3, P132; Richmond BG, 2005, ANAT REC PART A, V283A, P259, DOI 10.1002/ar.a.20169; SCHOONEES J., 1963, ANN UNIV STELLENBOSCH, V38, P215; SIMS SW, 1955, B BRIT MUSEUM ZOOL, V2, P371; SINCLAIR WILLIAM J., 1932, REPT PRINCETON UNIV EXPED PATAGONIA 1896 1899, V7, P157; Sustaita D, 2008, J MORPHOL, V269, P283, DOI 10.1002/jmor.10577; Tambussi C, 1999, J VERTEBR PALEONTOL, V19, P404, DOI 10.1080/02724634.1999.10011154; Tambussi Claudia, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P245; TAMBUSSI CP, 1997, AMEGHINIANA, V34, P541; Tizzard A, 2005, PHYSIOL MEAS, V26, pS251, DOI 10.1088/0967-3334/26/2/024; van der Meij MAA, 2006, J EXP BIOL, V209, P3329, DOI 10.1242/jeb.02379; van der Meij MAA, 2004, J EXP BIOL, V207, P2745, DOI 10.1242/jeb.01091; Wroe S, 2008, J ZOOL, V274, P332, DOI 10.1111/j.1469-7998.2007.00389.x; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2004, P ROY SOC B-BIOL SCI, V271, P1203, DOI 10.1098/rspb.2004.2694; Wroe S, 2008, J ZOOL, V276, P336, DOI 10.1111/j.1469-7998.2008.00494.x; Wroe S, 2007, ANAT REC, V290, P1248, DOI 10.1002/ar.20594; ZUSI RL, 1993, SKULL, V2, P391	52	56	61	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e11856	10.1371/journal.pone.0011856	http://dx.doi.org/10.1371/journal.pone.0011856			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805872	Green Submitted, Green Published, gold			2022-12-25	WOS:000281011600003
J	Glynn, JR; Alghamdi, S; Mallard, K; McNerney, R; Ndlovu, R; Munthali, L; Houben, RM; Fine, PEM; French, N; Crampin, AC				Glynn, Judith R.; Alghamdi, Saad; Mallard, Kim; McNerney, Ruth; Ndlovu, Richard; Munthali, Lumbani; Houben, Rein M.; Fine, Paul E. M.; French, Neil; Crampin, Amelia C.			Changes in Mycobacterium tuberculosis Genotype Families Over 20 Years in a Population-Based Study in Northern Malawi	PLOS ONE			English	Article							BEIJING GENOTYPE; STRAINS; HIV; EPIDEMIOLOGY; TRANSMISSION; INFECTION; EMERGENCE; BACTERIA; AFRICA	Background: Despite increasing interest in possible differences in virulence and transmissibility between different genotypes of M. tuberculosis, very little is known about how genotypes within a population change over decades, or about relationships to HIV infection. Methods and Principal Findings: In a population-based study in rural Malawi we have examined smears and cultures from tuberculosis patients over a 20-year period using spoligotyping. Isolates were grouped into spoligotype families and lineages following previously published criteria. Time trends, HIV status, drug resistance and outcome were examined by spoligotype family and lineage. In addition, transmissibility was examined among pairs of cases with known epidemiological contact by assessing the proportion of transmissions confirmed for each lineage, on the basis of IS6110 RFLP similarity of the M tuberculosis strains. 760 spoligotypes were obtained from smears from 518 patients from 1986-2002, and 377 spoligotypes from cultures from 347 patients from 2005-2008. There was good consistency in patients with multiple specimens. Among 781 patients with first episode tuberculosis, the majority (76%) had Lineage 4 ("European/American'') strains; 9% had Lineage 3 ("East-African/Indian''); 8% Lineage 1 ("Indo-Oceanic''); and 2% Lineage 2 ("East-Asian''); others unclassifiable. Over time the proportion of Lineage 4 decreased from >90% to 60%, with an increase in the other 3 lineages (p<0.001). Lineage 1 strains were more common in those with HIV infection, even after adjusting for age, sex and year. There were no associations with drug resistance or outcome, and no differences by lineage in the proportion of pairs in which transmission was confirmed. Conclusions: This is the first study to describe long term trends in the four M. tuberculosis lineages in a population. Lineage 4 has probably been longstanding in this population, with relatively recent introductions and spread of Lineages1-3, perhaps influenced by the HIV epidemic.	[Glynn, Judith R.; Alghamdi, Saad; Mallard, Kim; McNerney, Ruth; Houben, Rein M.; Fine, Paul E. M.; French, Neil; Crampin, Amelia C.] London Sch Hyg & Trop Med, London WC1, England; [Ndlovu, Richard; Munthali, Lumbani] Karonga Prevent Study, Chilumba, Malawi	University of London; London School of Hygiene & Tropical Medicine; Malawi Epidemiology and Intervention Research Unit	Glynn, JR (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	judith.glynn@lshtm.ac.uk	French, Neil/A-2994-2012; Alghamdi, Saad/AAJ-7072-2021; Alghamdi, Saad/AAJ-7063-2021	Alghamdi, Saad/0000-0003-4532-9128; Alghamdi, Saad/0000-0003-4532-9128; French, Neil/0000-0003-4814-8293; Crampin, Amelia/0000-0002-1513-4330; MCNERNEY, Ruth/0000-0002-1957-443X	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded by the Wellcome Trust, with contributions from LEPRA (The British Leprosy Association), DFID (UK Department for International Development, via the TARGETS Research Consortium), and the Ministry of Health and Government of the Kingdom of Saudi Arabia (for S Alghamdi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown T, 2010, EMERG INFECT DIS, V16, P272, DOI 10.3201/eid1602.091032; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Chihota V, 2007, INT J TUBERC LUNG D, V11, P311; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Crampin AC, 2006, EMERG INFECT DIS, V12, P729; Dale JW, 2001, INT J TUBERC LUNG D, V5, P216; de Boer AS, 1999, J INFECT DIS, V180, P1238, DOI 10.1086/314979; Easterbrook PJ, 2004, J CLIN MICROBIOL, V42, P4536, DOI 10.1128/JCM.42.10.4536-4544.2004; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Glynn JR, 2005, J INFECT DIS, V192, P480, DOI 10.1086/431517; Glynn JR, 2005, EMERG INFECT DIS, V11, P150, DOI 10.3201/eid1101.040869; Glynn JR, 2004, AIDS, V18, P1459, DOI 10.1097/01.aids.0000131336.15301.06; Glynn JR, 2008, EMERG INFECT DIS, V14, P1060, DOI 10.3201/eid1407.060468; Houben RMGJ, 2009, T ROY SOC TROP MED H, V103, P1187, DOI 10.1016/j.trstmh.2009.03.013; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Narayanan S, 2008, INFECT GENET EVOL, V8, P474, DOI 10.1016/j.meegid.2007.09.007; Newton SM, 2006, P NATL ACAD SCI USA, V103, P15594, DOI 10.1073/pnas.0604283103; Palanisamy GS, 2009, TUBERCULOSIS, V89, P203, DOI 10.1016/j.tube.2009.01.005; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; van der Zanden AGM, 1998, J CLIN PATHOL-MOL PA, V51, P209, DOI 10.1136/mp.51.4.209; Yeh RW, 1998, J INFECT DIS, V177, P1107, DOI 10.1086/517406	24	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12259	10.1371/journal.pone.0012259	http://dx.doi.org/10.1371/journal.pone.0012259			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808874	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000280968100034
J	Li, ZS; Mulligan, MK; Wang, XS; Miles, MF; Lu, L; Williams, RW				Li, Zhengsheng; Mulligan, Megan K.; Wang, Xusheng; Miles, Michael F.; Lu, Lu; Williams, Robert W.			A Transposon in Comt Generates mRNA Variants and Causes Widespread Expression and Behavioral Differences among Mice	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; COMPLEX TRAIT ANALYSIS; GENE-EXPRESSION; FUNCTIONAL POLYMORPHISM; DOPAMINE RELEASE; INBRED STRAINS; WORKING-MEMORY; DEFICIENT MICE; COGNITION; SCHIZOPHRENIA	Background: Catechol-O-methyltransferase (COMT) is a key enzyme responsible for the degradation of dopamine and norepinephrine. COMT activity influences cognitive and emotional states in humans and aggression and drug responses in mice. This study identifies the key sequence variant that leads to differences in Comt mRNA and protein levels among mice, and that modulates synaptic function and pharmacological and behavioral traits. Methodology/Principal Findings: We examined Comt expression in multiple tissues in over 100 diverse strains and several genetic crosses. Differences in expression map back to Comt and are generated by a 230 nt insertion of a B2 short interspersed element (B2 SINE) in the proximal 3' UTR of Comt in C57BL/6J. This transposon introduces a premature polyadenylation signal and creates a short 3' UTR isoform. The B2 SINE is shared by a subset of strains, including C57BL/6J, A/J, BALB/cByJ, and AKR/J, but is absent in others, including DBA/2J, FVB/NJ, SJL/J, and wild subspecies. The short isoform is associated with increased protein expression in prefrontal cortex and hippocampus relative to the longer ancestral isoform. The Comt variant causes downstream differences in the expression of genes involved in synaptic function, and also modulates phenotypes such as dopamine D1 and D2 receptor binding and pharmacological responses to haloperidol. Conclusions/Significance: We have precisely defined the B2 SINE as the source of variation in Comt and demonstrated that a transposon in a 3' UTR can alter mRNA isoform use and modulate behavior. The recent fixation of the variant in a subset of strains may have contributed to the rapid divergence of inbred strains.	[Li, Zhengsheng; Mulligan, Megan K.; Wang, Xusheng; Lu, Lu; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Ctr Integrat & Translat Genom, Memphis, TN USA; [Miles, Michael F.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA USA	University of Tennessee System; University of Tennessee Health Science Center; Virginia Commonwealth University	Li, ZS (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Ctr Integrat & Translat Genom, Memphis, TN USA.	rwilliam@nb.utmem.edu	lu, lu/HII-7530-2022; lu, lu/HGA-0894-2022; Williams, Robert W./H-8789-2016	Williams, Robert W./0000-0001-8924-4447; Mulligan, Megan/0000-0003-4909-635X	National Institute on Drug Abuse [P20-DA 21131]; National Institute on Alcohol Abuse and Alcoholism [U01AA13499, U24AA13513, U01AA016667, U01AA014425]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016667, U01AA014425, U01AA016662, P20AA017828, R01AA013678, U01AA013499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA021131] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute on Drug Abuse (P20-DA 21131) and the National Institute on Alcohol Abuse and Alcoholism (U01AA13499, U24AA13513, U01AA016667, and U01AA014425) to RWW, MFM, and LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilder RM, 2002, BIOL PSYCHIAT, V52, P701, DOI 10.1016/S0006-3223(02)01416-6; Buckholtz JW, 2007, MOL PSYCHIATR, V12, P893, DOI 10.1038/sj.mp.4002008; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chesler EJ, 2004, NAT NEUROSCI, V7, P485, DOI 10.1038/nn0504-485; Demarest K, 1999, J NEUROSCI, V19, P549; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Fernandes C, 2004, EUR J NEUROSCI, V19, P2576, DOI 10.1111/j.0953-816X.2004.03358.x; Ferrigno O, 2001, NAT GENET, V28, P77, DOI 10.1038/ng0501-77; GEORGIEV GP, 1984, EUR J BIOCHEM, V145, P203, DOI 10.1111/j.1432-1033.1984.tb08541.x; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Goldman-Rakic P S, 1998, Adv Pharmacol, V42, P707; Grice DE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-76; Hosak L, 2007, EUR PSYCHIAT, V22, P276, DOI 10.1016/j.eurpsy.2007.02.002; Huotari M, 2002, EUR J NEUROSCI, V15, P246, DOI 10.1046/j.0953-816x.2001.01856.x; Jones BC, 1999, PHARMACOGENETICS, V9, P607, DOI 10.1097/01213011-199910000-00007; Kanes S, 1996, J PHARMACOL EXP THER, V277, P1016; KAROUM F, 1994, J NEUROCHEM, V63, P972, DOI 10.1046/j.1471-4159.1994.63030972.x; Koide T, 2000, MAMM GENOME, V11, P664, DOI 10.1007/s003350010129; KRESS M, 1984, SCIENCE, V226, P974, DOI 10.1126/science.6095445; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lee JY, 2008, NUCLEIC ACIDS RES, V36, P5581, DOI 10.1093/nar/gkn540; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Nicodemus KK, 2007, HUM GENET, V120, P889, DOI 10.1007/s00439-006-0257-3; OVERALL RW, 2009, FRONTIERS NEUROGENET, V1; Papaleo F, 2008, J NEUROSCI, V28, P8709, DOI 10.1523/JNEUROSCI.2077-08.2008; PHILIP VM, 2009, GENES BRAIN BEHAV; Puls I, 2008, BIOL PSYCHOL, V79, P126, DOI 10.1016/j.biopsycho.2008.03.001; ROTH JA, 1992, REV PHYSIOL BIOCH P, V120, P1, DOI 10.1007/BFb0036121; Savitz J, 2006, GENES BRAIN BEHAV, V5, P311, DOI 10.1111/j.1601-183X.2005.00163.x; Straub RE, 2007, MOL PSYCHIATR, V12, P854, DOI 10.1038/sj.mp.4001988; Tan HY, 2007, P NATL ACAD SCI USA, V104, P12536, DOI 10.1073/pnas.0610125104; TENHUNEN J, 1993, BIOCHEM J, V296, P595, DOI 10.1042/bj2960595; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Tunbridge EM, 2004, J NEUROSCI, V24, P5331, DOI 10.1523/JNEUROSCI.1124-04.2004; Uetani N, 2000, EMBO J, V19, P2775, DOI 10.1093/emboj/19.12.2775; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wang J, 1999, MOL CELL NEUROSCI, V14, P370, DOI 10.1006/mcne.1999.0789; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	44	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12181	10.1371/journal.pone.0012181	http://dx.doi.org/10.1371/journal.pone.0012181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808911	Green Published, Green Submitted, gold			2022-12-25	WOS:000280968100009
J	Shiojiri, K; Ozawa, R; Kugimiya, S; Uefune, M; van Wijk, M; Sabelis, MW; Takabayashi, J				Shiojiri, Kaori; Ozawa, Rika; Kugimiya, Soichi; Uefune, Masayoshi; van Wijk, Michiel; Sabelis, Maurice W.; Takabayashi, Junji			Herbivore-Specific, Density-Dependent Induction of Plant Volatiles: Honest or "Cry Wolf'' Signals?	PLOS ONE			English	Article							COTESIA-PLUTELLAE HYMENOPTERA; DIAMONDBACK MOTH; PARASITIC WASPS; TRITROPHIC INTERACTION; TETRANYCHUS-URTICAE; GENETIC-VARIATION; INFESTED PLANTS; PREDATORY MITE; PREY; LEPIDOPTERA	Plants release volatile chemicals upon attack by herbivorous arthropods. They do so commonly in a dose-dependent manner: the more herbivores, the more volatiles released. The volatiles attract predatory arthropods and the amount determines the probability of predator response. We show that seedlings of a cabbage variety (Brassica oleracea var. capitata, cv Shikidori) also show such a response to the density of cabbage white (Pieris rapae) larvae and attract more (naive) parasitoids (Cotesia glomerata) when there are more herbivores on the plant. However, when attacked by diamondback moth (Plutella xylostella) larvae, seedlings of the same variety (cv Shikidori) release volatiles, the total amount of which is high and constant and thus independent of caterpillar density, and naive parasitoids (Cotesia vestalis) of diamondback moth larvae fail to discriminate herbivore-rich from herbivore-poor plants. In contrast, seedlings of another cabbage variety of B. oleracea (var. acephala: kale) respond in a dose-dependent manner to the density of diamondback moth larvae and attract more parasitoids when there are more herbivores. Assuming these responses of the cabbage cultivars reflect behaviour of at least some genotypes of wild plants, we provide arguments why the behaviour of kale (B. oleracea var acephala) is best interpreted as an honest signaling strategy and that of cabbage cv Shikidori (B. oleracea var capitata) as a "cry wolf'' signaling strategy, implying a conflict of interest between the plant and the enemies of its herbivores: the plant profits from being visited by the herbivore's enemies, but the latter would be better off by visiting other plants with more herbivores. If so, evolutionary theory on alarm signaling predicts consequences of major interest to students of plant protection, tritrophic systems and communication alike.	[Shiojiri, Kaori; Ozawa, Rika; Uefune, Masayoshi; Takabayashi, Junji] Kyoto Univ, Ctr Ecol Res, Shiga, Japan; [Shiojiri, Kaori] Kyoto Univ, Hakubi Ctr, Kyoto, Japan; [Kugimiya, Soichi] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 305, Japan; [van Wijk, Michiel; Sabelis, Maurice W.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	Kyoto University; Kyoto University; National Institute for Agro-Environmental Sciences (NIAES) Japan; University of Amsterdam	Shiojiri, K (corresponding author), Kyoto Univ, Ctr Ecol Res, Shiga, Japan.	M.W.Sabelis@uva.nl; junji@ecology.kyoto-u.ac.jp	Takabayashi, Junji/G-2212-2010	Takabayashi, Junji/0000-0002-3575-9952; Uefune, Masayoshi/0000-0002-9570-8938	Bio-oriented Technology Research Advancement Institution; Subsidy nr [9101009]; Global Center for Excellence, Kyoto University; Grants-in-Aid for Scientific Research [19101009] Funding Source: KAKEN	Bio-oriented Technology Research Advancement Institution; Subsidy nr; Global Center for Excellence, Kyoto University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Bio-oriented Technology Research Advancement Institution, by Grant-in-Aid for Scientific Research (Subsidy nr 9101009), by the Global Center for Excellence Program entitled similar to Formation of a Strategic Base for Biodiversity and Evolutionary Research: From Genome to Ecosystem (Kyoto University) and by a Kyoto University grant to MWS for a visiting professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNAMALAI S, 1988, RES POPUL ECOL, V30, P329, DOI 10.1007/BF02513253; Choh Y, 2006, OECOLOGIA, V147, P455, DOI 10.1007/s00442-005-0289-8; Choh Y, 2008, ECOL ENTOMOL, V33, P565, DOI 10.1111/j.1365-2311.2008.01003.x; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DICKE M, 1988, NETH J ZOOL, V38, P148, DOI 10.1163/156854288X00111; DICKE M, 1990, J CHEM ECOL, V16, P3091, DOI 10.1007/BF00979614; Gols R, 2003, J CHEM ECOL, V29, P2651, DOI 10.1023/B:JOEC.0000008010.40606.b0; Gu H, 2000, J INSECT BEHAV, V13, P141, DOI 10.1023/A:1007723811573; Hassell M P, 1984, IMA J Math Appl Med Biol, V1, P123, DOI 10.1093/imammb/1.1.123; HASSELL MP, 1974, J ANIM ECOL, V43, P567, DOI 10.2307/3384; Horiuchi J, 2003, APPL ENTOMOL ZOOL, V38, P109, DOI 10.1303/aez.2003.109; Jansen VAA, 2006, NATURE, V440, P663, DOI 10.1038/nature04387; Jia F, 2002, HEREDITY, V89, P371, DOI 10.1038/sj.hdy.6800145; Kappers IF, 2005, SCIENCE, V309, P2070, DOI 10.1126/science.1116232; Kawaguchi M, 1999, APPL ENTOMOL ZOOL, V34, P213, DOI 10.1303/aez.34.213; Khan ZR, 1997, NATURE, V388, P631, DOI 10.1038/41681; Liu SS, 2002, ENVIRON ENTOMOL, V31, P221, DOI 10.1603/0046-225X-31.2.221; Maeda T, 2001, EXP APPL ACAROL, V25, P55, DOI 10.1023/A:1010667812788; Margolies DC, 1997, J INSECT BEHAV, V10, P695, DOI 10.1007/BF02765387; Mitsunaga T, 2004, APPL ENTOMOL ZOOL, V39, P691, DOI 10.1303/aez.2004.691; MUNN CA, 1986, NATURE, V319, P143, DOI 10.1038/319143a0; MURDOCH WW, 1989, AM NAT, V134, P288, DOI 10.1086/284981; OHSAKI N, 1994, ECOLOGY, V75, P59, DOI 10.2307/1939382; Papaj D.R., 1993, INSECT LEARNING ECOL; Sabelis Maurice W., 2005, P109, DOI 10.1017/CBO9780511542220.005; Sabelis Maurice W., 2007, P188, DOI 10.1017/CBO9780511542701.010; Sabelis MW, 2005, ADV ECOL RES, V37, P183, DOI 10.1016/S0065-2504(04)37006-6; SABELIS MW, 1988, OIKOS, V53, P247, DOI 10.2307/3566070; Sato Y, 1999, APPL ENTOMOL ZOOL, V34, P333, DOI 10.1303/aez.34.333; SCHOONHOVEN LM, 1990, J CHEM ECOL, V16, P3043, DOI 10.1007/BF00979611; Shi ZH, 2002, BIOCONTROL, V47, P499, DOI 10.1023/A:1016577406820; Shiojiri K, 2000, APPL ENTOMOL ZOOL, V35, P519, DOI 10.1303/aez.2000.519; Shiojiri K, 2003, ECOL ENTOMOL, V28, P573, DOI 10.1046/j.1365-2311.2003.00539.x; Shiojiri K, 2002, ECOL LETT, V5, P186, DOI 10.1046/j.1461-0248.2002.00292.x; Shiojiri K, 2006, P NATL ACAD SCI USA, V103, P16672, DOI 10.1073/pnas.0607780103; Sokal RR, 1995, BIOMETRY; TURLINGS TCJ, 1995, P NATL ACAD SCI USA, V92, P4169, DOI 10.1073/pnas.92.10.4169; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; van Baalen M, 2003, P ROY SOC B-BIOL SCI, V270, P69, DOI 10.1098/rspb.2002.2151; van Baalen M, 1999, AM NAT, V154, P69, DOI 10.1086/303215; VANBAALEN M, 1993, AM NAT, V142, P646, DOI 10.1086/285562; WILGENBURG E, 2006, FRONTIERS ZOOLOGY, V3, P1; Wright GA, 2005, P ROY SOC B-BIOL SCI, V272, P2417, DOI 10.1098/rspb.2005.3252; Zayed A, 2005, P NATL ACAD SCI USA, V102, P10742, DOI 10.1073/pnas.0502271102	44	110	112	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12161	10.1371/journal.pone.0012161	http://dx.doi.org/10.1371/journal.pone.0012161			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808961	Green Submitted, gold, Green Published			2022-12-25	WOS:000280968100005
J	Lenting, PJ; Westerlaken, GHA; Denis, CV; Akkerman, JW; Meyaard, L				Lenting, Peter J.; Westerlaken, Geertje H. A.; Denis, Cecile V.; Akkerman, Jan Willem; Meyaard, Linde			Efficient Inhibition of Collagen-Induced Platelet Activation and Adhesion by LAIR-2, a Soluble Ig-Like Receptor Family Member	PLOS ONE			English	Article							BINDING-SITE; LIGANDS; GPVI	LAIR-1 (Leukocyte Associated Ig-like Receptor-1) is a collagen receptor that functions as an inhibitory receptor on immune cells. It has a soluble family member, LAIR-2, that also binds collagen and can interfere with LAIR-1/collagen interactions. Collagen is a main initiator for platelet adhesion and aggregation. Here, we explored the potential of soluble LAIR proteins to inhibit thrombus formation in vitro. LAIR-2/Fc but not LAIR-1/Fc inhibited collagen-induced platelet aggregation. In addition, LAIR-2/Fc also interfered with platelet adhesion to collagen at low shear rate (300 s(-1); IC50 = 18 mu g/ml) and high shear rate (1500 s(-1); IC50 = 30 mu g/ml). Additional experiments revealed that LAIR-2/Fc leaves interactions between collagen and alpha 2 beta 1 unaffected, but efficiently prevents binding of collagen to Glycoprotein VI and von Willebrand factor. Thus, LAIR-2/Fc has the capacity to interfere with platelet-collagen interactions mediated by Glycoprotein VI and the VWF/Glycoprotein Ib axis.	[Lenting, Peter J.; Denis, Cecile V.] INSERM, U770, F-94275 Le Kremlin Bicetre, France; [Lenting, Peter J.; Denis, Cecile V.] Univ Paris Sud, F-94275 Le Kremlin Bicetre, France; [Lenting, Peter J.; Akkerman, Jan Willem] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands; [Westerlaken, Geertje H. A.; Meyaard, Linde] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Lenting, PJ (corresponding author), INSERM, U770, F-94275 Le Kremlin Bicetre, France.	l.meyaard@umcutrecht.nl	Lenting, Peter/F-8269-2013; Lenting, Peter/AAH-5663-2019; Denis, Cecile/A-7649-2011	Lenting, Peter/0000-0002-7937-3429; Lenting, Peter/0000-0002-7937-3429; Denis, Cecile/0000-0001-5152-9156; Meyaard, Linde/0000-0003-0707-4793	Division of Laboratory and Pharmacy at the UMC Utrecht	Division of Laboratory and Pharmacy at the UMC Utrecht	This study was funded by a seeding grant from the Division of Laboratory and Pharmacy at the UMC Utrecht to PJL and LM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Brondijk THC, 2010, BLOOD, V115, P1364, DOI 10.1182/blood-2009-10-246322; Chauhan AK, 2007, BLOOD, V109, P2424, DOI 10.1182/blood-2006-06-028241; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; Denis CV, 2007, ARTERIOSCL THROM VAS, V27, P728, DOI 10.1161/01.ATV.0000259359.52265.62; Farndale RW, 2007, J THROMB HAEMOST, V5, P220, DOI 10.1111/j.1538-7836.2007.02521.x; Jackson SP, 2007, BLOOD, V109, P5087, DOI 10.1182/blood-2006-12-027698; Jarvis GE, 2008, BLOOD, V111, P4986, DOI 10.1182/blood-2007-08-108472; Lebbink RJ, 2004, J IMMUNOL, V172, P5535, DOI 10.4049/jimmunol.172.9.5535; LEBBINK RJ, 2009, MATRIX BIOL IN PRESS; Lebbink RJ, 2008, J IMMUNOL, V180, P1662, DOI 10.4049/jimmunol.180.3.1662; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Lisman T, 2006, BLOOD, V108, P3753, DOI 10.1182/blood-2006-03-011965; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; Meyaard L, 1999, J IMMUNOL, V162, P5800; Meyaard L, 2008, J LEUKOCYTE BIOL, V83, P799, DOI 10.1189/jlb.0907609; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Ouyang WM, 2003, BIOCHEM BIOPH RES CO, V310, P1236, DOI 10.1016/j.bbrc.2003.09.152; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Sixma JJ, 1998, THROMB RES, V92, pS43, DOI 10.1016/S0049-3848(98)00159-5; Steevels TAM, 2010, J IMMUNOL, V184, P4741, DOI 10.4049/jimmunol.0902039; Tomlinson MG, 2007, J THROMB HAEMOST, V5, P2274, DOI 10.1111/j.1538-7836.2007.02746.x; Van de Walle GR, 2005, J BIOL CHEM, V280, P36873, DOI 10.1074/jbc.M508148200; Verbrugge A, 2006, J LEUKOCYTE BIOL, V79, P828, DOI 10.1189/jlb.0705370	24	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12174	10.1371/journal.pone.0012174	http://dx.doi.org/10.1371/journal.pone.0012174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730098	Green Published, gold, Green Submitted			2022-12-25	WOS:000280862200025
J	Merrill, SA; Hanson, PI				Merrill, Samuel A.; Hanson, Phyllis I.			Activation of Human VPS4A by ESCRT-III Proteins Reveals Ability of Substrates to Relieve Enzyme Autoinhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA-ATPASE VPS4; STRUCTURAL BASIS; PORE LOOPS; COMPLEX; TRANSLOCATION; RECOGNITION; BINDING; RESIDUES; DOMAIN; IST1	VPS4 proteins are AAA(+) ATPases required to form multive-sicular bodies, release viral particles, and complete cytokinesis. They act by disassembling ESCRT-III heteropolymers during or after their proposed function in membrane scission. Here we show that purified human VPS4A is essentially inactive but can be stimulated to hydrolyze ATP by ESCRT-III proteins in a reaction that requires both their previously defined MIT interacting motifs and similar to 50 amino acids of the adjacent sequence. Importantly, C-terminal fragments of all ESCRT-III proteins tested, including CHMP2A, CHMP1B, CHMP3, CHMP4A, CHMP6, and CHMP5, activated VPS4A suggesting that it disassembles ESCRT-III heteropolymers by affecting each component protein. VPS4A is thought to act as a ring-shaped cylindrical oligomer like other AAA(+) ATPases, but this has been difficult to directly demonstrate. We found that concentrating His(6)-VPS4A on liposomes containing Ni2+-nitrilotriacetic acid-tagged lipid increased ATP hydrolysis, confirming the importance of inter-subunit interactions for activity. We also found that mutating pore loops expected to line the center of a cylindrical oligomer changed the response of VPS4A to ESCRT-III proteins. Based on these data, we propose that ESCRT-III proteins facilitate assembly of functional but transient VPS4A oligomers and interact with sequences inside the pore of the assembled enzyme. Deleting the N-terminal MIT domain and adjacent linker from VPS4A increased both basal and liposome-enhanced ATPase activity, indicating that these elements play a role in autoinhibiting VPS4A until it encounters ESCRT-III proteins. These findings reveal new ways in which VPS4 activity is regulated and specifically directed to ESCRT-III polymers.	[Merrill, Samuel A.; Hanson, Phyllis I.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Hanson, PI (corresponding author), 660 S Euclid Ave,Campus Box 8228, St Louis, MO 63110 USA.	phanson22@wustl.edu	Hanson, Phyllis/E-9420-2012		National Institutes of Health [R01 GM076686]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076686] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM076686.	Agromayor M, 2009, MOL BIOL CELL, V20, P1374, DOI 10.1091/mbc.E08-05-0474; Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Bajorek M, 2009, MOL BIOL CELL, V20, P1360, DOI 10.1091/mbc.E08-05-0475; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; Carlton JG, 2009, BIOCHEM SOC T, V37, P195, DOI 10.1042/BST0370195; Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Farbman ME, 2008, BIOCHEMISTRY-US, V47, P13497, DOI 10.1021/bi801140y; Ghazi-Tabatabai S, 2009, BIOCHEM SOC T, V37, P151, DOI 10.1042/BST0370151; Gonciarz MD, 2008, J MOL BIOL, V384, P878, DOI 10.1016/j.jmb.2008.09.066; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hanson PI, 2009, CURR OPIN CELL BIOL, V21, P568, DOI 10.1016/j.ceb.2009.06.002; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Hartmann C, 2008, J MOL BIOL, V377, P352, DOI 10.1016/j.jmb.2008.01.010; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Im YJ, 2009, DEV CELL, V17, P234, DOI 10.1016/j.devcel.2009.07.008; Inoue M, 2008, TRAFFIC, V9, P2180, DOI 10.1111/j.1600-0854.2008.00831.x; Kaksonen M, 2008, J CELL BIOL, V180, P1059, DOI 10.1083/jcb.200802174; Kieffer C, 2008, DEV CELL, V15, P62, DOI 10.1016/j.devcel.2008.05.014; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Landsberg MJ, 2009, STRUCTURE, V17, P427, DOI 10.1016/j.str.2008.12.020; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Lata S, 2009, BIOCHEM SOC T, V37, P156, DOI 10.1042/BST0370156; Lauer JM, 2006, J BIOL CHEM, V281, P14823, DOI 10.1074/jbc.M512706200; Leung KF, 2008, TRAFFIC, V9, P1698, DOI 10.1111/j.1600-0854.2008.00797.x; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200; Misura KMS, 2001, J BIOL CHEM, V276, P41301, DOI 10.1074/jbc.M106853200; Monsey J, 2010, J BIOL CHEM, V285, P7035, DOI 10.1074/jbc.M109.096032; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nickerson DP, 2010, MOL BIOL CELL, V21, P1023, DOI 10.1091/mbc.E09-09-0776; NICKERSON DP, 2006, J CELL BIOL, V175, pNIL1; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Park EY, 2005, J BIOL CHEM, V280, P22892, DOI 10.1074/jbc.M500035200; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shim S, 2008, MOL BIOL CELL, V19, P2661, DOI 10.1091/mbc.E07-12-1263; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Strub C, 2003, FEBS LETT, V553, P125, DOI 10.1016/S0014-5793(03)00985-2; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Xiao JY, 2007, J MOL BIOL, V374, P655, DOI 10.1016/j.jmb.2007.09.067; Xiao JY, 2009, MOL BIOL CELL, V20, P3514, DOI 10.1091/mbc.E09-05-0403; Yu ZH, 2008, J MOL BIOL, V377, P364, DOI 10.1016/j.jmb.2008.01.009; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103; Zhang XD, 2008, NAT STRUCT MOL BIOL, V15, P1223, DOI 10.1038/nsmb.1501; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zolkiewski M, 2006, MOL MICROBIOL, V61, P1094, DOI 10.1111/j.1365-2958.2006.05309.x	72	48	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35428	35438		10.1074/jbc.M110.126318	http://dx.doi.org/10.1074/jbc.M110.126318			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20805225	hybrid, Green Published			2022-12-25	WOS:000283845300020
J	Blacketer, MJ; Feely, SJ; Shogren-Knaak, MA				Blacketer, Melissa J.; Feely, Sarah J.; Shogren-Knaak, Michael A.			Nucleosome Interactions and Stability in an Ordered Nucleosome Array Model System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROCHROMATIN PROTEIN-1 HP1; CHROMATIN FIBER STRUCTURE; HISTONE OCTAMER; CORE PARTICLE; PHO5 PROMOTER; TAIL DOMAIN; DNA; IDENTIFICATION; COMPACTION; TRANSCRIPTION	Although it is well established that the majority of eukaryotic DNA is sequestered as nucleosomes, the higher-order structure resulting from nucleosome interactions as well as the dynamics of nucleosome stability are not as well understood. To characterize the structural and functional contribution of individual nucleosomal sites, we have developed a chromatin model system containing up to four nucleosomes, where the array composition, saturation, and length can be varied via the ordered ligation of distinct mononucleosomes. Using this system we find that the ligated tetranucleosomal arrays undergo intra-array compaction. However, this compaction is less extensive than for longer arrays and is histone H4 tail-independent, suggesting that well ordered stretches of four or fewer nucleosomes do not fully compact to the 30-nm fiber. Like longer arrays, the tetranucleosomal arrays exhibit cooperative self-association to form species composed of many copies of the array. This propensity for self-association decreases when the fraction of nucleosomes lacking H4 tails is systematically increased. However, even tetranucleosomal arrays with only two octamers possessing H4 tails recapitulate most of the inter-array self-association. Varying array length shows that systems as short as dinucleosomes demonstrate significant self-association, confirming that relatively few determinants are required for inter-array interactions and suggesting that in vivo multiple interactions of short runs of nucleosomes might contribute to complex fiber-fiber interactions. Additionally, we find that the stability of nucleosomes toward octamer loss increases with array length and saturation, suggesting that in vivo stretches of ordered, saturated nucleosomes could serve to protect these regions from histone ejection.	[Blacketer, Melissa J.; Feely, Sarah J.; Shogren-Knaak, Michael A.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Shogren-Knaak, MA (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, 4214 Mol Biol Bldg, Ames, IA 50011 USA.	knaak@iastate.edu			National Institutes of Health [GM79663]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM79663 (to M. A. S.-K.).	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Carruthers LM, 1999, METHOD ENZYMOL, V304, P19; Dialynas GK, 2008, MUTAT RES-FUND MOL M, V647, P13, DOI 10.1016/j.mrfmmm.2008.09.007; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Eltsov M, 2008, P NATL ACAD SCI USA, V105, P19732, DOI 10.1073/pnas.0810057105; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Grigoryev SA, 1999, J BIOL CHEM, V274, P5626, DOI 10.1074/jbc.274.9.5626; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Jessen WJ, 2006, NAT STRUCT MOL BIOL, V13, P256, DOI 10.1038/nsmb1062; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; KO H, 2008, Trends Cell Biol */*, V18, P236; Kwon SH, 2008, MOL CELLS, V26, P217; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Li S, 2008, P NATL ACAD SCI USA, V105, P18243, DOI 10.1073/pnas.0804530105; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200; NOLL H, 1989, METHOD ENZYMOL, V170, P55; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sinha D, 2010, J BIOL CHEM, V285, P16572, DOI 10.1074/jbc.M109.091298; Springhetti EM, 2003, J BIOL CHEM, V278, P43384, DOI 10.1074/jbc.M307635200; Strick R, 2001, J CELL BIOL, V155, P899, DOI 10.1083/jcb.200105026; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; THSTRO MA, 2004, J BIOCH */* BIOCHEMI, V43, P736; Tse C, 1997, BIOCHEMISTRY-US, V36, P11381, DOI 10.1021/bi970801n; VAN H, 1978, BIOPOLYMERS */* W O, V17, P1387; van Holde K, 2007, SEMIN CELL DEV BIOL, V18, P651, DOI 10.1016/j.semcdb.2007.08.005; VANHOLDE KE, 1989, SPRINGER SERIES MOL, P289; Widlund HR, 1997, J MOL BIOL, V267, P807, DOI 10.1006/jmbi.1997.0916; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zheng CY, 2005, J BIOL CHEM, V280, P33552, DOI 10.1074/jbc.M507241200; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	48	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34597	34607		10.1074/jbc.M110.140061	http://dx.doi.org/10.1074/jbc.M110.140061			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739276	Green Published, hybrid			2022-12-25	WOS:000283659100035
J	Schmidt, S; Schneider, L; Essmann, F; Cirstea, IC; Kuck, F; Kletke, A; Janicke, RU; Wiek, C; Hanenberg, H; Ahmadian, MR; Schulze-Osthoff, K; Nurnberg, B; Piekorz, RP				Schmidt, S.; Schneider, L.; Essmann, F.; Cirstea, I. C.; Kuck, F.; Kletke, A.; Jaenicke, R. U.; Wiek, C.; Hanenberg, H.; Ahmadian, M. R.; Schulze-Osthoff, K.; Nuernberg, B.; Piekorz, R. P.			The centrosomal protein TACC3 controls paclitaxel sensitivity by modulating a premature senescence program	ONCOGENE			English	Article						centrosome; mitosis; paclitaxel; p21(WAF); premature senescence; TACC3	SPINDLE POLE ORGANIZATION; CELLULAR SENESCENCE; BREAST-CANCER; AURORA-A; APOPTOSIS; CELLS; ERK; P53; PHOSPHORYLATION; CHECKPOINT	Microtubule-interfering cancer drugs such as paclitaxel (PTX) often cause chemoresistance and severe side effects, including neurotoxicity. To explore potentially novel antineoplastic molecular targets, we investigated the cellular response of breast carcinoma cells to short hairpin(sh)RNA-mediated depletion of the centrosomal protein transforming acidic coiled coil (TACC) 3, an Aurora A kinase target expressed during mitosis. Unlike PTX, knockdown of TACC3 did not trigger a cell death response, but instead resulted in a progressive loss of the pro-apoptotic Bcl-2 protein Bim that links microtubule integrity to spindle poison-induced cell death. Interestingly, TACC3-depleted cells arrested in G(1) through a cellular senescence program characterized by the upregulation of nuclear p21(WAF), downregulation of the retinoblastoma protein and extracellular signal-regulated kinase 1/2, formation of HP1 gamma (phospho-Ser83)-positive senescence-associated heterochromatic foci and increased senescence-associated beta-galactosidase activity. Remarkably, the onset of senescence following TACC3 knockdown was strongly accelerated in the presence of non-toxic PTX concentrations. Thus, we conclude that mitotic spindle stress is a major trigger of premature senescence and propose that the combined targeting of the centrosomal Aurora A-TACC3 axis together with drugs interfering with microtubule dynamics may efficiently improve the chemosensitivity of cancer cells. Oncogene (2010) 29, 6184-6192; doi:10.1038/onc.2010.354; published online 23 August 2010	[Schmidt, S.; Schneider, L.; Cirstea, I. C.; Kuck, F.; Ahmadian, M. R.; Nuernberg, B.; Piekorz, R. P.] Univ Dusseldorf, Inst Biochem & Mol Biol 2, Univ Klinikum, D-40225 Dusseldorf, Germany; [Jaenicke, R. U.] Univ Dusseldorf, Klin Strahlentherapie & Radioonkol, Univ Klinikum, D-40225 Dusseldorf, Germany; [Wiek, C.; Hanenberg, H.] Univ Dusseldorf, Klin Kinder Onkol Hamatol & Klin Immunol, Univ Klinikum, D-40225 Dusseldorf, Germany; [Essmann, F.; Schulze-Osthoff, K.] Univ Tubingen, Abt Mol Med, IFIB, Tubingen, Germany; [Hanenberg, H.] Indiana Univ Sch Med, Riley Hosp Children, Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN USA; [Nuernberg, B.] Klinikum Eberhard Karls Univ, Inst Expt & Klin Pharmakol, Tubingen, Germany; [Nuernberg, B.] Klinikum Eberhard Karls Univ, Interfak Zentrum Pharmakogenom & Arzneimittelfors, Tubingen, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Eberhard Karls University of Tubingen; Indiana University System; Indiana University Bloomington; James Whitcomb Riley Hospital Children; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Piekorz, RP (corresponding author), Univ Dusseldorf, Inst Biochem & Mol Biol 2, Univ Klinikum, D-40225 Dusseldorf, Germany.	roland.piekorz@uni-duesseldorf.de	Essmann, Frank/ABG-7409-2020; Schneider, Leonid/H-3275-2013; Schulze-Osthoff, Klaus/N-9025-2013; Cirstea, Ion Cristian/AAQ-7670-2020	Essmann, Frank/0000-0003-4369-8456; Schneider, Leonid/0000-0002-6204-9470; Schulze-Osthoff, Klaus/0000-0003-1443-2720; Cirstea, Ion Cristian/0000-0003-3204-1598; Nurnberg, Bernd/0000-0002-5995-6555; Wiek, Constanze/0000-0003-2214-8148	Collaborative Research Centers of the Deutsche Forschungsgemeinschaft [SFB728, SFB773, SPP1230]; Forschungskommission (Medizinische Fakultat) of the Heinrich-Heine-Universitat; NGFNplus program [01GS08100]; Bundesministerium fur Bildung und Forschung	Collaborative Research Centers of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungskommission (Medizinische Fakultat) of the Heinrich-Heine-Universitat; NGFNplus program; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	Grant support: Collaborative Research Centers SFB728 (RUJ, RPP), SFB773 (FE, KSO), and SPP1230 (HH) of the Deutsche Forschungsgemeinschaft; Forschungskommission (Medizinische Fakultat) of the Heinrich-Heine-Universitat (ICC, MRA, RUJ, RPP); and the NGFNplus program (grant 01GS08100 to MRA) and the network for bone marrow failure syndromes (bmfs to HH) of the Bundesministerium fur Bildung und Forschung.	Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Blagosklonny MV, 2006, J CELL PHYSIOL, V209, P592, DOI 10.1002/jcp.20750; Blagosklonny MV, 2006, CELL CYCLE, V5, P1574, DOI 10.4161/cc.5.14.3113; Blagosklonny MV, 2006, CELL CYCLE, V5, P971, DOI 10.4161/cc.5.9.2711; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Broude EV, 2007, ONCOGENE, V26, P6954, DOI 10.1038/sj.onc.1210516; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Czernick M, 2009, BIOCHEM BIOPH RES CO, V379, P145, DOI 10.1016/j.bbrc.2008.12.025; Demidenko ZN, 2008, ONCOGENE, V27, P4402, DOI 10.1038/onc.2008.82; Essmann F, 2004, CANCER RES, V64, P7065, DOI 10.1158/0008-5472.CAN-04-1082; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gaumont-Leclerc MF, 2004, J BIOL CHEM, V279, P46802, DOI 10.1074/jbc.M403893200; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Gergely F, 2002, BIOESSAYS, V24, P915, DOI 10.1002/bies.10162; Gire V, 1998, MOL CELL BIOL, V18, P1611, DOI 10.1128/MCB.18.3.1611; Horgan AM, 2003, EXP CELL RES, V285, P208, DOI 10.1016/S0014-4827(03)00037-5; Huck JJ, 2010, MOL CANCER RES, V8, P373, DOI 10.1158/1541-7786.MCR-09-0300; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Janssen K, 2007, BLOOD, V110, P3662, DOI 10.1182/blood-2007-02-073213; Jung CK, 2006, PATHOL INT, V56, P503, DOI 10.1111/j.1440-1827.2006.01998.x; Kadura S, 2005, CELL MOTIL CYTOSKEL, V61, P145, DOI 10.1002/cm.20072; Khodjakov Alexey, 2009, Journal of Biology (London), V8, P1, DOI 10.1186/jbiol195; Kiemeney LA, 2010, NAT GENET, V42, P415, DOI 10.1038/ng.558; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Lauffart Brenda, 2005, BMC Womens Health, V5, P8, DOI 10.1186/1472-6874-5-8; LeRoy PJ, 2007, CANCER RES, V67, P5362, DOI 10.1158/0008-5472.CAN-07-0122; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Li Z, 2007, CELL DEATH DIFFER, V14, P318, DOI 10.1038/sj.cdd.4401983; Liang Y, 2001, ONCOGENE, V20, P6570, DOI 10.1038/sj.onc.1204815; Maehara K, 2010, MOL CELL BIOL, V30, P2090, DOI 10.1128/MCB.01318-09; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; Piekorz RP, 2002, EMBO J, V21, P653, DOI 10.1093/emboj/21.4.653; Prencipe M, 2009, BRIT J CANCER, V101, P1900, DOI 10.1038/sj.bjc.6605419; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Schneider L, 2008, ONCOGENE, V27, P116, DOI 10.1038/sj.onc.1210628; Schneider L, 2007, J BIOL CHEM, V282, P29273, DOI 10.1074/jbc.M704151200; Schuendeln MM, 2004, MOL CELL BIOL, V24, P6403, DOI 10.1128/MCB.24.14.6403-6409.2004; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Simstein R, 2003, EXP BIOL MED, V228, P995, DOI 10.1177/153537020322800903; Srsen V, 2006, J CELL BIOL, V174, P625, DOI 10.1083/jcb.200606051; Tierno MB, 2009, J PHARMACOL EXP THER, V328, P715, DOI 10.1124/jpet.108.147330; Torii S, 2006, CANCER SCI, V97, P697, DOI 10.1111/j.1349-7006.2006.00244.x; Tresini M, 2007, J BIOL CHEM, V282, P4136, DOI 10.1074/jbc.M604955200; Yao R, 2007, CANCER SCI, V98, P555, DOI 10.1111/j.1349-7006.2007.00433.x; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Zhang RG, 2007, MOL CELL BIOL, V27, P949, DOI 10.1128/MCB.01639-06; Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001	55	35	37	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	46					6184	6192		10.1038/onc.2010.354	http://dx.doi.org/10.1038/onc.2010.354			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	681XD	20729911				2022-12-25	WOS:000284356500010
J	Tian, L; Peng, G; Parant, JM; Leventaki, V; Drakos, E; Zhang, Q; Parker-Thornburg, J; Shackleford, TJ; Dai, H; Lin, SY; Lozano, G; Rassidakis, GZ; Claret, FX				Tian, L.; Peng, G.; Parant, J. M.; Leventaki, V.; Drakos, E.; Zhang, Q.; Parker-Thornburg, J.; Shackleford, T. J.; Dai, H.; Lin, S-Y; Lozano, G.; Rassidakis, G. Z.; Claret, F. X.			Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair	ONCOGENE			English	Article						DNA repair; DNA damage; null mutation; embryonic lethality; Rad51	RAD51 RECOMBINATION PROTEIN; HOMOLOGOUS RECOMBINATION; EXPRESSION; P53; DEGRADATION; ACTIVATION; P27(KIP1); OVEREXPRESSION; PROLIFERATION; LOCALIZATION	Jun activation domain-binding protein 1 (JAB1) is a multifunctional protein that participates in the control of cell proliferation and the stability of multiple proteins. JAB1 overexpression has been implicated in the pathogenesis of human cancer. JAB1 regulates several key proteins and thereby produces varied effects on cell cycle progression, genome stability and cell survival. However, the biological significance of JAB1 activity in these cellular signaling pathways is unclear. Therefore, we developed mice that were deficient in Jab1 and analyzed the null embryos and heterozygous cells. This disruption of Jab1 in mice resulted in early embryonic lethality due to accelerated apoptosis. Loss of Jab1 expression sensitized both mouse primary embryonic fibroblasts and osteosarcoma cells to gamma-radiation-induced apoptosis, with an increase in spontaneous DNA damage and homologous recombination (HR) defects, both of which correlated with reduced levels of the DNA repair protein Rad51 and elevated levels of p53. Furthermore, the accumulated p53 directly binds to Rad51 promoter, inhibits its activity and represents a major mechanism underlying the HR repair defect in Jab1-deficient cells. These results indicate that Jab1 is essential for efficient DNA repair and mechanistically link Jab1 to the maintenance of genome integrity and to cell survival. Oncogene (2010) 29, 6125-6137; doi:10.1038/onc.2010.345; published online 30 August 2010	[Tian, L.; Peng, G.; Zhang, Q.; Shackleford, T. J.; Dai, H.; Lin, S-Y; Claret, F. X.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Peng, G.; Lozano, G.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Leventaki, V.; Drakos, E.; Rassidakis, G. Z.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Parker-Thornburg, J.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Claret, FX (corresponding author), Univ Texas MD Anderson, Dept Syst Biol, Div Canc Med, 7435 Fannin St,Unit 950, Houston, TX 77054 USA.	fxclaret@mdanderson.org	Rassidakis, George/V-9553-2019; Claret, Francois X/R-2104-2016; Leventaki, Vasiliki/N-8175-2018	Claret, Francois X/0000-0003-4629-6495; Shackleford, Terry/0000-0002-3621-2289	National Institutes of Health [RO1 CA90853, CA16672]; Susan G Komen for the Cure; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA090853] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Jeffrey Medeiros's laboratory for providing technical help, Dina Lev and Zhi-Xiang Xu for kindly providing the pRad51-luciferase reporter, Rad51 and p53 constructs and Dr Bert Vogelstein for sharing PG13-luc and MG15-Luc plasmids. We also thank Christine Wogan for assistance with the manuscript preparation. This research was supported by the National Institutes of Health Grant RO1 CA90853, the Susan G Komen for the Cure and the NIH Core Grant CA16672.	Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Arias-Lopez C, 2006, EMBO REP, V7, P219, DOI 10.1038/sj.embor.7400587; Bae MK, 2002, J BIOL CHEM, V277, P9, DOI 10.1074/jbc.C100442200; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Buscemi G, 2004, ONCOGENE, V23, P7691, DOI 10.1038/sj.onc.1207986; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Collis SJ, 2001, NUCLEIC ACIDS RES, V29, P1534, DOI 10.1093/nar/29.7.1534; Dong YY, 2005, CLIN CANCER RES, V11, P259; Doronkin S, 2002, DEVELOPMENT, V129, P5053; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gupta RC, 1997, P NATL ACAD SCI USA, V94, P463, DOI 10.1073/pnas.94.2.463; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; Harada K, 2006, ANTICANCER RES, V26, P1615; Harari-Steinberg O, 2007, GENES CELLS, V12, P183, DOI 10.1111/j.1365-2443.2007.01049.x; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kouvaraki MA, 2003, CANCER RES, V63, P2977; KOUVARAKI MA, 2006, CANCER RES, V66, P6589; Kwok SF, 1998, PLANT CELL, V10, P1779, DOI 10.1105/tpc.10.11.1779; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lykke-Andersen K, 2003, MOL CELL BIOL, V23, P6790, DOI 10.1128/MCB.23.19.6790-6797.2003; Maacke H, 2000, ONCOGENE, V19, P2791, DOI 10.1038/sj.onc.1203578; Mundt KE, 1999, CURR BIOL, V9, P1427, DOI 10.1016/S0960-9822(00)80091-3; Oh W, 2006, J BIOL CHEM, V281, P17457, DOI 10.1074/jbc.M601857200; Oron E, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100150; Peng G, 2009, NAT CELL BIOL, V11, P865, DOI 10.1038/ncb1895; Pierce AJ, 2005, METH MOL B, V291, P373; Raderschall E, 2002, CANCER RES, V62, P219; Rassidakis GZ, 2003, CLIN CANCER RES, V9, P1121; Russell JS, 2003, CANCER RES, V63, P7377; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Suh GSB, 2002, NEURON, V33, P35, DOI 10.1016/S0896-6273(01)00576-1; Sui L, 2001, CLIN CANCER RES, V7, P4130; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Tomoda K, 2004, J BIOL CHEM, V279, P43013, DOI 10.1074/jbc.M406559200; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Vispe S, 1998, NUCLEIC ACIDS RES, V26, P2859, DOI 10.1093/nar/26.12.2859; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wan M, 2002, EMBO REP, V3, P171, DOI 10.1093/embo-reports/kvf024; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Xia SJJ, 1997, MOL CELL BIOL, V17, P7151, DOI 10.1128/MCB.17.12.7151; Yan J, 2003, MOL CELL BIOL, V23, P6798, DOI 10.1128/MCB.23.19.6798-6808.2003; Zhang QX, 2005, FEBS LETT, V579, P3932, DOI 10.1016/j.febslet.2005.06.012	47	51	52	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	46					6125	6137		10.1038/onc.2010.345	http://dx.doi.org/10.1038/onc.2010.345			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	681XD	20802511	Green Accepted			2022-12-25	WOS:000284356500005
J	Nistala, H; Lee-Arteaga, S; Smaldone, S; Siciliano, G; Ramirez, F				Nistala, Harikiran; Lee-Arteaga, Sui; Smaldone, Silvia; Siciliano, Gabriella; Ramirez, Francesco			Extracellular Microfibrils Control Osteoblast-supported Osteoclastogenesis by Restricting TGF beta Stimulation of RANKL Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE MODEL; TRANSFORMING GROWTH-FACTOR-BETA-1; BONE; PATHOGENESIS; EXPRESSION; PROTEIN; DIFFERENTIATION; FIBRILLINS; INHIBITION; REGULATOR	Mutations in fibrillin-1 or fibrillin-2, the major structural components of extracellular microfibrils, cause pleiotropic manifestations in Marfan syndrome and congenital contractural arachnodactyly, respectively. We recently found that fibrillin-1 and fibrillin-2 control bone formation by regulating osteoblast differentiation through the differential modulation of endogenous TGF beta and bone morphogenetic protein signals. Here, we describe in vivo and ex vivo experiments that implicate the fibrillins as negative regulators of bone resorption. Adult Fbn2(-/-) mice display a greater than normal osteolytic response to locally implanted lipopolysaccharide-coated titanium particles. Although isolated cultures of Fbn2(-/-) preosteoclasts exhibited normal differentiation and activity, these features were substantially augmented when mutant or wild-type preosteoclasts were co-cultured with Fbn2(-/-) but not wild-type osteoblasts. Greater osteoclastogenic potential of Fbn2(-/-) osteoblasts was largely accounted for by up-regulation of the Rankl gene secondary to heightened TGF beta activity. This conclusion was based on the findings that blockade of TGF beta signaling blunts Rankl up-regulation in Fbn2(-/-) osteoblasts and bones and that systemic TGF beta antagonism improves locally induced osteolysis in Fbn2(-/-) mice. Abnormally high Rankl expression secondary to elevated TGF beta activity was also noted in cultured osteoblasts from Fbn1(-/-) mice. Collectively our data demonstrated that extracellular microfibrils balance local catabolic and anabolic signals during bone remodeling in addition to implying distinct mechanisms of bone loss in Marfan syndrome and congenital contractural arachnodactyly.	[Nistala, Harikiran; Lee-Arteaga, Sui; Smaldone, Silvia; Siciliano, Gabriella; Ramirez, Francesco] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10021 USA	Icahn School of Medicine at Mount Sinai	Ramirez, F (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10021 USA.	francesco.ramirez@mssm.edu	Siciliano, Gabriele/K-7259-2016	Siciliano, Gabriele/0000-0002-6142-2384; Nistala, Harikiran/0000-0003-4928-7527	National Institutes of Health [AR42044]; National Marfan Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042044] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Marfan Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR42044 (to F. R.). This work was also supported by the National Marfan Foundation.	Alliston Tamara, 2008, P667; Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Bi YM, 2006, BONE, V38, P778, DOI 10.1016/j.bone.2005.11.005; BONADIO J, 1990, P NATL ACAD SCI USA, V87, P7145, DOI 10.1073/pnas.87.18.7145; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Carta L, 2009, J BIOL CHEM, V284, P5630, DOI 10.1074/jbc.M806962200; Chellaiah MA, 2003, MOL BIOL CELL, V14, P173, DOI 10.1091/mbc.E02-06-0354; CHIPMAN SD, 1993, P NATL ACAD SCI USA, V90, P1701, DOI 10.1073/pnas.90.5.1701; Choi JW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000750; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Craft CS, 2010, J BIOL CHEM, V285, P23858, DOI 10.1074/jbc.M110.113019; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Delany AM, 2003, ENDOCRINOLOGY, V144, P2588, DOI 10.1210/en.2002-221044; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hubmacher D, 2006, CURR TOP DEV BIOL, V75, P93, DOI 10.1016/S0070-2153(06)75004-9; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Karst M, 2004, J CELL PHYSIOL, V200, P99, DOI 10.1002/jcp.20036; Kitahama S, 2000, BONE, V27, P61, DOI 10.1016/S8756-3282(00)00292-1; Mishina Y, 2004, J BIOL CHEM, V279, P27560, DOI 10.1074/jbc.M404222200; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Murakami T, 1998, BIOCHEM BIOPH RES CO, V252, P747, DOI 10.1006/bbrc.1998.9723; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; NISTALA H, 2010, J CELL BIOL IN PRESS; Okamoto M, 2006, J BONE MINER RES, V21, P1022, DOI 10.1359/JBMR.060411; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; RAMIREZ F, 2008, PRIMER METABOLIC BON, P450; Ramirez F, 2007, CURR OPIN GENET DEV, V17, P252, DOI 10.1016/j.gde.2007.04.006; Ramirez F, 2010, CELL TISSUE RES, V339, P71, DOI 10.1007/s00441-009-0822-x; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Sohaskey ML, 2010, J CELL BIOL, V189, P511, DOI 10.1083/jcb.201003006; Subramaniam M, 2005, MOL CELL BIOL, V25, P1191, DOI 10.1128/MCB.25.3.1191-1199.2005; Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760; Thirunavukkarasu K, 2001, J BIOL CHEM, V276, P36241, DOI 10.1074/jbc.M104319200; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746	46	40	40	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34126	34133		10.1074/jbc.M110.125328	http://dx.doi.org/10.1074/jbc.M110.125328			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729550	hybrid, Green Published			2022-12-25	WOS:000283354000058
J	Zhou, YS; Jetton, TL; Goshorn, S; Lynch, CJ; She, PX				Zhou, Yingsheng; Jetton, Thomas L.; Goshorn, Stephanie; Lynch, Christopher J.; She, Pengxiang			Transamination Is Required for alpha-Ketoisocaproate but Not Leucine to Stimulate Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRANCHED-CHAIN AMINO; PANCREATIC-ISLET METABOLISM; B-CELL MITOCHONDRIA; GLUTAMATE-DEHYDROGENASE; 2-KETO ACIDS; BETA-CELLS; PYRUVATE-CARBOXYLASE; MALIC ENZYME; RELEASE; GLUCOSE	It remains unclear how alpha-ketoisocaproate (KIC) and leucine are metabolized to stimulate insulin secretion. Mitochondrial BCATm (branched-chain aminotransferase) catalyzes reversible transamination of leucine and alpha-ketoglutarate to KIC and glutamate, the first step of leucine catabolism. We investigated the biochemical mechanisms of KIC and leucine-stimulated insulin secretion (KICSIS and LSIS, respectively) using BCATm(-/-) mice. In static incubation, BCATm disruption abolished insulin secretion by KIC, D,L-alpha-keto-beta-methylvalerate, and alpha-ketocaproate without altering stimulation by glucose, leucine, or alpha-ketoglutarate. Similarly, during pancreas perfusions in BCATm(-/-) mice, glucose and arginine stimulated insulin release, whereas KICSIS was largely abolished. During islet perifusions, KIC and 2 mM glutamine caused robust dose-dependent insulin secretion in BCATm(+/+) not BCATm(-/-) islets, whereas LSIS was unaffected. Consistently, in contrast to BCATm(+/+) islets, the increases of the ATP concentration and NADPH/NADP(+) ratio in response to KIC were largely blunted in BCATm(-/-) islets. Compared with nontreated islets, the combination of KIC/glutamine (10/2 mM) did not influence alpha-ketoglutarate concentrations but caused 120 and 33% increases in malate in BCATm(+/+) and BCATm(-/-) islets, respectively. Although leucine oxidation and KIC transamination were blocked in BCATm(-/-) islets, KIC oxidation was unaltered. These data indicate that KICSIS requires transamination of KIC and glutamate to leucine and alpha-ketoglutarate, respectively. LSIS does not require leucine catabolism and may be through leucine activation of glutamate dehydrogenase. Thus, KICSIS and LSIS occur by enhancing the metabolism of glutamine/glutamate to alpha-ketoglutarate, which, in turn, is metabolized to produce the intracellular signals such as ATP and NADPH for insulin secretion.	[She, Pengxiang] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Jetton, Thomas L.] Univ Vermont, Dept Med, Burlington, VT 05405 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Vermont	She, PX (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr,Mail Code H166, Hershey, PA 17033 USA.	pengxiangshe@gmail.com		Lynch, Christopher/0000-0003-2453-5838	National Institutes of Health [DK062880]; Ajinomoto Amino Acid Research grant; Pennsylvania State University College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ajinomoto Amino Acid Research grant; Pennsylvania State University College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK062880 (to C. J. L.). This work was also supported by an Ajinomoto Amino Acid Research grant and a Pennsylvania State University College of Medicine Departmental Seed grant (to P. S.).	ANIENTO F, 1988, MOL CELL BIOCHEM, V79, P107, DOI 10.1007/BF02424551; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; Fahien LA, 2002, DIABETES, V51, P2669, DOI 10.2337/diabetes.51.9.2669; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; Fex M, 2007, DIABETOLOGIA, V50, P74, DOI 10.1007/s00125-006-0464-4; Gao Z, 2003, ENDOCRINOLOGY, V144, P1949, DOI 10.1210/en.2002-0072; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Henquin JC, 2006, DIABETES, V55, P3470, DOI 10.2337/db06-0868; HUTTON JC, 1979, BIOCHEM J, V184, P303, DOI 10.1042/bj1840303; HUTTON JC, 1980, ENDOCRINOLOGY, V106, P203, DOI 10.1210/endo-106-1-203; HUTTON JC, 1979, BIOCHEM J, V184, P291, DOI 10.1042/bj1840291; HUTTON JC, 1980, J BIOL CHEM, V255, P7340; Ishiyama N, 2006, AM J PHYSIOL-ENDOC M, V290, pE540, DOI 10.1152/ajpendo.00032.2005; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; LaNoue KF, 2001, J NEUROSCI RES, V66, P914, DOI 10.1002/jnr.10064; Lembert N, 1998, DIABETES, V47, P339, DOI 10.2337/diabetes.47.3.339; LENZEN S, 1982, J BIOL CHEM, V257, P6631; LENZEN S, 1986, BIOSCIENCE REP, V6, P163, DOI 10.1007/BF01115002; LENZEN S, 1985, J BIOL CHEM, V260, P2629; Li CH, 2003, J BIOL CHEM, V278, P2853, DOI 10.1074/jbc.M210577200; Liu YQ, 2002, J BIOL CHEM, V277, P39163, DOI 10.1074/jbc.M207157200; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; Lynch CJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE621, DOI 10.1152/ajpendo.00462.2005; MacDonald MJ, 2007, J BIOL CHEM, V282, P6043, DOI 10.1074/jbc.M606652200; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MALAISSE WJ, 1982, J BIOL CHEM, V257, P8731; MALAISSE WJ, 1982, ENDOCRINOLOGY, V111, P392, DOI 10.1210/endo-111-2-392; MALAISSE WJ, 1981, BIOCHIM BIOPHYS ACTA, V677, P39, DOI 10.1016/0304-4165(81)90143-4; MALAISSE WJ, 1986, ADV ENZYME REGUL, V25, P203, DOI 10.1016/0065-2571(86)90015-4; PASSONNEAU JV, 1993, ENZYMATIC ANAL PRACT, P85; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Rabaglia ME, 2005, AM J PHYSIOL-ENDOC M, V289, pE218, DOI 10.1152/ajpendo.00573.2004; RUDIGER HW, 1972, BIOCHEM J, V126, P445, DOI 10.1042/bj1260445; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0; SENER A, 1981, P NATL ACAD SCI-BIOL, V78, P5460, DOI 10.1073/pnas.78.9.5460; SENER A, 1983, J BIOL CHEM, V258, P6693; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; She PX, 2010, J APPL PHYSIOL, V108, P941, DOI 10.1152/japplphysiol.01248.2009; Sherry AD, 1998, AM J PHYSIOL-HEART C, V274, pH591, DOI 10.1152/ajpheart.1998.274.2.H591; Shiota C, 2002, J BIOL CHEM, V277, P37176, DOI 10.1074/jbc.M206757200; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Sweatt AJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE64, DOI 10.1152/ajpendo.00276.2003; Tanizawa Y, 2002, DIABETES, V51, P712, DOI 10.2337/diabetes.51.3.712; Weyer C, 2000, DIABETES, V49, P2094, DOI 10.2337/diabetes.49.12.2094; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu J, 2008, DIABETOLOGIA, V51, P2022, DOI 10.1007/s00125-008-1130-9	50	41	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33718	33726		10.1074/jbc.M110.136846	http://dx.doi.org/10.1074/jbc.M110.136846			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20736162	Green Published, hybrid			2022-12-25	WOS:000283354000017
J	Resendis-Antonio, O; Checa, A; Encarnacion, S				Resendis-Antonio, Osbaldo; Checa, Alberto; Encarnacion, Sergio			Modeling Core Metabolism in Cancer Cells: Surveying the Topology Underlying the Warburg Effect	PLOS ONE			English	Article							ESCHERICHIA-COLI; AEROBIC GLYCOLYSIS; TUMOR SUPPRESSORS; DRUG-RESISTANCE; GROWTH; RECONSTRUCTION; CONSTRAINTS; INHIBITION; NETWORKS; BALANCE	Background: Alterations on glucose consumption and biosynthetic activity of amino acids, lipids and nucleotides are metabolic changes for sustaining cell proliferation in cancer cells. Irrevocable evidence of this fact is the Warburg effect which establishes that cancer cells prefers glycolysis over oxidative phosphorylation to generate ATP. Regulatory action over metabolic enzymes has opened a new window for designing more effective anti-cancer treatments. This enterprise is not trivial and the development of computational models that contribute to identifying potential enzymes for breaking the robustness of cancer cells is a priority. Methodology/Principal Findings: This work presents a constraint-base modeling of the most experimentally studied metabolic pathways supporting cancer cells: glycolysis, TCA cycle, pentose phosphate, glutaminolysis and oxidative phosphorylation. To evaluate its predictive capacities, a growth kinetics study for Hela cell lines was accomplished and qualitatively compared with in silico predictions. Furthermore, based on pure computational criteria, we concluded that a set of enzymes (such as lactate dehydrogenase and pyruvate dehydrogenase) perform a pivotal role in cancer cell growth, findings supported by an experimental counterpart. Conclusions/Significance: Alterations on metabolic activity are crucial to initiate and sustain cancer phenotype. In this work, we analyzed the phenotype capacities emerged from a constructed metabolic network conformed by the most experimentally studied pathways sustaining cancer cell growth. Remarkably, in silico model was able to resemble the physiological conditions in cancer cells and successfully identified some enzymes currently studied by its therapeutic effect. Overall, we supplied evidence that constraint-based modeling constitutes a promising computational platform to: 1) integrate high throughput technology and establish a crosstalk between experimental validation and in silico prediction in cancer cell phenotype; 2) explore the fundamental metabolic mechanism that confers robustness in cancer; and 3) suggest new metabolic targets for anticancer treatments. All these issues being central to explore cancer cell metabolism from a systems biology perspective.	[Resendis-Antonio, Osbaldo; Checa, Alberto; Encarnacion, Sergio] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Resendis-Antonio, O (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62191, Morelos, Mexico.	resendis@ccg.unam.mx	RESENDIS, OSBALDO/ADE-5280-2022	RESENDIS, OSBALDO/0000-0001-5220-541X	National Council of Science and Technology (CONACyT-Mexico) [83461]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica-Universidad Nacional Autonoma de Mexico (PAPIIT) [IN203809-3]	National Council of Science and Technology (CONACyT-Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica-Universidad Nacional Autonoma de Mexico (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	This work was partially supported by National Council of Science and Technology (CONACyT-Mexico: grant 83461) and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica-Universidad Nacional Autonoma de Mexico (PAPIIT: grant IN203809-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachtiary B, 2006, CLIN CANCER RES, V12, P5632, DOI 10.1158/1078-0432.CCR-06-0357; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Cascante M, 2002, NAT BIOTECHNOL, V20, P243, DOI 10.1038/nbt0302-243; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; KREEGER PK, 2009, CANC SYSTEMS BIOL NE; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; PALSSON B, 2009, FEBS LETT; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Price ND, 2004, BIOPHYS J, V87, P2172, DOI 10.1529/biophysj.104.043000; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Ramos-Montoya A, 2006, INT J CANCER, V119, P2733, DOI 10.1002/ijc.22227; Resendis-Antonio O, 2007, PLOS COMPUT BIOL, V3, P1887, DOI 10.1371/journal.pcbi.0030192; Resendis-Antonio O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004967; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weinberg RA, 2007, BIOL CANC; Wiback SJ, 2004, J THEOR BIOL, V228, P437, DOI 10.1016/j.jtbi.2004.02.006; WOLKENHAUER O, CANC RES, V70, P12; Xu RH, 2005, CANCER RES, V65, P613; Zhang Y, 2009, SCIENCE, V325, P1544, DOI 10.1126/science.1174671	42	52	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12383	10.1371/journal.pone.0012383	http://dx.doi.org/10.1371/journal.pone.0012383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811631	gold, Green Published, Green Submitted			2022-12-25	WOS:000281234700013
J	Wikramaratna, PS; Simmons, CP; Gupta, S; Recker, M				Wikramaratna, Paul S.; Simmons, Cameron P.; Gupta, Sunetra; Recker, Mario			The Effects of Tertiary and Quaternary Infections on the Epidemiology of Dengue	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; HEMORRHAGIC-FEVER; PLASMODIUM-FALCIPARUM; DEPENDENT ENHANCEMENT; VIRUS-INFECTION; HUMAN MOVEMENT; AEDES-AEGYPTI; ANTIBODY; DISEASE; PATTERN	The epidemiology of dengue is characterised by irregular epidemic outbreaks and desynchronised dynamics of its four co-circulating virus serotypes. Whilst infection by one serotype appears to convey life-long protection to homologous infection, it is believed to be a risk factor for severe disease manifestations upon secondary, heterologous infection due to the phenomenon of Antibody-Dependent Enhancement (ADE). Subsequent clinical infections are rarely reported and, since the majority of dengue infections are generally asymptomatic, it is not clear if and to what degree tertiary or quaternary infections contribute to dengue epidemiology. Here we investigate the effect of third and subsequent infections on the transmission dynamics of dengue and show that although the qualitative patterns are largely equivalent, the system more readily exhibits the desynchronised serotype oscillations and multi-annual epidemic outbreaks upon their inclusion. More importantly, permitting third and fourth infections significantly increases the force of infection without resorting to high basic reproductive numbers. Realistic age-prevalent patterns and seroconversion rates are therefore easier reconciled with a low value of dengue's transmission potential if allowing for more than two infections; this should have important consequences for dengue control and intervention measures.	[Wikramaratna, Paul S.; Gupta, Sunetra; Recker, Mario] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Simmons, Cameron P.] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam	University of Oxford; University of Oxford	Wikramaratna, PS (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	mario.recker@zoo.ox.ac.uk	Simmons, Cameron P/ABA-3896-2021	Simmons, Cameron P/0000-0002-9039-7392; Recker, Mario/0000-0001-9489-1315	BBSRC; Royal Society	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London)	This work was funded by the BBSRC (PSW) and the Royal Society (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103; Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763; Aguiar M, 2008, MATH MODEL NAT PHENO, V3, P48, DOI 10.1051/mmnp:2008070; Anderson KB, 2007, LANCET, V369, P1452, DOI 10.1016/S0140-6736(07)60671-0; Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616; Cummings DAT, 2005, P NATL ACAD SCI USA, V102, P15259, DOI 10.1073/pnas.0507320102; Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139; Favier C, 2006, TROP MED INT HEALTH, V11, P332, DOI 10.1111/j.1365-3156.2006.01560.x; Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790; Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428; Gibbons RV, 2007, AM J TROP MED HYG, V77, P910, DOI 10.4269/ajtmh.2007.77.910; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; GUPTA S, 1994, PARASITE IMMUNOL, V16, P361, DOI 10.1111/j.1365-3024.1994.tb00361.x; GUPTA S, 1994, SCIENCE, V263, P961, DOI 10.1126/science.8310293; Halstead SB, 2001, AM J TROP MED HYG, V65, P180, DOI 10.4269/ajtmh.2001.65.180; Halstead SB, 2005, EMERG INFECT DIS, V11, P740, DOI 10.3201/eid1105.050346; HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Kongsomboon K., 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P913; KOOPMAN JS, 1991, AM J EPIDEMIOL, V133, P1168, DOI 10.1093/oxfordjournals.aje.a115829; Kuno Goro, 1997, P61; Massad E, 2003, REV SAUDE PUBL, V37, P477, DOI 10.1590/S0034-89102003000400013; Nagao Y, 2008, P NATL ACAD SCI USA, V105, P2238, DOI 10.1073/pnas.0709029105; Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191; Recker M, 2007, P NATL ACAD SCI USA, V104, P7711, DOI 10.1073/pnas.0702154104; Recker M, 2009, P ROY SOC B-BIOL SCI, V276, P2541, DOI 10.1098/rspb.2009.0331; Schwartz IB, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.066201; Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Thein S, 1997, AM J TROP MED HYG, V56, P566, DOI 10.4269/ajtmh.1997.56.566; TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103	35	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12347	10.1371/journal.pone.0012347	http://dx.doi.org/10.1371/journal.pone.0012347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808806	gold, Green Published			2022-12-25	WOS:000281153500025
J	Chichlowski, M; Westwood, GS; Abraham, SN; Hale, LP				Chichlowski, Maciej; Westwood, Greg S.; Abraham, Soman N.; Hale, Laura P.			Role of Mast Cells in Inflammatory Bowel Disease and Inflammation-Associated Colorectal Neoplasia in IL-10-Deficient Mice	PLOS ONE			English	Article							CROHNS-DISEASE; INTESTINAL PERMEABILITY; ULCERATIVE-COLITIS; PROTECTIVE ROLE; DEFICIENT MICE; MURINE MODEL; W-SH; CANCER; MODULATION; EXPRESSION	Background: Inflammatory bowel disease (IBD) is hypothesized to result from stimulation of immune responses against resident intestinal bacteria within a genetically susceptible host. Mast cells may play a critical role in IBD pathogenesis, since they are typically located just beneath the intestinal mucosal barrier and can be activated by bacterial antigens. Methodology/Principal Findings: This study investigated effects of mast cells on inflammation and associated neoplasia in IBD-susceptible interleukin (IL)-10-deficient mice with and without mast cells. IL-10-deficient mast cells produced more pro-inflammatory cytokines in vitro both constitutively and when triggered, compared with wild type mast cells. However despite this enhanced in vitro response, mast cell-sufficient Il10(-/-) mice actually had decreased cecal expression of tumor necrosis factor (TNF) and interferon (IFN)-gamma mRNA, suggesting that mast cells regulate inflammation in vivo. Mast cell deficiency predisposed Il10(-/-) mice to the development of spontaneous colitis and resulted in increased intestinal permeability in vivo that preceded the development of colon inflammation. However, mast cell deficiency did not affect the severity of IBD triggered by non-steroidal anti-inflammatory agents (NSAID) exposure or helicobacter infection that also affect intestinal permeability. Conclusions/Significance: Mast cells thus appear to have a primarily protective role within the colonic microenvironment by enhancing the efficacy of the mucosal barrier. In addition, although mast cells were previously implicated in progression of sporadic colon cancers, mast cells did not affect the incidence or severity of colonic neoplasia in this inflammation-associated model.	[Chichlowski, Maciej; Westwood, Greg S.; Abraham, Soman N.; Hale, Laura P.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Hale, Laura P.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Chichlowski, M (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	laura.hale@duke.edu			National Institutes of Health [R21-DK075522, 1R01-CA115480]; NATIONAL CANCER INSTITUTE [R01CA115480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075522, R01DK077159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the National Institutes of Health R21-DK075522 and 1R01-CA115480. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg DJ, 2002, GASTROENTEROLOGY, V123, P1527, DOI 10.1053/gast.2002.1231527; Berrozpe G, 1999, BLOOD, V94, P2658, DOI 10.1182/blood.V94.8.2658.420k23_2658_2666; Bischoff SC, 2009, SEMIN IMMUNOPATHOL, V31, P185, DOI 10.1007/s00281-009-0165-4; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Burich A, 2001, AM J PHYSIOL-GASTR L, V281, pG764, DOI 10.1152/ajpgi.2001.281.3.G764; Cardoso CR, 2008, CLIN EXP ALLERGY, V38, P338; Chichlowski M, 2008, COMPARATIVE MED, V58, P534; Chichlowski M, 2008, AM J PHYSIOL-GASTR L, V295, pG1139, DOI 10.1152/ajpgi.90516.2008; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; FOX CC, 1990, GASTROENTEROLOGY, V99, P119, DOI 10.1016/0016-5085(90)91238-2; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Gassler N, 2001, AM J PHYSIOL-GASTR L, V281, pG216, DOI 10.1152/ajpgi.2001.281.1.G216; GIBSON P, 1995, GUT, V36, P857, DOI 10.1136/gut.36.6.857; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Groschwitz KR, 2009, P NATL ACAD SCI USA, V106, P22381, DOI 10.1073/pnas.0906372106; Hale LP, 2007, HELICOBACTER, V12, P598, DOI 10.1111/j.1523-5378.2007.00552.x; Hale LP, 2005, INFLAMM BOWEL DIS, V11, P1060, DOI 10.1097/01.MIB.0000187582.90423.bc; Hale LP, 2005, CLIN IMMUNOL, V116, P135, DOI 10.1016/j.clim.2005.04.011; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; HEATLEY RV, 1975, GUT, V16, P559, DOI 10.1136/gut.16.7.559; Hofmann AM, 2009, CURR OPIN IMMUNOL, V21, P679, DOI 10.1016/j.coi.2009.09.007; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; INABA Y, 2010, INFLAMMATORY BOWEL D, V9999; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Madsen KL, 1999, INFLAMM BOWEL DIS, V5, P262, DOI 10.1097/00054725-199911000-00004; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005; Mekori YA, 1999, J ALLERGY CLIN IMMUN, V104, P517, DOI 10.1016/S0091-6749(99)70316-7; NAKAMURA J, 1985, CHEM PHARM BULL, V33, P3527; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; NOLTE H, 1990, GUT, V31, P791, DOI 10.1136/gut.31.7.791; Peeters M, 1997, GASTROENTEROLOGY, V113, P802, DOI 10.1016/S0016-5085(97)70174-4; RAITHEL M, 1995, INT ARCH ALLERGY IMM, V108, P127, DOI 10.1159/000237129; Santos J, 2008, PSYCHONEUROENDOCRINO, V33, P1248, DOI 10.1016/j.psyneuen.2008.07.002; Shen Z, 1997, INT J SYST BACTERIOL, V47, P627, DOI 10.1099/00207713-47-3-627; Shin JS, 2006, J IMMUNOL, V177, P5791, DOI 10.4049/jimmunol.177.9.5791; Sinnamon MJ, 2008, CARCINOGENESIS, V29, P880, DOI 10.1093/carcin/bgn040; Soderholm JD, 1999, GUT, V44, P96, DOI 10.1136/gut.44.1.96; Sollid LM, 2008, PLOS MED, V5, P1338, DOI 10.1371/journal.pmed.0050198; Suenaert P, 2002, AM J GASTROENTEROL, V97, P2000; Thuijls Geertje, 2010, J Clin Gastroenterol, V44, pe14, DOI 10.1097/MCG.0b013e31819f5652; WEIDNER N, 1991, J INVEST DERMATOL, V96, pS26, DOI 10.1111/1523-1747.ep12468966; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Wood JD, 2004, GASTROENTEROLOGY, V127, P635, DOI 10.1053/j.gastro.2004.02.017	48	58	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12220	10.1371/journal.pone.0012220	http://dx.doi.org/10.1371/journal.pone.0012220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808919	gold, Green Published			2022-12-25	WOS:000280968100019
J	Fellenberg, J; Kunz, P; Sahr, H; Depeweg, D				Fellenberg, Joerg; Kunz, Pierre; Saehr, Heiner; Depeweg, Daniela			Overexpression of Inosine 5 '-Monophosphate Dehydrogenase Type II Mediates Chemoresistance to Human Osteosarcoma Cells	PLOS ONE			English	Article							MULTIPLE-MYELOMA CELLS; DRUG-REGULATED GENES; IMP-DEHYDROGENASE; MONOPHOSPHATE DEHYDROGENASE; LEUKEMIA-CELLS; CANCER CELLS; CYCLE ARREST; APOPTOSIS; CHEMOTHERAPY; EXPRESSION	Background: Chemoresistance is the principal reason for poor survival and disease recurrence in osteosarcoma patients. Inosine 5'-monophosphate dehydrogenase type II (IMPDH2) encodes the rate-limiting enzyme in the de novo guanine nucleotide biosynthesis and has been linked to cell growth, differentiation, and malignant transformation. In a previous study we identified IMPDH2 as an independent prognostic factor and observed frequent IMPDH2 overexpression in osteosarcoma patients with poor response to chemotherapy. The aim of this study was to provide evidence for direct involvement of IMPDH2 in the development of chemoresistance. Methodology/Principal Findings: Stable cell lines overexpressing IMPDH2 and IMPDH2 knock-down cells were generated using the osteosarcoma cell line Saos-2 as parental cell line. Chemosensitivity, proliferation, and the expression of apoptosis-related proteins were analyzed by flow cytometry, WST-1-assay, and western blot analysis. Overexpression of IMPDH2 in Saos-2 cells induced strong chemoresistance against cisplatin and methotrexate. The observed chemoresistance was mediated at least in part by increased expression of the anti-apoptotic proteins Bcl-2, Mcl-1, and XIAP, reduced activation of caspase-9, and, consequently, reduced cleavage of the caspase substrate PARP. Pharmacological inhibition of IMPDH induced a moderate reduction of cell viability and a strong decrease of cell proliferation, but no increase in chemosensitivity. However, chemoresistant IMPDH2-overexpressing cells could be resensitized by RNA interference-mediated downregulation of IMPDH2. Conclusions: IMPDH2 is directly involved in the development of chemoresistance in osteosarcoma cells, suggesting that targeting of IMPDH2 by RNAi or more effective pharmacological inhibitors in combination with chemotherapy might be a promising means of overcoming chemoresistance in osteosarcomas with high IMPDH2 expression.	[Fellenberg, Joerg; Kunz, Pierre; Saehr, Heiner; Depeweg, Daniela] Orthoped Univ Hosp Heidelberg, Dept Expt Orthoped, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Fellenberg, J (corresponding author), Orthoped Univ Hosp Heidelberg, Dept Expt Orthoped, Heidelberg, Germany.	joerg.fellenberg@med.uni-heidelberg.de			Deutsche Krebshilfe e.V; EuroBoNeT	Deutsche Krebshilfe e.V(Deutsche Krebshilfe); EuroBoNeT(European CommissionEuropean Commission Joint Research Centre)	This study was supported by a grant from the Deutsche Krebshilfe e.V and the EuroBoNeT. The Department of Experimental Orthopedics, Orthopedic University Hospital Heidelberg is a partner of the EuroBoNeT consortium, a European Commission-granted Network of Excellence for studying the pathology and genetics of bone tumors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen LQ, 2007, CURR OPIN DRUG DISC, V10, P403; Fellenberg J, 2003, INT J CANCER, V105, P636, DOI 10.1002/ijc.11135; Fellenberg J, 2007, MODERN PATHOL, V20, P1085, DOI 10.1038/modpathol.3800937; Franchetti P, 1996, FARMACO, V51, P457; GHAREHBAGHI K, 1994, LEUKEMIA, V8, P1257; GOORIN AM, 1991, J CLIN ONCOL, V9, P600, DOI 10.1200/JCO.1991.9.4.600; Ishitsuka K, 2005, ONCOGENE, V24, P5888, DOI 10.1038/sj.onc.1208739; ITOH O, 1989, CANCER RES, V49, P996; JACKSON RC, 1975, NATURE, V256, P331, DOI 10.1038/256331a0; Jayaram HN, 1999, CURR MED CHEM, V6, P561; Kempf-Bielack B, 2005, J CLIN ONCOL, V23, P559, DOI 10.1200/JCO.2005.04.063; Khanna N, 2004, LIFE SCI, V75, P179, DOI 10.1016/j.lfs.2003.11.026; KNIGHT RD, 1987, BLOOD, V69, P634; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Messina E, 2004, INT J CANCER, V108, P812, DOI 10.1002/ijc.11642; MEYERS PA, 1992, J CLIN ONCOL, V10, P5, DOI 10.1200/JCO.1992.10.1.5; NAGAI M, 1991, CANCER RES, V51, P3886; NAGAI M, 1992, CANCER RES, V52, P258; NATSUMEDA Y, 1993, ANN NY ACAD SCI, V696, P88; OLAH E, 1988, P NATL ACAD SCI USA, V85, P6533, DOI 10.1073/pnas.85.17.6533; Penuelas S, 2005, FEBS J, V272, P696, DOI 10.1111/j.1742-4658.2004.04504.x; Penuelas S, 2005, MED SCI MONITOR, V11, pBR6; Provisor AJ, 1997, J CLIN ONCOL, V15, P76, DOI 10.1200/JCO.1997.15.1.76; Ratcliffe AJ, 2006, CURR OPIN DRUG DISC, V9, P595; SIDI Y, 1988, BRIT J CANCER, V58, P61, DOI 10.1038/bjc.1988.162; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Takebe N, 2006, MOL CANCER THER, V5, P457, DOI 10.1158/1535-7163.MCT-05-0340; TRICOT GJ, 1989, CANCER RES, V49, P3696; URIBEBOTERO G, 1977, AM J CLIN PATHOL, V67, P427; Wright DG, 1996, ANTICANCER RES, V16, P3349; Yalowitz JA, 2000, ANTICANCER RES, V20, P2329; Zimmermann A, 1996, ADV ENZYME REGUL, V36, P75, DOI 10.1016/0065-2571(95)00012-7	32	33	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12179	10.1371/journal.pone.0012179	http://dx.doi.org/10.1371/journal.pone.0012179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808934	Green Published, Green Submitted, gold			2022-12-25	WOS:000280968000010
J	Emre, N; Vidal, JG; Elia, J; O'Connor, ED; Paramban, RI; Hefferan, MP; Navarro, R; Goldberg, DS; Varki, NM; Marsala, M; Carson, CT				Emre, Nil; Vidal, Jason G.; Elia, Jeanne; O'Connor, Eric D.; Paramban, Rosanto I.; Hefferan, Michael P.; Navarro, Roman; Goldberg, Danielle S.; Varki, Nissi M.; Marsala, Martin; Carson, Christian T.			The ROCK Inhibitor Y-27632 Improves Recovery of Human Embryonic Stem Cells after Fluorescence-Activated Cell Sorting with Multiple Cell Surface Markers	PLOS ONE			English	Article							IN-VITRO; HUMAN BLASTOCYSTS; SURVIVAL; LINES; DIFFERENTIATION; DERIVATION; CRYOPRESERVATION; PLURIPOTENCY; GENERATION; CULTURE	Background: Due to the inherent sensitivity of human embryonic stem cells (hESCs) to manipulations, the recovery and survival of hESCs after fluorescence-activated cell sorting (FACS) can be low. Additionally, a well characterized and robust methodology for performing FACS on hESCs using multiple-cell surface markers has not been described. The p160-Rho-associated coiled kinase (ROCK) inhibitor, Y-27632, previously has been identified as enhancing survival of hESCs upon single-cell dissociation, as well as enhancing recovery from cryopreservation. Here we examined the application of Y-27632 to hESCs after FACS to improve survival in both feeder-dependent and feeder-independent growth conditions. Methodology/Principal Findings: HESCs were sorted using markers for SSEA-3, TRA-1-81, and SSEA-1. Cells were plated after sorting for 24 hours in either the presence or the absence of Y-27632. In both feeder-dependent and feeder-independent conditions, cell survival was greater when Y-27632 was applied to the hESCs after sort. Specifically, treatment of cells with Y-27632 improved post-sort recovery up to four fold. To determine the long-term effects of sorting with and without the application of Y-27632, hESCs were further analyzed. Specifically, hESCs sorted with and without the addition of Y-27632 retained normal morphology, expressed hESC-specific markers as measured by immunocytochemistry and flow cytometry, and maintained a stable karyotype. In addition, the hESCs could differentiate into three germ layers in vitro and in vivo in both feeder-dependent and feeder-independent growth conditions. Conclusions/Significance: The application of Y-27632 to hESCs after cell sorting improves cell recovery with no observed effect on pluripotency, and enables the consistent recovery of hESCs by FACS using multiple surface markers. This improved methodology for cell sorting of hESCs will aid many applications such as removal of hESCs from secondary cell types, identification and isolation of stem cell subpopulations, and generation of single cell clones. Finally, these results demonstrate an additional application of ROCK inhibition to hESC research.	[Emre, Nil; Vidal, Jason G.; Elia, Jeanne; Paramban, Rosanto I.; Carson, Christian T.] BD Biosci, La Jolla, CA USA; [O'Connor, Eric D.] Univ Calif San Diego, Human Embryon Stem Cell Core Facil, La Jolla, CA 92093 USA; [Hefferan, Michael P.; Navarro, Roman; Goldberg, Danielle S.; Marsala, Martin] Univ Calif San Diego, Sch Med, Dept Anesthesiol, La Jolla, CA 92093 USA; [Varki, Nissi M.] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Emre, N (corresponding author), BD Biosci, La Jolla, CA USA.	chistian_carson@bd.com			BD Biosciences; California Institute for Regenerative Medicine [RC1-00131-1-M.M.]	BD Biosciences; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This study was funded by BD Biosciences and the California Institute for Regenerative Medicine (RC1-00131-1-M.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; BAHARVAND H, NAT PROTOC, V5, P588; Bajpai R, 2008, MOL REPROD DEV, V75, P818, DOI 10.1002/mrd.20809; BRAAM SR, ANN N Y ACAD SCI, V1188, P52; BUENO C, STEM CELL REV; Carpenter MK, 2003, CLONING STEM CELLS, V5, P79, DOI 10.1089/153623003321512193; CLAASSEN DA, 2009, MOL REPROD DEV; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; FONG CY, 2009, STEM CELL REV; HENG BC, 2009, TISSUE CELL; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Kakinohana O, 2004, EXP NEUROL, V190, P122, DOI 10.1016/j.expneurol.2004.07.014; KING FW, 2009, STEM CELLS DEV; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; Krawetz RJ, 2009, BIOESSAYS, V31, P336, DOI 10.1002/bies.200800157; Li XY, 2008, STEM CELLS DEV, V17, P1079, DOI 10.1089/scd.2007.0247; Li XY, 2009, HUM REPROD, V24, P580, DOI 10.1093/humrep/den404; Lingor P, 2008, BRAIN, V131, P250, DOI 10.1093/brain/awm284; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Martin-Ibanez R, 2008, HUM REPROD, V23, P2744, DOI 10.1093/humrep/den316; MOLLAMOHAMMADI S, 2009, HUM REPROD; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Nicholas CR, 2007, STEM CELLS DEV, V16, P109, DOI 10.1089/scd.2006.0059; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; PAKZAD M, STEM CELL REV, V6, P96; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Peh GSL, 2009, STEM CELLS DEV, V18, P269, DOI 10.1089/scd.2008.0124; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sidhu KS, 2006, STEM CELLS DEV, V15, P61, DOI 10.1089/scd.2006.15.61; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Sundberg M, 2009, STEM CELL RES, V2, P113, DOI 10.1016/j.scr.2008.08.001; Takehara T, 2008, MOL HUM REPROD, V14, P627, DOI 10.1093/molehr/gan061; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trounson A, 2006, ENDOCR REV, V27, P208, DOI 10.1210/er.2005-0016; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Zhao DX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006468	45	48	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12148	10.1371/journal.pone.0012148	http://dx.doi.org/10.1371/journal.pone.0012148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730054	Green Submitted, gold, Green Published			2022-12-25	WOS:000280862200008
J	Ortigue, S; Sinigaglia, C; Rizzolatti, G; Grafton, ST				Ortigue, Stephanie; Sinigaglia, Corrado; Rizzolatti, Giacomo; Grafton, Scott T.			Understanding Actions of Others: The Electrodynamics of the Left and Right Hemispheres. A High-Density EEG Neuroimaging Study	PLOS ONE			English	Article							MIRROR-NEURON SYSTEM; AUTISM-SPECTRUM-DISORDERS; ELECTROMAGNETIC TOMOGRAPHY; SPATIOTEMPORAL DYNAMICS; MAGNETIC STIMULATION; ELECTRICAL-ACTIVITY; MOTOR FACILITATION; SOCIAL-INTERACTION; IDEOMOTOR APRAXIA; HAND ACTIONS	Background: When we observe an individual performing a motor act (e. g. grasping a cup) we get two types of information on the basis of how the motor act is done and the context: what the agent is doing (i.e. grasping) and the intention underlying it (i.e. grasping for drinking). Here we examined the temporal dynamics of the brain activations that follow the observation of a motor act and underlie the observer's capacity to understand what the agent is doing and why. Methodology/Principal Findings: Volunteers were presented with two-frame video-clips. The first frame (T0) showed an object with or without context; the second frame (T1) showed a hand interacting with the object. The volunteers were instructed to understand the intention of the observed actions while their brain activity was recorded with a high-density 128-channel EEG system. Visual event-related potentials (VEPs) were recorded time-locked with the frame showing the hand-object interaction (T1). The data were analyzed by using electrical neuroimaging, which combines a cluster analysis performed on the group-averaged VEPs with the localization of the cortical sources that give rise to different spatio-temporal states of the global electrical field. Electrical neuroimaging results revealed four major steps: 1) bilateral posterior cortical activations; 2) a strong activation of the left posterior temporal and inferior parietal cortices with almost a complete disappearance of activations in the right hemisphere; 3) a significant increase of the activations of the right temporo-parietal region with simultaneously co-active left hemispheric sources, and 4) a significant global decrease of cortical activity accompanied by the appearance of activation of the orbito-frontal cortex. Conclusions/Significance: We conclude that the early striking left hemisphere involvement is due to the activation of a lateralized action-observation/action execution network. The activation of this lateralized network mediates the understanding of the goal of object-directed motor acts (mirror mechanism). The successive right hemisphere activation indicates that this hemisphere plays an important role in understanding the intention of others.	[Ortigue, Stephanie; Grafton, Scott T.] Univ Calif Santa Barbara, Brain Electrodynam Lab 4D, Dept Pathol, Inst Collaborat Biotechnol,UCSB Brain Imaging Ctr, Santa Barbara, CA 93106 USA; [Ortigue, Stephanie] Syracuse Univ, Dept Psychol, Lab Adv Translat Neurosc, Cent New York Med Ctr, Syracuse, NY USA; [Sinigaglia, Corrado] Univ Milan, Dept Philosophy, Milan, Italy; [Rizzolatti, Giacomo] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Rizzolatti, Giacomo] Univ Parma, Ist Italiano Tecnol, I-43100 Parma, Italy	University of California System; University of California Santa Barbara; Syracuse University; University of Milan; University of Parma; Istituto Italiano di Tecnologia - IIT; University of Parma	Ortigue, S (corresponding author), Univ Calif Santa Barbara, Brain Electrodynam Lab 4D, Dept Pathol, Inst Collaborat Biotechnol,UCSB Brain Imaging Ctr, Santa Barbara, CA 93106 USA.	giacomo.rizzolatti@unipr.it	SINIGAGLIA, CORRADO/AGY-7196-2022; sinigaglia, corrado/AAI-2220-2021	SINIGAGLIA, CORRADO/0000-0002-3365-7522; 	Institute for Collaborative Biotechnologies, U.S. Army Research Office [DAAD19-03-D-0004]; IUAP [5/04]; Ministero dell'Istruzione, dell'Universita e della Ricerca; dalla Regione Emilia-Romagna	Institute for Collaborative Biotechnologies, U.S. Army Research Office; IUAP; Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); dalla Regione Emilia-Romagna	This study was supported in part by the Institute for Collaborative Biotechnologies through grant DAAD19-03-D-0004 from the U.S. Army Research Office to S. T. G., and by IUAP 5/04, and Ministero dell'Istruzione, dell'Universita e della Ricerca to G. R. and C. S., and dalla Regione Emilia-Romagna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2009, NEUROPSYCHOLOGIA, V47, P2593, DOI 10.1016/j.neuropsychologia.2009.05.006; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Bird G, 2007, P ROY SOC B-BIOL SCI, V274, P3027, DOI 10.1098/rspb.2007.1019; Boria S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005596; Borroni P, 2005, BRAIN RES, V1065, P115, DOI 10.1016/j.brainres.2005.10.034; Brandeis Daniel, 1995, Brain Topography, V8, P145, DOI 10.1007/BF01199778; Brass M, 2007, CURR BIOL, V17, P2117, DOI 10.1016/j.cub.2007.11.057; Brown KS, 2010, NEUROIMAGE, V49, P2401, DOI 10.1016/j.neuroimage.2009.10.011; Carruthers P., 1996, THEORIES THEORIES MI, DOI 10.1017/CBO9780511597985; Cattaneo L, 2007, P NATL ACAD SCI USA, V104, P17825, DOI 10.1073/pnas.0706273104; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; De Renzi E., 1999, CLIN EXPT NEUROPSYCH; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fecteau S, 2005, NEUROREPORT, V16, P1591, DOI 10.1097/01.wnr.0000179079.54906.1b; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Galati G, 2008, NEUROIMAGE, V40, P1274, DOI 10.1016/j.neuroimage.2007.12.044; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2009, DEV PSYCHOL, V45, P103, DOI 10.1037/a0014436; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gazzola V, 2007, CURR BIOL, V17, P1235, DOI 10.1016/j.cub.2007.06.045; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Hamilton AFD, 2008, CEREB CORTEX, V18, P1160, DOI 10.1093/cercor/bhm150; Hamilton AFD, 2007, NEUROPSYCHOLOGIA, V45, P1859, DOI 10.1016/j.neuropsychologia.2006.11.022; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; HEILMAN KM, 1982, NEUROLOGY, V32, P342, DOI 10.1212/WNL.32.4.342; Heilman KM., 2003, INT J CLIN NEUROPSYC; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Kilner JM, 2007, P NATL ACAD SCI USA, V104, P8683, DOI 10.1073/pnas.0702937104; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Lehmann D., 1987, HDB ELECTROENCEPHALO, V1, P309; Leighton J, 2008, NEUROPSYCHOLOGIA, V46, P1041, DOI 10.1016/j.neuropsychologia.2007.11.013; Lewis JW, 2006, NEUROSCIENTIST, V12, P211, DOI 10.1177/1073858406288327; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; Liepelt R, 2008, J EXP PSYCHOL HUMAN, V34, P578, DOI 10.1037/0096-1523.34.3.578; Liepelt R, 2008, NEUROIMAGE, V43, P784, DOI 10.1016/j.neuroimage.2008.08.007; Liepmann H, 1900, KRANKHEITSBILD APRAX; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Mahon BZ, 2007, NEURON, V55, P507, DOI 10.1016/j.neuron.2007.07.011; Malle BF, 2001, INTENTIONS INTENTION; Michel C.M., 2009, ELECT NEUROIMAGING; Michel CM, 1999, NEWS PHYSIOL SCI, V14, P206; Michel CM, 1999, J CLIN NEUROPHYSIOL, V16, P239, DOI 10.1097/00004691-199905000-00005; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Murray MM, 2004, NEUROIMAGE, V21, P125, DOI 10.1016/j.neuroimage.2003.09.035; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ortigue S, 2004, NEUROIMAGE, V21, P1242, DOI 10.1016/j.neuroimage.2003.11.007; Ortigue S., 2009, BMJ CASE REPORTS, V2009, DOI [10.1136/bcr.07.2008.0593, DOI 10.1136/BCR.07.2008.0593]; Ortigue S, 2008, NEUROIMAGE, V43, P337, DOI 10.1016/j.neuroimage.2008.07.059; Ortigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006962; Ortigue S, 2009, J SEX MED, V6, P1830, DOI 10.1111/j.1743-6109.2009.01271.x; Pascual-Marqui RD, 1999, PSYCHIAT RES-NEUROIM, V90, P169, DOI 10.1016/S0925-4927(99)00013-X; Pascual-Marqui RD., 1999, INT J BIOELECTROMAGN, V1, P1, DOI DOI 10.1186/1743-0003-5-25; PASCUALMARQUI RD, 1995, IEEE T BIO-MED ENG, V42, P658, DOI 10.1109/10.391164; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pazzaglia M, 2008, CURR BIOL, V18, P1766, DOI 10.1016/j.cub.2008.09.061; Peeters R, 2009, J NEUROSCI, V29, P11523, DOI 10.1523/JNEUROSCI.2040-09.2009; Pegna AJ, 2004, HUM BRAIN MAPP, V22, P300, DOI 10.1002/hbm.20039; PERRIN F, 1987, ELECTROEN CLIN NEURO, V66, P75, DOI 10.1016/0013-4694(87)90141-6; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1999, ARCH ITAL BIOL, V137, P85; RIZZOLATTI G, 1996, BRAIN RES COGN BRAIN, V3, P131, DOI DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2009, EXP BRAIN RES; Rizzolatti G, 2008, CURR OPIN NEUROBIOL, V18, P179, DOI 10.1016/j.conb.2008.08.001; Rizzolatti G, 2009, NAT CLIN PRACT NEURO, V5, P24, DOI 10.1038/ncpneuro0990; Rizzolatti Giacomo, 2008, MIRRORS BRAIN OUR MI; ROTHI LJG, 1985, J NEUROL NEUROSUR PS, V48, P207, DOI 10.1136/jnnp.48.3.207; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; SKRANDIES W, 1990, Brain Topography, V3, P137, DOI 10.1007/BF01128870; Southgate V, 2008, TRENDS COGN SCI, V12, P225, DOI 10.1016/j.tics.2008.03.005; Spinelli L, 2000, BRAIN TOPOGR, V13, P115, DOI 10.1023/A:1026607118642; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Thierry G, 2007, NAT NEUROSCI, V10, P505, DOI 10.1038/nn1864; Tunik E, 2008, J NEUROSCI, V28, P13615, DOI 10.1523/JNEUROSCI.3303-08.2008	78	81	84	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12160	10.1371/journal.pone.0012160	http://dx.doi.org/10.1371/journal.pone.0012160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730095	Green Published, gold			2022-12-25	WOS:000280862200016
J	Lujambio, A; Portela, A; Liz, J; Melo, SA; Rossi, S; Spizzo, R; Croce, CM; Calin, GA; Esteller, M				Lujambio, A.; Portela, A.; Liz, J.; Melo, S. A.; Rossi, S.; Spizzo, R.; Croce, C. M.; Calin, G. A.; Esteller, M.			CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer	ONCOGENE			English	Article						DNA methylation; CpG island; non-coding RNA; epigenetics	MICRORNA; GENES; METHYLATION; EPIGENETICS; SITES; CONTRIBUTES; EPIGENOMICS; SIGNATURES; MUTATIONS; ELEMENTS	Although only 1.5% of the human genome appears to code for proteins, much effort in cancer research has been devoted to this minimal fraction of our DNA. However, the last few years have witnessed the realization that a large class of non-coding RNAs (ncRNAs), named microRNAs, contribute to cancer development and progression by acting as oncogenes or tumor suppressor genes. Recent studies have also shown that epigenetic silencing of microRNAs with tumor suppressor features by CpG island hypermethylation is a common hallmark of human tumors. Thus, we wondered whether there were other ncRNAs undergoing aberrant DNA methylation-associated silencing in transformed cells. We focused on the transcribed-ultraconserved regions (T-UCRs), a subset of DNA sequences that are absolutely conserved between orthologous regions of the human, rat and mouse genomes and that are located in both intra-and intergenic regions. We used a pharmacological and genomic approach to reveal the possible existence of an aberrant epigenetic silencing pattern of T-UCRs by treating cancer cells with a DNA-demethylating agent followed by hybridization to an expression microarray containing these sequences. We observed that DNA hypomethylation induces release of T-UCR silencing in cancer cells. Among the T-UCRs that were reactivated upon drug treatment, Uc.160+, Uc283+A and Uc.346+ were found to undergo specific CpG island hypermethylation-associated silencing in cancer cells compared with normal tissues. The analysis of a large set of primary human tumors (n = 283) demonstrated that hypermethylation of the described T-UCR CpG islands was a common event among the various tumor types. Our finding that, in addition to microRNAs, another class of ncRNAs (T-UCRs) undergoes DNA methylation-associated inactivation in transformed cells supports a model in which epigenetic and genetic alterations in coding and non-coding sequences cooperate in human tumorigenesis. Oncogene (2010) 29, 6390-6401; doi:10.1038/onc.2010.361; published online 30 August 2010	[Esteller, M.] Hosp Duran & Reynals, Bellvitge Inst Biomed Res IDI BELL, Canc Epigenet & Biol Program, Barcelona 08907, Catalonia, Spain; [Rossi, S.; Spizzo, R.; Calin, G. A.] Texas State Univ, MD Anderson Canc Ctr, Houston, TX USA; [Croce, C. M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Esteller, M.] ICREA, Barcelona, Catalonia, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Texas State University System; Texas State University San Marcos; University of Texas System; UTMD Anderson Cancer Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; ICREA	Esteller, M (corresponding author), Hosp Duran & Reynals, Bellvitge Inst Biomed Res IDI BELL, Canc Epigenet & Biol Program, 08907 Hosp,3rd Floor,Avda Gran Via 199-203, Barcelona 08907, Catalonia, Spain.	mesteller@iconcologia.net	Calin, George/E-9390-2011; MELO, SONIA/H-8972-2013; Esteller, Manel/L-5956-2014; Spizzo, Riccardo/V-1057-2019; Young, Richard A/F-6495-2012	MELO, SONIA/0000-0002-2291-4263; Esteller, Manel/0000-0003-4490-6093; Spizzo, Riccardo/0000-0001-7772-0960; Young, Richard A/0000-0001-8855-8647; Portela, Anna/0000-0003-2184-2584; Calin, George/0000-0001-6704-5615; Lujambio, Amaia/0000-0002-2798-1481	Consolider [CSD2006-49]; CANCERDIP [HEALTH-F2-2007-200620]; Dr Josef Steiner Cancer Research Foundation; FPU;  [SAF2007-00027-65134]; ICREA Funding Source: Custom	Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CANCERDIP; Dr Josef Steiner Cancer Research Foundation; FPU(Spanish Government); ; ICREA(ICREA)	This work was supported by Grants SAF2007-00027-65134, Consolider CSD2006-49, CANCERDIP HEALTH-F2-2007-200620 and the Dr Josef Steiner Cancer Research Foundation. AL is supported by a FPU Fellowship. AP is a Sara Borell Postdoctoral Fellow. ME is an ICREA Research Professor.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ballestar E, 2003, EMBO J, V22, P6335, DOI 10.1093/emboj/cdg604; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Davalos V, 2010, CURR OPIN ONCOL, V22, P35, DOI 10.1097/CCO.0b013e328333dcbb; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; Han L, 2007, CANCER BIOL THER, V6, P1284; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Henikoff S, 2007, CANCER CELL, V12, P407, DOI 10.1016/j.ccr.2007.10.024; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Iwama H, 2007, FEBS LETT, V581, P1805, DOI 10.1016/j.febslet.2007.03.066; Jacinto FV, 2009, ONCOGENE, V28, P4212, DOI 10.1038/onc.2009.267; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Lin JC, 2007, CANCER CELL, V12, P432, DOI 10.1016/j.ccr.2007.10.014; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lujambio A, 2007, CELL CYCLE, V6, P1455; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Lujambio A, 2009, CELL CYCLE, V8, P377, DOI 10.4161/cc.8.3.7526; Mattick JS, 2003, BIOESSAYS, V25, P930, DOI 10.1002/bies.10332; McGarvey KM, 2008, CANCER RES, V68, P5753, DOI 10.1158/0008-5472.CAN-08-0700; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Nguyen CT, 2002, CANCER RES, V62, P6456; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rossi S, 2008, MAMM GENOME, V19, P526, DOI 10.1007/s00335-008-9119-8; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Spizzo R, 2009, CELL, V137, P586, DOI 10.1016/j.cell.2009.04.040; Takai Daiya, 2003, In Silico Biology, V3, P235; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Velculescu VE, 2008, CARCINOGENESIS, V29, P1087, DOI 10.1093/carcin/bgn096; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	60	145	151	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2010	29	48					6390	6401		10.1038/onc.2010.361	http://dx.doi.org/10.1038/onc.2010.361			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	688SW	20802525	Green Published, hybrid			2022-12-25	WOS:000284874700009
J	Astuti, P; Boutros, R; Ducommun, B; Gabrielli, B				Astuti, Puji; Boutros, Rose; Ducommun, Bernard; Gabrielli, Brian			Mitotic Phosphorylation of Cdc25B Ser(321) Disrupts 14-3-3 Binding to the High Affinity Ser(323) Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; SUBCELLULAR-LOCALIZATION; DEPENDENT DEGRADATION; DNA-DAMAGE; PHOSPHATASE; MITOSIS; A/CDK2; CHK1; ACTIVATION; TRIGGERS	Cdc25B is a key regulator of entry into mitosis, and its activity and localization are regulated by binding of the 14-3-3 dimer. There are three 14-3-3 binding sites on Cdc25B, with Ser(323) being the highest affinity binding and is highly homologous to the Ser(216) 14-3-3 binding site on Cdc25C. Loss of 14-3-3 binding to Ser(323) increases cyclin/Cdk substrate access to the catalytic site, thereby increasing its activity. It also affects the localization of Cdc25B. Thus, phosphorylation and 14-3-3 binding to this site is essential for down-regulating Cdc25B activity, blocking its mitosis promoting function. The question of how this inhibitory signal is relieved to allow Cdc25B activation and entry into mitosis is yet to be resolved. Here, we show that Ser(323) phosphorylation is maintained into mitosis, but phosphorylation of Ser(321) disrupts 14-3-3 binding to Ser(323), mimicking the effect of inhibiting Ser(323) phosphorylation on both Cdc25B activity and localization. The unphosphorylated Ser(321) appears to have a role in stabilizing 14-3-3 binding to Ser(323), and loss of the Ser hydroxyl group appears to be sufficient to significantly reduce 14-3-3 binding. A consequence of loss of 14-3-3 binding is dephosphorylation of Ser(323). Ser(321) is phosphorylated in mitosis by Cdk1. The mitotic phosphorylation of Ser(321) acts to maintain full activation of Cdc25B by disrupting 14-3-3 binding to Ser(323) and enhancing the dephosphorylation of Ser(323) to block 14-3-3 binding to this site.	Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld 4102, Australia; [Ducommun, Bernard] Univ Toulouse, LBCMCP, F-31062 Toulouse, France; [Ducommun, Bernard] CNRS, LBCMCP UMR5088, F-31062 Toulouse, France; [Ducommun, Bernard] CHU Purpan, F-31059 Toulouse, France; [Boutros, Rose] Childrens Med Res Inst, Westmead, NSW 2145, Australia	University of Queensland; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU de Toulouse; Children's Medical Research Institute - Australia		brianG@uq.edu.au	Gabrielli, Brian G/B-3655-2011; Astuti, Puji/GLV-5075-2022; DUCOMMUN, Bernard/B-3208-2008	Gabrielli, Brian G/0000-0003-3933-1651; Astuti, Puji/0000-0003-3316-6149; DUCOMMUN, Bernard/0000-0002-7126-8368; Boutros, Rose/0000-0001-9025-2057	National Health and Medical Research Council of Australia (NHMRC); Australian Research Council; AusAID	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); AusAID(Australian Aid (AusAID))	This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC) and the Australian Research Council.; Supported by a scholarship from AusAID.	Astuti P, 2009, J BIOL CHEM, V284, P33781, DOI 10.1074/jbc.M109.027516; ATHERTONFESSLER S, 1994, MOL BIOL CELL, V5, P989, DOI 10.1091/mbc.5.9.989; Baldin V, 1997, J BIOL CHEM, V272, P32731, DOI 10.1074/jbc.272.52.32731; Baldin V, 1997, ONCOGENE, V14, P2485, DOI 10.1038/sj.onc.1201063; Bouche JP, 2008, J PROTEOME RES, V7, P1264, DOI 10.1021/pr700623p; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Bugler B, 2006, MOL CANCER THER, V5, P1446, DOI 10.1158/1535-7163.MCT-06-0099; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; De Boer L, 2008, ONCOGENE, V27, P4261, DOI 10.1038/onc.2008.74; Forrest A, 2001, ONCOGENE, V20, P4393, DOI 10.1038/sj.onc.1204574; Forrest ARR, 1999, BIOCHEM BIOPH RES CO, V260, P510, DOI 10.1006/bbrc.1999.0870; Gabrielli BG, 1996, J CELL SCI, V109, P1081; Gabrielli BG, 1997, J BIOL CHEM, V272, P28607, DOI 10.1074/jbc.272.45.28607; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Giles N, 2003, J BIOL CHEM, V278, P28580, DOI 10.1074/jbc.M304027200; Goldstone S, 2001, ONCOGENE, V20, P921, DOI 10.1038/sj.onc.1204177; Isoda M, 2009, MOL BIOL CELL, V20, P2186, DOI 10.1091/mbc.E09-01-0008; Karlsson C, 1999, J CELL BIOL, V146, P573, DOI 10.1083/jcb.146.3.573; Lammer C, 1998, J CELL SCI, V111, P2445; Lindqvist A, 2004, J CELL SCI, V117, P4979, DOI 10.1242/jcs.01395; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Margolis SS, 2006, MOL BIOL CELL, V17, P1779, DOI 10.1091/mbc.E05-08-0751; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; ROSSOMANDO AJ, 1994, MOL CELL BIOL, V14, P1594, DOI 10.1128/MCB.14.3.1594; Schmitt E, 2006, J CELL SCI, V119, P4269, DOI 10.1242/jcs.03200; Sohn J, 2004, P NATL ACAD SCI USA, V101, P16437, DOI 10.1073/pnas.0407663101; SOHN J, 2005, J BIOCH */* BIOCHEMI, V44, P16563; STOKOE D, 1993, BIOCHEM J, V296, P843, DOI 10.1042/bj2960843; Theis-Febvre N, 2003, ONCOGENE, V22, P220, DOI 10.1038/sj.onc.1206107; Uchida S, 2004, J CELL SCI, V117, P3011, DOI 10.1242/jcs.01086; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Xu X, 1996, J BIOL CHEM, V271, P5118	33	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34364	34370		10.1074/jbc.M110.138412	http://dx.doi.org/10.1074/jbc.M110.138412			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801879	hybrid, Green Published			2022-12-25	WOS:000283659100010
J	Duggan, KC; Walters, MJ; Musee, J; Harp, JM; Kiefer, JR; Oates, JA; Marnett, LJ				Duggan, Kelsey C.; Walters, Matthew J.; Musee, Joel; Harp, Joel M.; Kiefer, James R.; Oates, John A.; Marnett, Lawrence J.			Molecular Basis for Cyclooxygenase Inhibition by the Non-steroidal Anti-inflammatory Drug Naproxen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPEROXIDE-H SYNTHASE-1; PROSTAGLANDIN H-2 SYNTHASE; ACTIVE-SITE; SELECTIVE-INHIBITION; ARACHIDONIC-ACID; STRUCTURAL BASIS; ARGININE 120; BINDING; CYCLO-OXYGENASE-2; DETERMINANTS	Naproxen ((S)-6-methoxy-alpha-methyl-2-naphthaleneacetic acid) is a powerful non-selective non-steroidal anti-inflammatory drug that is extensively used as a prescription and over-the-counter medication. Naproxen exhibits gastrointestinal toxicity, but its cardiovascular toxicity may be reduced compared with other drugs in its class. Despite the fact that naproxen has been marketed for many years, the molecular basis of its interaction with cyclooxygenase (COX) enzymes is unknown. We performed a detailed study of naproxen-COX-2 interactions using site-directed mutagenesis, structure-activity analysis, and x-ray crystallography. The results indicate that each of the pendant groups of the naphthyl scaffold are essential for COX inhibition, and only minimal substitutions are tolerated. Mutation of Trp-387 to Phe significantly reduced inhibition by naproxen, a result that appears unique to this inhibitor. Substitution of S or CH2 for the O atom of the p-methoxy group yielded analogs that were not affected by the W387F substitution and that exhibited increased COX-2 selectivity relative to naproxen. Crystallization and x-ray analysis yielded structures of COX-2 complexed to naproxen and its methylthio analog at 1.7 and 2.3 angstrom resolution, respectively. The combination of mutagenesis, structure analysis, and x-ray crystallography provided comprehensive information on the unique interactions responsible for naproxen binding to COX-2.	[Duggan, Kelsey C.; Walters, Matthew J.; Musee, Joel; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Dept Biochem,Vanderbilt Inst Chem Biol, AB Hancock Jr Mem Lab Canc Res,Ctr Mol Toxicol, Nashville, TN 37232 USA; [Duggan, Kelsey C.; Walters, Matthew J.; Musee, Joel; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Dept Chem,Vanderbilt Inst Chem Biol, AB Hancock Jr Mem Lab Canc Res,Ctr Mol Toxicol, Nashville, TN 37232 USA; [Duggan, Kelsey C.; Walters, Matthew J.; Musee, Joel; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Dept Pharmacol,Vanderbilt Inst Chem Biol, AB Hancock Jr Mem Lab Canc Res,Ctr Mol Toxicol, Nashville, TN 37232 USA; [Duggan, Kelsey C.; Walters, Matthew J.; Musee, Joel; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Harp, Joel M.] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Struct Biol Ctr, Nashville, TN 37232 USA; [Oates, John A.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Kiefer, James R.] Pfizer Inc, St Louis, MO 63141 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Pfizer	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem,Vanderbilt Inst Chem Biol, AB Hancock Jr Mem Lab Canc Res,Ctr Mol Toxicol, 23rd Ave S Pierce,850 RRB, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu		Kiefer, James/0000-0001-6317-0902	Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; National Institutes of Health [CA89450, GM15431, T90 DA022873]; NATIONAL CANCER INSTITUTE [R01CA089450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015431, P01GM015431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022873] Funding Source: NIH RePORTER	Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful to Pfizer Inc. and Karen Seibert for the release of internal protocols and reagents for the COX-2 crystallography. Data were collected at the Southeastern Regional Collaborative Access Team beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Life Sciences Collaborative Access Team Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor for the support of this research program (Grant 085P1000817). Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.; This work was supported, in whole or in part, by National Institutes of Health Research Grant CA89450 and Center Grant GM15431.; Supported by National Institutes of Health Training Grant T90 DA022873.	Arewang CJ, 2007, CARBOHYD RES, V342, P970, DOI 10.1016/j.carres.2007.01.014; Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; Blobaum AL, 2007, J BIOL CHEM, V282, P16379, DOI 10.1074/jbc.M609883200; Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Boutaud O, 2002, P NATL ACAD SCI USA, V99, P7130, DOI 10.1073/pnas.102588199; Capone ML, 2007, J PHARMACOL EXP THER, V322, P453, DOI 10.1124/jpet.107.122283; Colloc'h N, 2008, BIOPHYS J, V95, P2415, DOI 10.1529/biophysj.107.122184; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GANT TG, 2007, Patent No. 2007140189; Gierse JK, 1996, J BIOL CHEM, V271, P15810, DOI 10.1074/jbc.271.26.15810; Gierse JK, 1999, BIOCHEM J, V339, P607, DOI 10.1042/0264-6021:3390607; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; Gupta K, 2006, ACTA CRYSTALLOGR D, V62, P151, DOI 10.1107/S0907444905036309; HARRISON IT, 1970, J MED CHEM, V13, P203, DOI 10.1021/jm00296a008; Kalgutkar AS, 1998, SCIENCE, V280, P1268, DOI 10.1126/science.280.5367.1268; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; KOVA C, 2003, INORG CHEM */* A INO, V42, P2988; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; LANEUVILLE O, 1994, J PHARMACOL EXP THER, V271, P927; Loll PJ, 1996, BIOCHEMISTRY-US, V35, P7330, DOI 10.1021/bi952776w; Lubet RA, 2010, J UROLOGY, V183, P1598, DOI 10.1016/j.juro.2009.12.001; MCGETTIGAN P, 2006, D JAMA, V296, P1633; Miners JO, 1996, BIOCHEM PHARMACOL, V51, P1003, DOI 10.1016/0006-2952(96)85085-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Peretto I, 2005, J MED CHEM, V48, P5705, DOI 10.1021/jm0502541; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Prusakiewicz JJ, 2004, BIOCHEMISTRY-US, V43, P15439, DOI 10.1021/bi048534q; Ray WA, 2009, CIRC-CARDIOVASC QUAL, V2, P155, DOI 10.1161/CIRCOUTCOMES.108.805689; Rieke CJ, 1999, J BIOL CHEM, V274, P17109, DOI 10.1074/jbc.274.24.17109; ROME LH, 1975, W E P Natl Acad Sci, V72, P4863; Rowlinson SW, 2003, J BIOL CHEM, V278, P45763, DOI 10.1074/jbc.M305481200; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Selinsky BS, 2001, BIOCHEMISTRY-US, V40, P5172, DOI 10.1021/bi010045s; Steiner RA, 2010, P NATL ACAD SCI USA, V107, P657, DOI 10.1073/pnas.0909033107; Stevens AM, 1999, J CRYST GROWTH, V196, P350, DOI 10.1016/S0022-0248(98)00847-1; Stock N, 2006, BIOORG MED CHEM LETT, V16, P2219, DOI 10.1016/j.bmcl.2006.01.033; Thuresson ED, 2000, J BIOL CHEM, V275, P8501, DOI 10.1074/jbc.275.12.8501; VAGIN A, 1997, A J APPL CRYSTALLOGR, V30, P1022	38	154	161	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34950	34959		10.1074/jbc.M110.162982	http://dx.doi.org/10.1074/jbc.M110.162982			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810665	Green Published, hybrid			2022-12-25	WOS:000283659100069
J	Kale, AJ; McGlinchey, RP; Moore, BS				Kale, Andrew J.; McGlinchey, Ryan P.; Moore, Bradley S.			Characterization of 5-Chloro-5-Deoxy-D-Ribose 1-Dehydrogenase in Chloroethylmalonyl Coenzyme A Biosynthesis SUBSTRATE AND REACTION PROFILING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ARABINOSE METABOLISM; ARCHAEON SULFOLOBUS-SOLFATARICUS; GLUCOSE-DEHYDROGENASE; ALCOHOL-DEHYDROGENASE; ALTERNATIVE PATHWAY; STRUCTURAL BASIS; IDENTIFICATION; PROMISCUITY; LACTONASE; MECHANISM	SalM is a short-chain dehydrogenase/reductase enzyme from the marine actinomycete Salinispora tropica that is involved in the biosynthesis of chloroethylmalonyl-CoA, a novel halogenated polyketide synthase extender unit of the proteasome inhibitor salinosporamide A. SalM was heterologously overexpressed in Escherichia coli and characterized in vitro for its substrate specificity, kinetics, and reaction profile. A sensitive real-time C-13 NMR assay was developed to visualize the oxidation of 5-chloro-5-deoxy-D-ribose to 5-chloro-5-deoxy-D-ribono-gamma-lactone in an NAD(+)-dependent reaction, followed by spontaneous lactone hydrolysis to 5-chloro-5-deoxy-D-ribonate. Although short-chain dehydrogenase/reductase enzymes are widely regarded as metal-independent, a strong divalent metal cation dependence for Mg2+, Ca2+, or Mn2+ was observed with SalM. Oxidative activity was also measured with the alternative substrates D-erythrose and D-ribose, making SalM the first reported stereospecific non-phosphorylative ribose 1-dehydrogenase.	[Moore, Bradley S.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Marine Biotechnol & Biomed, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography	Moore, BS (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	bsmoore@ucsd.edu		Moore, Bradley/0000-0002-4652-1253	National Institutes of Health [CA127622]; NATIONAL CANCER INSTITUTE [R01CA127622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA127622 (to B. S. M.).	Angelov A, 2005, FEBS J, V272, P1054, DOI 10.1111/j.1742-4658.2004.04539.x; ANGYAL SJ, 1972, AUST J CHEM, V25, P1695, DOI 10.1071/CH9721695; Baker PJ, 2009, P NATL ACAD SCI USA, V106, P779, DOI 10.1073/pnas.0807529106; Blankenfeldt W, 2002, STRUCTURE, V10, P773, DOI 10.1016/S0969-2126(02)00770-0; Bonete MJ, 1996, FEBS LETT, V383, P227, DOI 10.1016/0014-5793(96)00235-9; Bouchez V, 1997, CARBOHYD RES, V300, P139, DOI 10.1016/S0008-6215(97)00044-X; Brouns SJJ, 2006, J BIOL CHEM, V281, P27378, DOI 10.1074/jbc.M605549200; Eustaquio AS, 2008, ANGEW CHEM INT EDIT, V47, P3936, DOI 10.1002/anie.200800177; Eustaquio AS, 2008, NAT CHEM BIOL, V4, P69, DOI 10.1038/nchembio.2007.56; Eustaquio AS, 2009, P NATL ACAD SCI USA, V106, P12295, DOI 10.1073/pnas.0901237106; Graninger M, 1999, J BIOL CHEM, V274, P25069, DOI 10.1074/jbc.274.35.25069; GULDER TA, 2010, ANGEW CHEM IN PRESS; HESTRIN S, 1949, J BIOL CHEM, V180, P249; Jacobsen NE, 2007, NMR SPECTROSCOPY EXPLAINED: SIMPLIFIED THEORY, APPLICATIONS AND EXAMPLES FOR ORGANIC CHEMISTRY AND STRUCTURAL BIOLOGY, P1, DOI 10.1002/9780470173350; JERMYN MA, 1960, BIOCHIM BIOPHYS ACTA, V37, P78, DOI 10.1016/0006-3002(60)90081-0; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Johnsen U, 2004, J BACTERIOL, V186, P6198, DOI 10.1128/JB.186.18.6198-6207.2004; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Lamble HJ, 2003, J BIOL CHEM, V278, P34066, DOI 10.1074/jbc.M305818200; MATHIAS AL, 1989, J BACTERIOL, V171, P5206, DOI 10.1128/jb.171.9.5206-5209.1989; Milburn CC, 2006, J BIOL CHEM, V281, P14796, DOI 10.1074/jbc.M601334200; Niefind K, 2003, J MOL BIOL, V327, P317, DOI 10.1016/S0022-2836(03)00081-0; Penn K, 2009, ISME J, V3, P1193, DOI 10.1038/ismej.2009.58; SCHER BM, 1966, ARCH BIOCHEM BIOPHYS, V116, P117, DOI 10.1016/0003-9861(66)90020-8; SCHIWARA HW, 1968, H-S Z PHYSIOL CHEM, V349, P1575, DOI 10.1515/bchm2.1968.349.2.1575; Stephens C, 2007, J BACTERIOL, V189, P2181, DOI 10.1128/JB.01438-06; SUZUKI Y, 1974, B CHEM SOC JPN, V47, P2077, DOI 10.1246/bcsj.47.2077; Tanaka Y, 2007, J BIOL CHEM, V282, P5770, DOI 10.1074/jbc.M607340200; Udwary DW, 2007, P NATL ACAD SCI USA, V104, P10376, DOI 10.1073/pnas.0700962104; Watanabe S, 2006, J BIOL CHEM, V281, P2612, DOI 10.1074/jbc.M506477200; Watanabe S, 2006, J BIOL CHEM, V281, P33521, DOI 10.1074/jbc.M606727200; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2	33	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33710	33717		10.1074/jbc.M110.153833	http://dx.doi.org/10.1074/jbc.M110.153833			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20736169	hybrid, Green Published			2022-12-25	WOS:000283354000016
J	Song, HW; Rohrs, H; Tan, M; Wohltmann, M; Ladenson, JH; Turk, J				Song, Haowei; Rohrs, Henry; Tan, Min; Wohltmann, Mary; Ladenson, Jack H.; Turk, John			Effects of Endoplasmic Reticulum Stress on Group VIA Phospholipase A(2) in Beta Cells Include Tyrosine Phosphorylation and Increased Association with Calnexin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; GROUP-VIA PHOSPHOLIPASE-A(2); PANCREATIC-ISLETS EXPRESS; SMOOTH-MUSCLE-CELLS; INDUCED APOPTOSIS; INSULINOMA CELLS; PROTEIN-KINASE; P388D(1) MACROPHAGES; CERAMIDE GENERATION; BINDING DOMAIN	The Group VIA phospholipase A(2) (iPLA(2)beta) hydrolyzes glycerophospholipids at the sn-2-position to yield a free fatty acid and a 2-lysophospholipid, and iPLA(2)beta has been reported to participate in apoptosis, phospholipid remodeling, insulin secretion, transcriptional regulation, and other processes. Induction of endoplasmic reticulum (ER) stress in beta-cells and vascular myocytes with SERCA inhibitors activates iPLA(2)beta, resulting in hydrolysis of arachidonic acid from membrane phospholipids, by a mechanism that is not well understood. Regulatory proteins interact with iPLA(2)beta, including the Ca2+/calmodulin-dependent protein kinase II beta, and we have characterized the iPLA(2)beta interactome further using affinity capture and LC/electrospray ionization/MS/MS. An iPLA(2)beta -FLAG fusion protein was expressed in an INS-1 insulinoma cell line and then adsorbed to an anti-FLAG matrix after cell lysis. iPLA(2)beta and any associated proteins were then displaced with FLAG peptide and analyzed by SDS-PAGE. Gel sections were digested with trypsin, and the resultant peptide mixtures were analyzed by LC/MS/MS with database searching. This identified 37 proteins that associate with iPLA(2)beta, and nearly half of them reside in ER or mitochondria. They include the ER chaperone calnexin, whose association with iPLA(2)beta increases upon induction of ER stress. Phosphorylation of iPLA(2)beta at Tyr(616) also occurs upon induction of ER stress, and the phosphoprotein associates with calnexin. The activity of iPLA(2)beta in vitro increases upon co-incubation with calnexin, and overexpression of calnexin in INS-1 cells results in augmentation of ER stress-induced, iPLA(2)beta-catalyzed hydrolysis of arachidonic acid from membrane phospholipids, reflecting the functional significance of the interaction. Similar results were obtained with mouse pancreatic islets.	[Song, Haowei; Tan, Min; Wohltmann, Mary; Turk, John] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Rohrs, Henry] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Rohrs, Henry] Washington Univ, Sch Med, Dept Chem, St Louis, MO 63110 USA; [Ladenson, Jack H.] Washington Univ, Sch Med, Div Lab & Genom Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Turk, J (corresponding author), Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, Campus Box 8127,660 S Euclid Ave, St Louis, MO 63110 USA.	jturk@DOM.wustl.edu			National Institutes of Health United States Public Health Service [R37-DK34388, P41-RR00954, P60-DK20579, P30-DK56341]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034388, P60DK020579, P30DK020579, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health United States Public Health Service Grants R37-DK34388, P41-RR00954, P60-DK20579, and P30-DK56341.	Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Balboa MA, 1997, J BIOL CHEM, V272, P8576, DOI 10.1074/jbc.272.13.8576; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Bao S, 2008, AM J PHYSIOL-ENDOC M, V294, pE217, DOI 10.1152/ajpendo.00474.2007; Bao S, 2007, J BIOL CHEM, V282, P27100, DOI 10.1074/jbc.M701316200; BOURGUIGNON LYW, 1995, J BIOL CHEM, V270, P7257, DOI 10.1074/jbc.270.13.7257; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Chao TSO, 1997, CANCER RES, V57, P3168; Chevet E, 2010, SEMIN CELL DEV BIOL, V21, P486, DOI 10.1016/j.semcdb.2009.12.005; deCarvalho MGS, 1996, J BIOL CHEM, V271, P6987, DOI 10.1074/jbc.271.12.6987; Delom F, 2007, APOPTOSIS, V12, P293, DOI 10.1007/s10495-006-0625-4; Dickson KM, 2002, P NATL ACAD SCI USA, V99, P9852, DOI 10.1073/pnas.152621799; Guerin R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006244; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Kordeli E, 1998, J CELL SCI, V111, P2197; Lei XY, 2007, BIOCHEMISTRY-US, V46, P10170, DOI 10.1021/bi700017z; Lei XY, 2010, BIOCHIMIE, V92, P627, DOI 10.1016/j.biochi.2010.01.005; Lei XY, 2010, J BIOL CHEM, V285, P6693, DOI 10.1074/jbc.M109.084293; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; Ma ZM, 2001, J BIOL CHEM, V276, P13198, DOI 10.1074/jbc.M010423200; Ma ZM, 2001, PROG NUCLEIC ACID RE, V67, P1, DOI 10.1016/S0079-6603(01)67023-5; Ma ZM, 1999, J BIOL CHEM, V274, P9607, DOI 10.1074/jbc.274.14.9607; Ma ZM, 1997, J BIOL CHEM, V272, P11118; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; Mohan C, 2009, CELL STRESS CHAPERON, V14, P49, DOI 10.1007/s12192-008-0054-0; Moon SH, 2008, J BIOL CHEM, V283, P33975, DOI 10.1074/jbc.M805817200; Moran JM, 2005, J BIOL CHEM, V280, P28162, DOI 10.1074/jbc.M500013200; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Myhill N, 2008, MOL BIOL CELL, V19, P2777, DOI 10.1091/mbc.E07-10-0995; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Nowatzke W, 1998, ENDOCRINOLOGY, V139, P4073, DOI 10.1210/en.139.10.4073; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; Owada S, 1999, J BIOL CHEM, V274, P2000, DOI 10.1074/jbc.274.4.2000; Pollock S, 2004, EMBO J, V23, P1020, DOI 10.1038/sj.emboj.7600119; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; Ramanadham S, 2003, BIOCHEMISTRY-US, V42, P13929, DOI 10.1021/bi034843p; Ramanadham S, 1999, J BIOL CHEM, V274, P13915, DOI 10.1074/jbc.274.20.13915; Ren GH, 2010, BBA-MOL CELL RES, V1803, P468, DOI 10.1016/j.bbamcr.2010.01.020; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Smani T, 2007, CIRC RES, V101, P1194, DOI 10.1161/CIRCRESAHA.107.159053; Song HW, 2006, BIOCHEMISTRY-US, V45, P6392, DOI 10.1021/bi060502a; Song HW, 2010, BBA-MOL CELL BIOL L, V1801, P547, DOI 10.1016/j.bbalip.2010.01.006; Song HW, 2004, J AM SOC MASS SPECTR, V15, P1780, DOI 10.1016/j.jasms.2004.08.012; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Takizawa T, 2004, J BIOCHEM, V136, P399, DOI 10.1093/jb/mvh133; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Tay HK, 2004, J BIOL CHEM, V279, P22505, DOI 10.1074/jbc.M308788200; Thammavongsa V, 2005, J BIOL CHEM, V280, P33497, DOI 10.1074/jbc.M503648200; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Turk J, 2004, CAN J PHYSIOL PHARM, V82, P824, DOI 10.1139/Y04-064; Wang ZP, 2005, J BIOL CHEM, V280, P6840, DOI 10.1074/jbc.M405287200; Williams SD, 2001, AM J PHYSIOL-HEART C, V281, pH168, DOI 10.1152/ajpheart.2001.281.1.H168; Wolf MJ, 1997, J BIOL CHEM, V272, P1522, DOI 10.1074/jbc.272.3.1522; Xie Z, 2007, J BIOL CHEM, V282, P25278, DOI 10.1074/jbc.M611206200; Yang HC, 1999, J NEUROCHEM, V73, P1278, DOI 10.1046/j.1471-4159.1999.0731278.x; Zhao ZS, 2010, ENDOCRINOLOGY, V151, P3038, DOI 10.1210/en.2010-0016	64	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33843	33857		10.1074/jbc.M110.153197	http://dx.doi.org/10.1074/jbc.M110.153197			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20732873	Green Published, hybrid			2022-12-25	WOS:000283354000031
J	Rahajeng, J; Giridharan, SSP; Naslavsky, N; Caplan, S				Rahajeng, Juliati; Giridharan, Sai S. P.; Naslavsky, Naava; Caplan, Steve			Collapsin Response Mediator Protein-2 (Crmp2) Regulates Trafficking by Linking Endocytic Regulatory Proteins to Dynein Motors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EH-DOMAIN; RECYCLING COMPARTMENT; ENDOSOMAL TRANSPORT; CYTOPLASMIC DYNEIN; FAMILY PROTEINS; PLASMA-MEMBRANE; GOLGI-COMPLEX; IN-VIVO; RME-1; BINDS	Endocytosis is a conserved cellular process in which nutrients, lipids, and receptors are internalized and transported to early endosomes, where they are sorted and either channeled to degradative pathways or recycled to the plasma membrane. MICAL-L1 and EHD1 are important regulatory proteins that control key endocytic transport steps. However, the precise mechanisms by which they mediate transport, and particularly the mode by which they connect to motor proteins, have remained enigmatic. Here we have identified the collapsin response mediator protein-2 (Crmp2) as an interaction partner of MICAL-L1 in non-neuronal cells. Crmp2 interacts with tubulin dimers and kinesin and negatively regulates dynein-based transport in neuronal cells, but its expression and function in non-neuronal cells have remained poorly characterized. Upon Crmp2 depletion, we observed dramatic relocalization of internalized transferrin (Tf) from peripheral vesicles to the endocytic recycling compartment (ERC), similar to the effect of depleting either MICAL-L1 or EHD1. Moreover, Tf relocalization to the ERC could be inhibited by interfering with microtubule polymerization, consistent with a role for uncoupled motor protein-based transport upon depletion of Crmp2, MICAL-L1, or EHD1. Finally, transfection of dynamitin, a component of the dynactin complex whose overexpression inhibits dynein activity, prevented the relocalization of internalized Tf to the ERC upon depletion of Crmp2, MICAL-L1, or EHD1. These data provide the first trafficking regulatory role for Crmp2 in non-neuronal cells and support a model in which Crmp2 is an important endocytic regulatory protein that links MICAL-L1.EHD1-based vesicular transport to dynein motors.	[Naslavsky, Naava] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Eppley Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Naslavsky, N (corresponding author), Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, 600 S 42nd St, Omaha, NE 68198 USA.	nnaslavsky@unmc.edu; scaplan@unmc.edu	giridharan, sai srinivas panapakkam/X-9083-2019		National Institutes of Health [R01GM074876, R01GM087455]; National Center for Research Resources [P20 RR018759]; Nebraska Department of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087455, R01GM074876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Nebraska Department of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM074876 (to S. C. and N. N.) and R01GM087455 (S. C.) and National Center for Research Resources Grant P20 RR018759 (to N. N.). This work was also supported by a grant from the Nebraska Department of Health (to N. N.).	Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Arimura N, 2009, J NEUROCHEM, V111, P380, DOI 10.1111/j.1471-4159.2009.06317.x; Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142; Chae YC, 2009, CELL SIGNAL, V21, P1818, DOI 10.1016/j.cellsig.2009.07.017; Chibalina MV, 2007, J CELL SCI, V120, P4278, DOI 10.1242/jcs.014217; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Henry GD, 2010, BIOCHEMISTRY-US, V49, P3381, DOI 10.1021/bi100065r; Horgan CP, 2010, BIOCHEM BIOPH RES CO, V394, P387, DOI 10.1016/j.bbrc.2010.03.028; Horgan CP, 2010, J CELL SCI, V123, P181, DOI 10.1242/jcs.052670; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; Jovic M, 2009, MOL BIOL CELL, V20, P2731, DOI 10.1091/mbc.E08-11-1102; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Kieken F, 2007, J BIOMOL NMR, V39, P323, DOI 10.1007/s10858-007-9196-0; Kieken F, 2010, J BIOL CHEM, V285, P8687, DOI 10.1074/jbc.M109.045666; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mayor S, 1998, EMBO J, V17, P4626, DOI 10.1093/emboj/17.16.4626; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Picciano JA, 2003, AM J PHYSIOL-CELL PH, V285, pC1009, DOI 10.1152/ajpcell.00140.2003; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Roland JT, 2007, MOL BIOL CELL, V18, P2828, DOI 10.1091/mbc.E07-02-0169; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Schonteich E, 2008, J CELL SCI, V121, P3824, DOI 10.1242/jcs.032441; Sharma M, 2009, MOL BIOL CELL, V20, P5181, DOI 10.1091/mbc.E09-06-0535; Sun Y, 2007, MOL BIOL CELL, V18, P4129, DOI 10.1091/mbc.E07-01-0080; Tahimic CGT, 2006, BIOCHEM BIOPH RES CO, V340, P1244, DOI 10.1016/j.bbrc.2005.12.132; Valente C, 2010, NAT CELL BIOL, V12, P635, DOI 10.1038/ncb0710-635; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; Wanschers B, 2008, CELL MOTIL CYTOSKEL, V65, P183, DOI 10.1002/cm.20254	41	46	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					31918	31922		10.1074/jbc.C110.166066	http://dx.doi.org/10.1074/jbc.C110.166066			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20801876	hybrid, Green Published			2022-12-25	WOS:000282683000004
J	Ulanet, DB; Hanahan, D				Ulanet, Danielle B.; Hanahan, Douglas			Loss of p19(Arf) Facilitates the Angiogenic Switch and Tumor Initiation in a Multi-Stage Cancer Model via p53-Dependent and Independent Mechanisms	PLOS ONE			English	Article							CELL-CYCLE ARREST; NF-KAPPA-B; ENDOTHELIAL-CELLS; TRANSGENIC MICE; MOUSE MODEL; SUPPRESSOR; ARF; P53; TUMORIGENESIS; APOPTOSIS	The Arf tumor suppressor acts as a sensor of oncogenic signals, countering aberrant proliferation in large part via activation of the p53 transcriptional program, though a number of p53-independent functions have been described. Mounting evidence suggests that, in addition to promoting tumorigenesis via disruptions in the homeostatic balance between cell proliferation and apoptosis of overt cancer cells, genetic alterations leading to tumor suppressor loss of function or oncogene gain of function can also incite tumor development via effects on the tumor microenvironment. In a transgenic mouse model of multi-stage pancreatic neuroendocrine carcinogenesis (PNET) driven by inhibition of the canonical p53 and Rb tumor suppressors with SV40 large T-antigen (Tag), stochastic progression to tumors is limited in part by a requirement for initiation of an angiogenic switch. Despite inhibition of p53 by Tag in this mouse PNET model, concomitant disruption of Arf via genetic knockout resulted in a significantly accelerated pathway to tumor formation that was surprisingly not driven by alterations in tumor cell proliferation or apoptosis, but rather via earlier activation of the angiogenic switch. In the setting of a constitutional p53 gene knockout, loss of Arf also accelerated tumor development, albeit to a lesser degree. These findings demonstrate that Arf loss of function can promote tumorigenesis via facilitating angiogenesis, at least in part, through p53-independent mechanisms.	[Ulanet, Danielle B.; Hanahan, Douglas] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Hanahan, Douglas] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Hanahan, Douglas] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Ulanet, DB (corresponding author), Agios Pharmaceut Inc, Cambridge, MA USA.	dh@epfl.ch			National Cancer Institute [R01CA45234]; A.P. Giannini Foundation for Medical Research; NATIONAL CANCER INSTITUTE [R01CA045234] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); A.P. Giannini Foundation for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a grant from the National Cancer Institute (D.H.; R01CA45234) and the A.P. Giannini Foundation for Medical Research (D.B.U.; http://www.apgianninifoundation.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Chen ZB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000053; CHRISTOFORI G, 1994, SEMIN CANCER BIOL, V5, P3; CHRISTOFORI G, 1994, NATURE, V369, P414, DOI 10.1038/369414a0; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Eymin B, 2003, ONCOGENE, V22, P1822, DOI 10.1038/sj.onc.1206303; Fatyol K, 2001, J BIOL CHEM, V276, P28421, DOI 10.1074/jbc.M102847200; FOLKMAN J, 2006, SCI STKE, pPE35; Fulci G, 2000, ONCOGENE, V19, P3816, DOI 10.1038/sj.onc.1203700; Giuriato S, 2006, P NATL ACAD SCI USA, V103, P16266, DOI 10.1073/pnas.0608017103; Ha L, 2007, P NATL ACAD SCI USA, V104, P10968, DOI 10.1073/pnas.0611638104; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Hemmati PG, 2002, ONCOGENE, V21, P3149, DOI 10.1038/sj.onc.1205458; Herzig M, 1999, BIOL CHEM, V380, P203, DOI 10.1515/BC.1999.028; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kawagishi H, 2010, CANCER RES, V70, P4749, DOI 10.1158/0008-5472.CAN-10-0368; Kelly-Spratt KS, 2004, PLOS BIOL, V2, P1138, DOI 10.1371/journal.pbio.0020242; LESSARD F, MOL CELL, V38, P539; Lopez T, 2002, CANCER CELL, V1, P339, DOI 10.1016/S1535-6108(02)00055-7; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; McKeller RN, 2002, P NATL ACAD SCI USA, V99, P3848, DOI 10.1073/pnas.052484199; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Normand G, 2005, J BIOL CHEM, V280, P7118, DOI 10.1074/jbc.M412330200; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; PARANGI S, 1995, CANCER RES, V55, P6071; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; QUELLE DE, 1995, CELL, V83, P993; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; Shchors K, 2007, CANCER RES, V67, P7059, DOI 10.1158/0008-5472.CAN-07-2053; Shchors K, 2006, GENE DEV, V20, P2527, DOI 10.1101/gad.1455706; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Silva RLA, 2005, EMBO J, V24, P2803, DOI 10.1038/sj.emboj.7600751; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Teodoro JG, 2006, SCIENCE, V313, P968, DOI 10.1126/science.1126391; Thornton JD, 2007, INVEST OPHTH VIS SCI, V48, P491, DOI 10.1167/iovs.06-0765; Tsuji K, 2002, BIOCHEM BIOPH RES CO, V295, P621, DOI 10.1016/S0006-291X(02)00723-4; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424; Zindy F, 2003, P NATL ACAD SCI USA, V100, P15930, DOI 10.1073/pnas.2536808100	48	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12454	10.1371/journal.pone.0012454	http://dx.doi.org/10.1371/journal.pone.0012454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805995	gold, Green Published, Green Submitted			2022-12-25	WOS:000281301500020
J	Watt, K; Waddle, E; Jhaveri, R				Watt, Kevin; Waddle, Erica; Jhaveri, Ravi			Changing Epidemiology of Serious Bacterial Infections in Febrile Infants without Localizing Signs	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; ESCHERICHIA-COLI SEPSIS; ANTIMICROBIAL RESISTANCE; PRACTICE GUIDELINES; RISK-FACTORS; MANAGEMENT; CHILDREN; FEVER; ERA; PROPHYLAXIS	Objective: Historically, management of infants with fever without localizing signs (FWLS) has generated much controversy, with attempts to risk stratify based on several criteria. Advances in medical practice may have altered the epidemiology of serious bacterial infections (SBIs) in this population. We conducted this study to test the hypothesis that the rate of SBIs in this patient population has changed over time. Patients and Methods: We performed a retrospective review of all infants meeting FWLS criteria at our institution from 1997-2006. We examined all clinical and outcome data and performed statistical analysis of SBI rates and ampicillin resistance rates. Results: 668 infants met criteria for FWLS. The overall rate of SBIs was 10.8%, with a significant increase from 2002-2006 (52/361, 14.4%) compared to 1997-2001 (20/307, 6.5%) (p = 0.001). This increase was driven by an increase in E. coli urinary tract infections (UTI), particularly in older infants (31-90 days). Conclusions: We observed a significant increase in E. coli UTI among FWLS infants with high rates of ampicillin resistance. The reasons are likely to be multifactorial, but the results themselves emphasize the need to examine urine in all febrile infants,<90days and consider local resistance patterns when choosing empiric antibiotics.	[Watt, Kevin; Waddle, Erica; Jhaveri, Ravi] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Waddle, Erica; Jhaveri, Ravi] Duke Univ, Med Ctr, Div Infect Dis, Durham, NC 27710 USA	Duke University; Duke University	Watt, K (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA.	ravi.jhaveri@duke.edu		Jhaveri, Ravi/0000-0001-9921-0419				Alarcon A, 2004, PEDIATR INFECT DIS J, V23, P295, DOI 10.1097/00006454-200404000-00004; BAKER MD, 1993, NEW ENGL J MED, V329, P1437, DOI 10.1056/NEJM199311113292001; Baraff LJ, 2000, ANN EMERG MED, V36, P602, DOI 10.1067/mem.2000.110820; BASKIN MN, 1992, J PEDIATR-US, V120, P22, DOI 10.1016/S0022-3476(05)80591-8; Belfer RA, 2001, PEDIATR EMERG CARE, V17, P83, DOI 10.1097/00006565-200104000-00001; Bizzarro MJ, 2008, PEDIATRICS, V121, P689, DOI 10.1542/peds.2007-2171; BROPHY JM, 1995, JAMA-J AM MED ASSOC, V273, P871, DOI 10.1001/jama.273.11.871; Byington CL, 2003, PEDIATRICS, V111, P964, DOI 10.1542/peds.111.5.964; *CDC, 2008, ACT BACT COR SUV REP; *CIRC REF LIB, 2004, INC CIRC STAT; CRAIN EF, 1982, J PEDIATR-US, V101, P686, DOI 10.1016/S0022-3476(82)80291-6; DAGAN R, 1985, J PEDIATR-US, V107, P855, DOI 10.1016/S0022-3476(85)80175-X; Glasgow TS, 2005, PEDIATRICS, V116, P696, DOI 10.1542/peds.2004-2421; Hyde TB, 2002, PEDIATRICS, V110, P690, DOI 10.1542/peds.110.4.690; JASKIEWICZ JA, 1994, PEDIATRICS, V94, P390; Johnson JR, 2002, J INFECT DIS, V186, P859, DOI 10.1086/342490; MARSHALL R, 1979, J PEDIATR-US, V95, P690, DOI 10.1016/S0022-3476(79)80712-X; MCGOWAN JE, 1973, NEW ENGL J MED, V288, P1309, DOI 10.1056/NEJM197306212882501; Pantell RH, 2004, JAMA-J AM MED ASSOC, V291, P1203, DOI 10.1001/jama.291.10.1203; Rentz AC, 2004, ARCH PEDIAT ADOL MED, V158, P556, DOI 10.1001/archpedi.158.6.556; ROBERTS KB, 1983, J PEDIATR-US, V103, P864, DOI 10.1016/S0022-3476(83)80702-1; Sadow KB, 1999, ARCH PEDIAT ADOL MED, V153, P611, DOI 10.1001/archpedi.153.6.611; Schrag SJ, 2006, PEDIATRICS, V118, P570, DOI 10.1542/peds.2005-3083; Singh-Grewal D, 2005, ARCH DIS CHILD, V90, P853, DOI 10.1136/adc.2004.049353; Watt S, 2003, J CLIN MICROBIOL, V41, P1929, DOI 10.1128/JCM.41.5.1929-1935.2003; WISWELL TE, 1992, J UROLOGY, V148, P739, DOI 10.1016/S0022-5347(17)36708-3; YOUNG PC, 1995, PEDIATRICS, V95, P623; Zangwill Kenneth M., 1992, Morbidity and Mortality Weekly Report, V41, P25; Zorc JJ, 2005, PEDIATRICS, V116, P644, DOI 10.1542/peds.2004-1825; 2007, MMWR MORB MORTAL WKL, V56, P701; 2005, MMWR MORB MORTAL WKL, V54, P1205	31	65	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12448	10.1371/journal.pone.0012448	http://dx.doi.org/10.1371/journal.pone.0012448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805983	Green Submitted, Green Published, gold			2022-12-25	WOS:000281301500014
J	Frere, CH; Krzyszczyk, E; Patterson, EM; Hunter, S; Ginsburg, A; Mann, J				Frere, Celine H.; Krzyszczyk, Ewa; Patterson, Eric M.; Hunter, Sue; Ginsburg, Alison; Mann, Janet			Thar She Blows! A Novel Method for DNA Collection from Cetacean Blow	PLOS ONE			English	Article							POPULATION-STRUCTURE; MITOCHONDRIAL-DNA; DOLPHINS; MICROSATELLITE; TESTOSTERONE; EVOLUTION; BEHAVIOR; SALIVA	Background: Molecular tools are now widely used to address crucial management and conservation questions. To date, dart biopsying has been the most commonly used method for collecting genetic data from cetaceans; however, this method has some drawbacks. Dart biopsying is considered inappropriate for young animals and has recently come under scrutiny from ethical boards, conservationists, and the general public. Thus, identifying alternative genetic collection techniques for cetaceans remains a priority, especially for internationally protected species. Methodology/Principal Findings: In this study, we investigated whether blow-sampling, which involves collecting exhalations from the blowholes of cetaceans, could be developed as a new less invasive method for DNA collection. Our current methodology was developed using six bottlenose dolphins, Tursiops truncatus, housed at the National Aquarium, Baltimore (USA), from which we were able to collect both blow and blood samples. For all six individuals, we found that their mitochondrial and microsatellite DNA profile taken from blow, matched their corresponding mitochondrial and microsatellite DNA profile collected from blood. This indicates that blow-sampling is a viable alternative method for DNA collection. Conclusion/Significance: In this study, we show that blow-sampling provides a viable and less invasive method for collection of genetic data, even for small cetaceans. In contrast to dart biopsying, the advantage of this method is that it capitalizes on the natural breathing behaviour of dolphins and can be applied to even very young dolphins. Both biopsy and blow-sampling require close proximity of the boat, but blow-sampling can be achieved when dolphins voluntarily bow-ride and involves no harmful contact.	[Frere, Celine H.] Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia; [Krzyszczyk, Ewa; Patterson, Eric M.; Mann, Janet] Georgetown Univ, Dept Biol, Washington, DC 20057 USA; [Krzyszczyk, Ewa; Patterson, Eric M.; Mann, Janet] Georgetown Univ, Dept Psychol, Washington, DC 20057 USA; [Hunter, Sue; Ginsburg, Alison] Natl Aquarium, Baltimore, MD USA	University of Queensland; Georgetown University; Georgetown University	Frere, CH (corresponding author), Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia.	c.frere@uq.edu.au	Mann, Janet/L-2311-2019; Frere, Celine Henria/B-4905-2013; Frere, Celine Henria/GYJ-3882-2022	Frere, Celine Henria/0000-0002-9671-2138; 	Georgetown University; National Science Foundation [0847922]	Georgetown University; National Science Foundation(National Science Foundation (NSF))	All research was approved and permitted through the Georgetown University Animal Care and Use Committee (Georgetown GUACUC 07-041). Funding was provided by Georgetown University and the National Science Foundation grant number 0847922. The authors thank the National Aquarium in Baltimore, USA for extensive logistical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2010, ANIM CONSERV, V13, P217, DOI 10.1111/j.1469-1795.2009.00326.x; Baker CS, 2010, BIOL LETTERS, V6, P647, DOI 10.1098/rsbl.2010.0239; BAKER CS, 1993, P NATL ACAD SCI USA, V90, P8239, DOI 10.1073/pnas.90.17.8239; Bearzi Giovanni, 2000, Journal of Cetacean Research and Management, V2, P217; Bernhard W, 2001, COMP BIOCHEM PHYS A, V129, P173, DOI 10.1016/S1095-6433(01)00314-2; BERTA A, 2006, MARINE MAMMALS EVOLU; Bilgmann K, 2008, ANIM CONSERV, V11, P518, DOI 10.1111/j.1469-1795.2008.00213.x; Cassens I, 2005, MOL ECOL, V14, P107, DOI 10.1111/j.1365-294X.2004.02407.x; CONNOR RC, 1985, J MAMMAL, V66, P398, DOI 10.2307/1381260; Frere CH, 2008, MAR FRESHWATER RES, V59, P259, DOI 10.1071/MF07120; Gero S, 2007, MAR MAMMAL SCI, V23, P398, DOI 10.1111/j.1748-7692.2007.00113.x; Gorgone AM, 2008, J WILDLIFE MANAGE, V72, P926, DOI 10.2193/2007-202; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harlin AD, 1999, MAR MAMMAL SCI, V15, P409, DOI 10.1111/j.1748-7692.1999.tb00810.x; Hogg CJ, 2005, J CHROMATOGR B, V814, P339, DOI 10.1016/j.jchromb.2004.10.058; HOGG CJ, 2005, THESIS U SYDNEY SYDN; Hooker SK, 2001, FISH B-NOAA, V99, P303; Jefferson Thomas A., 2008, Aquatic Mammals, V34, P310, DOI 10.1578/AM.34.3.2008.310; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; Krutzen M, 2004, MAR MAMMAL SCI, V20, P28, DOI 10.1111/j.1748-7692.2004.tb01139.x; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Parsons KM, 1999, MOL ECOL, V8, P1766, DOI 10.1046/j.1365-294x.1999.00723-8.x; PAULA AC, 2008, PAN AM J AQU SCI, V3, P130; Rosel PE, 2009, MOL ECOL, V18, P5030, DOI 10.1111/j.1365-294X.2009.04413.x; SMOLKER RA, 1992, BEHAVIOUR, V123, P38, DOI 10.1163/156853992X00101; Takemoto M, 2001, IEEE T IND APPL, V37, P26, DOI 10.1109/28.903123; Trout GJ, 2008, J CHROMATOGR B, V863, P192, DOI 10.1016/j.jchromb.2007.12.018; WARTZOK D, 2002, ENCY MAINE MAMMALS; Wells R., 1999, HDB MARINE MAMMALS, V6, P137; Wells R.S., 1991, P199; Wells R.S., 1987, Current Mammalogy, V1, P247	31	36	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12299	10.1371/journal.pone.0012299	http://dx.doi.org/10.1371/journal.pone.0012299			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811619	gold, Green Published			2022-12-25	WOS:000281234700005
J	Al-Anzi, B; Zinn, K				Al-Anzi, Bader; Zinn, Kai			Colorimetric Measurement of Triglycerides Cannot Provide an Accurate Measure of Stored Fat Content in Drosophila	PLOS ONE			English	Article							TRIACYLGLYCEROL; DIACYLGLYCEROLS	Drosophila melanogaster has recently emerged as a useful model system in which to study the genetic basis of regulation of fat storage. One of the most frequently used methods for evaluating the levels of stored fat (triglycerides) in flies is a coupled colorimetric assay available as a kit from several manufacturers. This is an aqueous-based enzymatic assay that is normally used for measurement of mammalian serum triglycerides, which are present in soluble lipoprotein complexes. In this short communication, we show that coupled colorimetric assay kits cannot accurately measure stored triglycerides in Drosophila. First, they fail to give accurate readings when tested on insoluble triglyceride mixtures with compositions like that of stored fat, or on fat extracted from flies with organic solvents. This is probably due to an inability of the lipase used in the kits to efficiently cleave off the glycerol head group from fat molecules in insoluble samples. Second, the measured final products of the kits are quinoneimines, which absorb visible light in the same wavelength range as Drosophila eye pigments. Thus, when extracts from crushed flies are assayed, much of the measured signal is actually due to eye pigments. Finally, the lipoprotein lipases used in colorimetric assays also cleave non-fat glycerides. The glycerol backbones liberated from all classes of glycerides are measured through the remaining reactions in the assay. As a consequence, when these assay kits are used to evaluate tissue extracts, the observed signal actually represents the amount of free glycerols together with all types of glycerides. For these reasons, findings obtained through use of coupled colorimetric assays on Drosophila samples must be interpreted with caution. We also show here that using thin-layer chromatography to measure stored triglycerides in flies eliminates all of these problems.	[Al-Anzi, Bader; Zinn, Kai] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Al-Anzi, B (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	zinnk@caltech.edu; alanzi@caltech.edu			NIH [DK0170154, NS28182]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH RO1 grants DK0170154, NS28182. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2009, NEURON, V63, P329, DOI 10.1016/j.neuron.2009.07.021; Barsh GS, 2002, NAT REV GENET, V3, P589, DOI [10.1038/nrn902, 10.1038/nrg862]; Bharucha KN, 2009, PEDIATR RES, V65, P132, DOI 10.1203/PDR.0b013e318191fc68; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Harbison ST, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006211; JUMBOLUCIONI P, 2010, SYSTEMS GENETICS ANA, V11, P297; MORLEY NH, 1975, J BIOL CHEM, V250, P3414; NILSSONEHLE P, 1974, LIPIDS, V9, P548, DOI 10.1007/BF02532503; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Schwartz DM, 2007, J LIPID RES, V48, P2514, DOI 10.1194/jlr.D700017-JLR200; Sieber MH, 2009, CELL METAB, V10, P481, DOI 10.1016/j.cmet.2009.10.010; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Song W, 2010, CELL METAB, V11, P427, DOI 10.1016/j.cmet.2010.04.002; Vieu C, 1996, J LIPID RES, V37, P1153; WOOD P, 2006, FAT WORKS, P38; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1	17	19	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12353	10.1371/journal.pone.0012353	http://dx.doi.org/10.1371/journal.pone.0012353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808765	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000281154300002
J	Tikhmyanova, N; Tulin, AV; Roegiers, F; Golemis, EA				Tikhmyanova, Nadezhda; Tulin, Alexei V.; Roegiers, Fabrice; Golemis, Erica A.			Dcas Supports Cell Polarization and Cell-Cell Adhesion Complexes in Development	PLOS ONE			English	Article							POLARITY GENE ARMADILLO; DROSOPHILA E-CADHERIN; CAS FAMILY-MEMBER; HUMAN B-CELLS; PROTEASOMAL DEGRADATION; ANTIGEN RECEPTOR; DOCKING PROTEIN; FILAMENTATION 1; HUMAN ENHANCER; BREAST-CANCER	Mammalian Cas proteins regulate cell migration, division and survival, and are often deregulated in cancer. However, the presence of four paraiogous Cas family members in mammals (BCAR1/p130Cas, EFS/Sin1, NEDD9/HEF1/Cas-L, and CASS4/HEPL) has limited their analysis in development. We deleted the single Drosophila Cas gene, Dcas, to probe the developmental function of Dcas. Loss of Dcas had limited effect on embryonal development. However, we found that Dcas is an important modulator of the severity of the developmental phenotypes of mutations affecting integrins (If and mew) and their downstream effectors Fak56D or Src42A. Strikingly, embryonic lethal Fak56D-Dcas double mutant embryos had extensive cell polarity defects, including mislocalization and reduced expression of E-cadherin. Further genetic analysis established that loss of Dcas modified the embryonal lethal phenotypes of embryos with mutations in E-cadherin (Shg) or its signaling partners p120- and beta-catenin (Arm). These results support an important role for Cas proteins in cell-cell adhesion signaling in development.	[Tikhmyanova, Nadezhda; Tulin, Alexei V.; Roegiers, Fabrice; Golemis, Erica A.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Tikhmyanova, Nadezhda] Drexel Univ, Sch Med, Dept Biochem, Philadelphia, PA 19104 USA	Fox Chase Cancer Center; Drexel University	Tikhmyanova, N (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Fabrice.Roegiers@fccc.edu; ea_golemis@fccc.edu		Golemis, Erica/0000-0003-3618-3673	National Institutes of Health (NIH) [CA63366, CA113342, CA06927]; Pennsylvania Tobacco Settlement Funds; Commonwealth of Pennsylvania; Pew Charitable Fund;  [R01 GM077452];  [R01 NS059971]; NATIONAL CANCER INSTITUTE [R01CA063366, R01CA113342, P30CA006927, R29CA063366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059971] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Tobacco Settlement Funds; Commonwealth of Pennsylvania; Pew Charitable Fund; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) R01s CA63366 and CA113342, and by Pennsylvania Tobacco Settlement Funds (to EAG), and by an appropriation from the Commonwealth of Pennsylvania, by NIH core grant CA06927 (to Fox Chase Cancer Center) and support from the Pew Charitable Fund (to Fox Chase Cancer Center). Alexei Tulin was supported by R01 GM077452, and FR by R01 NS059971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AQUINO JB, 2009, NEUROSCIENCE; Astier A, 1997, LEUKEMIA LYMPHOMA, V28, P65, DOI 10.3109/10428199709058332; Beaty TH, 2005, GENETICS, V171, P259, DOI 10.1534/genetics.105.043075; Bloor JW, 1998, GENETICS, V148, P1127; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Brinkman A, 2000, JNCI-J NATL CANCER I, V92, P112, DOI 10.1093/jnci/92.2.112; Bui LC, 2009, ONCOGENE, V28, P3642, DOI 10.1038/onc.2009.224; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Cai DP, 2003, J IMMUNOL, V170, P969, DOI 10.4049/jimmunol.170.2.969; Cary LA, 1998, J CELL BIOL, V140, P211, DOI 10.1083/jcb.140.1.211; CHO SY, 2002, J CELL BIOL IN PRESS; Cox RT, 1999, DEVELOPMENT, V126, P1327; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Donaldson JC, 2000, EXP CELL RES, V256, P168, DOI 10.1006/excr.2000.4822; Dumstrei K, 2002, DEVELOPMENT, V129, P3983; Fashena SJ, 2002, J CELL SCI, V115, P99; Feng Biao, 2004, Med Immunol, V3, P1, DOI 10.1186/1476-9433-3-1; Grabbe C, 2004, DEVELOPMENT, V131, P5795, DOI 10.1242/dev.01462; Honda H, 1999, BIOCHEM BIOPH RES CO, V262, P25, DOI 10.1006/bbrc.1999.1162; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Huang ZY, 2007, DEVELOPMENT, V134, P2337, DOI 10.1242/dev.004242; INAMOTO S, 2006, ONCOGENE; Ishino M, 1995, ONCOGENE, V11, P2331; Izumchenko E, 2009, CANCER RES, V69, P7198, DOI 10.1158/0008-5472.CAN-09-0795; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kim SH, 2010, CANCER RES, V70, P4054, DOI 10.1158/0008-5472.CAN-09-2110; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Law SF, 1996, MOL CELL BIOL, V16, P3327; Liu XH, 2000, EMBO J, V19, P6759, DOI 10.1093/emboj/19.24.6759; Lu XY, 1999, DEV BIOL, V208, P233, DOI 10.1006/dbio.1999.9196; LUCAS JT, 2010, ONCOGENE; Manie SN, 1997, J BIOL CHEM, V272, P4230, DOI 10.1074/jbc.272.7.4230; Minegishi M, 1996, J EXP MED, V184, P1365, DOI 10.1084/jem.184.4.1365; Murakami S, 2007, DEVELOPMENT, V134, P1539, DOI 10.1242/dev.001529; Myster SH, 2003, J CELL BIOL, V160, P433, DOI 10.1083/jcb.200211083; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; Natarajan M, 2003, CANCER J, V9, P126, DOI 10.1097/00130404-200303000-00008; Nourry C, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-20; O'Neill GM, 2007, CANCER RES, V67, P8975, DOI 10.1158/0008-5472.CAN-07-1328; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Reuver SM, 1998, J CELL SCI, V111, P1071; Rivera GM, 2006, P NATL ACAD SCI USA, V103, P9536, DOI 10.1073/pnas.0603786103; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sattler M, 1997, J BIOL CHEM, V272, P14320, DOI 10.1074/jbc.272.22.14320; Schock F, 2002, DEV BIOL, V248, P29, DOI 10.1006/dbio.2002.0698; Seo S, 2005, J IMMUNOL, V175, P3492, DOI 10.4049/jimmunol.175.6.3492; Shindo M, 2008, DEVELOPMENT, V135, P1355, DOI 10.1242/dev.015982; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Singh MK, 2008, MOL BIOL CELL, V19, P1627, DOI 10.1091/mbc.E07-09-0953; Singh MK, 2007, CELL BIOCHEM BIOPHYS, V48, P54, DOI 10.1007/s12013-007-0036-3; Takahashi M, 2005, DEVELOPMENT, V132, P2547, DOI 10.1242/dev.01850; Tateno M, 2000, SCIENCE, V287, P324, DOI 10.1126/science.287.5451.324; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; TIKHMYANOVA N, 2009, CELL MOL LIFE SCI; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; van der Flier S, 2000, JNCI-J NATL CANCER I, V92, P120, DOI 10.1093/jnci/92.2.120; van Seventer GA, 2001, EUR J IMMUNOL, V31, P1417, DOI 10.1002/1521-4141(200105)31:5<1417::AID-IMMU1417>3.0.CO;2-C; VOGEL T, 2009, CEREB CORTEX; WARN RM, 1983, EXP CELL RES, V143, P103, DOI 10.1016/0014-4827(83)90113-1; WIESCHAUS E, 1987, CELL, V49, P177, DOI 10.1016/0092-8674(87)90558-7; Wong EWP, 2008, P NATL ACAD SCI USA, V105, P9657, DOI 10.1073/pnas.0801527105; Xie HB, 2004, GENETICS, V168, P1477, DOI 10.1534/genetics.104.030882; Zheng MZ, 2002, J BIOL CHEM, V277, P39599, DOI 10.1074/jbc.M202263200	72	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12369	10.1371/journal.pone.0012369	http://dx.doi.org/10.1371/journal.pone.0012369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808771	Green Published, gold, Green Submitted			2022-12-25	WOS:000281154300010
J	Huang, MH; Lin, SC; Hsiao, CH; Chao, HJ; Yang, HR; Liao, CC; Chuang, PW; Wu, HP; Huang, CY; Leng, CH; Liu, SJ; Chen, HW; Chou, AH; Hu, AYC; Chong, PL				Huang, Ming-Hsi; Lin, Su-Chen; Hsiao, Chia-Hsin; Chao, Hsin-Ju; Yang, Hung-Ren; Liao, Chien-Chun; Chuang, Po-Wei; Wu, Huang-Pi; Huang, Chiung-Yi; Leng, Chih-Hsiang; Liu, Shih-Jen; Chen, Hsin-Wei; Chou, Ai-Hsiang; Hu, Alan Yung-Chih; Chong, Pele			Emulsified Nanoparticles Containing Inactivated Influenza Virus and CpG Oligodeoxynucleotides Critically Influences the Host Immune Responses in Mice	PLOS ONE			English	Article							EFFECTIVE DELIVERY-SYSTEM; VACCINE ADJUVANTS; POTENT ANTIBODY; SAFETY	Background: Antigen sparing and cross-protective immunity are regarded as crucial in pandemic influenza vaccine development. Both targets can be achieved by adjuvantation strategy to elicit a robust and broadened immune response. We assessed the immunogenicity of an inactivated H5N1 whole-virion vaccine (A/Vietnam/1194/2004 NIBRG-14, clade 1) formulated with emulsified nanoparticles and investigated whether it can induce cross-clade protecting immunity. Methodology/Principal Findings: After formulation with PELC, a proprietary water-in-oil-in-water nanoemulsion comprising of bioresorbable polymer/Span (R) 85/squalene, inactivated virus was intramuscularly administered to mice in either one-dose or two-dose schedule. We found that the antigen-specific serum antibody responses elicited after two doses of non-adjuvanted vaccine were lower than those observed after a single dose of adjuvanted vaccine, PELC and the conventional alum adjuvant as well. Moreover, 5 mu g HA of PELC-formulated inactivated virus were capable of inducing higher antibodies than those obtained from alum-adjuvanted vaccine. In single-dose study, we found that encapsulating inactivated virus into emulsified PELC nanoparticles could induce better antibody responses than those formulated with PELC-adsorbed vaccine. However, the potency was rather reduced when the inactivated virus and CpG (an immunostimulatory oligodeoxynucleotide containing unmethylated cytosine-guanosine motifs) were co-encapsulated within the emulsion. Finally, the mice who received PELC/CpG(adsorption)-vaccine could easily and quickly reach 100% of seroprotection against a homologous virus strain and effective cross-protection against a heterologous virus strain (A/Whooper swan/Mongolia/244/2005, clade 2.2). Conclusions/Significance: Encapsulating inactivated H5N1 influenza virus and CpG into emulsified nanoparticles critically influences the humoral responses against pandemic influenza. These results demonstrated that the use of PELC could be as antigen-sparing in preparation for a potential shortage of prophylactic vaccines against local infectious diseases, in particular pandemic influenza. Moreover, the cross-clade neutralizing antibody responses data verify the potential of such adjuvanted H5N1 candidate vaccine as an effective tool in pre-pandemic preparedness.	[Huang, Ming-Hsi; Lin, Su-Chen; Hsiao, Chia-Hsin; Chao, Hsin-Ju; Yang, Hung-Ren; Liao, Chien-Chun; Chuang, Po-Wei; Wu, Huang-Pi; Huang, Chiung-Yi; Leng, Chih-Hsiang; Liu, Shih-Jen; Chen, Hsin-Wei; Chou, Ai-Hsiang; Hu, Alan Yung-Chih; Chong, Pele] Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan Town, Taiwan	National Health Research Institutes - Taiwan	Huang, MH (corresponding author), Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan Town, Taiwan.	huangminghsi@nhri.org.tw; pelechong@nhri.org.tw	Hu, Alan Yung-Chih/G-3708-2011; Chen, Hsin-Wei/C-3304-2009; Huang, Ming-Hsi/E-3872-2010; Chen, Hsin-Wei/ABA-7436-2021; Liu, Shih-Jen/E-3942-2010; Liu, Shih-Jen/AAV-1931-2021; Leng, Chih-Hsiang/E-3874-2010; Chong, Pele/E-3855-2010	Huang, Ming-Hsi/0000-0002-9670-3821; Chen, Hsin-Wei/0000-0002-3207-2397; Liu, Shih-Jen/0000-0002-8736-1452; 	Department of Health [98A1-VCSPBC]; Taiwan Centers for Disease Control, Taiwan [97A1-VCSP31-019]; National Science Council [NSC-99-2218-E-400-001]	Department of Health; Taiwan Centers for Disease Control, Taiwan; National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by Department of Health (grant no. 98A1-VCSPBC) to the Vaccine Research and Development Center, National Health Research Institutes, and by the Taiwan Centers for Disease Control, Taiwan pandemic influenza vaccine research and development program (grant no. 97A1-VCSP31-019), and from National Science Council (to MHH, grant no. NSC-99-2218-E-400-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WHO REC PAND H1N1 20; Aucouturier Jerome, 2002, Expert Rev Vaccines, V1, P111, DOI 10.1586/14760584.1.1.111; Baudner BC, 2009, PHARM RES-DORDR, V26, P1477, DOI 10.1007/s11095-009-9859-5; Cooper CL, 2004, VACCINE, V22, P3136, DOI 10.1016/j.vaccine.2004.01.058; Del Giudice G, 2006, CLIN VACCINE IMMUNOL, V13, P1010, DOI 10.1128/CVI.00191-06; Garcon N, 2009, SCI AM, V301, P72, DOI 10.1038/scientificamerican1009-72; Gupta RK, 1998, ADV DRUG DELIVER REV, V32, P155, DOI 10.1016/S0169-409X(98)00008-8; Hu AYC, 2008, VACCINE, V26, P5736, DOI 10.1016/j.vaccine.2008.08.015; Huang MH, 2009, MICROBES INFECT, V11, P654, DOI 10.1016/j.micinf.2009.03.003; Huang MH, 2009, PHARM RES-DORD, V26, P1856, DOI 10.1007/s11095-009-9898-y; Huang MH, 2009, J BIOMED MATER RES B, V90B, P832, DOI 10.1002/jbm.b.31352; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Kovacs-Nolan J, 2009, VACCINE, V27, P2055, DOI 10.1016/j.vaccine.2009.01.118; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Newman MJ, 1998, ADV DRUG DELIVER REV, V32, P199, DOI 10.1016/S0169-409X(98)00011-8; Ninomiya A, 2007, VACCINE, V25, P3554, DOI 10.1016/j.vaccine.2007.01.083; Schubert C, 2009, NAT MED, V15, P984, DOI [10.1038/nm0909-986, 10.1038/nm0909-985, 10.1038/nm0909-984]; Schultze V, 2008, VACCINE, V26, P3209, DOI 10.1016/j.vaccine.2008.03.093; Singh M, 2001, PHARM RES-DORDR, V18, P1476, DOI 10.1023/A:1012269226066; Weeratna RD, 2000, VACCINE, V18, P1755, DOI 10.1016/S0264-410X(99)00526-5; WHO, 2010, ANT GEN CHAR INFL A	22	37	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12279	10.1371/journal.pone.0012279	http://dx.doi.org/10.1371/journal.pone.0012279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808862	Green Published, gold, Green Submitted			2022-12-25	WOS:000281075500013
J	Lee, S; Lee, J; Hohng, S				Lee, Sanghwa; Lee, Jinwoo; Hohng, Sungchul			Single-Molecule Three-Color FRET with Both Negligible Spectral Overlap and Long Observation Time	PLOS ONE			English	Article							ALTERNATING-LASER EXCITATION; RESONANCE ENERGY-TRANSFER; HOLLIDAY JUNCTION; SPECTROSCOPY; DYNAMICS	Full understanding of complex biological interactions frequently requires multi-color detection capability in doing single-molecule fluorescence resonance energy transfer (FRET) experiments. Existing single-molecule three-color FRET techniques, however, suffer from severe photobleaching of Alexa 488, or its alternative dyes, and have been limitedly used for kinetics studies. In this work, we developed a single-molecule three-color FRET technique based on the Cy3-Cy5-Cy7 dye trio, thus providing enhanced observation time and improved data quality. Because the absorption spectra of three fluorophores are well separated, real-time monitoring of three FRET efficiencies was possible by incorporating the alternating laser excitation (ALEX) technique both in confocal microscopy and in total-internal-reflection fluorescence (TIRF) microscopy.	[Lee, Sanghwa; Lee, Jinwoo; Hohng, Sungchul] Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea; [Hohng, Sungchul] Seoul Natl Univ, Dept Biophys & Chem Biol, Seoul, South Korea; [Lee, Sanghwa; Lee, Jinwoo; Hohng, Sungchul] Seoul Natl Univ, Natl Ctr Creat Res Initiat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, S (corresponding author), Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea.	shohng@snu.ac.kr		Hohng, Sungchul/0000-0002-7131-2138; Lee, Sanghwa/0000-0001-6986-7583	Creative Research Initiatives (Physical Genetics Laboratory) of National Research Foundation of Korea [2009-0081562]; World Class University, Ministry of Education, Science & Technology of Korea [R31-2009-100320]; Seoul Scholarship Foundation	Creative Research Initiatives (Physical Genetics Laboratory) of National Research Foundation of Korea; World Class University, Ministry of Education, Science & Technology of Korea; Seoul Scholarship Foundation	This work was supported by Creative Research Initiatives (Physical Genetics Laboratory, 2009-0081562) of National Research Foundation of Korea, and by the World Class University project (R31-2009-100320) of the Ministry of Education, Science & Technology of Korea, and by Hi Seoul Science (Humanities) Fellowship from Seoul Scholarship Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Clamme JP, 2005, CHEMPHYSCHEM, V6, P74, DOI 10.1002/cphc.200400261; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; DUCKETT DR, 1988, CELL, V55, P79, DOI 10.1016/0092-8674(88)90011-6; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; Hohng S, 2004, BIOPHYS J, V87, P1328, DOI 10.1529/biophysj.104.043935; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; Iqbal A, 2008, P NATL ACAD SCI USA, V105, P11176, DOI 10.1073/pnas.0801707105; Joo C, 2004, J MOL BIOL, V341, P739, DOI 10.1016/j.jmb.2004.06.024; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Lee M, 2010, P NATL ACAD SCI USA, V107, P4985, DOI 10.1073/pnas.0911528107; Lee NK, 2007, BIOPHYS J, V92, P303, DOI 10.1529/biophysj.106.093211; Margeat E, 2006, BIOPHYS J, V90, P1419, DOI 10.1529/biophysj.105.069252; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; MURCHIE AIH, 1989, NATURE, V341, P763, DOI 10.1038/341763a0; Ortiz-Lombardia M, 1999, NAT STRUCT BIOL, V6, P913; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Ross J, 2007, J PHYS CHEM B, V111, P321, DOI 10.1021/jp066082g; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Shroff H, 2005, NANO LETT, V5, P1509, DOI 10.1021/nl050875h; Tarsa PB, 2007, ANGEW CHEM INT EDIT, V46, P1999, DOI 10.1002/anie.200604546	22	77	82	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12270	10.1371/journal.pone.0012270	http://dx.doi.org/10.1371/journal.pone.0012270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808851	Green Published, gold, Green Submitted			2022-12-25	WOS:000281075500009
J	Watanabe, TM; Iwane, AH; Tanaka, H; Ikebe, M; Yanagida, T				Watanabe, Tomonobu M.; Iwane, Atsuko H.; Tanaka, Hiroto; Ikebe, Mitsuo; Yanagida, Toshio			Mechanical Characterization of One-Headed Myosin-V Using Optical Tweezers	PLOS ONE			English	Article							MOTOR DOMAIN DETERMINES; HAND-OVER-HAND; MOLECULAR MOTORS; PROCESSIVE MOVEMENT; STEPPING KINETICS; ACTIN-FILAMENT; SINGLE; FORCE; STEPS; BINDING	Class V myosin (myosin-V) is a cargo transporter that moves along an actin filament with large (similar to 36-nm) successive steps. It consists of two heads that each includes a motor domain and a long (23 nm) neck domain. One of the more popular models describing these steps, the hand-over-hand model, assumes the two-headed structure is imperative. However, we previously succeeded in observing successive large steps by one-headed myosin-V upon optimizing the angle of the actomyosin interaction. In addition, it was reported that wild type myosin-VI and myosin-IX, both one-headed myosins, can also generate successive large steps. Here, we describe the mechanical properties (stepsize and stepping kinetics) of successive large steps by one-headed and two-headed myosin-Vs. This study shows that the stepsize and stepping kinetics of one-headed myosin-V are very similar to those of the two-headed one. However, there was a difference with regards to stability against load and the number of multisteps. One-headed myosin-V also showed unidirectional movement that like two-headed myosin-V required 3.5 k(B)T from ATP hydrolysis. This value is also similar to that of smooth muscle myosin-II, a non-processive motor, suggesting the myosin family uses a common mechanism for stepping regardless of the steps being processive or non-processive. In this present paper, we conclude that one-headed myosin-V can produce successive large steps without following the hand-over-hand mechanism.	[Watanabe, Tomonobu M.; Yanagida, Toshio] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Watanabe, Tomonobu M.; Ikebe, Mitsuo] Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA USA; [Iwane, Atsuko H.; Yanagida, Toshio] Osaka Univ, Grad Sch Frontier Biosci, Soft Biosyst Grp, Labs Nanobiol, Suita, Osaka, Japan; [Tanaka, Hiroto] Natl Inst Informat & Commun Technol, Kobe Adv ICT Res Ctr, Kobe, Hyogo, Japan	Osaka University; University of Massachusetts System; University of Massachusetts Worcester; Osaka University; National Institute of Information & Communications Technology (NICT) - Japan	Watanabe, TM (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan.	Hyanagida@phys1.med.osaka-u.ac.jp	Watanabe, Tomonobu/J-4812-2013	Watanabe, Tomonobu/0000-0002-2420-4230; Iwane, Atsuko/0000-0003-2641-2268	National Institutes of Health (NIH) [DC006103, AR048526, AR048898]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048526, R01AR048898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006103] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) Grants DC006103, AR048526 and AR048898 (http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; Clemen AEM, 2005, BIOPHYS J, V88, P4402, DOI 10.1529/biophysj.104.053504; CRAIG SW, 1982, METHOD ENZYMOL, V85, P316; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Forgacs E, 2008, J BIOL CHEM, V283, P766, DOI 10.1074/jbc.M704313200; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; Homma K, 2001, NATURE, V412, P831, DOI 10.1038/35090597; Ishijima A, 1998, CELL, V92, P161, DOI 10.1016/S0092-8674(00)80911-3; Iwaki M, 2006, BIOPHYS J, V90, P3643, DOI 10.1529/biophysj.105.075721; Iwaki M, 2009, NAT CHEM BIOL, V5, P403, DOI 10.1038/nchembio.171; Kad NM, 2008, J BIOL CHEM, V283, P17477, DOI 10.1074/jbc.M800539200; Kitamura Kazuo, 2005, Biophysics (Nagoya-shi), V1, P1, DOI 10.2142/biophysics.1.1; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Nishikawa M, 2006, BIOCHEM BIOPH RES CO, V343, P1159, DOI 10.1016/j.bbrc.2006.03.057; Nishiyama M, 2002, NAT CELL BIOL, V4, P790, DOI 10.1038/ncb857; Oguchi Y, 2008, P NATL ACAD SCI USA, V105, P7714, DOI 10.1073/pnas.0800564105; Park H, 2007, Q REV BIOPHYS, V40, P87, DOI 10.1017/S0033583507004611; Purcell TJ, 2002, P NATL ACAD SCI USA, V99, P14159, DOI 10.1073/pnas.182539599; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2008, NATURE, V455, P128, DOI 10.1038/nature07188; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; Steffen W, 2001, P NATL ACAD SCI USA, V98, P14949, DOI 10.1073/pnas.261560698; Tanaka H, 1998, BIOPHYS J, V75, P1886, DOI 10.1016/S0006-3495(98)77629-5; Tanaka H, 2002, NATURE, V415, P192, DOI 10.1038/415192a; Taniguchi Y, 2005, NAT CHEM BIOL, V1, P342, DOI 10.1038/nchembio741; Thompson RF, 2002, ANAT RECORD, V268, P276, DOI 10.1002/ar.10160; Toprak E, 2006, P NATL ACAD SCI USA, V103, P6495, DOI 10.1073/pnas.0507134103; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Warshaw DM, 2005, BIOPHYS J, V88, pL30, DOI 10.1529/biophysj.105.061903; Watanabe TM, 2004, P NATL ACAD SCI USA, V101, P9630, DOI 10.1073/pnas.0402914101; Yanagida T, 2008, PHILOS T R SOC B, V363, P2123, DOI 10.1098/rstb.2008.2265; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	42	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12224	10.1371/journal.pone.0012224	http://dx.doi.org/10.1371/journal.pone.0012224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805877	Green Published, gold, Green Submitted			2022-12-25	WOS:000281011600009
J	Castiello, U; Giordano, BL; Begliomini, C; Ansuini, C; Grassi, M				Castiello, Umberto; Giordano, Bruno L.; Begliomini, Chiara; Ansuini, Caterina; Grassi, Massimo			When Ears Drive Hands: The Influence of Contact Sound on Reaching to Grasp	PLOS ONE			English	Article							AUDITORY EVENT PERCEPTION; FEEDBACK-CONTROL; MIRROR NEURONS; MOVEMENTS; IDENTIFICATION; REPRESENTATION; PREHENSION; LOCATION; VISION; PLATES	Background: Most research on the roles of auditory information and its interaction with vision has focused on perceptual performance. Little is known on the effects of sound cues on visually-guided hand movements. Methodology/Principal Findings: We recorded the sound produced by the fingers upon contact as participants grasped stimulus objects which were covered with different materials. Then, in a further session the pre-recorded contact sounds were delivered to participants via headphones before or following the initiation of reach-to-grasp movements towards the stimulus objects. Reach-to-grasp movement kinematics were measured under the following conditions: (i) congruent, in which the presented contact sound and the contact sound elicited by the to-be-grasped stimulus corresponded; (ii) incongruent, in which the presented contact sound was different to that generated by the stimulus upon contact; (iii) control, in which a synthetic sound, not associated with a real event, was presented. Facilitation effects were found for congruent trials; interference effects were found for incongruent trials. In a second experiment, the upper and the lower parts of the stimulus were covered with different materials. The presented sound was always congruent with the material covering either the upper or the lower half of the stimulus. Participants consistently placed their fingers on the half of the stimulus that corresponded to the presented contact sound. Conclusions/Significance: Altogether these findings offer a substantial contribution to the current debate about the type of object representations elicited by auditory stimuli and on the multisensory nature of the sensorimotor transformations underlying action.	[Castiello, Umberto; Begliomini, Chiara; Ansuini, Caterina; Grassi, Massimo] Univ Padua, Dipartimento Psicol Gen, Padua, Italy; [Giordano, Bruno L.] McGill Univ, Schulic Sch Mus, Montreal, PQ, Canada	University of Padua; McGill University	Castiello, U (corresponding author), Univ Padua, Dipartimento Psicol Gen, Piazza Capitaniato 3, Padua, Italy.	umberto.castiello@unipd.it	BEGLIOMINI, CHIARA/D-1516-2014; Giordano, Bruno L./A-4398-2008; Grassi, Massimo/I-8234-2012	BEGLIOMINI, CHIARA/0000-0001-7433-0414; Giordano, Bruno L./0000-0001-7002-0486; Grassi, Massimo/0000-0002-3784-2784; Castiello, Umberto/0000-0003-0629-1286	Ministero dell'Istruzione, dell'Universita e della Ricerca [N. 23432]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	The study has been funded by a grant from the Ministero dell'Istruzione, dell'Universita e della Ricerca (N. 23432). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp MS, 2008, NEUROIMAGE, V41, P1011, DOI 10.1016/j.neuroimage.2008.03.015; Brouwer AM, 2006, EXP BRAIN RES, V173, P629, DOI 10.1007/s00221-006-0406-x; Carello C, 1998, PSYCHOL SCI, V9, P211, DOI 10.1111/1467-9280.00040; Castiello U, 2006, CHEM SENSES, V31, P665, DOI 10.1093/chemse/bjl007; CROSSMAN ERFW, 1983, Q J EXP PSYCHOL-A, V35, P251, DOI 10.1080/14640748308402133; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Fogassi L, 2004, HDB MULTISENSORY PRO, P425; GAVER WW, 1993, ECOL PSYCHOL, V5, P1, DOI 10.1207/s15326969eco0501_1; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Gentilucci M, 1998, NEUROREPORT, V9, P887, DOI 10.1097/00001756-199803300-00023; Giordano BL, 2006, J ACOUST SOC AM, V119, P1171, DOI 10.1121/1.2149839; Glover S, 2004, BEHAV BRAIN SCI, V27, P3; Grassi M, 2005, PERCEPT PSYCHOPHYS, V67, P274, DOI 10.3758/BF03206491; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; Guest S, 2002, EXP BRAIN RES, V146, P161, DOI 10.1007/s00221-002-1164-z; Gygi B, 2004, J ACOUST SOC AM, V115, P1252, DOI 10.1121/1.1635840; JAKOBSON LS, 1991, EXP BRAIN RES, V86, P199; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Keysers C, 2003, EXP BRAIN RES, V153, P628, DOI 10.1007/s00221-003-1603-5; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Kunkler-Peck AJ, 2000, J EXP PSYCHOL HUMAN, V26, P279, DOI 10.1037/0096-1523.26.1.279; Lederman SJ, 2003, EXP BRAIN RES, V152, P156, DOI 10.1007/s00221-003-1522-5; Lederman SJ, 2002, 10TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P97, DOI 10.1109/HAPTIC.2002.998946; LI XF, 1991, J ACOUST SOC AM, V90, P3036, DOI 10.1121/1.401778; Lukos J, 2007, J NEUROSCI, V27, P3894, DOI 10.1523/JNEUROSCI.4693-06.2007; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pastore RE, 2008, PERCEPT PSYCHOPHYS, V70, P13, DOI 10.3758/PP.70.1.13; Patchay S, 2003, PSYCHON B REV, V10, P924, DOI 10.3758/BF03196553; PATCHAY S, 2005, EXP BRAIN RES, V23, P1; Plamondon R, 1997, BEHAV BRAIN SCI, V20, P279, DOI 10.1017/S0140525X97001441; REPP BH, 1987, J ACOUST SOC AM, V81, P1100, DOI 10.1121/1.394630; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Tubaldi F, 2008, CHEM SENSES, V33, P433, DOI 10.1093/chemse/bjn010; Tubaldi F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001795; Wing AM, 1998, J EXP PSYCHOL HUMAN, V24, P1571, DOI 10.1037/0096-1523.24.6.1571; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; ZAHARIEV MA, 2003, P 5 INT C MULT INT I, P273; Zahariev MA, 2008, EXP BRAIN RES, V186, P619, DOI 10.1007/s00221-008-1269-0	42	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12240	10.1371/journal.pone.0012240	http://dx.doi.org/10.1371/journal.pone.0012240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	639II	20808929	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000280968100030
J	Corona, E; Dudley, JT; Butte, AJ				Corona, Erik; Dudley, Joel T.; Butte, Atul J.			Extreme Evolutionary Disparities Seen in Positive Selection across Seven Complex Diseases	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; NATURAL-SELECTION; POPULATION DIFFERENTIATION; TUBERCULOSIS; VARIANTS; GENETICS; PATIENT; BLOCKS; GENOME; GENES	Positive selection is known to occur when the environment that an organism inhabits is suddenly altered, as is the case across recent human history. Genome-wide association studies (GWASs) have successfully illuminated disease-associated variation. However, whether human evolution is heading towards or away from disease susceptibility in general remains an open question. The genetic-basis of common complex disease may partially be caused by positive selection events, which simultaneously increased fitness and susceptibility to disease. We analyze seven diseases studied by the Wellcome Trust Case Control Consortium to compare evidence for selection at every locus associated with disease. We take a large set of the most strongly associated SNPs in each GWA study in order to capture more hidden associations at the cost of introducing false positives into our analysis. We then search for signs of positive selection in this inclusive set of SNPs. There are striking differences between the seven studied diseases. We find alleles increasing susceptibility to Type 1 Diabetes (T1D), Rheumatoid Arthritis (RA), and Crohn's Disease (CD) underwent recent positive selection. There is more selection in alleles increasing, rather than decreasing, susceptibility to T1D. In the 80 SNPs most associated with T1D (p-value <7.01 x 10(-5)) showing strong signs of positive selection, 58 alleles associated with disease susceptibility show signs of positive selection, while only 22 associated with disease protection show signs of positive selection. Alleles increasing susceptibility to RA are under selection as well. In contrast, selection in SNPs associated with CD favors protective alleles. These results inform the current understanding of disease etiology, shed light on potential benefits associated with the genetic-basis of disease, and aid in the efforts to identify causal genetic factors underlying complex disease.	[Corona, Erik; Dudley, Joel T.; Butte, Atul J.] Lucile Packard Childrens Hosp, Stanford, CA USA; [Corona, Erik; Dudley, Joel T.; Butte, Atul J.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA	Lucile Packard Children's Hospital (LPCH); Stanford University	Corona, E (corresponding author), Lucile Packard Childrens Hosp, Stanford, CA USA.	abutte@stanford.edu			Lucile Packard Foundation for Children's Health; Hewlett Packard Foundation; Armin and Linda Miller Fellowship Fund; National Library of Medicine [T15 LM 007033]; National Institute of General Medical Sciences [R01 GM079719]; National Science Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079719] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	Lucile Packard Foundation for Children's Health; Hewlett Packard Foundation; Armin and Linda Miller Fellowship Fund; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Lucile Packard Foundation for Children's Health, the Hewlett Packard Foundation, the Armin and Linda Miller Fellowship Fund, the National Library of Medicine (T15 LM 007033), the National Institute of General Medical Sciences (R01 GM079719), a National Science Foundation Graduate Research Fellowship, and the Howard Hughes Medical Institute. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial funder provided funds for hardware equipment and unrestricted funds for research. No commercial organization had any role in the research design, implementation, or findings.	Arbiza L, 2006, J MOL BIOL, V358, P1390, DOI 10.1016/j.jmb.2006.02.067; Askling J, 2005, ARTHRITIS RHEUM-US, V52, P1986, DOI 10.1002/art.21137; Babbitt CC, 2010, GENOME BIOL EVOL, V2, P67, DOI 10.1093/gbe/evq002; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Butty V, 2007, P NATL ACAD SCI USA, V104, P570, DOI 10.1073/pnas.0610124104; Chevin LM, 2008, GENETICS, V180, P301, DOI 10.1534/genetics.108.089706; Costamagna P., 2004, Morbidity and Mortality Weekly Report, V53, P683; Currat M, 2002, AM J HUM GENET, V70, P207, DOI 10.1086/338304; Di Rienzo A, 2006, CURR OPIN GENET DEV, V16, P630, DOI 10.1016/j.gde.2006.10.002; Ding KY, 2008, PHARMACOGENET GENOM, V18, P169, DOI 10.1097/FPC.0b013e3282f44d99; Fabre S, 2005, J RHEUMATOL, V32, P2432; Filler SG, 2005, CLIN INFECT DIS, V41, pS208, DOI 10.1086/430000; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GUINAN KJ, 2010, GENES IMMUN; Jimenez FG, 2005, J INFECTION, V50, P370, DOI 10.1016/j.jinf.2004.12.016; Kirsner JB, 2001, WORLD J GASTROENTERO, V7, P175; MADDOX J, 1994, NATURE, V372, P32; Mobley JL, 2004, MED HYPOTHESES, V62, P839, DOI 10.1016/j.mehy.2003.12.006; Myles S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-22; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Podder S, 2010, MOL BIOL EVOL, V27, P934, DOI 10.1093/molbev/msp297; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; ROTHSCHILD BM, 1992, SEMIN ARTHRITIS RHEU, V22, P181, DOI 10.1016/0049-0172(92)90018-9; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schaub MA, 2009, BIOINFORMATICS, V25, pI21, DOI 10.1093/bioinformatics/btp226; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; Spencer CCA, 2006, PLOS GENET, V2, P1375, DOI 10.1371/journal.pgen.0020148; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Walsh EC, 2006, HUM GENET, V119, P92, DOI 10.1007/s00439-005-0090-0; Zhang K, 2005, BIOINFORMATICS, V21, P131, DOI 10.1093/bioinformatics/bth482	39	42	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12236	10.1371/journal.pone.0012236	http://dx.doi.org/10.1371/journal.pone.0012236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808933	Green Published, gold, Green Submitted			2022-12-25	WOS:000280968100028
J	Al-Daghri, NM; Al-Attas, OS; Alokail, MS; Alkharfy, KM; Sabico, SLB; Chrousos, GP				Al-Daghri, Nasser M.; Al-Attas, Omar S.; Alokail, Majed S.; Alkharfy, Khalid M.; Sabico, Shaun Louie B.; Chrousos, George P.			Decreasing Prevalence of the Full Metabolic Syndrome but a Persistently High Prevalence of Dyslipidemia among Adult Arabs	PLOS ONE			English	Article							DIABETES-MELLITUS; HERITABILITY; POPULATION; POLYMORPHISM; DEFINITIONS; ASSOCIATION; CHOLESTEROL; DISEASE	A decade has passed since metabolic syndrome (MetS) was documented to be highly prevalent in the kingdom of Saudi Arabia. No follow-up epidemiologic study was done. This study aims to fill this gap. In this cross-sectional, observational study, a total of 2850 randomly selected Saudi adults aged 18-55 years were recruited. Subjects' information was generated from a database of more than 10,000 Saudi citizens from the existing Biomarkers Screening in Riyadh Program (RIYADH Cohort), Saudi Arabia. Anthropometrics included body mass index (BMI), blood pressure, as well as waist and hip circumferences. Fasting blood glucose and lipid profile were determined using routine laboratory procedures. The definition of ATP-III (NHANES III) was used for the diagnosis of the full MetS. The overall prevalence of complete MetS was 35.3% [Confidence-Interval (CI) 33.5-37.01]. Age-adjusted prevalence according to the European standard population is 37.0%. Low HDL-cholesterol was the most prevalent of all MetS risk factors, affecting 88.6% (CI 87.5-89.7) and hypertriglyceridemia the second most prevalent, affecting 34% (CI 32.3-35.7) of the subjects. The prevalence of the full MetS decreased from previous estimates but remains high, while dyslipidemia remains extremely high, affecting almost 90% of middle-aged Arabs. Screening for dyslipidemia among Saudi adults is warranted, especially among those most at risk. Scientific inquiry into the molecular causes of these manifestations should be pursued as a first step in the discovery of etiologic therapies.	[Al-Daghri, Nasser M.; Al-Attas, Omar S.; Alokail, Majed S.; Sabico, Shaun Louie B.; Chrousos, George P.] King Saud Univ, Dept Biochem, Coll Sci, Riyadh, Saudi Arabia; [Alkharfy, Khalid M.] King Saud Univ, Dept Clin Pharm, Coll Pharm, Riyadh, Saudi Arabia; [Chrousos, George P.] Univ Athens, Sch Med, Aghia Sophia Childrens Hosp, Div Endocrinol Metab & Diabet, GR-11527 Athens, Greece	King Saud University; King Saud University; Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital	Al-Daghri, NM (corresponding author), King Saud Univ, Dept Biochem, Coll Sci, Riyadh, Saudi Arabia.	aldaghri2000@hotmail.com	Al-Daghri, Nasser/G-7736-2011; Sabico, Shaun/C-9086-2011; Al-Daghri, Nasser/A-8360-2011; Al-okail, Majed S/E-5565-2016	Al-Daghri, Nasser/0000-0001-5472-1725; Sabico, Shaun/0000-0002-5248-2350; Al-Daghri, Nasser/0000-0001-5472-1725; Al-okail, Majed S/0000-0001-8147-3499				Al-Daghri N, 2003, DIABETIC MED, V20, P832, DOI 10.1046/j.1464-5491.2003.01044.x; Al-Daghri NM, 2008, DIABETES-METAB RES, V24, P52, DOI 10.1002/dmrr.763; Al-Daghri NM, 2007, SAUDI MED J, V28, P339; Al-Daghri NM, 2009, SAUDI MED J, V30, P267; Al-Daghri NM, 2003, CLIN SCI, V105, P467, DOI 10.1042/CS20030007; Al-Nozha MM, 2005, SAUDI MED J, V26, P1918; ALDAGHRI NM, 2010, EUR J CLIN INVEST; Alfadda AA, 2008, SAUDI MED J, V29, P821; Bassiony MM, 2009, SAUDI MED J, V30, P876; Bayoumi RA, 2007, OBESITY, V15, P551, DOI 10.1038/oby.2007.555; Bellia A, 2009, NUTR METAB CARDIOVAS, V19, P455, DOI 10.1016/j.numecd.2008.11.002; Cea-Calvo L, 2009, INT J CLIN PRACT, V63, P71, DOI 10.1111/j.1742-1241.2008.01902.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Harzallah F, 2006, DIABETIC MED, V23, P441, DOI 10.1111/j.1464-5491.2006.01866.x; Henneman P, 2008, J MED GENET, V45, P572, DOI 10.1136/jmg.2008.058388; Khader Y, 2007, J DIABETES COMPLICAT, V21, P214, DOI 10.1016/j.jdiacomp.2005.11.003; LIN JW, 2010, J CLIN ENDOCRINOL ME; NG SW, 2010, OBES REV; Regitz-Zagrosek V, 2007, GENDER MED, V4, pS162, DOI 10.1016/S1550-8579(07)80056-8; Saadi H, 2008, DIABETES RES CLIN PR, V80, P392, DOI 10.1016/j.diabres.2008.01.008; Sung J, 2009, J CLIN ENDOCR METAB, V94, P4946, DOI 10.1210/jc.2009-1268; Ulasi II, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-71	22	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12159	10.1371/journal.pone.0012159	http://dx.doi.org/10.1371/journal.pone.0012159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730053	Green Submitted, gold, Green Published			2022-12-25	WOS:000280862200015
J	Kermen, F; Sultan, S; Sacquet, J; Mandairon, N; Didier, A				Kermen, Florence; Sultan, Sebastien; Sacquet, Joelle; Mandairon, Nathalie; Didier, Anne			Consolidation of an Olfactory Memory Trace in the Olfactory Bulb Is Required for Learning-Induced Survival of Adult-Born Neurons and Long-Term Memory	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; RECOGNITION MEMORY; DISCRIMINATION TASK; GENERATED NEURONS; PREFRONTAL CORTEX; ODOR RECOGNITION; SPATIAL MEMORY; GRANULE CELL; C-FOS; NEUROGENESIS	Background: It has recently been proposed that adult-born neurons in the olfactory bulb, whose survival is modulated by learning, support long-term olfactory memory. However, the mechanism used to select which adult-born neurons following learning will participate in the long-term retention of olfactory information is unknown. We addressed this question by investigating the effect of bulbar consolidation of olfactory learning on memory and neurogenesis. Methodology/Principal Findings: Initially, we used a behavioral ecological approach using adult mice to assess the impact of consolidation on neurogenesis. Using learning paradigms in which consolidation time was varied, we showed that a spaced (across days), but not a massed (within day), learning paradigm increased survival of adult-born neurons and allowed long-term retention of the task. Subsequently, we used a pharmacological approach to block consolidation in the olfactory bulb, consisting in intrabulbar infusion of the protein synthesis inhibitor anisomycin, and found impaired learning and no increase in neurogenesis, while basic olfactory processing and the basal rate of adult-born neuron survival remained unaffected. Taken together these data indicate that survival of adult-born neurons during learning depends on consolidation processes taking place in the olfactory bulb. Conclusion/Significance: We can thus propose a model in which consolidation processes in the olfactory bulb determine both survival of adult-born neurons and long-term olfactory memory. The finding that adult-born neuron survival during olfactory learning is governed by consolidation in the olfactory bulb strongly argues in favor of a role for bulbar adult-born neurons in supporting olfactory memory.	[Kermen, Florence; Sultan, Sebastien; Sacquet, Joelle; Mandairon, Nathalie; Didier, Anne] Univ Lyon 1, CNRS, UMR Neurosci Sensorielles 5020, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Kermen, F (corresponding author), Univ Lyon 1, CNRS, UMR Neurosci Sensorielles 5020, F-69365 Lyon, France.	fkermen@olfac.univ-lyon1.fr	DIDIER, Anne/H-4413-2017; Mandairon, Nathalie/H-4439-2017	DIDIER, Anne/0000-0003-3118-9961; Mandairon, Nathalie/0000-0001-7935-5215; KERMEN, Florence/0000-0002-2247-9636	OSEO-Anvar [E1482.037]; Centre National de Recherche Scientifique (National Center of Scientific Research); University Lyon1; French Ministry for Research	OSEO-Anvar; Centre National de Recherche Scientifique (National Center of Scientific Research); University Lyon1; French Ministry for Research(Ministry of Research, France)	This work was supported by OSEO-Anvar (contract EZUS Lyon1 E1482.037), Centre National de Recherche Scientifique (National Center of Scientific Research), University Lyon1 and the French Ministry for Research (doctoral fellowship to FK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7; Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Artinian J, 2008, EUR J NEUROSCI, V27, P3009, DOI 10.1111/j.1460-9568.2008.06262.x; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Buonviso N, 1998, EUR J NEUROSCI, V10, P2472, DOI 10.1046/j.1460-9568.1998.00266.x; Busto GU, 2009, EUR J NEUROSCI, V29, P1431, DOI 10.1111/j.1460-9568.2009.06689.x; Carballo-Marquez A, 2009, HIPPOCAMPUS, V19, P446, DOI 10.1002/hipo.20530; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Coureaud G, 2009, LEARN MEMORY, V16, P470, DOI 10.1101/lm.1434009; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Desgranges B, 2008, BRAIN RES, V1236, P166, DOI 10.1016/j.brainres.2008.07.123; Doucette W, 2008, PLOS BIOL, V6, P2266, DOI 10.1371/journal.pbio.0060258; Elaagouby A, 1996, CHEM SENSES, V21, P159, DOI 10.1093/chemse/21.2.159; Fletcher ML, 2003, J NEUROSCI, V23, P6946; Guerin D, 2008, BEHAV NEUROSCI, V122, P816, DOI 10.1037/a0012522; Hernandez PJ, 2002, NAT NEUROSCI, V5, P1327, DOI 10.1038/nn973; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Izquierdo I, 2006, TRENDS NEUROSCI, V29, P496, DOI 10.1016/j.tins.2006.07.005; KABA H, 1989, NEUROSCIENCE, V32, P657, DOI 10.1016/0306-4522(89)90287-X; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Keller M, 2005, NEUROSCIENCE, V133, P359, DOI 10.1016/j.neuroscience.2005.02.027; Keller M, 2004, BEHAV NEUROSCI, V118, P1274, DOI 10.1037/0735-7044.118.6.1274; Keverne EB, 1996, J PHYSIOLOGY-PARIS, V90, P399, DOI 10.1016/S0928-4257(97)87929-6; Lazarini F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007017; Litaudon P, 1997, EUR J NEUROSCI, V9, P1593, DOI 10.1111/j.1460-9568.1997.tb01517.x; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Mandairon N, 2006, NEUROSCIENCE, V141, P443, DOI 10.1016/j.neuroscience.2006.03.066; Mandairon N, 2008, NEUROBIOL LEARN MEM, V90, P178, DOI 10.1016/j.nlm.2008.02.008; Mandairon N, 2006, EUR J NEUROSCI, V24, P3578, DOI 10.1111/j.1460-9568.2006.05235.x; Mandairon N, 2009, J NEUROSCI METH, V180, P296, DOI 10.1016/j.jneumeth.2009.04.008; Martin C, 2006, EUR J NEUROSCI, V23, P1801, DOI 10.1111/j.1460-9568.2006.04711.x; Martin C, 2004, J NEUROSCI, V24, P389, DOI 10.1523/JNEUROSCI.3433-03.2004; McLean JH, 2005, NEUROSCIENCE, V135, P329, DOI 10.1016/j.neuroscience.2005.06.029; Montag-Sallaz M, 2002, J NEUROBIOL, V52, P61, DOI 10.1002/neu.10069; Moreno MM, 2009, P NATL ACAD SCI USA, V106, P17980, DOI 10.1073/pnas.0907063106; MOULY AM, 1993, BEHAV NEUROSCI, V107, P451, DOI 10.1037/0735-7044.107.3.451; Mouly AM, 2001, NEUROSCIENCE, V102, P11, DOI 10.1016/S0306-4522(00)00476-0; Mouret A, 2008, J NEUROSCI, V28, P11511, DOI 10.1523/JNEUROSCI.2954-08.2008; Nissant A, 2009, NAT NEUROSCI, V12, P728, DOI 10.1038/nn.2298; Petreanu L, 2002, J NEUROSCI, V22, P6106; Richter K, 2005, LEARN MEMORY, V12, P407, DOI 10.1101/lm.97505; Roullet F, 2005, LEARN MEMORY, V12, P307, DOI 10.1101/lm.89605; Roullet F, 2005, BEHAV BRAIN RES, V157, P127, DOI 10.1016/j.bbr.2004.06.017; Salcedo E, 2005, CHEM SENSES, V30, P615, DOI 10.1093/chemse/bji055; Sara SJ, 2006, LEARN MEMORY, V13, P515, DOI 10.1101/lm.338406; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Shepherd GM, 2007, BRAIN RES REV, V55, P373, DOI 10.1016/j.brainresrev.2007.03.005; Sisti HM, 2007, LEARN MEMORY, V14, P368, DOI 10.1101/lm.488707; Sultan S, 2010, FASEB J, V24, P2355, DOI 10.1096/fj.09-151456; Touzani K, 2007, P NATL ACAD SCI USA, V104, P5632, DOI 10.1073/pnas.0611554104; Tronel S, 2004, LEARN MEMORY, V11, P453, DOI 10.1101/lm.74504; Tronel S, 2003, J NEUROSCI, V23, P5472; Tronel S, 2002, LEARN MEMORY, V9, P105, DOI 10.1101/lm.47802; Trouche S, 2009, P NATL ACAD SCI USA, V106, P5919, DOI 10.1073/pnas.0811054106; Wanisch K, 2008, BEHAV BRAIN RES, V186, P191, DOI 10.1016/j.bbr.2007.08.008	56	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12118	10.1371/journal.pone.0012118	http://dx.doi.org/10.1371/journal.pone.0012118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	638AP	20730099	Green Published, gold, Green Submitted			2022-12-25	WOS:000280862200002
J	Reynolds, BF; Powers, SP; Bishop, MA				Reynolds, Brad F.; Powers, Sean P.; Bishop, Mary Anne			Application of Acoustic Telemetry to Assess Residency and Movements of Rockfish and Lingcod at Created and Natural Habitats in Prince William Sound	PLOS ONE			English	Article							OPHIODON-ELONGATUS; ARTIFICIAL REEFS; CONSERVATION; PATTERNS	Loss and/or degradation of nearshore habitats have led to increased efforts to restore or enhance many of these habitats, particularly those that are deemed essential for marine fishes. Copper rockfish (Sebastes caurinus) and lingcod (Ophiodon enlongatus) are dominant members of the typical reef fish community that inhabit rocky and high-relief substrates along the Pacific Northwest. We used acoustic telemetry to document their residency and movements in the nearshore waters of Prince William Sound, Alaska in order to assess use of created reef habitat in an individual-based manner. A total of 57 fish were surgically implanted with acoustic transmitters. Forty-five fish were captured and monitored in three habitats: artificial reef, low-relief natural reef, and patchy high-relief natural reef. Within each habitat, both rockfish and lingcod exhibited long periods of residency with limited movements. Twelve rockfish were captured at the natural reefs and displaced a distance of 4.0 km to the artificial reef. Five of the 12 rockfish returned within 10 d of their release to their initial capture site. Another five of the 12 displaced fish established residency at the artificial reef through the duration of our study. Our results suggest the potential for artificial reefs to provide rockfish habitat in the event of disturbances to natural habitat.	[Reynolds, Brad F.; Powers, Sean P.] Univ S Alabama, Dept Marine Sci, Dauphin Isl, AL 36528 USA; [Reynolds, Brad F.; Powers, Sean P.] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Reynolds, Brad F.; Bishop, Mary Anne] Prince William Sound Sci Ctr, Cordova, AK USA	University of South Alabama; Dauphin Island Sea Lab	Reynolds, BF (corresponding author), Univ S Alabama, Dept Marine Sci, Dauphin Isl, AL 36528 USA.	breynolds@pwssc.org	Bizzarro, Joseph/A-2988-2012	Powers, Sean/0000-0002-4770-9944	North Pacific Research Board; Prince William Sound Oil Spill Recovery Institute; Dauphin Island Sea Lab	North Pacific Research Board; Prince William Sound Oil Spill Recovery Institute; Dauphin Island Sea Lab	Funding for this project was provided by grants from the North Pacific Research Board and the Prince William Sound Oil Spill Recovery Institute. The lead author received support from a graduate fellowship provided by the Dauphin Island Sea Lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Baine M, 2001, OCEAN COAST MANAGE, V44, P241, DOI 10.1016/S0964-5691(01)00048-5; Brown H, 2010, MAR ECOL PROG SER, V403, P205, DOI 10.3354/meps08465; Cass AJ, 1990, CAN SPEC PUBL FISH A, V109, P40; *EXX VALD OIL SPIL, 1999, EXX VALD OIL SPILL R; Gordon David A., 1994, Alaska Fishery Research Bulletin, V1, P140; Hobbs RJ, 2001, RESTOR ECOL, V9, P239, DOI 10.1046/j.1526-100x.2001.009002239.x; JAGIELO TH, 1990, FISH B-NOAA, V88, P815; Johnson SW, 2003, ENVIRON BIOL FISH, V66, P259, DOI 10.1023/A:1023981908146; Lawton JH, 1996, OIKOS, V76, P3, DOI 10.2307/3545742; Love M, 1996, PROBABLY MORE YOU WA; LOVESTAM G, 1990, AMBIO, V19, P87; Martell SJD, 2000, B MAR SCI, V66, P729; MATTHEWS KR, 1990, CAN J ZOOL, V68, P2243, DOI 10.1139/z90-312; MATTHEWS KR, 1990, FISH B-NOAA, V88, P223; MATTHEWS KR, 1992, FISH B-NOAA, V90, P784; MATTHEWS KR, 1990, ENVIRON BIOL FISH, V29, P161, DOI 10.1007/BF00002217; MEYER S, 2004, SGED40 U AL FAIRB AL; Miller MW, 2002, ICES J MAR SCI, V59, pS27, DOI 10.1006/jmsc.2001.1162; Munk Kristen M., 2001, Alaska Fishery Research Bulletin, V8, P12; PETERSON CH, 2003, MARINE ECOLOGY PROGR, V264, P251; PINCOCK DG, 2008, DOC004691 VEMCO; Powers SP, 2009, MAR ECOL PROG SER, V389, P159, DOI 10.3354/meps08164; Powers SP, 2003, MAR ECOL PROG SER, V264, P265, DOI 10.3354/meps264265; REYNOLDS BF, 2009, THESIS U S AL; Starr RM, 2005, MAR TECHNOL SOC J, V39, P19, DOI 10.4031/002533205787521677; Starr RM, 2004, CAN J FISH AQUAT SCI, V61, P1083, DOI 10.1139/F04-054; Thorsteinson LK, 2002, FISHES ALASKA; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2	29	13	13	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12130	10.1371/journal.pone.0012130	http://dx.doi.org/10.1371/journal.pone.0012130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730090	Green Submitted, gold, Green Published			2022-12-25	WOS:000280862200004
J	Textoris, J; Ban, LH; Capo, C; Raoult, D; Leone, M; Mege, JL				Textoris, Julien; Ban, Leang Heng; Capo, Christian; Raoult, Didier; Leone, Marc; Mege, Jean-Louis			Sex-Related Differences in Gene Expression Following Coxiella burnetii Infection in Mice: Potential Role of Circadian Rhythm	PLOS ONE			English	Article							GENDER-DIFFERENCES; IMMUNE-RESPONSE; DIMORPHISM; RECEPTOR; PATTERN; SEPSIS; LIVER; EPIDEMIOLOGY; ANDROGENS; HEPCIDIN	Background: Q fever, a zoonosis due to Coxiella burnetii infection, exhibits sexual dimorphism; men are affected more frequently and severely than women for a given exposure. Here we explore whether the severity of C. burnetii infection in mice is related to differences in male and female gene expression profiles. Methodology/Principal Findings: Mice were infected with C. burnetii for 24 hours, and gene expression was measured in liver cells using microarrays. Multiclass analysis identified 2,777 probes for which expression was specifically modulated by C. burnetti infection. Only 14% of the modulated genes were sex-independent, and the remaining 86% were differentially expressed in males and females. Castration of males and females showed that sex hormones were responsible for more than 60% of the observed gene modulation, and this reduction was most pronounced in males. Using functional annotation of modulated genes, we identified four clusters enriched in males that were related to cell-cell adhesion, signal transduction, defensins and cytokine/Jak-Stat pathways. Up-regulation of the IL-10 and Stat-3 genes may account for the high susceptibility of men with Q fever to C. burnetii infection and autoantibody production. Two clusters were identified in females, including the circadian rhythm pathway, which consists of positive (Clock, Arntl) and negative (Per) limbs of a feedback loop. We found that Clock and Arntl were down-modulated whereas Per was up-regulated; these changes may be associated with efficient bacterial elimination in females but not in males, in which an exacerbated host response would be prominent. Conclusion: This large-scale study revealed for the first time that circadian rhythm plays a major role in the anti-infectious response of mice, and it provides a new basis for elucidating the role of sexual dimorphism in human infections.	[Textoris, Julien; Ban, Leang Heng; Capo, Christian; Raoult, Didier; Leone, Marc; Mege, Jean-Louis] CNRS, Unite Rech Malad Infect Trop & Emergentes, Fac Med, UMR 6236, Marseille, France; [Textoris, Julien; Ban, Leang Heng; Leone, Marc] Univ Mediterranee, Serv Anesthesie & Reanimat, Hop Nord, Assistance Publ Hop Marseille, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Textoris, J (corresponding author), CNRS, Unite Rech Malad Infect Trop & Emergentes, Fac Med, UMR 6236, Marseille, France.	Jean-Louis.Mege@univmed.fr	MEGE, JEAN-LOUIS/O-6063-2016; Textoris, Julien/H-3317-2019; Leone, Marc/P-4835-2016; RAOULT, Didier/A-8434-2008	Textoris, Julien/0000-0002-3821-9337; Leone, Marc/0000-0002-3097-758X; RAOULT, Didier/0000-0002-0633-5974				Amador-Noguez D, 2005, BIOCHEM BIOPH RES CO, V332, P1086, DOI 10.1016/j.bbrc.2005.05.063; Arjona A, 2005, J IMMUNOL, V174, P7618, DOI 10.4049/jimmunol.174.12.7618; Arjona A, 2006, J INTERF CYTOK RES, V26, P645, DOI 10.1089/jir.2006.26.645; Azad AF, 2007, CLIN INFECT DIS, V45, pS52, DOI 10.1086/518147; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Basant A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-110; Bastonero S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005357; Bird MD, 2008, CELL IMMUNOL, V252, P57, DOI 10.1016/j.cellimm.2007.09.007; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Briggs HL, 2008, INFECT IMMUN, V76, P2189, DOI 10.1128/IAI.01609-07; Cai W, 2008, MOL CELL BIOL, V28, P784, DOI 10.1128/MCB.00233-07; Capo C, 1999, J IMMUNOL, V163, P6078; Ceribelli A, 2007, J THORAC ONCOL, V2, pS15, DOI 10.1097/01.JTO.0000268635.25579.7e; Chappell PE, 2005, J NEUROENDOCRINOL, V17, P119, DOI 10.1111/j.1365-2826.2005.01270.x; Courselaud B, 2004, BLOOD CELL MOL DIS, V32, P283, DOI 10.1016/j.bcmd.2003.11.003; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Davidoff AM, 2003, BLOOD, V102, P480, DOI 10.1182/blood-2002-09-2889; Dellacasagrande J, 2002, J IMMUNOL, V169, P6309, DOI 10.4049/jimmunol.169.11.6309; DELLINGER RP, 2008, CRIT CARE MED, V296, P327; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Esemuede N, 2004, J SURG RES, V122, P135, DOI 10.1016/j.jss.2004.05.015; Farbrother P, 2006, CELL MICROBIOL, V8, P438, DOI 10.1111/j.1462-5822.2005.00633.x; Froy O, 2005, CELL MICROBIOL, V7, P1387, DOI 10.1111/j.1462-5822.2005.00590.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gery S, 2007, ONCOGENE, V26, P7916, DOI 10.1038/sj.onc.1210585; Ghigo E, 2004, J INFECT DIS, V190, P1767, DOI 10.1086/425041; Greig JE, 2004, MED J AUSTRALIA, V180, P566, DOI 10.5694/j.1326-5377.2004.tb06093.x; Habbal OA, 2009, INT REV IMMUNOL, V28, P93, DOI 10.1080/08830180802645050; Haimovich B, 2010, CRIT CARE MED, V38, P751, DOI 10.1097/CCM.0b013e3181cd131c; He YW, 2004, NAT IMMUNOL, V5, P88, DOI 10.1038/ni1021; Hollm-Delgado MG, 2005, EMERG INFECT DIS, V11, P77, DOI 10.3201/eid1101.030651; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; Houpikian P, 2005, MEDICINE, V84, P162, DOI 10.1097/01.md.0000165658.82869.17; Howe D, 2006, CELL MICROBIOL, V8, P496, DOI 10.1111/j.1462-5822.2005.00641.x; Hsieh YC, 2007, CRIT CARE MED, V35, pS621, DOI 10.1097/01.CCM.0000278603.18687.4F; Iwahana E, 2008, HORM BEHAV, V53, P422, DOI 10.1016/j.yhbeh.2007.11.014; Jimenez-Corona ME, 2006, THORAX, V61, P348, DOI 10.1136/thx.2005.049452; Kahlke V, 2000, CYTOKINE, V12, P69, DOI 10.1006/cyto.1999.0511; Kaiser V, 2000, J LEUKOCYTE BIOL, V68, P779; Karatsoreos IN, 2007, ENDOCRINOLOGY, V148, P5487, DOI 10.1210/en.2007-0775; Krijt J, 2004, J HEPATOL, V40, P891, DOI 10.1016/j.jhep.2004.02.029; Lee JE, 2008, CURR BIOL, V18, P195, DOI 10.1016/j.cub.2007.12.054; Leone M, 2004, J INFECT DIS, V189, P339, DOI 10.1086/380798; Lopez F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004001; Marriott I, 2006, J REPROD IMMUNOL, V71, P12, DOI 10.1016/j.jri.2006.01.004; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Mege JL, 2006, LANCET INFECT DIS, V6, P557, DOI 10.1016/S1473-3099(06)70577-1; Meghari S, 2006, J INFECT DIS, V194, P365, DOI 10.1086/505227; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Mokart D, 2005, BRIT J ANAESTH, V95, P776, DOI 10.1093/bja/aei257; Moxley G, 2002, ARTHRITIS RHEUM, V46, P250, DOI 10.1002/1529-0131(200201)46:1<250::AID-ART10064>3.0.CO;2-T; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; Nemeth E, 2009, ACTA HAEMATOL-BASEL, V122, P78, DOI 10.1159/000243791; PARETSKY D, 1964, J BACTERIOL, V88, P137, DOI 10.1002/path.1700880118; Penaloza C, 2009, FASEB J, V23, P1869, DOI 10.1096/fj.08-119388; Pierce CY, 2007, ANAL CHIM ACTA, V583, P23, DOI 10.1016/j.aca.2006.09.065; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Sopena N, 2005, CHEST, V127, P213, DOI 10.1378/chest.127.1.213; Theobald S, 2006, T ROY SOC TROP MED H, V100, P299, DOI 10.1016/j.trstmh.2005.05.023; Treister NS, 2005, J DENT RES, V84, P1187, DOI 10.1177/154405910508401218; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Yeretssian G, 2009, P NATL ACAD SCI USA, V106, P9016, DOI 10.1073/pnas.0813362106	65	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12190	10.1371/journal.pone.0012190	http://dx.doi.org/10.1371/journal.pone.0012190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730052	gold, Green Published, Green Submitted			2022-12-25	WOS:000280862200027
J	Lee, VHY; Lee, LTO; Chu, JYS; Lam, IPY; Siu, FKY; Vaudry, H; Chow, BKC				Lee, Vien H. Y.; Lee, Leo T. O.; Chu, Jessica Y. S.; Lam, Ian P. Y.; Siu, Francis K. Y.; Vaudry, Hubert; Chow, Billy K. C.			An indispensable role of secretin in mediating the osmoregulatory functions of angiotensin II	FASEB JOURNAL			English	Article						fluid homeostasis; secretin receptor-deficient mice; circumventricular organs; vasopressin	RECEPTOR SUBTYPES; LAMINA TERMINALIS; FOS EXPRESSION; VASOPRESSIN; MICE; WATER; THIRST; BRAIN; APPETITE; RELEASE	Fluid balance is critical to life and hence is tightly controlled in the body. Angiotensin II (ANGII), one of the most important components of this regulatory system, is recognized as a dipsogenic hormone that stimulates vasopressin (VP) expression and release. However, detailed mechanisms regarding how ANGII brings about these changes are not fully understood. In the present study, we show initially that the osmoregulatory functions of secretin (SCT) in the brain are similar to those of ANGII in mice and, more important, we discovered the role of SCT as the link between ANGII and its downstream effects. This was substantiated by the use of two knockout mice, SCTR-/- and SCT-/-, in which we show the absence of an intact SCT/secretin receptor (SCTR) axis resulted in an abolishment or much reduced ANGII osmoregulatory functions. By immunohistochemical staining and in situ hybridization, the proteins and transcripts of SCT and its receptor are found in the paraventricular nucleus (PVN) and lamina terminalis. We propose that SCT produced in the circumventricular organs is transported and released in the PVN to stimulate vasopressin expression and release. In summary, our findings identify SCT and SCTR as novel elements of the ANGII osmoregulatory pathway in maintaining fluid balance in the body.-Lee, V. H. Y., Lee, L. T. O., Chu, J. Y. S., Lam, I. P. Y., Siu, F. K. Y, Vaudry, H., Chow, B. K. C. An indispensable role of secretin in mediating the osmoregulatory functions of angiotensin II. FASEB J. 24, 5024-5032 (2010). www.fasebj.org	[Lee, Vien H. Y.; Lee, Leo T. O.; Chu, Jessica Y. S.; Lam, Ian P. Y.; Siu, Francis K. Y.; Chow, Billy K. C.] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China; [Vaudry, Hubert] Univ Rouen, Inst Natl Sante & Rech Med, Mont St Aignan, France	University of Hong Kong; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie	Chow, BKC (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China.	bkcc@hkusua.hku.hk	Lee, Leo T.O./AAB-1581-2021; Chow, Billy/D-3064-2009	Chow, Billy/0000-0003-3390-0307; /0000-0003-2167-6926	Hong Kong Research Grants Council [GRF7686/08, GRF738/09]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	The authors thank Prof. Cheah K. S. (University of Hong Kong; supported by HKU 02/02C) for the development of the SCT<SUP>-/-</SUP> mice, Prof. Chung S. K. (University of Hong Kong) for the development of SCTR<SUP>-/-</SUP> mice, and Dr. Neal Copeland (National Cancer Institute, Frederick, MD, USA) for providing the bacterial recombination cells and vectors. This study was supported by the Hong Kong Research Grants Council (GRF7686/08 to L.T.O.L. and GRF738/09 to B.K.C.C.).	Bolbecker AR, 2009, AM J PSYCHIAT, V166, P460, DOI 10.1176/appi.ajp.2008.08040597; Chen YF, 2003, BRAIN RES, V965, P35, DOI 10.1016/S0006-8993(02)04059-3; Cheng CYY, 2009, J MOL ENDOCRINOL, V43, P81, DOI 10.1677/JME-08-0123; Chu JYS, 2007, MOL CELL BIOL, V27, P2499, DOI 10.1128/MCB.01088-06; Chu JYS, 2009, P NATL ACAD SCI USA, V106, P15961, DOI 10.1073/pnas.0903695106; Crews EC, 2005, AM J PHYSIOL-REG I, V288, pR638, DOI 10.1152/ajpregu.00525.2004; DENTON DA, 1990, AM J PHYSIOL, V259, pR729, DOI 10.1152/ajpregu.1990.259.4.R729; Ferguson AV, 2001, EXP BIOL MED, V226, P85, DOI 10.1177/153537020122600205; Han L, 1996, BRAIN RES, V708, P45, DOI 10.1016/0006-8993(95)01326-1; HEALY DP, 1984, HYPERTENSION, V6, pI130, DOI 10.1161/01.HYP.6.2_Pt_2.I130; JOHNSON AD, 1993, FASEB J, V7, pA1055; Johnson AK, 1996, CLIN EXP PHARMACOL P, V23, P183, DOI 10.1111/j.1440-1681.1996.tb02594.x; Lauand F, 2007, NEUROSCIENCE, V147, P247, DOI 10.1016/j.neuroscience.2007.04.021; Lee SMY, 2005, NEUROSCIENCE, V134, P377, DOI 10.1016/j.neuroscience.2005.04.009; Li XC, 2009, KIDNEY INT, V76, P169, DOI 10.1038/ki.2009.134; LIND RW, 1984, PHYSIOL BEHAV, V32, P69; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lochard N, 2003, J BIOL CHEM, V278, P2184, DOI 10.1074/jbc.M209933200; MACGREGOR DP, 1995, BRAIN RES, V675, P231, DOI 10.1016/0006-8993(95)00076-3; MAHON JM, 1995, NEUROSCIENCE, V69, P199, DOI 10.1016/0306-4522(95)00238-E; McKinley MJ, 2008, AM J PHYSIOL-REG I, V294, pR1533, DOI 10.1152/ajpregu.00848.2007; McKinley MJ, 2004, J NEUROENDOCRINOL, V16, P340, DOI 10.1111/j.0953-8194.2004.01184.x; SAAVEDRA JM, 1992, ENDOCR REV, V13, P329, DOI 10.1210/er.13.2.329; Sitniewska EM, 2002, REGUL PEPTIDES, V105, P163, DOI 10.1016/S0167-0115(02)00018-6; TANIMOTO K, 1994, J BIOL CHEM, V269, P31334; Wilson WL, 2005, BRAIN RES, V1060, P108, DOI 10.1016/j.brainres.2005.08.032; Yung WH, 2001, J NEUROSCI, V21, P7063, DOI 10.1523/JNEUROSCI.21-18-07063.2001	27	36	36	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					5024	5032		10.1096/fj.10-165399	http://dx.doi.org/10.1096/fj.10-165399			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20739612	Green Published			2022-12-25	WOS:000284824400040
J	Bove, PF; Grubb, BR; Okada, SF; Ribeiro, CMP; Rogers, TD; Randell, SH; O'Neal, WK; Boucher, RC				Bove, Peter F.; Grubb, Barbara R.; Okada, Seiko F.; Ribeiro, Carla M. P.; Rogers, Troy D.; Randell, Scott H.; O'Neal, Wanda K.; Boucher, Richard C.			Human Alveolar Type II Cells Secrete and Absorb Liquid in Response to Local Nucleotide Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMAN AIRWAY EPITHELIA; ACUTE LUNG INJURY; CYSTIC-FIBROSIS; FLUID TRANSPORT; ION-TRANSPORT; SODIUM-CHANNELS; MUCUS CLEARANCE; NA+ TRANSPORT; ATP RELEASE	A balance sheet describing the integrated homeostasis of secretion, absorption, and surface movement of liquids on pulmonary surfaces has remained elusive. It remains unclear whether the alveolus exhibits an intra-alveolar ion/liquid transport physiology or whether it secretes ions/liquid that may communicate with airway surfaces. Studies employing isolated human alveolar type II (AT2) cells were utilized to investigate this question. Human AT2 cells exhibited both epithelial Na+ channel-mediated Na+ absorption and cystic fibrosis transmembrane conductance regulator-mediated Cl- secretion, both significantly regulated by extracellular nucleotides. In addition, we observed in normal AT2 cells an absence of cystic fibrosis transmembrane conductance regulator regulation of epithelial Na+ channel activity and an absence of expression/activity of reported calcium-activated chloride channels (TMEM16A, Bestrophin-1, ClC2, and SLC26A9), both features strikingly different from normal airway epithelial cells. Measurements of alveolar surface liquid volume revealed that normal AT2 cells: 1) achieved an extracellular nucleotide concentration-dependent steady state alveolar surface liquid height of similar to 4 mu m in vitro; 2) absorbed liquid when the lumen was flooded; and 3) secreted liquid when treated with UTP or forskolin or subjected to cyclic compressive stresses mimicking tidal breathing. Collectively, our studies suggest that human AT2 cells in vitro have the capacity to absorb or secrete liquid in response to local alveolar conditions.	[Bove, Peter F.; Grubb, Barbara R.; Okada, Seiko F.; Ribeiro, Carla M. P.; Rogers, Troy D.; Randell, Scott H.; O'Neal, Wanda K.; Boucher, Richard C.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Boucher, RC (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Dept Med, 7011 Thurston Bowles Bldg,96 Manning Dr, Chapel Hill, NC 27599 USA.	R_Boucher@med.unc.edu	Ribeiro, Carla Maria P/A-6955-2009		National Institutes of Health [HL34322, 2P30DK065988, P50HL084934]; Cystic Fibrosis Foundation [RDP R026-CR07]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034322, P50HL084934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL34322, 2P30DK065988, and P50HL084934. This work was also supported by Cystic Fibrosis Foundation Grant RDP R026-CR07.	Berthiaume Y, 2007, RESP PHYSIOL NEUROBI, V159, P350, DOI 10.1016/j.resp.2007.05.010; Blouquit S, 2006, AM J RESP CRIT CARE, V174, P299, DOI 10.1164/rccm.200506-987OC; Boncoeur E, 2010, AM J PHYSIOL-LUNG C, V298, pL417, DOI 10.1152/ajplung.00170.2009; Borok Z, 2002, AM J PHYSIOL-LUNG C, V282, pL599, DOI 10.1152/ajplung.00130.2000; BOUCHER RC, 1989, J CLIN INVEST, V84, P1424, DOI 10.1172/JCI114316; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Button B, 2008, RESP PHYSIOL NEUROBI, V163, P189, DOI 10.1016/j.resp.2008.04.020; Button B, 2007, J PHYSIOL-LONDON, V580, P577, DOI 10.1113/jphysiol.2006.126086; Calfee CS, 2007, CHEST, V131, P913, DOI 10.1378/chest.06-1743; CASTRANOVA V, 1988, TOXICOL APPL PHARM, V93, P472, DOI 10.1016/0041-008X(88)90051-8; Dobbs LG, 2007, RESP PHYSIOL NEUROBI, V159, P283, DOI 10.1016/j.resp.2007.06.011; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Eaton Douglas C, 2004, Proc Am Thorac Soc, V1, P10, DOI 10.1513/pats.2306008; Eaton DC, 2009, ANNU REV PHYSIOL, V71, P403, DOI 10.1146/annurev.physiol.010908.163250; Factor P, 1998, J CLIN INVEST, V102, P1421, DOI 10.1172/JCI3214; Factor P, 2007, P NATL ACAD SCI USA, V104, P4083, DOI 10.1073/pnas.0601117104; Fang X, 2002, J GEN PHYSIOL, V119, P199, DOI 10.1085/jgp.119.2.199; Fang XH, 2006, AM J PHYSIOL-LUNG C, V290, pL242, DOI 10.1152/ajplung.00178.2005; Fang XH, 2004, AM J PHYSIOL-LUNG C, V287, pL104, DOI 10.1152/ajplung.00176.2003; Faria D, 2009, PFLUG ARCH EUR J PHY, V457, P1373, DOI 10.1007/s00424-008-0606-2; Folkesson HG, 1998, AM J PHYSIOL-LUNG C, V275, pL478, DOI 10.1152/ajplung.1998.275.3.L478; Grubb BR, 2009, AM J PHYSIOL-CELL PH, V296, pC1301, DOI 10.1152/ajpcell.00578.2008; GRUBB BR, 1995, AM J PHYSIOL-GASTR L, V268, pG505, DOI 10.1152/ajpgi.1995.268.3.G505; Gutierrez JA, 2003, AM J RESP CELL MOL, V29, P81, DOI 10.1165/rcmb.2002-0135OC; Ingbar DH, 2009, AM J PHYSIOL-LUNG C, V297, pL813, DOI 10.1152/ajplung.00324.2009; Inglis SK, 1996, AM J PHYSIOL-LUNG C, V270, pL289, DOI 10.1152/ajplung.1996.270.2.L289; Jain L, 1999, CLIN PERINATOL, V26, pXI, DOI 10.1016/S0095-5108(18)30035-6; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Kiefmann R, 2009, AM J PHYSIOL-LUNG C, V296, pL901, DOI 10.1152/ajplung.90549.2008; KIM KJ, 1991, RESP PHYSIOL, V85, P245, DOI 10.1016/0034-5687(91)90065-Q; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; KO NIGJ, 2001, EMBO REP */* K EMBO, V2, P1047; KROUSE ME, 1989, AM J PHYSIOL, V257, pC129, DOI 10.1152/ajpcell.1989.257.1.C129; Lazarowski ER, 2009, CURR OPIN PHARMACOL, V9, P262, DOI 10.1016/j.coph.2009.02.004; Lazrak A, 2000, AM J PHYSIOL-LUNG C, V278, pL233, DOI 10.1152/ajplung.2000.278.2.L233; Leroy C, 2006, AM J PHYSIOL-LUNG C, V291, pL1207, DOI 10.1152/ajplung.00376.2005; Lindert J, 2007, AM J RESP CELL MOL, V36, P688, DOI 10.1165/rcmb.2006-0347OC; Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x; Matthay MA, 1996, AM J PHYSIOL-LUNG C, V270, pL487, DOI 10.1152/ajplung.1996.270.4.L487; Matthay Michael A, 2005, Proc Am Thorac Soc, V2, P206, DOI 10.1513/pats.200501-009AC; NAMKUNG W, MOL BIOL CELL, V21, P2639; Nielsen VG, 1998, AM J PHYSIOL-LUNG C, V275, pL1127, DOI 10.1152/ajplung.1998.275.6.L1127; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Reddy MM, 1996, SCIENCE, V271, P1876, DOI 10.1126/science.271.5257.1876; Ribeiro CMP, 2005, J BIOL CHEM, V280, P10202, DOI 10.1074/jbc.M410317200; Ribeiro CMP, 2005, J BIOL CHEM, V280, P17798, DOI 10.1074/jbc.M410618200; RICE WR, 1995, AM J RESP CELL MOL, V12, P27, DOI 10.1165/ajrcmb.12.1.7811468; Rich PB, 2003, J TRAUMA, V55, P290, DOI 10.1097/01.TA.0000078882.11919.AF; Rochelle LG, 2000, AM J PHYSIOL-LUNG C, V279, pL14, DOI 10.1152/ajplung.2000.279.1.L14; Rollins BM, 2008, AM J RESP CELL MOL, V39, P190, DOI 10.1165/rcmb.2007-0450OC; Roomans Godfried M, 2004, J Cyst Fibros, V3 Suppl 2, P135, DOI 10.1016/j.jcf.2004.05.029; Roux J, 2010, J BIOL CHEM, V285, P4278, DOI 10.1074/jbc.M109.036731; Song WF, 2009, J BIOL CHEM, V284, P7294, DOI 10.1074/jbc.M806816200; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Tarran R, 2005, J BIOL CHEM, V280, P35751, DOI 10.1074/jbc.M505832200; Thiagarajah JR, 2004, FASEB J, V18, P875, DOI 10.1096/fj.03-1248fje; Yan WS, 2004, J BIOL CHEM, V279, P23183, DOI 10.1074/jbc.M402373200; Yang CX, 2009, AM J PHYSIOL-LUNG C, V297, pL439, DOI 10.1152/ajplung.90268.2008; YUE G, 1995, P NATL ACAD SCI USA, V92, P8418, DOI 10.1073/pnas.92.18.8418; Zuo PY, 2008, J BIOL CHEM, V283, P26805, DOI 10.1074/jbc.M801516200	61	58	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34939	34949		10.1074/jbc.M110.162933	http://dx.doi.org/10.1074/jbc.M110.162933			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801871	Green Published, hybrid			2022-12-25	WOS:000283659100068
J	Wu, YY; Zhang, YQ; Zhang, HW; Yang, X; Wang, YY; Ren, FL; Liu, HT; Zhai, YG; Jia, BQ; Yu, J; Chang, ZJ				Wu, Yinyuan; Zhang, Yanquan; Zhang, Haiwei; Yang, Xi; Wang, Yinyin; Ren, Fangli; Liu, Huitu; Zhai, Yonggong; Jia, Baoqing; Yu, Jun; Chang, Zhijie			p15RS Attenuates Wnt/beta-Catenin Signaling by Disrupting beta-Catenin.TCF4 Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; ARMADILLO/BETA-CATENIN; COLON-CARCINOMA; BINDING PROTEIN; TCF COMPLEX; CYCLIN D1; PATHWAY; TARGET; CELLS; GENE	The formation of a beta-catenin.TCF4 complex in the nucleus of cells is well known as a prerequisite for the transcription of Wnt target genes. Although many co-factors have been identified to regulate the activity of the beta-catenin.TCF4 complex, it remains unclear how the complex association is negatively regulated. In this study, we report that p15RS, a negative regulator of the cell cycle, blocks beta-catenin.TCF4 complex formation and inhibits Wnt signaling. We observed that p15RS interacts with beta-catenin and TCF4. Interestingly, whereas the interaction of p15RS with beta-catenin is increased, its interaction with TCF4 is decreased upon Wnt1 stimulation. Moreover, overexpression of p15RS reduces the interaction of beta-catenin with TCF4, whereas the depletion of p15RS enhances their interaction. We further demonstrate that overexpression of p15RS suppresses canonical Wnt signaling and results in retarded cell growth, whereas depletion of p15RS shows an enhanced effect on Wnt signaling. We analyzed that inhibition of Wnt signaling by p15RS leads to decreased expression of CYCLIN D1 and c-MYC, two Wnt targeted genes critical for cell growth. Our data suggest that p15RS inhibits Wnt signaling by interrupting beta-catenin.TCF4 complex formation and that Wnt signaling initiates downstream gene expression by removing p15RS from promoters.	[Chang, Zhijie] Tsinghua Univ, Sch Med, Sch Life Sci,Natl Engn Lab Antitumor Therapeut, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Liu, Huitu; Zhai, Yonggong] Beijing Normal Univ, Key Lab Cell Proliferat & Regulat Biol, Minist Educ, Coll Life Sci, Beijing 100875, Peoples R China; [Jia, Baoqing] Chinese Peoples Liberat Army Gen Hosp, Dept Gen Surg, Beijing 100853, Peoples R China; [Yu, Jun] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Yu, Jun] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Tsinghua University; Beijing Normal University; Chinese People's Liberation Army General Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong	Chang, ZJ (corresponding author), Tsinghua Univ, Sch Med, Sch Life Sci,Natl Engn Lab Antitumor Therapeut, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	zhijiec@tsinghua.edu.cn	Wu, Yinyuan/H-5682-2013; Yu, Jun/D-8569-2015; Chang, Zhijie/AAH-8109-2019; Zhang, Yanquan/D-5615-2017	Yu, Jun/0000-0001-5008-2153; Zhang, Yanquan/0000-0003-3527-9972; Chang, Zhijie/0000-0003-1567-3227	Tsinghua Yue-Yuen Medical Sciences Fund; National Science Foundation of China [30530420, 30470888, 30518002]; Chinese National Support Project [2006CB910102, 2010CB529305]; 863 project [2007AA021505]; Ministry of Science and Technology of China [2008ZX1011-006]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021505] Funding Source: NIH RePORTER	Tsinghua Yue-Yuen Medical Sciences Fund; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Support Project; 863 project(National High Technology Research and Development Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Tsinghua Yue-Yuen Medical Sciences Fund and National Science Foundation of China Grants 30530420, 30470888, and 30518002, Chinese National Support Project Grants 2006CB910102 and 2010CB529305, 863 project Grant 2007AA021505, and Ministry of Science and Technology of China project Grant 2008ZX1011-006.	Bauer A, 1998, P NATL ACAD SCI USA, V95, P14787, DOI 10.1073/pnas.95.25.14787; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bienz M, 2003, NAT CELL BIOL, V5, P179, DOI 10.1038/ncb0303-179; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hecht A, 1999, J BIOL CHEM, V274, P18017, DOI 10.1074/jbc.274.25.18017; Hecht A, 2000, EMBO REP, V1, P24, DOI 10.1093/embo-reports/kvd012; Hirose Y, 2000, GENE DEV, V14, P1415; Hong CF, 2009, J BIOL CHEM, V284, P19613, DOI 10.1074/jbc.M109.005017; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Klein TJ, 2006, CURR BIOL, V16, P1337, DOI 10.1016/j.cub.2006.06.030; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu J, 2002, BIOCHEM BIOPH RES CO, V299, P880, DOI 10.1016/S0006-291X(02)02684-0; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Tago K, 2000, GENE DEV, V14, P1741; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Topol LL, 2009, J BIOL CHEM, V284, P3323, DOI 10.1074/jbc.M808048200; Townsley FM, 2004, NAT CELL BIOL, V6, P626, DOI 10.1038/ncb1141; Tzeng SL, 2006, J BIOL CHEM, V281, P15405, DOI 10.1074/jbc.M601807200; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Yamada M, 2006, J BIOL CHEM, V281, P20749, DOI 10.1074/jbc.M602089200; Zhang XY, 2005, PROG BIOCHEM BIOPHYS, V32, P771	38	34	37	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34621	34631		10.1074/jbc.M110.148791	http://dx.doi.org/10.1074/jbc.M110.148791			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739273	hybrid, Green Published			2022-12-25	WOS:000283659100038
J	Zhang, ZC; Florez, S; Gutierrez-Hartmann, A; Martin, JF; Amendt, BA				Zhang, Zichao; Florez, Sergio; Gutierrez-Hartmann, Arthur; Martin, James F.; Amendt, Brad A.			MicroRNAs Regulate Pituitary Development, and MicroRNA 26b Specifically Targets Lymphoid Enhancer Factor 1 (Lef-1), Which Modulates Pituitary Transcription Factor 1 (Pit-1) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; GENE-EXPRESSION; PITX2; MORPHOGENESIS; ACTIVATION; REPRESSORS; SECRETION; INTERACT; PROMOTER; DOMAIN	To understand the role of microRNAs (miRNAs) in pituitary development, a group of pituitary-specific miRNAs were identified, and Dicer1 was then conditionally knocked out using the Pitx2-Cre mouse, resulting in the loss of mature miRNAs in the anterior pituitary. The Pitx2-Cre/Dicer1 mutant mice demonstrate growth retardation, and the pituitaries are hypoplastic with an abnormal branching of the anterior lobe, revealing a role for microRNAs in pituitary development. Growth hormone, prolactin, and thyroid-stimulating hormone beta-subunit expression were decreased in the Dicer1 mutant mouse, whereas proopiomelanocortin and luteinizing hormone beta-subunit expression were normal in the mutant pituitary. Further analyses revealed decreased Pit-1 and increased Lef-1 expression in the mutant mouse pituitary, consistent with the repression of the Pit-1 promoter by Lef-1. Lef-1 directly targets and represses the Pit-1 promoter. miRNA-26b (miR-26b) was identified as targeting Lef-1 expression, and miR-26b represses Lef-1 in pituitary and non-pituitary cell lines. Furthermore, miR-26b up-regulates Pit-1 and growth hormone expression by attenuating Lef-1 expression in GH3 cells. This study demonstrates that microRNAs are critical for anterior pituitary development and that miR-26b regulates Pit-1 expression by inhibiting Lef-1 expression and may promote Pit-1 lineage differentiation during pituitary development.	[Zhang, Zichao; Florez, Sergio; Martin, James F.; Amendt, Brad A.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Environm & Genet Med, Houston, TX 77030 USA; [Gutierrez-Hartmann, Arthur] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; [Gutierrez-Hartmann, Arthur] Univ Colorado Denver, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Amendt, BA (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Environm & Genet Med, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	bamendt@ibt.tamhsc.edu	Gutierrez-Hartmann, Arthur/F-1295-2011	Amendt, Brad A./0000-0001-6524-1006	National Institutes of Health, NIDCR [DE 13941]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013941] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health, NIDCR, Grant DE 13941 (to B. A. A.).	Amen M, 2008, NUCLEIC ACIDS RES, V36, P462, DOI 10.1093/nar/gkm1047; Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Bradford AP, 1997, MOL CELL BIOL, V17, P1065, DOI 10.1128/MCB.17.3.1065; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Cha KB, 2004, MECH DEVELOP, V121, P183, DOI 10.1016/j.mod.2003.12.002; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; GIESE K, 1991, GENE DEV, V5, P2567, DOI 10.1101/gad.5.12b.2567; Gruszka A, 2007, ENDOCRINOLOGY, V148, P6107, DOI 10.1210/en.2007-0378; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Jimenez J, 2005, RNA, V11, P1385, DOI 10.1261/rna.7226105; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; Li TWH, 2006, MOL CELL BIOL, V26, P5284, DOI 10.1128/MCB.00105-06; Liu W, 2003, DEVELOPMENT, V130, P6375, DOI 10.1242/dev.00849; Nasonkin IO, 2004, HUM MOL GENET, V13, P2727, DOI 10.1093/hmg/ddh311; *NAT RES COUNC, 1996, NIH PUBL, V8623; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; VAN G, 1994, Genes Dev, V8, P2691; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006	34	72	77	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34718	34728		10.1074/jbc.M110.126441	http://dx.doi.org/10.1074/jbc.M110.126441			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20807761	Green Published, hybrid			2022-12-25	WOS:000283659100047
J	Hadfield, KD; Smith, MJ; Urquhart, JE; Wallace, AJ; Bowers, NL; King, AT; Rutherford, SA; Trump, D; Newman, WG; Evans, DG				Hadfield, K. D.; Smith, M. J.; Urquhart, J. E.; Wallace, A. J.; Bowers, N. L.; King, A. T.; Rutherford, S. A.; Trump, D.; Newman, W. G.; Evans, D. G.			Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas	ONCOGENE			English	Article						mitotic recombination; schwannomatosis; SMARCB1; NF2; vestibular schwannoma	COMPARATIVE GENOMIC HYBRIDIZATION; FAMILIAL SCHWANNOMATOSIS; SMARCB1; IDENTIFICATION; NEUROFIBROMAS; METHYLATION; MUTATION; GENE; DNA	Biallelic inactivation of the NF2 gene occurs in the majority of schwannomas. This usually involves a combination of a point mutation or multiexon deletion, in conjunction with either a second point mutation or loss of heterozygosity (LOH). We have performed DNA sequence and dosage analysis of the NF2 gene in a panel of 239 schwannoma tumours: 97 neurofibromatosis type 2 (NF2)-related schwannomas, 104 sporadic vestibular schwannomas (VS) and 38 schwannomatosis-related schwannomas. In total, we identified germline NF2 mutations in 86 out of 97 (89%) NF2 patients and a second mutational event in 77 out of 97 (79%). LOH was by far the most common form of second hit. A combination of microsatellite analysis with either conventional comparative genomic hybridization (CGH) or multiplex ligation-dependent probe amplification (MLPA) identified mitotic recombination (MR) as the cause of LOH in 14 out of 72 (19%) total evaluable tumours. Among sporadic VS, at least one NF2 mutation was identified by sequence analysis or MLPA in 65 out of 98 (66%) tumours. LOH occurred in 54 out of 96 (56%) evaluable tumours, but MR only accounted for 5 out of 77 (6%) tested. LOH was present in 28 out of 34 (82%) schwannomatosis-related schwannomas. In all eight patients who had previously tested positive for a germline SMARCB1 mutation, this involved loss of the whole, or part of the long arm, of chromosome 22. In contrast, 5 out of 22 (23%) tumours from patients with no germline SMARCB1 mutation exhibited MR. High-resolution Affymetrix SNP6 genotyping and copy number (CN) analysis (Affymetrix, Santa Clara, CA, USA) were used to determine the chromosomal breakpoint locations in tumours with MR. A range of unique recombination sites, spanning approximately 11.4Mb, were identified. This study shows that MR is a mechanism of LOH in NF2 and SMARCB1-negative schwannomatosis-related schwannomas, occurring less frequently in sporadic VS. We found no evidence of MR in SMARCB1-positive schwannomatosis, suggesting that susceptibility to MR varies according to the disease context. Oncogene (2010) 29, 6216-6221; doi:10.1038/onc.2010.363; published online 23 August 2010	[Hadfield, K. D.; Smith, M. J.; Urquhart, J. E.; Wallace, A. J.; Bowers, N. L.; Trump, D.; Newman, W. G.; Evans, D. G.] Univ Manchester, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Dept Med Genet, Manchester M13 9WL, Lancs, England; [King, A. T.; Rutherford, S. A.] Hope Hosp, Dept Neurosurg, Manchester, Lancs, England	University of Manchester	Evans, DG (corresponding author), Univ Manchester, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Dept Med Genet, Manchester M13 9WL, Lancs, England.	gareth.evans@cmft.nhs.uk	Rutherford, Scott/GMX-2404-2022; Evans, D Gareth/AAB-4308-2022; Urquhart, Jill/G-2282-2015; King, Andrew/AAR-1656-2020; Smith, Miriam/J-4001-2015	Evans, D Gareth/0000-0002-8482-5784; Urquhart, Jill/0000-0002-5788-5511; Smith, Miriam/0000-0002-3184-0817; Rutherford, Scott/0000-0002-6749-2295; Newman, William/0000-0002-6382-4678; King, Andrew/0000-0002-6546-7248	Children's Tumor Foundation; NIHR Manchester Biomedical Research Centre	Children's Tumor Foundation; NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR))	This work was supported by a grant from the Children's Tumor Foundation. The Department of Genetic Medicine is supported by the NIHR Manchester Biomedical Research Centre. We also thank all the patients who provided samples for the study.	Boyd C, 2008, CLIN GENET, V74, P358, DOI 10.1111/j.1399-0004.2008.01060.x; Carbone L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000538; De Raedt T, 2006, GENE CHROMOSOME CANC, V45, P893, DOI 10.1002/gcc.20353; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; EVANS DGR, 1992, Q J MED, V84, P603; Gonzalez-Gomez P, 2003, CLIN CANCER RES, V9, P5601; Hadfield KD, 2008, J MED GENET, V45, P332, DOI 10.1136/jmg.2007.056499; Hulsebos TJM, 2007, AM J HUM GENET, V80, P805, DOI 10.1086/513207; James L, 1996, CHROMOSOME RES, V4, P163, DOI 10.1007/BF02259711; James LA, 1999, BRIT J CANCER, V81, P300, DOI 10.1038/sj.bjc.6990691; KAPLAN JC, 1987, J MED GENET, V24, P65, DOI 10.1136/jmg.24.2.65; Kino T, 2001, GENES CELLS, V6, P441, DOI 10.1046/j.1365-2443.2001.00432.x; MacCollin M, 2003, NEUROLOGY, V60, P1968, DOI 10.1212/01.WNL.0000070184.08740.E0; Serra E, 2001, NAT GENET, V28, P294, DOI 10.1038/90148; Sestini R, 2008, HUM MUTAT, V29, P227, DOI 10.1002/humu.20679; Warren C, 2003, J MED GENET, V40, P802, DOI 10.1136/jmg.40.11.802	17	74	79	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	47					6216	6221		10.1038/onc.2010.363	http://dx.doi.org/10.1038/onc.2010.363			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	685CG	20729918	Bronze			2022-12-25	WOS:000284601700003
J	Soria-Castro, I; Krzyzanowska, A; Pelaez, ML; Regadera, J; Ferrer, G; Montoliu, L; Rodreguez-Ramos, R; Fernandez, M; Alemany, S				Soria-Castro, Irene; Krzyzanowska, Agnieszka; Lopez Pelaez, Marta; Regadera, Javier; Ferrer, Gema; Montoliu, Lluis; Rodreguez-Ramos, Rosario; Fernandez, Margarita; Alemany, Susana			Cot/tpl2 (MAP3K8) Mediates Myeloperoxidase Activity and Hypernociception following Peripheral Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-KINASE; SIGNAL-REGULATED KINASE; NECROSIS-FACTOR-ALPHA; NERVE GROWTH-FACTOR; IN-VIVO; NEUTROPHIL MIGRATION; IMMUNE-SYSTEM; TPL2 KINASE; TNF-ALPHA; CD11B/CD18 INTEGRINS	Cot/tpl2 (also known as MAP3K8) has emerged as a new and potentially interesting therapeutic anti-inflammatory target. Here, we report the first study of Cot/tpl2 involvement in acute peripheral inflammation in vivo. Six hours after an intraplantar injection of zymosan, Cot/tpl2(-/-) mice showed a 47% reduction in myeloperoxidase activity, concomitant with a 46% lower neutrophil recruitment and a 40% decreased luminol-mediated bioluminescence imaging in vivo. Accordingly, Cot/tpl2 deficiency provoked a 25-30% reduction in luminol-mediated bioluminescence and neutrophil recruitment together with a 65% lower macrophage recruitment 4 h following zymosan-induced peritonitis. Significantly impaired levels of G-CSF and GM-CSF and of other cytokines such as TNF alpha, IL-1 beta, and IL-6, as well as some chemokines such as MCP-1, MIP-1 beta, and keratinocyte-derived chemokine, were detected during the acute zymosan-induced intraplantar inflammatory response in Cot/tpl2(-/-) mice. Moreover, Cot/tpl2 deficiency dramatically decreased the production of the hypernociceptive ligand NGF at the inflammatory site during the course of inflammation. Most importantly, Cot/tpl2 deficiency significantly reduced zymosan-induced inflammatory hypernociception in mice, with a most pronounced effect of a 50% decrease compared with wild type (WT) at 24 h following intraplantar injection of zymosan. At this time, Cot/tpl2(-/-) mice showed significantly reduced NGF, TNF alpha, and prostaglandin E-2 levels compared with WT littermates. In conclusion, our study demonstrates an important role of Cot/tpl2 in the NGF, G-CSF, and GM-CSF production and myeloperoxidase activity in the acute inflammatory response process and its implication in inflammatory hypernociception.	[Fernandez, Margarita; Alemany, Susana] Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, E-28049 Madrid, Spain; [Krzyzanowska, Agnieszka; Regadera, Javier] Univ Autonoma Madrid, Dept Anat Histol & Neurociencia, Fac Med, E-28049 Madrid, Spain; [Montoliu, Lluis] Univ San Pablo, Fac Med, Dept Biol Mol & Celular, CNB,CSIC,CEU, Madrid 28668, Spain; [Rodreguez-Ramos, Rosario] Univ San Pablo, Fac Med, CEU, Dept Ciencias Med, Madrid 28668, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); San Pablo CEU University; San Pablo CEU University	Alemany, S (corresponding author), IIBm CSIC UAM, Arturo Duperier 4, Madrid 28029, Spain.	salemany@iib.uam.es	Montoliu, Lluis/I-2039-2015; Alemany, Susana/J-6307-2014	Montoliu, Lluis/0000-0003-3941-1176; Alemany, Susana/0000-0002-4089-7620; krzyzanowska, agnieszka/0000-0002-1288-7054; Lopez Pelaez, Marta/0000-0003-3892-9694	Comunidad de Madrid [SAF 2008-00819]; Mutua Madrilena; Formacion Personal Investigador fellowship	Comunidad de Madrid(Comunidad de Madrid); Mutua Madrilena; Formacion Personal Investigador fellowship	This work was supported by Comunidad de Madrid Grants SAF 2008-00819 and Mutua Madrilena.; Recipient of the Formacion Personal Investigador fellowship.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; Banerjee A, 2007, IMMUNOL CELL BIOL, V85, P420, DOI 10.1038/sj.icb.7100098; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Beinke S, 2003, MOL CELL BIOL, V23, P4739, DOI 10.1128/MCB.23.14.4739-4752.2003; Bhatia M, 2005, BRIT J PHARMACOL, V145, P141, DOI 10.1038/sj.bjp.0706186; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Caivano M, 2003, J BIOL CHEM, V278, P52124, DOI 10.1074/jbc.M306583200; Cho JH, 2005, P NATL ACAD SCI USA, V102, P2350, DOI 10.1073/pnas.0409856102; Cohen P, 2009, CURR OPIN CELL BIOL, V21, P317, DOI 10.1016/j.ceb.2009.01.015; Cowburn AS, 2002, BLOOD, V100, P2607, DOI 10.1182/blood-2001-11-0122; Coxon A, 1999, J EXP MED, V190, P923, DOI 10.1084/jem.190.7.923; Cunha TM, 2005, P NATL ACAD SCI USA, V102, P1755, DOI 10.1073/pnas.0409225102; Cusack K, 2009, BIOORG MED CHEM LETT, V19, P1722, DOI 10.1016/j.bmcl.2009.01.088; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; El Kebir D, 2008, CIRC RES, V103, P352, DOI 10.1161/01.RES.0000326772.76822.7a; El Kebir D, 2009, AM J RESP CRIT CARE, V180, P311, DOI 10.1164/rccm.200810-1601OC; Eliopoulos AG, 2002, J VIROL, V76, P4567, DOI 10.1128/JVI.76.9.4567-4579.2002; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Frossard JL, 2002, AM J PHYSIOL-LUNG C, V283, pL541, DOI 10.1152/ajplung.00413.2001; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Gandara ML, 2003, MOL CELL BIOL, V23, P7377, DOI 10.1128/MCB.23.20.7377-7390.2003; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; George D, 2008, BIOORG MED CHEM LETT, V18, P4952, DOI 10.1016/j.bmcl.2008.08.037; Giannini E, 2009, P NATL ACAD SCI USA, V106, P14646, DOI 10.1073/pnas.0903720106; Green N, 2007, J MED CHEM, V50, P4728, DOI 10.1021/jm070436q; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Guerrero ATG, 2008, J LEUKOCYTE BIOL, V83, P122, DOI 10.1189/jlb.0207123; Haegens A, 2009, J IMMUNOL, V182, P7990, DOI 10.4049/jimmunol.0800377; Hall JP, 2007, J BIOL CHEM, V282, P33295, DOI 10.1074/jbc.M703694200; Handoyo H, 2009, BIOCHEM J, V424, P109, DOI 10.1042/BJ20091271; Haqqani AS, 1999, ANAL BIOCHEM, V273, P126, DOI 10.1006/abio.1999.4206; Heissmeyer V, 1999, EMBO J, V18, P4766, DOI 10.1093/emboj/18.17.4766; Kaila N, 2007, BIOORGAN MED CHEM, V15, P6425, DOI 10.1016/j.bmc.2007.06.054; Kingery WS, 2001, BRAIN RES, V913, P140, DOI 10.1016/S0006-8993(01)02763-9; Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Li YL, 2007, BIOCHIMIE, V89, P1257, DOI 10.1016/j.biochi.2007.07.002; Li YL, 2009, FEBS J, V276, P303, DOI 10.1111/j.1742-4658.2008.06780.x; Loniewski KJ, 2007, MOL IMMUNOL, V44, P3715, DOI 10.1016/j.molimm.2007.04.002; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; McMahon SB, 1996, PHILOS T R SOC B, V351, P431, DOI 10.1098/rstb.1996.0039; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mielke LA, 2009, J IMMUNOL, V183, P7984, DOI 10.4049/jimmunol.0901336; Olynych TJ, 2006, J ALLERGY CLIN IMMUN, V118, P837, DOI 10.1016/j.jaci.2006.06.008; Orian A, 2000, EMBO J, V19, P2580, DOI 10.1093/emboj/19.11.2580; Perruche S, 2004, J IMMUNOL METHODS, V294, P53, DOI 10.1016/j.jim.2004.08.011; Ribeiro RA, 1997, INT ARCH ALLERGY IMM, V112, P27, DOI 10.1159/000237427; Rittner HL, 2001, ANESTHESIOLOGY, V95, P500, DOI 10.1097/00000542-200108000-00036; Robinson MJ, 2007, MOL CELL BIOL, V27, P7355, DOI 10.1128/MCB.00301-07; Rodriguez C, 2008, CELL SIGNAL, V20, P1625, DOI 10.1016/j.cellsig.2008.05.008; Rodriguez C, 2006, CELL SIGNAL, V18, P1376, DOI 10.1016/j.cellsig.2005.10.016; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Salmeron A, 2001, J BIOL CHEM, V276, P22215, DOI 10.1074/jbc.M101754200; SOUZA GEP, 1988, AGENTS ACTIONS, V24, P377, DOI 10.1007/BF02028296; Stafford MJ, 2006, FEBS LETT, V580, P4010, DOI 10.1016/j.febslet.2006.06.004; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Traves PG, 2007, MOL PHARMACOL, V71, P1545, DOI 10.1124/mol.106.031906; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Van Acker GJD, 2007, J BIOL CHEM, V282, P22140, DOI 10.1074/jbc.M702225200; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; Verri WA, 2009, N-S ARCH PHARMACOL, V379, P271, DOI 10.1007/s00210-008-0360-1; Waterfield M, 2004, MOL CELL BIOL, V24, P6040, DOI 10.1128/MCB.24.13.6040-6048.2004; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Woolf CJ, 1997, BRIT J PHARMACOL, V121, P417, DOI 10.1038/sj.bjp.0701148; Yang HT, 2008, CELL SIGNAL, V20, P375, DOI 10.1016/j.cellsig.2007.10.025	67	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33805	33815		10.1074/jbc.M110.169409	http://dx.doi.org/10.1074/jbc.M110.169409			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20736176	Green Published, hybrid			2022-12-25	WOS:000283354000027
J	Benameur, T; Tual-Chalot, S; Andriantsitohaina, R; Martinez, MC				Benameur, Tarek; Tual-Chalot, Simon; Andriantsitohaina, Ramaroson; Martinez, Maria Carmen			PPAR alpha Is Essential for Microparticle-Induced Differentiation of Mouse Bone Marrow-Derived Endothelial Progenitor Cells and Angiogenesis	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED-RECEPTOR; STEM-CELLS; CIRCULATING MICROPARTICLES; MONONUCLEAR-CELLS; NEOVASCULARIZATION; RECRUITMENT; GROWTH; GAMMA; MICROVESICLES; TRANSCRIPTION	Background: Bone marrow-derived endothelial progenitor cells (EPCs) are critical for neovascularization. We hypothesized that microparticles (MPs), small fragments generated from the plasma membrane, can activate angiogenic programming of EPCs. Methodology/Principal Findings: We studied the effects of MPs obtained from wild type (MPs(PPARa+/+)) and knock-out (MPs(PPAR alpha-/-)) mice on EPC differentiation and angiogenesis. Bone marrow-derived cells were isolated from WT or KO mice and were cultured in the presence of MPs(PPARa+/+) or MPs(PPAR alpha-/-) obtained from blood of mice. Only MPs(PPARa+/+) harboring PPAR a significantly increased EPC, but not monocytic, differentiation. Bone marrow-derived cells treated with MPs(PPARa+/+) displayed increased expression of pro-angiogenic genes and increased in vivo angiogenesis. MPs(PPARa+/+) increased capillarylike tube formation of endothelial cells that was associated with enhanced expressions of endothelial cell-specific markers. Finally, the effects of MPs(PPARa+/+) were mediated by NF-kB-dependent mechanisms. Conclusions/Significance: Our results underscore the obligatory role of PPARa carried by MPs for EPC differentiation and angiogenesis. PPARa-NF-kB-Akt pathways may play a pivotal stimulatory role for neovascularization, which may, at least in part, be mediated by bone marrow-derived EPCs. Improvement of EPC differentiation may represent a useful strategy during reparative neovascularization.	[Benameur, Tarek; Tual-Chalot, Simon; Andriantsitohaina, Ramaroson; Martinez, Maria Carmen] CNRS, UMR 6214, Angers, France; [Benameur, Tarek; Tual-Chalot, Simon; Andriantsitohaina, Ramaroson; Martinez, Maria Carmen] INSERM, U771, Angers, France; [Benameur, Tarek; Tual-Chalot, Simon; Andriantsitohaina, Ramaroson; Martinez, Maria Carmen] Univ Angers, Fac Med, Angers, France	Centre National de la Recherche Scientifique (CNRS); Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers	Benameur, T (corresponding author), CNRS, UMR 6214, Angers, France.	carmen.martinez@univ-angers.fr	B, T/ABD-6713-2020; ANDRIANTSITOHAINA, Ramaroson/H-5286-2018; BENAMEUR, TAREK/P-9053-2019	Tual-Chalot, Simon/0000-0002-9307-7175; andriantsitohaina, ramaroson/0000-0002-4770-3585; Martinez, M Carmen/0000-0003-3897-7397				Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Agouni A, 2008, AM J PATHOL, V173, P1210, DOI 10.2353/ajpath.2008.080228; Asahara T, 2004, AM J PHYSIOL-CELL PH, V287, pC572, DOI 10.1152/ajpcell.00330.2003; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Benameur T, 2009, PHARMACOL REP, V61, P49, DOI 10.1016/S1734-1140(09)70006-4; Biscetti F, 2008, DIABETES, V57, P1394, DOI 10.2337/db07-0765; Biscetti F, 2009, J VASC RES, V46, P103, DOI 10.1159/000143793; Brill A, 2005, CARDIOVASC RES, V67, P30, DOI 10.1016/j.cardiores.2005.04.007; Cimini A, 2008, STEM CELL REV, V4, P293, DOI 10.1007/s12015-008-9024-2; De Bosscher K, 2006, ONCOGENE, V25, P6868, DOI 10.1038/sj.onc.1209935; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Ding L, 2007, CELL BIOL INT, V31, P1002, DOI 10.1016/j.cellbi.2007.03.013; Duan SZ, 2008, CIRC RES, V102, P283, DOI 10.1161/CIRCRESAHA.107.164384; Fadini GP, 2006, EUR HEART J, V27, P2247, DOI 10.1093/eurheartj/ehl198; Fujiyama S, 2003, CIRC RES, V93, P980, DOI 10.1161/01.RES.0000099245.08637.CE; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Han SW, 2008, AM J PHYSIOL-LUNG C, V294, pL1238, DOI 10.1152/ajplung.00017.2008; Hanley K, 1998, J INVEST DERMATOL, V110, P368, DOI 10.1046/j.1523-1747.1998.00139.x; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Jin H, 2006, J CLIN INVEST, V116, P652, DOI 10.1172/JCI24751; Jones DC, 2003, J IMMUNOL, V171, P196, DOI 10.4049/jimmunol.171.1.196; Jones DC, 2002, J BIOL CHEM, V277, P6838, DOI 10.1074/jbc.M106908200; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Kaplanski C, 2000, CANCER RES, V60, P580; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kim SJ, 2009, AM J PATHOL, V174, P1972, DOI 10.2353/ajpath.2009.080819; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Lacroix R, 2007, BLOOD, V110, P2432, DOI 10.1182/blood-2007-02-069997; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Mezentsev A, 2005, AM J PHYSIOL-HEART C, V289, pH1106, DOI 10.1152/ajpheart.00265.2005; Mostefai HA, 2008, AM J RESP CRIT CARE, V178, P1148, DOI 10.1164/rccm.200712-1835OC; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ray DM, 2008, THROMB HAEMOSTASIS, V99, P86, DOI 10.1160/TH07-05-0328; Ridnour LA, 2005, P NATL ACAD SCI USA, V102, P13147, DOI 10.1073/pnas.0502979102; Sharifpanah F, 2008, STEM CELLS, V26, P64, DOI 10.1634/stemcells.2007-0532; Soleti R, 2009, CARCINOGENESIS, V30, P580, DOI 10.1093/carcin/bgp030; Steinmetz M, 2010, HYPERTENSION, V55, P593, DOI 10.1161/HYPERTENSIONAHA.109.134213; Szmitko PE, 2003, CIRCULATION, V107, P3093, DOI 10.1161/01.CIR.0000074242.66719.4A; Tabernero Antonia, 2002, BMC Pharmacol, V2, P10, DOI 10.1186/1471-2210-2-10; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wang CH, 2004, CIRCULATION, V109, P1392, DOI 10.1161/01.CIR.0000123231.49594.21; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814	49	43	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12392	10.1371/journal.pone.0012392	http://dx.doi.org/10.1371/journal.pone.0012392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811625	Green Published, gold			2022-12-25	WOS:000281234700017
J	Giannone, RJ; McDonald, HW; Hurst, GB; Shen, RF; Wang, YS; Liu, Y				Giannone, Richard J.; McDonald, Hayes W.; Hurst, Gregory B.; Shen, Rong-Fong; Wang, Yisong; Liu, Yie			The Protein Network Surrounding the Human Telomere Repeat Binding Factors TRF1, TRF2, and POT1	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; DOUBLE-STRAND BREAKS; MAMMALIAN TELOMERES; HOMOLOGOUS RECOMBINATION; DYSFUNCTIONAL TELOMERES; INDUCED PHOSPHORYLATION; IMPORTIN-ALPHA; HUMAN-CELLS; HUMAN RAP1; COMPLEX	Telomere integrity (including telomere length and capping) is critical in overall genomic stability. Telomere repeat binding factors and their associated proteins play vital roles in telomere length regulation and end protection. In this study, we explore the protein network surrounding telomere repeat binding factors, TRF1, TRF2, and POT1 using dual-tag affinity purification in combination with multidimensional protein identification technology liquid chromatography - tandem mass spectrometry (MudPIT LC-MS/MS). After control subtraction and data filtering, we found that TRF2 and POT1 co-purified all six members of the telomere protein complex, while TRF1 identified five of six components at frequencies that lend evidence towards the currently accepted telomere architecture. Many of the known TRF1 or TRF2 interacting proteins were also identified. Moreover, putative associating partners identified for each of the three core components fell into functional categories such as DNA damage repair, ubiquitination, chromosome cohesion, chromatin modification/remodeling, DNA replication, cell cycle and transcription regulation, nucleotide metabolism, RNA processing, and nuclear transport. These putative protein-protein associations may participate in different biological processes at telomeres or, intriguingly, outside telomeres.	[Giannone, Richard J.; Wang, Yisong] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Giannone, Richard J.; Hurst, Gregory B.] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN USA; [McDonald, Hayes W.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Shen, Rong-Fong; Liu, Yie] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Wang, Yisong] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Giannone, RJ (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA.	yisong.wang@nih.gov; liuyie@mail.nih.gov	Liu, Yie/AAO-2092-2020; Giannone, Richard/ABC-8247-2020	Giannone, Richard/0000-0001-8551-0138; Hurst, Gregory/0000-0002-7650-8009	National Institute on Aging, National Institutes of Health; Oak Ridge National Laboratory; Office of Biological and Environmental Research, U.S. Department of Energy [DE-AC05-00OR22725]	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Oak Ridge National Laboratory(United States Department of Energy (DOE)); Office of Biological and Environmental Research, U.S. Department of Energy(United States Department of Energy (DOE))	This study was supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. Y.W. and R.J.G. acknowledge the support of the Laboratory Directed Research and Development Program (LDRD), Oak Ridge National Laboratory, and the Office of Biological and Environmental Research, U.S. Department of Energy (DE-AC05-00OR22725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Atanasiu C, 2006, EMBO REP, V7, P716, DOI 10.1038/sj.embor.7400730; Ballal RD, 2009, J BIOL CHEM, V284, P36083, DOI 10.1074/jbc.M109.025825; Barbash O, 2008, CANCER CELL, V14, P68, DOI 10.1016/j.ccr.2008.05.017; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Bradshaw PS, 2005, NAT GENET, V37, P193, DOI 10.1038/ng1506; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Canudas S, 2007, EMBO J, V26, P4867, DOI 10.1038/sj.emboj.7601903; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chen LY, 2007, MOL CELL BIOL, V27, P5898, DOI 10.1128/MCB.00603-07; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng Z, 2003, J VIROL, V77, P11992, DOI 10.1128/JVI.77.22.11992-12001.2003; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; Dynek JN, 2004, SCIENCE, V304, P97, DOI 10.1126/science.1094754; Forwood JK, 2002, BIOCHEMISTRY-US, V41, P9333, DOI 10.1021/bi025548s; Giannone RJ, 2007, BIOTECHNIQUES, V43, P296, DOI 10.2144/000112550; Gomez M, 2006, MOL BIOL CELL, V17, P1686, DOI 10.1091/mbc.E05-07-0672; Greider CW, 1996, SCI AM, V274, P92, DOI 10.1038/scientificamerican0296-92; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Huda N, 2009, MOL CELL BIOL, V29, P3597, DOI 10.1128/MCB.00944-08; Karlseder J, 2004, PLOS BIOL, V2, P1150, DOI 10.1371/journal.pbio.0020240; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Koering CE, 2002, EMBO REP, V3, P1055, DOI 10.1093/embo-reports/kvf215; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee TH, 2009, NAT CELL BIOL, V11, P97, DOI 10.1038/ncb1818; Lee TH, 2006, J BIOL CHEM, V281, P759, DOI 10.1074/jbc.M509855200; Lenain C, 2006, CURR BIOL, V16, P1303, DOI 10.1016/j.cub.2006.05.021; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Linger BR, 2009, CRIT REV BIOCHEM MOL, V44, P434, DOI 10.3109/10409230903307329; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Longhese MP, 2008, GENE DEV, V22, P125, DOI 10.1101/gad.1626908; Mao ZY, 2007, P NATL ACAD SCI USA, V104, P13068, DOI 10.1073/pnas.0702410104; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Nakamura M, 2001, CURR BIOL, V11, P1512, DOI 10.1016/S0960-9822(01)00456-0; Nijjar T, 2005, ONCOGENE, V24, P3369, DOI 10.1038/sj.onc.1208482; O'Connor MS, 2004, J BIOL CHEM, V279, P28585, DOI 10.1074/jbc.M312913200; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Saharia A, 2008, CURR BIOL, V18, P496, DOI 10.1016/j.cub.2008.02.071; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Song K, 2000, FEBS LETT, V481, P81, DOI 10.1016/S0014-5793(00)01958-X; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tanaka H, 2005, P NATL ACAD SCI USA, V102, P15539, DOI 10.1073/pnas.0507915102; Tatsumi Y, 2008, GENES CELLS, V13, P1045, DOI 10.1111/j.1365-2443.2008.01224.x; TEMIMESMAALI N, 2008, EMBO J; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Xin HW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-232; Xu Yi-yi, 2007, Zhejiang Da Xue Xue Bao Yi Xue Ban, V36, P325; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Zeng SC, 2009, NAT CELL BIOL, V11, P616, DOI 10.1038/ncb1867; Zhang P, 2008, CURR BIOL, V18, P1489, DOI 10.1016/j.cub.2008.08.048; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	75	41	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12407	10.1371/journal.pone.0012407	http://dx.doi.org/10.1371/journal.pone.0012407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811636	Green Published, Green Submitted, gold			2022-12-25	WOS:000281234700028
J	Goh, LL; Manser, E				Goh, Liuh Ling; Manser, Ed			The RhoA GEF Syx Is a Target of Rnd3 and Regulated via a Raf1-Like Ubiquitin-Related Domain	PLOS ONE			English	Article							NUCLEOTIDE-EXCHANGE FACTORS; IN-VIVO; ROCK-I; VERTEBRATE GASTRULATION; CONVERGENT EXTENSION; XENOPUS GASTRULATION; ACTS DOWNSTREAM; CELL-ADHESION; STEM-CELLS; PROTEIN	Background: Rnd3 (RhoE) protein belongs to the unique branch of Rho family GTPases that has low intrinsic GTPase activity and consequently remains constitutively active [1,2]. The current consensus is that Rnd1 and Rnd3 function as important antagonists of RhoA signaling primarily by activating the ubiquitous p190 RhoGAP [3], but not by inhibiting the ROCK family kinases. Methodology/Principal Findings: Rnd3 is abundant in mouse embryonic stem (mES) cells and in an unbiased two-step affinity purification screen we identified a new Rnd3 target, termed synectin-binding RhoA exchange factor (Syx), by mass spectrometry. The Syx interaction with Rnd3 does not occur through the Syx DH domain but utilizes a region similar to the classic Raf1 Ras-binding domain (RBD), and most closely related to those in RGS12 and RGS14. We show that Syx behaves as a genuine effector of Rnd3 (and perhaps Rnd1), with binding characteristics similar to p190-RhoGAP. Morpholino-oligonucleotide knockdown of Syx in zebrafish at the one cell stage resulted in embryos with shortened anterior-posterior body axis: this phenotype was effectively rescued by introducing mouse Syx1b mRNA. A Rnd3-binding defective mutant of Syx1b mutated in the RBD (E164A/R165D) was more potent in rescuing the embryonic defects than wild-type Syx1b, showing that Rnd3 negatively regulates Syx activity in vivo. Conclusions/Significance: This study uncovers a well defined Rnd3 effector Syx which is widely expressed and directly impacts RhoA activation. Experiments conducted in vivo indicate that Rnd3 negatively regulates Syx, and that as a RhoA-GEF it plays a key role in early embryonic cell shape changes. Thus a connection to signaling via the planar cell polarity pathway is suggested.	[Goh, Liuh Ling; Manser, Ed] Inst Med Biol, Rho GTPases Stem Cells RGS Grp, Singapore, Singapore; [Manser, Ed] IMCB, Small G Prot Signaling & Kinases sGSK Grp, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Goh, LL (corresponding author), Inst Med Biol, Rho GTPases Stem Cells RGS Grp, Singapore, Singapore.	ed.manser@imb.a-star.edu.sg	Manser, Edward/ABD-2301-2020		Agency for Science, Technology and Research (A-STAR)	Agency for Science, Technology and Research (A-STAR)(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology and Research (A-STAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; De Toledo M, 2001, ONCOGENE, V20, P7307, DOI 10.1038/sj.onc.1204921; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Fortier M, 2008, CELL DEATH DIFFER, V15, P1221, DOI 10.1038/cdd.2008.34; Foster R, 1996, MOL CELL BIOL, V16, P2689; Garnaas MK, 2008, CIRC RES, V103, P710, DOI 10.1161/CIRCRESAHA.108.181388; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hansen SH, 2000, MOL CELL BIOL, V20, P9364, DOI 10.1128/MCB.20.24.9364-9375.2000; Harb N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003001; Jopling C, 2005, EMBO REP, V6, P426, DOI 10.1038/sj.embor.7400386; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; Kiel C, 2007, J MOL BIOL, V370, P1020, DOI 10.1016/j.jmb.2007.05.015; Klein RM, 2008, MOL BIOL CELL, V19, P498, DOI 10.1091/mbc.E07-09-0895; Komander D, 2008, EMBO J, V27, P3175, DOI 10.1038/emboj.2008.226; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; Lambert JM, 2002, NAT CELL BIOL, V4, P621, DOI 10.1038/ncb833; Liu ML, 2006, MOL BIOL CELL, V17, P1880, DOI 10.1091/mbc.E06-01-0002; Madigan JP, 2009, BIOCHEM J, V424, P153, DOI 10.1042/BJ20082377; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Marx R, 2005, J NEUROCHEM, V92, P850, DOI 10.1111/j.1471-4159.2004.02930.x; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Ongusaha PP, 2006, CURR BIOL, V16, P2466, DOI 10.1016/j.cub.2006.10.056; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rubenstein NM, 2005, EXP CELL RES, V305, P74, DOI 10.1016/j.yexcr.2004.12.010; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Stam J C, 1999, Prog Mol Subcell Biol, V22, P51; Tahinci E, 2003, DEV BIOL, V259, P318, DOI 10.1016/S0012-1606(03)00206-9; TALENSVISCONTI R, 2009, J NEUROCHEM; Tanegashima K, 2008, EMBO J, V27, P606, DOI 10.1038/emboj.2008.9; Tong YF, 2009, J BIOL CHEM, V284, P35962, DOI 10.1074/jbc.M109.056275; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Wunnenberg-Stapleton K, 1999, DEVELOPMENT, V126, P5339; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019	42	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12409	10.1371/journal.pone.0012409	http://dx.doi.org/10.1371/journal.pone.0012409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811643	gold, Green Submitted, Green Published			2022-12-25	WOS:000281234700030
J	Nookaew, I; Gabrielsson, BG; Holmang, A; Sandberg, AS; Nielsen, J				Nookaew, Intawat; Gabrielsson, Britt G.; Holmang, Agneta; Sandberg, Ann-Sofie; Nielsen, Jens			Identifying Molecular Effects of Diet through Systems Biology: Influence of Herring Diet on Sterol Metabolism and Protein Turnover in Mice	PLOS ONE			English	Article							FISH-OIL; LDL RECEPTOR; OXYGEN-CONSUMPTION; SKELETAL-MUSCLE; ADIPOSE-TISSUE; GENE ONTOLOGY; FATTY-ACIDS; IN-VIVO; ATHEROSCLEROSIS; CHOLESTEROL	Background: Changes in lifestyle have resulted in an epidemic development of obesity-related diseases that challenge the healthcare systems worldwide. To develop strategies to tackle this problem the focus is on diet to prevent the development of obesity-associated diseases such as cardiovascular disease (CVD). This will require methods for linking nutrient intake with specific metabolic processes in different tissues. Methodology/Principal Finding: Low-density lipoprotein receptor-deficient (Ldlr -/-) mice were fed a high fat/high sugar diet to mimic a westernized diet, being a major reason for development of obesity and atherosclerosis. The diets were supplemented with either beef or herring, and matched in macronutrient contents. Body composition, plasma lipids and aortic lesion areas were measured. Transcriptomes of metabolically important tissues, e.g. liver, muscle and adipose tissue were analyzed by an integrated approach with metabolic networks to directly map the metabolic effects of diet in these different tissues. Our analysis revealed a reduction in sterol metabolism and protein turnover at the transcriptional level in herring-fed mice. Conclusion: This study shows that an integrated analysis of transcriptome data using metabolic networks resulted in the identification of signature pathways. This could not have been achieved using standard clustering methods. In particular, this systems biology analysis could enrich the information content of biomedical or nutritional data where subtle changes in several tissues together affects body metabolism or disease progression. This could be applied to improve diets for subjects exposed to health risks associated with obesity.	[Nookaew, Intawat; Gabrielsson, Britt G.; Sandberg, Ann-Sofie; Nielsen, Jens] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Holmang, Agneta] Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden	Chalmers University of Technology; University of Gothenburg	Nookaew, I (corresponding author), Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.	nielsenj@chalmers.se	Gabrielsson, Britt/B-9870-2011; sandberg, ann-sofie/B-6857-2016; Nielsen, Jens/Q-1347-2017	Gabrielsson, Britt/0000-0003-4318-8704; sandberg, ann-sofie/0000-0002-9681-3342; Nielsen, Jens/0000-0002-9955-6003	National Board of Fisheries Sweden (EU); Knut and Alice Wallenberg Foundation; Novo Nordisk Foundation; Swedish Medical Research Council [12206]; Swedish Diabetes Association Research Foundation; Swedish federal government; Vastra Gotaland Region; Chalmers Foundation	National Board of Fisheries Sweden (EU)(European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Diabetes Association Research Foundation; Swedish federal government; Vastra Gotaland Region; Chalmers Foundation	This work received financial support from the National Board of Fisheries Sweden (EU Structural Funds), the Chalmers Foundation and the Knut and Alice Wallenberg Foundation, the Novo Nordisk Foundation, the Swedish Medical Research Council (Project No. 12206), the Swedish Diabetes Association Research Foundation, the Swedish federal government under the LUA/ALF agreement and The Vastra Gotaland Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BANG HO, 1980, AM J CLIN NUTR, V33, P2657, DOI 10.1093/ajcn/33.12.2657; Barber MD, 2000, CLIN SCI, V98, P389, DOI 10.1042/CS19990273; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bjorkbacka H, 2006, CURR OPIN LIPIDOL, V17, P527; Bourghardt J, 2007, ENDOCRINOLOGY, V148, P4128, DOI 10.1210/en.2007-0259; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; Chapkin RS, 2009, PROSTAG LEUKOTR ESS, V81, P187, DOI 10.1016/j.plefa.2009.05.010; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; DULLOO AG, 1994, METABOLISM, V43, P931, DOI 10.1016/0026-0495(94)90169-4; Dupasquier CMC, 2007, AM J PHYSIOL-HEART C, V293, pH2394, DOI 10.1152/ajpheart.01104.2006; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Elvevoll EO, 2008, ATHEROSCLEROSIS, V200, P396, DOI 10.1016/j.atherosclerosis.2007.12.021; Goldberg RB, 2008, CURR OPIN ENDOCRINOL, V15, P167, DOI 10.1097/MED.0b013e3282f76728; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Le Lay S, 2001, J BIOL CHEM, V276, P16904, DOI 10.1074/jbc.M010955200; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lionetti L, 2009, NUTR METAB CARDIOVAS, V19, P146, DOI 10.1016/j.numecd.2008.10.010; Muller M, 2003, NAT REV GENET, V4, P315, DOI 10.1038/nrg1047; Nagahuedi S, 2009, J EXP BIOL, V212, P1106, DOI 10.1242/jeb.027888; Oliveira AP, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-17; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; Peoples GE, 2008, J CARDIOVASC PHARM, V52, P540, DOI 10.1097/FJC.0b013e3181911913; Pepe S, 2002, CIRCULATION, V105, P2303, DOI 10.1161/01.CIR.0000015604.88808.74; Quek LE, 2008, GENOME INFORM SER, V21, P89; Rasmussen BB, 2009, J APPL PHYSIOL, V106, P1365, DOI 10.1152/japplphysiol.00081.2009; Ruxton CHS, 2004, J HUM NUTR DIET, V17, P449, DOI 10.1111/j.1365-277X.2007.00770.x; Ryan AM, 2009, ANN SURG, V249, P355, DOI 10.1097/SLA.0b013e31819a4789; Saraswathi V, 2007, J NUTR, V137, P1776, DOI 10.1093/jn/137.7.1776; Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, pE207, DOI 10.1152/ajpendo.2002.282.1.E207; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Shukla A, 2006, BRIT J NUTR, V96, P674, DOI 10.1079/BJN20061895; Sjogren K, 2001, J NUTR, V131, P2963, DOI 10.1093/jn/131.11.2963; SOHAL PS, 1992, BIOCHEM J, V286, P405, DOI 10.1042/bj2860405; Van Assche T, 2007, CELL CALCIUM, V41, P295, DOI 10.1016/j.ceca.2006.06.010; VanderLaan PA, 2009, J LIPID RES, V50, P376, DOI 10.1194/jlr.M800284-JLR200; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Wu L, 2006, J LIPID RES, V47, P2215, DOI 10.1194/jlr.M600146-JLR200; Yudkin JS, 2003, INT J OBESITY, V27, pS25, DOI 10.1038/sj.ijo.0802496; Zampolli A, 2006, ATHEROSCLEROSIS, V184, P78, DOI 10.1016/j.atherosclerosis.2005.04.018; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	45	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12361	10.1371/journal.pone.0012361	http://dx.doi.org/10.1371/journal.pone.0012361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808764	gold, Green Published			2022-12-25	WOS:000281154300004
J	Chan, S; Head, SI				Chan, Stephen; Head, Stewart I.			Age- and Gender-Related Changes in Contractile Properties of Non-Atrophied EDL Muscle	PLOS ONE			English	Article							EXTENSOR DIGITORUM LONGUS; SINGLE MOTOR UNITS; SKELETAL-MUSCLE; MDX MOUSE; LENGTHENING CONTRACTIONS; HISTOCHEMICAL PROPERTIES; MECHANICAL-PROPERTIES; INDUCED INJURY; FEMALE MICE; FAST-FIBERS	Background: In humans, ageing causes skeletal muscles to become atrophied, weak, and easily fatigued. In rodent studies, ageing has been associated with significant muscle atrophy and changes in the contractile properties of the muscles. However, it is not entirely clear whether these changes in contractile properties can occur before there is significant atrophy, and whether males and females are affected differently. Methods and Results: We investigated various contractile properties of whole isolated fast-twitch EDL muscles from adult (2-6 months-old) and aged (12-22 months-old) male and female mice. Atrophy was not present in the aged mice. Compared with adult mice, EDL muscles of aged mice had significantly lower specific force, longer tetanus relaxation times, and lower fatiguability. In the properties of absolute force and muscle relaxation times, females were affected by ageing to a greater extent than males. Additionally, EDL muscles from a separate group of male mice were subjected to eccentric contractions of 15% strain, and larger force deficits were found in aged than in adult mice. Conclusion: Our findings provide further insight into the muscle atrophy, weakness and fatiguability experienced by the elderly. We have shown that even in the absence of muscle atrophy, there are definite alterations in the physiological properties of whole fast-twitch muscle from ageing mice, and for some of these properties the alterations are more pronounced in female mice than in male mice.	[Chan, Stephen; Head, Stewart I.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia	University of New South Wales Sydney	Chan, S (corresponding author), Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia.	s.head@unsw.edu.au	Head, Stewart I/F-4435-2010; Head, Stewart/O-7016-2019	Head, Stewart/0000-0002-6891-7590	National Health and Medical Research Council of Australia; University of New South Wales School of Medical Sciences	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of New South Wales School of Medical Sciences	The authors acknowledge the National Health and Medical Research Council of Australia and the University of New South Wales School of Medical Sciences for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akima H, 2001, MED SCI SPORT EXER, V33, P220; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; ANDERSON JE, 1988, J MUSCLE RES CELL M, V9, P499, DOI 10.1007/BF01738755; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Bilodeau M, 2001, J APPL PHYSIOL, V91, P2654, DOI 10.1152/jappl.2001.91.6.2654; Bortz WM, 2002, J GERONTOL A-BIOL, V57, pM283, DOI 10.1093/gerona/57.5.M283; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Brooks SV, 1996, J PHYSIOL-LONDON, V497, P573, DOI 10.1113/jphysiol.1996.sp021790; BROOKS SV, 1995, J PHYSIOL-LONDON, V488, P459, DOI 10.1113/jphysiol.1995.sp020980; Brown M, 1996, J GERONTOL A-BIOL, V51, pB117, DOI 10.1093/gerona/51A.2.B117; Dickstein DL, 2007, AGING CELL, V6, P275, DOI 10.1111/j.1474-9726.2007.00289.x; EDSTROM L, 1987, J PHYSIOL-LONDON, V392, P129, DOI 10.1113/jphysiol.1987.sp016773; Faulkner JA, 1995, ADV EXP MED BIOL, V384, P471; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; FLITNEY FW, 1978, J PHYSIOL-LONDON, V276, P449, DOI 10.1113/jphysiol.1978.sp012246; FRONTERA WR, 1991, J APPL PHYSIOL, V71, P644, DOI 10.1152/jappl.1991.71.2.644; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gonzalez E, 2000, J MEMBRANE BIOL, V178, P175, DOI 10.1007/s002320010025; Gonzalez E, 2001, MECH AGEING DEV, V122, P1019, DOI 10.1016/S0047-6374(01)00229-9; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; HEAD SI, 1992, P ROY SOC B-BIOL SCI, V248, P163, DOI 10.1098/rspb.1992.0058; Imagita H, 2009, BIOMED RES-TOKYO, V30, P337, DOI 10.2220/biomedres.30.337; ISHIHARA A, 1988, MECH AGEING DEV, V45, P213, DOI 10.1016/0047-6374(88)90003-6; Jimenez-Moreno R, 2008, BIOPHYS J, V94, P3178, DOI 10.1529/biophysj.107.118786; Kadhiresan VA, 1996, J PHYSIOL-LONDON, V493, P543, DOI 10.1113/jphysiol.1996.sp021402; KARPATI G, 1988, MUSCLE NERVE, V11, P795, DOI 10.1002/mus.880110802; LARSSON L, 1986, J NEUROL SCI, V76, P69, DOI 10.1016/0022-510X(86)90143-7; Larsson L, 2000, DRUG AGING, V17, P303, DOI 10.2165/00002512-200017040-00006; Lowe DA, 2002, AM J PHYSIOL-CELL PH, V283, pC187, DOI 10.1152/ajpcell.00008.2002; Lowe DA, 2001, AM J PHYSIOL-CELL PH, V280, pC540, DOI 10.1152/ajpcell.2001.280.3.C540; Lowe DA, 2010, EXERC SPORT SCI REV, V38, P61, DOI 10.1097/JES.0b013e3181d496bc; Luff AR, 1998, ANN NY ACAD SCI, V854, P92, DOI 10.1111/j.1749-6632.1998.tb09895.x; Lynch GS, 2008, AM J PHYSIOL-CELL PH, V295, pC249, DOI 10.1152/ajpcell.90640.2007; MCCULLY KK, 1986, J APPL PHYSIOL, V61, P293, DOI 10.1152/jappl.1986.61.1.293; Moran AL, 2006, J APPL PHYSIOL, V100, P548, DOI 10.1152/japplphysiol.01029.2005; Moran AL, 2005, EXP GERONTOL, V40, P966, DOI 10.1016/j.exger.2005.09.005; Moran AL, 2007, J APPL PHYSIOL, V102, P1387, DOI 10.1152/japplphysiol.01305.2006; Motulsky H, 2003, PRACTICAL GUIDE CURV; Oliviero A, 2006, NEUROSCI RES, V55, P74, DOI 10.1016/j.neures.2006.02.002; Pagala MK, 1998, MUSCLE NERVE, V21, P1729, DOI 10.1002/(SICI)1097-4598(199812)21:12<1729::AID-MUS16>3.0.CO;2-V; Payne AM, 2003, J APPL PHYSIOL, V95, P2554, DOI 10.1152/japplphysiol.00758.2003; Payne AM, 2009, EXP GERONTOL, V44, P261, DOI 10.1016/j.exger.2008.09.013; Pinniger GJ, 2006, J PHYSIOL-LONDON, V573, P627, DOI 10.1113/jphysiol.2005.095448; PINNIGER GJ, 2006, PHYSL NEWS, V65, P13; Plant DR, 2002, J PHYSIOL-LONDON, V543, P169, DOI 10.1113/jphysiol.2002.022418; RACK PMH, 1974, J PHYSIOL-LONDON, V240, P331, DOI 10.1113/jphysiol.1974.sp010613; Rader EP, 2006, J APPL PHYSIOL, V100, P656, DOI 10.1152/japplphysiol.00663.2005; Rader EP, 2006, J APPL PHYSIOL, V101, P887, DOI 10.1152/japplphysiol.00380.2006; Renganathan M, 1997, J MEMBRANE BIOL, V157, P247, DOI 10.1007/s002329900233; Stackhouse SKS, 2001, PHYS THER, V81, P1102, DOI 10.1093/ptj/81.5.1102; Sugiura M, 2004, J NEUROPHYSIOL, V92, P1357, DOI 10.1152/jn.00947.2003; TINETTI ME, 1986, AM J MED, V80, P429, DOI 10.1016/0002-9343(86)90717-5; WESTERBLAD H, 1991, J PHYSIOL-LONDON, V434, P323, DOI 10.1113/jphysiol.1991.sp018472; Westerblad H, 2002, CURR OPIN RHEUMATOL, V14, P648, DOI 10.1097/00002281-200211000-00003; Yoon T, 2008, MUSCLE NERVE, V37, P457, DOI 10.1002/mus.20969	55	48	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12345	10.1371/journal.pone.0012345	http://dx.doi.org/10.1371/journal.pone.0012345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808812	gold, Green Published, Green Submitted			2022-12-25	WOS:000281153500024
J	Mora, JS; Assi, SA; Fernandez-Fuentes, N				Mora, Joan Segura; Assi, Salam A.; Fernandez-Fuentes, Narcis			Presaging Critical Residues in Protein interfaces-Web Server (PCRPi-W): A Web Server to Chart Hot Spots in Protein Interfaces	PLOS ONE			English	Article								Background: It is well established that only a portion of residues that mediate protein-protein interactions (PPIs), the so-called hot spot, contributes the most to the total binding energy, and thus its identification is an important and relevant question that has clear applications in drug discovery and protein design. The experimental identification of hot spots is however a lengthy and costly process, and thus there is an interest in computational tools that can complement and guide experimental efforts. Principal Findings: Here, we present Presaging Critical Residues in Protein interfaces-Web server (http://www.bioinsilico.org/PCRPi), a web server that implements a recently described and highly accurate computational tool designed to predict critical residues in protein interfaces: PCRPi. PRCPi depends on the integration of structural, energetic, and evolutionary-based measures by using Bayesian Networks (BNs). Conclusions: PCRPi-W has been designed to provide an easy and convenient access to the broad scientific community. Predictions are readily available for download or presented in a web page that includes among other information links to relevant files, sequence information, and a Jmol applet to visualize and analyze the predictions in the context of the protein structure.	[Mora, Joan Segura; Assi, Salam A.; Fernandez-Fuentes, Narcis] Univ Leeds, Leeds Inst Mol Med, Sect Expt Therapeut, Leeds, W Yorkshire, England	University of Leeds	Mora, JS (corresponding author), Univ Leeds, Leeds Inst Mol Med, Sect Expt Therapeut, Leeds, W Yorkshire, England.	N.Fernandez-Fuentes@leeds.ac.uk		Segura, Joan/0000-0001-5593-735X; Fernandez-Fuentes, Narcis/0000-0002-6421-1080	Research Councils United Kingdom Academic Fellow scheme; Wellcome; Leeds Institute of Molecular Medicine	Research Councils United Kingdom Academic Fellow scheme; Wellcome; Leeds Institute of Molecular Medicine	This work was supported by the Research Councils United Kingdom Academic Fellow scheme (to NFF), Wellcome ViP award (to SAS), and an internal scholarship awarded by the Leeds Institute of Molecular Medicine (to JSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Assi SA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1158; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; JIN L, 1994, PROTEIN SCI, V3, P2351, DOI 10.1002/pro.5560031219; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Tanaka T, 2007, EMBO J, V26, P3250, DOI 10.1038/sj.emboj.7601744; Tuncbag N, 2009, BIOINFORMATICS, V25, P1513, DOI 10.1093/bioinformatics/btp240; Wang Q, 2008, NAT PROTOC, V3, P1832, DOI 10.1038/nprot.2008.184; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526	18	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12352	10.1371/journal.pone.0012352	http://dx.doi.org/10.1371/journal.pone.0012352			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808810	Green Published, gold			2022-12-25	WOS:000281153500028
J	Visscher, AM; Paul, AL; Kirst, M; Guy, CL; Schuerger, AC; Ferl, RJ				Visscher, Anne M.; Paul, Anna-Lisa; Kirst, Matias; Guy, Charles L.; Schuerger, Andrew C.; Ferl, Robert J.			Growth Performance and Root Transcriptome Remodeling of Arabidopsis in Response to Mars-Like Levels of Magnesium Sulfate	PLOS ONE			English	Article							TRANSPORT; PROTEIN; SYSTEM; GENES; IDENTIFICATION; MERIDIANI; PLANTS	Background: Martian regolith (unconsolidated surface material) is a potential medium for plant growth in bioregenerative life support systems during manned missions on Mars. However, hydrated magnesium sulfate mineral levels in the regolith of Mars can reach as high as 10 wt%, and would be expected to be highly inhibitory to plant growth. Methodology and Principal Findings: Disabling ion transporters AtMRS2-10 and AtSULTR1;2, which are plasma membrane localized in peripheral root cells, is not an effective way to confer tolerance to magnesium sulfate soils. Arabidopsis mrs2-10 and sel1-10 knockout lines do not mitigate the growth inhibiting impacts of high MgSO4 center dot 7H(2)O concentrations observed with wildtype plants. A global approach was used to identify novel genes with potential to enhance tolerance to high MgSO4 center dot 7H(2)O (magnesium sulfate) stress. The early Arabidopsis root transcriptome response to elevated concentrations of magnesium sulfate was characterized in Col-0, and also between Col-0 and the mutant line cax1-1, which was confirmed to be relatively tolerant of high levels of MgSO4 center dot 7H(2)O in soil solution. Differentially expressed genes in Col-0 treated for 45 min. encode enzymes primarily involved in hormone metabolism, transcription factors, calcium-binding proteins, kinases, cell wall related proteins and membrane-based transporters. Over 200 genes encoding transporters were differentially expressed in Col-0 up to 180 min. of exposure, and one of the first down-regulated genes was CAX1. The importance of this early response in wildtype Arabidopsis is exemplified in the fact that only four transcripts were differentially expressed between Col-0 and cax1-1 at 180 min. after initiation of treatment. Conclusions/Significance: The results provide a solid basis for the understanding of the metabolic response of plants to elevated magnesium sulfate soils; it is the first transcriptome analysis of plants in this environment. The results foster the development of Mars soil-compatible plants by showing that cax1 mutants exhibit partial tolerance to magnesium sulfate, and by elucidating a small subset (500 vs. >10,000) of candidate genes for mutation or metabolic engineering that will enhance tolerance to magnesium sulfate soils.	[Visscher, Anne M.; Paul, Anna-Lisa; Ferl, Robert J.] Univ Florida, Dept Hort Sci, Gainesville, FL USA; [Kirst, Matias] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Guy, Charles L.] Univ Florida, Dept Environm Hort, Gainesville, FL 32611 USA; [Schuerger, Andrew C.] Univ Florida, Kennedy Space Ctr, Gainesville, FL USA; [Ferl, Robert J.] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Visscher, AM (corresponding author), Univ Oxford, Dept Plant Sci, Oxford, England.	robferl@ufl.edu		Paul, Anna-Lisa/0000-0003-2211-2604; Ferl, Robert/0000-0003-4178-764X	Prins Bernard Cultuurfonds of the Netherlands; NASA [NNX07AH27G]	Prins Bernard Cultuurfonds of the Netherlands; NASA(National Aeronautics & Space Administration (NASA))	Prins Bernard Cultuurfonds of the Netherlands. NASA NNX07AH27G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, METH MOL B, V236, P177; Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; Barber S.A., 1995, SOIL NUTRIENT BIOAVA; BARTA DJ, 1994, ADV SPACE RES, V14, P403, DOI 10.1016/0273-1177(94)90329-8; Baxter I, 2007, PLANT PHYSIOL, V143, P600, DOI 10.1104/pp.106.092528; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Bradshaw HD, 2005, NEW PHYTOL, V167, P81, DOI 10.1111/j.1469-8137.2005.01408.x; Brooks R. R., 1987, SERPENTINE ITS VEGET; Buchner P, 2004, J EXP BOT, V55, P1765, DOI 10.1093/jxb/erh206; Chen WE, 2005, WIREL NETW MOB COMP, V1, P3; Cheng NH, 2003, PLANT CELL, V15, P347, DOI 10.1105/tpc.007385; Christensen PR, 2004, SCIENCE, V306, P1733, DOI 10.1126/science.1104909; Ciftci-Yilmaz S, 2007, J BIOL CHEM, V282, P9260, DOI 10.1074/jbc.M611093200; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Deng W, 2006, J EXP BOT, V57, P4235, DOI 10.1093/jxb/erl201; Edmond C, 2009, BIOCHEM J, V418, P145, DOI 10.1042/BJ20081814; Fontes EPB, 2004, GENE DEV, V18, P2545, DOI 10.1101/gad.1245904; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Haskin LA, 2005, NATURE, V436, P66, DOI 10.1038/nature03640; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Koiwa H, 2006, J EXP BOT, V57, P1119, DOI 10.1093/jxb/erj093; Laurie S, 2002, PLANT J, V32, P139, DOI 10.1046/j.1365-313X.2002.01410.x; Li LG, 2001, PLANT CELL, V13, P2761, DOI 10.1105/tpc.13.12.2761; Ma SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r49; Ma SS, 2006, J EXP BOT, V57, P1097, DOI 10.1093/jxb/erj098; Mao DD, 2008, J INTEGR PLANT BIOL, V50, P1530, DOI 10.1111/j.1744-7909.2008.00770.x; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Maruyama-Nakashita A, 2003, PLANT PHYSIOL, V132, P597, DOI 10.1104/pp.102.019802; Maruyama-Nakashita A, 2006, PLANT CELL, V18, P3235, DOI 10.1105/tpc.106.046458; Ming D. W., 1989, LUNAR BASE AGR SOILS; Ming DW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002560; Pandey GK, 2007, CELL RES, V17, P411, DOI 10.1038/cr.2007.39; Roberts SK, 2000, J EXP BOT, V51, P1585, DOI 10.1093/jexbot/51.350.1585; Schuerger Andrew C, 2002, Life Support Biosph Sci, V8, P137; Shaul O, 2002, BIOMETALS, V15, P309, DOI 10.1023/A:1016091118585; Smeets K, 2008, PLANT PHYSIOL BIOCH, V46, P212, DOI 10.1016/j.plaphy.2007.09.014; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tocquin Pierre, 2003, BMC Plant Biology, V3, P2, DOI 10.1186/1471-2229-3-2; Ulker B, 2007, PLANTA, V226, P125, DOI 10.1007/s00425-006-0474-y; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Yoshimoto N, 2002, PLANT J, V29, P465, DOI 10.1046/j.0960-7412.2001.01231.x; Zhao J, 2009, J BIOL CHEM, V284, P4605, DOI 10.1074/jbc.M804462200	42	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12348	10.1371/journal.pone.0012348	http://dx.doi.org/10.1371/journal.pone.0012348			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808807	gold, Green Submitted, Green Published			2022-12-25	WOS:000281153500026
J	Johansson, MEV; Gustafsson, JK; Sjoberg, KE; Petersson, J; Holm, L; Sjovall, H; Hansson, GC				Johansson, Malin E. V.; Gustafsson, Jenny K.; Sjoberg, Karolina E.; Petersson, Joel; Holm, Lena; Sjovall, Henrik; Hansson, Gunnar C.			Bacteria Penetrate the Inner Mucus Layer before Inflammation in the Dextran Sulfate Colitis Model	PLOS ONE			English	Article							BARRIER FUNCTION; MURINE COLITIS; MUCIN; MICE; SODIUM; GLYCOSYLATION; BIOSYNTHESIS; DISEASE; MOUSE; COLON	Background: Protection of the large intestine with its enormous amount of commensal bacteria is a challenge that became easier to understand when we recently could describe that colon has an inner attached mucus layer devoid of bacteria (Johansson et al. (2008) Proc. Natl. Acad. Sci. USA 105, 15064-15069). The bacteria are thus kept at a distance from the epithelial cells and lack of this layer, as in Muc2-null mice, allow bacteria to contact the epithelium. This causes colitis and later on colon cancer, similar to the human disease Ulcerative Colitis, a disease that still lacks a pathogenetic explanation. Dextran Sulfate (DSS) in the drinking water is the most widely used animal model for experimental colitis. In this model, the inflammation is observed after 3-5 days, but early events explaining why DSS causes this has not been described. Principal Findings: When mucus formed on top of colon explant cultures were exposed to 3% DSS, the thickness of the inner mucus layer decreased and became permeable to 2 mm fluorescent beads after 15 min. Both DSS and Dextran readily penetrated the mucus, but Dextran had no effect on thickness or permeability. When DSS was given in the drinking water to mice and the colon was stained for bacteria and the Muc2 mucin, bacteria were shown to penetrate the inner mucus layer and reach the epithelial cells already within 12 hours, long before any infiltration of inflammatory cells. Conclusion: DSS thus causes quick alterations in the inner colon mucus layer that makes it permeable to bacteria. The bacteria that reach the epithelial cells probably trigger an inflammatory reaction. These observations suggest that altered properties or lack of the inner colon mucus layer may be an initial event in the development of colitis.	[Johansson, Malin E. V.; Gustafsson, Jenny K.; Sjoberg, Karolina E.; Hansson, Gunnar C.] Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden; [Gustafsson, Jenny K.; Sjoberg, Karolina E.; Sjovall, Henrik] Univ Gothenburg, Dept Internal Med, Gothenburg, Sweden; [Petersson, Joel; Holm, Lena] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	University of Gothenburg; University of Gothenburg; Uppsala University	Johansson, MEV (corresponding author), Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden.	gunnar.hansson@medkem.gu.se	Johansson, Malin E. V./HCH-7451-2022; Hansson, Gunnar C./AAF-7324-2019; Hansson, Gunnar C/A-1236-2009	Hansson, Gunnar C./0000-0002-1900-1869; Hansson, Gunnar C/0000-0002-1900-1869; Jabbar, Karolina/0000-0001-8994-3280; Johansson, Malin E. V./0000-0002-4237-6677	Swedish Research Council [7461, 8288, 21027, 342-2004-4434]; Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation [KAW2007.0118]; IngaBritt and Arne Lundberg Foundation; Sahlgren's University Hospital (LUA-ALF); EU; Wilhelm and Martina Lundgren's Foundation; Soderberg's Stiftelser; Swedish Foundation; Mucosal Immunobiology and Vaccine Center (MIVAC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); IngaBritt and Arne Lundberg Foundation; Sahlgren's University Hospital (LUA-ALF); EU(European Commission); Wilhelm and Martina Lundgren's Foundation; Soderberg's Stiftelser; Swedish Foundation; Mucosal Immunobiology and Vaccine Center (MIVAC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swedish Research Council (no. 7461, 8288, 21027, and 342-2004-4434), The Swedish Cancer Foundation, The Knut and Alice Wallenberg Foundation (KAW2007.0118), IngaBritt and Arne Lundberg Foundation, Sahlgren's University Hospital (LUA-ALF), EU-FP7 IBDase, Wilhelm and Martina Lundgren's Foundation, Soderberg's Stiftelser, and The Swedish Foundation for Strategic Research - Innate Immunity Program and The Mucosal Immunobiology and Vaccine Center (MIVAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Asker N, 1998, J BIOL CHEM, V273, P18857, DOI 10.1074/jbc.273.30.18857; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Axelsson LG, 1996, INFLAMM RES, V45, P181, DOI 10.1007/BF02285159; Axelsson MAB, 1998, J BIOL CHEM, V273, P18864, DOI 10.1074/jbc.273.30.18864; COOPER HS, 1993, LAB INVEST, V69, P238; Dawson PA, 2009, GUT, V58, P910, DOI 10.1136/gut.2007.147595; Godl K, 2002, J BIOL CHEM, V277, P47248, DOI 10.1074/jbc.M208483200; HANSSON GC, 2010, GUT MICROBES, V1, P10; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; ISAO O, 1990, GASTROENTEROLOGY, V98, P694; Johansson M, 2000, GASTROENTEROLOGY, V119, P1297, DOI 10.1053/gast.2000.19455; Johansson MEV, 2009, J PROTEOME RES, V8, P3549, DOI 10.1021/pr9002504; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; JURJUS AR, 2009, J PHARMACOL TOX MET, V50, P81; Kitajima S, 2000, EXP ANIM TOKYO, V49, P9, DOI 10.1538/expanim.49.9; Kitajima S, 2001, EXP ANIM TOKYO, V50, P387, DOI 10.1538/expanim.50.387; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; Mahler M, 1998, AM J PHYSIOL-GASTR L, V274, pG544, DOI 10.1152/ajpgi.1998.274.3.G544; Malmberg EK, 2006, AM J PHYSIOL-GASTR L, V291, pG203, DOI 10.1152/ajpgi.00491.2005; MARCUS R, 1971, LANCET, V2, P765; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Renes IB, 2002, AM J PHYSIOL-GASTR L, V282, pG382, DOI 10.1152/ajpgi.00229.2001; Schulz BL, 2002, ANAL CHEM, V74, P6088, DOI 10.1021/ac025890a; Tai EKK, 2007, EXP BIOL MED, V232, P799; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073	31	241	256	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12238	10.1371/journal.pone.0012238	http://dx.doi.org/10.1371/journal.pone.0012238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805871	Green Published, Green Submitted, gold			2022-12-25	WOS:000281011600014
J	Saito, T; Nakamura, A; Aoki, Y; Yokota, T; Okada, T; Osawa, M; Takeda, S				Saito, Takashi; Nakamura, Akinori; Aoki, Yoshitsugu; Yokota, Toshifumi; Okada, Takashi; Osawa, Makiko; Takeda, Shin'ichi			Antisense PMO Found in Dystrophic Dog Model Was Effective in Cells from Exon 7-Deleted DMD Patient	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MUSCLE-CELLS; GENE; PROTEIN; EXPRESSION; INDUCTION; MYOBLASTS; TOOL	Background: Antisense oligonucleotide-induced exon skipping is a promising approach for treatment of Duchenne muscular dystrophy (DMD). We have systemically administered an antisense phosphorodiamidate morpholino oligomer (PMO) targeting dystrophin exons 6 and 8 to a dog with canine X-linked muscular dystrophy in Japan (CXMDJ) lacking exon 7 and achieved recovery of dystrophin in skeletal muscle. To date, however, antisense chemical compounds used in DMD animal models have not been directly applied to a DMD patient having the same type of exon deletion. We recently identified a DMD patient with an exon 7 deletion and tried direct translation of the antisense PMO used in dog models to the DMD patient's cells. Methodology/Principal Findings: We converted fibroblasts of CXMDJ and the DMD patient to myotubes by FACS-aided MyoD transduction. Antisense PMOs targeting identical regions of dog and human dystrophin exons 6 and 8 were designed. These antisense PMOs were mixed and administered as a cocktail to either dog or human cells in vitro. In the CXMDJ and human DMD cells, we observed a similar efficacy of skipping of exons 6 and 8 and a similar extent of dystrophin protein recovery. The accompanying skipping of exon 9, which did not alter the reading frame, was different between cells of these two species. Conclusion/Significance: Antisense PMOs, the effectiveness of which has been demonstrated in a dog model, achieved multi-exon skipping of dystrophin gene on the FACS-aided MyoD-transduced fibroblasts from an exon 7-deleted DMD patient, suggesting the feasibility of systemic multi-exon skipping in humans.	[Saito, Takashi; Nakamura, Akinori; Aoki, Yoshitsugu; Okada, Takashi; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Tokyo, Japan; [Saito, Takashi; Osawa, Makiko] Tokyo Womens Med Univ, Sch Med, Dept Pediat, Shinjuku Ku, Tokyo, Japan; [Yokota, Toshifumi] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA	National Center for Neurology & Psychiatry - Japan; Tokyo Women's Medical University; Children's National Health System	Saito, T (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Tokyo, Japan.	takeda@ncnp.go.jp		Yokota, Toshifumi/0000-0001-7316-3546; Saito, Takashi/0000-0002-5672-8856; Aoki, MD, PhD, Yoshitsugu/0000-0002-9038-7506; , toshifumi/0000-0001-6672-6742	Ministry of Health, Labour and Welfare of Japan [H19-Translational Research-003, H21-Translational Research-011, H21-Clinical Research-011]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Health and Labour Sciences Research Grants for Translational Research from the Ministry of Health, Labour and Welfare of Japan (H19-Translational Research-003, H21-Translational Research-011, H21-Clinical Research-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2002, NEUROMUSCULAR DISORD, V12, pS71, DOI 10.1016/S0960-8966(02)00086-X; Aartsma-Rus A, 2005, OLIGONUCLEOTIDES, V15, P284, DOI 10.1089/oli.2005.15.284; Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Aartsma-Rus A, 2004, AM J HUM GENET, V74, P83, DOI 10.1086/381039; Aartsma-Rus A, 2007, RNA, V13, P1609, DOI 10.1261/rna.653607; Aartsma-Rus A, 2006, MOL THER, V14, P401, DOI 10.1016/j.ymthe.2006.02.022; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Beroud C, 2007, HUM MUTAT, V28, P196, DOI 10.1002/humu.20428; CHELLY J, 1991, J CLIN INVEST, V88, P1161, DOI 10.1172/JCI115417; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Cooper ST, 2007, NEUROMUSCULAR DISORD, V17, P276, DOI 10.1016/j.nmd.2006.12.010; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Etzion S, 2002, CIRCULATION, V106, pI125, DOI 10.1161/01.cir.0000032888.55215.b8; Goncalves MAFV, 2008, MOL THER, V16, P741, DOI 10.1038/mt.2008.16; Hallegger M, 2010, FEBS J, V277, P856, DOI 10.1111/j.1742-4658.2009.07521.x; Harding PL, 2007, MOL THER, V15, P157, DOI 10.1038/sj.mt.6300006; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; McClorey G, 2006, NEUROMUSCULAR DISORD, V16, P583, DOI 10.1016/j.nmd.2006.05.017; McClorey G, 2006, GENE THER, V13, P1373, DOI 10.1038/sj.gt.3302800; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; Mitrpant C, 2009, MOL THER, V17, P1418, DOI 10.1038/mt.2009.49; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; Noda T, 2009, BIOCHEM BIOPH RES CO, V382, P473, DOI 10.1016/j.bbrc.2009.03.060; Pramono ZAD, 1996, BIOCHEM BIOPH RES CO, V226, P445, DOI 10.1006/bbrc.1996.1375; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; REISS J, 1994, HUM MOL GENET, V3, P295, DOI 10.1093/hmg/3.2.295; SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J; Shimatsu Yoshiki, 2005, Acta Myol, V24, P145; Sironi M, 2002, FEBS LETT, V517, P163, DOI 10.1016/S0014-5793(02)02613-3; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Wee KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001844; Wilton SD, 2007, MOL THER, V15, P1288, DOI 10.1038/sj.mt.6300095; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627; Zheng JK, 2006, CELL RES, V16, P713, DOI 10.1038/sj.cr.7310080	35	46	47	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12239	10.1371/journal.pone.0012239	http://dx.doi.org/10.1371/journal.pone.0012239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805873	gold, Green Submitted, Green Published			2022-12-25	WOS:000281011600015
J	Le Bras, A; Samson, C; Trentini, M; Caetano, B; Lelievre, E; Mattot, V; Beermann, F; Soncin, F				Le Bras, Alexandra; Samson, Chantal; Trentini, Matteo; Caetano, Bertrand; Lelievre, Etienne; Mattot, Virginie; Beermann, Friedrich; Soncin, Fabrice			VE-statin/egfl7 Expression in Endothelial Cells Is Regulated by a Distal Enhancer and a Proximal Promoter under the Direct Control of Erg and GATA-2	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ETS-1 TRANSCRIPTION FACTOR; TIE GENE PROMOTER; BINDING-SITES; VE-CADHERIN; IN-VIVO; MICRORNA MIR-126; TRANSGENIC MICE; ROBO4 PROMOTER; ANGIOGENESIS	Angiogenesis is the process by which new blood vessels arise from existing ones by the budding out of endothelial cell capillaries from the luminal side of blood vessels. Blood vessel formation is essential for organ development during embryogenesis and is associated with several physiological and pathological processes, such as wound healing and tumor development. The VE-statin/egfl7 gene is specifically expressed in endothelial cells during embryonic development and in the adult. We studied here the regulatory mechanisms that control this tissue-specific expression. RT-qPCR analyses showed that the specificity of expression of VE-statin/egfl7 in endothelial cells is not shared with its closest neighbor genes notch1 and agpat2 on the mouse chromosome 2. Chromatin-immunoprecipitation analysis of histone modifications at the VE-statin/egfl7 locus showed that the chromatin is specifically opened in endothelial cells, but not in fibroblasts at the transcription start sites. A 13 kb genomic fragment of promoter was cloned and analyzed by gene reporter assays which showed that two conserved regions are important for the specific expression of VE-statin/egfl7 in endothelial cells; a -8409/-7563 enhancer and the -252/+38 region encompassing the exon-1b transcription start site. The latter contains essential GATA and ETS-binding sites, as assessed by linker-scanning analysis and site-directed mutagenesis. An analysis of expression of the ETS and GATA transcription factors showed that Erg, Fli-1 and GATA-2 are the most highly expressed factors in endothelial cells. Erg and GATA-2 directly control the expression of the endogenous VE-statin/egfl7 while Fli-1 probably exerts an indirect control, as assessed by RNA interference and chromatin immunoprecipitation. This first detailed analysis of the mechanisms that govern the expression of the VE-statin/egfl7 gene in endothelial cells pinpoints the specific importance of ETS and GATA factors in the specific regulation of genes in this cell lineage.	[Le Bras, Alexandra; Samson, Chantal; Trentini, Matteo; Caetano, Bertrand; Lelievre, Etienne; Mattot, Virginie; Soncin, Fabrice] Inst Biol Lille, CNRS, UMR 8161, Equipe Iabellise La Ligue, Lille, France; [Le Bras, Alexandra; Samson, Chantal; Trentini, Matteo; Caetano, Bertrand; Lelievre, Etienne; Mattot, Virginie; Soncin, Fabrice] Univ Lille Nord France, Lille, France; [Le Bras, Alexandra; Samson, Chantal; Trentini, Matteo; Caetano, Bertrand; Lelievre, Etienne; Mattot, Virginie; Soncin, Fabrice] Inst Pasteur, F-59019 Lille, France; [Beermann, Friedrich] Swiss Fed Inst Technol, Sch Life Sci, CPG, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Le Bras, A (corresponding author), Inst Biol Lille, CNRS, UMR 8161, Equipe Iabellise La Ligue, Lille, France.	fabrice.soncin@ibl.fr	SONCIN, Fabrice/A-1475-2009	SONCIN, Fabrice/0000-0001-6312-0673; Le Bras, Alexandra/0000-0001-7898-4618; Lelievre, Etienne/0000-0003-0452-1578	Ligue Nationale Contre le Cancer; Association for International Cancer Research; Oncosuisse; Swiss National Science Foundation	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Association for International Cancer Research; Oncosuisse; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Ligue Nationale Contre le Cancer (Equipe Labellisee La Ligue 2005- and 2008-) and Association for International Cancer Research. FB was supported by Oncosuisse and the Swiss National Science Foundation. ALB and BC were supported by Ligue Nationale contre le Cancer PhD fellowships. MT was an European ERASMUS program student. EL and FS are scientists from the Institut National de la Sante et de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayadi A, 2001, EMBO J, V20, P5139, DOI 10.1093/emboj/20.18.5139; Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Campagnolo L, 2008, GENE EXPR PATTERNS, V8, P389, DOI 10.1016/j.gep.2008.05.001; Chan Y, 2004, J BIOL CHEM, V279, P35087, DOI 10.1074/jbc.M405063200; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Cowan PJ, 1998, J BIOL CHEM, V273, P11737, DOI 10.1074/jbc.273.19.11737; CULLEN KE, 1993, SCIENCE, V261, P203, DOI 10.1126/science.8327891; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Dejana E, 2007, BBA-REV CANCER, V1775, P298, DOI 10.1016/j.bbcan.2007.05.003; DELAMO FF, 1992, DEVELOPMENT, V115, P737; Deleuze V, 2007, MOL CELL BIOL, V27, P2687, DOI 10.1128/MCB.00493-06; DHORDAIN P, 1995, MECH DEVELOP, V50, P17, DOI 10.1016/0925-4773(94)00322-E; Donaldson IJ, 2005, HUM MOL GENET, V14, P595, DOI 10.1093/hmg/ddi056; Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599; DORFMAN DM, 1992, J BIOL CHEM, V267, P1279; Dube A, 1999, CIRC RES, V84, P1177, DOI 10.1161/01.RES.84.10.1177; Eberhardt C, 1997, J BIOL CHEM, V272, P20299, DOI 10.1074/jbc.272.32.20299; Ferdous A, 2009, P NATL ACAD SCI USA, V106, P814, DOI 10.1073/pnas.0807583106; Fish JE, 2005, J BIOL CHEM, V280, P24824, DOI 10.1074/jbc.M502115200; GARLANDA C, 1994, P NATL ACAD SCI USA, V91, P7291, DOI 10.1073/pnas.91.15.7291; Gory S, 1998, J BIOL CHEM, V273, P6750, DOI 10.1074/jbc.273.12.6750; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Iljin K, 1999, FASEB J, V13, P377, DOI 10.1096/fasebj.13.2.377; JAHROUDI N, 1994, MOL CELL BIOL, V14, P999, DOI 10.1128/MCB.14.2.999; Kappel A, 2000, BLOOD, V96, P3078; Kappel A, 1999, BLOOD, V93, P4284, DOI 10.1182/blood.V93.12.4284.412k25_4284_4292; KORHONEN J, 1995, BLOOD, V86, P1828, DOI 10.1182/blood.V86.5.1828.bloodjournal8651828; Krebs LT, 2000, GENE DEV, V14, P1343; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Lelievre E, 2002, J BIOL CHEM, V277, P25143, DOI 10.1074/jbc.M201628200; Lelievre E, 2001, INT J BIOCHEM CELL B, V33, P391, DOI 10.1016/S1357-2725(01)00025-5; Lelievre E, 2000, ONCOGENE, V19, P2438, DOI 10.1038/sj.onc.1203563; Lelievre E, 2008, EMBO J, V27, P1658, DOI 10.1038/emboj.2008.103; Liu F, 2008, CIRC RES, V103, P1147, DOI 10.1161/CIRCRESAHA.108.179713; Loughran SJ, 2008, NAT IMMUNOL, V9, P810, DOI 10.1038/ni.1617; Mager AM, 1998, INT J DEV BIOL, V42, P561; Meireles ACA, 2009, CURR OPIN GENET DEV, V19, P565, DOI 10.1016/j.gde.2009.10.006; Mollica LR, 2006, BLOOD, V108, P1251, DOI 10.1182/blood-2006-02-001461; MORISHITA K, 1995, J BIOL CHEM, V270, P27948, DOI 10.1074/jbc.270.46.27948; MURTHY SCS, 1985, P NATL ACAD SCI USA, V82, P2230, DOI 10.1073/pnas.82.8.2230; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Okada Y, 2008, BLOOD, V112, P2336, DOI 10.1182/blood-2008-01-135079; Okada Y, 2007, CIRC RES, V100, P1712, DOI 10.1161/01.RES.0000269779.10644.dc; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Peng YW, 2003, J BIOL CHEM, V278, P8385, DOI 10.1074/jbc.M213156200; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Pimanda JE, 2006, BLOOD, V107, P4737, DOI 10.1182/blood-2005-12-4929; Sambrook J., 2002, MOL CLONING LAB MANU; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Schmidt M, 2007, DEVELOPMENT, V134, P2913, DOI 10.1242/dev.002576; Schmidt MHH, 2009, NAT CELL BIOL, V11, P873, DOI 10.1038/ncb1896; Soncin F, 2003, EMBO J, V22, P5700, DOI 10.1093/emboj/cdg549; VANDENBUNDER B, 1989, DEVELOPMENT, V107, P265; Wakiya K, 1996, J BIOL CHEM, V271, P30823, DOI 10.1074/jbc.271.48.30823; Wang LC, 1997, EMBO J, V16, P4374, DOI 10.1093/emboj/16.14.4374; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; WEI G, 2009, BLOOD IN PRESS, P18701; WILSON DB, 1990, MOL CELL BIOL, V10, P4854, DOI 10.1128/MCB.10.9.4854; Wozniak RJ, 2007, J BIOL CHEM, V282, P14665, DOI 10.1074/jbc.M700792200; Wu J, 2005, MOL CELL BIOL, V25, P1458, DOI 10.1128/MCB.25.4.1458-1474.2005; ZHANG R, 1995, J BIOL CHEM, V270, P15320, DOI 10.1074/jbc.270.25.15320	67	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12156	10.1371/journal.pone.0012156	http://dx.doi.org/10.1371/journal.pone.0012156			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808444	gold, Green Published, Green Submitted			2022-12-25	WOS:000280968000007
J	Li, D; Jackson, RA; Yusoff, P; Guy, GR				Li, Dan; Jackson, Rebecca A.; Yusoff, Permeen; Guy, Graeme R.			Direct Association of Sprouty-related Protein with an EVH1 Domain (SPRED) 1 or SPRED2 with DYRK1A Modifies Substrate/Kinase Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR STIMULATION; KINASE DYRK1A; DOWN-SYNDROME; DUAL-SPECIFICITY; ERK ACTIVATION; SUBCELLULAR-LOCALIZATION; PHOSPHORYLATION SITE; EXPRESSION PATTERN; DROSOPHILA-SPROUTY; RAS	The mammalian SPRED (Sprouty-related protein with an EVH1 domain) proteins include a family of three members, SPRED1-3. Currently, little is known about their biochemistry. The best described, SPRED1, has been shown to inhibit the Ras/ERK pathway downstream of Ras. All three SPREDs have a cysteine-rich domain (CRD) that has high homology to the CRD of the Sprouty family of proteins, several of which are also Ras/ERK inhibitors. In the belief that binding partners would clarify SPRED function, we assayed for their associated proteins. Here, we describe the direct and endogenous interaction of SPRED1 and SPRED2 with the novel kinase, DYRK1A. DYRK1A has become the subject of recent research focus as it plays a central role in Caenorhabditis elegans oocyte maturation and egg activation, and there is strong evidence that it could be involved in Down syndrome in humans. Both SPRED1 and SPRED2 inhibit the ability of DYRK1A to phosphorylate its substrates, Tau and STAT3. This inhibition occurs via an interaction of the CRD of the SPREDs with the kinase domain of DYRK1A. DYRK1A substrates must bind to the kinase to enable phosphorylation, and SPRED proteins compete for the same binding site to modify this process. Our accumulated evidence indicates that the SPRED proteins are likely physiological modifiers of DYRK1A.	[Li, Dan; Jackson, Rebecca A.; Yusoff, Permeen; Guy, Graeme R.] Inst Mol & Cell Biol, Signal Transduct Lab, Proteos 138673, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Guy, GR (corresponding author), Inst Mol & Cell Biol, Signal Transduct Lab, 61 Biopolis Dr, Proteos 138673, Singapore.	mcbgg@imcb.a-star.edu.sg			Agency of Science and Technology Research, A*Star, Singapore	Agency of Science and Technology Research, A*Star, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by Agency of Science and Technology Research, A*Star, Singapore.	Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Alvarez M, 2003, J CELL SCI, V116, P3099, DOI 10.1242/jcs.00618; Aranda S, 2008, MOL CELL BIOL, V28, P5899, DOI 10.1128/MCB.00394-08; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Bundschu K, 2007, BIOESSAYS, V29, P897, DOI 10.1002/bies.20632; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chandramouli S, 2008, J BIOL CHEM, V283, P1679, DOI 10.1074/jbc.M705457200; Chow SY, 2009, J BIOL CHEM, V284, P19623, DOI 10.1074/jbc.M109.021600; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Edwin F, 2009, MOL PHARMACOL, V76, P679, DOI 10.1124/mol.109.055848; Engelhardt CM, 2004, HISTOCHEM CELL BIOL, V122, P527, DOI 10.1007/s00418-004-0725-6; Guimera J, 1999, GENOMICS, V57, P407, DOI 10.1006/geno.1999.5775; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Himpel S, 2001, BIOCHEM J, V359, P497, DOI 10.1042/0264-6021:3590497; Huang Y, 2004, BIOCHEMISTRY-US, V43, P10173, DOI 10.1021/bi036060+; Johne C, 2008, MOL BIOL CELL, V19, P1391, DOI 10.1091/mbc.E07-07-0730; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Kato R, 2003, BIOCHEM BIOPH RES CO, V302, P767, DOI 10.1016/S0006-291X(03)00259-6; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kirsch DG, 1998, J CLIN ONCOL, V16, P3158, DOI 10.1200/JCO.1998.16.9.3158; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lao DH, 2007, J BIOL CHEM, V282, P9117, DOI 10.1074/jbc.M607563200; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lochhead PA, 2003, BIOCHEM J, V374, P381, DOI 10.1042/BJ20030500; Maenz B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-30; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mao JH, 2002, J BIOL CHEM, V277, P35156, DOI 10.1074/jbc.M206743200; Mardakheh FK, 2009, J CELL BIOL, V187, P265, DOI 10.1083/jcb.200905118; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Matsuo R, 2001, J IMMUNOL METHODS, V247, P141, DOI 10.1016/S0022-1759(00)00313-6; Midgley RS, 2002, CRIT REV ONCOL HEMAT, V44, P109, DOI 10.1016/S1040-8428(01)00189-5; Miyata Y, 1999, BIOCHEM BIOPH RES CO, V266, P291, DOI 10.1006/bbrc.1999.1705; Nonami A, 2005, GENES CELLS, V10, P887, DOI 10.1111/j.1365-2443.2005.00886.x; Pang KM, 2004, DEV BIOL, V265, P127, DOI 10.1016/j.ydbio.2003.09.024; Park J, 2007, MOL CELL NEUROSCI, V36, P270, DOI 10.1016/j.mcn.2007.07.007; Raich WB, 2003, GENETICS, V163, P571; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Seifert A, 2008, FEBS J, V275, P6268, DOI 10.1111/j.1742-4658.2008.06751.x; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shen Y, 2001, ADV CANCER RES, V82, P55, DOI 10.1016/S0065-230X(01)82002-9; Tatebe H, 2008, CURR BIOL, V18, P322, DOI 10.1016/j.cub.2008.02.005; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Tsumura Y, 2005, BIOCHEM J, V387, P627, DOI 10.1042/BJ20041181; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wiechmann S, 2003, BIOCHEM BIOPH RES CO, V302, P403, DOI 10.1016/S0006-291X(03)00148-7; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; Yamaguchi H, 2009, J BIOL CHEM, V284, P11171, DOI 10.1074/jbc.M809268200; Yang EJ, 2001, J BIOL CHEM, V276, P39819, DOI 10.1074/jbc.M104091200; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200; Zwick E, 2001, ENDOCR-RELAT CANCER, V8, P161, DOI 10.1677/erc.0.0080161	67	18	19	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35374	35385		10.1074/jbc.M110.148445	http://dx.doi.org/10.1074/jbc.M110.148445			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20736167	hybrid, Green Published			2022-12-25	WOS:000283845300015
J	Cho, HJ; Kim, K; Sohn, SY; Cho, HY; Kim, KJ; Kim, MH; Kim, D; Kim, E; Kang, BS				Cho, Hyo Je; Kim, Kyungsun; Sohn, Seo Yean; Cho, Ha Yeon; Kim, Kyung Jin; Kim, Myung Hee; Kim, Dockyu; Kim, Eungbin; Kang, Beom Sik			Substrate Binding Mechanism of a Type I Extradiol Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2,3-DIHYDROXYBIPHENYL 1,2-DIOXYGENASE; CATALYTIC MECHANISMS; O-XYLENE; CLEAVAGE; TOLUENE; METABOLISM; CATECHOLS; ENZYMES; FAMILY	A meta-cleavage pathway for the aerobic degradation of aromatic hydrocarbons is catalyzed by extradiol dioxygenases via a two-step mechanism: catechol substrate binding and dioxygen incorporation. The binding of substrate triggers the release of water, thereby opening a coordination site for molecular oxygen. The crystal structures of AkbC, a type I extradiol dioxygenase, and the enzyme substrate (3-methylcatechol) complex revealed the substrate binding process of extradiol dioxygenase. AkbC is composed of an N-domain and an active C-domain, which contains iron coordinated by a 2-His-1-carboxylate facial triad motif. The C-domain includes a beta-hairpin structure and a C-terminal tail. In substrate-bound AkbC, 3-methylcatechol interacts with the iron via a single hydroxyl group, which represents an intermediate stage in the substrate binding process. Structure-based mutagenesis revealed that the C-terminal tail and beta-hairpin form part of the substrate binding pocket that is responsible for substrate specificity by blocking substrate entry. Once a substrate enters the active site, these structural elements also play a role in the correct positioning of the substrate. Based on the results presented here, a putative substrate binding mechanism is proposed.	[Kang, Beom Sik] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Kim, Kyung Jin] POSTECH, Pohang Accelerator Lab, Pohang 790784, South Korea; [Kim, Kyungsun; Sohn, Seo Yean; Kim, Eungbin] Yonsei Univ, Dept Biol, Seoul 120749, South Korea; [Kim, Myung Hee] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Kim, Dockyu] KORDI, Polar BioCtr, Korea Polar Res Inst, Inchon 406840, South Korea	Kyungpook National University; Pohang University of Science & Technology (POSTECH); Yonsei University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI)	Kim, E (corresponding author), 262 Seongsanno, Seoul 120749, South Korea.	eungbin@yonsei.ac.kr; bskang2@knu.ac.kr		, Eungbin/0000-0002-4851-4743	Ministry of Education, Science and Technology of the Republic of Korea; Brain Korea 21 scholarship; NRF [2010-0001440]	Ministry of Education, Science and Technology of the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Korea 21 scholarship(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); NRF	This work was supported by a grant from the Ministry of Education, Science and Technology of the Republic of Korea through the 21C Frontier Microbial Genomics and Applications Center Program.; Recipient of the Brain Korea 21 scholarship.; Recipient of the support of NRF through Basic Science Research Program Grants (2010-0001440).	BAYLY RC, 1966, BIOCHEM J, V101, P293, DOI 10.1042/bj1010293; Brivio M, 2009, ORG BIOMOL CHEM, V7, P1368, DOI 10.1039/b821559f; Broderick JB, 1999, ESSAYS BIOCHEM, V34, P173, DOI 10.1042/bse0340173; Bugg TDH, 2003, TETRAHEDRON, V59, P7075, DOI 10.1016/S0040-4020(03)00944-X; Bugg TDH, 2004, BIOORG CHEM, V32, P367, DOI 10.1016/j.bioorg.2004.05.005; Bugg TDH, 2008, CURR OPIN CHEM BIOL, V12, P134, DOI 10.1016/j.cbpa.2007.12.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRITSCHE W, 2005, ENV BIOTECHNOLOGY; FURUKAWA K, 1983, J BACTERIOL, V154, P1356, DOI 10.1128/JB.154.3.1356-1362.1983; Ishida T, 2004, J BIOCHEM, V135, P721, DOI 10.1093/jb/mvh089; Kim D, 2002, APPL ENVIRON MICROB, V68, P3270, DOI 10.1128/AEM.68.7.3270-3278.2002; Kim D, 2005, BIOCHEM BIOPH RES CO, V326, P880, DOI 10.1016/j.bbrc.2004.11.123; Kim DY, 2004, APPL ENVIRON MICROB, V70, P7086, DOI 10.1128/AEM.70.12.7086-7092.2004; Lin G, 2001, J AM CHEM SOC, V123, P5030, DOI 10.1021/ja004280u; Lipscomb JD, 2008, CURR OPIN STRUC BIOL, V18, P644, DOI 10.1016/j.sbi.2008.11.001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sakamoto T, 2001, APPL ENVIRON MICROB, V67, P3882, DOI 10.1128/AEM.67.9.3882-3887.2001; Sato N, 2002, J MOL BIOL, V321, P621, DOI 10.1016/S0022-2836(02)00673-3; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Siegbahn PEM, 2004, J AM CHEM SOC, V126, P8919, DOI 10.1021/ja0493805; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vaillancourt FH, 1998, J BIOL CHEM, V273, P34887, DOI 10.1074/jbc.273.52.34887; Vaillancourt FH, 2002, J BIOL CHEM, V277, P2019, DOI 10.1074/jbc.M106890200; Vaillancourt FH, 2002, J AM CHEM SOC, V124, P2485, DOI 10.1021/ja0174682; Vaillancourt FH, 2006, CRIT REV BIOCHEM MOL, V41, P241, DOI 10.1080/10409230600817422	28	20	20	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34643	34652		10.1074/jbc.M110.130310	http://dx.doi.org/10.1074/jbc.M110.130310			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810655	Green Published, hybrid			2022-12-25	WOS:000283659100040
J	Guo, SS; Bao, SL				Guo, Shaoshi; Bao, Shilai			srGAP2 Arginine Methylation Regulates Cell Migration and Cell Spreading through Promoting Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BAR PROTEINS; MEMBRANE INVAGINATION; SIGNAL-TRANSDUCTION; NEURONAL MIGRATION; ACTIN CYTOSKELETON; RHO-GTPASES; DOMAIN; PRMT5; METHYLTRANSFERASE; METASTASIS	The Slit-Robo GTPase-activating proteins (srGAPs) are critical for neuronal migration through inactivation of Rho GTPases Cdc42, Rac1, and RhoA. Here we report that srGAP2 physically interacts with protein arginine methyltransferase 5 (PRMT5). srGAP2 localizes to the cytoplasm and plasma membrane protrusion. srGAP2 knockdown reduces cell adhesion spreading and increases cell migration, but has no effect on cell proliferation. PRMT5 binds to the N terminus of srGAP2 (225-538 aa) and methylates its C-terminal arginine residue Arg-927. The methylation mutant srGAP2-R927A fails to rescue the cell spreading rate, is unable to localize to the plasma membrane leading edge, and perturbs srGAP2 homodimer formation mediated by the F-BAR domain. These results suggest that srGAP2 arginine methylation plays important roles in cell spreading and cell migration through influencing membrane protrusion.	[Bao, Shilai] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Mol & Dev Biol, Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China; [Guo, Shaoshi] Chinese Acad Sci, Grad Univ, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Bao, SL (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Mol & Dev Biol, Key Lab Mol & Dev Biol, 1 W Beichen Rd, Beijing 100101, Peoples R China.	slbao@genetics.ac.cn			National Basic Research Program of China [2005CB22400]; National High Technology Development Program [2006AA02Z140]; Chinese Academy of Sciences [KSCX1-YW-R-59]; National Natural Sciences Foundation of China [30670479]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Development Program(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2005CB22400), National High Technology Development Program (2006AA02Z140), Chinese Academy of Sciences (KSCX1-YW-R-59), and National Natural Sciences Foundation of China (30670479).	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; ASPENSTRO MP, 1997, CURR BIOL, V7, P479; Bao SL, 2004, ONCOGENE, V23, P5586, DOI 10.1038/sj.onc.1207753; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Boucrot E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001477; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; CHARI A, 2008, U Cell, V135, P497; Dacwag CS, 2009, MOL CELL BIOL, V29, P1909, DOI 10.1128/MCB.00742-08; DELA H, 1959, J BIOL CHEM */* G L, V234, P603; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2007, STRUCTURE, V15, P751, DOI 10.1016/j.str.2007.06.006; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Mattila PK, 2003, J BIOL CHEM, V278, P8452, DOI 10.1074/jbc.M212113200; Narumiya S, 1996, J BIOCHEM-TOKYO, V120, P215; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Ren JQ, 2010, J BIOL CHEM, V285, P12695, DOI 10.1074/jbc.M110.103911; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Shu S, 2006, P NATL ACAD SCI USA, V103, P19788, DOI 10.1073/pnas.0609385103; Suetsugu S, 2006, J BIOL CHEM, V281, P35347, DOI 10.1074/jbc.M606814200; Takenawa T, 2001, J CELL SCI, V114, P1801; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Woodings JA, 2003, BIOCHEM J, V371, P463, DOI 10.1042/BJ20021962; Yamagishi A, 2004, J BIOL CHEM, V279, P14929, DOI 10.1074/jbc.M309408200; Yang Y, 2006, EXP CELL RES, V312, P2379, DOI 10.1016/j.yexcr.2006.04.001; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zhou ZW, 2010, CELL RES, V20, P1023, DOI 10.1038/cr.2010.56	43	33	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35133	35141		10.1074/jbc.M110.153429	http://dx.doi.org/10.1074/jbc.M110.153429			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810653	Green Published, hybrid			2022-12-25	WOS:000283659100087
J	Haque, ME; Spremulli, LL; Fecko, CJ				Haque, Md Emdadul; Spremulli, Linda L.; Fecko, Christopher J.			Identification of Protein-Protein and Protein-Ribosome Interacting Regions of the C-terminal Tail of Human Mitochondrial Inner Membrane Protein Oxa1L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; XANTHENE DYES; FLUCTUATIONS; TRANSLATION; RHODAMINE; INSERTION; MOLECULE; BINDING	The mammalian mitochondrial inner membrane protein Oxa1L is involved in the insertion of a number of mitochondrial translation products into the inner membrane. During this process, the C-terminal tail of Oxa1L (Oxa1L-CTT) binds mitochondrial ribosomes and is believed to coordinate the synthesis and membrane insertion of the nascent chains into the membrane. The C-terminal tail of Oxa1L does not contain any Cys residues. Four variants of this protein with a specifically placed Cys residue at position 4, 39, 67, or 94 of Oxa1L-CTT have been prepared. These Cys residues have been derivatized with a fluorescent probe, tetramethylrhodamine-5-maleimide, for biophysical studies. Oxa1L-CTT forms oligomers cooperatively with a binding constant in the submicromolar range. Fluorescence anisotropy and fluorescence lifetime measurements indicate that contacts near a long helix close to position 39 of Oxa1L-CTT occur during oligomer formation. Fluorescence correlation spectroscopy measurements demonstrate that all of the Oxa1L-CTT derivatives bind to mammalian mitochondrial ribosomes. Steady-state fluorescence quenching and fluorescence lifetime data indicate that there are extensive contacts between Oxa1L-CTT and the ribosome-encompassing regions around positions 39, 67, and 94. The results of this study suggest that Oxa1L-CTT undergoes conformational changes and induced oligomer formation when it binds to the ribosome.	[Haque, Md Emdadul; Spremulli, Linda L.; Fecko, Christopher J.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Fecko, CJ (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	cfecko@email.unc.edu			National Institutes of Health [GM32734]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32734 (to L. L. S.).	Banerjee A, 2006, BIOCHEMISTRY-US, V45, P2333, DOI 10.1021/bi0522551; Bonnefoy N, 2009, BBA-MOL CELL RES, V1793, P60, DOI 10.1016/j.bbamcr.2008.05.004; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; CASEY KG, 1988, J PHYS CHEM-US, V92, P6590, DOI 10.1021/j100334a023; Forouhar F, 2003, J BIOL CHEM, V278, P21980, DOI 10.1074/jbc.M208650200; Hamman BD, 1996, J BIOL CHEM, V271, P7568, DOI 10.1074/jbc.271.13.7568; Haque ME, 2010, J BIOL CHEM, V285, P28353, DOI 10.1074/jbc.M110.148262; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Jermutus L, 2002, EUR BIOPHYS J BIOPHY, V31, P179, DOI 10.1007/s00249-001-0204-0; Jia YW, 1997, P NATL ACAD SCI USA, V94, P7932, DOI 10.1073/pnas.94.15.7932; Kao PH, 2007, TOXICON, V50, P952, DOI 10.1016/j.toxicon.2007.07.011; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Liu MQ, 2000, J BIOL CHEM, V275, P29400, DOI 10.1074/jbc.M002173200; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; MACDONALD RI, 1990, J BIOL CHEM, V265, P13533; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Magde D, 1999, PHOTOCHEM PHOTOBIOL, V70, P737, DOI 10.1111/j.1751-1097.1999.tb08277.x; MATTHEWS DE, 1982, J BIOL CHEM, V257, P8788; Nomura Y, 2001, CYTOMETRY, V44, P1; OBRIEN TW, 1993, TRANSLATIONAL APPARATUS, P575; Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010; Sato T, 2009, J BIOL CHEM, V284, P14819, DOI 10.1074/jbc.M809520200; Sherman E, 2008, BIOPHYS J, V94, P4819, DOI 10.1529/biophysj.107.120220; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623	26	24	25	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34991	34998		10.1074/jbc.M110.163808	http://dx.doi.org/10.1074/jbc.M110.163808			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739282	Green Published, hybrid			2022-12-25	WOS:000283659100073
J	Park, J; Kang, SI; Lee, SY; Zhang, XF; Kim, MS; Beers, LF; Lim, DS; Avruch, J; Kim, HS; Lee, SB				Park, Jikyoung; Kang, Soo Im; Lee, Sun-Young; Zhang, Xian F.; Kim, Myoung Shin; Beers, Lisa F.; Lim, Dae-Sik; Avruch, Joseph; Kim, Ho-Shik; Lee, Sean Bong			Tumor Suppressor Ras Association Domain Family 5 (RASSF5/NORE1) Mediates Death Receptor Ligand-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN CONDENSATION; NUCLEAR TRANSLOCATION; HIPPO PATHWAY; KINASE MST1; RASSF1A; ACTIVATION; PROTEIN; IDENTIFICATION; NORE1; PHOSPHORYLATION	Epigenetic silencing of RASSF (Ras association domain family) genes RASSF1 and RASSF5 (also called NORE1) by CpG hypermethylation is found frequently in many cancers. Although the physiological roles of RASSF1 have been studied in some detail, the exact functions of RASSF5 are not well understood. Here, we show that RASSF5 plays an important role in mediating apoptosis in response to death receptor ligands, TNF-alpha and TNF-related apoptosis-inducing ligand. Depletion of RASSF5 by siRNA significantly reduced TNF-alpha-mediated apoptosis, likely through its interaction with proapoptotic kinase MST1, a mammalian homolog of Hippo. Consistent with this, siRNA knockdown of MST1 also resulted in resistance to TNF-alpha-induced apoptosis. To further study the role of Rassf5 in vivo, we generated Rassf5-deficient mouse. Inactivation of Rassf5 in mouse embryonic fibroblasts (MEFs) resulted in resistance to TNF-alpha- and TNF-related apoptosis-inducing ligand-mediated apoptosis. Importantly, Rassf5-null mice were significantly more resistant to TNF-alpha-induced apoptosis and failed to activate Mst1. Loss of Rassf5 also resulted in spontaneous immortalization of MEFs at earlier passages than the control MEFs, and Rassf5-null immortalized MEFs, but not the immortalized wild type MEFs, were fully transformed by K-RasG12V. Together, our results demonstrate a direct role for RASSF5 in death receptor ligand-mediated apoptosis and provide further evidence for RASSF5 as a tumor suppressor.	[Park, Jikyoung; Kang, Soo Im; Kim, Myoung Shin; Beers, Lisa F.; Lee, Sean Bong] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Lee, Sun-Young; Kim, Ho-Shik] Catholic Univ Korea, Coll Med, Dept Biochem, Seoul 137701, South Korea; [Zhang, Xian F.; Avruch, Joseph] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Lim, Dae-Sik] Korea Adv Inst Sci & Technol, Biomed Res Ctr, Dept Biol Sci, Natl Res Lab Mol Genet, Taejon 305701, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Catholic University of Korea; Harvard University; Massachusetts General Hospital; Korea Advanced Institute of Science & Technology (KAIST)	Lee, SB (corresponding author), NIDDK, Genet Dev & Dis Branch, NIH, 9000 Rockville Pike,Bldg 10,9D11, Bethesda, MD 20892 USA.	seanL@intra.niddk.nih.gov	Lim, Dae-Sik/C-1599-2011	Lim, Dae-Sik/0000-0003-2356-7555; Lee, Sean/0000-0001-6211-3498	National Institutes of Health NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056002] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by a grant the National Institutes of Health NIDDK Intramural Research Program (to S. B. L.).	Avruch J, 2009, J BIOL CHEM, V284, P11001, DOI 10.1074/jbc.R800073200; Baksh S, 2005, MOL CELL, V18, P637, DOI 10.1016/j.molcel.2005.05.010; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Foley CJ, 2008, MOL CELL BIOL, V28, P4520, DOI 10.1128/MCB.02011-07; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hesson L, 2003, ONCOGENE, V22, P947, DOI 10.1038/sj.onc.1206191; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; Ikeda M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000300; Jang SW, 2007, J BIOL CHEM, V282, P30836, DOI 10.1074/jbc.M704542200; Kakeya H, 1998, CANCER RES, V58, P4888; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; LEIST M, 1994, J IMMUNOL, V153, P1778; Lin YS, 2002, J BIOL CHEM, V277, P47991, DOI 10.1074/jbc.M202630200; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Morris MR, 2003, ONCOGENE, V22, P6794, DOI 10.1038/sj.onc.1206914; Oh HJ, 2006, CANCER RES, V66, P2562, DOI 10.1158/0008-5472.CAN-05-2951; Ortiz-Vega S, 2002, ONCOGENE, V21, P1381, DOI 10.1038/sj.onc.1205192; Polesello C, 2006, CURR BIOL, V16, P2459, DOI 10.1016/j.cub.2006.10.060; PRASKOVA M, 2004, J BIOCH J */* BIOCH, V381, P453; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Shivakumar L, 2002, MOL CELL BIOL, V22, P4309, DOI 10.1128/MCB.22.12.4309-4318.2002; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tommasi S, 2005, CANCER RES, V65, P92; Tommasi S, 2002, ONCOGENE, V21, P2713, DOI 10.1038/sj.onc.1205365; Ura S, 2001, P NATL ACAD SCI USA, V98, P10148, DOI 10.1073/pnas.181161698; Ura S, 2007, MOL CELL BIOL, V27, P5514, DOI 10.1128/MCB.00199-07; VANDER W, 2005, MOL CELL BIOL */* A, V25, P8356; VANDER WL, 2007, BIOCHIM BIOPHYS ACTA, V1776, P58; Vavvas D, 1998, J BIOL CHEM, V273, P5439, DOI 10.1074/jbc.273.10.5439; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Vos MD, 2004, CANCER RES, V64, P4244, DOI 10.1158/0008-5472.CAN-04-0339	43	58	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35029	35038		10.1074/jbc.M110.165506	http://dx.doi.org/10.1074/jbc.M110.165506			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810663	Green Published, hybrid			2022-12-25	WOS:000283659100077
J	Riedinger, C; Boehringer, J; Trempe, JF; Lowe, ED; Brown, NR; Gehring, K; Noble, MEM; Gordon, C; Endicott, JA				Riedinger, Christiane; Boehringer, Jonas; Trempe, Jean-Francois; Lowe, Edward D.; Brown, Nicholas R.; Gehring, Kalle; Noble, Martin E. M.; Gordon, Colin; Endicott, Jane A.			Structure of Rpn10 and Its Interactions with Polyubiquitin Chains and the Proteasome Subunit Rpn12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBA DOMAIN; REGULATORY PARTICLE; 26S PROTEASOME; UBIQUITIN RECOGNITION; PROTEIN COMPLEXES; BINDING PROTEIN; DEGRADATION; SPECIFICITY; REVEALS; RAP80	Schizosaccharomyces pombe Rpn10 (SpRpn10) is a proteasomal ubiquitin (Ub) receptor located within the 19 S regulatory particle where it binds to subunits of both the base and lid subparticles. We have solved the structure of full-length SpRpn10 by determining the crystal structure of the von Willebrand factor type A domain and characterizing the full-length protein by NMR. We demonstrate that the single Ub-interacting motif (UIM) of SpRpn10 forms a 1:1 complex with Lys(48)-linked diUb, which it binds selectively over monoUb and Lys(63)-linked diUb. We further show that the SpRpn10 UIM binds to SpRpn12, a subunit of the lid subparticle, with an affinity comparable with Lys(48)-linked diUb. This is the first observation of a UIM binding other than a Ub fold and suggests that SpRpn12 could modulate the activity of SpRpn10 as a proteasomal Ub receptor.	[Riedinger, Christiane; Boehringer, Jonas; Lowe, Edward D.; Brown, Nicholas R.; Noble, Martin E. M.; Endicott, Jane A.] Univ Oxford, Dept Biochem, Lab Mol Biophys, Oxford OX1 3QU, England; [Trempe, Jean-Francois; Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Gordon, Colin] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Oxford; McGill University; University of Edinburgh	Endicott, JA (corresponding author), Univ Oxford, Dept Biochem, Lab Mol Biophys, S Parks Rd, Oxford OX1 3QU, England.	jane.endicott@bioch.ox.ac.uk	Gehring, Kalle/N-2945-2019; Gehring, Kalle/I-4403-2013; Lowe, Edward/AAP-5381-2021	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184; Lowe, Edward/0000-0002-1757-0208; Riedinger, Christiane/0000-0002-9310-9894; Endicott, Jane/0000-0003-4868-0116; Noble, Martin/0000-0002-3595-9807	United Kingdom Medical Research Council; Canadian Institutes of Health Research; Wellcome Trust; MRC [G0700053, MC_U127584486] Funding Source: UKRI; Medical Research Council [MC_U127584486, G0700053] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the United Kingdom Medical Research Council, the Canadian Institutes of Health Research, and the Wellcome Trust.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Drews O, 2007, PROTEOMICS, V7, P1047, DOI 10.1002/pmic.200600574; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fu HY, 2001, EMBO J, V20, P7096, DOI 10.1093/emboj/20.24.7096; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Glickman MH, 1999, MOL BIOL REP, V26, P21, DOI 10.1023/A:1006928316738; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nickell S, 2009, P NATL ACAD SCI USA, V106, P11943, DOI 10.1073/pnas.0905081106; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Pick E, 2009, MOL CELL, V35, P260, DOI 10.1016/j.molcel.2009.07.009; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Ryu KS, 2003, J BIOL CHEM, V278, P36621, DOI 10.1074/jbc.M304628200; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Seeger M, 2003, J BIOL CHEM, V278, P16791, DOI 10.1074/jbc.M208281200; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Springer TA, 2006, STRUCTURE, V14, P1611, DOI 10.1016/j.str.2006.10.001; Taverner T, 2008, ACCOUNTS CHEM RES, V41, P617, DOI 10.1021/ar700218q; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Trempe JF, 2010, ACTA CRYSTALLOGR F, V66, P994, DOI 10.1107/S1744309110027600; Trempe JF, 2005, EMBO J, V24, P3178, DOI 10.1038/sj.emboj.7600797; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Walters KJ, 2003, P NATL ACAD SCI USA, V100, P12694, DOI 10.1073/pnas.1634989100; Walters KJ, 2009, EMBO J, V28, P2307, DOI 10.1038/emboj.2009.221; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Wilkinson CRM, 2000, J BIOL CHEM, V275, P15182, DOI 10.1074/jbc.275.20.15182; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Zhang DN, 2009, MOL CELL, V36, P1018, DOI 10.1016/j.molcel.2009.11.012; Zhang NX, 2009, MOL CELL, V35, P280, DOI 10.1016/j.molcel.2009.06.010	50	49	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33992	34003		10.1074/jbc.M110.134510	http://dx.doi.org/10.1074/jbc.M110.134510			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20739285	Green Published, hybrid			2022-12-25	WOS:000283354000046
J	Graham, JA; Fray, M; de Haseth, S; Lee, KM; Lian, MM; Chase, CM; Madsen, JC; Markmann, J; Benichou, G; Colvin, RB; Cosimi, AB; Deng, SP; Kim, J; Alessandrini, A				Graham, Jay A.; Fray, Michael; de Haseth, Stephanie; Lee, Kang Mi; Lian, Moh-Moh; Chase, Catharine M.; Madsen, Joren C.; Markmann, James; Benichou, Gilles; Colvin, Robert B.; Cosimi, A. Benedict; Deng, Shaoping; Kim, James; Alessandrini, Alessandro			Suppressive Regulatory T Cell Activity Is Potentiated by Glycogen Synthase Kinase 3 beta Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXP3; BETA-CATENIN; TGF-BETA; IN-VIVO; GSK3-BETA; STABILIZATION; PROLIFERATION; EXPRESSION; GSK-3-BETA; INDUCTION	The mechanism by which regulatory T (Treg) cells suppress the immune response is not well defined. A recent study has shown that beta-catenin prolongs Treg cell survival. Because beta-catenin is regulated by glycogen synthase kinase 3 beta(GSK-3 beta)-directed phosphorylation, we focused on GSK-3 beta and the role it plays in Treg cell function. Inhibition of GSK-3 beta led to increased suppression activity by Treg cells. Inhibitor-treated Treg cells exhibited prolonged FoxP3 expression and increased levels of beta-catenin and of the antiapoptotic protein Bcl-xL. Systemic administration of GSK-3 beta inhibitor resulted in prolonged islet survival in an allotransplant mouse model. Our data suggest that GSK-3 beta could be a useful target in developing strategies designed to increase the stability and function of Treg cells for inducing allotransplant tolerance or treating autoimmune conditions.	[Madsen, Joren C.; Markmann, James; Benichou, Gilles; Cosimi, A. Benedict; Deng, Shaoping; Alessandrini, Alessandro] Harvard Univ, Sch Med, Transplantat Unit, Massachusetts Gen Hosp,Dept Surg, Boston, MA 02114 USA; [Colvin, Robert B.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Madsen, Joren C.] Massachusetts Gen Hosp, Div Cardiac Surg, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Alessandrini, A (corresponding author), Harvard Univ, Sch Med, Transplantat Unit, Massachusetts Gen Hosp,Dept Surg, 55 Fruit St,Thier 807, Boston, MA 02114 USA.	aalessandrini@partners.org	Graham, Jay A/A-4896-2014; Graham, Jay/AAL-5732-2020	Graham, Jay A/0000-0003-2054-1253; Graham, Jay/0000-0003-2054-1253	National Institutes of Health [K01 DK079207-02, K02 AI53103, R01 HD050484, R01 HL071932, R01 AI048820-09, 5P01 HL18646, U19 DK080652, R01 AI081734-01]; Surgical Research Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050484] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018646, R01HL071932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI053103, R01AI048820, R01AI081734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK079207, U19DK080652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Surgical Research Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K01 DK079207-02 (to J.K.), K02 AI53103 and R01 HD050484 (to G. B.), R01 HL071932 (to J.C.M.), R01 AI048820-09 (to J.M.), 5P01 HL18646 and U19 DK080652 (to A. B. C.), and R01 AI081734-01 (to R. B. C.). This work was also supported by a Surgical Research Council junior faculty award (to A. A.).	Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Clifford RL, 2008, J BIOL CHEM, V283, P35337, DOI 10.1074/jbc.M803342200; Cline GW, 2002, DIABETES, V51, P2903, DOI 10.2337/diabetes.51.10.2903; de Lafaille MAC, 2004, J IMMUNOL, V173, P7259, DOI 10.4049/jimmunol.173.12.7259; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Dugo L, 2006, SHOCK, V25, P485, DOI 10.1097/01.shk.0000209545.29671.31; Dugo L, 2005, CRIT CARE MED, V33, P1903, DOI 10.1097/01.CCM.0000178350.21839.44; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Gavin M, 2003, CURR OPIN IMMUNOL, V15, P690, DOI 10.1016/j.coi.2003.09.011; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Letai A, 2006, MOL CELL, V21, P728, DOI 10.1016/j.molcel.2006.03.005; Marchetti A, 2008, CELL SIGNAL, V20, P2113, DOI 10.1016/j.cellsig.2008.08.002; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Nakashima H, 2005, ACTA NEUROPATHOL, V110, P547, DOI 10.1007/s00401-005-1087-4; Neal JW, 2001, J BIOL CHEM, V276, P3666, DOI 10.1074/jbc.M004888200; Ohteki T, 2000, J EXP MED, V192, P99, DOI 10.1084/jem.192.1.99; Papkoff J, 1998, BIOCHEM BIOPH RES CO, V247, P851, DOI 10.1006/bbrc.1998.8888; Park HB, 2004, INT IMMUNOL, V16, P1203, DOI 10.1093/intimm/dxh123; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Sakaguchi S, 2005, INT REV IMMUNOL, V24, P211, DOI 10.1080/08830180590934976; Staal FJT, 2004, J IMMUNOL, V172, P1099, DOI 10.4049/jimmunol.172.2.1099; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Xu YY, 2003, EUR J IMMUNOL, V33, P12, DOI 10.1002/immu.200390002; Zheng SG, 2004, J IMMUNOL, V172, P5213, DOI 10.4049/jimmunol.172.9.5213; Zheng SG, 2004, J IMMUNOL, V172, P1531, DOI 10.4049/jimmunol.172.3.1531; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	39	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32852	32859		10.1074/jbc.M110.150904	http://dx.doi.org/10.1074/jbc.M110.150904			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729209	Green Published, hybrid			2022-12-25	WOS:000283048200022
J	Biarnes, X; Marchiori, A; Giorgetti, A; Lanzara, C; Gasparini, P; Carloni, P; Born, S; Brockhoff, A; Behrens, M; Meyerhof, W				Biarnes, Xevi; Marchiori, Alessandro; Giorgetti, Alejandro; Lanzara, Carmela; Gasparini, Paolo; Carloni, Paolo; Born, Stephan; Brockhoff, Anne; Behrens, Maik; Meyerhof, Wolfgang			Insights into the Binding of Phenyltiocarbamide (PTC) Agonist to Its Target Human TAS2R38 Bitter Receptor	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; TASTE; SEQUENCE; FAMILY; SENSITIVITY; RHODOPSIN; REVEALS; LIGANDS; PATTERN	Humans' bitter taste perception is mediated by the hTAS2R subfamily of the G protein-coupled membrane receptors (GPCRs). Structural information on these receptors is currently limited. Here we identify residues involved in the binding of phenylthiocarbamide (PTC) and in receptor activation in one of the most widely studied hTAS2Rs (hTAS2R38) by means of structural bioinformatics and molecular docking. The predictions are validated by site-directed mutagenesis experiments that involve specific residues located in the putative binding site and trans-membrane (TM) helices 6 and 7 putatively involved in receptor activation. Based on our measurements, we suggest that (i) residue N103 participates actively in PTC binding, in line with previous computational studies. (ii) W99, M100 and S259 contribute to define the size and shape of the binding cavity. (iii) W99 and M100, along with F255 and V296, play a key role for receptor activation, providing insights on bitter taste receptor activation not emerging from the previously reported computational models.	[Biarnes, Xevi; Carloni, Paolo] Int Sch Adv Studies SISSA ISAS, Trieste, Italy; [Born, Stephan; Brockhoff, Anne; Behrens, Maik; Meyerhof, Wolfgang] German Inst Human Nutr Potsdam Rebrucke DIfE, Dept Mol Genet, Nuthetal, Germany; [Giorgetti, Alejandro] Univ Verona, Dept Biotechnol, I-37100 Verona, Italy; [Biarnes, Xevi; Carloni, Paolo] DEMOCRITOS Modeling Ctr Res Atomist Simulat, Trieste, Italy; [Carloni, Paolo] German Res Sch Simulat Sci, Aachen, Germany; [Marchiori, Alessandro; Lanzara, Carmela; Gasparini, Paolo] Univ Trieste, Dept Reprod & Dev Sci, Trieste, Italy; [Lanzara, Carmela; Gasparini, Paolo] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy	International School for Advanced Studies (SISSA); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Verona; University of Trieste; IRCCS Burlo Garofolo	Biarnes, X (corresponding author), Int Sch Adv Studies SISSA ISAS, Trieste, Italy.	alejandro.giorgetti@univr.it; p.carloni@grs-sim.de	Gasparini, Paolo/B-6173-2014; Behrens, Maik/B-6753-2016; Carloni, Paolo/H-8736-2013; Biarnés, Xevi/AAA-3107-2019	Behrens, Maik/0000-0003-2082-8860; Biarnés, Xevi/0000-0003-4121-9474; Born, Stephan/0000-0001-6841-1410; Gasparini, Paolo/0000-0002-0859-0856; Giorgetti, Alejandro/0000-0001-8738-6150; Carloni, Paolo/0000-0002-9010-0149				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; BALLESTEROS JA, 1992, BIOPHYS J, V62, P107, DOI 10.1016/S0006-3495(92)81794-0; Battey JND, 2007, PROTEINS, V69, P68, DOI 10.1002/prot.21761; Behrens M, 2009, RESULTS PROBL CELL D, V47, P203, DOI 10.1007/400_2008_5; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; Brockhoff A, 2010, P NATL ACAD SCI USA, V107, P11110, DOI 10.1073/pnas.0913862107; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Clapp TR, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-6; Costanzi S, 2008, J MED CHEM, V51, P2907, DOI 10.1021/jm800044k; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Floriano WB, 2006, J MOL MODEL, V12, P931, DOI 10.1007/s00894-006-0102-6; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Khafizov K, 2007, J MOL MODEL, V13, P401, DOI 10.1007/s00894-006-0160-9; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kleinau G, 2007, MOL ENDOCRINOL, V21, P574, DOI 10.1210/me.2006-0309; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Meyerhof W, 2005, REV PHYSIOL BIOCH P, V154, P37, DOI 10.1007/s10254-005-0041-0; Miguet L, 2006, J RECEPT SIG TRANSD, V26, P611, DOI 10.1080/10799890600928210; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Pronin AN, 2004, CHEM SENSES, V29, P583, DOI 10.1093/chemse/bjh064; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Ropelewski A. J., 2004, CURR PROTOC BIOINFOR; SAKURAI T, 2010, J BIOL CHEM IN PRESS; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shi P, 2006, MOL BIOL EVOL, V23, P292, DOI 10.1093/molbev/msj028; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soranzo N, 2005, CURR BIOL, V15, P1257, DOI 10.1016/j.cub.2005.06.042; Ueda T, 2005, CHEM SENSES, V30, pI16, DOI 10.1093/chemse/bjh090; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Worth CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007011; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161	41	79	83	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12394	10.1371/journal.pone.0012394	http://dx.doi.org/10.1371/journal.pone.0012394			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811630	gold, Green Published, Green Submitted			2022-12-25	WOS:000281234700019
J	Pearton, M; Kang, SM; Song, JM; Anstey, AV; Ivory, M; Compans, RW; Birchall, JC				Pearton, Marc; Kang, Sang-Moo; Song, Jae-Min; Anstey, Alexander V.; Ivory, Matthew; Compans, Richard W.; Birchall, James C.			Changes in Human Langerhans Cells Following Intradermal Injection of Influenza Virus-Like Particle Vaccines	PLOS ONE			English	Article							DERMAL DENDRITIC CELLS; ANTIBODY-RESPONSES; MICROINJECTION SYSTEM; IMMUNE-RESPONSES; IMMUNOGENICITY; VACCINATION; DELIVERY; SKIN; SAFETY; MOUSE	There is a significant gap in our fundamental understanding of early morphological and migratory changes in human Langerhans cells (LCs) in response to vaccine stimulation. As the vast majority of LCs studies are conducted in small animal models, substantial interspecies variation in skin architecture and immunity must be considered when extrapolating the results to humans. This study aims to determine whether excised human skin, maintained viable in organ culture, provides a useful human model for measuring and understanding early immune response to intradermally delivered vaccine candidates. Excised human breast skin was maintained viable in air-liquid-interface organ culture. This model was used for the first time to show morphological changes in human LCs stimulated with influenza virus-like particle (VLP) vaccines delivered via intradermal injection. Immunohistochemistry of epidermal sheets and skin sections showed that LCs in VLP treated skin lost their typical dendritic morphology. The cells were more dispersed throughout the epidermis, often in close proximity to the basement membrane, and appeared vertically elongated. Our data provides for increased understanding of the complex morphological, spatial and temporal changes that occur to permit LC migration through the densely packed keratinocytes of the epidermis following exposure to vaccine. Significantly, the data not only supports previous animal data but also provides new and essential evidence of host response to this vaccination strategy in the real human skin environment.	[Pearton, Marc; Ivory, Matthew; Birchall, James C.] Cardiff Univ, Welsh Sch Pharm, Cardiff, S Glam, Wales; [Kang, Sang-Moo; Song, Jae-Min; Compans, Richard W.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Anstey, Alexander V.] Aneurin Bevan Hlth Board Royal Gwent Hosp, Newport, Gwent, Wales	Cardiff University; Emory University; Royal Gwent Hospital	Pearton, M (corresponding author), Cardiff Univ, Welsh Sch Pharm, Cardiff, S Glam, Wales.	birchalljc@cardiff.ac.uk	Birchall, James/N-1711-2014; Compans, Richard W/I-4087-2013; Ivory, Matthew Owen/B-7646-2015	Birchall, James/0000-0001-8521-6924; Compans, Richard W/0000-0003-2360-335X; Ivory, Matthew Owen/0000-0002-8736-395X	National Institutes of Health [EB006369]; NIH/NIAID [AI0680003]; Georgia Research Alliance; Korea Research Foundation [KRF-2007-357-C00088]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006369] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Georgia Research Alliance; Korea Research Foundation(National Research Foundation of Korea); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by the National Institutes of Health Grant EB006369, and also partially supported by NIH/NIAID grant AI0680003 (R.W.C.) and by funds from the Georgia Research Alliance (S.M.K.) and the Korea Research Foundation Grant KRF-2007-357-C00088 (J.M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auewarakul P, 2007, VACCINE, V25, P659, DOI 10.1016/j.vaccine.2006.08.026; Baldwin SL, 2009, VACCINE, V27, P3063, DOI 10.1016/j.vaccine.2009.03.018; Belshe RB, 2004, NEW ENGL J MED, V351, P2286, DOI 10.1056/NEJMoa043555; Beran J, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-13; Birchall J, 2005, J DRUG TARGET, V13, P415, DOI 10.1080/10611860500383705; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Chiu SS, 2007, PEDIATRICS, V119, P1076, DOI 10.1542/peds.2006-3176; Chowell G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008164; Cutts FT, 1997, BIOLOGICALS, V25, P323, DOI 10.1006/biol.1997.0103; de Jong MAWP, 2010, METHODS MOL BIOL, V595, P55, DOI 10.1007/978-1-60761-421-0_4; Dearman RJ, 2004, EXP DERMATOL, V13, P452, DOI 10.1111/j.0906-6705.2004.00199.x; Francis T, 1937, J Exp Med, V65, P251, DOI 10.1084/jem.65.2.251; Furio L, 2010, J INVEST DERMATOL, V130, P1345, DOI 10.1038/jid.2009.424; Griffiths CEM, 2005, CYTOKINE, V32, P67, DOI 10.1016/j.cyto.2005.07.011; GSCHWANDTNER M, 2009, ALLERGY IN PRESS; Haynes JR, 2009, VACCINE, V27, P530, DOI 10.1016/j.vaccine.2008.11.011; Holland D, 2008, J INFECT DIS, V198, P650, DOI 10.1086/590434; Kang SM, 2009, VIRUS RES, V143, P140, DOI 10.1016/j.virusres.2009.04.005; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Lambert PH, 2008, VACCINE, V26, P3197, DOI 10.1016/j.vaccine.2008.03.095; LARSEN CP, 1990, J EXP MED, V172, P1483, DOI 10.1084/jem.172.5.1483; Laurent PE, 2007, VACCINE, V25, P8833, DOI 10.1016/j.vaccine.2007.10.020; Merad M, 2008, NAT REV IMMUNOL, V8, P935, DOI 10.1038/nri2455; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; MILLER KD, 1983, LANCET, V2, P1454, DOI 10.1016/S0140-6736(83)90800-0; Ng KW, 2009, VACCINE, V27, P5948, DOI 10.1016/j.vaccine.2009.07.088; Nirmal S, 1998, VACCINE, V16, P928, DOI 10.1016/S0264-410X(97)00293-4; Nishibu A, 2007, J DERMATOL SCI, V45, P23, DOI 10.1016/j.jdermsci.2006.10.003; PEARTON M, 2010, VACCINE IN PRESS; Quan FS, 2009, J VIROL, V83, P4489, DOI 10.1128/JVI.02035-08; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Quan FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007152; RAMBUKKANA A, 1995, LAB INVEST, V73, P521; Schwarz A, 2010, J INVEST DERMATOL, V130, P1419, DOI 10.1038/jid.2009.429; Shklovskaya E, 2008, J IMMUNOL, V181, P418, DOI 10.4049/jimmunol.181.1.418; Stutte S, 2008, J INVEST DERMATOL, V128, P1470, DOI 10.1038/sj.jid.5701228; Sugimura T, 2008, VACCINE, V26, P2700, DOI 10.1016/j.vaccine.2008.03.016; Swetman CA, 2002, EUR J IMMUNOL, V32, P2074, DOI 10.1002/1521-4141(200207)32:7<2074::AID-IMMU2074>3.0.CO;2-S; TRAN JN, 2010, EXP DERMATO IN PRESS; Van Damme P, 2009, VACCINE, V27, P454, DOI 10.1016/j.vaccine.2008.10.077; VANWILSEM EJG, 1994, J INVEST DERMATOL, V103, P217, DOI 10.1111/1523-1747.ep12393088; Wang BH, 1999, J LEUKOCYTE BIOL, V66, P33, DOI 10.1002/jlb.66.1.33; WHO Publication, 2010, Vaccine, V28, P589, DOI 10.1016/j.vaccine.2009.10.110; Wu XF, 2009, VACCINE, V27, P7202, DOI 10.1016/j.vaccine.2009.09.025	45	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12410	10.1371/journal.pone.0012410	http://dx.doi.org/10.1371/journal.pone.0012410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811642	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000281234700031
J	Jiang, YH; Pan, YZ; Zhu, L; Landa, L; Yoo, J; Spencer, C; Lorenzo, I; Brilliant, M; Noebels, J; Beaudet, AL				Jiang, Yong-hui; Pan, Yanzhen; Zhu, Li; Landa, Luis; Yoo, Jong; Spencer, Corinne; Lorenzo, Isabel; Brilliant, Murray; Noebels, Jeffrey; Beaudet, Arthur L.			Altered Ultrasonic Vocalization and Impaired Learning and Memory in Angelman Syndrome Mouse Model with a Large Maternal Deletion from Ube3a to Gabrb3	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; PRADER-WILLI-SYNDROME; GENOMIC REARRANGEMENTS; BEHAVIORAL PHENOTYPES; IMPRINTED EXPRESSION; LANGUAGE DISORDER; UBIQUITIN LIGASE; MUTANT MICE; GENE; ATP10C	Angelman syndrome (AS) is a neurobehavioral disorder associated with mental retardation, absence of language development, characteristic electroencephalography (EEG) abnormalities and epilepsy, happy disposition, movement or balance disorders, and autistic behaviors. The molecular defects underlying AS are heterogeneous, including large maternal deletions of chromosome 15q11-q13 (70%), paternal uniparental disomy (UPD) of chromosome 15 (5%), imprinting mutations (rare), and mutations in the E6-AP ubiquitin ligase gene UBE3A (15%). Although patients with UBE3A mutations have a wide spectrum of neurological phenotypes, their features are usually milder than AS patients with deletions of 15q11-q13. Using a chromosomal engineering strategy, we generated mutant mice with a 1.6-Mb chromosomal deletion from Ube3a to Gabrb3, which inactivated the Ube3a and Gabrb3 genes and deleted the Atp10a gene. Homozygous deletion mutant mice died in the perinatal period due to a cleft palate resulting from the null mutation in Gabrb3 gene. Mice with a maternal deletion (m-/p+) were viable and did not have any obvious developmental defects. Expression analysis of the maternal and paternal deletion mice confirmed that the Ube3a gene is maternally expressed in brain, and showed that the Atp10a and Gabrb3 genes are biallelically expressed in all brain sub-regions studied. Maternal (m-/p+), but not paternal (m+/p-), deletion mice had increased spontaneous seizure activity and abnormal EEG. Extensive behavioral analyses revealed significant impairment in motor function, learning and memory tasks, and anxiety-related measures assayed in the light-dark box in maternal deletion but not paternal deletion mice. Ultrasonic vocalization (USV) recording in newborns revealed that maternal deletion pups emitted significantly more USVs than wild-type littermates. The increased USV in maternal deletion mice suggests abnormal signaling behavior between mothers and pups that may reflect abnormal communication behaviors in human AS patients. Thus, mutant mice with a maternal deletion from Ube3a to Gabrb3 provide an AS mouse model that is molecularly more similar to the contiguous gene deletion form of AS in humans than mice with Ube3a mutation alone. These mice will be valuable for future comparative studies to mice with maternal deficiency of Ube3a alone.	[Jiang, Yong-hui; Pan, Yanzhen; Landa, Luis; Spencer, Corinne; Lorenzo, Isabel; Beaudet, Arthur L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Jiang, Yong-hui; Zhu, Li] Duke Univ, Sch Med, Dept Pediat & Neurobiol, Div Med Genet, Durham, NC USA; [Yoo, Jong; Noebels, Jeffrey] Baylor Coll Med, Neurogenet Lab, Dept Neurol, Houston, TX 77030 USA; [Brilliant, Murray] Univ Arizona, Hlth Sci Ctr, Dept Pediat, Tucson, AZ 85721 USA	Baylor College of Medicine; Duke University; Baylor College of Medicine; University of Arizona; University of Arizona Health Sciences	Jiang, YH (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	yong-hui.jiang@duke.edu		Noebels, Jeffrey/0000-0002-2887-0839	National Institutes of Health (NIH) [HD-37283]; Angelman Syndrome Foundation; Duke University Institute for Brain Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037283, K12HD043494] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Angelman Syndrome Foundation; Duke University Institute for Brain Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health (NIH) grant HD-37283 to ALB and Angelman Syndrome Foundation grant and Duke University Institute for Brain Science to YHJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Bi WM, 2007, HUM MOL GENET, V16, P1802, DOI 10.1093/hmg/ddm128; BRADLEY A, 2005, MOUSE CHROMOSOME ENG; Branchi I, 2001, BEHAV BRAIN RES, V125, P49, DOI 10.1016/S0166-4328(01)00277-7; Chai JH, 2003, AM J HUM GENET, V73, P898, DOI 10.1086/378816; Clayton-Smith J, 2003, J MED GENET, V40, P87, DOI 10.1136/jmg.40.2.87; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Dhar MS, 2006, J NUTR BIOCHEM, V17, P811, DOI 10.1016/j.jnutbio.2006.01.002; Dhar MS, 2004, J NUTR, V134, P799, DOI 10.1093/jn/134.4.799; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Dubose AJ, 2009, NEUROGENETICS; Fujita E, 2008, P NATL ACAD SCI USA, V105, P3117, DOI 10.1073/pnas.0712298105; Galvan-Manso M, 2005, EPILEPTIC DISORD, V7, P19; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Hahn ME, 2005, BEHAV GENET, V35, P31, DOI 10.1007/s10519-004-0854-7; Hahn ME, 2002, BEHAV GENET, V32, P267, DOI 10.1023/A:1019728813891; Heck DH, 2008, HUM MOL GENET, V17, P2181, DOI 10.1093/hmg/ddn117; Herzing LBK, 2001, AM J HUM GENET, V68, P1501, DOI 10.1086/320616; Hofer Myron A, 2002, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0814s17; Hogan C., 2007, Searcher, V15, P13; Hogart A, 2008, HUM GENET, V124, P235, DOI 10.1007/s00439-008-0546-0; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Horsler K, 2006, AM J MENT RETARD, V111, P311, DOI 10.1352/0895-8017(2006)111[311:EIOTBP]2.0.CO;2; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; JAMAIN S, 2008, P NATL ACAD SCI US; Jedele Kerry Baldwin, 2007, Semin Pediatr Neurol, V14, P108, DOI 10.1016/j.spen.2007.07.002; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jiang YH, 1999, AM J HUM GENET, V65, P1, DOI 10.1086/302473; Jiang YH, 2008, BMC GENOMICS, V9, DOI [10.1186/1471-2164-9-50, 10.1186/1471-2164-9-S1-S6]; Kashiwagi A, 2003, J HUM GENET, V48, P194, DOI 10.1007/s10038-003-0009-3; Kayashima T, 2003, J HUM GENET, V48, P492, DOI 10.1007/s10038-003-0061-z; Kayashima T, 2003, GENOMICS, V81, P644, DOI 10.1016/S0888-7543(03)00077-6; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Liljelund P, 2005, DEV BRAIN RES, V157, P150, DOI 10.1016/j.devbrainres.2005.03.014; Lossie AC, 2001, J MED GENET, V38, P834, DOI 10.1136/jmg.38.12.834; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Meguro M, 1997, HUM MOL GENET, V6, P2127, DOI 10.1093/hmg/6.12.2127; Meguro M, 2001, NAT GENET, V28, P19, DOI 10.1038/ng0501-19; Minassian BA, 1998, ANN NEUROL, V43, P485, DOI 10.1002/ana.410430412; Miura K, 2002, NEUROBIOL DIS, V9, P149, DOI 10.1006/nbdi.2001.0463; Moles A, 2004, SCIENCE, V304, P1983, DOI 10.1126/science.1095943; Moy SS, 2006, AM J MED GENET C, V142C, P40, DOI 10.1002/ajmg.c.30081; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; NICHOLLS RD, 1993, P NATL ACAD SCI USA, V90, P2050, DOI 10.1073/pnas.90.5.2050; Nishijima I, 2003, GENESIS, V36, P142, DOI 10.1002/gene.10207; Oliver C, 2002, AM J MENT RETARD, V107, P194, DOI 10.1352/0895-8017(2002)107<0194:EOEEOS>2.0.CO;2; Oliver C, 2007, J CHILD PSYCHOL PSYC, V48, P571, DOI 10.1111/j.1469-7610.2007.01736.x; Paprocka J, 2007, NEUROLOGIST, V13, P305, DOI 10.1097/01.nrl.0000253067.32759.aa; Paylor R, 2006, PHYSIOL BEHAV, V87, P95, DOI 10.1016/j.physbeh.2005.09.002; Peters SU, 2004, CLIN GENET, V66, P530, DOI 10.1111/j.1399-0004.2004.00362.x; Picker JD, 2006, NEUROREPORT, V17, P541, DOI 10.1097/01.wnr.0000208995.38695.2f; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; SCATTONI ML, 2008, NEUROSCI BIOBEHAV RE; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Stankiewicz P, 2007, CURR OPIN GENET DEV, V17, P182, DOI 10.1016/j.gde.2007.04.009; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; VANWOERDEN GM, 2007, NAT NEUROSCI; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Veltman MWM, 2005, PSYCHIAT GENET, V15, P243, DOI 10.1097/00041444-200512000-00006; Walz K, 2003, MOL CELL BIOL, V23, P3646, DOI 10.1128/MCB.23.10.3646-3655.2003; Walz K, 2006, J CLIN INVEST, V116, P3035, DOI 10.1172/JCI28953; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; YOUNG DM, 2007, P NATL ACAD SCI USA, V107, P11079; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000	70	117	119	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12278	10.1371/journal.pone.0012278	http://dx.doi.org/10.1371/journal.pone.0012278			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808828	Green Submitted, Green Published, gold			2022-12-25	WOS:000281077000004
J	Popesku, JT; Martyniuk, CJ; Denslow, ND; Trudeau, VL				Popesku, Jason T.; Martyniuk, Christopher J.; Denslow, Nancy D.; Trudeau, Vance L.			Rapid Dopaminergic Modulation of the Fish Hypothalamic Transcriptome and Proteome	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; GOLDFISH CARASSIUS-AURATUS; S-TRANSFERASE-PI; GENE-EXPRESSION; MOLECULAR-CLONING; FEMALE GOLDFISH; AFRICAN CATFISH; MESSENGER-RNA; GLUTATHIONE; PITUITARY	Background: Dopamine (DA) is a major neurotransmitter playing an important role in the regulation of vertebrate reproduction. We developed a novel method for the comparison of transcriptomic and proteomic data obtained from in vivo experiments designed to study the neuroendocrine actions of DA. Methods and Findings: Female goldfish were injected (i.p.) with DA agonists (D1-specific; SKF 38393, or D2-specific; LY 171555) and sacrificed after 5 h. Serum LH levels were reduced by 57% and 75% by SKF 38393 and LY 171555, respectively, indicating that the treatments produced physiologically relevant responses in vivo. Bioinformatic strategies and a ray-finned fish database were established for microarray and iTRAQ proteomic analysis of the hypothalamus, revealing a total of 3088 mRNAs and 42 proteins as being differentially regulated by the treatments. Twenty one proteins and mRNAs corresponding to these proteins appeared on both lists. Many of the mRNAs and proteins affected by the treatments were grouped into the Gene Ontology categorizations of protein complex, signal transduction, response to stimulus, and regulation of cellular processes. There was a 57% and 14% directional agreement between the differentially-regulated mRNAs and proteins for SKF 38393 and LY 171555, respectively. Conclusions: The results demonstrate the applicability of advanced high-throughput genomic and proteomic analyses in an amendable well-studied teleost model species whose genome has yet to be sequenced. We demonstrate that DA rapidly regulates multiple hypothalamic pathways and processes that are also known to be involved in pathologies of the central nervous system.	[Popesku, Jason T.; Trudeau, Vance L.] Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON, Canada; [Martyniuk, Christopher J.; Denslow, Nancy D.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA; [Martyniuk, Christopher J.; Denslow, Nancy D.] Univ Florida, Ctr Environm & Human Toxicol, Gainesville, FL USA	University of Ottawa; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Popesku, JT (corresponding author), Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON, Canada.	trudeauv@uottawa.ca	Trudeau, Vance L./P-5542-2019	Trudeau, Vance L./0000-0002-0845-9444; Martyniuk, Christopher J./0000-0003-0921-4796	Ontario Graduate Scholarship; Parkinson's Research Consortium; NSERC [203152]; National Institute of Environmental Health Sciences [RO1 ES015449]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015449] Funding Source: NIH RePORTER	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Parkinson's Research Consortium; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported financially by an Ontario Graduate Scholarship (JTP), the Parkinson's Research Consortium (JTP, VLT), NSERC Grant 203152 (VLT) and National Institute of Environmental Health Sciences Superfund Research Program RO1 ES015449 (NDD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen J, 2005, GEN COMP ENDOCR, V142, P212, DOI 10.1016/j.ygcen.2005.01.002; Altar CA, 2009, NEUROPSYCHOPHARMACOL, V34, P18, DOI 10.1038/npp.2008.172; Babin PJ, 1997, P NATL ACAD SCI USA, V94, P8622, DOI 10.1073/pnas.94.16.8622; BARBEAU A, 1970, CAN MED ASSOC J, V103, P824; BHANDARI B, 1988, P NATL ACAD SCI USA, V85, P5789, DOI 10.1073/pnas.85.16.5789; Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; Chang JP, 2009, GEN COMP ENDOCR, V161, P42, DOI 10.1016/j.ygcen.2008.09.005; CHANG JP, 1984, GEN COMP ENDOCR, V55, P351, DOI 10.1016/0016-6480(84)90003-0; CHANG JP, 1983, GEN COMP ENDOCR, V49, P22, DOI 10.1016/0016-6480(83)90004-7; CHANG JP, 1983, NEUROENDOCRINOLOGY, V36, P351, DOI 10.1159/000123480; Choudhury M, 2009, ACTA BIOCH BIOPH SIN, V41, P370, DOI 10.1093/abbs/gmp015; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DELEEUW R, 1986, GEN COMP ENDOCR, V63, P171, DOI 10.1016/0016-6480(86)90153-X; DELEEUW R, 1988, GEN COMP ENDOCR, V72, P408, DOI 10.1016/0016-6480(88)90163-3; Dihal AA, 2008, PROTEOMICS, V8, P45, DOI 10.1002/pmic.200700364; Dourado DFAR, 2008, CURR PROTEIN PEPT SC, V9, P325, DOI 10.2174/138920308785132677; Dufour S, 2005, ANN NY ACAD SCI, V1040, P9, DOI 10.1196/annals.1327.002; DUFOUR S, 1988, GEN COMP ENDOCR, V70, P20, DOI 10.1016/0016-6480(88)90090-1; Finch CE, 2003, NEUROBIOL AGING, V24, pS123, DOI 10.1016/S0197-4580(03)00051-4; Giraudo CG, 2009, SCIENCE, V323, P512, DOI 10.1126/science.1166500; GOPING G, 1995, BRAIN RES, V687, P35, DOI 10.1016/0006-8993(95)00391-3; Hack Catherine Jane, 2004, Briefings in Functional Genomics & Proteomics, V3, P212, DOI 10.1093/bfgp/3.3.212; Henderson CJ, 2000, P NATL ACAD SCI USA, V97, P12741, DOI 10.1073/pnas.220176997; HORNBY PJ, 1990, BRAIN BEHAV EVOLUT, V35, P49, DOI 10.1159/000115856; Huo LF, 2004, ENDOCRINOLOGY, V145, P5056, DOI 10.1210/en.2004-0584; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ishisaki A, 2001, J NEUROCHEM, V77, P1362, DOI 10.1046/j.1471-4159.2001.00351.x; KAH O, 1992, NEUROENDOCRINOLOGY, V55, P396, DOI 10.1159/000126150; KEBABIAN JW, 1979, NATURE, V277, P93, DOI 10.1038/277093a0; Kondo H, 2005, GENE, V346, P257, DOI 10.1016/j.gene.2004.11.015; Levavi-Sivan B, 2006, BIOL REPROD, V75, P642, DOI 10.1095/biolreprod.106.051540; Maiya R, 2007, GENES BRAIN BEHAV, V6, P97, DOI 10.1111/j.1601-183X.2006.00236.x; Marlatt VL, 2008, MOL CELL ENDOCRINOL, V283, P38, DOI 10.1016/j.mce.2007.10.013; Martyniuk CJ, 2007, J NEUROENDOCRINOL, V19, P390, DOI 10.1111/j.1365-2826.2007.01543.x; Martyniuk CJ, 2006, PHYSIOL GENOMICS, V27, P328, DOI 10.1152/physiolgenomics.00090.2006; Martyniuk CJ, 2009, GEN COMP ENDOCR, V164, P135, DOI 10.1016/j.ygcen.2009.01.023; Martyniuk CJ, 2009, J PROTEOME RES, V8, P2186, DOI 10.1021/pr800627n; Masserano JM, 1996, MOL PHARMACOL, V50, P1309; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; Mennigen JA, 2008, PHYSIOL GENOMICS, V35, P273, DOI 10.1152/physiolgenomics.90263.2008; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Otto CJ, 1999, REGUL PEPTIDES, V83, P97, DOI 10.1016/S0167-0115(99)00052-X; PETER RE, 1980, NEUROENDOCRINOLOGY, V31, P133, DOI 10.1159/000123064; PETER RE, 1984, GEN COMP ENDOCR, V55, P337, DOI 10.1016/0016-6480(84)90001-7; PETER RE, 1975, J COMP NEUROL, V159, P69, DOI 10.1002/cne.901590106; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Popesku J, 2008, BIOL REPROD, P53; Popesku JT, 2008, MOL CELL ENDOCRINOL, V293, P43, DOI 10.1016/j.mce.2008.06.017; Saligaut C, 1998, GEN COMP ENDOCR, V109, P302, DOI 10.1006/gcen.1997.7033; Shi M, 2009, AM J PATHOL, V175, P54, DOI 10.2353/ajpath.2009.081019; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Smeyne M, 2007, P NATL ACAD SCI USA, V104, P1977, DOI 10.1073/pnas.0610978104; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Takeuchi Y, 2002, J NEUROCHEM, V83, P784, DOI 10.1046/j.1471-4159.2002.01180.x; Trudeau V L, 1997, Rev Reprod, V2, P55, DOI 10.1530/ror.0.0020055; Trudeau VL, 2000, BIOCHEM CELL BIOL, V78, P241, DOI 10.1139/bcb-78-3-241; TRUDEAU VL, 1993, AM J PHYSIOL, V265, pR348, DOI 10.1152/ajpregu.1993.265.2.R348; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vitale ML, 2004, J HISTOCHEM CYTOCHEM, V52, P517, DOI 10.1177/002215540405200410; Williams DR, 2008, J FISH BIOL, V72, P2095, DOI 10.1111/j.1095-8649.2008.01875.x; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Xiong HL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-25; Yamamoto K, 2010, MOL CELL NEUROSCI, V43, P394, DOI 10.1016/j.mcn.2010.01.006; Zhang DP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005816; Zhao E, 2006, NEUROPEPTIDES, V40, P275, DOI 10.1016/j.npep.2006.05.002; Zhou L, 2005, COMP BIOCHEM PHYS B, V142, P432, DOI 10.1016/j.cbpb.2005.09.007	70	30	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12338	10.1371/journal.pone.0012338	http://dx.doi.org/10.1371/journal.pone.0012338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808832	gold, Green Published, Green Submitted			2022-12-25	WOS:000281077000019
J	Ruckert, F; Dawelbait, G; Winter, C; Hartmann, A; Denz, A; Ammerpohl, O; Schroeder, M; Schackert, HK; Sipos, B; Kloppel, G; Kalthoff, H; Saeger, HD; Pilarsky, C; Grutzmann, R				Rueckert, Felix; Dawelbait, Gihan; Winter, Christof; Hartmann, Arndt; Denz, Axel; Ammerpohl, Ole; Schroeder, Michael; Schackert, Hans Konrad; Sipos, Bence; Kloeppel, Guenter; Kalthoff, Holger; Saeger, Hans-Detlev; Pilarsky, Christian; Gruetzmann, Robert			Examination of Apoptosis Signaling in Pancreatic Cancer by Computational Signal Transduction Analysis	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; CARCINOMA CELL-LINES; PROTEIN INTERFACES; FAS LIGAND; EXPRESSION; CHEMORESISTANCE; GEMCITABINE; RESISTANCE; ADENOCARCINOMA; CHEMOTHERAPY	Background: Pancreatic ductal adenocarcinoma (PDAC) remains an important cause of cancer death. Changes in apoptosis signaling in pancreatic cancer result in chemotherapy resistance and aggressive growth and metastasizing. The aim of this study was to characterize the apoptosis pathway in pancreatic cancer computationally by evaluation of experimental data from high-throughput technologies and public data bases. Therefore, gene expression analysis of microdissected pancreatic tumor tissue was implemented in a model of the apoptosis pathway obtained by computational protein interaction prediction. Methodology/Principal Findings: Apoptosis pathway related genes were assembled from electronic databases. To assess expression of these genes we constructed a virtual subarray from a whole genome analysis from microdissected native tumor tissue. To obtain a model of the apoptosis pathway, interactions of members of the apoptosis pathway were analysed using public databases and computational prediction of protein interactions. Gene expression data were implemented in the apoptosis pathway model. 19 genes were found differentially expressed and 12 genes had an already known pathophysiological role in PDAC, such as Survivin/BIRC5, BNIP3 and TNF-R1. Furthermore we validated differential expression of IL1R2 and Livin/BIRC7 by RT-PCR and immunohistochemistry. Implementation of the gene expression data in the apoptosis pathway map suggested two higher level defects of the pathway at the level of cell death receptors and within the intrinsic signaling cascade consistent with references on apoptosis in PDAC. Protein interaction prediction further showed possible new interactions between the single pathway members, which demonstrate the complexity of the apoptosis pathway. Conclusions/Significance: Our data shows that by computational evaluation of public accessible data an acceptable virtual image of the apoptosis pathway might be given. By this approach we could identify two higher level defects of the apoptosis pathway in PDAC. We could further for the first time identify IL1R2 as possible candidate gene in PDAC.	[Rueckert, Felix; Denz, Axel; Saeger, Hans-Detlev; Pilarsky, Christian; Gruetzmann, Robert] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Visceral Thorac & Vasc Surg, Dresden, Germany; [Dawelbait, Gihan; Winter, Christof; Schroeder, Michael] Tech Univ Dresden, Bioinformat Grp, Ctr Biotechnol, Dresden, Germany; [Hartmann, Arndt] Univ Erlangen Nurnberg, Dept Pathol, Erlangen, Germany; [Ammerpohl, Ole; Kalthoff, Holger] Schleswig Holstein Univ Hosp, Div Mol Oncol, Clin Gen Surg & Thorac Surg, Kiel, Germany; [Schackert, Hans Konrad] Tech Univ Dresden, Dept Surg Res, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Sipos, Bence; Kloeppel, Guenter] Schleswig Holstein Univ Hosp, Div Mol Oncol, Inst Expt Canc Res, Kiel, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; University of Erlangen Nuremberg; University of Kiel; Schleswig Holstein University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Kiel; Schleswig Holstein University Hospital	Ruckert, F (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Visceral Thorac & Vasc Surg, Dresden, Germany.	Felix.Rueckert@uniklinikum-dresden.de	Schroeder, Michael/A-3040-2010; Winter, Christof/A-1887-2011; Kalthoff, Holger/B-1618-2010; Ammerpohl, Ole/G-2691-2010; Winter, Christof/AAF-1860-2020	Winter, Christof/0000-0002-0253-9056; Winter, Christof/0000-0002-0253-9056; Pilarsky, Christian/0000-0002-7968-3283	Deutsche Krebshilfe; medical faculty of Technische Universitat Dresden	Deutsche Krebshilfe(Deutsche Krebshilfe); medical faculty of Technische Universitat Dresden	This study was supported by Deutsche Krebshilfe and the MedDrive38 program of the medical faculty of Technische Universitat Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akada M, 2005, CLIN CANCER RES, V11, P3094, DOI 10.1158/1078-0432.CCR-04-1785; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arlt A, 2002, CANCER RES, V62, P910; Bai JR, 2005, CANCER RES, V65, P2344, DOI 10.1158/0008-5472.CAN-04-3502; Bernstorff WV, 2002, CANCER, V94, P2552, DOI 10.1002/cncr.10549; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Dupraz P, 2000, J BIOL CHEM, V275, P37672, DOI 10.1074/jbc.M005150200; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Fink L, 1998, NAT MED, V4, P1329, DOI 10.1038/3327; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; Grutzmann R, 2004, INT J COLORECTAL DIS, V19, P401, DOI 10.1007/s00384-003-0563-3; HEPPNER GH, 1984, CANCER RES, V44, P2259; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; KARIKARI CA, 2007, MOL CANC THER; Lopes RB, 2007, INT J CANC; Lowenfels AB, 2006, BEST PRACT RES CL GA, V20, P197, DOI 10.1016/j.bpg.2005.10.001; Mahon PC, 2007, CANCER RES, V67, P6786, DOI 10.1158/0008-5472.CAN-07-0440; Matsuo Y, 2004, PANCREAS, V28, P344, DOI 10.1097/00006676-200404000-00025; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Miyamoto Y, 1999, ONCOLOGY-BASEL, V56, P73, DOI 10.1159/000011933; Mori T, 2005, SURGERY, V138, P71, DOI 10.1016/j.surg.2005.03.001; Pilarsky C, 2008, J CELL MOL MED, V12, P2823, DOI 10.1111/j.1582-4934.2008.00289.x; Ringel B, 1999, ANN NY ACAD SCI, V880, P175, DOI 10.1111/j.1749-6632.1999.tb09521.x; Ruckdeschel K, 2002, J IMMUNOL, V168, P4601, DOI 10.4049/jimmunol.168.9.4601; Ruckert F, 2009, CURR CANCER THER REV, V5, P122, DOI 10.2174/157339409788166760; Rupnow BA, 1999, APOPTOSIS, V4, P115, DOI 10.1023/A:1009675028784; Schniewind B, 2004, INT J CANCER, V109, P182, DOI 10.1002/ijc.11679; Shi X, 2002, ONCOLOGY-BASEL, V62, P354, DOI 10.1159/000065068; Stoehr R, 2004, LAB INVEST, V84, P465, DOI 10.1038/labinvest.3700068; Tsai CJ, 1996, J MOL BIOL, V260, P604, DOI 10.1006/jmbi.1996.0424; Tsuji S, 2003, INT J CANCER, V106, P17, DOI 10.1002/ijc.11170; Ungefroren H, 1999, ANN NY ACAD SCI, V880, P243, DOI 10.1111/j.1749-6632.1999.tb09529.x; Vogler M, 2007, ONCOGENE, V26, P248, DOI 10.1038/sj.onc.1209776; Winter C, 2006, NUCLEIC ACIDS RES, V34, pD310, DOI 10.1093/nar/gkj099; Wolff RA, 2000, INVEST NEW DRUG, V18, P43, DOI 10.1023/A:1006383831045; Wright CW, 2005, J CLIN INVEST, V115, P2673, DOI 10.1172/JCI26251; Yamamoto S, 2004, CLIN CANCER RES, V10, P2846, DOI 10.1158/1078-0432.CCR-02-1441; Yoshida Y, 2004, J BIOL CHEM, V279, P1768, DOI 10.1074/jbc.M311498200	41	25	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12243	10.1371/journal.pone.0012243	http://dx.doi.org/10.1371/journal.pone.0012243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808857	Green Published, Green Submitted, gold			2022-12-25	WOS:000281075500004
J	Fernandes, LP; Annibale, A; Kleinjung, J; Coolen, ACC; Fraternali, F				Fernandes, Luis P.; Annibale, Alessia; Kleinjung, Jens; Coolen, Anthony C. C.; Fraternali, Franca			Protein Networks Reveal Detection Bias and Species Consistency When Analysed by Information-Theoretic Methods	PLOS ONE			English	Article							SCALE-FREE NETWORKS; INTERACTION MAP; INTERACTOME; YEAST; COMPLEXES; IDENTIFICATION; STABILITY; TOPOLOGY	We apply our recently developed information-theoretic measures for the characterisation and comparison of protein-protein interaction networks. These measures are used to quantify topological network features via macroscopic statistical properties. Network differences are assessed based on these macroscopic properties as opposed to microscopic overlap, homology information or motif occurrences. We present the results of a large-scale analysis of protein-protein interaction networks. Precise null models are used in our analyses, allowing for reliable interpretation of the results. By quantifying the methodological biases of the experimental data, we can define an information threshold above which networks may be deemed to comprise consistent macroscopic topological properties, despite their small microscopic overlaps. Based on this rationale, data from yeast-two-hybrid methods are sufficiently consistent to allow for intra-species comparisons (between different experiments) and inter-species comparisons, while data from affinity-purification mass-spectrometry methods show large differences even within intra-species comparisons.	[Fernandes, Luis P.; Coolen, Anthony C. C.; Fraternali, Franca] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Annibale, Alessia; Coolen, Anthony C. C.] Kings Coll London, Dept Math, London WC2R 2LS, England; [Kleinjung, Jens] Natl Inst Med Res, MRC, Div Math Biol, London NW7 1AA, England	University of London; King's College London; University of London; King's College London; MRC National Institute for Medical Research	Fernandes, LP (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	franca.fraternali@kcl.ac.uk	Fraternali, Franca/C-8912-2009; Fraternali, Franca/D-4410-2011	Fraternali, Franca/0000-0002-3143-6574; Annibale, Alessia/0000-0003-4010-6742; Kleinjung, Jens/0000-0002-7875-5724	Engineering and Physical Sciences Research Council (EPSRC); Medical Research Council (MRC) [U.1175.03.001.00001.01]; Leverhulme Trust [F/07040/AL]; BBSRC [BB/H018409/1] Funding Source: UKRI; EPSRC [EP/E032400/1] Funding Source: UKRI; MRC [MC_U117581331] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H018409/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E032400/1] Funding Source: researchfish; Medical Research Council [MC_U117581331] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Engineering and Physical Sciences Research Council (EPSRC), Medical Research Council (MRC) (grant U.1175.03.001.00001.01) and the Leverhulme Trust (grant F/07040/AL to FF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Annibale A, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/48/485001; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Batada NN, 2006, PLOS BIOL, V4, P1720, DOI 10.1371/journal.pbio.0040317; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Cesareni G, 2005, FEBS LETT, V579, P1828, DOI 10.1016/j.febslet.2005.01.064; CLAUDE A, 2006, NATURE, V440, P631; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Coolen ACC, 2009, J STAT PHYS, V136, P1035, DOI 10.1007/s10955-009-9821-2; de Silva E, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-39; DONG J, 2004, NATURE, V430, P88; Dorogovstev S. N., 2003, EVOLUTION NETWORKS B; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Friedel CC, 2009, J COMPUT BIOL, V16, P971, DOI 10.1089/cmb.2009.0023; Friedel CC, 2009, BIOINFORMATICS, V25, P2140, DOI 10.1093/bioinformatics/btp353; Friedel CC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-297; Gallos LK, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.248701; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Hart GT, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-120; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ivanic J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005815; Ivanic J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000114; Kar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000601; Kelley BP, 2004, NUCLEIC ACIDS RES, V32, pW83, DOI 10.1093/nar/gkh411; Kelley BP, 2003, P NATL ACAD SCI USA, V100, P11394, DOI 10.1073/pnas.1534710100; Kiemer Lars, 2007, Trends Biotechnol, V25, P448, DOI 10.1016/j.tibtech.2007.08.002; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuchaiev O, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P39; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; LEVY ED, 2009, SCI SIGNAL, V25, P193; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Milenkovic T, 2008, CANCER INFORM, V6, P257; Narayanan M, 2007, J COMPUT BIOL, V14, P892, DOI 10.1089/cmb.2007.0025; Newman MEJ, 2007, P NATL ACAD SCI USA, V104, P9564, DOI 10.1073/pnas.0610537104; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Parrish JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r130; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Perez-Vicente Conrad, 2008, J PHYS A, V41; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; R Development Core Team, 2007, R LANG ENV STAT COMP; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Ramakrishnan SR, 2009, BIOINFORMATICS, V25, P2955, DOI 10.1093/bioinformatics/btp461; Sato S, 2007, DNA RES, V14, P207, DOI 10.1093/dnares/dsm021; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schadt EE, 2009, GENETICA, V136, P259, DOI 10.1007/s10709-009-9359-x; SEIDEL JJ, 1976, P INT C THEOR COMB R, V1, P481; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Shimoda Y, 2008, DNA RES, V15, P13, DOI 10.1093/dnares/dsm028; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Titz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002292; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vidal M, 2009, FEBS LETT, V583, P3891, DOI 10.1016/j.febslet.2009.11.024; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wodak SJ, 2009, MOL CELL PROTEOMICS, V8, P3, DOI 10.1074/mcp.R800014-MCP200; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu XP, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000515	67	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12083	10.1371/journal.pone.0012083	http://dx.doi.org/10.1371/journal.pone.0012083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805870	Green Submitted, Green Published, gold			2022-12-25	WOS:000281011600006
J	Fasanella, A; Scasciamacchia, S; Garofolo, G; Giangaspero, A; Tarsitano, E; Adone, R				Fasanella, Antonio; Scasciamacchia, Silvia; Garofolo, Giuliano; Giangaspero, Annunziata; Tarsitano, Elvira; Adone, Rosanna			Evaluation of the House Fly Musca domestica as a Mechanical Vector for an Anthrax	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; HELICOBACTER-PYLORI; MAJOR EPIDEMIC; TRANSMISSION; ECOLOGY; FLIES	Anthrax is a disease of human beings and animals caused by the encapsulated, spore-forming, Bacillus anthracis. The potential role of insects in the spread of B. anthracis to humans and domestic animals during an anthrax outbreak has been confirmed by many studies. Among insect vectors, the house fly Musca domestica is considered a potential agent for disease transmission. In this study, laboratory-bred specimens of Musca domestica were infected by feeding on anthrax-infected rabbit carcass or anthrax contaminated blood, and the presence of anthrax spores in their spots (faeces and vomitus) was microbiologically monitored. It was also evaluated if the anthrax spores were able to germinate and replicate in the gut content of insects. These results confirmed the role of insects in spreading anthrax infection. This role, although not major, given the huge size of fly populations often associated with anthrax epidemics in domestic animals, cannot be neglected from an epidemiological point of view and suggest that fly control should be considered as part of anthrax control programs.	[Fasanella, Antonio; Scasciamacchia, Silvia; Garofolo, Giuliano] Anthrax Reference Inst, Ist Zooprofilatt Sperimentale Puglia & Basilicata, Foggia, Italy; [Giangaspero, Annunziata] Univ Foggia, Fac Agr, Foggia, Italy; [Tarsitano, Elvira] Univ Bari, Dept Publ Hlth & Anim Sci, Fac Vet Med, Bari, Italy; [Adone, Rosanna] Ist Super Sanita, I-00161 Rome, Italy	IZS Puglia e Basilicata; University of Foggia; Universita degli Studi di Bari Aldo Moro; Istituto Superiore di Sanita (ISS)	Fasanella, A (corresponding author), Anthrax Reference Inst, Ist Zooprofilatt Sperimentale Puglia & Basilicata, Foggia, Italy.	a.fasanella@izsfg.it	Giangaspero, Annunziata/ABB-3727-2021; Garofolo, Giuliano/B-8551-2016; FRANCIA, MASSIMILIANO/C-7035-2015	Garofolo, Giuliano/0000-0001-7017-3888; FRANCIA, MASSIMILIANO/0000-0002-0672-8639; Giangaspero, Annunziata/0000-0002-3357-8672	Founds Ministry of Health of Italy [IZSPB 004/08 RC]	Founds Ministry of Health of Italy	Founds Ministry of Health of Italy: Ricerca corrente 2008. Title of the research: "Modello sperimentale per la valutazione di Musca domestica come potenziale vettore di Bacillus anthracis.'' Code: IZSPB 004/08 RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosioni P, 1948, CLIN VET, V71, P143; DAVIES JCA, 1985, CENT AFR J MED, V31, P176; DAVIES JCA, 1983, CENT AFR J MED, V29, P8; DEVOS V, 1998, P S LIONS LEOP GAM R, P198; DRAGON DC, 1995, CAN VET J, V36, P295; Dragon DC, 1999, J APPL MICROBIOL, V87, P208, DOI 10.1046/j.1365-2672.1999.00872.x; ESTEN WN, 2008, CONNECTICUT AGR EXPT, V51, P94; Fasanella A, 2005, J CLIN MICROBIOL, V43, P3398, DOI 10.1128/JCM.43.7.3398-3401.2005; Fasanella A, 2001, VACCINE, V19, P4214, DOI 10.1016/S0264-410X(01)00159-1; Fasanella A, 2007, EMERG INFECT DIS, V13, P1118, DOI 10.3201/eid1307.061465; Fasanella A, 2010, NEW MICROBIOL, V33, P83; Fasanella A, 2009, VET MICROBIOL, V133, P208, DOI 10.1016/j.vetmic.2008.06.012; Fortini D, 2007, CLIN CHEM, V53, P1377, DOI 10.1373/clinchem.2007.085993; GREENBERG B, 1965, SCI AM, V213, P92, DOI 10.1038/scientificamerican0765-92; Greenberg B, 1971, FLIES DIS; Harwood RF, 1979, ENTOMOLOGY HUMAN ANI, P248; Hugh-Jones ME, 2002, REV SCI TECH OIE, V21, P359, DOI 10.20506/rst.21.2.1336; Karthikeyan K, 2001, Indian Pediatr, V38, P777; KELLY SM, 1994, GASTROENTEROLOGY, V107, P1671, DOI 10.1016/0016-5085(94)90806-0; Kozel TR, 2007, INFECT IMMUN, V75, P152, DOI 10.1128/IAI.01133-06; LAFORCE FM, 1994, CLIN INFECT DIS, V19, P1009, DOI 10.1093/clinids/19.6.1009; MCKENDRICK DRA, 1980, CENT AFR J MED, V26, P126; MERYL N, 1978, ANTHRAX EPIZOOTIC ZI; Mitzmain MB, 1914, PUBLIC HEALTH REP, V29, P75, DOI 10.2307/4570379; MORRIS H, 1920, J AM VET MED ASSOC, V56, P606; NANZI WA, 2005, TROPICAL BIOMEDICINE, V22, P225; RAO NSK, 1958, INDIAN VET J, V35, P348; RICHARDS CS, 1969, B WORLD HEALTH ORGAN, V41, P952; Sen S. K., 1944, INDIAN JOUR VET SCI AND ANIMAL HUSBANDRY, V14, P149; Tellam R. L., 1996, P86; THOMAS JE, 1992, LANCET, V340, P1194, DOI 10.1016/0140-6736(92)92894-L; TURELL MJ, 1987, INFECT IMMUN, V55, P1859, DOI 10.1128/IAI.55.8.1859-1861.1987; Turnbull P., 1990, Topley & Wilson's Principles of bacteriology, virology and immunity. Volume 2. Systematic bacteriology., P187; TURNER M, 1980, CENT AFR J MED, V26, P160; VANNESS GB, 1971, SCIENCE, V172, P1303, DOI 10.1126/science.172.3990.1303; [No title captured]	36	40	42	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12219	10.1371/journal.pone.0012219	http://dx.doi.org/10.1371/journal.pone.0012219			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808920	Green Submitted, gold, Green Published			2022-12-25	WOS:000280968100018
J	Wan, YW; Sabbagh, E; Raese, R; Qian, Y; Luo, DJ; Denvir, J; Vallyathan, V; Castranova, V; Guo, NL				Wan, Ying-Wooi; Sabbagh, Ebrahim; Raese, Rebecca; Qian, Yong; Luo, Dajie; Denvir, James; Vallyathan, Val; Castranova, Vincent; Guo, Nancy Lan			Hybrid Models Identified a 12-Gene Signature for Lung Cancer Prognosis and Chemoresponse Prediction	PLOS ONE			English	Article							GENE-EXPRESSION; CELL; SURVIVAL; ADENOCARCINOMA; PROFILES	Background: Lung cancer remains the leading cause of cancer-related deaths worldwide. The recurrence rate ranges from 35-50% among early stage non-small cell lung cancer patients. To date, there is no fully-validated and clinically applied prognostic gene signature for personalized treatment. Methodology/Principal Findings: From genome-wide mRNA expression profiles generated on 256 lung adenocarcinoma patients, a 12-gene signature was identified using combinatorial gene selection methods, and a risk score algorithm was developed with Naive Bayes. The 12-gene model generates significant patient stratification in the training cohort HLM & UM (n = 256; log-rank P = 6.96e-7) and two independent validation sets, MSK (n = 104; log-rank P = 9.88e-4) and DFCI (n = 82; log-rank P = 2.57e-4), using Kaplan-Meier analyses. This gene signature also stratifies stage I and IB lung adenocarcinoma patients into two distinct survival groups (log-rank P<0.04). The 12-gene risk score is more significant (hazard ratio = 4.19, 95% CI: [2.08, 8.46]) than other commonly used clinical factors except tumor stage (III vs. I) in multivariate Cox analyses. The 12-gene model is more accurate than previously published lung cancer gene signatures on the same datasets. Furthermore, this signature accurately predicts chemoresistance/chemosensitivity to Cisplatin, Carboplatin, Paclitaxel, Etoposide, Erlotinib, and Gefitinib in NCl-60 cancer cell lines (P<0.017). The identified 12 genes exhibit curated interactions with major lung cancer signaling hallmarks in functional pathway analysis. The expression patterns of the signature genes have been confirmed in RT-PCR analyses of independent tumor samples. Conclusions/Significance: The results demonstrate the clinical utility of the identified gene signature in prognostic categorization. With this 12-gene risk score algorithm, early stage patients at high risk for tumor recurrence could be identified for adjuvant chemotherapy; whereas stage I and II patients at low risk could be spared the toxic side effects of chemotherapeutic drugs.	[Wan, Ying-Wooi; Sabbagh, Ebrahim; Raese, Rebecca; Luo, Dajie; Denvir, James; Guo, Nancy Lan] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Qian, Yong; Vallyathan, Val; Castranova, Vincent] NIOSH, Pathol & Physiol Res Branch, Hlth Effects Lab Div, Morgantown, WV USA	West Virginia University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Wan, YW (corresponding author), W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA.	lguo@hsc.wvu.edu			NIH/NLM [R01LM009500]; NCRR [P20RR16440]; NIH/NCRR [P2016477]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440, P20RR016477] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009500] Funding Source: NIH RePORTER	NIH/NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study is supported by NIH/NLM R01LM009500 (PI: Guo) and NCRR P20RR16440 and Supplement (PD: Guo). The software license and training for IPA and Pathway Studio was supported by NIH/NCRR P2016477. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2005, CANC FACTS FIG 2005; Baker Stuart G, 2002, BMC Med Res Methodol, V2, P4, DOI 10.1186/1471-2288-2-4; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Borczuk AC, 2005, AM J RESP CRIT CARE, V172, P729, DOI 10.1164/rccm.200504-615OC; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Dalton WS, 2006, SCIENCE, V312, P1165, DOI 10.1126/science.1125948; Emir B, 1998, STAT MED, V17, P2563, DOI 10.1002/(SICI)1097-0258(19981130)17:22<2563::AID-SIM952>3.0.CO;2-O; Guo L, 2006, CLIN CANCER RES, V12, P3344, DOI 10.1158/1078-0432.CCR-05-2336; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Hall MA, 2003, IEEE T KNOWL DATA EN, V15, P1437, DOI 10.1109/TKDE.2003.1245283; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Lau SK, 2007, J CLIN ONCOL, V25, P5562, DOI 10.1200/JCO.2007.12.0352; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Ma Y, 2006, CLIN CANCER RES, V12, P4583, DOI 10.1158/1078-0432.CCR-06-0290; Ma Y, 2009, INT J ONCOL, V34, P107, DOI 10.3892/ijo_00000134; MITCHELL TM, 1997, MACH LEARN, P413; NARUKE T, 1988, J THORAC CARDIOV SUR, V96, P440; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Potti A, 2006, NEW ENGL J MED, V355, P570, DOI 10.1056/NEJMoa060467; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Witten I. H., 2005, DATA MINING PRACTICA; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683	36	42	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12222	10.1371/journal.pone.0012222	http://dx.doi.org/10.1371/journal.pone.0012222			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808922	Green Published, gold, Green Submitted			2022-12-25	WOS:000280968100021
J	Devlin, AM; Brain, U; Austin, J; Oberlander, TF				Devlin, Angela M.; Brain, Ursula; Austin, Jehannine; Oberlander, Tim F.			Prenatal Exposure to Maternal Depressed Mood and the MTHFR C677T Variant Affect SLC6A4 Methylation in Infants at Birth	PLOS ONE			English	Article							REUPTAKE INHIBITOR ANTIDEPRESSANTS; GENOMIC DNA METHYLATION; METHYLENETETRAHYDROFOLATE REDUCTASE; EPIGENETIC REGULATION; COMMON MUTATION; GLUCOCORTICOID-RECEPTOR; MAJOR DEPRESSION; SEROTONIN; HOMOCYSTEINE; POLYMORPHISM	Background: Prenatal and early postnatal exposure to maternal depression may "program" childhood behavior via epigenetic processes such as DNA methylation. Methylenetetrahydro-folate reductase (MTHFR) is an important enzyme in the generation of methyl groups for DNA methylation. The common MTHFR C677T variant is associated with depression in men and non-pregnant women, and with global changes in DNA methylation. This study investigated the effect of maternal MTHFR C677T genotype on antenatal maternal mood, and their impact on the gene-specific methylation in pregnant women and their newborn infants. The methylation status of SLC6A4, which encodes the transmembrane serotonin transporter, and BDNF, which encodes brain derived neurotrophic factor, were assessed because of their potential role in behaviour. Methods/Principal Findings: Depressed mood was assessed by the Edinburgh Postnatal Depression Scale (EPDS) and the Hamilton Rating Scale for Depression (HAM-D) in women (n = 82, all taking folate) during the 2(nd) and 3(rd) trimesters of pregnancy. The methylation status of SLC6A4 and BDNF were assessed in 3rd trimester maternal peripheral leukocytes and in umbilical cord leukocytes collected from their infants at birth. Women with the MTHFR 677TT genotype had greater 2(nd) trimester depressed mood (p<0.05). Increased 2(nd) trimester maternal depressed mood (EPDS scores) was associated with decreased maternal and infant SLC6A4 promoter methylation (p<0.05), but had no effect on BDNF promoter methylation. Conclusions: These findings show that the MTHFR C677T variant is associated with greater depressed mood during pregnancy. We further showed that prenatal exposure to maternal depressed mood affects gene-specific DNA methylation patterns. These findings support the concept that alterations in epigenetic processes may contribute to developmental programming of behaviour by maternal depression.	[Devlin, Angela M.; Oberlander, Tim F.] Univ British Columbia, Dept Pediat, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada; [Brain, Ursula; Oberlander, Tim F.] Univ British Columbia, Early Human Experience Unit, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada; [Austin, Jehannine] Univ British Columbia, Dept Psychiat, Child & Family Res Inst, Vancouver, BC, Canada	Child & Family Research Institute; University of British Columbia; Child & Family Research Institute; University of British Columbia; Child & Family Research Institute; University of British Columbia	Devlin, AM (corresponding author), Univ British Columbia, Dept Pediat, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada.	angela.devlin@ubc.ca		Oberlander, Tim/0000-0003-4781-6579; Devlin, Angela/0000-0002-1390-6587; Austin, Jehannine/0000-0003-0338-7055	Canadian Institutes for Health Research; Heart and Stroke Foundation of Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by grants from the Canadian Institutes for Health Research (T.F.O.). A. M. D. holds a New Investigator Salary Award from the Heart and Stroke Foundation of Canada. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 2008, ARCH GEN PSYCHIAT, V65, P1286, DOI 10.1001/archpsyc.65.11.1286; Ansorge MS, 2008, J NEUROSCI, V28, P199, DOI 10.1523/JNEUROSCI.3973-07.2008; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Bjelland I, 2003, ARCH GEN PSYCHIAT, V60, P618, DOI 10.1001/archpsyc.60.6.618; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Castro R, 2004, J MED GENET, V41, P454, DOI 10.1136/jmg.2003.017244; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Devlin AM, 2006, AM J CLIN NUTR, V83, P708, DOI 10.1093/ajcn.83.3.708; Dupont JM, 2004, ANAL BIOCHEM, V333, P119, DOI 10.1016/j.ab.2004.05.007; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gilbody S, 2007, AM J EPIDEMIOL, V165, P1, DOI 10.1093/aje/kwj347; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Heils A, 1996, J NEUROCHEM, V66, P2621; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hwang JP, 2006, NEUROBIOL AGING, V27, P1834, DOI 10.1016/j.neurobiolaging.2005.10.013; Jacques PF, 1996, CIRCULATION, V93, P7, DOI 10.1161/01.CIR.93.1.7; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jans LAW, 2007, MOL PSYCHIATR, V12, P522, DOI 10.1038/sj.mp.4001920; Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 1998, BIOL PSYCHIAT, V44, P179, DOI 10.1016/S0006-3223(98)00121-8; Lewis SJ, 2006, MOL PSYCHIATR, V11, P352, DOI 10.1038/sj.mp.4001790; Lopez-Leon S, 2008, MOL PSYCHIATR, V13, P772, DOI 10.1038/sj.mp.4002088; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Mortensen OV, 1999, MOL BRAIN RES, V68, P141, DOI 10.1016/S0169-328X(99)00083-2; O'Connor TG, 2002, BRIT J PSYCHIAT, V180, P502, DOI 10.1192/bjp.180.6.502; Oberlander TF, 2008, MOL PSYCHIATR, V13, P65, DOI 10.1038/sj.mp.4002007; Oberlander TF, 2008, EARLY HUM DEV, V84, P689, DOI 10.1016/j.earlhumdev.2008.06.008; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Oberlander TF, 2006, ARCH GEN PSYCHIAT, V63, P898, DOI 10.1001/archpsyc.63.8.898; Oberlander TF, 2010, ARCH PEDIAT ADOL MED, V164, P444, DOI 10.1001/archpediatrics.2010.51; Philibert R, 2007, AM J MED GENET B, V144B, P101, DOI 10.1002/ajmg.b.30414; Philibert RA, 2008, AM J MED GENET B, V147B, P543, DOI 10.1002/ajmg.b.30657; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Sohn KJ, 2009, INT J CANCER, V124, P1999, DOI 10.1002/ijc.24003; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WhitakerAzmitia PM, 1996, BEHAV BRAIN RES, V73, P19	43	211	218	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12201	10.1371/journal.pone.0012201	http://dx.doi.org/10.1371/journal.pone.0012201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808944	gold, Green Submitted, Green Published			2022-12-25	WOS:000280968000024
J	Klopp, AH; Lacerda, L; Gupta, A; Debeb, BG; Solley, T; Li, L; Spaeth, E; Xu, W; Zhang, XM; Lewis, MT; Reuben, JM; Krishnamurthy, S; Ferrari, M; Gaspar, R; Buchholz, TA; Cristofanilli, M; Marini, F; Andreeff, M; Woodward, WA				Klopp, Ann H.; Lacerda, Lara; Gupta, Anshul; Debeb, Bisrat G.; Solley, Travis; Li, Li; Spaeth, Erika; Xu, Wei; Zhang, Xiaomei; Lewis, Michael T.; Reuben, James M.; Krishnamurthy, Savitri; Ferrari, Mauro; Gaspar, Rogerio; Buchholz, Thomas A.; Cristofanilli, Massimo; Marini, Frank; Andreeff, Michael; Woodward, Wendy A.			Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells	PLOS ONE			English	Article							TENASCIN-C EXPRESSION; STEM/PROGENITOR CELLS; TUMOR STROMA; CANCER CELLS; IN-VITRO; BONE; METASTASIS; TRANSITION; CARCINOMA; DELIVERY	Introduction: Normal and malignant breast tissue contains a rare population of multi-potent cells with the capacity to self-renew, referred to as stem cells, or tumor initiating cells (TIC). These cells can be enriched by growth as "mammospheres" in three-dimensional cultures. Objective: We tested the hypothesis that human bone-marrow derived mesenchymal stem cells (MSC), which are known to support tumor growth and metastasis, increase mammosphere formation. Results: We found that MSC increased human mammary epithelial cell (HMEC) mammosphere formation in a dose-dependent manner. A similar increase in sphere formation was seen in human inflammatory (SUM149) and non-inflammatory breast cancer cell lines (MCF-7) but not in primary inflammatory breast cancer cells (MDA-IBC-3). We determined that increased mammosphere formation can be mediated by secreted factors as MSC conditioned media from MSC spheroids significantly increased HMEC, MCF-7 and SUM149 mammosphere formation by 6.4 to 21-fold. Mammospheres grown in MSC conditioned media had lower levels of the cell adhesion protein, E-cadherin, and increased expression of N-cadherin in SUM149 and HMEC cells, characteristic of a pro-invasive mesenchymal phenotype. Co-injection with MSC in vivo resulted in a reduced latency time to develop detectable MCF-7 and MDA-IBC-3 tumors and increased the growth of MDA-IBC-3 tumors. Furthermore, E-cadherin expression was decreased in MDA-IBC-3 xenografts with co-injection of MSC. Conclusions: MSC increase the efficiency of primary mammosphere formation in normal and malignant breast cells and decrease E-cadherin expression, a biologic event associated with breast cancer progression and resistance to therapy.	[Klopp, Ann H.; Lacerda, Lara; Gupta, Anshul; Debeb, Bisrat G.; Solley, Travis; Li, Li; Xu, Wei; Woodward, Wendy A.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Lacerda, Lara; Gaspar, Rogerio] Univ Lisbon, Fac Farm, IMed UL, Lisbon, Portugal; [Lacerda, Lara; Ferrari, Mauro] Univ Texas Hlth Sci Ctr Houston, Dept Nanomed & Biomed Engn, Houston, TX USA; [Spaeth, Erika; Marini, Frank; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplant & Cellular Therapy, Houston, TX 77030 USA; [Zhang, Xiaomei; Lewis, Michael T.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Krishnamurthy, Savitri] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Universidade de Lisboa; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Klopp, AH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.	wwoodward@mdanderson.org	Gaspar, Rogerio S./F-6238-2014; Lacerda, Lara/E-2639-2015; iMed.ULisboa, InTraCellADD/B-4826-2014; Woodward, Wendy/AAX-6593-2020; Lewis, Michael T/A-9572-2009	Gaspar, Rogerio S./0000-0002-5950-0291; Woodward, Wendy/0000-0002-7935-739X; Spaeth, Erika/0000-0002-5397-3493	National Institutes of Health [R01CA138239-01]; State of Texas Grant for Rare and Aggressive Cancers; University of Texas M.D. Anderson Cancer Center; University of Texas Health Sciences Center [KL2RR024149]; National Cancer Institute [RC1CA146381, CA109451, CA116199]; Portuguese Foundation for Science and Technology (FCT/MCTES) [SFRH/BPD/46854/2008]; NATIONAL CANCER INSTITUTE [R01CA138239, R01CA127857, P50CA116199, RC1CA146381, P30CA016672, R01CA109451] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Texas Grant for Rare and Aggressive Cancers; University of Texas M.D. Anderson Cancer Center; University of Texas Health Sciences Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Portuguese Foundation for Science and Technology (FCT/MCTES)(Portuguese Foundation for Science and Technology); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institutes of Health R01CA138239-01; The State of Texas Grant for Rare and Aggressive Cancers; The University of Texas M.D. Anderson Cancer Center Institutional Research Grant; The University of Texas Health Sciences Center KL2RR024149. This work was supported in part by grants from the National Cancer Institute (RC1CA146381, CA109451 and CA116199 for FM). L. Lacerda is grateful to the Portuguese Foundation for Science and Technology (FCT/MCTES) for the award of a postdoctoral fellowship (Ref.: SFRH/BPD/46854/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alpaugh ML, 2002, ONCOGENE, V21, P3631, DOI 10.1038/sj.onc.1205389; Bakker AHF, 2004, OBES RES, V12, P488, DOI 10.1038/oby.2004.55; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; CHUNG CY, 1995, J BIOL CHEM, V270, P29012, DOI 10.1074/jbc.270.48.29012; Dittmer A, 2009, CELL MOL LIFE SCI, V66, P3053, DOI 10.1007/s00018-009-0089-0; Dontu G, 2005, J MAMMARY GLAND BIOL, V10, P75, DOI 10.1007/s10911-005-2542-5; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hay ED, 1995, ACTA ANAT, V154, P8; Hutchison N, 2009, CELL SIGNAL, V21, P1522, DOI 10.1016/j.cellsig.2009.05.012; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kleer CG, 2004, BREAST CANCER RES, V6, pR110, DOI 10.1186/bcr755; Kleer CG, 2001, MODERN PATHOL, V14, P458, DOI 10.1038/modpathol.3880334; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Li Y, 2005, J MAMMARY GLAND BIOL, V10, P17, DOI 10.1007/s10911-005-2537-2; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lundin M, 2007, ONCOLOGY-BASEL, V72, P403, DOI 10.1159/000113490; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MARTIN FT, BREAST CANC RES TREA, P18701; Mohammadizadeh F, 2009, CANCER BIOMARK, V5, P1, DOI 10.3233/CBM-2009-0551; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pittenger MF, 2000, CURR TOP MICROBIOL, V251, P3; RHODES LV, BREAST CANC RES TREA, V121, P293; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Studeny M, 2002, CANCER RES, V62, P3603; Walker MR, 2009, J PATHOL, V217, P169, DOI 10.1002/path.2474; Wiksten JP, 2003, ONCOLOGY-BASEL, V64, P245, DOI 10.1159/000069305	31	128	134	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12180	10.1371/journal.pone.0012180	http://dx.doi.org/10.1371/journal.pone.0012180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808935	Green Submitted, Green Published, gold			2022-12-25	WOS:000280968000011
J	Llorens-Martin, M; Tejeda, GS; Trejo, JL				Llorens-Martin, Maria; Tejeda, Gonzalo S.; Trejo, Jose L.			Differential Regulation of the Variations Induced by Environmental Richness in Adult Neurogenesis as a Function of Time: A Dual Birthdating Analysis	PLOS ONE			English	Article							HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; PHYSICAL-ACTIVITY; ENRICHED ENVIRONMENT; CELL-PROLIFERATION; SYNAPTIC PLASTICITY; TRANSGENIC MICE; MEMORY; NEURONS; BEHAVIOR	Adult hippocampal neurogenesis (AHN) augments after environmental enrichment (EE) and it has been related to some of the anxiolytic, antidepressant and neuroprotective effects of EE. Indeed, it has been suggested that EE specifically modulates hippocampal neurogenic cell populations over the course of time. Here we have used dual-birthdating to study two subpopulations of newborn neuron in mice (Mus musculus): those born at the beginning and at the end of enrichment. In this way, we demonstrate that while short-term cell survival is upregulated after an initial 1 week period of enrichment in 2 month old female mice, after long-term enrichment (2 months) neither cell proliferation nor the survival of the younger newly born cell populations are distinguishable from that observed in non-enriched control mice. In addition, we show that the survival of older newborn neurons alone (i.e. those born at the beginning of the enrichment) is higher than in controls, due to the significantly lower levels of cell death. Indeed, these parameters are rapidly adjusted to the sudden cessation of the EE conditions. These findings suggest both an early selective, long-lasting effect of EE on the neurons born in the initial stages of enrichment, and a quick response when the environment again becomes impoverished. Therefore, EE induces differential effects on distinct subpopulations of newborn neurons depending on the age of the immature cells and on the duration of the EE itself. The interaction of these two parameters constitutes a new, specific regulation of these neurogenic populations that might account for the long-term enrichment's behavioral effects.	[Llorens-Martin, Maria; Trejo, Jose L.] Ctr Invest Red Enfermedades Neurodegenerat CIBERN, Madrid, Spain; [Llorens-Martin, Maria; Tejeda, Gonzalo S.; Trejo, Jose L.] CSIC, Inst Cajal, E-28002 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Llorens-Martin, M (corresponding author), Ctr Invest Red Enfermedades Neurodegenerat CIBERN, Madrid, Spain.	jltrejo@cajal.csic.es	Llorens-Martin, Maria/R-4613-2017; Trejo, Jose Luis/F-5518-2016	Llorens-Martin, Maria/0000-0001-9129-5198; Tejeda, Gonzalo S./0000-0002-2900-6276	Ministerio de Educacion y Ciencia [BFU2007-60195/BFI]	Ministerio de Educacion y Ciencia(Spanish Government)	Grant awarded to J.L.T. from the Ministerio de Educacion y Ciencia. Grant number: BFU2007-60195/BFI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Ambrogini P, 2004, BRAIN RES, V1017, P21, DOI 10.1016/j.brainres.2004.05.039; Balu DT, 2009, NEUROSCI BIOBEHAV R, V33, P232, DOI 10.1016/j.neubiorev.2008.08.007; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Catlow BJ, 2009, BRAIN RES, V1256, P173, DOI 10.1016/j.brainres.2008.12.028; Choi SH, 2008, NEURON, V59, P568, DOI 10.1016/j.neuron.2008.07.033; Deng W, NAT REV NEUROSCI, V11, P339; Dhanushkodi A, 2008, NEUROSCI BIOBEHAV R, V32, P657, DOI 10.1016/j.neubiorev.2007.10.004; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Ehninger D, 2003, CEREB CORTEX, V13, P845, DOI 10.1093/cercor/13.8.845; Eisch AJ, 2008, J NEUROSCI, V28, P11785, DOI 10.1523/JNEUROSCI.3798-08.2008; Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Herring A, 2009, EXP NEUROL, V216, P184, DOI 10.1016/j.expneurol.2008.11.027; Howard C, 1998, UNBIASED STEREOLOGY; Hutchinson E, 2005, ILAR J, V46, P148, DOI 10.1093/ilar.46.2.148; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kempermann G, 2006, ADULT NEUROGENESIS; Kempermann G, 2008, CURR OPIN PSYCHIATR, V21, P290, DOI 10.1097/YCO.0b013e3282fad375; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Kohl Z, 2002, GENES BRAIN BEHAV, V1, P46, DOI 10.1046/j.1601-1848.2001.00009.x; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lazic SE, 2006, EUR J NEUROSCI, V23, P1829, DOI 10.1111/j.1460-9568.2006.04715.x; Leal-Galicia P, 2008, NEUROBIOL LEARN MEM, V90, P511, DOI 10.1016/j.nlm.2008.07.005; Leuner B, 2009, J COMP NEUROL, V517, P123, DOI 10.1002/cne.22107; Li Y, 2009, CURR TOP DEV BIOL, V87, P149, DOI 10.1016/S0070-2153(09)01205-8; Llorens-Martin M, 2006, HIPPOCAMPUS, V16, P480, DOI 10.1002/hipo.20175; Llorens-Martin MV, 2007, NEUROSCIENCE, V147, P631, DOI 10.1016/j.neuroscience.2007.04.054; LLorens-Martin M, 2009, NEUROSCIENTIST, V15, P134, DOI 10.1177/1073858408331371; LLORENSMARTIN M, MOL CELL NEUROSCI, V44, P109; Martinez-Cue C, 2002, BEHAV BRAIN RES, V134, P185, DOI 10.1016/S0166-4328(02)00026-8; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Milgram NW, 2006, AGEING RES REV, V5, P354, DOI 10.1016/j.arr.2006.04.004; MIROCHNIC S, 2009, HIPPOCAMPUS; Navailles S, 2008, J COMP NEUROL, V509, P372, DOI 10.1002/cne.21775; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; PAKKENBERG B, 1988, J MICROSC-OXFORD, V150, P20; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Steiner B, 2008, NEUROSCIENCE, V154, P521, DOI 10.1016/j.neuroscience.2008.04.023; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Trejo JI, 2007, MOL PSYCHIATR, V12, P1118, DOI 10.1038/sj.mp.4002076; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Williams BM, 2001, PHYSIOL BEHAV, V73, P649, DOI 10.1016/S0031-9384(01)00543-1; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562	62	33	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12188	10.1371/journal.pone.0012188	http://dx.doi.org/10.1371/journal.pone.0012188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808440	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000280968000015
J	Ji, C; Yang, B; Yang, YL; He, SH; Miao, DS; He, L; Bi, ZG				Ji, C.; Yang, B.; Yang, Y-L; He, S-H; Miao, D-S; He, L.; Bi, Z-G			Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-induced apoptosis by promoting AMPK activation and mTORC1 inhibition	ONCOGENE			English	Article						C6 ceramide; cancer chemotherapy; Doxorubicin; AMPK; mTORC1 and apoptosis	HEPATOCELLULAR-CARCINOMA CELLS; PROTEIN-KINASE; IN-VITRO; GROWTH; DEATH; METABOLISM; EXPRESSION; PACLITAXEL; INDUCTION; MECHANISM	New chemotherapy-enhancing strategies are needed for better cancer therapy. Previous studies suggest that exogenous cell-permeable C6 ceramide may be a useful adjunct to the anti-tumor effects of chemotherapeutic agents (such as Taxol) against multiple cancers. Here we demonstrate that exogenous cell-permeable C6 ceramide largely sensitizes multiple progressive cancer cell lines to Doxorubicin-induced cell death and apoptosis. We found for the first time that Doxorubicin induces AMP-activated protein kinase (AMPK) activation in a reactive oxygen species-dependent manner. Activation of AMPK contributes to Doxorubicin-induced cancer cell death and apoptosis. Inhibition of AMPK by small interfering RNA knockdown or a pharmacological inhibitor reduces Doxorubicin-induced cancer cell apoptosis, whereas AMPK activator AICAR enhances it. Importantly, we found that C6 ceramide largely enhances Doxorubicin-induced activation of AMPK, which leads to mTOR complex 1 inhibition and chemo-sensitization. Our data suggest that the combination of C6 ceramide with traditional chemotherapy drugs such as Doxorubicin may have the potential to be used as a new therapeutic intervention against multiple cancers. Oncogene (2010) 29, 6557-6568; doi:10.1038/onc.2010.379; published online 30 August 2010	[Bi, Z-G] Nanjing Med Univ, Affiliated BenQ Hosp, Dept Dermatol, Nanjing 210019, Jiangsu, Peoples R China; [Ji, C.] Nanjing Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanjing 210024, Jiangsu, Peoples R China; [Yang, B.] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China; [Yang, Y-L] Nanjing Med Univ, Affiliated Hosp 1, Dept Otolaryngol, Nanjing, Jiangsu, Peoples R China; [He, S-H] Nanjing Med Univ, Affiliated Hosp 1, Clin Expt Ctr, Nanjing, Jiangsu, Peoples R China; [Miao, D-S] Nanjing Med Univ, Dept Human Anat, Nanjing, Jiangsu, Peoples R China; [He, L.] Kunming Med Univ, Yunnan Prov Inst Dermatol, Affiliated Hosp 1, Dept Dermatol, Kunming, Yunnan, Peoples R China	Nanjing Medical University; Nanjing Medical University; Fudan University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Kunming Medical University	Bi, ZG (corresponding author), Nanjing Med Univ, Affiliated BenQ Hosp, Dept Dermatol, Nanjing 210019, Jiangsu, Peoples R China.	surpassing_ji@yahoo.com.cn; heli2662@163.com; eltonbibenqhospital@yahoo.com.cn		Miao, Dengshun/0000-0002-2682-3502	National Natural Science Foundation of China [30271195, 30671894]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported in part by grants from the National Natural Science Foundation of China (30271195 and 30671894).	Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Auzenne E, 1998, MELANOMA RES, V8, P227, DOI 10.1097/00008390-199806000-00005; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Cao C, 2008, J BIOL CHEM, V283, P28897, DOI 10.1074/jbc.M804144200; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chiang PC, 2010, BIOCHEM PHARMACOL, V79, P162, DOI 10.1016/j.bcp.2009.08.022; Grunwald V, 2002, CANCER RES, V62, P6141; Hortobagyi GN, 1997, DRUGS, V54, P1, DOI 10.2165/00003495-199700544-00003; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jaswal JS, 2006, AM J PHYSIOL-HEART C, V291, pH1883, DOI 10.1152/ajpheart.01147.2005; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jung SN, 2008, CARCINOGENESIS, V29, P713, DOI 10.1093/carcin/bgn032; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim do Y, 2009, J AGR FOOD CHEM, V57, P10573; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Mehta S, 2000, CANCER CHEMOTH PHARM, V46, P85, DOI 10.1007/s002800000140; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Nithipongvanitch R, 2007, ANTIOXID REDOX SIGN, V9, P1001, DOI 10.1089/ars.2007.1632; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Piguet AC, 2008, J HEPATOL, V49, P78, DOI 10.1016/j.jhep.2008.03.024; Qiu LH, 2006, ONCOL REP, V16, P907; Radin NS, 2003, BIOCHEM J, V371, P243, DOI 10.1042/BJ20021878; Rath G, 2009, INT J BIOCHEM CELL B, V41, P1165, DOI 10.1016/j.biocel.2008.10.021; Ravid A, 1999, CANCER RES, V59, P862; Romano MF, 2004, EUR J CANCER, V40, P2829, DOI 10.1016/j.ejca.2004.08.017; Ruderman NB, 2006, DIABETES, V55, pS48, DOI 10.2337/db06-S007; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Yamauchi M, 2008, MOL ENDOCRINOL, V22, P893, DOI 10.1210/me.2007-0249; Yoon H, 2008, BIOCHEM BIOPH RES CO, V371, P495, DOI 10.1016/j.bbrc.2008.04.102; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322; Zhang JF, 2007, TRANSPL IMMUNOL, V17, P162, DOI 10.1016/j.trim.2006.12.003; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700	34	108	111	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2010	29	50					6557	6568		10.1038/onc.2010.379	http://dx.doi.org/10.1038/onc.2010.379			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	695OA	20802518				2022-12-25	WOS:000285380200005
J	Jiang, SX; Heller, B; Tagliabracci, VS; Zhai, LM; Irimia, JM; DePaoli-Roach, AA; Wells, CD; Skurat, AV; Roach, PJ				Jiang, Sixin; Heller, Brigitte; Tagliabracci, Vincent S.; Zhai, Lanmin; Irimia, Jose M.; DePaoli-Roach, Anna A.; Wells, Clark D.; Skurat, Alexander V.; Roach, Peter J.			Starch Binding Domain-containing Protein 1/Genethonin 1 Is a Novel Participant in Glycogen Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE CLYCOGEN PARTICLE; PHOSPHORYLASE ACTIVITY; MYOCLONUS EPILEPSY; MEMBRANE-PROTEINS; LAFORA-DISEASE; PHOSPHATASE; AUTOPHAGY; SYNTHASE; MICE; ACCUMULATION	Stbd1 is a protein of previously unknown function that is most prevalent in liver and muscle, the major sites for storage of the energy reserve glycogen. The protein is predicted to contain a hydrophobic N terminus and a C-terminal CBM20 glycan binding domain. Here, we show that Stbd1 binds to glycogen in vitro and that endogenous Stbd1 locates to perinuclear compartments in cultured mouse FL83B or Rat1 cells. When overexpressed in COSM9 cells, Stbd1 concentrated at enlarged perinuclear structures, co-localized with glycogen, the late endosomal/lysosomal marker LAMP1 and the autophagy protein GABARAPL1. Mutant Stbd1 lacking the N-terminal hydrophobic segment had a diffuse distribution throughout the cell. Point mutations in the CBM20 domain did not change the perinuclear localization of Stbd1, but glycogen was no longer concentrated in this compartment. Stable overexpression of glycogen synthase in Rat1WT4 cells resulted in accumulation of glycogen as massive perinuclear deposits, where a large fraction of the detectable Stbd1 co-localized. Starvation of Rat1WT4 cells for glucose resulted in dissipation of the massive glycogen stores into numerous and much smaller glycogen deposits that retained Stbd1. In vitro, in cells, and in animal models, Stbd1 consistently tracked with glycogen. We conclude that Stbd1 is involved in glycogen metabolism by binding to glycogen and anchoring it to membranes, thereby affecting its cellular localization and its intracellular trafficking to lysosomes.	[Jiang, Sixin; Heller, Brigitte; Tagliabracci, Vincent S.; Zhai, Lanmin; Irimia, Jose M.; DePaoli-Roach, Anna A.; Wells, Clark D.; Skurat, Alexander V.; Roach, Peter J.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Roach, PJ (corresponding author), 635 Barnhill Dr,MS405A, Indianapolis, IN 46202 USA.	proach@iupui.edu			National Institutes of Health [DK27221, NS56454]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027221, R37DK027221, R56DK027221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK27221 and NS56454.	Andrade D M, 2007, Acta Myol, V26, P83; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Blennow A, 2002, TRENDS PLANT SCI, V7, P445, DOI 10.1016/S1360-1385(02)02332-4; Bouju S, 1998, BIOCHEM J, V335, P549, DOI 10.1042/bj3350549; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRESLOW JL, 1973, EXP CELL RES, V78, P441, DOI 10.1016/0014-4827(73)90089-X; CARDELL RR, 1985, J CELL BIOL, V101, P201, DOI 10.1083/jcb.101.1.201; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Christiansen C, 2009, FEBS J, V276, P5006, DOI 10.1111/j.1742-4658.2009.07221.x; Delgado-Escueta AV, 2007, CURR NEUROL NEUROSCI, V7, P428, DOI 10.1007/s11910-007-0066-7; DiMauro S, 2001, MUSCLE NERVE, V24, P984, DOI 10.1002/mus.1103; Fukuda T, 2006, ANN NEUROL, V59, P700, DOI 10.1002/ana.20807; Fukuda T, 2006, AUTOPHAGY, V2, P318, DOI 10.4161/auto.2984; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Gentry MS, 2009, TRENDS BIOCHEM SCI, V34, P628, DOI 10.1016/j.tibs.2009.08.002; Greenberg CC, 2006, AM J PHYSIOL-ENDOC M, V291, pE1, DOI 10.1152/ajpendo.00652.2005; HASCHKE RH, 1970, J BIOL CHEM, V245, P6657; HEILMEYER LM, 1970, J BIOL CHEM, V245, P6649; Hu ZZ, 2007, INT J MASS SPECTROM, V259, P147, DOI 10.1016/j.ijms.2006.09.024; Irimia JM, 2010, J BIOL CHEM, V285, P12851, DOI 10.1074/jbc.M110.106534; Janecek S, 2002, BIOINFORMATICS, V18, P1534, DOI 10.1093/bioinformatics/18.11.1534; Komatsu M, 2010, GENES CELLS, V15, P923, DOI 10.1111/j.1365-2443.2010.01433.x; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; MEYER F, 1970, J BIOL CHEM, V245, P6642; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Pederson BA, 2005, J BIOL CHEM, V280, P17260, DOI 10.1074/jbc.M410448200; Pederson BA, 2004, MOL CELL BIOL, V24, P7179, DOI 10.1128/MCB.24.16.7179-7187.2004; RABEN N, 2010, AUTOPHAGY IN PRESS; RABEN N, 2007, H Acta Myol, V26, P45; Raben Nina, 2002, Current Molecular Medicine (Hilversum), V2, P145, DOI 10.2174/1566524024605789; REUSER AJ, 1995, MUSCLE NERVE, V3, pS61; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; Roach PJ, 2001, HDB PHYSL 7, VII, P609, DOI DOI 10.1002/CPHY.CP070219; Romero Pedro, 2004, Appl Bioinformatics, V3, P105, DOI 10.2165/00822942-200403020-00005; ROSENFELD EL, 1975, PATHOL BIOL, V23, P71; Rybicka KK, 1996, TISSUE CELL, V28, P253, DOI 10.1016/S0040-8166(96)80013-9; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; Schaart G, 2004, HISTOCHEM CELL BIOL, V122, P161, DOI 10.1007/s00418-004-0690-0; Shearer J, 2004, EXERC SPORT SCI REV, V32, P120, DOI 10.1097/00003677-200407000-00008; Skurat AV, 2000, DIABETES, V49, P1096, DOI 10.2337/diabetes.49.7.1096; Stapleton D, 2010, PROTEOMICS, V10, P2320, DOI 10.1002/pmic.200900628; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tagliabracci VS, 2008, J BIOL CHEM, V283, P33816, DOI 10.1074/jbc.M807428200; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Wang W, 2004, BIOCHEM BIOPH RES CO, V325, P726, DOI 10.1016/j.bbrc.2004.10.083; Wang W, 2006, BIOCHEM BIOPH RES CO, V350, P588, DOI 10.1016/j.bbrc.2006.09.091; Wang Z, 2001, MOL CELL BIOL, V21, P5742, DOI 10.1128/MCB.21.17.5742-5752.2001; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1	51	93	102	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34960	34971		10.1074/jbc.M110.150839	http://dx.doi.org/10.1074/jbc.M110.150839			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810658	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000283659100070
J	Sakabe, K; Hart, GW				Sakabe, Kaoru; Hart, Gerald W.			O-GlcNAc Transferase Regulates Mitotic Chromatin Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-N-ACETYLGLUCOSAMINE; MITOSIS-SPECIFIC PHOSPHORYLATION; HISTONE H3; ALZHEIMERS-DISEASE; CELL-CYCLE; AURORA-B; NUCLEOCYTOPLASMIC PROTEINS; CHROMOSOME CONDENSATION; MONOCLONAL-ANTIBODY; X-CHROMOSOME	Mitosis must faithfully divide the genome such that each progeny inherits the same genetic material. DNA condensation is crucial in ensuring that chromosomes are correctly attached to the mitotic spindle for segregation, preventing DNA breaks or constrictions from the contractile ring. Histones form an octameric complex of basic proteins important in regulating DNA organization and accessibility. Histone post-translational modifications are altered during mitosis, although the roles of these post-translational modifications remain poorly characterized. Here, we report that N-acetylglucosamine (O-GlcNAc) transferase (OGT), the enzyme catalyzing the addition of O-GlcNAc moieties to nuclear and cytoplasmic proteins at serine and threonine residues, regulates some aspects of mitotic chromatin dynamics. OGT protein amounts decrease during M phase. Modest overexpression of OGT alters mitotic histone post-translational modifications at Lys-9, Ser-10, Arg-17, and Lys-27 of histone H3. Overexpression of OGT also prevents mitotic phosphorylation of coactivator-associated arginine methyltransferase 1 (CARM1) and prevents its correct cellular localization during mitosis. Moreover, OGT overexpression results in an increase in abnormal chromosomal bridge formation. Together, these results show that regulating the amount of OGT during mitosis is important in ensuring correct chromosomal segregation during mitosis.	[Sakabe, Kaoru; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Hart, GW (corresponding author), 725 N Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu		Hart, Gerald/0000-0001-7812-4351	National Institutes of Health [R01 DK61671, R01 CA2486]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061671, P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (R01 DK61671 and R01 CA2486, to G. W. H.).	Arnaud L, 1998, CHROMOSOMA, V107, P424, DOI 10.1007/s004120050326; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Belmont AS, 2006, CURR OPIN CELL BIOL, V18, P632, DOI 10.1016/j.ceb.2006.09.007; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Bonenfant D, 2007, MOL CELL PROTEOMICS, V6, P1917, DOI 10.1074/mcp.M700070-MCP200; Chadee DN, 1999, J BIOL CHEM, V274, P24914, DOI 10.1074/jbc.274.35.24914; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cheung WD, 2008, J BIOL CHEM, V283, P33935, DOI 10.1074/jbc.M806199200; Cimini D, 2003, MOL BIOL CELL, V14, P3821, DOI 10.1091/mbc.E03-01-0860; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; Feng Q, 2009, J BIOL CHEM, V284, P36167, DOI 10.1074/jbc.M109.065524; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Georgatos SD, 2009, FRONT BIOSCI-LANDMRK, V14, P2017, DOI 10.2741/3360; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Higashimoto K, 2007, P NATL ACAD SCI USA, V104, P12318, DOI 10.1073/pnas.0610792104; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Jayne S, 2009, J MOL BIOL, V394, P485, DOI 10.1016/j.jmb.2009.09.032; Kamemura K, 2002, J BIOL CHEM, V277, P19229, DOI 10.1074/jbc.M201729200; Knapp S, 1996, J AM CHEM SOC, V118, P6804, DOI 10.1021/ja960826u; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Liu F, 2009, BRAIN, V132, P1820, DOI 10.1093/brain/awp099; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Malik R, 2009, J PROTEOME RES, V8, P4553, DOI 10.1021/pr9003773; ME T, 2003, F Cell, V115, P751; Monaco EA, 2005, FRONT BIOSCI-LANDMRK, V10, P143, DOI 10.2741/1516; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Polioudaki H, 2004, FEBS LETT, V560, P39, DOI 10.1016/S0014-5793(04)00060-2; Preuss U, 2003, NUCLEIC ACIDS RES, V31, P878, DOI 10.1093/nar/gkg176; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Ruchaud S, 2007, CELL, V131, P230, DOI 10.1016/j.cell.2007.10.002; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shin HJ, 2003, ONCOGENE, V22, P3853, DOI 10.1038/sj.onc.1206502; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Song M, 2008, CELL SIGNAL, V20, P94, DOI 10.1016/j.cellsig.2007.09.002; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Yamashita YM, 2009, FRONT BIOSCI-LANDMRK, V14, P3003, DOI 10.2741/3430; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96	63	89	92	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34460	34468		10.1074/jbc.M110.158170	http://dx.doi.org/10.1074/jbc.M110.158170			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20805223	hybrid, Green Published			2022-12-25	WOS:000283659100020
J	Marshall, GM; Bell, JL; Koach, J; Tan, O; Kim, P; Malyukova, A; Thomas, W; Sekyere, EO; Liu, T; Cunningham, AM; Tobias, V; Norris, MD; Haber, M; Kavallaris, M; Cheung, BB				Marshall, G. M.; Bell, J. L.; Koach, J.; Tan, O.; Kim, P.; Malyukova, A.; Thomas, W.; Sekyere, E. O.; Liu, T.; Cunningham, A. M.; Tobias, V.; Norris, M. D.; Haber, M.; Kavallaris, M.; Cheung, B. B.			TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells	ONCOGENE			English	Article						TRIM16; EBBP; neuroblastoma; vimentin; E2F1; tumour suppressor	B-BOX PROTEIN; HIGH-RISK NEUROBLASTOMA; RING FINGER; 13-CIS-RETINOIC ACID; UBIQUITIN LIGASE; BINDING DOMAIN; RETINOIC ACID; BREAST-CANCER; EXPRESSION; FAMILY	The family of tripartite-motif (TRIM) proteins are involved in diverse cellular processes, but are often characterized by critical protein-protein interactions necessary for their function. TRIM16 is induced in different cancer types, when the cancer cell is forced to proceed down a differentiation pathway. We have identified TRIM16 as a DNA-binding protein with histone acetylase activity, which is required for the retinoic acid receptor beta(2) transcriptional response in retinoid-treated cancer cells. In this study, we show that overexpressed TRIM16 reduced neuroblastoma cell growth, enhanced retinoid-induced differentiation and reduced tumourigenicity in vivo. TRIM16 was only expressed in the differentiated ganglion cell component of primary human neuroblastoma tumour tissues. TRIM16 bound directly to cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells. TRIM16 reduced cell motility and this required downregulation of vimentin. Retinoid treatment and enforced overexpression caused TRIM16 to translocate to the nucleus, and bind to and downregulate nuclear E2F1, required for cell replication. This study, for the first time, demonstrates that TRIM16 acts as a tumour suppressor, affecting neuritic differentiation, cell migration and replication through interactions with cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells. Oncogene (2010) 29, 6172-6183; doi:10.1038/onc.2010.340; published online 23 August 2010	[Marshall, G. M.; Bell, J. L.; Koach, J.; Tan, O.; Kim, P.; Malyukova, A.; Thomas, W.; Sekyere, E. O.; Liu, T.; Norris, M. D.; Haber, M.; Kavallaris, M.; Cheung, B. B.] Childrens Canc Inst Australia Med Res, Randwick, NSW, Australia; [Marshall, G. M.] Sydney Childrens Hosp, Ctr Childrens Canc & Blood Disorders, Randwick, NSW, Australia; [Cunningham, A. M.] UNSW, Sch Womens & Childrens Hlth, Fac Med, Kensington, NSW, Australia; [Tobias, V.] Sydney Childrens Hosp, S Eastern Area Lab Serv, Randwick, NSW, Australia	Children's Cancer Institute; University of New South Wales Sydney	Cheung, BB (corresponding author), Univ NSW, Lowy Canc Res Ctr, Mol Carcinogenesis Program, Childrens Canc Inst Australia, High St,POB 81, Randwick, NSW 2031, Australia.	bcheung@ccia.unsw.edu.au	Liu, Tao/A-3922-2015; Kavallaris, Maria/J-5240-2014	Tan, Owen/0000-0002-0303-7138; Haber, Michelle/0000-0003-2036-8817; Norris, Murray/0000-0002-0632-4589; Liu, Tao/0000-0001-6244-7316; Bell, Jessica/0000-0002-8875-0943; Cheung, Belamy/0000-0001-8784-860X	National Health and Medical Research Council, Australia; Cancer Institute NSW	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW	This research was supported by programme grants from the National Health and Medical Research Council, Australia. This research project was also supported by an Early Career Development Fellowship from the Cancer Institute NSW. The Children's Cancer Institute Australia for Medical Research is affiliated with the University of NSW and Sydney Children's Hospital. We thank Ms Tala Kaplinovsky of the Westfield Research Laboratory at Sydney Children's Hospital for help with using confocal microscopy. We thank Mr Andrew Gayagay of the Paediatric Anatomical Pathology, SEALS for help with preparation of patient samples.	Beer HD, 2002, J BIOL CHEM, V277, P20740, DOI 10.1074/jbc.M111233200; BORDEN KLB, 1993, FEBS LETT, V335, P255, DOI 10.1016/0014-5793(93)80741-C; Brennan DJ, 2008, CLIN CANCER RES, V14, P2681, DOI 10.1158/1078-0432.CCR-07-1760; Cao TY, 1998, J CELL SCI, V111, P1319; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Cheung BB, 2006, J BIOL CHEM, V281, P18246, DOI 10.1074/jbc.M600879200; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; EVANS AE, 1971, CANCER, V27, P374, DOI 10.1002/1097-0142(197102)27:2<374::AID-CNCR2820270221>3.0.CO;2-G; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Johnson DG, 2006, CURR MOL MED, V6, P731; Joshi VV, 2000, PEDIATR DEVEL PATHOL, V3, P184, DOI 10.1007/s100240050024; KATSETOS CD, 1991, LAB INVEST, V64, P45; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Lalonde JP, 2004, J BIOL CHEM, V279, P8181, DOI 10.1074/jbc.M306751200; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; Liu HLC, 1998, MOL ENDOCRINOL, V12, P1733, DOI 10.1210/me.12.11.1733; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; McInroy L, 2007, BIOCHEM BIOPH RES CO, V360, P109, DOI 10.1016/j.bbrc.2007.06.036; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Mrosek M, 2008, BIOCHEMISTRY-US, V47, P10722, DOI 10.1021/bi800733z; Mu ZM, 1997, CARCINOGENESIS, V18, P2063, DOI 10.1093/carcin/18.11.2063; Muley PD, 2008, DEV NEUROBIOL, V68, P1441, DOI 10.1002/dneu.20670; Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200; Raif A, 2009, CANCER LETT, V277, P82, DOI 10.1016/j.canlet.2008.11.030; Rexhepaj E, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2187; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Vichi A, 2005, P NATL ACAD SCI USA, V102, P1945, DOI 10.1073/pnas.0409800102; Vora HH, 2009, INT J BIOL MARKER, V24, P38, DOI 10.1177/172460080902400106; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Yabe JT, 2003, CELL MOTIL CYTOSKEL, V56, P193, DOI 10.1002/cm.10137	39	51	54	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2010	29	46					6172	6183		10.1038/onc.2010.340	http://dx.doi.org/10.1038/onc.2010.340			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	681XD	20729920	Green Published, hybrid			2022-12-25	WOS:000284356500009
J	Donkin, JJ; Stukas, S; Hirsch-Reinshagen, V; Namjoshi, D; Wilkinson, A; May, S; Chan, J; Fan, JJ; Collins, J; Wellington, CL				Donkin, James J.; Stukas, Sophie; Hirsch-Reinshagen, Veronica; Namjoshi, Dhananjay; Wilkinson, Anna; May, Sharon; Chan, Jeniffer; Fan, Jianjia; Collins, Jon; Wellington, Cheryl L.			ATP-binding Cassette Transporter A1 Mediates the Beneficial Effects of the Liver X Receptor Agonist GW3965 on Object Recognition Memory and Amyloid Burden in Amyloid Precursor Protein/Presenilin 1 Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; MOUSE MODEL; APOLIPOPROTEIN-E; TANGIER-DISEASE; LIPID-METABOLISM; IN-VITRO; BETA; ABCA1; CHOLESTEROL	The cholesterol transpoter ATP-binding cassette transporter A1 (ABCA1) moves lipids onto apolipoproteins including apolipoprotein E (apoE), which is the major cholesterol carrier in the brain and an established genetic risk factor for late-onset Alzheimer disease (AD). In amyloid mouse models of AD, ABCA1 deficiency exacerbates amyloidogenesis, whereas ABCA1 overexpression ameliorates amyloid load, suggesting a role for ABCA1 in A beta metabolism. Agonists of liver X receptors (LXR), including GW3965, induce transcription of several genes including ABCA1 and apoE, and reduce A beta levels and improve cognition in AD mice. However, the specific role of ABCA1 in mediating beneficial responses to LXR agonists in AD mice is unknown. We evaluated behavioral and neuropathogical outcomes in GW3965-treated female APP/PS1 mice with and without ABCA1. Treatment of APP/PS1 mice with GW3965 increased ABCA1 and apoE protein levels. ABCA1 was required to observe significantly elevated apoE levels in brain tissue and cerebrospinal fluid upon therapeutic (33 mg/kg/day) GW3965 treatment. At 33 mg/kg/day, GW3965 was also associated with a trend toward redistribution of A beta to the carbonate-soluble pool independent of ABCA1. APP/PS1 mice treated with either 2.5 or 33 mg/kg/day of GW3965 showed a clear trend toward reduced amyloid burden in hippocampus and whole brain, whereas APP/PS1-treated mice lacking ABCA1 failed to display reduced amyloid load in the whole brain and showed trends toward increased hippocampal amyloid. Treatment of APP/PS1 mice with either dose of GW3965 completely restored novel object recognition memory to wild-type levels, which required ABCA1. These results suggest that ABCA1 contributes to several beneficial effects of the LXR agonist GW3965 in APP/PS1 mice.	[Donkin, James J.; Stukas, Sophie; Hirsch-Reinshagen, Veronica; Namjoshi, Dhananjay; Wilkinson, Anna; May, Sharon; Chan, Jeniffer; Fan, Jianjia; Wellington, Cheryl L.] Univ British Columbia, Child & Family Res Inst, Dept Pathol & Lab Med, Vancouver, BC V5Z 4H4, Canada; [Collins, Jon] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA	Child & Family Research Institute; University of British Columbia; GlaxoSmithKline	Wellington, CL (corresponding author), 980 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	Cheryl@cmmt.ubc.ca	Stukas, Sophie/GQO-7639-2022	Namjoshi, Dhananjay/0000-0003-1753-5581; Reece, Sharon Christine May/0000-0001-8251-8409; Stukas, Sophie/0000-0001-8819-8821	Canadian Institutes of Health Research; Pacific Alzheimer's Research Foundation; New Scientist Award; University of British Columbia; Alzheimer's Society of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pacific Alzheimer's Research Foundation; New Scientist Award; University of British Columbia; Alzheimer's Society of Canada	This work was supported in part by operating grants from the Canadian Institutes of Health Research and the Pacific Alzheimer's Research Foundation and a New Scientist Award (to C. L. W.).; Supported by University of British Columbia Arthur and June Williams Postdoctoral Fellowship and the Roy Congdon fellowship from the Alzheimer's Society of Canada.; Supported by a Vanier Canada Graduate Scholarship (Canadian Institutes of Health Research) and a University of British Columbia Ph.D. fellowship.	Bates KA, 2009, MOL PSYCHIATR, V14, P469, DOI 10.1038/mp.2008.96; Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Bellgowan PSF, 2009, LEARN MEMORY, V16, P433, DOI 10.1101/lm.1357309; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Burns MP, 2006, J NEUROCHEM, V98, P792, DOI 10.1111/j.1471-4159.2006.03925.x; Chang KA, 2005, J PHARMACOL SCI, V97, P461, DOI 10.1254/jphs.CR0050014; DeMattos RB, 2002, J NEUROCHEM, V81, P229, DOI 10.1046/j.1471-4159.2002.00889.x; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fan JJ, 2009, BIOFACTORS, V35, P239, DOI 10.1002/biof.37; Genest J, 1999, J INVEST MED, V47, P31; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Groot PHE, 2005, J LIPID RES, V46, P2182, DOI 10.1194/jlr.M500116-JLR200; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; Hirsch-Reinshagen V, 2004, J BIOL CHEM, V279, P41197, DOI 10.1074/jbc.M407962200; Jamroz-Wisniewska Anna, 2007, Postepy Hig Med Dosw (Online), V61, P760; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Koldamova RP, 2001, BIOCHEMISTRY-US, V40, P3553, DOI 10.1021/bi002186k; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; LaDu MJ, 2000, ANN NY ACAD SCI, V903, P167, DOI 10.1111/j.1749-6632.2000.tb06365.x; Lefterov I, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-20; Lund EG, 2006, BIOCHEM PHARMACOL, V71, P453, DOI 10.1016/j.bcp.2005.11.004; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Miao B, 2004, J LIPID RES, V45, P1410, DOI 10.1194/jlr.M300450-JLR200; Morris JC, 1997, NEUROLOGY, V49, pS7, DOI 10.1212/WNL.49.3_Suppl_3.S7; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; VANMIERLO T, 2009, NEUROBIOL AGING; Wahrle SE, 2005, J BIOL CHEM, V280, P43236, DOI 10.1074/jbc.M508780200; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Walf AA, 2006, NEUROBIOL LEARN MEM, V86, P35, DOI 10.1016/j.nlm.2006.01.004; Wojcicka Grazyna, 2007, Postepy Hig Med Dosw (Online), V61, P736; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104	43	148	152	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34144	34154		10.1074/jbc.M110.108100	http://dx.doi.org/10.1074/jbc.M110.108100			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20739291	Green Published, hybrid			2022-12-25	WOS:000283354000060
J	Kassel, KM; Au, DR; Higgins, MJ; Hines, M; Graves, LM				Kassel, Karen M.; Au, Da Ryung; Higgins, Matthew J.; Hines, Maria; Graves, Lee M.			Regulation of Human Cytidine Triphosphate Synthetase 2 by Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CTP SYNTHETASE; PROTEIN-KINASE-A; ALLOSTERIC EFFECTOR GTP; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; GLUTAMINE HYDROLYSIS; LACTOCOCCUS-LACTIS; URA7 GENE; SYNTHASE; IDENTIFICATION	Cytidine triphosphate synthetase (CTPS) is the rate-limiting enzyme in de novo CTP synthesis and is required for the formation of RNA, DNA, and phospholipids. This study determined the kinetic properties of the individual human CTPS isozymes (hCTPS1 and hCTPS2) and regulation through substrate concentration, oligomerization, and phosphorylation. Kinetic analysis demonstrated that both hCTPS1 and hCTPS2 were maximally active at physiological concentrations of ATP, GTP, and glutamine, whereas the K-m and IC50 values for the substrate UTP and the product CTP, respectively, were close to their physiological concentrations, indicating that the intracellular concentrations of UTP and CTP may precisely regulate hCTPS activity. Low serum treatment increased hCTPS2 phosphorylation, and five probable phosphorylation sites were identified in the hCTPS2 C-terminal domain. Metabolic labeling of hCTPS2 with [P-32]H3PO4 demonstrated that Ser(568) and Ser(571) were two major phosphorylation sites, and additional studies demonstrated that Ser(568) was phosphorylated by casein kinase 1 both in vitro and in vivo. Interestingly, mutation of Ser(568) (S568A) but not Ser(571) significantly increased hCTPS2 activity, demonstrating that Ser(568) is a major inhibitory phosphorylation site. The S568A mutation had a greater effect on the glutamine than ammonia-dependent activity, indicating that phosphorylation of this site may influence the glutaminase domain of hCTPS2. Deletion of the C-terminal regulatory domain of hCTPS1 also greatly increased the V-max of this enzyme. In summary, this is the first study to characterize the kinetic properties of hCTPS1 and hCTPS2 and to identify Ser(568) as a major site of CTPS2 regulation by phosphorylation.	[Graves, Lee M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Hines, Maria] Univ N Carolina, Univ N Carolina Michael Hooker Prote Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Graves, LM (corresponding author), Univ N Carolina, Dept Pharmacol, 4111 Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	lmg@med.unc.edu	, Proteomics Core UNC/AFQ-7201-2022; Graves, Lee/AAG-5470-2021		National Institutes of Health [R01-GM069976]; Pharmaceutical Research and Manufacturers of America Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmaceutical Research and Manufacturers of America Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM069976 (to L. M. G.).; Supported by a post-doctoral fellowship from the Pharmaceutical Research and Manufacturers of America Foundation. Present address: University of Kansas Medical Center, 3901 Rainbow Blvd., MS-1018, Kansas City, KS 66160.	Bearne SL, 2001, BIOCHEM J, V356, P223, DOI 10.1042/0264-6021:3560223; Chang YF, 2007, J BIOL CHEM, V282, P17613, DOI 10.1074/jbc.M702799200; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Endrizzi JA, 2005, BIOCHEMISTRY-US, V44, P13491, DOI 10.1021/bi051282o; Endrizzi JA, 2004, BIOCHEMISTRY-US, V43, P6447, DOI 10.1021/bi0496945; FLOTOW H, 1989, J BIOL CHEM, V264, P9126; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Goto M, 2004, STRUCTURE, V12, P1413, DOI 10.1016/j.str.2004.05.013; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Higgins MJ, 2007, J BIOL CHEM, V282, P29493, DOI 10.1074/jbc.M703948200; Huang M, 2003, CELL MOL LIFE SCI, V60, P321, DOI 10.1007/s000180300027; Kursula P, 2006, ACTA CRYSTALLOGR F, V62, P613, DOI 10.1107/S1744309106018136; LEVITZKI A, 1972, BIOCHEMISTRY-US, V11, P247, DOI 10.1021/bi00752a016; LEVITZKI A, 1972, BIOCHEMISTRY-US, V11, P241, DOI 10.1021/bi00752a015; LONG CW, 1970, J BIOL CHEM, V245, P80; LONG CW, 1967, J BIOL CHEM, V242, P4715; Lunn FA, 2008, BIOCHEM J, V412, P113, DOI 10.1042/BJ20071163; MacDonnell JE, 2004, BBA-PROTEINS PROTEOM, V1699, P213, DOI 10.1016/j.bbapap.2004.03.002; MacLeod TJ, 2006, BBA-PROTEINS PROTEOM, V1764, P199, DOI 10.1016/j.bbapap.2005.11.021; NADKARNI AK, 1995, J BIOL CHEM, V270, P24982, DOI 10.1074/jbc.270.42.24982; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; OZIERKALOGEROPOULOS O, 1991, MOL GEN GENET, V231, P7, DOI 10.1007/BF00293815; OZIERKALOGEROPOULOS O, 1994, MOL GEN GENET, V242, P431, DOI 10.1007/BF00281793; Pappas A, 1998, J BIOL CHEM, V273, P15954, DOI 10.1074/jbc.273.26.15954; Park TS, 2003, J BIOL CHEM, V278, P20785, DOI 10.1074/jbc.M301394200; Park TS, 1999, BIOCHEMISTRY-US, V38, P8839, DOI 10.1021/bi990784x; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P446, DOI 10.1016/S0753-3322(02)00285-8; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; van Kuilenburg ABP, 2000, BBA-GENE STRUCT EXPR, V1492, P548, DOI 10.1016/S0167-4781(00)00141-X; VONDERSAAL W, 1985, J AM CHEM SOC, V107, P703, DOI 10.1021/ja00289a031; VONDERSAAL W, 1985, J BIOL CHEM, V260, P4993; Wadskov-Hansen SLL, 2001, J BIOL CHEM, V276, P38002; Willemoes M, 2002, EUR J BIOCHEM, V269, P4772, DOI 10.1046/j.1432-1033.2002.03175.x; Yang WL, 1996, J BIOL CHEM, V271, P28777, DOI 10.1074/jbc.271.46.28777; Yang WL, 1996, J BIOL CHEM, V271, P11113, DOI 10.1074/jbc.271.19.11113; YANG WL, 1994, BIOCHEMISTRY-US, V33, P10785, DOI 10.1021/bi00201a028; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983	38	25	26	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33727	33736		10.1074/jbc.M110.178566	http://dx.doi.org/10.1074/jbc.M110.178566			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20739275	Green Published, hybrid			2022-12-25	WOS:000283354000018
J	Srikanth, B; Vaidya, MM; Kalraiya, RD				Srikanth, Budnar; Vaidya, Milind M.; Kalraiya, Rajiv D.			O-GlcNAcylation Determines the Solubility, Filament Organization, and Stability of Keratins 8 and 18	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLE EPITHELIAL KERATINS; MALLORY-DENK-BODIES; INTERMEDIATE-FILAMENTS; N-ACETYLGLUCOSAMINE; 14-3-3 PROTEINS; SHEAR-STRESS; TETRATRICOPEPTIDE REPEATS; LINKED GLYCOSYLATION; CYTOSOLIC PROTEINS; GLCNAC TRANSFERASE	Keratins 8 and 18 (K8/18) are intermediate filament proteins expressed specifically in simple epithelial tissues. Dynamic equilibrium of these phosphoglycoproteins in the soluble and filament pool is an important determinant of their cellular functions, and it is known to be regulated by site-specific phosphorylation. However, little is known about the role of dynamic O-GlcNAcylation on this keratin pair. Here, by comparing immortalized (Chang) and transformed hepatocyte (HepG2) cell lines, we have demonstrated that O-GlcNAcylation of K8/18 exhibits a positive correlation with their solubility (Nonidet P-40 extractability). Heat stress, which increases K8/18 solubility, resulted in a simultaneous increase in O-GlcNAc on these proteins. Conversely, increasing O-GlcNAc levels were associated with a concurrent increase in their solubility. This was also associated with a notable decrease in total cellular levels of K8/18. Unaltered levels of transcripts and the reduced half-life of K8 and K18 indicated their decreased stability on increasing O-GlcNAcylation. On the contrary, the K18 glycosylation mutant (K18 S29A/S30A/S48A) was notably more stable than the wild type K18 in Chang cells. The K18-O-GlcNAc mutant accumulated as aggregates upon stable expression, which possibly altered endogenous filament architecture. These results strongly indicate the involvement of O-GlcNAc on K8/18 in regulating their solubility and stability, which may have a bearing on the functions of these keratins.	[Kalraiya, Rajiv D.] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Sector 22, Kalraiya Lab,KS 131, Kharghar 410210, Navi Mumbai, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Kalraiya, RD (corresponding author), Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Sector 22, Kalraiya Lab,KS 131, Kharghar 410210, Navi Mumbai, India.	rkalraiya@actrec.gov.in	Budnar, Srikanth/J-1827-2014	Budnar, Srikanth/0000-0002-8951-9081	Department of Biotechnology, Government of India; Advanced Centre for Treatment Research and Education in Cancer	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Advanced Centre for Treatment Research and Education in Cancer	This work was supported in part by grants from the Department of Biotechnology, Government of India, and Advanced Centre for Treatment Research and Education in Cancer.	CHOU CF, 1993, J BIOL CHEM, V268, P4465; CHOU CF, 1992, J BIOL CHEM, V267, P3901; Denk H, 2006, J PATHOL, V208, P653, DOI 10.1002/path.1946; Flitney EW, 2009, FASEB J, V23, P2110, DOI 10.1096/fj.08-124453; Flitney EW, 2004, METHOD CELL BIOL, V78, P297; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; GEISLER N, 1982, EMBO J, V1, P1649, DOI 10.1002/j.1460-2075.1982.tb01368.x; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Guinez C, 2008, FASEB J, V22, P2901, DOI 10.1096/fj.07-102509; Haltiwanger RS, 1997, J BIOL CHEM, V272, P8752, DOI 10.1074/jbc.272.13.8752; Heckel D, 1998, HUM MOL GENET, V7, P1859, DOI 10.1093/hmg/7.12.1859; HEINS S, 1994, CURR OPIN CELL BIOL, V6, P25, DOI 10.1016/0955-0674(94)90112-0; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Iwaya K, 2005, SEMIN CANCER BIOL, V15, P309, DOI 10.1016/j.semcancer.2005.04.006; Jaitovich A, 2008, J BIOL CHEM, V283, P25348, DOI 10.1074/jbc.M801635200; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; Ku NO, 2000, J CELL BIOL, V149, P547, DOI 10.1083/jcb.149.3.547; Ku NO, 2002, P NATL ACAD SCI USA, V99, P4373, DOI 10.1073/pnas.072624299; Ku NO, 2002, J BIOL CHEM, V277, P10775, DOI 10.1074/jbc.M107623200; KU NO, 1995, J BIOL CHEM, V270, P11820, DOI 10.1074/jbc.270.20.11820; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIAO J, 1995, EXP CELL RES, V219, P348, DOI 10.1006/excr.1995.1238; Liao J, 1996, J CELL BIOL, V133, P345, DOI 10.1083/jcb.133.2.345; LIAO J, 1995, J CELL BIOL, V131, P1291, DOI 10.1083/jcb.131.5.1291; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Lubas WA, 1997, J BIOL CHEM, V272, P9316; McGowan K, 1998, Subcell Biochem, V31, P173; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Omary M B, 1998, Subcell Biochem, V31, P105; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Owens DW, 2003, BIOESSAYS, V25, P748, DOI 10.1002/bies.10316; Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516; Ridge KM, 2005, J BIOL CHEM, V280, P30400, DOI 10.1074/jbc.M504239200; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P889, DOI 10.1073/pnas.0710728105; Sivaramakrishnan S, 2009, MOL BIOL CELL, V20, P2755, DOI 10.1091/mbc.E08-10-1028; Slawson C, 2001, BBA-MOL BASIS DIS, V1537, P147, DOI 10.1016/S0925-4439(01)00067-9; Spector D. L., 1998, CELLS LAB MANUAL; Strnad R, 2008, BBA-MOL BASIS DIS, V1782, P764, DOI 10.1016/j.bbadis.2008.08.008; Tao GZ, 2006, BIOCHEM BIOPH RES CO, V351, P708, DOI 10.1016/j.bbrc.2006.10.092; Toivola DA, 2004, HEPATOLOGY, V40, P459, DOI 10.1002/hep.20277; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Windoffer R, 2004, MOL BIOL CELL, V15, P2436, DOI 10.1091/mbc.E03-09-0707; Woll S, 2007, J CELL BIOL, V177, P795, DOI 10.1083/jcb.200703174; Yki-Jarvinen H, 1998, METABOLISM, V47, P449, DOI 10.1016/S0026-0495(98)90058-0; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024	56	51	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34062	34071		10.1074/jbc.M109.098996	http://dx.doi.org/10.1074/jbc.M109.098996			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729549	Green Published, hybrid			2022-12-25	WOS:000283354000052
J	Tsuboi, T; Inada, T				Tsuboi, Tatsuhisa; Inada, Toshifumi			Tethering of Poly(A)-binding Protein Interferes with Non-translated mRNA Decay from the 5 ' End in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(A) TAIL; SACCHAROMYCES-CEREVISIAE; DEPENDENT TRANSLATION; P-BODIES; DEGRADATION; INITIATION; TURNOVER; COMPLEX; EXOSOME; CAP	The decay of eukaryotic mRNA is triggered mainly by deadenylation, which leads to decapping and degradation from the 5' end of an mRNA. Poly(A)-binding protein has been proposed to inhibit the decapping process and to stabilize mRNA by blocking the recruitment of mRNA to the P-bodies where mRNA degradation takes place after stimulation of translation initiation. In contrast, several lines of evidence show that poly(A)-binding protein (Pab1p) has distinct functions in mRNA decay and translation in yeast. To address the translation-independent function of Pab1p in inhibition of decapping, we examined the contribution of Pab1p to the stability of non-translated mRNAs, an AUG codon-less mRNA or an mRNA containing a stable stem-loop structure at the 5'-UTR. Tethering of Pab1p stabilized non-translated mRNAs, and this stabilization did not require either the eIF4G-interacting domain of Pab1p or the Pab1p-interacting domain of eIF4G. In a ski2 Delta mutant in which 3' to 5' mRNA degradation activity is defective, stabilization of non-translated mRNAs by the tethering of Pab1p lacking an eIF4G-interacting domain (Pab1-34Cp) requires a cap structure but not a poly(A) tail. In wild type cells, stabilization of non-translated mRNA by tethered Pab1-34Cp results in the accumulation of deadenylated mRNA. These results strongly suggest that tethering of Pab1p may inhibit the decapping reaction after deadenylation, independent of translation. We propose that Pab1p inhibits the decapping reaction in a translation-independent manner in vivo.	[Tsuboi, Tatsuhisa; Inada, Toshifumi] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University	Inada, T (corresponding author), Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	p47294a@nucc.cc.nagoya-u.ac.jp	Tsuboi, Tatsuhisa/AAA-1926-2022; Inada, Toshifumi/AAE-1517-2019; Tsuboi, Tatsuhisa/AAL-5360-2020	Tsuboi, Tatsuhisa/0000-0003-3249-030X; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [20112006] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. I.).	Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; Brown CE, 1998, MOL CELL BIOL, V18, P6548, DOI 10.1128/MCB.18.11.6548; CAPONIGRO G, 1995, GENE DEV, V9, P2421, DOI 10.1101/gad.9.19.2421; Carninci P, 2008, NAT CELL BIOL, V10, P1023, DOI 10.1038/ncb0908-1023; Chowdhury A, 2008, RNA, V14, P2149, DOI 10.1261/rna.1094208; Chowdhury A, 2009, RNA, V15, P1837, DOI 10.1261/rna.1650109; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 1998, GENE DEV, V12, P3226, DOI 10.1101/gad.12.20.3226; DECKER CJ, 1994, TRENDS BIOCHEM SCI, V19, P336, DOI 10.1016/0968-0004(94)90073-6; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Kessler SH, 1998, MOL CELL BIOL, V18, P51, DOI 10.1128/MCB.18.1.51; Khanna R, 2004, EMBO J, V23, P1968, DOI 10.1038/sj.emboj.7600213; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Kulkarni M, 2010, BIOCHEM SOC T, V38, P242, DOI 10.1042/BST0380242; Kuroha K, 2009, EMBO REP, V10, P1265, DOI 10.1038/embor.2009.200; Meaux S, 2006, RNA, V12, P1323, DOI 10.1261/rna.46306; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Morrissey JP, 1999, YEAST, V15, P687, DOI 10.1002/(SICI)1097-0061(19990615)15:8<687::AID-YEA412>3.0.CO;2-L; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Otero LJ, 1999, EMBO J, V18, P3153, DOI 10.1093/emboj/18.11.3153; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Sambrook J., 2001, MOL CLONING; Steiger M, 2003, RNA, V9, P231, DOI 10.1261/rna.2151403; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; Tharun S, 2001, MOL CELL, V8, P1075, DOI 10.1016/S1097-2765(01)00395-1; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599; Wang ZR, 2001, CELL, V107, P751, DOI 10.1016/S0092-8674(01)00592-X; Wilusz CJ, 2001, RNA, V7, P1416	42	6	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33589	33601		10.1074/jbc.M110.117150	http://dx.doi.org/10.1074/jbc.M110.117150			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20732870	hybrid, Green Published			2022-12-25	WOS:000283354000004
J	Shen, ZT; Brehm, MA; Daniels, KA; Sigalov, AB; Selin, LK; Welsh, RM; Stern, LJ				Shen, Zu T.; Brehm, Michael A.; Daniels, Keith A.; Sigalov, Alexander B.; Selin, Liisa K.; Welsh, Raymond M.; Stern, Lawrence J.			Bi-specific MHC Heterodimers for Characterization of Cross-reactive T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROLOGOUS ANTIVIRAL IMMUNITY; CRYSTAL-STRUCTURE; VIRUS; MEMORY; BINDING; TCR; CORECEPTOR; AFFINITY; ALPHA; RECOGNITION	T cell cross-reactivity describes the phenomenon whereby a single T cell can recognize two or more different peptide antigens presented in complex with MHC proteins. Cross-reactive T cells have previously been characterized at the population level by cytokine secretion and MHC tetramer staining assays, but single-cell analysis is difficult or impossible using these methods. In this study, we describe development of a novel peptide MHC heterodimer specific for cross-reactive T cells. MHC-peptide monomers were independently conjugated to hydrazide or aldehyde-containing cross-linkers using thiol-maleimide coupling at cysteine residues introduced into recombinant MHC heavy chain proteins. Hydrazone formation provided bi-specific MHC heterodimers carrying two different peptides. Using this approach we prepared heterodimers of the murine class I MHC protein H-2K(b) carrying peptides from lymphocytic choriomeningitis virus and vaccinia virus, and used these to identify cross-reactive CD8+ T cells recognizing both lymphocytic choriomeningitis virus and vaccinia virus antigens. A similar strategy could be used to develop reagents to analyze cross-reactive T cell responses in humans.	[Stern, Lawrence J.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA; [Brehm, Michael A.] Univ Massachusetts, Sch Med, Div Diabet, Worcester, MA 01655 USA; [Stern, Lawrence J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Stern, LJ (corresponding author), S2-127,55 Lake Ave N, Worcester, MA 01655 USA.	lawrence.stern@umassmed.edu		Brehm, Michael/0000-0001-6813-3262; Selin, Liisa/0000-0002-6993-4333	National Institutes of Health [U19-AI057319, AI081675]; Diabetes Endocrinology Research Center [DK32520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI038996, U19AI057319, U19AI109858, R01AI081675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrinology Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants U19-AI057319 (to L. J. S.) and AI081675 (to R. M. W.) and University of Massachusetts Medical School FACS and Proteomics Core resources supported by Diabetes Endocrinology Research Center Grant DK32520.	Achour A, 2002, IMMUNITY, V17, P757, DOI 10.1016/S1074-7613(02)00478-8; Altman BM, 2003, RES SOC SCI DISABIL, V3, P1, DOI 10.1016/S1479-3547(03)03001-X; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Boen E, 2000, J IMMUNOL, V165, P2040, DOI 10.4049/jimmunol.165.4.2040; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Chaudhri G, 2009, P NATL ACAD SCI USA, V106, P14984, DOI 10.1073/pnas.0906554106; Chen HD, 2001, NAT IMMUNOL, V2, P1067, DOI 10.1038/ni727; Clute SC, 2005, J CLIN INVEST, V115, P3602, DOI 10.1172/JCI25078; Cochran JR, 2001, J BIOL CHEM, V276, P28068, DOI 10.1074/jbc.M103280200; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Cornberg M, 2006, J CLIN INVEST, V116, P1443, DOI 10.1172/JCI27804; Cornberg M, 2007, J VIROL, V81, P934, DOI 10.1128/JVI.01280-06; Cornberg M, 2010, J IMMUNOL, V184, P2825, DOI 10.4049/jimmunol.0902168; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Dirksen A, 2006, J AM CHEM SOC, V128, P15602, DOI 10.1021/ja067189k; Dutoit V, 2003, J IMMUNOL, V170, P5110, DOI 10.4049/jimmunol.170.10.5110; Fahmy TM, 2002, J IMMUNOL METHODS, V268, P93, DOI 10.1016/S0022-1759(02)00203-X; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; HARDARDOTTIR F, 1995, P NATL ACAD SCI USA, V92, P354, DOI 10.1073/pnas.92.2.354; He X, 2002, NAT IMMUNOL, V3, P127, DOI 10.1038/ni751; Kern P, 1999, J BIOL CHEM, V274, P27237, DOI 10.1074/jbc.274.38.27237; Kerry SE, 2003, J IMMUNOL, V171, P4493, DOI 10.4049/jimmunol.171.9.4493; Khanolkar A, 2004, J IMMUNOL, V172, P2834, DOI 10.4049/jimmunol.172.5.2834; Kim SK, 2005, J EXP MED, V201, P523, DOI 10.1084/jem.20041337; KING TP, 1986, BIOCHEMISTRY-US, V25, P5774, DOI 10.1021/bi00367a064; KITAGAWA T, 1976, J BIOCHEM-TOKYO, V79, P233, DOI 10.1093/oxfordjournals.jbchem.a131053; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Laugel B, 2007, J BIOL CHEM, V282, P23799, DOI 10.1074/jbc.M700976200; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Moody AM, 2001, EUR J IMMUNOL, V31, P2791, DOI 10.1002/1521-4141(200109)31:9<2791::AID-IMMU2791>3.0.CO;2-X; Nugent CT, 2005, IMMUNOL LETT, V98, P208, DOI 10.1016/j.imlet.2004.11.016; PADOVAN E, 1995, ANN NY ACAD SCI, V756, P66, DOI 10.1111/j.1749-6632.1995.tb44482.x; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; Puglielli MT, 2001, J VIROL, V75, P5099, DOI 10.1128/JVI.75.11.5099-5107.2001; Rothman AL, 2009, ANN NY ACAD SCI, V1171, pE36, DOI 10.1111/j.1749-6632.2009.05055.x; Schott E, 2002, EUR J IMMUNOL, V32, P3425, DOI 10.1002/1521-4141(2002012)32:12<3425::AID-IMMU3425>3.0.CO;2-Q; Selin LK, 1998, J EXP MED, V188, P1705, DOI 10.1084/jem.188.9.1705; SELIN LK, 1994, J EXP MED, V179, P1933, DOI 10.1084/jem.179.6.1933; Stones JD, 2006, J IMMUNOL, V176, P1498, DOI 10.4049/jimmunol.176.3.1498; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; Udaka K, 1996, J IMMUNOL, V157, P670; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Wedemeyer H, 2001, J VIROL, V75, P11392, DOI 10.1128/JVI.75.23.11392-11400.2001; Welsh RM, 2006, CURR TOP MICROBIOL, V311, P117	46	8	9	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33144	33153		10.1074/jbc.M110.141051	http://dx.doi.org/10.1074/jbc.M110.141051			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729210	Green Published, hybrid			2022-12-25	WOS:000283048200052
J	Chen, PE; Willner, KM; Butani, A; Dorsey, S; George, M; Stewart, A; Lentz, SM; Cook, CE; Akmal, A; Price, LB; Keim, PS; Mateczun, A; Brahmbhatt, TN; Bishop-Lilly, KA; Zwick, ME; Read, TD; Sozhamannan, S				Chen, Peter E.; Willner, Kristin M.; Butani, Amy; Dorsey, Shakia; George, Matroner; Stewart, Andrew; Lentz, Shannon M.; Cook, Christopher E.; Akmal, Arya; Price, Lance B.; Keim, Paul S.; Mateczun, Alfred; Brahmbhatt, Trupti N.; Bishop-Lilly, Kimberly A.; Zwick, Michael E.; Read, Timothy D.; Sozhamannan, Shanmuga			Rapid Identification of Genetic Modifications in Bacillus anthracis Using Whole Genome Draft Sequences Generated by 454 Pyrosequencing	PLOS ONE			English	Article							INHALATIONAL ANTHRAX; TECHNOLOGIES; CEREUS; BIOTERRORISM; EVOLUTION; STRAIN	Background: The anthrax letter attacks of 2001 highlighted the need for rapid identification of biothreat agents not only for epidemiological surveillance of the intentional outbreak but also for implementing appropriate countermeasures, such as antibiotic treatment, in a timely manner to prevent further casualties. It is clear from the 2001 cases that survival may be markedly improved by administration of antimicrobial therapy during the early symptomatic phase of the illness; i. e., within 3 days of appearance of symptoms. Microbiological detection methods are feasible only for organisms that can be cultured in vitro and cannot detect all genetic modifications with the exception of antibiotic resistance. Currently available immuno or nucleic acid-based rapid detection assays utilize known, organism-specific proteins or genomic DNA signatures respectively. Hence, these assays lack the ability to detect novel natural variations or intentional genetic modifications that circumvent the targets of the detection assays or in the case of a biological attack using an antibiotic resistant or virulence enhanced Bacillus anthracis, to advise on therapeutic treatments. Methodology/ Principal Findings: We show here that the Roche 454-based pyrosequencing can generate whole genome draft sequences of deep and broad enough coverage of a bacterial genome in less than 24 hours. Furthermore, using the unfinished draft sequences, we demonstrate that unbiased identification of known as well as heretofore-unreported genetic modifications that include indels and single nucleotide polymorphisms conferring antibiotic and phage resistances is feasible within the next 12 hours. Conclusions/ Significance: Second generation sequencing technologies have paved the way for sequence-based rapid identification of both known and previously undocumented genetic modifications in cultured, conventional and newly emerging biothreat agents. Our findings have significant implications in the context of whole genome sequencing-based routine clinical diagnostics as well as epidemiological surveillance of natural disease outbreaks caused by bacterial and viral agents.	[Chen, Peter E.; Willner, Kristin M.; Butani, Amy; Dorsey, Shakia; George, Matroner; Stewart, Andrew; Lentz, Shannon M.; Cook, Christopher E.; Akmal, Arya; Mateczun, Alfred; Brahmbhatt, Trupti N.; Bishop-Lilly, Kimberly A.; Sozhamannan, Shanmuga] USN, Med Res Ctr, Biol Def Res Directorate, Silver Spring, MD USA; [Price, Lance B.; Keim, Paul S.] Translat Genom Res Inst, Flagstaff, AZ USA; [Keim, Paul S.] No Arizona Univ, Flagstaff, AZ 86011 USA; [Zwick, Michael E.; Read, Timothy D.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Read, Timothy D.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA	United States Department of Defense; United States Navy; Translational Genomics Research Institute; Northern Arizona University; Emory University; Emory University	Chen, PE (corresponding author), USN, Med Res Ctr, Biol Def Res Directorate, Silver Spring, MD USA.	Shanmuga.Sozhamannan@med.navy.mil	Sozhamannan, Shanmuga/AAN-7809-2020; Keim, Paul S/A-2269-2010; Read, Timothy/E-6240-2011; Sozhamannan, Shanmuga/AGF-2410-2022	Sozhamannan, Shanmuga/0000-0002-6762-7874; Bishop-Lilly, Kimberly/0000-0002-5744-8493; Read, Timothy/0000-0001-8966-9680				ABRAMOVA FA, 1993, P NATL ACAD SCI USA, V90, P2291, DOI 10.1073/pnas.90.6.2291; Athamna A, 2004, J ANTIMICROB CHEMOTH, V54, P424, DOI 10.1093/jac/dkh258; Bartlett JG, 2002, CLIN INFECT DIS, V35, P851, DOI 10.1086/341902; Brachman P S, 1980, Ann N Y Acad Sci, V353, P83, DOI 10.1111/j.1749-6632.1980.tb18910.x; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chen PE, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r1; Cowan ST, 2003, COWAN STEELS MANUAL; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Davis BM, 2009, NUCLEIC ACIDS RES, V37, P5757, DOI 10.1093/nar/gkp568; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hobert O, 2010, GENETICS, V184, P317, DOI 10.1534/genetics.109.112938; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Klee SR, 2006, J BACTERIOL, V188, P5333, DOI 10.1128/JB.00303-06; La Scola B, 2008, GENOME RES, V18, P742, DOI 10.1101/gr.071266.107; Lim DV, 2005, CLIN MICROBIOL REV, V18, P583, DOI 10.1128/CMR.18.4.583-607.2005; Lipkin WI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000002; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Miller JM, 1997, J CLIN MICROBIOL, V35, P504, DOI 10.1128/JCM.35.2.504-507.1997; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Okinaka R, 2006, PLOS PATHOG, V2, P1025, DOI 10.1371/journal.ppat.0020122; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; POMERANTSEV AP, 1992, ANTIBIOT KHIMIOTERAP, V37, P31; Price LB, 2003, ANTIMICROB AGENTS CH, V47, P2362, DOI 10.1128/AAC.47.7.2362-2365.2003; SERIZAWA M, 2010, ANTIMICROB AGENTS CH; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sozhamannan S, 2008, APPL ENVIRON MICROB, V74, P6792, DOI 10.1128/AEM.01124-08; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; Steinberg KM, 2008, ANAL CHEM, V80, P520, DOI 10.1021/ac086027z; Sternbach G, 2003, J EMERG MED, V24, P463, DOI 10.1016/S0736-4679(03)00079-9; Stewart AC, 2009, BIOINFORMATICS, V25, P962, DOI 10.1093/bioinformatics/btp097; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06; Weiner M, 2003, J BACTERIOL, V185, P1462, DOI 10.1128/JB.185.4.1462-1464.2003; Zwick ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002513	44	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12397	10.1371/journal.pone.0012397	http://dx.doi.org/10.1371/journal.pone.0012397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811637	Green Published, gold, Green Submitted			2022-12-25	WOS:000281234700021
J	Clifton, JD; Lucumi, E; Myers, MC; Napper, A; Hama, K; Farber, SA; Smith, AB; Huryn, DM; Diamond, SL; Pack, M				Clifton, Justin D.; Lucumi, Edinson; Myers, Michael C.; Napper, Andrew; Hama, Kotaro; Farber, Steven A.; Smith, Amos B., III; Huryn, Donna M.; Diamond, Scott L.; Pack, Michael			Identification of Novel Inhibitors of Dietary Lipid Absorption Using Zebrafish	PLOS ONE			English	Article							SMALL MOLECULES; OBESE-PATIENTS; EZETIMIBE; CHOLESTEROL; GENE; PROTEIN; CHOLECYSTOKININ; COMBINATION; ORLISTAT; NPC1L1	Pharmacological inhibition of dietary lipid absorption induces favorable changes in serum lipoprotein levels in patients that are at risk for cardiovascular disease and is considered an adjuvant or alternative treatment with HMG-CoA reductase inhibitors (statins). Here we demonstrate the feasibility of identifying novel inhibitors of intestinal lipid absorption using the zebrafish system. A pilot screen of an unbiased chemical library identified novel compounds that inhibited processing of fluorescent lipid analogues in live zebrafish larvae. Secondary assays identified those compounds suitable for testing in mammals and provided insight into mechanism of action, which for several compounds could be distinguished from ezetimibe, a drug used to inhibit cholesterol absorption in humans that broadly inhibited lipid absorption in zebrafish larvae. These findings support the utility of zebrafish screening assays to identify novel compounds that target complex physiological processes.	[Clifton, Justin D.; Pack, Michael] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Lucumi, Edinson; Smith, Amos B., III; Huryn, Donna M.; Diamond, Scott L.] Univ Penn, Inst Med & Engn, Penn Ctr Mol Discovery, Philadelphia, PA 19104 USA; [Myers, Michael C.; Napper, Andrew; Smith, Amos B., III; Huryn, Donna M.; Diamond, Scott L.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Hama, Kotaro; Farber, Steven A.] Carnegie Inst, Dept Embryol, Baltimore, MD USA; [Pack, Michael] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Carnegie Institution for Science; University of Pennsylvania	Clifton, JD (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.	mpack@mail.med.upenn.edu	Clifton, Justin/ABG-5610-2021; Farber, Steven A/G-5851-2012	Farber, Steven A/0000-0002-8037-7312; Huryn, Donna/0000-0001-5542-4968; Clifton, Justin David/0000-0001-9664-107X	National Institutes of Health; National Human Genome Research Institute [HG003915]; National Institute of Diabetes, Digestive and Kidney Diseases [DK54942]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK054942, R01DK054942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the National Institutes of Health. This includes the National Human Genome Research Institute (grant HG003915) and the National Institute of Diabetes, Digestive and Kidney Diseases (grant DK54942). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Athyros VG, 2008, AM J CARDIOL, V101, P483, DOI 10.1016/j.amjcard.2007.09.096; Bayliss PE, 2006, NAT CHEM BIOL, V2, P265, DOI 10.1038/nchembio778; Beaslas O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004278; Brown BG, 2008, NEW ENGL J MED, V358, P1504, DOI 10.1056/NEJMe0801608; Burns CG, 2005, NAT CHEM BIOL, V1, P263, DOI 10.1038/nchembio732; Cheng ZJ, 2001, J BIOL CHEM, V276, P48040, DOI 10.1074/jbc.M105668200; Davies JP, 2006, CURR OPIN LIPIDOL, V17, P221, DOI 10.1097/01.mol.0000226112.12684.5e; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Dujovne CA, 2002, AM J CARDIOL, V90, P1092, DOI 10.1016/S0002-9149(02)02798-4; Esengil H, 2007, NAT CHEM BIOL, V3, P154, DOI 10.1038/nchembio858; Farber SA, 2001, SCIENCE, V292, P1385, DOI 10.1126/science.1060418; FARELL JJ, 2006, SLEISENGER FORDTRANS, P2150; Fazio S, 2010, AM J CARDIOL, V105, P487, DOI 10.1016/j.amjcard.2009.10.001; Field FJ, 2007, J LIPID RES, V48, P1735, DOI 10.1194/jlr.M700029-JLR200; Field SK, 2003, CHEST, V124, P1482, DOI 10.1378/chest.124.4.1482; Gaffield MA, 2006, NAT PROTOC, V1, P2916, DOI 10.1038/nprot.2006.476; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Guerciolini R, 1997, INT J OBESITY, V21, pS12; Hama K, 2009, AM J PHYSIOL-GASTR L, V296, pG445, DOI 10.1152/ajpgi.90513.2008; Hawes BE, 2007, MOL PHARMACOL, V71, P19, DOI 10.1124/mol.106.027896; Jones SC, 2008, DRUG ALCOHOL REV, V27, P5, DOI 10.1080/09595230701710787; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; Kampf JP, 2007, PHYSIOLOGY, V22, P7, DOI 10.1152/physiol.00011.2006; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Kiortsis DN, 2005, DIABETES METAB, V31, P15, DOI 10.1016/S1262-3636(07)70161-1; Labonte ED, 2008, AM J PHYSIOL-GASTR L, V295, pG776, DOI 10.1152/ajpgi.90275.2008; Liu YJ, 2008, J HUM GENET, V53, P709, DOI 10.1007/s10038-008-0302-2; Matthews RP, 2005, DEVELOPMENT, V132, P5295, DOI 10.1242/dev.02140; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Miller LJ, 2007, CURR TOP MED CHEM, V7, P1166; Mitka M, 2010, JAMA-J AM MED ASSOC, V303, P211, DOI 10.1001/jama.2009.1915; Nakou ES, 2008, CURR MED RES OPIN, V24, P1919, DOI [10.1185/03007990802177150, 10.1185/03007990802177150 ]; Nakou ES, 2008, EXPERT OPIN PHARMACO, V9, P3151, DOI 10.1517/14656560802548430 ; Ostrom Rennolds S., 2007, V400, P459; Parizhskaya M, 2001, J PEDIATR-US, V138, P574, DOI 10.1067/mpd.2001.111327; Perez-Martinez P, 2004, J MOL ENDOCRINOL, V32, P237, DOI 10.1677/jme.0.0320237; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Schlegel A, 2006, BIOCHEMISTRY-US, V45, P15179, DOI 10.1021/bi0619268; SHERIDAN MA, 1986, COMP BIOCH PHYSL B, V90, P679; Shestopalov IA, 2007, NAT CHEM BIOL, V3, P650, DOI 10.1038/nchembio.2007.30; Stern HM, 2005, NAT CHEM BIOL, V1, P366, DOI 10.1038/nchembio749; Tanaka T, 2007, J NUTR, V137, P578, DOI 10.1093/jn/137.3.578; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; Weinglass AB, 2008, P NATL ACAD SCI USA, V105, P11140, DOI 10.1073/pnas.0800936105; Yamaoka-Tojo M, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-41; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	50	65	66	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12386	10.1371/journal.pone.0012386	http://dx.doi.org/10.1371/journal.pone.0012386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811635	Green Published, Green Submitted, gold			2022-12-25	WOS:000281234700014
J	Tang, XX; Chen, H; Yu, S; Zhang, L; Caplan, MJ; Chan, HC				Tang, Xiao Xiao; Chen, Hao; Yu, Sidney; Zhang, Li; Caplan, Michael J.; Chan, Hsiao Chang			Lymphocytes Accelerate Epithelial Tight Junction Assembly: Role of AMP-Activated Protein Kinase (AMPK)	PLOS ONE			English	Article							CELLS; BARRIER	The tight junctions (TJs), characteristically located at the apicolateral borders of adjacent epithelial cells, are required for the proper formation of epithelial cell polarity as well as for sustaining the mucosal barrier to the external environment. The observation that lymphocytes are recruited by epithelial cells to the sites of infection [1] suggests that they may play a role in the modulation of epithelial barrier function and thus contribute to host defense. To test the ability of lymphocytes to modulate tight junction assembly in epithelial cells, we set up a lymphocyte-epithelial cell co-culture system, in which Madin-Darby canine kidney (MDCK) cells, a well-established model cell line for studying epithelial TJ assembly [2], were co-cultured with mouse lymphocytes to mimic an infection state. In a typical calcium switch experiment, the TJ assembly in co-culture was found to be accelerated compared to that in MDCK cells alone. This accelaration was found to be mediated by AMP-activated protein kinase (AMPK). AMPK activation was independent of changes in cellular ATP levels but it was found to be activated by the pro-inflammatory cytokine TNF-alpha. Forced suppression of AMPK, either with a chemical inhibitor or by knockdown, abrogated the accelerating effect of lymphocytes on TJ formation. Similar results were also observed in a co-culture with lymphocytes and Calu-3 human airway epithelial cells, suggesting that the activation of AMPK may be a general mechanism underlying lymphocyte-accelerated TJ assembly in different epithelia. These results suggest that signals from lymphocytes, such as cytokines, facilitate TJ assembly in epithelial cells via the activation of AMPK.	[Tang, Xiao Xiao; Chen, Hao; Yu, Sidney; Chan, Hsiao Chang] Chinese Univ Hong Kong, Epithelial Cell Biol Res Ctr, Sch Biomed Sci, Fac Med, Shatin, Hong Kong, Peoples R China; [Zhang, Li; Caplan, Michael J.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT USA; [Chan, Hsiao Chang] Minist Educ China, Key Lab Regenerat Med, Guangzhou, Guangdong, Peoples R China	Chinese University of Hong Kong; Yale University; Ministry of Education, China	Tang, XX (corresponding author), Chinese Univ Hong Kong, Epithelial Cell Biol Res Ctr, Sch Biomed Sci, Fac Med, Shatin, Hong Kong, Peoples R China.	michael.caplan@yale.edu; hsiaocchan@cuhk.edu.hk	Chan, Hsiao Chang/E-1507-2016; Chen, Hao/D-3425-2012; Bin Sidney Yu, Siu/R-4936-2018; Zhang, Li/N-3674-2013; Chen, Hao/AAH-4124-2020	Chen, Hao/0000-0001-8319-8101; Bin Sidney Yu, Siu/0000-0001-9643-2729; Chen, Hao/0000-0001-8319-8101; Caplan, Michael/0000-0001-5768-4405	National 973 project [2009CB522102]; National Institutes of Health [DK17433]; Global Scholarship Program for Research Excellence; Focused Investment Scheme of The Chinese University of Hong Kong; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK017433, R01DK072614] Funding Source: NIH RePORTER	National 973 project(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Global Scholarship Program for Research Excellence; Focused Investment Scheme of The Chinese University of Hong Kong(Chinese University of Hong Kong); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National 973 project (No. 2009CB522102), National Institutes of Health grant (DK17433 MJC), Global Scholarship Program for Research Excellence and the Focused Investment Scheme of The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenman JE, 2007, CELL CYCLE, V6, P2755, DOI 10.4161/cc.6.22.4927; CEREIJIDO M, 1978, J CELL BIOL, V77, P853, DOI 10.1083/jcb.77.3.853; Chen J, 2004, WORLD J GASTROENTERO, V10, P1594, DOI 10.3748/wjg.v10.i11.1594; Chen ML, 2002, J BIOL CHEM, V277, P4247, DOI 10.1074/jbc.M109254200; CONTRERAS RG, 1992, AM J PHYSIOL, V263, P313; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; GONZALEZMARISCAL L, 1990, AM J PHYSIOL, V259, pC978, DOI 10.1152/ajpcell.1990.259.6.C978; GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Herard AL, 1996, AM J RESP CELL MOL, V15, P624, DOI 10.1165/ajrcmb.15.5.8918369; Ho LS, 2006, CELL BIOL INT, V30, P977, DOI 10.1016/j.cellbi.2006.07.004; HO LS, 2010, CELL BIOL I IN PRESS; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Nava P, 2004, J CELL SCI, V117, P5509, DOI 10.1242/jcs.01425; ROBBINS RA, 1989, AM J PHYSIOL, V257, pL109, DOI 10.1152/ajplung.1989.257.2.L109; Sanz P, 2008, CURR PROTEIN PEPT SC, V9, P478, DOI 10.2174/138920308785915254; Steinberg GR, 2009, FRONT BIOSCI-LANDMRK, V14, P1902, DOI 10.2741/3350; Su RY, 2007, MOL CANCER THER, V6, P1562, DOI 10.1158/1535-7163.MCT-06-0800; Utech M, 2005, MOL BIOL CELL, V16, P5040, DOI 10.1091/mbc.E05-03-0193; Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104	23	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12343	10.1371/journal.pone.0012343	http://dx.doi.org/10.1371/journal.pone.0012343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808811	Green Published, Green Submitted, gold			2022-12-25	WOS:000281153500023
J	Rajasekaran, S; Mi, TA; Merlin, JC; Oommen, A; Gradie, P; Schiller, MR				Rajasekaran, Sanguthevar; Mi, Tian; Merlin, Jerlin Camilus; Oommen, Aaron; Gradie, Patrick; Schiller, Martin R.			Partitioning of Minimotifs Based on Function with Improved Prediction Accuracy	PLOS ONE			English	Article							WIDE PREDICTION; MINER; TOOL	Background: Minimotifs are short contiguous peptide sequences in proteins that are known to have a function in at least one other protein. One of the principal limitations in minimotif prediction is that false positives limit the usefulness of this approach. As a step toward resolving this problem we have built, implemented, and tested a new data-driven algorithm that reduces false-positive predictions. Methodology/Principal Findings: Certain domains and minimotifs are known to be strongly associated with a known cellular process or molecular function. Therefore, we hypothesized that by restricting minimotif predictions to those where the minimotif containing protein and target protein have a related cellular or molecular function, the prediction is more likely to be accurate. This filter was implemented in Minimotif Miner using function annotations from the Gene Ontology. We have also combined two filters that are based on entirely different principles and this combined filter has a better predictability than the individual components. Conclusions/Significance: Testing these functional filters on known and random minimotifs has revealed that they are capable of separating true motifs from false positives. In particular, for the cellular function filter, the percentage of known minimotifs that are not removed by the filter is similar to 4.6 times that of random minimotifs. For the molecular function filter this ratio is similar to 2.9. These results, together with the comparison with the published frequency score filter, strongly suggest that the new filters differentiate true motifs from random background with good confidence. A combination of the function filters and the frequency score filter performs better than these two individual filters.	[Rajasekaran, Sanguthevar; Mi, Tian; Merlin, Jerlin Camilus; Oommen, Aaron] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA; [Gradie, Patrick; Schiller, Martin R.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA	University of Connecticut; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Rajasekaran, S (corresponding author), Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT 06269 USA.	rajasek@engr.uconn.edu; martin.schiller@unlv.edu		Schiller, Martin R/0000-0003-1671-6823	National Institutes of Health [GM079689]; National Science Foundation (NSF) [0829916]; University of Nevada Las Vegas; University of Connecticut; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079689] Funding Source: NIH RePORTER; Division of Computing and Communication Foundations [0829916] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); University of Nevada Las Vegas; University of Connecticut; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by National Institutes of Health grant number GM079689 to M.R.S., National Science Foundation (NSF) Grant 0829916 to S.R., by the University of Nevada Las Vegas, and by the University of Connecticut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; R Development Core Team, 2009, R FDN STAT COMP; Rajasekaran S, 2009, NUCLEIC ACIDS RES, V37, pD185, DOI 10.1093/nar/gkn865; Rodriguez MC, 2008, FRONT BIOSCI-LANDMRK, V13, P5905, DOI 10.2741/3125; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Via A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-351; Vyas J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-360; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yaffe MB, 2000, METHOD ENZYMOL, V328, P157, DOI 10.1016/S0076-6879(00)28397-3; Zhou SY, 1998, METH MOL B, V87, P87	15	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12276	10.1371/journal.pone.0012276	http://dx.doi.org/10.1371/journal.pone.0012276			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808856	Green Published, gold			2022-12-25	WOS:000281075500011
J	Firneisz, G; Varga, T; Lengyel, G; Feher, J; Ghyczy, D; Wichmann, B; Selmeci, L; Tulassay, Z; Racz, K; Somogyi, A				Firneisz, Gabor; Varga, Timea; Lengyel, Gabriella; Feher, Janos; Ghyczy, Dora; Wichmann, Barna; Selmeci, Laszlo; Tulassay, Zsolt; Racz, Karoly; Somogyi, Aniko			Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; ALANINE AMINOTRANSFERASE; IV ACTIVITY; SENSITIVITY; POPULATION; INHIBITION; PREVALENCE; CIRRHOSIS; PROTEIN; COHORT	Background: In a cross-sectional study we studied the fasting serum DPP-4 enzymatic activity (sDPP-4) and the insulin resistance index (HOMA2-IR) in gliptin naive patients with type 2 diabetes and in non-alcoholic fatty liver disease (NAFLD) and in healthy controls (CNTRL). Methods and Findings: sDPP-4 was measured by kinetic assay in 39 NAFLD (F/M: 19/20, mean age: 47.42 yrs) and 82 type 2 diabetes (F/M:48/34, 62.8 yrs) patients and 26 (F/M:14/12, 35.3 yrs) controls. Definition of T2D group as patients with type 2 diabetes but without clinically obvious liver disease created non-overlapping study groups. Diagnosis of NAFLD was based on ultrasonography and the exclusion of other etiololgy. Patients in T2D and NAFLD groups were similarly obese. 75 g CH OGTT in 39 NAFLD patients: 24-NGT, 4-IGT or IFG ("prediabetes''), 11-type 2 diabetes. HOMA2-IR: CNTRL: 1.44; T2D-group: 2.62 (p = 0.046 vs CNTRL, parametric tests); NAFLD(NGTonly): 3.23 (p = 0.0013 vs CNTRL); NAFLD(IFG/IGT/type 2 diabetes): 3.82 (p<0.001 vs CNTRL, p = 0.049 vs 2TD group). sDPP-4 activity was higher in NAFLD both with NGT (mean: 33.08U/L) and abnormal glucose metabolism (30.38U/L) than in CNTRL (25.89U/L, p<0.001 and p = 0.013) or in T2D groups (23.97U/L, p<0.001 and p = 0.004). Correlations in NAFLD among sDPP-4 and ALT: r = 0.4637, p = 0.0038 and gamma GT: r = 0.4991, p = 0.0017 and HOMA2-IR: r = 0.5295, p = 0.0026 and among HOMA2-IR and ALT: r = 0.4340, p = 0.0147 and gamma GT: r = 0.4128, p = 0.0210. Conclusions: The fasting serum DPP-4 activity was not increased in T2D provided that patients with liver disease were intentionally excluded. The high serum DPP-4 activities in NAFLD were correlated with liver tests but not with the fasting plasma glucose or HbA1C supporting that the excess is of hepatic origin and it might contribute to the speedup of metabolic deterioration. The correlation among cGT, ALT and serum DPP-4 activity and also between serum DPP-4 activity and HOMA2-IR in NAFLD strongly suggests that serum DPP-4 activity should be considered as a novel liver disease biomarker.	[Firneisz, Gabor; Varga, Timea; Lengyel, Gabriella; Feher, Janos; Ghyczy, Dora; Wichmann, Barna; Selmeci, Laszlo; Tulassay, Zsolt; Racz, Karoly; Somogyi, Aniko] Semmelweis Univ, Dept Med, H-1085 Budapest, Hungary	Semmelweis University	Firneisz, G (corresponding author), Semmelweis Univ, Dept Med, H-1085 Budapest, Hungary.	firneisz@bel2.sote.hu	Firneisz, Gabor/AAC-9654-2021	Firneisz, Gabor/0000-0002-9123-8131	Hungarian Liver Research Foundation [PD73606 OTKA, ETT-258/2009]; Hungarian Diabetes Association	Hungarian Liver Research Foundation; Hungarian Diabetes Association	This study was supported by the Szekelyhidi Miklos award of the Hungarian Liver Research Foundation, the PD73606 OTKA, the ETT-258/2009 grants and the Hungarian Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Andrieu T, 2003, J CLIN VIROL, V27, P59, DOI 10.1016/S1386-6532(02)00128-2; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Balaban YH, 2007, ANN HEPATOL, V6, P242, DOI 10.1016/S1665-2681(19)31905-2; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; de Marco R, 1999, DIABETES CARE, V22, P756, DOI 10.2337/diacare.22.5.756; Drucker DJ, 2007, DIABETES CARE, V30, P1335, DOI 10.2337/dc07-0228; Edgerton DS, 2009, DIABETES, V58, P243, DOI 10.2337/db08-0515; Firneisz G, 2001, SCAND J GASTROENTERO, V36, P877, DOI 10.1080/003655201750313423; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Gautier A, 2010, DIABETOLOGIA, V53, P247, DOI 10.1007/s00125-009-1602-6; Gorrell MD, 2001, SCAND J IMMUNOL, V54, P249, DOI 10.1046/j.1365-3083.2001.00984.x; Hanley AJG, 2007, DIABETES CARE, V30, P1819, DOI 10.2337/dc07-0086; Ioannou GN, 2003, GASTROENTEROLOGY, V125, P1053, DOI 10.1016/S0016-5085(03)01200-9; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Levy MT, 1999, HEPATOLOGY, V29, P1768, DOI 10.1002/hep.510290631; Mentzel S, 1996, J HISTOCHEM CYTOCHEM, V44, P445, DOI 10.1177/44.5.8627002; Pala L, 2005, DIABETOLOGIA, V48, P1168, DOI 10.1007/s00125-005-1749-8; Ryskjaer J, 2006, EUR J ENDOCRINOL, V155, P485, DOI 10.1530/eje.1.02221; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487	23	99	109	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12226	10.1371/journal.pone.0012226	http://dx.doi.org/10.1371/journal.pone.0012226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805868	Green Published, Green Submitted, gold			2022-12-25	WOS:000281011600010
J	Chen, JHK; Wong, KH; Chen, ZW; Chan, K; Lam, HY; To, SWC; Cheng, VCC; Yuen, KY; Yam, WC				Chen, Jonathan Hon-Kwan; Wong, Ka-Hing; Chen, Zhiwei; Chan, Kenny; Lam, Ho-Yin; To, Sabrina Wai-Chi; Cheng, Vincent Chi-Chung; Yuen, Kwok-Yung; Yam, Wing-Cheong			Increased Genetic Diversity of HIV-1 Circulating in Hong Kong	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; DRUG-USERS; SUBTYPE-B; CRF01-AE; INFECTION; ACCURACY	HIV-1 group M strains are characterized into 9 pure subtypes and 48 circulating recombinant forms (CRFs). Recent studies have identified the presence of new HIV-1 recombinants in Hong Kong and their complexity continues to increase. This study aims to characterize the HIV-1 genetic diversity in Hong Kong. Phylogenetic analyses were performed by using HIV-1 pol sequences including protease and partial reverse transcriptase isolated from 1045 local patients in Hong Kong from 2003 to 2008. For the pol sequences with unassigned genotype, the evidence of recombination was determined by using sliding-window based bootscan plots and their env C2V3 region were also sequenced. Epidemiological background of these patients was further collected. The pol phylogenetic analyses highlighted the extent of HIV-1 genetic diversity in Hong Kong. Subtype B (450/1045; 43.1%) and CRF01_AE (469/1045; 44.9%) variants were clearly predominant. Other genotypes (126/1045; 12.1%) including 3 defined subtypes, 10 CRFs, 1 unassigned subtype and 33 recombinants with 11 different mosaic patterns were observed. Recombinants of subtype B and CRF01_AE were mainly found among local Chinese MSM throughout 2004 to 2008, while the CRF02_AG and subtype G recombinants were circulating among non-Chinese Asian population in Hong Kong through heterosexual transmission starting from 2008. Our study demonstrated the complex recombination of HIV-1 in Hong Kong and the need in developing surveillance system for tracking the distribution of new HIV-1 genetic variants.	[Chen, Jonathan Hon-Kwan; Lam, Ho-Yin; To, Sabrina Wai-Chi; Cheng, Vincent Chi-Chung; Yuen, Kwok-Yung; Yam, Wing-Cheong] Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Chen, Jonathan Hon-Kwan; Chen, Zhiwei] Univ Hong Kong, AIDS Inst, Hong Kong, Hong Kong, Peoples R China; [Wong, Ka-Hing; Chan, Kenny] Ctr Hlth Protect, Special Prevent Programme, Integrated Treatment Ctr, Dept Hlth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Chen, JHK (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	wcyam@hkucc.hku.hk	Chen, Zhiwei/B-7793-2019	Chen, Zhiwei/0000-0002-4511-2888; CHENG, Vincent Chi-Chung/0000-0003-1765-7706; Yuen, Kwok-yung/0000-0002-2083-1552	Hong Kong Special Administrative Region Government [MSS-155R, MSS-164R]	Hong Kong Special Administrative Region Government	The study was supported by the AIDS Trust Fund of Hong Kong Special Administrative Region Government (Grant MSS-155R and MSS-164R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JHK, 2008, AIDS RES HUM RETROV, V24, P537, DOI 10.1089/aid.2007.0231; Chen JHK, 2007, J CLIN VIROL, V39, P125, DOI 10.1016/j.jcv.2007.03.008; Chen JHK, 2009, JAIDS-J ACQ IMM DEF, V51, P530, DOI 10.1097/QAI.0b013e3181aac516; Chen YJ, 2010, JAIDS-J ACQ IMM DEF, V53, P425, DOI 10.1097/QAI.0b013e3181ccba1a; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gueudin M, 2007, JAIDS-J ACQ IMM DEF, V44, P500, DOI 10.1097/QAI.0b013e31803260df; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Leitner T, 2005, HIV 1 SUBTYPE CIRCUL; Leung TWC, 2008, AIDS RES HUM RETROV, V24, P903, DOI 10.1089/aid.2007.0272; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; McCutchan FE, 2006, J MED VIROL, V78, pS7, DOI 10.1002/jmv.20599; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Thomson MM, 2005, AIDS REV, V7, P210; Xiridou M, 2007, JAIDS-J ACQ IMM DEF, V45, P468, DOI 10.1097/QAI.0b013e318093dea5; Zhang X, 2006, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2005/01/003	17	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12198	10.1371/journal.pone.0012198	http://dx.doi.org/10.1371/journal.pone.0012198			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808942	Green Published, gold			2022-12-25	WOS:000280968000022
J	De Franchi, E; Schalon, C; Messa, M; Onofri, F; Benfenati, F; Rognan, D				De Franchi, Enrico; Schalon, Claire; Messa, Mirko; Onofri, Franco; Benfenati, Fabio; Rognan, Didier			Binding of Protein Kinase Inhibitors to Synapsin I Inferred from Pair-Wise Binding Site Similarity Measurements	PLOS ONE			English	Article							SILICO PHARMACOLOGY; STRUCTURAL GENOMICS; DRUG DISCOVERY; ATP-BINDING; PHOSPHORYLATION; TARGETS; ACTIN; IDENTIFICATION; DOCKING; ROSCOVITINE	Predicting off-targets by computational methods is getting increasing importance in early drug discovery stages. We herewith present a computational method based on binding site three-dimensional comparisons, which prompted us to investigate the cross-reaction of protein kinase inhibitors with synapsin I, an ATP-binding protein regulating neurotransmitter release in the synapse. Systematic pair-wise comparison of the staurosporine-binding site of the protooncogene Pim-1 kinase with 6,412 druggable protein-ligand binding sites suggested that the ATP-binding site of synapsin I may recognize the pan-kinase inhibitor staurosporine. Biochemical validation of this hypothesis was realized by competition experiments of staurosporine with ATP-gamma S-35 for binding to synapsin I. Staurosporine, as well as three other inhibitors of protein kinases (cdk2, Pim-1 and casein kinase type 2), effectively bound to synapsin I with nanomolar affinities and promoted synapsin-induced F-actin bundling. The selective Pim-1 kinase inhibitor quercetagetin was shown to be the most potent synapsin I binder (IC50 = 0.15 mu M), in agreement with the predicted binding site similarities between synapsin I and various protein kinases. Other protein kinase inhibitors (protein kinase A and chk1 inhibitor), kinase inhibitors (diacylglycerolkinase inhibitor) and various other ATP-competitors (DNA topoisomerase II and HSP-90 alpha inhibitors) did not bind to synapsin I, as predicted from a lower similarity of their respective ATP-binding sites to that of synapsin I. The present data suggest that the observed downregulation of neurotransmitter release by some but not all protein kinase inhibitors may also be contributed by a direct binding to synapsin I and phosphorylation-independent perturbation of synapsin I function. More generally, the data also demonstrate that cross-reactivity with various targets may be detected by systematic pair-wise similarity measurement of ligand-annotated binding sites.	[De Franchi, Enrico; Messa, Mirko; Benfenati, Fabio] Italian Inst Technol, Dept Neurosci & Brain Technol, Genoa, Italy; [Schalon, Claire; Rognan, Didier] Univ Strasbourg, Lab Therapeut Innovat, CNRS, UMR 7200, Illkirch Graffenstaden, France; [Onofri, Franco; Benfenati, Fabio] Univ Genoa, Dept Expt Med, Genoa, Italy; [Onofri, Franco; Benfenati, Fabio] Ist Nazl Neurosci, Genoa, Italy	Istituto Italiano di Tecnologia - IIT; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Genoa	De Franchi, E (corresponding author), Italian Inst Technol, Dept Neurosci & Brain Technol, Genoa, Italy.	rognan@unistra.fr	Rognan, Didier/B-9939-2014		French Ministry of Research and Technology; Ministry of the University and Research; Compagnia di San Paolo Torino; Telethon-Italy [GCP09134]	French Ministry of Research and Technology; Ministry of the University and Research(Ministry of Education, Universities and Research (MIUR)); Compagnia di San Paolo Torino(Compagnia di San Paolo); Telethon-Italy(Fondazione Telethon)	The project was supported by the French Ministry of Research and Technology (Ph.D. grant to C. S.), the Ministry of the University and Research (PRIN 2008 grant), The Compagnia di San Paolo Torino and Telethon-Italy (GCP09134 grant to F. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ACC LTD, PIP PIL V7 5; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; BAHLER M, 1987, NATURE, V326, P704, DOI 10.1038/326704a0; BAHLER M, 1989, J CELL BIOL, V108, P1841, DOI 10.1083/jcb.108.5.1841; Bajorath J, 2008, CURR OPIN CHEM BIOL, V12, P352, DOI 10.1016/j.cbpa.2008.01.044; BENFENATI F, 1992, NATURE, V359, P417, DOI 10.1038/359417a0; BENFENATI F, 1992, NEURON, V8, P377, DOI 10.1016/0896-6273(92)90303-U; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonanomi D, 2005, J NEUROSCI, V25, P7299, DOI 10.1523/JNEUROSCI.1573-05.2005; Brautigam CA, 2004, J BIOL CHEM, V279, P11948, DOI 10.1074/jbc.M312015200; Brehmer D, 2005, CANCER RES, V65, P379; Cai JH, 2006, PROTEIN SCI, V15, P2071, DOI 10.1110/ps.062238406; Caron PR, 2001, CURR OPIN CHEM BIOL, V5, P464, DOI 10.1016/S1367-5931(00)00229-5; CECCALDI PE, 1995, J CELL BIOL, V128, P905, DOI 10.1083/jcb.128.5.905; *CHEMAXON KFT, 1037 CHEMAXON KFT; Chen YZ, 2001, PROTEINS, V43, P217, DOI 10.1002/1097-0134(20010501)43:2<217::AID-PROT1032>3.0.CO;2-G; Chi P, 2003, NEURON, V38, P69, DOI 10.1016/S0896-6273(03)00151-X; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; Dessailly BH, 2009, STRUCTURE, V17, P869, DOI 10.1016/j.str.2009.03.015; Do Quoc-Tuan, 2005, Curr Drug Discov Technol, V2, P161, DOI 10.2174/1570163054866873; Durrant JD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000648; Ekins S, 2007, BRIT J PHARMACOL, V152, P9, DOI 10.1038/sj.bjp.0707305; Esser L, 1998, EMBO J, V17, P977, DOI 10.1093/emboj/17.4.977; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fdez E, 2006, BRAIN CELL BIOL, V35, P107, DOI 10.1007/s11068-007-9013-4; Ferrara P, 2004, J MED CHEM, V47, P3032, DOI 10.1021/jm030489h; Gold ND, 2006, J MOL BIOL, V355, P1112, DOI 10.1016/j.jmb.2005.11.044; Grant S, 2009, CELL MOL LIFE SCI, V66, P1163, DOI 10.1007/s00018-008-8539-7; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Hilfiker S, 2005, J NEUROSCI, V25, P2658, DOI 10.1523/JNEUROSCI.4278-04.2005; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hosaka M, 1999, J BIOL CHEM, V274, P16747, DOI 10.1074/jbc.274.24.16747; Hosaka M, 1998, J BIOL CHEM, V273, P13371, DOI 10.1074/jbc.273.22.13371; Hosaka M, 1998, J BIOL CHEM, V273, P1425, DOI 10.1074/jbc.273.3.1425; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Jovanovic JN, 2001, J NEUROSCI, V21, P7944, DOI 10.1523/JNEUROSCI.21-20-07944.2001; Kao HT, 1999, J EXP ZOOL, V285, P360, DOI 10.1002/(SICI)1097-010X(19991215)285:4<360::AID-JEZ4>3.3.CO;2-V; Kao HT, 2002, NAT NEUROSCI, V5, P431, DOI 10.1038/nn840; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kellenberger E, 2006, J CHEM INF MODEL, V46, P717, DOI 10.1021/ci050372x; Kellenberger E, 2008, CURR COMPUT-AID DRUG, V4, P209, DOI 10.2174/157340908785747401; Kellenberger E, 2008, J CHEM INF MODEL, V48, P1014, DOI 10.1021/ci800023x; Kinnings SL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000423; Klabunde T, 2005, CHEMBIOCHEM, V6, P876, DOI 10.1002/cbic.200400369; Knockaert M, 2002, J BIOL CHEM, V277, P25493, DOI 10.1074/jbc.M202651200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lane-Guermonprez L, 2005, J NEUROCHEM, V93, P1401, DOI 10.1111/j.1471-4159.2005.03125.x; Li HL, 2006, NUCLEIC ACIDS RES, V34, pW219, DOI 10.1093/nar/gkl114; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin YC, 2002, J MED CHEM, V45, P4350, DOI 10.1021/jm020155c; MCGUINNESS TL, 1985, J BIOL CHEM, V260, P1696; Menegon A, 2006, J NEUROSCI, V26, P11670, DOI 10.1523/JNEUROSCI.3321-06.2006; Mestres J, 2006, J CHEM INF MODEL, V46, P2725, DOI 10.1021/ci600300k; *MOL NETW GMBH, D91052 MOL NETW GMBH; Morton D, 2009, ANGEW CHEM INT EDIT, V48, P104, DOI 10.1002/anie.200804486; Muller P, 2006, J MED CHEM, V49, P6768, DOI 10.1021/jm0606589; Nair Rajesh, 2009, Journal of Structural and Functional Genomics, V10, P181, DOI 10.1007/s10969-008-9055-6; Nettles JH, 2006, J MED CHEM, V49, P6802, DOI 10.1021/jm060902w; Nidhi, 2006, J CHEM INF MODEL, V46, P1124, DOI 10.1021/ci060003g; Nielsen TE, 2008, ANGEW CHEM INT EDIT, V47, P48, DOI 10.1002/anie.200703073; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Onofri F, 2007, J BIOL CHEM, V282, P15754, DOI 10.1074/jbc.M701051200; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Paul N, 2004, PROTEINS, V54, P671, DOI 10.1002/prot.10625; Peltason L, 2007, J MED CHEM, V50, P5571, DOI 10.1021/jm0705713; Rognan D, 2007, BRIT J PHARMACOL, V152, P38, DOI 10.1038/sj.bjp.0707307; Rognan D, 2010, MOL INFORM, V29, P176, DOI 10.1002/minf.200900081; Sakurada K, 2002, J BIOL CHEM, V277, P45473, DOI 10.1074/jbc.M206673200; Schalon C, 2008, PROTEINS, V71, P1755, DOI 10.1002/prot.21858; Schneider M, 2009, J PROTEOMICS, V72, P567, DOI 10.1016/j.jprot.2008.11.010; Schuster D, 2005, CURR PHARM DESIGN, V11, P3545, DOI 10.2174/138161205774414510; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Shoshan MC, 2008, EXPERT OPIN DRUG MET, V4, P273, DOI [10.1517/17425255.4.3.273, 10.1517/17425255.4.3.273 ]; Shulman-Peleg A, 2004, J MOL BIOL, V339, P607, DOI 10.1016/j.jmb.2004.04.012; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stauch B, 2009, P NATL ACAD SCI USA, V106, P12079, DOI 10.1073/pnas.0900979106; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Tang L, 2005, J BIOL CHEM, V280, P31220, DOI 10.1074/jbc.M500805200; Triballeau N, 2005, J MED CHEM, V48, P2534, DOI 10.1021/jm049092j; VALTORTA F, 1992, J BIOL CHEM, V267, P11281; Wallach I, 2009, BIOINFORMATICS, V25, pI296, DOI 10.1093/bioinformatics/btp204; Wang RX, 2004, J MED CHEM, V47, P2977, DOI 10.1021/jm030580l; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Weill N, 2010, J CHEM INF MODEL, V50, P123, DOI 10.1021/ci900349y; Weisel M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-7; Wermuth CG, 2006, DRUG DISCOV TODAY, V11, P348, DOI 10.1016/j.drudis.2006.02.006; Xie L, 2007, PLOS COMPUT BIOL, V3, P2324, DOI 10.1371/journal.pcbi.0030217; Xie L, 2008, P NATL ACAD SCI USA, V105, P5441, DOI 10.1073/pnas.0704422105; Yang L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000441; Yeturu K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-543; Zahler S, 2007, CHEM BIOL, V14, P1207, DOI 10.1016/j.chembiol.2007.10.010	95	65	67	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12214	10.1371/journal.pone.0012214	http://dx.doi.org/10.1371/journal.pone.0012214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808948	gold, Green Published, Green Submitted			2022-12-25	WOS:000280968000029
J	Dvorak-Ewell, M; Wendt, D; Hague, C; Christianson, T; Koppaka, V; Crippen, D; Kakkis, E; Vellard, M				Dvorak-Ewell, Melita; Wendt, Dan; Hague, Chuck; Christianson, Terri; Koppaka, Vish; Crippen, Danielle; Kakkis, Emil; Vellard, Michel			Enzyme Replacement in a Human Model of Mucopolysaccharidosis IVA In Vitro and Its Biodistribution in the Cartilage of Wild Type Mice	PLOS ONE			English	Article							N-ACETYLGALACTOSAMINE-6-SULFATE SULFATASE; MORQUIO-SYNDROME; KERATAN SULFATE; MATRIX COMPONENTS; MURINE MODEL; MPS IVA; DISEASE; DEFICIENCY; GENE; PURIFICATION	Mucopolysaccharidosis IVA (MPS IVA; Morquio A syndrome) is a lysosomal storage disorder caused by deficiency of N-acetylgalactosamine-6-sulfatase (GALNS), an enzyme that degrades keratan sulfate (KS). Currently no therapy for MPS IVA is available. We produced recombinant human (rh) GALNS as a potential enzyme replacement therapy for MPS IVA. Chinese hamster ovary cells stably overexpressing GALNS and sulfatase modifying factor-1 were used to produce active (similar to 2 U/mg) and pure (>= 97%) rhGALNS. The recombinant enzyme was phosphorylated and was dose-dependently taken up by mannose-6-phosphate receptor (K-uptake = 2.5 nM), thereby restoring enzyme activity in MPS IVA fibroblasts. In the absence of an animal model with a skeletal phenotype, we established chondrocytes isolated from two MPS IVA patients as a disease model in vitro. MPS IVA chondrocyte GALNS activity was not detectable and the cells exhibited KS storage up to 11-fold higher than unaffected chondrocytes. MPS IVA chondrocytes internalized rhGALNS into lysosomes, resulting in normalization of enzyme activity and decrease in KS storage. rhGALNS treatment also modulated gene expression, increasing expression of chondrogenic genes Collagen II, Collagen X, Aggrecan and Sox9 and decreasing abnormal expression of Collagen I. Intravenous administration of rhGALNS resulted in biodistribution throughout all layers of the heart valve and the entire thickness of the growth plate in wild-type mice. We show that enzyme replacement therapy with recombinant human GALNS results in clearance of keratan sulfate accumulation, and that such treatment ameliorates aberrant gene expression in human chondrocytes in vitro. Penetration of the therapeutic enzyme throughout poorly vascularized, but clinically relevant tissues, including growth plate cartilage and heart valve, as well as macrophages and hepatocytes in wild-type mouse, further supports development of rhGALNS as enzyme replacement therapy for MPS IVA.	[Dvorak-Ewell, Melita; Wendt, Dan; Hague, Chuck; Christianson, Terri; Koppaka, Vish; Kakkis, Emil; Vellard, Michel] BioMarin Pharmaceut Inc, Novato, CA USA; [Crippen, Danielle] Buck Inst, Novato, CA USA	BioMarin Pharmaceutical Inc.; Buck Institute for Research on Aging	Dvorak-Ewell, M (corresponding author), BioMarin Pharmaceut Inc, Novato, CA USA.	mvellard@bmrn.com			BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.	This study was funded by BioMarin Pharmaceutical Inc. the employer of all the authors except DC. The described study was a part of the drug development program at BioMarin. The internal publication review committee approved the manuscript for publication.	ANDERSON CE, 1962, J BONE JOINT SURG AM, V44, P295, DOI 10.2106/00004623-196244020-00006; Bank RA, 2009, MOL GENET METAB, V97, P196, DOI 10.1016/j.ymgme.2009.03.008; Beck M, 2001, J INHERIT METAB DIS, V24, P47, DOI 10.1023/A:1012463605992; BIELICKI J, 1995, BIOCHEM J, V311, P333, DOI 10.1042/bj3110333; Castaneda JA, 2008, ACTA NEUROPATHOL, V115, P159, DOI 10.1007/s00401-007-0296-4; CHAN D, 1995, J BIOL CHEM, V270, P1747, DOI 10.1074/jbc.270.4.1747; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; Dangel JH, 1998, EUR J PEDIATR, V157, P534, DOI 10.1007/s004310050872; De Franceschi L, 2007, OSTEOARTHR CARTILAGE, V15, P1311, DOI 10.1016/j.joca.2007.04.008; ELIMA K, 1989, FEBS LETT, V258, P195, DOI 10.1016/0014-5793(89)81651-5; ENGFELDT B, 1982, ACTA PAEDIATR SCAND, V71, P353, DOI 10.1111/j.1651-2227.1982.tb09434.x; FACTOR SM, 1978, VIRCHOWS ARCH A, V379, P1, DOI 10.1007/BF00432778; Fraldi A, 2007, BIOCHEM J, V403, P305, DOI 10.1042/BJ20061783; Funderburgh ML, 2008, MOL VIS, V14, P308; Gagne TA, 2000, J ORTHOPAED RES, V18, P882, DOI 10.1002/jor.1100180606; Goldring MB, 2006, BEST PRACT RES CL RH, V20, P1003, DOI 10.1016/j.berh.2006.06.003; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Grande-Allen KJ, 2004, GLYCOBIOLOGY, V14, P621, DOI 10.1093/glycob/cwh076; HAMMON JW, 1974, J THORAC CARDIOV SUR, V68, P352; HOLLISTER DW, 1975, JOHNS HOPKINS MED J, V137, P176; JOHN RM, 1990, ARCH DIS CHILD, V65, P746, DOI 10.1136/adc.65.7.746; Kakkis ED, 2002, EXPERT OPIN INV DRUG, V11, P675, DOI 10.1517/13543784.11.5.675; Landgrebe J, 2003, GENE, V316, P47, DOI 10.1016/S0378-1119(03)00746-7; MARODI L, 1995, BLOOD, V86, P4645, DOI 10.1182/blood.V86.12.4645.bloodjournal86124645; MASUE M, 1991, J BIOCHEM-TOKYO, V110, P965, DOI 10.1093/oxfordjournals.jbchem.a123697; MCCLURE J, 1986, PATHOLOGY, V18, P217, DOI 10.3109/00313028609059462; Melching LI, 1999, MATRIX BIOL, V18, P381, DOI 10.1016/S0945-053X(99)00033-5; MINAMI R, 1979, CLIN CHIM ACTA, V93, P207; MINAMI R, 1983, TOHOKU J EXP MED, V139, P321, DOI 10.1620/tjem.139.321; Montano AM, 2007, J INHERIT METAB DIS, V30, P165, DOI 10.1007/s10545-007-0529-7; MONTANO AM, 2008, IMPLICATIONS ABSENCE; Mundlos S, 1997, FASEB J, V11, P227, DOI 10.1096/fasebj.11.4.9068611; NEUFELD EF, 1995, METABOLIC MOL BASIS; Northover H, 1996, J INHERIT METAB DIS, V19, P357, DOI 10.1007/BF01799267; Peters C, 2003, BONE MARROW TRANSPL, V31, P229, DOI 10.1038/sj.bmt.1703839; SHIM SS, 1986, CLIN ORTHOP RELAT R, P119; STEVENS JM, 1991, J BONE JOINT SURG BR, V73, P851, DOI 10.1302/0301-620X.73B5.1910048; Tomatsu S, 2005, HUM MOL GENET, V14, P3321, DOI 10.1093/hmg/ddi364; Tomatsu S, 2003, HUM MOL GENET, V12, P3349, DOI 10.1093/hmg/ddg366; TOMATSU S, MOL THER; Tomatsu S, 2008, HUM MOL GENET, V17, P815, DOI 10.1093/hmg/ddm353; Tomatsu S, 2007, MOL GENET METAB, V91, P251, DOI 10.1016/j.ymgme.2007.02.009; Tomatsu S, 2007, MOL GENET METAB, V91, P69, DOI 10.1016/j.ymgme.2007.01.004; VANDIGGELEN OP, 1990, CLIN CHIM ACTA, V187, P131, DOI 10.1016/0009-8981(90)90339-T; Vogler C, 1987, Am J Med Genet Suppl, V3, P243	46	47	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12194	10.1371/journal.pone.0012194	http://dx.doi.org/10.1371/journal.pone.0012194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808938	gold, Green Published, Green Submitted			2022-12-25	WOS:000280968000019
J	Bate, R; Hess, K				Bate, Roger; Hess, Kimberly			Assessing Website Pharmacy Drug Quality: Safer Than You Think?	PLOS ONE			English	Article							RAMAN-SPECTROSCOPY	Background: Internet-sourced drugs are often considered suspect. The World Health Organization reports that drugs from websites that conceal their physical address are counterfeit in over 50 percent of cases; the U. S. Food and Drug Administration (FDA) works with the National Association of Boards of Pharmacy (NABP) to regularly update a list of websites likely to sell drugs that are illegal or of questionable quality. Methods and Findings: This study examines drug purchasing over the Internet, by comparing the sales of five popular drugs from a selection of websites stratified by NABP or other ratings. The drugs were assessed for price, conditions of purchase, and basic quality. Prices and conditions of purchase varied widely. Some websites advertised single pills while others only permitted the purchase of large quantities. Not all websites delivered the exact drugs ordered, some delivered no drugs at all; many websites shipped from multiple international locations, and from locations that were different from those advertised on the websites. All drug samples were tested against approved U. S. brand formulations using Raman spectrometry. Many (17) websites substituted drugs, often in different formulations from the brands requested. These drugs, some of which were probably generics or perhaps non-bioequivalent copy versions, could not be assessed accurately. Of those drugs that could be assessed, none failed from "approved", "legally compliant" or "not recommended" websites (0 out of 86), whereas 8.6% (3 out of 35) failed from "highly not recommended" and unidentifiable websites. Conclusions: Of those drugs that could be assessed, all except Viagra (R) passed spectrometry testing. Of those that failed, few could be identified either by a country of manufacture listed on the packaging, or by the physical location of the website pharmacy. If confirmed by future studies on other drug samples, then U. S. consumers should be able to reduce their risk by relying on credentialing agencies recommended lists and by using common sense when examining packaging and pills.	[Bate, Roger] Amer Enterprise Inst Publ Policy Res, Washington, DC 20036 USA; [Bate, Roger; Hess, Kimberly] Africa Fighting Malaria, Washington, DC USA	American Enterprise Institute for Public Policy Research	Bate, R (corresponding author), Amer Enterprise Inst Publ Policy Res, Washington, DC 20036 USA.	RBate@aei.org			Searle Freedom Trust; Legatum Institute; Legatum Foundation	Searle Freedom Trust; Legatum Institute; Legatum Foundation	The Searle Freedom Trust provided the initial grant and bulk of funding for this project. Subsequent funding was provided by the Legatum Institute and Legatum Foundation. The authors thank their funders for this support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bugay DE, 2010, APPL SPECTROSC, V64, P467, DOI 10.1366/000370210791211745; de Veij M, 2007, J RAMAN SPECTROSC, V38, P181, DOI 10.1002/jrs.1621; Deloitte Center for Health Solutions, 2009, 2009 SURV HLTH CAR C; *EUR COMM TAX CUST, 2005, REP COMM CUST ACT CO; Gryniewicz C.M., 2007, AM PHARM REV, V10, P24; *IMH HLTH, 2008, CHANN DISTR US SAL; *KAIS FAM FDN, 2008, PRESCR DRUG TRENDS; LIVINGSTON G, 2009, DAILY REFLECTOR 0603; *MARK MON, 2008, BRANDJ IND; *STAE FOOD DRUG AD, 2009, SDFA ISS 2009 1 SAF; *US FDA, 2007, FDA SAYS CONS CONT; US Government Accountability Office, 2004, INT PHARM SOM POS SA; WITKOWSKI M, 2005, USE RAMAN SPECTROSCO; 2004, WALL STREET J ONLINE, V3	14	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12199	10.1371/journal.pone.0012199	http://dx.doi.org/10.1371/journal.pone.0012199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730049	Green Published, gold			2022-12-25	WOS:000280862200030
J	Liao, MC; Hoos, MD; Aucoin, D; Ahmed, M; Davis, J; Smith, SO; Van Nostrand, WE				Liao, Mei-Chen; Hoos, Michael D.; Aucoin, Darryl; Ahmed, Mahiuddin; Davis, Judianne; Smith, Steven O.; Van Nostrand, William E.			N-terminal Domain of Myelin Basic Protein Inhibits Amyloid beta-Protein Fibril Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY CEREBRAL-HEMORRHAGE; ALZHEIMERS-DISEASE; TRANSGENIC MICE; IN-VITRO; CDNA CLONING; GENE; PRECURSOR; PEPTIDE; ANGIOPATHY; POLYPEPTIDE	Accumulation of amyloid beta-protein (A beta) into brain parenchymal plaques and the cerebral vasculature is a pathological feature of Alzheimer disease and related disorders. A beta peptides readily form beta-sheet-containing oligomers and fibrils. Previously, we reported a strong interaction between myelin basic protein (MBP) and A beta peptides that resulted in potent inhibition of fibril assembly (Hoos, M. D., Ahmed, M., Smith, S. O., and Van Nostrand, W. E. (2007) J. Biol. Chem. 282, 9952-9961; Hoos, M. D., Ahmed, M., Smith, S. O., and Van Nostrand, W. E. (2009) Biochemistry 48, 4720-4727). MBP is recognized as a highly post-translationally modified protein. In the present study, we demonstrate that human MBP purified from either brain or a bacterial recombinant expression system comparably bound to A beta and inhibited A beta fibril assembly indicating that post-translational modifications are not required for this activity. We also show that purified mouse brain MBP and recombinantly expressed mouse MBP similarly inhibited A beta fibril formation. Through a combination of biochemical and ultrastructural techniques, we demonstrate that the binding site for A beta is located in the N-terminal 64 amino acids of MBP and that a stable peptide (MBP1) comprising these residues was sufficient to inhibit A beta fibrillogenesis. Under conditions comparable with those used for A beta, the fibrillar assembly of amylin, another amyloidogenic peptide, was not inhibited by MBP1, although MBP1 still bound to it. This observation suggests that the potent inhibitory effect of MBP on fibril formation is not general to amyloidogenic peptides. Finally, MBP1 could prevent the cytotoxic effects of A beta in primary cortical neurons. Our findings suggest that inhibition of A beta fibril assembly by MBP, mediated through its N-terminal domain, could play a role in influencing amyloid formation in Alzheimer disease brain and corresponding mouse models.	[Van Nostrand, William E.] SUNY Stony Brook, Dept Neurosurg & Med, Stony Brook, NY 11794 USA; [Aucoin, Darryl; Ahmed, Mahiuddin; Smith, Steven O.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Van Nostrand, WE (corresponding author), SUNY Stony Brook, Dept Neurosurg, HSC T-12-089, Stony Brook, NY 11794 USA.	William.VanNostrand@stonybrook.edu	Smith, Steven/HDM-9496-2022		National Institutes of Health [NS35781, AG27317]; Alzheimer's Association [IIRG-06-26805]; Cure Alzheimer's Disease Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027317, RF1AG027317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Cure Alzheimer's Disease Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS35781 (to W. E. V. N.) and AG27317 (to S. O. S.). This work was also supported by Alzheimer's Association Grant IIRG-06-26805, a Collaborative MS Research Award, and a grant from the Cure Alzheimer's Disease Fund.	Abedini A, 2005, BIOCHEMISTRY-US, V44, P16284, DOI 10.1021/bi051432v; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; BARBARESE E, 1978, J NEUROCHEM, V31, P779, DOI 10.1111/j.1471-4159.1978.tb00110.x; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BETSHOLTZ C, 1989, EXP CELL RES, V183, P484, DOI 10.1016/0014-4827(89)90407-2; Brender JR, 2008, J AM CHEM SOC, V130, P6424, DOI 10.1021/ja710484d; BURDICK D, 1992, J BIOL CHEM, V267, P546; CAMPAGNONI AT, 1993, J BIOL CHEM, V268, P4930; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; DEFERRA F, 1985, R A CELL, V43, P721; Givogri MI, 2000, J NEUROSCI RES, V59, P153, DOI 10.1002/(SICI)1097-4547(20000115)59:2<153::AID-JNR1>3.3.CO;2-6; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Harauz G, 2004, MICRON, V35, P503, DOI 10.1016/j.micron.2004.04.005; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Hoos MD, 2007, J BIOL CHEM, V282, P9952, DOI 10.1074/jbc.M603494200; Hoos MD, 2009, BIOCHEMISTRY-US, V48, P4720, DOI 10.1021/bi900037s; HOPPENER JWM, 1994, J CELL BIOCHEM, V55, P39, DOI 10.1002/jcb.240550006; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; KAMHOLZ J, 1988, J NEUROSCI RES, V21, P62, DOI 10.1002/jnr.490210110; KAMINO K, 1992, AM J HUM GENET, V51, P998; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Miravalle L, 2000, J BIOL CHEM, V275, P27110; PIKE CJ, 1993, J NEUROSCI, V13, P1676; PRIBYL TM, 1993, P NATL ACAD SCI USA, V90, P10695, DOI 10.1073/pnas.90.22.10695; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; ROTH HJ, 1987, J NEUROSCI RES, V17, P321, DOI 10.1002/jnr.490170402; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Thal DR, 2003, J NEUROPATH EXP NEUR, V62, P1287, DOI 10.1093/jnen/62.12.1287; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; Van Nostrand WE, 2001, J BIOL CHEM, V276, P32860, DOI 10.1074/jbc.M104135200; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wilcock DM, 2008, J NEUROSCI, V28, P1537, DOI 10.1523/JNEUROSCI.5066-07.2008; WOOD DD, 1989, J BIOL CHEM, V264, P5121; Yoshiike Y, 2007, BIOCHEMISTRY-US, V46, P9805, DOI 10.1021/bi700455c; Zand R, 1998, BIOCHEMISTRY-US, V37, P2441, DOI 10.1021/bi972347t	44	22	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35590	35598		10.1074/jbc.M110.169599	http://dx.doi.org/10.1074/jbc.M110.169599			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20807757	Green Published, hybrid			2022-12-25	WOS:000283845300037
J	Chalabaev, S; Kim, TH; Ross, R; Derian, A; Kasper, DL				Chalabaev, Sabina; Kim, Tae-Hyun; Ross, Robin; Derian, Alec; Kasper, Dennis L.			3-Deoxy-D-manno-octulosonic Acid (Kdo) Hydrolase Identified in Francisella tularensis, Helicobacter pylori, and Legionella pneumophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; LIPID-A; SIALIC ACIDS; CELL-WALL; CAPSULAR POLYSACCHARIDE; RHAMNOGALACTURONAN-II; LIPOPOLYSACCHARIDE; ANTIGEN; BIOSYNTHESIS; SEQUENCES	3-Deoxy-D-manno-octulosonic acid (Kdo) is an eight-carbon sugar ubiquitous in Gram-negative bacterial lipopolysaccharides (LPS). Although its biosynthesis is well described, no protein has yet been identified as a Kdo hydrolase. However, Kdo hydrolase enzymatic activity has been detected in membranes of Helicobacter pylori and Francisella tularensis and may be responsible for the removal of side-chain Kdo from the LPS core saccharides. We now report the identification of genes encoding a Kdo hydrolase in F. tularensis Schu S4 and live vaccine strain strains, in H. pylori 26695 strain and in Legionella pneumophila Philadelphia 1 strain. We have renamed the genes kdhA for keto-deoxyoctulosonate hydrolase A. Deletion of kdhA abolished Kdo hydrolase activity in membranes of F. tularensis live vaccine strain. The F. tularensis kdhA mutant synthesized a core oligosaccharide containing a Kdo disaccharide with one of the Kdo residues being a terminal side chain. This side-chain Kdo monosaccharide was absent in the wild-type core oligosaccharide. Expression in Escherichia coli of recombinant KdhA from F. tularensis, H. pylori, and L. pneumophila resulted in a reduction of membrane-associated side-chain Kdo. The identification of this previously faceless enzyme will accelerate study of the biosynthetic basis and biologic impact for postbiosynthetic LPS structural modification.	[Chalabaev, Sabina; Kim, Tae-Hyun; Ross, Robin; Kasper, Dennis L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA; [Chalabaev, Sabina; Kim, Tae-Hyun; Ross, Robin; Derian, Alec; Kasper, Dennis L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kasper, DL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, 180 Longwood Ave, Boston, MA 02115 USA.	dennis_kasper@hms.harvard.edu			National Institutes of Health, NIAID [AI057159]; New England Center of Excellence in Biodefense and Emerging Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); New England Center of Excellence in Biodefense and Emerging Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI057159 from the NIAID (to D. L. K.). This work was also supported by the New England Center of Excellence in Biodefense and Emerging Infectious Disease.	Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Baron G S, 1995, Methods Mol Biol, V47, P149; BECKER B, 1989, EUR J BIOCHEM, V182, P153, DOI 10.1111/j.1432-1033.1989.tb14811.x; Bernard A, 2001, CURR PROTOC PROTEIN; BHATTACHARJEE AK, 1978, BIOCHEMISTRY-US, V17, P645, DOI 10.1021/bi00597a013; Cipolla Laura, 2009, Curr Drug Discov Technol, V6, P19; Delmas F, 2008, J EXP BOT, V59, P2639, DOI 10.1093/jxb/ern118; GALANOS C, 1985, EUR J BIOCHEM, V148, P1, DOI 10.1111/j.1432-1033.1985.tb08798.x; GHALAMBOR MA, 1966, J BIOL CHEM, V241, P3222; Girard R, 2003, J CELL SCI, V116, P293, DOI 10.1242/jcs.00212; Golovliov I, 2003, FEMS MICROBIOL LETT, V222, P273, DOI 10.1016/S0378-1097(03)00313-6; Gronow S, 2001, J ENDOTOXIN RES, V7, P3, DOI 10.1179/096805101101532468; Hardy E, 1997, ANAL BIOCHEM, V244, P28, DOI 10.1006/abio.1996.9719; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Kiang J, 1997, ANAL BIOCHEM, V245, P97, DOI 10.1006/abio.1996.9951; Kim TH, 2010, J BIOL CHEM, V285, P27839, DOI 10.1074/jbc.M110.143859; Lauriano CM, 2003, FEMS MICROBIOL LETT, V229, P195, DOI 10.1016/S0378-1097(03)00820-6; Lee EJ, 2007, PLANT CELL PHYSIOL, V48, P405, DOI 10.1093/pcp/pcm009; LENTER M, 1990, CARBOHYD RES, V197, P197, DOI 10.1016/0008-6215(90)84142-H; LESSE AJ, 1990, J IMMUNOL METHODS, V126, P109, DOI 10.1016/0022-1759(90)90018-Q; Li YT, 1997, J BIOL CHEM, V272, P26419, DOI 10.1074/jbc.272.42.26419; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Moll H, 1997, CARBOHYD RES, V304, P91, DOI 10.1016/S0008-6215(97)00210-3; Nimtz M, 1997, EUR J BIOCHEM, V250, P608, DOI 10.1111/j.1432-1033.1997.0608a.x; Palmer JD, 2004, AM J BOT, V91, P1437, DOI 10.3732/ajb.91.10.1437; PEREZPEREZ GI, 1995, INFECT IMMUN, V63, P1183; Phillips NJ, 2004, INFECT IMMUN, V72, P5340, DOI 10.1128/IAI.72.9.5340-5348.2004; Pupo E, 2007, ELECTROPHORESIS, V28, P2351, DOI 10.1002/elps.200600744; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; ROGGENTIN P, 1989, GLYCOCONJUGATE J, V6, P349, DOI 10.1007/BF01047853; SANDSTROM G, 1992, FEMS MICROBIOL IMMUN, V105, P201, DOI 10.1111/j.1574-6968.1992.tb05902.x; Sebastian S, 2007, INFECT IMMUN, V75, P2591, DOI 10.1128/IAI.01789-06; Stead C, 2005, J BACTERIOL, V187, P3374, DOI 10.1128/JB.187.10.3374-3383.2005; Stead CM, 2010, MOL MICROBIOL, V78, P837, DOI 10.1111/j.1365-2958.2010.07304.x; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Vinogradov E, 2002, EUR J BIOCHEM, V269, P6112, DOI 10.1046/j.1432-1033.2002.03321.x; Wang XY, 2006, BIOCHEMISTRY-US, V45, P14427, DOI 10.1021/bi061767s; Wang XY, 2004, J BIOL CHEM, V279, P49470, DOI 10.1074/jbc.M409078200; WARREN L, 1959, J BIOL CHEM, V234, P1971; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; YORK WS, 1985, CARBOHYD RES, V138, P109, DOI 10.1016/0008-6215(85)85228-9; Zahringer U, 1995, Prog Clin Biol Res, V392, P113; Zeleny R, 2006, PLANTA, V224, P222, DOI 10.1007/s00425-005-0206-8; Zhao JS, 2010, MOL MICROBIOL, V78, P820, DOI 10.1111/j.1365-2958.2010.07305.x	45	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34330	34336		10.1074/jbc.M110.166314	http://dx.doi.org/10.1074/jbc.M110.166314			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801884	Green Published, hybrid			2022-12-25	WOS:000283659100006
J	Hammad, MM; Kuang, YQ; Yan, R; Allen, H; Dupre, DJ				Hammad, Maha M.; Kuang, Yi-Qun; Yan, Ronald; Allen, Heather; Dupre, Denis J.			Na+/H+ Exchanger Regulatory Factor-1 Is Involved in Chemokine Receptor Homodimer CCR5 Internalization and Signal Transduction but Does Not Affect CXCR4 Homodimer or CXCR4-CCR5 Heterodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARATHYROID-HORMONE RECEPTOR; BINDING PHOSPHOPROTEIN-50 EBP50; PDZ DOMAINS; CELL-SURFACE; BETA(1)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; ACTIN REORGANIZATION; SCAFFOLD PROTEINS; ASSOCIATION; EZRIN	Chemokine receptors are members of the G protein-coupled receptor (GPCR) family. CCR5 is also the principal co-receptor for macrophage-tropic strains of human immunodeficiency virus, type 1 (HIV-1), and efforts have been made to develop ligands to inhibit HIV-1 infection by promoting CCR5 receptor endocytosis. Given the nature of GPCRs and their propensity to form oligomers, one can consider ligand-based therapies as unselective in terms of the oligomeric composition of complexes. For example, a ligand targeting a CCR5 homomer could likely induce signal transduction on a heteromeric CCR5-CXCR4. Other avenues could therefore be explored. We identified a receptor adaptor interacting specifically with one receptor complex but not others. NHERF1, an adaptor known for its role in desensitization, internalization, and regulation of the ERK signaling cascade for several GPCRs, interacts via its PDZ2 domain with the CCR5 homodimer but not with the CXCR4-CCR5 heterodimer or CXCR4 homodimer. To further characterize this interaction, we also show that NHERF1 increases the CCR5 recruitment of arrestin2 following stimulation. NHERF1 is also involved in CCR5 internalization, as we demonstrate that co-expression of constructs bearing the PDZ2 domain can block CCR5 internalization. We also show that NHERF1 potentiates RANTES (regulated on activation normal T cell expressed and secreted)-induced ERK1/2 phosphorylation via CCR5 activation and that this activation requires NHERF1 but not arrestin2. Taken together, our results suggest that oligomeric receptor complexes can associate specifically with partners and that in this case NHERF1 could represent an interesting new target for the regulation of CCR5 internalization and potentially HIV infection.	[Hammad, Maha M.; Kuang, Yi-Qun; Yan, Ronald; Allen, Heather; Dupre, Denis J.] Dalhousie Univ, Dept Pharmacol, Fac Med, Halifax, NS B3H 1X5, Canada	Dalhousie University	Dupre, DJ (corresponding author), Dalhousie Univ, Dept Pharmacol, Fac Med, Rm 6C,Sir Charles Tupper Med Bldg,5850 Coll St, Halifax, NS B3H 1X5, Canada.	denis.dupre@dal.ca	Dupre, Denis J/AAI-2631-2021; Kuang, Yi-Qun/AAW-4884-2021; Kuang, Yi-Qun/K-6161-2013	Dupre, Denis J/0000-0001-6401-6157; Kuang, Yi-Qun/0000-0002-1452-4388; Hammad, Maha/0000-0002-8974-8255	Canadian Institutes of Health Research [HOP-86863]; Natural Sciences and Engineering Research Council of Canada [EQPEQ-3591097-2008]; Canada Foundation for Innovation; Nova Scotia Health Research Foundation; Dalhousie Medical Research Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Nova Scotia Health Research Foundation; Dalhousie Medical Research Foundation	This work was supported in part by Canadian Institutes of Health Research Grant HOP-86863, Natural Sciences and Engineering Research Council of Canada Grant EQPEQ-3591097-2008, and Canada Foundation for Innovation (to D. J. D.).; Holds a Nova Scotia Health Research Foundation graduate student award.; Holds a Natural Sciences and Engineering Research Council of Canada undergraduate research award.; Recipient of a Canadian Institutes of Health Research New Investigator award and Dalhousie Medical Research Foundation New Investigator award.	Achour L, 2009, BLOOD, V113, P1938, DOI 10.1182/blood-2008-02-141275; Agrawal L, 2004, J VIROL, V78, P2277, DOI 10.1128/JVI.78.5.2277-2287.2004; Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Brady AE, 2002, CELL SIGNAL, V14, P297, DOI 10.1016/S0898-6568(01)00239-X; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Delhaye M, 2007, MOL PHARMACOL, V72, P1497, DOI 10.1124/mol.107.038422; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Di Marzio P, 2005, BIOCHEM BIOPH RES CO, V331, P909, DOI 10.1016/j.bbrc.2005.04.015; Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6; Fouassier L, 2000, J BIOL CHEM, V275, P25039, DOI 10.1074/jbc.C000092200; Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03; Harris BZ, 2001, J CELL SCI, V114, P3219; Heydorn A, 2004, J BIOL CHEM, V279, P54291, DOI 10.1074/jbc.M406169200; Hu C. D., 2005, CURR PROTOC PROTEIN, P19101; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Hu LYA, 2003, J BIOL CHEM, V278, P26295, DOI 10.1074/jbc.M212352200; Isik N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003424; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Lazar CS, 2004, MOL BIOL CELL, V15, P5470, DOI 10.1091/mbc.E04-03-0239; Lezcano N, 2000, SCIENCE, V287, P1660, DOI 10.1126/science.287.5458.1660; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Mayasundari A, 2008, BIOORG MED CHEM LETT, V18, P942, DOI 10.1016/j.bmcl.2007.12.038; Mohler PJ, 1999, J CELL BIOL, V147, P879, DOI 10.1083/jcb.147.4.879; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Morales FC, 2004, P NATL ACAD SCI USA, V101, P17705, DOI 10.1073/pnas.0407974101; Moyer BD, 2000, J BIOL CHEM, V275, P27069; Mueller A, 2004, EUR J BIOCHEM, V271, P243, DOI 10.1046/j.1432-1033.2003.03918.x; Murthy A, 1998, J BIOL CHEM, V273, P1273, DOI 10.1074/jbc.273.3.1273; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Rochdi MD, 2002, J BIOL CHEM, V277, P40751, DOI 10.1074/jbc.M207910200; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Schmieder S, 2004, J AM SOC NEPHROL, V15, P2289, DOI 10.1097/01.ASN.0000135968.49899.E8; Sheng M, 2000, J CELL SCI, V113, P1851; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shenolikar S, 2001, FEBS LETT, V489, P233, DOI 10.1016/S0014-5793(01)02109-3; Shenolikar S, 2001, AM J PHYSIOL-RENAL, V280, pF389, DOI 10.1152/ajprenal.2001.280.3.F389; Sneddon WB, 2007, ENDOCRINOLOGY, V148, P4073, DOI 10.1210/en.2007-0343; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sun C, 2005, J PEPT RES, V65, P411, DOI 10.1111/j.1399-3011.2005.00240.x; Wang B, 2008, MOL BIOL CELL, V19, P1637, DOI 10.1091/mbc.E07-11-1114; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903	50	31	33	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34653	34664		10.1074/jbc.M110.106591	http://dx.doi.org/10.1074/jbc.M110.106591			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801883	Green Published, hybrid			2022-12-25	WOS:000283659100041
J	Mermelekas, G; Georgopoulou, E; Kallis, A; Botou, M; Vlantos, V; Frillingos, S				Mermelekas, George; Georgopoulou, Ekaterini; Kallis, Alexander; Botou, Maria; Vlantos, Vassilios; Frillingos, Stathis			Cysteine-scanning Analysis of Helices TM8, TM9a, and TM9b and Intervening Loops in the YgfO Xanthine Permease A CARBOXYL GROUP IS ESSENTIAL AT ASP-276	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORTER SIGNATURE MOTIF; ESCHERICHIA-COLI; LACTOSE PERMEASE; FUNCTIONAL-CHARACTERIZATION; MEMBRANE-PROTEINS; BACTERIAL; FAMILY; SPECIFICITY; MUTAGENESIS; MECHANISM	Bacterial and fungal members of the ubiquitous nucleobase-ascorbate transporter (NAT/NCS2) family use the NAT signature motif, a conserved 11-amino acid sequence between amphipathic helices TM9a and TM9b, to define function and selectivity of the purine binding site. To examine the role of flanking helices TM9a, TM9b, and TM8, we employed Cys-scanning analysis of the xanthine-specific homolog YgfO from Escherichia coli. Using a functional mutant devoid of Cys residues (C-less), each amino acid residue in sequences (259)FLVVG-TIYLLSVLEAVGDITATAMVSRRPIQGEEYQSRLKGGVLAD-GLVSVIASAV(314) and (342)TIAVMLVILGLFP(354) including these TMs(underlined) was replaced individually with Cys, except the irreplaceable Glu-272 and Asp-304, which had been studied previously. Of 67 single Cys mutants, 55 accumulate xanthine to 35-140% of the steady state observed with C-less, five (I265C, D276C, I277C, G299C, L350C) accumulate to low levels (10-20%) and seven (T278C, A279C, T280C, A281C, G305C, G351C, P354C) show negligible expression in the membrane. Extensive mutagenesis reveals that a carboxyl group is needed at Asp-276 for high activity and that D276E differs from wild type as it recognizes 8-methylxanthine (K-t 79 mu M) but fails to recognize 2-thioxanthine, 3-methylxanthine or 6-thioxanthine; bulky replacements of Ala-279 or Thr-280 and replacements of Gly-305, Gly-351, or Pro-354 impair activity or expression. Single Cys mutants V261C, A273C, G275C, and S284C are sensitive to inactivation by N-ethylmaleimide and sensitivity of G275C(IC50 15 mu M) is enhanced in the presence of substrate. The data suggest that residues crucial for the transport mechanism cluster in two conserved motifs, at the cytoplasmic end of TM8 (EXXG-DXXAT) and in TM9a (GXXXDG).	[Mermelekas, George; Georgopoulou, Ekaterini; Kallis, Alexander; Botou, Maria; Vlantos, Vassilios; Frillingos, Stathis] Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece	University of Ioannina	Frillingos, S (corresponding author), Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece.	efriligo@cc.uoi.gr	Frillingos, Stathis/AAQ-3148-2021; Kallis, Aristotle/A-5717-2016		Greek Ministry of Development, General Secretariat for Research and Technology; European Union	Greek Ministry of Development, General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); European Union(European Commission)	This work is part of the 03ED204 research project, implemented within the framework of the "Reinforcement Programme of Human Research Manpower" (PENED) and co-financed by National and Community Funds (25% from the Greek Ministry of Development, General Secretariat for Research and Technology, and 75% from the European Union European Social Fund).	Diallinas G, 1998, EMBO J, V17, P3827, DOI 10.1093/emboj/17.14.3827; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Frillingos S, 1996, BIOCHEMISTRY-US, V35, P10166, DOI 10.1021/bi960995r; Georgopoulou E, 2010, J BIOL CHEM, V285, P19422, DOI 10.1074/jbc.M110.120543; Gournas C, 2008, MOL BIOSYST, V4, P404, DOI 10.1039/b719777b; Granseth E, 2005, J MOL BIOL, V352, P489, DOI 10.1016/j.jmb.2005.07.053; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Karatza P, 2005, MOL MEMBR BIOL, V22, P251, DOI 10.1080/09687860500092927; Karatza P, 2006, J BIOL CHEM, V281, P39881, DOI 10.1074/jbc.M605748200; Karena E, 2009, J BIOL CHEM, V284, P24257, DOI 10.1074/jbc.M109.030734; Kosti V, 2010, J MOL BIOL, V397, P1132, DOI 10.1016/j.jmb.2010.02.037; Koukaki M, 2005, J MOL BIOL, V350, P499, DOI 10.1016/j.jmb.2005.04.076; Kulikowska E, 2004, ACTA BIOCHIM POL, V51, P493; Papageorgiou L, 2008, J MOL BIOL, V382, P1121, DOI 10.1016/j.jmb.2008.08.005; Papakostas K, 2008, J BIOL CHEM, V283, P13666, DOI 10.1074/jbc.M800261200; Sahin-Toth M, 2000, P NATL ACAD SCI USA, V97, P10729, DOI 10.1073/pnas.200351797; Tamura N, 2001, J BIOL CHEM, V276, P20330, DOI 10.1074/jbc.M007993200; TEATHER RM, 1980, EUR J BIOCHEM, V108, P223, DOI 10.1111/j.1432-1033.1980.tb04715.x; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Velho AM, 2009, EXP CELL RES, V315, P2312, DOI 10.1016/j.yexcr.2009.04.007; Weinglass AB, 2002, J MOL BIOL, V315, P561, DOI 10.1006/jmbi.2001.5289; Weinglass AB, 2001, BIOCHEMISTRY-US, V40, P769, DOI 10.1021/bi002171m; Yamamoto S, 2010, J BIOL CHEM, V285, P6522, DOI 10.1074/jbc.M109.032961; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	24	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35011	35020		10.1074/jbc.M110.170415	http://dx.doi.org/10.1074/jbc.M110.170415			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20802252	Green Published, hybrid			2022-12-25	WOS:000283659100075
J	Nonaka, T; Watanabe, ST; Iwatsubo, T; Hasegawa, M				Nonaka, Takashi; Watanabe, Sayuri T.; Iwatsubo, Takeshi; Hasegawa, Masato			Seeded Aggregation and Toxicity of alpha-Synuclein and Tau CELLULAR MODELS OF NEURODEGENERATIVE DISEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; HUMAN BRAIN; PROTEIN; FILAMENTS; TRANSMISSION; INCLUSIONS; MECHANISM	The deposition of amyloid-like filaments in the brain is the central event in the pathogenesis of neurodegenerative diseases. Here we report cellular models of intracytoplasmic inclusions of alpha-synuclein, generated by introducing nucleation seeds into SH-SY5Y cells with a transfection reagent. Upon introduction of preformed seeds into cells overexpressing alpha-synuclein, abundant, highly filamentous alpha-synuclein-positive inclusions, which are extensively phosphorylated and ubiquitinated and partially thioflavin-positive, were formed within the cells. SH-SY5Y cells that formed such inclusions underwent cell death, which was blocked by small molecular compounds that inhibit beta-sheet formation. Similar seed-dependent aggregation was observed in cells expressing four-repeat Tau by introducing four-repeat Tau fibrils but not three-repeat Tau fibrils or alpha-synuclein fibrils. No aggregate formation was observed in cells overexpressing three-repeat Tau upon treatment with four-repeat Tau fibrils. Our cellular models thus provide evidence of nucleation-dependent and protein-specific polymerization of intracellular amyloid-like proteins in cultured cells.	[Nonaka, Takashi] Tokyo Inst Psychiat, Dept Mol Neurobiol, Setagaya Ku, Tokyo 1568585, Japan; [Watanabe, Sayuri T.; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo 1130033, Japan; [Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropathol, Tokyo 1130033, Japan	Tokyo Institute of Psychiatry; University of Tokyo; University of Tokyo	Nonaka, T (corresponding author), Tokyo Inst Psychiat, Dept Mol Neurobiol, Setagaya Ku, 2-1-8 Kamikitazawa, Tokyo 1568585, Japan.	nonaka-tk@igakuken.or.jp; hasegawa-ms@igakuken.or.jp	Nonaka, Takashi/L-8572-2017	Nonaka, Takashi/0000-0002-0830-9403	Ministry of Education, Culture, Sports, Science, and Technology of Japan [19590297, 22500345]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research on Priority Areas, Research on Pathomechanisms of Brain Disorders (to T. I. and M. H.) and Grant-in-aid for Scientific Research (C) 19590297 and 22500345 (to T.N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Goedert M, 1998, CURR OPIN NEUROBIOL, V8, P619, DOI 10.1016/S0959-4388(98)80090-1; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NGUYEN JT, 1995, J MOL BIOL, V252, P412, DOI 10.1006/jmbi.1995.0507; Nonaka T, 2005, BIOCHEMISTRY-US, V44, P361, DOI 10.1021/bi0485528; Nonaka T, 2009, BIOCHEMISTRY-US, V48, P8014, DOI 10.1021/bi900619j; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Olesen OF, 1997, MOL BRAIN RES, V44, P105, DOI 10.1016/S0169-328X(96)00196-9; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Yonetani M, 2009, J BIOL CHEM, V284, P7940, DOI 10.1074/jbc.M807482200; Zerbinatti CV, 2006, J BIOL CHEM, V281, P36180, DOI 10.1074/jbc.M604436200	42	231	239	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34885	34898		10.1074/jbc.M110.148460	http://dx.doi.org/10.1074/jbc.M110.148460			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20805224	hybrid, Green Published			2022-12-25	WOS:000283659100063
J	Ehsanian, R; Brown, M; Lu, H; Yang, XP; Pattatheyil, A; Yan, B; Duggal, P; Chuang, R; Doondeea, J; Feller, S; Sudol, M; Chen, Z; Van Waes, C				Ehsanian, R.; Brown, M.; Lu, H.; Yang, X. P.; Pattatheyil, A.; Yan, B.; Duggal, P.; Chuang, R.; Doondeea, J.; Feller, S.; Sudol, M.; Chen, Z.; Van Waes, C.			YAP dysregulation by phosphorylation or Delta Np63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets	ONCOGENE			English	Article						YAP; p53; Delta Np63; p73; apoptosis; cancer	SQUAMOUS-CELL CARCINOMA; YES-ASSOCIATED PROTEIN; NF-KAPPA-B; GROWTH-FACTOR-RECEPTOR; TUMOR-SUPPRESSOR; WW DOMAIN; PROANGIOGENIC CYTOKINES; HIPPO PATHWAY; DNA-DAMAGE; ACTIVATION	Overexpression of the Yes-associated protein (YAP), and TP53 family members Delta Np63 and p73, have been independently detected in subsets of head and neck squamous cell carcinomas (HNSCCs). YAP may serve as a nuclear cofactor with Delta Np63 and p73, but the functional role of YAP and their potential relationship in HNSCCs are unknown. In this study, we show that in a subset of HNSCC lines and tumors, YAP expression is increased but localized in the cytoplasm in association with increased AKT and YAP phosphorylation, and with decreased expression of Delta Np63 and p73. In another subset, YAP expression is decreased but detectable in the nucleus in association with lower AKT and YAP phosphorylation, and with increased Delta Np63 and p73 expression. Inhibiting AKT decreased serine-127 phosphorylation and enhanced nuclear translocation of YAP. Delta Np63 bound to the YAP promoter and suppressed its expression. Transfection of a YAP-serine-127-alanine phosphoacceptor-site mutant or Delta Np63 knockdown significantly increased nuclear YAP and cell death. Conversely, YAP knockdown enhanced cell proliferation, survival, migration and cisplatin chemoresistance. Thus, YAP function as a tumor suppressor may alternatively be dysregulated by AKT phosphorylation at serine-127 and cytoplasmic sequestration, or by transcriptional repression by Delta Np63, in different subsets of HNSCC. AKT and/or Delta Np63 are potential targets for enhancing YAP-mediated apoptosis and chemosensitivity in HNSCCs. Oncogene (2010) 29, 6160-6171; doi:10.1038/onc.2010.339; published online 23 August 2010	[Ehsanian, R.; Brown, M.; Lu, H.; Yang, X. P.; Pattatheyil, A.; Yan, B.; Duggal, P.; Chuang, R.; Chen, Z.; Van Waes, C.] Natl Inst Deafness & Other Commun Disorders, Tumor Biol Sect, Head & Neck Surg Branch, NIH, Bethesda, MD USA; [Ehsanian, R.] Howard Hughes Med Inst, Natl Inst Hlth Res Scholars Program, Bethesda, MD 20817 USA; [Ehsanian, R.] NIH Oxford Univ Stanford Univ, Sch Med, Grad Partnership Program, NIH, Bethesda, MD USA; [Brown, M.] NIH, NIH Pfizer Clin Res Training Program, Bethesda, MD USA; [Doondeea, J.; Feller, S.] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Sudol, M.] Weis Ctr Res, Geisinger Clin, Lab Signal Transduct & Prote Profiling, Danville, PA 17822 USA; [Sudol, M.] Mt Sinai Sch Med, Dept Med, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; Pfizer; University of Oxford; Icahn School of Medicine at Mount Sinai	Van Waes, C (corresponding author), NIDCD, Head & Neck Surg Branch, NIH, 10-5D55,MSC 1419, Bethesda, MD 20892 USA.	vanwaesc@nidcd.nih.gov		Brown, Matthew/0000-0003-0575-3696; Lu, Hai/0000-0002-4212-3282; /0000-0002-2168-3379	NIDCD [Z1ADC-000073, Z1ADC-000074]; Head and Neck Cancer Charity; Pennsylvania Department of Health; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000073] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Head and Neck Cancer Charity; Pennsylvania Department of Health; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank Drs Tsutomu Oka, Maie St John and Ms Cindy Clark for their critical review; Ning Yeh, Dr Liesl Nottingham, Dr Jay Friedman, Dr Yansong Bian and Jonah Cohen for technical assistance; and Dr Paul Albert for assistance with statistical analysis. This study was supported by the NIDCD Intramural project Z1ADC-000073, Z1ADC-000074, Head and Neck Cancer Charity Grant and the Breast Cancer Coalition Grant from the Pennsylvania Department of Health.	Amornphimoltham P, 2004, CLIN CANCER RES, V10, P4029, DOI 10.1158/1078-0432.CCR-03-0249; Amornphimoltham P, 2008, CLIN CANCER RES, V14, P8094, DOI 10.1158/1078-0432.CCR-08-0703; Baldwin C, 2005, CANCER RES, V65, P7561, DOI 10.1158/0008-5472.CAN-05-1513; Bancroft CC, 2002, INT J CANCER, V99, P538, DOI 10.1002/ijc.10398; Barbieri CE, 2006, EXP CELL RES, V312, P695, DOI 10.1016/j.yexcr.2005.11.028; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bertini E, 2009, CELL CYCLE, V8, P49, DOI 10.4161/cc.8.1.7259; Bian YS, 2009, CANCER RES, V69, P5918, DOI 10.1158/0008-5472.CAN-08-4623; CAREY TE, 1993, ANTICANCER RES, V13, P2561; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chen Z, 1999, CLIN CANCER RES, V5, P1369; Danovi SA, 2008, CELL DEATH DIFFER, V15, P217, DOI 10.1038/sj.cdd.4402226; Dong G, 1997, J CELL BIOCHEM, P90; Dong G, 2001, CANCER RES, V61, P4797; Dong G, 2001, CANCER RES, V61, P5911; Downward J, 2008, MOL CELL, V32, P749, DOI 10.1016/j.molcel.2008.12.002; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Friedman J, 2007, CLIN CANCER RES, V13, P6568, DOI 10.1158/1078-0432.CCR-07-1591; Howell M, 2004, J BIOL CHEM, V279, P26300, DOI 10.1074/jbc.M401070200; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Lee TL, 2008, INT J CANCER, V122, P1987, DOI 10.1002/ijc.23324; Lee TL, 2007, CLIN CANCER RES, V13, P5680, DOI 10.1158/1078-0432.CCR-07-0670; Lee TL, 2006, MOL CANCER THER, V5, P8, DOI 10.1158/1535-7163.MCT-05-0069; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Massarelli E, 2005, CANCER-AM CANCER SOC, V104, P2430, DOI 10.1002/cncr.21476; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Molinolo AA, 2007, CLIN CANCER RES, V13, P4964, DOI 10.1158/1078-0432.CCR-07-1041; Moral M, 2009, CANCER RES, V69, P1099, DOI 10.1158/0008-5472.CAN-08-3240; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Rocco JW, 2006, CELL CYCLE, V5, P936, DOI 10.4161/cc.5.9.2716; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Rosenbluth JM, 2008, GENE DEV, V22, P2591, DOI 10.1101/gad.1727408; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; SUDOL M, 1994, ONCOGENE, V9, P2145; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Thurfjell N, 2005, INT J MOL MED, V16, P1065; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Worden B, 2005, CANCER RES, V65, P7071, DOI 10.1158/0008-5472.CAN-04-0989; Yan B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r78; Yu M, 2006, CANCER RES, V66, P6722, DOI 10.1158/0008-5472.CAN-05-3758; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	52	79	83	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	46					6160	6171		10.1038/onc.2010.339	http://dx.doi.org/10.1038/onc.2010.339			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	681XD	20729916	Green Accepted			2022-12-25	WOS:000284356500008
J	Fujimoto, Z; Ichinose, H; Maehara, T; Honda, M; Kitaoka, M; Kaneko, S				Fujimoto, Zui; Ichinose, Hitomi; Maehara, Tomoko; Honda, Mariko; Kitaoka, Motomitsu; Kaneko, Satoshi			Crystal Structure of an Exo-1,5-alpha-L-arabinofuranosidase from Streptomyces avermitilis Provides Insights into the Mechanism of Substrate Discrimination between Exo- and Endo-type Enzymes in Glycoside Hydrolase Family 43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-L-ARABINOFURANOSIDASE; CARBOHYDRATE-BINDING MODULE; GEOBACILLUS-STEAROTHERMOPHILUS; CATALYTIC RESIDUES; ASPERGILLUS-NIGER; ARABINANASE 43A; PURIFICATION; ARABINOSE; SPECIFICITY; REVEALS	Exo-1,5-alpha-L-arabinofuranosidases belonging to glycoside hydrolase family 43 have strict substrate specificity. These enzymes hydrolyze only the alpha-1,5-linkages of linear arabinan and arabino-oligosaccharides in an exo-acting manner. The enzyme from Streptomyces avermitilis contains a core catalytic domain belonging to glycoside hydrolase family 43 and a C-terminal arabinan binding module belonging to carbohydrate binding module family 42. We determined the crystal structure of intact exo-1,5-alpha-L-arabinofuranosidase. The catalytic module is composed of a 5-bladed beta-propeller topologically identical to the other family 43 enzymes. The arabinan binding module had three similar subdomains assembled against one another around a pseudo-3-fold axis, forming a beta-trefoil-fold. A sugar complex structure with alpha-1,5-L-arabinofuranotriose revealed three subsites in the catalytic domain, and a sugar complex structure with alpha-L-arabinofuranosyl azide revealed three arabinose-binding sites in the carbohydrate binding module. A mutagenesis study revealed that substrate specificity was regulated by residues Asn-159, Tyr-192, and Leu-289 located at the aglycon side of the substrate-binding pocket. The exo-acting manner of the enzyme was attributed to the strict pocket structure of subsite -1, formed by the flexible loop region Tyr-281-Arg-294 and the side chain of Tyr-40, which occupied the positions corresponding to the catalytic glycon cleft of GH43 endo-acting enzymes.	[Ichinose, Hitomi; Maehara, Tomoko; Honda, Mariko; Kitaoka, Motomitsu; Kaneko, Satoshi] Natl Food Res Inst, Food Biotechnol Div, Tsukuba, Ibaraki 3058642, Japan; [Fujimoto, Zui] Natl Inst Agrobiol Sci, Prot Res Unit, Tsukuba, Ibaraki 3058602, Japan	National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; National Institute of Agrobiological Sciences - Japan	Kaneko, S (corresponding author), Natl Food Res Inst, Food Biotechnol Div, 2-1-12 Kannondai, Tsukuba, Ibaraki 3058642, Japan.	sakaneko@affrc.go.jp	Kitaoka, Motomitsu/R-1536-2019	Kitaoka, Motomitsu/0000-0002-0083-1838; Fujimoto, Zui/0000-0002-3551-6854	Ministry of Agriculture, Forestry, and Fisheries of Japan	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported, in part, by a grant-in-aid (Development of Biomass Utilization Technologies for Revitalizing Rural Areas) from the Ministry of Agriculture, Forestry, and Fisheries of Japan.	Aristidou A, 2000, CURR OPIN BIOTECH, V11, P187, DOI 10.1016/S0958-1669(00)00085-9; Beisel HG, 1999, EMBO J, V18, P2313, DOI 10.1093/emboj/18.9.2313; Berlin W, 1996, ANAL BIOCHEM, V243, P171, DOI 10.1006/abio.1996.0497; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujimoto Z, 2002, J MOL BIOL, V316, P65, DOI 10.1006/jmbi.2001.5338; Fujimoto Z, 2008, ACTA CRYSTALLOGR F, V64, P1007, DOI 10.1107/S1744309108029692; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Ichinose H, 2005, J BIOL CHEM, V280, P25820, DOI 10.1074/jbc.M501024200; Ichinose H, 2008, APPL MICROBIOL BIOT, V80, P399, DOI 10.1007/s00253-008-1551-x; Ichinose H, 2009, J BIOL CHEM, V284, P25097, DOI 10.1074/jbc.M109.022723; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaneko S, 1998, BIOSCI BIOTECH BIOCH, V62, P695, DOI 10.1271/bbb.62.695; KANEKO S, 1993, BIOSCI BIOTECH BIOCH, V57, P1161, DOI 10.1271/bbb.57.1161; KANEKO S, 1994, APPL ENVIRON MICROB, V60, P3425, DOI 10.1128/AEM.60.9.3425-3428.1994; KANEKO S, 1995, BIOSCI BIOTECH BIOCH, V59, P2132, DOI 10.1271/bbb.59.2132; Kaneko S, 1998, APPL ENVIRON MICROB, V64, P4021; Kaneko S, 1998, BIOSCI BIOTECH BIOCH, V62, P2205, DOI 10.1271/bbb.62.2205; Kaneko S, 1998, J FERMENT BIOENG, V85, P518, DOI 10.1016/S0922-338X(98)80073-1; KAWABATA Y, 1995, CARBOHYD RES, V267, P39, DOI 10.1016/0008-6215(94)00290-V; Matsuo N, 2000, BIOCHEM J, V346, P9, DOI 10.1042/0264-6021:3460009; Miyanaga A, 2004, J BIOL CHEM, V279, P44907, DOI 10.1074/jbc.M405390200; Miyanaga A, 2006, BIOCHEM J, V399, P503, DOI 10.1042/BJ20060567; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; Nurizzo D, 2002, NAT STRUCT BIOL, V9, P665, DOI 10.1038/nsb835; Osaki S, 2001, J NUTR, V131, P796, DOI 10.1093/jn/131.3.796; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pitson SM, 1996, FEBS LETT, V398, P7, DOI 10.1016/S0014-5793(96)01153-2; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Sanai K., 1997, Nippon Eiyo Shokuryo Gakkaishi = Journal of the Japanese Society of Nutrition and Food Science, V50, P133; Seri K, 1996, METABOLISM, V45, P1368, DOI 10.1016/S0026-0495(96)90117-1; Shallom D, 2005, BIOCHEMISTRY-US, V44, P387, DOI 10.1021/bi048059w; SKOOG K, 1988, ENZYME MICROB TECH, V10, P66, DOI 10.1016/0141-0229(88)90001-4; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Vandermarliere E, 2009, BIOCHEM J, V418, P39, DOI 10.1042/BJ20081256; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	40	35	36	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34134	34143		10.1074/jbc.M110.164251	http://dx.doi.org/10.1074/jbc.M110.164251			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20739278	hybrid, Green Published			2022-12-25	WOS:000283354000059
J	Gerin, I; Clerbaux, LA; Haumont, O; Lanthier, N; Das, AK; Burant, CF; Leclercq, IA; MacDougald, OA; Bommer, GT				Gerin, Isabelle; Clerbaux, Laure-Alix; Haumont, Olivier; Lanthier, Nicolas; Das, Arun K.; Burant, Charles F.; Leclercq, Isabelle A.; MacDougald, Ormond A.; Bommer, Guido T.			Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL TRIFUNCTIONAL PROTEIN; DENSITY-LIPOPROTEIN CHOLESTEROL; HEPATIC STEATOSIS; TRANSGENIC MICE; MESSENGER-RNAS; MALONYL-COA; ABCA1 GENE; MICRORNAS; EFFLUX; REPRESSION	The regulation of synthesis, degradation, and distribution of lipids is crucial for homeostasis of organisms and cells. The sterol regulatory element-binding protein (SREBP) transcription factor family is post-translationally activated in situations of reduced lipid abundance and activates numerous genes involved in cholesterol, fatty acid, and phospholipid synthesis. In this study, we provide evidence that the primary transcript of SREBP2 contains an intronic miRNA (miR-33) that reduces cellular cholesterol export via inhibition of translation of the cholesterol export pump ABCA1. Notably, miR-33 also inhibits translation of several transcripts encoding proteins involved in fatty acid beta-oxidation including CPT1A, HADHB, and CROT, thereby reducing fatty acid degradation. The genetic locus encoding SREBP2 and miR-33 therefore contains a protein that increases lipid synthesis and a miRNA that prevents export and degradation of newly synthesized lipids. These results add an additional layer of complexity to our understanding of lipid homeostasis and might open possibilities for future therapeutic intervention.	[Bommer, Guido T.] Catholic Univ Louvain, Physiol Chem Lab, de Duve Inst, B-1200 Brussels, Belgium; [Lanthier, Nicolas; Leclercq, Isabelle A.] Catholic Univ Louvain, Dept Gastroenterol, B-1200 Brussels, Belgium; [Das, Arun K.; Burant, Charles F.; MacDougald, Ormond A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Universite Catholique Louvain; Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Michigan System; University of Michigan	Bommer, GT (corresponding author), Catholic Univ Louvain, Physiol Chem Lab, de Duve Inst, Ave Hippocrate 75, B-1200 Brussels, Belgium.	guido.bommer@uclouvain.be	Burant, Charles/GPC-5690-2022; Lanthier, Nicolas/AAT-2930-2021; Bommer, Guido/A-8425-2011	Burant, Charles/0000-0001-9189-5003; Lanthier, Nicolas/0000-0002-7651-9314; MacDougald, Ormond/0000-0001-6907-7960; Das, Arun/0000-0002-0883-1816; Bommer, Guido/0000-0001-6898-4884; Clerbaux, Laure-Alix/0000-0003-2707-482X	Region-Bruxelles-Capitales; Fonds Speciaux de Recherche - Universite Catholique de Louvain; Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA); Belgian Science Policy; Fonds de la Recherche Scientifique; de Duve Institute; National Institute of Health [DK51563]; Michigan Nutrition Obesity Research Center [5P30DK089503]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051563, P30DK089503] Funding Source: NIH RePORTER	Region-Bruxelles-Capitales; Fonds Speciaux de Recherche - Universite Catholique de Louvain; Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); Belgian Science Policy(Belgian Federal Science Policy Office); Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); de Duve Institute; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Nutrition Obesity Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Brains-Back-to-Brussels grant of the Region-Bruxelles-Capitales (to G. T. B.), by a fellowship of the Fonds Speciaux de Recherche - Universite Catholique de Louvain (FRS-UCL) and the Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA) (to L.-A. C.), by a return grant of the Belgian Science Policy (to I. G.), by a grant of the Fonds de la Recherche Scientifique (to I. A. L.), by funds from the de Duve Institute (to G. T. B.), by the National Institute of Health Grant DK51563 (to O. A. M.), and the Michigan Nutrition Obesity Research Center Grant 5P30DK089503 (to C. F. B.).	ABHAIRD NN, 1992, BIOCHEM J, V286, P637, DOI 10.1042/bj2860637; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Benes V, 2010, METHODS, V50, P244, DOI 10.1016/j.ymeth.2010.01.026; Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; Brunham LR, 2008, JAMA-J AM MED ASSOC, V300, P1997, DOI 10.1001/jama.2008.539; Brunham LR, 2009, ARTERIOSCL THROM VAS, V29, P548, DOI 10.1161/ATVBAHA.108.182303; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Caballero F, 2009, J HEPATOL, V50, P789, DOI 10.1016/j.jhep.2008.12.016; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Eaton S, 2000, BIOCHEM SOC T, V28, P177, DOI 10.1042/bst0280177; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Ibdah JA, 2005, GASTROENTEROLOGY, V128, P1381, DOI 10.1053/j.gastro.2005.02.001; Ibdah JA, 2001, J CLIN INVEST, V107, P1403, DOI 10.1172/JCI12590; KANNEL WB, 1983, AM J CARDIOL, V52, pB9, DOI 10.1016/0002-9149(83)90649-5; Kao HJ, 2006, HUM MOL GENET, V15, P3569, DOI 10.1093/hmg/ddl433; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LOPASCHUK GD, 1988, CIRC RES, V63, P1036, DOI 10.1161/01.RES.63.6.1036; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Marchesini G, 2008, J CLIN ENDOCR METAB, V93, pS74, DOI 10.1210/jc.2008-1399; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Morash AJ, 2010, AM J PHYSIOL-REG I, V299, pR579, DOI 10.1152/ajpregu.00088.2010; Morillas M, 2000, BIOCHEM J, V351, P495, DOI 10.1042/0264-6021:3510495; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Pantano L, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1127; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Sambrook J, 2001, MOL CLONING LAB MANU; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Singaraja RR, 2006, ARTERIOSCL THROM VAS, V26, P1821, DOI 10.1161/01.ATV.0000229219.13757.a2; Singaraja RR, 2001, J BIOL CHEM, V276, P33969, DOI 10.1074/jbc.M102503200; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Tsuchiya S, 2009, NUCLEIC ACIDS RES, V37, P3821, DOI 10.1093/nar/gkp255; Tubb MR, 2009, J LIPID RES, V50, P1497, DOI 10.1194/jlr.D900003-JLR200; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wanders RJA, 2010, BBA-MOL CELL BIOL L, V1801, P272, DOI 10.1016/j.bbalip.2010.01.001; White T, 1998, ANAL BIOCHEM, V258, P109, DOI 10.1006/abio.1997.2545; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372	58	273	300	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33652	33661		10.1074/jbc.M110.152090	http://dx.doi.org/10.1074/jbc.M110.152090			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20732877	Green Published, hybrid			2022-12-25	WOS:000283354000010
J	Nickens, DG; Bardiya, N; Patterson, JT; Burke, DH				Nickens, David G.; Bardiya, Nirmala; Patterson, James T.; Burke, Donald H.			Template-Directed Ligation of Tethered Mononucleotides by T4 DNA Ligase for Kinase Ribozyme Selection	PLOS ONE			English	Article							PHOSPHORYLATING DNA; NUCLEIC-ACID; RNA; STABILIZATION; MECHANISM; PRIMERS; GROWTH; BASES; MOTIF	Background: In vitro selection of kinase ribozymes for small molecule metabolites, such as free nucleosides, will require partition systems that discriminate active from inactive RNA species. While nucleic acid catalysis of phosphoryl transfer is well established for phosphorylation of 5' or 2' OH of oligonucleotide substrates, phosphorylation of diffusible small molecules has not been demonstrated. Methodology/Principal Findings: This study demonstrates the ability of T4 DNA ligase to capture RNA strands in which a tethered monodeoxynucleoside has acquired a 5' phosphate. The ligation reaction therefore mimics the partition step of a selection for nucleoside kinase (deoxy)ribozymes. Ligation with tethered substrates was considerably slower than with nicked, fully duplex DNA, even though the deoxynucleotides at the ligation junction were Watson-Crick base paired in the tethered substrate. Ligation increased markedly when the bridging template strand contained unpaired spacer nucleotides across from the flexible tether, according to the trends: A(2)>A(1)>A(3)>A(4)>A(0)>A(6)>A(8)>A(10) and T-2>T-3>T-4>T-6 approximate to T-1>T-8>T-10. Bridging T's generally gave higher yield of ligated product than bridging A's. ATP concentrations above 33 mu M accumulated adenylated intermediate and decreased yields of the gap-sealed product, likely due to re-adenylation of dissociated enzyme. Under optimized conditions, T4 DNA ligase efficiently (>90%) joined a correctly paired, or T:G wobble-paired, substrate on the 3' side of the ligation junction while discriminating approximately 100-fold against most mispaired substrates. Tethered dC and dG gave the highest ligation rates and yields, followed by tethered deoxyinosine (dl) and dT, with the slowest reactions for tethered dA. The same kinetic trends were observed in ligase-mediated capture in complex reaction mixtures with multiple substrates. The "universal" analog 5-nitroindole (dNI) did not support ligation when used as the tethered nucleotide. Conclusions/Significance: Our results reveal a novel activity for T4 DNA ligase (template-directed ligation of a tethered mononucleotide) and establish this partition scheme as being suitable for the selection of ribozymes that phosphorylate mononucleoside substrates.	[Nickens, David G.; Patterson, James T.; Burke, Donald H.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Nickens, David G.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Bardiya, Nirmala; Burke, Donald H.] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO USA; [Bardiya, Nirmala; Burke, Donald H.] Univ Missouri, Dept Biochem, Columbia, MO USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Nickens, DG (corresponding author), Indiana Univ, Dept Chem, Bloomington, IN 47405 USA.	burkedh@missouri.edu		Patterson, James/0000-0001-6006-7184	National Aeronautics and Space Administration (NASA) [NAG5-12360]; David and Lucille Packard Foundation	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); David and Lucille Packard Foundation(The David & Lucile Packard Foundation)	This work was supported by National Aeronautics and Space Administration (NASA) Exobiology award NAG5-12360 and by an Interdisciplinary Science Award from the David and Lucille Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RC, 2003, NUCLEIC ACIDS RES, V31, P3208, DOI 10.1093/nar/gkg415; Ball S, 1998, NUCLEIC ACIDS RES, V26, P5225, DOI 10.1093/nar/26.22.5225; BIONDI E, 2010, NUCL ACIDS IN PRESS; Burke DH, 2004, MOL B INT U, P48; Chen IA, 2004, BIOPHYS J, V87, P988, DOI 10.1529/biophysj.104.039875; Chen X, 2007, CHEM BIODIVERS, V4, P633, DOI 10.1002/cbdv.200790055; Cherepanov AV, 2003, EUR J BIOCHEM, V270, P4315, DOI 10.1046/j.1432-1033.2003.03824.x; Chiuman W, 2002, BIOORG CHEM, V30, P332, DOI 10.1016/S0045-2068(02)00018-4; Cho BR, 2007, B KOR CHEM SOC, V28, P689; Cho B, 2006, RNA, V12, P2118, DOI 10.1261/rna.173506; Curtis EA, 2005, NAT STRUCT MOL BIOL, V12, P994, DOI 10.1038/nsmb1003; Doherty AJ, 2000, NUCLEIC ACIDS RES, V28, P4051, DOI 10.1093/nar/28.21.4051; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Ho CK, 1997, J VIROL, V71, P1931, DOI 10.1128/JVI.71.3.1931-1937.1997; Jarvius Jonas, 2003, Methods Mol Biol, V212, P215; Jaschke A, 2001, CURR OPIN STRUC BIOL, V11, P321, DOI 10.1016/S0959-440X(00)00208-6; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; LANDEGREN U, 1988, SCIENCE, V241, P1077, DOI 10.1126/science.3413476; LEHMAN IR, 1974, SCIENCE, V186, P790; Li YF, 1999, P NATL ACAD SCI USA, V96, P2746, DOI 10.1073/pnas.96.6.2746; Liu PF, 2004, NUCLEIC ACIDS RES, V32, P4503, DOI 10.1093/nar/gkh781; LOAKES D, 1995, NUCLEIC ACIDS RES, V23, P2361, DOI 10.1093/nar/23.13.2361; LOAKES D, 1994, NUC ACIDS RES, V22; LORSCH JR, 1995, BIOCHEMISTRY-US, V34, P15315, DOI 10.1021/bi00046a041; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; Nilsson M, 2001, NUCLEIC ACIDS RES, V29, P578, DOI 10.1093/nar/29.2.578; RHEE S, 2010, ACTIVE SITE AS UNPUB; Rhee SS, 2004, ANAL BIOCHEM, V325, P137, DOI 10.1016/j.ab.2003.10.019; Rossi R, 1997, NUCLEIC ACIDS RES, V25, P2106, DOI 10.1093/nar/25.11.2106; Rumbaugh JA, 1997, J BIOL CHEM, V272, P22591, DOI 10.1074/jbc.272.36.22591; Saikia M, 2006, RNA, V12, P2025, DOI 10.1261/rna.208906; Saran D, 2005, BIOCHEMISTRY-US, V44, P15007, DOI 10.1021/bi051086h; Saran D, 2006, NUCLEIC ACIDS RES, V34, P3201, DOI 10.1093/nar/gkl413; Seelig B, 1999, CHEM BIOL, V6, P167, DOI 10.1016/S1074-5521(99)89008-5; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P525, DOI 10.1093/nar/26.2.525; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P4618, DOI 10.1093/nar/26.20.4618; Vallone PM, 1999, NUCLEIC ACIDS RES, V27, P3589, DOI 10.1093/nar/27.17.3589; Wang W, 2002, CHEM BIOL, V9, P507, DOI 10.1016/S1074-5521(02)00127-8; Wang Y, 2007, BIOCHEMISTRY-US, V46, P4962, DOI 10.1021/bi0621516	39	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12368	10.1371/journal.pone.0012368	http://dx.doi.org/10.1371/journal.pone.0012368			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20811490	Green Published, gold, Green Submitted			2022-12-25	WOS:000281154300009
J	Marsit, CJ; Houseman, EA; Christensen, BC; Gagne, L; Wrensch, MR; Nelson, HH; Wiemels, J; Zheng, SC; Wiencke, JK; Andrew, AS; Schned, AR; Karagas, MR; Kelsey, KT				Marsit, Carmen J.; Houseman, E. Andres; Christensen, Brock C.; Gagne, Luc; Wrensch, Margaret R.; Nelson, Heather H.; Wiemels, Joseph; Zheng, Shichun; Wiencke, John K.; Andrew, Angeline S.; Schned, Alan R.; Karagas, Margaret R.; Kelsey, Karl T.			Identification of Methylated Genes Associated with Aggressive Bladder Cancer	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; DNA METHYLATION; PROMOTER HYPERMETHYLATION; EPIGENETIC INACTIVATION; PROGNOSTIC MARKER; SFRP GENES; P53; PROGRESSION; EXPRESSION; PATTERNS	Approximately 500,000 individuals diagnosed with bladder cancer in the U. S. require routine cystoscopic follow-up to monitor for disease recurrences or progression, resulting in over $2 billion in annual expenditures. Identification of new diagnostic and monitoring strategies are clearly needed, and markers related to DNA methylation alterations hold great promise due to their stability, objective measurement, and known associations with the disease and with its clinical features. To identify novel epigenetic markers of aggressive bladder cancer, we utilized a high-throughput DNA methylation bead-array in two distinct population-based series of incident bladder cancer (n = 73 and n = 264, respectively). We then validated the association between methylation of these candidate loci with tumor grade in a third population (n = 245) through bisulfite pyrosequencing of candidate loci. Array based analyses identified 5 loci for further confirmation with bisulfite pyrosequencing. We identified and confirmed that increased promoter methylation of HOXB2 is significantly and independently associated with invasive bladder cancer and methylation of HOXB2, KRT13 and FRZB together significantly predict high-grade non-invasive disease. Methylation of these genes may be useful as clinical markers of the disease and may point to genes and pathways worthy of additional examination as novel targets for therapeutic treatment.	[Marsit, Carmen J.; Christensen, Brock C.; Gagne, Luc; Kelsey, Karl T.] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA; [Marsit, Carmen J.; Houseman, E. Andres; Christensen, Brock C.; Kelsey, Karl T.] Brown Univ, Dept Community Hlth, Ctr Environm Hlth & Technol, Providence, RI 02912 USA; [Wrensch, Margaret R.; Wiemels, Joseph; Zheng, Shichun; Wiencke, John K.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Nelson, Heather H.] Univ Minnesota, Div Epidemiol & Community Hlth, Mason Canc Ctr, Minneapolis, MN USA; [Andrew, Angeline S.; Karagas, Margaret R.] Dartmouth Med Sch, Epidemiol & Biostat Sect, Dept Community & Family Med, Lebanon, NH USA; [Schned, Alan R.] Dartmouth Med Sch, Dept Pathol, Lebanon, NH USA	Brown University; Brown University; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; Dartmouth College; Dartmouth College	Marsit, CJ (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	carmen_marsit@brown.edu	Kelsey, Karl T/I-1252-2014; Gagne, Luc/G-5528-2010; Christensen, Brock/B-8460-2009	Gagne, Luc/0000-0003-2998-1132; Houseman, Eugene Andres/0000-0003-0703-1830; Nelson, Heather/0000-0003-1901-9513; Marsit, Carmen/0000-0003-4566-150X	Flight Attendant Medical Research Institute [YCSA 052341]; National Institutes of Health [R01CA121147, K07CA102327, P42ES007373]; NATIONAL CANCER INSTITUTE [K07CA102327, R01CA121147, P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Flight Attendant Medical Research Institute [YCSA 052341 to C.J.M.]; and the National Institutes of Health [R01CA121147, K07CA102327, and P42ES007373]. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Aleman A, 2008, BRIT J CANCER, V98, P466, DOI 10.1038/sj.bjc.6604143; Aleman A, 2008, CLIN CANCER RES, V14, P8236, DOI 10.1158/1078-0432.CCR-08-0778; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Baris D, 2009, JNCI-J NATL CANCER I, V101, P1553, DOI 10.1093/jnci/djp361; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carrilho C, 2004, HUM PATHOL, V35, P546, DOI 10.1016/j.humpath.2004.01.021; Cashen AF, 2008, CANCER CHEMOTH PHARM, V61, P759, DOI 10.1007/s00280-007-0531-7; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Christensen BC, 2009, CANCER RES, V69, P227, DOI 10.1158/0008-5472.CAN-08-2586; Dinney CPN, 2004, CANCER CELL, V6, P111, DOI 10.1016/j.ccr.2004.08.002; Esteller M, 2003, ADV EXP MED BIOL, V532, P39; Esuvaranathan K, 2007, CANCER-AM CANCER SOC, V109, P1097, DOI 10.1002/cncr.22503; Fleshner N, 2000, J UROLOGY, V164, P1177, DOI 10.1016/S0022-5347(05)67136-4; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; GARDINER RA, 1994, BRIT J UROL, V73, P526, DOI 10.1111/j.1464-410X.1994.tb07638.x; Grossman HB, 1998, CLIN CANCER RES, V4, P829; Hemal AK, 2003, UROL INT, V70, P42, DOI 10.1159/000067703; Hoque MO, 2006, JNCI-J NATL CANCER I, V98, P996, DOI 10.1093/jnci/djj265; Houseman EA, 2006, BIOMETRICS, V62, P1062, DOI 10.1111/j.1541-0420.2006.00566.x; Houseman EA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-365; Iacobuzio-Donahue CA, 2009, ANNU REV PATHOL-MECH, V4, P229, DOI 10.1146/annurev.pathol.3.121806.151442; Jarmalaite S, 2008, ONCOLOGY-BASEL, V75, P145, DOI 10.1159/000158665; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji Y, 2005, BIOINFORMATICS, V21, P2118, DOI 10.1093/bioinformatics/bti318; Karagas MR, 1998, ENVIRON HEALTH PERSP, V106, P1047, DOI 10.1289/ehp.98106s41047; Kelsey KT, 2005, INT J CANCER, V117, P370, DOI 10.1002/ijc.21195; Kelsey KT, 2004, BRIT J CANCER, V90, P1572, DOI 10.1038/sj.bjc.6601748; Khin SS, 2009, INT J CANCER, V125, P328, DOI 10.1002/ijc.24318; Killian JK, 2009, CANCER RES, V69, P758, DOI 10.1158/0008-5472.CAN-08-2984; Kim EJ, 2008, J UROLOGY, V180, P1141, DOI 10.1016/j.juro.2008.05.002; Kim YK, 2009, INT J UROL, V16, P17, DOI 10.1111/j.1442-2042.2008.02143.x; Malats W, 2005, LANCET ONCOL, V6, P678; Marsit CJ, 2007, CARCINOGENESIS, V28, P1745, DOI 10.1093/carcin/bgm116; Marsit CJ, 2006, CANCER RES, V66, P10621, DOI 10.1158/0008-5472.CAN-06-1687; Marsit CJ, 2009, CARCINOGENESIS, V30, P416, DOI 10.1093/carcin/bgp006; Marsit CJ, 2005, CANCER RES, V65, P7081, DOI 10.1158/0008-5472.CAN-05-0267; Mathews LA, 2009, DIFFERENTIATION, V78, P1, DOI 10.1016/j.diff.2009.04.002; OCKRIM JL, 2007, UROLOGICAL CANCERS C, P75; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sathyanarayana UG, 2004, CANCER RES, V64, P1425, DOI 10.1158/0008-5472.CAN-03-0701; SERTH J, 1995, BRIT J CANCER, V71, P201, DOI 10.1038/bjc.1995.41; Siegmund KD, 2004, BIOINFORMATICS, V20, P1896, DOI 10.1093/bioinformatics/bth176; Stoehr R, 2004, LAB INVEST, V84, P465, DOI 10.1038/labinvest.3700068; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Urakami S, 2006, CLIN CANCER RES, V12, P2109, DOI 10.1158/1078-0432.CCR-05-2468; Watanabe R, 1994, Int J Urol, V1, P43, DOI 10.1111/j.1442-2042.1994.tb00007.x; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Yates DR, 2007, CLIN CANCER RES, V13, P2046, DOI 10.1158/1078-0432.CCR-06-2476; Yates DR, 2006, ONCOGENE, V25, P1984, DOI 10.1038/sj.onc.1209209; Yu J, 2007, CLIN CANCER RES, V13, P7296, DOI 10.1158/1078-0432.CCR-07-0861	53	68	68	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12334	10.1371/journal.pone.0012334	http://dx.doi.org/10.1371/journal.pone.0012334			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808801	Green Submitted, Green Published, gold			2022-12-25	WOS:000281153500016
J	Drineas, P; Lewis, J; Paschou, P				Drineas, Petros; Lewis, Jamey; Paschou, Peristera			Inferring Geographic Coordinates of Origin for Europeans Using Small Panels of Ancestry Informative Markers	PLOS ONE			English	Article							GENETIC SUBSTRUCTURE; POPULATION-STRUCTURE; ADMIXTURE; DISEASE; GENOME; ASSOCIATION; STRATIFICATION; SELECTION; PATTERNS; LINKAGE	Recent large-scale studies of European populations have demonstrated the existence of population genetic structure within Europe and the potential to accurately infer individual ancestry when information from hundreds of thousands of genetic markers is used. In fact, when genomewide genetic variation of European populations is projected down to a two-dimensional Principal Components Analysis plot, a surprising correlation with actual geographic coordinates of self-reported ancestry has been reported. This substructure can hamper the search of susceptibility genes for common complex disorders leading to spurious correlations. The identification of genetic markers that can correct for population stratification becomes therefore of paramount importance. Analyzing 1,200 individuals from 11 populations genotyped for more than 500,000 SNPs (Population Reference Sample), we present a systematic exploration of the extent to which geographic coordinates of origin within Europe can be predicted, with small panels of SNPs. Markers are selected to correlate with the top principal components of the dataset, as we have previously demonstrated. Performing thorough cross-validation experiments we show that it is indeed possible to predict individual ancestry within Europe down to a few hundred kilometers from actual individual origin, using information from carefully selected panels of 500 or 1,000 SNPs. Furthermore, we show that these panels can be used to correctly assign the HapMap Phase 3 European populations to their geographic origin. The SNPs that we propose can prove extremely useful in a variety of different settings, such as stratification correction or genetic ancestry testing, and the study of the history of European populations.	[Drineas, Petros; Lewis, Jamey] Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA; [Paschou, Peristera] Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece	Rensselaer Polytechnic Institute; Democritus University of Thrace	Drineas, P (corresponding author), Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA.	ppaschou@mbg.duth.gr		Paschou, Peristera/0000-0002-9783-1024	National Science Foundation Computing and Communication Foundations (NSF CCF) [0447950, 0824684]; European Molecular Biology Organization Arab Science & Technology Foundation (EMBO ASTF) [235-2009]; two Tourette Syndrome Association (TSA)	National Science Foundation Computing and Communication Foundations (NSF CCF); European Molecular Biology Organization Arab Science & Technology Foundation (EMBO ASTF); two Tourette Syndrome Association (TSA)	This work was supported, in part, by a National Science Foundation Computing and Communication Foundations (NSF CCF) 0447950 CAREER award to PD; an NSF CCF 0824684 award to PD; a European Molecular Biology Organization Arab Science & Technology Foundation (EMBO ASTF) 235-2009 Short-Term Fellowship to PD; and two Tourette Syndrome Association (TSA) Research Grant Awards to PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Belle EMS, 2006, P ROY SOC B-BIOL SCI, V273, P1595, DOI 10.1098/rspb.2006.3494; Biswas S, 2009, AM J HUM GENET, V84, P641, DOI 10.1016/j.ajhg.2009.04.015; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Collins-Schramm HE, 2002, AM J HUM GENET, V70, P737, DOI 10.1086/339368; DEAN M, 1994, AM J HUM GENET, V55, P788; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; McEvoy BP, 2009, GENOME RES, V19, P804, DOI 10.1101/gr.083394.108; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Paschou P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000114; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tian C, 2009, MOL MED, V15, P371, DOI 10.2119/molmed.2009.00094; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; WRIGHT S, 1951, ANN EUGENIC, V15, P323	27	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e11892	10.1371/journal.pone.0011892	http://dx.doi.org/10.1371/journal.pone.0011892			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805874	Green Published, Green Submitted, gold			2022-12-25	WOS:000281011600004
J	Olberding, JE; Thouless, MD; Arruda, EM; Garikipati, K				Olberding, Joseph E.; Thouless, Michael D.; Arruda, Ellen M.; Garikipati, Krishna			The Non-Equilibrium Thermodynamics and Kinetics of Focal Adhesion Dynamics	PLOS ONE			English	Article							CELL-MATRIX ADHESIONS; EXTRACELLULAR-MATRIX; LIPID-BILAYERS; MOLECULAR-BOND; F-ACTIN; FORCE; INTEGRIN; FIBROBLASTS; ACTIVATION; BINDING	Background: We consider a focal adhesion to be made up of molecular complexes, each consisting of a ligand, an integrin molecule, and associated plaque proteins. Free energy changes drive the binding and unbinding of these complexes and thereby controls the focal adhesion's dynamic modes of growth, treadmilling and resorption. Principal Findings: We have identified a competition among four thermodynamic driving forces for focal adhesion dynamics: (i) the work done during the addition of a single molecular complex of a certain size, (ii) the chemical free energy change associated with the addition of a molecular complex, (iii) the elastic free energy change associated with deformation of focal adhesions and the cell membrane, and (iv) the work done on a molecular conformational change. We have developed a theoretical treatment of focal adhesion dynamics as a nonlinear rate process governed by a classical kinetic model. We also express the rates as being driven by out-of-equilibrium thermodynamic driving forces, and modulated by kinetics. The mechanisms governed by the above four effects allow focal adhesions to exhibit a rich variety of behavior without the need to introduce special constitutive assumptions for their response. For the reaction-limited case growth, treadmilling and resorption are all predicted by a very simple chemo-mechanical model. Treadmilling requires symmetry breaking between the ends of the focal adhesion, and is achieved by driving force (i) above. In contrast, depending on its numerical value (ii) causes symmetric growth, resorption or is neutral, (iii) causes symmetric resorption, and (iv) causes symmetric growth. These findings hold for a range of conditions: temporally-constant force or stress, and for spatially-uniform and non-uniform stress distribution over the FA. The symmetric growth mode dominates for temporally-constant stress, with a reduced treadmilling regime. Significance: In addition to explaining focal adhesion dynamics, this treatment can be coupled with models of cytoskeleton dynamics and contribute to the understanding of cell motility.	[Olberding, Joseph E.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Garikipati, Krishna] Univ Michigan, Dept Mech Engn, Michigan Ctr Theoret Phys, Ann Arbor, MI 48109 USA; [Thouless, Michael D.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; [Arruda, Ellen M.] Univ Michigan, Program Macromol Sci & Engn, Ann Arbor, MI 48109 USA; [Garikipati, Krishna] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Olberding, JE (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	krishna@umich.edu			University of Michigan; Department of Energy	University of Michigan(University of Michigan System); Department of Energy(United States Department of Energy (DOE))	JEO was supported by a Rackham pre-doctoral fellowship from the University of Michigan. KG was supported by a Presidential Early Career Award for Scientists and Engineers (PECASE) grant from the Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Aroush DRB, 2008, SOFT MATTER, V4, P2410, DOI 10.1039/b804643n; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Besser A, 2006, BIOPHYS J, V90, P3469, DOI 10.1529/biophysj.105.074377; Besser A, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/425; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; de Groot S., 1984, NONEQUILIBRIUM THERM; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Deshpande VS, 2008, J MECH PHYS SOLIDS, V56, P1484, DOI 10.1016/j.jmps.2007.08.006; Erb EM, 1997, BIOCHEMISTRY-US, V36, P7395, DOI 10.1021/bi9702187; EVANS EA, 1985, BIOPHYS J, V48, P175, DOI 10.1016/S0006-3495(85)83770-X; Freund LB, 2009, P NATL ACAD SCI USA, V106, P8818, DOI 10.1073/pnas.0903003106; Freund LB, 2004, J MECH PHYS SOLIDS, V52, P2455, DOI 10.1016/j.jmps.2004.05.004; Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114; Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GEIGER B, 2008, COMMUNICATION; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JUNGBAUER S, 2008, J CELL BIOL, V171, P283; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Lee SE, 2007, J BIOMECH, V40, P2096, DOI 10.1016/j.jbiomech.2007.04.006; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; Li FY, 2003, BIOPHYS J, V84, P1252, DOI 10.1016/S0006-3495(03)74940-6; Lin Y, 2008, J MECH PHYS SOLIDS, V56, P241, DOI 10.1016/j.jmps.2007.02.008; Lin Y, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.021909; Nicolas A, 2006, BIOPHYS J, V91, P61, DOI 10.1529/biophysj.105.077115; Nicolas A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051902; Nicolas A, 2004, P NATL ACAD SCI USA, V101, P12520, DOI 10.1073/pnas.0403539101; Nicolas A, 2008, BIOPHYS J, V95, P527, DOI 10.1529/biophysj.107.127399; OOSAWA F, 1977, BIORHEOLOGY, V14, P11; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Qian J, 2008, LANGMUIR, V24, P1262, DOI 10.1021/la702401b; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Shemesh T, 2005, P NATL ACAD SCI USA, V102, P12383, DOI 10.1073/pnas.0500254102; Shen CJ, 2008, CELL MOL BIOENG, V1, P15, DOI 10.1007/s12195-008-0005-y; Smilenov LB, 1999, SCIENCE, V286, P1172, DOI 10.1126/science.286.5442.1172; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Tsuda Y, 1996, P NATL ACAD SCI USA, V93, P12937, DOI 10.1073/pnas.93.23.12937; VINEYARD GH, 1957, J PHYS CHEM SOLIDS, V3, P121, DOI 10.1016/0022-3697(57)90059-8; Wang JZ, 2008, J MECH PHYS SOLIDS, V56, P251, DOI 10.1016/j.jmps.2007.05.011; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zamir E, 2001, J CELL SCI, V114, P3583	48	21	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12043	10.1371/journal.pone.0012043	http://dx.doi.org/10.1371/journal.pone.0012043			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805876	Green Published, Green Submitted, gold			2022-12-25	WOS:000281011600005
J	Zahid, M; Phillips, BE; Albers, SM; Giannoukakis, N; Watkins, SC; Robbins, PD				Zahid, Maliha; Phillips, Brett E.; Albers, Sean M.; Giannoukakis, Nick; Watkins, Simon C.; Robbins, Paul D.			Identification of a Cardiac Specific Protein Transduction Domain by In Vivo Biopanning Using a M13 Phage Peptide Display Library in Mice	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; NATIONAL REGISTRY; SELECTION; DELIVERY; TISSUE		[Zahid, Maliha; Robbins, Paul D.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Phillips, Brett E.; Giannoukakis, Nick] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Albers, Sean M.; Watkins, Simon C.] Univ Pittsburgh, Sch Med, Ctr Biol Imaging, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zahid, M (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	probb@pitt.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552; Phillips, Brett/0000-0001-6062-4892	DOD [17-03-1-0488, 17-03-0142]	DOD(United States Department of Defense)	This work was supported by DOD grants 17-03-1-0488 and 17-03-0142 to P.D.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Hyun S, 2008, BIOORG MED CHEM LETT, V18, P4011, DOI 10.1016/j.bmcl.2008.06.003; Kawano S, 2006, AM J PHYSIOL-HEART C, V291, pH1337, DOI 10.1152/ajpheart.01175.2005; Kelly KA, 2006, MOL IMAGING BIOL, V8, P201, DOI 10.1007/s11307-006-0043-6; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; McGuire MJ, 2004, J MOL BIOL, V342, P171, DOI 10.1016/j.jmb.2004.06.029; Mi ZB, 2003, MOL THER, V8, P295, DOI 10.1016/S1525-0016(03)00181-3; Molenaar TJM, 2002, VIROLOGY, V293, P182, DOI 10.1006/viro.2001.1254; Pachori AS, 2004, P NATL ACAD SCI USA, V101, P12282, DOI 10.1073/pnas.0404616101; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Segvich SJ, 2009, BIOMATERIALS, V30, P1287, DOI 10.1016/j.biomaterials.2008.11.008; Wiviott SD, 2004, J AM COLL CARDIOL, V44, P783, DOI 10.1016/j.jacc.2004.05.045; Yao VJ, 2005, AM J PATHOL, V166, P625, DOI 10.1016/S0002-9440(10)62283-3; Zhang LL, 2005, CIRCULATION, V112, P1601, DOI 10.1161/CIRCULATIONAHA.104.529537	15	50	56	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12252	10.1371/journal.pone.0012252	http://dx.doi.org/10.1371/journal.pone.0012252			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808875	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000280968100033
J	Wegwitz, F; Kluth, MA; Manz, C; Otto, B; Gruner, K; Heinlein, C; Kuhl, M; Warnecke, G; Schumacher, U; Deppert, W; Tolstonog, GV				Wegwitz, Florian; Kluth, Mark-Andreas; Maenz, Claudia; Otto, Benjamin; Gruner, Katharina; Heinlein, Christina; Kuehl, Marion; Warnecke, Gabriele; Schumacher, Udo; Deppert, Wolfgang; Tolstonog, Genrich V.			Tumorigenic WAP-T Mouse Mammary Carcinoma Cells: A Model for a Self-Reproducing Homeostatic Cancer Cell System	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-INITIATING CELLS; STEM-CELLS; BREAST-CANCER; TRANSGENIC MICE; BASAL-LIKE; EXPRESSION; GLAND; DIFFERENTIATION; IDENTIFICATION	Background: In analogy to normal stem cell differentiation, the current cancer stem cell (CSC) model presumes a hierarchical organization and an irreversible differentiation in tumor tissue. Accordingly, CSCs should comprise only a small subset of the tumor cells, which feeds tumor growth. However, some recent findings raised doubts on the general applicability of the CSC model and asked for its refinement. Methodology/Principal Findings: In this study we analyzed the CSC properties of mammary carcinoma cells derived from transgenic (WAP-T) mice. We established a highly tumorigenic WAP-T cell line (G-2 cells) that displays stem-like traits. G-2 cells, as well as their clonal derivates, are closely related to primary tumors regarding histology and gene expression profiles, and reflect heterogeneity regarding their differentiation states. G-2 cultures comprise cell populations in distinct differentiation states identified by co-expression of cytoskeletal proteins (cytokeratins and vimentin), a combination of cell surface markers and a set of transcription factors. Cellular subsets sorted according to expression of CD24a, CD49f, CD61, Epcam, Sca1, and Thy1 cell surface proteins, or metabolic markers (e.g. ALDH activity) are competent to reconstitute the initial cellular composition. Repopulation efficiency greatly varies between individual subsets and is influenced by interactions with the respective complementary G-2 cellular subset. The balance between differentiation states is regulated in part by the transcription factor Sox10, as depletion of Sox10 led to up-regulation of Twist2 and increased the proportion of Thy1-expressing cells representing cells in a self-renewable, reversible, quasi-mesenchymal differentiation state. Conclusions/Significance: G-2 cells constitute a self-reproducing cancer cell system, maintained by bi- and unidirectional conversion of complementary cellular subsets. Our work contributes to the current controversial discussion on the existence and nature of CSC and provides a basis for the incorporation of alternative hypotheses into the CSC model.	[Wegwitz, Florian; Kluth, Mark-Andreas; Maenz, Claudia; Gruner, Katharina; Heinlein, Christina; Kuehl, Marion; Warnecke, Gabriele; Deppert, Wolfgang; Tolstonog, Genrich V.] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Dept Tumor Virol, D-2000 Hamburg, Germany; [Otto, Benjamin] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Cent Labs, Hamburg, Germany; [Schumacher, Udo] Univ Med Ctr Hamburg Eppendorf, Dept Anat 2, Hamburg, Germany	Heinrich Pette Institute; University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Wegwitz, F (corresponding author), Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Dept Tumor Virol, Martinistr 52, D-2000 Hamburg, Germany.	wolfgang.deppert@hpi.uni-hamburg.de; genrich.tolstonog@hpi.uni-hamburg.de			Deutsche Forschungsgemeinschaft [De 212/23-1-3]; Deutsche Krebshilfe (Forschungsverbund "Tumorstammzellen''); VFK Krebsforschung gGmbH; Fonds der Chemischen Industrie; Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe (Forschungsverbund "Tumorstammzellen'')(Deutsche Krebshilfe); VFK Krebsforschung gGmbH; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit	This study was supported by grants from the Deutsche Forschungsgemeinschaft (De 212/23-1-3 to W. D. and G. T.), the Deutsche Krebshilfe (Forschungsverbund "Tumorstammzellen'') to W. D. and G. T., the VFK Krebsforschung gGmbH to W. D., and the Fonds der Chemischen Industrie. The Heinrich-Pette-Institute is financially supported by the Freie und Hansestadt Hamburg and the Bundesministerium fur Gesundheit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bassuk AG, 1998, MOL MED, V4, P392, DOI 10.1007/BF03401746; Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105; Buono KD, 2006, DEV BIOL, V293, P565, DOI 10.1016/j.ydbio.2006.02.043; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Choi YS, 2009, DEV BIOL, V329, P227, DOI 10.1016/j.ydbio.2009.02.032; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Dakir ELH, 2008, CARCINOGENESIS, V29, P2377, DOI 10.1093/carcin/bgn190; DEXTER DL, 1978, CANCER RES, V38, P3174; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Firlej V, 2008, J CELL SCI, V121, P3393, DOI 10.1242/jcs.027201; Galang CK, 2004, J BIOL CHEM, V279, P11281, DOI 10.1074/jbc.M311887200; Gilles C, 1999, J CELL SCI, V112, P4615; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grange C, 2008, NEOPLASIA, V10, P1433, DOI 10.1593/neo.08902; Greenberg JM, 2004, DEV DYNAM, V230, P350, DOI 10.1002/dvdy.20045; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Heinlein C, 2008, INT J CANCER, V122, P1701, DOI 10.1002/ijc.23317; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jannasch K, 2009, INT J CANCER, V125, P62, DOI 10.1002/ijc.24332; Kai K, 2009, CANCER SCI, V100, P2275, DOI 10.1111/j.1349-7006.2009.01318.x; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Krepulat F, 2005, ONCOGENE, V24, P4645, DOI 10.1038/sj.onc.1208557; Lander Arthur D., 2009, Journal of Biology (London), V8, P70, DOI 10.1186/jbiol177; LENNON VA, 1978, P NATL ACAD SCI USA, V75, P6093, DOI 10.1073/pnas.75.12.6093; Li Z, 2007, CANCER CELL, V12, P542, DOI 10.1016/j.ccr.2007.11.012; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lotem J, 2006, ONCOGENE, V25, P7663, DOI 10.1038/sj.onc.1209816; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manie E, 2009, CANCER RES, V69, P663, DOI 10.1158/0008-5472.CAN-08-1560; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Meyer MJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2449; Moen I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006381; Mollaaghababa R, 2003, ONCOGENE, V22, P3024, DOI 10.1038/sj.onc.1206442; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; NOWELL PC, 1986, CANCER RES, V46, P2203; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reiman JM, 2010, CANCER RES, V70, P3005, DOI 10.1158/0008-5472.CAN-09-4041; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; Rubin H, 2007, ADV CANCER RES, V98, P117, DOI 10.1016/S0065-230X(06)98004-X; RUDLAND PS, 1982, J NATL CANCER I, V68, P799; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Schulze-Garg C, 2000, ONCOGENE, V19, P1028, DOI 10.1038/sj.onc.1203281; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Smalley MJ, 1998, IN VITRO CELL DEV-AN, V34, P711; Smalley MJ, 2005, J MAMMARY GLAND BIOL, V10, P37, DOI 10.1007/s10911-005-2539-0; Smith GH, 2005, STEM CELL REV, V1, P215, DOI 10.1385/SCR:1:3:215; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; Strickland P, 2006, DEVELOPMENT, V133, P823, DOI 10.1242/dev.02261; Sun P, 2010, HISTOCHEM CELL BIOL, V133, P213, DOI 10.1007/s00418-009-0662-5; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Tzeng YJ, 1998, ONCOGENE, V16, P2103, DOI 10.1038/sj.onc.1201733; TZENG YJ, 1993, ONCOGENE, V8, P1965; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Vassilopoulos A, 2008, INT J BIOL SCI, V4, P133, DOI 10.7150/ijbs.4.133; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Ward RJ, 2007, ANNU REV PATHOL-MECH, V2, P175, DOI 10.1146/annurev.pathol.2.010506.091847; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang L, 2008, WD SCI P COMP ENG, V1, P295, DOI 10.1142/9789812799470_0048; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zipori D, 2005, STEM CELLS, V23, P719, DOI 10.1634/stemcells.2005-0030	80	18	19	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2010	5	8							e12103	10.1371/journal.pone.0012103	http://dx.doi.org/10.1371/journal.pone.0012103			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637WJ	20730114	gold, Green Published, Green Submitted			2022-12-25	WOS:000280849100025
J	Saether, T; Pattabiraman, DR; Alm-Kristiansen, AH; Vogt-Kielland, LT; Gonda, TJ; Gabrielsen, OS				Saether, T.; Pattabiraman, D. R.; Alm-Kristiansen, A. H.; Vogt-Kielland, L. T.; Gonda, T. J.; Gabrielsen, O. S.			A functional SUMO-interacting motif in the transactivation domain of c-Myb regulates its myeloid transforming ability	ONCOGENE			English	Article						c-Myb; SUMO; SUMO-interacting motif; myeloid; transformation; hematopoiesis	UBIQUITIN-LIKE PROTEINS; TRANSCRIPTION-FACTOR; V-MYB; SACCHAROMYCES-CEREVISIAE; BINDING MOTIF; DNA-BINDING; NF-M; COACTIVATOR; ACTIVATION; LEUKEMIA	c-Myb is an essential hematopoietic transcription factor that controls proliferation and differentiation of progenitors during blood cell development. Whereas sumoylation of the C-terminal regulatory domain (CRD) is known to have a major impact on the activity of c-Myb, no role for noncovalent binding of small ubiquitin-like modifier (SUMO) to c-Myb has been described. Based on the consensus SUMO-interacting motif (SIM), we identified and examined putative SIMs in human c-Myb. Interaction and reporter assays showed that the SIM in the in the transactivation domain of c-Myb (V(267)NIV) is functional. This motif is necessary for c-Myb to be able to interact noncovalently with SUMO, preferentially SUMO2/3. Destroying the SUMO-binding properties by mutation resulted in a large increase in the transactivation potential of c-Myb. Mutational analysis and overexpression of conjugation-defective SUMO argued against intramolecular repression caused by sumoylated CRD and in favor of SUMO-dependent repression in trans. Using both a myeloid cell line-based assay and a primary hematopoietic cell assay, we addressed the transforming abilities of SUMO binding and conjugation mutants. Interestingly, only loss of SUMO binding, and not SUMO conjugation, enhanced the myeloid transformational potential of c-Myb. c-Myb with the SIM mutated conferred a higher proliferative ability than the wild-type and caused an effective differentiation block. This establishes SUMO binding as a mechanism involved in modulating the transactivation activity of c-Myb, and responsible for keeping the transforming potential of the oncoprotein in check. Oncogene (2011) 30, 212-222; doi:10.1038/onc.2010.397; published online 30 August 2010	[Saether, T.; Alm-Kristiansen, A. H.; Vogt-Kielland, L. T.; Gabrielsen, O. S.] Univ Oslo, Dept Mol Biosci, N-0316 Oslo, Norway; [Pattabiraman, D. R.; Gonda, T. J.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia	University of Oslo; University of Queensland	Saether, T (corresponding author), Univ Oslo, Dept Mol Biosci, POB 1041 Blindern, N-0316 Oslo, Norway.	thomas.sather@imbv.uio.no	Pattabiraman, Diwakar/AAE-6338-2020; Gonda, Thomas J/A-3620-2012	Pattabiraman, Diwakar/0000-0002-2418-6458; Gonda, Thomas/0000-0002-8792-3021; Saether, Thomas/0000-0003-4976-3810	Norwegian Cancer Society; Norwegian Research Council; Leukaemia Foundation	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Research Council(Research Council of NorwayEuropean Commission); Leukaemia Foundation	We thank Marit Ledsaak for excellent technical assistance and Professor D Livingston, Professor G Del Sal, Professor RT Hay, Professor R Grosschedl and Professor ET Yeh for providing us with relevant expression constructs. This work was supported by the Norwegian Cancer Society (TS) and the FUGE program of the Norwegian Research Council. DRP was supported by a scholarship from The Leukaemia Foundation (Australia).	Alm-Kristiansen AH, 2008, ONCOGENE, V27, P4644, DOI 10.1038/onc.2008.105; Andersson KB, 2003, J BIOL CHEM, V278, P3816, DOI 10.1074/jbc.M209404200; Bies J, 2002, J BIOL CHEM, V277, P8999, DOI 10.1074/jbc.M110453200; Brown AL, 2006, J LEUKOCYTE BIOL, V80, P433, DOI 10.1189/jlb.0206112; BURK O, 1993, EMBO J, V12, P2027, DOI 10.1002/j.1460-2075.1993.tb05852.x; CHEN RH, 1993, MOL CELL BIOL, V13, P4423, DOI 10.1128/MCB.13.7.4423; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; Dahle O, 2003, EUR J BIOCHEM, V270, P1338, DOI 10.1046/j.1432-1033.2003.03504.x; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; Dash AB, 1996, GENE DEV, V10, P1858, DOI 10.1101/gad.10.15.1858; DUBENDORFF JW, 1992, GENE DEV, V6, P2524, DOI 10.1101/gad.6.12b.2524; GABRIELSEN OS, 1991, SCIENCE, V253, P1140, DOI 10.1126/science.1887237; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; GONDA TJ, 1989, EMBO J, V8, P1777, DOI 10.1002/j.1460-2075.1989.tb03571.x; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; HU YL, 1991, ONCOGENE, V6, P1549; Jin SH, 2010, J CLIN INVEST, V120, P593, DOI 10.1172/JCI38030; Karafiat V, 2001, BLOOD, V98, P3668, DOI 10.1182/blood.V98.13.3668; Kasper LH, 2002, NATURE, V419, P738, DOI 10.1038/nature01062; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; LANE T, 1990, MOL CELL BIOL, V10, P2591, DOI 10.1128/MCB.10.6.2591; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; McCormack MP, 2000, BLOOD, V95, P120, DOI 10.1182/blood.V95.1.120.001k08_120_127; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Molvaersmyr AK, 2010, NUCLEIC ACIDS RES, V38, P4970, DOI 10.1093/nar/gkq245; Murati A, 2009, LEUKEMIA, V23, P85, DOI 10.1038/leu.2008.257; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; Oelgeschlager M, 1996, EMBO J, V15, P2771, DOI 10.1002/j.1460-2075.1996.tb00637.x; Pattabiraman DR, 2009, MOL CANCER RES, V7, P1477, DOI 10.1158/1541-7786.MCR-09-0070; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Saether T, 2007, J BIOL CHEM, V282, P13994, DOI 10.1074/jbc.M700755200; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Sramko M, 2006, J BIOL CHEM, V281, P40065, DOI 10.1074/jbc.M609404200; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; VORBRUEGGEN G, 1994, NUCLEIC ACIDS RES, V22, P2466, DOI 10.1093/nar/22.13.2466	47	18	19	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2011	30	2					212	222		10.1038/onc.2010.397	http://dx.doi.org/10.1038/onc.2010.397			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	709LG	20802522				2022-12-25	WOS:000286438900009
J	Wheeler, DS; Barrick, SR; Grubisha, MJ; Brufsky, AM; Friedman, PA; Romero, G				Wheeler, D. S.; Barrick, S. R.; Grubisha, M. J.; Brufsky, A. M.; Friedman, P. A.; Romero, G.			Direct interaction between NHERF1 and Frizzled regulates beta-catenin signaling	ONCOGENE			English	Article						NHERF1; EBP50; breast cancer; Wnt; Frizzled; beta-catenin	PROTEIN-COUPLED-RECEPTORS; HUMAN BREAST-CANCER; CYCLIN D1; EXPRESSION; CELLS; RECOGNITION; ASSOCIATION; ENDOCYTOSIS; PROGNOSIS; MECHANISM	Although Wnt-Frizzled (Fzd) signaling is critical in the pathophysiology of carcinomas, its role in human breast cancer has been difficult to establish. We show here that the adaptor protein Na+/H+ exchange regulatory factor1 (NHERF1), a protein abundantly expressed in normal mammary epithelium, regulates Wnt signaling, maintaining low levels of beta-catenin activation. NHERF1's effects are mediated by direct interactions between one of its PSD-95/drosophila discs large/ZO-1 (PDZ) domains and the C-terminus of a subset of Fzd receptors. Loss of NHERF1 in breast cancer cell lines enhances canonical Wnt signaling and Wnt-dependent cell proliferation. Furthermore, the mammary glands of NHERF1-knockout mice exhibit increased mammary duct density accompanied by increased proliferation and beta-catenin activity. Finally, we demonstrate a negative correlation between NHERF1 expression and nuclear beta-catenin in human breast carcinomas. Taken together, these results provide a novel insight into the regulation of Wnt signaling in normal and neoplastic breast tissues, and identify NHERF1 as an important regulator of the pathogenesis of breast tumors. Oncogene (2011) 30, 32-42; doi: 10.1038/onc.2010.389; published online 30 August 2010	[Wheeler, D. S.; Barrick, S. R.; Grubisha, M. J.; Friedman, P. A.; Romero, G.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15261 USA; [Wheeler, D. S.; Grubisha, M. J.] Univ Pittsburgh, Sch Med, Med Scientist Training Program, Pittsburgh, PA 15261 USA; [Brufsky, A. M.; Friedman, P. A.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA; [Brufsky, A. M.; Romero, G.] Univ Pittsburgh, Sch Med, Univ Pittsburgh Canc Inst, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Romero, G (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, E1355 BST, Pittsburgh, PA 15261 USA.	ggr@pitt.edu	Brufsky, Adam/AAE-7470-2020; Barrick, Stacey/J-1595-2015	Brufsky, Adam/0000-0001-8080-7960; Barrick, Stacey/0000-0002-4837-3741	National Institutes of Health [DK083211, DK079864, DK54171]; Office of the Senior Vice Chancellor for the Health Sciences of the University of Pittsburgh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK083211, R01DK054171, R01DK069998, R56DK079864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Senior Vice Chancellor for the Health Sciences of the University of Pittsburgh(University of Pittsburgh); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants DK083211 (DSW), DK079864 (GR) and DK54171 (PAF) from the National Institutes of Health. We also acknowledge support from the Office of the Senior Vice Chancellor for the Health Sciences of the University of Pittsburgh (GR).	Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Bates IR, 2006, BIOPHYS J, V91, P1046, DOI 10.1529/biophysj.106.084830; Cardone RA, 2007, MOL BIOL CELL, V18, P1768, DOI 10.1091/mbc.E06-07-0617; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Dai JL, 2004, ONCOGENE, V23, P8681, DOI 10.1038/sj.onc.1207962; Dolled-Filhart M, 2006, CANCER RES, V66, P5487, DOI 10.1158/0008-5472.CAN-06-0100; Ediger TR, 1999, ENDOCRINOLOGY, V140, P2976, DOI 10.1210/en.140.7.2976; Ellis MJ, 2009, JAMA-J AM MED ASSOC, V302, P774, DOI 10.1001/jama.2009.1204; Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530; Garrido JL, 2009, MOL ENDOCRINOL, V23, P2048, DOI 10.1210/me.2008-0436; Gillett C, 1996, INT J CANCER, V69, P92, DOI 10.1002/(SICI)1097-0215(19960422)69:2<92::AID-IJC4>3.3.CO;2-I; Karthikeyan S, 2001, J MOL BIOL, V308, P963, DOI 10.1006/jmbi.2001.4634; Koo TH, 2002, ONCOGENE, V21, P4080, DOI 10.1038/sj.onc.1205514; Kreimann EL, 2007, ONCOGENE, V26, P5290, DOI 10.1038/sj.onc.1210336; Laura RP, 2002, EXP CELL RES, V275, P155, DOI 10.1006/excr.2002.5475; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Luyten A, 2008, MOL BIOL CELL, V19, P1594, DOI 10.1091/mbc.E07-08-0832; Mangia A, 2009, HISTOPATHOLOGY, V55, P600, DOI 10.1111/j.1365-2559.2009.03424.x; Pan Y, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1846; Pan Y, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1616; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Song J, 2007, HISTOPATHOLOGY, V51, P40, DOI 10.1111/j.1365-2559.2007.02730.x; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stemmer-Rachamimov AO, 2001, AM J PATHOL, V158, P57, DOI 10.1016/S0002-9440(10)63944-2; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Umekita Y, 2002, INT J CANCER, V98, P415, DOI 10.1002/ijc.10151; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wawrzak D, 2009, ADV ENZYME REGUL, V49, P98, DOI 10.1016/j.advenzreg.2009.01.002; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Yao R, 2004, ONCOGENE, V23, P6023, DOI 10.1038/sj.onc.1207817; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015	32	37	40	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2011	30	1					32	42		10.1038/onc.2010.389	http://dx.doi.org/10.1038/onc.2010.389			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	703EQ	20802536	Green Accepted			2022-12-25	WOS:000285959300003
J	Arvatz, G; Barash, U; Nativ, O; Ilan, N; Vlodavsky, I				Arvatz, Gil; Barash, Uri; Nativ, Ofer; Ilan, Neta; Vlodavsky, Israel			Post-transcriptional regulation of heparanase gene expression by a 3 ' AU-rich element	FASEB JOURNAL			English	Article						enzymatic activity; invasion; tumor xenograft; U87 glioma; luciferase	MAMMALIAN HEPARANASE; CANCER METASTASIS; SPLICE VARIANT; GROWTH; PHOSPHORYLATION; HEPARIN; CLONING; HYPOMETHYLATION; LOCALIZATION; ESTROGEN	Heparanase up-regulation was documented in an increasing number of human carcinomas, associated with poor prognosis. The purpose of the current study was to identify mechanisms responsible for heparanase induction. We provide evidence that heparanase expression is regulated at the post-transcriptional level by sequences at the 3' untranslated region (3' UTR) of the gene. Constructing the 3' UTR immediately following the heparanase cDNA reduces heparanase enzymatic activity and protein levels, resulting in decreased cellular invasion capacity. We further identified a 185-bp sequence within the 3' UTR that mediates heparanase down-regulation, and characterized an adenine (A)/uracil (U)-rich consensus element (ARE) within this region. Deletion of the entire 185-bp region or the ARE eliminated the inhibitory effect of the 3' UTR, resulting in elevated heparanase levels and formation of larger tumor xenografts indistinguishable from those produced by heparanase-overexpressing cells in terms of size, vascularization, and Akt activation. These results suggest that loss of the ARE is an important regulatory mechanism contributing to heparanase induction in human cancer.-Arvatz, G., Barash, U., Nativ, O., Ilan, N., Vlodavsky, I. Post-transcriptional regulation of heparanase gene expression by a 3' AU-rich element. FASEB J. 24, 4969-4976 (2010). www.fasebj.org	[Arvatz, Gil; Barash, Uri; Ilan, Neta; Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel; [Nativ, Ofer] Bnai Zion Med Ctr, Dept Urol, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Bnai Zion Medical Center	Vlodavsky, I (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, POB 9649, IL-31096 Haifa, Israel.	vlodavsk@cc.huji.ac.il		Barash, Uri/0000-0003-1049-270X	Israel Science Foundation [549/06]; National Cancer Institute; National Institutes of Health [CA106456]; Israel Cancer Research Fund (ICRF); Rappaport Family Institute; NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Cancer Research Fund (ICRF); Rappaport Family Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Joseph A. Madri (Yale University, New Haven, CT, USA) for providing us with anti-mouse PECAM-1 (CD31) antibodies. This work was supported by grants from the Israel Science Foundation (grant 549/06); the National Cancer Institute, the National Institutes of Health (grant CA106456); the Israel Cancer Research Fund (ICRF); and the Rappaport Family Institute Fund to I.V. I.V. is a Research Professor of the ICRF.	Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Barash U, 2010, FASEB J, V24, P1239, DOI 10.1096/fj.09-147074; Baraz L, 2006, ONCOGENE, V25, P3939, DOI 10.1038/sj.onc.1209425; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Borset M, 2000, BLOOD, V96, P2528; Casu B, 2007, PATHOPHYSIOL HAEMO T, V36, P195, DOI 10.1159/000175157; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Cohen I, 2006, INT J CANCER, V118, P1609, DOI 10.1002/ijc.21552; Cohen I, 2007, CLIN CANCER RES, V13, P4069, DOI 10.1158/1078-0432.CCR-06-2546; Cohen-Kaplan V, 2008, CANCER RES, V68, P10077, DOI 10.1158/0008-5472.CAN-08-2910; Dempsey LA, 2000, TRENDS BIOCHEM SCI, V25, P349, DOI 10.1016/S0968-0004(00)01619-4; Dong J, 2000, GENE, V253, P171, DOI 10.1016/S0378-1119(00)00251-1; Eberhardt W, 2007, PHARMACOL THERAPEUT, V114, P56, DOI 10.1016/j.pharmthera.2007.01.002; Elkin M, 2003, CANCER RES, V63, P8821; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Miao HQ, 2006, CURR MED CHEM, V13, P2101, DOI 10.2174/092986706777935230; Nasser NJ, 2007, BIOCHEM BIOPH RES CO, V354, P33, DOI 10.1016/j.bbrc.2006.12.189; Ogishima T, 2005, CLIN CANCER RES, V11, P1028; Ogishima T, 2005, ONCOGENE, V24, P6765, DOI 10.1038/sj.onc.1208811; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Sato M, 2008, CELL BIOCHEM FUNCT, V26, P676, DOI 10.1002/cbf.1492; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shteper PJ, 2003, ONCOGENE, V22, P7737, DOI 10.1038/sj.onc.1207056; Toyoshima M, 1999, J BIOL CHEM, V274, P24153, DOI 10.1074/jbc.274.34.24153; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Vlodavsky I, 2006, PATHOPHYSIOL HAEMO T, V35, P116, DOI 10.1159/000093553; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068; Zetser A, 2003, CANCER RES, V63, P7733	40	30	30	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4969	4976		10.1096/fj.10-156372	http://dx.doi.org/10.1096/fj.10-156372			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20798248	Green Published			2022-12-25	WOS:000284824400035
J	Radulescu, S; Ridgway, RA; Appleton, P; Kroboth, K; Patel, S; Woodgett, J; Taylor, S; Nathke, IS; Sansom, OJ				Radulescu, S.; Ridgway, R. A.; Appleton, P.; Kroboth, K.; Patel, S.; Woodgett, J.; Taylor, S.; Nathke, I. S.; Sansom, O. J.			Defining the role of APC in the mitotic spindle checkpoint in vivo: APC-deficient cells are resistant to Taxol	ONCOGENE			English	Article						APC; WNT signalling; Taxol; mitotic spindle assembly checkpoint	POLYPOSIS-COLI PROTEIN; SUPPRESSOR GENE; CANCER; EXPRESSION; MUTATIONS; PROLIFERATION; MICROTUBULE; HOMEOSTASIS; INSTABILITY; PROGRESSION	Mutations in the adenomatous polyposis coli (APC) tumour suppressor are the key initiating event of colorectal cancer. Although the control of WNT signalling is well established as a central tumour-suppressive function, the significance of APC in regulating chromosome instability is less well established. In this study, we test whether APC-deficient cells have a functional spindle assembly checkpoint (SAC) in vivo by examining the response of these cells to Taxol and Vinorelbine. We also show for the first time that APC deficiency compromises the arrest response to Taxol in vivo. This effect is independent of the role that APC has in WNT signalling. At higher levels of Taxol, APC-deficient cells arrest as efficiently as wild-type cells. Importantly, this dose of Taxol strongly suppresses intestinal tumourigenesis in models of benign (APC(Min/+) mouse) and invasive (AhCreER(+) APC(fl/+) PTENfl/fl) cancer. In contrast to intestinal enterocytes with a general SAC defect because of Bub1 (budding uninhibited by benzimidazole 1) deletion, APC-deficient enterocytes arrest equivalently to wild type when treated with Vinorelbine. This suggests that the failed arrest in response to Taxol is because of a specific defect in microtubule stabilization following Taxol treatment rather than a general role of the APC protein in the mitotic spindle checkpoint. In summary, this study clarifies the role of APC as a mitotic spindle checkpoint protein in vivo and shows that APC-deficient cells have a compromised response to Taxol. Oncogene (2010) 29, 6418-6427; doi:10.1038/onc.2010.373; published online 23 August 2010	[Radulescu, S.; Ridgway, R. A.; Sansom, O. J.] CR UK Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Appleton, P.; Kroboth, K.; Nathke, I. S.] Univ Dundee, WTB MSI, Dundee, Scotland; [Patel, S.; Woodgett, J.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Taylor, S.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Beatson Institute; University of Dundee; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Manchester	Sansom, OJ (corresponding author), CR UK Beatson Inst Canc Res, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	o.sansom@beatson.gla.ac.uk	Woodgett, Jim/F-1087-2010; Taylor, Stephen/GZL-6499-2022	Woodgett, Jim/0000-0003-3731-5797; Sansom, Owen J./0000-0001-9540-3010; Taylor, Stephen/0000-0003-4621-9326; Nathke, Inke/0000-0003-2420-4385	CR-UK; AICR; Cancer Research UK [11913, 12481, 11243] Funding Source: researchfish	CR-UK(Cancer Research UK); AICR; Cancer Research UK(Cancer Research UK)	This work was funded by the CR-UK project and programme grants to Inke Nathke and Owen Sansom. Sorina Radulescu was funded by an AICR grant. Help from Colin Nixon with histology and from Derek Miller and Tom Hamilton with transgenic work was much appreciated.	Baena E, 2005, P NATL ACAD SCI USA, V102, P7286, DOI 10.1073/pnas.0409260102; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Dikovskaya D, 2004, MOL BIOL CELL, V15, P2978, DOI 10.1091/mbc.E03-08-0613; Dikovskaya D, 2001, TRENDS CELL BIOL, V11, P378, DOI 10.1016/S0962-8924(01)02069-4; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Draviam VM, 2006, EMBO J, V25, P2814, DOI 10.1038/sj.emboj.7601168; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kemp R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh090; KRIKORIAN A, 1991, ONKOLOGIE, V14, P7; Kroboth K, 2007, MOL BIOL CELL, V18, P910, DOI 10.1091/mbc.E06-03-0179; LINN SC, 1995, EUR J CANCER, V31A, P1291, DOI 10.1016/0959-8049(95)00278-Q; Marsh V, 2008, NAT GENET, V40, P1436, DOI 10.1038/ng.256; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Perera D, 2007, DEV CELL, V13, P566, DOI 10.1016/j.devcel.2007.08.008; RADULESCU S, BUB1 HAPLOINSU UNPUB; Rusan NM, 2008, J CELL BIOL, V181, P719, DOI 10.1083/jcb.200802107; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; SU LK, 1995, CANCER RES, V55, P2972; Suzuki A, 2003, CANCER RES, V63, P674; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014	32	24	24	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2010	29	49					6418	6427		10.1038/onc.2010.373	http://dx.doi.org/10.1038/onc.2010.373			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	692FP	20729907	Green Accepted			2022-12-25	WOS:000285138900002
J	Kocher, O; Birrane, G; Tsukamoto, K; Fenske, S; Yesilaltay, A; Pal, R; Daniels, K; Ladias, JAA; Krieger, M				Kocher, Olivier; Birrane, Gabriel; Tsukamoto, Kosuke; Fenske, Sara; Yesilaltay, Ayce; Pal, Rinku; Daniels, Kathleen; Ladias, John A. A.; Krieger, Monty			In Vitro and in Vivo Analysis of the Binding of the C Terminus of the HDL Receptor Scavenger Receptor Class B, Type I (SR-BI), to the PDZ1 Domain of Its Adaptor Protein PDZK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; SURFACE LOCALIZATION; TARGETED DISRUPTION; INTERACTING DOMAIN; CRYSTAL-STRUCTURE; LIPID-METABOLISM; APOLIPOPROTEIN-E; CYSTIC-FIBROSIS; EXPRESSION; RECOGNITION	The PDZ1 domain of the four PDZ domain-containing protein PDZK1 has been reported to bind the C terminus of the HDL receptor scavenger receptor class B, type I (SR-BI), and to control hepatic SR-BI expression and function. We generated wild-type (WT) and mutant murine PDZ1 domains, the mutants bearing single amino acid substitutions in their carboxylate binding loop (Lys(14)-Xaa(4)-Asn(19)-Tyr-Gly-Phe-Phe-Leu(24)), and measured their binding affinity for a 7-residue peptide corresponding to the C terminus of SR-BI ((503)VLQEAKL(509)). The Y20A and G21Y substitutions abrogated all binding activity. Surprisingly, binding affinities (K-d) of the K14A and F22A mutants were 3.2 and 4.0 mu M, respectively, similar to 2.6 mu M measured for the WT PDZ1. To understand these findings, we determined the high resolution structure of WT PDZ1 bound to a 5-residue sequence from the C-terminal SR-BI ((505)QEAKL(509)) using x-ray crystallography. In addition, we incorporated the K14A and Y20A substitutions into full-length PDZK1 liver-specific transgenes and expressed them in WT and PDZK1 knock-out mice. In WT mice, the transgenes did not alter endogenous hepatic SR-BI protein expression (intracellular distribution or amount) or lipoprotein metabolism (total plasma cholesterol, lipoprotein size distribution). In PDZK1 knock-out mice, as expected, the K14A mutant behaved like wild-type PDZK1 and completely corrected their hepatic SR-BI and plasma lipoprotein abnormalities. Unexpectedly, the 10-20-fold overexpressed Y20A mutant also substantially, but not completely, corrected these abnormalities. The results suggest that there may be an additional site(s) within PDZK1 that bind(s) SR-BI and mediate(s) productive SR-BI-PDZK1 interaction previously attributed exclusively to the canonical binding of the C-terminal SR-BI to PDZ1.	[Kocher, Olivier; Pal, Rinku; Daniels, Kathleen] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Kocher, Olivier; Pal, Rinku; Daniels, Kathleen] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Birrane, Gabriel; Ladias, John A. A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Expt Med,Mol Med Lab, Boston, MA 02215 USA; [Birrane, Gabriel; Ladias, John A. A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Expt Med,Macromol Crystallog Unit, Boston, MA 02215 USA; [Tsukamoto, Kosuke; Fenske, Sara; Yesilaltay, Ayce; Krieger, Monty] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Kocher, O (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	okocher@bidmc.harvard.edu		Birrane, Gabriel/0000-0002-1759-5499	National Institutes of Health [HL077780, HL52212, HL66105]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052212, P01HL066105, R01HL077780] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL077780 (to O. K.) and HL52212 and HL66105 (to M. K.).	Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI23858; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; Braun A, 2003, P NATL ACAD SCI USA, V100, P7283, DOI 10.1073/pnas.1237725100; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Dole VS, 2008, ARTERIOSCL THROM VAS, V28, P1111, DOI 10.1161/ATVBAHA.108.162347; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenske SA, 2008, J BIOL CHEM, V283, P22097, DOI 10.1074/jbc.M800029200; Fenske SA, 2009, J BIOL CHEM, V284, P5797, DOI 10.1074/jbc.M808211200; Guo Q, 1996, J BIOL CHEM, V271, P11191, DOI 10.1074/jbc.271.19.11191; Holm TM, 2002, BLOOD, V99, P1817, DOI 10.1182/blood.V99.5.1817; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; Karthikeyan S, 2001, J MOL BIOL, V308, P963, DOI 10.1006/jmbi.2001.4634; Kimura T, 2006, J BIOL CHEM, V281, P37457, DOI 10.1074/jbc.M605823200; Kocher O, 1998, LAB INVEST, V78, P117; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; Kocher O, 2008, BBA-MOL BASIS DIS, V1782, P310, DOI 10.1016/j.bbadis.2008.02.004; Kocher O, 2009, CURR OPIN LIPIDOL, V20, P236, DOI 10.1097/MOL.0b013e32832aee82; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Seidler U, 2009, EXP PHYSIOL, V94, P175, DOI 10.1113/expphysiol.2008.043018; Silver DL, 2002, J BIOL CHEM, V277, P34042, DOI 10.1074/jbc.M206584200; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; Skelton NJ, 2003, J BIOL CHEM, V278, P7645, DOI 10.1074/jbc.M209751200; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; VAN HAMM, 2003, MOL BIOL REP */* W M, P69; von Ossowski I, 2006, FEBS J, V273, P5219, DOI 10.1111/j.1742-4658.2006.05521.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Yesilaltay A, 2006, ENDOCRINOLOGY, V147, P1577, DOI 10.1210/en.2005-1286; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5; Yesilaltay A, 2006, J BIOL CHEM, V281, P28975, DOI 10.1074/jbc.M603802200; Yesilaltay A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008103; Zhu WF, 2008, CIRC RES, V102, P480, DOI 10.1161/CIRCRESAHA.107.159079	48	19	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34999	35010		10.1074/jbc.M110.164418	http://dx.doi.org/10.1074/jbc.M110.164418			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739281	Green Published, hybrid			2022-12-25	WOS:000283659100074
J	Sethi, N; Yan, Y; Quek, D; Schupbach, T; Kang, YB				Sethi, Nilay; Yan, Yan; Quek, Debra; Schupbach, Trudi; Kang, Yibin			Rabconnectin-3 Is a Functional Regulator of Mammalian Notch Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-ATPASE; OSTEOCLAST PRECURSORS; CELL FATE; ACTIVATION; CANCER; DROSOPHILA; RECEPTOR; PATHWAY; TUMOR; RAVE	The Notch signaling pathway is important for cell fate decisions in embryonic development and adult life. Defining the functional importance of the Notch pathway in these contexts requires the elucidation of essential signal transduction components that have not been fully characterized. Here, we show that Rabconnectin-3B is required for the Notch pathway in mammalian cells. siRNA-mediated silencing of Rabconnectin-3B in mammalian cells attenuated Notch signaling and disrupted the activation and nuclear accumulation of the Notch target Hes1. Rabconnectin-3B knockdown also disrupted V-ATPase activity in mammalian cells, consistent with previous observations in Drosophila. Pharmacological inhibition of the V-ATPase complex significantly reduced Notch signaling in mammalian cells. Finally, Rabconnectin-3B knockdown phenocopied functional disruption of Notch signaling during osteoclast differentiation. Collectively, these findings define an important role for Rabconnectin-3 and V-ATPase activity in the Notch signaling pathway in mammalian cells.	[Sethi, Nilay; Yan, Yan; Quek, Debra; Schupbach, Trudi; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Schupbach, Trudi] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Quek, Debra] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Kang, Yibin] Canc Inst New Jersey, Breast Canc Program, New Brunswick, NJ 08903 USA	Princeton University; Howard Hughes Medical Institute; Princeton University; University of Oxford; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Kang, YB (corresponding author), Princeton Univ, Dept Mol Biol, LTL 255,Washington Rd, Princeton, NJ 08544 USA.	ykang@princeton.edu		Kang, Yibin/0000-0002-1626-6730	National Institutes of Health [R01CA134519]; Department of Defense [BC051647]; New Jersey Commission on Cancer Research [09-1075-CCR-EO]; USPHS [R01GM077620]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA134519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077620] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); New Jersey Commission on Cancer Research; USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA134519 (to Y.K.). This work was also supported by Department of Defense Grant BC051647 and the New Jersey Commission on Cancer Research Grant 09-1075-CCR-EO.; Supported by a predoctoral fellowship from New Jersey Commission on Cancer Research.; Supported by National Institutes of Health Grant R01GM077620 from USPHS and the Howard Hughes Medical Institute.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Demehri S, 2009, CANCER CELL, V16, P55, DOI 10.1016/j.ccr.2009.05.016; Fortini ME, 2009, CURR OPIN GENET DEV, V19, P323, DOI 10.1016/j.gde.2009.04.005; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; JE K, 2003, EMBO REP, V4, P1163; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Sasazawa Y, 2009, CANCER SCI, V100, P1460, DOI 10.1111/j.1349-7006.2009.01194.x; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Tao JN, 2010, ANN NY ACAD SCI, V1192, P257, DOI 10.1111/j.1749-6632.2009.05307.x; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Vaccari T, 2010, DEVELOPMENT, V137, P1825, DOI 10.1242/dev.045484; Watt FM, 2008, CURR OPIN CELL BIOL, V20, P171, DOI 10.1016/j.ceb.2008.01.010; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Wu YC, 2009, BIOCHEM BIOPH RES CO, V382, P451, DOI 10.1016/j.bbrc.2009.03.051; Yamada T, 2003, BLOOD, V101, P2227, DOI 10.1182/blood-2002-06-1740; Yan Y, 2009, DEV CELL, V17, P387, DOI 10.1016/j.devcel.2009.07.001; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004	27	50	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34757	34764		10.1074/jbc.M110.158634	http://dx.doi.org/10.1074/jbc.M110.158634			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810660	hybrid, Green Published			2022-12-25	WOS:000283659100051
J	Fukunaga-Kalabis, M; Martinez, G; Nguyen, TK; Kim, D; Santiago-Walker, A; Roesch, A; Herlyn, M				Fukunaga-Kalabis, M.; Martinez, G.; Nguyen, T. K.; Kim, D.; Santiago-Walker, A.; Roesch, A.; Herlyn, M.			Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population	ONCOGENE			English	Article						tenascin; ABCB5; side population	STEM-CELLS; MATRICELLULAR PROTEINS; GENE-EXPRESSION; CANCER CELLS; GROWTH; RESISTANCE; SURVIVAL; IDENTIFICATION; SUBPOPULATION; ACTIVATION	Tenascin-C (TNC) is highly expressed in melanoma; however, little is known about its functions. Recent studies indicate that TNC has a role within the stem cell niche. We hypothesized that TNC creates a specific environment for melanoma cells to show a stem cell-like phenotype, promoting tumor growth and evading conventional therapies. TNC expression was strongly upregulated in melanoma cells grown as 3D spheres (enriched for stem-like cells) when compared to adherent cells. Down-modulation of TNC by shRNA lentiviruses significantly decreased the growth of melanoma spheres. The incidence of pulmonary metastases after intravenous injection of TNC knockdown cells was significantly lower in NOD/SCID IL2R gamma(null) mice compared with control cells. Melanoma spheres contain an increased number of side population (SP) cells, which show stem cell characteristics, and have the potential for drug resistance due to their high efflux capacity. Knockdown of TNC dramatically decreased the SP fraction in melanoma spheres and lowered their resistance to doxorubicin treatment, likely because of the downregulation of multiple ATP-binding cassette (ABC) transporters, including ABCB5. These data suggest that TNC is critical in melanoma progression as it mediates protective signals in the therapy-resistant population of melanoma. Oncogene (2010) 29, 6115-6124; doi:10.1038/onc.2010.350; published online 23 August 2010	[Fukunaga-Kalabis, M.; Martinez, G.; Nguyen, T. K.; Kim, D.; Santiago-Walker, A.; Roesch, A.; Herlyn, M.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Div Mol & Cellular Biol, Philadelphia, PA 19104 USA	The Wistar Institute	Herlyn, M (corresponding author), Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Div Mol & Cellular Biol, 3601 Spruce St,489 WISTAR, Philadelphia, PA 19104 USA.	herlynm@wistar.org			NCI [CA25874, CA47159, CA93372, CA10815]; NATIONAL CANCER INSTITUTE [P50CA093372, P30CA010815, R01CA047159, R01CA225874, P01CA025874, R01CA076674] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the NCI (CA25874, CA47159, CA93372, CA10815). We thank Angela Cipolla, Sarah Telson and Kate M Belser for technical assistance. This work was also supported by Ellen Heber-Katz, James Hayden and Frederick Keeney (The Wistar Microscopy Facility), Russell Delgiacco (The Wistar Histotechnology Facility), Jonni Moore and Hank Fletcher (University of Pennsylvania, Flow Cytometry Core Facility) and The Wistar Animal Facility.	Bidard FC, 2008, CANCER METAST REV, V27, P5, DOI 10.1007/s10555-007-9103-x; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; Cohen ED, 2009, J CLIN INVEST, V119, P2538, DOI 10.1172/JCI38079; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Fukunaga-Kalabis M, 2006, J CELL BIOL, V175, P563, DOI 10.1083/jcb.200602132; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Grichnik JM, 2006, J INVEST DERMATOL, V126, P142, DOI 10.1038/sj.jid.5700017; Helleman J, 2008, CLIN CANCER RES, V14, P5555, DOI 10.1158/1078-0432.CCR-08-0555; HERLYN M, 1991, CANCER RES, V51, P4853; Hsu MY, 1998, AM J PATHOL, V153, P1435, DOI 10.1016/S0002-9440(10)65730-6; Jang JH, 2005, CANCER LETT, V229, P101, DOI 10.1016/j.canlet.2004.12.012; Jones PL, 1997, J CELL BIOL, V139, P279, DOI 10.1083/jcb.139.1.279; Jonker JW, 2005, STEM CELLS, V23, P1059, DOI 10.1634/stemcells.2005-0150; Kabashima A, 2009, INT J CANCER, V124, P2771, DOI 10.1002/ijc.24349; Katoh SY, 2008, J BIOCHEM, V143, P517, DOI 10.1093/jb/mvm242; Kloepper JE, 2008, EXP DERMATOL, V17, P592, DOI 10.1111/j.1600-0625.2008.00720.x; Kuo MT, 2002, ONCOGENE, V21, P1945, DOI 10.1038/sj.onc.1205117; Marchionini DM, 2003, J COMP NEUROL, V464, P172, DOI 10.1002/cne.10785; Matsuzaki Y, 2008, AM J RESP CELL MOL, V38, P551, DOI 10.1165/rcmb.2007-0311OC; Mouthon MA, 2006, J NEUROCHEM, V99, P807, DOI 10.1111/j.1471-4159.2006.04118.x; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; Nakanishi T, 2006, BLOOD, V108, P678, DOI 10.1182/blood-2005-10-4020; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nishii T, 2009, CANCER SCI, V100, P1397, DOI 10.1111/j.1349-7006.2009.01211.x; Orend G, 2006, CANCER LETT, V244, P143, DOI 10.1016/j.canlet.2006.02.017; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Refaeli Y, 2009, EMBO REP, V10, P965, DOI 10.1038/embor.2009.184; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; Susanto J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004023; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TUOMINEN H, 1994, J CUTAN PATHOL, V21, P424, DOI 10.1111/j.1600-0560.1994.tb00284.x; Villuendas R, 2006, LEUKEMIA, V20, P1047, DOI 10.1038/sj.leu.2404197; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984	46	65	68	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	46					6115	6124		10.1038/onc.2010.350	http://dx.doi.org/10.1038/onc.2010.350			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	681XD	20729912	Green Accepted			2022-12-25	WOS:000284356500004
J	Melillo, RM; Guarino, V; Avilla, E; Galdiero, MR; Liotti, F; Prevete, N; Rossi, FW; Basolo, F; Ugolini, C; de Paulis, A; Santoro, M; Marone, G				Melillo, R. M.; Guarino, V.; Avilla, E.; Galdiero, M. R.; Liotti, F.; Prevete, N.; Rossi, F. W.; Basolo, F.; Ugolini, C.; de Paulis, A.; Santoro, M.; Marone, G.			Mast cells have a protumorigenic role in human thyroid cancer	ONCOGENE			English	Article						chemokine; mast cell; thyroid cancer	ENDOTHELIAL GROWTH-FACTOR; PAPILLARY CARCINOMA; FOLLICULAR CELLS; TUMOR-GROWTH; INFLAMMATION; EXPRESSION; LINES; BRAF; ANGIOGENESIS; ACTIVATION	In different human carcinoma types, mast cell infiltrate increases with respect to normal tissue and mast cell density correlates with a bad prognosis. To assess the role of mast cells in human thyroid cancer, we compared the density of tryptase-positive mast cells in 96 papillary thyroid carcinomas (PTCs) versus normal thyroid tissue from 14 healthy individuals. Mast cell density was higher in 95% of PTCs (n - 91) than in control tissue. Mast cell infiltrate correlated with extrathyroidal extension (P = 0.0005) of PTCs. We show that thyroid cancer cell-line-derived soluble factors induce mast cell activation and chemoattraction in vitro. Different mast cell lines (HMC-1 and LAD2) and primary human lung mast cells induced thyroid cancer cell invasive ability, survival and DNA synthesis in vitro. The latter effect was mainly mediated by three mast-cell-derived mediators: histamine, and chemokines CXCL1/GRO alpha and CXCL10/IP10. We show that xenografts of thyroid carcinoma cells (8505-C) could recruit mast cells injected into the tail vein of mice. Co-injection of human mast cells accelerated the growth of thyroid cancer cell (8505-C) xenografts in athymic mice. This effect was mediated by increased tumor vascularization and proliferation, and was reverted by treating mice with sodium cromoglycate (Cromolyn), a specific mast cell inhibitor. In conclusion, our study data suggest that mast cells are recruited into thyroid carcinomas and promote proliferation, survival and invasive ability of cancer cells, thereby contributing to thyroid carcinoma growth and invasiveness. Oncogene (2010) 29, 6203-6215; doi:10.1038/onc.2010.348; published online 23 August 2010	[Melillo, R. M.; Guarino, V.; Avilla, E.; Liotti, F.; Santoro, M.] Univ Naples Federico 2, DBPCM, IEOS, CNR, I-80131 Naples, Italy; [Galdiero, M. R.; Prevete, N.; Rossi, F. W.; de Paulis, A.; Marone, G.] Univ Naples Federico 2, Div Immunol Clin & Allergol, Ctr Interdipartimentale Ric Sci Immunol Base & Cl, I-80131 Naples, Italy; [Melillo, R. M.] Fac Sci Biotecnol, Naples, Italy; [Basolo, F.; Ugolini, C.] Univ Pisa, Dipartimento Chirurg, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Naples Federico II; University of Pisa	Melillo, RM (corresponding author), Univ Naples Federico 2, DBPCM, IEOS, CNR, Via S Pansini 5, I-80131 Naples, Italy.	rosmelil@unina.it	GALDIERO, MARIA ROSARIA/J-6869-2018; UGOLINI, Clara/AAG-1760-2019; Liotti, Federica/AAC-1614-2019; melillo, rosa marina/O-5255-2015; Basolo, Fulvio/AAC-2727-2019; UGOLINI, CLARA/AAI-6489-2021	GALDIERO, MARIA ROSARIA/0000-0002-8086-9130; UGOLINI, Clara/0000-0002-3489-8280; Liotti, Federica/0000-0002-0145-988X; Basolo, Fulvio/0000-0003-1657-5020; MELILLO, Rosa Marina/0000-0002-9233-5275; de Paulis, Amato/0000-0003-0347-2540	Associazione Italiana per la Ricerca sul Cancro (AIRC); Istituto Superiore di Oncologia (ISO); Project 'Applicazioni Biotecnologiche dalle molecole all'uomo' (MoMa); EC [03695]; Project 'Sviluppo di nuovi farmaci capaci alterare il microambiente tumorale e ripristinare la risposta immune anti-tumorale' (ACC); Project 'Molecular diagnostic and prognostic markers of thyroid neoplasis' [RF-CAM-353005]	Associazione Italiana per la Ricerca sul Cancro (AIRC); Istituto Superiore di Oncologia (ISO); Project 'Applicazioni Biotecnologiche dalle molecole all'uomo' (MoMa); EC(European CommissionEuropean Commission Joint Research Centre); Project 'Sviluppo di nuovi farmaci capaci alterare il microambiente tumorale e ripristinare la risposta immune anti-tumorale' (ACC); Project 'Molecular diagnostic and prognostic markers of thyroid neoplasis'	We would like to dedicate this paper to the memory of Professor Gaetano Salvatore, who continues to inspire our work. We are indebted to AS Kirshenbaum and JH Butterfield for the LAD2 and HMC-1 cell lines, respectively and to F Curcio for the P5 primary thyroid culture. We thank Mario Galgani and Salvatore De Simone for PBMC purification and 8505-C GFP-expressing cell sorting. We also thank Jean Ann Gilder for text editing. This study was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC), the Istituto Superiore di Oncologia (ISO), the Project 'Applicazioni Biotecnologiche dalle molecole all'uomo' (MoMa), the EC Contract 03695 (GenRisk-T), the Project 'Sviluppo di nuovi farmaci capaci alterare il microambiente tumorale e ripristinare la risposta immune anti-tumorale' (ACC) and the Project 'Molecular diagnostic and prognostic markers of thyroid neoplasis' RF-CAM-353005 of the Health Ministry. VG was a fellow of the Fondazione Italiana per la Ricerca sul Cancro (FIRC).	Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Borrello MG, 2008, CANCER LETT, V267, P262, DOI 10.1016/j.canlet.2008.03.060; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Castellone MD, 2004, ONCOGENE, V23, P5958, DOI 10.1038/sj.onc.1207790; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; CURCIO F, 1994, P NATL ACAD SCI USA, V91, P9004, DOI 10.1073/pnas.91.19.9004; de la Torre NG, 2006, ENDOCR-RELAT CANCER, V13, P931, DOI 10.1677/erc.1.01210; de Paulis A, 2006, J IMMUNOL, V177, P7322, DOI 10.4049/jimmunol.177.10.7322; Detoraki A, 2009, J ALLERGY CLIN IMMUN, V123, P1142, DOI 10.1016/j.jaci.2009.01.044; Di Pasquale M, 2001, HUM PATHOL, V32, P24, DOI 10.1053/hupa.2001.21138; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Huang B, 2008, BLOOD, V112, P1269, DOI 10.1182/blood-2008-03-147033; Jo YS, 2006, J CLIN ENDOCR METAB, V91, P3667, DOI 10.1210/jc.2005-2836; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Klein M, 2001, J CLIN ENDOCR METAB, V86, P656, DOI 10.1210/jc.86.2.656; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marone G, 2005, ADV IMMUNOL, V88, P97, DOI 10.1016/S0065-2776(05)88004-6; Melillo RM, 2005, J CLIN INVEST, V115, P1068, DOI 10.1172/JCI22758; Nakayama T, 2004, J CLIN INVEST, V114, P1317, DOI 10.1172/JCI200422089; Parsons ME, 2006, BRIT J PHARMACOL, V147, pS127, DOI 10.1038/sj.bjp.0706440; Pufnock JS, 2009, J IMMUNOL, V182, P5498, DOI 10.4049/jimmunol.0801284; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Rhoden KJ, 2006, J CLIN ENDOCR METAB, V91, P2414, DOI 10.1210/jc.2006-0240; Rivera ES, 2000, SEMIN CANCER BIOL, V10, P15, DOI 10.1006/scbi.2000.0303; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Salvatore G, 2006, CLIN CANCER RES, V12, P1623, DOI 10.1158/1078-0432.CCR-05-2378; Scarpino S, 2000, AM J PATHOL, V156, P831, DOI 10.1016/S0002-9440(10)64951-6; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Theoharides TC, 2004, TRENDS IMMUNOL, V25, P235, DOI 10.1016/j.it.2004.02.013; VIGLIETTO G, 1995, ONCOGENE, V11, P1569; Visconti R, 1997, ONCOGENE, V15, P1987, DOI 10.1038/sj.onc.1201373; Welsh TJ, 2005, J CLIN ONCOL, V23, P8959, DOI 10.1200/JCO.2005.01.4910; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041	39	147	152	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2010	29	47					6203	6215		10.1038/onc.2010.348	http://dx.doi.org/10.1038/onc.2010.348			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	685CG	20729915				2022-12-25	WOS:000284601700002
J	Bora, NS; Jha, P; Lyzogubov, VV; Kaliappan, S; Liu, JA; Tytarenko, RG; Fraser, DA; Morgan, BP; Bora, PS				Bora, Nalini S.; Jha, Purushottam; Lyzogubov, Valeriy V.; Kaliappan, Sankaranarayanan; Liu, Juan; Tytarenko, Ruslana G.; Fraser, Deborah A.; Morgan, B. Paul; Bora, Puran S.			Recombinant Membrane-targeted Form of CD59 Inhibits the Growth of Choroidal Neovascular Complex in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOCHOROIDAL HEALING-PROCESSES; MACULAR DEGENERATION; ATTACK COMPLEX; CELL APOPTOSIS; MOUSE MODEL; AGE; REGULATOR; ACTIVATION; INJECTION	This study was designed to explore the effect of recombinant, membrane-targeted CD59 (rCD59-APT542) on the growth and size of fully developed neovascular complex using the murine model of laser-induced choroidal neovascularization (CNV). CNV was induced by laser photocoagulation in C57BL/6 mice using an argon laser, and the animals received rCD59-APT542 via intravitreal (ivt) route. Western blot analysis, immunohistochemistry, and total complement hemolytic assay demonstrated that exogenously administered rCD59-APT542 was incorporated as well as retained in RPE and choroid and was functionally active in vivo. Single ivt injection during the growth of the CNV (i.e. at day 3 post-laser) resulted in similar to 79% inhibition of the further growth of neovascular complex. The size of the CNV complex was significantly (p< 0.05) reduced by the administration of rCD59-APT542 after the CNV complex has fully developed (i.e. at day 7 post-laser). Treatment with rCD59-APT542 blocked the formation of membrane attack complex (MAC), increased apoptosis and decreased cell proliferation in the neovascular complex. On the basis of results presented here we conclude that recombinant membrane targeted CD59 inhibited the growth of the CNV complex and reduced the size of fully developed CNV in the laser-induced mouse model. We propose that a combination of two mechanisms: increased apoptosis and decreased cell proliferation, both resulting from local inhibition of MAC, may be responsible for inhibition of CNV by rCD59-APT542.	[Bora, Nalini S.; Jha, Purushottam; Lyzogubov, Valeriy V.; Kaliappan, Sankaranarayanan; Liu, Juan; Tytarenko, Ruslana G.; Bora, Puran S.] Univ Arkansas Med Sci, Jones Eye Inst, Dept Ophthalmol, Pat & Willard Walker Eye Res Ctr, Little Rock, AR 72205 USA; [Fraser, Deborah A.; Morgan, B. Paul] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales	University of Arkansas System; University of Arkansas Medical Sciences; Cardiff University	Bora, NS (corresponding author), Univ Arkansas Med Sci, Jones Eye Inst, Dept Ophthalmol, Pat & Willard Walker Eye Res Ctr, 4301 W Markham,523, Little Rock, AR 72205 USA.	NBora@UAMS.edu; PBora@UAMS.edu		Bora, Puran/0000-0003-4781-1217; Morgan, Paul/0000-0003-4075-7676	National Institutes of Health [EY014623, EY018812, 2P20 RR16460]; Pat & Willard Walker Eye Research Center, Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR; National Institutes of Health/NCRR [1 S10 RR 19395]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016460, S10RR019395] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018812, R01EY014623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pat & Willard Walker Eye Research Center, Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR; National Institutes of Health/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in, whole or in part, by National Institutes of Health Grants EY014623 and EY018812, and the Pat & Willard Walker Eye Research Center, Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR.; We thank Dr. Claire L. Harris and Dr. Richard A. Smith for helpful comments. The Digital and Confocal Microscopy Laboratory, University of Arkansas for Medical Sciences was supported by National Institutes of Health Grant 2P20 RR16460 and National Institutes of Health/NCRR Grant 1 S10 RR 19395.	Acosta J, 2000, P NATL ACAD SCI USA, V97, P5450, DOI 10.1073/pnas.97.10.5450; Baalasubramanian S, 2004, J IMMUNOL, V173, P3684, DOI 10.4049/jimmunol.173.6.3684; Bora NS, 2007, J IMMUNOL, V178, P1783, DOI 10.4049/jimmunol.178.3.1783; Bora NS, 2006, J IMMUNOL, V177, P1872, DOI 10.4049/jimmunol.177.3.1872; Bora PS, 2006, FEBS J, V273, P1403, DOI 10.1111/j.1742-4658.2006.05163.x; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491; Campochiaro PA, 2000, J CELL PHYSIOL, V184, P301, DOI 10.1002/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H; Capey S, 2007, MOL IMMUNOL, V44, P608, DOI 10.1016/j.molimm.2006.01.014; Cole DS, 2003, CLIN SCI, V104, P455, DOI 10.1042/CS20020362; Dot C, 2007, EXP EYE RES, V84, P1081, DOI 10.1016/j.exer.2007.01.024; Dot C, 2009, MOL VIS, V15, P670; Evans JR, 2001, PROG RETIN EYE RES, V20, P227, DOI 10.1016/S1350-9462(00)00023-9; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Fraser DA, 2003, J BIOL CHEM, V278, P48921, DOI 10.1074/jbc.M302598200; Fraser DA, 2002, PROTEIN SCI, V11, P2512, DOI 10.1110/ps.0212402; HALPERIN JA, 1993, J CLIN INVEST, V91, P1974, DOI 10.1172/JCI116418; Harris CL, 2003, IMMUNOLOGY, V109, P117, DOI 10.1046/j.1365-2567.2003.01628.x; Hughes J, 2000, AM J PHYSIOL-RENAL, V278, pF747, DOI 10.1152/ajprenal.2000.278.5.F747; Husain Deeba, 2002, Ophthalmol Clin North Am, V15, P87, DOI 10.1016/S0896-1549(01)00009-8; Jha P, 2007, MOL IMMUNOL, V44, P3901, DOI 10.1016/j.molimm.2007.06.145; Lewis RD, 2010, MOL IMMUNOL, V47, P1098, DOI 10.1016/j.molimm.2009.10.035; Lyzogubov VV, 2009, CELL BIOL INT, V33, P765, DOI 10.1016/j.cellbi.2009.04.013; Nauta AJ, 2002, EUR J IMMUNOL, V32, P783, DOI 10.1002/1521-4141(200203)32:3<783::AID-IMMU783>3.0.CO;2-Q; Ryan S J, 1979, Trans Am Ophthalmol Soc, V77, P707; Sato T, 1999, J AM SOC NEPHROL, V10, P1242; Schmack I, 2009, MOL VIS, V15, P146; Smith GP, 2001, MOL IMMUNOL, V38, P249, DOI 10.1016/S0161-5890(01)00047-5; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P4195	29	41	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33826	33833		10.1074/jbc.M110.153130	http://dx.doi.org/10.1074/jbc.M110.153130			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20736175	hybrid, Green Published			2022-12-25	WOS:000283354000029
J	Shichi, D; Arimura, T; Ishikawa, T; Kimura, A				Shichi, Daisuke; Arimura, Takuro; Ishikawa, Taisuke; Kimura, Akinori			Heart-specific Small Subunit of Myosin Light Chain Phosphatase Activates Rho-associated Kinase and Regulates Phosphorylation of Myosin Phosphatase Target Subunit 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING PROTEIN-KINASE; SMOOTH-MUSCLE; BINDING SUBUNIT; CA2+ SENSITIVITY; IN-VIVO; IDENTIFICATION; ISOFORM; MYPT2; CARDIOMYOPATHY; CONTRACTION	Phosphorylation of myosin regulatory light chain (MLC) plays a regulatory role in muscle contraction, and the level of MLC phosphorylation is balanced by MLC kinase and MLC phosphatase (MLCP). MLCP consists of a catalytic subunit, a large subunit (MYPT1 or MYPT2), and a small subunit. MLCP activity is regulated by phosphorylation of MYPTs, whereas the role of small subunit in the regulation remains unknown. We previously characterized a human heart-specific small subunit (hHS-M-21) that increased the sensitivity to Ca2+ in muscle contraction. In this study, we investigated the role of hHS-M-21 in the regulation of MLCP phosphorylation. Two isoforms of hHS-M-21, hHS-M(21)A and hHS-M21B, preferentially bound the C-terminal one-third region of MYPT1 and MYPT2, respectively. Amino acid substitutions at a phosphorylation site of MYPT1, Ser-852, impaired the binding of MYPT1 and hHS-M-21. The hHS-M21 increased the phosphorylation level of MYPT1 at Thr-696, which was attenuated by Rho-associated kinase (ROCK) inhibitors and small interfering RNAs for ROCK. In addition, hHS-M-21 bound ROCK and enhanced the ROCK activity. These findings suggest that hHS-M-21 is a heart-specific effector of ROCK and plays a regulatory role in the MYPT1 phosphorylation at Thr-696 by ROCK.	[Shichi, Daisuke; Arimura, Takuro; Ishikawa, Taisuke; Kimura, Akinori] Tokyo Med & Dent Univ, Dept Mol Pathogenesis, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan; [Kimura, Akinori] Tokyo Med & Dent Univ, Lab Genome Divers, Sch Biomed Sci, Bunkyo Ku, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Kimura, A (corresponding author), Tokyo Med & Dent Univ, Dept Mol Pathogenesis, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan.	akitis@mri.tmd.ac.jp	Kimura, Akinori/I-5989-2018; Ishikawa, Taisuke/D-1567-2019; Arimura, Takuro/AAA-2745-2022	Kimura, Akinori/0000-0002-4933-2132; Ishikawa, Taisuke/0000-0001-8195-4700; Arimura, Takuro/0000-0002-0929-3140	Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science; Ministry of Health, Labour, and Welfare, Japan; Health Sciences of the National Institute of Biomedical Innovation; Medical Research Institute, Tokyo Medical and Dental University [11737]; Institute of Life Science; Tokyo Medical and Dental University	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Medical Research Institute, Tokyo Medical and Dental University; Institute of Life Science; Tokyo Medical and Dental University	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan, grants for Japan-France collaboration research and Japan-Korea collaboration research from the Japan Society for the Promotion of Science, research grants from the Ministry of Health, Labour, and Welfare, Japan, grants from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Grant 11737 from the "Association Francaise Contre les Myopathies," a research grant for young investigators from Medical Research Institute, Tokyo Medical and Dental University, research grants from the Institute of Life Science, and by follow-up grants provided from the Tokyo Medical and Dental University.	Amano M, 2003, J NEUROCHEM, V87, P780, DOI 10.1046/j.1471-4159.2003.02054.x; Aoki H, 2000, NAT MED, V6, P183, DOI 10.1038/72287; Arimura T, 2001, J BIOL CHEM, V276, P6073, DOI 10.1074/jbc.M008566200; Arimura T, 2009, CARDIOVASC RES, V83, P80, DOI 10.1093/cvr/cvp119; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; CHEN YH, 1994, FEBS LETT, V356, P51, DOI 10.1016/0014-5793(94)01231-8; Davis JS, 2001, CELL, V107, P631, DOI 10.1016/S0092-8674(01)00586-4; Endo A, 2004, J BIOL CHEM, V279, P42055, DOI 10.1074/jbc.M403676200; Feng JH, 1999, J BIOL CHEM, V274, P37385, DOI 10.1074/jbc.274.52.37385; Fujioka M, 1998, GENOMICS, V49, P59, DOI 10.1006/geno.1998.5222; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Hagerty L, 2007, J BIOL CHEM, V282, P4884, DOI 10.1074/jbc.M609990200; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; KAMISOYAMA H, 1994, BIOCHEMISTRY-US, V33, P840, DOI 10.1021/bi00169a027; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Khromov A, 2009, J BIOL CHEM, V284, P21569, DOI 10.1074/jbc.M109.019729; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Matsumura F, 2001, CELL STRUCT FUNCT, V26, P639, DOI 10.1247/csf.26.639; Moorhead G, 1998, FEBS LETT, V438, P141, DOI 10.1016/S0014-5793(98)01276-9; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Murata-Hori M, 2001, ONCOGENE, V20, P8175, DOI 10.1038/sj.onc.1205055; Okamoto R, 2006, CELL SIGNAL, V18, P1408, DOI 10.1016/j.cellsig.2005.11.001; Seguchi O, 2007, J CLIN INVEST, V117, P2812, DOI 10.1172/JCI30804; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Takizawa N, 2002, BIOCHEM BIOPH RES CO, V297, P773, DOI 10.1016/S0006-291X(02)02302-1; Wang YP, 2009, CIRC RES, V104, P531, DOI 10.1161/CIRCRESAHA.108.188524; WILSON AK, 1991, J CELL BIOL, V114, P277, DOI 10.1083/jcb.114.2.277; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200; Zhou YB, 1999, BIOCHEM BIOPH RES CO, V254, P158, DOI 10.1006/bbrc.1998.9915	34	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33680	33690		10.1074/jbc.M110.122390	http://dx.doi.org/10.1074/jbc.M110.122390			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20801872	hybrid, Green Published			2022-12-25	WOS:000283354000013
J	Bremer, J; O'Connor, T; Tiberi, C; Rehrauer, H; Weis, J; Aguzzi, A				Bremer, Juliane; O'Connor, Tracy; Tiberi, Cinzia; Rehrauer, Hubert; Weis, Joachim; Aguzzi, Adriano			Ablation of Dicer from Murine Schwann Cells Increases Their Proliferation while Blocking Myelination	PLOS ONE			English	Article							DIFFERENTIATION; MORPHOGENESIS; INHIBITION; MECHANISMS; MICRORNA; PATHWAY; MIRNAS	The myelin sheaths that surround the thick axons of the peripheral nervous system are produced by the highly specialized Schwann cells. Differentiation of Schwann cells and myelination occur in discrete steps. Each of these requires coordinated expression of specific proteins in a precise sequence, yet the regulatory mechanisms controlling protein expression during these events are incompletely understood. Here we report that Schwann cell-specific ablation of the enzyme Dicer1, which is required for the production of small non-coding regulatory microRNAs, fully arrests Schwann cell differentiation, resulting in early postnatal lethality. Dicer(-/-) Schwann cells had lost their ability to myelinate, yet were still capable of sorting axons. Both cell death and, paradoxically, proliferation of immature Schwann cells was markedly enhanced, suggesting that their terminal differentiation is triggered by growth-arresting regulatory microRNAs. Using microRNA microarrays, we identified 16 microRNAs that are upregulated upon myelination and whose expression is controlled by Dicer in Schwann cells. This set of microRNAs appears to drive Schwann cell differentiation and myelination of peripheral nerves, thereby fulfilling a crucial function for survival of the organism.	[Bremer, Juliane; O'Connor, Tracy; Tiberi, Cinzia; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Weis, Joachim] Rhein Westfal TH Aachen, Fac Med, Inst Neuropathol, Aachen, Germany; [Rehrauer, Hubert] Univ Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland	University of Zurich; University Zurich Hospital; RWTH Aachen University; University of Zurich	Bremer, J (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch	Bremer, Juliane/AAH-9487-2020; Bremer, Juliane/E-2298-2012; Weis, Joachim/G-1984-2014; Aguzzi, Adriano/A-3351-2008	Weis, Joachim/0000-0003-3280-6773; Aguzzi, Adriano/0000-0002-0344-6708	European Research Council; European Union; Swiss National Foundation; Novartis Foundation; University of Zurich	European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Novartis Foundation(Novartis); University of Zurich	AA is the recipient of an Advanced Investigator Grant of the European Research Council and of grants by the European Union (PRIORITY and LUPAS), the Swiss National Foundation, and the Novartis Foundation. JB received a Career Development Award of the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Ebenezer GJ, 2007, BRAIN, V130, P2703, DOI 10.1093/brain/awm199; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; HEUSS D, 2008, DIAGNOSTIK BEI POLYN; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; KIM HA, 1995, ONCOGENE, V11, P325; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Letzen BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010480; LEWIS MA, 2010, MICRORNAS MOUSE DEV; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Lindeboom F, 2003, NUCLEIC ACIDS RES, V31, P5405, DOI 10.1093/nar/gkg723; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; PANG RT, 2010, CARCINOGENESIS; Pereira JA, 2010, J NEUROSCI, V30, P6763, DOI 10.1523/JNEUROSCI.0801-10.2010; RIDLEY AJ, 1988, EMBO J, V7, P1635, DOI 10.1002/j.1460-2075.1988.tb02990.x; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Subramanian S, 2010, J PATHOL, V220, P58, DOI 10.1002/path.2633; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Tapinos N, 2005, P NATL ACAD SCI USA, V102, P9188, DOI 10.1073/pnas.0501196102; Verrier JD, 2009, GLIA, V57, P1265, DOI 10.1002/glia.20846; Woodhoo A, 2009, NAT NEUROSCI, V12, P839, DOI 10.1038/nn.2323; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	33	66	68	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12450	10.1371/journal.pone.0012450	http://dx.doi.org/10.1371/journal.pone.0012450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805985	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000281301500016
J	Poroyko, V; White, JR; Wang, M; Donovan, S; Alverdy, J; Liu, DC; Morowitz, MJ				Poroyko, Valeriy; White, James Robert; Wang, Mei; Donovan, Sharon; Alverdy, John; Liu, Donald C.; Morowitz, Michael J.			Gut Microbial Gene Expression in Mother-Fed and Formula-Fed Piglets	PLOS ONE			English	Article							REAL-TIME PCR; HUMAN PLASMINOGEN; ESCHERICHIA-COLI; NECROTIZING ENTEROCOLITIS; SALMONELLA-TYPHIMURIUM; GASTROINTESTINAL-TRACT; INTESTINAL MICROBIOTA; FED INFANTS; HUMAN-MILK; BIFIDOBACTERIUM	Background: Effects of diet on the structure and function of gut microbial communities in newborn infants are poorly understood. High-resolution molecular studies are needed to definitively ascertain whether gut microbial communities are distinct in milk-fed and formula-fed infants. Methodology/Principal Findings: Pyrosequencing-based whole transcriptome shotgun sequencing (RNA-seq) was used to evaluate community wide gut microbial gene expression in 21 day old neonatal piglets fed either with sow's milk (mother fed, MF; n = 4) or with artificial formula (formula fed, FF; n = 4). Microbial DNA and RNA were harvested from cecal contents for each animal. cDNA libraries and 16S rDNA amplicons were sequenced on the Roche 454 GS-FLX Titanium system. Communities were similar at the level of phylum but were dissimilar at the level of genus; Prevotella was the dominant genus within MF samples and Bacteroides was most abundant within FF samples. Screened cDNA sequences were assigned functional annotations by the MG-RAST annotation pipeline and based upon best-BLASTX-hits to the NCBI COG database. Patterns of gene expression were very similar in MF and FF animals. All samples were enriched with transcripts encoding enzymes for carbohydrate and protein metabolism, as well as proteins involved in stress response, binding to host epithelium, and lipopolysaccharide metabolism. Carbohydrate utilization transcripts were generally similar in both groups. The abundance of enzymes involved in several pathways related to amino acid metabolism (e.g., arginine metabolism) and oxidative stress response differed in MF and FF animals. Conclusions/Significance: Abundant transcripts identified in this study likely contribute to a core microbial metatranscriptome in the distal intestine. Although microbial community gene expression was generally similar in the cecal contents of MF and FF neonatal piglets, several differentially abundant gene clusters were identified. Further investigations of gut microbial gene expression will contribute to a better understanding of normal and abnormal enteric microbiology in animals and humans.	[Poroyko, Valeriy; Alverdy, John; Liu, Donald C.; Morowitz, Michael J.] Univ Chicago, Pritzker Sch Med, Dept Surg, Chicago, IL 60637 USA; [Liu, Donald C.; Morowitz, Michael J.] Univ Chicago, Pritzker Sch Med, Dept Pediat, Chicago, IL 60637 USA; [Wang, Mei; Donovan, Sharon] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [White, James Robert] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	University of Chicago; University of Chicago; University of Illinois System; University of Illinois Urbana-Champaign; University System of Maryland; University of Maryland College Park	Poroyko, V (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Surg, Chicago, IL 60637 USA.	morowitz@uchicago.edu	Donovan, Sharon/AAY-6787-2020	Donovan, Sharon/0000-0002-9785-4189; Wang, Mei/0000-0003-0379-6633	Surgical Infection Society; March of Dimes Foundation; NIH [R01 HD61929]; Bristol Myers-Squibb; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061929] Funding Source: NIH RePORTER	Surgical Infection Society; March of Dimes Foundation(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol Myers-Squibb(Bristol-Myers Squibb); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by funding from the Surgical Infection Society (MM) and the March of Dimes Foundation (MM), as well as Bristol Myers-Squibb (SMD) and NIH R01 HD61929 (SMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EE, 2005, NAT REV MICROBIOL, V3, P489, DOI 10.1038/nrmicro1157; Amin HJ, 2002, J PEDIATR-US, V140, P425, DOI 10.1067/mpd.2002.123289; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Aycicek A, 2006, NUTRITION, V22, P616, DOI 10.1016/j.nut.2005.12.011; Bertolo RF, 2008, J NUTR, V138, p2032S, DOI 10.1093/jn/138.10.2032S; Candela M, 2007, J BACTERIOL, V189, P5929, DOI 10.1128/JB.00159-07; Candela M, 2009, MICROBIOL-SGM, V155, P3294, DOI 10.1099/mic.0.028795-0; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Egea L, 2007, INT J BIOCHEM CELL B, V39, P1190, DOI 10.1016/j.biocel.2007.03.008; EIDELS L, 1971, P NATL ACAD SCI USA, V68, P1673, DOI 10.1073/pnas.68.8.1673; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Friel JK, 2002, PEDIATR RES, V51, P612, DOI 10.1203/00006450-200205000-00012; Fugier E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000487; Ge JP, 2004, INFECT IMMUN, V72, P6748, DOI 10.1128/IAI.72.11.6748-6752.2004; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; GOLDBERG JB, 1993, J BACTERIOL, V175, P1605, DOI 10.1128/JB.175.6.1605-1611.1993; Gonzalez R, 2008, APPL ENVIRON MICROB, V74, P4686, DOI 10.1128/AEM.00122-08; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hopkins MJ, 2005, FEMS MICROBIOL ECOL, V54, P77, DOI 10.1016/j.femsec.2005.03.001; Houle VM, 1997, PEDIATR RES, V42, P78, DOI 10.1203/00006450-199707000-00013; Houot L, 2010, INFECT IMMUN, V78, P1482, DOI 10.1128/IAI.01356-09; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Klaassens ES, 2007, APPL ENVIRON MICROB, V73, P1388, DOI 10.1128/AEM.01921-06; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Kurtz DM, 2006, J INORG BIOCHEM, V100, P679, DOI 10.1016/j.jinorgbio.2005.12.017; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lerner A, 2009, MICROBIOL-SGM, V155, P4058, DOI 10.1099/mic.0.031807-0; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; LEY RE, P NATL ACAD SCI, V102, P11070; Lin PW, 2006, LANCET, V368, P1271, DOI 10.1016/S0140-6736(06)69525-1; LUNDEQUIST B, 1985, ACTA PAEDIATR SCAND, V74, P45, DOI 10.1111/j.1651-2227.1985.tb10919.x; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Mailloux RJ, 2009, J BACTERIOL, V191, P3804, DOI 10.1128/JB.00046-09; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Morales Y, 2007, SEMIN PERINATOL, V31, P83, DOI 10.1053/j.semperi.2007.02.002; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2005, FEMS MICROBIOL LETT, V243, P141, DOI 10.1016/j.femsle.2004.11.052; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; PRANGLI AL, 2009, PEDIAT ALLERGY IMMUN; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sanchez B, 2009, J MOL MICROB BIOTECH, V17, P158, DOI 10.1159/000233579; Saric J, 2008, J PROTEOME RES, V7, P352, DOI 10.1021/pr070340k; SASAJIMA K, 1983, AGR BIOL CHEM TOKYO, V47, P1375, DOI 10.1080/00021369.1983.10858526; SCHUTTE JB, 1992, BRIT J NUTR, V68, P195, DOI 10.1079/BJN19920077; Sears CL, 2005, ANAEROBE, V11, P247, DOI 10.1016/j.anaerobe.2005.05.001; SHAH P, 2007, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004339.PUB3; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Terra VS, 2010, INFECT IMMUN, V78, P348, DOI 10.1128/IAI.00721-09; Torres AG, 2001, INFECT IMMUN, V69, P6179, DOI 10.1128/IAI.69.10.6179-6185.2001; Tsolis RM, 1996, INFECT IMMUN, V64, P4549, DOI 10.1128/IAI.64.11.4549-4556.1996; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Vaillancourt K, 2008, APPL ENVIRON MICROB, V74, P1264, DOI 10.1128/AEM.01585-07; van Vliet AHM, 2010, FEMS MICROBIOL LETT, V302, P1, DOI 10.1111/j.1574-6968.2009.01767.x; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Zoetendal EG, 2006, NAT PROTOC, V1, P870, DOI 10.1038/nprot.2006.142	74	78	87	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12459	10.1371/journal.pone.0012459	http://dx.doi.org/10.1371/journal.pone.0012459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805981	Green Submitted, Green Published, gold			2022-12-25	WOS:000281301500025
J	Mutch, CA; Schulte, JD; Olson, E; Chenn, A				Mutch, Christopher A.; Schulte, Jessica D.; Olson, Eric; Chenn, Anjen			Beta-Catenin Signaling Negatively Regulates Intermediate Progenitor Population Numbers in the Developing Cortex	PLOS ONE			English	Article							POLYPOSIS-COLI PROTEIN; RADIAL GLIAL-CELLS; SUBVENTRICULAR ZONE; ASYMMETRIC DIVISION; CEREBRAL-CORTEX; NEURONS ARISE; COUP-TFI; EXPRESSION; MOUSE; NEUROGENESIS	Intermediate progenitor cells constitute a second proliferative cell type in the developing mammalian cerebral cortex. Little is known about the factors that govern the production of intermediate progenitors. Although persistent expression of stabilized beta-catenin was found to delay the maturation of radial glial progenitors into intermediate progenitors, the relationship between beta-catenin signaling and intermediate progenitors remains poorly understood. Using a transgenic reporter mouse for Axin2, a direct target of Wnt/beta-catenin signaling, we observed that beta-catenin signaling is decreased in intermediate progenitor cells relative to radial glial progenitors. Conditional deletion of beta-catenin from mouse cortical neural progenitors increased intermediate progenitor numbers, while conditional expression of stabilized beta-catenin reduced the intermediate progenitor population. Together, these findings provide evidence that beta-catenin signaling in radial progenitors negatively regulates intermediate progenitor cell number during cortical development.	[Mutch, Christopher A.; Schulte, Jessica D.; Chenn, Anjen] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Olson, Eric] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY USA	Northwestern University; Feinberg School of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Mutch, CA (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA.	achenn@northwestern.edu		Mutch, Christopher/0000-0003-4556-8460	National Institute of Neurological Disorders and Stroke (NINDS) [RO1 NS047191]; Sontag Foundation Distinguished Scientist Award; March of Dimes Research [6-FY07-401, F30NS051864]; Northwestern University Cellular; Molecular Basis of Disease Training [GM-08061]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS051864, R01NS047191] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Sontag Foundation Distinguished Scientist Award; March of Dimes Research(March of Dimes); Northwestern University Cellular; Molecular Basis of Disease Training; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke (NINDS) RO1 NS047191, Sontag Foundation Distinguished Scientist Award, and March of Dimes Research Grant 6-FY07-401 (A. C.), F30NS051864 (C. M.). J.D.S. is a fellow of the Northwestern University Cellular and Molecular Basis of Disease Training Grant (GM-08061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2007, STEM CELLS, V25, P2827, DOI 10.1634/stemcells.2007-0177; Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Attardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002388; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Bayatti N, 2008, EUR J NEUROSCI, V28, P1449, DOI 10.1111/j.1460-9568.2008.06475.x; Brault V, 2001, DEVELOPMENT, V128, P1253; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; Britz O, 2006, CEREB CORTEX, V16, pI138, DOI 10.1093/cercor/bhj168; Bulfone A, 1999, MECH DEVELOP, V84, P133, DOI 10.1016/S0925-4773(99)00053-2; Castro DS, 2006, DEV CELL, V11, P831, DOI 10.1016/j.devcel.2006.10.006; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Faedo A, 2008, CEREB CORTEX, V18, P2117, DOI 10.1093/cercor/bhm238; Farkas LM, 2008, NEURON, V60, P40, DOI 10.1016/j.neuron.2008.09.020; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Huttner WB, 1997, CURR OPIN NEUROBIOL, V7, P29, DOI 10.1016/S0959-4388(97)80117-1; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kan LX, 2004, DEV BIOL, V269, P580, DOI 10.1016/j.ydbio.2004.02.005; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kormish JD, 2010, DEV DYNAM, V239, P56, DOI 10.1002/dvdy.22046; KOWALCZYK T, 2009, CEREB CORTEX; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kuwahara A, 2010, DEVELOPMENT, V137, P1035, DOI 10.1242/dev.046417; Liu Q, 2000, J NEUROSCI, V20, P7682; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Machon O, 2007, DEV BIOL, V311, P223, DOI 10.1016/j.ydbio.2007.08.038; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Martinez-Cerdeno V, 2006, CEREB CORTEX, V16, pI152, DOI 10.1093/cercor/bhk017; Martinez-Morales PL, 2010, EMBO REP, V11, P466, DOI 10.1038/embor.2010.61; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Mutch CA, 2009, J NEUROSCI, V29, P13710, DOI 10.1523/JNEUROSCI.3022-09.2009; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Quinn JC, 2007, DEV BIOL, V302, P50, DOI 10.1016/j.ydbio.2006.08.035; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Siegenthaler JA, 2008, CEREB CORTEX, V18, P1865, DOI 10.1093/cercor/bhm209; Sinner D, 2004, DEVELOPMENT, V131, P3069, DOI 10.1242/dev.01176; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; SMART IHM, 1973, J ANAT, V116, P67; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; TAKAHASHI T, 1995, J NEUROSCI, V15, P6058; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Weimer JM, 2009, DEVELOPMENT, V136, P2965, DOI 10.1242/dev.036616; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Wrobel CN, 2007, DEV BIOL, V309, P285, DOI 10.1016/j.ydbio.2007.07.013; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025	69	53	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12376	10.1371/journal.pone.0012376	http://dx.doi.org/10.1371/journal.pone.0012376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811503	gold, Green Published, Green Submitted			2022-12-25	WOS:000281234700012
J	Huntington, BE; Karnauskas, M; Babcock, EA; Lirman, D				Huntington, Brittany E.; Karnauskas, Mandy; Babcock, Elizabeth A.; Lirman, Diego			Untangling Natural Seascape Variation from Marine Reserve Effects Using a Landscape Approach	PLOS ONE			English	Article							REEF FISH COMMUNITIES; PROTECTED AREAS; CORAL; ENVIRONMENT; DIVERSITY	Distinguishing management effects from the inherent variability in a system is a key consideration in assessing reserve efficacy. Here, we demonstrate how seascape heterogeneity, defined as the spatial configuration and composition of coral reef habitats, can mask our ability to discern reserve effects. We then test the application of a landscape approach, utilizing advances in benthic habitat mapping and GIS techniques, to quantify this heterogeneity and alleviate the confounding influence during reserve assessment. Seascape metrics were quantified at multiple spatial scales using a combination of spatial image analysis and in situ surveys at 87 patch reef sites in Glover's Reef Lagoon, Belize, within and outside a marine reserve enforced since 1998. Patch reef sites were then clustered into classes sharing similar seascape attributes using metrics that correlated significantly to observed variations in both fish and coral communities. When the efficacy of the marine reserve was assessed without including landscape attributes, no reserve effects were detected in the diversity and abundance of fish and coral communities, despite 10 years of management protection. However, grouping sites based on landscape attributes revealed significant reserve effects between site classes. Fish had higher total biomass (1.5x) and commercially important biomass (1.75x) inside the reserve and coral cover was 1.8 times greater inside the reserve, though direction and degree of response varied by seascape class. Our findings show that the application of a landscape classification approach vastly improves our ability to evaluate the efficacy of marine reserves by controlling for confounding effects of seascape heterogeneity and suggests that landscape heterogeneity should be considered in future reserve design.	[Huntington, Brittany E.; Karnauskas, Mandy; Babcock, Elizabeth A.; Lirman, Diego] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	University of Miami	Huntington, BE (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	bhuntington@rsmas.miami.edu	Babcock, Elizabeth A/E-7753-2013	Karnauskas, Mandy/0000-0002-6631-0592; Babcock, Elizabeth A/0000-0002-2279-6762	Pew Institute for Ocean Science; University of Miami; Explorer's Club	Pew Institute for Ocean Science; University of Miami; Explorer's Club	The Pew Institute for Ocean Science and University of Miami Fellowships provided support to BH and MK. An Explorer's Club Exploration Grant awarded to BH provided additional funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta CA, 2002, MAR ECOL PROG SER, V227, P87, DOI 10.3354/meps227087; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Ault TR, 1998, ECOL MONOGR, V68, P25, DOI 10.1890/0012-9615(1998)068[0025:SATPFO]2.0.CO;2; Balasubramanian H, 2007, MAR ECOL PROG SER, V345, P229, DOI 10.3354/meps06782; Bell SS, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P625; Bohnsack J.A., 1988, NOAA (National Oceanic Atmospheric Administration) Technical Memorandum NMFS (National Marine Fisheries Service) SEFC (Southeast Fisheries Center), P1; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Clarke K., 2001, CHANGES MARINE COMMU, DOI DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Cushman SA, 2004, ECOL APPL, V14, P1090, DOI 10.1890/03-5131; Davis JD, 2007, LANDSCAPE ECOL, V22, P1341, DOI 10.1007/s10980-007-9111-9; Fraschetti S, 2002, MAR ECOL-P S Z N I, V23, P190, DOI 10.1111/j.1439-0485.2002.tb00018.x; Friedlander AM, 2007, ECOL APPL, V17, P715, DOI 10.1890/06-0536; Garcia-Charton JA, 2000, ENVIRON CONSERV, V27, P159, DOI 10.1017/S0376892900000199; GIBSON J, 2006, MANAGEMENT EFFECTIVE, P1; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Grober-Dunsmore R, 2007, CORAL REEFS, V26, P201, DOI 10.1007/s00338-006-0180-z; Grober-Dunsmore R, 2008, LANDSCAPE ECOL, V23, P37, DOI 10.1007/s10980-007-9147-x; Grober-Dunsmore R, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P493, DOI 10.1007/978-90-481-2406-0_14; Halpern BS, 2003, ECOL APPL, V13, pS117; Hamilton SL, 2010, P NATL ACAD SCI USA, V107, P18272, DOI 10.1073/pnas.0908091107; Harborne AR, 2008, J APPL ECOL, V45, P1010, DOI 10.1111/j.1365-2664.2008.01490.x; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; LUBCHENCO J, 2003, ECOL APPL, V13, P3, DOI DOI 10.1890/1051-0761(2003)013[0003:PAHITO]2.0.CO;2; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Mellin C, 2009, MAR POLLUT BULL, V58, P11, DOI 10.1016/j.marpolbul.2008.10.010; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Osenberg CW., 2006, FDN RESTORATION ECOL, P280; Overholtzer-McLeod KL, 2006, ECOLOGY, V87, P1017, DOI 10.1890/0012-9658(2006)87[1017:COPRSF]2.0.CO;2; Pande A, 2009, AQUAT CONSERV, V19, P237, DOI 10.1002/aqc.984; Pittman SJ, 2004, MAR ECOL PROG SER, V283, P233, DOI 10.3354/meps283233; ROHNSACK JA, 1986, STATIONARY VISUAL CE, P1; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Starr RM, 2007, MAR ECOL PROG SER, V343, P239, DOI 10.3354/meps06897; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Wallace RJ, 1975, THESIS PRINCETON U P; Willis TJ, 2003, ENVIRON CONSERV, V30, P97, DOI 10.1017/S0376892903000092; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3	41	39	41	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12327	10.1371/journal.pone.0012327	http://dx.doi.org/10.1371/journal.pone.0012327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808833	Green Submitted, Green Published, gold			2022-12-25	WOS:000281077000016
J	von Burstin, J; Reichert, M; Wescott, MP; Rustgi, AK				von Burstin, Johannes; Reichert, Maximilian; Wescott, Melanie P.; Rustgi, Anil K.			The Pancreatic and Duodenal Homeobox Protein PDX-1 Regulates the Ductal Specific Keratin 19 through the Degradation of MEIS1 and DNA Binding	PLOS ONE			English	Article							HOMEODOMAIN TRANSCRIPTION FACTOR; SYNTHASE EXON 1C; GENE-TRANSCRIPTION; PROTEASOMAL DEGRADATION; HISTONE DEACETYLASES; PBX COMPLEXES; IN-VIVO; CELLS; EXPRESSION; PROMOTER	Background: Pancreas organogenesis is the result of well-orchestrated and balanced activities of transcription factors. The homeobox transcription factor PDX-1 plays a crucial role in the development and function of the pancreas, both in the maintenance of progenitor cells and in determination and maintenance of differentiated endocrine cells. However, the activity of homeobox transcription factors requires coordination with co-factors, such as PBX and MEIS proteins. PBX and MEIS proteins belong to the family of three amino acid loop extension (TALE) homeodomain proteins. In a previous study we found that PDX-1 negatively regulates the transcriptional activity of the ductal specific keratin 19 (Krt19). In this study, we investigate the role of different domains of PDX-1 and elucidate the functional interplay of PDX-1 and MEIS1 necessary for Krt19 regulation. Methodology/Principal Findings: Here, we demonstrate that PDX-1 exerts a dual manner of regulation of Krt19 transcriptional activity. Deletion studies highlight that the NH(2)-terminus of PDX-1 is functionally relevant for the down-regulation of Krt19, as it is required for DNA binding of PDX-1 to the Krt19 promoter. Moreover, this effect occurs independently of PBX. Second, we provide insight on how PDX-1 regulates the Hox co-factor MEIS1 post-transcriptionally. We find specific binding of MEIS1 and MEIS2 to the Krt19 promoter using IP-EMSA, and siRNA mediated silencing of Meis1, but not Meis2, reduces transcriptional activation of Krt19 in primary pancreatic ductal cells. Over-expression of PDX-1 leads to a decreased level of MEIS1 protein, and this decrease is prevented by inhibition of the proteasome. Conclusions/Significance: Taken together, our data provide evidence for a dual mechanism of how PDX-1 negatively regulates Krt19 ductal specific gene expression. These findings imply that transcription factors may efficiently regulate target gene expression through diverse, non-redundant mechanisms.	[von Burstin, Johannes] Univ Penn, Div Gastroenterol, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Div Gastroenterol, Dept Genet, Abramson Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	von Burstin, J (corresponding author), Univ Penn, Div Gastroenterol, Dept Med, Philadelphia, PA 19104 USA.	anil2@mail.med.upenn.edu	Reichert, Maximilian/GOH-1246-2022		National Institutes of Health [R01-DK060694]; National Pancreas Foundation; Deutsche Forschungsgemeinschaft [JvB BU 2412-1/1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060694, P30DK050306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Pancreas Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R01-DK060694 (AKR, JvB, MR), National Pancreas Foundation (MR, MPW), and the Deutsche Forschungsgemeinschaft (JvB BU 2412-1/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Bossis G, 2003, MOL CELL BIOL, V23, P7425, DOI 10.1128/MCB.23.20.7425-7436.2003; Brembeck FH, 2000, J BIOL CHEM, V275, P28230; Choe SK, 2009, DEV CELL, V17, P561, DOI 10.1016/j.devcel.2009.08.007; Deramaudt TB, 2006, J BIOL CHEM, V281, P38385, DOI 10.1074/jbc.M605891200; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Dutta S, 2001, P NATL ACAD SCI USA, V98, P1065, DOI 10.1073/pnas.031561298; Esparza SD, 2008, LEUKEMIA, V22, P665, DOI 10.1038/sj.leu.2404933; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Hale MA, 2005, DEV BIOL, V286, P225, DOI 10.1016/j.ydbio.2005.07.026; Heine P, 2008, DEVELOPMENT, V135, P805, DOI 10.1242/dev.012088; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Jamaluddin M, 2005, J VIROL, V79, P15302, DOI 10.1128/JVI.79.24.15302-15313.2005; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kim SK, 2002, NAT GENET, V30, P430, DOI 10.1038/ng860; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Mojsin M, 2010, BIOCHEM J, V425, P107, DOI 10.1042/BJ20090694; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MOSKOW JJ, 1995, MOL CELL BIOL, V15, P5434; Mosley AL, 2004, J BIOL CHEM, V279, P54241, DOI 10.1074/jbc.M410379200; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1991, MOL ENDOCRINOL, V5, P897, DOI 10.1210/mend-5-7-897; Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200; Peshavaria M, 1997, MOL CELL BIOL, V17, P3987, DOI 10.1128/MCB.17.7.3987; Petersen HV, 1998, FEBS LETT, V431, P362, DOI 10.1016/S0014-5793(98)00776-5; Pillay LM, 2010, DEV BIOL; Qiu Y, 2002, MOL CELL BIOL, V22, P412, DOI 10.1128/MCB.22.2.412-420.2002; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Saleh M, 2000, MOL CELL BIOL, V20, P8623, DOI 10.1128/MCB.20.22.8623-8633.2000; Saur D, 2004, P NATL ACAD SCI USA, V101, P1662, DOI 10.1073/pnas.0305473101; Saur D, 2002, J BIOL CHEM, V277, P25798, DOI 10.1074/jbc.M109802200; Schreiber FS, 2004, GASTROENTEROLOGY, V127, P250, DOI 10.1053/j.gastro.2004.03.058; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; Shen WF, 1999, MOL CELL BIOL, V19, P3051; Steeman S, 1997, GENOME RES, V7, P142, DOI 10.1101/gr.7.2.142; Stoffers DA, 1997, TRENDS ENDOCRIN MET, V8, P145, DOI 10.1016/S1043-2760(97)00008-8; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Wescott MP, 2009, MOL BIOL CELL, V20, P4838, DOI 10.1091/mbc.E09-03-0203; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhang X, 2006, DEV BIOL, V300, P748, DOI 10.1016/j.ydbio.2006.06.030	46	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12311	10.1371/journal.pone.0012311	http://dx.doi.org/10.1371/journal.pone.0012311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808819	Green Published, gold, Green Submitted			2022-12-25	WOS:000281075500028
J	Schepens, I; Jaunin, F; Begre, N; Laderach, U; Marcus, K; Hashimoto, T; Favre, B; Borradori, L				Schepens, Isabelle; Jaunin, Fabienne; Begre, Nadja; Laederach, Ursula; Marcus, Katrin; Hashimoto, Takashi; Favre, Bertrand; Borradori, Luca			The Protease Inhibitor Alpha-2-Macroglobuline-Like-1 Is the p170 Antigen Recognized by Paraneoplastic Pemphigus Autoantibodies in Human	PLOS ONE			English	Article							AUTOIMMUNE MULTIORGAN SYNDROME; PLAKIN FAMILY; ALPHA(2)-MACROGLOBULIN; PERIPLAKIN; ANTIBODIES	Background: Paraneoplastic pemphigus (PNP) is a devastating autoimmune blistering disease, involving mucocutaneous and internal organs, and associated with underlying neoplasms. PNP is characterized by the production of autoantibodies targeting proteins of the plakin and cadherin families involved in maintenance of cell architecture and tissue cohesion. Nevertheless, the identity of an antigen of Mr 170,000 (p170), thought to be critical in PNP pathogenesis, has remained unknown. Methodology/Principal Findings: Using an immunoprecipitation and mass spectrometry based approach, we identified p170 as alpha-2-macroglobuline-like-1, a broad range protease inhibitor expressed in stratified epithelia and other tissues damaged in the PNP disease course. We demonstrate that 10 PNP sera recognize alpha-2-macroglobuline-like-1 (A2ML1), while none of the control sera obtained from patients with bullous pemphigoid, pemphigus vulgaris, pemphigus foliaceus and normal subjects does. Conclusions/Significance: Our study unravels a broad range protease inhibitor as a new class of target antigens in a paraneoplastic autoimmune multiorgan syndrome and opens a new challenging investigation avenue for a better understanding of PNP pathogenesis.	[Schepens, Isabelle; Begre, Nadja; Laederach, Ursula; Favre, Bertrand; Borradori, Luca] Univ Hosp Bern, Inselspital, Dept Dermatol, CH-3010 Bern, Switzerland; [Schepens, Isabelle; Begre, Nadja; Laederach, Ursula; Favre, Bertrand; Borradori, Luca] Univ Bern, Bern, Switzerland; [Jaunin, Fabienne] Univ Hosp Geneva, Dept Dermatol, Geneva, Switzerland; [Marcus, Katrin] Ruhr Univ Bochum, MPC, Bochum, Germany; [Hashimoto, Takashi] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 830, Japan	University of Bern; University Hospital of Bern; University of Bern; University of Geneva; Ruhr University Bochum; Kurume University	Schepens, I (corresponding author), Univ Hosp Bern, Inselspital, Dept Dermatol, CH-3010 Bern, Switzerland.	isabelle.schepens@insel.ch; luca.borradori@insel.ch	Hashimoto, Takashi/H-6947-2019	Hashimoto, Takashi/0000-0002-0144-3255; Schepens, Isabelle/0000-0002-6718-9608	European Community [HEALTH-F2-2008-200515]; Swiss National Foundation [FNS/SNF 31003A-121966, 31003A-09811]	European Community(European Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF))	This project was supported by Coordination Theme 1 (Health) of the European Community's FP7, Grant agreement number HEALTH-F2-2008-200515 (http://ec.europa.eu/research/health/medical-research/rare-diseases/projects/pemphigus_en.html)(to L.B.) and the Swiss National Foundation for Scientific Research (FNS/SNF 31003A-121966 and 31003A-09811, to L.B.)(http://www.projectdb.snf.ch/WebForms/Frameset.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagai M, 1998, J CLIN INVEST, V102, P775, DOI 10.1172/JCI3647; Anhalt G J, 1997, Adv Dermatol, V12, P77; ANHALT GJ, 1990, NEW ENGL J MED, V323, P1729, DOI 10.1056/NEJM199012203232503; Armstrong PB, 1999, DEV COMP IMMUNOL, V23, P375, DOI 10.1016/S0145-305X(99)00018-X; Billet SE, 2006, AUTOIMMUNITY, V39, P617, DOI 10.1080/08916930600972099; Borradori L, 1998, J INVEST DERMATOL, V111, P338, DOI 10.1046/j.1523-1747.1998.00280.x; Bowen GM, 2000, ARCH DERMATOL, V136, P652, DOI 10.1001/archderm.136.5.652; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Cugno M, 2009, TRENDS MOL MED, V15, P69, DOI 10.1016/j.molmed.2008.12.001; Eissa A, 2008, BIOL CHEM, V389, P669, DOI 10.1515/BC.2008.079; Galliano MF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002729; Galliano MF, 2006, J BIOL CHEM, V281, P5780, DOI 10.1074/jbc.M508017200; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; HASHIMOTO T, 1995, J INVEST DERMATOL, V104, P829, DOI 10.1111/1523-1747.ep12607012; Heizmann M, 2001, AM J HEMATOL, V66, P142, DOI 10.1002/1096-8652(200102)66:2<142::AID-AJH1032>3.3.CO;2-S; JACKSON J, 1989, J CLIN INVEST, V83, P698, DOI 10.1172/JCI113934; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACIEJEWSKARODR.H, ARTHRITIS RHEUM, V62, P93; Mahoney MG, 1998, J INVEST DERMATOL, V111, P308, DOI 10.1046/j.1523-1747.1998.00279.x; Meyer-Hoffert U, 2009, ARCH IMMUNOL THER EX, V57, P345, DOI 10.1007/s00005-009-0045-6; Mimouni D, 2002, BRIT J DERMATOL, V147, P725, DOI 10.1046/j.1365-2133.2002.04992.x; Nguyen VT, 2001, ARCH DERMATOL, V137, P193; Niessen CM, 1996, J CELL SCI, V109, P1695; Nikolskaia OV, 2003, BRIT J DERMATOL, V149, P1143, DOI 10.1111/j.1365-2133.2003.05659.x; Nousari HC, 1999, NEW ENGL J MED, V340, P1406, DOI 10.1056/NEJM199905063401805; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; OURSLER JR, 1992, J CLIN INVEST, V89, P1775, DOI 10.1172/JCI115781; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Reich K, 1999, BRIT J DERMATOL, V141, P739; Ruhrberg C, 1997, J CELL BIOL, V139, P1835, DOI 10.1083/jcb.139.7.1835; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sehgal VN, 2009, INT J DERMATOL, V48, P162, DOI 10.1111/j.1365-4632.2009.03995.x; Wang J, 2005, BRIT J DERMATOL, V153, P558, DOI 10.1111/j.1365-2133.2005.06599.x; Wang LC, 2004, LANCET, V363, P525, DOI 10.1016/S0140-6736(04)15539-6; Zeeuwen PLJM, 2009, J INVEST DERMATOL, V129, P1327, DOI 10.1038/jid.2009.40; Zhu XJ, 2007, J DERMATOL, V34, P503, DOI 10.1111/j.1346-8138.2007.00322.x	39	67	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12250	10.1371/journal.pone.0012250	http://dx.doi.org/10.1371/journal.pone.0012250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805888	Green Published, Green Submitted, gold			2022-12-25	WOS:000281011600022
J	Shi, ZD; Abraham, G; Tarbell, JM				Shi, Zhong-Dong; Abraham, Giya; Tarbell, John M.			Shear Stress Modulation of Smooth Muscle Cell Marker Genes in 2-D and 3-D Depends on Mechanotransduction by Heparan Sulfate Proteoglycans and ERK1/2	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; INTERSTITIAL FLOW; FLUID-FLOW; NEOINTIMA FORMATION; COLLAGEN I; PROLIFERATION; EXPRESSION; FIBROBLAST; DIFFERENTIATION; MIGRATION	Background: During vascular injury, vascular smooth muscle cells (SMCs) and fibroblasts/myofibroblasts (FBs/MFBs) are exposed to altered luminal blood flow or transmural interstitial flow. We investigate the effects of these two types of fluid flows on the phenotypes of SMCs and MFBs and the underlying mechanotransduction mechanisms. Methodology/Principal Findings: Exposure to 8 dyn/cm(2) laminar flow shear stress (2-dimensional, 2-D) for 15 h significantly reduced expression of alpha-smooth muscle actin (alpha-SMA), smooth muscle protein 22 (SM22), SM myosin heavy chain (SM-MHC), smoothelin, and calponin. Cells suspended in collagen gels were exposed to interstitial flow (1 cmH(2)O, similar to 0.05 dyn/cm(2), 3-D), and after 6 h of exposure, expression of SM-MHC, smoothelin, and calponin were significantly reduced, while expression of alpha-SMA and SM22 were markedly enhanced. PD98059 (an ERK1/2 inhibitor) and heparinase III (an enzyme to cleave heparan sulfate) significantly blocked the effects of laminar flow on gene expression, and also reversed the effects of interstitial flow on SM-MHC, smoothelin, and calponin, but enhanced interstitial flow-induced expression of alpha-SMA and SM22. SMCs and MFBs have similar responses to fluid flow. Silencing ERK1/2 completely blocked the effects of both laminar flow and interstitial flow on SMC marker gene expression. Western blotting showed that both types of flows induced ERK1/2 activation that was inhibited by disruption of heparan sulfate proteoglycans (HSPGs). Conclusions/Significance: The results suggest that HSPG-mediated ERK1/2 activation is an important mechanotransduction pathway modulating SMC marker gene expression when SMCs and MFBs are exposed to flow. Fluid flow may be involved in vascular remodeling and lesion formation by affecting phenotypes of vascular wall cells. This study has implications in understanding the flow-related mechanobiology in vascular lesion formation, tumor cell invasion, and stem cell differentiation.	[Shi, Zhong-Dong; Abraham, Giya; Tarbell, John M.] CUNY, City Coll New York, Dept Biomed Engn, New York, NY 10021 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Shi, ZD (corresponding author), CUNY, City Coll New York, Dept Biomed Engn, New York, NY 10021 USA.	zdshi@hotmail.com; tarbell@ccny.cuny.edu	Shi, Zhong-Dong/A-7212-2012		NIH NHLBI [RO1 HL 57093, RO1 HL 094889]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057093, R01HL094889] Funding Source: NIH RePORTER	NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH NHLBI grants RO1 HL 57093 (JMT) and RO1 HL 094889 (JMT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie KM, 2005, J APPL PHYSIOL, V98, P242, DOI 10.1152/japplphysiol.01006.2003; Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; Asada H, 2005, J VASC SURG, V42, P772, DOI 10.1016/j.jvs.2005.05.046; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Chambers RC, 2003, AM J PATHOL, V162, P533, DOI 10.1016/S0002-9440(10)63847-3; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Fitzgerald TN, 2008, J CELL PHYSIOL, V216, P389, DOI 10.1002/jcp.21404; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Garanich JS, 2007, AM J PHYSIOL-HEART C, V292, pH3128, DOI 10.1152/ajpheart.00578.2006; Garanich JS, 2005, AM J PHYSIOL-HEART C, V288, pH2244, DOI 10.1152/ajpheart.00428.2003; Gennaro G, 2003, ARTERIOSCL THROM VAS, V23, P204, DOI 10.1161/01.ATV.0000053182.58636.BE; Haga M, 2003, J VASC SURG, V37, P1277, DOI 10.1016/S0741-5214(03)00329-X; Harfouche R, 2009, CIRCULATION, V120, P1883, DOI 10.1161/CIRCULATIONAHA.108.837724; Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729; Hosseinkhani H, 2005, TISSUE ENG, V11, P1476, DOI 10.1089/ten.2005.11.1476; Hu YH, 1997, ARTERIOSCL THROM VAS, V17, P2808, DOI 10.1161/01.ATV.17.11.2808; Kharebava G, 2008, J NEUROSCI, V28, P11409, DOI 10.1523/JNEUROSCI.2135-08.2008; Kirkpatrick CA, 2007, J CELL SCI, V120, P1829, DOI 10.1242/jcs.03432; Koyama H, 1999, THROMB HAEMOSTASIS, V82, P806, DOI 10.1055/s-0037-1615915; Lai KH, 1996, J CLIN INVEST, V98, P1560, DOI 10.1172/JCI118949; Lawson D, 1997, CELL MOTIL CYTOSKEL, V38, P250, DOI 10.1002/(SICI)1097-0169(1997)38:3<250::AID-CM3>3.0.CO;2-9; Leguillette R, 2009, AM J RESP CRIT CARE, V179, P194, DOI 10.1164/rccm.200609-1367OC; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Li CH, 2007, CELL SIGNAL, V19, P881, DOI 10.1016/j.cellsig.2007.01.004; Louis H, 2006, CLIN EXP PHARMACOL P, V33, P131, DOI 10.1111/j.1440-1681.2006.04339.x; Low RB, 1999, DIFFERENTIATION, V65, P151, DOI 10.1046/j.1432-0436.1999.6530151.x; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Ng CP, 2005, J CELL SCI, V118, P4731, DOI 10.1242/jcs.02605; Ni J, 2010, J BIOL CHEM, V285, P4038, DOI 10.1074/jbc.M109.078345; Oishi K, 2002, J PHYSIOL-LONDON, V540, P139, DOI 10.1113/jphysiol.2001.013278; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; PARK F, 1997, AM J PHYSIOL-REG I, V273, pR1742; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Rensen SSM, 2006, CARDIOVASC RES, V70, P136, DOI 10.1016/j.cardiores.2005.12.018; Rizzo V, 2009, AM J PHYSIOL-HEART C, V297, pH1196, DOI 10.1152/ajpheart.00499.2009; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Roy J, 2001, DIFFERENTIATION, V67, P50, DOI 10.1046/j.1432-0436.2001.067001050.x; Rutkowski JM, 2007, TRENDS CELL BIOL, V17, P44, DOI 10.1016/j.tcb.2006.11.007; Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844; Shi Y, 1996, CIRCULATION, V94, P1655, DOI 10.1161/01.CIR.94.7.1655; Shi ZD, 2010, AM J PHYSIOL-HEART C, V298, pH127, DOI 10.1152/ajpheart.00732.2009; Shi ZD, 2009, AM J PHYSIOL-HEART C, V297, pH1225, DOI 10.1152/ajpheart.00369.2009; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Stegemann JP, 2005, J APPL PHYSIOL, V98, P2321, DOI 10.1152/japplphysiol.01114.2004; STERPETTI AV, 1993, SURGERY, V113, P691; Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annurev.bioeng.9.060906.151850; Tada S, 2002, AM J PHYSIOL-HEART C, V282, pH576, DOI 10.1152/ajpheart.00751.2001; TAKEUCHI K, 1991, J BIOCHEM, V109, P311; Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x; Tsai RYL, 2000, J NEUROSCI, V20, P3725, DOI 10.1523/JNEUROSCI.20-10-03725.2000; Ueba H, 1997, ARTERIOSCL THROM VAS, V17, P1512, DOI 10.1161/01.ATV.17.8.1512; van Eys GJ, 2007, TRENDS CARDIOVAS MED, V17, P26, DOI 10.1016/j.tcm.2006.11.001; Vera RH, 2009, TISSUE ENG PT A, V15, P175, DOI 10.1089/ten.tea.2007.0314; Walsh MJ, 2003, FASEB J, V17, pA1007; Wang H, 2006, BIOCHEM BIOPH RES CO, V346, P860, DOI 10.1016/j.bbrc.2006.05.196; Wang S, 2000, ARTERIOSCL THROM VAS, V20, P2220, DOI 10.1161/01.ATV.20.10.2220; WANG WJ, 1995, J VIB ACOUST, V117, P363, DOI 10.1115/1.2874462; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007	61	55	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12196	10.1371/journal.pone.0012196	http://dx.doi.org/10.1371/journal.pone.0012196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808940	Green Published, gold			2022-12-25	WOS:000280968000020
J	Horst, D; Gu, XS; Bhasin, M; Yang, QL; Verzi, M; Lin, DX; Joseph, M; Zhang, XB; Chen, W; Li, YP; Shivdasani, RA; Libermann, TA				Horst, David; Gu, Xuesong; Bhasin, Manoj; Yang, Quanli; Verzi, Michael; Lin, Dongxu; Joseph, Marie; Zhang, Xiaobo; Chen, Wei; Li, Yi-Ping; Shivdasani, Ramesh A.; Libermann, Towia A.			Requirement of the Epithelium-specific Ets Transcription Factor Spdef for Mucous Gland Cell Function in the Gastric Antrum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDEF EXPRESSION; BINDING DOMAIN; NECK CELLS; GENE; FAMILY; CANCER; MEMBER; INTERACTS; RECEPTOR; DEFENSE	Mucus-secreting cells of the stomach epithelium provide a protective barrier against damage that might result from bacterial colonization or other stimuli. Impaired barrier function contributes to chronic inflammation and cancer. Knock-out mice for the epithelium-specific transcription factor Spdef (also called Pdef) have defects in terminal differentiation of intestinal and bronchial secretory cells. We sought to determine the physiologic function of Spdef in the stomach, another site of significant levels of Spdef expression. We used in situ hybridization and immunohistochemistry to localize Spdef-expressing cells in the mouse stomach; targeted gene disruption to generate mice lacking Spdef; and histologic, immunologic, and transcriptional profiling approaches to determine the requirements of Spdef in stomach epithelial homeostasis. In wild-type mice, Spdef RNA and protein are expressed predominantly in mucous gland cells of the antrum and in mucous neck cells of the glandular corpus. Within 1.5 years, nearly half of homozygous mutant mice developed profound mucosal hyperplasia of the gastric antrum. Submucosal infiltration of inflammatory cells preceded antral hyperplasia by several weeks. The absence of Spdef impaired terminal maturation of antral mucous gland cells, as reflected in reduced expression of Muc6 and Tff2 and reduced numbers of secretory granules. Antral gene expression abnormalities overlapped significantly with those in Spdef(-/-) colon, including genes implicated in secretory granule traffic and functions. Spdef is required for terminal maturation of antral mucous gland cells to protect animals from gastric inflammation and resulting hyperplasia. These requirements parallel Spdef functions in secretory intestinal cells and suggest a common molecular mechanism for maturation of gastrointestinal secretory lineages.	[Shivdasani, Ramesh A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Gu, Xuesong; Bhasin, Manoj; Yang, Quanli; Lin, Dongxu; Joseph, Marie; Shivdasani, Ramesh A.; Libermann, Towia A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Gu, Xuesong; Bhasin, Manoj; Yang, Quanli; Lin, Dongxu; Joseph, Marie; Libermann, Towia A.] Harvard Univ, Sch Med, BIDMC Genom & Prote Ctr, Boston, MA 02115 USA; [Gu, Xuesong; Bhasin, Manoj; Yang, Quanli; Lin, Dongxu; Joseph, Marie; Libermann, Towia A.] Harvard Univ, Sch Med, Div Interdisciplinary Med & Biotechnol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Zhang, Xiaobo] Massachusetts Gen Hosp, Gastrointestinal Unit, Charlestown, MA 02114 USA; [Zhang, Xiaobo] Massachusetts Gen Hosp, MGH Weight Ctr, Charlestown, MA 02114 USA; [Chen, Wei; Li, Yi-Ping] Forsyth Inst, Dept Cytokine Biol, Boston, MA 02115 USA; [Chen, Wei; Li, Yi-Ping] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine	Shivdasani, RA (corresponding author), 44 Binney St, Boston, MA 02215 USA.	ramesh_shivdasani@dfci.harvard.edu; tliberma@bidmc.harvard.edu		Libermann, Towia/0000-0002-4006-8179; Bhasin, Manoj/0000-0001-5172-420X	National Institutes of Health [CA85467, DK081113, AR44741]; Prostate Cancer Foundation; Deutsche Forschungsgemeinschaft; NATIONAL CANCER INSTITUTE [R01CA085467] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA85467 (to T. A. L.), DK081113 (to R. A. S.), and AR44741 (to Y. P. L.). This work was also supported by a Prostate Cancer Foundation award (to X. G.), and a fellowship from the Deutsche Forschungsgemeinschaft (to D. H.).	Akbarali Y, 1996, J BIOL CHEM, V271, P26007, DOI 10.1074/jbc.271.42.26007; Bartel FO, 2000, ONCOGENE, V19, P6443, DOI 10.1038/sj.onc.1204038; Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; Baus-Loncar M, 2005, CELL PHYSIOL BIOCHEM, V16, P31, DOI 10.1159/000087729; Beckwith CS, 1997, J CLIN MICROBIOL, V35, P1620, DOI 10.1128/JCM.35.6.1620-1623.1997; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; FALK P, 1994, AM J PHYSIOL, V266, pG987, DOI 10.1152/ajpgi.1994.266.6.G987; Feldman RJ, 2003, CANCER RES, V63, P4626; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghadersohi A, 2008, INT J CANCER, V123, P1376, DOI 10.1002/ijc.23667; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Gu XS, 2007, CANCER RES, V67, P4219, DOI 10.1158/0008-5472.CAN-06-3689; Gunawardane RN, 2005, CANCER RES, V65, P11572, DOI 10.1158/0008-5472.CAN-05-1196; Hartigan J., 1975, CLUSTERING ALGORITHM; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; HO SB, 1995, GASTROENTEROLOGY, V109, P735, DOI 10.1016/0016-5085(95)90380-1; HUGHES NR, 1994, J CLIN PATHOL, V47, P53, DOI 10.1136/jcp.47.1.53; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jain R, 2009, DIGEST DIS SCI, V54, P1839, DOI 10.1007/s10620-008-0572-8; JEFFREY GP, 1994, GASTROENTEROLOGY, V106, P336, DOI 10.1016/0016-5085(94)90590-8; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Judd LM, 2004, GASTROENTEROLOGY, V126, P196, DOI 10.1053/j.gastro.2003.10.066; Kang WQ, 2003, FEBS LETT, V540, P21, DOI 10.1016/S0014-5793(03)00217-5; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; KINDON H, 1995, GASTROENTEROLOGY, V109, P516, DOI 10.1016/0016-5085(95)90340-2; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Labrie C, 2008, J STEROID BIOCHEM, V108, P237, DOI 10.1016/j.jsbmb.2007.09.008; LAMONT JT, 1992, ANN NY ACAD SCI, V664, P190, DOI 10.1111/j.1749-6632.1992.tb39760.x; LEE ER, 1982, AM J ANAT, V164, P187, DOI 10.1002/aja.1001640302; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; Oettgen P, 2000, J BIOL CHEM, V275, P1216, DOI 10.1074/jbc.275.2.1216; Oettgen P, 1997, MOL CELL BIOL, V17, P4419, DOI 10.1128/MCB.17.8.4419; Oettgen P, 1999, J BIOL CHEM, V274, P29439, DOI 10.1074/jbc.274.41.29439; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Poulsen SS, 1999, GUT, V45, P516, DOI 10.1136/gut.45.4.516; Ramsey VG, 2007, DEVELOPMENT, V134, P211, DOI 10.1242/dev.02700; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Verzi MP, 2008, GASTROENTEROLOGY, V135, P591, DOI 10.1053/j.gastro.2008.04.019; Yamada N, 2000, GENE, V241, P267, DOI 10.1016/S0378-1119(99)00484-9; YAMAZAKI Y, 1992, EUR J HISTOCHEM, V36, P161	45	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35047	35055		10.1074/jbc.M110.164541	http://dx.doi.org/10.1074/jbc.M110.164541			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801882	hybrid, Green Published			2022-12-25	WOS:000283659100079
J	Salvati, E; Scarsella, M; Porru, M; Rizzo, A; Iachettini, S; Tentori, L; Graziani, G; D'Incalci, M; Stevens, MFG; Orlandi, A; Passeri, D; Gilson, E; Zupi, G; Leonetti, C; Biroccio, A				Salvati, E.; Scarsella, M.; Porru, M.; Rizzo, A.; Iachettini, S.; Tentori, L.; Graziani, G.; D'Incalci, M.; Stevens, M. F. G.; Orlandi, A.; Passeri, D.; Gilson, E.; Zupi, G.; Leonetti, C.; Biroccio, A.			PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy	ONCOGENE			English	Article						PARP1; G4 ligand; combination therapy	POLY(ADP-RIBOSE) POLYMERASE-2 PARP-2; QUADRUPLEX LIGAND RHPS4; DNA-REPAIR; ANTITUMOR-ACTIVITY; HUMAN-CHROMOSOMES; CANCER-THERAPY; DAMAGE; INHIBITORS; CELLS; TRF2	New anti-telomere strategies represent important goals for the development of selective cancer therapies. In this study, we reported that uncapped telomeres, resulting from pharmacological stabilization of quadruplex DNA by RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino [4,3,2-kl] acridinium methosulfate), trigger specific recruitment and activation of poly-adenosine diphosphate (ADP) ribose polymerase I (PARP1) at the telomeres, forming several ADP-ribose polymers that co-localize with the telomeric repeat binding factor 1 protein and are inhibited by selective PARP(s) inhibitors or PARP1-specific small interfering RNAs. The knockdown of PARP1 prevents repairing of RHPS4-induced telomere DNA breaks, leading to increases in chromosome abnormalities and eventually to the inhibition of tumor cell growth both in vitro and in xenografts. More interestingly, the integration of a TOPO1 inhibitor on the combination treatment proved to have a high therapeutic efficacy ensuing a complete regression of the tumor as well as a significant increase in overall survival and cure of mice even when treatments started at a very late stage of tumor growth. Overall, this work reveals the unexplored link between the PARP1 and G-quadruplex ligands and demonstrates the excellent efficacy of a multi-component strategy based on the use of PARP inhibitors in telomere-based therapy. Oncogene (2010) 29, 6280-6293; doi:10.1038/onc.2010.344; published online 30 August 2010	[Salvati, E.; Scarsella, M.; Porru, M.; Rizzo, A.; Iachettini, S.; Zupi, G.; Leonetti, C.; Biroccio, A.] Regina Elena Inst Canc Res, Expt Chemotherapy Lab, I-00158 Rome, Italy; [Tentori, L.; Graziani, G.] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; [D'Incalci, M.] Mario Negri Inst Pharmacol Res, Dept Oncol, Milan, Italy; [Stevens, M. F. G.] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England; [Orlandi, A.; Passeri, D.] Univ Roma Tor Vergata, Dept Biopathol & Image Diagnost, Inst Pathol Anat, Rome, Italy; [Gilson, E.] Univ Nice Sophia Antipolis, Fac Med, INSERM, Lab Biol & Pathol Genomes,CNRS, Nice, France; CHU Nice, Archet Hosp 2, Dept Med Genet, Nice, France	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Rome Tor Vergata; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Nottingham; University of Rome Tor Vergata; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice	Biroccio, A (corresponding author), Regina Elena Inst Canc Res, Expt Chemotherapy Lab, Via Messi Doro 156, I-00158 Rome, Italy.	leonetti@ifo.it; biroccio@ifo.it	PORRU, MANUELA/K-4809-2018; Rizzo, Angela/ABH-6753-2020; Biroccio, Annamaria/B-2861-2018; Leonetti, Carlo/B-2860-2018; Scarsella, Marco/AAA-1486-2020; Porru, Manuela/AAA-5510-2021; Graziani, Grazia/G-5747-2012; Orlandi, Augusto/AHE-8753-2022; IACHETTINI, SARA/AAY-6180-2021; D'Incalci, Maurizio/AAA-9021-2020	PORRU, MANUELA/0000-0002-6614-9110; Rizzo, Angela/0000-0001-5421-3085; Biroccio, Annamaria/0000-0003-3198-3532; Leonetti, Carlo/0000-0002-3526-7827; Porru, Manuela/0000-0002-6614-9110; Graziani, Grazia/0000-0002-0221-768X; IACHETTINI, SARA/0000-0002-9442-0326; D'Incalci, Maurizio/0000-0001-8784-1360; Salvati, Erica/0000-0002-3373-7442; TENTORI, LUCIO/0000-0002-7691-527X; Scarsella, Marco/0000-0002-3386-9664; orlandi, augusto/0000-0001-7202-5854	Italian Association for Cancer Research (AIRC); Ministero della Salute; Ligue Nationale contre le Cancer (EG equipe labellisee); Italian Foundation for Cancer Research (FIRC)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute(Ministry of Health, Italy); Ligue Nationale contre le Cancer (EG equipe labellisee); Italian Foundation for Cancer Research (FIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from the Italian Association for Cancer Research (AIRC), Ministero della Salute and Ligue Nationale contre le Cancer (EG equipe labellisee). ES and MP are recipients of fellowships from the Italian Foundation for Cancer Research (FIRC). We thank Mrs Carmen D'Angelo for generating HT29 cells that express the luciferase gene and Mrs Adele Petricca for her helpful assistance in typing the manuscript. We are also grateful to Tania Merlino for the English revision.	Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Bakondi E, 2002, J HISTOCHEM CYTOCHEM, V50, P91, DOI 10.1177/002215540205000110; Biroccio A, 2002, ONCOGENE, V21, P3011, DOI 10.1038/sj.onc.1205415; Brunori M, 2006, ONCOGENE, V25, P990, DOI 10.1038/sj.onc.1209135; BURKLE A, 2005, POLY ADP RIBOSYL ATI; Cook BD, 2002, MOL CELL BIOL, V22, P332, DOI 10.1128/MCB.22.1.332-342.2002; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Dantzer F, 2004, MOL CELL BIOL, V24, P1595, DOI 10.1128/MCB.24.4.1595-1607.2004; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Donigian JR, 2007, J BIOL CHEM, V282, P22662, DOI 10.1074/jbc.M702620200; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gagne JP, 2006, CURR OPIN CELL BIOL, V18, P145, DOI 10.1016/j.ceb.2006.02.013; Gavathiotis E, 2003, J MOL BIOL, V334, P25, DOI 10.1016/j.jmb.2003.09.018; GERAN RI, 1972, CANC CHEMOTHER REP, V3, P1; Gomez M, 2006, MOL BIOL CELL, V17, P1686, DOI 10.1091/mbc.E05-07-0672; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Heald RA, 2002, J MED CHEM, V45, P590, DOI 10.1021/jm011015q; Kaminker PG, 2001, J BIOL CHEM, V276, P35891, DOI 10.1074/jbc.M105968200; Kelland L, 2007, CLIN CANCER RES, V13, P4960, DOI 10.1158/1078-0432.CCR-07-0422; Lenain C, 2006, CURR BIOL, V16, P1303, DOI 10.1016/j.cub.2006.05.021; Leonetti C, 2008, CLIN CANCER RES, V14, P7284, DOI 10.1158/1078-0432.CCR-08-0941; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Marcellini M, 2006, AM J PATHOL, V169, P643, DOI 10.2353/ajpath.2006.051041; Oganesian L, 2007, BIOESSAYS, V29, P155, DOI 10.1002/bies.20523; Orlandi A, 2008, CELL CYCLE, V7, P3889, DOI 10.4161/cc.7.24.7323; Pisano C, 2008, MOL CANCER THER, V7, P2051, DOI 10.1158/1535-7163.MCT-08-0266; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Plummer ER, 2007, CLIN CANCER RES, V13, P6252, DOI 10.1158/1078-0432.CCR-07-0617; Ratnam K, 2007, CLIN CANCER RES, V13, P1383, DOI 10.1158/1078-0432.CCR-06-2260; Rippmann JF, 2002, J MOL BIOL, V323, P217, DOI 10.1016/S0022-2836(02)00946-4; Rizzo A, 2009, NUCLEIC ACIDS RES, V37, P5353, DOI 10.1093/nar/gkp582; Salvati E, 2007, J CLIN INVEST, V117, P3236, DOI 10.1172/JCI32461; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Smith S, 1999, J CELL SCI, V112, P3649; Sugimura K, 2008, J CELL BIOL, V183, P1203, DOI 10.1083/jcb.200806068; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tentori L, 2005, PHARMACOL RES, V52, P25, DOI 10.1016/j.phrs.2005.02.010; Tentori L, 2006, FASEB J, V20, P1709, DOI 10.1096/fj.06-5916fje; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801	43	87	91	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	47					6280	6293		10.1038/onc.2010.344	http://dx.doi.org/10.1038/onc.2010.344			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	685CG	20802516				2022-12-25	WOS:000284601700009
J	Dinkova-Kostova, AT; Talalay, P; Sharkey, J; Zhang, Y; Holtzclaw, WD; Wang, XJ; David, E; Schiavoni, KH; Finlayson, S; Mierke, DF; Honda, T				Dinkova-Kostova, Albena T.; Talalay, Paul; Sharkey, John; Zhang, Ying; Holtzclaw, W. David; Wang, Xiu Jun; David, Emilie; Schiavoni, Katherine H.; Finlayson, Stewart; Mierke, Dale F.; Honda, Tadashi			An Exceptionally Potent Inducer of Cytoprotective Enzymes ELUCIDATION OF THE STRUCTURAL FEATURES THAT DETERMINE INDUCER POTENCY AND REACTIVITY WITH Keap1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE PRODUCTION; MICHAEL REACTION ACCEPTORS; HIGHLY-ACTIVE INHIBITORS; TRANSGENIC MOUSE MODEL; CDDO-METHYL ESTER; MOLECULAR-MECHANISM; TRICYCLIC COMPOUNDS; SULFHYDRYL-GROUPS; ETHYL AMIDE; RING-A	The Keap1/Nrf2/ARE pathway controls a network of cytoprotective genes that defend against the damaging effects of oxidative and electrophilic stress, and inflammation. Induction of this pathway is a highly effective strategy in combating the risk of cancer and chronic degenerative diseases, including atherosclerosis and neurodegeneration. An acetylenic tricyclic bis(cyano enone) bearing two highly electrophilic Michael acceptors is an extremely potent inducer in cells and in vivo. We demonstrate spectroscopically that both cyano enone functions of the tricyclic molecule react with cysteine residues of Keap1 and activate transcription of cytoprotective genes. Novel monocyclic cyano enones, representing fragments of rings A and C of the tricyclic compound, reveal that the contribution to inducer potency of the ring C Michael acceptor is much greater than that of ring A, and that potency is further enhanced by spatial proximity of an acetylenic function. Critically, the simultaneous presence of two cyano enone functions in rings A and C within a rigid three-ring system results in exceptionally high inducer potency. Detailed understanding of the structural elements that contribute to the reactivity with the protein sensor Keap1 and to high potency of induction is essential for the development of specific and selective lead compounds as clinically relevant chemoprotective agents.	[Finlayson, Stewart] Univ Dundee, Biomed Res Inst, Dundee DD1 9SY, Scotland; [Dinkova-Kostova, Albena T.; Talalay, Paul; Holtzclaw, W. David] Johns Hopkins Univ, Sch Med, Lewis B & Dorothy Cullman Chemoprotect Ctr, Baltimore, MD 21205 USA; [Dinkova-Kostova, Albena T.; Talalay, Paul; Holtzclaw, W. David] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [David, Emilie; Schiavoni, Katherine H.; Mierke, Dale F.; Honda, Tadashi] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	University of Dundee; Johns Hopkins University; Johns Hopkins University; Dartmouth College	Dinkova-Kostova, AT (corresponding author), Ninewells Hosp & Med Sch, Biomed Res Inst, Level 5, Dundee DD1 9SY, Scotland.	a.dinkovakostova@dundee.ac.uk; tadashi.honda@stonybrook.edu		Dinkova-Kostova, Albena/0000-0003-0316-9859; Sharkey, John/0000-0001-8288-1857	National Institutes of Health [CA06793, CA93780, CA105294]; American Cancer Society [RSG-07-157-01-CNE]; Research Councils UK, Cancer Research UK [C20953/A10270]; Royal Society; Anonymous Trust; Tenovus Scotland; American Institute for Cancer Research; Lewis B. and Dorothy Cullman Foundation; W. Patrick McMullan and the McMullan Family Fund; Reata Pharmaceuticals Inc, Irving, TX; NATIONAL CANCER INSTITUTE [R01CA093780, R03CA105294] Funding Source: NIH RePORTER; Cancer Research UK [10270] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Research Councils UK, Cancer Research UK(UK Research & Innovation (UKRI)Cancer Research UK); Royal Society(Royal Society of London); Anonymous Trust; Tenovus Scotland; American Institute for Cancer Research; Lewis B. and Dorothy Cullman Foundation; W. Patrick McMullan and the McMullan Family Fund; Reata Pharmaceuticals Inc, Irving, TX; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	This work was supported, in whole or in part, by the National Institutes of Health (Grants CA06793, CA93780, and CA105294). This work was also supported by the American Cancer Society (Grant RSG-07-157-01-CNE), Research Councils UK, Cancer Research UK (C20953/A10270), the Royal Society, the Anonymous Trust, Tenovus Scotland, the American Institute for Cancer Research, the Lewis B. and Dorothy Cullman Foundation, W. Patrick McMullan and the McMullan Family Fund, and Reata Pharmaceuticals Inc, Irving, TX.	Ahn YH, 2010, P NATL ACAD SCI USA, V107, P9590, DOI 10.1073/pnas.1004104107; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Couch RD, 2005, BIOORG MED CHEM LETT, V15, P2215, DOI 10.1016/j.bmcl.2005.03.031; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2001, P NATL ACAD SCI USA, V98, P3404, DOI 10.1073/pnas.051632198; Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Dinkova-Kostova AT, 1998, J MED CHEM, V41, P5287, DOI 10.1021/jm980424s; Dumont M, 2009, J NEUROCHEM, V109, P502, DOI 10.1111/j.1471-4159.2009.05970.x; Fahey JW, 2004, METHOD ENZYMOL, V382, P243; Favaloro FG, 2002, J MED CHEM, V45, P4801, DOI 10.1021/jm025565f; Habig W H, 1981, Methods Enzymol, V77, P218; HAYES JD, 2010, ANTIOXID RE IN PRESS; Honda T, 2002, BIOORG MED CHEM LETT, V12, P1027, DOI 10.1016/S0960-894X(02)00105-1; Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230; Honda T., 2010, Patent No. [WO 2010011782 A1, 2010011782]; Honda T, 2007, J MED CHEM, V50, P1731, DOI 10.1021/jm070141c; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Kelly VP, 2000, CANCER RES, V60, P957; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Liby K, 2008, CANCER RES, V68, P6727, DOI 10.1158/0008-5472.CAN-08-1123; Liby K, 2008, CLIN CANCER RES, V14, P4556, DOI 10.1158/1078-0432.CCR-08-0040; Liby K, 2007, CANCER RES, V67, P2414, DOI 10.1158/0008-5472.CAN-06-4534; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Liu HJ, 2000, SYNLETT, P1119; Liu H, 2008, P NATL ACAD SCI USA, V105, P15926, DOI 10.1073/pnas.0808346105; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; PAQUETTE LA, 1989, TETRAHEDRON, V45, P107, DOI 10.1016/0040-4020(89)80038-9; POSNER GH, 1994, J MED CHEM, V37, P170, DOI 10.1021/jm00027a021; PROCHASKA HJ, 1988, ANAL BIOCHEM, V169, P328, DOI 10.1016/0003-2697(88)90292-8; Schwartz S. L., 2009, AM DIAB ASS M NEW OR; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stack C, 2010, FREE RADICAL BIO MED, V49, P147, DOI 10.1016/j.freeradbiomed.2010.03.017; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; TALALAY P, 1988, P NATL ACAD SCI USA, V85, P8261, DOI 10.1073/pnas.85.21.8261; Talalay P, 2003, ADV ENZYME REGUL, V43, P121, DOI 10.1016/S0065-2571(02)00038-9; Talalay P, 1995, TOXICOL LETT, V82-3, P173, DOI 10.1016/0378-4274(95)03553-2; Wang XJ, 2006, CANCER RES, V66, P10983, DOI 10.1158/0008-5472.CAN-06-2298; Yang LC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005757; Yates MS, 2006, CANCER RES, V66, P2488, DOI 10.1158/0008-5472.CAN-05-3823; Zhang YS, 2001, CARCINOGENESIS, V22, P425, DOI 10.1093/carcin/22.3.425; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399	43	92	94	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33747	33755		10.1074/jbc.M110.163485	http://dx.doi.org/10.1074/jbc.M110.163485			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20801881	Green Published, hybrid			2022-12-25	WOS:000283354000020
J	LeBlanc, MA; McMaster, CR				LeBlanc, Marissa A.; McMaster, Christopher R.			Lipid Binding Requirements for Oxysterol-binding Protein Kes1 Inhibition of Autophagy and Endosome-trans-Golgi Trafficking Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MEMBRANE CURVATURE; CELL-GROWTH; YEAST; 3-KINASE; VACUOLE; COMPLEX; VPS34; PIK1; KINASE	The Saccharomyces cerevisiae protein Kes1/Osh4 is a member of the enigmatic family of oxysterol-binding proteins found throughout Eukarya united by a beta-barrel structure that binds sterols and oxysterols. In this study, we determined that phos-phoinositides are the major determinant in membranes that facilitate Kes1 association both in vitro and in cells. Increased expression of Kes1 in yeast cells decreased the levels of both phosphatidylinositol 4-phosphate (PI4P) and phosphatidylinositol 3-phosphate (PI3P). Phosphoinositide and sterol bindings by Kes1 were necessary for Kes1 to decrease the level of PI4P but not PI3P. Kes1 inhibited vesicular trafficking between the trans-Golgi and plasma membrane as evidenced by accumulation of the vacuolar soluble NSF attachment protein receptors Snc1 in the cytoplasmic vesicles. Sterol and phosphoinositide binding by Kes1 both contributed to its regulation of Snc1 trafficking. This study also describes a previously unknown role for Kes1 in the regulation of the autophagy/cytoplasm to the vacuole trafficking pathway. The Kes1-mediated regulation of the autophagy/cytoplasm to the vacuole trafficking pathway was prevented by increasing expression of the PI3K Vps34, suggesting that it is the Kes1-mediated decrease in PI3P level that contributes to this regulation.	[McMaster, Christopher R.] Dalhousie Univ, Dept Pediat, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada; Dalhousie Univ, Dept Biochem & Mol Biol, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada	Dalhousie University; Dalhousie University	McMaster, CR (corresponding author), Dalhousie Univ, Dept Pediat, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada.	christopher.mcmaster@dal.ca		McMaster, Christopher/0000-0003-0822-5776	National Sciences and Engineering Research Council; Nova Scotia Health Research Foundation	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Nova Scotia Health Research Foundation	This work was supported in part by a discovery award from the National Sciences and Engineering Research Council (to C.R.M.).; Recipient of a Nova Scotia Health Research Foundation Ph.D. studentship.	Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Beh CT, 2004, J CELL SCI, V117, P2983, DOI 10.1242/jcs.01157; Beh CT, 2001, GENETICS, V157, P1117; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Curwin AJ, 2009, J BIOL CHEM, V284, P7364, DOI 10.1074/jbc.M808732200; Demmel L, 2008, MOL BIOL CELL, V19, P1046, DOI 10.1091/mbc.E07-02-0134; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Fairn GD, 2008, CELL MOL LIFE SCI, V65, P228, DOI 10.1007/s00018-007-7325-2; Fairn GD, 2005, BIOCHEM J, V387, P889, DOI 10.1042/BJ20041915; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Fang M, 1996, EMBO J, V15, P6447, DOI 10.1002/j.1460-2075.1996.tb01036.x; Faulhammer F, 2007, TRAFFIC, V8, P1554, DOI 10.1111/j.1600-0854.2007.00632.x; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Knodler A, 2005, BIOTECHNIQUES, V38, P858, DOI 10.2144/05386BM02; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Legakis JE, 2007, AUTOPHAGY, V3, P422, DOI 10.4161/auto.4129; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Nair U, 2005, J BIOL CHEM, V280, P41785, DOI 10.1074/jbc.R500016200; Nazarko TY, 2005, AUTOPHAGY, V1, P37, DOI 10.4161/auto.1.1.1512; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; RAYCHAUDURI J, 2010, ANN REV CEL IN PRESS; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Suriapranata I, 2000, J CELL SCI, V113, P4025; Teasdale RD, 2001, BIOCHEM J, V358, P7, DOI 10.1042/0264-6021:3580007; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; van der Vaart A, 2010, MOL BIOL CELL, V21, P2270, DOI 10.1091/mbc.E09-04-0345; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Wright R, 2000, MICROSC RES TECHNIQ, V51, P496, DOI 10.1002/1097-0029(20001215)51:6<496::AID-JEMT2>3.3.CO;2-0; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xu YQ, 2001, J BIOL CHEM, V276, P18407, DOI 10.1074/jbc.M101204200; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479	47	25	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33875	33884		10.1074/jbc.M110.147264	http://dx.doi.org/10.1074/jbc.M110.147264			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729555	Green Published, hybrid			2022-12-25	WOS:000283354000034
J	Greenfield, EM; Beidelschies, MA; Tatro, JM; Goldberg, VM; Hise, AG				Greenfield, Edward M.; Beidelschies, Michelle A.; Tatro, Joscelyn M.; Goldberg, Victor M.; Hise, Amy G.			Bacterial Pathogen-associated Molecular Patterns Stimulate Biological Activity of Orthopaedic Wear Particles by Activating Cognate Toll-like Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA PRODUCTION; RIBOSOMAL-RNA GENE; NALP3 INFLAMMASOME; ADHERENT ENDOTOXIN; TITANIUM PARTICLES; IMMUNE-RESPONSES; OSTEOCLAST DIFFERENTIATION; INDUCED OSTEOLYSIS; HIP-REPLACEMENT; POLYMYXIN-B	Aseptic loosening of orthopaedic implants is induced by wear particles generated from the polymeric and metallic components of the implants. Substantial evidence suggests that activation of Toll-like receptors (TLRs) may contribute to the biological activity of the wear particles. Although pathogen-associated molecular patterns (PAMPs) produced by Gram-positive bacteria are likely to be more common in patients with aseptic loosening, prior studies have focused on LPS, a TLR4-specific PAMP produced by Gram-negative bacteria. Here we show that both TLR2 and TLR4 contribute to the biological activity of titanium particles with adherent bacterial debris. In addition, lipoteichoic acid, a PAMP produced by Gram-positive bacteria that activates TLR2, can, like LPS, adhere to the particles and increase their biological activity, and the increased biological activity requires the presence of the cognate TLR. Moreover, three lines of evidence support the conclusion that TLR activation requires bacterially derived PAMPs and that endogenously produced alarmins are not sufficient. First, neither TLR2 nor TLR4 contribute to the activity of "endotoxin-free" particles as would be expected if alarmins are sufficient to activate the TLRs. Second, noncognate TLRs do not contribute to the activity of particles with adherent LPS or lipoteichoic acid as would be expected if alarmins are sufficient to activate the TLRs. Third, polymyxin B, which inactivates LPS, blocks the activity of particles with adherent LPS. These results support the hypothesis that PAMPs produced by low levels of bacterial colonization may contribute to aseptic loosening of orthopaedic implants.	[Greenfield, Edward M.; Beidelschies, Michelle A.; Tatro, Joscelyn M.; Goldberg, Victor M.] Case Western Reserve Univ, Dept Orthopaed, Cleveland, OH 44106 USA; [Hise, Amy G.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Case Med Ctr, Cleveland, OH 44106 USA; [Greenfield, Edward M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Greenfield, Edward M.] Case Western Reserve Univ, Ctr Comprehens Canc, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Greenfield, EM (corresponding author), Case Western Reserve Univ, Dept Orthopaed, 2109 Adelbert Rd,Biomed Res Bldg,Rm 331, Cleveland, OH 44106 USA.	emg3@cwru.edu	Beidelschies, Michelle/AAM-6446-2021	Beidelschies, Michelle/0000-0002-6344-0674; Hise, Amy/0000-0001-5075-5792	National Institutes of Health [T32 AR07505]; Sulzer Medical Research Trust; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sulzer Medical Research Trust; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant T32 AR07505 (to M.A.B.). This work was also supported by a grant from the Sulzer Medical Research Trust Fund (to E.M.G. and V.M.G.).	Ashwood P, 2007, EXP BIOL MED, V232, P107; Beidelschies MA, 2008, J CELL PHYSIOL, V217, P652, DOI 10.1002/jcp.21539; Bi YM, 2001, J BONE MINER RES, V16, P2082, DOI 10.1359/jbmr.2001.16.11.2082; Bi YM, 2002, J ORTHOP RES, V20, P696, DOI 10.1016/S0736-0266(01)00176-0; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Caicedo MS, 2009, J ORTHOP RES, V27, P847, DOI 10.1002/jor.20826; Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075; Dai JC, 2006, BONE, V38, P509, DOI 10.1016/j.bone.2005.10.007; Deininger S, 2008, IMMUNOBIOLOGY, V213, P519, DOI 10.1016/j.imbio.2008.01.001; Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034; Dempsey KE, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2201; DUFF GW, 1982, J IMMUNOL METHODS, V52, P333, DOI 10.1016/0022-1759(82)90005-9; Engesaeter LB, 2003, ACTA ORTHOP SCAND, V74, P644, DOI 10.1080/00016470310018135; Gao JJ, 2001, INFECT IMMUN, V69, P751, DOI 10.1128/IAI.69.2.751-757.2001; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Gillette-Ferguson I, 2007, INFECT IMMUN, V75, P5908, DOI 10.1128/IAI.00991-07; GREENFIELD E, 2006, ENCY BIOMATERIALS BI, P1; Greenfield EM, 2008, J AM ACAD ORTHOP SUR, V16, pS56, DOI 10.5435/00124635-200800001-00012; Greenfield EM, 2002, J ORTHOPAED RES, V20, P1, DOI 10.1016/S0736-0266(01)00070-5; Greenfield EM, 2005, J BIOMED MATER RES B, V72B, P179, DOI 10.1002/jbm.b.30150; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hanssen AD, 2004, CLIN ORTHOP RELAT R, P63; Hao HN, 2010, J BIOMED MATER RES A, V92A, P1373, DOI 10.1002/jbm.a.32474; Hise AG, 2007, J IMMUNOL, V178, P1068, DOI 10.4049/jimmunol.178.2.1068; Hoenders CSM, 2008, J BIOMED MATER RES B, V86B, P291, DOI 10.1002/jbm.b.30992; Holt G, 2007, CLIN ORTHOP RELAT R, P240, DOI 10.1097/BLO.0b013e31804b4147; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hoshino K, 1999, J IMMUNOL, V162, P3749; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Kaar SG, 2001, J ORTHOPAED RES, V19, P171, DOI 10.1016/S0736-0266(00)00033-4; Lahdeoja T, 2010, J ORTHOP RES, V28, P184, DOI 10.1002/jor.20979; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Lyle DB, 2010, J BIOMED MATER RES A, V94A, P893, DOI 10.1002/jbm.a.32760; Maitra R, 2009, MOL IMMUNOL, V47, P175, DOI 10.1016/j.molimm.2009.09.023; Maitra R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002438; Marshall A, 2008, J AM ACAD ORTHOP SUR, V16, pS1, DOI 10.5435/00124635-200800001-00003; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; MORRISON DC, 1976, IMMUNOCHEMISTRY, V13, P813, DOI 10.1016/0019-2791(76)90181-6; Nalepka JL, 2006, CLIN ORTHOP RELAT R, P229, DOI 10.1097/01.blo.0000224050.94248.38; Nalepka JL, 2004, BIOTECHNIQUES, V37, P413, DOI 10.2144/04373ST06; NELSON CL, 2005, CLIN ORTHOP RELAT R, V437, P25; NEUT D, 2003, CLIN ORTHOP RELAT R, V413, P261; Neut D, 2007, ACTA ORTHOP, V78, P299, DOI 10.1080/17453670710013843; Osterloh A, 2007, J BIOL CHEM, V282, P4669, DOI 10.1074/jbc.M608666200; PEARL J, 2008, T ORTHOP RES SOC, V33, P1936; Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603; Ru LB, 2005, ARTHRITIS RHEUM-US, V52, P2936, DOI 10.1002/art.21238; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; STPIERRE CA, 2010, J ORTHOP RE IN PRESS; Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902; Takagi M, 2007, J BIOMED MATER RES A, V81A, P1017, DOI 10.1002/jbm.a.31235; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taki N, 2005, J ORTHOP RES, V23, P376, DOI 10.1016/j.orthres.2004.08.023; Tamaki Y, 2009, J RHEUMATOL, V36, P598, DOI 10.3899/jrheum.080390; Tatro JM, 2007, J ORTHOP RES, V25, P361, DOI 10.1002/jor.20289; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Tunney MM, 1999, J CLIN MICROBIOL, V37, P3281, DOI 10.1128/JCM.37.10.3281-3290.1999; Warger T, 2006, J BIOL CHEM, V281, P22545, DOI 10.1074/jbc.M502900200; Xing ZQ, 2006, J ORTHOP RES, V24, P959, DOI 10.1002/jor.20038; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067	64	69	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42					32378	32384		10.1074/jbc.M110.136895	http://dx.doi.org/10.1074/jbc.M110.136895			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20729214	Green Published, hybrid			2022-12-25	WOS:000282683000051
J	Nalam, K; Ahmed, A; Devi, SM; Francalacci, P; Baig, M; Sechi, LA; Hartskeerl, RA; Ahmed, N				Nalam, Kishore; Ahmed, Ahmed; Devi, Sundru Manjulata; Francalacci, Paolo; Baig, Mumtaz; Sechi, Leonardo A.; Hartskeerl, Rudy A.; Ahmed, Niyaz			Genetic Affinities within a Large Global Collection of Pathogenic Leptospira: Implications for Strain Identification and Molecular Epidemiology	PLOS ONE			English	Article							SEQUENCE; NOV.; POPULATIONS; INSIGHTS; SEROVARS	Leptospirosis is an important zoonosis with widespread human health implications. The non-availability of accurate identification methods for the individualization of different Leptospira for outbreak investigations poses bountiful problems in the disease control arena. We harnessed fluorescent amplified fragment length polymorphism analysis (FAFLP) for Leptospira and investigated its utility in establishing genetic relationships among 271 isolates in the context of species level assignments of our global collection of isolates and strains obtained from a diverse array of hosts. In addition, this method was compared to an in-house multilocus sequence typing (MLST) method based on polymorphisms in three housekeeping genes, the rrs locus and two envelope proteins. Phylogenetic relationships were deduced based on bifurcating Neighbor-joining trees as well as median joining network analyses integrating both the FAFLP data and MLST based haplotypes. The phylogenetic relationships were also reproduced through Bayesian analysis of the multilocus sequence polymorphisms. We found FAFLP to be an important method for outbreak investigation and for clustering of isolates based on their geographical descent rather than by genome species types. The FAFLP method was, however, not able to convey much taxonomical utility sufficient to replace the highly tedious serotyping procedures in vogue. MLST, on the other hand, was found to be highly robust and efficient in identifying ancestral relationships and segregating the outbreak associated strains or otherwise according to their genome species status and, therefore, could unambiguously be applied for investigating phylogenetics of Leptospira in the context of taxonomy as well as gene flow. For instance, MLST was more efficient, as compared to FAFLP method, in clustering strains from the Andaman island of India, with their counterparts from mainland India and Sri Lanka, implying that such strains share genetic relationships and that leptospiral strains might be frequently circulating between the islands and the mainland.	[Nalam, Kishore; Ahmed, Niyaz] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India; [Ahmed, Ahmed; Hartskeerl, Rudy A.] Royal Trop Inst KIT, Dept Biomed Res, WHO FAO OIE, Amsterdam, Netherlands; [Ahmed, Ahmed; Hartskeerl, Rudy A.] Royal Trop Inst KIT, Dept Biomed Res, Natl Collaborating Ctr Reference & Res Leptospiro, Amsterdam, Netherlands; [Devi, Sundru Manjulata] Cent Food Technol Res Inst, Mysore 570013, Karnataka, India; [Francalacci, Paolo] Univ Sassari, Dept Zool & Evolutionary Genet, I-07100 Sassari, Italy; [Baig, Mumtaz] Govt Vidarbha Inst Sci & Humanities, Amravati, Maharashtra, India; [Sechi, Leonardo A.] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy	University of Hyderabad; Food & Agriculture Organization of the United Nations (FAO); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI); University of Sassari; Government Vidarbha Institute of Science & Humanities; University of Sassari	Nalam, K (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India.	niyazSL@uohyd.ernet.in	Sundru, Manjulata Devi/AAM-8462-2020; Sechi, Leonardo Antonio/Y-3109-2018; Ahmed, Niyaz/D-2589-2010	Sundru, Manjulata Devi/0000-0002-2744-1629; Ahmed, Niyaz/0000-0001-6425-7583; sechi, leonardo antonio/0000-0003-0566-2049; FRANCALACCI, Paolo/0000-0001-7912-162X	Council for Scientific and Industrial Research (CSIR) of India; EC [ICA4-CT-2001-10086]	Council for Scientific and Industrial Research (CSIR) of India(Council of Scientific & Industrial Research (CSIR) - India); EC(European CommissionEuropean Commission Joint Research Centre)	This study did not receive any designated funding and the work was carried out from the routine laboratory supplies and resources available to the investigators in the form of a core support. Kishore Nalam would like to acknowledge the Junior Research Fellowship of the Council for Scientific and Industrial Research (CSIR) of India. Rudy Hartskeerl would like to acknowledge support from the EC grant ICA4-CT-2001-10086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2008, NAT REV MICROBIOL, V6, P387, DOI 10.1038/nrmicro1889; Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28; Ahmed N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005831; Aziz RK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000713; BANDELT HJ, 1995, GENETICS, V141, P743; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839, DOI 10.1099/00207713-49-2-839; Cerqueira GM, 2009, INFECT GENET EVOL, V9, P760, DOI 10.1016/j.meegid.2009.06.009; Devi SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-184; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064; GRAVEKAMP C, 1993, J GEN MICROBIOL, V139, P1691, DOI 10.1099/00221287-139-8-1691; KMETY E, 1993, CLASSIFICATION SPECI, P17; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Levett PN, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000120; Levett PN, 2006, INT J SYST EVOL MICR, V56, P671, DOI 10.1099/ijs.0.63783-0; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Majed Z, 2005, J CLIN MICROBIOL, V43, P539, DOI 10.1128/JCM.43.2.539-545.2005; Matthias MA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000213; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Pavon ABI, 2009, METHODS MOL BIOL, V551, P129, DOI 10.1007/978-1-60327-999-4_11; Perolat P, 1998, INT J SYST BACTERIOL, V48, P851, DOI 10.1099/00207713-48-3-851; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110; Thaipadungpanit J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000056; Victoria B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002752; Vijayachari P, 2008, T ROY SOC TROP MED H, V102, P117, DOI 10.1016/j.trstmh.2007.08.012; Vijayachari P, 2004, J CLIN MICROBIOL, V42, P3575, DOI [10.1128/JCM.42.8.3575-3580.2004, 10.1128/jcm.42.8.3575-3580.2004]	34	46	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12637	10.1371/journal.pone.0012637	http://dx.doi.org/10.1371/journal.pone.0012637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805987	Green Published, gold, Green Submitted			2022-12-25	WOS:000281301500029
J	Hardell, S; Tilander, H; Welfinger-Smith, G; Burger, J; Carpenter, DO				Hardell, Sara; Tilander, Hanna; Welfinger-Smith, Gretchen; Burger, Joanna; Carpenter, David O.			Levels of Polychlorinated Biphenyls (PCBs) and Three Organochlorine Pesticides in Fish from the Aleutian Islands of Alaska	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; POLYBROMINATED DIPHENYL ETHERS; PUFFIN FRATERCULA-CIRRHATA; EIDER SOMATERIA-MOLLISSIMA; AMCHITKA ISLAND; ATLANTIC SALMON; POTENTIAL RISK; HUMAN HEALTH; ADAK ISLAND; EXPOSURE	Persistent organic pollutants (POPs), including polychlorinated biphenyls (PCBs) and chlorinated pesticides, have been shown to have many adverse human health effects. These contaminants therefore may pose a risk to Alaska Natives that follow a traditional diet high in marine mammals and fish, in which POPs bioaccumulate. Methods and Findings: This study examined the levels of PCBs and three pesticides [p, p9-DDE, mirex, and hexachlorobenzene (HCB)] in muscle tissue from nine fish species from several locations around the Aleutian Islands of Alaska. The highest median PCB level was found in rock sole (Lepidopsetta bilineata, 285 ppb, wet weight), while the lowest level was found in rock greenling (Hexagrammos lagocephalus, 104 ppb, wet weight). Lipid adjusted PCB values were also calculated and significant interspecies differences were found. Again, rock sole had the highest level (68,536 ppb, lipid weight). Concerning the PCB congener patterns, the more highly chlorinated congeners were most common as would be expected due to their greater persistence. Among the pesticides, p, p9-DDE generally dominated, and the highest level was found in sockeye salmon (Oncorhynchus nerka, 6.9 ppb, wet weight). The methodology developed by U. S. Environmental Protection Agency (USEPA) was used to calculate risk-based consumption limits for the analyzed fish species. For cancer health endpoints for PCBs, all species would trigger strict advisories of between two and six meals per year, depending upon species. For noncancer effects by PCBs, advisories of between seven and twenty-two meals per year were triggered. None of the pesticides triggered consumption limits. Conclusion: The fish analyzed, mainly from Adak, contain significant concentrations of POPs, in particular PCBs, which raises the question whether these fish are safe to eat, particularly for sensitive populations. However when assessing any risk of the traditional diet, one must also consider the many health and cultural benefits from eating fish.	[Hardell, Sara; Tilander, Hanna] Linkoping Univ, Fac Hlth Sci, Linkoping, Sweden; [Hardell, Sara; Tilander, Hanna; Welfinger-Smith, Gretchen; Carpenter, David O.] SUNY Albany, Inst Hlth & Environm, Rensselaer, NY USA; [Burger, Joanna] Rutgers State Univ, Dept Environm & Occupat Hlth, New Brunswick, NJ 08903 USA; [Carpenter, David O.] SUNY Albany, Sch Publ Hlth, Dept Environm Hlth Sci, Rensselaer, NY USA	Linkoping University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Rutgers State University New Brunswick; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Hardell, S (corresponding author), Linkoping Univ, Fac Hlth Sci, Linkoping, Sweden.	carpent@uamail.albany.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER; NIEHS NIH HHS [30ES005022, P30 ES005022] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AMAP, 1998, AMAP ASS REP ARCT PO; Arnold SM, 2005, AM J PUBLIC HEALTH, V95, P393, DOI 10.2105/AJPH.2004.042879; Bernes C., 1998, PERSISTENT ORGANIC P; Besselink HT, 1996, ENVIRON POLLUT, V92, P267, DOI 10.1016/0269-7491(95)00116-6; Braune BM, 2005, SCI TOTAL ENVIRON, V351, P4, DOI 10.1016/j.scitotenv.2004.10.034; Breivik K, 2004, ENVIRON POLLUT, V128, P3, DOI 10.1016/j.envpol.2003.08.031; Breivik K, 2007, SCI TOTAL ENVIRON, V377, P296, DOI 10.1016/j.scitotenv.2007.02.026; Burger J, 2006, ENVIRON RES, V101, P34, DOI 10.1016/j.envres.2005.07.003; Burger J, 2007, J ENVIRON RADIOACTIV, V98, P315, DOI 10.1016/j.jenvrad.2007.06.002; Burger J, 2007, SCI TOTAL ENVIRON, V384, P93, DOI 10.1016/j.scitotenv.2007.05.004; Burger J, 2007, J TOXICOL ENV HEAL A, V70, P1897, DOI 10.1080/15287390701551159; Burger J, 2007, J ENVIRON MANAGE, V85, P232, DOI 10.1016/j.jenvman.2006.10.005; Burger J, 2007, ENVIRON RES, V103, P62, DOI 10.1016/j.envres.2006.02.005; Burger J, 2009, ENVIRON RES, V109, P503, DOI 10.1016/j.envres.2009.01.002; Burger J, 2009, ENVIRON MONIT ASSESS, V152, P357, DOI 10.1007/s10661-008-0321-7; Burger J, 2009, ARCH ENVIRON CON TOX, V56, P596, DOI 10.1007/s00244-008-9207-5; Burger J, 2009, ENVIRON RES, V109, P343, DOI 10.1016/j.envres.2008.12.002; Burkow IC, 2000, TOXICOL LETT, V112, P87, DOI 10.1016/S0378-4274(99)00254-4; Carpenter David O, 2005, Int J Circumpolar Health, V64, P322; Carpenter David O., 2006, Reviews on Environmental Health, V21, P1; Chiu A, 2004, J ENVIRON SCI HEAL C, V22, P13, DOI 10.1081/GNC-120038004; Cook PM, 2003, ENVIRON SCI TECHNOL, V37, P3864, DOI 10.1021/es034045m; DAY GE, 2010, INT J CIRCUMPOL HEAL, V86, P69; DeCaprio AP, 2000, J ANAL TOXICOL, V24, P403, DOI 10.1093/jat/24.6.403; DEUTCH B, 2002, RECENTLY DIETARY STU; Dewailly E, 2008, FOOD ADDIT CONTAM A, V25, P1328, DOI 10.1080/02652030802175285; Domingo JL, 2007, ENVIRON INT, V33, P397, DOI 10.1016/j.envint.2006.12.004; DUFRESNE J, 2006, LONELY PLANET ALASKA; Egeland G.M., 1998, USE TRADITIONAL FOOD; ERICKSON MD, 2001, RECENT ADV ENV TOXIC; FALL JA, 1996, HARVEST USE FISH WIL; Friborg JT, 2008, LANCET ONCOL, V9, P892, DOI 10.1016/S1470-2045(08)70231-6; HAMRICK K, 2003, SUBSISTENCE FOOD USE; Hardell L, 2006, INT J ANDROL, V29, P228, DOI 10.1111/j.1365-2605.2005.00622.x; HARPER BL, 2008, EPASTARJ1R831046; HERTZPICCIOTTO I, 2008, ENV HLTH, V7, P1; Hodgson E, 1996, ENVIRON HEALTH PERSP, V104, P97, DOI 10.2307/3432700; HOLOUBEK I, 2001, RECENT ADV ENV TOXIC, P17; Huang XY, 2006, ENVIRON RES, V101, P263, DOI 10.1016/j.envres.2005.08.011; Isosaari P, 2006, ENVIRON POLLUT, V141, P213, DOI 10.1016/j.envpol.2005.08.055; JACOBSON JL, 2001, RECENT ADV ENV TOXIC, P127; Jones KC, 1999, ENVIRON POLLUT, V100, P209, DOI 10.1016/S0269-7491(99)00098-6; Jung JH, 2005, MAR POLLUT BULL, V51, P794, DOI 10.1016/j.marpolbul.2005.07.013; Kelly J, 2008, INT J CIRCUMPOL HEAL, V67, P408, DOI 10.3402/ijch.v67i5.18349; KORRICK SA, 2001, RECENT ADV ENV TOXIC, P143; Lerner DT, 2007, AQUAT TOXICOL, V81, P329, DOI 10.1016/j.aquatox.2006.12.018; Lohmann R, 2007, ENVIRON POLLUT, V150, P150, DOI 10.1016/j.envpol.2007.06.051; Longnecker MP, 1997, ANNU REV PUBL HEALTH, V18, P211, DOI 10.1146/annurev.publhealth.18.1.211; MACKAY D, 1995, SCI TOTAL ENVIRON, V160-61, P25, DOI 10.1016/0048-9697(95)04342-X; McLaughlin JB, 2004, JAMA-J AM MED ASSOC, V291, P2545, DOI 10.1001/jama.291.21.2545; MIDDAUGH J, 2001, STATE ALASKA EPIDEMI, V5; *NOAA, NOAA FISH WATCH US S; NOBMANN ED, 1992, AM J CLIN NUTR, V55, P1024, DOI 10.1093/ajcn/55.5.1024; Odland JO, 2003, ACTA PAEDIATR, V92, P1255, DOI 10.1080/08035250310005602; Rubin C H, 2001, Int J Circumpolar Health, V60, P157; Shaw SD, 2006, ENVIRON SCI TECHNOL, V40, P5347, DOI 10.1021/es061006c; STONGE M, 2009, ENERGY DIGITAL   JUN, P1; Stout JH, 2002, J WILDLIFE DIS, V38, P511, DOI 10.7589/0090-3558-38.3.511; Suk WA, 2004, ENVIRON HEALTH PERSP, V112, P113, DOI 10.1289/ehp.6383; Svendsen TC, 2007, J ENVIRON MONITOR, V9, P1213, DOI 10.1039/b707658d; Tan YS, 2004, TOXICOL SCI, V80, P54, DOI 10.1093/toxsci/kfh119; TRAVIS CC, 1991, ENVIRON SCI TECHNOL, V25, P814, DOI 10.1021/es00017a001; United States Environmental Protection Agency (USEPA), 2000, EPA GUID DEV FISH AD; *USEPA, NPL SIT NARR AD NAV; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Verbrugge L., 2007, FISH CONSUMPTION ADV; VERBRUGGE LA, 2004, USE TRADITIONAL FOOD, V1; WANIA F, 1995, SCI TOTAL ENVIRON, V160-61, P211, DOI 10.1016/0048-9697(95)04358-8; Wania F, 1998, ENVIRON POLLUT, V102, P25, DOI 10.1016/S0269-7491(98)00073-6; ZAMZOW K, 2002, CONTAMINANTS WILDLIF	70	44	50	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12396	10.1371/journal.pone.0012396	http://dx.doi.org/10.1371/journal.pone.0012396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811633	Green Published, Green Submitted, gold			2022-12-25	WOS:000281234700020
J	Nicholls, MER; Loetscher, T; Rademacher, M				Nicholls, Michael E. R.; Loetscher, Tobias; Rademacher, Maxwell			Miss to the Right: The Effect of Attentional Asymmetries on Goal-Kicking	PLOS ONE			English	Article							LINE-BISECTION JUDGMENTS; VISUOSPATIAL ATTENTION; FAR SPACE; TOOL USE; SPATIAL NEGLECT; PSEUDONEGLECT; ADAPTATION; COLLISIONS; TASK; BIAS	Cerebral asymmetries for spatial attention generate a bias of attention - causing lines to be bisected to the left or right in near (within reach) and far (outside reach) space, respectively. This study explored whether the rightward deviation for bisecting lines in far space extends to tasks where a ball is aimed between two goal-posts. Kicking was assessed in a laboratory and a real-life setting. In the laboratory setting, 212 participants carried out three conditions: (a) kick a soccer ball at a single goal post, (b) kick a soccer ball between two goal posts and (c) use a stick to indicate the middle between two goal posts. The goals were placed at a distance of 4.0 m. There was no deviation in the one-goal kicking condition demonstrating that no asymmetries exist in the perceptual motor system when aiming at a single point. When kicking or pointing at the middle between two goal posts, rightward deviations were observed. In the real-world setting, the number of misses to the left or right of goal (behinds) in the Australian Rules football for the 2005-2009 seasons was assessed. The data showed more rightward deviations for kicks at goal. Combined, the studies suggest that the rightward deviation for lines placed in far space extends to the kicking of a football in laboratory and real-life settings. This asymmetry in kicking builds on a body of research showing that attentional asymmetries impact everyday activities.	[Nicholls, Michael E. R.] Flinders Univ S Australia, Sch Psychol, Bedford Pk, SA 5042, Australia; [Loetscher, Tobias; Rademacher, Maxwell] Univ Melbourne, Dept Psychol Sci, Parkville, Vic 3052, Australia	Flinders University South Australia; University of Melbourne	Nicholls, MER (corresponding author), Flinders Univ S Australia, Sch Psychol, Bedford Pk, SA 5042, Australia.	mike.nicholls@flinders.edu.au	Loetscher, Tobias/I-1865-2019	Loetscher, Tobias/0000-0003-1967-2926; Nicholls, Mike/0000-0002-7072-3744				Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; Bjoertomt O, 2002, BRAIN, V125, P2012, DOI 10.1093/brain/awf211; BOWERS D, 1980, NEUROPSYCHOLOGIA, V18, P491, DOI 10.1016/0028-3932(80)90151-7; Bultitude JH, 2006, NEUROPSYCHOLOGIA, V44, P1849, DOI 10.1016/j.neuropsychologia.2006.03.001; Colby CL, 1998, NEURON, V20, P15, DOI 10.1016/S0896-6273(00)80429-8; CORBETTA M, 1993, J NEUROSCI, V13, P1202; COREN S, 1979, Journal of Clinical Neuropsychology, V1, P55, DOI 10.1080/01688637908401098; Foxe JJ, 2003, NEUROIMAGE, V19, P710, DOI 10.1016/S1053-8119(03)00057-0; Gamberini L, 2008, NEUROPSYCHOLOGIA, V46, P1298, DOI 10.1016/j.neuropsychologia.2007.12.016; HEILMAN KM, 1993, NEGLECT RELATED DISO, P279; Iriki A, 1996, NEUROREPORT, V7, P2325; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Loftus AM, 2008, COGNITION, V107, P1048, DOI 10.1016/j.cognition.2007.09.007; Loftus AM, 2009, CORTEX, V45, P537, DOI 10.1016/j.cortex.2007.12.011; Longo MR, 2006, NEUROPSYCHOLOGIA, V44, P977, DOI 10.1016/j.neuropsychologia.2005.09.003; LUH KE, 1995, NEUROPSYCHOLOGY, V9, P435, DOI 10.1037/0894-4105.9.4.435; McCourt ME, 2001, NEUROPSYCHOLOGIA, V39, P1065, DOI 10.1016/S0028-3932(01)00044-6; McCourt ME, 1999, NEUROPSYCHOLOGIA, V37, P843, DOI 10.1016/S0028-3932(98)00140-7; NICHELLI P, 1989, BRAIN COGNITION, V9, P57, DOI 10.1016/0278-2626(89)90044-4; NICHOLLS MER, ATTENTION P IN PRESS; Nicholls MER, 2008, BRAIN COGNITION, V68, P166, DOI 10.1016/j.bandc.2008.04.003; Nicholls MER, 2007, NEUROPSYCHOLOGIA, V45, P1122, DOI 10.1016/j.neuropsychologia.2006.07.015; PROVINS KA, 1972, NEUROPSYCHOLOGIA, V10, P199, DOI 10.1016/0028-3932(72)90060-7; Roberts R, 2010, J SPORT SCI, V28, P369, DOI 10.1080/02640410903536467; TROMP E, 1995, NEUROPSYCHOL REHABIL, V5, P319, DOI 10.1080/09602019508401475; Turnbull OH, 1998, BRAIN COGNITION, V37, P31; Waberski TD, 2008, NEUROPSYCHOLOGIA, V46, P1201, DOI 10.1016/j.neuropsychologia.2007.10.024; WEBSTER JS, 1995, ARCH PHYS MED REHAB, V76, P924, DOI 10.1016/S0003-9993(95)80068-9; WEBSTER JS, 1994, J CLIN EXP NEUROPSYC, V16, P129, DOI 10.1080/01688639408402623; Weiss PH, 2000, BRAIN, V123, P2531, DOI 10.1093/brain/123.12.2531	30	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12363	10.1371/journal.pone.0012363	http://dx.doi.org/10.1371/journal.pone.0012363			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808774	gold, Green Published			2022-12-25	WOS:000281154300006
J	Tawfeek, H; Bedi, B; Li, JY; Adams, J; Kobayashi, T; Weitzmann, MN; Kronenberg, HM; Pacifici, R				Tawfeek, Hesham; Bedi, Brahmchetna; Li, Jau-Yi; Adams, Jonathan; Kobayashi, Tatsuya; Weitzmann, M. Neale; Kronenberg, Henry M.; Pacifici, Roberto			Disruption of PTH Receptor 1 in T Cells Protects against PTH-Induced Bone Loss	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; MILD PRIMARY HYPERPARATHYROIDISM; HUMAN PARATHYROID-HORMONE; NECROSIS-FACTOR-ALPHA; ESTROGEN DEFICIENCY; TUBEROINFUNDIBULAR PEPTIDE; MECHANICAL-PROPERTIES; POSTMENOPAUSAL WOMEN; IFN-GAMMA; TNF-ALPHA	Background: Hyperparathyroidism in humans and continuous parathyroid hormone (cPTH) treatment in mice cause bone loss by regulating the production of RANKL and OPG by stromal cells (SCs) and osteoblasts (OBs). Recently, it has been reported that T cells are required for cPTH to induce bone loss as the binding of the T cell costimulatory molecule CD40L to SC receptor CD40 augments SC sensitivity to cPTH. However it is unknown whether direct PTH stimulation of T cells is required for cPTH to induce bone loss, and whether T cells contribute to the bone catabolic activity of PTH with mechanisms other than induction of CD40 signaling in SCs. Methodology/Principal Findings: Here we show that silencing of PTH receptor 1 (PPR) in T cells blocks the bone loss and the osteoclastic expansion induced by cPTH, thus demonstrating that PPR signaling in T cells is central for PTH-induced reduction of bone mass. Mechanistic studies revealed that PTH activation of the T cell PPR stimulates T cell production of the osteoclastogenic cytokine tumor necrosis factor a (TNF). Attesting to the relevance of this effect, disruption of T cell TNF production prevents PTH-induced bone loss. We also show that a novel mechanism by which TNF mediates PTH induced osteoclast formation is upregulation of CD40 expression in SCs, which increases their RANKL/OPG production ratio. Conclusions/Significance: These findings demonstrate that PPR signaling in T cells plays an essential role in PTH induced bone loss by promoting T cell production of TNF. A previously unknown effect of TNF is to increase SC expression of CD40, which in turn increases SC osteoclastogenic activity by upregulating their RANKL/OPG production ratio. PPR-dependent stimulation of TNF production by T cells and the resulting TNF regulation of CD40 signaling in SCs are potential new therapeutic targets for the bone loss of hyperparathyroidism.	[Tawfeek, Hesham; Bedi, Brahmchetna; Li, Jau-Yi; Adams, Jonathan; Weitzmann, M. Neale; Pacifici, Roberto] Emory Univ, Dept Med, Div Endocrinol Metab & Lipids, Atlanta, GA 30322 USA; [Pacifici, Roberto] Emory Univ, Immunol & Mol Pathogenesis Program, Atlanta, GA 30322 USA; [Kobayashi, Tatsuya; Kronenberg, Henry M.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Weitzmann, M. Neale] Atlanta VA Med Ctr, Decatur, GA USA	Emory University; Emory University; Harvard University; Massachusetts General Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center	Tawfeek, H (corresponding author), Emory Univ, Dept Med, Div Endocrinol Metab & Lipids, Atlanta, GA 30322 USA.	roberto.pacifici@emory.edu	Tawfeek, Hesham A/W-9530-2019	Tawfeek, Hesham A/0000-0002-6673-7393; Kobayashi, Tatsuya/0000-0003-4264-5117	National Institutes of Health [AR54625, AR49649, AR053607, AR056090, AR059364, DK007298, P30-AR46031]; Biomedical Laboratory Research & Development Service of the VA Office of Research and Development [5I01BX000105]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR053607, R01AR056090, R01AR059364, R01AR054625, P30AR046031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007298] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Laboratory Research & Development Service of the VA Office of Research and Development; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported, in part, by grants from the National Institutes of Health (AR54625 and AR49649). NMW was supported in part by grants from the National Institutes of Health (AR053607, AR056090 and AR059364) and by a grant from the Biomedical Laboratory Research & Development Service of the VA Office of Research and Development (5I01BX000105). BB is supported by a training grant from the National Institutes of Health (DK007298). The authors are grateful to the University of Alabama at Birmingham, Center for Metabolic Bone Disease-Histomorphometry and Molecular Analysis Core Laboratory, NIH Grant P30-AR46031 for the histomorphometric analysis presented herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SS, 2003, ENDOCRINOLOGY, V144, P1761, DOI 10.1210/en.2002-221136; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Brodt MD, 1999, J BONE MINER RES, V14, P2159, DOI 10.1359/jbmr.1999.14.12.2159; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Cenci S, 2003, P NATL ACAD SCI USA, V100, P10405, DOI 10.1073/pnas.1533207100; Corbi AL, 1997, LEUKEMIA LYMPHOMA, V25, P415, DOI 10.3109/10428199709039028; Dempster DW, 1999, J CLIN ENDOCR METAB, V84, P1562, DOI 10.1210/jc.84.5.1562; Divieti P, 2005, ENDOCRINOLOGY, V146, P1863, DOI 10.1210/en.2004-1262; Eichinger A, 2002, ENDOCRINOLOGY, V143, P3036, DOI 10.1210/en.143.8.3036; Everts V, 2002, J BONE MINER RES, V17, P77, DOI 10.1359/jbmr.2002.17.1.77; Galli C, 2009, J BIOL CHEM, V284, P12654, DOI 10.1074/jbc.M806628200; Gao Y, 2008, CELL METAB, V8, P132, DOI 10.1016/j.cmet.2008.07.001; GEFFNER ME, 1995, PEDIATR RES, V37, P507, DOI 10.1203/00006450-199504000-00021; Grassi F, 2007, P NATL ACAD SCI USA, V104, P15087, DOI 10.1073/pnas.0703610104; Grey A, 1996, J CLIN ENDOCR METAB, V81, P3450, DOI 10.1210/jc.81.10.3450; Grey AB, 1996, CLIN ENDOCRINOL, V44, P697; Hoare SRJ, 2000, J BIOL CHEM, V275, P27274; HOCK JM, 1992, J BONE MINER RES, V7, P65, DOI 10.1002/jbmr.5650070110; Hory BG, 2000, J ENDOCRINOL INVEST, V23, P273, DOI 10.1007/BF03343723; Iida-Klein A, 2005, J ENDOCRINOL, V186, P549, DOI 10.1677/joe.1.06270; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Kimble RB, 1996, J BIOL CHEM, V271, P28890, DOI 10.1074/jbc.271.46.28890; Kobayashi T, 2002, DEVELOPMENT, V129, P2977; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lanske B, 1999, J CLIN INVEST, V104, P399, DOI 10.1172/JCI6629; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lotinun S, 2004, J BONE MINER RES, V19, P1165, DOI 10.1359/JBMR.040404; Ma YFL, 2001, ENDOCRINOLOGY, V142, P4047, DOI 10.1210/en.142.9.4047; MCCAULEY LK, 1992, ENDOCRINOLOGY, V130, P300, DOI 10.1210/en.130.1.300; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; PACIFICI R, 2010, BONE; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Parisien M., 2001, HISTOMORPHOMETRIC AN, P423; Potts J, 1998, METABOLIC BONE DIS, P411; Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006; RIGGS BL, 1986, NEW ENGL J MED, V314, P1676, DOI 10.1056/NEJM198606263142605; Roggia C, 2001, P NATL ACAD SCI USA, V98, P13960, DOI 10.1073/pnas.251534698; SILVERBERG SJ, 1989, J BONE MINER RES, V4, P283, DOI 10.1002/jbmr.5650040302; STOJCEVATANEVA O, 1993, NEPHRON, V64, P592, DOI 10.1159/000187406; Tanaka Y, 2000, J BONE MINER RES, V15, P1912, DOI 10.1359/jbmr.2000.15.10.1912; Terauchi M, 2009, CELL METAB, V10, P229, DOI 10.1016/j.cmet.2009.07.010; Usdin TB, 1999, NAT NEUROSCI, V2, P941, DOI 10.1038/14724; Weir EC, 1996, J BONE MINER RES, V11, P1474; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550; Young N, 2005, J IMMUNOL, V175, P8287, DOI 10.4049/jimmunol.175.12.8287; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	49	59	64	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12290	10.1371/journal.pone.0012290	http://dx.doi.org/10.1371/journal.pone.0012290			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808842	gold, Green Submitted, Green Published			2022-12-25	WOS:000281077000006
J	Frimpong-Boateng, K; van Rooijen, N; Geiben-Lynn, R				Frimpong-Boateng, Kwesi; van Rooijen, Nico; Geiben-Lynn, Ralf			Regulatory T Cells Suppress Natural Killer Cells during Plasmid DNA Vaccination in Mice, Blunting the CD8(+) T Cell Immune Response by the Cytokine TGF beta	PLOS ONE			English	Article							EXPRESSION IN-VIVO; ANTIGEN-EXPRESSION; MONOCLONAL-ANTIBODY; TUMOR-IMMUNITY; CUTTING EDGE; DEPLETION; INDUCTION; TOLERANCE; CANCER; LYMPHOCYTES	Background: CD4(+)CD25(+) regulatory T cells (Tregs) suppress adaptive T cell-mediated immune responses to self- and foreign-antigens. Tregs may also suppress early innate immune responses to vaccine antigens and might decrease vaccine efficacy. NK and NKT cells are the first responders after plasmid DNA vaccination and are found at the site of inoculation. Earlier reports demonstrated that NKT cells could improve plasmid DNA efficacy, a phenomenon not found for NK cells. In fact, it has been shown that under certain disease conditions, NK cells are suppressed by Tregs via their release of IL-10 and/or TGF beta. Therefore, we tested the hypothesis that NK cell function is suppressed by Tregs in the setting of plasmid DNA vaccination. Methodology/Principal Findings: In this study we show that Tregs directly inhibit NK cell function during plasmid DNA vaccination by suppressing the potentially 10-fold, NK cell-mediated, augmentation of plasmid DNA antigen-specific CD8(+) T cells. We found that this phenomenon is dependent on the secretion of cytokine TGF beta by Tregs, and independent of IL-10. Conclusions: Our data indicate a crucial function for Tregs in blocking plasmid DNA vaccine-elicited immune responses, revealing potentially novel strategies for improving the efficiency of plasmid DNA vaccines including chemical- or antibody-induced localized blockage of Treg-mediated suppression of NK cells at the site of plasmid DNA vaccine inoculation.	[Frimpong-Boateng, Kwesi; Geiben-Lynn, Ralf] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Viral Pathogenesis, Boston, MA 02215 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, Dept Mol Cell Biol, Med Ctr, Amsterdam, Netherlands	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Vrije Universiteit Amsterdam	Frimpong-Boateng, K (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Viral Pathogenesis, Boston, MA 02215 USA.	rgeibenl@bidmc.harvard.edu	Van Rooijen, Nico/Z-1578-2019		National Institute of Allergy and Infectious Diseases Center for HIV/AIDS Vaccine Immunology [AI067854]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854, U19AI067854] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases Center for HIV/AIDS Vaccine Immunology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases Center for HIV/AIDS Vaccine Immunology, AI067854. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma T, 2003, CANCER RES, V63, P4516; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Borg C, 2004, BLOOD, V104, P3267, DOI 10.1182/blood-2004-01-0380; Chuang CM, 2009, VACCINE, V27, P684, DOI 10.1016/j.vaccine.2008.11.042; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Davis HL, 1997, GENE THER, V4, P181, DOI 10.1038/sj.gt.3300380; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; GALLIN JI, 1974, BLOOD, V43, P201, DOI 10.1182/blood.V43.2.201.201; Geiben-Lynn R, 2008, CLIN VACCINE IMMUNOL, V15, P691, DOI 10.1128/CVI.00418-07; Geiben-Lynn R, 2009, J BIOL CHEM, V284, P33800, DOI 10.1074/jbc.M109.019638; Geiben-Lynn R, 2008, BLOOD, V112, P4585, DOI 10.1182/blood-2008-06-165803; Ghiringhelli F, 2006, IMMUNOL REV, V214, P229, DOI 10.1111/j.1600-065X.2006.00445.x; Greenland JR, 2007, J IMMUNOL, V178, P5652, DOI 10.4049/jimmunol.178.9.5652; Hovav AH, 2007, J IMMUNOL, V179, P6725, DOI 10.4049/jimmunol.179.10.6725; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; Kullberg MC, 2002, J EXP MED, V196, P505, DOI 10.1084/jem.20020556; LaRosa DF, 2007, IMMUNOL LETT, V108, P183, DOI 10.1016/j.imlet.2006.12.007; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Liu RL, 2005, J IMMUNOL, V175, P7898, DOI 10.4049/jimmunol.175.12.7898; Lundqvist A, 2009, BLOOD, V113, P6120, DOI 10.1182/blood-2008-11-190421; MACATANGAY BJ, PLOS ONE, V5, pE9852; MIETHKE AG, J HEPATOL, V52, P718; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Nishimura E, 2004, INT IMMUNOL, V16, P1189, DOI 10.1093/intimm/dxh122; Onizuka S, 1999, CANCER RES, V59, P3128; Orlans FB, 1997, ETHICS BEHAV, V7, P163, DOI 10.1207/s15327019eb0702_7; Perou CM, 1996, NAT GENET, V13, P303, DOI 10.1038/ng0796-303; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; Ralainirina N, 2007, J LEUKOCYTE BIOL, V81, P144, DOI 10.1189/jlb.0606409; RODER J, 1979, NATURE, V278, P451, DOI 10.1038/278451a0; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shimizu J, 1999, J IMMUNOL, V163, P5211; SHIRAHATA T, 1994, J VET MED SCI, V56, P293, DOI 10.1292/jvms.56.293; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Smyth MJ, 2006, J IMMUNOL, V176, P1582, DOI 10.4049/jimmunol.176.3.1582; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Stan AC, 2001, EUR J IMMUNOL, V31, P301, DOI 10.1002/1521-4141(200101)31:1<301::AID-IMMU301>3.0.CO;2-K; Steitz J, 2001, CANCER RES, V61, P8643; Taams LS, 2005, HUM IMMUNOL, V66, P222, DOI 10.1016/j.humimm.2004.12.006; Trenado A, 2003, J CLIN INVEST, V112, P1688, DOI 10.1172/JCI17702; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Wing K, 2005, IMMUNOLOGY, V115, P516, DOI 10.1111/j.1365-2567.2005.02186.x; Woo EY, 2001, CANCER RES, V61, P4766; Zimmer J, 2008, EUR J IMMUNOL, V38, P2942, DOI 10.1002/eji.200838813	46	20	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12281	10.1371/journal.pone.0012281	http://dx.doi.org/10.1371/journal.pone.0012281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808850	Green Published, gold, Green Submitted			2022-12-25	WOS:000281075500015
J	Offer, SM; Pan-Hammarstrom, Q; Hammarstrom, L; Harris, RS				Offer, Steven M.; Pan-Hammarstrom, Qiang; Hammarstrom, Lennart; Harris, Reuben S.			Unique DNA Repair Gene Variations and Potential Associations with the Primary Antibody Deficiency Syndromes IgAD and CVID	PLOS ONE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; CLASS-SWITCH RECOMBINATION; STRAND BREAK REPAIR; CYTIDINE DEAMINASE AID; SOMATIC HYPERMUTATION; MUTATIONS; PROTEIN; MECHANISM; COMPLEX; MUTL	Background: Despite considerable effort, the genetic factors responsible for >90% of the antibody deficiency syndromes IgAD and CVID remain elusive. To produce a functionally diverse antibody repertoire B lymphocytes undergo class switch recombination. This process is initiated by AID-catalyzed deamination of cytidine to uridine in switch region DNA. Subsequently, these residues are recognized by the uracil excision enzyme UNG2 or the mismatch repair proteins MutS alpha (MSH2/MSH6) and MutL alpha (PMS2/MLH1). Further processing by ubiquitous DNA repair factors is thought to introduce DNA breaks, ultimately leading to class switch recombination and expression of a different antibody isotype. Methodology/Principal Findings: Defects in AID and UNG2 have been shown to result in the primary immunodeficiency hyper-IgM syndrome, leading us to hypothesize that additional, potentially more subtle, DNA repair gene variations may underlie the clinically related antibody deficiencies syndromes IgAD and CVID. In a survey of twenty-seven candidate DNA metabolism genes, markers in MSH2, RAD50, and RAD52 were associated with IgAD/CVID, prompting further investigation into these pathways. Resequencing identified four rare, non-synonymous alleles associated with IgAD/CVID, two in MLH1, one in RAD50, and one in NBS1. One IgAD patient carried heterozygous non-synonymous mutations in MLH1, MSH2, and NBS1. Functional studies revealed that one of the identified mutations, a premature RAD50 stop codon (Q372X), confers increased sensitivity to ionizing radiation. Conclusions: Our results are consistent with a class switch recombination model in which AID-catalyzed uridines are processed by multiple DNA repair pathways. Genetic defects in these DNA repair pathways may contribute to IgAD and CVID.	[Offer, Steven M.; Harris, Reuben S.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Pan-Hammarstrom, Qiang; Hammarstrom, Lennart] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Clin Immunol, Stockholm, Sweden	University of Minnesota System; University of Minnesota Twin Cities; Karolinska Institutet; Karolinska University Hospital	Offer, SM (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	rsh@umn.edu	Offer, Steven/AAA-3633-2021; Offer, Steven/A-7461-2013; hammarstrom, qiang pan/ABA-4589-2021	Offer, Steven/0000-0002-7513-9678; Offer, Steven/0000-0002-7513-9678; pan-hammarstrom, qiang/0000-0003-1990-8804	National Institutes of Health [U19 AI067152, R21 AI079743, R01 GM80437]; Swedish Cancerfound; University of Minnesota; Curtis L. Carlson University of Minnesota/Karolinska Institutet Medical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064046, R21AI079743, U19AI067152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Cancerfound; University of Minnesota(University of Minnesota System); Curtis L. Carlson University of Minnesota/Karolinska Institutet Medical Research(Karolinska Institutet); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (U19 AI067152 to L. H., R21 AI079743 and R01 GM80437 to R.H.) and by Swedish Cancerfound (to Q.P.). S.M.O. was also supported in part by a University of Minnesota Graduate School Doctoral Dissertation Fellowship and by the Curtis L. Carlson University of Minnesota/Karolinska Institutet Medical Research and Education Program Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Barnetson RA, 2008, HUM MUTAT, V29, P367, DOI 10.1002/humu.20635; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Castigli E, 2005, NAT GENET, V37, P829, DOI 10.1038/ng1601; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Concannon P, 1997, HUM MUTAT, V10, P100, DOI 10.1002/(SICI)1098-1004(1997)10:2<100::AID-HUMU2>3.0.CO;2-O; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Durandy A, 2006, CURR OPIN RHEUMATOL, V18, P369, DOI 10.1097/01.bor.0000231905.12172.b5; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Ehrenstein MR, 2001, P NATL ACAD SCI USA, V98, P14553, DOI 10.1073/pnas.241525998; Fuellen G, 2005, PROTEINS, V61, P888, DOI 10.1002/prot.20616; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Guerrette S, 1999, J BIOL CHEM, V274, P6336, DOI 10.1074/jbc.274.10.6336; Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Kanegane H, 2007, GENES IMMUN, V8, P663, DOI 10.1038/sj.gene.6364431; Kohli M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh009; Kondo E, 2001, NUCLEIC ACIDS RES, V29, P1695, DOI 10.1093/nar/29.8.1695; Kunz C, 2009, CELL MOL LIFE SCI, V66, P1021, DOI 10.1007/s00018-009-8739-9; Lahdesmaki A, 2004, J BIOL CHEM, V279, P16479, DOI 10.1074/jbc.M312796200; Li ZQ, 2004, J EXP MED, V200, P47, DOI 10.1084/jem.20040355; Liu T, 1999, HUM GENET, V105, P437, DOI 10.1007/s004390051127; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; Martin A, 2003, J EXP MED, V198, P1171, DOI 10.1084/jem.20030880; Martomo SA, 2004, J EXP MED, V200, P61, DOI 10.1084/jem.20040691; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neuberger MS, 2008, IMMUNOL CELL BIOL, V86, P124, DOI 10.1038/sj.icb.7100160; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Ostergaard JR, 2005, AM J MED GENET A, V139A, P96, DOI 10.1002/ajmg.a.30998; Pan Q, 2002, EUR J IMMUNOL, V32, P1300, DOI 10.1002/1521-4141(200205)32:5<1300::AID-IMMU1300>3.0.CO;2-L; Pan-Hammarstrom Q, 2008, EUR J IMMUNOL, V38, P327, DOI 10.1002/eji.200737927; Pan-Hammarstrom Q, 2007, NAT GENET, V39, P429, DOI 10.1038/ng0407-429; Peron S, 2008, J EXP MED, V205, P2465, DOI 10.1084/jem.20080789; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Raevaara TE, 2005, GASTROENTEROLOGY, V129, P537, DOI 10.1053/j.gastro.2005.06.005; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Ruis BL, 2008, MOL CELL BIOL, V28, P6182, DOI 10.1128/MCB.00355-08; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schaffer AA, 2007, CURR OPIN GENET DEV, V17, P201, DOI 10.1016/j.gde.2007.04.002; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; Scott RH, 2007, NAT CLIN PRACT ONCOL, V4, P130, DOI 10.1038/ncponc0719; Sekine H, 2007, P NATL ACAD SCI USA, V104, P7193, DOI 10.1073/pnas.0700815104; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; van Zelm MC, 2006, NEW ENGL J MED, V354, P1901, DOI 10.1056/NEJMoa051568; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; VORECHOVSKY I, 1995, CLIN IMMUNOL IMMUNOP, V77, P185, DOI 10.1006/clin.1995.1142; WATSON P, 1994, ANTICANCER RES, V14, P1635; Whiteside D, 2002, CANCER RES, V62, P359; Yong PFK, 2008, IMMUNOL ALLERGY CLIN, V28, P691, DOI 10.1016/j.iac.2008.06.003	59	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12260	10.1371/journal.pone.0012260	http://dx.doi.org/10.1371/journal.pone.0012260			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805886	Green Published, Green Submitted, gold			2022-12-25	WOS:000281011600025
J	Pendergrass, SA; Hayes, E; Farina, G; Lemaire, R; Farber, HW; Whitfield, ML; Lafyatis, R				Pendergrass, Sarah A.; Hayes, Everett; Farina, Giuseppina; Lemaire, Raphael; Farber, Harrison W.; Whitfield, Michael L.; Lafyatis, Robert			Limited Systemic Sclerosis Patients with Pulmonary Arterial Hypertension Show Biomarkers of Inflammation and Vascular Injury	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; INTERSTITIAL LUNG-DISEASE; GENE-EXPRESSION; SCLERODERMA SKIN; FACTOR-ALPHA; CUTANEOUS INVOLVEMENT; RHEUMATOID-ARTHRITIS; PERIPHERAL-BLOOD; ASSOCIATION; PROFILES	Background: Pulmonary arterial hypertension (PAH) is a common complication for individuals with limited systemic sclerosis (lSSc). The identification and characterization of biomarkers for lSSc-PAH should lead to less invasive screening, a better understanding of pathogenesis, and improved treatment. Methods and Findings: Forty-nine PBMC samples were obtained from 21 lSSc subjects without PAH (lSSc-noPAH), 15 lSSc subjects with PAH (lSSc-PAH), and 10 healthy controls; three subjects provided PBMCs one year later. Genome-wide gene expression was measured for each sample. The levels of 89 cytokines were measured in serum from a subset of subjects by Multi-Analyte Profiling (MAP) immunoassays. Gene expression clearly distinguished lSSc samples from healthy controls, and separated lSSc-PAH from lSSc-NoPAH patients. Real-time quantitative PCR confirmed increased expression of 9 genes (ICAM1, IFNGR1, IL1B, IL13Ra1, JAK2, AIF1, CCR1, ALAS2, TIMP2) in lSSc-PAH patients. Increased circulating cytokine levels of inflammatory mediators such as TNF-alpha, IL1-beta, ICAM-1, and IL-6, and markers of vascular injury such as VCAM-1, VEGF, and von Willebrand Factor were found in lSSc-PAH subjects. Conclusions and Significance: The gene expression and cytokine profiles of lSSc-PAH patients suggest the presence of activated monocytes, and show markers of vascular injury and inflammation. These genes and factors could serve as biomarkers of PAH involvement in lSSc.	[Pendergrass, Sarah A.; Whitfield, Michael L.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Genet, Hanover, NH 03756 USA; [Hayes, Everett; Farina, Giuseppina; Lemaire, Raphael; Lafyatis, Robert] Boston Univ, Sch Med, Ctr Arthritis, Rheumatol Sect, Boston, MA 02118 USA; [Farber, Harrison W.] Boston Univ, Sch Med, Pulm Sect, Boston, MA 02118 USA	Dartmouth College; Boston University; Boston University	Pendergrass, SA (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Genet, Hanover, NH 03756 USA.	michael.whitfield@dartmouth.edu; lafyatis@bu.edu	Farina, Giuseppina/B-1800-2019; Whitfield, Michael/AAC-5010-2020	Farina, Giuseppina/0000-0002-3948-6920; Farber, Harrison/0000-0002-0297-7902; Pendergrass, Rion/0000-0002-0565-6522; Lafyatis, Robert/0000-0002-9398-5034	Actelion Pharmaceuticals Ltd; Arthritis Foundation; NIAMS [T32 AR007575-11]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR062721, R01AR051089, P50AR060780] Funding Source: NIH RePORTER	Actelion Pharmaceuticals Ltd; Arthritis Foundation; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work has been supported by a grant from Actelion Pharmaceuticals Ltd (www.actelion.com) to RAL and a Hulda Irene Duggan Arthritis Investigator Award from the Arthritis Foundation to MLW (http://www.arthritis.org/). SAP was supported by the NIAMS Autoimmunity and Connective Tissue Training Grant T32 AR007575-11 and by funds from the Arthritis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADERKA D, 1992, J EXP MED, V175, P323, DOI 10.1084/jem.175.2.323; ANDREWS BS, 1987, J RHEUMATOL, V14, P930; Bae YH, 2009, BIOCHEM BIOPH RES CO, V379, P206, DOI 10.1016/j.bbrc.2008.12.042; Bargagli E, 2008, RESPIRATION, V75, P346, DOI 10.1159/000090248; Browning JL, 2008, IMMUNOL REV, V223, P202, DOI 10.1111/j.1600-065X.2008.00633.x; Bull TM, 2004, AM J RESP CRIT CARE, V170, P911, DOI 10.1164/rccm.200312-1686OC; Bull TM, 2007, CURR OPIN RHEUMATOL, V19, P598, DOI 10.1097/BOR.0b013e3282ec67d4; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chaouat A, 2009, CHEST, V136, P678, DOI 10.1378/chest.08-2420; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Cool CD, 1997, HUM PATHOL, V28, P434, DOI 10.1016/S0046-8177(97)90032-0; Del Galdo F, 2006, CURR OPIN RHEUMATOL, V18, P588, DOI 10.1097/01.bor.0000245724.94887.c4; Denton CP, 2009, ANN RHEUM DIS, V68, P1433, DOI 10.1136/ard.2008.096123; Dorfmuller P, 2007, HUM PATHOL, V38, P893, DOI 10.1016/j.humpath.2006.11.022; Duan H, 2008, ARTHRITIS RHEUM-US, V58, P1465, DOI 10.1002/art.23451; Faller DV, 1999, CLIN EXP PHARMACOL P, V26, P74, DOI 10.1046/j.1440-1681.1999.02992.x; Farina G, 2009, ANN RHEUM DIS, V68, P435, DOI 10.1136/ard.2007.086850; Fisher MR, 2006, ARTHRITIS RHEUM-US, V54, P3043, DOI 10.1002/art.22069; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Fujita M, 2002, J APPL PHYSIOL, V93, P2162, DOI 10.1152/japplphysiol.00083.2002; GARCOVICH A, 1989, PANMINERVA MED, V31, P76; Gardner H, 2006, ARTHRITIS RHEUM-US, V54, P1961, DOI 10.1002/art.21894; Goh NSL, 2008, AM J RESP CRIT CARE, V177, P1248, DOI 10.1164/rccm.200706-877OC; Grigoryev DN, 2008, TRANSL RES, V151, P197, DOI 10.1016/j.trsl.2007.12.010; Haider AS, 2008, J INVEST DERMATOL, V128, P606, DOI 10.1038/sj.jid.5701067; Hasegawa M, 1997, J RHEUMATOL, V24, P663; Herlitz J, 2008, Acute Card Care, V10, P197, DOI 10.1080/17482940802409662; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; HORVATH CJ, 1988, P NATL ACAD SCI USA, V85, P9219, DOI 10.1073/pnas.85.23.9219; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Itoh T, 2006, RESPIROLOGY, V11, P158, DOI 10.1111/j.1440-1843.2006.00821.x; Ivakhno SS, 2004, EXP ONCOL, V26, P250; Kawut SM, 2003, CHEST, V123, P344, DOI 10.1378/chest.123.2.344; KOMINATO Y, 1995, MOL CELL BIOL, V15, P58; Launay D, 2007, J RHEUMATOL, V34, P1005; LEROY EC, 1988, J RHEUMATOL, V15, P202; Liu Y, 2008, J AM STAT ASSOC, V103, P1281, DOI 10.1198/016214508000000454; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsushita Y, 2007, J IMMUNOL, V179, P698, DOI 10.4049/jimmunol.179.1.698; Mcgoon MD, 2008, MAYO CLIN PROC, V83, P923, DOI 10.4065/83.8.923; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Milano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Perros F, 2007, EUR RESPIR J, V29, P462, DOI 10.1183/09031936.00094706; Quarck R, 2009, J AM COLL CARDIOL, V53, P1211, DOI 10.1016/j.jacc.2008.12.038; Sacks DG, 1996, J RHEUMATOL, V23, P639; Savale L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-6; Steen V, 2003, ARTHRITIS RHEUM, V48, P516, DOI 10.1002/art.10775; Steen VD, 1996, RHEUM DIS CLIN N AM, V22, P861, DOI 10.1016/S0889-857X(05)70305-7; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Teixeira VH, 2008, J CLIN IMMUNOL, V28, P115, DOI 10.1007/s10875-007-9143-6; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Weinlander K, 2008, FASEB J, V22, P4168, DOI 10.1096/fj.08-107524; Whitfield ML, 2003, P NATL ACAD SCI USA, V100, P12319, DOI 10.1073/pnas.1635114100; Wort SJ, 2009, J BIOL CHEM, V284, P24297, DOI 10.1074/jbc.M109.032524; Zhang HG, 2004, ARTHRITIS RHEUM-US, V50, P420, DOI 10.1002/art.20037; Zhu JH, 2008, RESP MED, V102, P1073, DOI 10.1016/j.rmed.2007.12.030	61	102	105	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12106	10.1371/journal.pone.0012106	http://dx.doi.org/10.1371/journal.pone.0012106			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808962	Green Submitted, gold, Green Published			2022-12-25	WOS:000280968100003
J	Alvarez, S; Suela, J; Valencia, A; Fernandez, A; Wunderlich, M; Agirre, X; Prosper, F; Martin-Subero, JI; Maiques, A; Acquadro, F; Perales, SR; Calasanz, MJ; Roman-Gomez, J; Siebert, R; Mulloy, JC; Cervera, J; Sanz, MA; Esteller, M; Cigudosa, JC				Alvarez, Sara; Suela, Javier; Valencia, Ana; Fernandez, Agustin; Wunderlich, Mark; Agirre, Xabier; Prosper, Felipe; Ignacio Martin-Subero, Jose; Maiques, Alba; Acquadro, Francesco; Rodriguez Perales, Sandra; Jose Calasanz, Maria; Roman-Gomez, Jose; Siebert, Reiner; Mulloy, James C.; Cervera, Jose; Angel Sanz, Miguel; Esteller, Manel; Cigudosa, Juan C.			DNA Methylation Profiles and Their Relationship with Cytogenetic Status in Adult Acute Myeloid Leukemia	PLOS ONE			English	Article							CPG ISLAND METHYLATION; PREDICTS SURVIVAL; GENE DBCCR1; CELLS; MALIGNANCIES; CANCER; EXPRESSION; DBC1; EPIGENETICS; NEOPLASMS	Background: Aberrant promoter DNA methylation has been shown to play a role in acute myeloid leukemia (AML) pathophysiology. However, further studies to discuss the prognostic value and the relationship of the epigenetic signatures with defined genomic rearrangements in acute myeloid leukemia are required. Methodology/Principal Findings: We carried out high-throughput methylation profiling on 116 de novo AML cases and we validated the significant biomarkers in an independent cohort of 244 AML cases. Methylation signatures were associated with the presence of a specific cytogenetic status. In normal karyotype cases, aberrant methylation of the promoter of DBC1 was validated as a predictor of the disease-free and overall survival. Furthermore, DBC1 expression was significantly silenced in the aberrantly methylated samples. Patients with chromosome rearrangements showed distinct methylation signatures. To establish the role of fusion proteins in the epigenetic profiles, 20 additional samples of human hematopoietic stem/progenitor cells (HSPC) transduced with common fusion genes were studied and compared with patient samples carrying the same rearrangements. The presence of MLL rearrangements in HSPC induced the methylation profile observed in the MLL-positive primary samples. In contrast, fusion genes such as AML1/ETO or CBFB/MYH11 failed to reproduce the epigenetic signature observed in the patients. Conclusions/Significance: Our study provides a comprehensive epigenetic profiling of AML, identifies new clinical markers for cases with a normal karyotype, and reveals relevant biological information related to the role of fusion proteins on the methylation signature.	[Alvarez, Sara; Suela, Javier; Maiques, Alba; Acquadro, Francesco; Rodriguez Perales, Sandra; Cigudosa, Juan C.] Ctr Invest Enfermedades Raras CIBERER, CNIO, Mol Cytogenet Grp, Madrid, Spain; [Valencia, Ana; Cervera, Jose; Angel Sanz, Miguel] Hosp Univ La Fe, Hematol Serv, Valencia, Spain; [Fernandez, Agustin; Ignacio Martin-Subero, Jose; Esteller, Manel] Bellvitge Inst Biomed Res Catalan Inst Oncol IDIB, Canc Epigenet & Biol Program, Barcelona, Spain; [Wunderlich, Mark; Mulloy, James C.] Univ Cincinnati, Coll Med, Div Expt Hematol, Cincinnati Childrens Hosp,Med Ctr, Cincinnati, OH USA; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, Clin Univ, Fdn Appl Med Res, Div Canc, E-31080 Pamplona, Spain; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, Clin Univ, Fdn Appl Med Res, Area Cell Therapy, E-31080 Pamplona, Spain; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, Clin Univ, Fdn Appl Med Res, Hematol Serv, E-31080 Pamplona, Spain; [Jose Calasanz, Maria] Univ Navarra, Dept Genet, E-31080 Pamplona, Spain; [Roman-Gomez, Jose] Hosp Univ Reina Sofia, Hematol Serv, Cordoba, Spain; [Ignacio Martin-Subero, Jose; Siebert, Reiner] Univ Kiel, Inst Human Genet, Univ Hosp Schleswig Holstein, Kiel, Germany	Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitari i Politecnic La Fe; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Navarra; University of Navarra; University of Navarra; University of Navarra; Hospital Universitario Reina Sofia - Cordoba; University of Kiel; Schleswig Holstein University Hospital	Alvarez, S (corresponding author), Ctr Invest Enfermedades Raras CIBERER, CNIO, Mol Cytogenet Grp, Madrid, Spain.	salvarez@cnio.es; jccigudosa@cnio.es	Cervera, Jose/ABF-2143-2020; Cigudosa, Juan C/E-4105-2016; SUELA, JAVIER/K-3968-2016; Siebert, Reiner/A-8049-2010; Prosper, Felipe/H-6859-2017; Rodriguez-Perales, Sandra/T-7667-2017; Esteller, Manel/L-5956-2014; Agirre, Xabier/ABE-4110-2020; Calasanz, MJ/R-5813-2016; Fernandez, Agustin F./N-7302-2014; Sanz, Miguel A./F-7485-2018	Cervera, Jose/0000-0001-8252-1106; Prosper, Felipe/0000-0001-6115-8790; Rodriguez-Perales, Sandra/0000-0001-7221-3636; Esteller, Manel/0000-0003-4490-6093; Calasanz, MJ/0000-0002-0374-3008; Fernandez, Agustin F./0000-0002-3792-4085; Sanz, Miguel A./0000-0003-1489-1177; Martin-Subero, Jose Ignacio/0000-0001-8809-5195; Maiques-Diaz, Alba/0000-0002-3365-3775	Spanish Fondo de Investigacion Sanitaria (FIS) [PI040555, PI080440, PI080878]; Spanish Ministry of Health and Consumer Affairs; KinderKrebsInitiative Buchholz/Holm-Seppensen; Kiel University Medical Faculty; Miguel Servet Initiative (FIS); Red Tematica de Investigacion sobre Cancer (RETIC) [PI060657, RD06/0020]	Spanish Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Spanish Ministry of Health and Consumer Affairs(Spanish Government); KinderKrebsInitiative Buchholz/Holm-Seppensen; Kiel University Medical Faculty; Miguel Servet Initiative (FIS)(Instituto de Salud Carlos III); Red Tematica de Investigacion sobre Cancer (RETIC)	This work was partially financed by grants PI040555, PI080440, and PI080878 from the Spanish Fondo de Investigacion Sanitaria (FIS) and the Spanish Ministry of Health and Consumer Affairs awarded to JCC and SA. Funding was also awarded to RS and JIMS by KinderKrebsInitiative Buchholz/Holm-Seppensen and Kiel University Medical Faculty. SA is supported by a contract from the Miguel Servet Initiative (FIS). The validation studies were partially supported by grants PI060657 and RD06/0020 from Red Tematica de Investigacion sobre Cancer (RETIC) and FIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Boultwood J, 2007, BRIT J HAEMATOL, V138, P3, DOI 10.1111/j.1365-2141.2007.06604.x; Bullinger L, 2010, BLOOD, V115, P636, DOI 10.1182/blood-2009-03-211003; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Diaz-Uriarte R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-30; Esteller M, 2002, SCIENCE, V297, P1807; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; FIGUEROA ME, 2010, CANC CELL, P18701; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Frohling S, 2005, J CLIN ONCOL, V23, P6285, DOI 10.1200/JCO.2005.05.010; Galm O, 2006, BLOOD REV, V20, P1, DOI 10.1016/j.blre.2005.01.006; Gilliland DG, 2001, CURR OPIN HEMATOL, V8, P189, DOI 10.1097/00062752-200107000-00001; Gronbaek K, 2008, MODERN PATHOL, V21, P632, DOI 10.1038/modpathol.2008.27; Habuchi T, 1998, GENOMICS, V48, P277, DOI 10.1006/geno.1997.5165; Hess CJ, 2008, LEUKEMIA LYMPHOMA, V49, P1132, DOI 10.1080/10428190802035990; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Izumi H, 2005, HUM MOL GENET, V14, P997, DOI 10.1093/hmg/ddi092; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kroeger H, 2008, BLOOD, V112, P1366, DOI 10.1182/blood-2007-11-126227; Li ZJ, 2009, CANCER RES, V69, P1109, DOI 10.1158/0008-5472.CAN-08-3381; MARTIN V, 2009, CANC SCI, P18701; Martin-Subero JI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006986; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Nishiyama H, 2001, ONCOGENE, V20, P2956, DOI 10.1038/sj.onc.1204432; Opavsky R, 2007, PLOS GENET, V3, P1757, DOI 10.1371/journal.pgen.0030167; Rosu-Myles M, 2008, BLOOD CELL MOL DIS, V40, P406, DOI 10.1016/j.bcmd.2007.09.005; San Jose-Eneriz E, 2006, BRIT J HAEMATOL, V134, P137, DOI 10.1111/j.1365-2141.2006.06131.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen LL, 2010, J CLIN ONCOL, V28, P605, DOI 10.1200/JCO.2009.23.4781; Suarez L, 2005, HAEMATOLOGICA, V90, P54; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Toyota M, 2001, BLOOD, V97, P2823, DOI 10.1182/blood.V97.9.2823; Valencia A, 2009, LEUKEMIA, V23, P1658, DOI 10.1038/leu.2009.86; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Wong IHN, 2000, BLOOD, V95, P1942, DOI 10.1182/blood.V95.6.1942; Wunderlich M, 2006, BLOOD, V108, P1690, DOI 10.1182/blood-2005-12-012773; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2	39	60	63	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12197	10.1371/journal.pone.0012197	http://dx.doi.org/10.1371/journal.pone.0012197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808941	Green Published, gold			2022-12-25	WOS:000280968000021
J	Wiemuth, D; Lott, JS; Ly, K; Ke, Y; Teesdale-Spittle, P; Snyder, PM; McDonald, FJ				Wiemuth, Dominik; Lott, J. Shaun; Ly, Kevin; Ke, Ying; Teesdale-Spittle, Paul; Snyder, Peter M.; McDonald, Fiona J.			Interaction of Serum- and Glucocorticoid Regulated Kinase 1 (SGK1) with the WW-Domains of Nedd4-2 Is Required for Epithelial Sodium Channel Regulation	PLOS ONE			English	Article							NA+-CHANNEL; PHOSPHORYLATION; ENAC; ALDOSTERONE; INHIBITION; ISOFORMS; SPECIFICITY; BINDS	Background: The epithelial sodium channel (ENaC) is an integral component of the pathway for Na+ absorption in epithelial cells. The ubiquitin ligases Nedd4 and Nedd4-2 bind to ENaC and decrease its activity. Conversely, Serum- and Glucocorticoid regulated Kinase-1 (SGK1), a downstream mediator of aldosterone, increases ENaC activity. This effect is at least partly mediated by direct interaction between SGK and Nedd4-2. SGK binds both Nedd4 and Nedd4-2, but it is only able to phosphorylate Nedd4-2. Phosphorylation of Nedd4-2 reduces its ability to bind to ENaC, due to the interaction of phosphorylated Nedd4-2 with 14-3-3 proteins, and hence increases ENaC activity. WW-domains in Nedd4-like proteins bind PY-motifs (PPXY) present in ENaC subunits, and SGK also has a PY-motif. Principal Finding: Here we show that single or tandem WW-domains of Nedd4 and Nedd4-2 mediate binding to SGK and that different WW-domains of Nedd4 and Nedd4-2 are involved. Our data also show that WW-domains 2 and 3 of Nedd4-2 mediate the interaction with SGK in a cooperative manner, that activated SGK has increased affinity for the WW-domains of Nedd4-2 in vitro, and a greater stimulatory effect on ENaC Na+ transport compared to wildtype SGK. Further, SGK lacking a PY motif failed to stimulate ENaC activity in the presence of Nedd4-2. Conclusions: Binding of Nedd4-2 WW-domains to SGK is necessary for SGK-induced ENaC activity.	[Wiemuth, Dominik; Ly, Kevin; Ke, Ying; McDonald, Fiona J.] Univ Otago, Dept Physiol, Dunedin, New Zealand; [Lott, J. Shaun] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Teesdale-Spittle, Paul] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Snyder, Peter M.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA; [Snyder, Peter M.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA	University of Otago; University of Auckland; Victoria University Wellington; University of Iowa; University of Iowa	Wiemuth, D (corresponding author), Univ Otago, Dept Physiol, Dunedin, New Zealand.	fiona.mcdonald@otago.ac.nz		Lott, Shaun/0000-0003-3660-452X	Marsden Fund Council; Otago Medical Research Foundation; U.S.A. National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072256, R01HL058812] Funding Source: NIH RePORTER	Marsden Fund Council(Royal Society of New ZealandMarsden Fund (NZ)); Otago Medical Research Foundation; U.S.A. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research received funding support from the Marsden Fund Council from government funding administered by the Royal Society of New Zealand (http://marsden.rsnz.org/), the Otago Medical Research Foundation (http://hsframework36.otago.ac.nz/), and the U.S.A. National Institutes of Health (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher C, 2003, BBA-BIOMEMBRANES, V1612, P59, DOI 10.1016/S0005-2736(03)00083-X; Asher C, 2001, BIOCHEM BIOPH RES CO, V286, P1228, DOI 10.1006/bbrc.2001.5508; Boehmer C, 2003, CARDIOVASC RES, V57, P1079, DOI 10.1016/S0008-6363(02)00837-4; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Dieter M, 2004, OBES RES, V12, P862, DOI 10.1038/oby.2004.104; Farr TJ, 2000, BIOCHEM J, V345, P503, DOI 10.1042/0264-6021:3450503; Fotia AB, 2002, FASEB J, V16, P70, DOI 10.1096/fj.02-0497fje; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goulet CC, 1998, J BIOL CHEM, V273, P30012, DOI 10.1074/jbc.273.45.30012; Henry PC, 2003, J BIOL CHEM, V278, P20019, DOI 10.1074/jbc.M211153200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jennings MD, 2007, J BIOL CHEM, V282, P29032, DOI 10.1074/jbc.M703453200; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Kamynina E, 2001, AM J PHYSIOL-RENAL, V281, pF469, DOI 10.1152/ajprenal.2001.281.3.F469; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; Lott JS, 2002, BIOCHEM J, V361, P481, DOI 10.1042/0264-6021:3610481; McDonald FJ, 2002, AM J PHYSIOL-RENAL, V283, pF431, DOI 10.1152/ajprenal.00080.2002; Naray-Fejes-Toth A, 1999, J BIOL CHEM, V274, P16973, DOI 10.1074/jbc.274.24.16973; Rauh R, 2006, PFLUG ARCH EUR J PHY, V452, P290, DOI 10.1007/s00424-005-0026-5; SHEPPARD DN, 1994, AM J PHYSIOL, V266, pL405, DOI 10.1152/ajplung.1994.266.4.L405; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; Snyder PM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.279pe41; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Snyder PM, 2001, J BIOL CHEM, V276, P28321, DOI 10.1074/jbc.M011487200; Wang J, 2001, AM J PHYSIOL-RENAL, V280, pF303, DOI 10.1152/ajprenal.2001.280.2.F303; Zhou RF, 2005, J BIOL CHEM, V280, P4518, DOI 10.1074/jbc.M411053200	34	24	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12163	10.1371/journal.pone.0012163	http://dx.doi.org/10.1371/journal.pone.0012163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730100	Green Published, gold, Green Submitted			2022-12-25	WOS:000280862200018
J	Gresset, A; Hicks, SN; Harden, TK; Sondek, J				Gresset, Aurelie; Hicks, Stephanie N.; Harden, T. Kendall; Sondek, John			Mechanism of Phosphorylation-induced Activation of Phospholipase C-gamma Isozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC HOMOLOGY-2 DOMAIN; SH2 DOMAIN; TYROSINE PHOSPHORYLATION; CRYSTAL-STRUCTURE; LIMITED PROTEOLYSIS; STRUCTURAL BASIS; Y-DOMAIN; RESIDUES; SITE; RAC	The lipase activity of most phospholipases C (PLCs) is basally repressed by a highly degenerate and mostly disordered X/Y linker inserted within the catalytic domain. Release of this auto-inhibition is driven by electrostatic repulsion between the plasma membrane and the electronegative X/Y linker. In contrast, PLC-gamma isozymes (PLC-gamma 1 and -gamma 2) are structurally distinct from other PLCs because multiple domains are present in their X/Y linker. Moreover, although many tyrosine kinases directly phosphorylate PLC-gamma isozymes to enhance their lipase activity, the underlying molecular mechanism of this activation remains unclear. Here we define the mechanism for the unique regulation of PLC-gamma isozymes by their X/Y linker. Specifically, we identify the C-terminal SH2 domain within the X/Y linker as the critical determinant for auto-inhibition. Tyrosine phosphorylation of the X/Y linker mediates high affinity intramolecular interaction with the C-terminal SH2 domain that is coupled to a large conformational rearrangement and release of auto-inhibition. Consequently, PLC-gamma isozymes link phosphorylation to phospholipase activation by elaborating upon primordial regulatory mechanisms found in other PLCs.	[Gresset, Aurelie; Hicks, Stephanie N.; Harden, T. Kendall; Sondek, John] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Harden, T. Kendall; Sondek, John] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Sondek, John] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sondek, J (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, 120 Mason Farm Rd,4009 Genet Med,CB 4365, Chapel Hill, NC 27599 USA.	sondek@med.unc.edu		Sondek, John/0000-0002-1127-8310	National Institutes of Health [R01-GM57391]; American Heart Association (AHA) [AHA 0715332U]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057391, R01GM062299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM57391 (to J.S. and T. K. H.). This work was also supported by American Heart Association Pre-doctoral Fellowship AHA 0715332U (to A. G.).	Bae JH, 2009, CELL, V138, P514, DOI 10.1016/j.cell.2009.05.028; Bunney TD, 2009, MOL CELL, V34, P223, DOI 10.1016/j.molcel.2009.02.023; Cha JYY, 2009, J BIOL CHEM, V284, P6227, DOI 10.1074/jbc.M803998200; Chen HB, 2007, MOL CELL, V27, P717, DOI 10.1016/j.molcel.2007.06.028; ECK MJ, 1993, NATURE, V362, P87, DOI 10.1038/362087a0; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FERNALD AW, 1994, BIOCHEM J, V302, P503, DOI 10.1042/bj3020503; Groesch TD, 2006, J MOL BIOL, V356, P1222, DOI 10.1016/j.jmb.2005.11.095; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Homma MK, 1996, CELL GROWTH DIFFER, V7, P281; HOMMA Y, 1992, J BIOL CHEM, V267, P21844; HORSTMAN DA, 1995, PROTEIN EXPRES PURIF, V6, P278, DOI 10.1006/prep.1995.1036; Horstman DA, 1996, P NATL ACAD SCI USA, V93, P7518, DOI 10.1073/pnas.93.15.7518; Horstman DA, 1999, ARCH BIOCHEM BIOPHYS, V361, P149, DOI 10.1006/abbi.1998.0978; Hu JJ, 2003, MOL CELL, V12, P1379, DOI 10.1016/S1097-2765(03)00487-8; Humphries LA, 2004, J BIOL CHEM, V279, P37651, DOI 10.1074/jbc.M311985200; Jones GA, 2000, ARCH BIOCHEM BIOPHYS, V375, P229, DOI 10.1006/abbi.1999.1670; Kaneko T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000796; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; KOBLAN KS, 1995, BIOCHEM J, V305, P745, DOI 10.1042/bj3050745; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; Ozdener F, 2002, MOL PHARMACOL, V62, P672, DOI 10.1124/mol.62.3.672; PASCAL SM, 1994, CELL, V77, P461, DOI 10.1016/0092-8674(94)90160-0; Piechulek T, 2005, J BIOL CHEM, V280, P38923, DOI 10.1074/jbc.M509396200; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rodriguez R, 2001, J BIOL CHEM, V276, P47982, DOI 10.1074/jbc.M107577200; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; Serrano CJ, 2005, J IMMUNOL, V174, P6233, DOI 10.4049/jimmunol.174.10.6233; WAHL MI, 1990, J BIOL CHEM, V265, P3944; Walliser C, 2008, J BIOL CHEM, V283, P30351, DOI 10.1074/jbc.M803316200; Watanabe D, 2001, J BIOL CHEM, V276, P38595, DOI 10.1074/jbc.M103675200; Yang J, 2003, J BIOL CHEM, V278, P6516, DOI 10.1074/jbc.M210430200	37	78	78	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35836	35847		10.1074/jbc.M110.166512	http://dx.doi.org/10.1074/jbc.M110.166512			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20807769	Green Published, hybrid			2022-12-25	WOS:000283845300061
J	Yao, ZX; Jogunoori, W; Choufani, S; Rashid, A; Blake, T; Yao, WG; Kreishman, P; Amin, R; Sidawy, AA; Evans, SRT; Finegold, M; Reddy, EP; Mishra, B; Weksberg, R; Kumar, R; Mishra, L				Yao, Zhi-Xing; Jogunoori, Wilma; Choufani, Sanaa; Rashid, Asif; Blake, Tiffany; Yao, Wenguo; Kreishman, Peter; Amin, Rupen; Sidawy, Anton A.; Evans, Stephen R. T.; Finegold, Milton; Reddy, E. Premkumar; Mishra, Bibhuti; Weksberg, Rosanna; Kumar, Rakesh; Mishra, Lopa			Epigenetic Silencing of beta-Spectrin, a TGF-beta Signaling/Scaffolding Protein in a Human Cancer Stem Cell Disorder BECKWITH-WIEDEMANN SYNDROME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLABI-BEHMEL SYNDROME; IMPRINTED GENES; MOUSE MODEL; GROWTH; DISRUPTION; P57(KIP2); IGF2; OVERGROWTH; ELF; DIFFERENTIATION	Hereditary cancer syndromes provide powerful insights into dysfunctional signaling pathways that lead to sporadic cancers. Beckwith-Wiedemann syndrome (BWS) is a hereditary human cancer stem cell syndrome currently linked to deregulated imprinting at chromosome 11p15 and uniparental disomy. However, causal molecular defects and genetic models have remained elusive to date in the majority of cases. The non-pleckstrin homology domain beta-spectrin (beta 2SP) (the official name for human is Spectrin, beta, nonerythrocytic 1 (SPTBN1), isoform 2; the official name for mouse is Spectrin beta 2 (Spnb2), isoform 2), a scaffolding protein, functions as a potent TGF-beta signaling member adaptor in tumor suppression and development. Yet, the role of the beta 2SP in human tumor syndromes remains unclear. Here, we report that beta 2SP(+/-) mice are born with many phenotypic characteristics observed in BWS patients, suggesting that beta 2SP mutant mice phenocopy BWS, and beta 2SP loss could be one of the mechanisms associated with BWS. Our results also suggest that epigenetic silencing of beta 2SP is a new potential causal factor in human BWS patients. Furthermore, beta 2SP(+/-) mice provide an important animal model for BWS, as well as sporadic cancers associated with it, including lethal gastrointestinal and pancreatic cancer. Thus, these studies could lead to further insight into defects generated by dysfunctional stem cells and identification of new treatment strategies and functional markers for the early detection of these lethal cancers that otherwise cannot be detected at an early stage.	[Yao, Zhi-Xing; Jogunoori, Wilma; Blake, Tiffany; Yao, Wenguo; Amin, Rupen; Mishra, Bibhuti; Mishra, Lopa] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Rashid, Asif] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Evans, Stephen R. T.] Georgetown Univ, Dept Surg, Washington, DC 20057 USA; [Kumar, Rakesh] George Washington Univ, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Finegold, Milton] Baylor Univ, Dept Pathol, Houston, TX 77030 USA; [Sidawy, Anton A.] Dept Vet Affairs Med Ctr, Washington, DC 20422 USA; [Reddy, E. Premkumar] Mt Sinai Med Ctr, New York, NY 10029 USA; [Choufani, Sanaa; Weksberg, Rosanna] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Kreishman, Peter] Walter Reed Army Med Ctr, Washington, DC 20307 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Georgetown University; George Washington University; Baylor University; Icahn School of Medicine at Mount Sinai; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Mishra, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA.	lmishra@mdanderson.org	Choufani, Sanaa/GWC-1820-2022; Reddy, E. Premkumar/F-6233-2011; Kumar, Rakesh/ABD-1065-2020	Choufani, Sanaa/0000-0002-5241-2213; Kumar, Rakesh/0000-0001-7664-0803; Mishra, Lopa/0000-0002-6850-0808	National Institutes of Health [P01 CA130821, R01 CA106614A, R01 CA042857, R01 DK58637]; Veterans Affairs merit award; R. Robert and Sally D. Funderburg Research Scholar award; NATIONAL CANCER INSTITUTE [P01CA130821, R01CA042857, R01CA106614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit award(US Department of Veterans Affairs); R. Robert and Sally D. Funderburg Research Scholar award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 CA130821, R01 CA106614A, and R01 CA042857 (to L. M.) and R01 DK58637 (to B. M.). This work was also supported by a Veterans Affairs merit award (to L. M.), the R. Robert and Sally D. Funderburg Research Scholar award (to L. M.)	Allen C, 2005, BJOG-INT J OBSTET GY, V112, P1589, DOI 10.1111/j.1471-0528.2005.00784.x; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Caspary T, 1999, GENE DEV, V13, P3115, DOI 10.1101/gad.13.23.3115; COMBS JT, 1966, NEW ENGL J MED, V275, P236, DOI 10.1056/NEJM196608042750502; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Enklaar Thorsten, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000020; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; GARGANTA CL, 1992, AM J MED GENET, V44, P129, DOI 10.1002/ajmg.1320440202; Gosden R, 2003, LANCET, V361, P1975, DOI 10.1016/S0140-6736(03)13592-1; Halliday J, 2004, AM J HUM GENET, V75, P526, DOI 10.1086/423902; HughesBenzie RM, 1996, AM J MED GENET, V66, P227, DOI 10.1002/(SICI)1096-8628(19961211)66:2<227::AID-AJMG20>3.0.CO;2-U; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; John RM, 2001, HUM MOL GENET, V10, P1601, DOI 10.1093/hmg/10.15.1601; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kitisin K, 2007, ONCOGENE, V26, P7103, DOI 10.1038/sj.onc.1210513; Lapunzina P, 2005, AM J MED GENET C, V137C, P53, DOI 10.1002/ajmg.c.30064; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Li M, 1998, CLIN GENET, V53, P165; Lin L, 2009, ONCOGENE, V28, P961, DOI 10.1038/onc.2008.448; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Ludwig T, 1996, DEV BIOL, V177, P517, DOI 10.1006/dbio.1996.0182; Luton D, 1996, FETAL DIAGN THER, V11, P154, DOI 10.1159/000264296; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meyer E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000423; Miles HL, 2005, REV ENDOCR METAB DIS, V6, P261, DOI 10.1007/s11154-005-6184-0; Mishra L, 2005, SCIENCE, V310, P68, DOI 10.1126/science.1118389; Murrell A, 2004, HUM MOL GENET, V13, P247, DOI 10.1093/hmg/ddh013; Neri G, 1998, AM J MED GENET, V79, P279, DOI 10.1002/(SICI)1096-8628(19981002)79:4<279::AID-AJMG9>3.0.CO;2-H; Neufeld KL, 2000, P NATL ACAD SCI USA, V97, P12085, DOI 10.1073/pnas.220401797; PETTENATI MJ, 1986, HUM GENET, V74, P143, DOI 10.1007/BF00282078; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Song HH, 1997, J BIOL CHEM, V272, P7574, DOI 10.1074/jbc.272.12.7574; SPENCER GSG, 1980, ARCH DIS CHILD, V55, P151, DOI 10.1136/adc.55.2.151; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; Tang Y, 2005, CANCER RES, V65, P4228, DOI 10.1158/0008-5472.CAN-04-4585; Tang Y, 2003, SCIENCE, V299, P574, DOI 10.1126/science.1075994; Tang Y, 2008, P NATL ACAD SCI USA, V105, P2445, DOI 10.1073/pnas.0705395105; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; Weksberg R, 2005, AM J MED GENET C, V137C, P12, DOI 10.1002/ajmg.c.30058; WENG EY, 1995, AM J MED GENET, V56, P366, DOI 10.1002/ajmg.1320560405; WIEDEMANN H. R., 1964, J GENET HUM, V13, P223; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	49	30	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36112	36120		10.1074/jbc.M110.162347	http://dx.doi.org/10.1074/jbc.M110.162347			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20739274	Green Published, hybrid			2022-12-25	WOS:000283845300087
J	Magli, A; Angelelli, C; Ganassi, M; Baruffaldi, F; Matafora, V; Battini, R; Bachi, A; Messina, G; Rustighi, A; Del Sal, G; Ferrari, S; Molinari, S				Magli, Alessandro; Angelelli, Cecilia; Ganassi, Massimo; Baruffaldi, Fiorenza; Matafora, Vittoria; Battini, Renata; Bachi, Angela; Messina, Graziella; Rustighi, Alessandra; Del Sal, Giannino; Ferrari, Stefano; Molinari, Susanna			Proline Isomerase Pin1 Represses Terminal Differentiation and Myocyte Enhancer Factor 2C Function in Skeletal Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVITY; MEF2; PHOSPHORYLATION; MYOGENESIS; FAMILY; LOCALIZATION; INHIBITION; ACTIVATION	Reversible proline-directed phosphorylation at Ser/Thr-Pro motifs has an essential role in myogenesis, a multistep process strictly regulated by several signaling pathways that impinge on two families of myogenic effectors, the basic helix-loop-helix myogenic transcription factors and the MEF2 (myocyte enhancer factor 2) proteins. The question of how these signals are deciphered by the myogenic effectors remains largely unaddressed. In this study, we show that the peptidyl-prolyl isomerase Pin1, which catalyzes the isomerization of phosphorylated Ser/Thr-Pro peptide bonds to induce conformational changes of its target proteins, acts as an inhibitor of muscle differentiation because its knockdown in myoblasts promotes myotube formation. With the aim of clarifying the mechanism of Pin1 function in skeletal myogenesis, we investigated whether MEF2C, a critical regulator of the myogenic program that is the end point of several signaling pathways, might serve as a/the target for the inhibitory effects of Pin1 on muscle differentiation. We show that Pin1 interacts selectively with phosphorylated MEF2C in skeletal muscle cells, both in vitro and in vivo. The interaction with Pin1 requires two novel critical phospho-Ser/Thr-Pro motifs in MEF2C, Ser(98) and Ser(110), which are phosphorylated in vivo. Overexpression of Pin1 decreases MEF2C stability and activity and its ability to cooperate with MyoD to activate myogenic conversion. Collectively, these findings reveal a novel role for Pin1 as a regulator of muscle terminal differentiation and suggest that Pin1-mediated repression of MEF2C function could contribute to this function.	[Molinari, Susanna] Univ Modena & Reggio Emilia, Dept Biomed Sci, Biochem Sect, I-41100 Modena, Italy; [Matafora, Vittoria; Bachi, Angela] H San Raffaele Sci Inst, Mass Spectrometry Unit, I-20132 Milan, Italy; [Messina, Graziella] H San Raffaele Sci Inst, Stem Cell Res Inst, I-20132 Milan, Italy; [Messina, Graziella] Univ Milan, Dept Biol, I-20129 Milan, Italy; [Rustighi, Alessandra; Del Sal, Giannino] Univ Trieste, Lab Nazl Consorzio Interuniv Biotecnol, I-34100 Trieste, Italy; [Rustighi, Alessandra; Del Sal, Giannino] Univ Trieste, Dept Life Sci, I-34012 Trieste, Italy	Universita di Modena e Reggio Emilia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; University of Trieste; University of Trieste	Molinari, S (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Sci, Biochem Sect, Via G Campi 287, I-41100 Modena, Italy.	susanna.molinari@unimore.it	bachi, angela/B-3527-2015; Messina, Graziella/A-1469-2014; Battini, Renata/F-2113-2015; Molinari, Susanna/E-1670-2015; Magli, Alessandro/K-5961-2019	bachi, angela/0000-0003-4842-6556; Messina, Graziella/0000-0001-8189-0727; Battini, Renata/0000-0003-0876-4294; Molinari, Susanna/0000-0003-1649-4407; Magli, Alessandro/0000-0003-3874-2838; DEL SAL, GIANNINO/0000-0003-2185-6003; Ganassi, Massimo/0000-0003-3163-9707; matafora, vittoria/0000-0002-4311-998X	MURST; EC [223098]; Telethon and Associazione Italiana per la Ricerca sul Cancro	MURST(Ministry of Education, Universities and Research (MIUR)); EC(European CommissionEuropean Commission Joint Research Centre); Telethon and Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancroFondazione Telethon)	This work was supported by grants from MURST COFIN'06 and EC FP7-Health-2007-B Grant 223098 (OPTISTEM) (to S. F.) and by grants from Telethon and Associazione Italiana per la Ricerca sul Cancro (to G. D. S.).	Angelelli C, 2008, NUCLEIC ACIDS RES, V36, P915, DOI 10.1093/nar/gkm1114; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Borghi S, 2001, J CELL SCI, V114, P4477; Cox DM, 2003, J BIOL CHEM, V278, P15297, DOI 10.1074/jbc.M211312200; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Han JH, 2000, TRENDS CARDIOVAS MED, V10, P19, DOI 10.1016/S1050-1738(00)00039-6; HASHIMOTO N, 1994, FEBS LETT, V352, P236, DOI 10.1016/0014-5793(94)00964-3; Hinits Y, 2007, DEVELOPMENT, V134, P2511, DOI 10.1242/dev.007088; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kang Jungseog, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-5; Kato Y, 2000, J BIOL CHEM, V275, P18534, DOI 10.1074/jbc.M001573200; Kitzmann M, 1999, MOL CELL BIOL, V19, P3167; Lazaro JB, 1997, J CELL SCI, V110, P1251; Lazaro JB, 2002, GENE DEV, V16, P1792, DOI 10.1101/gad.U-9988R; Lluis F, 2006, TRENDS CELL BIOL, V16, P36, DOI 10.1016/j.tcb.2005.11.002; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lufei CC, 2009, FEBS LETT, V583, P271, DOI 10.1016/j.febslet.2008.12.011; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Molkentin JD, 1996, J BIOL CHEM, V271, P17199, DOI 10.1074/jbc.271.29.17199; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Naya FJ, 1999, DEVELOPMENT, V126, P2045; PINSET C, 1988, DIFFERENTIATION, V38, P28, DOI 10.1111/j.1432-0436.1988.tb00588.x; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Puente LG, 2006, MOL CELL PROTEOMICS, V5, P2244, DOI 10.1074/mcp.M600134-MCP200; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Skapek SX, 1996, MOL CELL BIOL, V16, P7043; Suelves M, 2004, EMBO J, V23, P365, DOI 10.1038/sj.emboj.7600056; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Verdel A, 2000, CURR BIOL, V10, P747, DOI 10.1016/S0960-9822(00)00542-X; YAFFE D, 1977, DIFFERENTIATION, V7, P159, DOI 10.1111/j.1432-0436.1977.tb01507.x; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X; Zhu BM, 2004, MOL CELL BIOL, V24, P8264, DOI 10.1128/MCB.24.18.8264-8275.2004	43	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34518	34527		10.1074/jbc.M110.104133	http://dx.doi.org/10.1074/jbc.M110.104133			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20801874	Green Published, hybrid			2022-12-25	WOS:000283659100027
J	Dhillon, J; Astanehe, A; Lee, C; Fotovati, A; Hu, K; Dunn, SE				Dhillon, J.; Astanehe, A.; Lee, C.; Fotovati, A.; Hu, K.; Dunn, S. E.			The expression of activated Y-box binding protein-1 serine 102 mediates trastuzumab resistance in breast cancer cells by increasing CD44(+) cells	ONCOGENE			English	Article						YB-1; trastuzumab; resistance; CD44; tumor-initiating cells	GROWTH-FACTOR RECEPTOR; MONOCLONAL-ANTIBODY; TUMOR-GROWTH; CHEMOTHERAPY; HER-2; YB-1; EFFICACY; RELAPSE; SAFETY	The development of acquired resistance to trastuzumab remains a prevalent challenge in the treatment of patients whose tumors express human epidermal growth factor 2 (HER2). We previously reported that HER2 overexpressing breast cancers are dependent on Y-box binding protein-1 (YB-1) for growth and survival. As YB-1 is also linked to drug resistance in other types of cancer, we address its possible role in trastuzumab insensitivity. Employing an in vivo model of acquired resistance, we demonstrate that resistant cell lines have elevated levels of P-YB-1(S102) and its activating kinase P-RSK and these levels are sustained following trastuzumab treatment. Further, to demonstrate the importance of YB-1 in mediating drug resistance, the expression of the active mutant YB-1(S102D) rendered the BT474 cell line insensitive to trastuzumab. Questioning the role of tumor-initiating cells (TIC) and their ability to escape cancer therapies, we investigate YB-1's role in inducing the cancer stem cell marker CD44. Notably, the resistant cells express more CD44 mRNA and protein compared with BT474 cells, which correlated with increased mammosphere formation. Expression of YB-1S102D in the BT474 cells increase CD44 protein levels, resulting in enhanced mammosphere formation. Further, exposing BT474 cells to trastuzumab selected for a resistant sub-population enriched for CD44. Conversely, small intefering RNA inhibition of CD44 restored trastuzumab sensitivity in the resistant cell lines. Our findings provide insight on a novel mechanism employed by tumor cells to acquire the ability to escape the effects of trastuzumab and suggest that targeting YB-1 may overcome resistance by eliminating the unresponsive TIC population, rendering the cancer sensitive to therapy. Oncogene (2010) 29, 6294-6300; doi:10.1038/onc.2010.365; published online 30 August 2010	[Dhillon, J.; Astanehe, A.; Lee, C.; Fotovati, A.; Hu, K.; Dunn, S. E.] Univ British Columbia, Dept Paediat, Child & Family Res Inst, Lab Oncogenom Res, Vancouver, BC V5Z 4H4, Canada; [Dhillon, J.; Astanehe, A.; Lee, C.; Dunn, S. E.] Expt Med Program, Dept Med, Vancouver, BC, Canada	Child & Family Research Institute; University of British Columbia	Dunn, SE (corresponding author), Univ British Columbia, Dept Paediat, Child & Family Res Inst, Lab Oncogenom Res, 950 W 28th Ave,Room 3083, Vancouver, BC V5Z 4H4, Canada.	sedunn@interchange.ubc.ca			Canadian Breast Cancer Research Alliance; National Cancer Institute of Canada; Child and Family Research Institute; Canadian Institute of Health Research; Michael Smith Foundation for Health Research	Canadian Breast Cancer Research Alliance; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Child and Family Research Institute; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	We thank Spencer Freeman from the Life Sciences Centre, UBC for his assistance with confocal microscopy. This work was supported by the Canadian Breast Cancer Research Alliance and the National Cancer Institute of Canada (SED). JD was a recipient of the Child and Family Research Institute Graduate Studentship and AA was a recipient of Canadian Institute of Health Research MD/PhD and the Michael Smith Foundation for Health Research Studentships.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Astanehe A, 2009, ONCOGENE, V28, P2406, DOI 10.1038/onc.2009.81; Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Finkbeiner MR, 2009, ONCOGENE, V28, P1421, DOI 10.1038/onc.2008.485; Gluz O, 2009, J CLIN ONCOL, V27, P6144, DOI 10.1200/JCO.2008.19.6261; Habibi G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2156; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Lee C, 2008, CANCER RES, V68, P8661, DOI 10.1158/0008-5472.CAN-08-1082; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Marangoni E, 2009, BRIT J CANCER, V100, P918, DOI 10.1038/sj.bjc.6604953; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stratford AL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1767; Stratford AL, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2202; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; To K, 2010, CANCER RES, V70, P2840, DOI 10.1158/0008-5472.CAN-09-3155; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Wu J, 2006, CANCER RES, V66, P4872, DOI 10.1158/0008-5472.CAN-05-3561	21	32	35	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2010	29	47					6294	6300		10.1038/onc.2010.365	http://dx.doi.org/10.1038/onc.2010.365			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	685CG	20802512				2022-12-25	WOS:000284601700010
J	Kong, DJ; Banerjee, S; Ahmad, A; Li, YW; Wang, ZW; Sethi, S; Sarkar, FH				Kong, Dejuan; Banerjee, Sanjeev; Ahmad, Aamir; Li, Yiwei; Wang, Zhiwei; Sethi, Seema; Sarkar, Fazlul H.			Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR-D; TUMOR-INITIATING CELLS; SELF-RENEWAL; DEVELOPMENTAL REGULATORS; DOWN-REGULATION; MIR-200 FAMILY; PDGF-D; INVASION; ANGIOGENESIS; TARGET	Background: Current management of patients diagnosed with prostate cancer (PCa) is very effective; however, tumor recurrence with Castrate Resistant Prostate Cancer (CRPC) and subsequent metastasis lead to poor survival outcome, suggesting that there is a dire need for novel mechanistic understanding of tumor recurrence, which would be critical for designing novel therapies. The recurrence and the metastasis of PCa are tightly linked with the biology of prostate cancer stem cells or cancer-initiating cells that is reminiscent of the acquisition of Epithelial to Mesenchymal Transition (EMT) phenotype. Increasing evidence suggests that EMT-type cells share many biological characteristics with cancer stem-like cells. Methodology/Principal Findings: In this study, we found that PCa cells with EMT phenotype displayed stem-like cell features characterized by increased expression of Sox2, Nanog, Oct4, Lin28B and/or Notch1, consistent with enhanced clonogenic and sphere (prostasphere)-forming ability and tumorigenecity in mice, which was associated with decreased expression of miR-200 and/or let-7 family. Reversal of EMT by re-expression of miR-200 inhibited prostasphere-forming ability of EMT-type cells and reduced the expression of Notch1 and Lin28B. Down-regulation of Lin28B increased let-7 expression, which was consistent with repressed self-renewal capability. Conclusions/Significance: These results suggest that miR-200 played a pivotal role in linking the characteristics of cancer stem-like cells with EMT-like cell signatures in PCa. Selective elimination of cancer stem-like cells by reversing the EMT phenotype to Mesenchymal-Epithelial Transition (MET) phenotype using novel agents would be useful for the prevention of tumor recurrence especially by eliminating those cells that are the "Root Cause" of tumor development and recurrence.	[Kong, Dejuan; Banerjee, Sanjeev; Ahmad, Aamir; Li, Yiwei; Wang, Zhiwei; Sethi, Seema; Sarkar, Fazlul H.] Wayne State Univ, Sch Med, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University	Kong, DJ (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48201 USA.	fsarkar@med.wayne.edu	Ahmad, Aamir/E-8747-2010; Wang, Zhiwei/A-6809-2011	Ahmad, Aamir/0000-0003-1784-5723; 	National Cancer Institute, National Institutes of Health (NIH) [5R01CA083695-08]; NATIONAL CANCER INSTITUTE [R01CA164318, R01CA083695] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by a grant from the National Cancer Institute, National Institutes of Health (NIH) (5R01CA083695-08 to FHS) (http://projectreporter.nih.gov/reporter_searchresults.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cano A, 2008, TRENDS CELL BIOL, V18, P357, DOI 10.1016/j.tcb.2008.05.005; Fischer ANM, 2007, ONCOGENE, V26, P3395, DOI 10.1038/sj.onc.1210121; Fox V, 2008, STEM CELLS, V26, P715, DOI 10.1634/stemcells.2007-0368; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Kasper S, 2008, J CELL PHYSIOL, V216, P332, DOI 10.1002/jcp.21489; Kasper S, 2009, UROL ONCOL-SEMIN ORI, V27, P301, DOI 10.1016/j.urolonc.2008.12.012; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Kong DJ, 2008, STEM CELLS, V26, P1425, DOI 10.1634/stemcells.2007-1076; Kong D, 2008, CANCER RES, V68, P1927, DOI 10.1158/0008-5472.CAN-07-3241; Kong DJ, 2007, CANCER RES, V67, P3310, DOI 10.1158/0008-5472.CAN-06-4277; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li H, 2003, ONCOGENE, V22, P1501, DOI 10.1038/sj.onc.1206223; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marian CO, 2009, BBA-MOL BASIS DIS, V1792, P289, DOI 10.1016/j.bbadis.2009.02.012; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Sotomayor P, 2009, PROSTATE, V69, P401, DOI 10.1002/pros.20895; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Ustach CV, 2005, MOL CELL BIOL, V25, P6279, DOI 10.1128/MCB.25.14.6279-6288.2005; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang ZW, 2007, CANCER RES, V67, P11377, DOI 10.1158/0008-5472.CAN-07-2803; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xu JC, 2006, PROSTATE, V66, P1664, DOI 10.1002/pros.20488; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	47	309	318	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12445	10.1371/journal.pone.0012445	http://dx.doi.org/10.1371/journal.pone.0012445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805998	gold, Green Published, Green Submitted			2022-12-25	WOS:000281301500012
J	Bao, W; Song, FF; Li, XY; Rong, SA; Yang, W; Zhang, MX; Yao, P; Hao, LP; Yang, NH; Hu, FB; Liu, LG				Bao, Wei; Song, Fangfang; Li, Xiangyang; Rong, Shuang; Yang, Wei; Zhang, Muxun; Yao, Ping; Hao, Liping; Yang, Nianhong; Hu, Frank B.; Liu, Liegang			Plasma Heme Oxygenase-1 Concentration Is Elevated in Individuals with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							ACTIVATED SIGNALING PATHWAYS; BETA-CELL DYSFUNCTION; OXIDATIVE STRESS; INSULIN-RESISTANCE; GENE-EXPRESSION; GLUCOSE; DEFENSE; DIAGNOSIS; P22(PHOX); DISEASE	Background: Circulating concentrations of heme oxygenase-1 (HO-1) have been recently reported to be elevated in several chronic disorders. However, no study has ever examined the association between circulating HO-1 concentrations and type 2 diabetes mellitus (T2DM). Methods and Findings: 581 cases with newly-diagnosed T2DM (New-T2DM) and 611 comparison controls were recruited in this two-phase case-control study, comprising 420 cases and 429 controls collected in the first phase study and 161 cases and 182 controls in the second phase replication study. Analyses, using both separated data and combined data from the two-phase studies, show that plasma HO-1 concentrations were significantly increased in New-T2DM cases compared to controls (P < 0.001). Plasma HO-1 concentrations were significantly correlated with plasma glucose concentrations, HOMA-beta and HOMA-IR (P < 0.001). After adjustment for age, sex, BMI and family history of diabetes, the ORs for New-T2DM in the highest quartile of plasma HO-1 concentrations, compared with the lowest, was 8.23 (95% CI 5.55-12.21; P for trend <0.001). The trend remained significant after additional adjustment for fasting plasma glucose/insulin, HOMA-beta/HOMAIR, TC/TG, smoking, drinking and history of hypertension, and even in further stratification analysis by age, sex, BMI, smoking, drinking and history of hypertension. Conclusions: Elevated plasma HO-1 concentrations are associated with higher ORs for New-T2DM, which add more knowledge regarding the important role of oxidative stress in T2DM. More consequent studies were warranted to confirm the clinical utility of plasma HO-1, especially in diagnosis and prognosis of T2DM and its complications.	[Bao, Wei; Song, Fangfang; Li, Xiangyang; Rong, Shuang; Yang, Wei; Yao, Ping; Hao, Liping; Yang, Nianhong; Liu, Liegang] Huazhong Univ Sci & Technol, Dept Food Hyg & Nutr, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Peoples R China; [Bao, Wei; Song, Fangfang; Li, Xiangyang; Rong, Shuang; Yang, Wei; Yao, Ping; Hao, Liping; Yang, Nianhong; Liu, Liegang] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Song, Fangfang] Tianjin Med Univ, Canc Inst & Hosp, Dept Epidemiol & Biostat, Tianjin, Peoples R China; [Zhang, Muxun] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med,Inst Endocrinol, Wuhan 430074, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hu, Frank B.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Hu, Frank B.] Harvard Univ, Sch Med, Boston, MA USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Tianjin Medical University; Huazhong University of Science & Technology; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Bao, W (corresponding author), Huazhong Univ Sci & Technol, Dept Food Hyg & Nutr, Tongji Med Coll, Sch Publ Hlth, Wuhan 430074, Peoples R China.	fhu@hsph.harvard.edu; lgliu@mails.tjmu.edu.cn	Bao, Wei/AAG-2431-2019	Bao, Wei/0000-0002-7301-5786	National Natural Science Foundation [NSFC-30872116]; National Basic Research Program (973 Program) of China [2009CB118803-1]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program) of China(National Basic Research Program of China)	This study was supported by National Natural Science Foundation (NSFC-30872116) and partly by National Basic Research Program (973 Program, 2009CB118803-1) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Adaikalakoteswari A, 2006, DIABETIC MED, V23, P666, DOI 10.1111/j.1464-5491.2006.01879.x; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Avogaro A, 2003, J CLIN ENDOCR METAB, V88, P1753, DOI 10.1210/jc.2002-021025; Bruce CR, 2003, DIABETES, V52, P2338, DOI 10.2337/diabetes.52.9.2338; Calabrese V, 2007, CELL STRESS CHAPERON, V12, P299, DOI 10.1379/CSC-270.1; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Jonas JC, 2003, DIABETOLOGIA, V46, P1234, DOI 10.1007/s00125-003-1174-9; Kaneto H, 2007, ANTIOXID REDOX SIGN, V9, P355, DOI 10.1089/ars.2006.1465; Kirino M, 2008, J ALLERGY CLIN IMMUN, V122, P290, DOI 10.1016/j.jaci.2008.05.031; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Mateo I, 2010, ACTA NEUROL SCAND, V121, P136, DOI 10.1111/j.1600-0404.2009.01261.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miyazaki T, 2010, INT J HEMATOL, V91, P229, DOI 10.1007/s12185-010-0495-y; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Morse D, 2002, AM J RESP CELL MOL, V27, P8, DOI 10.1165/ajrcmb.27.1.4862; Platt JL, 1998, NAT MED, V4, P1364, DOI 10.1038/3947; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sato T, 2006, AM J RESP CRIT CARE, V174, P906, DOI 10.1164/rccm.200508-1237OC; Schipper HM, 2004, FREE RADICAL BIO MED, V37, P1995, DOI 10.1016/j.freeradbiomed.2004.09.015; Schipper HM, 2000, NEUROLOGY, V54, P1297, DOI 10.1212/WNL.54.6.1297; Song FF, 2007, EUR J NUTR, V46, P61, DOI 10.1007/s00394-006-0632-9; Song FF, 2007, CLIN SCI, V112, P599, DOI 10.1042/CS20060323; Song FF, 2009, AM J EPIDEMIOL, V170, P747, DOI 10.1093/aje/kwp196; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Won KC, 2006, J KOREAN MED SCI, V21, P418, DOI 10.3346/jkms.2006.21.3.418; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	32	83	90	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12371	10.1371/journal.pone.0012371	http://dx.doi.org/10.1371/journal.pone.0012371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811623	Green Published, gold, Green Submitted			2022-12-25	WOS:000281234700008
J	Veiga, MI; Ferreira, PE; Schmidt, BA; Ribacke, U; Bjorkman, A; Tichopad, A; Gil, JP				Veiga, Maria Isabel; Ferreira, Pedro Eduardo; Schmidt, Berit Aydin; Ribacke, Ulf; Bjorkman, Anders; Tichopad, Ales; Gil, Jose Pedro			Antimalarial Exposure Delays Plasmodium falciparum Intra-Erythrocytic Cycle and Drives Drug Transporter Genes Expression	PLOS ONE			English	Article							CHLOROQUINE RESISTANCE; MALARIA PARASITES; PFMDR1 GENE; SENSITIVITY; MEFLOQUINE; PFCRT; RECRUDESCENCE; LUMEFANTRINE; COMBINATION; QUININE	Background: Multi-drug resistant Plasmodium falciparum is a major obstacle to malaria control and is emerging as a complex phenomenon. Mechanisms of drug evasion based on the intracellular extrusion of the drug and/or modification of target proteins have been described. However, cellular mechanisms related with metabolic activity have also been seen in eukaryotic systems, e. g. cancer cells. Recent observations suggest that such mechanism may occur in P. falciparum. Methodology/Principal Findings: We therefore investigated the effect of mefloquine exposure on the cell cycle of three P. falciparum clones (3D7, FCB, W2) with different drug susceptibilities, while investigating in parallel the expression of four genes coding for confirmed and putative drug transporters (pfcrt, pfmdr1, pfmrp1 and pfmrp2). Mefloquine induced a previously not described dose and clone dependent delay in the intra-erythrocytic cycle of the parasite. Drug impact on cell cycle progression and gene expression was then merged using a non-linear regression model to determine specific drug driven expression. This revealed a mild, but significant, mefloquine driven gene induction up to 1.5 fold. Conclusions/Significance: Both cell cycle delay and induced gene expression represent potentially important mechanisms for parasites to escape the effect of the antimalarial drug.	[Veiga, Maria Isabel; Ferreira, Pedro Eduardo; Schmidt, Berit Aydin; Bjorkman, Anders; Gil, Jose Pedro] Karolinska Inst, Dept Med, Malaria Res Lab, Stockholm, Sweden; [Veiga, Maria Isabel; Ferreira, Pedro Eduardo; Gil, Jose Pedro] Univ Algarve, Ctr Mol & Struct Biomed, Inst Biotechnol & Bioengn, Drug Resistance & Pharmacogenet Grp, Faro, Portugal; [Ribacke, Ulf] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Tichopad, Ales] Inst Biotechnol AS CR, Prague, Czech Republic; [Tichopad, Ales] Tech Univ Munich, D-8050 Freising Weihenstephan, Germany; [Gil, Jose Pedro] SUNY Binghamton, Dept Anthropol, Lab Mol Anthropol & Hlth, Binghamton, NY USA	Karolinska Institutet; Universidade do Algarve; Karolinska Institutet; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Technical University of Munich; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Veiga, MI (corresponding author), Karolinska Inst, Dept Med, Malaria Res Lab, Stockholm, Sweden.	isabel.veiga@ki.se	Ferreira, Pedro/AAD-4309-2020; Gil, José Pedro/AAB-6169-2020; Ferreira, Pedro/HDO-1346-2022; Veiga, Maria Isabel/H-9922-2018; Ferreira, Pedro/G-1717-2012; Ferreira, Pedro/Q-6748-2016	Ferreira, Pedro/0000-0002-2682-7722; Veiga, Maria Isabel/0000-0002-2205-8102; Ferreira, Pedro/0000-0002-2682-7722; Ferreira, Pedro/0000-0002-2682-7722; Gil, Jose Pedro/0000-0002-6107-9379	Swedish Development Cooperation Agency - Department for Research Cooperation [SWE 2005 - 0017, SWE 2005 - 4596, SWE-2007-174, SWE-2005-4027]; Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia e Ensino Superior, Portugal - MCES [SFRH/BD/28393/2006, SFRH/BD/28368/2006]	Swedish Development Cooperation Agency - Department for Research Cooperation; Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia e Ensino Superior, Portugal - MCES(Portuguese Foundation for Science and Technology)	This work was supported by project grants from the Swedish Development Cooperation Agency - Department for Research Cooperation (SWE 2005 0017, SWE 2005 - 4596, SWE-2007-174 and SWE-2005-4027). MIV and PEF are recipients of PhD grants from Fundacao para a Ciencia e Tecnologia (FCT)/Ministerio da Ciencia e Ensino Superior, Portugal - MCES (ref. SFRH/BD/28393/2006 and ref. SFRH/BD/28368/2006, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, WORLD MAL REP 2008; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; BARNES DA, 1992, EMBO J, V11, P3067, DOI 10.1002/j.1460-2075.1992.tb05378.x; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bozdech Z, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-17; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Cowman Alan F., 1993, Seminars in Cell Biology, V4, P29, DOI 10.1006/scel.1993.1004; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Ganesan K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000214; Gatton ML, 2006, AM J TROP MED HYG, V75, P212, DOI 10.4269/ajtmh.2006.75.212; Gunasekera AM, 2007, EXP PARASITOL, V117, P87, DOI 10.1016/j.exppara.2007.03.001; Johnson DJ, 2008, ANTIMICROB AGENTS CH, V52, P1438, DOI 10.1128/AAC.01392-07; Johnson DJ, 2004, MOL CELL, V15, P867, DOI 10.1016/j.molcel.2004.09.012; Klokouzas A, 2004, BIOCHEM BIOPH RES CO, V321, P197, DOI 10.1016/j.bbrc.2004.06.135; Lakshmanan V, 2005, EMBO J, V24, P2294, DOI 10.1038/sj.emboj.7600681; Lopes Dinora, 2002, Malar J, V1, P12, DOI 10.1186/1475-2875-1-12; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; Myrick A, 2003, MOL MICROBIOL, V49, P671, DOI 10.1046/j.1365-2958.2003.03597.x; Nakazawa S, 1995, EXP PARASITOL, V81, P556, DOI 10.1006/expr.1995.1149; Nakazawa S, 2002, ANTIMICROB AGENTS CH, V46, P958, DOI 10.1128/AAC.46.4.958-965.2002; Noedl H, 2005, ANTIMICROB AGENTS CH, V49, P3575, DOI 10.1128/AAC.49.8.3575-3577.2005; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Price RN, 2006, CLIN INFECT DIS, V42, P1570, DOI 10.1086/503423; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Rohrbach P, 2006, EMBO J, V25, P3000, DOI 10.1038/sj.emboj.7601203; Roninson IB, 2003, CANCER RES, V63, P2705; Sanchez CP, 2007, TRENDS PARASITOL, V23, P332, DOI 10.1016/j.pt.2007.04.013; Sauvage V, 2009, MOL BIOCHEM PARASIT, V167, P81, DOI 10.1016/j.molbiopara.2009.05.005; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Stahlberg A, 2003, CLIN CHEM, V49, P51, DOI 10.1373/49.1.51; Stepniewska K, 2010, J INFECT DIS, V201, P570, DOI 10.1086/650301; Thapar MM, 2005, T ROY SOC TROP MED H, V99, P62, DOI 10.1016/j.trstmh.2004.01.016; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Valderramos SG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000887; Varna M, 2009, INT J CANCER, V124, P991, DOI 10.1002/ijc.24049; WILSON CM, 1989, SCIENCE, V244, P1184, DOI 10.1126/science.2658061	41	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12408	10.1371/journal.pone.0012408	http://dx.doi.org/10.1371/journal.pone.0012408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811640	Green Submitted, Green Published, gold			2022-12-25	WOS:000281234700029
J	Aartsen, WM; van Cleef, KWR; Pellissier, LP; Hoek, RM; Vos, RM; Blits, B; Ehlert, EME; Balaggan, KS; Ali, RR; Verhaagen, J; Wijnholds, J				Aartsen, Wendy M.; van Cleef, Koen W. R.; Pellissier, Lucie P.; Hoek, Robert M.; Vos, Rogier M.; Blits, Bas; Ehlert, Erich M. E.; Balaggan, Kamaljit S.; Ali, Robin R.; Verhaagen, Joost; Wijnholds, Jan			GFAP-Driven GFP Expression in Activated Mouse Muller Glial Cells Aligning Retinal Blood Vessels Following Intravitreal Injection of AAV2/6 Vectors	PLOS ONE			English	Article							GENE-THERAPY; TRANSDUCTION; CRB1; MEMBRANE; PURIFICATION; DETACHMENT; PROMOTER; VISION; SIZE	Background: Muller cell gliosis occurs in various retinal pathologies regardless of the underlying cellular defect. Because activated Muller glial cells span the entire retina and align areas of injury, they are ideal targets for therapeutic strategies, including gene therapy. Methodology/Principal Findings: We used adeno-associated viral AAV2/6 vectors to transduce mouse retinas. The transduction pattern of AAV2/6 was investigated by studying expression of the green fluorescent protein (GFP) transgene using scanning-laser ophthalmoscopy and immuno-histochemistry. AAV2/6 vectors transduced mouse Muller glial cells aligning the retinal blood vessels. However, the transduction capacity was hindered by the inner limiting membrane (ILM) and besides Muller glial cells, several other inner retinal cell types were transduced. To obtain Muller glial cell-specific transgene expression, the cytomegalovirus (CMV) promoter was replaced by the glial fibrillary acidic protein (GFAP) promoter. Specificity and activation of the GFAP promoter was tested in a mouse model for retinal gliosis. Mice deficient for Crumbs homologue 1 (CRB1) develop gliosis after light exposure. Light exposure of Crb1(-/-) retinas transduced with AAV2/6-GFAP-GFP induced GFP expression restricted to activated Muller glial cells aligning retinal blood vessels. Conclusions/Significance: Our experiments indicate that AAV2 vectors carrying the GFAP promoter are a promising tool for specific expression of transgenes in activated glial cells.	[Aartsen, Wendy M.; van Cleef, Koen W. R.; Pellissier, Lucie P.; Hoek, Robert M.; Vos, Rogier M.; Wijnholds, Jan] Royal Netherlands Acad Arts & Sci, Dept Neuromed Genet, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Blits, Bas; Ehlert, Erich M. E.; Verhaagen, Joost] Royal Netherlands Acad Arts & Sci, Dept Neuroregenerat, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Blits, Bas] Amsterdam Mol Therapeut, Amsterdam, Netherlands; [Balaggan, Kamaljit S.; Ali, Robin R.] UCL, Div Mol Therapy, Inst Ophthalmol, London, England	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of London; University College London	Aartsen, WM (corresponding author), Royal Netherlands Acad Arts & Sci, Dept Neuromed Genet, Netherlands Inst Neurosci, Amsterdam, Netherlands.	j.wijnholds@nin.knaw.nl	Wijnholds, Jan/V-3896-2018; Pellissier, Lucie P/L-8239-2014; Ehlert, Erich M/A-4054-2012; Verhaagen, Joost/G-4773-2012	Wijnholds, Jan/0000-0003-0099-460X; Pellissier, Lucie P/0000-0001-7085-3242; Ali, Robin/0000-0003-3126-6517	ZonMw [43200004]; European Commission [HEALTH-F2-2008-200234]; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid	ZonMw(Netherlands Organization for Health Research and Development); European Commission(European CommissionEuropean Commission Joint Research Centre); Algemene Nederlandse Vereniging ter Voorkoming van Blindheid	This work was supported in part by Grants from ZonMw [http://www.zonmw.nl/en/organisation/; grant number 43200004 to J.W.], European Commission [HEALTH-F2-2008-200234 to J.W.], Rotterdamse Vereniging Blindenbelangen, Stichting Blindenpenning, Gelderse Blinden Stichting, Stichting Blindenhulp, Landelijke Stichting voor Blinden en Slechtzienden (LSBS) and Algemene Nederlandse Vereniging ter Voorkoming van Blindheid [to W.A. and J.W.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsen WM, 2006, HUM MOL GENET, V15, P1291, DOI 10.1093/hmg/ddl047; Allocca M, 2006, EXPERT OPIN BIOL TH, V6, P1279, DOI 10.1517/14712598.6.12.1279; Bainbridge J, 2008, EYE, V22, P1301, DOI 10.1038/eye.2008.23; Bainbridge JWB, 2006, GENE THER, V13, P1191, DOI 10.1038/sj.gt.3302812; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Blits B, 2010, J NEUROSCI METH, V185, P257, DOI 10.1016/j.jneumeth.2009.10.009; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Buch PK, 2008, GENE THER, V15, P849, DOI 10.1038/gt.2008.66; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Dalkara D, 2009, MOL THER, V17, P2096, DOI 10.1038/mt.2009.181; den Hollander AI, 2004, HUM MUTAT, V24, P355, DOI 10.1002/humu.20093; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Fisher SK, 2005, PROG RETIN EYE RES, V24, P395, DOI 10.1016/j.preteyeres.2004.10.004; Goldstein IM, 1996, VISION RES, V36, P2979, DOI 10.1016/0042-6989(96)00017-X; Greenberg KP, 2007, INVEST OPHTH VIS SCI, V48, P1844, DOI 10.1167/iovs.05-1570; Halfter W, 2006, INVEST OPHTH VIS SCI, V47, P3586, DOI 10.1167/iovs.05-1480; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Harvey AR, 2002, MOL CELL NEUROSCI, V21, P141, DOI 10.1006/mcne.2002.1168; HATA Y, 2005, GRAEFES ARCH CLIN EX, V245, P1019; Hellstrom M, 2009, GENE THER, V16, P521, DOI 10.1038/gt.2008.178; Hermens WTJMC, 1999, HUM GENE THER, V10, P1885, DOI 10.1089/10430349950017563; JOHNSON TV, 2008, EYE, P1980; Klein RL, 2008, MOL THER, V16, P89, DOI 10.1038/sj.mt.6300331; Klimczak RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007467; Koerber JT, 2009, MOL THER, V17, P2088, DOI 10.1038/mt.2009.184; Kuzmanovic M, 2003, INVEST OPHTH VIS SCI, V44, P3606, DOI 10.1167/iovs.02-1265; Luna G, 2009, INVEST OPHTH VIS SCI, V50, P3977, DOI 10.1167/iovs.08-2910; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mehalow AK, 2003, HUM MOL GENET, V12, P2179, DOI 10.1093/hmg/ddg232; Richard M, 2006, HUM MOL GENET, V15, pR235, DOI 10.1093/hmg/ddl195; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; van de Pavert SA, 2007, GLIA, V55, P1486, DOI 10.1002/glia.20561; van de Pavert SA, 2007, J NEUROSCI, V27, P564, DOI 10.1523/JNEUROSCI.3496-06.2007; van Rossum AGSH, 2006, HUM MOL GENET, V15, P2659, DOI 10.1093/hmg/ddl194; Verardo MR, 2008, INVEST OPHTH VIS SCI, V49, P3659, DOI 10.1167/iovs.07-1474; Wahlin KJ, 2000, INVEST OPHTH VIS SCI, V41, P927; Wang Y, 2002, CURR EYE RES, V24, P305, DOI 10.1076/ceyr.24.4.305.8408; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Wu KHC, 2003, BRIT J OPHTHALMOL, V87, P1159, DOI 10.1136/bjo.87.9.1159; Yanoff M, 1996, OCULAR PATHOLOGY; Zack DJ, 2000, NEURON, V26, P285, DOI 10.1016/S0896-6273(00)81160-5	44	32	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12387	10.1371/journal.pone.0012387	http://dx.doi.org/10.1371/journal.pone.0012387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808778	Green Published, gold, Green Submitted			2022-12-25	WOS:000281154300015
J	Woodward, OM; Li, Y; Yu, SQ; Greenwell, P; Wodarczyk, C; Boletta, A; Guggino, WB; Qian, F				Woodward, Owen M.; Li, Yun; Yu, Shengqiang; Greenwell, Patrick; Wodarczyk, Claas; Boletta, Alessandra; Guggino, William B.; Qian, Feng			Identification of a Polycystin-1 Cleavage Product, P100, That Regulates Store Operated Ca2+ Entry through Interactions with STIM1	PLOS ONE			English	Article							KIDNEY-DISEASE; CALCIUM-ENTRY; CHANNELS; CRAC; RECEPTOR; OLIGOMERIZATION; HOMEOSTASIS; EXPRESSION; APOPTOSIS; DEPLETION	Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a genetic disorder resulting in large kidney cysts and eventual kidney failure. Mutations in either the PKD1 or PKD2/TRPP2 genes and their respective protein products, polycystin-1 (PC1) and polycystin-2 (PC2) result in ADPKD. PC2 is known to function as a non-selective cation channel, but PC1's function and the function of PC1 cleavage products are not well understood. Here we identify an endogenous PC1 cleavage product, P100, a 100 kDa fragment found in both wild type and epitope tagged PKD1 knock-in mice. Expression of full length human PC1 (FL PC1) and the resulting P100 and C-Terminal Fragment (CTF) cleavage products in both MDCK and CHO cells significantly reduces the store operated Ca2+ entry (SOCE) resulting from thapsigargin induced store depletion. Exploration into the roles of P100 and CTF in SOCE inhibition reveal that P100, when expressed in Xenopus laevis oocytes, directly inhibits the SOCE currents but CTF does not, nor does P100 when containing the disease causing R4227X mutation. Interestingly, we also found that in PC1 expressing MDCK cells, translocation of the ER Ca2+ sensor protein STIM1 to the cell periphery was significantly altered. In addition, P100 Co-immunoprecipitates with STIM1 but CTF does not. The expression of P100 in CHO cells recapitulates the STIM1 translocation inhibition seen with FL PC1. These data describe a novel polycystin-1 cleavage product, P100, which functions to reduce SOCE via direct inhibition of STIM1 translocation; a function with consequences for ADPKD.	[Woodward, Owen M.; Li, Yun; Greenwell, Patrick; Guggino, William B.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Yu, Shengqiang; Qian, Feng] Johns Hopkins Sch Med, Div Nephrol, Dept Med, Baltimore, MD USA; [Wodarczyk, Claas; Boletta, Alessandra] Ist Sci San Raffaele, Div Genet & Cell Biol, Dulbecco Telethon Inst, I-20132 Milan, Italy	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Woodward, OM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	wguggino@jhmi.edu; fqjhupkd@jhmi.edu		Woodward, Owen M./0000-0001-9514-2180	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK032753-25A1, DK062199]; Fondazione Telethon Funding Source: Custom; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062199, R01DK032753, P30DK090868, R37DK032753] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Fondazione Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grants DK032753-25A1 (to W. B. G.) and DK062199 (to F. Q.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; Basavanna U, 2007, BIOCHEM BIOPH RES CO, V359, P367, DOI 10.1016/j.bbrc.2007.05.114; Bertuccio CA, 2009, J BIOL CHEM, V284, P21011, DOI 10.1074/jbc.M109.017756; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; Chiu WT, 2008, MOL BIOL CELL, V19, P2220, DOI 10.1091/mbc.E07-11-1170; Grimm DH, 2003, J BIOL CHEM, V278, P36786, DOI 10.1074/jbc.M306536200; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hartzell HC, 1996, J GEN PHYSIOL, V108, P157, DOI 10.1085/jgp.108.3.157; Hogan PG, 2007, TRENDS BIOCHEM SCI, V32, P235, DOI 10.1016/j.tibs.2007.03.009; Hooper KM, 2005, AM J PHYSIOL-RENAL, V289, pF521, DOI 10.1152/ajprenal.00355.2004; Kottgen M, 2007, BBA-MOL BASIS DIS, V1772, P836, DOI 10.1016/j.bbadis.2007.01.003; Lal M, 2008, HUM MOL GENET, V17, P3105, DOI 10.1093/hmg/ddn208; Li N, 2008, J CELL PHYSIOL, V216, P172, DOI 10.1002/jcp.21385; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Li Y, 2009, J BIOL CHEM, V284, P36431, DOI 10.1074/jbc.M109.068916; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Manzati E, 2005, EXP CELL RES, V304, P391, DOI 10.1016/j.yexcr.2004.10.023; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Simons M, 2006, KIDNEY INT, V70, P854, DOI 10.1038/sj.ki.5001534; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Somlo S, 2001, CURR BIOL, V11, pR356, DOI 10.1016/S0960-9822(01)00193-2; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Sutters M, 2003, J LAB CLIN MED, V141, P91, DOI 10.1067/mlc.2003.13; Vanden Abeele F, 2002, CANCER CELL, V1, P169; Vanoverberghe K, 2004, CELL DEATH DIFFER, V11, P321, DOI 10.1038/sj.cdd.4401375; Wegierski T, 2009, EMBO J, V28, P490, DOI 10.1038/emboj.2008.307; Wei W, 2007, J BIOL CHEM, V282, P21729, DOI 10.1074/jbc.M703218200; Wildman SS, 2003, AM J PHYSIOL-RENAL, V285, pF1168, DOI 10.1152/ajprenal.00171.2003; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Wodarczyk C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007137; Yao Y, 1997, J GEN PHYSIOL, V109, P703, DOI 10.1085/jgp.109.6.703; Yu SQ, 2007, P NATL ACAD SCI USA, V104, P18688, DOI 10.1073/pnas.0708217104	40	50	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12305	10.1371/journal.pone.0012305	http://dx.doi.org/10.1371/journal.pone.0012305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808796	Green Published, gold			2022-12-25	WOS:000281153500003
J	Gomez, G; Pallas, V				Gomez, Gustavo; Pallas, Vicente			Noncoding RNA Mediated Traffic of Foreign mRNA into Chloroplasts Reveals a Novel Signaling Mechanism in Plants	PLOS ONE			English	Article							TRANSGENIC PLANTS; EXPRESSION; EVOLUTION; TRANSPORT; PROTEINS; NUCLEUS; PATHWAY; VIROIDS; IMPORT	Communication between chloroplasts and the nucleus is one of the milestones of the evolution of plants on earth. Proteins encoded by ancestral chloroplast-endogenous genes were transferred to the nucleus during the endosymbiotic evolution and originated this communication, which is mainly dependent on specific transit-peptides. However, the identification of nuclear-encoded proteins targeted to the chloroplast lacking these canonical signals suggests the existence of an alternative cellular pathway tuning this metabolic crosstalk. Non-coding RNAS (NcRNAs) are increasingly recognized as regulators of gene expression as they play roles previously believed to correspond to proteins. Avsunviroidae family viroids are the only noncoding functional RNAs that have been reported to traffic inside the chloroplasts. Elucidating mechanisms used by these pathogens to enter this organelle will unearth novel transport pathways in plant cells. Here we show that a viroid-derived NcRNA acting as a 5'UTR-end mediates the functional import of Green Fluorescent Protein (GFP) mRNA into chloroplast. This claim is supported by the observation at confocal microscopy of a selective accumulation of GFP in the chloroplast of the leaves expressing the chimeric vd-5'UTR/GFP and by the detection of the GFP mRNA in chloroplasts isolated from cells expressing this construct. These results support the existence of an alternative signaling mechanism in plants between the host cell and chloroplasts, where an ncRNA functions as a key regulatory molecule to control the accumulation of nuclear-encoded proteins in this organelle. In addition, our findings provide a conceptual framework to develop new biotechnological tools in systems using plant chloroplast as bioreactors. Finally, viroids of the family Avsunviroidae have probably evolved to subvert this signaling mechanism to regulate their differential traffic into the chloroplast of infected cells.	[Gomez, Gustavo; Pallas, Vicente] Univ Politecn Valencia, CSIC, IBMCP, E-46071 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Gomez, G (corresponding author), Univ Politecn Valencia, CSIC, IBMCP, E-46071 Valencia, Spain.	vpallas@ibmcp.upv.es	Pallas, Vicente/N-1317-2014; Gomez, Gustavo/E-3663-2012	Pallas, Vicente/0000-0003-4954-989X; Gomez, Gustavo/0000-0003-3715-7792	Spanish granting agency DGICYT [BIO2008-03528]; CSIC	Spanish granting agency DGICYT; CSIC	This work was supported by grant BIO2008-03528 from the Spanish granting agency DGICYT (www.micinn.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr M. Fares form critical reading of this manuscript. G. Gomez is the recipient of a contract from the CSIC.	Bruce BD, 2000, TRENDS CELL BIOL, V10, P440, DOI 10.1016/S0962-8924(00)01833-X; Bungard RA, 2004, BIOESSAYS, V26, P235, DOI 10.1002/bies.10405; Daniell H, 2009, TRENDS PLANT SCI, V14, P669, DOI 10.1016/j.tplants.2009.09.009; Daros JA, 2006, EMBO REP, V7, P593, DOI 10.1038/sj.embor.7400706; Ding B, 2009, ANNU REV PHYTOPATHOL, V47, P105, DOI 10.1146/annurev-phyto-080508-081927; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Fadda Z, 2003, J VIROL, V77, P6528, DOI 10.1128/JVI.77.11.6528-6532.2003; Fan PX, 2009, ELECTROPHORESIS, V30, P3024, DOI 10.1002/elps.200900172; Floss DM, 2007, TRANSGENIC RES, V16, P315, DOI 10.1007/s11248-007-9095-x; Gomez G, 2007, PLANT J, V51, P1041, DOI 10.1111/j.1365-313X.2007.03203.x; Gomez G, 2008, PLANT PHYSIOL, V148, P414, DOI 10.1104/pp.108.120808; Gomez G, 2009, TRENDS PLANT SCI, V14, P264, DOI 10.1016/j.tplants.2009.03.002; Hannapel DJ, 2010, J INTEGR PLANT BIOL, V52, P40, DOI 10.1111/j.1744-7909.2010.00911.x; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Knoester M, 1998, P NATL ACAD SCI USA, V95, P1933, DOI 10.1073/pnas.95.4.1933; Koya V, 2005, INFECT IMMUN, V73, P8266, DOI 10.1128/IAI.73.12.8266-8274.2005; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; Lung B, 2006, NUCLEIC ACIDS RES, V34, P3842, DOI 10.1093/nar/gkl448; Nada A, 2004, J CELL SCI, V117, P3975, DOI 10.1242/jcs.01265; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Nicolai M, 2007, FEBS LETT, V581, P3921, DOI 10.1016/j.febslet.2007.07.017; Pogson BJ, 2008, TRENDS PLANT SCI, V13, P602, DOI 10.1016/j.tplants.2008.08.008; Roffey RA, 1996, PLANT PHYSIOL, V111, P1329, DOI 10.1104/pp.111.4.1329; Rymarquis LA, 2008, TRENDS PLANT SCI, V13, P329, DOI 10.1016/j.tplants.2008.02.009; Verma D, 2008, NAT PROTOC, V3, P739, DOI 10.1038/nprot.2007.522; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348	28	27	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12269	10.1371/journal.pone.0012269	http://dx.doi.org/10.1371/journal.pone.0012269			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808865	Green Published, gold			2022-12-25	WOS:000281075500008
J	Foussard, H; Ferrer, P; Valenti, P; Polesello, C; Carreno, S; Payre, F				Foussard, Helene; Ferrer, Pierre; Valenti, Philippe; Polesello, Cedric; Carreno, Sebastien; Payre, Francois			LRCH Proteins: A Novel Family of Cytoskeletal Regulators	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; SINGLE-NUCLEOTIDE POLYMORPHISM; STABLE MICROTUBULE FORMATION; F-ACTIN-BINDING; RETROVIRAL INFECTION; KNEE OSTEOARTHRITIS; CELL-DIVISION; DROSOPHILA; MOESIN; GENOME	Background: Comparative genomics has revealed an unexpected level of conservation for gene products across the evolution of animal species. However, the molecular function of only a few proteins has been investigated experimentally, and the role of many animal proteins still remains unknown. Here we report the characterization of a novel family of evolutionary conserved proteins, which display specific features of cytoskeletal scaffolding proteins, referred to as LRCHs. Principal Findings: Taking advantage of the existence of a single LRCH gene in flies, dLRCH, we explored its function in cultured cells, and show that dLRCH act to stabilize the cell cortex during cell division. dLRCH depletion leads to ectopic cortical blebs and alters positioning of the mitotic spindle. We further examined the consequences of dLRCH deletion throughout development and adult life. Although dLRCH is not essential for cell division in vivo, flies lacking dLRCH display a reduced fertility and fitness, particularly when raised at extreme temperatures. Conclusion/Significance: These results support the idea that some cytoskeletal regulators are important to buffer environmental variations and ensure the proper execution of basic cellular processes, such as the control of cell shape, under environmental variations.	[Foussard, Helene; Ferrer, Pierre; Valenti, Philippe; Polesello, Cedric; Carreno, Sebastien; Payre, Francois] Univ Toulouse UPS, Ctr Dev Biol, Toulouse, France; [Foussard, Helene; Ferrer, Pierre; Valenti, Philippe; Polesello, Cedric; Carreno, Sebastien; Payre, Francois] CNRS, UMR5547, Ctr Dev Biol, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Foussard, H (corresponding author), Univ Toulouse UPS, Ctr Dev Biol, Toulouse, France.	payre@cict.fr	Cédric, POLESELLO/ABC-3406-2021	Carreno, Sebastien/0000-0002-5839-2102; Polesello, Cedric/0000-0001-6859-2960; PAYRE, Francois/0000-0002-8144-6711	Fondation pour la Recherche Medicale; Human Frontier Science Program; Canadian Institutes for Health Research [MOP-89877]; Association pour la Recherche contre le Cancer [3832, 1111]; Fondation pour la Recherche Medicale [2005]; Agence Nationale de la Recherche	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Human Frontier Science Program(Human Frontier Science Program); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR))	S.C. was initially funded by a Fondation pour la Recherche Medicale (http://www. frm. org/) fellowship and a Human Frontier Science Program (http://www.hfsp.org/) Career Development Award. He is now a Fonds de la Recherche en Sante du Quebec (http://www.frsq.gouv.qc.ca/fr/index.shtml) Junior fellow and supported by the Canadian Institutes for Health Research (http://www. cihr. ca/) (grant no: MOP-89877). This work was supported by grants from the Association pour la Recherche contre le Cancer (http://www.arc-cancer.net/) (no 3832, no 1111), Fondation pour la Recherche Medicale (Equipe 2005) and Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/) Blanc (Netoshape). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Carreno S, 2008, J CELL BIOL, V180, P739, DOI 10.1083/jcb.200709161; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Coscoy S, 2002, P NATL ACAD SCI USA, V99, P12813, DOI 10.1073/pnas.192084599; D'Avino PP, 2005, J CELL SCI, V118, P1549, DOI 10.1242/jcs.02335; DAINES B, HIGH RESOLUTION MAP; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FRANKEL N, 2010, NATURE; GATTI M, 1991, METHOD CELL BIOL, V35, P543; Giansanti MG, 2004, MOL BIOL CELL, V15, P2509, DOI 10.1091/mbc.E03-08-0603; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Gimona M, 1998, J CELL SCI, V111, P1813; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Haedicke J, 2008, J VIROL, V82, P4665, DOI 10.1128/JVI.02403-07; Haynes KA, 2006, CURR BIOL, V16, P2222, DOI 10.1016/j.cub.2006.09.035; Hindle KL, 2009, PROTEINS, V77, P342, DOI 10.1002/prot.22440; Ikegawa S, 2007, CURR OPIN RHEUMATOL, V19, P429, DOI 10.1097/BOR.0b013e32825b079d; Jacobsen M, 2010, ANIM GENET, V41, P21, DOI 10.1111/j.1365-2052.2009.01952.x; Jefford CE, 2006, CRIT REV ONCOL HEMAT, V59, P1, DOI 10.1016/j.critrevonc.2006.02.005; Jiang Q, 2008, J HUM GENET, V53, P42, DOI 10.1007/s10038-007-0216-4; Karagiosis SA, 2004, DEVELOPMENT, V131, P725, DOI 10.1242/dev.00976; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; LASSERRE R, 2010, EMBO J; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Mateer SC, 2004, CELL MOTIL CYTOSKEL, V58, P231, DOI 10.1002/cm.20013; McClatchey AI, 2009, TRENDS CELL BIOL, V19, P198, DOI 10.1016/j.tcb.2009.02.006; Meireles M, 2009, J CELL BIOL, V184, P777, DOI 10.1083/jcb.200811102; Naghavi MH, 2007, EMBO J, V26, P41, DOI 10.1038/sj.emboj.7601475; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Polesello C, 2002, NAT CELL BIOL, V4, P782, DOI 10.1038/ncb856; Rankin KE, 2010, J CELL BIOL, V190, P35, DOI 10.1083/jcb.201004017; Raynaud-Messina B, 2001, EUR J CELL BIOL, V80, P643, DOI 10.1078/0171-9335-00195; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Sjoblom B, 2008, CURR OPIN STRUC BIOL, V18, P702, DOI 10.1016/j.sbi.2008.10.003; Somma MP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000126; Spector TD, 2006, ARTHRITIS RHEUM-US, V54, P524, DOI 10.1002/art.21624; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761	50	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12257	10.1371/journal.pone.0012257	http://dx.doi.org/10.1371/journal.pone.0012257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805893	Green Published, gold, Green Submitted			2022-12-25	WOS:000281011600024
J	Piton, J; Petrella, S; Delarue, M; Andre-Leroux, G; Jarlier, V; Aubry, A; Mayer, C				Piton, Jeremie; Petrella, Stephanie; Delarue, Marc; Andre-Leroux, Gwenaelle; Jarlier, Vincent; Aubry, Alexandra; Mayer, Claudine			Structural Insights into the Quinolone Resistance Mechanism of Mycobacterium tuberculosis DNA Gyrase	PLOS ONE			English	Article							BREAKAGE-REUNION DOMAIN; CRYSTAL-STRUCTURE; TOPOISOMERASE-IV; FUNCTIONAL-ANALYSIS; II TOPOISOMERASE; CRYSTALLIZATION; MUTATIONS; SEQUENCE; SUBUNITS; STRAINS	Mycobacterium tuberculosis DNA gyrase, an indispensable nanomachine involved in the regulation of DNA topology, is the only type II topoisomerase present in this organism and is hence the sole target for quinolone action, a crucial drug active against multidrug-resistant tuberculosis. To understand at an atomic level the quinolone resistance mechanism, which emerges in extensively drug resistant tuberculosis, we performed combined functional, biophysical and structural studies of the two individual domains constituting the catalytic DNA gyrase reaction core, namely the Toprim and the breakage-reunion domains. This allowed us to produce a model of the catalytic reaction core in complex with DNA and a quinolone molecule, identifying original mechanistic properties of quinolone binding and clarifying the relationships between amino acid mutations and resistance phenotype of M. tuberculosis DNA gyrase. These results are compatible with our previous studies on quinolone resistance. Interestingly, the structure of the entire breakage-reunion domain revealed a new interaction, in which the Quinolone-Binding Pocket (QBP) is blocked by the N-terminal helix of a symmetry-related molecule. This interaction provides useful starting points for designing peptide based inhibitors that target DNA gyrase to prevent its binding to DNA.	[Piton, Jeremie; Delarue, Marc; Mayer, Claudine] Inst Pasteur, Dept Biol Struct & Chim, Unite Dynam Struct Macromol, Paris, France; [Piton, Jeremie; Delarue, Marc; Andre-Leroux, Gwenaelle; Mayer, Claudine] CNRS, URA 2185, Paris, France; [Petrella, Stephanie; Jarlier, Vincent; Aubry, Alexandra] Univ Paris 06, EA1541, Paris, France; [Andre-Leroux, Gwenaelle] Inst Pasteur, Dept Biol Struct & Chim, Unite Biochim Struct, Paris, France; [Mayer, Claudine] Univ Paris Diderot Paris 7, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Piton, J (corresponding author), Inst Pasteur, Dept Biol Struct & Chim, Unite Dynam Struct Macromol, Paris, France.	mayer@pasteur.fr	Aubry, Alexandra/F-8783-2014	Aubry, Alexandra/0000-0003-4230-4793; Petrella, Stephanie/0000-0001-6641-5901; Piton, jeremie/0000-0003-4420-5027	Ministere de l'enseignement superieur et de la recherche	Ministere de l'enseignement superieur et de la recherche	J.P. is funded by the "Ministere de l'enseignement superieur et de la recherche.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DD, 2009, ANTIMICROB AGENTS CH, V53, P4835, DOI 10.1128/AAC.00541-09; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; Aubry A, 2004, ANTIMICROB AGENTS CH, V48, P1281, DOI 10.1128/AAC.48.4.1281-1288.2004; Aubry A, 2006, ANTIMICROB AGENTS CH, V50, P104, DOI 10.1128/AAC.50.1.104-112.2006; Aubry A, 2006, BIOCHEM BIOPH RES CO, V348, P158, DOI 10.1016/j.bbrc.2006.07.017; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Buhler C, 1998, NUCLEIC ACIDS RES, V26, P5157, DOI 10.1093/nar/26.22.5157; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Carr SB, 2006, ACTA CRYSTALLOGR F, V62, P1164, DOI 10.1107/S1744309106044150; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Conde MB, 2009, LANCET, V373, P1183, DOI 10.1016/S0140-6736(09)60333-0; Costenaro L, 2005, STRUCTURE, V13, P287, DOI 10.1016/j.str.2004.12.011; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Edwards MJ, 2009, SCIENCE, V326, P1415, DOI 10.1126/science.1179123; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fass D, 1999, NAT STRUCT BIOL, V6, P322; Fu GS, 2009, NUCLEIC ACIDS RES, V37, P5908, DOI 10.1093/nar/gkp586; Fu G, 2009, ACTA CRYSTALLOGR F, V65, P350, DOI 10.1107/S1744309109006575; Gadelle D, 2003, BIOESSAYS, V25, P232, DOI 10.1002/bies.10245; Gubaev A, 2009, P NATL ACAD SCI USA, V106, P13278, DOI 10.1073/pnas.0902493106; Guillemin I, 1998, ANTIMICROB AGENTS CH, V42, P2084, DOI 10.1128/AAC.42.8.2084; Heddle J, 2002, ANTIMICROB AGENTS CH, V46, P1805, DOI 10.1128/AAC.46.6.1805-1815.2002; HOOPER CD, 2003, QUINOLONE ANTIMICROB; Hooper DC, 1999, DRUG RESIST UPDATE, V2, P38, DOI 10.1054/drup.1998.0068; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laponogov I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000301; Laponogov I, 2009, NAT STRUCT MOL BIOL, V16, P667, DOI 10.1038/nsmb.1604; Levine C, 1998, BBA-GENE STRUCT EXPR, V1400, P29, DOI 10.1016/S0167-4781(98)00126-2; Matrat S, 2008, ANTIMICROB AGENTS CH, V52, P2909, DOI 10.1128/AAC.01380-07; Matrat S, 2006, ANTIMICROB AGENTS CH, V50, P4170, DOI 10.1128/AAC.00944-06; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mdluli Khisimuzi, 2007, Infectious Disorders - Drug Targets, V7, P159; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piton J, 2009, ACTA CRYSTALLOGR F, V65, P1182, DOI 10.1107/S1744309109042067; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Schoeffler AJ, 2005, BIOCHEM SOC T, V33, P1465, DOI 10.1042/BST0331465; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Smith CK, 1996, J MOL BIOL, V263, P237, DOI 10.1006/jmbi.1996.0572; Sun ZG, 2008, INT J ANTIMICROB AG, V31, P115, DOI 10.1016/j.ijantimicag.2007.10.014; TAKIFF HE, 1994, ANTIMICROB AGENTS CH, V38, P773, DOI 10.1128/AAC.38.4.773; Tretter EM, 2010, PROTEINS, V78, P492, DOI 10.1002/prot.22600; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagner J, 2008, CURR OPIN CHEM BIOL, V12, P292, DOI 10.1016/j.cbpa.2008.03.009; van Doorn HR, 2008, INT J TUBERC LUNG D, V12, P736; Veziris N, 2007, EUR J CLIN MICROBIOL, V26, P423, DOI 10.1007/s10096-007-0298-0; Von Groll A, 2009, ANTIMICROB AGENTS CH, V53, P4498, DOI 10.1128/AAC.00287-09; World Health Organization, 2009, WHOHTMTB2009	56	95	101	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12245	10.1371/journal.pone.0012245	http://dx.doi.org/10.1371/journal.pone.0012245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805881	Green Published, gold			2022-12-25	WOS:000281011600017
J	Smits, SA; Ouverney, CC				Smits, Samuel A.; Ouverney, Cleber C.			jsPhyloSVG: A Javascript Library for Visualizing Interactive and Vector-Based Phylogenetic Trees on the Web	PLOS ONE			English	Article							DISPLAY	Background: Many software packages have been developed to address the need for generating phylogenetic trees intended for print. With an increased use of the web to disseminate scientific literature, there is a need for phylogenetic trees to be viewable across many types of devices and feature some of the interactive elements that are integral to the browsing experience. We propose a novel approach for publishing interactive phylogenetic trees. Methods/Principal Findings: We present a javascript library, jsPhyloSVG, which facilitates constructing interactive phylogenetic trees from raw Newick or phyloXML formats directly within the browser in Scalable Vector Graphics (SVG) format. It is designed to work across all major browsers and renders an alternative format for those browsers that do not support SVG. The library provides tools for building rectangular and circular phylograms with integrated charting. Interactive features may be integrated and made to respond to events such as clicks on any element of the tree, including labels. Conclusions/Significance: jsPhyloSVG is an open-source solution for rendering dynamic phylogenetic trees. It is capable of generating complex and interactive phylogenetic trees across all major browsers without the need for plugins. It is novel in supporting the ability to interpret the tree inference formats directly, exposing the underlying markup to data-mining services. The library source code, extensive documentation and live examples are freely accessible at www.jsphylosvg.com.	[Smits, Samuel A.; Ouverney, Cleber C.] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA	California State University System; San Jose State University	Smits, SA (corresponding author), San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA.	samsmits@gmail.com; cleber.ouverney@sjsu.edu		Ouverney, Cleber/0000-0002-4135-7562	National Institutes of Health (NIH) [1SC3GM0822]; NIH MARC [5T34 GM008253]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008253, SC3GM082291] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH MARC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been funded in part by National Institutes of Health (NIH) Grant # 1SC3GM0822 and NIH MARC Grant # 5T34 GM008253. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	FELSENSTEIN J, 1989, CLADISTICS, V5, P166; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; *JAVASCRIPT LIB, 2010, IQUERY WRIT LESS DO; Jordan GE, 2008, BIOINFORMATICS, V24, P1641, DOI 10.1093/bioinformatics/btn235; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Page RD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0602S01; Palidwor G, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-79; Pethica R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008934; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; *YAH US INT LIB, YUI 3; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383	11	65	65	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12267	10.1371/journal.pone.0012267	http://dx.doi.org/10.1371/journal.pone.0012267			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805892	Green Published, Green Submitted, gold			2022-12-25	WOS:000281011600028
J	Ding, SL; Chi, MM; Scull, BP; Rigby, R; Schwerbrock, NMJ; Magness, S; Jobin, C; Lund, PK				Ding, Shengli; Chi, Michael M.; Scull, Brooks P.; Rigby, Rachael; Schwerbrock, Nicole M. J.; Magness, Scott; Jobin, Christian; Lund, Pauline K.			High-Fat Diet: Bacteria Interactions Promote Intestinal Inflammation Which Precedes and Correlates with Obesity and Insulin Resistance in Mouse	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE; TNF-ALPHA; HEPATIC STEATOSIS; GUT MICROBIOTA; KAPPA-B; MECHANISMS; MICE; JNK	Background: Obesity induced by high fat (HF) diet is associated with inflammation which contributes to development of insulin resistance. Most prior studies have focused on adipose tissue as the source of obesity-associated inflammation. Increasing evidence links intestinal bacteria to development of diet-induced obesity (DIO). This study tested the hypothesis that HF western diet and gut bacteria interact to promote intestinal inflammation, which contributes to the progression of obesity and insulin resistance. Methodology/Principal Findings: Conventionally raised specific-pathogen free (CONV) and germ-free (GF) mice were given HF or low fat (LF) diet for 2-16 weeks. Body weight and adiposity were measured. Intestinal inflammation was assessed by evaluation of TNF-alpha mRNA and activation of a NF-kappa B-EGFP reporter gene. In CONV but not GF mice, HF diet induced increases in body weight and adiposity. HF diet induced ileal TNF-alpha mRNA in CONV but not GF mice and this increase preceded obesity and strongly and significantly correlated with diet induced weight gain, adiposity, plasma insulin and glucose. In CONV mice HF diet also resulted in activation of NF-kappa B-EGFP in epithelial cells, immune cells and endothelial cells of small intestine. Further experiments demonstrated that fecal slurries from CONV mice fed HF diet are sufficient to activate NF-kappa B-EGFP in GF NF-kappa B-EGFP mice. Conclusions/Significance: Bacteria and HF diet interact to promote proinflammatory changes in the small intestine, which precede weight gain and obesity and show strong and significant associations with progression of obesity and development of insulin resistance. To our knowledge, this is the first evidence that intestinal inflammation is an early consequence of HF diet which may contribute to obesity and associated insulin resistance. Interventions which limit intestinal inflammation induced by HF diet and bacteria may protect against obesity and insulin resistance.	[Ding, Shengli; Chi, Michael M.; Schwerbrock, Nicole M. J.; Jobin, Christian; Lund, Pauline K.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA; [Ding, Shengli; Chi, Michael M.; Schwerbrock, Nicole M. J.; Jobin, Christian; Lund, Pauline K.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Scull, Brooks P.] Vanderbilt Univ, Dept Gastroenterol, Med Ctr, Nashville, TN USA; [Rigby, Rachael] Univ Lancaster, Sch Hlth & Med, Div Biomed & Life Sci, Lancaster, England; [Magness, Scott] Univ N Carolina, Div Gastroenterol & Hepatol, Dept Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University; Lancaster University; University of North Carolina; University of North Carolina Chapel Hill	Ding, SL (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA.	shengli_ding@med.unc.edu	Eckhardt, Erik/G-1567-2010; Rigby, Rachael/C-8206-2011; Stefanadis, Christodoulos/ABH-2232-2020	Rigby, Rachael/0000-0002-6605-9609; Magness, Scott/0000-0002-2746-1224; Stefanadis, Christodoulos/0000-0001-5974-6454	National Institute of Environmental Health Sciences [P30ES10126];  [T32 MH075854-05]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH075854] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a postdoctoral fellowship award to M. Chi (T32 MH075854-05) and a pilot grant from the National Institute of Environmental Health Sciences (P30ES10126). IDOC: http://www.cpc.unc.edu/idoc. NIEHS: http://cehs.sph.unc.edu/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BGREENBERG AS, 2006, J CLIN NUTR S, V86, pS461; Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Cani PD, 2008, PATHOL BIOL, V56, P305, DOI 10.1016/j.patbio.2007.09.008; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Dandona P, 1998, J CLIN ENDOCR METAB, V83, P2907, DOI 10.1210/jc.83.8.2907; De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Lee DE, 2009, AM J PHYSIOL-ENDOC M, V296, pE1210, DOI 10.1152/ajpendo.00015.2009; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Magness ST, 2004, J IMMUNOL, V173, P1561, DOI 10.4049/jimmunol.173.3.1561; Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1; Pamir N, 2009, ENDOCRINOLOGY, V150, P4124, DOI 10.1210/en.2009-0137; Panagiotakos DB, 2005, ATHEROSCLEROSIS, V183, P308, DOI 10.1016/j.atherosclerosis.2005.03.010; Romanatto T, 2009, J BIOL CHEM, V284, P36213, DOI 10.1074/jbc.M109.030874; Serino M, 2007, DIABETES, V56, P2541, DOI 10.2337/db07-0360; Syrenicz A, 2006, NEUROENDOCRINOL LETT, V27, P453; Trayhurn P, 2006, J NUTR, V136, p1935S, DOI 10.1093/jn/136.7.1935S; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Visser M, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.1.e13; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	33	423	445	4	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12191	10.1371/journal.pone.0012191	http://dx.doi.org/10.1371/journal.pone.0012191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808947	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000280968000017
J	Ueshima, K; Fujiwara, T; Takao, S; Suzuki, E; Iwase, T; Doi, H; Subramanian, SV; Kawachi, I				Ueshima, Kazumune; Fujiwara, Takeo; Takao, Soshi; Suzuki, Etsuji; Iwase, Toshihide; Doi, Hiroyuki; Subramanian, S. V.; Kawachi, Ichiro			Does Social Capital Promote Physical Activity? A Population-Based Study in Japan	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; OF-SPORTS-MEDICINE; PUBLIC-HEALTH; MULTILEVEL ANALYSIS; POLITICAL-ECONOMY; UNITED-STATES; OLDER-ADULTS; LIFE-STYLE; PARTICIPATION; LEVEL	Background: To examine the association between individual-level social capital and physical activity. Methodology/Principal Findings: In February 2009, data were collected in a population-based cross-sectional survey in Okayama city, Japan. A cluster-sampling approach was used to randomly select 4,000 residents from 20 school districts. A total of 2260 questionnaires were returned (response rate: 57.4%). Individual-level social capital was assessed by an item inquiring about perceived trust of others in the community (cognitive dimension of social capital) categorized as low trust (43.0%), mid trust (38.6%), and high trust (17.3%), as well as participation in voluntary groups (structural dimension of social capital), which further distinguished between bonding (8.9%) and bridging (27.1%) social capital. Using logistic regression, we calculated the odds ratios (ORs) and 95% confidence intervals (CIs) for physical inactivity associated with each domain of social capital. Multiple imputation method was employed for missing data. Among total participants, 68.8% were physically active and 28.9% were inactive. Higher trust was associated with a significantly lower odds of physical inactivity (OR = 0.58, 95% CI = 0.42-0.79) compared with low trust. Both bridging and bonding social capital were marginally significantly associated with lower odds of physical inactivity (bridging, OR = 0.79, 95% CI = 0.62-1.00; bonding, OR = 0.71, 95% CI = 0.48-1.03) compared with lack of structural social capital. Conclusions/Significance: Low individual-level social capital, especially lower trust of others in the community, was associated with physical inactivity among Japanese adults.	[Ueshima, Kazumune; Takao, Soshi; Suzuki, Etsuji; Iwase, Toshihide; Doi, Hiroyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Epidemiol, Okayama, Japan; [Fujiwara, Takeo] Natl Inst Publ Hlth, Dept Hlth Promot, Sect Behav Sci, Saitama, Japan; [Subramanian, S. V.; Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Okayama University; National Institute of Public Health - Japan; Harvard University; Harvard T.H. Chan School of Public Health	Ueshima, K (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Epidemiol, Okayama, Japan.	gmd19067@s.okayama-u.ac.jp	Suzuki, Etsuji/B-2342-2011	Suzuki, Etsuji/0000-0002-1290-5793	National Institutes of Health [NHLBI K25 HL081275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	No direct financial support or funding was available for conducting this study. S V Subramanian is partially supported by a National Institutes of Health Career Development Award (NHLBI K25 HL081275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SM, 2006, SCAND J PUBLIC HEALT, V34, P209, DOI 10.1080/14034940500307515; Dietz WH, 1996, P NUTR SOC, V55, P829, DOI 10.1079/PNS19960082; Duncan GE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002019; Fisher KJ, 2004, J AGING PHYS ACTIV, V12, P45, DOI 10.1123/japa.12.1.45; Fletcher GF, 1996, CIRCULATION, V94, P857, DOI 10.1161/01.CIR.94.4.857; Fujiwara T, 2008, J EPIDEMIOL COMMUN H, V62, P627, DOI 10.1136/jech.2007.064261; Fujiwara T, 2008, AM J PREV MED, V35, P139, DOI 10.1016/j.amepre.2008.04.015; Greiner KA, 2004, SOC SCI MED, V59, P2303, DOI 10.1016/j.socscimed.2004.03.023; HARPHAM T, 2006, SOCIAL CAPITAL MENTA, P11; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Humpel N, 2002, AM J PREV MED, V22, P188, DOI 10.1016/S0749-3797(01)00426-3; Inoue S, 2009, PREV MED, V48, P321, DOI 10.1016/j.ypmed.2009.01.014; Kawachi I, 2004, INT J EPIDEMIOL, V33, P682, DOI 10.1093/ije/dyh177; Kim D, 2006, SOC SCI MED, V63, P1045, DOI 10.1016/j.socscimed.2006.02.017; Lee HS, 2008, J GAMBL STUD, V24, P25, DOI 10.1007/s10899-007-9078-0; Leyden KM, 2003, AM J PUBLIC HEALTH, V93, P1546, DOI 10.2105/AJPH.93.9.1546; Lindstrom M, 2001, SOC SCI MED, V52, P441, DOI 10.1016/S0277-9536(00)00153-2; Lindstrom M, 2003, J EPIDEMIOL COMMUN H, V57, P23, DOI 10.1136/jech.57.1.23; LINDSTROM M, 2007, SOCIAL CAPITAL HLTH, P215; Mensink GBM, 1997, EUR J EPIDEMIOL, V13, P771, DOI 10.1023/A:1007474220830; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Yusuf HR, 1996, ARCH INTERN MED, V156, P1321, DOI 10.1001/archinte.156.12.1321	26	71	74	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2010	5	8							e12135	10.1371/journal.pone.0012135	http://dx.doi.org/10.1371/journal.pone.0012135			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	637ZU	20808822	Green Published, gold, Green Submitted			2022-12-25	WOS:000280859700022
J	Zhao, W; Jaganathan, S; Turkson, J				Zhao, Wei; Jaganathan, Soumya; Turkson, James			A Cell-permeable Stat3 SH2 Domain Mimetic Inhibits Stat3 Activation and Induces Antitumor Cell Effects in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER DRUG DISCOVERY; DNA-BINDING ACTIVITY; SMALL-MOLECULE; SIGNAL TRANSDUCER; TRANSCRIPTIONAL ACTIVITY; PHOSPHOTYROSYL MIMETICS; SRC ONCOPROTEIN; GENE-REGULATION; TARGETS; PROTEIN	Given the role of constitutively active Signal Transducer and Activator of Transcription (Stat) 3 in human tumors, Stat3 inhibitors would be useful as novel therapeutics and as tools for probing Stat3-mediated tumor processes. We here in report that a 28-mer peptide, SPI, derived from the Stat3 SH2 domain, replicates Stat3 biochemical properties. Studies show SPI and Stat3 (or Stat3 SH2 domain) bind with similar affinities to known Stat3-binding phosphotyrosine (pY) peptide motifs, including those of the epidermal growth factor receptor (EGFR) and the high-affinity, IL-6R/gp130-derived pY-peptide, GpYLPQTV-NH2. Consequently, SPI functions as a potent and selective inhibitor of Stat3 SH2 domain: pTyr interactions and disrupts the binding of Stat3 to the IL-6R/gp130 peptide, GpYLPQTV-NH2. Fluorescence imaging and immunofluorescence staining/laser-scanning confocal microscopy show SPI is cell membrane-permeable, associates with the cytoplasmic tail of EGFR in NIH3T3/hEGFR, and is present in the cytoplasm, but strongly localized at the plasma membrane and in the nucleus in malignant cells harboring persistently active Stat3. Moreover, SPI specifically blocks constitutive Stat3 phosphorylation, DNA binding activity, and transcriptional function in malignant cells, with little or no effect on the induction of Stat1, Stat5, and Erk1/2(MAPK) pathways, or on general pTyr profile at the concentrations that inhibit Stat3 activity. Significantly, treatment with SPI of human breast, pancreatic, prostate, and non-small cell lung cancer cells harboring constitutively active Stat3 induced extensive morphology changes, associated with viability loss and apoptosis. Our study identifies SPI as a novel molecular probe for interrogating Stat3 signaling and that functions as a selective inhibitor of Stat3 activation with antitumor cell effects.	[Zhao, Wei; Jaganathan, Soumya; Turkson, James] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA	State University System of Florida; University of Central Florida	Turkson, J (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, 6900 Lake Nona Blvd, Orlando, FL 32827 USA.	jturkson@mail.ucf.edu		Zhao, Wei/0000-0003-1516-9493	NCI, National Institutes of Health [CA106439, CA128865]; NATIONAL CANCER INSTITUTE [R01CA128865, R01CA106439] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grants CA106439 and CA128865 (to J. T.).	Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bhasin D, 2008, BIOORG MED CHEM LETT, V18, P391, DOI 10.1016/j.bmcl.2007.10.031; Bromberg J, 2000, BREAST CANCER RES, V2, P86, DOI 10.1186/bcr38; Burke TR, 1999, BIOORG MED CHEM LETT, V9, P347, DOI 10.1016/S0960-894X(98)00740-9; BURKE TR, 1994, BIOCHEMISTRY-US, V33, P6490, DOI 10.1021/bi00187a015; Chen JY, 2010, ACS MED CHEM LETT, V1, P85, DOI 10.1021/ml100010j; Coleman DR, 2005, J MED CHEM, V48, P6661, DOI 10.1021/jm050513m; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Dharmawardana PG, 2006, ANTI-CANCER DRUG, V17, P13, DOI 10.1097/01.cad.0000185180.72604.ac; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; FARR AG, 1989, CELL IMMUNOL, V119, P427, DOI 10.1016/0008-8749(89)90256-6; Fletcher S, 2008, CHEMMEDCHEM, V3, P1159, DOI 10.1002/cmdc.200800123; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; GOUILLEUX F, 1995, ENDOCRINOLOGY, V136, P5700, DOI 10.1210/en.136.12.5700; Gunning PT, 2008, CHEMBIOCHEM, V9, P2800, DOI 10.1002/cbic.200800291; Jaganathan S, 2010, J PHARMACOL EXP THER, V333, P373, DOI 10.1124/jpet.109.162669; JOHNSON PJ, 1985, MOL CELL BIOL, V5, P1073, DOI 10.1128/MCB.5.5.1073; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ren ZY, 2003, BIOORG MED CHEM LETT, V13, P633, DOI 10.1016/S0960-894X(02)01050-8; Sawyer TK, 1998, BIOPOLYMERS, V47, P243, DOI 10.1002/(SICI)1097-0282(1998)47:3<243::AID-BIP4>3.0.CO;2-P; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Siddiquee KAZ, 2007, ACS CHEM BIOL, V2, P787, DOI 10.1021/cb7001973; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Turkson J, 2004, MOL CANCER THER, V3, P261; Turkson J, 1999, MOL CELL BIOL, V19, P7519; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Turkson J, 2004, EXPERT OPIN THER TAR, V8, P409, DOI 10.1517/14728222.8.5.409; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; Yaffe MB, 2002, NAT REV MOL CELL BIO, V3, P177, DOI 10.1038/nrm759; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; Zhang XL, 2010, BIOCHEM PHARMACOL, V79, P1398, DOI 10.1016/j.bcp.2010.01.001; Zhang Y, 2000, J BIOL CHEM, V275, P24935, DOI 10.1074/jbc.M002383200	41	50	64	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35855	35865		10.1074/jbc.M110.154088	http://dx.doi.org/10.1074/jbc.M110.154088			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20807764	Green Published, hybrid			2022-12-25	WOS:000283845300063
J	Salomonsson, E; Carlsson, MC; Osla, V; Hendus-Altenburger, R; Kahl-Knutson, B; Oberg, CT; Sundin, A; Nilsson, R; Nordberg-Karlsson, E; Nilsson, UJ; Karlsson, A; Rini, JM; Leffler, H				Salomonsson, Emma; Carlsson, Michael C.; Osla, Veronica; Hendus-Altenburger, Ruth; Kahl-Knutson, Barbro; Oberg, Christopher T.; Sundin, Anders; Nilsson, Rickard; Nordberg-Karlsson, Eva; Nilsson, Ulf J.; Karlsson, Anna; Rini, James M.; Leffler, Hakon			Mutational Tuning of Galectin-3 Specificity and Biological Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING PROTEIN-35; CELL-SURFACE; SUGAR CHAINS; BLOOD-GROUP; N-GLYCANS; RECOMBINANT POLYPEPTIDE; HUMAN-GRANULOCYTES; HUMAN NEUTROPHILS; EPITHELIAL-CELLS; STRUCTURAL BASIS	Galectins are defined by a conserved beta-galactoside binding site that has been linked to many of their important functions in e. g. cell adhesion, signaling, and intracellular trafficking. Weak adjacent sites may enhance or decrease affinity for natural beta-galactoside-containing glycoconjugates, but little is known about the biological role of this modulation of affinity (fine specificity). We have now produced 10 mutants of human galectin-3, with changes in these adjacent sites that have altered carbohydrate-binding fine specificity but that retain the basic beta-galactoside binding activity as shown by glycan-array binding and a solution-based fluorescence anisotropy assay. Each mutant was also tested in two biological assays to provide a correlation between fine specificity and function. Galectin-3 R186S, which has selectively lost affinity for LacNAc, a disaccharide moiety commonly found on glycoprotein glycans, has lost the ability to activate neutrophil leukocytes and intracellular targeting into vesicles. K176L has increased affinity for beta-galactosides substituted with GlcNAc beta 1-3, as found in poly-N-acetyllactosaminoglycans, and increased potency to activate neutrophil leukocytes even though it has lost other aspects of galectin-3 fine specificity. G182A has altered carbohydrate-binding fine specificity and altered intracellular targeting into vesicles, a possible link to the intracellular galectin-3-mediated anti-apoptotic effect known to be lost by this mutant. Finally, the mutants have helped to define the differences in fine specificity shown by Xenopus, mouse, and human galectin-3 and, as such, the evidence for adaptive change during evolution.	[Nilsson, Rickard] Lund Univ, Dept Lab Med, Sect MIG Microbiol Immunol Glycobiol, S-22362 Lund, Sweden; [Osla, Veronica; Karlsson, Anna] Gothenburg Univ, Dept Rheumatol & Inflammat Res, Phagocyte Res Lab, S-41346 Gothenburg, Sweden; [Nordberg-Karlsson, Eva] Lund Univ, S-22200 Lund, Sweden; [Oberg, Christopher T.; Sundin, Anders; Nilsson, Ulf J.] Lund Univ, SE-22100 Lund, Sweden; [Rini, James M.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Rini, James M.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	Lund University; University of Gothenburg; Lund University; Lund University; University of Toronto; University of Toronto	Leffler, H (corresponding author), Lund Univ, ILM, MIG, Solvegatan 23, SE-22362 Lund, Sweden.	Hakon.Leffler@med.lu.se	Nordberg Karlsson, Eva/D-1426-2015; Hendus-Altenburger, Ruth/M-4943-2016; Leffler, Hakon/A-2416-2019; Hendus-Altenburger, Ruth/AAT-1249-2021; Karlsson, Anna/A-4130-2012; Nilsson, Ulf J./L-3219-2014	Nordberg Karlsson, Eva/0000-0002-8597-7050; Hendus-Altenburger, Ruth/0000-0001-5183-1507; Hendus-Altenburger, Ruth/0000-0001-5183-1507; Nilsson, Ulf J./0000-0001-5815-9522; Leffler, Hakon/0000-0003-4482-8945; Oberg, Christopher T./0000-0002-8804-829X; Sundin, Anders/0000-0001-6615-2419; Karlsson, Anna/0000-0001-6796-1154	NIGMS, National Institutes of Health [GM62116]; Lund University Research School in Pharmaceutical Sciences; Swedish Research Council; Swedish Strategic Research Foundation; Royal Physiographic Society in Lund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Lund University Research School in Pharmaceutical Sciences; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); Royal Physiographic Society in Lund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The glycan-array analysis was performed by the Consortium for Functional Glycomics (CoreH, Emory School of Medicine, Atlanta, GA) funded by NIGMS, National Institutes of Health Grant GM62116.; This work was funded by the Lund University Research School in Pharmaceutical Sciences, the Swedish Research Council, the programs "Glycoconjugates in Biological Systems" and "Chemistry for the Life Sciences" sponsored by the Swedish Strategic Research Foundation, and the Royal Physiographic Society in Lund.	AGRWAL N, 1993, J BIOL CHEM, V268, P14932; Akahani S, 1997, CANCER RES, V57, P5272; Almkvist J, 2001, INFECT IMMUN, V69, P832, DOI 10.1128/IAI.69.2.832-837.2001; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; ASADA M, 1991, BIOCHEMISTRY-US, V30, P1561, DOI 10.1021/bi00220a017; Ban M, 2005, J MOL BIOL, V351, P695, DOI 10.1016/j.jmb.2005.06.045; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Cabrera PV, 2006, BLOOD, V108, P2399, DOI 10.1182/blood-2006-04-018556; Carlsson S, 2007, GLYCOBIOLOGY, V17, P906, DOI 10.1093/glycob/cwm059; Carlsson S, 2007, GLYCOBIOLOGY, V17, P663, DOI 10.1093/glycob/cwm026; Cederfur C, 2008, GLYCOBIOLOGY, V18, P384, DOI 10.1093/glycob/cwn015; Cumpstey I, 2008, CHEM-EUR J, V14, P4233, DOI 10.1002/chem.200701932; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Delacour D, 2008, J CELL SCI, V121, P458, DOI 10.1242/jcs.020800; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Diehl C, 2009, J BIOMOL NMR, V45, P157, DOI 10.1007/s10858-009-9356-5; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Feuk-Lagerstedt E, 1999, J IMMUNOL, V163, P5592; FINNE J, 1989, J BIOL CHEM, V264, P5720; Forsman H, 2008, GLYCOBIOLOGY, V18, P905, DOI 10.1093/glycob/cwn081; FUKUDA M, 1986, J BIOL CHEM, V261, P2796; FUKUDA M, 1984, J BIOL CHEM, V259, P925; FUKUDA MN, 1985, J BIOL CHEM, V260, P1067; Furukawa K, 1998, EUR J BIOCHEM, V251, P288, DOI 10.1046/j.1432-1327.1998.2510288.x; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Henrick K, 1998, GLYCOBIOLOGY, V8, P45, DOI 10.1093/glycob/8.1.45; HIRABAYASHI J, 1991, J BIOL CHEM, V266, P23648; Houzelstein D, 2004, MOL BIOL EVOL, V21, P1177, DOI 10.1093/molbev/msh082; Hsu DK, 2009, IMMUNOL REV, V230, P114, DOI 10.1111/j.1600-065X.2009.00798.x; John CM, 2002, CELL MICROBIOL, V4, P649, DOI 10.1046/j.1462-5822.2002.00219.x; Karlsson A, 1998, BLOOD, V91, P3430, DOI 10.1182/blood.V91.9.3430.3430_3430_3438; Karlsson A, 2001, GLYCOCONJUGATE J, V18, P231, DOI 10.1023/A:1013183124004; Karlsson A, 2009, GLYCOBIOLOGY, V19, P16, DOI 10.1093/glycob/cwn104; KNIBBS RN, 1993, J BIOL CHEM, V268, P14940; Koch A, 2010, MOL BIOL CELL, V21, P219, DOI 10.1091/mbc.E09-03-0193; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; LEFFLER H, 1986, J BIOL CHEM, V261, P119; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Lin CL, 2009, MOL CANCER RES, V7, P1655, DOI 10.1158/1541-7786.MCR-09-0274; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; MASSA SM, 1993, BIOCHEMISTRY-US, V32, P260, DOI 10.1021/bi00052a033; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Rudd PM, 1999, BIOCHEMISTRY-US, V38, P13937, DOI 10.1021/bi991162e; Ruebel KH, 2005, CANCER RES, V65, P1136, DOI 10.1158/0008-5472.CAN-04-3578; SATO S, 1992, J BIOL CHEM, V267, P6983; SATO T, 1993, BIOCHEMISTRY-US, V32, P12694, DOI 10.1021/bi00210a019; Schneider D, 2010, EUR J CELL BIOL, V89, P788, DOI 10.1016/j.ejcb.2010.07.001; Seelenmeyer C, 2005, J CELL BIOL, V171, P373, DOI 10.1083/jcb.200506026; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Shalom-Feuerstein R, 2005, CANCER RES, V65, P7292, DOI 10.1158/0008-5472.CAN-05-0775; Shoji H, 2003, J BIOL CHEM, V278, P12285, DOI 10.1074/jbc.M209008200; SO RMEP, 2005, J Am Chem Soc */* U, V127, P1737; SO RMEP, 2004, ANAL BIOCH */* H ANA, V334, P36; SPARROW CP, 1987, J BIOL CHEM, V262, P7383; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Theilgaard-Monch K, 2005, J LEUKOCYTE BIOL, V78, P462, DOI 10.1189/jlb.0105042; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; van den Berg TK, 2004, J IMMUNOL, V173, P1902, DOI 10.4049/jimmunol.173.3.1902; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Walser PJ, 2004, STRUCTURE, V12, P689, DOI 10.1016/j.str.2004.03.002; Yang N, 2009, J MOL BIOL, V387, P694, DOI 10.1016/j.jmb.2009.02.002; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200	70	84	84	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35079	35091		10.1074/jbc.M109.098160	http://dx.doi.org/10.1074/jbc.M109.098160			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20807768	hybrid, Green Published			2022-12-25	WOS:000283659100082
J	Shingu-Vazquez, M; Camacho-Villasana, Y; Sandoval-Romero, L; Butler, CA; Fox, TD; Perez-Martinez, X				Shingu-Vazquez, Miguel; Camacho-Villasana, Yolanda; Sandoval-Romero, Luisa; Butler, Christine A.; Fox, Thomas D.; Perez-Martinez, Xochitl			The Carboxyl-terminal End of Cox1 Is Required for Feedback Assembly Regulation of Cox1 Synthesis in Saccharomyces cerevisiae Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; MESSENGER-RNA; INNER MEMBRANE; SUBUNIT-III; HUMAN-CELLS; IN-VIVO; YEAST; GENE; TRANSLATION; CHLOROPLAST	Synthesis of the largest cytochrome c oxidase (CcO) subunit, Cox1, on yeast mitochondrial ribosomes is coupled to assembly of CcO. The translational activator Mss51 is sequestered in early assembly intermediate complexes by an interaction with Cox14 that depends on the presence of newly synthesized Cox1. If CcO assembly is prevented, the level of Mss51 available for translational activation is reduced. We deleted the C-terminal 11 or 15 residues of Cox1 by site-directed mutagenesis of mtDNA. Although these deletions did not prevent respiratory growth of yeast, they eliminated the assembly-feedback control of Cox1 synthesis. Furthermore, these deletions reduced the strength of the Mss51-Cox14 interaction as detected by co-immunoprecipitation, confirming the importance of the Cox1 C-terminal residues for Mss51 sequestration. We surveyed a panel of mutations that block CcO assembly for the strength of their effect on Cox1 synthesis, both by pulse labeling and expression of the ARG8(m) reporter fused to COX1. Deletion of the nuclear gene encoding Cox6, one of the first subunits to be added to assembling CcO, caused the most severe reduction in Cox1 synthesis. Deletion of the C-terminal 15 amino acids of Cox1 increased Cox1 synthesis in the presence of each of these mutations, except pet54. Our data suggest a novel activity of Pet54 required for normal synthesis of Cox1 that is independent of the Cox1 C-terminal end.	[Shingu-Vazquez, Miguel; Camacho-Villasana, Yolanda; Perez-Martinez, Xochitl] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Mol Genet, Mexico City 04510, DF, Mexico; [Sandoval-Romero, Luisa] Inst Nacl Rehabil, Dept Morfol Celular & Mol, Mexico City 14389, DF, Mexico; [Butler, Christine A.; Fox, Thomas D.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Universidad Nacional Autonoma de Mexico; Cornell University	Perez-Martinez, X (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Mol Genet, Mexico City 04510, DF, Mexico.	xperez@ifc.unam.mx		Fox, Thomas/0000-0001-7629-3661	National Institutes of Health [GM029362]; CONACyT [47514]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT); UNAM [IN215008]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); UNAM(Universidad Nacional Autonoma de Mexico); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM029362 (to T. D. F.), research grants from CONACyT (47514) and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), and UNAM Grant IN215008 (to X. P.-M.).	Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2003, J BIOL CHEM, V278, P8881, DOI 10.1074/jbc.M212427200; Barros MH, 2001, FEBS LETT, V492, P133, DOI 10.1016/S0014-5793(01)02249-9; Bonnefoy N, 2001, MOL CELL BIOL, V21, P2359, DOI 10.1128/MCB.21.7.2359-2372.2001; Bonnefoy N, 2000, MOL GEN GENET, V262, P1036, DOI 10.1007/PL00008646; Bonnefoy N, 2007, METHOD CELL BIOL, V80, P525, DOI 10.1016/S0091-679X(06)80026-9; Broadley SA, 2001, MOL CELL BIOL, V21, P7663, DOI 10.1128/MCB.21.22.7663-7672.2001; Burke D., 2000, METHODS YEAST GENETI; CABRAL F, 1978, J BIOL CHEM, V253, P297; Carlson CG, 2003, J BIOL CHEM, V278, P3770, DOI 10.1074/jbc.M209893200; Choquet Y, 2003, PLANT CELL, V15, P1443, DOI 10.1105/tpc.011692; Church C, 2005, J BIOL CHEM, V280, P1854, DOI 10.1074/jbc.M410726200; COSTANZO MC, 1986, EMBO J, V5, P3637, DOI 10.1002/j.1460-2075.1986.tb04693.x; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Drapier D, 2007, EMBO J, V26, P3581, DOI 10.1038/sj.emboj.7601802; Fontanesi F, 2008, IUBMB LIFE, V60, P557, DOI 10.1002/iub.86; Fontanesi F, 2008, HUM MOL GENET, V17, P775, DOI 10.1093/hmg/ddm349; Gawryluk RMR, 2010, MOL BIOL EVOL, V27, P7, DOI 10.1093/molbev/msp223; Guthrie C., 2002, GUIDE YEAST GENETICS; Herrmann JM, 2005, GENE, V354, P43, DOI 10.1016/j.gene.2005.03.017; Hiser L, 2000, J BIOL CHEM, V275, P619, DOI 10.1074/jbc.275.1.619; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffbuhr KC, 2000, J BIOL CHEM, V275, P13994, DOI 10.1074/jbc.275.18.13994; Horan S, 2005, BIOCHEM J, V390, P703, DOI 10.1042/BJ20050598; Khalimonchuk O, 2008, EUKARYOT CELL, V7, P1427, DOI 10.1128/EC.00132-08; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Khalimonchuk O, 2010, MOL CELL BIOL, V30, P1004, DOI 10.1128/MCB.00640-09; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemaire C, 1998, CURR GENET, V34, P138, DOI 10.1007/s002940050378; MANTHEY GM, 1995, EMBO J, V14, P4031, DOI 10.1002/j.1460-2075.1995.tb00074.x; MEUNIER B, 1993, EUR J BIOCHEM, V213, P129, DOI 10.1111/j.1432-1033.1993.tb17742.x; Meunier B, 2001, BIOCHEM J, V354, P407, DOI 10.1042/0264-6021:3540407; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Minai L, 2006, PLANT CELL, V18, P159, DOI 10.1105/tpc.105.037705; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Muramoto K, 2007, P NATL ACAD SCI USA, V104, P7881, DOI 10.1073/pnas.0610031104; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Pecina P, 2004, PHYSIOL RES, V53, pS213; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Perez-Martinez X, 2009, MOL BIOL CELL, V20, P4371, DOI 10.1091/mbc.E09-06-0522; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Soto IC, 2009, BBA-MOL CELL RES, V1793, P1776, DOI 10.1016/j.bbamcr.2009.09.002; Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; VALENCIK ML, 1989, EMBO J, V8, P3899, DOI 10.1002/j.1460-2075.1989.tb08569.x; VALENCIK ML, 1991, MOL CELL BIOL, V11, P2399, DOI 10.1128/MCB.11.5.2399; Vempati UD, 2009, J BIOL CHEM, V284, P4383, DOI 10.1074/jbc.M805972200; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Westermann B, 2001, METHOD CELL BIOL, V65, P429, DOI 10.1016/S0091-679X(01)65025-8; Wostrikoff K, 2004, EMBO J, V23, P2696, DOI 10.1038/sj.emboj.7600266	53	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34382	34389		10.1074/jbc.M110.161976	http://dx.doi.org/10.1074/jbc.M110.161976			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20807763	Green Published, hybrid			2022-12-25	WOS:000283659100012
J	Tholanikunnel, BG; Joseph, K; Kandasamy, K; Baldys, A; Raymond, JR; Luttrell, LM; McDermott, PJ; Fernandes, DJ				Tholanikunnel, Baby G.; Joseph, Kusumam; Kandasamy, Karthikeyan; Baldys, Aleksander; Raymond, John R.; Luttrell, Louis M.; McDermott, Paul J.; Fernandes, Daniel J.			Novel Mechanisms in the Regulation of G Protein-coupled Receptor Trafficking to the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; MESSENGER-RNA LOCALIZATION; ELAV-LIKE PROTEIN; BETA(2)-ADRENERGIC RECEPTOR; BINDING PROTEINS; SIGNAL PEPTIDE; IN-VIVO; HUR; TRANSLATION; CELLS	beta(2)-Adrenergic receptors (beta(2)-AR) are low abundance, integral membrane proteins that mediate the effects of catecholamines at the cell surface. Whereas the processes governing desensitization of activated beta(2)-ARs and their subsequent removal from the cell surface have been characterized in considerable detail, little is known about the mechanisms controlling trafficking of neo-synthesized receptors to the cell surface. Since the discovery of the signal peptide, the targeting of the integral membrane proteins to plasma membrane has been thought to be determined by structural features of the amino acid sequence alone. Here we report that localization of translationally silenced beta(2)-AR mRNA to the peripheral cytoplasmic regions is critical for receptor localization to the plasma membrane. beta(2)-AR mRNA is recognized by the nucleocytoplasmic shuttling RNA-binding protein HuR, which silences translational initiation while chaperoning the mRNA-protein complex to the cell periphery. When HuR expression is down-regulated, beta(2)-AR mRNA translation is initiated prematurely in perinuclear polyribosomes, leading to overproduction of receptors but defective trafficking to the plasma membrane. Our results underscore the importance of the spatiotemporal relationship between beta(2)-AR mRNA localization, translation, and trafficking to the plasma membrane, and establish a novel mechanism whereby G protein-coupled receptor (GPCR) responsiveness is regulated by RNA-based signals.	[Tholanikunnel, Baby G.; Joseph, Kusumam; Luttrell, Louis M.; Fernandes, Daniel J.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Joseph, Kusumam; Kandasamy, Karthikeyan; Baldys, Aleksander; Raymond, John R.; Luttrell, Louis M.; McDermott, Paul J.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Tholanikunnel, BG (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 86 Jonathan Lucas St,HCC 709, Charleston, SC 29425 USA.	tholanik@musc.edu		Luttrell, Louis/0000-0003-2805-6949	National Institutes of Health; American Heart Association [0555470U, 0765356U]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by grants from the National Institutes of Health (to B. G. T.) and the American Heart Association (0555470U, to B. G. T. and 0765356U, to K. J.).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Antic D, 1998, J CELL SCI, V111, P183; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bi J, 2007, P NATL ACAD SCI USA, V104, P13810, DOI 10.1073/pnas.0703805104; Blaxall BC, 2000, J BIOL CHEM, V275, P4290, DOI 10.1074/jbc.275.6.4290; Blobel G, 2000, CHEMBIOCHEM, V1, P87; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007; DELOPEZ ZM, 2004, P NATL ACAD SCI USA, V101, P2987; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Izquierdo JM, 2008, J BIOL CHEM, V283, P19077, DOI 10.1074/jbc.M800017200; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Kandasamy K, 2005, J BIOL CHEM, V280, P1931, DOI 10.1074/jbc.M405937200; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; Kochl R, 2002, J BIOL CHEM, V277, P16131, DOI 10.1074/jbc.M111674200; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Leandersson K, 2006, NUCLEIC ACIDS RES, V34, P3988, DOI 10.1093/nar/gkl571; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lingappa V R, 1980, Recent Prog Horm Res, V36, P451; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Paquin N, 2005, NAT STRUCT MOL BIOL, V12, P1026, DOI 10.1038/nsmb1205-1026; RANDS E, 1990, J BIOL CHEM, V265, P10759; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Subramaniam K, 2004, J BIOL CHEM, V279, P27108, DOI 10.1074/jbc.M401352200; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; WALLIN E, 1995, PROTEIN ENG, V8, P693, DOI 10.1093/protein/8.7.693; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511	36	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33816	33825		10.1074/jbc.M110.168229	http://dx.doi.org/10.1074/jbc.M110.168229			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20739277	Green Published, hybrid			2022-12-25	WOS:000283354000028
J	Fernandez, PL; Dutra, FF; Alves, L; Figueiredo, RT; Mourao-Sa, D; Fortes, GB; Bergstrand, S; Lonn, D; Cevallos, RR; Pereira, RMS; Lopes, UG; Travassos, LH; Paiva, CN; Bozza, MT				Fernandez, Patricia L.; Dutra, Fabianno F.; Alves, Leticia; Figueiredo, Rodrigo T.; Mourao-Sa, Diego; Fortes, Guilherme B.; Bergstrand, Sophie; Loenn, David; Cevallos, Ricardo R.; Pereira, Renata M. S.; Lopes, Ulisses G.; Travassos, Leonardo H.; Paiva, Claudia N.; Bozza, Marcelo T.			Heme Amplifies the Innate Immune Response to Microbial Molecules through Spleen Tyrosine Kinase (Syk)-dependent Reactive Oxygen Species Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INCREASES MORTALITY; NLRP3 INFLAMMASOME; SEVERE MALARIA; HOST-DEFENSE; ACTIVATION; RECEPTORS; RECOGNITION; DECTIN-1; ALPHA	Infectious diseases that cause hemolysis are among the most threatening human diseases, because of severity and/or global distribution. In these conditions, hemeproteins and heme are released, but whether heme affects the inflammatory response to microorganism molecules remains to be characterized. Here, we show that heme increased the lethality and cytokine secretion induced by LPS in vivo and enhanced the secretion of cytokines by macrophages stimulated with various agonists of innate immune receptors. Activation of nuclear factor kappa B (NF-kappa B) and MAPKs and the generation of reactive oxygen species were essential to the increase in cytokine production induced by heme plus LPS. This synergistic effect of heme and LPS was blocked by a selective inhibitor of spleen tyrosine kinase (Syk) and was abrogated in dendritic cells deficient in Syk. Moreover, inhibition of Syk and the downstream molecules PKC and PI3K reduced the reactive oxygen species generation by heme. Our results highlight a mechanism by which heme amplifies the secretion of cytokines triggered by microbial molecule activation and indicates possible pathways for therapeutic intervention during hemolytic infectious diseases.	[Fernandez, Patricia L.; Dutra, Fabianno F.; Alves, Leticia; Figueiredo, Rodrigo T.; Fortes, Guilherme B.; Bergstrand, Sophie; Loenn, David; Travassos, Leonardo H.; Paiva, Claudia N.; Bozza, Marcelo T.] Univ Fed Rio de Janeiro, Dept Imunol, Inst Microbiol, Lab Inflamacao & Imunidade, BR-21941902 Rio De Janeiro, Brazil; [Fernandez, Patricia L.; Cevallos, Ricardo R.] Inst Invest Cient & Serv Alta Tecnol, Panama City 084301103, Panama; [Figueiredo, Rodrigo T.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, Brazil; [Mourao-Sa, Diego] London Res Inst, Lincolns Inn Fields Labs, Immunobiol Lab, London WC2A 3PX, England; [Pereira, Renata M. S.; Lopes, Ulisses G.; Travassos, Leonardo H.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941902 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Bozza, MT (corresponding author), Univ Fed Rio de Janeiro, Dept Imunol, Inst Microbiol, Lab Inflamacao & Imunidade, BR-21941902 Rio De Janeiro, Brazil.	mbozza@micro.ufrj.br	Lopes, Ulisses Gazos/T-6634-2019; Lopes, Ulisses/N-4416-2013; Dutra, Fabianno F/C-1387-2015; Pereira, Renata/V-6194-2019; Ferreira Dutra, Fabianno/AAE-2895-2022; Travassos, Leonardo/G-1925-2012; Figueiredo, Rodrigo/F-5176-2016	Dutra, Fabianno F/0000-0003-3106-7585; Ferreira Dutra, Fabianno/0000-0003-3106-7585; Travassos, Leonardo/0000-0003-1323-3797; Mourao, Diego/0000-0001-6618-6969; Bozza, Marcelo/0000-0003-3683-7550; Figueiredo, Rodrigo/0000-0002-7551-8782; Pereira, Renata/0000-0002-7719-8356; Cevallos, Ricardo/0000-0001-9759-7859; Llanes Fernandez, Patricia/0000-0002-0762-0566	Conselho de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Fundacao Jose Bonifacio; Programa de Nucleos de Excelencia; Secretaria Nacional de Ciencia Tecnologia e Innovacion de Panama	Conselho de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Jose Bonifacio; Programa de Nucleos de Excelencia; Secretaria Nacional de Ciencia Tecnologia e Innovacion de Panama	This work was supported by Conselho de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, Fundacao Jose Bonifacio, and Programa de Nucleos de Excelencia, Secretaria Nacional de Ciencia Tecnologia e Innovacion de Panama.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bittencourt VCB, 2006, J BIOL CHEM, V281, P22614, DOI 10.1074/jbc.M511417200; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Carneiro LAM, 2008, J PATHOL, V214, P136, DOI 10.1002/path.2271; Ferreira A, 2008, J MOL MED, V86, P1097, DOI 10.1007/s00109-008-0368-5; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Graca-Souza AV, 2002, BLOOD, V99, P4160, DOI 10.1182/blood.V99.11.4160; GRIFFITHS E, 1995, LANCET, V345, P158, DOI 10.1016/S0140-6736(95)90168-X; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Morse D, 2002, AM J RESP CELL MOL, V27, P8, DOI 10.1165/ajrcmb.27.1.4862; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; MULLEREBERHARD U, 1993, AM J HEMATOL, V42, P59, DOI 10.1002/ajh.2830420112; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Porto BN, 2007, J BIOL CHEM, V282, P24430, DOI 10.1074/jbc.M703570200; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060943; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; Seixas E, 2009, P NATL ACAD SCI USA, V106, P15837, DOI 10.1073/pnas.0903419106; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Su DH, 1997, INFECT IMMUN, V65, P1258, DOI 10.1128/IAI.65.4.1258-1266.1997; Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Wang L, 2010, IMMUNITY, V32, P518, DOI 10.1016/j.immuni.2010.03.014; Yang H, 2002, SHOCK, V17, P485, DOI 10.1097/00024382-200206000-00008	36	66	66	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32844	32851		10.1074/jbc.M110.146076	http://dx.doi.org/10.1074/jbc.M110.146076			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729208	Green Published, hybrid			2022-12-25	WOS:000283048200021
J	Goldwasser, J; Cohen, PY; Yang, E; Balaguer, P; Yarmush, ML; Nahmias, Y				Goldwasser, Jonathan; Cohen, Pazit Y.; Yang, Eric; Balaguer, Patrick; Yarmush, Martin L.; Nahmias, Yaakov			Transcriptional Regulation of Human and Rat Hepatic Lipid Metabolism by the Grapefruit Flavonoid Naringenin: Role of PPAR alpha, PPAR gamma and LXR alpha	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; FATTY-ACID OXIDATION; APOLIPOPROTEIN-B SECRETION; LIVER-X-RECEPTORS; HEPATOCYTE APO-B; NUCLEAR RECEPTORS; GENE-EXPRESSION; CROSS-TALK; CHOLESTEROL HOMEOSTASIS; NUTRITIONAL REGULATION	Disruption of lipid and carbohydrate homeostasis is an important factor in the development of prevalent metabolic diseases such as diabetes, obesity, and atherosclerosis. Therefore, small molecules that could reduce insulin dependence and regulate dyslipidemia could have a dramatic effect on public health. The grapefruit flavonoid naringenin has been shown to normalize lipids in diabetes and hypercholesterolemia, as well as inhibit the production of HCV. Here, we demonstrate that naringenin regulates the activity of nuclear receptors PPARa, PPARc, and LXRa. We show it activates the ligand-binding domain of both PPARa and PPARc, while inhibiting LXRa in GAL4-fusion reporters. Using TR-FRET, we show that naringenin is a partial agonist of LXRa, inhibiting its association with Trap220 co-activator in the presence of TO901317. In addition, naringenin induces the expression of PPARa co-activator, PGC1a. The flavonoid activates PPAR response element (PPRE) while suppressing LXRa response element (LXRE) in human hepatocytes, translating into the induction of PPAR-regulated fatty acid oxidation genes such as CYP4A11, ACOX, UCP1 and ApoAI, and inhibition of LXRa-regulated lipogenesis genes, such as FAS, ABCA1, ABCG1, and HMGR. This effect results in the induction of a fasted-like state in primary rat hepatocytes in which fatty acid oxidation increases, while cholesterol and bile acid production decreases. Our findings explain the myriad effects of naringenin and support its continued clinical development. Of note, this is the first description of a non-toxic, naturally occurring LXRa inhibitor.	[Goldwasser, Jonathan; Yang, Eric; Yarmush, Martin L.; Nahmias, Yaakov] Shriners Burns Hosp, Ctr Engn Med, Boston, MA USA; [Goldwasser, Jonathan] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Cohen, Pazit Y.; Nahmias, Yaakov] Hebrew Univ Jerusalem, Selim & Rachel Benin Sch Engn, Jerusalem, Israel; [Yang, Eric; Yarmush, Martin L.; Nahmias, Yaakov] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Balaguer, Patrick] Univ Montpellier I, INSERM, Montpellier, France	Harvard University; Massachusetts Institute of Technology (MIT); Hebrew University of Jerusalem; Harvard University; Harvard Medical School; Massachusetts General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Goldwasser, J (corresponding author), Shriners Burns Hosp, Ctr Engn Med, Boston, MA USA.	ynahmias@cs.huji.ac.il	Balaguer, Patrick/I-2973-2016; Nahmias, Yaakov/AAM-3872-2020; Nahmias, Yaakov/H-4725-2013	Nahmias, Yaakov/0000-0002-6051-616X; Nahmias, Yaakov/0000-0002-6051-616X; Yarmush, Martin/0000-0003-4986-8444	NIBIB NIH HHS [P41 EB-002503, P41 EB002503] Funding Source: Medline; NIDDK NIH HHS [K01 DK080241, P30-DK040561, P30 DK040561, P30 DK040561-15, K01DK080241] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK080241, P30DK040561] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allister EM, 2005, DIABETES, V54, P1676, DOI 10.2337/diabetes.54.6.1676; Borradaile NM, 2003, DIABETES, V52, P2554, DOI 10.2337/diabetes.52.10.2554; Borradaile NM, 2002, J LIPID RES, V43, P1544, DOI 10.1194/jlr.M200115-JLR200; BUCHMAN A, 2006, SCHIFFS DIS LIVER; Chang F, 2007, ANN PHARMACOTHER, V41, P973, DOI 10.1345/aph.1K013; Crestani M, 2004, EUR J LIPID SCI TECH, V106, P432, DOI 10.1002/ejlt.200300936; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; Edwards PA, 2002, VASC PHARMACOL, V38, P249, DOI 10.1016/S1537-1891(02)00175-1; Forman BM, 1997, P NATL ACAD SCI USA, V94, P10588, DOI 10.1073/pnas.94.20.10588; Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gervois P, 2007, NAT CLIN PRACT ENDOC, V3, P145, DOI 10.1038/ncpendmet0397; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Gupta S, 2002, BIOCHEM BIOPH RES CO, V293, P338, DOI 10.1016/S0006-291X(02)00229-2; HOGAN P, 2002, DIABETES CARE, V26, P917; Hu X, 2003, MOL ENDOCRINOL, V17, P1019, DOI 10.1210/me.2002-0399; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Huong DTT, 2006, NUTRITION, V22, P546, DOI 10.1016/j.nut.2005.11.006; Ide T, 2003, MOL ENDOCRINOL, V17, P1255, DOI 10.1210/me.2002-0191; Jeon SM, 2007, TRANSL RES, V149, P15, DOI 10.1016/j.trsl.2006.08.001; Jung UJ, 2003, CLIN NUTR, V22, P561, DOI 10.1016/S0261-5614(03)00059-1; Kidambi S, 2009, P NATL ACAD SCI USA, V106, P15714, DOI 10.1073/pnas.0906820106; Kim K, 2008, BIOCHEM J, V416, P219, DOI 10.1042/BJ20081336; Kim SY, 2006, J MED FOOD, V9, P582, DOI 10.1089/jmf.2006.9.582; Kurowska EM, 2000, NUTR RES, V20, P121, DOI 10.1016/S0271-5317(99)00144-X; Kurowska EM, 2004, LIPIDS, V39, P143, DOI 10.1007/s11745-004-1212-8; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Lee CH, 2001, BIOCHEM BIOPH RES CO, V284, P681, DOI 10.1006/bbrc.2001.5001; Lee SH, 1999, ANN NUTR METAB, V43, P173, DOI 10.1159/000012783; Liu L, 2008, PHYTOTHER RES, V22, P1400, DOI 10.1002/ptr.2504; Mahmood S, 2008, CANCER INFORM, V6, P381; MARCUS SL, 1993, P NATL ACAD SCI USA, V90, P5723, DOI 10.1073/pnas.90.12.5723; Martin PGP, 2007, HEPATOLOGY, V45, P767, DOI 10.1002/hep.21510; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Millatt LJ, 2003, BBA-MOL CELL BIOL L, V1631, P107, DOI 10.1016/S1388-1981(02)00366-9; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; Mittra S, 2008, DRUG DISCOV TODAY, V13, P211, DOI 10.1016/j.drudis.2008.01.006; Miyata KS, 1996, J BIOL CHEM, V271, P9189, DOI 10.1074/jbc.271.16.9189; MULVIHILL EE, 2009, DIABETES; Na TY, 2009, HEPATOLOGY, V49, P1122, DOI 10.1002/hep.22740; Nahmias Y, 2008, HEPATOLOGY, V47, P1437, DOI 10.1002/hep.22197; Noguchi-Yachide T, 2007, CHEM PHARM BULL, V55, P1750, DOI 10.1248/cpb.55.1750; Ory DS, 2004, CIRC RES, V95, P660, DOI 10.1161/01.RES.0000143422.83209.be; PAWAR B, 2003, J BIOL CHEM; Rochette-Egly C, 2003, CELL SIGNAL, V15, P355, DOI 10.1016/S0898-6568(02)00115-8; Seimandi M, 2005, ANAL BIOCHEM, V344, P8, DOI 10.1016/j.ab.2005.06.010; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Son YL, 2009, BIOCHEM BIOPH RES CO, V384, P389, DOI 10.1016/j.bbrc.2009.04.131; Tobin KAR, 2000, MOL ENDOCRINOL, V14, P741, DOI 10.1210/me.14.5.741; van Raalte DH, 2004, PHARM RES-DORDR, V21, P1531, DOI 10.1023/B:PHAM.0000041444.06122.8d; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603; Wilcox LJ, 2001, J LIPID RES, V42, P725; Wilcox LJ, 1999, CARDIOVASC DRUG REV, V17, P160, DOI 10.1111/j.1527-3466.1999.tb00011.x; Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001	59	164	170	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12399	10.1371/journal.pone.0012399	http://dx.doi.org/10.1371/journal.pone.0012399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811644	Green Submitted, Green Published, gold			2022-12-25	WOS:000281234700023
J	Sweiss, NJ; Bo, RH; Kapadia, R; Manst, D; Mahmood, F; Adhikari, T; Volkov, S; Badaracco, M; Smaron, M; Chang, A; Baron, J; Levine, JS				Sweiss, Nadera J.; Bo, Ronghai; Kapadia, Reena; Manst, Deborah; Mahmood, Farzan; Adhikari, Tara; Volkov, Suncica; Badaracco, Maria; Smaron, Mary; Chang, Anthony; Baron, Joseph; Levine, Jerrold S.			IgA Anti-beta 2-Glycoprotein I Autoantibodies Are Associated with an Increased Risk of Thromboembolic Events in Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							ANTI-BETA(2)-GLYCOPROTEIN I; ANTIPHOSPHOLIPID SYNDROME; ANTICARDIOLIPIN ANTIBODIES; CLINICAL-SIGNIFICANCE; THROMBOSIS; MANIFESTATIONS; CLASSIFICATION; CRITERIA	Background: The clinical utility of testing for antiphospholipid antibodies (aPL) of IgA isotype remains controversial. Methodology/Principal Findings: To address this issue, we reasoned that if IgA aPL contribute to the clinical manifestations of the antiphospholipid syndrome, then an association with thromboembolic events should manifest in patients whose only aPL is of IgA isotype. We performed a retrospective chart review of 56 patients (31 with systemic lupus erythematosus [SLE] and 25 without SLE) whose only positive aPL was IgA anti-beta 2-glycoprotein I (isolated IgA anti-beta 2GPI) and compared their clinical features with 56 individually matched control patients without any aPL. Patients with isolated IgA anti-beta 2GPI had a significantly increased number of thromboembolic events, as compared to controls. When patients were stratified into those with and without SLE, the association between isolated IgA anti-beta 2GPI and thromboembolic events persisted for patients with SLE, but was lost for those without SLE. Titers of IgA anti-beta 2GPI were significantly higher in SLE patients who suffered a thromboembolic event. Among patients with isolated IgA anti-beta 2GPI, there was an increased prevalence of diseases or morbidities involving organs of mucosal immunity (i.e., gastrointestinal system, pulmonary system, and skin). Conclusions/Significance: The presence of isolated IgA anti-beta 2GPI is associated with an increased risk of thromboembolic events, especially among patients with SLE. IgA anti-beta 2GPI is associated with an increased prevalence of morbidities involving organs of mucosal immunity.	[Sweiss, Nadera J.; Badaracco, Maria; Smaron, Mary] Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA; [Bo, Ronghai; Kapadia, Reena] Univ So Calif, Dept Med, Rheumatol Sect, Los Angeles, CA USA; [Manst, Deborah] Loyola Univ, Chicago Stritch Sch Med, Maywood, IL 60153 USA; [Mahmood, Farzan; Adhikari, Tara] Univ Cincinnati, Med Ctr, Div Pulm & Crit Care, Cincinnati, OH 45267 USA; [Volkov, Suncica] Univ Illinois, Dept Med, Rheumatol Sect, Chicago, IL USA; [Chang, Anthony] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Baron, Joseph] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Levine, Jerrold S.] Univ Illinois, Dept Med, Nephrol Sect, Chicago, IL USA; [Levine, Jerrold S.] Jesse Brown Vet Affairs Med Ctr, Dept Med, Nephrol Sect, Chicago, IL USA	University of Chicago; University of Southern California; Loyola University Chicago; University System of Ohio; University of Cincinnati; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Sweiss, NJ (corresponding author), Univ Chicago, Dept Med, Rheumatol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.	nsweiss@medicine.bsd.uchicago.edu		Sweiss, Nadera/0000-0003-2215-0221; Chang, Anthony/0000-0002-6877-5510	Genzyme, Inc.	Genzyme, Inc.(Sanofi-AventisGenzyme Corporation)	This work was supported by a GRIP Renal Innovations Program Award from Genzyme, Inc. to JSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma Y, 2003, NEW ENGL J MED, V349, P2407, DOI 10.1056/NEJMoa035611; Bertolaccini ML, 2001, J RHEUMATOL, V28, P2637; Boin F, 2009, ARTHRITIS RHEUM-US, V60, P2480, DOI 10.1002/art.24684; Danowski A, 2006, J RHEUMATOL, V33, P1775; de Laat B, 2005, BLOOD, V105, P1540, DOI 10.1182/blood-2004-09-3387; Dieude M, 2004, ARTHRITIS RHEUM-US, V50, P3221, DOI 10.1002/art.20564; DIEUDE M, 2009, ARTHRITIS RHEUM, V60, pS766; ESCALANTE A, 1995, AM J MED, V98, P559, DOI 10.1016/S0002-9343(99)80014-X; Fanopoulos D, 1998, J RHEUMATOL, V25, P675; Greco TP, 2000, LUPUS, V9, P33, DOI 10.1177/096120330000900107; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hodak E, 2003, LUPUS, V12, P564, DOI 10.1191/0961203303lu403oa; Kawakami T, 2008, ARTHRIT RHEUM-ARTHR, V59, P561, DOI 10.1002/art.23528; Kumar S, 2009, LUPUS, V18, P1011, DOI 10.1177/0961203309103048; Lakos G, 1999, CLIN EXP IMMUNOL, V117, P574; Lee RM, 2001, AM J OBSTET GYNECOL, V185, P748, DOI 10.1067/mob.2001.117659; Lee SS, 2001, J RHEUMATOL, V28, P520; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Romero-Diaz J, 2009, J RHEUMATOL, V36, P68, DOI 10.3899/jrheum.071244; Samarkos M, 2006, CLIN RHEUMATOL, V25, P199, DOI 10.1007/s10067-005-1156-z; Selva-O'Callaghan A, 1998, THROMB HAEMOSTASIS, V79, P282; Shen YM, 2008, LUPUS, V17, P996, DOI 10.1177/0961203308093460; Tajima C, 1998, J RHEUMATOL, V25, P1730; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tsutsumi A, 1998, J RHEUMATOL, V25, P74	26	36	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12280	10.1371/journal.pone.0012280	http://dx.doi.org/10.1371/journal.pone.0012280			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808864	Green Published, gold, Green Submitted			2022-12-25	WOS:000281075500014
J	Sengupta, A; Lichti, UF; Carlson, BA; Ryscavage, AO; Gladyshev, VN; Yuspa, SH; Hatfield, DL				Sengupta, Aniruddha; Lichti, Ulrike F.; Carlson, Bradley A.; Ryscavage, Andrew O.; Gladyshev, Vadim N.; Yuspa, Stuart H.; Hatfield, Dolph L.			Selenoproteins Are Essential for Proper Keratinocyte Function and Skin Development	PLOS ONE			English	Article							VITAMIN-E; IN-VITRO; SELENIUM DEFICIENCY; STRATUM-CORNEUM; TRANSGENIC MICE; HAIR FOLLICLE; BETA-CAROTENE; GENE TRSP; ANTIOXIDANTS; EXPRESSION	Dietary selenium is known to protect skin against UV-induced damage and cancer and its topical application improves skin surface parameters in humans, while selenium deficiency compromises protective antioxidant enzymes in skin. Furthermore, skin and hair abnormalities in humans and rodents may be caused by selenium deficiency, which are overcome by dietary selenium supplementation. Most important biological functions of selenium are attributed to selenoproteins, proteins containing selenium in the form of the amino acid, selenocysteine (Sec). Sec insertion into proteins depends on Sec tRNA; thus, knocking out the Sec tRNA gene (Trsp) ablates selenoprotein expression. We generated mice with targeted removal of selenoproteins in keratin 14 (K14) expressing cells and their differentiated descendents. The knockout progeny had a runt phenotype, developed skin abnormalities and experienced premature death. Lack of selenoproteins in epidermal cells led to the development of hyperplastic epidermis and aberrant hair follicle morphogenesis, accompanied by progressive alopecia after birth. Further analyses revealed that selenoproteins are essential antioxidants in skin and unveiled their role in keratinocyte growth and viability. This study links severe selenoprotein deficiency to abnormalities in skin and hair and provides genetic evidence for the role of these proteins in keratinocyte function and cutaneous development.	[Sengupta, Aniruddha; Carlson, Bradley A.; Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, NIH, Bethesda, MD 20892 USA; [Lichti, Ulrike F.; Ryscavage, Andrew O.; Yuspa, Stuart H.] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Gladyshev, Vadim N.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sengupta, A (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA.	yuspas@dc37a.nci.nih.gov; hatfield@mail.nih.gov	Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013	Sengupta, Aniruddha/0000-0001-5560-0837; Gladyshev, Vadim/0000-0002-0372-7016	National Institutes of Health, National Cancer Institute; Center for Cancer Research; NIH; NATIONAL CANCER INSTITUTE [ZIABC005445, ZIABC005317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, and Center for Cancer Research, and in addition, NIH grants awarded to VNG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates JM, 2000, ENDOCRINOLOGY, V141, P2490, DOI 10.1210/en.141.7.2490; Berger MM, 2007, AM J CLIN NUTR, V85, P1301, DOI 10.1093/ajcn/85.5.1301; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Carlson BA, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-57; Cross CE, 1998, ENVIRON HEALTH PERSP, V106, P1241, DOI 10.2307/3433992; D'Alessio S, 2008, J CELL SCI, V121, P3922, DOI 10.1242/jcs.037549; Fleming J, 2001, NUTR CANCER, V40, P42, DOI 10.1207/S15327914NC401_9; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Fuchs J, 1998, FREE RADICAL BIO MED, V25, P848, DOI 10.1016/S0891-5849(98)00161-0; Gollnick HPM, 1996, EUR J DERMATOL, V6, P200; GUYTON KZ, 1993, BRIT MED BULL, V49, P523, DOI 10.1093/oxfordjournals.bmb.a072628; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Heinrich U, 2006, SKIN PHARMACOL PHYS, V19, P224, DOI 10.1159/000093118; Hendrix S, 2005, J INVEST DERMATOL, V125, P42, DOI 10.1111/j.0022-202X.2005.23787.x; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kanekura T, 2005, CLIN EXP DERMATOL, V30, P346, DOI 10.1111/j.1365-2230.2005.01746.x; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kumaraswamy E, 2003, MOL CELL BIOL, V23, P1477, DOI 10.1128/MCB.23.5.1477-1488.2003; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; McKenzie RC, 2000, CLIN EXP DERMATOL, V25, P631, DOI 10.1046/j.1365-2230.2000.00725.x; Moll R, 1998, Subcell Biochem, V31, P205; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; PENCE BC, 1994, J INVEST DERMATOL, V102, P759, DOI 10.1111/1523-1747.ep12377571; Rafferty TS, 1998, BIOCHEM J, V332, P231, DOI 10.1042/bj3320231; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Richelle M, 2006, BRIT J NUTR, V96, P227, DOI 10.1079/BJN20061817; Rostan EF, 2002, INT J DERMATOL, V41, P606, DOI 10.1046/j.1365-4362.2002.01567.x; Sano T, 2009, J DERMATOL SCI, V53, P77, DOI 10.1016/j.jdermsci.2008.08.001; Sengupta A, 2008, BIOCHEM J, V413, P151, DOI 10.1042/BJ20080277; Sengupta A, 2009, BIOCHEM CELL BIOL, V87, P953, DOI [10.1139/O09-064, 10.1139/o09-064]; SHINDO Y, 1994, J INVEST DERMATOL, V102, P122, DOI 10.1111/1523-1747.ep12371744; Siemes C, 2006, EXP CELL RES, V312, P1939, DOI 10.1016/j.yexcr.2006.02.025; Steenvoorden DPT, 1997, J PHOTOCH PHOTOBIO B, V41, P1, DOI 10.1016/S1011-1344(97)00081-X; Thiele JJ, 1997, J INVEST DERMATOL, V108, P753, DOI 10.1111/1523-1747.ep12292144; Thiele JJ, 1998, J INVEST DERMATOL, V110, P756, DOI 10.1046/j.1523-1747.1998.00169.x; Trost A, 2007, EXP DERMATOL, V16, P185, DOI 10.1111/j.1600-0625.2006.00534.x; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wong P, 2003, J CELL BIOL, V163, P327, DOI 10.1083/jcb.200305032	41	55	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12249	10.1371/journal.pone.0012249	http://dx.doi.org/10.1371/journal.pone.0012249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805887	gold, Green Published, Green Submitted			2022-12-25	WOS:000281011600021
J	Minsaas, L; Planaguma, J; Madziva, M; Krakstad, BF; Masia-Balague, M; Katz, AA; Aragay, AM				Minsaas, Laura; Planaguma, Jesus; Madziva, Michael; Krakstad, Beate F.; Masia-Balague, Miriam; Katz, Arieh A.; Aragay, Anna M.			Filamin A Binds to CCR2B and Regulates Its Internalization	PLOS ONE			English	Article							CALCIUM-SENSING RECEPTOR; DOPAMINE D-3 RECEPTOR; INTRACELLULAR TRAFFICKING; KINASE ACTIVATION; PROTEIN FILAMIN; TERMINAL TAIL; ACTIN; CHEMOKINES; SIGNAL; CELLS	The chemokine (C-C motif) receptor 2B (CCR2B) is one of the two isoforms of the receptor for monocyte chemoattractant protein-1 (CCL2), the major chemoattractant for monocytes, involved in an array of chronic inflammatory diseases. Employing the yeast two-hybrid system, we identified the actin-binding protein filamin A (FLNa) as a protein that associates with the carboxyl-terminal tail of CCR2B. Co-immunoprecipitation experiments and in vitro pull down assays demonstrated that FLNa binds constitutively to CCR2B. The colocalization of endogenous CCR2B and filamin A was detected at the surface and in internalized vesicles of THP-1 cells. In addition, CCR2B and FLNa were colocalized in lamellipodia structures of CCR2B-expressing A7 cells. Expression of the receptor in filamin-deficient M2 cells together with siRNA experiments knocking down FLNa in HEK293 cells, demonstrated that lack of FLNa delays the internalization of the receptor. Furthermore, depletion of FLNa in THP-1 monocytes by RNA interference reduced the migration of cells in response to MCP-1. Therefore, FLNa emerges as an important protein for controlling the internalization and spatial localization of the CCR2B receptor in different dynamic membrane structures.	[Minsaas, Laura; Planaguma, Jesus; Krakstad, Beate F.; Aragay, Anna M.] Univ Bergen, Dept Biomed, Bergen, Norway; [Masia-Balague, Miriam; Aragay, Anna M.] CSIC, Inst Biol Mol Barcelona, Barcelona, Spain; [Madziva, Michael; Katz, Arieh A.] Univ Cape Town, Div Med Biochem, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Madziva, Michael; Katz, Arieh A.] Univ Cape Town, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa	University of Bergen; University of Cape Town; University of Cape Town	Minsaas, L (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	aarbmc@ibmb.csic.es	Aragay, Anna M/K-3813-2014; Katz, Arieh/F-5836-2012	Aragay, Anna M/0000-0002-8240-4126; 	Helse Vest and Ministerio de Ciencia e Innovacion [BFU2008-04262]	Helse Vest and Ministerio de Ciencia e Innovacion	The work was supported by the Helse Vest and Ministerio de Ciencia e Innovacion (BFU2008-04262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragay AM, 1998, P NATL ACAD SCI USA, V95, P2985, DOI 10.1073/pnas.95.6.2985; Awata H, 2001, J BIOL CHEM, V276, P34871, DOI 10.1074/jbc.M100775200; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cho EY, 2007, MOL ENDOCRINOL, V21, P2242, DOI 10.1210/me.2007-0202; Chuang JZ, 1998, J CELL BIOL, V142, P1245, DOI 10.1083/jcb.142.5.1245; Contento RL, 2008, P NATL ACAD SCI USA, V105, P10101, DOI 10.1073/pnas.0804286105; Enz R, 2002, FEBS LETT, V514, P184, DOI 10.1016/S0014-5793(02)02361-X; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Fletcher SJ, 2009, BIOCHEM SOC T, V37, P1072, DOI 10.1042/BST0371072; Franci C, 1996, J IMMUNOL, V157, P5606; Fromme BJ, 2008, AIDS RES HUM RETROV, V24, P1527, DOI 10.1089/aid.2008.0105; Hjalm G, 2001, J BIOL CHEM, V276, P34880, DOI 10.1074/jbc.M100784200; Huang CF, 2006, FEBS LETT, V580, P1795, DOI 10.1016/j.febslet.2006.02.035; Ithychanda SS, 2009, J BIOL CHEM, V284, P35113, DOI 10.1074/jbc.M109.060954; Jimenez-Baranda S, 2007, NAT CELL BIOL, V9, P838, DOI 10.1038/ncb1610; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kim KM, 2005, J BIOL CHEM, V280, P12774, DOI 10.1074/jbc.M408901200; KRUPNICK JG, 1998, ANN REV PHARM TOXICO, V289, P319; Li M, 2002, BIOCHEM PHARMACOL, V63, P859, DOI 10.1016/S0006-2952(01)00932-7; Lin RW, 2002, PHARMACOLOGY, V66, P173, DOI 10.1159/000065531; Lin RW, 2001, P NATL ACAD SCI USA, V98, P5258, DOI 10.1073/pnas.011538198; Liu GP, 1997, J CELL BIOL, V139, P1719, DOI 10.1083/jcb.139.7.1719; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; O'Hayre M, 2008, BIOCHEM J, V409, P635, DOI 10.1042/BJ20071493; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Onoprishvili I, 2003, MOL PHARMACOL, V64, P1092, DOI 10.1124/mol.64.5.1092; Petrecca K, 2000, J NEUROSCI, V20, P8736; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006; Seck T, 2003, J BIOL CHEM, V278, P10408, DOI 10.1074/jbc.M209655200; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Terashima Y, 2005, NAT IMMUNOL, V6, P827, DOI 10.1038/ni1222; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Vroon A, 2004, J LEUKOCYTE BIOL, V75, P901, DOI 10.1189/jlb.0403136; Vroon A, 2006, J LEUKOCYTE BIOL, V80, P1214, DOI 10.1189/jlb.0606373; Zhang ML, 2005, J BIOL CHEM, V280, P11140, DOI 10.1074/jbc.M412242200	38	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12212	10.1371/journal.pone.0012212	http://dx.doi.org/10.1371/journal.pone.0012212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808917	Green Published, Green Submitted, gold			2022-12-25	WOS:000280968100016
J	Reifur, L; Yu, LE; Cruz-Reyes, J; vanHartesvelt, M; Koslowsky, DJ				Reifur, Larissa; Yu, Laura E.; Cruz-Reyes, Jorge; vanHartesvelt, Michelle; Koslowsky, Donna J.			The Impact of mRNA Structure on Guide RNA Targeting in Kinetoplastid RNA Editing	PLOS ONE			English	Article							BINDING PROTEINS; COMPLEX; GRNA; MITOCHONDRIA; TRANSCRIPTS; ANTISENSE; MECHANISM; INSERTION; GENE; SITE	Mitochondrial mRNA editing in Trypanosoma brucei requires the specific interaction of a guide RNA with its cognate mRNA. Hundreds of gRNAs are involved in the editing process, each needing to target their specific editing domain within the target message. We hypothesized that the structure surrounding the mRNA target may be a limiting factor and involved in the regulation process. In this study, we selected four mRNAs with distinct target structures and investigated how sequence and structure affected efficient gRNA targeting. Two of the mRNAs, including the ATPase subunit 6 and ND7-550 (5' end of NADH dehydrogenase subunit 7) that have open, accessible anchor binding sites show very efficient gRNA targeting. Electrophoretic mobility shift assays indicate that the cognate gRNA for ND7-550 had 10-fold higher affinity for its mRNA than the A6 pair. Surface plasmon resonance studies indicate that the difference in affinity was due to a four-fold faster association rate. As expected, mRNAs with considerable structure surrounding the anchor binding sites were less accessible and had very low affinity for their cognate gRNAs. In vitro editing assays indicate that efficient pairing is crucial for gRNA directed cleavage. However, only the A6 substrate showed gRNA-directed cleavage at the correct editing site. This suggests that different gRNA/mRNA pairs may require different "sets'' of accessory factors for efficient editing. By characterizing a number of different gRNA/mRNA interactions, we may be able to define a "bank'' of RNA editing substrates with different putative chaperone and other co-factor requirements. This will allow the more efficient identification and characterization of transcript specific RNA editing accessory proteins.	[Reifur, Larissa; Koslowsky, Donna J.] Michigan State Univ, Coll Vet Med, Comparat Med & Integrat Biol Program, E Lansing, MI 48824 USA; [Yu, Laura E.; Koslowsky, Donna J.] Michigan State Univ, Coll Nat Sci, Cell & Mol Biol Program, E Lansing, MI 48824 USA; [Cruz-Reyes, Jorge] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Koslowsky, Donna J.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Texas A&M University System; Texas A&M University College Station; Michigan State University	Reifur, L (corresponding author), Michigan State Univ, Coll Vet Med, Comparat Med & Integrat Biol Program, E Lansing, MI 48824 USA.	koslowsk@msu.edu	Cruz-Reyes, Jorge/GQP-1338-2022	Cruz-Reyes, Jorge/0000-0003-0545-1508	National Institutes of Health [AI45835]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health, Grant number AI45835 to Donna Koslowsky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler BK, 1997, MOL CELL BIOL, V17, P5377, DOI 10.1128/MCB.17.9.5377; Amarzguioui M, 2000, NUCLEIC ACIDS RES, V28, P4113, DOI 10.1093/nar/28.21.4113; Ammerman ML, 2008, RNA, V14, P1069, DOI 10.1261/rna.982908; Aphasizhev R, 2003, RNA, V9, P62, DOI 10.1261/rna.2134303; Birikh KR, 1997, RNA, V3, P429; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; Cifuentes-Rojas C, 2007, J BIOL CHEM, V282, P4265, DOI 10.1074/jbc.M605554200; Cruz-Reyes J, 1998, MOL CELL, V1, P401, DOI 10.1016/S1097-2765(00)80040-4; Cruz-Reyes J, 2002, MOL CELL BIOL, V22, P4652, DOI 10.1128/MCB.22.13.4652-4660.2002; DECKER CJ, 1990, CELL, V61, P1001, DOI 10.1016/0092-8674(90)90065-M; FEAGIN JE, 1987, CELL, V49, P337, DOI 10.1016/0092-8674(87)90286-8; FEAGIN JE, 1988, MOL CELL BIOL, V8, P1259, DOI 10.1128/MCB.8.3.1259; Golden DE, 2006, J MOL BIOL, V359, P585, DOI 10.1016/j.jmb.2006.03.041; Hernandez A, 2008, J MOL BIOL, V381, P35, DOI 10.1016/j.jmb.2008.05.003; Igo RP, 2002, MOL CELL BIOL, V22, P1567, DOI 10.1128/MCB.22.5.1567-1576.2002; Kabb AL, 2001, NUCLEIC ACIDS RES, V29, P2575, DOI 10.1093/nar/29.12.2575; Kable ML, 1996, SCIENCE, V273, P1189, DOI 10.1126/science.273.5279.1189; Katsamba PS, 2002, METHODS, V26, P95, DOI 10.1016/S1046-2023(02)00012-9; KAY E, 2006, MICROBE, V1, P63; KOSLOWSKY DJ, 1991, CELL, V67, P537, DOI 10.1016/0092-8674(91)90528-7; KOSLOWSKY DJ, 1992, MOL CELL BIOL, V12, P2043, DOI 10.1128/MCB.12.5.2043; KOSLOWSKY DJ, 1990, CELL, V62, P901, DOI 10.1016/0092-8674(90)90265-G; Koslowsky Donna J, 2004, RNA Biol, V1, P28; Leung SS, 1999, NUCLEIC ACIDS RES, V27, P778, DOI 10.1093/nar/27.3.778; Leung SS, 2001, RNA, V7, P1803; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; MATTHEWS J, 1993, FUNDAMENTALS RECEPTO, P7; Mlotshwa S, 2008, TRENDS PLANT SCI, V13, P375, DOI 10.1016/j.tplants.2008.04.009; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; Muller UF, 2002, NUCLEIC ACIDS RES, V30, P447, DOI 10.1093/nar/30.2.447; Muller UF, 2001, EMBO J, V20, P1394, DOI 10.1093/emboj/20.6.1394; Myszka DG, 1997, CURR OPIN BIOTECH, V8, P50, DOI 10.1016/S0958-1669(97)80157-7; Neilson JR, 2008, CELL, V134, P899, DOI 10.1016/j.cell.2008.09.006; Nordgren S, 2001, J MOL BIOL, V310, P1125, DOI 10.1006/jmbi.2001.4802; Ochsenreiter T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001566; Ochsenreiter T, 2006, EMBO REP, V7, P1128, DOI 10.1038/sj.embor.7400817; Pai RD, 2003, RNA, V9, P469, DOI 10.1261/rna.2175703; Patzel V, 1998, NAT BIOTECHNOL, V16, P64, DOI 10.1038/nbt0198-64; Pelletier M, 2003, RNA, V9, P457, DOI 10.1261/rna.2160803; POLLARD VW, 1992, EMBO J, V11, P4429, DOI 10.1002/j.1460-2075.1992.tb05543.x; Reifur L, 2008, RNA, V14, P2195, DOI 10.1261/rna.1144508; Rusche LN, 1997, EMBO J, V16, P4069, DOI 10.1093/emboj/16.13.4069; Schneider A, 2001, INT J PARASITOL, V31, P1403, DOI 10.1016/S0020-7519(01)00296-X; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; von der Haar T, 2003, METHODS, V29, P167, DOI 10.1016/S1046-2023(02)00307-9; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P713, DOI 10.1146/annurev.mi.48.100194.003433; WALTER AE, 1994, P NATL ACAD SCI USA, V91, P9218, DOI 10.1073/pnas.91.20.9218	51	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12235	10.1371/journal.pone.0012235	http://dx.doi.org/10.1371/journal.pone.0012235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808932	Green Published, gold, Green Submitted			2022-12-25	WOS:000280968100027
J	Luo, Y; Good, CH; Diaz-Ruiz, O; Zhang, YJ; Hoffman, AF; Shan, LF; Kuang, SY; Malik, N; Chefer, VI; Tomac, AC; Lupica, CR; Backman, CM				Luo, Yu; Good, Cameron H.; Diaz-Ruiz, Oscar; Zhang, YaJun; Hoffman, Alexander F.; Shan, Lufei; Kuang, Serena Y.; Malik, Nasir; Chefer, Vladimir I.; Tomac, Andreas C.; Lupica, Carl R.; Backman, Cristina M.			NMDA Receptors on Non-Dopaminergic Neurons in the VTA Support Cocaine Sensitization	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; INDUCED NEUROBEHAVIORAL PLASTICITY; D-ASPARTATE RECEPTOR; DOPAMINE NEURONS; NUCLEUS-ACCUMBENS; SYNAPTIC PLASTICITY; ENVIRONMENTAL CONTEXT; PREFRONTAL CORTEX; GLUTAMATE; POTENTIATION	Background: The initiation of behavioral sensitization to cocaine and other psychomotor stimulants is thought to reflect N-methyl-D-aspartate receptor (NMDAR)-mediated synaptic plasticity in the mesolimbic dopamine (DA) circuitry. The importance of drug induced NMDAR mediated adaptations in ventral tegmental area (VTA) DA neurons, and its association with drug seeking behaviors, has recently been evaluated in Cre-loxp mice lacking functional NMDARs in DA neurons expressing Cre recombinase under the control of the endogenous dopamine transporter gene (NR1(DATCre) mice). Methodology and Principal Findings: Using an additional NR1(DATCre) mouse transgenic model, we demonstrate that while the selective inactivation of NMDARs in DA neurons eliminates the induction of molecular changes leading to synaptic strengthening, behavioral measures such as cocaine induced locomotor sensitization and conditioned place preference remain intact in NR1(DATCre) mice. Since VTA DA neurons projecting to the prefrontal cortex and amygdala express little or no detectable levels of the dopamine transporter, it has been speculated that NMDA receptors in DA neurons projecting to these brain areas may have been spared in NR1(DATCre) mice. Here we demonstrate that the NMDA receptor gene is ablated in the majority of VTA DA neurons, including those exhibiting undetectable DAT expression levels in our NR1(DATCre) transgenic model, and that application of an NMDAR antagonist within the VTA of NR1(DATCre) animals still blocks sensitization to cocaine. Conclusions/Significance: These results eliminate the possibility of NMDAR mediated neuroplasticity in the different DA neuronal subpopulations in our NR1(DATCre) mouse model and therefore suggest that NMDARs on non-DA neurons within the VTA must play a major role in cocaine-related addictive behavior.	[Luo, Yu; Good, Cameron H.; Diaz-Ruiz, Oscar; Zhang, YaJun; Hoffman, Alexander F.; Shan, Lufei; Kuang, Serena Y.; Malik, Nasir; Tomac, Andreas C.; Lupica, Carl R.; Backman, Cristina M.] Natl Inst Drug Abuse, Cellular Neurobiol Res Branch, NIH, Baltimore, MD USA; [Chefer, Vladimir I.] Natl Inst Drug Abuse, Behav Neurosci Branch, NIH, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Luo, Y (corresponding author), Natl Inst Drug Abuse, Cellular Neurobiol Res Branch, NIH, Baltimore, MD USA.	cbackman@mail.nih.gov	backman, cristina/C-1276-2013; Lupica, Carl/AAY-3193-2021; Diaz-Ruiz, Oscar/F-3162-2010; Hoffman, Alex/AIF-4544-2022; Hoffman, Alex/H-3035-2012	Lupica, Carl/0000-0002-5375-3263; Hoffman, Alex/0000-0002-2676-0628; Hoffman, Alex/0000-0002-2676-0628; Luo, Yu/0000-0002-7939-5505	National Institute on Drug Abuse, National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000457, ZIADA000561] Funding Source: NIH RePORTER	National Institute on Drug Abuse, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiani A, 2004, BEHAV PHARMACOL, V15, P327, DOI 10.1097/00008877-200409000-00004; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Bassareo V, 2002, J NEUROSCI, V22, P4709, DOI 10.1523/JNEUROSCI.22-11-04709.2002; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Carr DB, 2008, NEURON, V59, P353, DOI 10.1016/j.neuron.2008.07.025; Chen YH, 2008, FASEB J, V22, P261, DOI 10.1096/fj.07-8797com; Coulter CL, 1996, DEV BRAIN RES, V92, P172, DOI 10.1016/0165-3806(96)00004-1; Doetschman Thomas, 2009, V530, P423, DOI 10.1007/978-1-59745-471-1_23; Dunn JM, 2005, PSYCHOPHARMACOLOGY, V179, P172, DOI 10.1007/s00213-004-2054-9; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gracy KN, 1996, BRAIN RES, V739, P169, DOI 10.1016/S0006-8993(96)00822-0; Harris GC, 2004, NEUROSCIENCE, V129, P841, DOI 10.1016/j.neuroscience.2004.09.018; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P73, DOI 10.1038/sj.npp.1300011; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; KALIVAS PW, 1993, J PHARMACOL EXP THER, V267, P486; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Li X, 2009, PSYCHOPHARMACOLOGY, V204, P1, DOI 10.1007/s00213-008-1432-0; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Parlato R, 2006, GENESIS, V44, P454, DOI 10.1002/dvg.20236; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Sombers LA, 2009, J NEUROSCI, V29, P1735, DOI 10.1523/JNEUROSCI.5562-08.2009; Stefani MR, 2006, J NEUROSCI, V26, P8810, DOI 10.1523/JNEUROSCI.1656-06.2006; Szumlinski KK, 2004, BEHAV PHARMACOL, V15, P373, DOI 10.1097/00008877-200409000-00010; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vezina P, 2000, PSYCHOPHARMACOLOGY, V151, P184, DOI 10.1007/s002130000463; Yamaguchi T, 2007, EUR J NEUROSCI, V25, P106, DOI 10.1111/j.1460-9568.2006.05263.x; Zweifel LS, 2008, NEURON, V59, P486, DOI 10.1016/j.neuron.2008.05.028; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	36	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12141	10.1371/journal.pone.0012141	http://dx.doi.org/10.1371/journal.pone.0012141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808436	Green Published, gold, Green Submitted			2022-12-25	WOS:000280968000003
J	Hegge, S; Kudryashev, M; Barniol, L; Frischknecht, F				Hegge, Stephan; Kudryashev, Mikhail; Barniol, Luis; Frischknecht, Friedrich			Key factors regulating Plasmodium berghei sporozoite survival and transformation revealed by an automated visual assay	FASEB JOURNAL			English	Article						glucose; bicarbonate; screening; Apicomplexa; differentiation	MALARIA PARASITES; TRANSCRIPTION FACTOR; MOSQUITO; CELLS; STAGE; IDENTIFICATION; TRANSMISSION; FALCIPARUM; THOUSANDS; TARGET	Malaria is transmitted to the host when Plasmodium sporozoites are injected by a mosquito vector. Sporozoites eventually enter hepatocytes, where they differentiate into liver-stage parasites. During the first hours after hepatocyte invasion, the crescent-shaped sporozoites transform into spherical intracellular exoerythrocytic parasites. This process, which precedes genome replication, can be mimicked in vitro in the absence of host cells. Here, we developed an automated method to follow transformation and cell death of sporozoites in vitro. This assay provides a rapid tool to test sporozoite survival and to screen for antiparasitic drugs. We found that extracellular bicarbonate and high temperature trigger transformation, whereas physiological serum albumin concentrations and media lacking bicarbonate delayed sporozoite death. Because bicarbonate also triggers ookinete transformation and exflagellation of gametocytes, we suggest that a common molecular mechanism regulates similar aspects of stage conversion in Plasmodium.-Hegge, S., Kudryashev, M., Barniol, L., Frischknecht, F. Key factors regulating Plasmodium berghei sporozoite survival and transformation revealed by an automated visual assay. FASEB J. 24, 5003-5012 (2010). www.fasebj.org	[Hegge, Stephan; Kudryashev, Mikhail; Barniol, Luis; Frischknecht, Friedrich] Univ Heidelberg, Sch Med, Dept Infect Dis, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Frischknecht, F (corresponding author), Univ Heidelberg, Sch Med, Dept Infect Dis, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	freddy.frischknecht@med.uni-heidelberg.de		Kudryashev, Misha/0000-0003-3550-6274; Frischknecht, Friedrich/0000-0002-8332-6668	Federal German Ministry for Education and Research (BioFuture and National Genome Research Network); German Research Foundation [SFB544]; University of Heidelberg Medical School; Cluster of Excellence CellNetworks; Chica and Heinz Schaller Foundation	Federal German Ministry for Education and Research (BioFuture and National Genome Research Network)(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); University of Heidelberg Medical School; Cluster of Excellence CellNetworks; Chica and Heinz Schaller Foundation	The authors thank Jenny Pestel for help with the experiments, Diana Scheppan and Iris Arnold for mosquito infection, Alexander Rotmann for discussion, and Ann-Kristin Muller, Claudia Kuss, Steffen Borrmann, Maria Mota, and Carina Gomes-Santos for comments on the article. This work was funded by the Federal German Ministry for Education and Research (BioFuture and National Genome Research Network) and the German Research Foundation through SFB544. Support from the University of Heidelberg Medical School, the Cluster of Excellence CellNetworks, and the Chica and Heinz Schaller Foundation is gratefully acknowledged. F. F. is a member of the European Network of Excellence European Virtual Institute of Malaria Research.	Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Butcher GA, 1996, EXP PARASITOL, V84, P371, DOI 10.1006/expr.1996.0125; Cunha-Rodrigues Margarido, 2006, Biotechnology Journal, V1, P321, DOI 10.1002/biot.200500038; Ejigiri I, 2009, CURR OPIN MICROBIOL, V12, P401, DOI 10.1016/j.mib.2009.06.006; Frischknecht F, 2004, CELL MICROBIOL, V6, P687, DOI 10.1111/j.1462-5822.2004.00395.x; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Kaiser K, 2003, J EXP MED, V197, P1045, DOI 10.1084/jem.20022100; Lingelbach K, 1998, J CELL SCI, V111, P1467; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; MEIS JFGM, 1983, NATURE, V302, P424, DOI 10.1038/302424a0; NIJHOUT MM, 1978, PARASITOLOGY, V76, P39, DOI 10.1017/S0031182000047375; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Prudencio M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000201; RENIA L, 1990, EUR J IMMUNOL, V20, P1445, DOI 10.1002/eji.1830200706; Rodrigues CD, 2008, CELL HOST MICROBE, V4, P271, DOI 10.1016/j.chom.2008.07.012; Sidjanski S, 1997, AM J TROP MED HYG, V57, P426, DOI 10.4269/ajtmh.1997.57.426; Silvie O, 2006, CELL MICROBIOL, V8, P1134, DOI 10.1111/j.1462-5822.2006.00697.x; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; Yuda M, 2010, MOL MICROBIOL, V75, P854, DOI 10.1111/j.1365-2958.2009.07005.x; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x; Zhang M, 2010, J EXP MED, V207, P1, DOI 10.1084/jem.20091975	23	16	16	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					5003	5012		10.1096/fj.10-164814	http://dx.doi.org/10.1096/fj.10-164814			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20798246				2022-12-25	WOS:000284824400038
J	Zheng, J; Machida, K; Antoku, S; Ng, KY; Claffey, KP; Mayer, BJ				Zheng, J.; Machida, K.; Antoku, S.; Ng, K. Y.; Claffey, K. P.; Mayer, B. J.			Proteins that bind the Src homology 3 domain of CrkI have distinct roles in Crk transformation	ONCOGENE			English	Article						SH3 domain; SH2/SH3 adaptor; Abl family kinase; SOS1; C3G	PHOSPHOINOSITIDE 3-KINASE/AKT PATHWAY; NUCLEOTIDE-RELEASING FACTOR; FOCAL ADHESION KINASE; ABL TYROSINE KINASE; V-CRK; ADAPTER PROTEIN; MALIGNANT FEATURE; CELL-MIGRATION; POSITIVE CELLS; SH3 DOMAIN	The v-Crk oncogene product consists of two protein interaction modules, a Src homology 2 (SH2) domain and a Src homology 3 (SH3) domain. Overexpression of CrkI, the cellular homolog of v-Crk, transforms mouse fibroblasts, and elevated CrkI expression is observed in several human cancers. The SH2 and SH3 domains of Crk are required for transformation, but the identity of the critical cellular binding partners is not known. A number of candidate Crk SH3-binding proteins have been identified, including the nonreceptor tyrosine kinases c-Abl and Arg, and the guanine nucleotide exchange proteins C3G, SOS1 and DOCK180. The aim of this study is to determine which of these are required for transformation by CrkI. We found that short hairpin RNA-mediated knockdown of C3G or SOS1 suppressed anchorage-independent growth of NIH-3T3 cells over-expressing CrkI, whereas knockdown of SOS1 alone was sufficient to suppress tumor formation by these cells in nude mice. Knockdown of C3G was sufficient to revert morphological changes induced by CrkI expression. By contrast, knockdown of Abl family kinases or their inhibition with imatinib enhanced anchorage-independent growth and tumorigenesis induced by Crk. These results show that SOS1 is essential for CrkI-induced fibroblast transformation, and also reveal a surprising negative role for Abl kinases in Crk transformation. Oncogene (2010) 29, 6378-6389; doi:10.1038/onc.2010.369; published online 23 August 2010	[Zheng, J.; Machida, K.; Antoku, S.; Ng, K. Y.; Mayer, B. J.] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Raymond & Beverly Sackler Lab Genet & Mol Med, Farmington, CT 06030 USA; [Claffey, K. P.] Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT 06030 USA; [Claffey, K. P.] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut; University of Connecticut	Mayer, BJ (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Raymond & Beverly Sackler Lab Genet & Mol Med, 263 Farmington Ave, Farmington, CT 06030 USA.	bmayer@neuron.uchc.edu			National Institutes of Health [CA82258, CA064436]; NATIONAL CANCER INSTITUTE [R01CA064436, R01CA082258, R29CA064436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Michiyuki Matsuda (Kyoto University) for providing the shRNAs targeting DOCK180 and the antibody against DOCK180, Dr Peter Davies (Albert Einstein College of Medicine) for Arg antibody and Novartis Pharmaceuticals for imatinib. We thank Kathryn Phoenix and Frank Vumbaca for the technical help. This work was supported by grants CA82258 (to BJM) and CA064436 (to KPC) from the National Institutes of Health.	Akagi T, 2000, P NATL ACAD SCI USA, V97, P7290, DOI 10.1073/pnas.140210297; Akagi T, 2002, MOL CELL BIOL, V22, P7015, DOI 10.1128/MCB.22.20.7015-7023.2002; Antoku S, 2009, J CELL SCI, V122, P4228, DOI 10.1242/jcs.054627; BIRGE RB, 1993, MOL CELL BIOL, V13, P4648, DOI 10.1128/MCB.13.8.4648; Cipres A, 2007, CELL SIGNAL, V19, P1662, DOI 10.1016/j.cellsig.2007.02.011; Crawford M, 2008, BIOCHEM BIOPH RES CO, V373, P607, DOI 10.1016/j.bbrc.2008.06.090; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Deininger MWN, 1997, BLOOD, V90, P3691, DOI 10.1182/blood.V90.9.3691; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2009, NAT MED, V15, P1149, DOI 10.1038/nm1009-1149; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; Gotoh T, 1997, J BIOL CHEM, V272, P18602, DOI 10.1074/jbc.272.30.18602; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; Greulich H, 1996, CELL GROWTH DIFFER, V7, P1443; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Hemmeryckx B, 2001, CANCER RES, V61, P1398; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Iwahara T, 2004, P NATL ACAD SCI USA, V101, P17693, DOI 10.1073/pnas.0408413102; Iwahara T, 2003, ONCOGENE, V22, P5946, DOI 10.1038/sj.onc.1206633; Kain KH, 2003, ONCOGENE, V22, P6071, DOI 10.1038/sj.onc.1206930; Kain KH, 2001, J BIOL CHEM, V276, P16185, DOI 10.1074/jbc.M100095200; Kobashigawa Y, 2007, NAT STRUCT MOL BIOL, V14, P503, DOI 10.1038/nsmb1241; Linghu H, 2006, ONCOGENE, V25, P3547, DOI 10.1038/sj.onc.1209398; Matsuda M, 1996, J BIOL CHEM, V271, P14468, DOI 10.1074/jbc.271.24.14468; MATSUDA M, 1994, MOL CELL BIOL, V14, P5495, DOI 10.1128/MCB.14.8.5495; MATSUDA M, 1992, MOL CELL BIOL, V12, P3482, DOI 10.1128/MCB.12.8.3482; MAYER BJ, 1990, J VIROL, V64, P3581, DOI 10.1128/JVI.64.8.3581-3589.1990; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; Miller CT, 2003, ONCOGENE, V22, P7950, DOI 10.1038/sj.onc.1206529; Mochizuki N, 2000, J BIOL CHEM, V275, P12667, DOI 10.1074/jbc.275.17.12667; Nievers MG, 1997, J CELL SCI, V110, P389; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Qian XL, 2000, EMBO J, V19, P642, DOI 10.1093/emboj/19.4.642; REICHMAN CT, 1992, CELL GROWTH DIFFER, V3, P451; REN RB, 1994, GENE DEV, V8, P783, DOI 10.1101/gad.8.7.783; Riggins RB, 2003, MOL CANCER RES, V1, P428; SAKAI R, 1994, J BIOL CHEM, V269, P32740; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Senechal K, 1998, MOL CELL BIOL, V18, P5082, DOI 10.1128/MCB.18.9.5082; Sharma A, 2004, PRIN PRACT, P165, DOI 10.1109/ICTTA.2004.1307673; Shishido T, 2001, GENES CELLS, V6, P431, DOI 10.1046/j.1365-2443.2001.00431.x; Stam JC, 2001, J BIOL CHEM, V276, P25176, DOI 10.1074/jbc.M009825200; Takino T, 2003, CANCER RES, V63, P2335; TANAKA M, 1995, MOL CELL BIOL, V15, P6829; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; Tanaka S, 1997, P NATL ACAD SCI USA, V94, P2356, DOI 10.1073/pnas.94.6.2356; TENHOEVE J, 1993, ONCOGENE, V8, P2469; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Wang BL, 1996, ONCOGENE, V13, P1379; Wang JYJ, 2000, ONCOGENE, V19, P5643, DOI 10.1038/sj.onc.1203878; Wang L, 2007, BIOCHEM BIOPH RES CO, V362, P976, DOI 10.1016/j.bbrc.2007.08.106; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006	55	7	9	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2010	29	48					6378	6389		10.1038/onc.2010.369	http://dx.doi.org/10.1038/onc.2010.369			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	688SW	20729917	Green Accepted			2022-12-25	WOS:000284874700008
J	Lefterov, I; Fitz, NF; Cronican, AA; Fogg, A; Lefterov, P; Kodali, R; Wetzel, R; Koldamova, R				Lefterov, Iliya; Fitz, Nicholas F.; Cronican, Andrea A.; Fogg, Allison; Lefterov, Preslav; Kodali, Ravindra; Wetzel, Ronald; Koldamova, Radosveta			Apolipoprotein A-I Deficiency Increases Cerebral Amyloid Angiopathy and Cognitive Deficits in APP/PS1 Delta E9 Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR RISK-FACTORS; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; MOUSE MODEL; PRECURSOR PROTEIN; DENSITY-LIPOPROTEIN; CEREBROSPINAL-FLUID; CHOLESTEROL EFFLUX; ENDOTHELIAL-CELLS; BETA PEPTIDE	A hallmark of Alzheimer disease (AD) is the deposition of amyloid beta (A beta) in brain parenchyma and cerebral blood vessels, accompanied by cognitive decline. Previously, we showed that human apolipoprotein A-I (apoA-I) decreases A beta(40) aggregation and toxicity. Here we demonstrate that apoA-I in lipidated or non-lipidated form prevents the formation of high molecular weight aggregates of A beta(42) and decreases A beta(42) toxicity in primary brain cells. To determine the effects of apoA-I on AD phenotype in vivo, we crossed APP/PS1 Delta E9 to apoA-I-KO mice. Using a Morris water maze, we demonstrate that the deletion of mouse Apoa-I exacerbates memory deficits in APP/PS1 Delta E9 mice. Further characterization of APP/PS1 Delta E9/apoA-I-KO mice showed that apoA-I deficiency did not affect amyloid precursor protein processing, soluble A beta oligomer levels, A beta plaque load, or levels of insoluble A beta in brain parenchyma. To examine the effect of Apoa-I deletion on cerebral amyloid angiopathy, we measured insoluble A beta isolated from cerebral blood vessels. Our data show that in APP/PS1 Delta E9/apoA-I-KO mice, insoluble A beta(40) is increased more than 10-fold, and A beta(42) is increased 1.5-fold. The increased levels of deposited amyloid in the vessels of cortices and hippocampi of APP/PS1 Delta E9/apoA-I-KO mice, measured by X-34 staining, confirmed the results. Finally, we demonstrate that lipidated and non-lipidated apoA-I significantly decreased A beta toxicity against brain vascular smooth muscle cells. We conclude that lack of apoA-I aggravates the memory deficits in APP/PS1 Delta E9 mice in parallel to significantly increased cerebral amyloid angiopathy.	[Lefterov, Iliya] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Kodali, Ravindra; Wetzel, Ronald] Univ Pittsburgh, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Kodali, Ravindra; Wetzel, Ronald] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Disorders, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lefterov, I (corresponding author), Univ Pittsburgh, Dept Environm & Occupat Hlth, BRIDG Bldg,100 Technol Dr, Pittsburgh, PA 15219 USA.	iliyal@pitt.edu; radak@pitt.edu	Lefterov, Iliya/B-4767-2008; kodali, ravi/D-1148-2011; Wetzel, Ronald/G-7453-2011	Lefterov, Iliya/0000-0002-0249-0280; Koldamova, Radosveta/0000-0002-6761-0984; Fitz, Nicholas/0000-0001-6938-6536	National Institutes of Health, NIA [AG027973, AG031956, F32]; Alzheimer's Association [IIRG-0627077]; NATIONAL INSTITUTE ON AGING [R01AG027973, R21AG031956] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health, NIA, Grants AG027973 (to R. K.) and AG031956 (to I. L.). This work was also supported by Alzheimer's Association Grant IIRG-0627077 (to R. K.).; Supported by NIA, National Institutes of Health, Fellowship F32.	Alonzo NC, 1998, J NEUROPATH EXP NEUR, V57, P353, DOI 10.1097/00005072-199804000-00008; Bates KA, 2009, J ALZHEIMERS DIS, V17, P305, DOI 10.3233/JAD-2009-1050; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bonarek M, 2000, NEUROEPIDEMIOLOGY, V19, P141, DOI 10.1159/000026249; Bouwman FH, 2009, NEUROBIOL AGING, V30, P1895, DOI 10.1016/j.neurobiolaging.2008.02.007; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Fagan AM, 2004, AM J PATHOL, V165, P1413, DOI 10.1016/S0002-9440(10)63399-8; Fagan AM, 2000, ANN NEUROL, V48, P201, DOI 10.1002/1531-8249(200008)48:2<201::AID-ANA10>3.0.CO;2-X; Fillit H, 2008, AM J GERIATR PHARMAC, V6, P100, DOI 10.1016/j.amjopharm.2008.06.004; Fitz NF, 2010, J NEUROSCI, V30, P6862, DOI 10.1523/JNEUROSCI.1051-10.2010; Fryer JD, 2005, J NEUROSCI, V25, P2803, DOI 10.1523/JNEUROSCI.5170-04.2005; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Hawkes CA, 2009, P NATL ACAD SCI USA, V106, P1261, DOI 10.1073/pnas.0805453106; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Hsu MJ, 2010, BBA-GEN SUBJECTS, V1800, P290, DOI 10.1016/j.bbagen.2009.08.003; Jordan J, 1997, J NEUROCHEM, V68, P1612; KAWANO M, 1995, CLIN CHIM ACTA, V239, P209, DOI 10.1016/0009-8981(95)06115-T; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Kivipelto M, 2002, CNS DRUGS, V16, P435, DOI 10.2165/00023210-200216070-00001; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Koldamova RP, 2003, J BIOL CHEM, V278, P13244, DOI 10.1074/jbc.M300044200; Koldamova RP, 2001, BIOCHEMISTRY-US, V40, P3553, DOI 10.1021/bi002186k; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; Kuo YM, 1998, BIOCHEM BIOPH RES CO, V252, P711, DOI 10.1006/bbrc.1998.9652; KURIYAMA M, 1994, JPN J PSYCHIAT NEUR, V48, P589; LaDu MJ, 1997, J NEUROSCI RES, V49, P9, DOI 10.1002/(SICI)1097-4547(19970701)49:1<9::AID-JNR2>3.0.CO;2-H; Lefterov I, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-20; Lefterov I, 2009, ASN NEURO, V1, DOI 10.1042/AN20090015; Lesser G, 2001, DEMENT GERIATR COGN, V12, P138, DOI 10.1159/000051248; Lewis TL, 2010, J BIOL CHEM, V285, P36958, DOI 10.1074/jbc.M110.127829; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Maezawa I, 2004, J NEUROCHEM, V91, P1312, DOI 10.1111/j.1471-4159.2004.02818.x; Matsubara E, 1996, BIOCHEM J, V316, P671, DOI 10.1042/bj3160671; Merched A, 2000, NEUROBIOL AGING, V21, P27, DOI 10.1016/S0197-4580(99)00103-7; O'Nuallain B, 2006, METHOD ENZYMOL, V413, P34, DOI 10.1016/S0076-6879(06)13003-7; Panzenboeck U, 2002, J BIOL CHEM, V277, P42781, DOI 10.1074/jbc.M207601200; Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003; PITAS RE, 1987, J BIOL CHEM, V262, P14352; Saczynski JS, 2007, AM J EPIDEMIOL, V165, P985, DOI 10.1093/aje/kwm027; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; Tanaka M, 2008, BIOCHEMISTRY-US, V47, P2172, DOI 10.1021/bi702332b; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; WEILERGUTTLER H, 1990, J NEUROCHEM, V54, P444, DOI 10.1111/j.1471-4159.1990.tb01892.x; Weller RO, 2009, ACTA NEUROPATHOL, V118, P87, DOI 10.1007/s00401-009-0498-z; Wilcock DM, 2006, NAT PROTOC, V1, P1591, DOI 10.1038/nprot.2006.277; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283	53	91	94	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36945	36957		10.1074/jbc.M110.127738	http://dx.doi.org/10.1074/jbc.M110.127738			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20739292	Green Published, hybrid			2022-12-25	WOS:000284146100061
J	Marais, A; Ji, ZL; Child, ES; Krause, E; Mann, DJ; Sharrocks, AD				Marais, Anett; Ji, Zongling; Child, Emma S.; Krause, Eberhard; Mann, David J.; Sharrocks, Andrew D.			Cell Cycle-dependent Regulation of the Forkhead Transcription Factor FOXK2 by CDK.Cyclin Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC PROGRAM; BINDING-FACTOR; FHA DOMAIN; PROTEIN; PHOSPHORYLATION; FKH2P; RECRUITMENT; GENES; FOXM1; YEAST	Several mammalian forkhead transcription factors have been shown to impact on cell cycle regulation and are themselves linked to cell cycle control systems. Here we have investigated the little studied mammalian forkhead transcription factor FOXK2 and demonstrate that it is subject to control by cell cycle-regulated protein kinases. FOXK2 exhibits a periodic rise in its phosphorylation levels during the cell cycle, with hyperphosphorylation occurring in mitotic cells. Hyperphosphorylation occurs in a cyclin-dependent kinase (CDK).cyclin-dependent manner with CDK1.cyclin B as the major kinase complex, although CDK2 and cyclin A also appear to be important. We have mapped two CDK phosphorylation sites, serines 368 and 423, which play a role in definingFOXK2 function through regulating its stability and its activity as a transcriptional repressor protein. These two CDK sites appear vital for FOXK2 function because expression of a mutant lacking these sites cannot be tolerated and causes apoptosis.	[Marais, Anett; Ji, Zongling; Sharrocks, Andrew D.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Marais, Anett] Univ Leipzig, Max Burger Forschungszentrum, Med Klin 2, D-04103 Leipzig, Germany; [Child, Emma S.; Mann, David J.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England; [Krause, Eberhard] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany	University of Manchester; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Imperial College London; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Sharrocks, AD (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	a.d.sharrocks@manchester.ac.uk	Sharrocks, Andrew/J-6756-2013		Biotechnology and Biological Sciences Research Council; Wellcome Trust; Royal Society-Wolfson; Interdisziplinares Zentrum fur Klinische Forschung at the University of Leipzig [D02]; Biotechnology and Biological Sciences Research Council [BB/C508134/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society-Wolfson(Royal Society of London); Interdisziplinares Zentrum fur Klinische Forschung at the University of Leipzig; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Biotechnology and Biological Sciences Research Council (to D.J.M.), by the Wellcome Trust and a Royal Society-Wolfson award (to A.D.S.), and by an overseas research scholarship of Interdisziplinares Zentrum fur Klinische Forschung at the University of Leipzig (D02) (to A.M.).	Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Buck V, 2004, J CELL SCI, V117, P5623, DOI 10.1242/jcs.01473; Bulmer R, 2004, EUKARYOT CELL, V3, P944, DOI 10.1128/EC.3.4.944-954.2004; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chen YJ, 2009, J BIOL CHEM, V284, P30695, DOI 10.1074/jbc.M109.007997; Cooper K, 2006, ONCOGENE, V25, P5228, DOI 10.1038/sj.onc.1209630; Darieva Z, 2003, CURR BIOL, V13, P1740, DOI 10.1016/j.cub.2003.08.053; Darieva Z, 2006, NATURE, V444, P494, DOI 10.1038/nature05339; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Freddie CT, 2007, NUCLEIC ACIDS RES, V35, P5203, DOI 10.1093/nar/gkm528; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Fung TK, 2005, SEMIN CELL DEV BIOL, V16, P335, DOI 10.1016/j.semcdb.2005.02.014; Garry DJ, 2000, P NATL ACAD SCI USA, V97, P5416, DOI 10.1073/pnas.100501197; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Hawke TJ, 2003, J BIOL CHEM, V278, P4015, DOI 10.1074/jbc.M209200200; Ho KK, 2008, ONCOGENE, V27, P2300, DOI 10.1038/onc.2008.23; Jarviluoma A, 2006, MOL CELL BIOL, V26, P2430, DOI 10.1128/MCB.26.6.2430-2440.2006; Klemm C, 2006, J MASS SPECTROM, V41, P1623, DOI 10.1002/jms.1129; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Kumar R, 2000, CURR BIOL, V10, P896, DOI 10.1016/S0960-9822(00)00618-7; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; LI C, 1991, P NATL ACAD SCI USA, V88, P7739, DOI 10.1073/pnas.88.17.7739; Luscher-Firzlaff JM, 2006, FEBS LETT, V580, P1716, DOI 10.1016/j.febslet.2006.02.021; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nirula A, 1997, J BIOL CHEM, V272, P7736, DOI 10.1074/jbc.272.12.7736; Pic A, 2000, EMBO J, V19, P3750, DOI 10.1093/emboj/19.14.3750; Pic-Taylor A, 2004, MOL CELL BIOL, V24, P10036, DOI 10.1128/MCB.24.22.10036-10046.2004; Reynolds D, 2003, GENE DEV, V17, P1789, DOI 10.1101/gad.1074103; SHORE P, 1994, MOL CELL BIOL, V14, P3283, DOI 10.1128/MCB.14.5.3283; Yan JZ, 2006, MOL CELL BIOL, V26, P155, DOI 10.1128/MCB.26.1.155-168.2006; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Zhang XD, 2008, NAT METHODS, V5, P163, DOI [10.1038/nmeth1170, 10.1038/NMETH1170]; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	38	55	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35728	35739		10.1074/jbc.M110.154005	http://dx.doi.org/10.1074/jbc.M110.154005			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20810654	Green Published, hybrid			2022-12-25	WOS:000283845300051
J	Rao, VA; Klein, SR; Bonar, SJ; Zielonka, J; Mizuno, N; Dickey, JS; Keller, PW; Joseph, J; Kalyanaraman, B; Shacter, E				Rao, V. Ashutosh; Klein, Sarah R.; Bonar, Spencer J.; Zielonka, Jacek; Mizuno, Naoko; Dickey, Jennifer S.; Keller, Paul W.; Joseph, Joy; Kalyanaraman, Balaraman; Shacter, Emily			The Antioxidant Transcription Factor Nrf2 Negatively Regulates Autophagy and Growth Arrest Induced by the Anticancer Redox Agent Mitoquinone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE ADAPTER PROTEIN; MALIGNANT GLIOMA-CELLS; CANCER-CELLS; TARGETED ANTIOXIDANTS; OXIDATIVE DAMAGE; ARSENIC TRIOXIDE; TOPOISOMERASE-I; DT-DIAPHORASE; MCF-7 CELLS; DNA-DAMAGE	Mitoquinone (MitoQ) is a synthetically modified, redox-active ubiquinone compound that accumulates predominantly in mitochondria. We found that MitoQ is 30-fold more cytotoxic to breast cancer cells than to healthy mammary cells. MitoQ treatment led to irreversible inhibition of clonogenic growth of breast cancer cells through a combination of autophagy and apoptotic cell death mechanisms. Relatively limited cytotoxicity was seen with the parent ubiquinone coenzyme Q(10). Inhibition of cancer cell growth by MitoQ was associated with G(1)/S cell cycle arrest and phosphorylation of the checkpoint kinases Chk1 and Chk2. The possible role of oxidative stress in MitoQ activity was investigated by measuring the products of hydroethidine oxidation. Increases in ethidium and dihydroethidium levels, markers of one-electron oxidation of hydroethidine, were observed at cytotoxic concentrations of MitoQ. Keap1, an oxidative stress sensor protein that regulates the antioxidant transcription factor Nrf2, underwent oxidation, degradation, and dissociation from Nrf2 in MitoQ-treated cells. Nrf2 protein levels, nuclear localization, and transcriptional activity also increased following MitoQ treatment. Knockdown of Nrf2 caused a 2-fold increase in autophagy and an increase in G(1) cell cycle arrest in response to MitoQ but had no apparent effect on apoptosis. The Nrf2-regulated enzyme NQO1 is partly responsible for controlling the level of autophagy. Keap1 and Nrf2 act as redox sensors for oxidative perturbations that lead to autophagy. MitoQ and similar compounds should be further evaluated for novel anticancer activity.	[Rao, V. Ashutosh; Klein, Sarah R.; Bonar, Spencer J.; Dickey, Jennifer S.; Shacter, Emily] US FDA, Biochem Lab, Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA; [Zielonka, Jacek; Joseph, Joy; Kalyanaraman, Balaraman] Med Coll Wisconsin, Free Radical Res Ctr, Milwaukee, WI 53226 USA; [Mizuno, Naoko; Keller, Paul W.] NIAMSD, Struct Biol Res Lab, NIH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); Medical College of Wisconsin; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Rao, VA (corresponding author), 29 Lincoln Dr,Bldg 29A,Rm 2A-09,HFD-122, Bethesda, MD 20892 USA.	ashutosh.rao@fda.hhs.gov; emily.shacter@fda.hhs.gov	Mizuno, Naoko/AAY-1926-2021; Zielonka, Jacek/N-9546-2014; Rao, V Ashutosh/A-3569-2013	Mizuno, Naoko/0000-0002-1594-2821; Zielonka, Jacek/0000-0002-2524-0145; Rao, V Ashutosh/0000-0001-6817-8049	NIAMS; NCI; National Institutes of Health [RO1CA125112, RO1CA136799]; NATIONAL CANCER INSTITUTE [R01CA152810, R01CA136799, R01CA125112] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Intramural Research Programs of NIAMS and NCI and by National Institutes of Health Grants RO1CA125112 and RO1CA136799.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Armstrong JS, 2006, BRIT J PHARMACOL, V147, P239, DOI 10.1038/sj.bjp.0706556; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Bentle MS, 2006, J BIOL CHEM, V281, P33684, DOI 10.1074/jbc.M603678200; BERNAL SD, 1982, SCIENCE, V218, P1117, DOI 10.1126/science.7146897; Chandran K, 2009, BIOPHYS J, V96, P1388, DOI 10.1016/j.bpj.2008.10.042; Chen YQ, 2008, AUTOPHAGY, V4, P246, DOI 10.4161/auto.5432; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Chen YQ, 2010, CAN J PHYSIOL PHARM, V88, P285, DOI 10.1139/Y10-010; Cocheme HM, 2007, MITOCHONDRION, V7, pS94, DOI 10.1016/j.mito.2007.02.007; Cui Q, 2007, BIOL PHARM BULL, V30, P859, DOI 10.1248/bpb.30.859; DAVIS S, 1985, J BIOL CHEM, V260, P3844; Dhanasekaran A, 2004, J BIOL CHEM, V279, P37575, DOI 10.1074/jbc.M404003200; Doughan AK, 2007, ANTIOXID REDOX SIGN, V9, P1825, DOI 10.1089/ars.2007.1693; Du JA, 2006, J BIOL CHEM, V281, P37416, DOI 10.1074/jbc.M605063200; Facompre Michael, 2000, Molecular Cell Biology Research Communications, V4, P37, DOI 10.1006/mcbr.2000.0251; Gao M, 2008, CANCER RES, V68, P9348, DOI 10.1158/0008-5472.CAN-08-1642; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Hoke EM, 2005, FREE RADICAL BIO MED, V39, P403, DOI 10.1016/j.freeradbiomed.2005.03.029; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; JAISWAL AK, 1988, J BIOL CHEM, V263, P13572; Kalivendi SV, 2005, BIOCHEM J, V389, P527, DOI 10.1042/BJ20050285; Kanzawa T, 2003, CANCER RES, V63, P2103; Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kelso GF, 2002, ANN NY ACAD SCI, V959, P263, DOI 10.1111/j.1749-6632.2002.tb02098.x; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Kunchithapautham K, 2007, AUTOPHAGY, V3, P433, DOI 10.4161/auto.4294; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; McDonald Kent L, 2007, Methods Mol Biol, V369, P143; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Murphy MP, 2008, BBA-BIOENERGETICS, V1777, P1028, DOI 10.1016/j.bbabio.2008.03.029; Murphy MP, 1997, TRENDS BIOTECHNOL, V15, P326, DOI 10.1016/S0167-7799(97)01068-8; Niida H, 2007, MOL CELL BIOL, V27, P2572, DOI 10.1128/MCB.01611-06; Paglin S, 2001, CANCER RES, V61, P439; Radjendirane V, 1998, J BIOL CHEM, V273, P7382, DOI 10.1074/jbc.273.13.7382; Rao VA, 2007, CANCER RES, V67, P9971, DOI 10.1158/0008-5472.CAN-07-0804; Rao VA, 2005, MOL CELL BIOL, V25, P8925, DOI 10.1128/MCB.25.20.8925-8937.2005; Ross D, 2004, METHOD ENZYMOL, V382, P115; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017; Tasdemir Ezgi, 2008, V445, P29, DOI 10.1007/978-1-59745-157-4_3; Tasdemir E, 2007, CELL CYCLE, V6, P2263, DOI 10.4161/cc.6.18.4681; VANDENABEELE P, 2006, SCI STKE, pPE44; Wang M, 2008, J BIOL CHEM, V283, P18678, DOI 10.1074/jbc.M801855200; WARBURG O, 1956, SCIENCE, V124, P269; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zielonka J, 2008, FREE RADICAL BIO MED, V44, P835, DOI 10.1016/j.freeradbiomed.2007.11.013; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zielonka J, 2009, FREE RADICAL BIO MED, V46, P329, DOI 10.1016/j.freeradbiomed.2008.10.031	58	106	109	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34447	34459		10.1074/jbc.M110.133579	http://dx.doi.org/10.1074/jbc.M110.133579			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20805228	Green Published, hybrid			2022-12-25	WOS:000283659100019
J	Unciuleac, MC; Shuman, S				Unciuleac, Mihaela-Carmen; Shuman, Stewart			Double Strand Break Unwinding and Resection by the Mycobacterial Helicase-Nuclease AdnAB in the Presence of Single Strand DNA-binding Protein (SSB)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI RECBCD ENZYME; MOTOR-NUCLEASE; RECA PROTEIN; TRANSLOCATION; DOMAIN; RECOMBINATION; ASSOCIATION; VARIABILITY; COMPLEXES; MECHANISM	Mycobacterial AdnAB is a heterodimeric DNA helicase-nuclease and 3' to 5' DNA translocase implicated in the repair of double strand breaks (DSBs). The AdnA and AdnB subunits are each composed of an N-terminal motor domain and a C-terminal nuclease domain. Inclusion of mycobacterial single strand DNA-binding protein (SSB) in reactions containing linear plasmid dsDNA allowed us to study the AdnAB helicase under conditions in which the unwound single strands are coated by SSB and thereby prevented from reannealing or promoting ongoing ATP hydrolysis. We found that the AdnAB motor catalyzed processive unwinding of 2.7-11.2-kbp linear duplex DNAs at a rate of similar to 250 bp s(-1), while hydrolyzing similar to 5 ATPs per bp unwound. Crippling the AdnA phosphohydrolase active site did not affect the rate of unwinding but lowered energy consumption slightly, to similar to 4.2 ATPs bp(-1). Mutation of the AdnB phosphohydrolase abolished duplex unwinding, consistent with a model in which the "leading" AdnB motor propagates a Y-fork by translocation along the 3' DNA strand, ahead of the "lagging" AdnA motor domain. By tracking the resection of the 5' and 3' strands at the DSB ends, we illuminated a division of labor among the AdnA and AdnB nuclease modules during dsDNA unwinding, whereby the AdnA nuclease processes the unwound 5' strand to liberate a short oligonucleotide product, and the AdnB nuclease incises the 3' strand on which the motor translocates. These results extend our understanding of presynaptic DSB processing by AdnAB and engender instructive comparisons with the RecBCD and AddAB clades of bacterial helicase-nuclease machines.	[Unciuleac, Mihaela-Carmen; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [AI64693]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI64693.	Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Cromie GA, 2009, J BACTERIOL, V191, P5076, DOI 10.1128/JB.00254-09; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Dillingham MS, 2005, J BIOL CHEM, V280, P37069, DOI 10.1074/jbc.M505520200; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Fili N, 2010, NUCLEIC ACIDS RES, V38, P4448, DOI 10.1093/nar/gkq173; Haijema BJ, 1996, J BACTERIOL, V178, P5086, DOI 10.1128/jb.178.17.5086-5091.1996; Haijema BJ, 1996, J BACTERIOL, V178, P5130, DOI 10.1128/jb.178.17.5130-5137.1996; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Reddy MS, 2001, J BIOL CHEM, V276, P45959, DOI 10.1074/jbc.M103523200; Reuter M, 2010, NUCLEIC ACIDS RES, V38, P3721, DOI 10.1093/nar/gkq100; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2863, DOI 10.1021/bi00433a018; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2873, DOI 10.1021/bi00433a019; Saikrishnan K, 2005, ACTA CRYSTALLOGR D, V61, P1140, DOI 10.1107/S0907444905016896; Saikrishnan K, 2003, J MOL BIOL, V331, P385, DOI 10.1016/S0022-2836(03)00729-0; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Sinha KM, 2009, GENE DEV, V23, P1423, DOI 10.1101/gad.1805709; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; Unciuleac MC, 2010, J BIOL CHEM, V285, P2632, DOI 10.1074/jbc.M109.076133; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Yeeles JTP, 2007, J MOL BIOL, V371, P66, DOI 10.1016/j.jmb.2007.05.053; Yeeles JTP, 2009, J BIOL CHEM, V284, P7746, DOI 10.1074/jbc.M808526200	25	25	25	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34319	34329		10.1074/jbc.M110.162925	http://dx.doi.org/10.1074/jbc.M110.162925			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20736178	Green Published, hybrid			2022-12-25	WOS:000283659100005
J	Planel, S; Salomon, A; Jalinot, P; Feige, JJ; Cherradi, N				Planel, S.; Salomon, A.; Jalinot, P.; Feige, J-J; Cherradi, N.			A novel concept in antiangiogenic and antitumoral therapy: multitarget destabilization of short-lived mRNAs by the zinc finger protein ZFP36L1	ONCOGENE			English	Article						tumor angiogenesis; VEGF; ZFP36L1; tristetraprolin; mRNA stability; multitarget therapy	ENDOTHELIAL GROWTH-FACTOR; CELL-PENETRATING PEPTIDES; ARGININE-RICH PEPTIDES; HORMONAL-REGULATION; IN-VIVO; TRISTETRAPROLIN; DELIVERY; TRANSDUCTION; ANGIOGENESIS; EXPRESSION	Angiogenesis inhibitors have shown clinical benefits in patients with advanced cancer, but further therapeutic improvement is needed. We have previously shown that the zinc finger protein 36, C3H type-like 1 (ZFP36L1) enhances vascular endothelial growth factor (VEGF) mRNA decay through its interaction with AU-rich elements within VEGF 3'-untranslated region. In this study, we evaluated the possibility to develop an antiangiogenic and antitumoral strategy using the mRNA-destabilizing activity of ZFP36L1. We engineered a cell-penetrating ZFP36L1, by fusing it to the protein transduction domains (PTDs) TAT derived from HIV, or the polyarginine peptides R7 or R9. PTD-ZFP36L1 fusion proteins were expressed in bacterial cells and affinity-purified to homogeneity. TAT-, R7- and R9-ZFP36L1 were efficiently internalized into living cells and decreased both endogenous VEGF mRNA half-life and VEGF protein levels in vitro. Importantly, a single injection of R9-TIS11b fusion protein into a high-VEGF expressing tissue in vivo (in this study, the mouse adrenal gland) markedly decreased VEGF expression. We further evaluated the effect of R9-ZFP36L1 on tumor growth using Lewis Lung Carcinoma (LL/2) cells implanted subcutaneously into nude mice. Intratumoral injection of R9-ZFP36L1 significantly reduced tumor growth and markedly decreased the expression of multiple angiogenic and inflammatory cytokines, including VEGF, acidic fibroblast growth factor, tumor necrosis factor alpha, interleukin (IL)-1 alpha and IL-6, with a concomitant obliteration of tumor vascularization. These findings indicate that R9-ZFP36L1 fusion protein may represent a novel antiangiogenic and antitumoral agent, and supports the emerging idea that modulation of mRNA stability represents a promising therapeutic approach to treat cancer. Oncogene (2010) 29, 5989-6003; doi:10.1038/onc.2010.341; published online 30 August 2010	[Cherradi, N.] CEA Grenoble, INSERM, U878, LPAV,iRTSV, F-38054 Grenoble 09, Rhone Alpes, France; [Planel, S.; Salomon, A.; Feige, J-J; Cherradi, N.] Univ Grenoble 1, Grenoble, France; [Jalinot, P.] ENS Lyon, LBMC CNRS UMR5239, Lyon, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet	Cherradi, N (corresponding author), CEA Grenoble, INSERM, U878, LPAV,iRTSV, 17 Rue Martyrs, F-38054 Grenoble 09, Rhone Alpes, France.	nadia.cherradi@cea.fr	Feige, Jean-Jacques/M-8905-2017; Cherradi, Nadia/K-9695-2016; Jalinot, Pierre/M-7940-2014	Feige, Jean-Jacques/0000-0002-1354-7692; Cherradi, Nadia/0000-0002-4292-774X; 	Institut National de la Sante et de la Recherche Medicale (INSERM) [U878]; Commissariat a l'Energie Atomique (iRTSV/LAPV); Institut du Cancer (INCa); Canceropole Rhone-Alpes (CLARA); Groupement des Entreprises Francaises pour la Lutte contre le Cancer (GEFLUC)-Comite Dauphine -Savoie; Association pour la Recherche sur le Cancer; Fondation pour la Recherche Medicale	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Commissariat a l'Energie Atomique (iRTSV/LAPV)(French Atomic Energy Commission); Institut du Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Rhone-Alpes (CLARA); Groupement des Entreprises Francaises pour la Lutte contre le Cancer (GEFLUC)-Comite Dauphine -Savoie; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM, U878), the Commissariat a l'Energie Atomique (iRTSV/LAPV), the Institut du Cancer (INCa, Program 'Emergence des Canceropoles 2004'), the Canceropole Rhone-Alpes (CLARA) and the Groupement des Entreprises Francaises pour la Lutte contre le Cancer (GEFLUC)-Comite Dauphine -Savoie. We also thank the Association pour la Recherche sur le Cancer and the Fondation pour la Recherche Medicale for their financial support to SP. We thank Dr Didier Grunwald (LTS, iRTSV, CEA-Grenoble) for helping us with the laser confocal microscopy platform of our institute. We also thank Dr Maryline Herbet and Dr Michael Thomas (INSERM U878, iRTSV, CEA-Grenoble) for their assistance in the 'in vivo' experiments and Dr Jean-Luc Coll (INSERM U883, UJF, Grenoble, France) for his generous gift of the LL/2-luciferase cell line.	Asoh S, 2008, ADV DRUG DELIVER REV, V60, P499, DOI 10.1016/j.addr.2007.09.011; Baou M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/634520; Bell SE, 2006, DEV DYNAM, V235, P3144, DOI 10.1002/dvdy.20949; Benjamin D, 2007, EXPERT OPIN BIOL TH, V7, P1515, DOI 10.1517/14712598.7.10.1515; Benjamin D, 2006, MOL CELL BIOL, V26, P9497, DOI 10.1128/MCB.01099-06; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bigelow RLH, 2009, BREAST CANCER RES TR, V117, P31, DOI 10.1007/s10549-008-0170-7; Cai SR, 2006, EUR J PHARM SCI, V27, P311, DOI 10.1016/j.ejps.2005.10.011; Cao H, 2008, BIOTECHNOL PROGR, V24, P326, DOI 10.1021/bp070269n; Cao HP, 2009, BIOTECHNOL PROGR, V25, P461, DOI 10.1002/btpr.121; Cao HP, 2004, BIOCHEMISTRY-US, V43, P13724, DOI 10.1021/bi049014y; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chauhan A, 2007, J CONTROL RELEASE, V117, P148, DOI 10.1016/j.jconrel.2006.10.031; Cherradi N, 2006, MOL ENDOCRINOL, V20, P916, DOI 10.1210/me.2005-0121; Ciais D, 2004, ONCOGENE, V23, P8673, DOI 10.1038/sj.onc.1207939; Dirkx AEM, 2006, J LEUKOCYTE BIOL, V80, P1183, DOI 10.1189/jlb.0905495; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fittipaldi A, 2005, ADV DRUG DELIVER REV, V57, P597, DOI 10.1016/j.addr.2004.10.011; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Gariano RF, 2006, GENE EXPR PATTERNS, V6, P187, DOI 10.1016/j.modgep.2005.06.008; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; Ho A, 2001, CANCER RES, V61, P474; Jalonen U, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/40691; Kuvaja P, 2005, ONCOLOGY-BASEL, V68, P196, DOI 10.1159/000086774; Lee SK, 2005, INT J CANCER, V117, P32, DOI 10.1002/ijc.21133; Levy AP, 1998, TRENDS CARDIOVAS MED, V8, P246, DOI 10.1016/S1050-1738(98)00020-6; Li B, 2009, CANCER RES, V69, P338, DOI 10.1158/0008-5472.CAN-08-1565; Lindsay MA, 2002, CURR OPIN PHARMACOL, V2, P587, DOI 10.1016/S1471-4892(02)00199-6; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Offenberg H, 2008, MOL ONCOL, V2, P233, DOI 10.1016/j.molonc.2008.06.003; Ogilvie RL, 2009, J BIOL CHEM, V284, P11216, DOI 10.1074/jbc.M901229200; Onesto C, 2004, J BIOL CHEM, V279, P34217, DOI 10.1074/jbc.M400219200; Petrelli A, 2008, CURR MED CHEM, V15, P422; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Saidi A, 2009, INT J CANCER, V125, P1054, DOI 10.1002/ijc.24380; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Snyder EL, 2004, PHARM RES-DORDR, V21, P389, DOI 10.1023/B:PHAM.0000019289.61978.f5; Stoecklin G, 2003, ONCOGENE, V22, P3554, DOI 10.1038/sj.onc.1206418; Stumpo DJ, 2009, BLOOD, V114, P2401, DOI 10.1182/blood-2009-04-214619; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Thomas M, 2004, ENDOCRINOLOGY, V145, P4320, DOI 10.1210/en.2004-0179; Tudor C, 2009, FEBS LETT, V583, P1933, DOI 10.1016/j.febslet.2009.04.039; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003	50	26	30	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	45					5989	6003		10.1038/onc.2010.341	http://dx.doi.org/10.1038/onc.2010.341			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	678VA	20802528				2022-12-25	WOS:000284108700002
J	Zenvirt, S; Kravchenko-Balasha, N; Levitzki, A				Zenvirt, S.; Kravchenko-Balasha, N.; Levitzki, A.			Status of p53 in human cancer cells does not predict efficacy of CHK1 kinase inhibitors combined with chemotherapeutic agents	ONCOGENE			English	Article						CHK1; checkpoint; cancer; p53	DNA-DAMAGE; S-PHASE; CHECKPOINT KINASES; MITOTIC CATASTROPHE; G(2)/M TRANSITION; PATHWAY; THERAPY; ARREST; ABROGATION; ATM	DNA damage checkpoints cause cell cycle arrest, allowing DNA repair before resumption of the cell cycle. These checkpoints can be activated through several signaling pathways. Checkpoint activators include p53, checkpoint kinase 1 (CHK1), checkpoint kinase 2 and/or MAPKAP kinase 2 (MK2). Many cancer cells lack p53 activity and, therefore, depend on alternative checkpoint activators to arrest the cell cycle following DNA damage. Inhibition of these pathways is expected to specifically sensitize these p53-deficient cells to DNA damage caused by chemotherapy. Using isogenic p53-proficient and p53-deficient cancer cell lines, we show that inactivation of CHK1, but not MK2, abrogates cell cycle arrest following chemotherapy, specifically in p53-deficient cells. However, we show that CHK1 is required to maintain genome integrity and cell viability, and that p53-proficient cells are no less sensitive than p53-deficient cells to CHK1 inhibition in the presence of DNA damage. Thus, combining CHK1 inhibition with DNA damage does not lead to preferential killing of p53-deficient over p53-proficient cells, and inhibiting CHK1 does not appear to be a promising approach for potentiation of cancer chemotherapy. Oncogene (2010) 29, 6149-6159; doi:10.1038/onc.2010.343; published online 23 August 2010	[Zenvirt, S.; Kravchenko-Balasha, N.; Levitzki, A.] Hebrew Univ Jerusalem, Dept Biol Chem, Unit Cellular Signaling, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Levitzki, A (corresponding author), Hebrew Univ Jerusalem, Dept Biol Chem, Unit Cellular Signaling, IL-91904 Jerusalem, Israel.	Levitzki@vms.huji.ac.il	Kravchenko-Balasha, Nataly/D-7683-2016	Kravchenko-Balasha, Nataly/0000-0001-6943-7479	Lady Davis Fellowship Trust; Algen Biopharmaceuticals, Ltd.	Lady Davis Fellowship Trust; Algen Biopharmaceuticals, Ltd.	We would like to thank Dr Shoshana Klein for discussions and editing. This work was partially supported by the Lady Davis Fellowship Trust and by Algen Biopharmaceuticals, Ltd.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ashwell S, 2008, EXPERT OPIN INV DRUG, V17, P1331, DOI [10.1517/13543784.17.9.1331, 10.1517/13543784.17.9.1331 ]; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen ZH, 2006, INT J CANCER, V119, P2784, DOI 10.1002/ijc.22198; Cho SH, 2005, CELL CYCLE, V4, P131, DOI 10.4161/cc.4.1.1299; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; DENT MF, 1995, CYTOTECHNOLOGY, V17, P27, DOI 10.1007/BF00749218; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Finkel E, 1999, SCIENCE, V286, P2256, DOI 10.1126/science.286.5448.2256; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hirose Y, 2001, CANCER RES, V61, P5843; Karisson-Rosenthal C, 2006, TRENDS CELL BIOL, V16, P285, DOI 10.1016/j.tcb.2006.04.002; Kawabe T, 2004, MOL CANCER THER, V3, P513; Kravchenko-Balasha N, 2009, J BIOL CHEM, V284, P11717, DOI 10.1074/jbc.M900217200; Levesque AA, 2008, MOL CANCER THER, V7, P252, DOI 10.1158/1535-7163.MCT-07-2066; Lieberman HB, 2008, CURR MED CHEM, V15, P360, DOI 10.2174/092986708783497328; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; O'Connor MJ, 2007, ONCOGENE, V26, P7816, DOI 10.1038/sj.onc.1210879; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Petermann E, 2006, CELL CYCLE, V5, P2203, DOI 10.4161/cc.5.19.3256; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Senderowicz AM, 2003, CANCER CHEMOTH PHARM, V52, pS61, DOI 10.1007/s00280-003-0624-x; Shao RG, 1997, CANCER RES, V57, P4029; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Tao YG, 2009, CELL CYCLE, V8, P1196, DOI 10.4161/cc.8.8.8203; Tse AN, 2004, CANCER RES, V64, P6635, DOI 10.1158/0008-5472.CAN-04-0841; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang QZ, 1996, J NATL CANCER I, V88, P956, DOI 10.1093/jnci/88.14.956; Xiao Z, 2006, MOL CANCER THER, V5, P1935, DOI 10.1158/1535-7163.MCT-06-0077; Zhang WH, 2008, CELL CYCLE, V7, P1668, DOI 10.4161/cc.7.11.5982; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296; Zhou BBS, 2003, CANCER BIOL THER, V2, pS16; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	42	45	46	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	46					6149	6159		10.1038/onc.2010.343	http://dx.doi.org/10.1038/onc.2010.343			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	681XD	20729914	Bronze			2022-12-25	WOS:000284356500007
J	Perales-Calvo, J; Muga, A; Moro, F				Perales-Calvo, Judit; Muga, Arturo; Moro, Fernando			Role of DnaJ G/F-rich Domain in Conformational Recognition and Binding of Protein Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; TRANSCRIPTION FACTOR SIGMA(32); MOLECULAR CHAPERONE DNAJ; ESCHERICHIA-COLI DNAJ; FINGER-LIKE DOMAIN; ENDOPLASMIC-RETICULUM; PEPTIDE SUBSTRATE; CRYSTAL-STRUCTURE; ATPASE ACTIVITY; HSP40 SIS1	DnaJ from Escherichia coli is a Type I Hsp40 that functions as a cochaperone of DnaK(Hsp70), stimulating its ATPase activity and delivering protein substrates. How DnaJ binds protein substrates is still poorly understood. Here we have studied the role of DnaJ G/F-rich domain in binding of several substrates with different conformational properties (folded, partially (un) folded and unfolded). Using partial proteolysis we find that RepE, a folded substrate, contacts a wide DnaJ area that involves part of the G/F-rich region and Zn-binding domain. Deletion of G/F-rich region hampers binding of native RepE and reduced the affinity for partially (un) folded substrates. However, binding of completely unfolded substrates is independent on the G/F-rich region. These data indicate that DnaJ distinguishes the substrate conformation and is able to adapt the use of the G/F-rich region to form stable substrate complexes.	[Muga, Arturo] Univ Basque Country, Fac Ciencia & Tecnol, Unidad Biofis CSIC UPV EHU, E-48080 Bilbao, Spain; Univ Basque Country, Fac Ciencia & Tecnol, Dept Bioquim & Biol Mol, E-48080 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country	Muga, A (corresponding author), Univ Basque Country, Fac Ciencia & Tecnol, Unidad Biofis CSIC UPV EHU, Apartado 644, E-48080 Bilbao, Spain.	arturo.muga@ehu.es; fernando.moro@ehu.es	Muga, Arturo/N-1174-2014; Moro Pérez, Fernando/P-3891-2015	Muga, Arturo/0000-0003-0345-6882; Moro Pérez, Fernando/0000-0002-3568-3388	Ministerio de Educacion e Innovacion [BFU2007-64452]; Gobierno Vasco [IT-358-07]; Diputacion Foral de Bizkaia [DIPE08/18]	Ministerio de Educacion e Innovacion; Gobierno Vasco(Basque Government); Diputacion Foral de Bizkaia	This work was supported by the Ministerio de Educacion e Innovacion (BFU2007-64452), Gobierno Vasco (Grant IT-358-07), and Diputacion Foral de Bizkaia (Grant DIPE08/18).	Aron R, 2005, GENETICS, V169, P1873, DOI 10.1534/genetics.104.037242; Banecki B, 1996, J BIOL CHEM, V271, P14840, DOI 10.1074/jbc.271.25.14840; Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; CYR DM, 1995, FEBS LETT, V359, P129, DOI 10.1016/0014-5793(95)00024-4; Fan CY, 2004, MOL BIOL CELL, V15, P761, DOI 10.1091/mbc.E03-03-0146; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Feifel B, 1998, J BIOL CHEM, V273, P11999, DOI 10.1074/jbc.273.20.11999; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Goffin L, 1998, MOL MICROBIOL, V30, P329, DOI 10.1046/j.1365-2958.1998.01067.x; Gruschus JM, 2004, BIOCHEMISTRY-US, V43, P3111, DOI 10.1021/bi0354740; ISHIAI M, 1994, P NATL ACAD SCI USA, V91, P3839, DOI 10.1073/pnas.91.9.3839; Jin Y, 2009, BIOCHEMISTRY-US, V48, P41, DOI 10.1021/bi8015923; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Lee S, 2002, J BIOL CHEM, V277, P21675, DOI 10.1074/jbc.M111075200; Li JZ, 2009, PROTEIN PEPTIDE LETT, V16, P606, DOI 10.2174/092986609788490159; Li JZ, 2005, BIOCHEM J, V386, P453, DOI 10.1042/BJ20041050; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Mehl AF, 2001, BIOCHEM BIOPH RES CO, V282, P562, DOI 10.1006/bbrc.2001.4567; Mokranjac D, 2006, EMBO J, V25, P4675, DOI 10.1038/sj.emboj.7601334; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; Moro F, 2005, FEBS J, V272, P3184, DOI 10.1111/j.1742-4658.2005.04737.x; Moro F, 2003, FEBS LETT, V533, P119, DOI 10.1016/S0014-5793(02)03752-3; Ramos CHI, 2008, J MOL BIOL, V383, P155, DOI 10.1016/j.jmb.2008.08.019; Rist W, 2003, J BIOL CHEM, V278, P51415, DOI 10.1074/jbc.M307160200; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; SADLER I, 1989, J CELL BIOL, V109, P2665, DOI 10.1083/jcb.109.6.2665; Schlieker C, 2004, FEBS LETT, V578, P351, DOI 10.1016/j.febslet.2004.11.051; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; SHECHTER Y, 1973, BIOCHEMISTRY-US, V12, P3407, DOI 10.1021/bi00742a007; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Shi YY, 2005, J BIOL CHEM, V280, P22761, DOI 10.1074/jbc.M503643200; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; WALL D, 1994, J BIOL CHEM, V269, P5446; WALL D, 1995, J BIOL CHEM, V270, P2139, DOI 10.1074/jbc.270.5.2139; WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19300, DOI 10.1074/jbc.270.33.19300; WOO KM, 1992, J BIOL CHEM, V267, P20429; ZYLICZ M, 1985, J BIOL CHEM, V260, P7591; Zzaman S, 2004, J BIOL CHEM, V279, P17404, DOI 10.1074/jbc.M400021200	46	48	49	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34231	34239		10.1074/jbc.M110.144642	http://dx.doi.org/10.1074/jbc.M110.144642			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729526	hybrid, Green Published			2022-12-25	WOS:000283354000068
J	Ribeiro-Resende, VT; Ribeiro-Guimaraes, ML; Lemes, RMR; Nascimento, IC; Alves, L; Mendez-Otero, R; Pessolani, MCV; Lara, FA				Ribeiro-Resende, Victor Tulio; Ribeiro-Guimaraes, Michelle Lopes; Rodrigues Lemes, Robertha Mariana; Nascimento, Isis Cristina; Alves, Lucineia; Mendez-Otero, Rosalia; Vidal Pessolani, Maria Cristina; Lara, Flavio Alves			Involvement of 9-O-Acetyl GD3 Ganglioside in Mycobacterium leprae Infection of Schwann Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL-NERVE; FUNCTIONAL-ROLE; NEURONAL MIGRATION; ALPHA-DYSTROGLYCAN; ENDOTHELIAL-CELLS; GROWTH-FACTOR; GLYCOSPHINGOLIPIDS; DEMYELINATION; LOCALIZATION; ORGANIZATION	Mycobacterium leprae (ML), the etiologic agent of leprosy, mainly affects the skin and peripheral nerves, leading to demyelization and loss of axonal conductance. Schwann cells (SCs) are the main cell population infected by ML in the nerves, and infection triggers changes in the SC phenotype from a myelinated to a nonmyelinated state. In the present study, we show that expression of 9-O-acetyl GD3, a ganglioside involved in cellular anti-apoptotic signaling and nerve regeneration, increases in SCs following infection with ML. Observation by confocal microscopy together with coimmunoprecipitation suggested that this ganglioside participates in ML attachment and internalization by SC. Immunoblockage of 9-O-acetyl GD3 in vitro significantly reduced adhesion of ML to SC surfaces. Finally, we show that activation of the MAPK (ERK 1/2) pathway and SC proliferation, two known effects of ML on SCs that result in demyelization, are significantly reduced when the 9-O-acetyl GD3 ganglioside is immunoblocked. Taken together, these data suggest the involvement of 9-O-acetyl GD3 in ML infection on SCs.	[Alves, Lucineia; Vidal Pessolani, Maria Cristina] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Microbiol Celular, BR-21045900 Rio De Janeiro, Brazil; [Ribeiro-Resende, Victor Tulio; Nascimento, Isis Cristina; Mendez-Otero, Rosalia] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Biofis Carlos Chagas Filho, Lab Neurobiol Celular & Mol, BR-21941902 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Ribeiro-Resende, VT (corresponding author), Pavilhao Hanseniase IOC, Av Brasil 4365 Manguinhos, BR-21045900 Rio De Janeiro, Brazil.	vtulio@biof.ufrj.br	Lara, Flavio Alves/L-1861-2013; Lemes, Robertha/AAE-8757-2019; Mendez-Otero, Rosalia/AAL-7551-2020; Neurociencia, Inct/I-1011-2013	Lemes, Robertha/0000-0001-9322-4262; Mendez-Otero, Rosalia/0000-0002-1798-9930; Nascimento, Isis/0000-0002-2633-8216	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; American Leprosy Missions; Order of St. Lazarus; Universidade Federal do Rio de Janeiro	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Oswaldo Cruz; American Leprosy Missions; Order of St. Lazarus; Universidade Federal do Rio de Janeiro	This work was supported by grants from the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro and from the Fundacao Oswaldo Cruz and by funds from the American Leprosy Missions and the Order of St. Lazarus.; We thank Dr. Janet W. Reid for the English revision, Dr. Jose Oswaldo Previato and Dr. Adriane Todeschini from Universidade Federal do Rio de Janeiro for the excellent scientific support, the American Leprosy Missions and the Order of St. Lazarus, which support Dr. James Krahenbuhl and Dr. Ramanuj Lahiri from National Hansen's Disease Program, who kindly donated the Mycobacterium leprae used in this work and trained us to produce ML in the nude mice model, and Dr. Patrick Brennan from Colorado State University for kindly providing the IgG anti-alpha-HLP and IgG anti-alpha-Lam.	COLSTON MJ, 1976, NATURE, V262, P399, DOI 10.1038/262399a0; Gong Y, 2002, BRAIN, V125, P2491, DOI 10.1093/brain/awf258; Hall H, 2003, MOL CELL NEUROSCI, V24, P1062, DOI 10.1016/j.mcn.2003.08.007; HARRIS EB, 1986, INT J LEPROSY, V54, P289; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Katoch V M, 1999, Indian J Lepr, V71, P45; KHANOLKAR VR, 1964, INDIAN J MED RES, V52, P139; Kniep B, 2006, INT J CANCER, V119, P67, DOI 10.1002/ijc.21788; Malisan F, 2002, BBA-MOL CELL BIOL L, V1585, P179, DOI 10.1016/S1388-1981(02)00339-6; MANZI AE, 1990, J BIOL CHEM, V265, P8094; Marques MAM, 2001, J MED MICROBIOL, V50, P23, DOI 10.1099/0022-2615-50-1-23; Mendez-Otero R, 2003, Prog Mol Subcell Biol, V32, P97; Mendez-Otero R, 2003, BRAZ J MED BIOL RES, V36, P1003, DOI 10.1590/S0100-879X2003000800006; MendezOtero R, 1996, EUR J CELL BIOL, V71, P192; Miyakoshi LM, 2001, BRAZ J MED BIOL RES, V34, P669, DOI 10.1590/S0100-879X2001000500016; Mukhejee P, 2008, J LIPID RES, V49, P929, DOI 10.1194/jlr.R800006-JLR200; Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2; Occhi S, 2005, J NEUROSCI, V25, P9418, DOI 10.1523/JNEUROSCI.2068-05.2005; Rambukkana A, 1998, SCIENCE, V282, P2076, DOI 10.1126/science.282.5396.2076; Rambukkana A, 1997, CELL, V88, P811, DOI 10.1016/S0092-8674(00)81927-3; Rambukkana A, 2002, SCIENCE, V296, P927, DOI 10.1126/science.1067631; Rambukkana A, 2000, LEPROSY REV, V71, pS168; Ribeiro-Resende VT, 2007, NEUROSCIENCE, V147, P97, DOI 10.1016/j.neuroscience.2007.03.046; Rodrigues LS, 2010, CELL MICROBIOL, V12, P42, DOI 10.1111/j.1462-5822.2009.01377.x; Saito F, 2003, NEURON, V38, P747, DOI 10.1016/S0896-6273(03)00301-5; Santiago MF, 2004, J NEUROSCI, V24, P474, DOI 10.1523/JNEUROSCI.0116-03.2004; Santiago MF, 2001, MOL CELL NEUROSCI, V17, P488, DOI 10.1006/mcne.2000.0943; SCHLOSSHAUER B, 1988, J NEUROSCI, V8, P580; Scollard DM, 1999, AM J PATHOL, V154, P1611, DOI 10.1016/S0002-9440(10)65414-4; Scollard DM, 2000, MICROBES INFECT, V2, P1835, DOI 10.1016/S1286-4579(00)01335-6; Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006; Shepard C C, 1968, Int J Lepr Other Mycobact Dis, V36, P78; Simons M, 2001, AM J PATHOL, V159, P1069, DOI 10.1016/S0002-9440(10)61782-8; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; Tapinos N, 2005, P NATL ACAD SCI USA, V102, P9188, DOI 10.1073/pnas.0501196102; Tapinos N, 2006, NAT MED, V12, P961, DOI 10.1038/nm1433; THOMPSON TE, 1985, ANNU REV BIOPHYS BIO, V14, P361, DOI 10.1146/annurev.biophys.14.1.361; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; VANLENTEN L, 1971, J BIOL CHEM, V246, P1889; Vyas AA, 2002, P NATL ACAD SCI USA, V99, P8412, DOI 10.1073/pnas.072211699; Vyas AA, 2001, BIOCHIMIE, V83, P677, DOI 10.1016/S0300-9084(01)01308-6; Vyas KA, 2001, BIOL CHEM, V382, P241, DOI 10.1515/BC.2001.031; Yang CR, 2007, J NEUROSCI RES, V85, P1381, DOI 10.1002/jnr.21264	43	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34086	34096		10.1074/jbc.M110.147272	http://dx.doi.org/10.1074/jbc.M110.147272			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20739294	hybrid, Green Published			2022-12-25	WOS:000283354000054
J	Dey, S; Baird, TD; Zhou, DH; Palam, LR; Spandau, DF; Wek, RC				Dey, Souvik; Baird, Thomas D.; Zhou, Donghui; Palam, Lakshmi Reddy; Spandau, Dan F.; Wek, Ronald C.			Both Transcriptional Regulation and Translational Control of ATF4 Are Central to the Integrated Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; HEPATITIS-C VIRUS; NF-KAPPA-B; EIF2-ALPHA KINASE; EUKARYOTIC INITIATION-FACTOR-2; OXIDATIVE STRESS; MAMMALIAN-CELLS; GENE-EXPRESSION; GCN2	In response to different environmental stresses, phosphorylation of eIF2 (eIF2 similar to P) represses global translation coincident with preferential translation of ATF4. ATF4 is a transcriptional activator of the integrated stress response, a program of gene expression involved in metabolism, nutrient uptake, anti-oxidation, and the activation of additional transcription factors, such as CHOP/GADD153, that can induce apoptosis. Although eIF2-P elicits translational control in response to many different stress arrangements, there are selected stresses, such as exposure to UV irradiation, that do not increase ATF4 expression despite robust eIF2 similar to P. In this study we addressed the underlying mechanism for variable expression of ATF4 in response to eIF2 similar to P during different stress conditions and the biological significance of omission of enhanced ATF4 function. We show that in addition to translational control, ATF4 expression is subject to transcriptional regulation. Stress conditions such as endoplasmic reticulum stress induce both transcription and translation of ATF4, which together enhance expression of ATF4 and its target genes in response to eIF2 similar to P. By contrast, UV irradiation represses ATF4 transcription, which diminishes ATF4 mRNA available for translation during eIF2 similar to P. eIF2 similar to P enhances cell survival in response to UV irradiation. However, forced expression of ATF4 and its target gene CHOP leads to increased sensitivity to UV irradiation. This combination of transcriptional regulation and translational control allows the eIF2 kinase pathway to selectively repress or activate key regulatory genes subject to preferential translation, providing the integrated stress response versatility to direct the transcriptome that is essential for maintaining the balance between stress remediation and apoptosis.	[Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Spandau, Dan F.] Indiana Univ, Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Wek, RC (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iupui.edu	palam, lakshmi reddy/H-4902-2015	Baird, Thomas/0000-0002-0280-9984	National Institutes of Health [R01 GM49164, GM64350]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164, R01GM064350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM49164 and GM64350 (to R. C. W.).	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; ENGELBERG D, 1994, CELL, V77, P381, DOI 10.1016/0092-8674(94)90153-8; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Jiang HY, 2005, BIOCHEM J, V385, P371, DOI 10.1042/BJ20041164; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Kumar R, 2003, J CEREBR BLOOD F MET, V23, P462, DOI 10.1097/01.WCB.0000056064.25434.CA; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Lewis DA, 2008, MOL BIOL CELL, V19, P1346, DOI 10.1091/mbc.E07-10-1041; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Nakka VP, 2010, NEUROTOX RES, V17, P189, DOI 10.1007/s12640-009-9110-5; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Oh YK, 2008, J NEUROCHEM, V104, P993, DOI 10.1111/j.1471-4159.2007.05053.x; Powley IR, 2009, GENE DEV, V23, P1207, DOI 10.1101/gad.516509; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Staschke KA, 2010, J BIOL CHEM, V285, P16893, DOI 10.1074/jbc.M110.121947; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Wang X, 2009, TRENDS CELL BIOL, V19, P260, DOI 10.1016/j.tcb.2009.03.005; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	48	148	153	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					33165	33174		10.1074/jbc.M110.167213	http://dx.doi.org/10.1074/jbc.M110.167213			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20732869	hybrid, Green Published			2022-12-25	WOS:000283048200054
J	Goh, YY; Pal, M; Chong, HC; Zhu, PC; Tan, MJ; Punugu, L; Tan, CK; Huang, RL; Sze, SK; Tang, MBY; Ding, JL; Kersten, S; Tan, NS				Goh, Yan Yih; Pal, Mintu; Chong, Han Chung; Zhu, Pengcheng; Tan, Ming Jie; Punugu, Lakshmi; Tan, Chek Kun; Huang, Royston-Luke; Sze, Siu Kwan; Tang, Mark Boon Yang; Ding, Jeak Ling; Kersten, Sander; Tan, Nguan Soon			Angiopoietin-like 4 Interacts with Matrix Proteins to Modulate Wound Healing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-BETA/DELTA; HUMAN EPIDERMAL-KERATINOCYTES; PPAR-BETA/DELTA; TRANSCRIPTIONAL CONTROL; CELL-GROWTH; EXPRESSION; BETA; MIGRATION; TARGET; REPAIR	A dynamic cell-matrix interaction is crucial for a rapid cellular response to changes in the environment. Appropriate cell behavior in response to the changing wound environment is required for efficient wound closure. However, the way in which wound keratinocytes modify the wound environment to coordinate with such cellular responses remains less studied. We demonstrated that angiopoietin-like 4 (ANGPTL4) produced by wound keratinocytes coordinates cell-matrix communication. ANGPTL4 interacts with vitronectin and fibronectin in the wound bed, delaying their proteolytic degradation by metalloproteinases. This interaction does not interfere with integrin-matrix protein recognition and directly affects cell-matrix communication by altering the availability of intact matrix proteins. These interactions stimulate integrin- focal adhesion kinase, 14-3-3, and PKC-mediated signaling pathways essential for effective wound healing. The deficiency of ANGPTL4 in mice delays wound re-epithelialization. Further analysis revealed that cell migration was impaired in the ANGPTL4-deficient keratinocytes. Altogether, the findings provide molecular insight into a novel control of wound healing via ANGPTL4-dependent regulation of cell-matrix communication. Given the known role of ANGPTL4 in glucose and lipid homeostasis, it is a prime therapeutic candidate for the treatment of diabetic wounds. It also underscores the importance of cell-matrix communication during angiogenesis and cancer metastasis.	[Goh, Yan Yih; Pal, Mintu; Chong, Han Chung; Zhu, Pengcheng; Tan, Ming Jie; Punugu, Lakshmi; Tan, Chek Kun; Huang, Royston-Luke; Sze, Siu Kwan; Tan, Nguan Soon] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Tang, Mark Boon Yang] Natl Skin Ctr, Singapore 308205, Singapore; [Ding, Jeak Ling] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Kersten, Sander] Wageningen Univ, NL-6700 EV Wageningen, Netherlands	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Skin Centre; National University of Singapore; Wageningen University & Research	Tan, NS (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	nstan@ntu.edu.sg	Ding, Jeak/H-8057-2012; Kersten, Sander/A-1116-2011; Sze, Siu Kwan/AAO-3342-2020; Goh, Yan Yih/J-1926-2015; Sze, Siu_kwan Newman/A-2199-2011; Tan, Nguan Soon/A-2220-2011	Kersten, Sander/0000-0003-4488-7734; Sze, Siu Kwan/0000-0002-5652-1687; Goh, Yan Yih/0000-0002-8922-9869; Sze, Siu_kwan Newman/0000-0002-5652-1687; Tan, Nguan Soon/0000-0003-0136-7341	A*STAR BMRC [05/1/22/19/377]; Ministry of Education [ARC 18/08]; Nanyang Technological University [RGD 127/05, 158/06]	A*STAR BMRC(Agency for Science Technology & Research (A*STAR)); Ministry of Education; Nanyang Technological University(Nanyang Technological University)	This work was supported by A*STAR BMRC Grant 05/1/22/19/377, Ministry of Education Grant ARC 18/08, and Nanyang Technological University Grants RGD 127/05 and 158/06.	Belanger AJ, 2002, J MOL CELL CARDIOL, V34, P765, DOI 10.1006/jmcc.2002.2021; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Bulcao C, 2006, CURR DIABETES REV, V2, P19, DOI 10.2174/157339906775473617; Burdick AD, 2006, CELL SIGNAL, V18, P9, DOI 10.1016/j.cellsig.2005.07.009; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chong HC, 2009, J CELL BIOL, V184, P817, DOI 10.1083/jcb.200809028; DELLAMBRA E, 1995, J CELL SCI, V108, P3569; Denning MF, 2004, INT J BIOCHEM CELL B, V36, P1141, DOI 10.1016/j.biocel.2003.12.004; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Frank S, 2000, J CLIN INVEST, V106, P501, DOI 10.1172/JCI9148; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Grose R, 2002, EMBO REP, V3, P575, DOI 10.1093/embo-reports/kvf119; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Legler DF, 2001, J CELL SCI, V114, P1545; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Oike Y, 2005, TRENDS MOL MED, V11, P473, DOI 10.1016/j.molmed.2005.08.002; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; Roberts MS, 2004, MOL CELL BIOL, V24, P1505, DOI 10.1128/MCB.24.4.1505-1515.2004; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tan NS, 2007, MOL CELL BIOL, V27, P7161, DOI 10.1128/MCB.00436-07; Tan NS, 2000, FASEB J, V14, P859, DOI 10.1096/fasebj.14.7.859; Tan NS, 2005, J BIOL CHEM, V280, P18163, DOI 10.1074/jbc.M412829200; Tan NS, 2004, EMBO J, V23, P4211, DOI 10.1038/sj.emboj.7600437; Tan NS, 2004, EXPERT OPIN THER TAR, V8, P39, DOI 10.1517/eott.8.1.39.26404; Tan NS, 2003, AM J CLIN DERMATOL, V4, P523, DOI 10.2165/00128071-200304080-00001; Tan NS, 2002, PROTEIN ENG, V15, P337, DOI 10.1093/protein/15.4.337; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Tan SH, 2009, J BIOL CHEM, V284, P18047, DOI 10.1074/jbc.M109.002691; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102	45	97	99	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32999	33009		10.1074/jbc.M110.108175	http://dx.doi.org/10.1074/jbc.M110.108175			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20729546	Green Published, hybrid			2022-12-25	WOS:000283048200037
J	Hannas, BR; Das, PC; Li, H; LeBlanc, GA				Hannas, Bethany R.; Das, Parikshit C.; Li, Hong; LeBlanc, Gerald A.			Intracellular Conversion of Environmental Nitrate and Nitrite to Nitric Oxide with Resulting Developmental Toxicity to the Crustacean Daphnia magna	PLOS ONE			English	Article							CYTOCHROME-OXIDASE; HYPOXIC CONDITIONS; IN-VIVO; REDUCTION; NITROGEN; GENERATION; EUTROPHICATION; NITRIFICATION; REPRODUCTION; DEGRADATION	Background: Nitrate and nitrite (jointly referred to herein as NO(x)) are ubiquitous environmental contaminants to which aquatic organisms are at particularly high risk of exposure. We tested the hypothesis that NO(x) undergo intracellular conversion to the potent signaling molecule nitric oxide resulting in the disruption of endocrine-regulated processes. Methodology/Principal Findings: These experiments were performed with insect cells (Drosophila S2) and whole organisms Daphnia magna. We first evaluated the ability of cells to convert nitrate (NO(3)(-)) and nitrite (NO(2)(-)) to nitric oxide using amperometric real-time nitric oxide detection. Both NO(3)(-) and NO(2)(-) were converted to nitric oxide in a substrate concentration-dependent manner. Further, nitric oxide trapping and fluorescent visualization studies revealed that perinatal daphnids readily convert NO(2)(-) to nitric oxide. Next, daphnids were continuously exposed to concentrations of the nitric oxide-donor sodium nitroprusside (positive control) and to concentrations of NO(3)(-) and NO(2)(-). All three compounds interfered with normal embryo development and reduced daphnid fecundity. Developmental abnormalities were characteristic of those elicited by compounds that interfere with ecdysteroid signaling. However, no compelling evidence was generated to indicate that nitric oxide reduced ecdysteroid titers. Conclusions/Significance: Results demonstrate that nitrite elicits developmental and reproductive toxicity at environmentally relevant concentrations due likely to its intracellular conversion to nitric oxide.	[Hannas, Bethany R.; Das, Parikshit C.; Li, Hong; LeBlanc, Gerald A.] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Hannas, BR (corresponding author), US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA.	Gerald_leblanc@ncsu.edu			US Environmental Protection Agency [RD-83273901]; National Science Foundation [IOS-0744210]; EPA; National Institute of Environmental Health Sciences [T32 ES007046]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007046] Funding Source: NIH RePORTER	US Environmental Protection Agency(United States Environmental Protection Agency); National Science Foundation(National Science Foundation (NSF)); EPA(United States Environmental Protection Agency); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by US Environmental Protection Agency STAR grant RD-83273901 and National Science Foundation grant IOS-0744210 to GAL. BRH was supported by an EPA STAR Fellowship and National Institute of Environmental Health Sciences training grant #T32 ES007046. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer DL, 2002, J FOOD PROTECT, V65, P872, DOI 10.4315/0362-028X-65.5.872; BALTHIS WL, CCMADR0001 NOAA; BENJAMIN N, 1994, NATURE, V368, P502, DOI 10.1038/368502a0; Bjorne H, 2006, FREE RADICAL BIO MED, V41, P1404, DOI 10.1016/j.freeradbiomed.2006.07.020; BOCK E, 1995, ARCH MICROBIOL, V163, P16, DOI 10.1007/BF00262198; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Camargo JA, 2006, ENVIRON INT, V32, P831, DOI 10.1016/j.envint.2006.05.002; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; Dave G, 2005, AQUAT TOXICOL, V73, P11, DOI 10.1016/j.aquatox.2005.02.006; DOWNES MT, 1988, APPL ENVIRON MICROB, V54, P172, DOI 10.1128/AEM.54.1.172-175.1988; FARRELL AJ, 1992, ANN RHEUM DIS, V51, P1219, DOI 10.1136/ard.51.11.1219; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; Godber BLJ, 2000, J BIOL CHEM, V275, P7757, DOI 10.1074/jbc.275.11.7757; Guillette LJ, 2005, INTEGR COMP BIOL, V45, P19, DOI 10.1093/icb/45.1.19; Harris SH, 2009, CHEM GEOL, V267, P77, DOI 10.1016/j.chemgeo.2009.01.028; Howarth R. W., 2000, ISSUES ECOLOGY, V7, P1; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; Ignarro IG, 2000, NITRIC OXIDE BIOL PA; Jansson EA, 2008, NAT CHEM BIOL, V4, P411, DOI 10.1038/nchembio.92; Jensen FB, 2003, COMP BIOCHEM PHYS A, V135, P9, DOI 10.1016/S1095-6433(02)00323-9; Kelso BHL, 1997, APPL ENVIRON MICROB, V63, P4679, DOI 10.1128/AEM.63.12.4679-4685.1997; Larsen FJ, 2006, NEW ENGL J MED, V355, P2792, DOI 10.1056/NEJMc062800; Leavesley HB, 2008, TOXICOL SCI, V101, P101, DOI 10.1093/toxsci/kfm254; LeBlanc GA, 2000, ENVIRON HEALTH PERSP, V108, P1133, DOI 10.2307/3434824; Li HT, 2006, J BIOL CHEM, V281, P12546, DOI 10.1074/jbc.M511803200; Li HT, 2001, J BIOL CHEM, V276, P24482, DOI 10.1074/jbc.M011648200; Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573; Mu XY, 2002, GEN COMP ENDOCR, V129, P127, DOI 10.1016/S0016-6480(02)00518-X; Mu XY, 2002, J EXP ZOOL, V292, P287, DOI 10.1002/jez.10020; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Nordin R.N., 2001, WATER QUALITY CRITER; PAITIAN NA, 1985, BIOCHEM BIOPH RES CO, V133, P1104, DOI 10.1016/0006-291X(85)91250-1; Palma P, 2009, CHEMOSPHERE, V74, P676, DOI 10.1016/j.chemosphere.2008.10.021; Panesar NS, 2000, TOXICOL APPL PHARM, V169, P222, DOI 10.1006/taap.2000.9079; Philips Sarah, 2002, Re/Views in Environmental Science and Bio/Technology, V1, P115, DOI 10.1023/A:1020892826575; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Rosselli M, 1998, HUM REPROD UPDATE, V4, P3, DOI 10.1093/humupd/4.1.3; Scavia D, 2006, BIOGEOCHEMISTRY, V79, P187, DOI 10.1007/s10533-006-9011-0; SCHNEIDER F, 1994, HEPATOLOGY, V19, P38, DOI 10.1016/0270-9139(94)90050-7; SHARMA B, 1977, WATER RES, V11, P897, DOI 10.1016/0043-1354(77)90078-1; Smith VH, 1999, ENVIRON POLLUT, V100, P179, DOI 10.1016/S0269-7491(99)00091-3; SORENSEN J, 1978, APPL ENVIRON MICROB, V35, P301; Subramoniam T, 2000, COMP BIOCHEM PHYS C, V125, P135, DOI 10.1016/S0742-8413(99)00098-5; Turner RE, 2008, ENVIRON SCI TECHNOL, V42, P2323, DOI 10.1021/es071617k; United States Environmental Protection Agency, 2002, EPA822R02038; *US EPA, 1977, 570976003 USEPA; Virag L, 2003, TOXICOL LETT, V140, P113, DOI 10.1016/S0378-4274(02)00508-8; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VLADUTIU AO, 2002, CLIN IMMUNOL IMMUNOP, V76, P1; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; ZWEIER JL, 1995, NAT MED, V1, P804, DOI 10.1038/nm0895-804	52	39	40	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12453	10.1371/journal.pone.0012453	http://dx.doi.org/10.1371/journal.pone.0012453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805993	gold, Green Published, Green Submitted			2022-12-25	WOS:000281301500019
J	Wankhade, UD; Vella, KR; Fox, DL; Good, DJ				Wankhade, Umesh D.; Vella, Kristen R.; Fox, Dana L.; Good, Deborah J.			Deletion of Nhlh2 Results in a Defective Torpor Response and Reduced Beta Adrenergic Receptor Expression in Adipose Tissue	PLOS ONE			English	Article							COLD-EXPOSURE; BETA-3-ADRENERGIC RECEPTOR; MOLECULAR CHARACTERIZATION; GENE-EXPRESSION; OBESE GENE; BROWN; TRANSCRIPTION; CLONING; MICE; FAT	Background: Mice with a targeted deletion of the basic helix-loop-helix transcription factor, Nescient Helix-Loop-Helix 2 (Nhlh2), display adult-onset obesity with significant increases in their fat depots, abnormal responses to cold exposure, and reduced spontaneous physical activity levels. These phenotypes, accompanied by the hypothalamic expression of Nhlh2, make the Nhlh2 knockout (N2KO) mouse a useful model to study the role of central nervous system (CNS) control on peripheral tissue such as adipose tissue. Methodology: Differences in body temperature and serum analysis of leptin were performed in fasted and ad lib fed wildtype (WT) and N2KO mice. Histological analysis of white (WAT) and brown adipose tissue (BAT) was performed. Gene and protein level expression of inflammatory and metabolic markers were compared between the two genotypes. Principal Findings: We report significant differences in serum leptin levels and body temperature in N2KO mice compared with WT mice exposed to a 24-hour fast, suggestive of a defect in both white (WAT) and brown adipose tissue (BAT) function. As compared to WT mice, N2KO mice showed increased serum IL-6 protein and WAT IL-6 mRNA levels. This was accompanied by slight elevations of mRNA for several macrophage markers, including expression of macrophage specific protein F4/80 in adipose, suggestive of macrophage infiltration of WAT in the mutant animals. The mRNAs for beta 3-adrenergic receptors (beta 3-AR), beta 2-AR and uncoupling proteins were significantly reduced in WAT and BAT from N2KO mice compared with WT mice. Conclusions: These studies implicate Nhlh2 in the central control of WAT and BAT function, with lack of Nhlh2 leading to adipose inflammation and altered gene expression, impaired leptin response to fasting, all suggestive of a deficient torpor response in mutant animals.	[Wankhade, Umesh D.; Fox, Dana L.; Good, Deborah J.] Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA; [Vella, Kristen R.; Fox, Dana L.; Good, Deborah J.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Vella, Kristen R.; Fox, Dana L.; Good, Deborah J.] Univ Massachusetts, Mol & Cellular Biol Grad Program, Amherst, MA 01003 USA	Virginia Polytechnic Institute & State University; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Wankhade, UD (corresponding author), Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA.	goodd@vt.edu	Wankhade, Umesh/J-8739-2015	Wankhade, Umesh/0000-0003-4810-221X	National Institutes of Health (NIH) [R01 DK59903, T32 MH020051]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020051] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by funding from the National Institutes of Health (NIH): R01 DK59903 (to DJG) and T32 MH020051 (to KRV) and internal departmental and college funds (DJG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Bamshad M, 1998, AM J PHYSIOL-REG I, V275, pR291, DOI 10.1152/ajpregu.1998.275.1.R291; Bamshad M, 1999, AM J PHYSIOL-REG I, V276, pR1569, DOI 10.1152/ajpregu.1999.276.6.R1569; Bartness TJ, 2007, PHYSIOL BEHAV, V91, P343, DOI 10.1016/j.physbeh.2007.04.002; Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; BRAY GA, 1978, NATURE, V274, P900, DOI 10.1038/274900a0; Brito MN, 2007, ENDOCRINOLOGY, V148, P5339, DOI 10.1210/en.2007-0621; BRODIE BB, 1966, J PHARMACOL EXP THER, V154, P493; CANTU RC, 1967, AM J PHYSIOL, V212, P207, DOI 10.1152/ajplegacy.1967.212.1.207; Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193; Coyle CA, 2002, PHYSIOL BEHAV, V77, P387, DOI 10.1016/S0031-9384(02)00885-5; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dodt C, 2003, ACTA PHYSIOL SCAND, V177, P351, DOI 10.1046/j.1365-201X.2003.01077.x; EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461; Flier JS, 1998, J CLIN ENDOCR METAB, V83, P1407, DOI 10.1210/jc.83.5.1407; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; FOSTER MT, 2009, OBESITY SILVER SPRIN; Fox DL, 2008, MOL ENDOCRINOL, V22, P1438, DOI 10.1210/me.2008-0010; Garofalo MAR, 1996, J AUTONOM NERV SYST, V60, P206, DOI 10.1016/0165-1838(96)00037-9; Gettys TW, 1996, ENDOCRINOLOGY, V137, P4054, DOI 10.1210/en.137.9.4054; Gnacinska M, 2010, ENDOKRYNOL POL, V61, P160; Good DJ, 2008, EXERC SPORT SCI REV, V36, P187, DOI 10.1097/JES.0b013e31818782dd; Good DJ, 1997, NAT GENET, V15, P397, DOI 10.1038/ng0497-397; GOOD DJ, 2007, SOURCEBOOK MODELS BI, P683; GRANNEMAN JG, 1991, MOL PHARMACOL, V40, P895; GRANNEMAN JG, 1993, MOL PHARMACOL, V44, P264; Hardie LJ, 1996, BIOCHEM BIOPH RES CO, V223, P660, DOI 10.1006/bbrc.1996.0951; Jing EX, 2004, ENDOCRINOLOGY, V145, P1503, DOI 10.1210/en.2003-0834; LAZZARINI SJ, 1991, AM J PHYSIOL, V260, pR47, DOI 10.1152/ajpregu.1991.260.1.R47; Migliorini RH, 1997, AM J PHYSIOL-REG I, V272, pR656, DOI 10.1152/ajpregu.1997.272.2.R656; MOINAT M, 1995, FEBS LETT, V373, P131, DOI 10.1016/0014-5793(95)01030-I; MUZZIN P, 1991, J BIOL CHEM, V266, P24053; Nagase I, 1996, J CLIN INVEST, V97, P2898, DOI 10.1172/JCI118748; NAHMIAS C, 1991, EMBO J, V10, P3721, DOI 10.1002/j.1460-2075.1991.tb04940.x; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; Rikke BA, 2003, MECH AGEING DEV, V124, P663, DOI 10.1016/S0047-6374(03)00003-4; Ruschke K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005516; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Song CK, 2008, AM J PHYSIOL-REG I, V295, pR417, DOI 10.1152/ajpregu.00174.2008; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483, DOI 10.1074/jbc.270.49.29483; Swoap SJ, 2006, J NEUROSCI, V26, P241, DOI 10.1523/JNEUROSCI.3721-05.2006; Swoap SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004038; TRAYHURN P, 1995, FEBS LETT, V368, P488, DOI 10.1016/0014-5793(95)00719-P; Vella KR, 2007, J NEUROENDOCRINOL, V19, P499, DOI 10.1111/j.1365-2826.2007.01556.x; VELLA KR, 2010, NEUROENDOCRINOLOGY J, V3, P38; Voss-Andreae A, 2007, ENDOCRINOLOGY, V148, P1550, DOI 10.1210/en.2006-1389; Youngstrom TG, 1998, AM J PHYSIOL-REG I, V275, pR1488, DOI 10.1152/ajpregu.1998.275.5.R1488; YOUNGSTROM TG, 1995, AM J PHYSIOL-REG I, V268, pR744, DOI 10.1152/ajpregu.1995.268.3.R744; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	51	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12324	10.1371/journal.pone.0012324	http://dx.doi.org/10.1371/journal.pone.0012324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808804	gold, Green Submitted, Green Published			2022-12-25	WOS:000281153500010
J	Tyagi, A; Bag, SK; Shukla, V; Roy, S; Tuli, R				Tyagi, Antariksh; Bag, Sumit K.; Shukla, Virendra; Roy, Sribash; Tuli, Rakesh			Oligonucleotide Frequencies of Barcoding Loci Can Discriminate Species across Kingdoms	PLOS ONE			English	Article							DNA BARCODES; TAXONOMY; IDENTIFY; IDENTIFICATION; LIFE	Background: DNA barcoding refers to the use of short DNA sequences for rapid identification of species. Genetic distance or character attributes of a particular barcode locus discriminate the species. We report an efficient approach to analyze short sequence data for discrimination between species. Methodology and Principal Findings: A new approach, Oligonucleotide Frequency Range (OFR) of barcode loci for species discrimination is proposed. OFR of the loci that discriminates between species was characteristic of a species, i.e., the maxima and minima within a species did not overlap with that of other species. We compared the species resolution ability of different barcode loci using p-distance, Euclidean distance of oligonucleotide frequencies, nucleotide-character based approach and OFR method. The species resolution by OFR was either higher or comparable to the other methods. A short fragment of 126 bp of internal transcribed spacer region in ribosomal RNA gene was sufficient to discriminate a majority of the species using OFR. Conclusions/Significance: Oligonucleotide frequency range of a barcode locus can discriminate between species. Ability to discriminate species using very short DNA fragments may have wider applications in forensic and conservation studies.	[Tyagi, Antariksh; Bag, Sumit K.; Shukla, Virendra; Roy, Sribash; Tuli, Rakesh] CSIR, Natl Bot Res Inst, Ctr Plant Mol Biol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI)	Tyagi, A (corresponding author), CSIR, Natl Bot Res Inst, Ctr Plant Mol Biol, Lucknow, Uttar Pradesh, India.	rakeshtuli@hotmail.com	Bag, Sumit/AAP-5728-2020; Bag, Sumit K/B-4010-2013; TULI, RAKESH/AAD-3047-2021; Tyagi, Antariksh/F-4367-2015	Bag, Sumit/0000-0001-8907-2841; Bag, Sumit K/0000-0001-8907-2841; Tyagi, Antariksh/0000-0002-4662-077X				Abe T, 2003, GENOME RES, V13, P693, DOI 10.1101/gr.634603; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Campbell A, 1999, P NATL ACAD SCI USA, V96, P9184, DOI 10.1073/pnas.96.16.9184; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hudson RR, 2003, EVOLUTION, V57, P182; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; KARLIN S, 1994, P NATL ACAD SCI USA, V91, P12832, DOI 10.1073/pnas.91.26.12832; KARLIN S, 1995, TRENDS GENET, V11, P283; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lipscomb D, 2003, TRENDS ECOL EVOL, V18, P65, DOI 10.1016/S0169-5347(02)00060-5; Machado CA, 2003, P ROY SOC B-BIOL SCI, V270, P1193, DOI 10.1098/rspb.2003.2333; Marshall E, 2005, SCIENCE, V307, P1037, DOI 10.1126/science.307.5712.1037; MAYR E, 1957, SPECIES PROBLEM, P371; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Nakashima H, 1998, DNA Res, V5, P251, DOI 10.1093/dnares/5.5.251; Nakashima H, 1997, DNA Res, V4, P185, DOI 10.1093/dnares/4.3.185; Newmaster SG, 2008, MOL ECOL RESOUR, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Rubinoff D, 2006, TRENDS ECOL EVOL, V21, P1, DOI 10.1016/j.tree.2005.10.019; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; Takahashi M, 2009, GENOMICS, V93, P525, DOI 10.1016/j.ygeno.2009.01.009; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tautz D, 2002, NATURE, V418, P479, DOI 10.1038/418479a; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x	45	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12330	10.1371/journal.pone.0012330	http://dx.doi.org/10.1371/journal.pone.0012330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808837	gold, Green Published, Green Submitted			2022-12-25	WOS:000281077000018
J	Lomholt, HB; Kilian, M				Lomholt, Hans B.; Kilian, Mogens			Population Genetic Analysis of Propionibacterium acnes Identifies a Subpopulation and Epidemic Clones Associated with Acne	PLOS ONE			English	Article							INFLAMMATORY ACNE; ESCHERICHIA-COLI; GENOME SEQUENCE; EXPRESSION; KERATINOCYTES; DIVERSITY; RESISTANT; VULGARIS; STRAINS; LIPOGENESIS	The involvement of Propionibacterium acnes in the pathogenesis of acne is controversial, mainly owing to its dominance as an inhabitant of healthy skin. This study tested the hypothesis that specific evolutionary lineages of the species are associated with acne while others are compatible with health. Phylogenetic reconstruction based on nine housekeeping genes was performed on 210 isolates of P. acnes from well-characterized patients with acne, various opportunistic infections, and from healthy carriers. Although evidence of recombination was observed, the results showed a basically clonal population structure correlated with allelic variation in the virulence genes tly and camp5, with pulsed field gel electrophoresis (PFGE)- and biotype, and with expressed putative virulence factors. An unexpected geographically and temporal widespread dissemination of some clones was demonstrated. The population comprised three major divisions, one of which, including an epidemic clone, was strongly associated with moderate to severe acne while others were associated with health and opportunistic infections. This dichotomy correlated with previously observed differences in in vitro inflammation-inducing properties. Comparison of five genomes representing acne-and health-associated clones revealed multiple both cluster-and strain-specific genes that suggest major differences in ecological preferences and redefines the spectrum of disease-associated virulence factors. The results of the study indicate that particular clones of P. acnes play an etiologic role in acne while others are associated with health.	[Lomholt, Hans B.; Kilian, Mogens] Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark	Aarhus University	Lomholt, HB (corresponding author), Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark.	kilian@microbiology.au.dk		Kilian, Mogens/0000-0002-5861-0472	LeoPharma Research Foundation	LeoPharma Research Foundation(LEO Pharma)	The project was supported by a non-conditional grant from the LeoPharma Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaza N, 2009, J DERMATOL, V36, P213, DOI 10.1111/j.1346-8138.2009.00626.x; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bek-Thomsen M, 2008, J CLIN MICROBIOL, V46, P3355, DOI 10.1128/JCM.00799-08; Brochet M, 2008, P NATL ACAD SCI USA, V105, P15961, DOI 10.1073/pnas.0803654105; BROOK I, 1991, REV INFECT DIS, V13, P819; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; BURKE BM, 1984, BRIT J DERMATOL, V111, P83, DOI 10.1111/j.1365-2133.1984.tb04020.x; CAUGANT DA, 1981, GENETICS, V98, P467; Coenye T, 2007, RES MICROBIOL, V158, P386, DOI 10.1016/j.resmic.2007.02.001; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Grange PA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000527; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; HOFFLER U, 1981, ZBL BAKT-INT J MED M, V250, P122; Hohwy J, 2001, INFECT IMMUN, V69, P6055, DOI 10.1128/IAI.69.10.6055-6063.2001; HOLLAND KT, 1974, J APPL BACTERIOL, V37, P289, DOI 10.1111/j.1365-2672.1974.tb00443.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Iinuma K, 2009, J INVEST DERMATOL, V129, P2113, DOI 10.1038/jid.2009.46; Jakab E, 1996, YALE J BIOL MED, V69, P477; James WD, 2005, NEW ENGL J MED, V352, P1463, DOI 10.1056/NEJMcp033487; Jappe U, 2004, J EUR ACAD DERMATOL, V18, P450, DOI 10.1111/j.1468-3083.2004.00950.x; JOHNSON JL, 1972, J BACTERIOL, V109, P1047, DOI 10.1128/JB.109.3.1047-1066.1972; Kang S, 2005, AM J PATHOL, V166, P1691, DOI 10.1016/S0002-9440(10)62479-0; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; KISHISHITA M, 1979, APPL ENVIRON MICROB, V38, P585, DOI 10.1128/AEM.38.4.585-589.1979; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; McDowell A, 2005, J CLIN MICROBIOL, V43, P326, DOI 10.1128/JCM.43.1.326-334.2005; McDowell A, 2008, J MED MICROBIOL, V57, P218, DOI 10.1099/jmm.0.47489-0; MILLS OH, 1983, DERMATOLOGICA, V167, P57; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Nagy I, 2005, J INVEST DERMATOL, V124, P931, DOI 10.1111/j.0022-202X.2005.23705.x; Nagy I, 2006, MICROBES INFECT, V8, P2195, DOI 10.1016/j.micinf.2006.04.001; Nakatsuji T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001551; Oprica C, 2004, ANAEROBE, V10, P155, DOI 10.1016/j.anaerobe.2004.02.002; Ross JI, 2003, BRIT J DERMATOL, V148, P467, DOI 10.1046/j.1365-2133.2003.05067.x; Sapadin AN, 2006, J AM ACAD DERMATOL, V54, P258, DOI 10.1016/j.jaad.2005.10.004; Schaller M, 2005, BRIT J DERMATOL, V153, P66, DOI 10.1111/j.1365-2133.2005.06530.x; SELANDER RK, 1990, BACTERIA TREATISE ST, V11, P11; SMITH RF, 1968, APPL MICROBIOL, V16, P1434, DOI 10.1128/AEM.16.9.1434-1436.1968; Sugisaki H, 2009, J DERMATOL SCI, V55, P47, DOI 10.1016/j.jdermsci.2009.02.015; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Trivedi NR, 2006, J INVEST DERMATOL, V126, P1071, DOI 10.1038/sj.jid.5700213; Valanne S, 2005, MICROBIOL-SGM, V151, P1369, DOI 10.1099/mic.0.27788-0; VOWELS BR, 1995, INFECT IMMUN, V63, P3158, DOI 10.1128/IAI.63.8.3158-3165.1995; WHITTAM TS, 1996, ESCHERICHIA COLI SAL, P2708; WILLIAMS.P, 1965, J INVEST DERMATOL, V45, P498, DOI 10.1038/jid.1965.164; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zouboulis CC, 2009, J INVEST DERMATOL, V129, P2093, DOI 10.1038/jid.2009.190	50	174	188	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12277	10.1371/journal.pone.0012277	http://dx.doi.org/10.1371/journal.pone.0012277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808860	Green Submitted, Green Published, gold			2022-12-25	WOS:000281075500012
J	Spitznagel, D; O'Rourke, JF; Leddy, N; Hanrahan, O; Nolan, DP				Spitznagel, Diana; O'Rourke, John F.; Leddy, Neal; Hanrahan, Orla; Nolan, Derek P.			Identification and Characterization of an Unusual Class I Myosin Involved in Vesicle Traffic in Trypanosoma brucei	PLOS ONE			English	Article							BLOOD-STREAM FORMS; HOST-CELL INVASION; ACANTHAMOEBA MYOSIN; UNCONVENTIONAL MYOSINS; GLIDING MOTILITY; PLASMA-MEMBRANE; EARLY ENDOSOMES; FYVE DOMAIN; ACTIN; ENDOCYTOSIS	Myosins are a multimember family of motor proteins with diverse functions in eukaryotic cells. African trypanosomes possess only two candidate myosins and thus represent a useful system for functional analysis of these motors. One of these candidates is an unusual class I myosin (TbMyo1) that is expressed at similar levels but organized differently during the life cycle of Trypanosoma brucei. This myosin localizes to the polarized endocytic pathway in bloodstream forms of the parasite. This organization is actin dependent. Knock down of TbMyo1 results in a significant reduction in endocytic activity, a cessation in cell division and eventually cell death. A striking morphological feature in these cells is an enlargement of the flagellar pocket, which is consistent with an imbalance in traffic to and from the surface. In contrast TbMyo1 is distributed throughout procyclic forms of the tsetse vector and a loss of similar to 90% of the protein has no obvious effects on growth or morphology. These results reveal a life cycle stage specific requirement for this myosin in essential endocytic traffic and represent the first description of the involvement of a motor protein in vesicle traffic in these parasites.	[Spitznagel, Diana; Hanrahan, Orla; Nolan, Derek P.] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Mol Parasitol Grp, Dublin 2, Ireland; [Leddy, Neal] Univ Dublin Trinity Coll, Ctr Microscopy & Anal, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin	Spitznagel, D (corresponding author), Univ Dublin Trinity Coll, Sch Biochem & Immunol, Mol Parasitol Grp, Dublin 2, Ireland.	denolan@tcd.ie		Nolan, Derek/0000-0002-3742-4304	Wellcome Trust; Science Foundation Ireland (SFI) [07/RFP/BICF358]	Wellcome Trust(Wellcome TrustEuropean Commission); Science Foundation Ireland (SFI)(Science Foundation Ireland)	This work has been supported by the Wellcome Trust senior fellowship award (DN) and Research Frontiers Programme Award (07/RFP/BICF358) from Science Foundation Ireland (SFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; BANNISTER LH, 1995, ANN TROP MED PARASIT, V89, P105, DOI 10.1080/00034983.1995.11812940; Barylko B, 2000, BBA-MOL CELL RES, V1496, P23, DOI 10.1016/S0167-4889(00)00006-9; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Brawley CM, 2009, P NATL ACAD SCI USA, V106, P9685, DOI 10.1073/pnas.0810451106; BRICKMAN MJ, 1993, EXP PARASITOL, V76, P329, DOI 10.1006/expr.1993.1041; BRUN R, 1979, ACTA TROP, V36, P289; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; DOBERSTEIN SK, 1992, J CELL BIOL, V117, P1241, DOI 10.1083/jcb.117.6.1241; Dobrowolski JM, 1997, MOL MICROBIOL, V26, P163, DOI 10.1046/j.1365-2958.1997.5671913.x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; ENGSTLER M, 2007, TRYPANSOMES GENOME; Field MC, 2007, TRAFFIC, V8, P629, DOI 10.1111/j.1600-0854.2007.00558.x; Field MC, 1999, PARASITOL TODAY, V15, P365, DOI 10.1016/S0169-4758(99)01499-4; Field MC, 2004, TRAFFIC, V5, P905, DOI 10.1111/j.1600-0854.2004.00234.x; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; GIRAO H, 2008, FEBS LETT, V21, P12; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall BS, 2006, J BIOL CHEM, V281, P27600, DOI 10.1074/jbc.M602183200; Hayakawa A, 2004, J BIOL CHEM, V279, P5958, DOI 10.1074/jbc.M310503200; Hayakawa A, 2006, P NATL ACAD SCI USA, V103, P11928, DOI 10.1073/pnas.0508832103; HAYDEN SM, 1990, J CELL BIOL, V111, P443, DOI 10.1083/jcb.111.2.443; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Idrissi FZ, 2008, J CELL BIOL, V180, P1219, DOI 10.1083/jcb.200708060; Jonsdottir GA, 2004, CURR BIOL, V14, P1604, DOI 10.1016/j.cub.2004.08.055; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kappe SHI, 2004, TRENDS PARASITOL, V20, P13, DOI 10.1016/j.pt.2003.10.011; Katta SS, 2009, MOL BIOCHEM PARASIT, V164, P105, DOI 10.1016/j.molbiopara.2008.12.002; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Kumar S, 2007, EUKARYOT CELL, V6, P2029, DOI 10.1128/EC.00213-07; Kutateladze TG, 2006, BBA-MOL CELL BIOL L, V1761, P868, DOI 10.1016/j.bbalip.2006.03.011; Lee WL, 1999, J BIOL CHEM, V274, P35159, DOI 10.1074/jbc.274.49.35159; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; Morgan GW, 2004, J BIOL CHEM, V279, P10692, DOI 10.1074/jbc.M312178200; Morgan GW, 2002, TRENDS PARASITOL, V18, P540, DOI 10.1016/S1471-4922(02)02392-9; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; Neuhaus EM, 2000, J CELL BIOL, V150, P1013, DOI 10.1083/jcb.150.5.1013; Nolan DP, 2008, MOL BIOCHEM PARASIT, V157, P233, DOI 10.1016/j.molbiopara.2007.10.006; Nolan DP, 1999, CURR BIOL, V9, P1169, DOI 10.1016/S0960-9822(00)80018-4; O'Beirne C, 1998, MOL BIOCHEM PARASIT, V91, P165, DOI 10.1016/S0166-6851(97)00191-6; Oberholzer U, 2004, EUKARYOT CELL, V3, P1272, DOI 10.1128/EC.3.5.1272-1286.2004; Ostap EM, 2003, CELL MOTIL CYTOSKEL, V54, P29, DOI 10.1002/cm.10081; Overath P, 2004, MOL MICROBIOL, V53, P735, DOI 10.1111/j.1365-2958.2004.04224.x; Peck RF, 2008, MOL MICROBIOL, V68, P933, DOI 10.1111/j.1365-2958.2008.06195.x; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; POLLARD TD, 1973, J BIOL CHEM, V248, P4691; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Raposo G, 1999, MOL BIOL CELL, V10, P1477, DOI 10.1091/mbc.10.5.1477; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; Salas-Cortes L, 2005, J CELL SCI, V118, P4823, DOI 10.1242/jcs.02607; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Senda S, 2000, FEBS LETT, V484, P125, DOI 10.1016/S0014-5793(00)02137-2; Soldati T, 2003, TRAFFIC, V4, P358, DOI 10.1034/j.1600-0854.2003.t01-1-00095.x; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; SPITZNAGEL D, 2009, FEBS J; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Tang NY, 2002, J BIOL CHEM, V277, P42763, DOI 10.1074/jbc.M206388200; Taunton J, 2001, CURR OPIN CELL BIOL, V13, P85, DOI 10.1016/S0955-0674(00)00178-2; Tazeh NN, 2009, EUKARYOT CELL, V8, P1352, DOI 10.1128/EC.00156-09; Titus MA, 2000, J EUKARYOT MICROBIOL, V47, P191, DOI 10.1111/j.1550-7408.2000.tb00038.x; Tsiavaliaris G, 2008, J BIOL CHEM, V283, P4520, DOI 10.1074/jbc.M708113200; Tuxworth RI, 2000, TRAFFIC, V1, P11, DOI 10.1034/j.1600-0854.2000.010103.x; VOORHEIS HP, 1979, BIOCHEM J, V180, P11, DOI 10.1042/bj1800011; WEBSTER P, 1990, J CELL SCI, V96, P249; Wetzel DM, 2003, MOL BIOL CELL, V14, P396, DOI 10.1091/mbc.E02-08-0458; Yamashita RA, 1998, J BIOL CHEM, V273, P14644, DOI 10.1074/jbc.273.23.14644; Ye J, 2008, GENE DEV, V22, P322, DOI 10.1101/gad.455908	72	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12282	10.1371/journal.pone.0012282	http://dx.doi.org/10.1371/journal.pone.0012282			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808867	Green Published, Green Submitted, gold			2022-12-25	WOS:000281075500016
J	Wright, AP; Fox, AN; Johnson, KG; Zinn, K				Wright, Ashley P.; Fox, A. Nicole; Johnson, Karl G.; Zinn, Kai			Systematic Screening of Drosophila Deficiency Mutations for Embryonic Phenotypes and Orphan Receptor Ligands	PLOS ONE			English	Article							MOTOR AXON GUIDANCE; GROWTH CONE GUIDANCE; NERVOUS-SYSTEM; TYROSINE PHOSPHATASES; GENE ENCODES; MELANOGASTER; PROTEIN; MIDLINE; CELLS; GLIA	This paper defines a collection of Drosophila deletion mutations (deficiencies) that can be systematically screened for embryonic phenotypes, orphan receptor ligands, and genes affecting protein localization. It reports the results of deficiency screens we have conducted that have revealed new axon guidance phenotypes in the central nervous system and neuromuscular system and permitted a quantitative assessment of the number of potential genes involved in regulating guidance of specific motor axon branches. Deficiency "kits" that cover the genome with a minimum number of lines have been established to facilitate gene mapping. These kits cannot be systematically analyzed for phenotypes, however, since embryos homozygous for many deficiencies in these kits fail to develop due to the loss of key gene products encoded within the deficiency. To create new kits that can be screened for phenotype, we have examined the development of the nervous system in embryos homozygous for more than 700 distinct deficiency mutations. A kit of similar to 400 deficiency lines for which homozygotes have a recognizable nervous system and intact body walls encompasses >80% of the genome. Here we show examples of screens of this kit for orphan receptor ligands and neuronal antigen expression. It can also be used to find genes involved in expression, patterning, and subcellular localization of any protein that can be visualized by antibody staining. A subset kit of 233 deficiency lines, for which homozygotes develop relatively normally to late stage 16, covers similar to 50% of the genome. We have screened it for axon guidance phenotypes, and we present examples of new phenotypes we have identified. The subset kit can be used to screen for phenotypes affecting all embryonic organs. In the future, these deficiency kits will allow Drosophila researchers to rapidly and efficiently execute genome-wide anatomical screens that require examination of individual embryos at high magnification.	[Wright, Ashley P.; Fox, A. Nicole; Zinn, Kai] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Johnson, Karl G.] Pomona Coll, Dept Biol, Claremont, CA 91711 USA; [Johnson, Karl G.] Pomona Coll, Program Neurosci, Claremont, CA 91711 USA	California Institute of Technology; Claremont Colleges; Pomona College; Claremont Colleges; Pomona College	Wright, AP (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	zinnk@caltech.edu		Fox, Nicole/0000-0001-5012-9177; Johnson, Karl/0000-0003-3931-5985	NIH [NS028182, NS062821]; NSF [IOS-0841551]; NRSA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028182, R01NS062821] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH RO1 grants NS028182 and NS062821 to Kai Zinn, NSF grant IOS-0841551 to Karl Johnson and NRSA postdoctoral fellowship to A. Nicole Fox. The funders had no role in study design, collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso TB, 2002, DEV BIOL, V248, P369, DOI 10.1006/dbio.2002.0740; ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; CAMPBELL G, 1994, DEVELOPMENT, V120, P2957; CREWS ST, 1988, CELL, V52, P143, DOI 10.1016/0092-8674(88)90538-7; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Desai CJ, 1997, DEVELOPMENT, V124, P1941; Erhardt S, 2008, J CELL BIOL, V183, P805, DOI 10.1083/jcb.200806038; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; Giesen K, 2003, MECH DEVELOP, V120, P401, DOI 10.1016/S0925-4773(03)00009-1; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Gryzik T, 2004, CURR BIOL, V14, P659, DOI 10.1016/j.cub.2004.03.058; HALTER DA, 1995, DEVELOPMENT, V121, P317; Hidalgo A, 2000, DEVELOPMENT, V127, P393; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Kammerer M, 2001, EMBO J, V20, P4664, DOI 10.1093/emboj/20.17.4664; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545, DOI 10.1146/annurev.ne.19.030196.002553; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Le Du MH, 2001, J BIOL CHEM, V276, P9158, DOI 10.1074/jbc.M009250200; Lee HY, 2009, J VIS EXP; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; Schindelholz B, 2001, DEVELOPMENT, V128, P4371; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Sink H, 2001, CELL, V105, P57, DOI 10.1016/S0092-8674(01)00296-3; Stathopoulos A, 2004, GENE DEV, V18, P687, DOI 10.1101/gad.1166404; THOMAS JB, 1988, CELL, V52, P133, DOI 10.1016/0092-8674(88)90537-5; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Vincent S, 1996, DEVELOPMENT, V122, P131; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981	36	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12288	10.1371/journal.pone.0012288	http://dx.doi.org/10.1371/journal.pone.0012288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808815	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000281075500020
J	Barone, MV; Nanayakkara, M; Paolella, G; Maglio, M; Vitale, V; Troiano, R; Ribecco, MTS; Lania, G; Zanzi, D; Santagata, S; Auricchio, R; Troncone, R; Auricchio, S				Barone, Maria Vittoria; Nanayakkara, Merlin; Paolella, Giovanni; Maglio, Mariantonia; Vitale, Virginia; Troiano, Raffaele; Ribecco, Maria Teresa Silvia; Lania, Giuliana; Zanzi, Delia; Santagata, Sara; Auricchio, Renata; Troncone, Riccardo; Auricchio, Salvatore			Gliadin Peptide P31-43 Localises to Endocytic Vesicles and Interferes with Their Maturation	PLOS ONE			English	Article							CELIAC-DISEASE; INTRAEPITHELIAL LYMPHOCYTES; IMMUNE-RESPONSE; ALPHA-GLIADIN; HRS; PROTEIN; ACTIVATION; CHALLENGE; RECEPTOR; MUCOSA	Background: Celiac Disease (CD) is both a frequent disease (1:100) and an interesting model of a disease induced by food. It consists in an immunogenic reaction to wheat gluten and glutenins that has been found to arise in a specific genetic background; however, this reaction is still only partially understood. Activation of innate immunity by gliadin peptides is an important component of the early events of the disease. In particular the so-called "toxic'' A-gliadin peptide P31-43 induces several pleiotropic effects including Epidermal Growth Factor Receptor (EGFR)-dependent actin remodelling and proliferation in cultured cell lines and in enterocytes from CD patients. These effects are mediated by delayed EGFR degradation and prolonged EGFR activation in endocytic vesicles. In the present study we investigated the effects of gliadin peptides on the trafficking and maturation of endocytic vesicles. Methods/Principal Findings: Both P31-43 and the control P57-68 peptide labelled with fluorochromes were found to enter CaCo-2 cells and interact with the endocytic compartment in pulse and chase, time-lapse, experiments. P31-43 was localised to vesicles carrying early endocytic markers at time points when P57-68-carrying vesicles mature into late endosomes. In time-lapse experiments the trafficking of P31-43-labelled vesicles was delayed, regardless of the cargo they were carrying. Furthermore in celiac enterocytes, from cultured duodenal biopsies, P31-43 trafficking is delayed in early endocytic vesicles. A sequence similarity search revealed that P31-43 is strikingly similar to Hrs, a key molecule regulating endocytic maturation. A-gliadin peptide P31-43 interfered with Hrs correct localisation to early endosomes as revealed by western blot and immunofluorescence microscopy. Conclusions: P31-43 and P57-68 enter cells by endocytosis. Only P31-43 localises at the endocytic membranes and delays vesicle trafficking by interfering with Hrs-mediated maturation to late endosomes in cells and intestinal biopsies. Consequently, in P31-43-treated cells, Receptor Tyrosin Kinase (RTK) activation is extended. This finding may explain the role played by gliadin peptides in inducing proliferation and other effects in enterocytes from CD biopsies.	[Barone, Maria Vittoria; Nanayakkara, Merlin; Maglio, Mariantonia; Vitale, Virginia; Troiano, Raffaele; Ribecco, Maria Teresa Silvia; Lania, Giuliana; Zanzi, Delia; Santagata, Sara; Auricchio, Renata; Troncone, Riccardo; Auricchio, Salvatore] Univ Naples Federico II, Dept Pediat, Naples, Italy; [Barone, Maria Vittoria; Nanayakkara, Merlin; Maglio, Mariantonia; Vitale, Virginia; Troiano, Raffaele; Ribecco, Maria Teresa Silvia; Lania, Giuliana; Zanzi, Delia; Santagata, Sara; Auricchio, Renata; Troncone, Riccardo; Auricchio, Salvatore] Univ Naples Federico II, European Lab Invest Food Induced Dis ELFID, Naples, Italy; [Paolella, Giovanni; Ribecco, Maria Teresa Silvia] CEINGE Biotecnol Avanzate, Naples, Italy; [Paolella, Giovanni] Univ Naples Federico II, Dept Biochem, Naples, Italy	University of Naples Federico II; University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II	Barone, MV (corresponding author), Univ Naples Federico II, Dept Pediat, Naples, Italy.	salauric@unina.it	santagata, sara/AAA-5225-2020; AURICCHIO, RENATA/AAC-7718-2022	santagata, sara/0000-0001-8680-084X; Ribecco, Maria Teresa Silvia/0000-0003-3278-9221; NANAYAKKARA, MERLIN/0000-0002-2569-4606; BARONE, Maria Vittoria/0000-0001-6190-4917	LEGGE	LEGGE	Grant Support: LEGGE (Regional Low) 5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; AURICCHIO S, 1982, PEDIATR RES, V16, P1004, DOI 10.1203/00006450-198212000-00006; AURICCHIO S, 1984, BIOCHEM BIOPH RES CO, V121, P428, DOI 10.1016/0006-291X(84)90200-6; Barone MV, 2007, GUT, V56, P480, DOI 10.1136/gut.2005.086637; Bouamr F, 2007, J VIROL, V81, P2909, DOI 10.1128/JVI.01413-06; Cantarella C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S12-S12; CAPUTO I, 2010, BBA MOL BAS IN PRESS; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Ciclitira PJ, 1998, DIGEST DIS, V16, P337, DOI 10.1159/000016887; Clemente MG, 2003, GUT, V52, P218, DOI 10.1136/gut.52.2.218; DERITIS G, 1988, GASTROENTEROLOGY, V94, P41, DOI 10.1016/0016-5085(88)90607-5; Diosdado B, 2004, GUT, V53, P944, DOI 10.1136/gut.2003.018374; FRIIS S, 1992, GUT, V33, P1487, DOI 10.1136/gut.33.11.1487; Giovannini C, 2000, TOXICOLOGY, V145, P63, DOI 10.1016/S0300-483X(99)00223-1; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Hayakawa A, 2000, J BIOL CHEM, V275, P29636, DOI 10.1074/jbc.M002696200; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Jabri B, 2000, GASTROENTEROLOGY, V118, P867, DOI 10.1016/S0016-5085(00)70173-9; Juuti-Uusitalo K, 2007, CLIN EXP IMMUNOL, V150, P294, DOI 10.1111/j.1365-2249.2007.03500.x; KOMADA M, 1995, MOL CELL BIOL, V15, P6213; Lahteenoja H, 2000, AM J GASTROENTEROL, V95, P2880, DOI 10.1016/S0002-9270(00)01049-2; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Maiuri L, 1996, SCAND J GASTROENTERO, V31, P247, DOI 10.3109/00365529609004874; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Maiuri L, 2001, AM J GASTROENTEROL, V96, P150; Maiuri L, 2010, GUT, V59, P311, DOI 10.1136/gut.2009.183608; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MARSH MN, 1995, GASTROENTEROLOGY, V108, pA871; Matysiak-Budnik T, 2003, GASTROENTEROLOGY, V125, P696, DOI 10.1016/S0016-5085(03)01049-7; Matysiak-Budnik T, 2008, J EXP MED, V205, P143, DOI 10.1084/jem.20071204; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Nikulina M, 2004, J IMMUNOL, V173, P1925, DOI 10.4049/jimmunol.173.3.1925; Pal A, 2006, J CELL BIOL, V172, P605, DOI 10.1083/jcb.200509091; Pullan L, 2006, STRUCTURE, V14, P661, DOI 10.1016/j.str.2006.01.012; Raiborg C, 2002, CELL STRUCT FUNCT, V27, P403, DOI 10.1247/csf.27.403; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Raiborg C, 2001, BIOCHEM SOC T, V29, P472, DOI 10.1042/BST0290472; Raiborg C, 2008, EXP CELL RES, V314, P801, DOI 10.1016/j.yexcr.2007.10.014; SAVIDGE TC, 1995, GUT, V36, P321, DOI 10.1136/gut.36.3.321; Schumann M, 2008, GUT, V57, P747, DOI 10.1136/gut.2007.136366; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Thomas KE, 2006, J IMMUNOL, V176, P2512, DOI 10.4049/jimmunol.176.4.2512; Tollefsen S, 2006, J CLIN INVEST, V116, P2226, DOI 10.1172/JCI27620; Tuckova L, 2002, J LEUKOCYTE BIOL, V71, P625; Vilasi S, 2010, J MOL RECOGNIT, V23, P322, DOI 10.1002/jmr.987; WRIGHT N, 1973, GUT, V14, P603, DOI 10.1136/gut.14.8.603; Zimmer KP, 2010, GUT, V59, P300, DOI 10.1136/gut.2008.169656; Zimmer KP, 1998, FASEB J, V12, P1349, DOI 10.1096/fasebj.12.13.1349	50	50	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12246	10.1371/journal.pone.0012246	http://dx.doi.org/10.1371/journal.pone.0012246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805894	Green Published, gold, Green Submitted			2022-12-25	WOS:000281011600018
J	Nourissat, G; Diop, A; Maurel, N; Salvat, C; Dumont, S; Pigenet, A; Gosset, M; Houard, X; Berenbaum, F				Nourissat, Geoffroy; Diop, Amadou; Maurel, Nathalie; Salvat, Colette; Dumont, Sylvie; Pigenet, Audrey; Gosset, Marjolaine; Houard, Xavier; Berenbaum, Francis			Mesenchymal Stem Cell Therapy Regenerates the Native Bone-Tendon Junction after Surgical Repair in a Degenerative Rat Model	PLOS ONE			English	Article							ROTATOR CUFF REPAIR; FULL-THICKNESS TEARS; CHONDROGENIC DIFFERENTIATION; SUPRASPINATUS TENDON; GROWTH-FACTORS; CARTILAGE; TISSUE; AUGMENTATION; CHONDROCYTES; DEFECTS	Background: The enthesis, which attaches the tendon to the bone, naturally disappears with aging, thus limiting joint mobility. Surgery is frequently needed but the clinical outcome is often poor due to the decreased natural healing capacity of the elderly. This study explored the benefits of a treatment based on injecting chondrocyte and mesenchymal stem cells (MSC) in a new rat model of degenerative enthesis repair. Methodology: The Achilles' tendon was cut and the enthesis destroyed. The damage was repaired by classical surgery without cell injection (group G1, n = 52) and with chondrocyte (group G2, n = 51) or MSC injection (group G3, n = 39). The healing rate was determined macroscopically 15, 30 and 45 days later. The production and organization of a new enthesis was assessed by histological scoring of collagen II immunostaining, glycoaminoglycan production and the presence of columnar chondrocytes. The biomechanical load required to rupture the bone-tendon junction was determined. Principal Findings: The spontaneous healing rate in the G1 control group was 40%, close to those observed in humans. Cell injection significantly improved healing (69%, p = 0.0028 for G2 and p = 0.006 for G3) and the load-to-failure after 45 days (p<0.05) over controls. A new enthesis was clearly produced in cell-injected G2 and G3 rats, but not in the controls. Only the MSC-injected G3 rats had an organized enthesis with columnar chondrocytes as in a native enthesis 45 days after surgery. Conclusions: Cell therapy is an efficient procedure for reconstructing degenerative entheses. MSC treatment produced better organ regeneration than chondrocyte treatment. The morphological and biomechanical properties were similar to those of a native enthesis.	[Nourissat, Geoffroy; Salvat, Colette; Pigenet, Audrey; Gosset, Marjolaine; Houard, Xavier; Berenbaum, Francis] Univ Paris 06, UR 4, Paris, France; [Diop, Amadou; Maurel, Nathalie] Arts & Metiers ParisTech, Biomech & Bone Remodeling EPBRO, Paris, France; [Dumont, Sylvie] Univ Paris 06, St Antoine Hosp, AP HP, Dept Anatomopathol, Paris, France; [Berenbaum, Francis] Univ Paris 06, St Antoine Hosp, AP HP, Dept Rheumatol, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Arts et Metiers Institute of Technology; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Nourissat, G (corresponding author), Univ Paris 06, UR 4, Paris, France.	francis.berenbaum@sat.aphp.fr	Berenbaum, Francis/AAO-5690-2020; Gosset, Marjolaine/ACE-0183-2022	Berenbaum, Francis/0000-0001-8252-7815; Gosset, Marjolaine/0000-0002-4875-7892	SOFCOT (Societe Francaise de Chirurgie Orthopedique et Traumatologique)	SOFCOT (Societe Francaise de Chirurgie Orthopedique et Traumatologique)	This work was funded by a grant from SOFCOT (Societe Francaise de Chirurgie Orthopedique et Traumatologique): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan H, 2008, J CLIN INVEST, V118, P439, DOI 10.1172/JCI33944; Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267; BEST TM, 1993, J ORTHOP RES, V11, P897, DOI 10.1002/jor.1100110617; Blum EK, 2007, J BIOMECH, V40, P891, DOI 10.1016/j.jbiomech.2006.03.003; Boileau P, 2005, J BONE JOINT SURG AM, V87A, P1229, DOI 10.2106/JBJS.D.02035; Burkhart SS, 2006, J AM ACAD ORTHOP SUR, V14, P333, DOI 10.5435/00124635-200606000-00003; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Carpenter JE, 1999, CLIN ORTHOP RELAT R, pS296; Derfoul A, 2006, STEM CELLS, V24, P1487, DOI 10.1634/stemcells.2005-0415; Derwin KA, 2007, J SHOULDER ELB SURG, V16, p140S, DOI 10.1016/j.jse.2007.04.002; Funakoshi T, 2006, J SHOULDER ELB SURG, V15, P112, DOI 10.1016/j.jse.2005.05.012; Funakoshi T, 2005, AM J SPORT MED, V33, P1193, DOI 10.1177/0363546504272689; Galatz LM, 2006, J ORTHOP RES, V24, P541, DOI 10.1002/jor.20067; Gerber C, 1999, J BONE JOINT SURG AM, V81A, P1281, DOI 10.2106/00004623-199909000-00009; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Goutallier D, 2005, REV CHIR ORTHOP, V91, P109, DOI 10.1016/S0035-1040(05)84287-4; Grove JE, 2004, STEM CELLS, V22, P487, DOI 10.1634/stemcells.22-4-487; Gulotta LV, 2009, AM J SPORT MED, V37, P2126, DOI 10.1177/0363546509339582; Gupta R, 2007, J SHOULDER ELB SURG, V16, p149S, DOI 10.1016/j.jse.2007.05.002; Huang CYC, 2004, STEM CELLS, V22, P313, DOI 10.1634/stemcells.22-3-313; Iannotti JP, 2006, J BONE JOINT SURG AM, V88A, P1238, DOI 10.2106/JBJS.E.00524; Im GI, 2006, TISSUE ENG, V12, P527, DOI 10.1089/ten.2006.12.527; Kim DH, 2006, AM J SPORT MED, V34, P407, DOI 10.1177/0363546505281238; Kovacevic D, 2008, CLIN ORTHOP RELAT R, V466, P622, DOI 10.1007/s11999-007-0112-4; Lee KBL, 2007, STEM CELLS, V25, P2964, DOI 10.1634/stemcells.2006-0311; Liu JH, 2004, ARCH SURG-CHICAGO, V139, P423, DOI 10.1001/archsurg.139.4.423; Matsuda C, 2005, CYTOTECHNOLOGY, V47, P11, DOI 10.1007/s10616-005-3751-x; Moffat KL, 2008, P NATL ACAD SCI USA, V105, P7947, DOI 10.1073/pnas.0712150105; Murrell G A, 1993, Foot Ankle, V14, P400; Park JY, 2008, AM J SPORT MED, V36, P1310, DOI 10.1177/0363546508315039; Peretti GM, 2004, AM J SPORT MED, V32, P146, DOI 10.1177/0095399703258790; Randolph MA, 2003, CLIN PLAST SURG, V30, P519, DOI 10.1016/S0094-1298(03)00070-1; Rodeo SA, 2007, J BONE JOINT SURG AM, V89A, P2485, DOI 10.2106/JBJS.C.01627; Salvat C, 2005, OSTEOARTHR CARTILAGE, V13, P243, DOI 10.1016/j.joca.2004.11.008; Silverman RP, 1999, PLAST RECONSTR SURG, V103, P1809, DOI 10.1097/00006534-199906000-00001; Steck E, 2005, STEM CELLS, V23, P403, DOI 10.1634/stemcells.2004-0107; Thomopoulos S, 2002, J SHOULDER ELB SURG, V11, P239, DOI 10.1067/mse.2002.122228; Tytherleigh-Strong G, 2001, CURR OPIN RHEUMATOL, V13, P135, DOI 10.1097/00002281-200103000-00007; Weinand C, 2006, AM J SPORT MED, V34, P1779, DOI 10.1177/0363546506290666; Wong MWN, 2004, J BIOMED MATER RES B, V70B, P362, DOI 10.1002/jbm.b.30049; WOO SL, 1987, INJURY REPAIR MUSCUL, P126; Wood JJ, 2006, J BONE JOINT SURG AM, V88A, P503, DOI 10.2106/JBJS.E.00103; Yamaguchi K, 2006, J BONE JOINT SURG AM, V88A, P1699, DOI 10.2106/JBJS.E.00835	43	90	97	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12248	10.1371/journal.pone.0012248	http://dx.doi.org/10.1371/journal.pone.0012248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805884	Green Submitted, Green Published, gold			2022-12-25	WOS:000281011600020
J	Xie, JL; Vilchez, I; Mateos, M				Xie, Jialei; Vilchez, Igor; Mateos, Mariana			Spiroplasma Bacteria Enhance Survival of Drosophila hydei Attacked by the Parasitic Wasp Leptopilina heterotoma	PLOS ONE			English	Article							NATURAL-POPULATIONS; SYMBIONT INFECTION; ENDOSYMBIONTS; WOLBACHIA; INSECTS; APHIDS; COLEOPTERA; RESISTANCE; CARDINIUM; DIVERSITY	Background: Maternally-transmitted associations between endosymbiotic bacteria and insects are ubiquitous. While many of these associations are obligate and mutually beneficial, many are facultative, and the mechanism(s) by which these microbes persist in their host lineages remain elusive. Inherited microbes with imperfect transmission are expected to be lost from their host lineages if no other mechanisms increase their persistence (i.e., host reproductive manipulation and/or fitness benefits to host). Indeed numerous facultative heritable endosymbionts are reproductive manipulators. Nevertheless, many do not manipulate reproduction, so they are expected to confer fitness benefits to their hosts, as has been shown in several studies that report defense against natural enemies, tolerance to environmental stress, and increased fecundity. Methodology/Principal Findings: We examined whether larval to adult survival of Drosophila hydei against attack by a common parasitoid wasp (Leptopilina heterotoma), differed between uninfected flies and flies that were artificially infected with Spiroplasma, a heritable endosymbiont of Drosophila hydei that does not appear to manipulate host reproduction. Survival was significantly greater for Spiroplasma-infected flies, and the effect of Spiroplasma infection was most evident during the host's pupal stage. We examined whether or not increased survival of Spiroplasma-infected flies was due to reduced oviposition by the wasp (i.e., pre-oviposition mechanism). The number of wasp eggs per fly larva did not differ significantly between Spiroplasma-free and Spiroplasma-infected fly larvae, suggesting that differential fly survival is due to a post-oviposition mechanism. Conclusions/Significance: Our results suggest that Spiroplasma confers protection to D. hydei against wasp parasitism. This is to our knowledge the first report of a potential defensive mutualism in the genus Spiroplasma. Whether it explains the persistence and high abundance of this strain in natural populations of D. hydei, as well as the widespread distribution of heritable Spiroplasma in Drosophila and other arthropods, remains to be investigated.	[Xie, Jialei; Vilchez, Igor; Mateos, Mariana] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Xie, JL (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	mmateos@tamu.edu	Mateos, Mariana/B-5235-2008; Xie, Jialei/J-2516-2019	Mateos, Mariana/0000-0001-5738-0145; Xie, Jialei/0000-0001-6208-5749	National Institutes of Health (NIH) [R03 AI078348]; National Science Foundation (NSF) [DEB 0743782]; Texas AM University; Chinese Scholarship Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI078348] Funding Source: NIH RePORTER; Direct For Biological Sciences [0743782] Funding Source: National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Texas AM University; Chinese Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institutes of Health (NIH) grant R03 AI078348 and National Science Foundation (NSF) grant DEB 0743782 to MM and Texas A&M University. The Chinese Scholarship Council provided funding for JX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKER K, 1990, NETH J ZOOL, V40, P514, DOI 10.1163/156854290X00064; Bi K, 2008, J INVERTEBR PATHOL, V99, P57, DOI 10.1016/j.jip.2008.06.008; Carton Y., 1986, P347; Carton Y, 2008, INSECT SCI, V15, P67, DOI 10.1111/j.1744-7917.2008.00188.x; Chiu H, 2002, CELL DEATH DIFFER, V9, P1379, DOI 10.1038/sj.cdd.4401134; COHEN AJ, 1987, ISRAEL J MED SCI, V23, P429; Degnan PH, 2008, MOL ECOL, V17, P916, DOI 10.1111/j.1365-294X.2007.03616.x; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Enigl M, 2007, EXP APPL ACAROL, V42, P75, DOI 10.1007/s10493-007-9080-3; Fleury F, 2009, ADV PARASIT, V70, P3, DOI 10.1016/S0065-308X(09)70001-6; Gasparich GE, 2002, FRONT BIOSCI, V7, pD619, DOI 10.2741/gaspari; Hansen AK, 2007, APPL ENVIRON MICROB, V73, P7531, DOI 10.1128/AEM.01672-07; Haselkorn TS, 2009, MOL ECOL, V18, P1294, DOI 10.1111/j.1365-294X.2009.04085.x; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hemerik L, 2003, ENTOMOL EXP APPL, V107, P81, DOI 10.1046/j.1570-7458.2003.00032.x; Henning K, 2006, INT J MED MICROBIOL, V296, P157, DOI 10.1016/j.ijmm.2006.01.012; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Kageyama D, 2006, APPL ENVIRON MICROB, V72, P6667, DOI 10.1128/AEM.00803-06; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Lasalle John, 1993, P1; Lundgren JG, 2007, ANN ENTOMOL SOC AM, V100, P275, DOI 10.1603/0013-8746(2007)100[275:BCWDTO]2.0.CO;2; Martin OY, 2009, J ARACHNOL, V37, P106, DOI 10.1636/SH08-05.1; Mateos M, 2006, GENETICS, V174, P363, DOI 10.1534/genetics.106.058818; Montenegro H, 2006, J ZOOL SYST EVOL RES, V44, P130, DOI 10.1111/j.1439-0469.2006.00353.x; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Moro CV, 2009, RES MICROBIOL, V160, P63, DOI 10.1016/j.resmic.2008.10.006; Oliver KM, 2009, MYCOL SER, V27, P129; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Osaka R, 2008, CURR MICROBIOL, V57, P335, DOI 10.1007/s00284-008-9199-4; OTA T, 1979, J HERED, V70, P211, DOI 10.1093/oxfordjournals.jhered.a109235; Peng Y, 2008, APPL ENVIRON MICROB, V74, P3943, DOI 10.1128/AEM.02607-07; Regassa LB, 2006, FRONT BIOSCI-LANDMRK, V11, P2983, DOI 10.2741/2027; RIZKI TM, 1994, ANN NY ACAD SCI, V712, P178, DOI 10.1111/j.1749-6632.1994.tb33572.x; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Schutte C, 2008, EXP APPL ACAROL, V46, P307, DOI 10.1007/s10493-008-9188-0; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Thiel A, 2009, ADV PARASIT, V70, P45, DOI 10.1016/S0065-308X(09)70002-8; Tinsley MC, 2006, PARASITOLOGY, V132, P757, DOI 10.1017/S0031182005009789; Toh H, 2006, GENOME RES, V16, P149, DOI 10.1101/gr.4106106; Tsuchida T, 2006, APPL ENTOMOL ZOOL, V41, P129, DOI 10.1303/aez.2006.129; VANALPHEN JJM, 1990, ANNU REV ENTOMOL, V35, P59, DOI 10.1146/annurev.en.35.010190.000423; Vorburger C, 2009, EVOLUTION, V63, P1439, DOI 10.1111/j.1558-5646.2009.00660.x; Watts T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005703; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Weinert LA, 2007, BIOL LETTERS, V3, P678, DOI 10.1098/rsbl.2007.0373; Werren JH, 1997, INFLUENTIAL PASSENGERS, P1; Williamson DL., 1979, MYCOPLASMAS, P175, DOI [10.1016/B978-0-12-078403-5.50012-8, DOI 10.1016/B978-0-12-078403-5.50012-8]	51	167	176	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12149	10.1371/journal.pone.0012149	http://dx.doi.org/10.1371/journal.pone.0012149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730104	Green Published, gold, Green Submitted			2022-12-25	WOS:000280862200009
J	Ocak, S; Yamashita, H; Udyavar, AR; Miller, AN; Gonzalez, AL; Zou, Y; Jiang, A; Yi, Y; Shyr, Y; Estrada, L; Quaranta, V; Massion, PP				Ocak, S.; Yamashita, H.; Udyavar, A. R.; Miller, A. N.; Gonzalez, A. L.; Zou, Y.; Jiang, A.; Yi, Y.; Shyr, Y.; Estrada, L.; Quaranta, V.; Massion, P. P.			DNA copy number aberrations in small-cell lung cancer reveal activation of the focal adhesion pathway	ONCOGENE			English	Article						array CGH; copy number alterations; pathway analysis; FAK; adhesion; spreading	COMPARATIVE GENOMIC HYBRIDIZATION; GROWTH-FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION; KINASE INHIBITOR; GENE-EXPRESSION; CARCINOMAS; PROTEIN; OVEREXPRESSION; SIGNATURES; TUMORS	Small-cell lung cancer (SCLC) is the most aggressive subtype of lung cancer in its clinical behavior, with a 5-year overall survival as low as 5%. Despite years of research in the field, molecular determinants of SCLC behavior are still poorly understood, and this deficiency has translated into an absence of specific diagnostics and targeted therapeutics. We hypothesized that tumor DNA copy number alterations would allow the identification of molecular pathways involved in SCLC progression. Array comparative genomic hybridization was performed on DNA extracted from 46 formalin-fixed paraffin-embedded SCLC tissue specimens. Genomic profiling of tumor and sex-matched control DNA allowed the identification of 70 regions of copy number gain and 55 regions of copy number loss. Using molecular pathway analysis, we found a strong enrichment in these regions of copy number alterations for 11 genes associated with the focal adhesion pathway. We verified these findings at the genomic, gene expression and protein level. Focal Adhesion Kinase (FAK), one of the central genes represented in this pathway, was commonly expressed in SCLC tumors and constitutively phosphorylated in SCLC cell lines. Those were poorly adherent to most substrates but not to laminin-322. Inhibition of FAK phosphorylation at Tyr(397) by a small-molecule inhibitor, PF-573,228, induced a dose-dependent decrease of adhesion and an increase of spreading in SCLC cell lines on laminin-322. Cells that tended to spread also showed a decrease in focal adhesions, as demonstrated by a decreased vinculin expression. These results support the concept that pathway analysis of genes in regions of copy number alterations may uncover molecular mechanisms of disease progression and demonstrate a new role of FAK and associated adhesion pathways in SCLC. Further investigations of FAK at the functional level may lead to a better understanding of SCLC progression and may have therapeutic implications. Oncogene (2010) 29, 6331-6342; doi:10.1038/onc.2010.362; published online 30 August 2010	[Massion, P. P.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA; [Yamashita, H.; Udyavar, A. R.; Estrada, L.; Quaranta, V.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA; [Gonzalez, A. L.] Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA; [Jiang, A.; Shyr, Y.] Vanderbilt Univ, Canc Biostat Ctr, Nashville, TN 37232 USA; [Yi, Y.] Vanderbilt Univ, Div Med Genet, Nashville, TN 37232 USA; [Miller, A. N.; Massion, P. P.] Vet Affairs Med Ctr, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Massion, PP (corresponding author), Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Div Allergy Pulm & Crit Care Med, 2220 Pierce Ave,Preston Res Bldg 640, Nashville, TN 37232 USA.	pierre.massion@vanderbilt.edu	Quaranta, Vito/G-6512-2016; Wang, Weili/D-1546-2011	Quaranta, Vito/0000-0001-7491-8672; Estrada, Lourdes/0000-0002-3645-4456; Yamashita, Hironobu/0000-0003-2587-7100; Jiang, Aixiang/0000-0002-6153-7595	Cancer Center Support [5P30 CA068485]; Department of Veterans Affairs; IASLC; Universite Catholique de Louvain (Bourse Clinicien-Chercheur), Belgium; NATIONAL CANCER INSTITUTE [U54CA113007, P30CA068485] Funding Source: NIH RePORTER	Cancer Center Support; Department of Veterans Affairs(US Department of Veterans Affairs); IASLC; Universite Catholique de Louvain (Bourse Clinicien-Chercheur), Belgium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Kathy Taylor, Director of the Research Institute at St Thomas Health Services, Nashville, TN, for sharing archived SCLC tissue blocks; Dr Coe for providing array CGH data (Coe et al., 2006); and Vanderbilt's Immunohistochemistry Core (supported by a Cancer Center Support Grant 5P30 CA068485) for their contribution. We also thank Steven K Hanks, Alissa M Weaver and Donna J Webb for their useful input in the interpretation of the paper. This work was supported by a Merit Review grant from the Department of Veterans Affairs. Dr Ocak was supported by an IASLC Young Investigator Fellowship Award and by a grant from Universite Catholique de Louvain (Bourse Clinicien-Chercheur), Belgium.	Balsara BR, 2002, ONCOGENE, V21, P6877, DOI 10.1038/sj.onc.1205836; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Coe BP, 2006, BRIT J CANCER, V94, P1927, DOI 10.1038/sj.bjc.6603167; Cooper S, 2006, RESPIROLOGY, V11, P241, DOI 10.1111/j.1440-1843.2006.00850.x; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Gallia GL, 2006, MOL CANCER RES, V4, P709, DOI 10.1158/1541-7786.MCR-06-0172; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; GUAN JL, 1991, CELL REGUL, V2, P951, DOI 10.1091/mbc.2.11.951; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; Kirov SA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-72; LEVIN NA, 1994, CANCER RES, V54, P5086; Lindblad-Toh K, 2000, NAT BIOTECHNOL, V18, P1001, DOI 10.1038/79269; Massion PP, 2008, AM J RESP CRIT CARE, V178, P1164, DOI 10.1164/rccm.200801-142OC; Massion PP, 2003, CANCER RES, V63, P7113; Massion PP, 2002, CANCER RES, V62, P3636; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; MIURA I, 1992, CANCER RES, V52, P1322; Olejniczak ET, 2007, MOL CANCER RES, V5, P331, DOI 10.1158/1541-7786.MCR-06-0367; Osada H, 2008, CANCER RES, V68, P1647, DOI 10.1158/0008-5472.CAN-07-5039; OWENS LV, 1995, CANCER RES, V55, P2752; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Peng WX, 2005, CANCER SCI, V96, P661, DOI 10.1111/j.1349-7006.2005.00092.x; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Qian J, 2009, MOL CANCER THER, V8, P101, DOI 10.1158/1535-7163.MCT-08-0973; RIED T, 1994, CANCER RES, V54, P1801; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shi Q, 2007, MOL CARCINOGEN, V46, P488, DOI 10.1002/mc.20297; SIDHU GS, 1979, AM J PATHOL, V96, P5; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; SOZZI G, 1987, CANCER GENET CYTOGEN, V27, P45, DOI 10.1016/0165-4608(87)90259-7; Taniwaki M, 2006, INT J ONCOL, V29, P567; Tanno S, 2004, LUNG CANCER, V46, P11, DOI 10.1016/j.lungcan.2004.03.006; Ullmann R, 1998, HUM PATHOL, V29, P1145, DOI 10.1016/S0046-8177(98)90428-2; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	46	37	37	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC	2010	29	48					6331	6342		10.1038/onc.2010.362	http://dx.doi.org/10.1038/onc.2010.362			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	688SW	20802517	Green Accepted			2022-12-25	WOS:000284874700004
J	Angelova, K; de Jonge, H; Granneman, JCM; Puett, D; Bogerd, J				Angelova, Krassimira; de Jonge, Hugo; Granneman, Joke C. M.; Puett, David; Bogerd, Jan			Functional Differences of Invariant and Highly Conserved Residues in the Extracellular Domain of the Glycoprotein Hormone Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; PROTEIN-COUPLED RECEPTOR; LEUCINE-RICH REPEATS; HUMAN CHORIONIC-GONADOTROPIN; HUMAN CHORIOGONADOTROPIN-ALPHA; LIGAND-SELECTIVE DETERMINANTS; AMINO-ACID-RESIDUES; CRYSTAL-STRUCTURE; LUTROPIN-RECEPTOR; 3-DIMENSIONAL STRUCTURE	Multiple interactions exist between human follicle-stimulating hormone (FSH) and the N-terminal hormone-binding fragment of the human FSH receptor (FSHR) extracellular domain (ECD). Binding of the other human glycoprotein hormones to their cognate human receptors (luteinizing hormone receptor (LHR) and thyroid-stimulating hormone receptor (TSHR)) was expected to be similar. This study focuses on amino acid residues in beta-strands 2 (Lys(74)), 4 (Tyr(124), Asn(129), and Thr(130)), and 5 (Asp(150) and Asp(153)) of the FSHR ECD identified in the human FSH.FSHR ECD crystal structure as contact sites with the common glycoprotein hormone alpha-subunit, and on noncontact residues in beta-strands 2 (Ser(78)) and 8 (Asp(224) and Ser(226)) as controls. These nine residues are either invariant or highly conserved in LHR and TSHR. Mutagenesis and functional characterization of these residues in all three human receptors allowed an assessment of their contribution to binding and receptor activation. Surprisingly, the six reported alpha-subunit contact residues of the FSHR ECD could be replaced without significant loss of FSH binding, while cAMP signaling potency was diminished significantly with several replacements. Comparative studies of the homologous residues in LHR and TSHR revealed both similarities and differences. The results for FSH/FSHR were analyzed on the basis of the crystal structure of the FSH.FSHR ECD complex, and comparative modeling was used to generate structures for domains, proteins, and complexes for which no structures were available. Although structural information of hormone-receptor interaction allowed the identification of hormone-receptor contact sites, functional analysis of each contact site was necessary to assess its contribution to hormone binding and receptor activation.	[de Jonge, Hugo; Granneman, Joke C. M.; Bogerd, Jan] Univ Utrecht, Fac Sci, Dept Biol, Div Dev Biol, NL-3584 CH Utrecht, Netherlands; [Angelova, Krassimira; Puett, David] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	Utrecht University; University System of Georgia; University of Georgia	Bogerd, J (corresponding author), Univ Utrecht, Fac Sci, Dept Biol, Div Dev Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	j.bogerd@uu.nl	Puett, J. David/AIE-8612-2022; de Jonge, Hugo/D-4036-2018; de Jonge, Hugo/AAI-1861-2019; Bogerd, Jan/B-8858-2011	de Jonge, Hugo/0000-0003-2777-4084; de Jonge, Hugo/0000-0003-2777-4084; Bogerd, Jan/0000-0003-1120-7974	National Institutes of Health [DK069711, DK033793]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033793, R01DK069711, R37DK033793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK069711 and DK033793.	Agrawal G, 2009, J BIOL CHEM, V284, P2636, DOI 10.1074/jbc.M808199200; Angelova K, 2003, MOL CELL ENDOCRINOL, V204, P1, DOI 10.1016/S0303-7207(03)00155-2; Angelova K, 2002, ENDOCRINE, V19, P147, DOI 10.1385/ENDO:19:2:147; Angelova K, 2002, J BIOL CHEM, V277, P32202, DOI 10.1074/jbc.M203272200; Angelova K, 2008, MOL ENDOCRINOL, V22, P126, DOI 10.1210/me.2007-0352; Ascoli M., 2009, YEN JAFFES REPROD EN, P35, DOI [10.1016/B978-1-4160-4907-4.00002-4, DOI 10.1016/B978-1-4160-4907-4.00002-4]; Ballesteros J, 1998, J BIOL CHEM, V273, P10445, DOI 10.1074/jbc.273.17.10445; Bhowmick N, 1996, MOL ENDOCRINOL, V10, P1147, DOI 10.1210/me.10.9.1147; Bhowmick N, 1999, ENDOCRINOLOGY, V140, P4558, DOI 10.1210/en.140.10.4558; Bogerd J, 2007, MOL CELL ENDOCRINOL, V260, P144, DOI 10.1016/j.mce.2006.01.019; BRAUN T, 1991, EMBO J, V10, P1885, DOI 10.1002/j.1460-2075.1991.tb07714.x; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bruysters M, 2008, J BIOL CHEM, V283, P25821, DOI 10.1074/jbc.M804395200; Caltabiano G, 2008, CELL MOL LIFE SCI, V65, P2484, DOI 10.1007/s00018-008-8002-9; CHEN F, 1991, J BIOL CHEM, V266, P19357; CHEN F, 1991, BIOCHEMISTRY-US, V30, P10171, DOI 10.1021/bi00106a014; CHEN F, 1992, FASEB J, V6, pA209; CHEN WB, 1995, ANAL BIOCHEM, V226, P349, DOI 10.1006/abio.1995.1235; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DIAS JA, 1994, J BIOL CHEM, V269, P25289; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Fanelli F, 2005, CHEM REV, V105, P3297, DOI 10.1021/cr000095n; Fox KM, 2001, MOL ENDOCRINOL, V15, P378, DOI 10.1210/me.15.3.378; Hong SH, 1998, J BIOL CHEM, V273, P13835, DOI 10.1074/jbc.273.22.13835; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; HUANG JN, 1995, J BIOL CHEM, V270, P30023; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; JI IH, 1993, J BIOL CHEM, V268, P22971; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Jiang XL, 1995, STRUCTURE, V3, P1341, DOI 10.1016/S0969-2126(01)00272-6; KAJAVA AV, 1995, STRUCTURE, V3, P867, DOI 10.1016/S0969-2126(01)00222-2; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; Laskowski RA, 1995, J MOL GRAPHICS, V13, P328; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Miguel RN, 2008, J MOL ENDOCRINOL, V41, P145, DOI 10.1677/JME-08-0040; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; MOYLE WR, 1994, NATURE, V368, P251, DOI 10.1038/368251a0; Moyle WR, 2004, J BIOL CHEM, V279, P44442, DOI 10.1074/jbc.M406948200; Mueller S, 2008, J BIOL CHEM, V283, P18048, DOI 10.1074/jbc.M800449200; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Puett D, 2009, METHODS MOL BIOL, V590, P1, DOI 10.1007/978-1-60327-378-7_1; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; Sanders J, 2006, THYROID, V16, P1195, DOI 10.1089/thy.2006.16.1195; Schmidt A, 2001, J BIOL CHEM, V276, P23373, DOI 10.1074/jbc.M100057200; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Smits G, 2002, MOL ENDOCRINOL, V16, P722, DOI 10.1210/me.16.4.722; Smits G, 2003, EMBO J, V22, P2692, DOI 10.1093/emboj/cdg260; Song YS, 2001, J BIOL CHEM, V276, P3426, DOI 10.1074/jbc.M003772200; Song YS, 2001, J BIOL CHEM, V276, P3436, DOI 10.1074/jbc.M003773200; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Touraine P, 1999, MOL ENDOCRINOL, V13, P1844, DOI 10.1210/me.13.11.1844; Vischer HF, 2006, MOL ENDOCRINOL, V20, P1880, DOI 10.1210/me.2005-0202; Vischer HF, 2003, MOL ENDOCRINOL, V17, P1972, DOI 10.1210/me.2003-0172; Vischer HF, 2003, J BIOL CHEM, V278, P15505, DOI 10.1074/jbc.M300634200; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; XIA H, 1993, J MOL ENDOCRINOL, V10, P337, DOI 10.1677/jme.0.0100337; YOO J, 1991, J BIOL CHEM, V266, P17741; YOO JK, 1993, J BIOL CHEM, V268, P13034	71	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34813	34827		10.1074/jbc.M110.148221	http://dx.doi.org/10.1074/jbc.M110.148221			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20736161	hybrid, Green Published			2022-12-25	WOS:000283659100057
J	Mohan, S; Tse, CM; Gabelli, SB; Sarker, R; Cha, BY; Fahie, K; Nadella, M; Zachos, NC; Tu-Sekine, B; Raben, D; Amzel, LM; Donowitz, M				Mohan, Sachin; Tse, Chung Ming; Gabelli, Sandra B.; Sarker, Rafiquel; Cha, Boyoung; Fahie, Kamau; Nadella, Mythili; Zachos, Nicholas C.; Tu-Sekine, Becky; Raben, Daniel; Amzel, L. Mario; Donowitz, Mark			NHE3 Activity Is Dependent on Direct Phosphoinositide Binding at the N Terminus of Its Intracellular Cytosolic Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/H+ EXCHANGER NHE3; PLASMA-MEMBRANE; BRUSH-BORDER; SENSITIVE PHOSPHATASE; MOLECULAR PHYSIOLOGY; CYTOPLASMIC DOMAIN; CHANNEL; PIP2; TRAFFICKING; PI(4,5)P-2	The small intestinal BB Na+/H+ antiporter NHE3 accounts for the majority of intestinal sodium and water absorption. It is highly regulated with both postprandial inhibition and stimulation sequentially occurring. Phosphatidylinositide 4,5-bisphosphate (PI(4,5)P-2) and phosphatidylinositide 3,4,5-trisphosphate (PI(3,4,5)P-3) binding is involved with regulation of multiple transporters. We tested the hypothesis that phosphoinositides bind NHE3 under basal conditions and are necessary for its acute regulation. His(6) proteins were made from the NHE3 C-terminal region divided into four parts as follows: F1 (amino acids 475-589), F2 (amino acids 590-667), F3 (amino acids 668-747), and F4 (amino acids 748-832) and purified by a nickel column. Mutations were made in the F1 region of NHE3 and cloned in pet30a and pcDNA3.1 vectors. PI(4,5)P-2 and PI(3,4,5)P-3 bound only to the NHE3 F1 fusion protein (amino acids 475-589) on liposomal pulldown assays. Mutations were made in the putative lipid binding region of the F1 domain and studied for alterations in lipid binding and Na+/H+ exchange as follows: Y501A/R503A/K505A; F509A/R511A/R512A; R511L/R512L; R520/FR527F; and R551L/R552L. Our results indicate the following. 1) The F1 domain of the NHE3 C terminus has phosphoinositide binding regions. 2) Mutations of these regions alter PI(4,5)P-2 and PI(3,4,5)P-3 binding and basal NHE3 activity. 3) The magnitude of serum stimulation of NHE3 correlates with PI(4,5)P-2 and PI(3,4,5)P-3 binding of NHE3. 4) Wortmannin inhibition of PI3K did not correlate with PI(4,5)P-2 or PI(3,4,5)P-3 binding of NHE3. Two functionally distinct phosphoinositide binding regions (Tyr501-Arg512 and Arg520-Arg552) are present in the NHE3 F1 domain; both regions are important for serum stimulation, but they display differences in phosphoinositide binding, and the latter but not the former alters NHE3 surface expression.	[Mohan, Sachin; Tse, Chung Ming; Sarker, Rafiquel; Cha, Boyoung; Zachos, Nicholas C.; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, Div Gastroenterol, Baltimore, MD 21205 USA; [Mohan, Sachin; Tse, Chung Ming; Sarker, Rafiquel; Cha, Boyoung; Zachos, Nicholas C.; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA; [Gabelli, Sandra B.; Fahie, Kamau; Nadella, Mythili; Amzel, L. Mario] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Tu-Sekine, Becky; Raben, Daniel] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Div Gastroenterol & Hepatol, Ross Res Bldg,720 Rutland Ave,Ross 925, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu	Gabelli, Sandra B/A-3705-2008; mohan, sachin/H-4017-2015; Zachos, Nicholas/GWC-7914-2022	Gabelli, Sandra B/0000-0003-1205-5204; Amzel, L. Mario/0000-0002-0129-9572; Mohan, Sachin/0000-0002-6798-4767	National Institutes of Health [R01-DK26523, R01-DK61765, PO1-DK72084, R24-DK64388]; Hopkins Center for Epithelial Disorders; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026523, K01DK080930, R24DK064388, P01DK072084, P30DK079637, R01DK061765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hopkins Center for Epithelial Disorders; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK26523, R01-DK61765, PO1-DK72084, and R24-DK64388 (the Hopkins Basic Research Digestive Diseases Development Core Center). This work was also supported by Hopkins Center for Epithelial Disorders.	Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Akhter S, 2000, BIOCHEMISTRY-US, V39, P1990, DOI 10.1021/bi991739s; Akhter S, 2002, AM J PHYSIOL-CELL PH, V283, pC927, DOI 10.1152/ajpcell.00613.2001; Atkinson T, 2009, BIOCHEM BIOPH RES CO, V378, P394, DOI 10.1016/j.bbrc.2008.11.036; Cha B, 2003, J MEMBRANE BIOL, V191, P49, DOI 10.1007/s00232-002-1044-2; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Collins MO, 2009, SCIENCE, V325, P1635, DOI 10.1126/science.1180331; Donowitz M, 2009, J EXP BIOL, V212, P1638, DOI 10.1242/jeb.028605; Dynia DW, 2010, AM J PHYSIOL-RENAL, V298, pF745, DOI 10.1152/ajprenal.00182.2009; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P99, DOI 10.1085/jgp.200910345; Fuster D, 2004, P NATL ACAD SCI USA, V101, P10482, DOI 10.1073/pnas.0403930101; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Gelman Marina S, 2003, Methods Mol Biol, V232, P27; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Huang CL, 2007, AM J PHYSIOL-RENAL, V293, pF1761, DOI 10.1152/ajprenal.00400.2007; Janecki AJ, 2000, J BIOL CHEM, V275, P8133, DOI 10.1074/jbc.275.11.8133; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; Logothetis DE, 2010, PFLUG ARCH EUR J PHY, V460, P321, DOI 10.1007/s00424-010-0828-y; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Pochynyuk O, 2008, CURR OPIN NEPHROL HY, V17, P533, DOI 10.1097/MNH.0b013e328308fff3; Pochynyuk O, 2007, J GEN PHYSIOL, V130, P399, DOI 10.1085/jgp.200709800; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rohacs T, 2009, CELL CALCIUM, V45, P554, DOI 10.1016/j.ceca.2009.03.011; Rosenhouse-Dantsker A, 2007, PFLUG ARCH EUR J PHY, V455, P45, DOI 10.1007/s00424-007-0291-6; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; Wakabayashi S, 2010, J BIOL CHEM, V285, P26652, DOI 10.1074/jbc.M110.130120; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004	35	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34566	34578		10.1074/jbc.M110.165712	http://dx.doi.org/10.1074/jbc.M110.165712			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20736165	Green Published, hybrid			2022-12-25	WOS:000283659100032
J	Nunn, CEM; Johnsen, U; Schonheit, P; Fuhrer, T; Sauer, U; Hough, DW; Danson, MJ				Nunn, Charlotte E. M.; Johnsen, Ulrike; Schoenheit, Peter; Fuhrer, Tobias; Sauer, Uwe; Hough, David W.; Danson, Michael J.			Metabolism of Pentose Sugars in the Hyperthermophilic Archaea Sulfolobus solfataricus and Sulfolobus acidocaldarius	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTNER-DOUDOROFF PATHWAY; 2-KETO-3-DEOXYGLUCONATE ALDOLASE; GLUCOSE-DEHYDROGENASE; SUBSTRATE PROMISCUITY; STRUCTURAL BASIS; GC-MS; BACTERIA; ENZYME; GENUS	We have previously shown that the hyperthermophilic archaeon, Sulfolobus solfataricus, catabolizes D-glucose and D-galactose to pyruvate and glyceraldehyde via a non-phosphorylative version of the Entner-Doudoroff pathway. At each step, one enzyme is active with both C6 epimers, leading to a metabolically promiscuous pathway. On further investigation, the catalytic promiscuity of the first enzyme in this pathway, glucose dehydrogenase, has been shown to extend to the C5 sugars, D-xylose and L-arabinose. In the current paper we establish that this promiscuity for C6 and C5 metabolites is also exhibited by the third enzyme in the pathway, 2-keto-3-deoxygluconate aldolase, but that the second step requires a specific C5-dehydratase, the gluconate dehydratase being active only with C6 metabolites. The products of this pathway for the catabolism of D-xylose and L-arabinose are pyruvate and glycolaldehyde, pyruvate entering the citric acid cycle after oxidative decarboxylation to acetyl-coenzyme A. We have identified and characterized the enzymes, both native and recombinant, that catalyze the conversion of glycolaldehyde to glycolate and then to glyoxylate, which can enter the citric acid cycle via the action of malate synthase. Evidence is also presented that similar enzymes for this pentose sugar pathway are present in Sulfolobus acidocaldarius, and metabolic tracer studies in this archaeon demonstrate its in vivo operation in parallel with a route involving no aldol cleavage of the 2-keto-3-deoxy-pentanoates but direct conversion to the citric acid cycle C5-metabolite, 2-oxoglutarate.	[Danson, Michael J.] Univ Bath, Ctr Extremophile Res, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Johnsen, Ulrike; Schoenheit, Peter] Univ Kiel, Inst Allgemeine Mikrobiol, D-24116 Kiel, Germany; [Fuhrer, Tobias; Sauer, Uwe] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	University of Bath; University of Kiel; Swiss Federal Institutes of Technology Domain; ETH Zurich	Danson, MJ (corresponding author), Univ Bath, Ctr Extremophile Res, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	m.j.danson@bath.ac.uk	Sauer, Uwe/Y-3556-2019; Fuhrer, Tobias/B-5667-2013	Fuhrer, Tobias/0000-0001-5006-6874	UK Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/E020704/1] Funding Source: researchfish; BBSRC [BB/E020704/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by a UK Biotechnology and Biological Sciences Research Council studentship.	Ahmed H, 2005, BIOCHEM J, V390, P529, DOI 10.1042/BJ20041711; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Brouns SJJ, 2006, J BIOL CHEM, V281, P27378, DOI 10.1074/jbc.M605549200; Buchanan CL, 1999, BIOCHEM J, V343, P563, DOI 10.1042/0264-6021:3430563; Cozzone AJ, 1998, ANNU REV MICROBIOL, V52, P127, DOI 10.1146/annurev.micro.52.1.127; Danson MJ, 2007, ARCHAEA: MOLECULAR AND CELLULAR BIOLOGY, P260; Dauner M, 2000, BIOTECHNOL PROGR, V16, P642, DOI 10.1021/bp000058h; DEROSA M, 1984, BIOCHEM J, V224, P407, DOI 10.1042/bj2240407; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; GROGAN DW, 1989, J BACTERIOL, V171, P6710, DOI 10.1128/jb.171.12.6710-6719.1989; Johnsen U, 2004, J BACTERIOL, V186, P6198, DOI 10.1128/JB.186.18.6198-6207.2004; Johnsen U, 2009, J BIOL CHEM, V284, P27290, DOI 10.1074/jbc.M109.003814; Kardinahl S, 1999, EUR J BIOCHEM, V260, P540, DOI 10.1046/j.1432-1327.1999.00201.x; Lamble FJ, 2004, FEBS LETT, V576, P133, DOI 10.1016/j.febslet.2004.08.074; Lamble HJ, 2005, FEBS LETT, V579, P6865, DOI 10.1016/j.febslet.2005.11.028; Lamble HJ, 2003, J BIOL CHEM, V278, P34066, DOI 10.1074/jbc.M305818200; Lubelska JM, 2006, EXTREMOPHILES, V10, P383, DOI 10.1007/s00792-006-0510-7; Milburn CC, 2006, J BIOL CHEM, V281, P14796, DOI 10.1074/jbc.M601334200; Potter JA, 2008, ACTA CRYSTALLOGR D, V64, P1283, DOI 10.1107/S0907444908036111; REITER WD, 1990, P NATL ACAD SCI USA, V87, P9509, DOI 10.1073/pnas.87.24.9509; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Theodossis A, 2004, J BIOL CHEM, V279, P43886, DOI 10.1074/jbc.M407702200; Tolstrup N, 2000, EXTREMOPHILES, V4, P175, DOI 10.1007/s007920070032; Uhrigshardt H, 2002, FEBS LETT, V513, P223, DOI 10.1016/S0014-5793(02)02317-7; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Yoshikawa S, 2007, ACTA CRYSTALLOGR D, V63, P357, DOI 10.1107/S0907444906055442; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58	28	61	62	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33701	33709		10.1074/jbc.M110.146332	http://dx.doi.org/10.1074/jbc.M110.146332			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20736170	Green Published, hybrid			2022-12-25	WOS:000283354000015
J	Bereczky-Veress, B; Abdelmagid, N; Piehl, F; Bergstrom, T; Olsson, T; Skoldenberg, B; Diez, M				Bereczky-Veress, Biborka; Abdelmagid, Nada; Piehl, Fredrik; Bergstrom, Tomas; Olsson, Tomas; Skoldenberg, Birgit; Diez, Margarita			Influence of Perineurial Cells and Toll-Like Receptors 2 and 9 on Herpes simplex Type 1 Entry to the Central Nervous System in Rat Encephalitis	PLOS ONE			English	Article							SCHWANN-CELLS; VIRUS; TLR9; PROLIFERATION; RECOGNITION; ACTIVATION; EXPRESSION; MODEL	Herpes simplex encephalitis (HSE) is a rare disease with high mortality and significant morbidity among survivors. We have previously shown that susceptibility to HSE was host-strain dependent, as severe, lethal HSE developed after injection of human Herpes simplex type 1 virus (HSV-1) into the whiskers area of DA rats, whereas PVG rats remained completely asymptomatic. In the present study we investigated the early immunokinetics in these strains to address the underlying molecular mechanisms for the observed difference. The virus distribution and the immunological responses were compared in the whiskers area, trigeminal ganglia and brain stem after 12 hours and the first four days following infection using immunohistochemistry and qRT-PCR. A conspicuous immunopathological finding was a strain-dependent difference in the spread of the HSV-1 virus to the trigeminal ganglia, only seen in DA rats already from 12 hpi. In the whiskers area infected perineurial cells were abundant in the susceptible DA strain after 2 dpi, whereas in the resistant PVG rats HSV-1 spread was confined only to the epineurium. In both strains activation of Iba1(+)/ED1(+) phagocytic cells followed the distribution pattern of HSV-1 staining, which was visible already at 12 hours after infection. Notably, in PVG rats higher mRNA expression of Toll-like receptors (Tlr) -2 and -9, together with increased staining for Iba1/ED1 was detected in the whiskers area. In contrast, all other Tlr-pathway markers were expressed at higher levels in the susceptible DA rats. Our data demonstrate the novel observation that genetically encoded properties of the host nerve and perineurial cells, recruitment of phagocyting cells together with the low expression of Tlr2 and -9 in the periphery define the susceptibility to HSV-1 entry into the nervous system.	[Bereczky-Veress, Biborka; Skoldenberg, Birgit] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Med Solna,Unit Infect Dis, Stockholm, Sweden; [Abdelmagid, Nada; Piehl, Fredrik; Olsson, Tomas; Diez, Margarita] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Clin Neurosci,Neuroimmunol Unit, Stockholm, Sweden; [Bergstrom, Tomas] Univ Gothenburg, Dept Clin Virol, Gothenburg, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Gothenburg	Bereczky-Veress, B (corresponding author), Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Med Solna,Unit Infect Dis, Stockholm, Sweden.	margarita.diez@ki.se	Piehl, Fredrik/E-3451-2013	Bergstrom, Tomas/0000-0002-9257-6757; Abdelmagid, Nada/0000-0002-8200-347X; Olsson, Tomas/0000-0002-2938-1877	European Union [LSHM-CT-2005-018637, LSHG-CT-2005-019015]; Swedish Brain Foundation; Swedish Society of Medicine; Magnus Bergvalls Foundation; Wadsworth Foundation; Torsten and Ragnar Soderbergs Foundation; Foundation for the Memory of Sigurd and Elsa Golje; Borklunds Foundation; Nils and Bibbi Jenssens Foundation; Montel Williams Foundation; Swedish Society for Medical Research; Swedish Research Council; Swedish Association of Persons with Neurological Disabilities	European Union(European Commission); Swedish Brain Foundation; Swedish Society of Medicine; Magnus Bergvalls Foundation; Wadsworth Foundation; Torsten and Ragnar Soderbergs Foundation; Foundation for the Memory of Sigurd and Elsa Golje; Borklunds Foundation; Nils and Bibbi Jenssens Foundation; Montel Williams Foundation; Swedish Society for Medical Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Association of Persons with Neurological Disabilities	This work is supported by 6th Framework Program of the European Union, NeuroproMiSe, LSHM-CT-2005-018637 and the EURATools, LSHG-CT-2005-019015, as well as by grants from the Swedish Brain Foundation, Swedish Society of Medicine, Magnus Bergvalls Foundation, Wadsworth Foundation, Torsten and Ragnar Soderbergs Foundation, Foundation for the Memory of Sigurd and Elsa Golje, Borklunds Foundation, Nils and Bibbi Jenssens Foundation, Montel Williams Foundation, Swedish Society for Medical Research, Swedish Research Council and The Swedish Association of Persons with Neurological Disabilities. The funders had no role in study design, data collection and analysis, preparation of the manuscript or decision to publish.	Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; AURELIUS E, 1993, J INFECT DIS, V168, P1248, DOI 10.1093/infdis/168.5.1248; Bereczky-Veress B, 2008, J NEUROVIROL, V14, P102, DOI 10.1080/13550280701883832; BERGSTROM T, 1990, J GEN VIROL, V71, P405, DOI 10.1099/0022-1317-71-2-405; Boehme KW, 2006, J IMMUNOL, V177, P7094, DOI 10.4049/jimmunol.177.10.7094; Bove GM, 2009, J NEUROIMMUNOL, V213, P26, DOI 10.1016/j.jneuroim.2009.06.005; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Cheng C, 2002, NEUROSCIENCE, V115, P321, DOI 10.1016/S0306-4522(02)00291-9; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Danielii J.F., 1958, GENERAL CYTOCHEMICAL, P399; GOETHALS S, 2010, GLIA; Hjalmarsson A, 2009, J NEUROL, V256, P1243, DOI 10.1007/s00415-009-5106-6; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; JESSEN KR, 1984, J NEUROCYTOL, V13, P923, DOI 10.1007/BF01148594; Kastrukoff LF, 2010, VIROLOGY, V400, P248, DOI 10.1016/j.virol.2010.02.013; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Mansur DS, 2005, AM J PATHOL, V166, P1419, DOI 10.1016/S0002-9440(10)62359-0; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PEASE DC, 1962, ANAT REC, V142, P342; Peltier DC, 2010, J IMMUNOL, V184, P7010, DOI 10.4049/jimmunol.0904133; Sarangi PP, 2007, J VIROL, V81, P11128, DOI 10.1128/JVI.01008-07; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; Skoldenberg B, 2006, J NEUROL, V253, P163, DOI 10.1007/s00415-005-0941-6; SKOLDENBERG B, 1984, LANCET, V2, P707; Smirkin A, 2010, J CEREBR BLOOD F MET, V30, P603, DOI 10.1038/jcbfm.2009.233; Sorensen LN, 2008, J IMMUNOL, V181, P8604, DOI 10.4049/jimmunol.181.12.8604; Sorkin LS, 1997, NEUROSCIENCE, V81, P255, DOI 10.1016/S0306-4522(97)00147-4; Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168; Wuest TR, 2008, FRONT BIOSCI-LANDMRK, V13, P4862, DOI 10.2741/3045; YAMAZAKI T, 1993, AM J PATHOL, V143, P410; ZAMBONI L, 1967, J CELL BIOL, V35, pA148; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	34	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12350	10.1371/journal.pone.0012350	http://dx.doi.org/10.1371/journal.pone.0012350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20806060	Green Submitted, Green Published, gold			2022-12-25	WOS:000281301500003
J	Bonsall, MB				Bonsall, Michael B.			Parasite Replication and the Evolutionary Epidemiology of Parasite Virulence	PLOS ONE			English	Article							HOST POPULATION-DYNAMICS; WITHIN-HOST; INCLUSIVE FITNESS; VISCOUS POPULATIONS; MULTIPLE INFECTION; KIN SELECTION; COMPETITION; COOPERATION; PHARAOH; CURSE	Parasite virulence evolution is shaped by both within-host and population-level processes yet the link between these differing scales of infection is often neglected. Population structure and heterogeneity in both parasites and hosts will affect how hosts are exploited by pathogens and the intensity of infection. Here, it is shown how the degree of relatedness among parasites together with epidemiological parameters such as pathogen yield and longevity influence the evolution of virulence. Furthermore, the role of kin competition and the degree of cheating within highly structured parasite populations also influences parasite fitness and infectivity patterns. Understanding how the effects of within-host processes scale up to affect the epidemiology has importance for understanding host-pathogen interactions.	[Bonsall, Michael B.] Univ Oxford, Dept Zool, Math Ecol Res Grp, Oxford OX1 3PS, England; [Bonsall, Michael B.] Univ Oxford, St Peters Coll, Oxford, England	University of Oxford; University of Oxford	Bonsall, MB (corresponding author), Univ Oxford, Dept Zool, Math Ecol Res Grp, S Parks Rd, Oxford OX1 3PS, England.	michael.bonsall@zoo.ox.ac.uk		Bonsall, Michael/0000-0003-0250-0423	Royal Society; UK Biotechnology and Biological Sciences Research Council [BB/C005172/1]	Royal Society(Royal Society of London); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by the Royal Society and the UK Biotechnology and Biological Sciences Research Council (BB/C005172/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2008, AM NAT, V172, pE244, DOI 10.1086/592404; ANDERSON R M, 1991; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; Andre JB, 2006, J THEOR BIOL, V241, P402, DOI 10.1016/j.jtbi.2005.12.011; ANTIA R, 1994, AM NAT, V144, P457, DOI 10.1086/285686; Binmore K., 2002, CALCULUS CONCEPTS ME; Bonhoeffer S, 1996, P ROY SOC B-BIOL SCI, V263, P715, DOI 10.1098/rspb.1996.0107; Boots M, 2007, SCIENCE, V315, P1284, DOI 10.1126/science.1137126; BREMERMANN HJ, 1983, J THEOR BIOL, V100, P411, DOI 10.1016/0022-5193(83)90438-1; Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; Chao L, 2000, Q REV BIOL, V75, P261, DOI 10.1086/393499; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Day T, 2001, EVOLUTION, V55, P2389, DOI 10.1111/j.0014-3820.2001.tb00754.x; Ebert D, 2003, TRENDS MICROBIOL, V11, P15, DOI 10.1016/S0966-842X(02)00003-3; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Fenton A, 2006, P ROY SOC B-BIOL SCI, V273, P2083, DOI 10.1098/rspb.2006.3552; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Gandon S, 1998, P ROY SOC B-BIOL SCI, V265, P1545, DOI 10.1098/rspb.1998.0470; Gandon S, 2001, EVOLUTION, V55, P1056, DOI 10.1554/0014-3820(2001)055[1056:HLHATE]2.0.CO;2; Ganusov VV, 2002, EVOLUTION, V56, P213, DOI 10.1111/j.0014-3820.2002.tb01332.x; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harrison F, 2008, ISME J, V2, P49, DOI 10.1038/ismej.2007.96; Kamo M, 2004, J THEOR BIOL, V231, P435, DOI 10.1016/j.jtbi.2004.07.005; Levin BR, 1999, SCIENCE, V283, P806, DOI 10.1126/science.283.5403.806; Levin Bruce R., 1994, Trends in Microbiology, V2, P76, DOI 10.1016/0966-842X(94)90538-X; LEVIN S, 1981, AM NAT, V117, P308, DOI 10.1086/283708; Massey RC, 2004, P ROY SOC B-BIOL SCI, V271, P785, DOI 10.1098/rspb.2004.2676; METZ JAJ, 1992, TRENDS ECOL EVOL, V7, P198, DOI 10.1016/0169-5347(92)90073-K; MICHOD RE, 1980, NATURE, V288, P694, DOI 10.1038/288694a0; Mideo N, 2008, TRENDS ECOL EVOL, V23, P511, DOI 10.1016/j.tree.2008.05.009; Nesse R.M., 1996, WHY WE GET SICK NEW; NOWAK MA, 1994, P ROY SOC B-BIOL SCI, V255, P81, DOI 10.1098/rspb.1994.0012; Pasztor L, 1996, J EVOLUTION BIOL, V9, P511, DOI 10.1046/j.1420-9101.1996.9040511.x; Porcelli SA, 2008, NATURE, V454, P702, DOI 10.1038/454702a; QUELLER DC, 1994, EVOL ECOL, V8, P70, DOI 10.1007/BF01237667; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Raymond B, 2008, J INVERTEBR PATHOL, V99, P103, DOI 10.1016/j.jip.2008.04.007; Raymond B, 2007, J INVERTEBR PATHOL, V96, P151, DOI 10.1016/j.jip.2007.03.003; Roussett F, 2004, GENETIC STRUCTURE SE; Spratt BG, 1999, PHILOS T R SOC B, V354, P701, DOI 10.1098/rstb.1999.0423; Taylor PD, 2007, J EVOLUTION BIOL, V20, P301, DOI 10.1111/j.1420-9101.2006.01196.x; Taylor PD, 1996, J THEOR BIOL, V180, P27, DOI 10.1006/jtbi.1996.0075; TAYLOR PD, 1992, P ROY SOC B-BIOL SCI, V249, P299, DOI 10.1098/rspb.1992.0118; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Thrall PH, 2003, SCIENCE, V299, P1735, DOI 10.1126/science.1080070; van Baalen M, 1998, J THEOR BIOL, V193, P631, DOI 10.1006/jtbi.1998.0730; vanBaalen M, 1995, AM NAT, V146, P881, DOI 10.1086/285830; Walther BA, 2004, BIOL REV, V79, P849, DOI 10.1017/S1464793104006475; West SA, 2003, P ROY SOC B-BIOL SCI, V270, P37, DOI 10.1098/rspb.2002.2209	51	3	3	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12440	10.1371/journal.pone.0012440	http://dx.doi.org/10.1371/journal.pone.0012440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805976	Green Submitted, Green Published, gold			2022-12-25	WOS:000281301500009
J	Melnikova, VO; Dobroff, AS; Zigler, M; Villares, GJ; Braeuer, RR; Wang, H; Huang, L; Bar-Eli, M				Melnikova, Vladislava O.; Dobroff, Andrey S.; Zigler, Maya; Villares, Gabriel J.; Braeuer, Russell R.; Wang, Hua; Huang, Li; Bar-Eli, Menashe			CREB Inhibits AP-2 alpha Expression to Regulate the Malignant Phenotype of Melanoma	PLOS ONE			English	Article							TRANSCRIPTION FACTOR AP-2; PROTEASE-ACTIVATED RECEPTOR-1; ELEMENT-BINDING PROTEIN; CANCER-CELL GROWTH; TUMOR-GROWTH; IN-VIVO; QUANTITATIVE-ANALYSIS; PROMOTER REGION; GENE-EXPRESSION; METASTASIS	Background: The loss of AP-2 alpha and increased activity of cAMP-responsive element binding (CREB) protein are two hallmarks of malignant progression of cutaneous melanoma. However, the molecular mechanism responsible for the loss of AP-2 alpha during melanoma progression remains unknown. Methodology/Principal Findings: Herein, we demonstrate that both inhibition of PKA-dependent CREB phosphorylation, as well as silencing of CREB expression by shRNA, restored AP-2 alpha protein expression in two metastatic melanoma cell lines. Moreover, rescue of CREB expression in CREB-silenced cell lines downregulates expression of AP-2 alpha. Loss of AP-2 alpha expression in metastatic melanoma occurs via a dual mechanism involving binding of CREB to the AP-2 alpha promoter and CREB-induced overexpression of another oncogenic transcription factor, E2F-1. Upregulation of AP-2 alpha expression following CREB silencing increases endogenous p21(Waf1) and decreases MCAM/MUC18, both known to be downstream target genes of AP-2 alpha involved in melanoma progression. Conclusions/Significance: Since AP-2 alpha regulates several genes associated with the metastatic potential of melanoma including cKIT, VEGF, PAR-1, MCAM/MUC18, and p21(Waf1), our data identified CREB as a major regulator of the malignant melanoma phenotype.	[Melnikova, Vladislava O.; Dobroff, Andrey S.; Zigler, Maya; Villares, Gabriel J.; Braeuer, Russell R.; Wang, Hua; Huang, Li; Bar-Eli, Menashe] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Melnikova, VO (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	mbareli@mdanderson.org	Dobroff, Andrey/A-9814-2016	Dobroff, Andrey/0000-0003-2162-9951	National Institutes of Health [CA76098]; NATIONAL CANCER INSTITUTE [R01CA076098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research was supported by National Institutes of Health R01 Grant CA76098 (to M.B-E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINO AP, 1981, J EXP MED, V154, P1764, DOI 10.1084/jem.154.6.1764; Bar-Eli M, 2001, PIGM CELL RES, V14, P78, DOI 10.1034/j.1600-0749.2001.140202.x; Bar-Eli M, 1999, CANCER METAST REV, V18, P377, DOI 10.1023/A:1006377309524; BAUER R, 1994, NUCLEIC ACIDS RES, V22, P1413, DOI 10.1093/nar/22.8.1413; Bell LA, 2004, CELL DEATH DIFFER, V11, P137, DOI 10.1038/sj.cdd.4401324; Berger AJ, 2005, CANCER RES, V65, P11185, DOI 10.1158/0008-5472.CAN-05-2300; Berger AJ, 2003, CANCER RES, V63, P8103; Bhoumik A, 2008, CELL CYCLE, V7, P2341, DOI 10.4161/cc.6388; COPEMAN MC, 1992, PATHOLOGY, V24, P307, DOI 10.3109/00313029209068886; Cowley GP, 1996, J PATHOL, V179, P183, DOI 10.1002/(SICI)1096-9896(199606)179:2<183::AID-PATH554>3.0.CO;2-W; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DESCHEEMAEKER KA, 1992, J BIOL CHEM, V267, P15086; Dobroff AS, 2009, J BIOL CHEM, V284, P26194, DOI 10.1074/jbc.M109.019836; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Gee JMW, 1999, J PATHOL, V189, P514, DOI 10.1002/(SICI)1096-9896(199912)189:4<514::AID-PATH463>3.0.CO;2-9; Gershenwald JE, 2001, ONCOGENE, V20, P3363, DOI 10.1038/sj.onc.1204450; Gille J, 1997, EMBO J, V16, P750, DOI 10.1093/emboj/16.4.750; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Heimberger AB, 2005, CLIN CANCER RES, V11, P267; Huang S, 1998, EMBO J, V17, P4358, DOI 10.1093/emboj/17.15.4358; Jean D, 2000, MOL CELL BIOCHEM, V212, P19, DOI 10.1023/A:1007128101751; Jean D, 1998, J BIOL CHEM, V273, P16501, DOI 10.1074/jbc.273.26.16501; Jean D, 2001, CRIT REV IMMUNOL, V21, P275; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P9160, DOI 10.1073/pnas.93.17.9160; Jonckheere N, 2009, BRIT J CANCER, V101, P637, DOI 10.1038/sj.bjc.6605190; Leslie MC, 2005, J CELL BIOCHEM, V94, P25, DOI 10.1002/jcb.20296; LI LM, 1989, JNCI-J NATL CANCER I, V81, P1406, DOI 10.1093/jnci/81.18.1406; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McGary EC, 2002, CANCER BIOL THER, V1, P459, DOI 10.4161/cbt.1.5.158; McPherson LA, 2002, J BIOL CHEM, V277, P45028, DOI 10.1074/jbc.M208924200; Melnikova VO, 2008, CANCER BIOL THER, V7, P997, DOI 10.4161/cbt.7.7.6535; Melnikova VO, 2006, PIGM CELL RES, V19, P395, DOI 10.1111/j.1600-0749.2006.00331.x; Melnikova VO, 2009, J BIOL CHEM, V284, P28845, DOI 10.1074/jbc.M109.042150; Melnikova VO, 2006, J BIOL CHEM, V281, P2911, DOI 10.1074/jbc.M508683200; Miele ME, 1996, MOL CARCINOGEN, V15, P284, DOI 10.1002/(SICI)1098-2744(199604)15:4<284::AID-MC6>3.0.CO;2-G; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; NATALI PG, 1994, INT J CANCER, V56, P341, DOI 10.1002/ijc.2910560308; Nyormoi O, 2003, CLIN EXP METASTAS, V20, P251, DOI 10.1023/A:1022991302172; PATHAK S, 1983, CYTOGENET CELL GENET, V36, P573, DOI 10.1159/000131975; Poser I, 2004, HISTOL HISTOPATHOL, V19, P173, DOI 10.14670/HH-19.173; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Ropponen KM, 1999, BRIT J CANCER, V81, P133, DOI 10.1038/sj.bjc.6690662; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Schwartz B, 2007, ONCOGENE, V26, P4049, DOI 10.1038/sj.onc.1210193; Sharpless NE, 2003, ONCOGENE, V22, P5055, DOI 10.1038/sj.onc.1206809; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Silins G, 1997, BIOCHEM BIOPH RES CO, V230, P413, DOI 10.1006/bbrc.1996.5979; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Stevens C, 2003, ARCH BIOCHEM BIOPHYS, V412, P157, DOI 10.1016/S0003-9861(03)00054-7; Tellez C, 2003, J BIOL CHEM, V278, P46632, DOI 10.1074/jbc.M309159200; Tellez CS, 2007, J INVEST DERMATOL, V127, P387, DOI 10.1038/sj.jid.5700539; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; VANDENOORD JJ, 1994, AM J PATHOL, V145, P294; VERSCHRAEGEN CF, 1991, ANTICANCER RES, V11, P529; Villares GJ, 2009, CANCER RES, V69, P6730, DOI 10.1158/0008-5472.CAN-09-0300; Wajapeyee N, 2003, J BIOL CHEM, V278, P52093, DOI 10.1074/jbc.M305624200; WALKER GJ, 1995, GENE CHROMOSOME CANC, V12, P134, DOI 10.1002/gcc.2870120208; Walker GJ, 1998, GENE CHROMOSOME CANC, V22, P157, DOI 10.1002/(SICI)1098-2264(199806)22:2<157::AID-GCC11>3.0.CO;2-N; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; WELCH DR, 1994, ONCOGENE, V9, P255; WERNER H, 1990, BIOCHEM BIOPH RES CO, V169, P1021, DOI 10.1016/0006-291X(90)91996-6; White PC, 2006, ONCOGENE, V25, P2170, DOI 10.1038/sj.onc.1209255; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Xie SH, 1997, ONCOGENE, V15, P2069, DOI 10.1038/sj.onc.1201358; Xie YB, 2009, ONCOL REP, V21, P1345, DOI 10.3892/or_00000360; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78; ZHANG J, 1995, CANCER RES, V55, P4640; Zhang J, 2003, DEV DYNAM, V228, P194, DOI 10.1002/dvdy.10365; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	70	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12452	10.1371/journal.pone.0012452	http://dx.doi.org/10.1371/journal.pone.0012452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805990	gold, Green Published, Green Submitted			2022-12-25	WOS:000281301500018
J	Bohn, M; Heermann, DW				Bohn, Manfred; Heermann, Dieter W.			Diffusion-Driven Looping Provides a Consistent Framework for Chromatin Organization	PLOS ONE			English	Article							HUMAN INTERPHASE CHROMOSOMES; 3-DIMENSIONAL STRUCTURE; GENE-EXPRESSION; RING POLYMERS; MONTE-CARLO; IN-SITU; ARCHITECTURE; TERRITORIES; MODEL; DNA	Chromatin folding inside the interphase nucleus of eukaryotic cells is done on multiple scales of length and time. Despite recent progress in understanding the folding motifs of chromatin, the higher-order structure still remains elusive. Various experimental studies reveal a tight connection between genome folding and function. Chromosomes fold into a confined subspace of the nucleus and form distinct territories. Chromatin looping seems to play a dominant role both in transcriptional regulation as well as in chromatin organization and has been assumed to be mediated by long-range interactions in many polymer models. However, it remains a crucial question which mechanisms are necessary to make two chromatin regions become co-located, i.e. have them in spatial proximity. We demonstrate that the formation of loops can be accomplished solely on the basis of diffusional motion. The probabilistic nature of temporary contacts mimics the effects of proteins, e. g. transcription factors, in the solvent. We establish testable quantitative predictions by deriving scale-independent measures for comparison to experimental data. In this Dynamic Loop (DL) model, the co-localization probability of distant elements is strongly increased compared to linear non-looping chains. The model correctly describes folding into a confined space as well as the experimentally observed cell-to-cell variation. Most importantly, at biological densities, model chromosomes occupy distinct territories showing less inter-chromosomal contacts than linear chains. Thus, dynamic diffusion-based looping, i.e. gene co-localization, provides a consistent framework for chromatin organization in eukaryotic interphase nuclei.	[Bohn, Manfred; Heermann, Dieter W.] Heidelberg Univ, Inst Theoret Phys, Heidelberg, Germany; [Heermann, Dieter W.] Inst Mol Biophys, Jackson Lab, Bar Harbor, ME USA	Ruprecht Karls University Heidelberg; Jackson Laboratory	Bohn, M (corresponding author), Heidelberg Univ, Inst Theoret Phys, Heidelberg, Germany.	bohn@tphys.uni-heidelberg.de			Landesgraduiertenforderung Baden-Wurttemberg	Landesgraduiertenforderung Baden-Wurttemberg	M. B. has received funding from the Landesgraduiertenforderung Baden-Wurttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Belmont AS, 2001, TRENDS CELL BIOL, V11, P250, DOI 10.1016/S0962-8924(01)02000-1; Binder K, 2002, MONTE CARLO SIMULATI; Binder K., 1995, MONTE CARLO MOL DYNA; Bode J, 2003, CHROMOSOME RES, V11, P435, DOI 10.1023/A:1024918525818; BOHN M, 2010, J CHEM PHYS IN PRESS; Bohn M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051805; Bohn M, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3126651; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; BRANCO M, 2006, PLOS BIOL, V4, P97; BRUNS W, 1992, MAKROMOL CHEM-THEOR, V1, P287; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; CARMESIN I, 1988, MACROMOLECULES, V21, P2819, DOI 10.1021/ma00187a030; Cook PR, 2009, J CELL BIOL, V186, P825, DOI 10.1083/jcb.200903083; Cook PR, 2002, NAT GENET, V32, P347, DOI 10.1038/ng1102-347; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; De Gennes P.-G., 1979, SCALING CONCEPTS POL; de Nooijer S, 2009, NUCLEIC ACIDS RES, V37, P3558, DOI 10.1093/nar/gkp219; Dekker J, 2003, TRENDS BIOCHEM SCI, V28, P277, DOI 10.1016/S0968-0004(03)00089-6; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DEUTSCH HP, 1991, J CHEM PHYS, V94, P2294, DOI 10.1063/1.459901; Diesinger PM, 2009, BIOPHYS J, V97, P2146, DOI 10.1016/j.bpj.2009.06.057; Dietzel S, 2004, J CELL SCI, V117, P4603, DOI 10.1242/jcs.01330; Dundr M, 2001, BIOCHEM J, V356, P297, DOI 10.1042/0264-6021:3560297; DUPLANTIER B, 1989, J STAT PHYS, V54, P581, DOI 10.1007/BF01019770; Eils R, 1996, J CELL BIOL, V135, P1427, DOI 10.1083/jcb.135.6.1427; Emanuel M, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025008; Fraser P, 2006, CURR OPIN GENET DEV, V16, P490, DOI 10.1016/j.gde.2006.08.002; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Gilbert N, 2005, INT REV CYTOL, V242, P283; Goetze S, 2007, MOL CELL BIOL, V27, P4475, DOI 10.1128/MCB.00208-07; GROSBERG A, 1993, EUROPHYS LETT, V23, P373, DOI 10.1209/0295-5075/23/5/012; Grosberg A.Y., 1994, STAT PHYS MACROMOLEC; HAHNFELDT P, 1993, P NATL ACAD SCI USA, V90, P7854, DOI 10.1073/pnas.90.16.7854; HOROWITZ RA, 1994, J CELL BIOL, V125, P1, DOI 10.1083/jcb.125.1.1; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Khalil A, 2007, CHROMOSOME RES, V15, P899, DOI 10.1007/s10577-007-1172-8; Langowski J, 2006, EUR PHYS J E, V19, P241, DOI 10.1140/epje/i2005-10067-9; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lowenstein MG, 2004, MOL BIOL CELL, V15, P5678, DOI 10.1091/mbc.E04-04-0289; Lua R, 2004, POLYMER, V45, P717, DOI 10.1016/j.polymer.2003.10.073; Marenduzzo D, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/09/L09002; Marenduzzo D, 2007, TRENDS GENET, V23, P126, DOI 10.1016/j.tig.2007.01.007; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Muller M, 1996, PHYS REV E, V53, P5063, DOI 10.1103/PhysRevE.53.5063; Muller M, 2000, PHYS REV E, V61, P4078, DOI 10.1103/PhysRevE.61.4078; Munkel C, 1998, PHYS REV E, V57, P5888, DOI 10.1103/PhysRevE.57.5888; Munkel C, 1999, J MOL BIOL, V285, P1053, DOI 10.1006/jmbi.1998.2361; PAUL W, 1991, J PHYS II, V1, P37, DOI 10.1051/jp2:1991138; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rosa A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000153; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; Scheuermann MO, 2004, EXP CELL RES, V301, P266, DOI 10.1016/j.yexcr.2004.08.031; Schiessel H, 2001, BIOPHYS J, V80, P1940, DOI 10.1016/S0006-3495(01)76164-4; SIKORAV JL, 1994, BIOPHYS J, V66, P827, DOI 10.1016/S0006-3495(94)80859-8; SIKORSKI A, 1994, POLYMER, V35, P3792, DOI 10.1016/0032-3861(94)90565-7; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; SOKAL AD, 1996, FUNCTIONAL INTEGRATI; St-Jean P, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061923; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; vanHolde K, 1996, P NATL ACAD SCI USA, V93, P10548, DOI 10.1073/pnas.93.20.10548; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; WOODCOCK CLF, 1984, J CELL BIOL, V99, P42, DOI 10.1083/jcb.99.1.42; YOKOTA H, 1995, J CELL BIOL, V130, P1239, DOI 10.1083/jcb.130.6.1239; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107	68	119	122	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12218	10.1371/journal.pone.0012218	http://dx.doi.org/10.1371/journal.pone.0012218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811620	Green Submitted, Green Published, gold			2022-12-25	WOS:000281234700002
J	Hildebrandt, MAT; Komaki, R; Liao, Z; Gu, JA; Chang, JY; Ye, YQ; Lu, C; Stewart, DJ; Minna, JD; Roth, JA; Lippman, SM; Cox, JD; Hong, WK; Spitz, MR; Wu, XF				Hildebrandt, Michelle A. T.; Komaki, Ritsuko; Liao, Zhongxing; Gu, Jian; Chang, Joe Y.; Ye, Yuanqing; Lu, Charles; Stewart, David J.; Minna, John D.; Roth, Jack A.; Lippman, Scott M.; Cox, James D.; Hong, Waun Ki; Spitz, Margaret R.; Wu, Xifeng			Genetic Variants in Inflammation-Related Genes Are Associated with Radiation-Induced Toxicity Following Treatment for Non-Small Cell Lung Cancer	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; NORMAL TISSUE-REACTIONS; TNF POLYMORPHISM; TRANSCRIPTION; EXPRESSION; RADIOTHERAPY; REGION; RISK; PNEUMONITIS; STATISTICS	Treatment of non-small cell lung cancer (NSCLC) with radiotherapy or chemoradiotherapy is often accompanied by the development of esophagitis and pneumonitis. Identifying patients who might be at increased risk for normal tissue toxicity would help in determination of the optimal radiation dose to avoid these events. We profiled 59 single nucleotide polymorphisms (SNPs) from 37 inflammation-related genes in 173 NSCLC patients with stage IIIA/IIIB (dry) disease who were treated with definitive radiation or chemoradiation. For esophagitis risk, nine SNPs were associated with a 1.5-to 4-fold increase in risk, including three PTGS2 (COX2) variants: rs20417 (HR: 1.93, 95% CI: 1.10-3.39), rs5275 (HR: 1.58, 95% CI: 1.09-2.27), and rs689470 (HR: 3.38, 95% CI: 1.09-10.49). Significantly increased risk of pneumonitis was observed for patients with genetic variation in the proinflammatory genes IL1A, IL8, TNF, TNFRSF1B, and MIF. In contrast, NOS3: rs1799983 displayed a protective effect with a 45% reduction in pneumonitis risk (HR: 0.55, 95% CI: 0.31-0.96). Pneumonitis risk was also modulated by polymorphisms in anti-inflammatory genes, including genetic variation in IL13. rs20541 and rs180925 each resulted in increased risk (HR: 2.95, 95% CI: 1.14-7.63 and HR: 3.23, 95% CI: 1.03-10.18, respectively). The cumulative effect of these SNPs on risk was dose-dependent, as evidenced by a significantly increased risk of either toxicity with an increasing number of risk genotypes (P, 0.001). These results suggest that genetic variations among inflammation pathway genes may modulate the development of radiation-induced toxicity and, ultimately, help in identifying patients who are at an increased likelihood for such events.	[Hildebrandt, Michelle A. T.; Gu, Jian; Ye, Yuanqing; Spitz, Margaret R.; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Komaki, Ritsuko; Liao, Zhongxing; Chang, Joe Y.; Cox, James D.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Lu, Charles; Stewart, David J.; Lippman, Scott M.; Hong, Waun Ki] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Roth, Jack A.] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center	Hildebrandt, MAT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	xwu@mdanderson.org	Gu, Jian/Q-4780-2018; Wang, Weili/D-1546-2011	Gu, Jian/0000-0003-3499-0973; 	NATIONAL CANCER INSTITUTE [R01CA111646, P50CA070907, R01CA127219, R01CA055769] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA055769, P50 CA070907, R01 CA111646, R01 CA127219, R01 CA127219-04, R01 CA55769] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andreassen CN, 2003, RADIOTHER ONCOL, V69, P127, DOI 10.1016/j.radonc.2003.09.010; Andreassen CN, 2002, RADIOTHER ONCOL, V64, P131, DOI 10.1016/S0167-8140(02)00154-8; Andreassen CN, 2005, RADIOTHER ONCOL, V75, P18, DOI 10.1016/j.radonc.2004.12.012; Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Cameron L, 2006, J IMMUNOL, V177, P8633, DOI 10.4049/jimmunol.177.12.8633; Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dixon DA, 2004, CURR PHARM DESIGN, V10, P635, DOI 10.2174/1381612043453171; Dominici R, 2002, IMMUNOGENETICS, V54, P82, DOI 10.1007/s00251-002-0445-9; Engels EA, 2007, CANCER RES, V67, P6520, DOI 10.1158/0008-5472.CAN-07-0370; FINKELSTEIN JN, 1994, INT J RADIAT ONCOL, V28, P621, DOI 10.1016/0360-3016(94)90187-2; Gao LB, 2009, CARCINOGENESIS, V30, P295, DOI 10.1093/carcin/bgn281; Gasche C, 2003, J IMMUNOL, V170, P5578, DOI 10.4049/jimmunol.170.11.5578; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; Higuchi T, 1998, TISSUE ANTIGENS, V51, P605, DOI 10.1111/j.1399-0039.1998.tb03002.x; Hill MR, 2006, AM J RESP CRIT CARE, V174, P915, DOI 10.1164/rccm.200512-1839OC; Hohjoh H, 2001, GENES IMMUN, V2, P105, DOI 10.1038/sj.gene.6363721; Hull J, 2000, THORAX, V55, P1023, DOI 10.1136/thorax.55.12.1023; HUTH C, 2008, ANN MED, P1; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kabesch M, 2003, J ALLERGY CLIN IMMUN, V112, P893, DOI 10.1016/j.jaci.2003.08.033; Kawaguchi Y, 2007, IMMUNOGENETICS, V59, P441, DOI 10.1007/s00251-007-0213-y; Kiszel P, 2007, CYTOKINE, V40, P17, DOI 10.1016/j.cyto.2007.08.001; Lv K, 2006, SCAND J IMMUNOL, V64, P164, DOI 10.1111/j.1365-3083.2006.01786.x; Morita C, 2001, ARTHRITIS RHEUM-US, V44, P2819, DOI 10.1002/1529-0131(200112)44:12<2819::AID-ART469>3.0.CO;2-2; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Papafili A, 2002, ARTERIOSCL THROM VAS, V22, P1631, DOI 10.1161/01.ATV.0000030340.80207.C5; PUTHOTHU B, 2008, PEDIAT ALLERGY IMMUN; Quarmby S, 2003, INT J RADIAT BIOL, V79, P137, DOI 10.1080/0955300021000045673; Robnett TJ, 2000, INT J RADIAT ONCOL, V48, P89, DOI 10.1016/S0360-3016(00)00648-9; ROSE J, 2008, RADIOTHER ONCOL; RUBIN P, 1995, INT J RADIAT ONCOL, V33, P99, DOI 10.1016/0360-3016(95)00095-G; Sato H, 2007, J ALLERGY CLIN IMMUN, V119, P687, DOI 10.1016/j.jaci.2006.10.028; Singh AK, 2003, INT J RADIAT ONCOL, V55, P337, DOI 10.1016/S0360-3016(02)03937-8; Soga Y, 2003, J CLIN PERIODONTOL, V30, P524, DOI 10.1034/j.1600-051X.2003.00287.x; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Terry CF, 2000, J BIOL CHEM, V275, P18138, DOI 10.1074/jbc.M000379200; Till A, 2005, J BIOL CHEM, V280, P5994, DOI 10.1074/jbc.M411541200; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Tucker SL, 2008, INT J RADIAT ONCOL, V72, P568, DOI 10.1016/j.ijrobp.2008.04.053; van Heel DA, 2002, HUM MOL GENET, V11, P1281, DOI 10.1093/hmg/11.11.1281; Veldman BA, 2002, J HYPERTENS, V20, P2023, DOI 10.1097/00004872-200210000-00022; Vladich FD, 2005, J CLIN INVEST, V115, P747, DOI 10.1172/JCI200522818; Wang SL, 2006, INT J RADIAT ONCOL, V66, P1399, DOI 10.1016/j.ijrobp.2006.07.1337; Wang XL, 2000, FEBS LETT, V471, P45, DOI 10.1016/S0014-5793(00)01356-9	47	79	84	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12402	10.1371/journal.pone.0012402	http://dx.doi.org/10.1371/journal.pone.0012402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811626	gold, Green Published, Green Submitted			2022-12-25	WOS:000281234700025
J	Hov, JR; Keitel, V; Laerdahl, JK; Spomer, L; Ellinghaus, E; ElSharawy, A; Melum, E; Boberg, KM; Manke, T; Balschun, T; Schramm, C; Bergquist, A; Weismuller, T; Gotthardt, D; Rust, C; Henckaerts, L; Onnie, CM; Weersma, RK; Sterneck, M; Teufel, A; Runz, H; Stiehl, A; Ponsioen, CY; Wijmenga, C; Vatn, MH; Stokkers, PCF; Vermeire, S; Mathew, CG; Lie, BA; Beuers, U; Manns, MP; Schreiber, S; Schrumpf, E; Haussinger, D; Franke, A; Karlsen, TH				Hov, Johannes R.; Keitel, Verena; Laerdahl, Jon K.; Spomer, Lina; Ellinghaus, Eva; ElSharawy, Abdou; Melum, Espen; Boberg, Kirsten M.; Manke, Thomas; Balschun, Tobias; Schramm, Christoph; Bergquist, Annika; Weismueller, Tobias; Gotthardt, Daniel; Rust, Christian; Henckaerts, Liesbet; Onnie, Clive M.; Weersma, Rinse K.; Sterneck, Martina; Teufel, Andreas; Runz, Heiko; Stiehl, Adolf; Ponsioen, Cyriel Y.; Wijmenga, Cisca; Vatn, Morten H.; Stokkers, Pieter C. F.; Vermeire, Severine; Mathew, Christopher G.; Lie, Benedicte A.; Beuers, Ulrich; Manns, Michael P.; Schreiber, Stefan; Schrumpf, Erik; Haeussinger, Dieter; Franke, Andre; Karlsen, Tom H.		IBSEN Study Grp	Mutational Characterization of the Bile Acid Receptor TGR5 in Primary Sclerosing Cholangitis	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENTS; PROTEIN-COUPLED RECEPTORS; ULCERATIVE-COLITIS; GENE-EXPRESSION; CYSTIC-FIBROSIS; CROHN-DISEASE; BOWEL-DISEASE; LIVER-DISEASE; WEB SERVER; SUSCEPTIBILITY	Background: TGR5, the G protein-coupled bile acid receptor 1 (GPBAR1), has been linked to inflammatory pathways as well as bile homeostasis, and could therefore be involved in primary sclerosing cholangitis (PSC) a chronic inflammatory bile duct disease. We aimed to extensively investigate TGR5 sequence variation in PSC, as well as functionally characterize detected variants. Methodology/Principal Findings: Complete resequencing of TGR5 was performed in 267 PSC patients and 274 healthy controls. Six nonsynonymous mutations were identified in addition to 16 other novel single-nucleotide polymorphisms. To investigate the impact from the nonsynonymous variants on TGR5, we created a receptor model, and introduced mutated TGR5 constructs into human epithelial cell lines. By using confocal microscopy, flow cytometry and a cAMP-sensitive luciferase assay, five of the nonsynonymous mutations (W83R, V178M, A217P, S272G and Q296X) were found to reduce or abolish TGR5 function. Fine-mapping of the previously reported PSC and UC associated locus at chromosome 2q35 in large patient panels revealed an overall association between the TGR5 single-nucleotide polymorphism rs11554825 and PSC (odds ratio = 1.14, 95% confidence interval: 1.03-1.26, p = 0.010) and UC (odds ratio = 1.19, 95% confidence interval 1.11-1.27, p = 8.5x10(-7)), but strong linkage disequilibrium precluded demarcation of TGR5 from neighboring genes. Conclusions/Significance: Resequencing of TGR5 along with functional investigations of novel variants provided unique insight into an important candidate gene for several inflammatory and metabolic conditions. While significant TGR5 associations were detected in both UC and PSC, further studies are needed to conclusively define the role of TGR5 variation in these diseases.	[Hov, Johannes R.; Melum, Espen; Boberg, Kirsten M.; Schrumpf, Erik; Karlsen, Tom H.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Norwegian PSC Res Ctr,Clin Specialized Med & Surg, N-0027 Oslo, Norway; [Hov, Johannes R.; Melum, Espen] Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway; [Hov, Johannes R.; Melum, Espen; Vatn, Morten H.; Schrumpf, Erik] Univ Oslo, Inst Clin Med, Oslo, Norway; [Keitel, Verena; Spomer, Lina; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, Dusseldorf, Germany; [Laerdahl, Jon K.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Ctr Mol Biol & Neurosci, N-0027 Oslo, Norway; [Laerdahl, Jon K.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Med Microbiol, N-0027 Oslo, Norway; [Ellinghaus, Eva; ElSharawy, Abdou; Balschun, Tobias; Schreiber, Stefan; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [ElSharawy, Abdou; Schreiber, Stefan] Univ Hosp Schleswig Holstein, Dept Med 1, Kiel, Germany; [Manke, Thomas] Max Planck Inst Mol Genet, Berlin, Germany; [Schramm, Christoph; Sterneck, Martina] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Bergquist, Annika] Karolinska Univ Hosp Huddinge, Dept Gastroenterol & Hepatol, Stockholm, Sweden; [Balschun, Tobias; Manns, Michael P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany; [Weismueller, Tobias; Manns, Michael P.] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, D-3000 Hannover, Germany; [Gotthardt, Daniel; Stiehl, Adolf] Univ Heidelberg Hosp, Dept Med, Heidelberg, Germany; [Rust, Christian] Univ Munich, Dept Med 2, Munich, Germany; [Henckaerts, Liesbet; Vermeire, Severine] Univ Hosp Gasthuisberg, Dept Gastroenterol, B-3000 Louvain, Belgium; [Onnie, Clive M.; Mathew, Christopher G.] Kings Coll London, Dept Med & Mol Genet, Sch Med, London WC2R 2LS, England; [Weersma, Rinse K.] Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, NL-9713 AV Groningen, Netherlands; [Weersma, Rinse K.; Wijmenga, Cisca] Univ Groningen, Groningen, Netherlands; [Teufel, Andreas] Johannes Gutenberg Univ Mainz, Dept Med 1, D-6500 Mainz, Germany; [Runz, Heiko] Univ Heidelberg Hosp, Dept Human Genet, Heidelberg, Germany; [Ponsioen, Cyriel Y.; Stokkers, Pieter C. F.; Beuers, Ulrich] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Vatn, Morten H.] Akershus Univ Hosp, Inst Clin Epidemiol & Mol Biol Epigen, Lorenskog, Norway; [Vatn, Morten H.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Clin Specialized Med & Surg, N-0027 Oslo, Norway; [Lie, Benedicte A.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Immunol, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; Heinrich Heine University Dusseldorf; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf; Karolinska Institutet; Karolinska University Hospital; Hannover Medical School; Hannover Medical School; Ruprecht Karls University Heidelberg; University of Munich; KU Leuven; University Hospital Leuven; University of London; King's College London; University of Groningen; University of Groningen; Johannes Gutenberg University of Mainz; Ruprecht Karls University Heidelberg; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Hov, JR (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Norwegian PSC Res Ctr,Clin Specialized Med & Surg, N-0027 Oslo, Norway.	j.e.r.hov@medisin.uio.no	Ellinghaus, Eva/E-6490-2012; Teufel, Andreas/ABD-8000-2021; Hov, Johannes R/J-1480-2019; Keitel, Verena/AAF-3471-2019; Wijmenga, Cisca/D-2173-2009; Franke, Andre/B-2151-2010; Weismüller, Tobias J./I-1879-2019; Keitel, Verena/AAH-9016-2021; Weersma, Rinse/ABE-3807-2021; Henckaerts, Liesbet/AAB-5706-2021; Wijmenga, Cisca/AAE-7719-2019; Mathew, Christopher G/G-3434-2015; Manke, Thomas/L-9075-2019	Ellinghaus, Eva/0000-0003-2914-3382; Hov, Johannes R/0000-0002-5900-8096; Franke, Andre/0000-0003-1530-5811; Weismüller, Tobias J./0000-0001-9736-1483; Keitel, Verena/0000-0003-1383-7662; Wijmenga, Cisca/0000-0002-5635-1614; Mathew, Christopher G/0000-0003-4178-1838; Henckaerts, Liesbet/0000-0003-2880-1400; Bergquist, Annika/0000-0002-3858-6241; Vermeire, Severine/0000-0001-9942-3019; Laerdahl, Jon Kristen/0000-0002-0826-9464; Schramm, Christoph/0000-0002-4264-1928	Norwegian PSC research center; Research Council of Norway; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 575, Klinische Forschergruppe-217]; German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN); Popgen biobank; DFG; Integrated Research and Treatment Center - Transplantation [01EO0802]; United Kingdom Medical Research Council (MRC) [G0000934]; Wellcome Trust [068545/Z/02]; Medical Research Council [G0000934] Funding Source: researchfish; MRC [G0000934] Funding Source: UKRI	Norwegian PSC research center; Research Council of Norway(Research Council of Norway); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); Popgen biobank; DFG(German Research Foundation (DFG)); Integrated Research and Treatment Center - Transplantation; United Kingdom Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Norwegian PSC research center, Research Council of Norway, the Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 575 Dusseldorf "Experimental Hepatology'' and Klinische Forschergruppe-217 Dusseldorf "Hepatobiliary transport and liver disease'' and the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN), the Popgen biobank, the DFG excellence cluster "Inflammation at Interfaces'' and the Integrated Research and Treatment Center - Transplantation (reference number: 01EO0802). The 1958 British Birth Cohort collection is funded by the United Kingdom Medical Research Council (MRC, grant G0000934) and The Wellcome Trust (grant 068545/Z/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bergquist A, 2008, CLIN GASTROENTEROL H, V6, P939, DOI 10.1016/j.cgh.2008.03.016; Blanco PG, 2004, AM J PHYSIOL-GASTR L, V287, pG491, DOI 10.1152/ajpgi.00452.2003; Boberg KM, 1998, SCAND J GASTROENTERO, V33, P99; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Broome U, 2006, SEMIN LIVER DIS, V26, P31, DOI 10.1055/s-2006-933561; CHAPMAN RWG, 1980, GUT, V21, P870, DOI 10.1136/gut.21.10.870; Colombo C, 2007, CURR OPIN PULM MED, V13, P529, DOI 10.1097/MCP.0b013e3282f10a16; COTECCHIA S, 1992, J BIOL CHEM, V267, P1633; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; De La Vega FA, 2005, MUTAT RES-FUND MOL M, V573, P111, DOI 10.1016/j.mrfmmm.2005.01.008; de Ligt RAF, 2005, EUR J PHARMACOL, V510, P1, DOI 10.1016/j.ejphar.2005.01.007; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Gaborik Z, 1998, FEBS LETT, V428, P147, DOI 10.1016/S0014-5793(98)00511-0; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; HUNYADY L, 1995, J BIOL CHEM, V270, P9702, DOI 10.1074/jbc.270.17.9702; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Karlsen TH, 2010, DIGEST LIVER DIS, V42, P390, DOI 10.1016/j.dld.2010.01.011; Karlsen TH, 2010, CURR OPIN GASTROEN, V26, P251, DOI 10.1097/MOG.0b013e328336807d; Karlsen TH, 2010, GASTROENTEROLOGY, V138, P1102, DOI 10.1053/j.gastro.2009.11.046; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2008, BIOCHEM BIOPH RES CO, V372, P78, DOI 10.1016/j.bbrc.2008.04.171; Keitel V, 2007, HEPATOLOGY, V45, P695, DOI 10.1002/hep.21458; Keitel V, 2009, HEPATOLOGY, V50, P861, DOI 10.1002/hep.23032; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Maruyama T, 2006, J ENDOCRINOL, V191, P197, DOI 10.1677/joe.1.06546; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; O'Mahony CA, 2006, SEMIN LIVER DIS, V26, P3, DOI 10.1055/s-2006-933559; Pall H, 2007, J PEDIATR-US, V151, P255, DOI 10.1016/j.jpeds.2007.03.062; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sato H, 2008, J MED CHEM, V51, P1831, DOI 10.1021/jm7015864; Sheth S, 2003, HUM GENET, V113, P286, DOI 10.1007/s00439-003-0963-z; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tobler Andreas R, 2005, J Biomol Tech, V16, P398; Vassileva G, 2006, BIOCHEM J, V398, P423, DOI 10.1042/BJ20060537; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005; WIESNER RH, 1980, GASTROENTEROLOGY, V79, P200	51	91	92	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12403	10.1371/journal.pone.0012403	http://dx.doi.org/10.1371/journal.pone.0012403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811628	Green Submitted, Green Published, gold			2022-12-25	WOS:000281234700026
J	Katanayeva, N; Kopein, D; Portmann, R; Hess, D; Katanaev, VL				Katanayeva, Natalya; Kopein, Damir; Portmann, Reto; Hess, Daniel; Katanaev, Vladimir L.			Competing Activities of Heterotrimeric G Proteins in Drosophila Wing Maturation	PLOS ONE			English	Article							TRIMERIC G-PROTEIN; ASYMMETRIC CELL-DIVISION; SIGNALING PATHWAY; ALPHA; MELANOGASTER; ACTIVATION; EXPRESSION; SUBUNIT; DEATH; GENE	Drosophila genome encodes six alpha-subunits of heterotrimeric G proteins. The G alpha s alpha-subunit is involved in the post-eclosion wing maturation, which consists of the epithelial-mesenchymal transition and cell death, accompanied by unfolding of the pupal wing into the firm adult flight organ. Here we show that another alpha-subunit G alpha o can specifically antagonize the G alpha s activities by competing for the G beta 13F/G gamma 1 subunits of the heterotrimeric Gs protein complex. Loss of G beta 13F, G gamma 1, or G alpha s, but not any other G protein subunit, results in prevention of post-eclosion cell death and failure of the wing expansion. However, cell death prevention alone is not sufficient to induce the expansion defect, suggesting that the failure of epithelial-mesenchymal transition is key to the folded wing phenotypes. Overactivation of G alpha s with cholera toxin mimics expression of constitutively activated G alpha s and promotes wing blistering due to precocious cell death. In contrast, co-overexpression of G beta 13F and G gamma 1 does not produce wing blistering, revealing the passive role of the G beta gamma in the G alpha s mediated activation of apoptosis, but hinting at the possible function of G beta gamma in the epithelial-mesenchymal transition. Our results provide a comprehensive functional analysis of the heterotrimeric G protein proteome in the late stages of Drosophila wing development.	[Katanayeva, Natalya; Kopein, Damir; Katanaev, Vladimir L.] Univ Konstanz, Dept Biol, Constance, Germany; [Portmann, Reto; Hess, Daniel] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Katanaev, Vladimir L.] Russian Acad Sci, Inst Prot Res, Pushchino 142292, Russia	University of Konstanz; Friedrich Miescher Institute for Biomedical Research; Russian Academy of Sciences	Katanayeva, N (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.	vladimir.katanaev@uni-konstanz.de	Katanaev, Vladimir/F-9480-2014; Portmann, Reto/K-9122-2017	Katanaev, Vladimir/0000-0002-7909-5617; Portmann, Reto/0000-0001-8979-7439; Kopein, Damir/0000-0003-1176-5829	Deutsche Forschungsgemeinschaft [TR-SFB11, KA2721/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was funded by TR-SFB11 and KA2721/1-1(Deutsche Forschungsgemeinschaft) to V. L. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brody T, 2000, J CELL BIOL, V150, pF83, DOI 10.1083/jcb.150.2.F83; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Chen CM, 1999, DEVELOPMENT, V126, P5441; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Dave RH, 2009, NEUROSIGNALS, V17, P100, DOI 10.1159/000186693; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DOLPH PJ, 1994, NATURE, V370, P59, DOI 10.1038/370059a0; Egger-Adam D, 2010, DEV DYNAM, V239, P168, DOI 10.1002/dvdy.22060; Ferris J, 2006, NAT NEUROSCI, V9, P1036, DOI 10.1038/nn1738; FITCH CL, 1993, CELL SIGNAL, V5, P187, DOI 10.1016/0898-6568(93)90070-3; Fremion E, 1999, J CELL BIOL, V145, P1063, DOI 10.1083/jcb.145.5.1063; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; HAY BA, 1994, DEVELOPMENT, V120, P2121; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; JOHNSON SA, 1987, TISSUE CELL, V19, P505, DOI 10.1016/0040-8166(87)90044-9; Kalidas S, 2002, NEURON, V33, P177, DOI 10.1016/S0896-6273(02)00560-3; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Katanaev VL, 2006, P NATL ACAD SCI USA, V103, P6524, DOI 10.1073/pnas.0601853103; Katanaev VL, 2006, CELL CYCLE, V5, P2464, DOI 10.4161/cc.5.21.3410; Katanaev VL, 2007, BIOCHEM J, V401, P485, DOI 10.1042/BJ20060517; Kiger JA, 2007, DEV BIOL, V301, P178, DOI 10.1016/j.ydbio.2006.08.011; Kimura KI, 2004, DEVELOPMENT, V131, P1597, DOI 10.1242/dev.01049; Kopein D, 2009, MOL BIOL CELL, V20, P3865, DOI 10.1091/mbc.E09-01-0021; Lunde K, 1998, DEVELOPMENT, V125, P4145; Malbon CC, 2005, NAT REV MOL CELL BIO, V6, P689, DOI 10.1038/nrm1716; McIntire WE, 2009, NEUROSIGNALS, V17, P82, DOI 10.1159/000186692; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; Natzle JE, 2008, GENETICS, V180, P885, DOI 10.1534/genetics.108.092908; Neumann CJ, 1996, DEVELOPMENT, V122, P1781; OGDEN SK, 2008, NATURE; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; QUAN F, 1993, P NATL ACAD SCI USA, V90, P4236, DOI 10.1073/pnas.90.9.4236; Ratnaparkhi A, 2002, J NEUROSCI, V22, P4499, DOI 10.1523/JNEUROSCI.22-11-04499.2002; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schulz S, 1999, J BIOL CHEM, V274, P37605, DOI 10.1074/jbc.274.53.37605; Schwabe T, 2005, CELL, V123, P133, DOI 10.1016/j.cell.2005.08.037; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WOLFGANG WJ, 1990, J NEUROSCI, V10, P1014; Wolfgang WJ, 1996, P NATL ACAD SCI USA, V93, P14542, DOI 10.1073/pnas.93.25.14542; Wolfgang WJ, 2004, DEV BIOL, V268, P295, DOI 10.1016/j.ydbio.2004.01.007; Wolfgang WJ, 2001, GENETICS, V158, P1189; Yi P, 2008, DEV CELL, V15, P704, DOI 10.1016/j.devcel.2008.10.001; Yi P, 2006, SCIENCE, V313, P1301, DOI 10.1126/science.1127704	49	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12331	10.1371/journal.pone.0012331	http://dx.doi.org/10.1371/journal.pone.0012331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808795	Green Published, gold, Green Submitted			2022-12-25	WOS:000281153500013
J	Nantajit, D; Fan, M; Duru, N; Wen, YF; Reed, JC; Li, JJ				Nantajit, Danupon; Fan, Ming; Duru, Nadire; Wen, Yunfei; Reed, John C.; Li, Jian Jian			Cyclin B1/Cdk1 Phosphorylation of Mitochondrial p53 Induces Anti-Apoptotic Response (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							BREAST-CANCER CELLS; PROTEIN-KINASE; IONIZING-RADIATION; DNA-BINDING; TRANSLOCATION; ARREST; B1; LOCALIZATION; ACTIVATION; EXPRESSION	The pro-apoptotic function of p53 has been well defined in preventing genomic instability and cell transformation. However, the intriguing fact that p53 contributes to a pro-survival advantage of tumor cells under DNA damage conditions raises a critical question in radiation therapy for the 50% human cancers with intact p53 function. Herein, we reveal an antiapoptotic role of mitochondrial p53 regulated by the cell cycle complex cyclin B1/Cdk1 in irradiated human colon cancer HCT116 cells with p53(+/+) status. Steady-state levels of p53 and cyclin B1/Cdk1 were identified in the mitochondria of many human and mouse cells, and their mitochondrial influx was significantly enhanced by radiation. The mitochondrial kinase activity of cyclin B1/Cdk1 was found to specifically phosphorylate p53 at Ser-315 residue, leading to enhanced mitochondrial ATP production and reduced mitochondrial apoptosis. The improved mitochondrial function can be blocked by transfection of mutant p53 Ser-315-Ala, or by siRNA knockdown of cyclin B1 and Cdk1 genes. Enforced translocation of cyclin B1 and Cdk1 into mitochondria with a mitochondrial-targeting-peptide increased levels of Ser-315 phosphorylation on mitochondrial p53, improved ATP production and decreased apoptosis by sequestering p53 from binding to Bcl-2 and Bcl-xL. Furthermore, reconstitution of wild-type p53 in p53-deficient HCT116 p53(-/-) cells resulted in an increased mitochondrial ATP production and suppression of apoptosis. Such phenomena were absent in the p53-deficient HCT116 p53(-/-) cells reconstituted with the mutant p53. These results demonstrate a unique anti-apoptotic function of mitochondrial p53 regulated by cyclin B1/Cdk1-mediated Ser-315 phosphorylation in p53-wild-type tumor cells, which may provide insights for improving the efficacy of anti-cancer therapy, especially for tumors that retain p53.	[Nantajit, Danupon; Fan, Ming; Duru, Nadire; Li, Jian Jian] Univ Calif Davis, Dept Radiat Oncol, Sacramento, CA 95817 USA; [Wen, Yunfei; Reed, John C.] Sanford Burnham Med Res Inst, Program Cell Death & Apoptosis, La Jolla, CA USA; [Li, Jian Jian] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA	University of California System; University of California Davis; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Davis	Nantajit, D (corresponding author), Univ Calif Davis, Dept Radiat Oncol, Sacramento, CA 95817 USA.	jijli@ucdavis.edu	Nantajit, Danupon/CAF-7353-2022	Li, Jian Jian/0000-0003-3694-9675	National Institutes of Health [CA133402]; US Department of Energy Office of Science [DE-SC0001271]; NATIONAL CANCER INSTITUTE [R01CA152313, R01CA133402] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA133402 and the US Department of Energy Office of Science DE-SC0001271. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KM, 2008, ONCOGENE, V27, P6738, DOI 10.1038/onc.2008.265; Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Bache M, 2001, INT J CANCER, V96, P110, DOI 10.1002/ijc.1002; Bakhanashvili M, 2008, CELL DEATH DIFFER, V15, P1865, DOI 10.1038/cdd.2008.122; BERNHARD EJ, 1994, RADIAT RES, V138, pS64, DOI 10.2307/3578764; BIARD DSF, 1994, CANCER RES, V54, P3361; BISCHOFF JR, 1990, P NATL ACAD SCI USA, V87, P4766, DOI 10.1073/pnas.87.12.4766; Blaydes JP, 2001, J BIOL CHEM, V276, P4699, DOI 10.1074/jbc.M003485200; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen DX, 2006, CANCER RES, V66, P3485, DOI 10.1158/0008-5472.CAN-05-4103; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Deveraux Quinn L., 2001, Cardiology Clinics, V19, P57; Essmann F, 2005, J BIOL CHEM, V280, P37169, DOI 10.1074/jbc.M502052200; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Ferecatu I, 2009, BIOCHEM BIOPH RES CO, V387, P772, DOI 10.1016/j.bbrc.2009.07.111; Finley NL, 2004, J BIOL CHEM, V279, P54833, DOI 10.1074/jbc.M408304200; Fuster JJ, 2007, TRENDS MOL MED, V13, P192, DOI 10.1016/j.molmed.2007.03.002; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HARLEY ME, 2010, EMBO J; Hassan KA, 2002, CANCER RES, V62, P6414; Helton ES, 2007, J CELL BIOCHEM, V100, P883, DOI 10.1002/jcb.21091; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Kirsch DG, 2010, SCIENCE, V327, P593, DOI 10.1126/science.1166202; Kojima K, 2009, CANCER SCI, V100, P1128, DOI 10.1111/j.1349-7006.2009.01150.x; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Li ZK, 2001, RADIAT RES, V155, P543, DOI 10.1667/0033-7587(2001)155[0543:EGAIMH]2.0.CO;2; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Maity A, 1996, ONCOGENE, V13, P1647; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; MARCOTE MJ, 1993, MOL CELL BIOL, V13, P5122, DOI 10.1128/MCB.13.8.5122; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Murphy ME, 2004, CELL CYCLE, V3, P836; MUSCHEL RJ, 1991, CANCER RES, V51, P5113; Nemajerova A, 2005, FEBS LETT, V579, P6079, DOI 10.1016/j.febslet.2005.09.074; Nemajerova A, 2005, CELL DEATH DIFFER, V12, P197, DOI 10.1038/sj.cdd.4401526; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Ozeki M, 2004, ANTICANCER RES, V24, P2657; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Park JY, 2009, CIRC RES, V105, P705, DOI 10.1161/CIRCRESAHA.109.205310; RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X; RIZZUTO R, 1989, J BIOL CHEM, V264, P10595; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Saleem A, 2009, PHYSIOL GENOMICS, V37, P58, DOI 10.1152/physiolgenomics.90346.2008; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Sansome C, 2001, FEBS LETT, V488, P110, DOI 10.1016/S0014-5793(00)02368-1; Song YM, 2008, CARCINOGENESIS, V29, P307, DOI 10.1093/carcin/bgm269; Su ZZ, 2006, ONCOGENE, V25, P2339, DOI 10.1038/sj.onc.1209271; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Tedeschi A, 2009, EMBO REP, V10, P576, DOI 10.1038/embor.2009.89; Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09; TISHLER RB, 1993, CANCER RES, V53, P2212; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Vousden KH, 2010, P NATL ACAD SCI USA, V107, P7117, DOI 10.1073/pnas.1002656107; WANG Y, 1995, NATURE, V376, P88, DOI 10.1038/376088a0; Xia LQ, 2004, CANCER RES, V64, P221, DOI 10.1158/0008-5472.CAN-03-0969; Yoshida Y, 2003, CANCER RES, V63, P3729; Yuan JP, 2004, ONCOGENE, V23, P5843, DOI 10.1038/sj.onc.1207757; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	66	42	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12341	10.1371/journal.pone.0012341	http://dx.doi.org/10.1371/journal.pone.0012341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808790	Green Submitted, gold, Green Published			2022-12-25	WOS:000281153500021
J	Kemper, K; Tol, MJPM; Medema, JP				Kemper, Kristel; Tol, Marc J. P. M.; Medema, Jan Paul			Mouse Tissues Express Multiple Splice Variants of Prominin-1	PLOS ONE			English	Article							HUMAN HEMATOPOIETIC STEM; CD133 EXPRESSION; CELL ANTIGEN; AC133; PROTEIN; MARKER; PROMOTER; MUTATION; GROWTH; GENE	Prominin-1, a heavily glycosylated pentaspan membrane protein, is mainly known for its function as a marker for (cancer) stem cells, although it can also be detected on differentiated cells. Mouse prominin-1 expression is heavily regulated by splicing in eight different variants. The function or the expression pattern of prominin-1 and its splice variants (SVs) is thus far unknown. In this study, we analyzed the expression of the prominin-1 splice variants on mRNA level in several mouse tissues and found a broad tissue expression of the majority of SVs, but a specific set of SVs had a much more restricted expression profile. For instance, the testis expressed only SV3 and SV7. Moreover, SV8 was solely detected in the eye. Intriguingly, prominin-1 knockout mice do not suffer from gross abnormalities, but do show signs of blindness, which suggest that SV8 has a specific function in this tissue. In addition, databases searches for putative promoter regions in the mouse prominin-1 gene revealed three potential promoter regions that could be linked to specific SVs. Interestingly, for both SV7 and SV8, a specific potential promoter region could be identified. To conclude, the majority of mouse prominin-1 splice variants are widely expressed in mouse tissues. However, specific expression of a few variants, likely driven by specific promoters, suggests distinct regulation and a potential important function for these variants in certain tissues.	[Kemper, Kristel; Tol, Marc J. P. M.; Medema, Jan Paul] Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, LEXOR Lab Expt Oncol & Radiobiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Kemper, K (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, LEXOR Lab Expt Oncol & Radiobiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	k.kemper@amc.uva.nl		Medema, Jan Paul/0000-0003-3045-2924; Tol, Marcus/0000-0002-8312-699X	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO); Academic Medical Center Graduate School	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Academic Medical Center Graduate School	This work was supported by a Vici grant of the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) (Jan Paul Medema) and a scholarship of the Academic Medical Center Graduate School (Kristel Kemper). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boivin D, 2009, BIOCHEMISTRY-US, V48, P3998, DOI 10.1021/bi900159d; Bots M, 2005, BLOOD, V105, P1153, DOI 10.1182/blood-2004-03-0791; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; CORBEIL D, 2009, EXPRESSION DISTINCT; Fargeas CA, 2007, TISSUE ANTIGENS, V69, P602, DOI 10.1111/j.1399-0039.2007.00825.x; Fargeas CA, 2004, J CELL SCI, V117, P4301, DOI 10.1242/jcs.01315; Florek M, 2005, CELL TISSUE RES, V319, P15, DOI 10.1007/s00441-004-1018-z; Immervoll H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-48; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; OH H, 2005, INVESTIGATIVE OPHTHA, V46; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; SARGE KD, 1994, BIOL REPROD, V50, P1334, DOI 10.1095/biolreprod50.6.1334; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; Singh SK, 2004, NEURO-ONCOLOGY, V6, P348; SNIPPERT H, 2009, GASTROENTEROLOGY; Tabu K, 2008, CELL RES, V18, P1037, DOI 10.1038/cr.2008.270; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Wilkerson DC, 2008, BIOL REPROD, V79, P283, DOI 10.1095/biolreprod.107.066241; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Yi JM, 2008, CANCER RES, V68, P8094, DOI 10.1158/0008-5472.CAN-07-6208; Yin A, 1997, EXP HEMATOL, V25, P523; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhang QJ, 2007, HUM GENET, V122, P293, DOI 10.1007/s00439-007-0395-2; ZHU L, 2008, NATURE	30	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12325	10.1371/journal.pone.0012325	http://dx.doi.org/10.1371/journal.pone.0012325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808829	Green Submitted, Green Published, gold			2022-12-25	WOS:000281077000015
J	Houseley, J; Tollervey, D				Houseley, Jonathan; Tollervey, David			Apparent Non-Canonical Trans-Splicing Is Generated by Reverse Transcriptase In Vitro	PLOS ONE			English	Article							CDNA; GENE	Background: Trans-splicing, the in vivo joining of two independently transcribed RNA molecules, is well characterized in lower eukaryotes, but was long thought absent from metazoans. However, recent bioinformatic analyses of EST sequences suggested widespread trans-splicing in mammals. These apparently spliced transcripts generally lacked canonical splice sites, leading us to question their authenticity. Particularly, the native ability of reverse transcriptase enzymes to template switch during transcription could produce apparently trans-spliced sequences. Principal Findings: Here we report an in vitro system for the analysis of template switching in reverse transcription. Using highly purified RNA substrates, we show the reproducible occurrence of apparent trans-splicing between two RNA molecules. Other reported non-canonical splicing events such as exon shuffling and sense-antisense fusions were also readily detected. The latter caused the production of apparent antisense non-coding RNAs, which are also reported to be abundant in humans. Conclusions: We propose that most reported examples of non-canonical splicing in metazoans arise through template switching by reverse transcriptase during cDNA preparation. We further show that the products of template switching can vary between reverse transcriptases, providing a simple diagnostic for identifying many of these experimental artifacts.	[Houseley, Jonathan; Tollervey, David] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Houseley, J (corresponding author), Babraham Inst, Dept Dev Genet & Imprinting, Cambridge, England.	jon.houseley@bbsrc.ac.uk; d.tollervey@ed.ac.uk	Houseley, Jon/AAF-7409-2021; Tollervey, David/AAR-6662-2020	Tollervey, David/0000-0003-2894-2772; Houseley, Jonathan/0000-0001-8509-1500	Wellcome Trust; BBSRC [BBS/E/B/0000H247] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000H247] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013; Geiszt M, 2004, J BIOL CHEM, V279, P51661, DOI 10.1074/jbc.M409325200; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; Gingeras TR, 2009, NATURE, V461, P206, DOI 10.1038/nature08452; Hastings KEM, 2005, TRENDS GENET, V21, P240, DOI 10.1016/j.tig.2005.02.005; Herai RH, 2010, BRIEF BIOINFORM, V11, P198, DOI 10.1093/bib/bbp041; Horiuchi T, 2006, BIOL CELL, V98, P135, DOI 10.1042/BC20050002; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Li X, 2009, J MOL EVOL, V68, P56, DOI 10.1007/s00239-008-9187-0; LUO G, 1990, J VIROL, V64, P4321, DOI 10.1128/JVI.64.9.4321-4328.1990; Mader RM, 2001, J LAB CLIN MED, V137, P422, DOI 10.1067/mlc.2001.115452; Niu XL, 2010, J GENET GENOMICS, V37, P85, DOI 10.1016/S1673-8527(09)60028-X; OUHAMMOUCH M, 1992, NUCLEIC ACIDS RES, V20, P5443, DOI 10.1093/nar/20.20.5443; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Rickman DS, 2009, CANCER RES, V69, P2734, DOI 10.1158/0008-5472.CAN-08-4926; Roy SW, 2008, BIOESSAYS, V30, P601, DOI 10.1002/bies.20749; Sambrook J, 2001, MOL CLONING LAB MANU; Svarovskaia ES, 2003, FRONT BIOSCI-LANDMRK, V8, pD117, DOI 10.2741/957; TEMIN HM, 1993, P NATL ACAD SCI USA, V90, P6900, DOI 10.1073/pnas.90.15.6900; Unneberg P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000254; Zeng XC, 2002, FEBS LETT, V520, P183, DOI 10.1016/S0014-5793(02)02812-0; Zhu SY, 2002, FEBS LETT, V520, P185, DOI 10.1016/S0014-5793(02)02813-2	24	99	102	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12271	10.1371/journal.pone.0012271	http://dx.doi.org/10.1371/journal.pone.0012271			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805885	Green Published, gold, Green Submitted			2022-12-25	WOS:000281011600029
J	Robinson, RA; Lawson, B; Toms, MP; Peck, KM; Kirkwood, JK; Chantrey, J; Clatworthy, IR; Evans, AD; Hughes, LA; Hutchinson, OC; John, SK; Pennycott, TW; Perkins, MW; Rowley, PS; Simpson, VR; Tyler, KM; Cunningham, AA				Robinson, Robert A.; Lawson, Becki; Toms, Mike P.; Peck, Kirsi M.; Kirkwood, James K.; Chantrey, Julian; Clatworthy, Innes R.; Evans, Andy D.; Hughes, Laura A.; Hutchinson, Oliver C.; John, Shinto K.; Pennycott, Tom W.; Perkins, Matthew W.; Rowley, Peter S.; Simpson, Vic R.; Tyler, Kevin M.; Cunningham, Andrew A.			Emerging Infectious Disease Leads to Rapid Population Declines of Common British Birds	PLOS ONE			English	Article							IN-HOUSE FINCHES; WEST-NILE-VIRUS; TRICHOMONAS-GALLINAE; WILD BIRDS; MYCOPLASMAL CONJUNCTIVITIS; SALMONELLA-ENTERICA; AVIAN WILDLIFE; GREAT-BRITAIN; UNITED-STATES; PARASITE	Emerging infectious diseases are increasingly cited as threats to wildlife, livestock and humans alike. They can threaten geographically isolated or critically endangered wildlife populations; however, relatively few studies have clearly demonstrated the extent to which emerging diseases can impact populations of common wildlife species. Here, we report the impact of an emerging protozoal disease on British populations of greenfinch Carduelis chloris and chaffinch Fringilla coelebs, two of the most common birds in Britain. Morphological and molecular analyses showed this to be due to Trichomonas gallinae. Trichomonosis emerged as a novel fatal disease of finches in Britain in 2005 and rapidly became epidemic within greenfinch, and to a lesser extent chaffinch, populations in 2006. By 2007, breeding populations of greenfinches and chaffinches in the geographic region of highest disease incidence had decreased by 35% and 21% respectively, representing mortality in excess of half a million birds. In contrast, declines were less pronounced or absent in these species in regions where the disease was found in intermediate or low incidence. Also, populations of dunnock Prunella modularis, which similarly feeds in gardens, but in which T. gallinae was rarely recorded, did not decline. This is the first trichomonosis epidemic reported in the scientific literature to negatively impact populations of free-ranging non-columbiform species, and such levels of mortality and decline due to an emerging infectious disease are unprecedented in British wild bird populations. This disease emergence event demonstrates the potential for a protozoan parasite to jump avian host taxonomic groups with dramatic effect over a short time period.	[Robinson, Robert A.; Toms, Mike P.] British Trust Ornithol, Thetford, Norfolk, England; [Lawson, Becki; Hutchinson, Oliver C.; John, Shinto K.; Perkins, Matthew W.; Cunningham, Andrew A.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Peck, Kirsi M.; Evans, Andy D.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Kirkwood, James K.] Univ Federat Anim Welf, Wheathampstead, England; [Chantrey, Julian; Hughes, Laura A.] Univ Liverpool, Dept Vet Pathol, Wirral, England; [Clatworthy, Innes R.; Rowley, Peter S.] UCL Med Sch, Electron Microscopy Unit, London, England; [Pennycott, Tom W.] Scottish Agr Coll, Dis Surveillance Ctr, Ayr, Scotland; [Simpson, Vic R.] Wildlife Vet Invest Ctr, Truro, England; [Tyler, Kevin M.] Univ E Anglia, Sch Med Hlth Policy & Practice, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England	British Trust for Ornithology; Zoological Society of London; Royal Society for Protection of Birds; University of Liverpool; University of London; University College London; Scottish Agricultural College; University of East Anglia	Robinson, RA (corresponding author), British Trust Ornithol, Thetford, Norfolk, England.	becki.lawson@ioz.ac.uk	Tyler, Kevin/AGZ-3926-2022; Robinson, Robert/B-8237-2009; Tyler, Kevin M/B-3857-2010; Cunningham, Andrew A/E-7536-2010	Tyler, Kevin/0000-0002-0647-8158; Robinson, Robert/0000-0003-0504-9906; Tyler, Kevin M/0000-0002-0647-8158; lawson, becki/0000-0003-1706-7140; Toms, Mike/0000-0002-0823-5336	BTO; Joint Nature Conservation Committee (JNCC); Countryside, the Countryside Council for Wales, Natural England and Scottish Natural Heritage,; Royal Society; Birdcare Standards Association; British Veterinary Association Animal Welfare Foundation; CJ Wildbird Foods; Cranswick Pet Products; Gardman Ltd.; Royal College of Veterinary Surgeons (RCVS) Trust [000443]; RSPB; John and Pamela Salter Trust [R16982]; Universities Federation for Animal Welfare	BTO; Joint Nature Conservation Committee (JNCC); Countryside, the Countryside Council for Wales, Natural England and Scottish Natural Heritage,; Royal Society(Royal Society of London); Birdcare Standards Association; British Veterinary Association Animal Welfare Foundation; CJ Wildbird Foods; Cranswick Pet Products; Gardman Ltd.; Royal College of Veterinary Surgeons (RCVS) Trust; RSPB; John and Pamela Salter Trust; Universities Federation for Animal Welfare	The Bird Breeding Survey (BBS) is organised by the British Trust for Ornithology (BTO) and jointly funded by BTO, the Joint Nature Conservation Committee (JNCC) on behalf of the Council for Nature Conservation and the Countryside, the Countryside Council for Wales, Natural England and Scottish Natural Heritage, and the Royal Society for the Protection of Birds (RSPB). This study received financial support from the following organisations: Birdcare Standards Association (http://www.birdcare.org.uk), the British Veterinary Association Animal Welfare Foundation (http://www.bva-awf.org.uk), CJ Wildbird Foods (http://www.birdfood.co.uk/), Cranswick Pet Products (http://www.cranswickpetproducts.co.uk/), Gardman Ltd. (http://www.gardman.co.uk/), the Royal College of Veterinary Surgeons (RCVS) Trust Small Grants Programme Reference 000443 (http://www.rcvs.org.uk/RCVSTrust), the RSPB (http://www.rspb.org.uk/), the John and Pamela Salter Trust (R16982) and the Universities Federation for Animal Welfare (http://www.ufaw.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2004, J ANIM ECOL, V73, P309, DOI 10.1111/j.0021-8790.2004.00807.x; Anderson NL, 2009, VET PARASITOL, V161, P178, DOI 10.1016/j.vetpar.2009.01.023; Benchimol M, 2004, MICROSC MICROANAL, V10, P528, DOI 10.1017/S1431927604040905; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Bondurant R. H., 1994, P111; Bunbury N, 2008, BIOL CONSERV, V141, P153, DOI 10.1016/j.biocon.2007.09.008; Bunbury N, 2007, J WILDLIFE DIS, V43, P399, DOI 10.7589/0090-3558-43.3.399; Bunbury N, 2005, J CLIN MICROBIOL, V43, P1005, DOI 10.1128/JCM.43.2.1005-1006.2005; Cannon AR, 2005, J APPL ECOL, V42, P659, DOI 10.1111/j.1365-2664.2005.01050.x; Census 2001, 2002, 2001 CENSUS ENGLAND; Cepicka I, 2005, VET PARASITOL, V128, P11, DOI 10.1016/j.vetpar.2004.11.003; Chamberlain DE, 2005, IBIS, V147, P563, DOI 10.1111/j.1474-919x.2005.00430.x; Chvala S, 2007, VET MICROBIOL, V122, P237, DOI 10.1016/j.vetmic.2007.01.029; da Silva DG, 2007, INFECT GENET EVOL, V7, P433, DOI [10.1016/j.meegid.2006.01.002, 10.1016/j.meegid.2007.01.002]; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Dhondt AA, 1998, J WILDLIFE DIS, V34, P265, DOI 10.7589/0090-3558-34.2.265; Eidson M, 2001, EMERG INFECT DIS, V7, P615; Erwin KG, 2000, J WILDLIFE DIS, V36, P551, DOI 10.7589/0090-3558-36.3.551; Forrester Donald J., 2008, P120; Friend M, 2001, AUK, V118, P290, DOI 10.1642/0004-8038(2001)118[0290:DEIBCF]2.0.CO;2; Gerhold RW, 2008, J PARASITOL, V94, P1335, DOI 10.1645/GE-1585.1; Hall AJ, 2008, J WILDLIFE DIS, V44, P585, DOI 10.7589/0090-3558-44.3.585; Hochachka WM, 2000, P NATL ACAD SCI USA, V97, P5303, DOI 10.1073/pnas.080551197; HOFLE U, 2000, RAPTOR BIOMEDICINE, V3, P4; Holmes P, 2005, VET REC, V157, P455, DOI 10.1136/vr.157.15.455; HUDSON PJ, 1989, PARASITOL TODAY, V5, P283, DOI 10.1016/0169-4758(89)90019-7; Kleina P, 2004, INT J PARASITOL, V34, P963, DOI 10.1016/j.ijpara.2004.04.004; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; MESA CP, 1961, AVIAN DIS, V5, P48, DOI 10.2307/1587659; *MET OFF, 2010, MET OFF UK ACT AN MA; NARCISI EM, 1991, AVIAN DIS, V35, P55, DOI 10.2307/1591295; *NAT WILDL HLTH CA, 2002, USGS NAT WILDL HLTH; Newson SE, 2008, J APPL ECOL, V45, P1330, DOI 10.1111/j.1365-2664.2008.01480.x; Pennycott T, 2005, VET REC, V157, P360, DOI 10.1136/vr.157.12.360; Pennycott TW, 2006, VET REC, V158, P817, DOI 10.1136/vr.158.24.817; Pennycott TW, 2002, VET REC, V151, P563, DOI 10.1136/vr.151.19.563; R Development Core Team, 2007, R LANG ENV STAT COMP; Real J, 2000, J WILDLIFE DIS, V36, P64, DOI 10.7589/0090-3558-36.1.64; Reed TE, 2008, SCIENCE, V321, P1681, DOI 10.1126/science.1159466; Refsum T, 2002, APPL ENVIRON MICROB, V68, P5595, DOI 10.1128/AEM.68.11.5595-5599.2002; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Robinson RA, 2007, IBIS, V149, P357, DOI 10.1111/j.1474-919X.2006.00648.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Snow D. W., 1998, BIRDS W PALEARCTIC, V2; SOULSBY EJL, HELMINTHS ARTHROPODS, P583; STABLER RM, 1954, EXP PARASITOL, V3, P368, DOI 10.1016/0014-4894(54)90035-1; Toms Mike, 2007, British Wildlife, V19, P77; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Wood S.N., 2017, GEN ADDITIVE MODELS, V2, P1, DOI [DOI 10.1201/9781315370279, 10.1201/9781315370279]; [No title captured]	52	154	164	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12215	10.1371/journal.pone.0012215	http://dx.doi.org/10.1371/journal.pone.0012215			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805869	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000281011600008
J	Conde, E; Angulo, B; Redondo, P; Toldos, O; Garcia-Garcia, E; Suarez-Gauthier, A; Rubio-Viqueira, B; Marron, C; Garcia-Lujan, R; Sanchez-Cespedes, M; Lopez-Encuentra, A; Paz-Ares, L; Lopez-Rios, F				Conde, Esther; Angulo, Barbara; Redondo, Pilar; Toldos, Oscar; Garcia-Garcia, Elena; Suarez-Gauthier, Ana; Rubio-Viqueira, Belen; Marron, Carmen; Garcia-Lujan, Ricardo; Sanchez-Cespedes, Montse; Lopez-Encuentra, Angel; Paz-Ares, Luis; Lopez-Rios, Fernando			The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung	PLOS ONE			English	Article							TISSUE MICROARRAY; GENE-EXPRESSION; PHASE-III; CANCER; ADENOCARCINOMA; CLASSIFICATION; OVEREXPRESSION; CARBOPLATIN; PACLITAXEL; SIGNATURES	Introduction: While some targeted agents should not be used in squamous cell carcinomas (SCCs), other agents might preferably target SCCs. In a previous microarray study, one of the top differentially expressed genes between adenocarcinomas (ACs) and SCCs is P63. It is a well-known marker of squamous differentiation, but surprisingly, its expression is not widely used for this purpose. Our goals in this study were (1) to further confirm our microarray data, (2) to analize the value of P63 immunohistochemistry (IHC) in reducing the number of large cell carcinoma (LCC) diagnoses in surgical specimens, and (3) to investigate the potential of P63 IHC to minimize the proportion of "carcinoma NOS (not otherwise specified)'' in a prospective series of small tumor samples. Methods: With these goals in mind, we studied (1) a tissue-microarray comprising 33 ACs and 99 SCCs on which we performed P63 IHC, (2) a series of 20 surgically resected LCCs studied for P63 and TTF-1 IHC, and (3) a prospective cohort of 66 small thoracic samples, including 32 carcinoma NOS, that were further classified by the result of P63 and TTF-1 IHC. Results: The results in the three independent cohorts were as follows: (1) P63 IHC was differentially expressed in SCCs when compared to ACs (p<0.0001); (2) half of the 20 (50%) LCCs were positive for P63 and were reclassified as SCCs; and (3) all P63 positive cases (34%) were diagnosed as SCCs. Conclusions: P63 IHC is useful for the identification of lung SCCs.	[Conde, Esther; Angulo, Barbara; Redondo, Pilar; Garcia-Garcia, Elena; Suarez-Gauthier, Ana; Lopez-Rios, Fernando] Univ San Pablo, CEU, Lab Dianas Terapeut, Ctr Integral Oncol Clara Campal,Hosp Univ Madrid, Madrid, Spain; [Toldos, Oscar] Pathol Thorac Surg & Hosp Univ 12 Octubre, Madrid, Spain; [Rubio-Viqueira, Belen] Univ San Pablo, CEU, Dept Oncol, Hosp Univ Madrid Sanchinarro, Madrid, Spain; [Garcia-Lujan, Ricardo; Lopez-Encuentra, Angel] Hosp Univ 12 Octubre, Dept Pulm, Madrid, Spain; [Sanchez-Cespedes, Montse] Hop Llobregat, Genes & Canc Grp, PEBC, IDIBELL, Barcelona, Spain; [Paz-Ares, Luis] Inst Biomed Sevilla, Dept Oncol, Seville, Spain; [Paz-Ares, Luis] Hosp Univ Virgen Rocio, Seville, Spain	San Pablo CEU University; Hospital Universitario 12 de Octubre; San Pablo CEU University; Hospital Universitario 12 de Octubre; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Conde, E (corresponding author), Univ San Pablo, CEU, Lab Dianas Terapeut, Ctr Integral Oncol Clara Campal,Hosp Univ Madrid, Madrid, Spain.	flopezrios@hospitaldemadrid.com	Diez Redondo, Pilar/GQZ-7708-2022; Paz-Ares, Luis/AAH-2750-2019; Sanchez-Cespedes, Montse/H-8485-2012	Sanchez-Cespedes, Montse/0000-0002-6045-5627; Lopez-Encuentra, Angel/0000-0003-1285-0777	Fundacion Mutua Madrilena; CIBER Respiratory Disease [ISCIII-CB06/06]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC) [RD06/0020/0062]	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); CIBER Respiratory Disease; Red Tematica de Investigacion Cooperativa en Cancer (RTICC)	This work was partially funded by grants from Fundacion Mutua Madrilena to EC, FLR, and LPA; CIBER Respiratory Disease to ALE (ISCIII-CB06/06); and Red Tematica de Investigacion Cooperativa en Cancer (RTICC) to MSC (RD06/0020/0062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatschek S, 2004, CANCER RES, V64, P844, DOI 10.1158/0008-5472.CAN-03-2361; ANG DC, 2010, EXPRESSION SQUAMOUS; Angulo B, 2008, J PATHOL, V214, P347, DOI 10.1002/path.2267; Au NHC, 2004, APPL IMMUNOHISTO M M, V12, P240, DOI 10.1097/00129039-200409000-00010; Au NHC, 2004, J PATHOL, V204, P101, DOI 10.1002/path.1612; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Borczuk AC, 2003, AM J PATHOL, V163, P1949, DOI 10.1016/S0002-9440(10)63553-5; BRAMBILLA E, 2004, WHO CLASSIFICATION T, P45; Camilo R, 2006, HUM PATHOL, V37, P542, DOI 10.1016/j.humpath.2005.12.019; de Marinis F, 2008, J THORAC ONCOL, V3, P30, DOI 10.1097/JTO.0b013e31815e8b48; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Hayes DN, 2006, J CLIN ONCOL, V24, P5079, DOI 10.1200/JCO.2005.05.1748; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Johansson Leif, 2004, Ann Diagn Pathol, V8, P259, DOI 10.1016/j.anndiagpath.2004.07.001; Kargi A, 2007, APPL IMMUNOHISTO M M, V15, P415, DOI 10.1097/PAI.0b013e31802fab75; Karp DD, 2009, J CLIN ONCOL, V27, P2516, DOI 10.1200/JCO.2008.19.9331; Kaufmann O, 2001, AM J CLIN PATHOL, V116, P823; Kim DH, 2010, ACTA CYTOL, V54, P55, DOI 10.1159/000324967; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Massion PP, 2003, CANCER RES, V63, P7113; Monica V, 2009, MODERN PATHOL, V22, P709, DOI 10.1038/modpathol.2009.30; Nylander K, 2002, J PATHOL, V198, P417, DOI 10.1002/path.1231; Pelosi G, 2002, J PATHOL, V198, P100, DOI 10.1002/path.1166; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ring BZ, 2009, MODERN PATHOL, V22, P1032, DOI 10.1038/modpathol.2009.60; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Rossi G, 2009, J CLIN ONCOL, V27, pE141, DOI 10.1200/JCO.2009.24.0515; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Shah RB, 2004, AM J CLIN PATHOL, V122, P517, DOI 10.1309/WRM51C70P1NBFE4K; Sheikh HA, 2004, MODERN PATHOL, V17, P1134, DOI 10.1038/modpathol.3800163; Shimada Y, 2009, CANCER SCI, V100, P2054, DOI 10.1111/j.1349-7006.2009.01295.x; Tan DF, 2003, HUM PATHOL, V34, P597, DOI 10.1016/S0046-8177(03)00180-1; Ullmann R, 2004, J PATHOL, V203, P798, DOI 10.1002/path.1584; Wang BY, 2002, HUM PATHOL, V33, P921, DOI 10.1053/hupa.2002.126878; Werling RW, 2003, AM J SURG PATHOL, V27, P82, DOI 10.1097/00000478-200301000-00009; Wu MX, 2003, AM J CLIN PATHOL, V119, P696, DOI 10.1309/XCP6EWPB3BMRKA; Yamagata N, 2003, CLIN CANCER RES, V9, P4695	38	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12209	10.1371/journal.pone.0012209	http://dx.doi.org/10.1371/journal.pone.0012209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808915	gold, Green Submitted, Green Published			2022-12-25	WOS:000280968100013
J	Gerber, LR; Gonzalez-Suarez, M; Hernandez-Camacho, CJ; Young, JK; Sabo, JL				Gerber, Leah R.; Gonzalez-Suarez, Manuela; Hernandez-Camacho, Claudia J.; Young, Julie K.; Sabo, John L.			The Cost of Male Aggression and Polygyny in California Sea Lions (Zalophus californianus)	PLOS ONE			English	Article							ANTARCTIC FUR SEALS; GULF-OF-CALIFORNIA; FELIS-CATUS L; REPRODUCTIVE SUCCESS; SEXUAL SELECTION; AGONISTIC INTERACTIONS; ARCTOCEPHALUS-GAZELLA; MALE HARASSMENT; MATING SUCCESS; BEHAVIOR	In polygynous mating systems, males often increase their fecundity via aggressive defense of mates and/or resources necessary for successful mating. Here we show that both male and female reproductive behavior during the breeding season (June-August) affect female fecundity, a vital rate that is an important determinant of population growth rate and viability. By using 4 years of data on behavior and demography of California sea lions (Zalophus californianus), we found that male behavior and spatial dynamics-aggression and territory size-are significantly related to female fecundity. Higher rates of male aggression and larger territory sizes were associated with lower estimates of female fecundity within the same year. Female aggression was significantly and positively related to fecundity both within the same year as the behavior was measured and in the following year. These results indicate that while male aggression and defense of territories may increase male fecundity, such interactions may cause a reduction in the overall population growth rate by lowering female fecundity. Females may attempt to offset male-related reductions in female fecundity by increasing their own aggression-perhaps to defend pups from incidental injury or mortality. Thus in polygynous mating systems, male aggression may increase male fitness at the cost of female fitness and overall population viability.	[Gerber, Leah R.; Gonzalez-Suarez, Manuela; Hernandez-Camacho, Claudia J.; Young, Julie K.; Sabo, John L.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Gonzalez-Suarez, Manuela] Univ Paris 06, CNRS, UMR 7625, Lab Ecol & Evolut, Paris, France	Arizona State University; Arizona State University-Tempe; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Gerber, LR (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	leah.gerber@asu.edu	Camacho, Claudia J. Hernández/Q-8914-2018; González-Suárez, Manuela/B-9740-2008	Camacho, Claudia J. Hernández/0000-0002-6309-9728; González-Suárez, Manuela/0000-0001-5069-8900; Gerber, Leah/0000-0002-6763-6842; Young, Julie/0000-0003-4522-0157	National Science Foundation (NSF) [0347960]; National Center for Ecological Analysis and Synthesis (NCEAS); European Community [FP7/2007-2013, 235897]; Spanish Ministry of Science and Innovation [CGL2009-07301/BOS]	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); National Center for Ecological Analysis and Synthesis (NCEAS); European Community(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the National Science Foundation (NSF), Grant No. 0347960. LRG was supported as a National Center for Ecological Analysis and Synthesis (NCEAS) sabbatical fellow while writing this paper. MGS was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 235897, and the Spanish Ministry of Science and Innovation (Project: CGL2009-07301/BOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1973, 2 S INF THEOR BUD AK; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; ALVAREZ F, 1993, CAN J ZOOL, V71, P376, DOI 10.1139/z93-052; ARNOLD SJ, 1994, AM NAT, V143, P317, DOI 10.1086/285606; BALDI RC, 1996, ANIMAL BEHAV, V51; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BESTER MN, 1994, S AFR J ZOOL, V29, P168; BONESS DJ, 1995, BEHAV ECOL SOCIOBIOL, V36, P1; BONNELL ML, 1987, J WILDLIFE MANAGE, V51, P13, DOI 10.2307/3801621; BOWEN WD, 1991, BEHAV ECOLOGY PINNIP; Bradshaw CJA, 2002, ICES J MAR SCI, V59, P770, DOI 10.1006/jmsc.2002.1246; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cassini MH, 2003, CAN J ZOOL, V81, P1154, DOI 10.1139/Z03-098; Cassini MH, 2001, MAMMAL REV, V31, P169, DOI 10.1046/j.1365-2907.2001.00084.x; Cassini MH, 1999, BEHAV ECOL, V10, P612, DOI 10.1093/beheco/10.5.612; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Chilvers BL, 2005, CAN J ZOOL, V83, P642, DOI 10.1139/Z05-048; Clutton-Brock T.H., 1982, BEHAV ECOLOGY 2 SEXE; CLUTTONBROCK TH, 1989, P ROY SOC LOND B BIO, V236, P158; DOIDGE DW, 1984, J ZOOL, V202, P449, DOI 10.1111/j.1469-7998.1984.tb05095.x; Duckworth RA, 2006, BEHAV ECOL, V17, P1011, DOI 10.1093/beheco/arl035; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FERNANDEZ G, 2007, GLOBAL SAS FORUM, V191; FRANCIS JM, 1987, INTERFEMALE AGGRESSI; Garcia-Aguilar Maria Concepcion, 2003, Aquatic Mammals, V29, P67, DOI 10.1578/016754203101024086; Gemmell NJ, 2001, MOL ECOL, V10, P451, DOI 10.1046/j.1365-294x.2001.01186.x; Gerber LR, 2006, FRONT ECOL ENVIRON, V4, P419, DOI 10.1890/1540-9295(2006)4[419:IBDIDM]2.0.CO;2; HARCOURT R, 1992, CAN J ZOOL, V70, P320, DOI 10.1139/z92-048; Heath C, 1989, THESIS U CALIFORNIA; Hernandez-Camacho CJ, 2008, MAR MAMMAL SCI, V24, P664, DOI 10.1111/j.1748-7692.2008.00199.x; HIRUKI LM, 1993, CAN J ZOOL, V71, P469, DOI 10.1139/z93-067; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Jacobs DF, 2008, J MAMMAL, V89, P1212, DOI 10.1644/07-MAMM-A-171.1; le Boeuf B.J., 1983, Proceedings of the California Academy of Sciences, V43, P77; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; LEBOEUF BJ, 1977, MAMMALIA, V41, P167, DOI 10.1515/mamm.1977.41.2.167; Lewis S, 2006, OECOLOGIA, V147, P606, DOI 10.1007/s00442-005-0321-z; MACKENZIE A, 1995, AM NAT, V145, P633, DOI 10.1086/285759; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; MCCANN TS, 1980, J ZOOL, V192, P295; MELIN SR, 2002, THESIS U MINNESOTA; Milner-Gulland EJ, 2003, NATURE, V422, P135, DOI 10.1038/422135a; Mysterud A, 2002, J ANIM ECOL, V71, P907, DOI 10.1046/j.1365-2656.2002.00655.x; NATOLI E, 1990, ANIM BEHAV, V40, P183, DOI 10.1016/S0003-3472(05)80679-7; NATOLI E, 1991, ANIM BEHAV, V42, P227, DOI 10.1016/S0003-3472(05)80554-8; Ono KA, 1996, BEHAV ECOL SOCIOBIOL, V38, P31, DOI 10.1007/s002650050214; PACKER C, 1983, INFANTICIDE ANIMALS; Peterson RS, 1967, NATURAL HIST BEHAV C, V1; Porschmann U, 2010, MOL ECOL, V19, P2574, DOI 10.1111/j.1365-294X.2010.04665.x; PONTIER D, 1995, OIKOS, V73, P299, DOI 10.2307/3545954; Rankin DJ, 2007, OIKOS, V116, P335, DOI [10.1111/j.2006.0030-1299.15451.x, 10.1111/j.0030-1299.2007.15451.x]; Renison D, 2003, WILSON BULL, V115, P58, DOI 10.1676/02-040; RIEDMAN M, 1990, PINNIPEDS SEALS SEA; Robertson KL, 2008, CAN J ZOOL, V86, P237, DOI 10.1139/Z07-136; *SAS I, 2008, SAS SYST WIND VERS 9; SINGER F, 1995, BEHAV ECOL SOCIOBIOL, V36, P313, DOI 10.1007/BF00167792; SMITH JNM, 1982, AUK, V99, P555; Trillmich F., 1991, PINNIPEDS EL NINO RE, P293; Trivers R, 1972, PARENTAL INVESTMENT; Tuljapurkar SD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000785; WADE MJ, 1979, AM NAT, V114, P742, DOI 10.1086/283520; WADE MJ, 1980, ANIM BEHAV, V28, P446, DOI 10.1016/S0003-3472(80)80052-2; Wilkinson IS, 2000, MAR MAMMAL SCI, V16, P494, DOI 10.1111/j.1748-7692.2000.tb00942.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Yoccoz NG, 2002, P ROY SOC B-BIOL SCI, V269, P1523, DOI 10.1098/rspb.2002.2047; Young JK, 2008, BEHAVIOUR, V145, P1797, DOI 10.1163/156853908786279646; Young Julie K., 2008, Aquatic Mammals, V34, P102, DOI 10.1578/AM.34.1.2008.102	67	13	14	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12230	10.1371/journal.pone.0012230	http://dx.doi.org/10.1371/journal.pone.0012230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808931	Green Submitted, gold, Green Published			2022-12-25	WOS:000280968100026
J	Vanaerschot, M; Maes, I; Ouakad, M; Adaui, V; Maes, L; De Doncker, S; Rijal, S; Chappuis, F; Dujardin, JC; Decuypere, S				Vanaerschot, Manu; Maes, Ilse; Ouakad, Meriem; Adaui, Vanessa; Maes, Louis; De Doncker, Simonne; Rijal, Suman; Chappuis, Francois; Dujardin, Jean-Claude; Decuypere, Saskia			Linking In Vitro and In Vivo Survival of Clinical Leishmania donovani Strains	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; SODIUM STIBOGLUCONATE; ANTIMONY; RESISTANCE; SUSCEPTIBILITY; MECHANISMS; METACYCLOGENESIS; SIGNALS; PCR	Background: Leishmania donovani is an intracellular protozoan parasite that causes a lethal systemic disease, visceral leishmaniasis (VL), and is transmitted between mammalian hosts by phlebotomine sandflies. Leishmania expertly survives in these 'hostile' environments with a unique redox system protecting against oxidative damage, and host manipulation skills suppressing oxidative outbursts of the mammalian host. Treating patients imposes an additional stress on the parasite and sodium stibogluconate (SSG) was used for over 70 years in the Indian subcontinent. Methodology/Principal Findings: We evaluated whether the survival capacity of clinical L. donovani isolates varies significantly at different stages of their life cycle by comparing proliferation, oxidative stress tolerance and infection capacity of 3 Nepalese L. donovani strains in several in vitro and in vivo models. In general, the two strains that were resistant to SSG, a stress encountered in patients, attained stationary phase at a higher parasite density, contained a higher amount of metacyclic parasites and had a greater capacity to cause in vivo infection in mice compared to the SSG-sensitive strain. Conclusions/Significance: The 2 SSG-resistant strains had superior survival skills as promastigotes and as amastigotes compared to the SSG-sensitive strain. These results could indicate that Leishmania parasites adapting successfully to antimonial drug pressure acquire an overall increased fitness, which stands in contrast to what is found for other organisms, where drug resistance is usually linked to a fitness cost. Further validation experiments are under way to verify this hypothesis.	[Vanaerschot, Manu; Maes, Ilse; Ouakad, Meriem; Adaui, Vanessa; De Doncker, Simonne; Dujardin, Jean-Claude; Decuypere, Saskia] Inst Trop Med, Unit Mol Parasitol, Dept Parasitol, B-2000 Antwerp, Belgium; [Vanaerschot, Manu; Maes, Louis; Dujardin, Jean-Claude] Univ Antwerp, Lab Microbiol Parasitol & Hyg, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Adaui, Vanessa] Univ Peruana Cayetano Heredia, Inst Trop Med Alexander von Humboldt, Lima, Peru; [Rijal, Suman] BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan, Nepal; [Chappuis, Francois] Univ Hosp Geneva, Div Int & Humanitarian Med, Geneva, Switzerland; [Chappuis, Francois] Univ Geneva, Geneva, Switzerland	Institute of Tropical Medicine (ITM); University of Antwerp; Universidad Peruana Cayetano Heredia; B.P. Koirala Institute of Health Sciences; University of Geneva; University of Geneva	Vanaerschot, M (corresponding author), Inst Trop Med, Unit Mol Parasitol, Dept Parasitol, B-2000 Antwerp, Belgium.	jcdujardin@itg.be	Vanaerschot, Manu/B-6812-2013; Dujardin, Jean-Claude/AAO-1783-2021; Maes, Louis JRM/A-2384-2017; Adaui, Vanessa/AAU-7219-2020	Vanaerschot, Manu/0000-0002-9141-2347; Maes, Louis JRM/0000-0002-2324-9509; Decuypere, Saskia/0000-0001-5036-4601; Chappuis, Francois/0000-0003-0442-7610	EC [ICA4-CT-2001-10076, 222895]; FWO Flanders [G.0103.06, 1.5.147.09]; Agency for Innovation; Baillet-Latour Foundation	EC(European CommissionEuropean Commission Joint Research Centre); FWO Flanders(FWO); Agency for Innovation; Baillet-Latour Foundation	This research was funded by the EC-INCO-Dev project LeishNatDrug-R (contract ICA4-CT-2001-10076), the FWO Flanders (contract G.0103.06 and 1.5.147.09) and the EC-FP7 project Kaladrug-R (contract 222895). Manu Vanaerschot has a fellowship from the Agency for Innovation by Science and Technology in Flanders (IWT) and Saskia Decuypere has a grant from the Baillet-Latour Foundation. (EC:http://cordis.europa.eu/home_en.html, FWO Flanders: http://www.fwo.be/, IWT: http://www.iwt.be/, Baillet-Latour Foundation: http://www.inbevbailletlatour.com/.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; BANDYOPADHYAY P, 1991, J PARASITOL, V77, P411, DOI 10.2307/3283129; Basu JM, 2006, ANTIMICROB AGENTS CH, V50, P1788, DOI [10.1128/AAC.50.5.1788-1797.2006, 10.1128/AAC.50.5.1768-1797.2006]; Bates PA, 2004, CURR MOL MED, V4, P601, DOI 10.2174/1566524043360285; BERENS RL, 1976, J PARASITOL, V62, P360, DOI 10.2307/3279142; Bhardwaj S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/109189; Carter KC, 2005, PARASITOLOGY, V131, P747, DOI 10.1017/S0031182005008486; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; CUNNINGHAM ML, 1995, EUR J BIOCHEM, V230, P460, DOI 10.1111/j.1432-1033.1995.tb20583.x; DASILVA R, 1987, INFECT IMMUN, V55, P2802, DOI 10.1128/IAI.55.11.2802-2806.1987; Dominguez M, 2003, MICROBES INFECT, V5, P507, DOI 10.1016/S1286-4579(03)00071-6; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Gomez MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000213; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Holzmuller P, 2005, ANTIMICROB AGENTS CH, V49, P4406, DOI 10.1128/AAC.49.10.4406-4409.2005; Kamhawi S, 2006, TRENDS PARASITOL, V22, P439, DOI 10.1016/j.pt.2006.06.012; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Kumar D, 2009, ANTIMICROB AGENTS CH, V53, P835, DOI 10.1128/AAC.01233-08; Laurent T, 2007, INFECT GENET EVOL, V7, P206, DOI 10.1016/j.meegid.2006.08.005; Lazazzera BA, 2000, CURR OPIN MICROBIOL, V3, P177, DOI 10.1016/S1369-5274(00)00072-2; Mandal G, 2007, PARASITOLOGY, V134, P1679, DOI 10.1017/S0031182007003150; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741; Nandan D, 2005, CLIN IMMUNOL, V114, P266, DOI 10.1016/j.clim.2004.07.017; Nandan D, 2007, BIOCHEM BIOPH RES CO, V364, P601, DOI 10.1016/j.bbrc.2007.10.065; Nicolas L, 2002, J CLIN MICROBIOL, V40, P1666, DOI 10.1128/JCM.40.5.1666-1669.2002; OUAKAD M, 2009, P 4 WORLD C LEISHM 2; Poljsak B, 2005, J APPL TOXICOL, V25, P535, DOI 10.1002/jat.1093; Rijal S, 2003, T ROY SOC TROP MED H, V97, P350, DOI 10.1016/S0035-9203(03)90167-2; Rijal S, 2007, MICROBES INFECT, V9, P529, DOI 10.1016/j.micinf.2007.01.009; Rolao N, 2004, ACTA TROP, V90, P123, DOI 10.1016/j.actatropica.2003.09.010; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Thakur CP, 2003, T ROY SOC TROP MED H, V97, P409, DOI 10.1016/S0035-9203(03)90071-X; Tintaya KWQ, 2004, J INFECT DIS, V189, P1035, DOI 10.1086/382049; van Meirvenne N., 1975, Annales Soc belge Med trop, V55, P1; Vassella E, 1997, J CELL SCI, V110, P2661; VINCENT SH, 1989, SEMIN HEMATOL, V26, P105; WHO, 2002, WORLD HLTH REP, P192; Wyllie S, 2004, J BIOL CHEM, V279, P39925, DOI 10.1074/jbc.M405635200; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	40	51	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12211	10.1371/journal.pone.0012211	http://dx.doi.org/10.1371/journal.pone.0012211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808916	gold, Green Published, Green Submitted			2022-12-25	WOS:000280968100015
J	Shanware, NP; Zhan, LH; Hutchinson, JA; Kim, SH; Williams, LM; Tibbetts, RS				Shanware, Naval P.; Zhan, Lihong; Hutchinson, John A.; Kim, Sang Hwa; Williams, Leah M.; Tibbetts, Randal S.			Conserved and Distinct Modes of CREB/ATF Transcription Factor Regulation by PP2A/B56 gamma and Genotoxic Stress	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; PROTEIN-KINASE CK2; BINDING PROTEIN; DNA-DAMAGE; PHOSPHORYLATION; FAMILY; ELEMENT; ATM; IDENTIFICATION; INHIBITOR	Activating transcription factor 1 (ATF1) and the closely related proteins CREB (cyclic AMP resonse element binding protein) and CREM (cyclic AMP response element modulator) constitute a subfamily of bZIP transcription factors that play critical roles in the regulation of cellular growth, metabolism, and survival. Previous studies demonstrated that CREB is phosphorylated on a cluster of conserved Ser residues, including Ser-111 and Ser-121, in response to DNA damage through the coordinated actions of the ataxia-telangiectasia-mutated (ATM) protein kinase and casein kinases 1 and 2 (CK1/2). Here, we show that DNA damage-induced phosphorylation by ATM is a general feature of CREB and ATF1. ATF1 harbors a conserved ATM/CK cluster that is constitutively and stoichiometrically phosphorylated by CK1 and CK2 in asynchronously growing cells. Exposure to DNA damage further induced ATF1 phosphorylation on Ser-51 by ATM in a manner that required prior phosphorylation of the upstream CK residues. Hyperphosphorylated ATF1 showed a 4-fold reduced affinity for CREB-binding protein. We further show that PP2A, in conjunction with its targeting subunit B56 gamma, antagonized ATM and CK1/2-dependent phosphorylation of CREB and ATF1 in cellulo. Finally, we show that CK sites in CREB are phosphorylated during cellular growth and that phosphorylation of these residues reduces the threshold of DNA damage required for ATM-dependent phosphorylation of the inhibitory Ser-121 residue. These studies define overlapping and distinct modes of CREB and ATF1 regulation by phosphorylation that may ensure concerted changes in gene expression mediated by these factors.	[Shanware, Naval P.] Univ Wisconsin, Dept Pharmacol, Program Mol & Cellular Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA; Univ Wisconsin, Mol & Environm & Toxicol Ctr, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shanware, NP (corresponding author), Univ Wisconsin, Dept Pharmacol, Program Mol & Cellular Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297	NIH [CA124722, NS059001]; American Cancer Society; Greater Milwaukee Foundation; American Heart Association; Molecular and Environmental Toxicology training grant [T32ES007015]; NATIONAL CANCER INSTITUTE [R01CA124722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059001] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Greater Milwaukee Foundation; American Heart Association(American Heart Association); Molecular and Environmental Toxicology training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the NIH (CA124722, NS059001), The American Cancer Society, and a Shaw Scientist Award to R. S. T. from the Greater Milwaukee Foundation. N.P.S. was supported by an American Heart Association Predoctoral Fellowship. J.A.H was supported by a Molecular and Environmental Toxicology training grant (T32ES007015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Conkright MD, 2005, TRENDS CELL BIOL, V15, P457, DOI 10.1016/j.tcb.2005.07.007; Dodson GE, 2006, J BIOL CHEM, V281, P1692, DOI 10.1074/jbc.M509577200; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; FLINT KJ, 1991, ONCOGENE, V6, P2019; Ghoneim C, 2007, J BIOL CHEM, V282, P15490, DOI 10.1074/jbc.M610586200; Gueven N, 2003, GENE CHROMOSOME CANC, V38, P157, DOI 10.1002/gcc.10261; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Iwasaki K, 2007, J BIOL CHEM, V282, P22335, DOI 10.1074/jbc.M701477200; Jaspers S, 2007, J ANDROL, V28, P59, DOI 10.2164/jandrol.106.000976; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; MASSON N, 1993, NUCLEIC ACIDS RES, V21, P4166, DOI 10.1093/nar/21.18.4166; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Montminy M, 2004, ANN ENDOCRINOL-PARIS, V65, P73, DOI 10.1016/S0003-4266(04)95634-X; Parker D, 1996, MOL CELL BIOL, V16, P694; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Ruzzene M, 2002, BIOCHEM J, V364, P41, DOI 10.1042/bj3640041; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018; Shanware NP, 2007, J BIOL CHEM, V282, P6283, DOI 10.1074/jbc.M610674200; Shanware NP, 2009, BMB REP, V42, P142, DOI 10.5483/BMBRep.2009.42.3.142; Shaywitz AJ, 2000, MOL CELL BIOL, V20, P9409, DOI 10.1128/MCB.20.24.9409-9422.2000; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shi YL, 2004, P NATL ACAD SCI USA, V101, P5898, DOI 10.1073/pnas.0307718101; Shouse GP, 2008, MOL CELL BIOL, V28, P448, DOI 10.1128/MCB.00983-07; Swingle Mark, 2007, V365, P23; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	38	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12173	10.1371/journal.pone.0012173	http://dx.doi.org/10.1371/journal.pone.0012173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730097	Green Published, Green Submitted, gold			2022-12-25	WOS:000280862200024
J	Queiroz, KCS; Ruela-de-Sousa, RR; Fuhler, GM; Aberson, HL; Ferreira, CV; Peppelenbosch, MP; Spek, CA				Queiroz, K. C. S.; Ruela-de-Sousa, R. R.; Fuhler, G. M.; Aberson, H. L.; Ferreira, C. V.; Peppelenbosch, M. P.; Spek, C. A.			Hedgehog signaling maintains chemoresistance in myeloid leukemic cells	ONCOGENE			English	Article						Hedgehog; multidrug resistance; P-glycoprotein; leukemia	DRUG-RESISTANCE; STEM-CELLS; MULTIDRUG-RESISTANCE; PATHWAY; INHIBITION; RADIATION; THERAPY; GROWTH; TARGET	The development of resistance against chemotherapy remains one of the major challenges in the clinical management of leukemia. There is still limited insight into the molecular mechanisms that maintain the chemotherapy-resistant phenotype, despite the obvious clinical relevance that such knowledge would have. In this study, we show that the chemotherapy-resistant phenotype of myeloid leukemia cells correlates with activation of the Hedgehog (Hh) pathway, whereas in chemosensitive cells, such activation is less pronounced. Importantly, the overexpression of Hh pathway components induces chemoprotection and inhibition of the pathway reverts chemoresistance of Lucena-1 cells, apparently by interfering with P-glycoprotein-dependent drug resistance. Our data thus identify the Hh pathway as an essential component of multidrug resistance (MDR) myeloid leukemia and suggest that targeting the Hh pathway might be an interesting therapeutic avenue for overcoming MDR resistance in myeloid leukemia. Oncogene (2010) 29, 6314-6322; doi:10.1038/onc.2010.375; published online 30 August 2010	[Queiroz, K. C. S.; Aberson, H. L.; Spek, C. A.] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Queiroz, K. C. S.; Ruela-de-Sousa, R. R.; Ferreira, C. V.] Univ Estadual Campinas, Inst Biol, Dept Biochem, Sao Paulo, Brazil; [Queiroz, K. C. S.; Ruela-de-Sousa, R. R.; Fuhler, G. M.; Peppelenbosch, M. P.] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Universidade de Sao Paulo; Universidade Estadual de Campinas; Erasmus University Rotterdam; Erasmus MC	Queiroz, KCS (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	k.c.desouzaqueiroz@amc.uva.nl	Fuhler, Gwenny/AAC-7122-2019; Queiroz, Karla/L-6438-2014; Spek, Arnold/AAC-5866-2019; Ruela de Sousa, Roberta/C-6825-2012	Fuhler, Gwenny/0000-0001-9221-4855; Spek, Arnold/0000-0002-2149-4068; Ruela de Sousa, Roberta/0000-0002-3762-2247; Peppelenbosch, Maikel/0000-0001-9112-6028	CNPq; Top-Institute pharma; Maag-, Lever-, Darmstichting	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Top-Institute pharma; Maag-, Lever-, Darmstichting	KCS Queiroz is supported by the Maag-, Lever-, Darmstichting. CV Ferreira is supported by a research fellowship from CNPq. MP Peppelenbosch and CA Spek acknowledge the support of the Top-Institute pharma. We are grateful to Professor Vivian Rumjanek (Federal University of Rio de Janeiro) for donating Lucena-1 cells.	Bijlsma MF, 2006, PLOS BIOL, V4, P1397, DOI 10.1371/journal.pbio.0040232; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; DEAN M, 1997, BIOCHIM BIOPHYS ACTA, V1332, P43; Diehl KM, 2007, MOL CANCER THER, V6, P418, DOI 10.1158/1535-7163.MCT-06-0603; Dierks C, 2008, CANCER CELL, V14, P238, DOI 10.1016/j.ccr.2008.08.003; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hofmann I, 2009, CELL STEM CELL, V4, P559, DOI 10.1016/j.stem.2009.03.016; Kobune M, 2009, CANCER SCI, V100, P948, DOI 10.1111/j.1349-7006.2009.01111.x; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lauth M, 2007, CURR OPIN INVEST DR, V8, P457; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Lowenberg B, 2007, J CLIN ONCOL, V25, P1, DOI 10.1200/JCO.2006.08.6462; Martelli AM, 2003, LEUKEMIA, V17, P1794, DOI 10.1038/sj.leu.2403044; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; O'Hare T, 2006, CURR OPIN GENET DEV, V16, P92, DOI 10.1016/j.gde.2005.11.002; Rumjanek VM, 2001, AN ACAD BRAS CIENC, V73, P57, DOI 10.1590/S0001-37652001000100007; Sims-Mourtada J, 2006, CLIN CANCER RES, V12, P6565, DOI 10.1158/1078-0432.CCR-06-0176; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225	22	107	115	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC	2010	29	48					6314	6322		10.1038/onc.2010.375	http://dx.doi.org/10.1038/onc.2010.375			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	688SW	20802532				2022-12-25	WOS:000284874700002
J	Wendt, MK; Smith, JA; Schiemann, WP				Wendt, M. K.; Smith, J. A.; Schiemann, W. P.			Transforming growth factor-beta-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression	ONCOGENE			English	Article						EGFR; TGF-beta; FAK; breast cancer; metastasis; invasion	FOCAL ADHESION KINASE; FACTOR RECEPTOR INHIBITION; MAMMARY-CARCINOMA CELLS; TGF-BETA; GENE-EXPRESSION; TUMOR; METASTASIS; ACTIVATION; LINES; PROLIFERATION	Transforming growth factor-beta (TGF-beta) and epidermal growth factor (EGF) have critical roles in regulating the metastasis of aggressive breast cancers, yet the impact of epithelial-mesenchymal transition (EMT) induced by TGF-beta in altering the response of breast cancer cells to EGF remains unknown. We show in this study that murine metastatic 4T1 breast cancer cells formed compact and dense spheroids when cultured under three-dimensional (3D) conditions, which was in sharp contrast to the branching phenotypes exhibited by their nonmetastatic counterparts. Using the human MCF10A series, we show that epithelial-type and nonmetastatic breast cancer cells were unable to invade to EGF, whereas their mesenchymal-type and metastatic counterparts readily invaded to EGF. Furthermore, EMT induced by TGF-beta was sufficient to manifest dense spheroid morphologies, a phenotype that increased primary tumor exit and invasion to EGF. Post-EMT invasion to EGF was dependent on increased activation of EGF receptor (EGFR) and p38 mitogen-activated protein kinase, all of which could be abrogated either by pharmacologic (PF-562271) or by genetic (shRNA) targeting of focal adhesion kinase (FAK). Mechanistically, EMT induced by TGF-beta increased cell-surface levels of EGFR and prevented its physical interaction with E-cadherin, leading instead to the formation of oncogenic signaling complexes with T beta R-II. Elevated EGFR expression was sufficient to transform normal mammary epithelial cells, and to progress their 3D morphology from that of hollow acini to branched structures characteristic of nonmetastatic breast cancer cells. Importantly, we show that TGF-beta stimulation of EMT enabled this EGFR-driven breast cancer model to abandon their inherent branching architecture and form large, undifferentiated masses that were hyperinvasive to EGF and showed increased pulmonary tumor growth upon tail vein injection. Finally, chemotherapeutic targeting of FAK was sufficient to revert the aggressive behaviors of these structures. Collectively, this investigation has identified a novel EMT-based approach to neutralize the oncogenic activities of EGF and TGF-beta in aggressive and invasive forms of breast cancer. Oncogene (2010) 29, 6485-6498; doi:10.1038/onc.2010.377; published online 30 August 2010	[Wendt, M. K.; Smith, J. A.; Schiemann, W. P.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA	Case Western Reserve University	Schiemann, WP (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Div Gen Med Sci Oncol, Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44106 USA.	william.schiemann@case.edu		Wendt, Mike/0000-0002-3665-7413	National Institutes of Health [CA129359]; Susan G Komen for the Cure Foundation [BCTR0706967]; Department of Defense [BC084561]; American Cancer Society [PF-09-120-01]; NATIONAL CANCER INSTITUTE [R01CA129359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Pfizer for graciously providing the novel small molecule FAK inhibitor, PF-562271. We also thank Dr Alexander D Sorkin for providing the retroviral construct that encoded human EGFR. WPS was supported in part by grants from the National Institutes of Health (CA129359) and the Susan G Komen for the Cure Foundation (BCTR0706967) and the Department of Defense (BC084561), whereas MKW was supported by a fellowship from the American Cancer Society (PF-09-120-01).	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Barr S, 2008, CLIN EXP METASTAS, V25, P685, DOI 10.1007/s10585-007-9121-7; Bremm A, 2008, CANCER RES, V68, P707, DOI 10.1158/0008-5472.CAN-07-1588; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Cicchini C, 2008, EXP CELL RES, V314, P143, DOI 10.1016/j.yexcr.2007.09.005; Cowin P, 2007, J MAMMARY GLAND BIOL, V12, P99, DOI 10.1007/s10911-007-9041-9; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Dhasarathy A, 2007, MOL ENDOCRINOL, V21, P2907, DOI 10.1210/me.2007-0293; Ding Q, 2008, J BIOL CHEM, V283, P26839, DOI 10.1074/jbc.M803645200; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Joo CK, 2008, ONCOGENE, V27, P614, DOI 10.1038/sj.onc.1210649; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Mitra SK, 2006, ONCOGENE, V25, P4429, DOI 10.1038/sj.onc.1209482; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; Saha Debabrata, 1999, Neoplasia (New York), V1, P508; SALOMON DS, 1987, J CELL PHYSIOL, V130, P397, DOI 10.1002/jcp.1041300313; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Takahashi K, 1996, EXP CELL RES, V226, P214, DOI 10.1006/excr.1996.0221; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Thomson S, 2008, CLIN EXP METASTAS, V25, P843, DOI 10.1007/s10585-008-9200-4; Tian M, 2009, FUTURE ONCOL, V5, P259, DOI 10.2217/14796694.5.2.259; Tischkowitz M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-134; Wang SE, 2008, MOL CELL BIOL, V28, P5605, DOI 10.1128/MCB.00787-08; Wang SE, 2009, CANCER RES, V69, P475, DOI 10.1158/0008-5472.CAN-08-2649; Wendt MK, 2008, ONCOGENE, V27, P1461, DOI 10.1038/sj.onc.1210751; Wendt MK, 2009, J BIOL CHEM, V284, P34145, DOI 10.1074/jbc.M109.023614; Wendt MK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2360; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; Wilding J, 1996, CANCER RES, V56, P5285; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wyckoff JB, 2000, CANCER RES, V60, P5401; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	48	152	157	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC	2010	29	49					6485	6498		10.1038/onc.2010.377	http://dx.doi.org/10.1038/onc.2010.377			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	692FP	20802523	Green Accepted			2022-12-25	WOS:000285138900008
J	Akerfelt, M; Vihervaara, A; Laiho, A; Conter, A; Christians, ES; Sistonen, L; Henriksson, E				Akerfelt, Malin; Vihervaara, Anniina; Laiho, Asta; Conter, Annie; Christians, Elisabeth S.; Sistonen, Lea; Henriksson, Eva			Heat Shock Transcription Factor 1 Localizes to Sex Chromatin during Meiotic Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE Y-CHROMOSOME; LONG ARM; XY BODY; TARGETED DISRUPTION; SPERM DEVELOPMENT; EXPRESSION; GENE; HSF1; SPERMATOGENESIS; PROTEIN	Heat shock factor 1 (HSF1) is an important transcription factor in cellular stress responses, cancer, aging, and developmental processes including gametogenesis. Disruption of Hsf1, together with another HSF family member, Hsf2, causes male sterility and complete lack of mature sperm in mice, but the specific role of HSF1 in spermatogenesis has remained unclear. Here, we show that HSF1 is transiently expressed in meiotic spermatocytes and haploid round spermatids in mouse testis. The Hsf1(-/-) male mice displayed regions of seminiferous tubules containing only spermatogonia and increased morphological abnormalities in sperm heads. In search for HSF1 target genes, we identified 742 putative promoters in mouse testis. Among them, the sex chromosomal multicopy genes that are expressed in postmeiotic cells were occupied by HSF1. Given that the sex chromatin mostly is repressed during and after meiosis, it is remarkable that HSF1 directly regulates the transcription of sex-linked multicopy genes during postmeiotic repression. In addition, our results show that HSF1 localizes to the sex body prior to the meiotic divisions and to the sex chromocenter after completed meiosis. To the best of our knowledge, HSF1 is the first known transcription factor found at the repressed sex chromatin during meiosis.	[Sistonen, Lea] Abo Akad Univ, Dept Biosci, FI-20521 Turku, Finland; [Akerfelt, Malin; Vihervaara, Anniina; Laiho, Asta; Sistonen, Lea; Henriksson, Eva] Univ Turku, Turku Ctr Biotechnol, FI-20521 Turku, Finland; [Conter, Annie; Christians, Elisabeth S.] Univ Toulouse 3, Ctr Dev Biol, UMR 5547, F-31062 Toulouse, France	Abo Akademi University; University of Turku; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Sistonen, L (corresponding author), Abo Akad Univ, Dept Biosci, POB 123, FI-20521 Turku, Finland.	lea.sistonen@abo.fi		Akerfelt, Malin/0000-0003-4810-7862; Henriksson, Eva/0000-0001-8320-4591; Vihervaara, Anniina/0000-0001-6256-4694; Sistonen, Lea/0000-0003-1341-2867	Academy of Finland; Sigrid Juselius Foundation; Finnish Cancer Organizations; Abo Akademi University; Magnus Ehrnrooth Foundation; Foundation of Abo Akademi Research Institute; Turku Graduate School of Biomedical Sciences (TuBS)	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Organizations; Abo Akademi University; Magnus Ehrnrooth Foundation; Foundation of Abo Akademi Research Institute; Turku Graduate School of Biomedical Sciences (TuBS)	This work was supported by The Academy of Finland, The Sigrid Juselius Foundation, The Finnish Cancer Organizations, and Abo Akademi University (to L. S.), The Magnus Ehrnrooth Foundation and Foundation of Abo Akademi Research Institute (to M. A., A. V., and E. H.), and by the Turku Graduate School of Biomedical Sciences (TuBS) (to M. A. and A. V.).	Akerfelt M, 2008, P NATL ACAD SCI USA, V105, P11224, DOI 10.1073/pnas.0800620105; Alastalo TP, 1998, EXP CELL RES, V240, P16, DOI 10.1006/excr.1997.3926; ALMON E, 1993, DEV BIOL, V156, P107, DOI 10.1006/dbio.1993.1062; Bierkamp C, 2010, DEV BIOL, V339, P338, DOI 10.1016/j.ydbio.2009.12.037; Birch-Machin I, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r63; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; CALENDA A, 1994, EMBO J, V13, P100, DOI 10.1002/j.1460-2075.1994.tb06239.x; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Chang YH, 2006, GENE DEV, V20, P836, DOI 10.1101/gad.366906; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; CONWAY SJ, 1994, MAMM GENOME, V5, P203, DOI 10.1007/BF00360546; Crew FAE, 1922, J ANAT, V56, P98; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ellis Peter J I, 2006, Hum Fertil (Camb), V9, P1, DOI 10.1080/14647270500230114; Ellis PJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-171; Ellis PJI, 2005, HUM MOL GENET, V14, P2705, DOI 10.1093/hmg/ddi304; Greaves IK, 2006, MOL CELL BIOL, V26, P5394, DOI 10.1128/MCB.00519-06; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Hoyer-Fender S, 2003, CYTOGENET GENOME RES, V103, P245, DOI 10.1159/000076810; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Izu H, 2004, BIOL REPROD, V70, P18, DOI 10.1095/biolreprod.103.020065; Kallio M, 2002, EMBO J, V21, P2591, DOI 10.1093/emboj/21.11.2591; Khaleque MA, 2005, ONCOGENE, V24, P6564, DOI 10.1038/sj.onc.1208798; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; Kugel JF, 2006, MOL CELL, V22, P153, DOI 10.1016/j.molcel.2006.04.003; Lange J, 2009, CELL, V138, P855, DOI 10.1016/j.cell.2009.07.042; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Manuel M, 2002, EUR J BIOCHEM, V269, P2527, DOI 10.1046/j.1432-1033.2002.02917.x; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Metchat A, 2009, J BIOL CHEM, V284, P9521, DOI 10.1074/jbc.M808819200; Moore CR, 1924, SCIENCE, V59, P41, DOI 10.1126/science.59.1515.41; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Nakai A, 2000, EMBO J, V19, P1545, DOI 10.1093/emboj/19.7.1545; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Print CG, 2000, BIOESSAYS, V22, P423, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;423::AID-BIES4&gt;3.0.CO;2-0; Reynard LN, 2007, BIOL REPROD, V77, P329, DOI 10.1095/biolreprod.107.061101; Reynard LN, 2009, BIOL REPROD, V81, P250, DOI 10.1095/biolreprod.108.075382; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Salmand PA, 2008, BIOL REPROD, V79, P1092, DOI 10.1095/biolreprod.108.070334; Sandqvist A, 2009, MOL BIOL CELL, V20, P1340, DOI 10.1091/mbc.E08-08-0864; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SCHWARTZ D, 1993, ONCOGENE, V8, P1487; SOLARI AJ, 1974, INT REV CYTOL, V38, P273, DOI 10.1016/S0074-7696(08)60928-6; Toure A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r102; Toure A, 2004, GENETICS, V166, P901, DOI 10.1534/genetics.166.2.901; Toure A, 2004, GENOMICS, V83, P140, DOI 10.1016/S0888-7543(03)00216-7; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Turner JMA, 2005, CHROMOSOMA, V114, P300, DOI 10.1007/s00412-005-0007-7; Wang GH, 2004, GENESIS, V38, P66, DOI 10.1002/gene.20005; Wang GH, 2003, GENESIS, V36, P48, DOI 10.1002/gene.10200; Ward MA, 2006, BIOL REPROD, V74, P652, DOI 10.1095/biolreprod.105.048090; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946	60	53	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34469	34476		10.1074/jbc.M110.157552	http://dx.doi.org/10.1074/jbc.M110.157552			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20802198	Green Published, hybrid			2022-12-25	WOS:000283659100021
J	Kralova, J; Sheely, JI; Liss, AS; Bose, HR				Kralova, J.; Sheely, J. I.; Liss, A. S.; Bose, H. R., Jr.			ERK and JNK activation is essential for oncogenic transformation by v-Rel	ONCOGENE			English	Article						v-Rel; NF-kappa B; transformation; oncogenesis; MAPK	NF-KAPPA-B; SIGNAL-REGULATED KINASE; CELL-CYCLE ARREST; C-REL; TRANSCRIPTION FACTOR; CANCER PROGRESSION; GENE-EXPRESSION; BREAST-CANCER; TUMOR-GROWTH; JUN KINASE	v-Rel is the acutely oncogenic member of the NF-kappa B family of transcription factors. Infection with retroviruses expressing v-Rel rapidly induces fatal lymphomas in birds and transforms primary lymphocytes and fibroblasts in vitro. We have previously shown that AP-1 transcriptional activity contributes to v-Rel-mediated transformation. Although v-Rel increases the expression of these factors, their activity may also be induced through phosphorylation by the mitogen-activated protein kinases (MAPKs). The expression of v-Rel results in the strong and sustained activation of the ERK and JNK MAPK pathways. This induction is critical for the v-Rel-transformed phenotype, as suppression of MAPK activity with chemical inhibitors or small interfering RNA severely impairs colony formation of v-Rel-transformed lymphoid cell lines. However, signaling must be maintained within an optimal range in these cells, as strong additional activation of either pathway beyond the levels induced by v-Rel through the expression of constitutively active MAPK proteins attenuates the transformed phenotype. MAPK signaling also has an important role in the initial transformation of primary spleen cells by v-Rel, although distinct requirements for MAPK activity at different stages of v-Rel-mediated transformation were identified. We also show that the ability of v-Rel to induce MAPK signaling more strongly than c-Rel contributes to its greater oncogenicity. Oncogene (2010) 29, 6267-6279; doi:10.1038/onc.2010.359; published online 30 August 2010	[Kralova, J.; Sheely, J. I.; Liss, A. S.; Bose, H. R., Jr.] Univ Texas Austin, Inst Mol & Cellular Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Bose, HR (corresponding author), Univ Texas Austin, Inst Mol & Cellular Biol, Sect Mol Genet & Microbiol, 1 Univ Stn A5000, Austin, TX 78712 USA.	bose@mail.utexas.edu	Liss, Andrew/L-9696-2019; Kralova, Jarmila/G-3834-2014	Kralova, Jarmila/0000-0002-4735-8857	National Cancer Institute [CA33192, CA098151]; Grant Agency of the Academy of Sciences of the Czech Republic [KAN200200651]; NATIONAL CANCER INSTITUTE [R01CA098151, R01CA033192] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the laboratories of Natalie Ahn and Aming Lin for generously providing the CA MKK constructs. This work was supported by Public Health Service grants CA33192 and CA098151 from the National Cancer Institute. Jarmila Kralova was supported, in part, by grant KAN200200651 from the Grant Agency of the Academy of Sciences of the Czech Republic. We also thank R Hrdlickova and J Nehyba for their critical reading of the manuscript.	Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bost F, 1999, MOL CELL BIOL, V19, P1938; Bubendorf L, 1999, CANCER RES, V59, P803; Bunting K, 2007, J IMMUNOL, V178, P7097, DOI 10.4049/jimmunol.178.11.7097; Chen NY, 2001, CANCER RES, V61, P3908; Corzo C, 2006, CANCER GENET CYTOGEN, V165, P151, DOI 10.1016/j.cancergencyto.2005.08.013; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Fujii M, 1996, ONCOGENE, V12, P2193; Gilmore TD, 1999, ONCOGENE, V18, P6925, DOI 10.1038/sj.onc.1203222; Gilmore TD, 2004, ONCOGENE, V23, P2275, DOI 10.1038/sj.onc.1207410; Gupta N, 2008, CANCER RES, V68, P808, DOI 10.1158/0008-5472.CAN-07-3169; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; Houben R, 2008, J INVEST DERMATOL, V128, P2003, DOI 10.1038/jid.2008.30; Karakosta A, 2005, J EXP CLIN CANC RES, V24, P505; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kennedy NJ, 2003, GENE DEV, V17, P629, DOI 10.1101/gad.1062903; Kralova J, 1998, MOL CELL BIOL, V18, P2997, DOI 10.1128/MCB.18.5.2997; Kralova J, 1996, ONCOGENE, V12, P2595; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Liss AS, 2010, ONCOGENE, V29, P4925, DOI 10.1038/onc.2010.239; Majid SM, 2006, ONCOGENE, V25, P756, DOI 10.1038/sj.onc.1209107; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Nehyba J, 1997, ONCOGENE, V14, P2881, DOI 10.1038/sj.onc.1201150; Nelson DM, 1998, HUM GENE THER, V9, P2401, DOI 10.1089/hum.1998.9.16-2401; Nielsen C, 2007, CANCER RES, V67, P178, DOI 10.1158/0008-5472.CAN-06-2801; OKUNO H, 1991, ONCOGENE, V6, P1491; Oleinik NV, 2007, ONCOGENE, V26, P7222, DOI 10.1038/sj.onc.1210526; Potapova O, 2002, CANCER RES, V62, P3257; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Skarpen E, 2008, FASEB J, V22, P466, DOI 10.1096/fj.07-8650com; Suzukawa K, 2002, ENVIRON HEALTH PERSP, V110, P865, DOI 10.1289/ehp.02110865; Tsavachidou D, 2004, CANCER RES, V64, P5556, DOI 10.1158/0008-5472.CAN-04-1669; Ussar S, 2004, J BIOL CHEM, V279, P43861, DOI 10.1074/jbc.M406240200; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Yang YM, 2003, CLIN CANCER RES, V9, P391; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966	50	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	47					6267	6279		10.1038/onc.2010.359	http://dx.doi.org/10.1038/onc.2010.359			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	685CG	20802521	Green Accepted			2022-12-25	WOS:000284601700008
J	Jassal, MS; Nedeltchev, GG; Lee, JH; Choi, SW; Atudorei, V; Sharp, ZD; Deretic, V; Timmins, GS; Bishai, WR				Jassal, Mandeep S.; Nedeltchev, Gueno G.; Lee, Jong-Hee; Choi, Seong Won; Atudorei, Viorel; Sharp, Zachary D.; Deretic, Vojo; Timmins, Graham S.; Bishai, William R.			(13)[C]-Urea Breath Test as a Novel Point-of-Care Biomarker for Tuberculosis Treatment and Diagnosis	PLOS ONE			English	Article							UREASE TEST; MYCOBACTERIUM-TUBERCULOSIS; ANTITUBERCULOSIS DRUGS; PULMONARY TUBERCULOSIS; TREATMENT RESPONSE; PYLORI; IDENTIFICATION; THERAPY	Background: Pathogen-specific metabolic pathways may be detected by breath tests based on introduction of stable isotopically-labeled substrates and detection of labeled products in exhaled breath using portable infrared spectrometers. Methodology/Principal Findings: We tested whether mycobacterial urease activity could be utilized in such a breath test format as the basis of a novel biomarker and diagnostic for pulmonary TB. Sensitized New-Zealand White Rabbits underwent bronchoscopic infection with either Mycobacterium bovis or Mycobacterium tuberculosis. Rabbits were treated with 25 mg/kg of isoniazid (INH) approximately 2 months after infection when significant cavitary lung pathology was present. [C-13] urea was instilled directly into the lungs of intubated rabbits at selected time points, exhaled air samples analyzed, and the kinetics of delta(CO2)-C-13 formation were determined. Samples obtained prior to inoculation served as control samples for background (CO2)-C-13 conversion in the rabbit model. (CO2)-C-13, from metabolic conversion of [C-13]-urea by mycobacterial urease activity, was readily detectable in the exhaled breath of infected rabbits within 15 minutes of administration. Analyses showed a rapid increase in the rate of (CO2)-C-13 formation both early in disease and prior to treatment with INH. Following INH treatment, all evaluable rabbits showed a decrease in the rate of (CO2)-C-13 formation. Conclusions/Significance: Urea breath testing may provide a useful diagnostic and biomarker assay for tuberculosis and for treatment response. Future work will test specificity for M. tuberculosis using lung-targeted dry powder inhalation formulations, combined with co-administering oral urease inhibitors together with a saturating oral dose of unlabeled urea, which would prevent the delta(CO2)-C-13 signal from urease-positive gastrointestinal organisms.	[Jassal, Mandeep S.; Nedeltchev, Gueno G.; Lee, Jong-Hee; Bishai, William R.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA; [Jassal, Mandeep S.] Johns Hopkins Univ, Sch Med, Div Pediat Pulmonol, Baltimore, MD USA; [Choi, Seong Won; Timmins, Graham S.] Univ New Mexico, Div Pharmaceut Sci, Albuquerque, NM 87131 USA; [Atudorei, Viorel; Sharp, Zachary D.] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Deretic, Vojo] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	Johns Hopkins University; Johns Hopkins University; University of New Mexico; University of New Mexico; University of New Mexico	Jassal, MS (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA.	wbishai@jhmi.edu	Lee, JongHee/AAH-4129-2019	Lee, JongHee/0000-0001-9938-1306; timmins, graham/0000-0002-4971-718X; Deretic, Vojo/0000-0002-3624-5208	National Institutes of Health (NIH) [AI36973, AI37856, AI30036]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036973, R01AI042999, R01AI030036, R29AI036973, R01AI037856] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The support of National Institutes of Health (NIH) grants/contracts AI36973, AI37856, AI30036 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; BELL GD, 1987, LANCET, V1, P1367; Buzas GM, 2008, J GASTROENTEROL, V43, P108, DOI 10.1007/s00535-007-2135-8; CANETTI G, 1995, TUBERCLE BACILLUS; COX FR, 1977, J CLIN MICROBIOL, V5, P656; DAMATO JJ, 1982, J CLIN MICROBIOL, V15, P478, DOI 10.1128/JCM.15.3.478-480.1982; Davies PDO, 2008, INT J TUBERC LUNG D, V12, P1226; Donald PR, 2008, TUBERCULOSIS, V88, pS75, DOI 10.1016/S1472-9792(08)70038-6; Dowdy DW, 2008, INT J TUBERC LUNG D, V12, P1021; ELNUJUMI AM, 1991, GUT, V32, P866, DOI 10.1136/gut.32.8.866; Fujimura S, 2002, EUR J GASTROEN HEPAT, V14, P1161, DOI 10.1097/00042737-200210000-00019; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Gillespie SH, 2003, INT J TUBERC LUNG D, V7, P684; Go MF, 2002, ALIMENT PHARM THER, V16, P3, DOI 10.1046/j.1365-2036.2002.0160s1003.x; Grandjean L, 2008, CURR OPIN INFECT DIS, V21, P454, DOI 10.1097/QCO.0b013e32830ce783; HART PD, 1991, J EXP MED, V174, P881, DOI 10.1084/jem.174.4.881; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Jindani A, 2003, AM J RESP CRIT CARE, V167, P1348, DOI 10.1164/rccm.200210-1125OC; LEVYFREBAULT VV, 1992, INT J SYST BACTERIOL, V42, P315; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Millen SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001933; Mitchell JP, 2009, EXPERT REV MED DEVIC, V6, P147, DOI 10.1586/17434440.6.2.147; MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062; MITCHISON DA, 1992, J ANTIMICROB CHEMOTH, V29, P477, DOI 10.1093/jac/29.5.477; MURPHY DB, 1975, J CLIN MICROBIOL, V1, P465, DOI 10.1128/JCM.1.5.465-468.1975; NARDELL EA, 2000, TUBERCULOSIS COMPREH, P215; Nedeltchev GG, 2009, INFECT IMMUN, V77, P598, DOI 10.1128/IAI.01132-08; Opekun AR, 2005, CLIN BIOCHEM, V38, P731, DOI 10.1016/j.clinbiochem.2005.05.003; Pai M, 2010, CURR OPIN PULM MED, V16, P271, DOI 10.1097/MCP.0b013e328338094f; Perrin FMR, 2007, LANCET INFECT DIS, V7, P481, DOI 10.1016/S1473-3099(07)70112-3; ROSENSTEIN IJM, 1984, CRC CR REV MICROBIOL, V11, P1, DOI 10.3109/10408418409105901; Sanaka M, 1999, AM J GASTROENTEROL, V94, P1983, DOI 10.1111/j.1572-0241.1999.1983a.x; Sohngen N. L., 1913, ZBL BAKTERIOL      2, V27, P595; STEADHAM JE, 1979, J CLIN MICROBIOL, V10, P134, DOI 10.1128/JCM.10.2.134-137.1979; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; TODA T, 1961, AM REV RESPIR DIS, V83, P757; Uygun A, 2007, J DIGEST DIS, V8, P211, DOI 10.1111/j.1751-2980.2007.00308.x; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; Walzl G, 2008, J INFECTION, V57, P103, DOI 10.1016/j.jinf.2008.06.007; WAYNE LG, 1974, AM REV RESPIR DIS, V109, P147	41	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12451	10.1371/journal.pone.0012451	http://dx.doi.org/10.1371/journal.pone.0012451			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805989	Green Published, gold			2022-12-25	WOS:000281301500017
J	Baker, NM; Zeitlin, SG; Shi, LZ; Shah, J; Berns, MW				Baker, Norman M.; Zeitlin, Samantha G.; Shi, Linda Z.; Shah, Jagesh; Berns, Michael W.			Chromosome Tips Damaged in Anaphase Inhibit Cytokinesis	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; DNA-DAMAGE; CELLULAR-RESPONSES; CELLS; LASER; MITOSIS; KINETOCHORE; INSTABILITY; TELOMERES; TENSION	Genome maintenance is ensured by a variety of biochemical sensors and pathways that repair accumulated damage. During mitosis, the mechanisms that sense and resolve DNA damage remain elusive. Studies have demonstrated that damage accumulated on lagging chromosomes can activate the spindle assembly checkpoint. However, there is little known regarding damage to DNA after anaphase onset. In this study, we demonstrate that laser-induced damage to chromosome tips (presumptive telomeres) in anaphase of Potorous tridactylis cells (PtK2) inhibits cytokinesis. In contrast, equivalent irradiation of non-telomeric chromosome regions or control irradiations in either the adjacent cytoplasm or adjacent to chromosome tips near the spindle midzone during anaphase caused no change in the eventual completion of cytokinesis. Damage to only one chromosome tip caused either complete absence of furrow formation, a prolonged delay in furrow formation, or furrow regression. When multiple chromosome tips were irradiated in the same cell, the cytokinesis defects increased, suggesting a potential dose-dependent mechanism. These results suggest a mechanism in which dysfunctional telomeres inhibit mitotic exit.	[Baker, Norman M.] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Zeitlin, Samantha G.] Univ Calif San Diego, Ludwig Inst Canc Res, Cell Biol Lab, La Jolla, CA 92093 USA; [Shi, Linda Z.; Berns, Michael W.] Univ Calif San Diego, Ludwig Inst Canc Res, Dept Bioengn, La Jolla, CA 92093 USA; [Shah, Jagesh] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Shah, Jagesh] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Berns, Michael W.] Univ Calif Irvine, Beckman Laser Inst, Irvine, CA USA	University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of California System; University of California Irvine	Baker, NM (corresponding author), Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA.	jagesh@hms.harvard.edu; mwberns@uci.edu		Berns, Michael/0000-0002-9640-2885	NCI NIH HHS [BC085852] Funding Source: Medline; NIGMS NIH HHS [R01 GM077238] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077238] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anantha RW, 2008, P NATL ACAD SCI USA, V105, P12903, DOI 10.1073/pnas.0803001105; Berns MW, 2007, METHOD CELL BIOL, V82, P1; Botvinick EL, 2004, BIOPHYS J, V87, P4203, DOI 10.1529/biophysj.104.049528; Botvinick EL, 2005, MICROSC RES TECHNIQ, V68, P65, DOI 10.1002/jemt.20216; Ciapponi L, 2008, CYTOGENET GENOME RES, V122, P365, DOI 10.1159/000167824; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dynek JN, 2004, SCIENCE, V304, P97, DOI 10.1126/science.1094754; Gomez-Godinez V, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717684; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Khodjakov A, 1997, J CELL BIOL, V136, P229, DOI 10.1083/jcb.136.2.229; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; Mikhailov A, 2002, CURR BIOL, V12, P1797, DOI 10.1016/S0960-9822(02)01226-5; Musaro M, 2008, NAT GENET, V40, P362, DOI 10.1038/ng.2007.64; O'Connell CB, 2008, J CELL BIOL, V183, P29, DOI 10.1083/jcb.200801038; Pobiega S, 2010, GENE DEV, V24, P720, DOI 10.1101/gad.571510; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; SASAKI K, 1991, OPT LETT, V16, P1463, DOI 10.1364/OL.16.001463; Shrivastav N, 2010, CARCINOGENESIS, V31, P59, DOI 10.1093/carcin/bgp262; SKIBBENS RV, 1995, J CELL SCI, V108, P2537; Skoufias DA, 2004, MOL CELL, V15, P977, DOI 10.1016/j.molcel.2004.08.018; SPURCK TP, 1990, J CELL BIOL, V111, P1505, DOI 10.1083/jcb.111.4.1505; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Thanasoula M, 2010, CURR BIOL, V20, P521, DOI 10.1016/j.cub.2010.01.046; Wheatley SP, 1996, J CELL BIOL, V135, P981, DOI 10.1083/jcb.135.4.981	28	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12398	10.1371/journal.pone.0012398	http://dx.doi.org/10.1371/journal.pone.0012398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811641	Green Published, gold			2022-12-25	WOS:000281234700022
J	York, TP; Strauss, JF; Neale, MC; Eaves, LJ				York, Timothy P.; Strauss, Jerome F., III; Neale, Michael C.; Eaves, Lindon J.			Racial Differences in Genetic and Environmental Risk to Preterm Birth	PLOS ONE			English	Article							GESTATIONAL-AGE; DISPARITIES; WEIGHT; HEALTH; TNF	Preterm birth is more prevalent in African Americans than European Americans and contributes to 3.4 times more African American infant deaths. Models of social inequity do not appreciably account for this marked disparity and molecular genetic studies have yet to characterize whether allelic differences that exist between races contribute to this gap. In this study, biometrical genetic models are applied to a large mixed-race sample consisting of 733,339 births to measure the extent that heritable factors and environmental exposures predict the timing of birth and explain differences between racial groups. Although we expected significant differences in mean gestational age between racial groups, we did not anticipate the variance of gestational age in African Americans (sigma(2) = 7.097) to be nearly twice that of European Americans (sigma(2) = 3.764). Our results show that this difference in the variance of gestational age can largely be attributed to environmental sources; which were 3.1 times greater in African Americans. Specifically, environmental factors that change between pregnancies, versus exposures that influence all pregnancies within a family, are largely responsible for the increased reproductive heterogeneity observed in African American mothers. Although the contribution of both fetal and maternal genetic factors differed between race categories, genetic studies may best be directed to understanding the differences in the sociocultural sources of this heterogeneity, and their possible interaction with genetic differences within and between races. This study provides a comprehensive description of the relative genetic and environmental contributions to racial differences in gestational age.	[York, Timothy P.; Neale, Michael C.; Eaves, Lindon J.] Virginia Commonwealth Univ, Sch Med, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23284 USA; [York, Timothy P.; Strauss, Jerome F., III; Neale, Michael C.; Eaves, Lindon J.] Virginia Commonwealth Univ, Sch Med, Dept Human & Mol Genet, Richmond, VA USA; [Strauss, Jerome F., III] Virginia Commonwealth Univ, Sch Med, Dept Obstet & Gynecol, Richmond, VA USA; [Neale, Michael C.; Eaves, Lindon J.] Virginia Commonwealth Univ, Sch Med, Dept Psychiat, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	York, TP (corresponding author), Virginia Commonwealth Univ, Sch Med, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23284 USA.	tpyork@vcu.edu	Neale, Michael/AAD-5056-2020		National Institutes of Health [R01 HD034612, P60 MD002256, DA-18673]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA018673, R01DA018673] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD002256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was supported by National Institutes of Health grants R01 HD034612, P60 MD002256 and DA-18673. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LS, 2002, TWIN RES, V5, P449, DOI 10.1375/twin.5.5.449; Anum EA, 2009, PEDIATR RES, V65, P1, DOI 10.1203/PDR.0b013e31818912e7; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Behrman RE, 2007, PRETERM BIRTH CAUSES; EAVES LJ, 1978, HEREDITY, V41, P249, DOI 10.1038/hdy.1978.101; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fiscella Kevin, 2005, J Natl Med Assoc, V97, P1516; Goldenberg RL, 1996, AM J OBSTET GYNECOL, V175, P1317, DOI 10.1016/S0002-9378(96)70048-0; J/reskog K.G., 1988, LISREL 7 GUIDE PROGR; Kaufman JS, 1997, EPIDEMIOLOGY, V8, P621, DOI 10.1097/00001648-199710000-00002; Lang JM, 1996, EPIDEMIOLOGY, V7, P369, DOI 10.1097/00001648-199607000-00006; Lu MC, 2004, AM J OBSTET GYNECOL, V191, P691, DOI 10.1016/j.ajog.2004.04.018; Lu Michael C, 2003, Matern Child Health J, V7, P13, DOI 10.1023/A:1022537516969; Lunde A, 2007, AM J EPIDEMIOL, V165, P734, DOI 10.1093/aje/kwk107; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Macones GA, 2004, AM J OBSTET GYNECOL, V190, P1504, DOI 10.1016/j.ajog.2004.01.001; Martin JA., 2009, NATL VITAL STAT REP, V57, P1; MARTIN NG, 1977, HEREDITY, V38, P79, DOI 10.1038/hdy.1977.9; Mathews T J, 2008, Natl Vital Stat Rep, V57, P1; Menon R, 2006, HUM HERED, V62, P107, DOI 10.1159/000096301; Mountain JL, 2004, NAT GENET, V36, pS48, DOI 10.1038/ng1456; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Neale MC, 1992, METHODOLOGY GENETIC; NEALE MC, 1999, MX STAT MODELING RIC; Posthuma D, 2003, TWIN RES, V6, P361, DOI 10.1375/twin.6.5.361; Risch Neil, 2002, GENOME BIO, V3, P1, DOI DOI 10.1186/GB-2002-3-7-COMMENT2007; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Treloar S A, 2000, Twin Res, V3, P80, DOI 10.1375/twin.3.2.80; Van den Oord EJCG, 2000, DEMOGRAPHY, V37, P285, DOI 10.2307/2648042; York TP, 2009, TWIN RES HUM GENET, V12, P333, DOI 10.1375/twin.12.4.333	31	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12391	10.1371/journal.pone.0012391	http://dx.doi.org/10.1371/journal.pone.0012391			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811627	Green Submitted, gold, Green Published			2022-12-25	WOS:000281234700016
J	Stroeymeyt, N; Guerrieri, FJ; van Zweden, JS; d'Ettorre, P				Stroeymeyt, Nathalie; Guerrieri, Fernando J.; van Zweden, Jelle S.; d'Ettorre, Patrizia			Rapid Decision-Making with Side-Specific Perceptual Discrimination in Ants	PLOS ONE			English	Article							NESTMATE-RECOGNITION CUES; OLFACTORY DISCRIMINATION; CUTICULAR HYDROCARBONS; KIN RECOGNITION; SOCIAL INSECTS; SPEED; ACCURACY; HONEYBEE; TIME; HABITUATION	Background: Timely decision making is crucial for survival and reproduction. Organisms often face a speed-accuracy trade-off, as fully informed, accurate decisions require time-consuming gathering and treatment of information. Optimal strategies for decision-making should therefore vary depending on the context. In mammals, there is mounting evidence that multiple systems of perceptual discrimination based on different neural circuits emphasize either fast responses or accurate treatment of stimuli depending on the context. Methodology/Principal Findings: We used the ant Camponotus aethiops to test the prediction that fast information processing achieved through direct neural pathways should be favored in situations where quick reactions are adaptive. Social insects discriminate readily between harmless group-members and dangerous strangers using easily accessible cuticular hydrocarbons as nestmate recognition cues. We show that i) tethered ants display rapid aggressive reactions upon presentation of non-nestmate odor (120 to 160 ms); ii) ants' aggressiveness towards non-nestmates can be specifically reduced by exposure to non-nestmate odor only, showing that social interactions are not required to alter responses towards non-nestmates; iii) decision-making by ants does not require information transfer between brain hemispheres, but relies on side-specific decision rules. Conclusions/Significance: Our results strongly suggest that first-order olfactory processing centers (up to the antennal lobes) are likely to play a key role in ant nestmate recognition. We hypothesize that the coarse level of discrimination achieved in the antennal lobes early in odor processing provides enough information to determine appropriate behavioral responses towards non-nestmates. This asks for a reappraisal of the mechanisms underlying social recognition in insects.	[Stroeymeyt, Nathalie; Guerrieri, Fernando J.; van Zweden, Jelle S.; d'Ettorre, Patrizia] Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark	University of Copenhagen	Stroeymeyt, N (corresponding author), Univ Bristol, Ant Lab, Sch Biol Sci, Bristol, Avon, England.	Nathalie.Stroeymeyt@bristol.ac.uk	Guerrieri, Fernando/AAE-1745-2019; van Zweden, Jelle S./AAD-7858-2020; Guerrieri, Fernando J/B-5229-2016; Stroeymeyt, Nathalie/H-2371-2013	Guerrieri, Fernando/0000-0001-9872-9067; van Zweden, Jelle S./0000-0001-5283-5470; Guerrieri, Fernando J/0000-0001-9872-9067; Stroeymeyt, Nathalie/0000-0001-8047-449X	EU-Marie Curie Excellence	EU-Marie Curie Excellence(European Commission)	This study was supported by the EU-Marie Curie Excellence Grant "CODICES" assigned to PdE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; BRAUN G, 1992, J NEUROPHYSIOL, V67, P588, DOI 10.1152/jn.1992.67.3.588; BREED MD, 1992, ANIM BEHAV, V44, P519, DOI 10.1016/0003-3472(92)90060-M; Chaline N, 2005, CHEM SENSES, V30, P327, DOI 10.1093/chemse/bji027; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; D'Ettorre P, 2005, CURR BIOL, V15, P2170, DOI 10.1016/j.cub.2005.10.067; D'Ettorre P, 2004, P ROY SOC B-BIOL SCI, V271, P1427, DOI 10.1098/rspb.2004.2742; d'Ettorre P, 2010, ANT ECOLOGY, P194; Dani FR, 2005, CHEM SENSES, V30, P477, DOI 10.1093/chemse/bji040; Dani FR, 2001, ANIM BEHAV, V62, P165, DOI 10.1006/anbe.2001.1714; Devaud JM, 2001, J NEUROSCI, V21, P6274, DOI 10.1523/JNEUROSCI.21-16-06274.2001; Ditzen M, 2003, CHEM SENSES, V28, P781, DOI 10.1093/chemse/bjg070; Errard C, 1997, INSECT SOC, V44, P189, DOI 10.1007/s000400050040; FONTA C, 1993, CHEM SENSES, V18, P101, DOI 10.1093/chemse/18.2.101; GADAGKAR R, 1985, P INDIAN AS-ANIM SCI, V94, P587, DOI 10.1007/BF03191863; Giurfa M, 2003, CURR OPIN NEUROBIOL, V13, P726, DOI 10.1016/j.conb.2003.10.015; Greene MJ, 2003, NATURE, V423, P32, DOI 10.1038/423032a; Grossberg S, 2008, VISION RES, V48, P1345, DOI 10.1016/j.visres.2008.02.019; Guerrieri FJ, 2008, J EXP BIOL, V211, P1109, DOI 10.1242/jeb.008508; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; Hefetz Abraham, 2007, Myrmecological News, V10, P59; HOMBERG U, 1989, ANNU REV ENTOMOL, V34, P477, DOI 10.1146/annurev.en.34.010189.002401; HOMBERG U, 1988, CELL TISSUE RES, V254, P255; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Komischke B, 2003, BEHAV BRAIN RES, V145, P135, DOI 10.1016/S0166-4328(03)00105-0; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Krofczik S, 2009, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.009.2008; LACY RC, 1983, AM NAT, V121, P489, DOI 10.1086/284078; LAING DG, 1994, BRAIN RES, V651, P317, DOI 10.1016/0006-8993(94)90712-9; Langen TA, 2000, BEHAV ECOL SOCIOBIOL, V48, P285, DOI 10.1007/s002650000223; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; LeDoux J. E., 1996, EMOTIONAL BRAIN; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Lenoir A, 2009, J CHEM ECOL, V35, P913, DOI 10.1007/s10886-009-9669-6; Leon M, 2009, CELL MOL LIFE SCI, V66, P2135, DOI 10.1007/s00018-009-0011-9; Leonhardt SD, 2007, J COMP PHYSIOL A, V193, P993, DOI 10.1007/s00359-007-0252-8; Luce R. D., 1986, RESPONSE TIMES; Marshall JAR, 2006, J R SOC INTERFACE, V3, P243, DOI 10.1098/rsif.2005.0075; Marshall JAR, 2009, J R SOC INTERFACE, V6, P1065, DOI 10.1098/rsif.2008.0511; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Orivel J, 1997, BEHAV ECOL SOCIOBIOL, V40, P87, DOI 10.1007/s002650050319; Ottoni EB, 2000, BEHAV RES METH INS C, V32, P446, DOI 10.3758/BF03200814; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; Sandoz JC, 2002, LEARN MEMORY, V9, P337, DOI 10.1101/lm.50502; Sandoz JC, 2001, LEARN MEMORY, V8, P286, DOI 10.1101/lm.41401; Skorupski P, 2010, J NEUROSCI, V30, P3896, DOI 10.1523/JNEUROSCI.5700-09.2010; SLOTNICK BM, 1990, COMP PERCEPTION, P155; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; Stroeymeyt N, 2007, BEHAV ECOL SOCIOBIOL, V61, P1449, DOI 10.1007/s00265-007-0377-3; Sumana A, 2008, J ETHOL, V26, P207, DOI 10.1007/s10164-007-0049-9; Trimmer PC, 2008, P ROY SOC B-BIOL SCI, V275, P2353, DOI 10.1098/rspb.2008.0417; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Uchida N, 2006, NAT REV NEUROSCI, V7, P485, DOI 10.1038/nrn1933; van Zweden JS, 2007, P ROY SOC B-BIOL SCI, V274, P1421, DOI 10.1098/rspb.2007.0113; van Zweden JS, 2009, J INSECT PHYSIOL, V55, P158, DOI 10.1016/j.jinsphys.2008.11.001; Vander Meer Robert K., 1998, P79; Vasquez GM, 2008, BEHAV ECOL SOCIOBIOL, V62, P537, DOI 10.1007/s00265-007-0478-z; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Wright GA, 2009, BEHAV NEUROSCI, V123, P36, DOI 10.1037/a0014040; Wyatt TD, 2009, NATURE, V457, P262, DOI 10.1038/457262a	63	27	27	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12377	10.1371/journal.pone.0012377	http://dx.doi.org/10.1371/journal.pone.0012377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20808782	Green Submitted, Green Published, gold			2022-12-25	WOS:000281154300012
J	Han, JN; Sachdev, PS; Sidhu, KS				Han, Jinnuo; Sachdev, Perminder S.; Sidhu, Kuldip S.			A Combined Epigenetic and Non-Genetic Approach for Reprogramming Human Somatic Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NUCLEAR TRANSFER; GENE-EXPRESSION; DEFINED FACTORS; ES CELLS; FIBROBLASTS; MOUSE; INDUCTION; EXTRACTS; GENERATION	Reprogramming of somatic cells to different extents has been reported using different methods. However, this is normally accompanied by the use of exogenous materials, and the overall reprogramming efficiency has been low. Chemicals and small molecules have been used to improve the reprogramming process during somatic cell nuclear transfer (SCNT) and induced pluripotent stem (iPS) cell generation. We report here the first application of a combined epigenetic and non-genetic approach for reprogramming somatic cells, i.e., DNA methyltransferase (DNMT) and histone deacetylase (HDAC) inhibitors, and human embryonic stem cell (hESC) extracts. When somatic cells were pretreated with these inhibitors before exposure to hESC (MEL1) extracts, morphological analysis revealed a higher rate of hESC-like colony formation than without pretreatment. Quantitative PCR (qPCR) demonstrated that pluripotency genes were upregulated when compared to those of somatic cells or treated with hESC extracts alone. Overall changes in methylation and acetylation levels of pretreated somatic cells suggests that epigenetic states of the cells have an effect on reprogramming efficiency induced by hESC extracts. KnockOutserum replacement (KOSR (TM)) medium (KO-SR) played a positive role in inducing expression of the pluripotency genes. hESC extracts could be an alternative approach to reprogram somatic cells without introducing exogenous materials. The epigenetic pre-treatment of somatic cells could be used to improve the efficiency of reprogramming process. Under differentiation conditions, the reprogrammed cells exhibited differentiation ability into neurons suggesting that, although fully reprogramming was not achieved, the cells could be transdifferentiated after reprogramming.	[Han, Jinnuo; Sachdev, Perminder S.; Sidhu, Kuldip S.] Univ New S Wales, Fac Med, Sydney, NSW, Australia	University of New South Wales Sydney	Han, JN (corresponding author), Univ New S Wales, Fac Med, Sydney, NSW, Australia.	k.sidhu@unsw.edu.au	SIDHU, kuldip/AAI-8361-2020; Sachdev, Perminder/ABC-1137-2020	Sachdev, Perminder/0000-0002-9595-3220	Australia National Health and Medical Research Council (NHRMC) [ID 568969]	Australia National Health and Medical Research Council (NHRMC)(National Health and Medical Research Council (NHMRC) of Australia)	The project was funded by Australia National Health and Medical Research Council (NHRMC) Program, grant ID 568969 (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberio R, 2005, EXP CELL RES, V307, P131, DOI 10.1016/j.yexcr.2005.02.028; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Balasubramanian S, 2009, STEM CELLS, V27, P3053, DOI 10.1002/stem.242; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bian YH, 2009, EPIGENETICS-US, V4, P194, DOI 10.4161/epi.4.3.8787; BRU T, 2008, EXPT CELL RES   0815, P2634; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Cheng J, 2004, GENESIS, V39, P100, DOI 10.1002/gene.20031; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Dashwood RH, 2006, CARCINOGENESIS, V27, P344, DOI 10.1093/carcin/bgi253; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Eilertsen KJ, 2007, ANIM REPROD SCI, V98, P129, DOI 10.1016/j.anireprosci.2006.10.019; El Kharroubi A, 2001, J BIOL CHEM, V276, P8674, DOI 10.1074/jbc.M009392200; Enright BP, 2003, BIOL REPROD, V69, P896, DOI 10.1095/biolreprod.103.017954; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Han J, 2008, CURR STEM CELL RES T, V3, P66; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Hutchison CJ, 2004, NAT CELL BIOL, V6, P1062, DOI 10.1038/ncb1104-1062; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kimura H, 2004, MOL CELL BIOL, V24, P5710, DOI 10.1128/MCB.24.13.5710-5720.2004; Lagarkova MA, 2006, CELL CYCLE, V5, P416, DOI 10.4161/cc.5.4.2440; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li XY, 2008, STEM CELLS DEV, V17, P1079, DOI 10.1089/scd.2007.0247; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Miyamoto K, 2009, BIOL REPROD, V80, P935, DOI 10.1095/biolreprod.108.073676; Neri T, 2007, CLONING STEM CELLS, V9, P394, DOI 10.1089/clo.2006.0011; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Page RL, 2009, CLONING STEM CELLS, V11, P417, DOI 10.1089/clo.2009.0015; Pomp O, 2008, BRAIN RES, V1230, P50, DOI 10.1016/j.brainres.2008.07.029; Rajasingh J, 2008, CIRC RES, V102, pE107, DOI 10.1161/CIRCRESAHA.108.176115; Ruau D, 2008, STEM CELLS, V26, P920, DOI 10.1634/stemcells.2007-0649; Rybouchkin A, 2006, BIOL REPROD, V74, P1083, DOI 10.1095/biolreprod.105.047456; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranger CK, 2005, MOL BIOL CELL, V16, P5719, DOI 10.1091/mbc.e05-06-0572; Turek-Plewa J, 2005, CELL MOL BIOL LETT, V10, P631; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wu Dongmei, 2009, J Vis Exp, DOI 10.3791/1553; Xu YN, 2009, ANAT REC, V292, P1229, DOI 10.1002/ar.20919; Zhao XY, 2010, NAT PROTOC, V5, P963, DOI 10.1038/nprot.2010.61; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	49	44	48	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12297	10.1371/journal.pone.0012297	http://dx.doi.org/10.1371/journal.pone.0012297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808872	Green Published, Green Submitted, gold			2022-12-25	WOS:000281075500024
J	Koch, M; Denzler, J; Redies, C				Koch, Michael; Denzler, Joachim; Redies, Christoph			1/f(2) Characteristics and Isotropy in the Fourier Power Spectra of Visual Art, Cartoons, Comics, Mangas, and Different Categories of Photographs	PLOS ONE			English	Article							NATURAL IMAGES; DRIP PAINTINGS; STATISTICS; SCENES; RECOGNITION; PERCEPTION; CORTEX; FACES; CELLS	Art images and natural scenes have in common that their radially averaged (1D) Fourier spectral power falls according to a power-law with increasing spatial frequency (1/f(2) characteristics), which implies that the power spectra have scale-invariant properties. In the present study, we show that other categories of man-made images, cartoons and graphic novels (comics and mangas), have similar properties. Further on, we extend our investigations to 2D power spectra. In order to determine whether the Fourier power spectra of man-made images differed from those of other categories of images (photographs of natural scenes, objects, faces and plants and scientific illustrations), we analyzed their 2D power spectra by principal component analysis. Results indicated that the first fifteen principal components allowed a partial separation of the different image categories. The differences between the image categories were studied in more detail by analyzing whether the mean power and the slope of the power gradients from low to high spatial frequencies varied across orientations in the power spectra. Mean power was generally higher in cardinal orientations both in real-world photographs and artworks, with no systematic difference between the two types of images. However, the slope of the power gradients showed a lower degree of mean variability across spectral orientations (i.e., more isotropy) in art images, cartoons and graphic novels than in photographs of comparable subject matters. Taken together, these results indicate that art images, cartoons and graphic novels possess relatively uniform 1/f(2) characteristics across all orientations. In conclusion, the man-made stimuli studied, which were presumably produced to evoke pleasant and/or enjoyable visual perception in human observers, form a subset of all images and share statistical properties in their Fourier power spectra. Whether these properties are necessary or sufficient to induce aesthetic perception remains to be investigated.	[Koch, Michael; Denzler, Joachim] Univ Jena, Dept Comp Sci, Jena, Germany; [Koch, Michael; Redies, Christoph] Univ Jena, Inst Anat 1, Sch Med, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Koch, M (corresponding author), Univ Jena, Dept Comp Sci, Jena, Germany.	redies@mti.uni-jena.de			German Research Council [RE 616/5-1]	German Research Council(German Research Foundation (DFG))	This work was supported by a grant from the German Research Council (grant number RE 616/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Ramirez J, 2008, PHYSICA A, V387, P281, DOI 10.1016/j.physa.2007.08.047; [Anonymous], 1973, LANGUAGES ART APPROA; Beauvois MW, 2007, MUSIC PERCEPT, V24, P247, DOI 10.1525/MP.2007.24.3.247; Bosworth RG, 2006, J OPT SOC AM A, V23, P2085, DOI 10.1364/JOSAA.23.002085; Burke E., 1757, PHILOS ENQUIRY ORIGI; BURTON GJ, 1987, APPL OPTICS, V26, P157, DOI 10.1364/AO.26.000157; Danto Arthur., 1981, TRANSFIGURATION COMM; Fechner G.T., 1876, VORSCHULE STHETIK; Fernandez D, 2008, PERCEPTION, V37, P1098, DOI 10.1068/p5814; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Geisler WS, 2008, ANNU REV PSYCHOL, V59, P167, DOI 10.1146/annurev.psych.58.110405.085632; Georghiades AS, 2001, IEEE T PATTERN ANAL, V23, P643, DOI 10.1109/34.927464; Graham DJ, 2008, PERCEPTION, V37, P1341, DOI 10.1068/p5971; Graham DJ, 2010, VISION RES, V50, P1503, DOI 10.1016/j.visres.2010.05.002; Graham DJ, 2008, SPATIAL VISION, V21, P149, DOI 10.1163/156856808782713771; Hansen BC, 2004, J VISION, V4, P1044, DOI 10.1167/4.12.5; Hoyer PO, 2002, NEUROCOMPUTING, V44, P459, DOI 10.1016/S0925-2312(02)00400-9; Hyvarinen A, 2009, COMPUT IMAGING VIS, V39, P1; Joye Y, 2007, REV GEN PSYCHOL, V11, P305, DOI 10.1037/1089-2680.11.4.305; Kandinsky Wassily, 1914, ART SPIRITUAL HARMON; Kant I., 1790, WERKAUSGABE ZWOLF BA; Lee A. B., 1999, P IEEE WORKSH STAT C, P1; Mahalanobis P.C., 1936, P NAT I SCI INDIA, V2, P49; Martinez A., 1998, 24 CVC; MUREIKA JR, 2005, CHAOS, P15; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; PAUL G, 1988, BEAUTY BRAIN BIOL AS, P15; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Redies C, 2007, NETWORK-COMP NEURAL, V18, P235, DOI 10.1080/09548980701574496; Redies C, 2008, SPATIAL VISION, V21, P97, DOI 10.1163/156856808782713780; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; Spehar B, 2003, COMPUT GRAPH-UK, V27, P813, DOI 10.1016/S0097-8493(03)00154-7; Taylor RP, 1999, NATURE, V399, P422, DOI 10.1038/20833; TOLHURST DJ, 1992, OPHTHAL PHYSL OPT, V12, P229, DOI 10.1111/j.1475-1313.1992.tb00296.x; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; Yu YG, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108103; Zeki S., 1999, J CONSCIOUSNESS STUD, V6, P76	45	43	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12268	10.1371/journal.pone.0012268	http://dx.doi.org/10.1371/journal.pone.0012268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808863	gold, Green Submitted, Green Published			2022-12-25	WOS:000281075500007
J	Berretta, R; Moscato, P				Berretta, Regina; Moscato, Pablo			Cancer Biomarker Discovery: The Entropic Hallmark	PLOS ONE			English	Article							METHYLACYL-COA-RACEMASE; NF-KAPPA-B; HUMAN PROSTATE-CANCER; HUMAN-MELANOMA CELLS; COENZYME-A-RACEMASE; ENDOTHELIAL GROWTH-FACTOR; METASTATIC UVEAL MELANOMA; GENE-EXPRESSION PROFILES; PELVIC LYMPH-NODES; SISTER-CHROMATID COHESION	Background: It is a commonly accepted belief that cancer cells modify their transcriptional state during the progression of the disease. We propose that the progression of cancer cells towards malignant phenotypes can be efficiently tracked using high-throughput technologies that follow the gradual changes observed in the gene expression profiles by employing Shannon's mathematical theory of communication. Methods based on Information Theory can then quantify the divergence of cancer cells' transcriptional profiles from those of normally appearing cells of the originating tissues. The relevance of the proposed methods can be evaluated using microarray datasets available in the public domain but the method is in principle applicable to other high-throughput methods. Methodology/Principal Findings: Using melanoma and prostate cancer datasets we illustrate how it is possible to employ Shannon Entropy and the Jensen-Shannon divergence to trace the transcriptional changes progression of the disease. We establish how the variations of these two measures correlate with established biomarkers of cancer progression. The Information Theory measures allow us to identify novel biomarkers for both progressive and relatively more sudden transcriptional changes leading to malignant phenotypes. At the same time, the methodology was able to validate a large number of genes and processes that seem to be implicated in the progression of melanoma and prostate cancer. Conclusions/Significance: We thus present a quantitative guiding rule, a new unifying hallmark of cancer: the cancer cell's transcriptome changes lead to measurable observed transitions of Normalized Shannon Entropy values (as measured by high-througput technologies). At the same time, tumor cells increment their divergence from the normal tissue profile increasing their disorder via creation of states that we might not directly measure. This unifying hallmark allows, via the the Jensen-Shannon divergence, to identify the arrow of time of the processes from the gene expression profiles, and helps to map the phenotypical and molecular hallmarks of specific cancer subtypes. The deep mathematical basis of the approach allows us to suggest that this principle is, hopefully, of general applicability for other diseases.	[Berretta, Regina; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia; [Berretta, Regina; Moscato, Pablo] John Hunter Hosp, Hunter Med Res Inst, Informat Based Med Program, New Lambton Hts, NSW, Australia; [Moscato, Pablo] Australian Res Council, Ctr Excellence Bioinformat, Callaghan, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle	Berretta, R (corresponding author), Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia.	Pablo.Moscato@newcastle.edu.au	MOSCATO, PABLO ALBERTO/G-7668-2013	Moscato, Pablo/0000-0003-2570-5966; Berretta, Regina/0000-0002-4420-3446	Australian Research Council (ARC) Centre of Excellence in Bioinformatics; Hunter Medical Research Institute; University of Newcastle; ARC [DP0559755, DP0773279]	Australian Research Council (ARC) Centre of Excellence in Bioinformatics(Australian Research Council); Hunter Medical Research Institute; University of Newcastle; ARC(Australian Research Council)	The authors acknowledge the support of the Australian Research Council (ARC) Centre of Excellence in Bioinformatics, Hunter Medical Research Institute, The University of Newcastle, and ARC Discovery Projects DP0559755 (Evolutionary algorithms for problems in functional genomics data analysis) and DP0773279 (Application of novel exact combinatorial optimisation techniques and metaheuristic methods for problems in cancer research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalamian-Matheis M, 2007, ADV EXP MED BIOL, V601, P173; Acehan D, 2008, J INVEST DERMATOL, V128, P2665, DOI 10.1038/jid.2008.141; Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Adami C, 2000, P NATL ACAD SCI USA, V97, P4463, DOI 10.1073/pnas.97.9.4463; Adamsen BL, 2007, INT J ONCOL, V31, P1491; Agalliu I, 2007, BRIT J CANCER, V97, P826, DOI 10.1038/sj.bjc.6603929; Agarwal R, 2006, ANTICANCER RES, V26, P4457; Aghaei M, 2005, CLIN BIOCHEM, V38, P887, DOI 10.1016/j.clinbiochem.2005.05.015; Agre P, 1996, NEPHROLOGIE, V17, P409; Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; AGRE P, 1993, AM J PHYSIOL, V265, pF463; AGRE P, 1995, TRANSFUS CLIN BIOL, V2, P303, DOI 10.1016/S1246-7820(05)80096-5; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; ALCAIDE JRC, 2006, CLIN TRANSL ONCOL, V8, P148; Alcaraz A, 2001, PROSTATE, V47, P29; Allavena P, 2008, CURR OPIN GENET DEV, V18, P3, DOI 10.1016/j.gde.2008.01.003; Alonso SR, 2007, CANCER RES, V67, P3450, DOI 10.1158/0008-5472.CAN-06-3481; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; ANDREYEV NI, 1969, CORRELATION THEORY S; Arabzadeh A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-196; ARBITRARIO JP, 2009, CANC CHEMOTHER PHARM; Armstrong K, 2006, PROSTATE, V66, P1223, DOI 10.1002/pros.20376; Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020; Azzone GF, 1997, HIST PHIL LIFE SCI, V19, P163; Babiker AA, 2005, PROSTATE, V62, P105, DOI 10.1002/pros.20102; Babiker AA, 2002, AM J REPROD IMMUNOL, V47, P183, DOI 10.1034/j.1600-0897.2002.1o023.x; BACHMANN IM, 2008, BMC CANCER, V362, P3; Bae I, 2005, CELL CYCLE, V4, P1641, DOI 10.4161/cc.4.11.2152; Bagri A, 2009, CLIN CANCER RES, V15, P1860, DOI 10.1158/1078-0432.CCR-08-0563; Bahamontes-Rosa N, 2008, TRANSFUSION, V48, P1164, DOI 10.1111/j.1537-2995.2008.01683.x; Bai F, 2006, MOL CELL BIOL, V26, P4564, DOI 10.1128/MCB.00266-06; Bakhanashvili M, 2008, CELL DEATH DIFFER, V15, P1865, DOI 10.1038/cdd.2008.122; Balbin A, 2004, ACTA BIOTHEOR, V52, P173, DOI 10.1023/B:ACBI.0000043441.74099.0c; BALLAL RD, 2009, J BIOL CHEM; Bantis A, 2005, J EXP CLIN CANC RES, V24, P273; Barak V, 2007, ANTICANCER RES, V27, P1897; Bartkova J, 2003, APMIS, V111, P252, DOI 10.1034/j.1600-0463.2003.1110129.x; Bastide C, 2009, EJSO-EUR J SURG ONC, V35, P751, DOI 10.1016/j.ejso.2008.04.007; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Beitz Eric, 2009, Handb Exp Pharmacol, P77, DOI 10.1007/978-3-540-79885-9_4; Ben-Naim A., 2008, FAREWELL ENTROPY STA; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Benga G, 2006, CELL MOL BIOL, V52, P10, DOI 10.1170/T744; Berretta R, 2007, J RES PRACT INF TECH, V39, P287; BERTHON P, 1995, BRIT J CANCER, V72, P946, DOI 10.1038/bjc.1995.439; Bettendorf O, 2008, GENE CHROMOSOME CANC, V47, P565, DOI 10.1002/gcc.20560; Bhanot Gyan, 2005, Genome Inform, V16, P233; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Birnie R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r83; BISHOFF JT, 1995, UROLOGY, V45, P270, DOI 10.1016/0090-4295(95)80017-4; Blagosklonny MV, 2005, CANCER BIOL THER, V4, P621, DOI 10.4161/cbt.4.6.1818; Blandino G, 2004, CELL CYCLE, V3, P886; Blank ME, 2003, J PHYSIOL-LONDON, V550, P419, DOI 10.1113/jphysiol.2003.040113; Boguslavsky RL, 2006, HUM MOL GENET, V15, P653, DOI 10.1093/hmg/ddi480; Bolander A, 2007, ANTICANCER RES, V27, P3211; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Bonetto F, 1998, CHAOS, V8, P823, DOI 10.1063/1.166369; Bonn D, 2002, LANCET ONCOL, V3, P3, DOI 10.1016/S1470-2045(01)00603-9; Boralevi F, 2005, BRIT J DERMATOL, V153, P310, DOI 10.1111/j.1365-2133.2005.06664.x; BORDONI R, 1990, J CELL BIOCHEM, V44, P207, DOI 10.1002/jcb.240440403; Boukamp P, 1999, ONCOGENE, V18, P5638, DOI 10.1038/sj.onc.1202934; Boury-Jamot M, 2006, BBA-BIOMEMBRANES, V1758, P1034, DOI 10.1016/j.bbamem.2006.06.013; Boury-Jamot Mathieu, 2009, Handb Exp Pharmacol, P205, DOI 10.1007/978-3-540-79885-9_10; Brandner J. M., 2007, International Journal of Cosmetic Science, V29, P413, DOI 10.1111/j.1468-2494.2007.00402.x; Brey JJ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.011305; Bridger JM, 2007, FEBS J, V274, P1354, DOI 10.1111/j.1742-4658.2007.05694.x; Brinck U, 2002, INT J MOL MED, V10, P707; Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295; BROWN LF, 1994, AM J PATHOL, V145, P610; Brychtova S, 2008, NEOPLASMA, V55, P273; Bu YQ, 2008, ONCOLOGY-BASEL, V74, P198, DOI 10.1159/000151367; Buback F, 2009, EXP DERMATOL, V18, P750, DOI 10.1111/j.1600-0625.2009.00926.x; Buchanan G, 2007, CANCER RES, V67, P10087, DOI 10.1158/0008-5472.CAN-07-1646; Buhmeida A, 2006, DIAGN PATHOL, V1, DOI 10.1186/1746-1596-1-4; Burykin A, 2003, BIOPHYS J, V85, P3696, DOI 10.1016/S0006-3495(03)74786-9; Butler JS, 2006, PROTEIN SCI, V15, P2457, DOI 10.1110/ps.062324206; Butler JS, 2005, J MOL BIOL, V350, P906, DOI 10.1016/j.jmb.2005.05.060; Buxade M, 2008, J BIOL CHEM, V283, P57, DOI 10.1074/jbc.M705286200; Cabuy E, 2008, CYTOGENET GENOME RES, V122, P336, DOI 10.1159/000167820; Cai Y, 2008, INT J CANCER, V123, P195, DOI 10.1002/ijc.23481; Caino MC, 2009, APOPTOSIS, V14, P392, DOI 10.1007/s10495-009-0316-z; Camargo JA, 2008, ACTA BIOTHEOR, V56, P275, DOI 10.1007/s10441-008-9053-x; CANBOLAT O, 1994, J LARYNGOL OTOL, V108, P849, DOI 10.1017/S0022215100128300; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Cao C, 2008, J CELL PHYSIOL, V215, P506, DOI 10.1002/jcp.21336; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; Cardinale S, 2007, MOL BIOL CELL, V18, P1282, DOI 10.1091/mbc.E06-09-0846; Carlsson L, 2006, INT J ANDROL, V29, P331, DOI 10.1111/j.1365-2605.2005.00601.x; Casalini R, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2728898; Castro MAA, 2005, J THEOR BIOL, V234, P487, DOI 10.1016/j.jtbi.2004.12.006; CAVES CM, 1990, PHYS REV LETT, V64, P2111, DOI 10.1103/PhysRevLett.64.2111; CAVES CM, 1990, PHYS REV LETT, V65, P1387, DOI 10.1103/PhysRevLett.65.1387; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chang PL, 2008, J HISTOCHEM CYTOCHEM, V56, P57, DOI 10.1369/jhc.7A7325.2007; Chao YC, 2009, AM J RESP CRIT CARE, V179, P123, DOI 10.1164/rccm.200803-456OC; Chekmareva MA, 1997, PROSTATE, V33, P271; Chellaiah M, 1996, ENDOCRINOLOGY, V137, P2432, DOI 10.1210/en.137.6.2432; Chellaiah MA, 1998, DRUG NEWS PERSPECT, V11, P350, DOI 10.1358/dnp.1998.11.6.863656; Chen HN, 2007, BIOPHYS J, V92, P46, DOI 10.1529/biophysj.106.091934; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Chen WW, 2009, MOL BIOL REP, V36, P423, DOI 10.1007/s11033-007-9196-x; Chen XB, 1999, MOL MED TODAY, V5, P387, DOI 10.1016/S1357-4310(99)01545-2; Cheng L, 2005, J UROLOGY, V174, P2181, DOI 10.1097/01.ju.0000181215.41607.c3; Cheng X, 2004, MOL CELL BIOL, V24, P154, DOI 10.1128/MCB.24.1.154-163.2004; Chetcuti A, 2001, PROSTATE, V47, P132, DOI 10.1002/pros.1056; Cheung ALM, 2008, FRONT BIOSCI-LANDMRK, V13, P2075, DOI 10.2741/2825; Cheville JC, 2008, J CLIN ONCOL, V26, P3930, DOI 10.1200/JCO.2007.15.6752; Ciavarra RP, 2003, CANCER IMMUNOL IMMUN, V52, P535, DOI 10.1007/s00262-003-0383-x; Ciavarra RP, 2004, J IMMUNOTHER, V27, P13, DOI 10.1097/00002371-200401000-00002; Cimitan M, 2006, EUR J NUCL MED MOL I, V33, P1387, DOI 10.1007/s00259-006-0150-2; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Clark JP, 2009, NAT REV UROL, V6, P429, DOI 10.1038/nrurol.2009.127; Clarke LE, 2009, J CUTAN PATHOL, V36, P433, DOI 10.1111/j.1600-0560.2008.01077.x; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Cosme-Blanco W, 2008, EXP CELL RES, V314, P1973, DOI 10.1016/j.yexcr.2008.03.011; COSSUROCCA P, 2009, AM J SURG PATHOL; CRAIG AM, 1990, INT J CANCER, V46, P133, DOI 10.1002/ijc.2910460124; Craig M, 2008, J CELL BIOCHEM, V103, P1, DOI 10.1002/jcb.21379; Craven RA, 2004, PROTEOMICS, V4, P3998, DOI 10.1002/pmic.200400870; Crooks GE, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.100602; Cummins JM, 2006, ONCOGENE, V25, P6220, DOI 10.1038/sj.onc.1209914; Cybulski C, 2008, EUR J CANCER PREV, V17, P62, DOI 10.1097/CEJ.0b013e32809b4d20; Daley GQ, 2008, COLD SH Q B, V73, P171, DOI 10.1101/sqb.2008.73.041; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; Darley DJ, 2009, ORG BIOMOL CHEM, V7, P543, DOI 10.1039/b815396e; Das R, 2005, IUBMB LIFE, V57, P441, DOI 10.1080/15216540500159424; Das S, 2009, J BIOL CHEM, V284, P22888, DOI 10.1074/jbc.M109.021949; Das S, 2007, PROSTATE, V67, P1550, DOI 10.1002/pros.20640; de Baey A, 2000, J EXP MED, V191, P743, DOI 10.1084/jem.191.4.743; de Groot BL, 2003, J MOL BIOL, V333, P279, DOI 10.1016/j.jmb.2003.08.003; DEMEIS L, 1992, ANN NY ACAD SCI, V671, P19; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; DENHAM JW, 2008, RADIOTHER ONCOL; Denhardt D, 2005, J INVEST DERMATOL, V124, pXVI, DOI 10.1111/j.0022-202X.2005.23708.x; Desrosiers MD, 2007, J IMMUNOL, V179, P1884, DOI 10.4049/jimmunol.179.3.1884; Dettwiler S, 2004, J BIOL CHEM, V279, P35788, DOI 10.1074/jbc.M403927200; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; Dhawan P, 2002, J BIOL CHEM, V277, P7920, DOI 10.1074/jbc.M112210200; Di Cesare Sebastian, 2007, J Carcinog, V6, P2, DOI 10.1186/1477-3163-6-2; Diaz-Martinez LA, 2007, CELL CYCLE, V6, P714, DOI 10.4161/cc.6.6.3935; DIMITROV BD, 1993, MED HYPOTHESES, V41, P425, DOI 10.1016/0306-9877(93)90119-B; DING GF, 2009, UROL ONCOL; Dobson Roger, 2008, BMJ, V337, pa705, DOI 10.1136/bmj.a705; Dodin IY, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046602; Dong XS, 2005, J BIOL CHEM, V280, P13329, DOI 10.1074/jbc.M409187200; Dong XS, 2007, MOL CELL BIOL, V27, P4863, DOI 10.1128/MCB.02144-06; Donin N, 2003, CLIN EXP IMMUNOL, V131, P254, DOI 10.1046/j.1365-2249.2003.02066.x; Doratiotto S, 2009, HISTOL HISTOPATHOL, V24, P101, DOI 10.14670/HH-24.101; Dotan ZA, 2004, INT J CANCER, V111, P60, DOI 10.1002/ijc.20237; Douglas JA, 2007, CANCER EPIDEM BIOMAR, V16, P1510, DOI 10.1158/1055-9965.EPI-07-0137; Drewa T, 2008, PROSTATE CANCER P D, V11, P88, DOI 10.1038/sj.pcan.4500978; Dudley AC, 2008, CANCER CELL, V14, P201, DOI 10.1016/j.ccr.2008.06.017; Duesberg P, 2005, CELL ONCOL, V27, P293; Duesberg P, 1998, P NATL ACAD SCI USA, V95, P13692, DOI 10.1073/pnas.95.23.13692; Duesberg P, 2007, SCI AM, V296, P52, DOI 10.1038/scientificamerican0507-52; Duff MD, 2007, J SURG RES, V142, P119, DOI 10.1016/j.jss.2006.12.542; Dumas Marc, 2007, J Drugs Dermatol, V6, ps20; Dundr M, 2002, MOL CELL, V9, P5, DOI 10.1016/S1097-2765(02)00433-1; Dunsmuir WD, 2000, BJU INT, V86, P869, DOI 10.1046/j.1464-410x.2000.00916.x; Dzojic H, 2006, PROSTATE, V66, P831, DOI 10.1002/pros.20344; Ecke TH, 2007, ANTICANCER RES, V27, P4143; Edwards J, 2004, J PATHOL, V204, P153, DOI 10.1002/path.1605; Edwards SM, 2004, AM J MED GENET C, V129C, P65, DOI 10.1002/ajmg.c.30027; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; Ehlers JP, 2008, CLIN CANCER RES, V14, P115, DOI 10.1158/1078-0432.CCR-07-1825; Ekdahl KN, 2006, ADV EXP MED BIOL, V586, P107; Eroglu A, 2000, MED ONCOL, V17, P319, DOI 10.1007/BF02782198; Ersoy-Evans S, 2006, J AM ACAD DERMATOL, V55, P157, DOI 10.1016/j.jaad.2005.10.002; Esteller M, 2005, ANNU REV PHARMACOL, V45, P629, DOI 10.1146/annurev.pharmtox.45.120403.095832; Estler M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-478; Fabarius A, 2003, CANCER GENET CYTOGEN, V143, P59, DOI 10.1016/S0165-4608(03)00003-7; Fabbri M, 2008, CURR OPIN INVEST DR, V9, P583; Fachin AL, 2009, J RADIAT RES, V50, P61, DOI 10.1269/jrr.08034; Fagiani E, 2007, CANCER RES, V67, P3064, DOI 10.1158/0008-5472.CAN-06-2301; Fan SJ, 2001, ONCOGENE, V20, P77, DOI 10.1038/sj.onc.1204073; Fang JS, 2008, SEMIN CANCER BIOL, V18, P330, DOI 10.1016/j.semcancer.2008.03.011; Fellenberg J, 2007, MODERN PATHOL, V20, P1085, DOI 10.1038/modpathol.3800937; Feng EH, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.090602; Feng EH, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.012104; Ficazzola MA, 2001, CARCINOGENESIS, V22, P1271, DOI 10.1093/carcin/22.8.1271; Finlan LE, 2006, CELL CYCLE, V5, P2489, DOI 10.4161/cc.5.21.3393; Fisch NJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.205004; Flannery E, 2009, CURR DRUG TARGETS, V10, P611, DOI 10.2174/138945009788680383; Forget A, 2008, CELL CYCLE, V7, P3737, DOI 10.4161/cc.7.23.7187; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Fox RJ, 2005, NAT CLIN PRACT NEURO, V1, P16, DOI 10.1038/ncpneuro0041; Fradet V, 2004, CLIN CANCER RES, V10, P8460, DOI 10.1158/1078-0432.CCR-04-0764; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; French JD, 2006, GENE CHROMOSOME CANC, V45, P277, DOI 10.1002/gcc.20290; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Fu D, 2007, MOL MEMBR BIOL, V24, P366, DOI 10.1080/09687680701446965; Fujita A, 2009, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-106; Fujita K, 2009, CANCER SCI, V100, P1047, DOI 10.1111/j.1349-7006.2009.01146.x; Fukunaga-Kalabis M, 2008, ONCOGENE, V27, P2552, DOI 10.1038/sj.onc.1210896; Fukunaga-Kalabis M, 2008, CANCER MICROENVIRON, V1, P93, DOI 10.1007/s12307-008-0009-0; Furuno M, 2006, PLOS GENET, V2, P537, DOI 10.1371/journal.pgen.0020037; Gade Wayne, 2006, Clin Lab Sci, V19, P70; Gagos S, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-20; Gallagher PG, 2005, CANCER RES, V65, P4134, DOI 10.1158/0008-5472.CAN-04-0415; GALLUZZI L, 2009, MOL ASPECTS MED; Gao B, 2001, FEBS LETT, V488, P179, DOI 10.1016/S0014-5793(00)02430-3; Gartel AL, 2008, SEMIN CANCER BIOL, V18, P103, DOI 10.1016/j.semcancer.2008.01.008; Geirsson A, 2004, J HEART LUNG TRANSPL, V23, P1077, DOI 10.1016/j.healun.2004.07.020; Geirsson A, 2003, TRANSPLANTATION, V76, P387, DOI 10.1097/01.TP.0000073612.04525.46; Geirsson A, 2003, BIOCHEM BIOPH RES CO, V301, P718, DOI 10.1016/S0006-291X(03)00028-7; Geissinger E, 2002, CANCER RES, V62, P4820; Ghani KR, 2005, EUR UROL, V47, P196, DOI 10.1016/j.eururo.2004.07.029; Ghosh S, 2005, J CELL PHYSIOL, V204, P522, DOI 10.1002/jcp.20320; Gilbert M, 2000, J BIOL CHEM, V275, P16213, DOI 10.1074/jbc.M001773200; Gille J, 2007, INT J CANCER, V120, P1899, DOI 10.1002/ijc.22531; Gilley D, 2005, INT J BIOCHEM CELL B, V37, P1000, DOI 10.1016/j.biocel.2004.09.003; Gilmore BF, 2006, BIOCHEM BIOPH RES CO, V346, P436, DOI 10.1016/j.bbrc.2006.05.175; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125; Glinsky GV, 2008, J CLIN ONCOL, V26, P2846, DOI 10.1200/JCO.2008.17.0266; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Godsel LM, 2005, J CELL BIOL, V171, P1045, DOI 10.1083/jcb.200510038; GONCALVES BF, 2009, EXP MOL PATHOL; Graells J, 2004, J INVEST DERMATOL, V123, P1151, DOI 10.1111/j.0022-202X.2004.23460.x; Graeven U, 2000, J INVEST DERMATOL, V115, P118, DOI 10.1046/j.1523-1747.2000.00022.x; Gray CP, 2003, CLIN CANCER RES, V9, P2551; Gray CP, 2002, BLOOD, V99, P3326, DOI 10.1182/blood.V99.9.3326; Gray CP, 2001, INT J CANCER, V92, P843, DOI 10.1002/ijc.1269; Gray PJ, 2004, MOL CANCER THER, V3, P641; Grignon DJ, 1997, JNCI-J NATL CANCER I, V89, P158, DOI 10.1093/jnci/89.2.158; Gronberg H, 2001, GENE CHROMOSOME CANC, V30, P299; Grosse I, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041905; Grossmann ME, 2001, J IMMUNOTHER, V24, P237, DOI 10.1097/00002371-200105000-00007; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Gumerlock PH, 1997, J NATL CANCER I, V89, P66, DOI 10.1093/jnci/89.1.66; Gunia S, 2009, VIRCHOWS ARCH, V454, P573, DOI 10.1007/s00428-009-0759-1; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Haghnegahdar H, 2000, J LEUKOCYTE BIOL, V67, P53, DOI 10.1002/jlb.67.1.53; HAINAUT P, 1995, BRIT J CANCER, V71, P227, DOI 10.1038/bjc.1995.48; Halaban R, 2000, J EXP MED, V191, P1005, DOI 10.1084/jem.191.6.1005; HALSEY MA, 2009, J CUTAN PATHOL; Hanada S, 2008, J PATHOL, V216, P75, DOI 10.1002/path.2383; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hansel DE, 2009, PROSTATE, V69, P603, DOI 10.1002/pros.20910; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Hara-Chikuma M, 2006, CELL MOL LIFE SCI, V63, P1386, DOI 10.1007/s00018-006-6028-4; Hara-Chikuma M, 2008, J INVEST DERMATOL, V128, P2145, DOI 10.1038/jid.2008.70; Hara-Chikuma M, 2008, J MOL MED-JMM, V86, P221, DOI 10.1007/s00109-007-0272-4; Hara-Chikuma M, 2008, MOL CELL BIOL, V28, P326, DOI 10.1128/MCB.01482-07; Harant H, 2000, J CELL BIOCHEM, V78, P112, DOI 10.1002/(SICI)1097-4644(20000701)78:1<112::AID-JCB10>3.0.CO;2-7; Haritoglou I, 2009, OPHTHALMOLOGICA, V223, P239, DOI 10.1159/000206139; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Hatzfeld M, 2000, J CELL BIOL, V149, P209, DOI 10.1083/jcb.149.1.209; Hatzfeld M, 2007, BBA-MOL CELL RES, V1773, P69, DOI 10.1016/j.bbamcr.2006.04.009; Hauptmann S, 2002, MED HYPOTHESES, V58, P144, DOI 10.1054/mehy.2001.1477; Hayashi C, 2007, J CELL BIOCHEM, V101, P979, DOI 10.1002/jcb.21298; Heenen M, 2003, ANN DERMATOL VENER, V130, P1025; Hegele RA, 2007, EXP CELL RES, V313, P2134, DOI 10.1016/j.yexcr.2007.03.023; Herrmann JL, 1997, EXP CELL RES, V237, P101, DOI 10.1006/excr.1997.3737; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Ho SM, 2006, ANN NY ACAD SCI, V1089, P177, DOI 10.1196/annals.1386.005; Hoevel T, 2004, INT J CANCER, V108, P374, DOI 10.1002/ijc.11571; Hoffmann KH, 2003, J NON-EQUIL THERMODY, V28, P233, DOI 10.1515/JNETDY.2003.015; Hornig C, 2000, LAB INVEST, V80, P443, DOI 10.1038/labinvest.3780050; Horsburgh S, 2005, PROSTATE, V65, P124, DOI 10.1002/pros.20278; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Huang CZ, 2008, J DERMATOL SCI, V52, P130, DOI 10.1016/j.jdermsci.2008.05.006; Huang XY, 2008, MOL CANCER THER, V7, P1624, DOI 10.1158/1535-7163.MCT-07-2134; Hub Jochen S, 2009, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-540-79885-9_3; Huerta-Yepez S, 2006, CLIN IMMUNOL, V120, P297, DOI 10.1016/j.clim.2006.03.015; Hugel A, 1999, BRIT J CANCER, V79, P551, DOI 10.1038/sj.bjc.6690087; Hussein N G, 1998, J Egypt Public Health Assoc, V73, P97; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Hutchison CJ, 2004, NAT CELL BIOL, V6, P1062, DOI 10.1038/ncb1104-1062; Inoue A, 2008, BIOL CELL, V100, P523, DOI 10.1042/BC20070142; ISAACS WB, 1995, CANCER SURV, V23, P19; ISHIBASHI K, 2008, CLIN EXP NEPHROL; Ishitani K, 2003, BIOCHEM BIOPH RES CO, V306, P660, DOI 10.1016/S0006-291X(03)01021-0; Ishiyama T, 2007, CANCER SCI, V98, P50, DOI 10.1111/j.1349-7006.2006.00346.x; Isidoro A, 2004, BIOCHEM J, V378, P17, DOI 10.1042/BJ20031541; Ismail M, 2009, BRIT J CANCER, V100, P1889, DOI 10.1038/sj.bjc.6605093; Ito Y, 2005, PATHOBIOLOGY, V72, P186, DOI 10.1159/000086788; Itzhaki O, 2008, EXP GERONTOL, V43, P164, DOI 10.1016/j.exger.2007.12.007; Ivorra' C, 2006, GENE DEV, V20, P307, DOI 10.1101/gad.349506; Jaeger J, 2007, CLIN CANCER RES, V13, P806, DOI 10.1158/1078-0432.CCR-06-1820; JAMASPISHVILI T, 2009, PROSTATE CANC PROSTA; Jang A, 1997, CLIN EXP METASTAS, V15, P469, DOI 10.1023/A:1018470709523; Jarvis GA, 1997, INT J CANCER, V71, P1049, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1049::AID-IJC22>3.0.CO;2-7; Javelaud D, 2007, CANCER RES, V67, P2317, DOI 10.1158/0008-5472.CAN-06-3950; Jhavar S, 2009, PROSTATE CANCER P D, V12, P143, DOI 10.1038/pcan.2008.47; JHAVAR S, 2008, PROSTATE CANC PROSTA; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Jiang Z, 2004, AM J CLIN PATHOL, V122, P275, DOI 10.1309/EJUYUQPEX1MG68MK; Jiang Z, 2004, ADV ANAT PATHOL, V11, P316, DOI 10.1097/01.pap.0000146924.14246.be; Jiang Z, 2005, AM J CLIN PATHOL, V123, P231, DOI 10.1309/1G1NK9DBGFNB792L; Jiang Z, 2003, HUM PATHOL, V34, P792, DOI 10.1016/S0046-8177(03)00268-5; Jiang Z, 2004, HISTOPATHOLOGY, V45, P218, DOI 10.1111/j.1365-2559.2004.01930.x; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Johnson J, 2005, J INVEST DERMATOL, V125, P857, DOI 10.1111/j.0022-202X.2004.23920.x; Judge AD, 2009, J CLIN INVEST, V119, P661, DOI 10.1172/JCI37515; Kadkol SS, 2006, INVEST OPHTH VIS SCI, V47, P802, DOI 10.1167/iovs.05-0422; Kaic G, 2009, DIAGN CYTOPATHOL, V37, P803, DOI 10.1002/dc.21103; Kalcioglu M Tayyar, 2004, Kulak Burun Bogaz Ihtis Derg, V12, P16; Kami K, 2009, J MOL BIOL, V386, P531, DOI 10.1016/j.jmb.2008.12.054; Kang SK, 2008, AM J PATHOL, V173, P518, DOI 10.2353/ajpath.2008.071198; Karaivanov M, 2007, J MOL HISTOL, V38, P1, DOI 10.1007/s10735-006-9070-5; Karakiewicz PI, 2006, EUR UROL, V50, P218, DOI 10.1016/j.eururo.2006.05.009; Karam JA, 2008, CLIN CANCER RES, V14, P1418, DOI 10.1158/1078-0432.CCR-07-0901; Kashani-Sabet M, 2009, P NATL ACAD SCI USA, V106, P6268, DOI 10.1073/pnas.0901185106; Kasuno K, 2007, CELL DEATH DIFFER, V14, P1414, DOI 10.1038/sj.cdd.4402131; KATAGIRI Y, 1995, ANN NY ACAD SCI, V760, P371, DOI 10.1111/j.1749-6632.1995.tb44660.x; Katagiri YU, 1996, J CELL BIOCHEM, V62, P123, DOI 10.1002/(SICI)1097-4644(199607)62:1<123::AID-JCB13>3.0.CO;2-O; Kato M, 2006, PROTEINS, V64, P829, DOI 10.1002/prot.21012; Katoh M, 2007, INT J MOL MED, V20, P405; Kaufmann WK, 2008, J INVEST DERMATOL, V128, P175, DOI 10.1038/sj.jid.5700935; Kehinde EO, 2008, CAN J UROL, V15, P3967; Kida H, 2005, J MEMBRANE BIOL, V208, P55, DOI 10.1007/s00232-005-0819-7; Kikuchi E, 2003, CANCER RES, V63, P107; Kinoshita M, 2005, INT J UROL, V12, P390, DOI 10.1111/j.1442-2042.2005.01093.x; Klimek R, 2001, NEUROENDOCRINOL LETT, V22, P413; KLIMEK R, 1990, EUR J OBSTET GYN R B, V36, P229, DOI 10.1016/0028-2243(90)90202-C; Kneisel L, 2002, J CUTAN PATHOL, V29, P354, DOI 10.1034/j.1600-0560.2002.290605.x; Ko YJ, 2008, PROTEINS, V70, P1442, DOI 10.1002/prot.21696; Koivisto P, 1997, PROSTATE CANCER P D, V1, P21, DOI 10.1038/sj.pcan.4500200; KOLLARA A, 2009, J STEROID BIOCH MOL; KONG SL, 2009, VIRUS RES; Konig PH, 2006, J PHYS CHEM A, V110, P548, DOI 10.1021/jp052328q; Konishi N, 2008, CLIN CANCER RES, V14, P4408, DOI 10.1158/1078-0432.CCR-07-4120; Korabiowska M, 2000, ANTICANCER RES, V20, P2791; Koynova DK, 2007, MELANOMA RES, V17, P37, DOI 10.1097/CMR.0b013e3280141617; Kozuka Yuji, 2005, Nihon Rinsho, V63, P231; Krause FS, 2005, ANTICANCER RES, V25, P1783; Kristiansen G, 2008, BRIT J CANCER, V99, P939, DOI 10.1038/sj.bjc.6604614; KRISTIANSEN G, 2009, PATHOLOGE; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kroepfl I, 2006, BJU INT, V97, P985, DOI 10.1111/j.1464-410X.2006.06129.x; Kruse E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-206; Kube DM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-25; Kuchel PW, 2006, CELL MOL BIOL, V52, P2, DOI 10.1170/T741; Kuefer R, 2002, AM J PATHOL, V161, P841, DOI 10.1016/S0002-9440(10)64244-7; Kulesz-Martin M, 2005, J INVEST DERM SYMP P, V10, P142, DOI 10.1111/j.1087-0024.2005.200405.x; Kumagai K, 2006, INVEST OPHTH VIS SCI, V47, P2300, DOI 10.1167/iovs.05-0810; Kumanov A, 2007, FOLIA HISTOCHEM CYTO, V45, P75; Kumar-Sinha C, 2004, AM J PATHOL, V164, P787, DOI 10.1016/S0002-9440(10)63167-7; Kunju LP, 2005, HISTOPATHOLOGY, V47, P587, DOI 10.1111/j.1365-2559.2005.02281.x; Kusumi T, 2008, PATHOL INT, V58, P687, DOI 10.1111/j.1440-1827.2008.02294.x; Kuwahara S, 2006, BIOL REPROD, V75, P352, DOI 10.1095/biolreprod.106.051136; Kwon O, 2006, CARCINOGENESIS, V27, P2258, DOI 10.1093/carcin/bgl097; KYLE S, 2008, BR J RADIOL, V81; Lacal PM, 2005, INT J ONCOL, V27, P1625; Lacal PM, 2000, J INVEST DERMATOL, V115, P1000, DOI 10.1046/j.1523-1747.2000.00199.x; Lai YL, 2004, BIOINFORMATICS, V20, P3146, DOI 10.1093/bioinformatics/bth379; Lai-Cheong JE, 2007, J INVEST DERMATOL, V127, P2713, DOI 10.1038/sj.jid.5700727; Lamberti PW, 2004, PHYSICA A, V334, P119, DOI 10.1016/j.physa.2003.11.005; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Landreville S, 2008, FUTURE ONCOL, V4, P629, DOI 10.2217/14796694.4.5.629; LANDSBERG PT, 1984, PHYS LETT A, V102, P171, DOI 10.1016/0375-9601(84)90934-4; Langer F, 2007, THROMB HAEMOSTASIS, V97, P464, DOI 10.1160/TH06-09-0523; Langner C, 2006, VIRCHOWS ARCH, V448, P325, DOI 10.1007/s00428-005-0129-6; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lapteva N, 2007, CANCER RES, V67, P10528, DOI 10.1158/0008-5472.CAN-07-0833; Laski ME, 2006, SEMIN NEPHROL, V26, P189, DOI 10.1016/j.semnephrol.2006.03.002; Leav I, 2003, HUM PATHOL, V34, P228, DOI 10.1053/hupa.2003.42; Lee DK, 2000, J BIOL CHEM, V275, P9308, DOI 10.1074/jbc.275.13.9308; Lee HC, 2009, INT J MOL SCI, V10, P674, DOI 10.3390/ijms10020674; Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426; Lee JH, 2008, J BIOL CHEM, V283, P19826, DOI 10.1074/jbc.M706201200; Lee MY, 2008, CELL CYCLE, V7, P2705, DOI 10.4161/cc.7.17.6551; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Lee WK, 2006, AM J PHYSIOL-CELL PH, V291, pC195, DOI 10.1152/ajpcell.00641.2005; LEFF HS, 1990, MAXWELLS DEMON; Lei M, 2008, ONCOGENE, V27, P3935, DOI 10.1038/onc.2008.36; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Lessard L, 2007, CELL SIGNAL, V19, P1093, DOI 10.1016/j.cellsig.2006.12.012; Levin AM, 2007, PROSTATE, V67, P1507, DOI 10.1002/pros.20642; Lewis TB, 2005, CANCER-AM CANCER SOC, V104, P1678, DOI 10.1002/cncr.21372; Li HZ, 2007, INT J ONCOL, V31, P537; Li L, 2009, P NATL ACAD SCI USA, V106, P12956, DOI 10.1073/pnas.0906005106; Li X, 2009, CANCER RES, V69, P1685, DOI 10.1158/0008-5472.CAN-08-2164; Licchesi JDF, 2008, CLIN CANCER RES, V14, P2570, DOI 10.1158/1078-0432.CCR-07-2033; Lim IK, 2006, J CANCER RES CLIN, V132, P417, DOI 10.1007/s00432-006-0080-1; Lim YB, 2008, J BIOL CHEM, V283, P33110, DOI 10.1074/jbc.M804255200; Lin EY, 1999, PLAST RECONSTR SURG, V104, P1666, DOI 10.1097/00006534-199911000-00009; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Lin SH, 2004, ONCOGENE, V23, P2499, DOI 10.1038/sj.onc.1207343; Linden J, 2006, AM J PHYSIOL-CELL PH, V291, pC405, DOI 10.1152/ajpcell.00242.2006; Ling MT, 2003, ONCOGENE, V22, P4498, DOI 10.1038/sj.onc.1206693; Lisovsky M, 2006, HUM PATHOL, V37, P1601, DOI 10.1016/j.humpath.2006.06.009; Litman Thomas, 2009, Handb Exp Pharmacol, P327, DOI 10.1007/978-3-540-79885-9_17; Liu Ai-jun, 2007, Journal of Zhejiang University-Science B, V8, P853, DOI 10.1631/jzus.2007.B0853; Liu H, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-18; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Liu YL, 2007, HUM PATHOL, V38, P171, DOI 10.1016/j.humpath.2006.07.015; Liu YJ, 2007, P NATL ACAD SCI USA, V104, P12560, DOI 10.1073/pnas.0705313104; Liu Ying-na, 2006, Zhonghua Bing Li Xue Za Zhi, V35, P417; LIZCANO JM, 1990, J NEUR TR S, P323; Lloyd MD, 2008, FEBS J, V275, P1089, DOI 10.1111/j.1742-4658.2008.06290.x; Loberg RD, 2007, CANCER RES, V67, P9417, DOI 10.1158/0008-5472.CAN-07-1286; Loberg RD, 2007, NEOPLASIA, V9, P556, DOI 10.1593/neo.07307; Loberg RD, 2007, J CELL BIOCHEM, V101, P1292, DOI 10.1002/jcb.21252; Loberg RD, 2006, NEOPLASIA, V8, P578, DOI 10.1593/neo.06280; Lodygin D, 2005, CANCER RES, V65, P4218, DOI 10.1158/0008-5472.CAN-04-4407; LopezRuiz R, 1995, PHYS LETT A, V209, P321, DOI 10.1016/0375-9601(95)00867-5; LU Q, 2008, PROSTATE; Lu Y, 2007, INT J CANCER, V121, P724, DOI 10.1002/ijc.22704; Lu Y, 2007, CANCER RES, V67, P3646, DOI 10.1158/0008-5472.CAN-06-1210; Lundqvist A, 2005, J IMMUNOTHER, V28, P229, DOI 10.1097/01.cji.0000158854.15664.c2; Luo J, 2003, PROSTATE, V57, P134, DOI 10.1002/pros.10284; Luo J, 2002, CANCER RES, V62, P2220; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Luo JH, 2006, HEPATOLOGY, V44, P1012, DOI 10.1002/hep.21328; Ma TH, 2000, P NATL ACAD SCI USA, V97, P4386, DOI 10.1073/pnas.080499597; Maeda Norikazu, 2009, Handb Exp Pharmacol, P233, DOI 10.1007/978-3-540-79885-9_12; Magi-Galluzzi C, 2003, AM J SURG PATHOL, V27, P1128, DOI 10.1097/00000478-200308000-00010; Magi-Galluzzi C, 2007, CANCER-AM CANCER SOC, V110, P1248, DOI 10.1002/cncr.22897; Makarov DV, 2009, ANNU REV MED, V60, P139, DOI 10.1146/annurev.med.60.042307.110714; MAKAROV DV, 2008, ANN REV MED; MAKOVETS S, 2009, NAT CELL BIOL; Malmstrom PU, 2005, ACTA ONCOL, V44, P593, DOI 10.1080/02841860510029626; Mandelin J, 2009, CANCER-AM CANCER SOC, V115, P1753, DOI 10.1002/cncr.24170; Mangahas CR, 2005, J INVEST DERMATOL, V125, P307, DOI 10.1111/j.0022-202X.2005.23820.x; Maniccia AW, 2009, J CELL PHYSIOL, V219, P634, DOI 10.1002/jcp.21708; Maraldo D, 2007, ANAL CHEM, V79, P7683, DOI 10.1021/ac070895z; Gonzalez JM, 2008, J CELL BIOL, V183, P653, DOI 10.1083/jcb.200805049; Marinescu Ioana, 1991, Revue Roumaine de Physiologie, V28, P45; MARKO M, 2009, EXP CELL RES; Marreiros A, 2005, ONCOGENE, V24, P637, DOI 10.1038/sj.onc.1208216; Martens MB, 2006, MODERN PATHOL, V19, P287, DOI 10.1038/modpathol.3800531; Martin MT, 2003, PHYS LETT A, V311, P126, DOI 10.1016/S0375-9601(03)00491-2; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mattick JS, 2009, BIOESSAYS, V31, P51, DOI 10.1002/bies.080099; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Mavis CK, 2009, PROSTATE, V69, P1312, DOI 10.1002/pros.20976; Mazzucchelli R, 2007, VIRCHOWS ARCH, V450, P371, DOI 10.1007/s00428-007-0367-x; McCrohan AM, 2006, CANCER-AM CANCER SOC, V106, P2743, DOI 10.1002/cncr.21938; McDonnell TJ, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-1; McGrath JA, 1999, J DERMATOL SCI, V20, P85, DOI 10.1016/S0923-1811(99)00015-8; McGrath JA, 1999, BRIT J DERMATOL, V140, P297; McGrath John A, 2005, Australas J Dermatol, V46, P221, DOI 10.1111/j.1440-0960.2005.00188.x; McGrath John A., 1999, Journal of Dermatology (Tokyo), V26, P764; McMillan JR, 2001, J DERMATOL, V28, P291, DOI 10.1111/j.1346-8138.2001.tb00136.x; Meeker AK, 2002, CANCER RES, V62, P6405; Melamed J, 2002, TISSUE CELL, V34, P28, DOI 10.1054/tice.2001.0220; Mellado M, 2001, CURR BIOL, V11, P691, DOI 10.1016/S0960-9822(01)00199-3; Mendes Alexandre, 2008, V141, P131; Meng XB, 2004, CELL CYCLE, V3, P1457, DOI 10.4161/cc.3.11.1213; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Middleman BR, 2002, MODERN PATHOL, V15, P532, DOI 10.1038/modpathol.3880559; Mirtti T, 2009, APMIS, V117, P151, DOI 10.1111/j.1600-0463.2008.00002.x; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Mitra A, 2008, BRIT J CANCER, V98, P502, DOI 10.1038/sj.bjc.6604132; Miyake H, 2007, BJU INT, V99, P315, DOI 10.1111/j.1464-410X.2006.06622.x; MIZUTANI K, 2009, J CELL BIOCH; Mobley JA, 2003, CANCER EPIDEM BIOMAR, V12, P775; Mockenhaupt M, 2003, INT J MOL MED, V12, P597; Moghaddami M, 2002, IMMUNOL CELL BIOL, V80, P370, DOI 10.1046/j.1440-1711.2002.01100.x; Moghaddami M, 2001, UROLOGY, V57, P573, DOI 10.1016/S0090-4295(00)01005-0; Molinie V, 2006, HUM PATHOL, V37, P698, DOI 10.1016/j.humpath.2006.01.012; Molinie V, 2005, PROG UROL, V15, P611; Molinie V, 2004, MODERN PATHOL, V17, P1180, DOI 10.1038/modpathol.3800197; Molinie V, 2004, ANN PATHOL, V24, P6; Molinie V, 2007, Actas Urol Esp, V31, P1009; Molinie V, 2008, ANN PATHOL, V28, P417, DOI 10.1016/j.annpat.2008.05.004; Moll I, 1997, J INVEST DERMATOL, V108, P139, DOI 10.1111/1523-1747.ep12332388; Mora, 1999, Cancer Control, V6, P587; Mordaka Pawel Mateusz, 2007, Postepy Biochem, V53, P84; Moro L, 2005, J BIOL CHEM, V280, P22482, DOI 10.1074/jbc.M414091200; Moro L, 2008, CANCER SCI, V99, P553, DOI 10.1111/j.1349-7006.2007.00719.x; Morohashi S, 2007, INT J MOL MED, V20, P139; MORRISON ME, 1993, J EXP MED, V177, P1135, DOI 10.1084/jem.177.4.1135; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Mubiru JN, 2007, PROSTATE, V67, P1421, DOI 10.1002/pros.20622; Mubiru JN, 2005, PROSTATE, V65, P117, DOI 10.1002/pros.20277; Mubiru JN, 2004, GENE, V327, P89, DOI 10.1016/j.gene.2003.11.009; Mukherjee R, 2005, PROSTATE, V64, P101, DOI 10.1002/pros.20211; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; Muller-Tidow C, 2004, LUNG CANCER, V45, pS145, DOI 10.1016/j.lungcan.2004.07.000; Murakami T, 2001, BIOCHEM BIOPH RES CO, V288, P8, DOI 10.1006/bbrc.2001.5719; Murugaiyan G, 2006, J IMMUNOL, V177, P6642, DOI 10.4049/jimmunol.177.10.6642; Nadiminty N, 2006, CLIN CANCER RES, V12, P1420, DOI 10.1158/1078-0432.CCR-05-1849; Namiki K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006872; Narod SA, 2008, BRIT J CANCER, V99, P371, DOI 10.1038/sj.bjc.6604453; Nassar A, 2005, APPL IMMUNOHISTO M M, V13, P252, DOI 10.1097/00129039-200509000-00007; Nastiuk KL, 1999, PROSTATE, V40, P172; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Nedvetsky Pavel I, 2009, Handb Exp Pharmacol, P133, DOI 10.1007/978-3-540-79885-9_6; Nemoto H, 2001, J BONE MINER RES, V16, P652, DOI 10.1359/jbmr.2001.16.4.652; Nessler-Menardi C, 2000, PROSTATE, V45, P124, DOI 10.1002/1097-0045(20001001)45:2<124::AID-PROS6>3.0.CO;2-7; Nessling M, 1999, CYTOGENET CELL GENET, V87, P286, DOI 10.1159/000015451; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Nitta RT, 2006, MOL CELL BIOL, V26, P5360, DOI 10.1128/MCB.02464-05; Nunez C, 2008, HISTOPATHOLOGY, V53, P166, DOI 10.1111/j.1365-2559.2008.03092.x; O'Connor MS, 2004, J BIOL CHEM, V279, P28585, DOI 10.1074/jbc.M312913200; Ohyama Y, 2004, J BONE MINER RES, V19, P1706, DOI 10.1359/jbmr.2004.19.10.1706; Okorokov AL, 2009, CURR OPIN STRUC BIOL, V19, P197, DOI 10.1016/j.sbi.2009.02.003; Olgac S, 2006, MODERN PATHOL, V19, P218, DOI 10.1038/modpathol.3800520; Olsson M, 2006, ALLERGY, V61, P1132, DOI 10.1111/j.1398-9995.2006.01151.x; Onaitis Mark, 2002, Surg Oncol Clin N Am, V11, P645, DOI 10.1016/S1055-3207(02)00027-3; White RWD, 2009, UROL ONCOL-SEMIN ORI, V27, P307, DOI 10.1016/j.urolonc.2009.01.004; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Ortega AD, 2009, CANCER LETT, V276, P125, DOI 10.1016/j.canlet.2008.08.007; Ostrander EA, 2008, CANCER EPIDEM BIOMAR, V17, P1843, DOI 10.1158/1055-9965.EPI-08-0556; Ostrer H, 2000, SEMIN REPROD MED, V18, P41, DOI 10.1055/s-2000-13474; OUAZIA D, 2009, ANAL BIOCH; Ouyang B, 2009, J UROLOGY, V181, P2508, DOI 10.1016/j.juro.2009.01.110; Ouyang X, 2008, CANCER RES, V68, P2132, DOI 10.1158/0008-5472.CAN-07-6055; Owen JD, 1997, INT J CANCER, V73, P94, DOI 10.1002/(SICI)1097-0215(19970926)73:1<94::AID-IJC15>3.0.CO;2-5; Oyama T, 2005, ARCH PATHOL LAB MED, V129, P1004; Packer L, 2006, CARCINOGENESIS, V27, P1778, DOI 10.1093/carcin/bgl016; Palapattu GS, 2004, J UROLOGY, V172, P1860, DOI 10.1097/01.ju.0000139886.25848.4a; Palmer DH, 2004, ONCOL REP, V12, P679; Panigrahi AK, 2009, CRIT REV ONCOL HEMAT; Parisi M, 1997, BIOPHYS CHEM, V68, P255, DOI 10.1016/S0301-4622(97)00069-0; Park JJ, 2000, CANCER RES, V60, P5946; Park TJ, 2009, EXP CELL RES, V315, P3152, DOI 10.1016/j.yexcr.2009.07.009; Parrondo JMR, 2001, CHAOS, V11, P725, DOI 10.1063/1.1388006; Pasini L, 2009, EXPERT OPIN THER TAR, V13, P93, DOI 10.1517/14728220802607363 ; Payne AS, 2002, J INVEST DERMATOL, V118, P915, DOI 10.1046/j.1523-1747.2002.01725.x; Peehl DM, 2008, J UROLOGY, V180, P2206, DOI 10.1016/j.juro.2008.07.019; Pekovic V, 2008, J ANAT, V213, P5, DOI 10.1111/j.1469-7580.2008.00928.x; Pequeux C, 1999, Rev Med Liege, V54, P867; Perez DS, 2008, HUM MOL GENET, V17, P642, DOI 10.1093/hmg/ddm336; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Petitjean Audrey, 2006, Bull Cancer, V93, pE126; Petrovic MM, 2006, FOLIA BIOL-PRAGUE, V52, P173; Petrovics G, 2005, ONCOGENE, V24, P3847, DOI 10.1038/sj.onc.1208518; Pettus JA, 2008, J ENDOUROL, V22, P1021, DOI 10.1089/end.2007.0129; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Philip S, 2001, J BIOL CHEM, V276, P44926, DOI 10.1074/jbc.M103334200; Philip S, 2003, J BIOL CHEM, V278, P14487, DOI 10.1074/jbc.M207309200; Phillips JL, 2001, CANCER RES, V61, P8143; Pilch H, 2000, CANCER, V88, P1370, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1370::AID-CNCR14>3.0.CO;2-8; Pinzon-Charry A, 2005, NEOPLASIA, V7, P1112, DOI 10.1593/neo.05442; Pirtskhalaishvili G, 2000, BRIT J CANCER, V83, P506, DOI 10.1054/bjoc.2000.1289; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; PRICKETT TD, 2009, NAT GENET; Prislei S, 2008, MOL CANCER THER, V7, P233, DOI 10.1158/1535-7163.MCT-07-0390; Pronk CJ, 2008, CELL CYCLE, V7, P706, DOI 10.4161/cc.7.6.5565; Puebla-Mora Ana Graciela, 2006, Ann Diagn Pathol, V10, P205, DOI 10.1016/j.anndiagpath.2005.09.021; Quan HT, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.180402; Rabiau N, 2009, IN VIVO, V23, P387; Radosavljevic R, 2005, Acta Chir Iugosl, V52, P109; Raffoul JJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-107; Rai R, 2008, CELL CYCLE, V7, P2225, DOI 10.4161/cc.7.14.6303; Rajaram V, 2007, GENE CHROMOSOME CANC, V46, P508, DOI 10.1002/gcc.20437; Rajesh C, 2009, PROTEOMICS, V9, P4071, DOI 10.1002/pmic.200800977; Rangaswami H, 2004, J BIOL CHEM, V279, P38921, DOI 10.1074/jbc.M404674200; Rangaswami H, 2007, ONCOL REP, V18, P909; Rangaswami H, 2006, GLYCOCONJUGATE J, V23, P221, DOI 10.1007/s10719-006-7927-1; Rangel J, 2008, CANCER-AM CANCER SOC, V112, P144, DOI 10.1002/cncr.23147; Rankin S, 2005, CELL CYCLE, V4, P1039, DOI 10.4161/cc.4.8.1926; Rapley J, 2008, J CELL SCI, V121, P3912, DOI 10.1242/jcs.035360; Rashid Mizanur, 2002, Hokkaido Journal of Medical Science, V77, P341; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reiniger IW, 2007, AM J OPHTHALMOL, V143, P705, DOI 10.1016/j.ajo.2006.11.040; Ren BG, 2007, J NATL CANCER I, V99, P868, DOI 10.1093/jnci/djk199; Ren H, 2009, ANIM GENET, V40, P499, DOI 10.1111/j.1365-2052.2009.01868.x; Rettig MB, 2008, MOL CANCER THER, V7, P2662, DOI 10.1158/1535-7163.MCT-08-0136; Ribeiro GRH, 2004, J DERMATOL SCI, V36, P79, DOI 10.1016/j.jdermsci.2004.08.003; RICHMOND A, 1988, J CELL BIOCHEM, V36, P185, DOI 10.1002/jcb.240360209; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Ritchie W, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000011; Roca H, 2008, J BIOL CHEM, V283, P25057, DOI 10.1074/jbc.M801073200; Roca H, 2008, AUTOPHAGY, V4, P969, DOI 10.4161/auto.6822; Roche JB, 2008, PROG UROL, V18, P586, DOI 10.1016/j.purol.2008.05.003; Roder Martin Andreas, 2008, Ugeskr Laeger, V170, P2554; Roesch A, 2006, MODERN PATHOL, V19, P1378, DOI 10.1038/modpathol.3800663; Rogers CG, 2004, CANCER, V101, P2549, DOI 10.1002/cncr.20637; Rogers CG, 2004, J UROLOGY, V172, P1501, DOI 10.1097/01.ju.0000137659.53129.14; Rokhlin OW, 1997, CANCER RES, V57, P1758; Rosen EM, 2005, ENDOCR-RELAT CANCER, V12, P533, DOI 10.1677/erc.1.00972; Rosen EM, 2001, CANCER INVEST, V19, P396, DOI 10.1081/CNV-100103134; Rosner MR, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-1; Rosso OA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154102; RoyBurman P, 1997, MOL MED TODAY, V3, P476, DOI 10.1016/S1357-4310(97)01126-X; RUAN K, 2009, CANC LETT; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Rubin MA, 2005, CANCER EPIDEM BIOMAR, V14, P1424, DOI 10.1158/1055-9965.EPI-04-0801; Rubin MA, 2002, JAMA-J AM MED ASSOC, V287, P1662, DOI 10.1001/jama.287.13.1662; Rubin MA, 2004, AM J PATHOL, V164, P831, DOI 10.1016/S0002-9440(10)63171-9; Rudzki Z, 1997, J CLIN PATHOL-MOL PA, V50, P57, DOI 10.1136/mp.50.2.57; Ruiz-Ederra J, 2009, INVEST OPHTH VIS SCI, V50, P2132, DOI 10.1167/iovs.08-3033; Russo G, 2008, J MED VIROL, V80, P2100, DOI 10.1002/jmv.21312; Rustin P, 2007, Ernst Schering Found Symp Proc, P1; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Saad F, 2008, BJU INT, V101, P1071, DOI 10.1111/j.1464-410X.2007.07364.x; Saffin JM, 2005, P NATL ACAD SCI USA, V102, P11302, DOI 10.1073/pnas.0500964102; Sakai I, 2006, UROL INT, V76, P227, DOI 10.1159/000091624; Samanna V, 2006, EXP CELL RES, V312, P2214, DOI 10.1016/j.yexcr.2006.03.022; Samaratunga H, 2007, PATHOLOGY, V39, P476, DOI 10.1080/00313020701570004; Santinelli A, 2007, AM J CLIN PATHOL, V128, P657, DOI 10.1309/P065G467FKKUJDE5; Saparov SM, 2007, J BIOL CHEM, V282, P5296, DOI 10.1074/jbc.M609343200; Sardana G, 2008, CLIN CHEM, V54, P1951, DOI 10.1373/clinchem.2008.110668; Sasaki YTF, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-227; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; Satoh S, 2000, INT J ONCOL, V17, P707; Savli H, 2008, EXP MOL MED, V40, P176, DOI 10.3858/emm.2008.40.2.176; Sbisa E, 2006, CELL CYCLE, V5, P205, DOI 10.4161/cc.5.2.2361; Scadden D, 2009, MOL CELL, V35, P395, DOI 10.1016/j.molcel.2009.08.005; Schaeffer EM, 2008, ONCOGENE, V27, P7180, DOI 10.1038/onc.2008.327; Schlechte H, 1998, EUR UROL, V34, P433, DOI 10.1159/000019778; Schlomm T, 2005, INT J ONCOL, V27, P713; SCHLOMM T, 2008, EUR UROL; Schmidt A, 2005, EUR J CELL BIOL, V84, P189, DOI 10.1016/j.ejcb.2004.12.020; SCHMIT TL, 2009, J INVEST DERMATOL; Schmit TL, 2009, CELL CYCLE, V8, P2697, DOI 10.4161/cc.8.17.9413; Schoder H, 2007, EUR UROL, V52, P310, DOI 10.1016/j.eururo.2007.03.026; Schostak M, 2006, CANCER DETECT PREV, V30, P449, DOI 10.1016/j.cdp.2006.07.010; Schultz J, 2009, MOL CARCINOGEN, V48, P14, DOI 10.1002/mc.20452; Schumacher MC, 2006, EUR UROL, V50, P272, DOI 10.1016/j.eururo.2006.01.061; Setzer SV, 2004, J INVEST DERMATOL, V123, P426, DOI 10.1111/j.0022-202X.2004.23319.x; Shapiro A, 2008, ANTICANCER RES, V28, P3909; SHATTUCK RL, 1994, MOL CELL BIOL, V14, P791, DOI 10.1128/MCB.14.1.791; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Shen-Ong GL, 2003, CANCER RES, V63, P3296; Sheng HM, 2009, CURR MED CHEM, V16, P1561, DOI 10.2174/092986709788186255; Sheridan T, 2007, AM J SURG PATHOL, V31, P1351, DOI 10.1097/PAS.0b013e3180536678; Shih Ie-Ming, 1994, In Vivo (Attiki), V8, P113; Shilo K, 2007, ARCH PATHOL LAB MED, V131, P1555; Shimizu T, 2005, ONCOL REP, V14, P441; SHOSKES DA, 1993, CAN J SURG, V36, P33; SIMPSON KL, 1994, IMMUNOLOGY, V81, P452; Singh N, 2006, INVEST OPHTH VIS SCI, V47, P4787, DOI 10.1167/iovs.06-0419; Singh RP, 2006, MOL CARCINOGEN, V45, P436, DOI 10.1002/mc.20223; Sini P, 2008, CANCER RES, V68, P1581, DOI 10.1158/0008-5472.CAN-06-4685; Sircar K, 2006, CLIN CANCER RES, V12, P4178, DOI 10.1158/1078-0432.CCR-06-0328; Skamrov AV, 2004, J MOL CELL CARDIOL, V37, P717, DOI 10.1016/j.yjmcc.2004.06.006; Skinnider BF, 2004, AM J SURG PATHOL, V28, P701, DOI 10.1097/01.pas.0000126759.43227.d9; Sleeman JE, 2004, PHILOS T R SOC A, V362, P2775, DOI 10.1098/rsta.2004.1463; Slijepcevic P, 2006, DNA REPAIR, V5, P1299, DOI 10.1016/j.dnarep.2006.05.038; Smit DJ, 2007, INT J CANCER, V121, P2653, DOI 10.1002/ijc.23039; Smith LL, 1998, EXP CELL RES, V242, P351, DOI 10.1006/excr.1998.4108; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Sobolik-Delmaire T, 2007, CELL COMMUN ADHES, V14, P99, DOI 10.1080/15419060701463082; Soikkeli J, 2007, J PATHOL, V213, P180, DOI 10.1002/path.2229; Son DJ, 2007, MOL CANCER THER, V6, P675, DOI 10.1158/1535-7163.MCT-06-0328; SOTOMAYOR P, 2008, PROSTATE; Sotomayor P, 2009, PROSTATE, V69, P401, DOI 10.1002/pros.20895; Sougrat R, 2002, J INVEST DERMATOL, V118, P678, DOI 10.1046/j.1523-1747.2002.01710.x; South AP, 2003, J CELL SCI, V116, P3303, DOI 10.1242/jcs.00636; SPIRKL W, 1995, PHYS REV E, V52, P3485, DOI 10.1103/PhysRevE.52.3485; Sprecher E, 2004, J INVEST DERMATOL, V122, P647, DOI 10.1111/j.0022-202X.2004.22335.x; Sreekumar A, 2004, JNCI-J NATL CANCER I, V96, P834, DOI 10.1093/jnci/djh145; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Steijlen PM, 2004, J INVEST DERMATOL, V122, P1321, DOI 10.1111/j.0022-202X.2003.22302.x; Stewart CL, 2007, EXP CELL RES, V313, P2144, DOI 10.1016/j.yexcr.2007.03.026; Stewart J, 2007, J CLIN PATHOL, V60, P773, DOI 10.1136/jcp.2006.040808; Stirling G, 2001, AM NAT, V158, P286, DOI 10.1086/321317; Strauss BS, 2000, MUTAT RES-FUND MOL M, V457, P93, DOI 10.1016/S0027-5107(00)00135-4; Struewing JP, 1998, CURRENT TOPICS ON BRCA1, P71, DOI 10.3233/BD-1998-101-209; Sturgis CD, 2006, ACTA CYTOL, V50, P335, DOI 10.1159/000325965; Sturm RA, 2005, J INVEST DERMATOL, V124, pxiv, DOI 10.1111/j.0022-202X.2005.23741.x; Sugiyama Y, 2001, BBA-GENE STRUCT EXPR, V1522, P82, DOI 10.1016/S0167-4781(01)00320-7; Suh JH, 2002, PROSTATE, V52, P183, DOI 10.1002/pros.10082; Sun T, 2008, CANCER LETT, V263, P35, DOI 10.1016/j.canlet.2007.12.015; SUN Y, 2008, BREAST CANC RES TREA; Sung MT, 2007, HUM PATHOL, V38, P332, DOI 10.1016/j.humpath.2006.08.016; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Suzuki K, 2006, UROLOGY, V67, P647, DOI 10.1016/j.urology.2005.10.013; Swisshelm K, 2005, ADV DRUG DELIVER REV, V57, P919, DOI 10.1016/j.addr.2005.01.006; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Takahara K, 2009, ANTICANCER RES, V29, P2497; Takahashi S, 2002, PROSTATE, V50, P154, DOI 10.1002/pros.10044; Takahashi S, 2006, PROSTATE, V66, P211, DOI 10.1002/pros.20336; Takahashi T, 2003, CANCER SCI, V94, P148, DOI 10.1111/j.1349-7006.2003.tb01411.x; Takeda Taizo, 2009, Handb Exp Pharmacol, P171, DOI 10.1007/978-3-540-79885-9_8; Takeno A, 2008, BRIT J CANCER, V99, P1307, DOI 10.1038/sj.bjc.6604682; Tan EY, 2004, AM J PATHOL, V165, P319, DOI 10.1016/S0002-9440(10)63299-3; Tancharoen S, 2008, J CELL PHYSIOL, V217, P338, DOI 10.1002/jcp.21506; Tang XY, 2006, HUM PATHOL, V37, P1186, DOI 10.1016/j.humpath.2006.04.019; Tani K, 2009, J MOL BIOL, V389, P694, DOI 10.1016/j.jmb.2009.04.049; Tarhini AA, 2006, DERMATOL THER, V19, P19, DOI 10.1111/j.1529-8019.2005.00052.x; Tas F, 2006, MELANOMA RES, V16, P405, DOI 10.1097/01.cmr.0000222598.27438.82; Tasken Kristin Austlid, 2005, Tidsskr Nor Laegeforen, V125, P3279; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Tennant DA, 2009, CARCINOGENESIS, V30, P1269, DOI 10.1093/carcin/bgp070; TETTELBACH W, 1993, J CUTAN PATHOL, V20, P259, DOI 10.1111/j.1600-0560.1993.tb00653.x; THOMAS HG, 1988, ARCH BIOCHEM BIOPHYS, V260, P719, DOI 10.1016/0003-9861(88)90501-2; Thomsen MK, 2008, DIFFERENTIATION, V76, P728, DOI 10.1111/j.1432-0436.2008.00293.x; Thomsen MK, 2008, DEV BIOL, V316, P302, DOI 10.1016/j.ydbio.2008.01.030; Thornburg Todd, 2006, Future Oncol, V2, P213, DOI 10.2217/14796694.2.2.213; Tischkowitz M, 2003, LANCET, V362, P80, DOI 10.1016/S0140-6736(03)13823-8; Tokes AM, 2005, BREAST CANCER RES, V7, pR296, DOI 10.1186/bcr983; Tokunaga K, 2006, GENES CELLS, V11, P305, DOI 10.1111/j.1365-2443.2006.00936.x; Tomkova K, 2008, NEOPLASMA, V55, P177; Tourkova IL, 2002, J LEUKOCYTE BIOL, V72, P1037; Traka M, 2005, J NUTR, V135, P1865, DOI 10.1093/jn/135.8.1865; Tretiakova MS, 2004, AM J SURG PATHOL, V28, P69, DOI 10.1097/00000478-200401000-00007; TRIBUS M, 1961, THERMOSTATISTICS THE; Trpkov K, 2009, AM J CLIN PATHOL, V132, P211, DOI 10.1309/AJCPGFJP83IXZEUR; True L, 2006, P NATL ACAD SCI USA, V103, P10991, DOI 10.1073/pnas.0603678103; Truong CD, 2008, INT J CLIN EXP PATHO, V1, P518; Tscheudschilsuren G, 2006, EXP CELL RES, V312, P63, DOI 10.1016/j.yexcr.2005.09.017; TSENG JJ, 2009, MOL HUM REPROD; Tsui KH, 2008, PROSTATE, V68, P610, DOI 10.1002/pros.20725; Tycko B, 2003, ANN NY ACAD SCI, V983, P43, DOI 10.1111/j.1749-6632.2003.tb05961.x; Untergasser G, 2005, MECH AGEING DEV, V126, P59, DOI 10.1016/j.mad.2004.09.023; Urban RJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE794, DOI 10.1152/ajpendo.00174.2002; Urbanucci A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-219; Uzzo RG, 2006, CARCINOGENESIS, V27, P1980, DOI 10.1093/carcin/bgl034; Vaarala MH, 2000, LAB INVEST, V80, P1259, DOI 10.1038/labinvest.3780134; Van den Oord JJ, 1998, BRIT J DERMATOL, V138, P615; van Golen KL, 2008, J CELL BIOCHEM, V104, P1587, DOI 10.1002/jcb.21652; Vanguri VK, 2006, APPL IMMUNOHISTO M M, V14, P365, DOI 10.1097/00129039-200609000-00018; Varma M, 2005, HISTOPATHOLOGY, V47, P1, DOI 10.1111/j.1365-2559.2005.02188.x; Venkataraman G, 2007, PROSTATE, V67, P1524, DOI 10.1002/pros.20629; Venoux M, 2008, HUM MOL GENET, V17, P215, DOI 10.1093/hmg/ddm298; Verdier-Sevrain Sylvie, 2007, J Cosmet Dermatol, V6, P75, DOI 10.1111/j.1473-2165.2007.00300.x; Verdoucq L, 2008, BIOCHEM J, V415, P409, DOI 10.1042/BJ20080275; Verkman AS, 2008, J MOL MED, V86, P523, DOI 10.1007/s00109-008-0303-9; Verkman Alan S, 2009, Handb Exp Pharmacol, P359, DOI 10.1007/978-3-540-79885-9_18; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Verschooten L., 2006, International Journal of Cosmetic Science, V28, P1, DOI 10.1111/j.1467-2494.2006.00299.x; Verstraeten VLRM, 2007, CURR MED CHEM, V14, P1231; VONFIGURA G, 2009, J MOL MED; Vu HY, 2008, ARCH BIOCHEM BIOPHYS, V475, P156, DOI 10.1016/j.abb.2008.04.026; Vukovic B, 2007, CYTOGENET GENOME RES, V116, P1, DOI 10.1159/000097411; Vykhovanets EV, 2008, PROSTATE, V68, P34, DOI 10.1002/pros.20666; Wahl JK, 2005, J CELL BIOCHEM, V96, P390, DOI 10.1002/jcb.20514; Walden PD, 1998, EXP CELL RES, V245, P19, DOI 10.1006/excr.1998.4237; Walter-Yohrling J, 2003, CANCER RES, V63, P8939; Wang D, 2008, SEMIN RADIAT ONCOL, V18, P35, DOI 10.1016/j.semradonc.2007.09.005; Wang DZ, 2001, J BIOL CHEM, V276, P3650, DOI 10.1074/jbc.M006115200; Wang DZ, 2000, ONCOGENE, V19, P4647, DOI 10.1038/sj.onc.1203820; Wang H, 2008, CANCER RES, V68, P1625, DOI 10.1158/0008-5472.CAN-07-5915; Wang HY, 2007, CANCER RES, V67, P528, DOI 10.1158/0008-5472.CAN-06-1672; Wang JB, 2007, INT J UROL, V14, P1088, DOI 10.1111/j.1442-2042.2007.01901.x; Wang JH, 2006, PROSTATE, V66, P847, DOI 10.1002/pros.20389; Wang WL, 2008, AM J SURG PATHOL, V32A, P851, DOI 10.1097/PAS.0b013e31815a0508; Wang XQ, 2008, CLIN CANCER RES, V14, P6813, DOI 10.1158/1078-0432.CCR-08-0626; Wang Y, 2007, J NUTR, V137, p1509S, DOI 10.1093/jn/137.6.1509S; Wang YP, 2005, NEOPLASIA, V7, P748, DOI 10.1593/neo.05289; Watanabe M, 1998, ONCOLOGY-BASEL, V55, P569, DOI 10.1159/000011914; Watanabe T, 2009, J PHYSIOL SCI, V59, P113, DOI 10.1007/s12576-008-0017-3; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Weckermann D, 2006, BJU INT, V97, P1173, DOI 10.1111/j.1464-410X.2006.06166.x; Weichert W, 2006, CANCER SCI, V97, P271, DOI 10.1111/j.1349-7006.2006.00170.x; Weichert W, 2005, VIRCHOWS ARCH, V446, P442, DOI 10.1007/s00428-005-1212-8; Weichert W, 2005, WORLD J GASTROENTERO, V11, P5644, DOI 10.3748/wjg.v11.i36.5644; Weinberg RA, 2007, BIOL CANC; WEINSTEIN RS, 1987, CIBA F SYMP, V125, P240; Weiske J, 2001, J BIOL CHEM, V276, P41175, DOI 10.1074/jbc.M105769200; WEN J, 2009, SCAND J UROL NEPHROL, P1; Went PT, 2006, PATHOLOGY, V38, P426, DOI 10.1080/00313020600922470; Wertz IE, 1996, HUM PATHOL, V27, P573, DOI 10.1016/S0046-8177(96)90164-1; Wesley UV, 2005, CANCER RES, V65, P1325, DOI 10.1158/0008-5472.CAN-04-1852; Wessagowit V, 2005, ACTA DERM-VENEREOL, V85, P386, DOI 10.1080/00015550510011763; Whittock NV, 2000, EXP DERMATOL, V9, P323, DOI 10.1034/j.1600-0625.2000.009005323.x; Whittock NV, 2000, J INVEST DERMATOL, V115, P368, DOI 10.1046/j.1523-1747.2000.00082.x; Wierzbicki AS, 2007, BIOCHEM SOC T, V35, P881, DOI 10.1042/BST0350881; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Winfield HL, 2007, ARCH DERMATOL, V143, P1076, DOI 10.1001/archderm.143.8.1076; Winnepenninckx V, 2006, MODERN PATHOL, V19, P1170, DOI 10.1038/modpathol.3800627; Winter A, 2009, AKTUEL UROL, V40, P294, DOI 10.1055/s-0028-1098914; Witkiewicz AK, 2005, CANCER EPIDEM BIOMAR, V14, P1418, DOI 10.1158/1055-9965.EPI-04-0607; Wodarz D, 2008, MED HYPOTHESES, V70, P128, DOI 10.1016/j.mehy.2007.03.040; Wong DJ, 2008, CELL CYCLE, V7, P3622, DOI 10.4161/cc.7.23.7104; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Wu B, 2007, CELL MOL LIFE SCI, V64, P2413, DOI 10.1007/s00018-007-7163-2; Wu BH, 2009, EMBO J, V28, P2188, DOI 10.1038/emboj.2009.182; Wu CL, 2004, HUM PATHOL, V35, P1008, DOI 10.1016/j.humpath.2004.03.019; Wu XY, 2006, NAT CELL BIOL, V8, P756, DOI 10.1038/ncb1433; Wu Y, 2009, J HUAZHONG U SCI-MED, V29, P246, DOI 10.1007/s11596-009-0223-0; Xie SQ, 2006, MOL BIOL CELL, V17, P1723, DOI 10.1091/mbc.E05-08-0726; Xu CL, 2005, PROSTATE, V62, P224, DOI 10.1002/pros.20134; Xu JF, 2005, PROSTATE, V63, P209, DOI 10.1002/pros.20233; Xu L, 2005, BIOINFORMATICS, V21, P3905, DOI 10.1093/bioinformatics/bti647; Yamada K, 2006, CANCER SCI, V97, P106, DOI 10.1111/j.1349-7006.2006.00147.x; Yamamoto Y, 2006, ONCOLOGY-BASEL, V70, P231, DOI 10.1159/000094416; Yang F, 2005, CANCER RES, V65, P8887, DOI 10.1158/0008-5472.CAN-05-1702; Yang JM, 2001, CANCER RES, V61, P4901; Yang JM, 2001, CANCER RES, V61, P8150; Yang M, 2009, BRAIN RES, V1290, P121, DOI 10.1016/j.brainres.2009.07.018; Yang XMJ, 2003, UROLOGY, V62, P282, DOI 10.1016/S0090-4295(03)00259-0; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Yasui Masato, 2009, Handb Exp Pharmacol, P299, DOI 10.1007/978-3-540-79885-9_15; Yeh SY, 2000, P NATL ACAD SCI USA, V97, P11256, DOI 10.1073/pnas.190353897; Yemelyanov A, 2007, ONCOGENE, V26, P1885, DOI 10.1038/sj.onc.1209991; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; Yu Tao, 2007, Zhonghua Nan Ke Xue, V13, P222; Yuli C, 2007, ONCOGENE, V26, P6031, DOI 10.1038/sj.onc.1210420; Yurkovetsky ZR, 2007, CLIN CANCER RES, V13, P2422, DOI 10.1158/1078-0432.CCR-06-1805; Zehentner BK, 2006, MOL DIAGN THER, V10, P397, DOI 10.1007/BF03256217; Zerbini LF, 2005, CELL CYCLE, V4, P1247, DOI 10.4161/cc.4.9.1966; Zha S, 2005, PROSTATE, V63, P316, DOI 10.1002/pros.20177; Zha S, 2005, MOL CANCER RES, V3, P110, DOI 10.1158/1541-7786.MCR-04-0178; Zha S, 2003, CANCER RES, V63, P7365; Zhang Hui-Hen, 2007, Chinese Journal of Pathology, V36, P742; Zhang J, 2009, ANIMAL, V3, P1, DOI [10.1017/S1751731108003054, 10.1109/ISDRS.2009.5378133]; Zhang X, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000334; Zheng JZ, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041109; Zheng Li, 2006, Hum Mutat, V27, P1062, DOI 10.1002/humu.9457; Zheng SQL, 2002, CANCER RES, V62, P6485; Zhou M, 2002, AM J SURG PATHOL, V26, P926, DOI 10.1097/00000478-200207000-00012; Zhou M, 2004, AM J SURG PATHOL, V28, P239, DOI 10.1097/00000478-200402000-00012; Zhou M, 2003, AM J SURG PATHOL, V27, P772, DOI 10.1097/00000478-200306000-00007; Zhou Q, 2008, J HUAZHONG U SCI-MED, V28, P22, DOI 10.1007/s11596-008-0106-9; Zhou YW, 2005, J INVEST DERMATOL, V124, P1044, DOI 10.1111/j.0022-202X.2005.23680.x; Zielie PJ, 2004, J UROLOGY, V172, P1130, DOI 10.1097/01.ju.0000133560.87118.4d; Zuhlke KA, 2004, CLIN CANCER RES, V10, P5975, DOI 10.1158/1078-0432.CCR-04-0554	808	33	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12262	10.1371/journal.pone.0012262	http://dx.doi.org/10.1371/journal.pone.0012262			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805891	gold, Green Published			2022-12-25	WOS:000281011600026
J	Pitcher, BJ; Harcourt, RG; Charrier, I				Pitcher, Benjamin J.; Harcourt, Robert G.; Charrier, Isabelle			Rapid Onset of Maternal Vocal Recognition in a Colonially Breeding Mammal, the Australian Sea Lion	PLOS ONE			English	Article							PARENT-OFFSPRING RECOGNITION; AMERICAN FUR-SEAL; NEWBORN GOAT KIDS; ACOUSTIC RECOGNITION; MOTHER; PUPS; DISCRIMINATION; SIGNATURE; SWALLOWS; INFANTS	Background: In many gregarious mammals, mothers and offspring have developed the abilities to recognise each other using acoustic signals. Such capacity may develop at different rates after birth/parturition, varying between species and between the participants, i.e., mothers and young. Differences in selective pressures between species, and between mothers and offspring, are likely to drive the timing of the onset of mother-young recognition. We tested the ability of Australian sea lion mothers to identify their offspring by vocalisation, and examined the onset of this behaviour in these females. We hypothesise that a rapid onset of recognition may reflect an adaptation to a colonial lifestyle. Principal Findings: In a playback study maternal responses to own pup and non-filial vocalisations were compared at 12, 24 and every subsequent 24 hours until the females' first departure post-partum. Mothers showed a clear ability to recognise their pup's voice by 48 hours of age. At 24 hours mothers called more, at 48 hours they called sooner and at 72 hours they looked sooner in response to their own pup's vocalisations compared to those of non-filial pups. Conclusions: We demonstrate that Australian sea lion females can vocally identify offspring within two days of birth and before mothers leave to forage post-partum. We suggest that this rapid onset is a result of selection pressures imposed by a colonial lifestyle and may be seen in other colonial vertebrates. This is the first demonstration of the timing of the onset of maternal vocal recognition in a pinniped species.	[Pitcher, Benjamin J.; Harcourt, Robert G.] Macquarie Univ, Marine Mammal Res Grp, Grad Sch Environm, Sydney, NSW 2109, Australia; [Pitcher, Benjamin J.; Charrier, Isabelle] Univ Paris 11, Ctr Neurosci Paris Sud, Equipe Commun Acoust, UMR 8195, Orsay, France; [Pitcher, Benjamin J.; Charrier, Isabelle] CNRS, F-91405 Orsay, France	Macquarie University; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS)	Pitcher, BJ (corresponding author), Macquarie Univ, Marine Mammal Res Grp, Grad Sch Environm, Sydney, NSW 2109, Australia.	ben.pitcher@mq.edu.au	Pitcher, Benjamin/A-9631-2012	Pitcher, Benjamin/0000-0002-8580-0343; CHARRIER, Isabelle/0000-0003-4873-2342; Harcourt, Robert/0000-0003-4666-2934	Macquarie University; Centre National de la Recherche Scientifique (CNRS), France; Region Ile-de-France	Macquarie University; Centre National de la Recherche Scientifique (CNRS), France(Centre National de la Recherche Scientifique (CNRS)); Region Ile-de-France(Region Ile-de-France)	Funding and research equipment for this study was provided by Macquarie University and Centre National de la Recherche Scientifique (CNRS), France. Region Ile-de-France provided a cotutelle travel grant to allow B Pitcher to travel to Paris where this paper was written. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin T, 2002, ADV STUD BEHAV, V31, P243, DOI 10.1016/S0065-3454(02)80010-9; BALCOMBE JP, 1990, ANIM BEHAV, V39, P960, DOI 10.1016/S0003-3472(05)80961-3; BEECHER MD, 1981, ANIM BEHAV, V29, P95, DOI 10.1016/S0003-3472(81)80156-X; BIRKHEAD TR, 1978, ANIM BEHAV, V26, P321, DOI 10.1016/0003-3472(78)90050-7; Bradbury Jack W., 1998, pi; Charrier I, 2003, BIOL J LINN SOC, V80, P305, DOI 10.1046/j.1095-8312.2003.00239.x; Charrier I, 2002, J EXP BIOL, V205, P603; Charrier I, 2001, NATURE, V412, P873, DOI 10.1038/35091136; Charrier I, 2003, ANIM BEHAV, V65, P543, DOI 10.1006/anbe.2003.2073; Charrier I, 2006, J MAMMAL, V87, P929, DOI 10.1644/05-MAMM-A-344R3.1; Charrier I, 2010, ANIM COGN, V13, P471, DOI 10.1007/s10071-009-0298-9; Charrier I, 2009, ANIM BEHAV, V78, P1127, DOI 10.1016/j.anbehav.2009.07.032; DAVIES S. J. J. F., 1962, AUSTRALIAN JOUR ZOOL, V10, P171, DOI 10.1071/ZO9620171; FORMBY D, 1967, DEV MED CHILD NEUROL, V9, P293; GALES NJ, 1994, J ZOOL, V234, P353, DOI 10.1111/j.1469-7998.1994.tb04853.x; Goldsworthy S. D., 2009, UPDATE REPORT UNDERS; HARCOURT R, 1992, J ZOOL, V226, P259, DOI 10.1111/j.1469-7998.1992.tb03838.x; HARCOURT R, 1992, CAN J ZOOL, V70, P320, DOI 10.1139/z92-048; Hayes LD, 2004, ETHOL ECOL EVOL, V16, P145; Hepper PG., 1991, KIN RECOGNITION; HIGGINS LV, 1993, CAN J ZOOL, V71, P2047, DOI 10.1139/z93-290; HOLMES WG, 1984, J COMP PSYCHOL, V98, P246, DOI 10.1037/0735-7036.98.3.246; Insley SJ, 2001, ANIM BEHAV, V61, P129, DOI 10.1006/anbe.2000.1569; Insley Stephen J., 2003, Aquatic Mammals, V29, P181, DOI 10.1578/016754203101024149; King JE., 1983, SEALS WORLD BRIT MUS; Kober M, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-13; MASATAKA N, 1985, DEV PSYCHOBIOL, V18, P107, DOI 10.1002/dev.420180203; MCGREGOR PK, 1992, NATO ADV SCI I A-LIF, V228, P79; MEDVIN MB, 1986, ANIM BEHAV, V34, P1627, DOI 10.1016/S0003-3472(86)80251-2; MEDVIN MB, 1993, ANIM BEHAV, V45, P841, DOI 10.1006/anbe.1993.1105; PETRINOVICH L, 1974, Zeitschrift fuer Tierpsychologie, V34, P308; Pitcher BJ, 2009, NATURWISSENSCHAFTEN, V96, P901, DOI 10.1007/s00114-009-0546-5; PITCHER BJ, 2010, BIOL LETT, DOI DOI 10.1098/RSBL2010.0569; Poindron P, 2003, DEV PSYCHOBIOL, V43, P82, DOI 10.1002/dev.10123; POINDRON P, 1980, ADV STUD BEHAV, V11, P75; Rendall D, 1996, ANIM BEHAV, V51, P1007, DOI 10.1006/anbe.1996.0103; Searby A, 2003, P ROY SOC B-BIOL SCI, V270, P1765, DOI 10.1098/rspb.2003.2442; Sebe F, 2007, DEV PSYCHOBIOL, V49, P375, DOI 10.1002/dev.20218; SIEBER OJ, 1986, BEHAVIOUR, V96, P130, DOI 10.1163/156853986X00252; STODDARD PK, 1983, AUK, V100, P795, DOI 10.1093/auk/100.4.795; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Terrazas A, 2003, DEV PSYCHOBIOL, V43, P311, DOI 10.1002/dev.10139; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Torriani MVG, 2006, AM NAT, V168, P412, DOI 10.1086/506971; TRILLMICH F, 1981, BEHAVIOUR, V78, P21, DOI 10.1163/156853981X00248; TRIVERS RL, 1974, AM ZOOL, V14, P249; Valanne EH, 1967, EXPERIENTIA, V23, P768, DOI 10.1007/BF02154167; [No title captured], DOI DOI 10.1163/156853981X00347	48	38	38	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12195	10.1371/journal.pone.0012195	http://dx.doi.org/10.1371/journal.pone.0012195			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730045	Green Published, gold			2022-12-25	WOS:000280862200029
J	Alvarez-Moya, B; Lopez-Alcala, C; Drosten, M; Bachs, O; Agell, N				Alvarez-Moya, B.; Lopez-Alcala, C.; Drosten, M.; Bachs, O.; Agell, N.			K-Ras4B phosphorylation at Ser181 is inhibited by calmodulin and modulates K-Ras activity and function	ONCOGENE			English	Article						calmodulin; K-Ras; PKC; phosphorylation	C-MEDIATED PHOSPHORYLATION; ACTIVATED PROTEIN-KINASE; CELL-CYCLE; N-RAS; H-RAS; SIGNAL; GROWTH; RAF-1; GENE; PKC	Fine tuning of Ras activity is widely known as a mechanism to induce different cellular responses. Recently, we have shown that calmodulin (CaM) binds to K-Ras and that K-Ras phosphorylation inhibits its interaction with CaM. In this study we report that CaM inhibits K-Ras phosphorylation at Ser181 by protein kinase C (PKC) in vivo, and this is a mechanism to modulate K-Ras activity and signaling. Although CaM inhibition increased the activation of endogenous K-Ras, PKC inhibition decreased its activation status. We demonstrate that K-Ras phosphorylation decreased susceptibility to p120GAP activity. Accordingly, we also observed that non-phosphorylable K-Ras mutant exhibits a less sustained activation profile and do not efficiently activate AKT at low growth factor doses compared with wild-type K-Ras. It is interesting that the physiological responses induced by K-Ras are affected by this phosphorylation; when K-Ras cannot be phosphorylated it exhibits a remarkably decreased ability to stimulate proliferation in non-saturated serum conditions. Finally, we demonstrate that phosphorylation also regulates oncogenic K-Ras functions, as focus formation capacity, mobility and apoptosis resistance upon adriamycin treatment of cells expressing oncogenic K-Ras that cannot be phosphorylated are highly compromised. Moreover, at low serum concentration proliferation and survival is practically inhibited when cells cannot phosphorylate oncogenic K-Ras. In this condition, K-Ras phosphorylation is essential to ensure a proper activation of mitogen-activated protein kinase and PI3K/AKT pathways. In summary, our findings suggest that the interplay between CaM interaction and PKC phosphorylation is essential to regulate non-oncogenic and oncogenic K-Ras activity and functionality. Oncogene (2010) 29, 5911-5922; doi:10.1038/onc.2010.298; published online 30 August 2010	[Alvarez-Moya, B.; Lopez-Alcala, C.; Bachs, O.; Agell, N.] Univ Barcelona, Dept Biol Cellular Immunol & Neurociencies, Inst Invest Biomed August Pi & Sunyer, Fac Med, E-08036 Barcelona, Spain; [Drosten, M.] CNIO, Mol Oncol Programme, Madrid, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Centro Nacional de Investigaciones Oncologicas (CNIO)	Agell, N (corresponding author), Univ Barcelona, Dept Biol Cellular Immunol & Neurociencies, Inst Invest Biomed August Pi & Sunyer, Fac Med, C Casanova 143, E-08036 Barcelona, Spain.	neusagell@ub.edu	Agell, Neus/E-9640-2016	Agell, Neus/0000-0002-1205-6074; Drosten, Matthias/0000-0002-3205-456X; Alvarez Moya, Blanca/0000-0003-2573-7909	Ministerio de Educacion y Ciencia (Spain) [SAF2007-60491]; Generalitat de Catalunya (Spain)	Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Generalitat de Catalunya (Spain)(Generalitat de Catalunya)	We thank Dr M Barbacid (CNIO, Spain) for the generous gift of Rasless and K-Ras<SUP>-/-</SUP> MEFs. We are also indebt with Anna Bosch and Maria Calvo (Confocal microscopy facility, SCT-University of Barcelona) for their help of performing the cell mobility assays. This study was supported by grant SAF2007-60491 from the Ministerio de Educacion y Ciencia (Spain). Blanca Alvarez-Moya was recipient of a pre-doctoral fellowship from the Generalitat de Catalunya (Spain).	Agell N, 2006, CELL CYCLE, V5, P3, DOI 10.4161/cc.5.1.2270; Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Ashery U, 2006, CELL MOL NEUROBIOL, V26, P471, DOI 10.1007/s10571-006-9059-3; BALLESTER R, 1987, J BIOL CHEM, V262, P2688; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; BOS JL, 1989, CANCER RES, V49, P4682; Bosch M, 1998, J BIOL CHEM, V273, P22145, DOI 10.1074/jbc.273.34.22145; Chakravarthy B, 1999, TRENDS NEUROSCI, V22, P12, DOI 10.1016/S0166-2236(98)01288-0; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Downward J, 1996, CANCER SURV, V27, P87; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Elad-Sfadia G, 2004, J BIOL CHEM, V279, P34922, DOI 10.1074/jbc.M312697200; Elad-Sfadia G, 2002, J BIOL CHEM, V277, P37169, DOI 10.1074/jbc.M205698200; Hamilton M, 2001, J BIOL CHEM, V276, P29079, DOI 10.1074/jbc.M102001200; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; KAHAN C, 1992, J BIOL CHEM, V267, P13369; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; Liao JH, 2006, J BIOL CHEM, V281, P29730, DOI 10.1074/jbc.M600668200; Liou JS, 2004, J CELL PHYSIOL, V198, P277, DOI 10.1002/jcp.10409; Lopez-Alcala C, 2008, J BIOL CHEM, V283, P10621, DOI 10.1074/jbc.M706238200; LU KP, 1993, ENDOCR REV, V14, P40, DOI 10.1210/er.14.1.40; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Marshall C, 1999, CURR OPIN CELL BIOL, V11, P732, DOI 10.1016/S0955-0674(99)00044-7; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matallanas D, 2006, MOL CELL BIOL, V26, P100, DOI 10.1128/MCB.26.1.100-116.2006; Moreto J, 2008, CELL SIGNAL, V20, P1092, DOI 10.1016/j.cellsig.2008.01.022; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Plowman SJ, 2008, MOL CELL BIOL, V28, P4377, DOI 10.1128/MCB.00050-08; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Rodriguez-Vilarrupla A, 2005, MOL CELL BIOL, V25, P7364, DOI 10.1128/MCB.25.16.7364-7374.2005; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Schulman H, 1993, CURR OPIN CELL BIOL, V5, P247, DOI 10.1016/0955-0674(93)90111-3; SHALOMFEUERSTEI.R, 2008, RES, V68, P6608; UMANOFF H, 1995, P NATL ACAD SCI USA, V92, P1709, DOI 10.1073/pnas.92.5.1709; VEIGL ML, 1982, FED PROC, V41, P2283; Villalonga P, 2002, J BIOL CHEM, V277, P37929, DOI 10.1074/jbc.M202245200; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Xia SH, 2007, J BIOL CHEM, V282, P13199, DOI 10.1074/jbc.M610225200; Xia SH, 2009, CELL SIGNAL, V21, P502, DOI 10.1016/j.cellsig.2008.12.002; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052	43	46	46	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2010	29	44					5911	5922		10.1038/onc.2010.298	http://dx.doi.org/10.1038/onc.2010.298			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	675PS	20802526				2022-12-25	WOS:000283843400005
J	Wang, F; Huang, S; Ma, L				Wang, Fei; Huang, Shi; Ma, Long			Caenorhabditis elegans Operons Contain a Higher Proportion of Genes with Multiple Transcripts and Use 3 ' Splice Sites Differentially	PLOS ONE			English	Article							CONSERVATION; INTRONS	RNA splicing generates multiple transcript isoforms from a single gene and enhances the complexity of eukaryotic gene expression. In some eukaryotes, operon exists as an ancient regulatory mechanism of gene expression that requires strict positional and regulatory relationships among its genes. It remains unknown whether operonic genes generate transcript isoforms in a similar manner as non-operonic genes do, the expression of which is less likely limited by their positions and relationships with surrounding genes. We analyzed the number of transcript isoforms of Caenorhabditis elegans operonic genes and found that C. elegans operons contain a much higher proportion of genes with multiple transcript isoforms than non-operonic genes do. For genes that express multiple transcript isoforms, there is no apparent difference between the number of isoforms in operonic and non-operonic genes. C. elegans operonic genes also have a different preference of the 2' most common 3' splice sites compared to non-operonic genes. Our analyses suggest that C. elegans operons enhance expression complexity by increasing the proportion of genes that express multiple transcript isoforms and maintain splicing efficiency by differential use of common 3' splice sites.	[Wang, Fei; Huang, Shi; Ma, Long] Cent South Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China	Central South University	Wang, F (corresponding author), Cent South Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China.	longmace@gmail.com	Ma, Longtao/N-8458-2019		National Science Foundation of China [30971639]; Central South University of China	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central South University of China	This study was funded by the National Science Foundation of China grant 30971639 and a research grant provided by the Central South University of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumenthal T, 1998, BIOESSAYS, V20, P480, DOI 10.1002/(SICI)1521-1878(199806)20:6&lt;480::AID-BIES6&gt;3.0.CO;2-Q; Blumenthal T, 2003, NAT REV GENET, V4, P110, DOI 10.1038/nrg995; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Blumenthal Thomas, 2004, Briefings in Functional Genomics & Proteomics, V3, P199, DOI 10.1093/bfgp/3.3.199; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Hollins C, 2005, RNA, V11, P248, DOI 10.1261/rna.7221605; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kent WJ, 2000, NUCLEIC ACIDS RES, V28, P91, DOI 10.1093/nar/28.1.91; Kent WJ, 2000, GENOME RES, V10, P1115, DOI 10.1101/gr.10.8.1115; Ma L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000708; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; ZAHLER AM, 2005, ALTERNATIVE SPLICING; Zhang HB, 1996, RNA, V2, P380	15	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12456	10.1371/journal.pone.0012456	http://dx.doi.org/10.1371/journal.pone.0012456			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805997	gold, Green Submitted, Green Published			2022-12-25	WOS:000281301500022
J	Rosen, DB; Putta, S; Covey, T; Huang, YW; Nolan, GP; Cesano, A; Minden, MD; Fantl, WJ				Rosen, David B.; Putta, Santosh; Covey, Todd; Huang, Ying-Wen; Nolan, Garry P.; Cesano, Alessandra; Minden, Mark D.; Fantl, Wendy J.			Distinct Patterns of DNA Damage Response and Apoptosis Correlate with Jak/Stat and PI3Kinase Response Profiles in Human Acute Myelogenous Leukemia	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; RIBOSOMAL-PROTEIN S6; SIGNAL-TRANSDUCTION; CANCER; EXPRESSION; KINASE; MUTATIONS; NETWORK; IMPACT	Background: Single cell network profiling (SCNP) utilizing flow cytometry measures alterations in intracellular signaling responses. Here SCNP was used to characterize Acute Myeloid Leukemia (AML) disease subtypes based on survival, DNA damage response and apoptosis pathways. Methodology and Principal Findings: Thirty four diagnostic non-M3 AML samples from patients with known clinical outcome were treated with a panel of myeloid growth factors and cytokines, as well as with apoptosis-inducing agents. Analysis of induced Jak/Stat and PI3K pathway responses in blasts from individual patient samples identified subgroups with distinct signaling profiles that were not seen in the absence of a modulator. In vitro exposure of patient samples to etoposide, a DNA damaging agent, revealed three distinct "DNA damage response (DDR)/apoptosis'' profiles: 1) AML blasts with a defective DDR and failure to undergo apoptosis; 2) AML blasts with proficient DDR and failure to undergo apoptosis; 3) AML blasts with proficiency in both DDR and apoptosis pathways. Notably, AML samples from clinical responders fell within the "DDR/apoptosis'' proficient profile and, as well, had low PI3K and Jak/Stat signaling responses. In contrast, samples from clinical non responders had variable signaling profiles often with in vitro apoptotic failure and elevated PI3K pathway activity. Individual patient samples often harbored multiple, distinct, leukemia-associated cell populations identifiable by their surface marker expression, functional performance of signaling pathway in the face of cytokine or growth factor stimulation, as well as their response to apoptosis-inducing agents. Conclusions and Significance: Characterizing and tracking changes in intracellular pathway profiles in cell subpopulations both at baseline and under therapeutic pressure will likely have important clinical applications, potentially informing the selection of beneficial targeted agents, used either alone or in combination with chemotherapy.	[Rosen, David B.; Putta, Santosh; Covey, Todd; Huang, Ying-Wen; Cesano, Alessandra; Fantl, Wendy J.] Nodality Inc, San Francisco, CA USA; [Minden, Mark D.] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; [Nolan, Garry P.; Fantl, Wendy J.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Stanford University	Rosen, DB (corresponding author), Nodality Inc, San Francisco, CA USA.	wjfantl@stanford.edu	Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043; Huang, Ying-Wen/0000-0003-3727-7903	Nodality Inc.	Nodality Inc.	Nodality Inc. funded this research. Nodality had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Baldus CD, 2007, BRIT J HAEMATOL, V137, P387, DOI 10.1111/j.1365-2141.2007.06566.x; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Becker H, 2010, J CLIN ONCOL, V28, P596, DOI 10.1200/JCO.2009.25.1496; Benekli M, 2002, BLOOD, V99, P252, DOI 10.1182/blood.V99.1.252; Benekli M, 2003, BLOOD, V101, P2940, DOI 10.1182/blood-2002-04-1204; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bunting KD, 2007, FRONT BIOSCI-LANDMRK, V12, P2807, DOI 10.2741/2274; Cheong JW, 2003, BRIT J HAEMATOL, V122, P454, DOI 10.1046/j.1365-2141.2003.04452.x; Choudhary C, 2005, INT J HEMATOL, V82, P93, DOI 10.1532/IJH97.05090; Coffer PJ, 2000, ONCOGENE, V19, P2511, DOI 10.1038/sj.onc.1203479; COULDWELL WT, 1994, FEBS LETT, V345, P43, DOI 10.1016/0014-5793(94)00415-3; Cox J, 2007, CELL, V130, P395, DOI 10.1016/j.cell.2007.07.032; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Danna EA, 2006, CURR OPIN CHEM BIOL, V10, P20, DOI 10.1016/j.cbpa.2005.12.021; de Jonge-Peeters SDPWM, 2007, CRIT REV ONCOL HEMAT, V62, P214, DOI 10.1016/j.critrevonc.2007.02.003; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Doepfner KT, 2007, CRIT REV ONCOL HEMAT, V63, P215, DOI 10.1016/j.critrevonc.2007.05.005; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Fathi AT, 2010, CANCER TREAT REV, V36, P142, DOI 10.1016/j.ctrv.2009.12.004; Fraser IDC, 2009, NAT IMMUNOL, V10, P327, DOI 10.1038/ni.1711; Han L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007989; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Ho MM, 2008, EXP HEMATOL, V36, P433, DOI 10.1016/j.exphem.2007.11.014; Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Irish JM, 2006, BLOOD, V108, P3135, DOI 10.1182/blood-2006-02-003921; Irish JM, 2006, J IMMUNOL, V177, P1581, DOI 10.4049/jimmunol.177.3.1581; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jolliffe, 2002, PRINCIPAL COMPONENT; Kim HS, 2007, CELL SIGNAL, V19, P454, DOI 10.1016/j.cellsig.2006.09.003; Kishimoto T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1916; Kok K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005145; Kok K, 2009, TRENDS BIOCHEM SCI, V34, P115, DOI 10.1016/j.tibs.2009.01.003; KORNBLAU SM, 2010, CLIN CANC R IN PRESS; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Lowenberg Bob, 2008, Hematology Am Soc Hematol Educ Program, P1, DOI 10.1182/asheducation-2008.1.1; Marcucci Guido, 2009, Clin Adv Hematol Oncol, V7, P448; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Martelli AM, 2009, EXPERT OPIN INV DRUG, V18, P1333, DOI 10.1517/14728220903136775; Masson K, 2009, CELL SIGNAL, V21, P1717, DOI 10.1016/j.cellsig.2009.06.002; Meshinchi S, 2009, CLIN CANCER RES, V15, P4263, DOI 10.1158/1078-0432.CCR-08-1123; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Mrozek K, 2009, CURR OPIN HEMATOL, V16, P64, DOI 10.1097/MOH.0b013e3283257b42; Muslimovic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005859; Pawson T, 2008, FEBS LETT, V582, P1266, DOI 10.1016/j.febslet.2008.02.011; Ravandi F, 2007, CANCER-AM CANCER SOC, V110, P1900, DOI 10.1002/cncr.23000; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schlenk RF, 2009, CURR OPIN HEMATOL, V16, P98, DOI 10.1097/MOH.0b013e3283257adb; Seita J, 2008, BLOOD, V111, P1903, DOI 10.1182/blood-2007-06-093328; Shipley JL, 2009, EXP HEMATOL, V37, P649, DOI 10.1016/j.exphem.2009.04.002; STELZER GT, 1993, ANN NY ACAD SCI, V677, P265, DOI 10.1111/j.1749-6632.1993.tb38783.x; Sujobert P, 2005, BLOOD, V106, P1063, DOI 10.1182/blood-2004-08-3225; Svirnovski AI, 2009, HEMATOLOGY, V14, P204, DOI 10.1179/102453309X426218; Tallman MS, 2005, BLOOD, V106, P1154, DOI 10.1182/blood-2005-01-0178; Valentino L, 2006, BIOCHEM PHARMACOL, V71, P713, DOI 10.1016/j.bcp.2005.12.017; Vogt PK, 2009, CURR OPIN GENET DEV, V19, P12, DOI 10.1016/j.gde.2008.11.011; Wierenga ATJ, 2008, MOL CELL BIOL, V28, P6668, DOI 10.1128/MCB.01025-08; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoshida H, 2009, J LEUKOCYTE BIOL, V86, P1295, DOI 10.1189/jlb.0609445; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	68	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12405	10.1371/journal.pone.0012405	http://dx.doi.org/10.1371/journal.pone.0012405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811632	Green Submitted, gold, Green Published			2022-12-25	WOS:000281234700027
J	Carmon, A; Guertin, MJ; Grushko, O; Marshall, B; MacIntyre, R				Carmon, Amber; Guertin, Michael J.; Grushko, Olga; Marshall, Brad; MacIntyre, Ross			A Molecular Analysis of Mutations at the Complex dumpy Locus in Drosophila melanogaster	PLOS ONE			English	Article							GENETIC-ANALYSIS; SELECTION PRESSURE; RNA-SEQ; EVOLUTION; COMPLEMENTATION; MUTAGENESIS; EXPRESSION; CHARACTER; NONSENSE; ADHESION	The Drosophila dumpy gene consists of seventy eight coding exons and encodes a huge extracellular matrix protein containing large numbers of epidermal growth factor-like (EGF) modules and a novel module called dumpy (DPY). A molecular analysis of forty five mutations in the dumpy gene of Drosophila melanogaster was carried out. Mutations in this gene affect three phenotypes: wing shape, thoracic cuticular defects, and lethality. Most of the mutations were chemically induced in a single dumpy allele and were analyzed using a nuclease that cleaves single base pair mismatches in reannealed duplexes followed by dHPLC. Additionally, several spontaneous mutations were analyzed. Virtually all of the chemically induced mutations, except for several in a single exon, either generate nonsense codons or lesions that result in downstream stop codons in the reading frame. The remaining chemically induced mutations remove splice sites in the nascent dumpy message. We propose that the vast majority of nonsense mutations that affect all three basic dumpy phenotypes are in constitutive exons, whereas nonsense mutants that remove only one or two of the basic functions are in alternatively spliced exons. Evolutionary comparisons of the dumpy gene from seven Drosophila species show strong conservation of the 5' ends of exons where mutants with partial dumpy function are found. In addition, reverse transcription PCR analyses reveal transcripts in which exons marked by nonsense mutations with partial dumpy function are absent.	[Carmon, Amber; Guertin, Michael J.; Marshall, Brad; MacIntyre, Ross] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Grushko, Olga] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	Cornell University; University of Michigan System; University of Michigan	Carmon, A (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	rjm18@cornell.edu			United States Department of Agriculture [NYC-165426]; National Institutes of Health [1R21HD059073-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD059073] Funding Source: NIH RePORTER	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by the United States Department of Agriculture Hatch Project award NYC-165426 (http://www.usda.gov/) and National Institutes of Health grant 1R21HD059073-01A1 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenburg E, 1920, GENETICS, V5, P1; Behm-Ansmant I, 2006, GENE DEV, V20, P391, DOI 10.1101/gad.1407606; Bokel C, 2005, J CELL SCI, V118, P633, DOI 10.1242/jcs.01619; Bridges CB, 1919, GENETICS, V4, P283; CARLSON EA, 1962, GENETICS, V47, P321; CARLSON EA, 1959, GENETICS, V44, P347; CARLSON EA, 1959, Q REV BIOL, V34, P33, DOI 10.1086/402574; Carmon A, 2007, GENETICS, V176, P309, DOI 10.1534/genetics.106.060897; Carmon A, 2010, FLY, V4, P117, DOI 10.4161/fly.4.2.11953; Carmon A, 2010, J MOL EVOL, V70, P260, DOI 10.1007/s00239-010-9327-1; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; DAVIS MB, 1988, GENETICS, V120, P755; FINCHAM JRS, 1966, COMPLEMENTATION MAPS, P90; GRACE D, 1980, GENETICS, V94, P647; GRACE D, 1970, MUTAT RES, V10, P489, DOI 10.1016/0027-5107(70)90008-4; Graveley BR, 2005, CELL, V123, P65, DOI 10.1016/j.cell.2005.07.028; Horiuchi T, 2006, BIOL CELL, V98, P135, DOI 10.1042/BC20050002; Horiuchi T, 2003, GENE DEV, V17, P2496, DOI 10.1101/gad.1137303; JACK J, 1995, GENETICS, V139, P1689; Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049; JENKINS JB, 1967, GENETICS, V57, P783; Krauss V, 2004, GENE, V331, P165, DOI 10.1016/j.gene.2004.02.019; LEWIS EB, 1968, DROSOPHILA INFORM SE, V43, P193; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Lu HC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000608; Mahoney MB, 2006, GENETICS, V172, P2309, DOI 10.1534/genetics.104.035170; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mohr OL, 1923, STUD MENDELIANA AD C, P266; MOHR OTTO L., 1929, ZEITSCHR INDUKT ABSTAMMUNGS U VERERBUNGSLEHRE, V50, P113, DOI 10.1007/BF01742053; MONTGOMERIE DW, 1974, RECOMBINATION MUTATI; Morgan T. H, 1915, MECH MENDELIAN HERED; Morgan TH, 1911, SCIENCE, V33, P496, DOI 10.1126/science.33.848.496; MORGAN TH, 1929, CONTRIBUTIONS GENETI, P171; Muller HJ, 1922, AM NAT, V56, P32, DOI 10.1086/279846; Olson S, 2007, NAT STRUCT MOL BIOL, V14, P1134, DOI 10.1038/nsmb1339; Prout M, 1997, GENETICS, V146, P275; Rowley JD, 2008, SCIENCE, V321, P1302, DOI 10.1126/science.1163791; Rozen S, 2000, Methods Mol Biol, V132, P365; SEDEROFF R, 1967, NATURE, V216, P1348, DOI 10.1038/2161348b0; SEGRAVES WA, 1984, J MOL BIOL, V175, P1, DOI 10.1016/0022-2836(84)90441-8; SOUTHIN JL, 1966, MUTAT RES, V3, P54, DOI 10.1016/0027-5107(66)90007-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6; Xing Y, 2005, P NATL ACAD SCI USA, V102, P13526, DOI 10.1073/pnas.0501213102; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896	46	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12319	10.1371/journal.pone.0012319	http://dx.doi.org/10.1371/journal.pone.0012319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20811586	Green Published, gold, Green Submitted			2022-12-25	WOS:000281153500007
J	Durrmeyer, X; Hovhannisyan, S; Medard, Y; Jacqz-Aigrain, E; Decobert, F; Barre, J; Alberti, C; Aujard, Y; Danan, C; Baud, O				Durrmeyer, Xavier; Hovhannisyan, Shushanik; Medard, Yves; Jacqz-Aigrain, Evelyne; Decobert, Fabrice; Barre, Jerome; Alberti, Corinne; Aujard, Yannick; Danan, Claude; Baud, Olivier			Are Cytochrome P450 CYP2C8 and CYP2C9 Polymorphisms Associated with Ibuprofen Response in Very Preterm Infants?	PLOS ONE			English	Article							PATENT DUCTUS-ARTERIOSUS; HYALINE-MEMBRANE DISEASE; NEONATAL-MORTALITY; DEVELOPMENTAL EXPRESSION; GENETIC POLYMORPHISMS; RACIAL-DIFFERENCES; HUMAN LIVER; RISK; METABOLISM; PHARMACOKINETICS	Background: Patent ductus arteriosus (PDA) in extremely preterm infants remains a challenging condition with conflicting treatment strategies. Ibuprofen is currently used to treat PDA with ductal closure failure rate up to 40%. We test the hypothesis that cytochrome P450 CYP2C8/2C9 polymorphisms may predict ibuprofen response. Methodology/Principal Findings: We studied extremely preterm neonates with haemodynamically significant PDA and treated with ibuprofen. One or two variant CYP2C8 and/or 2C9 alleles were found in 17% of the population, most of them were from Caucasian ethnicity (67-74%). Response to ibuprofen and clinical course of infants carrying variants CYP2C8 and CYP2C9 were similar. Comparing infants with wild type or variant CYP2C8 and CYP2C9 genotypes, response rate to ibuprofen was significantly higher in wild type than in mutated carriers in univariate analysis (73% versus 52%, p = 0.04). Comparing responders (ductus closure; n = 75) and non-responders (surgical ligation; n = 36), the only two factors significantly associated with the response to ibuprofen using multivariate analysis were higher gestational age and non Caucasian ethnicity but not CYP2C polymorphism. Conclusions: CYP2C polymorphism was not associated with PDA response to ibuprofen and this factor appears not appropriate to optimize the ductal closure rate by modulating ibuprofen dosing strategy. This study points out the role for ethnicity in the interindividual variability of response to ibuprofen in extremely preterm infants.	[Durrmeyer, Xavier; Decobert, Fabrice; Danan, Claude] CHI Creteil, Neonatal Intens Care Unit, Creteil, France; [Hovhannisyan, Shushanik; Aujard, Yannick; Baud, Olivier] Robert Debre Childrens Hosp, Neonatal Intens Care Unit, Paris, France; [Medard, Yves; Jacqz-Aigrain, Evelyne] Robert Debre Childrens Hosp, CIC INSERM 9202, Dept Pediat Pharmacol & Pharmacogenet, Paris, France; [Barre, Jerome] CHI Creteil, Clin Res Funct Unit, Creteil, France; [Alberti, Corinne] Robert Debre Childrens Hosp, CIC EC, Clin Epidemiol Unit, Paris, France; [Durrmeyer, Xavier; Hovhannisyan, Shushanik; Medard, Yves; Jacqz-Aigrain, Evelyne; Decobert, Fabrice; Barre, Jerome; Alberti, Corinne; Aujard, Yannick; Danan, Claude; Baud, Olivier] Fdn PremUP, Paris, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Durrmeyer, X (corresponding author), CHI Creteil, Neonatal Intens Care Unit, Creteil, France.	olivier.baud@rdb.aphp.fr	Jacqz-Aigrain, Evelyne/AAW-7089-2021; Durrmeyer, Xavier/AAB-7519-2020	Jacqz-Aigrain, Evelyne/0000-0002-4285-7067; Durrmeyer, Xavier/0000-0002-6303-7252	Institut National Scientifique Et de la Recherche Medicale (INSERM); Mairie de Paris	Institut National Scientifique Et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Mairie de Paris(Region Ile-de-France)	Institut National Scientifique Et de la Recherche Medicale (INSERM) and Mairie de Paris funded this study. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agundez JAG, 2009, EXPERT OPIN DRUG MET, V5, P607, DOI [10.1517/17425250902970998, 10.1517/17425250902970998 ]; Alexander GR, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e61; Aranda JV, 1997, ACTA PAEDIATR, V86, P289, DOI 10.1111/j.1651-2227.1997.tb08892.x; Bhandari V, 2009, PEDIATRICS, V123, P669, DOI 10.1542/peds.2008-1117; Clyman RI, 2007, J PEDIATR-US, V150, P216, DOI 10.1016/j.jpeds.2006.12.048; Cogolludo AL, 2009, AM J PHYSIOL-LUNG C, V297, pL619, DOI 10.1152/ajplung.00092.2009; Dagle JM, 2009, PEDIATRICS, V123, P1116, DOI 10.1542/peds.2008-0313; Dai D, 2001, PHARMACOGENETICS, V11, P597, DOI 10.1097/00008571-200110000-00006; Desfrere L, 2005, J CLIN PHARM THER, V30, P121, DOI 10.1111/j.1365-2710.2005.00630.x; El Hajjar M, 2005, ARCH DIS CHILD-FETAL, V90, pF419, DOI 10.1136/adc.2003.027698; Engel SAM, 2005, EPIDEMIOLOGY, V16, P478, DOI 10.1097/01.ede.0000164535.36412.6b; Engel SAM, 2005, EPIDEMIOLOGY, V16, P469, DOI 10.1097/01.ede.0000164539.09250.31; FARRELL PM, 1976, PEDIATRICS, V58, P167; Fleming I, 2001, CIRC RES, V88, P44, DOI 10.1161/01.RES.88.1.44; Fontaine RH, 2008, P NATL ACAD SCI USA, V105, P16779, DOI 10.1073/pnas.0803004105; FUJIKURA T, 1966, AM J OBSTET GYNECOL, V95, P572; Garcia-Martin E, 2004, CLIN PHARMACOL THER, V76, P119, DOI 10.1016/j.clpt.2004.04.006; Garcia-Martin E, 2006, MOL DIAGN THER, V10, P29, DOI 10.1007/BF03256440; Gibson CS, 2007, OBSTET GYNECOL, V109, P384, DOI 10.1097/01.AOG.0000252712.62241.1a; Hamman MA, 1997, BIOCHEM PHARMACOL, V54, P33, DOI 10.1016/S0006-2952(97)00143-3; Hammerman C, 2001, DRUG SAFETY, V24, P537, DOI 10.2165/00002018-200124070-00005; Hamvas A, 1996, NEW ENGL J MED, V334, P1635, DOI 10.1056/NEJM199606203342504; Hessol NA, 2005, PEDIATRICS, V115, pE44, DOI 10.1542/peds.2004-0478; HULSEY TC, 1993, AM J OBSTET GYNECOL, V168, P572, DOI 10.1016/0002-9378(93)90496-6; Imig JD, 2000, AM J PHYSIOL-RENAL, V279, pF965, DOI 10.1152/ajprenal.2000.279.6.F965; Ivey KN, 2006, J CLIN INVEST, V116, P2863, DOI 10.1172/JCI30349; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; Koukouritaki SB, 2004, J PHARMACOL EXP THER, V308, P965, DOI 10.1124/jpet.103.060137; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; LEEMANN TD, 1993, DRUG EXP CLIN RES, V19, P189; Lopez-Rodriguez R, 2008, PHARMACOL RES, V58, P77, DOI 10.1016/j.phrs.2008.07.004; Martinez C, 2005, BRIT J CLIN PHARMACO, V59, P62, DOI 10.1111/j.1365-2125.2004.02183.x; Mata-Greenwood E, 2008, REPROD SCI, V15, P9, DOI 10.1177/1933719107312160; McCurnin D, 2008, PEDIATRICS, V121, P945, DOI 10.1542/peds.2007-2051; Moin F, 2003, AM J PERINAT, V20, P313; Narayanan M, 2000, J PEDIATR-US, V136, P330, DOI 10.1067/mpd.2000.103414; Nelson KB, 2005, PEDIATR RES, V57, P494, DOI 10.1203/01.PDR.0000156477.00386.E7; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; PALDER SB, 1987, J PEDIATR SURG, V22, P1171, DOI 10.1016/S0022-3468(87)80730-3; Ranganathan D, 2000, J PEDIATR-US, V136, P454, DOI 10.1016/S0022-3476(00)90007-6; RIFKIND AB, 1995, ARCH BIOCHEM BIOPHYS, V320, P380, DOI 10.1016/0003-9861(95)90023-3; ROSS S, 1981, PEDIATRICS, V68, P790; Totah RA, 2005, CLIN PHARMACOL THER, V77, P341, DOI 10.1016/j.clpt.2004.12.267; Treluyer JM, 1997, PHARMACOGENETICS, V7, P441, DOI 10.1097/00008571-199712000-00002; TRUS T, 1993, J PEDIATR SURG, V28, P1137, DOI 10.1016/0022-3468(93)90148-E; Van Overmeire B, 2001, CLIN PHARMACOL THER, V70, P336, DOI 10.1067/mcp.2001.118453; Yasar U, 2002, BIOCHEM BIOPH RES CO, V299, P25, DOI 10.1016/S0006-291X(02)02592-5	47	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12329	10.1371/journal.pone.0012329	http://dx.doi.org/10.1371/journal.pone.0012329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808793	Green Published, Green Submitted, gold			2022-12-25	WOS:000281153500012
J	Chen, J; Gomes, AR; Monteiro, LJ; Wong, SY; Wu, LH; Ng, TT; Karadedou, CT; Millour, J; Ip, YC; Cheung, YN; Sunters, A; Chan, KYK; Lam, EWF; Khoo, US				Chen, Jie; Gomes, Ana R.; Monteiro, Lara J.; Wong, San Yu; Wu, Lai Han; Ng, Ting-Ting; Karadedou, Christina T.; Millour, Julie; Ip, Ying-Chi; Cheung, Yuen Nei; Sunters, Andrew; Chan, Kelvin Y. K.; Lam, Eric W. -F.; Khoo, Ui-Soon			Constitutively Nuclear FOXO3a Localization Predicts Poor Survival and Promotes Akt Phosphorylation in Breast Cancer	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; ENDOCRINE THERAPY; LEUKEMIC-CELLS; ANTIESTROGEN RESISTANCE; GEFITINIB IRESSA; EXPRESSION; APOPTOSIS; KINASE; INHIBITOR; TAMOXIFEN	Background: The PI3K-Akt signal pathway plays a key role in tumorigenesis and the development of drug-resistance. Cytotoxic chemotherapy resistance is linked to limited therapeutic options and poor prognosis. Methodology/Principal Findings: Examination of FOXO3a and phosphorylated-Akt (P-Akt) expression in breast cancer tissue microarrays showed nuclear FOXO3a was associated with lymph node positivity (p = 0.052), poor prognosis (p = 0.014), and P-Akt expression in invasive ductal carcinoma. Using tamoxifen and doxorubicin-sensitive and -resistant breast cancer cell lines as models, we found that doxorubicin-but not tamoxifen-resistance is associated with nuclear accumulation of FOXO3a, consistent with the finding that sustained nuclear FOXO3a is associated with poor prognosis. We also established that doxorubicin treatment induces proliferation arrest and FOXO3a nuclear relocation in sensitive breast cancer cells. Induction of FOXO3a activity in doxorubicin-sensitive MCF-7 cells was sufficient to promote Akt phosphorylation and arrest cell proliferation. Conversely, knockdown of endogenous FOXO3a expression reduced PI3K/Akt activity. Using MDA-MB-231 cells, in which FOXO3a activity can be induced by 4-hydroxytamoxifen, we showed that FOXO3a induction up-regulates PI3K-Akt activity and enhanced doxorubicin resistance. However FOXO3a induction has little effect on cell proliferation, indicating that FOXO3a or its downstream activity is deregulated in the cytotoxic drug resistant breast cancer cells. Thus, our results suggest that sustained FOXO3a activation can enhance hyperactivation of the PI3K/Akt pathway. Conclusions/Significance: Together these data suggest that lymph node metastasis and poor survival in invasive ductal breast carcinoma are linked to an uncoupling of the Akt-FOXO3a signaling axis. In these breast cancers activated Akt fails to inactivate and re-localize FOXO3a to the cytoplasm, and nuclear-targeted FOXO3a does not induce cell death or cell cycle arrest. As such, sustained nuclear FOXO3a expression in breast cancer may culminate in cancer progression and the development of an aggressive phenotype similar to that observed in cytotoxic chemotherapy resistant breast cancer cell models.	[Chen, Jie; Wong, San Yu; Wu, Lai Han; Ip, Ying-Chi; Cheung, Yuen Nei; Chan, Kelvin Y. K.; Khoo, Ui-Soon] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Chen, Jie; Gomes, Ana R.; Monteiro, Lara J.; Ng, Ting-Ting; Karadedou, Christina T.; Millour, Julie; Sunters, Andrew; Lam, Eric W. -F.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Canc Res UK Labs, London, England; [Sunters, Andrew] Univ London Royal Vet Coll, Dept Vet Basic Sci, London, England	University of Hong Kong; Cancer Research UK; Imperial College London; University of London; University of London Royal Veterinary College	Chen, J (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.	eric.lam@imperial.ac.uk; uskhoo@pathology.hku.hk	Khoo, Ui Soon/C-4293-2009; Khoo, Ui Soon/C-1345-2014; Chan, Kelvin/HGA-3097-2022; Monteiro, Lara J/AAU-8518-2020; Lam, Eric W-F/AAW-8566-2020; Khoo, Ui Soon/K-2041-2019	Khoo, Ui Soon/0000-0003-2200-7505; Khoo, Ui Soon/0000-0003-2200-7505; Lam, Eric W-F/0000-0003-1274-3576; 	University of Hong Kong [200807176071]; Research Grants Council of Hong Kong [HKU 767307M]; Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/47191/2008, SFRH/BD/44818/2008]; Breast Cancer Campaign [2007NovPhD16 Lam]; Cancer Research UK [C37/A5606]; Cancer Research UK [12011] Funding Source: researchfish	University of Hong Kong(University of Hong Kong); Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Breast Cancer Campaign; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was partly funded by grants from the Committee on Research and Conference Grants from the University of Hong Kong (CRCG)(200807176071); the Research Grants Council of Hong Kong General Research Fund (GRF) (HKU 767307M); Fundacao para a Ciencia e a Tecnologia (FCT) (SFRH/BD/47191/2008) (SFRH/BD/44818/2008) (http://alfa.fct.mctes.pt); Breast Cancer Campaign (2007NovPhD16 Lam) (http://www.breastcancercampaign.org); and Cancer Research UK (C37/A5606) (http://www.cancerresearchuk.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BRUNNER N, 1989, CANCER CELL-MON REV, V1, P81; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Clark AS, 2002, MOL CANCER THER, V1, P707; Clarke R, 2001, J STEROID BIOCHEM, V76, P71, DOI 10.1016/S0960-0760(00)00193-X; Clarke R, 2001, PHARMACOL REV, V53, P25; deGraffenried LA, 2003, ANN ONCOL, V14, P1051, DOI 10.1093/annonc/mdg291; Duffy MJ, 2005, CLIN CHEM, V51, P494, DOI 10.1373/clinchem.2004.046227; Elkak AE, 2001, CURR MED RES OPIN, V17, P282, DOI 10.1185/030079901753403180; Faridi J, 2003, CLIN CANCER RES, V9, P2933; de Mattos SF, 2008, MOL CANCER THER, V7, P3237, DOI 10.1158/1535-7163.MCT-08-0398; Freedman O. C., 2005, Cancer Treatment Reviews, V31, P1, DOI 10.1016/j.ctrv.2004.09.008; Frogne T, 2005, ENDOCR-RELAT CANCER, V12, P599, DOI 10.1677/erc.1.00946; Goss PE, 2008, CLIN BREAST CANCER, V8, P411, DOI 10.3816/CBC.2008.n.049; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Hui RCY, 2008, MOL CELL BIOL, V28, P5886, DOI 10.1128/MCB.01265-07; Hui RCY, 2008, MOL CANCER THER, V7, P670, DOI 10.1158/1535-7163.MCT-07-0397; Jin GS, 2004, ACTA MED OKAYAMA, V58, P197; Johnston SRD, 1997, ANTI-CANCER DRUG, V8, P911, DOI 10.1097/00001813-199711000-00002; Krol J, 2007, MOL CANCER THER, V6, P3169, DOI 10.1158/1535-7163.MCT-07-0507; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; McGovern UB, 2009, MOL CANCER THER, V8, P582, DOI 10.1158/1535-7163.MCT-08-0805; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nordigarden A, 2009, BLOOD, V113, P2302, DOI 10.1182/blood-2008-07-167023; Riggins RB, 2005, VITAM HORM, V71, P201, DOI 10.1016/S0083-6729(05)71007-4; Riggins RB, 2005, MOL CANCER THER, V4, P33; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Storz P, 2009, MOL CELL BIOL, V29, P4906, DOI 10.1128/MCB.00077-09; Sunters A, 2006, CANCER RES, V66, P212, DOI 10.1158/0008-5472.CAN-05-1997; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Yamashita H, 2008, INT J CLIN ONCOL, V13, P380, DOI 10.1007/s10147-008-0818-7; Yang JY, 2009, CLIN CANCER RES, V15, P752, DOI 10.1158/1078-0432.CCR-08-0124	33	66	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12293	10.1371/journal.pone.0012293	http://dx.doi.org/10.1371/journal.pone.0012293			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808831	Green Published, gold, Green Submitted			2022-12-25	WOS:000281077000007
J	Mathews, WC; Cachay, ER; Caperna, J; Sitapati, A; Cosman, B; Abramson, I				Mathews, William C.; Cachay, Edward R.; Caperna, Joseph; Sitapati, Amy; Cosman, Bard; Abramson, Ian			Estimating the Accuracy of Anal Cytology in the Presence of an Imperfect Reference Standard	PLOS ONE			English	Article							SQUAMOUS INTRAEPITHELIAL LESIONS; HUMAN-PAPILLOMAVIRUS; MEN; HISTOPATHOLOGY; PERFORMANCE; INFECTION; NEOPLASIA; DISEASE; CANCER; TESTS	Background: The study aim is to estimate sensitivity and specificity of anal cytology for histologic HSIL in analyses adjusted for the imperfect biopsy reference standard. Methods and Principal Findings: Retrospective cohort study of an anal dysplasia screening program for HIV infected adults. We estimated the prevalence of histologic HSIL by concurrent cytology category and the associated cytology ROC area. Cytology operating characteristics for HSIL were estimated and adjusted for the imperfect reference standard by 3 methodologies. The study cohort included 261 patients with 3 available measures: (1) referral cytology; (2) HRA cytology; and (3) HRA directed biopsy. The prevalence of biopsy HSIL varied according to the concurrent HRA cytology result: 64.5% for HSIL or ASC-H, 12.6% for LSIL, 10.9% for ASCUS, and 6.3% for no abnormality. The cytology ROC area was 0.78. The observed prevalence of HSIL was 37% (referral cytology), 24% (HRA cytology), and 24% (HRA biopsy). Unadjusted estimates of sensitivity and specificity of cytology were 0.66 and 0.90, respectively. Adjusted estimates varied from 0.47-0.89 (sensitivity) and 0.89-1.0 (specificity). Conclusions: Analysis of a single dataset yields widely different estimates of anal cytology operating characteristics that depend on difficult to verify assumptions regarding the accuracy of the imperfect reference standard.	[Mathews, William C.; Cachay, Edward R.; Caperna, Joseph; Sitapati, Amy] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Cosman, Bard] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Abramson, Ian] Univ Calif San Diego, Dept Math, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Mathews, WC (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.	cmathews@ucsd.edu	Mathews, William C/E-4451-2010	Mathews, William C/0000-0002-2352-0725	Center for AIDS Research (CFAR)-Network of Integrated Clinical Systems [AI067039]; Pacific AIDS Education and Training Center [H4A HA 00058]; University of California at San Diego, CFAR [AI 36214]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI067039, P30AI036214] Funding Source: NIH RePORTER	Center for AIDS Research (CFAR)-Network of Integrated Clinical Systems; Pacific AIDS Education and Training Center; University of California at San Diego, CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the following grants: Center for AIDS Research (CFAR)-Network of Integrated Clinical Systems (AI067039), Pacific AIDS Education and Training Center (H4A HA 00058) and University of California at San Diego, CFAR (AI 36214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J, 2008, SEX TRANSM INFECT, V84, P94, DOI 10.1136/sti.2007.027250; Bjorge T, 2002, BRIT J CANCER, V87, P61, DOI 10.1038/sj.bjc.6600350; Byrom J, 2006, INT J GYNECOL CANCER, V16, P253, DOI 10.1111/j.1525-1438.2006.00344.x; Carns B, 2008, INT J CLIN EXP PATHO, V1, P285; Chiao EY, 2006, CLIN INFECT DIS, V43, P223, DOI 10.1086/505219; Chin-Hong PV, 2002, CLIN INFECT DIS, V35, P1127, DOI 10.1086/344057; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; DIBONITO L, 1993, CANCER-AM CANCER SOC, V72, P3002, DOI 10.1002/1097-0142(19931115)72:10<3002::AID-CNCR2820721023>3.0.CO;2-4; Fox PA, 2006, CURR OPIN INFECT DIS, V19, P62, DOI 10.1097/01.qco.0000199019.50451.a8; Fremont-Smith M, 2004, CANCER CYTOPATHOL, V102, P269, DOI 10.1002/cncr.20599; Hadgu A, 2005, EPIDEMIOLOGY, V16, P604, DOI 10.1097/01.ede.0000173042.07579.17; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Ho KS, 2010, CURR OPIN INFECT DIS, V23, P21, DOI 10.1097/QCO.0b013e328334fe5a; Jay N, 1997, DIS COLON RECTUM, V40, P919, DOI 10.1007/BF02051199; Lytwyn A, 2005, CANCER-AM CANCER SOC, V103, P1447, DOI 10.1002/cncr.20927; Mathews Christopher, 2007, Open AIDS J, V1, P11, DOI 10.2174/1874613600701010011; Mathews WC, 2004, JAIDS-J ACQ IMM DEF, V37, P1610, DOI 10.1097/00126334-200412150-00014; Mathews Wm Christopher, 2003, Top HIV Med, V11, P45; McCutcheon AL, 1987, LATENT CLASS ANAL; Nathan M, 2010, AIDS, V24, P373, DOI 10.1097/QAD.0b013e328333ab8e; Palefsky JM, 1998, AIDS, V12, P495, DOI 10.1097/00002030-199805000-00011; Pepe MS, 2007, BIOSTATISTICS, V8, P474, DOI 10.1093/biostatistics/kxl038; Reitsma JB, 2009, J CLIN EPIDEMIOL, V62, P797, DOI 10.1016/j.jclinepi.2009.02.005; Solomon D., 2004, BETHESDA SYSTEM REPO; STAQUET M, 1981, J CHRON DIS, V34, P599, DOI 10.1016/0021-9681(81)90059-X; *TRIPATH IM, BD SUREPATH PAP TEST	26	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12284	10.1371/journal.pone.0012284	http://dx.doi.org/10.1371/journal.pone.0012284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808869	Green Submitted, Green Published, gold			2022-12-25	WOS:000281075500017
J	Dehlink, E; Baker, AH; Yen, E; Nurko, S; Fiebiger, E				Dehlink, Eleonora; Baker, Alexandra H.; Yen, Elizabeth; Nurko, Samuel; Fiebiger, Edda			Relationships between Levels of Serum IgE, Cell-Bound IgE, and IgE-Receptors on Peripheral Blood Cells in a Pediatric Population	PLOS ONE			English	Article							FC-EPSILON-RI; IMMUNOGLOBULIN-E LEVELS; MEDIATOR RELEASE; LANGERHANS CELLS; HUMAN BASOPHILS; MAST-CELLS; EXPRESSION; MONOCYTES; CHILDREN; SURFACE	Background: Elevated serum immunoglobulin (Ig) E is a diagnostic marker of immediate-type allergic reactions. We hypothesize that serum IgE does not necessarily reflect total body IgE because in vivo IgE can be bound to cell surface receptors such as Fc epsilon RI and Fc epsilon RII (CD23). The aim of this study was to analyze the relationships between levels of serum IgE, cell-bound IgE, and IgE-receptors on peripheral blood cells in a pediatric population. Methodology: Whole blood samples from 48 children (26 boys, 22 girls, mean age 10,3 +/- 5,4 years) were analyzed by flow cytometry for Fc epsilon RI, CD23, and cell-bound IgE on dendritic cells (CD11c+MHC class II+), monocytes (CD14+), basophils (CD123+MHC class II-) and neutrophils (myeloperoxidase+). Total serum IgE was measured by ELISA and converted into z-units to account for age-dependent normal ranges. Correlations were calculated using Spearman rank correlation test. Principal Findings: Dendritic cells, monocytes, basophils, and neutrophils expressed the high affinity IgE-receptor Fc epsilon RI. Dendritic cells and monocytes also expressed the low affinity receptor CD23. The majority of IgE-receptor positive cells carried IgE on their surface. Expression of both IgE receptors was tightly correlated with cell-bound IgE. In general, cell-bound IgE on Fc epsilon RI+ cells correlated well with serum IgE. However, some patients carried high amounts of cell-bound IgE despite low total serum IgE levels. Conclusion/Significance: In pediatric patients, levels of age-adjusted serum IgE, cell-bound IgE, and Fc epsilon RI correlate. Even in the absence of elevated levels of serum IgE, cell-bound IgE can be detected on peripheral blood cells in a subgroup of patients.	[Dehlink, Eleonora; Baker, Alexandra H.; Yen, Elizabeth; Nurko, Samuel; Fiebiger, Edda] Harvard Univ, Sch Med, Div Gastroenterol & Nutr, Childrens Hosp Boston, Boston, MA 02115 USA; [Dehlink, Eleonora; Baker, Alexandra H.; Yen, Elizabeth; Nurko, Samuel; Fiebiger, Edda] Harvard Univ, Sch Med, EGID Ctr, Childrens Hosp Boston, Boston, MA USA; [Dehlink, Eleonora] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Medical University of Vienna	Dehlink, E (corresponding author), Harvard Univ, Sch Med, Div Gastroenterol & Nutr, Childrens Hosp Boston, Boston, MA 02115 USA.	edda.fiebiger@childrens.harvard.edu	Baker, Alexandra/ABF-1321-2021	Yen, Elizabeth/0000-0002-7172-8723; Nurko, Samuel/0000-0003-0936-4807	Gerber Foundation; Thrasher Research Fund; AGA; NIH [K24DK82792-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082792] Funding Source: NIH RePORTER	Gerber Foundation; Thrasher Research Fund; AGA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Gerber Foundation (Drs. Nurko and Fiebiger) and the Thrasher Research Fund (Dr. Dehlink). Further support came from a Research Scholar Award from the AGA (to E.F.) and NIH K24DK82792-1 (to S.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam JP, 2003, J ALLERGY CLIN IMMUN, V112, P141, DOI 10.1067/mai.2003.1607; Alphonse MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001921; Beck LA, 2004, J ALLERGY CLIN IMMUN, V114, P527, DOI 10.1016/j.jaci.2004.06.032; Benhamou AH, 2008, PEDIATR ALLERGY IMMU, V19, P173, DOI 10.1111/j.1399-3038.2007.00602.x; BIEBER T, 1992, RES IMMUNOL, V143, P445, DOI 10.1016/S0923-2494(05)80082-3; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Celik-Bilgili S, 2005, CLIN EXP ALLERGY, V35, P268, DOI 10.1111/j.1365-2222.2005.02150.x; Chehade M, 2007, CURR OPIN ALLERGY CL, V7, P264, DOI 10.1097/ACI.0b013e32814a5607; CONROY MC, 1977, J IMMUNOL, V118, P1317; Gomez G, 2007, J IMMUNOL, V179, P1353, DOI 10.4049/jimmunol.179.2.1353; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; KJELLMAN NIM, 1976, CLIN ALLERGY, V6, P51, DOI 10.1111/j.1365-2222.1976.tb01411.x; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Kubota T, 2006, J IMMUNOL, V176, P7008, DOI 10.4049/jimmunol.176.11.7008; Lemieux GA, 2007, J BIOL CHEM, V282, P14836, DOI 10.1074/jbc.M608414200; LIANG Y, 2009, J IMMUNOL METHODS; MacGlashan D, 2005, ANN NY ACAD SCI, V1050, P73, DOI 10.1196/annals.1313.009; MALVEAUX FJ, 1978, J CLIN INVEST, V62, P176, DOI 10.1172/JCI109103; MAURER D, 1994, J EXP MED, V179, P745, DOI 10.1084/jem.179.2.745; Mora J, 2009, CLIN IMMUNOL, V132, P132, DOI 10.1016/j.clim.2009.03.513; Nopp A, 2006, ALLERGY, V61, P298, DOI 10.1111/j.1398-9995.2006.00987.x; Novak N, 2003, J ALLERGY CLIN IMMUN, V112, P252, DOI 10.1067/mai.2003.1595; Prussin C, 2003, J ALLERGY CLIN IMMUN, V112, P1147, DOI 10.1016/j.jaci.2003.10.003; Rolinck-Werninghaus C, 2008, ALLERGY, V63, P1339, DOI 10.1111/j.1398-9995.2008.01692.x; Saini SS, 2000, J ALLERGY CLIN IMMUN, V106, P514, DOI 10.1067/mai.2000.108431; Saini SS, 1999, J IMMUNOL, V162, P5624; Sihra BS, 1997, J ALLERGY CLIN IMMUN, V99, P699, DOI 10.1016/S0091-6749(97)70033-2; Wada T, 1999, PEDIATR RES, V46, P603, DOI 10.1203/00006450-199911000-00018; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Wollenberg A, 1998, ARCH DERMATOL RES, V290, P517, DOI 10.1007/s004030050345; Yamaguchi M, 1999, J IMMUNOL, V162, P5455	31	49	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12204	10.1371/journal.pone.0012204	http://dx.doi.org/10.1371/journal.pone.0012204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808937	gold, Green Submitted, Green Published			2022-12-25	WOS:000280968000027
J	Elrod, HA; Fan, SQ; Muller, S; Chen, GZ; Pan, L; Tighiouart, M; Shin, DM; Khuri, FR; Sun, SY				Elrod, Heath A.; Fan, Songqing; Muller, Susan; Chen, Georgia Z.; Pan, Lin; Tighiouart, Mourad; Shin, Dong M.; Khuri, Fadlo R.; Sun, Shi-Yong			Analysis of Death Receptor 5 and Caspase-8 Expression in Primary and Metastatic Head and Neck Squamous Cell Carcinoma and Their Prognostic Impact	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; LYMPH-NODE METASTASIS; CANCER-THERAPY; TUMOR SURVEILLANCE; LUNG-CANCER; MU-CALPAIN; TRAIL; MIGRATION; NEUROBLASTOMA; ADHESION	Death receptor 5 (DR5) and caspase-8 are major components in the extrinsic apoptotic pathway. The alterations of the expression of these proteins during the metastasis of head and neck squamous cell carcinoma (HNSCC) and their prognostic impact have not been reported. The present study analyzes the expression of DR5 and caspase-8 by immunohistochemistry (IHC) in primary and metastatic HNSCCs and their impact on patient survival. Tumor samples in this study included 100 primary HNSCC with no evidence of metastasis, 100 primary HNSCC with lymph node metastasis (LNM) and 100 matching LNM. IHC analysis revealed a significant loss or downregulation of DR5 expression in primary tumors with metastasis and their matching LNM compared to primary tumors with no evidence of metastasis. A similar trend was observed in caspase-8 expression although it was not statistically significant. Downregulation of caspase-8 and DR5 expression was significantly correlated with poorly differentiated tumors compared to moderately and well differentiated tumors. Univariate analysis indicates that, in HNSCC with no metastasis, higher expression of caspase-8 significantly correlated with better disease-free survival and overall survival. However, in HNSCC with LNM, higher caspase-8 expression significantly correlated with poorer disease-free survival and overall survival. Similar results were also generated when we combined both DR5 and caspase-8. Taken together, we suggest that both DR5 and caspase-8 are involved in regulation of HNSCC metastasis. Our findings warrant further investigation on the dual role of caspase-8 in cancer development.	[Elrod, Heath A.; Fan, Songqing; Chen, Georgia Z.; Shin, Dong M.; Khuri, Fadlo R.; Sun, Shi-Yong] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Elrod, Heath A.; Fan, Songqing; Muller, Susan; Chen, Georgia Z.; Pan, Lin; Tighiouart, Mourad; Shin, Dong M.; Khuri, Fadlo R.; Sun, Shi-Yong] Winship Canc Inst, Atlanta, GA USA; [Muller, Susan] Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Pan, Lin; Tighiouart, Mourad] Emory Univ, Sch Med, Dept Biostat & Bioinformat, Atlanta, GA USA	Emory University; Emory University; Emory University	Elrod, HA (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.	ssun@emory.edu	Shin, Dong Moon/G-9649-2013; Khuri, Fadlo R./AAU-4942-2020; Ray, Dana M/C-3470-2013	Shin, Dong Moon/0000-0002-8245-4174; Khuri, Fadlo R./0000-0002-8638-7618; 	Georgia Cancer Coalition Distinguished Cancer Scholar award; National Institutes of Health [CA128613]; NATIONAL CANCER INSTITUTE [P50CA128613] Funding Source: NIH RePORTER	Georgia Cancer Coalition Distinguished Cancer Scholar award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Georgia Cancer Coalition Distinguished Cancer Scholar award (SYS) and National Institutes of Health SPORE P50 grant CA128613 (SYS and FRK for Project 2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasan A, 2003, CYTOKINE GROWTH F R, V14, P337, DOI 10.1016/S1359-6101(03)00029-7; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Barbero S, 2008, J BIOL CHEM, V283, P13031, DOI 10.1074/jbc.M800549200; Barbero S, 2009, CANCER RES, V69, P3755, DOI 10.1158/0008-5472.CAN-08-3937; Bellail AC, 2009, REV RECENT CLIN TRIA, V4, P34, DOI 10.2174/157488709787047530; Cooper WA, 2008, CANCER, V113, P135, DOI 10.1002/cncr.23528; Duiker EW, 2010, GYNECOL ONCOL, V116, P549, DOI 10.1016/j.ygyno.2009.09.014; Finlay D, 2007, CANCER RES, V67, P11704, DOI 10.1158/0008-5472.CAN-07-1906; Frisch SM, 2008, CANCER RES, V68, P4491, DOI 10.1158/0008-5472.CAN-08-0952; Fulda S, 2006, CANCER RES, V66, P10016, DOI 10.1158/0008-5472.CAN-05-4079; Ganten TM, 2009, J MOL MED, V87, P995, DOI 10.1007/s00109-009-0510-z; Grosse-Wilde A, 2008, J CLIN INVEST, V118, P100, DOI 10.1172/JCI33061; Harada K, 2002, CANCER RES, V62, P5897; Heijink DM, 2007, CELL ONCOL, V29, P409; Helfer B, 2006, CANCER RES, V66, P4273, DOI 10.1158/0008-5472.CAN-05-4183; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hopkins-Donaldson S, 2003, CELL DEATH DIFFER, V10, P356, DOI 10.1038/sj.cdd.4401157; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Koornstra JJ, 2005, EUR J CANCER, V41, P1195, DOI 10.1016/j.ejca.2005.02.018; Laguinge LM, 2008, CANCER RES, V68, P909, DOI 10.1158/0008-5472.CAN-06-1806; Lu LM, 2007, J IMMUNOL, V178, P936, DOI 10.4049/jimmunol.178.2.936; Maduro JH, 2009, INT J RADIAT ONCOL, V75, P203, DOI 10.1016/j.ijrobp.2009.03.071; Muller S, 2008, CANCER-AM CANCER SOC, V113, P97, DOI 10.1002/cncr.23557; Murin S, 2004, CHEST, V125, P1467, DOI 10.1378/chest.125.4.1467; Nagaraj NS, 2007, TOXICOL LETT, V170, P134, DOI 10.1016/j.toxlet.2007.02.014; Nam NJ, 2002, APMIS, V110, P825, DOI 10.1034/j.1600-0463.2002.1101109.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pingoud-Meier C, 2003, CLIN CANCER RES, V9, P6401; Reesink-Peters N, 2005, GYNECOL ONCOL, V96, P705, DOI 10.1016/j.ygyno.2004.10.046; Samara RN, 2007, CANCER RES, V67, P4774, DOI 10.1158/0008-5472.CAN-06-4315; Seiwert TY, 2005, BRIT J CANCER, V92, P1341, DOI 10.1038/sj.bjc.6602510; Senft J, 2007, CANCER RES, V67, P11505, DOI 10.1158/0008-5472.CAN-07-5755; Shivapurkar N, 2002, CANCER BIOL THER, V1, P65, DOI 10.4161/cbt.1.1.45; Soung YH, 2005, CANCER RES, V65, P815; Soung YH, 2005, ONCOGENE, V24, P141, DOI 10.1038/sj.onc.1208244; Spierings DCJ, 2003, CLIN CANCER RES, V9, P3397; Stupack DG, 2006, NATURE, V439, P95, DOI 10.1038/nature04323; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Trauzold A, 2006, ONCOGENE, V25, P7434, DOI 10.1038/sj.onc.1209719; Vakkala M, 1999, BRIT J CANCER, V81, P592, DOI 10.1038/sj.bjc.6690735; van Geelen CM, 2006, J CLIN ONCOL, V24, P4998, DOI 10.1200/JCO.2006.06.8809; Virkajarvi N, 1998, HISTOPATHOLOGY, V33, P432, DOI 10.1046/j.1365-2559.1998.00553.x; Wajant H, 2002, APOPTOSIS, V7, P449, DOI 10.1023/A:1020039225764; Wajant H, 2006, CANC TREAT, V130, P141; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Xu B, 2008, ONCOLOGY-BASEL, V74, P229, DOI 10.1159/000151392; Xu LJ, 2006, J BIOL CHEM, V281, P4457, DOI 10.1074/jbc.M510721200; Xu LJ, 2004, J BIOL CHEM, V279, P53683, DOI 10.1074/jbc.M409889200; Zhang X, 2004, CLIN CANCER RES, V10, P8451, DOI 10.1158/1078-0432.CCR-04-0546; Zhuang LQ, 2006, HUM PATHOL, V37, P1286, DOI 10.1016/j.humpath.2006.04.026; Zuzak TJ, 2002, EUR J CANCER, V38, P83, DOI 10.1016/S0959-8049(01)00355-0	52	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12178	10.1371/journal.pone.0012178	http://dx.doi.org/10.1371/journal.pone.0012178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808443	Green Submitted, Green Published, gold			2022-12-25	WOS:000280968000009
J	Hessel, A; Schwendinger, M; Fritz, D; Coulibaly, S; Holzer, GW; Sabarth, N; Kistner, O; Wodal, W; Kerschbaum, A; Savidis-Dacho, H; Crowe, BA; Kreil, TR; Barrett, PN; Falkner, FG				Hessel, Annett; Schwendinger, Michael; Fritz, Daniela; Coulibaly, Sogue; Holzer, Georg W.; Sabarth, Nicolas; Kistner, Otfried; Wodal, Walter; Kerschbaum, Astrid; Savidis-Dacho, Helga; Crowe, Brian A.; Kreil, Thomas R.; Barrett, P. Noel; Falkner, Falko G.			A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations	PLOS ONE			English	Article							CROSS-CLADE PROTECTION; CD8(+) T-CELLS; VIRUS-INFECTION; A/H5N1 VIRUSES; IMMUNITY; H5N1; RECOMBINANTS; ANTIBODIES; SEQUENCE; ANTIGEN	Background: The development of novel influenza vaccines inducing a broad immune response is an important objective. The aim of this study was to evaluate live vaccines which induce both strong humoral and cell-mediated immune responses against the novel human pandemic H1N1 influenza virus, and to show protection in a lethal animal challenge model. Methodology/Principal Findings: For this purpose, the hemagglutinin (HA) and neuraminidase (NA) genes of the influenza A/California/07/2009 (H1N1) strain (CA/07) were inserted into the replication-deficient modified vaccinia Ankara (MVA) virus - a safe poxviral live vector - resulting in MVA-H1-Ca and MVA-N1-Ca vectors. These live vaccines, together with an inactivated whole virus vaccine, were assessed in a lung infection model using immune competent Balb/c mice, and in a lethal challenge model using severe combined immunodeficient (SCID) mice after passive serum transfer from immunized mice. Balb/c mice vaccinated with the MVA-H1-Ca virus or the inactivated vaccine were fully protected from lung infection after challenge with the influenza H1N1 wild-type strain, while the neuraminidase virus MVA-N1-Ca induced only partial protection. The live vaccines were already protective after a single dose and induced substantial amounts of neutralizing antibodies and of interferon-gamma-secreting (IFN-gamma) CD4- and CD8 T-cells in lungs and spleens. In the lungs, a rapid increase of HA-specific CD4- and CD8 T cells was observed in vaccinated mice shortly after challenge with influenza swine flu virus, which probably contributes to the strong inhibition of pulmonary viral replication observed. In addition, passive transfer of antisera raised in MVA-H1-Ca vaccinated immune-competent mice protected SCID mice from lethal challenge with the CA/07 wild-type virus. Conclusions/Significance: The non-replicating MVA-based H1N1 live vaccines induce a broad protective immune response and are promising vaccine candidates for pandemic influenza.	[Hessel, Annett; Schwendinger, Michael; Fritz, Daniela; Coulibaly, Sogue; Holzer, Georg W.; Sabarth, Nicolas; Kistner, Otfried; Wodal, Walter; Kerschbaum, Astrid; Savidis-Dacho, Helga; Crowe, Brian A.; Kreil, Thomas R.; Barrett, P. Noel; Falkner, Falko G.] Baxter BioSci, Biomed Res Ctr, R&D Vaccines, Orth, Austria		Hessel, A (corresponding author), Baxter BioSci, Biomed Res Ctr, R&D Vaccines, Orth, Austria.	falknef@baxter.com	Sabarth, Nicolas/GQQ-0093-2022; Sabarth, Nicolas/GQP-7376-2022	Sabarth, Nicolas/0000-0003-3844-6297; 	Baxter BioScience	Baxter BioScience	This study was funded by Baxter BioScience. The funders were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	ALEXANDROVA GI, 1984, INFECT IMMUN, V44, P734, DOI 10.1128/IAI.44.3.734-739.1984; Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Cerwenka A, 1999, J IMMUNOL, V163, P5535; Epstein SL, 1998, J IMMUNOL, V160, P322; GUBAREVA LV, 1994, VIROLOGY, V199, P89, DOI 10.1006/viro.1994.1100; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Holzer GW, 1998, VIROLOGY, V249, P160, DOI 10.1006/viro.1998.9307; Karron RA, 2009, VACCINE, V27, P4953, DOI 10.1016/j.vaccine.2009.05.099; KILBOURNE ED, 1968, J VIROL, V2, P281, DOI 10.1128/JVI.2.4.281-288.1968; Kistner O, 2007, VACCINE, V25, P6028, DOI 10.1016/j.vaccine.2007.05.013; Kistner O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009349; Kreijtz JHCM, 2009, VACCINE, V27, P6296, DOI 10.1016/j.vaccine.2009.03.020; Kreijtz JHCM, 2009, J INFECT DIS, V199, P405, DOI 10.1086/595984; Kreijtz JHCM, 2007, J INFECT DIS, V195, P1598, DOI 10.1086/517614; Kreijtz JHCM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007790; Lawrence CW, 2005, J IMMUNOL, V174, P5332, DOI 10.4049/jimmunol.174.9.5332; Maassab HF, 1999, REV MED VIROL, V9, P237, DOI 10.1002/(SICI)1099-1654(199910/12)9:4&lt;237::AID-RMV252&gt;3.0.CO;2-G; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mayrhofer J, 2009, J VIROL, V83, P5192, DOI 10.1128/JVI.02081-08; McGill J, 2009, J IMMUNOL, V183, P4177, DOI 10.4049/jimmunol.0901109; MEYER H, 1991, J GEN VIROL, V72, P1031, DOI 10.1099/0022-1317-72-5-1031; Ober BT, 2002, J VIROL, V76, P7713, DOI 10.1128/JVI.76.15.7713-7723.2002; Palese P, 1999, ARCH VIROL, P131; Poon LLM, 2009, J IMMUNOL, V182, P3063, DOI 10.4049/jimmunol.0803467; Ramirez JC, 2000, J VIROL, V74, P7651, DOI 10.1128/JVI.74.16.7651-7655.2000; Sandbulte MR, 2009, INFLUENZA OTHER RESP, V3, P233, DOI 10.1111/j.1750-2659.2009.00094.x; Scheiflinger F, 1998, ARCH VIROL, V143, P467, DOI 10.1007/s007050050303; SCHERLE PA, 1992, J IMMUNOL, V148, P212; Seo SH, 2002, J VIROL, V76, P4886, DOI 10.1128/JVI.76.10.4886-4890.2002; Suguitan AL, 2009, VIROLOGY, V395, P280, DOI 10.1016/j.virol.2009.09.017; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Talon J, 2000, P NATL ACAD SCI USA, V97, P4309, DOI 10.1073/pnas.070525997; WILLIAMS SP, 1993, VIROLOGY, V196, P660, DOI 10.1006/viro.1993.1522; Wood JM, 2004, NAT REV MICROBIOL, V2, P842, DOI 10.1038/nrmicro979; World Health Organization, 2002, WHO MAN AN INFL DIAG; WRIGHT PF, 2005, ORTHOMYXOVIRUSES FIE, P1692; Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2; YAP KL, 1978, SCAND J IMMUNOL, V8, P413, DOI 10.1111/j.1365-3083.1978.tb00536.x; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417	40	28	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12217	10.1371/journal.pone.0012217	http://dx.doi.org/10.1371/journal.pone.0012217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808939	Green Submitted, Green Published, gold			2022-12-25	WOS:000280968000030
J	Patil, R; Das, S; Stanley, A; Yadav, L; Sudhakar, A; Varma, AK				Patil, Rohan; Das, Suranjana; Stanley, Ashley; Yadav, Lumbani; Sudhakar, Akulapalli; Varma, Ashok K.			Optimized Hydrophobic Interactions and Hydrogen Bonding at the Target-Ligand Interface Leads the Pathways of Drug-Designing	PLOS ONE			English	Article							BIOLOGICAL EVALUATION; RATIONAL DESIGN; PROTEIN; INHIBITORS; BINDING; COMPLEXES; SIALIDASE; DOCKING; KINASES	Background: Weak intermolecular interactions such as hydrogen bonding and hydrophobic interactions are key players in stabilizing energetically-favored ligands, in an open conformational environment of protein structures. However, it is still poorly understood how the binding parameters associated with these interactions facilitate a drug-lead to recognize a specific target and improve drugs efficacy. To understand this, comprehensive analysis of hydrophobic interactions, hydrogen bonding and binding affinity have been analyzed at the interface of c-Src and c-Abl kinases and 4-amino substituted 1H-pyrazolo [3, 4-d] pyrimidine compounds. Methodology: In-silico docking studies were performed, using Discovery Studio software modules LigandFit, CDOCKER and ZDOCK, to investigate the role of ligand binding affinity at the hydrophobic pocket of c-Src and c-Abl kinase. Hydrophobic and hydrogen bonding interactions of docked molecules were compared using LigPlot program. Furthermore, 3D-QSAR and MFA calculations were scrutinized to quantify the role of weak interactions in binding affinity and drug efficacy. Conclusions: The in-silico method has enabled us to reveal that a multi-targeted small molecule binds with low affinity to its respective targets. But its binding affinity can be altered by integrating the conformationally favored functional groups at the active site of the ligand-target interface. Docking studies of 4-amino-substituted molecules at the bioactive cascade of the c-Src and c-Abl have concluded that 3D structural folding at the protein-ligand groove is also a hallmark for molecular recognition of multi-targeted compounds and for predicting their biological activity. The results presented here demonstrate that hydrogen bonding and optimized hydrophobic interactions both stabilize the ligands at the target site, and help alter binding affinity and drug efficacy.	[Patil, Rohan; Das, Suranjana; Stanley, Ashley; Yadav, Lumbani; Varma, Ashok K.] Adv Ctr Treatment Res & Educ Canc, Navi Mumbai, Maharashtra, India; [Sudhakar, Akulapalli] Boys Town Natl Res Hosp, Cell Signaling & Tumor Angiogenesis Lab, Omaha, NE 68131 USA; [Sudhakar, Akulapalli] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Sudhakar, Akulapalli] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Boys Town National Research Hospital; Creighton University; University of Nebraska System; University of Nebraska Medical Center	Patil, R (corresponding author), Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA.	avarma@actrec.gov.in			Department of Science and Technology-Science And Engineering Research Council [SR/FT/LS-074/2007]; Advanced Centre for Treatment, Research and Education in Cancer, Kharghar; Flight Attendant Medical Research Institute [062558, RO1CA143128]; NATIONAL CANCER INSTITUTE [R01CA143128] Funding Source: NIH RePORTER	Department of Science and Technology-Science And Engineering Research Council; Advanced Centre for Treatment, Research and Education in Cancer, Kharghar; Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this study was fully supported by Department of Science and Technology-Science And Engineering Research Council fast track award grant (SR/FT/LS-074/2007), institutional funds from Advanced Centre for Treatment, Research and Education in Cancer, Kharghar to AKV. This work was partly supported by Flight Attendant Medical Research Institute Young Clinical Scientist Award Grant FAMRI#062558 and RO1CA143128 to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhinge A, 2004, STRUCTURE, V12, P1989, DOI 10.1016/j.str.2004.09.005; Bhise SB, 2004, INDIAN J BIOCHEM BIO, V41, P273; BLUNDELL T, 1983, NATURE, V304, P273, DOI 10.1038/304273a0; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Choulier L, 2002, PROTEIN ENG, V15, P373, DOI 10.1093/protein/15.5.373; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Davis AM, 1999, ANGEW CHEM INT EDIT, V38, P737, DOI 10.1002/(SICI)1521-3773(19990315)38:6<736::AID-ANIE736>3.0.CO;2-R; Desiraju GR, 2005, CHEM COMMUN, P2995, DOI 10.1039/b504372g; Desiraju GR, 1996, ACCOUNTS CHEM RES, V29, P441, DOI 10.1021/ar950135n; DESJARLAIS RL, 1990, P NATL ACAD SCI USA, V87, P6644, DOI 10.1073/pnas.87.17.6644; DiMagno SG, 2006, CURR TOP MED CHEM, V6, P1473, DOI 10.2174/156802606777951127; Fernandez A, 2007, CANCER RES, V67, P4028, DOI 10.1158/0008-5472.CAN-07-0345; Fontana P, 2005, BIOINFORMATICS, V21, P393, DOI 10.1093/bioinformatics/bti013; Gangjee A, 2008, ANTI-CANCER AGENT ME, V8, P205, DOI 10.2174/187152008783497064; Ghosh AK, 2008, ORG BIOMOL CHEM, V6, P3703, DOI 10.1039/b809178a; HANSCH C, 1991, METHOD ENZYMOL, V202, P512; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Kondru RK, 2000, SCIENCE, V288, P1981; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lipton SA, 2004, NATURE, V428, P473, DOI 10.1038/428473a; Lu YX, 2009, J PHYS CHEM B, V113, P12615, DOI 10.1021/jp906352e; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Mobley DL, 2009, STRUCTURE, V17, P489, DOI 10.1016/j.str.2009.02.010; Moza B, 2006, P NATL ACAD SCI USA, V103, P9867, DOI 10.1073/pnas.0600220103; Ohlson S, 2008, DRUG DISCOV TODAY, V13, P433, DOI 10.1016/j.drudis.2008.02.001; Panigrahi SK, 2008, AMINO ACIDS, V34, P617, DOI 10.1007/s00726-007-0015-4; Panigrahi SK, 2007, PROTEINS, V67, P128, DOI 10.1002/prot.21253; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Petsalaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000335; Qian SB, 2009, J BIOL CHEM, V284, P26797, DOI 10.1074/jbc.M109.032334; ROBERTS NA, 1990, SCIENCE, V248, P358, DOI 10.1126/science.2183354; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Schenone S, 2008, EUR J MED CHEM, V43, P2665, DOI 10.1016/j.ejmech.2008.01.034; Simeonov A, 2008, ANAL BIOCHEM, V375, P60, DOI 10.1016/j.ab.2007.11.039; Sun H, 2010, CHEM BIOL DRUG DES, V75, P3, DOI 10.1111/j.1747-0285.2009.00899.x; Szuromi P, 2004, SCIENCE, V303, P1795, DOI 10.1126/science.303.5665.1795; Taylor NR, 1998, J MED CHEM, V41, P798, DOI 10.1021/jm9703754; Valdar WSJ, 2001, PROTEINS, V42, P108; Varghese JN, 1999, DRUG DEVELOP RES, V46, P176, DOI 10.1002/(SICI)1098-2299(199903/04)46:3/4<176::AID-DDR4>3.0.CO;2-6; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; Verma S, 2007, MED CHEM, V3, P605, DOI 10.2174/157340607782360371; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; White Alex W., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000641	47	229	244	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12029	10.1371/journal.pone.0012029	http://dx.doi.org/10.1371/journal.pone.0012029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808434	Green Submitted, Green Published, gold			2022-12-25	WOS:000280968000002
J	Reimann, M; Friedrich, C; Gasch, J; Reichmann, H; Rudiger, H; Ziemssen, T				Reimann, Manja; Friedrich, Constanze; Gasch, Julia; Reichmann, Heinz; Ruediger, Heinz; Ziemssen, Tjalf			Trigonometric Regressive Spectral Analysis Reliably Maps Dynamic Changes in Baroreflex Sensitivity and Autonomic Tone: The Effect of Gender and Age	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; DIFFERENT EXTRAPYRAMIDAL SYNDROMES; BLOOD-PRESSURE; ARTERIAL BAROREFLEX; ESSENTIAL-HYPERTENSION; SYMPATHETIC ACTIVITY; HEALTHY-SUBJECTS; POSTURAL STRESS; YOUNG-WOMEN; MORTALITY	Background: The assessment of baroreflex sensitivity (BRS) has emerged as prognostic tool in cardiology. Although available computer-assisted methods, measuring spontaneous fluctuations of heart rate and blood pressure in the time and frequency domain are easily applicable, they do not allow for quantification of BRS during cardiovascular adaption processes. This, however, seems an essential criterion for clinical application. We evaluated a novel algorithm based on trigonometric regression regarding its ability to map dynamic changes in BRS and autonomic tone during cardiovascular provocation in relation to gender and age. Methodology/Principal Findings: We continuously recorded systemic arterial pressure, electrocardiogram and respiration in 23 young subjects (25+/-2 years) and 22 middle-aged subjects (56+/-4 years) during cardiovascular autonomic testing (metronomic breathing, Valsalva manoeuvre, head-up tilt). Baroreflex- and spectral analysis was performed using the algorithm of trigonometric regressive spectral analysis. There was an age-related decline in spontaneous BRS and high frequency oscillations of RR intervals. Changes in autonomic tone evoked by cardiovascular provocation were observed as shifts in the ratio of low to high frequency oscillations of RR intervals and blood pressure. Respiration at 0.1 Hz elicited an increase in BRS while head-up tilt and Valsalva manoeuvre resulted in a downregulation of BRS. The extent of autonomic adaption was in general more pronounced in young individuals and declined stronger with age in women than in men. Conclusions/Significance: The trigonometric regressive spectral analysis reliably maps age- and gender-related differences in baroreflex- and autonomic function and is able to describe adaption processes of baroreceptor circuit during cardiovascular stimulation. Hence, this novel algorithm may be a useful screening tool to detect abnormalities in cardiovascular adaption processes even when resting values appear to be normal.	[Reimann, Manja; Friedrich, Constanze; Gasch, Julia; Reichmann, Heinz; Ruediger, Heinz; Ziemssen, Tjalf] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Neurol, Auton & Neuroendocrinol Lab, D-8027 Dresden, Germany; [Reimann, Manja; Ruediger, Heinz; Ziemssen, Tjalf] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Neurol & Internal Med 3, Res Grp Neurometab, D-8027 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Reimann, M (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Neurol, Auton & Neuroendocrinol Lab, D-8027 Dresden, Germany.	manjareimann@uniklinikum-dresden.de	Ziemssen, Tjalf/J-2017-2019	Ziemssen, Tjalf/0000-0001-8799-8202	University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany; Cephalon; Novartis; TEVA; Lundbeck; GlaxoSmithKline; Boehringer Ingelheim; Schering/Bayer HealthCare; UCB/Schwarz Pharma; Desitin; Pfizer; Solvay; Roland Ernst Foundation	University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany; Cephalon; Novartis(Novartis); TEVA(Teva Pharmaceutical Industries); Lundbeck(Lundbeck Corporation); GlaxoSmithKline(GlaxoSmithKline); Boehringer Ingelheim(Boehringer Ingelheim); Schering/Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); UCB/Schwarz Pharma(UCB Pharma SA); Desitin; Pfizer(Pfizer); Solvay(Solvay SA); Roland Ernst Foundation	The study was supported by the University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; M. Reimann, C. Friedrich, J. Gasch and H. Rudiger report no disclosures. H. Reichmann serves on scientific advisory boards, receives speaker honoraria, and/or receives funding for travel from Cephalon, Novartis, TEVA, Lundbeck, GlaxoSmithKline, Boehringer Ingelheim, Schering/Bayer HealthCare, UCB/Schwarz Pharma, Desitin, Pfizer, and Solvay. T. Ziemssen has received speaker honoraria from Biogen Idec, Sanofi-Aventis, MerckSerono, Novartis, Teva, and Bayer Healthcare. He serves as a consultant for Teva, Novartis, and Bayer HealthCare, and receives research support from the Roland Ernst Foundation.	Barnett SR, 1999, HYPERTENSION, V33, P1195, DOI 10.1161/01.HYP.33.5.1195; Bernardi L, 1992, G Ital Cardiol, V22, P517; Bernardi L, 2001, J HYPERTENS, V19, P2221, DOI 10.1097/00004872-200112000-00016; Brown CM, 2003, EUR J CLIN INVEST, V33, P10, DOI 10.1046/j.1365-2362.2003.01093.x; ECKBERG DL, 1977, J PHYSIOL-LONDON, V269, P579, DOI 10.1113/jphysiol.1977.sp011916; Evans JM, 2001, J APPL PHYSIOL, V91, P2611, DOI 10.1152/jappl.2001.91.6.2611; Fauvel JP, 2007, HYPERTENSION, V50, P543, DOI 10.1161/HYPERTENSIONAHA.107.090811; Friedrich C, 2008, J NEURAL TRANSM, V115, P1527, DOI 10.1007/s00702-008-0127-3; Friedrich C, 2010, MOVEMENT DISORD, V25, P315, DOI 10.1002/mds.22844; GOLDSTEIN DS, 1983, CIRCULATION, V68, P234, DOI 10.1161/01.CIR.68.2.234; Hilz MJ, 2000, FORTSCHR NEUROL PSYC, V68, P37, DOI 10.1055/s-2000-11641; Johansson M, 2007, J HYPERTENS, V25, P163, DOI 10.1097/01.hjh.0000254377.18983.eb; Joseph CN, 2005, HYPERTENSION, V46, P714, DOI 10.1161/01.HYP.0000179581.68566.7d; KORNER PI, 1989, CLIN EXP PHARMACOL P, P45; Kornet L, 2005, J HYPERTENS, V23, P815, DOI 10.1097/01.hjh.0000163151.50825.e2; La Rovere MT, 2001, CIRCULATION, V103, P2072; La Rovere MT, 1998, LANCET, V351, P478; Lahiri MK, 2008, J AM COLL CARDIOL, V51, P1725, DOI 10.1016/j.jacc.2008.01.038; Laitinen T, 2004, J APPL PHYSIOL, V96, P2333, DOI 10.1152/japplphysiol.00444.2003; Laitinen T, 1998, J APPL PHYSIOL, V84, P576, DOI 10.1152/jappl.1998.84.2.576; LaRovere MT, 1997, PACE, V20, P2602; Laude D, 2004, AM J PHYSIOL-REG I, V286, pR226, DOI 10.1152/ajpregu.00709.2002; Lavi S, 2007, AM J PHYSIOL-REG I, V292, pR788, DOI 10.1152/ajpregu.00352.2006; LIPSITZ LA, 1990, CIRCULATION, V81, P1803, DOI 10.1161/01.CIR.81.6.1803; MALLIANI A, 1994, AM J CARDIOL, V73, pC3, DOI 10.1016/0002-9149(94)90617-3; Mattace-Raso FUS, 2007, J HYPERTENS, V25, P1421, DOI 10.1097/HJH.0b013e32811d6a07; MENSE L, CIRC J IN PRESS; Minson CT, 2000, CIRCULATION, V102, P1473, DOI 10.1161/01.CIR.102.13.1473; Minson CT, 2000, CIRCULATION, V101, P862, DOI 10.1161/01.CIR.101.8.862; Monahan KD, 2001, AM J PHYSIOL-HEART C, V281, pH284, DOI 10.1152/ajpheart.2001.281.1.H284; Mukai S, 2003, J GERONTOL A-BIOL, V58, P626; Oka H, 2003, EUR NEUROL, V50, P230, DOI 10.1159/000073865; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Parati G, 2000, J HYPERTENS, V18, P7, DOI 10.1097/00004872-200018010-00003; PARATI G, 1988, HYPERTENSION, V12, P214, DOI 10.1161/01.HYP.12.2.214; Radaelli A, 2004, J HYPERTENS, V22, P1361, DOI 10.1097/01.hjh.0000125446.28861.51; Rudiger H, 1999, COMPUT METH PROG BIO, V58, P1, DOI 10.1016/S0169-2607(98)00070-4; Saeed NP, 2009, J VASC RES, V46, P469, DOI 10.1159/000200962; Schmidt C, 2009, J NEURAL TRANSM, V116, P875, DOI 10.1007/s00702-009-0239-4; Skrapari I, 2007, OBESITY, V15, P1685, DOI 10.1038/oby.2007.201; Skrapari I, 2006, CURR DIABETES REV, V2, P329, DOI 10.2174/157339906777950589; Tank J, 2005, HYPERTENSION, V45, P1159, DOI 10.1161/01.HYP.0000165695.98915.9a; Tzeng YC, 2009, J APPL PHYSIOL, V107, P718, DOI 10.1152/japplphysiol.00548.2009; Westerhof BE, 2006, AM J PHYSIOL-HEART C, V291, pH2864, DOI 10.1152/ajpheart.01024.2005; Zhang R, 2002, J PHYSIOL-LONDON, V543, P337, DOI 10.1113/jphysiol.2001.013398; Ziemssen Tjalf, 2008, J Clin Monit Comput, V22, P159, DOI 10.1007/s10877-008-9117-0	46	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12187	10.1371/journal.pone.0012187	http://dx.doi.org/10.1371/journal.pone.0012187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808439	Green Submitted, Green Published, gold			2022-12-25	WOS:000280968000014
J	Shen, AL; O'Leary, KA; Dubielzig, RR; Drinkwater, N; Murphy, CJ; Kasper, CB; Bradfield, CA				Shen, Anna L.; O'Leary, Kathleen A.; Dubielzig, Richard R.; Drinkwater, Norman; Murphy, Christopher J.; Kasper, Charles B.; Bradfield, Christopher A.			The PPCD1 Mouse: Characterization of a Mouse Model for Posterior Polymorphous Corneal Dystrophy and Identification of a Candidate Gene	PLOS ONE			English	Article							IRIDOCORNEAL ENDOTHELIAL SYNDROME; MUTATIONS; COL8A2; CHROMOSOME-20; LINKAGE; MICE; METAPLASIA; EXCLUSION; INTERACTS; DISEASE	The PPCD1 mouse, a spontaneous mutant that arose in our mouse colony, is characterized by an enlarged anterior chamber resulting from metaplasia of the corneal endothelium and blockage of the iridocorneal angle by epithelialized corneal endothelial cells. The presence of stratified multilayered corneal endothelial cells with abnormal patterns of cytokeratin expression are remarkably similar to those observed in human posterior polymorphous corneal dystrophy (PPCD) and the sporadic condition, iridocorneal endothelial syndrome. Affected eyes exhibit epithelialized corneal endothelial cells, with inappropriate cytokeratin expression and proliferation over the iridocorneal angle and posterior cornea. We have termed this the "mouse PPCD1'' phenotype and mapped the mouse locus for this phenotype, designated "Ppcd1'', to a 6.1 Mbp interval on Chromosome 2, which is syntenic to the human Chromosome 20 PPCD1 interval. Inheritance of the mouse PPCD1 phenotype is autosomal dominant, with complete penetrance on the sensitive DBA/2J background and decreased penetrance on the C57BL/6J background. Comparative genome hybridization has identified a hemizygous 78 Kbp duplication in the mapped interval. The endpoints of the duplication are located in positions that disrupt the genes Csrp2bp and 6330439K17Rik and lead to duplication of the pseudogene LOC100043552. Quantitative reverse transcriptase-PCR indicates that expression levels of Csrp2bp and 6330439K17Rik are decreased in eyes of PPCD1 mice. Based on the observations of decreased gene expression levels, association with ZEB1-related pathways, and the report of corneal opacities in Csrp2bp(tm1a(KOMP)Wtsi) heterozygotes and embryonic lethality in nulls, we postulate that duplication of the 78 Kbp segment leading to haploinsufficiency of Csrp2bp is responsible for the mouse PPCD1 phenotype. Similarly, CSRP2BP haploinsufficiency may lead to human PPCD.	[Shen, Anna L.; O'Leary, Kathleen A.; Drinkwater, Norman; Kasper, Charles B.; Bradfield, Christopher A.] Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Dubielzig, Richard R.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Shen, Anna L.; Dubielzig, Richard R.; Murphy, Christopher J.; Bradfield, Christopher A.] Univ Wisconsin, Eye Res Inst, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Murphy, Christopher J.] Univ Wisconsin, Sch Vet Med, Dept Surg Sci, Madison, WI 53706 USA; [Dubielzig, Richard R.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shen, AL (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Sch Med & Publ Hlth, 1400 Univ Ave, Madison, WI 53706 USA.	alshen@wisc.edu			National Institutes of Health [R03-EY015565, P01-CA022484, P30-CA014520, ES013566]; Eye Research Institute, University of Wisconsin-Madison; NATIONAL CANCER INSTITUTE [P01CA022484, P30CA014520] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R03EY015565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eye Research Institute, University of Wisconsin-Madison; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research has been supported by Grants R03-EY015565, P01-CA022484, P30-CA014520, and ES013566 from the National Institutes of Health and a Rapid Response Initiative Grant from the Eye Research Institute, University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldave AJ, 2007, AM J MED GENET A, V143A, P2549, DOI 10.1002/ajmg.a.31978; Aldave AJ, 2009, CORNEA, V28, P801, DOI 10.1097/ICO.0b013e31819672fb; Anderson NJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P624; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Chow RL, 2004, P NATL ACAD SCI USA, V101, P1754, DOI 10.1073/pnas.0306520101; CIBIS GW, 1977, ARCH OPHTHALMOL-CHIC, V95, P1529; Ciralsky Jessica, 2007, Semin Ophthalmol, V22, P241, DOI 10.1080/08820530701745157; Cockerham GC, 2002, CORNEA, V21, P787, DOI 10.1097/00003226-200211000-00012; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P1934, DOI 10.1167/iovs.04-0937; Guelman S, 2009, MOL CELL BIOL, V29, P1176, DOI 10.1128/MCB.01599-08; Gwilliam R, 2005, INVEST OPHTH VIS SCI, V46, P4480, DOI 10.1167/iovs.05-0269; Haider NB, 2002, HUM MOL GENET, V11, P1195, DOI 10.1093/hmg/11.10.1195; HEON E, 1995, HUM MOL GENET, V4, P485, DOI 10.1093/hmg/4.3.485; Hidayat AA, 2006, CORNEA, V25, P956, DOI 10.1097/01.ico.0000228786.84581.ee; HIRST LW, 1995, INVEST OPHTH VIS SCI, V36, P820; Hopfer U, 2005, FASEB J, V19, P1232, DOI 10.1096/fj.04-3019com; Hosseini SM, 2008, MOL VIS, V14, P71; Howell DN, 1997, INVEST OPHTH VIS SCI, V38, P1896; Jirsova K, 2007, EXP EYE RES, V84, P680, DOI 10.1016/j.exer.2006.12.006; Klintworth GK, 2003, FRONT BIOSCI-LANDMRK, V8, pD687, DOI 10.2741/1018; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; Lee SJ, 2007, EXP MOL MED, V39, P450, DOI 10.1038/emm.2007.49; Lefebvre V, 2009, OPTOMETRY, V80, P431, DOI 10.1016/j.optm.2009.02.009; Liu YQ, 2008, INVEST OPHTH VIS SCI, V49, P1843, DOI 10.1167/iovs.07-0789; Moroi SE, 2003, AM J OPHTHALMOL, V135, P461, DOI 10.1016/S0002-9394(02)02032-9; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Ramalho JS, 2004, BRIT J OPHTHALMOL, V88, P428, DOI 10.1136/bjo.2003.028787; RIAZUDDIN SA, 1945, AM J HUM GENET, V53, P4; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; Shimizu S, 2004, AM J MED GENET A, V130A, P372, DOI 10.1002/ajmg.a.30267; TOMA NMG, 1995, HUM MOL GENET, V4, P2395, DOI 10.1093/hmg/4.12.2395; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Vincent AL, 2009, MOL VIS, V15, P2544; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Yellore VS, 2007, GENET MED, V9, P228, DOI 10.1097/GIM.0b013e31803c4dc2; Yellore VS, 2005, INVEST OPHTH VIS SCI, V46, P1599, DOI 10.1167/iovs.04-1321	36	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2010	5	8							e12213	10.1371/journal.pone.0012213	http://dx.doi.org/10.1371/journal.pone.0012213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639IH	20808945	Green Submitted, Green Published, gold			2022-12-25	WOS:000280968000028
J	Carvalho, CML; Lu, J; Zhang, X; Arner, ESJ; Holmgren, A				Carvalho, Cristina M. L.; Lu, Jun; Zhang, Xu; Arner, Elias S. J.; Holmgren, Arne			Effects of selenite and chelating agents on mammalian thioredoxin reductase inhibited by mercury: implications for treatment of mercury poisoning	FASEB JOURNAL			English	Article						mercury toxicity; selenium; antidotes; thioredoxin system; selenoproteins	INORGANIC MERCURY; METHYLMERCURY; RAT; GLUTATHIONE; METABOLISM; HEALTH; LIVER; ACID; PURIFICATION; TOXICOLOGY	Mercury toxicity is a highly interesting topic in biomedicine due to the severe endpoints and treatment limitations. Selenite serves as an antagonist of mercury toxicity, but the molecular mechanism of detoxification is not clear. Inhibition of the selenoenzyme thioredoxin reductase (TrxR) is a suggested mechanism of toxicity. Here, we demonstrated enhanced inhibition of activity by inorganic and organic mercury compounds in NADPH-reduced TrxR, consistent with binding of mercury also to the active site selenolthiol. On treatment with 5 mu M selenite and NADPH, TrxR inactivated by HgCl2 displayed almost full recovery of activity. Structural analysis indicated that mercury was complexed with TrxR, but enzyme-generated selenide removed mercury as mercury selenide, regenerating the active site selenocysteine and cysteine residues required for activity. The antagonistic effects on TrxR inhibition were extended to endogenous antioxidants, such as GSH, and clinically used exogenous chelating agents BAL, DMPS, DMSA, and alpha-lipoic acid. Consistent with the in vitro results, recovery of TrxR activity and cell viability by selenite was observed in HgCl2-treated HEK 293 cells. These results stress the role of TrxR as a target of mercurials and provide the mechanism of selenite as a detoxification agent for mercury poisoning.-Carvalho, C. M. L., Lu, J., Zhang, X., Arner, E. S. J., Holmgren, A. Effects of selenite and chelating agents on mammalian thioredoxin reductase inhibited by mercury: implications for treatment of mercury poisoning. FASEB J. 25, 370-381 (2011). www.fasebj.org	[Carvalho, Cristina M. L.; Lu, Jun; Zhang, Xu; Arner, Elias S. J.; Holmgren, Arne] Karolinska Inst, Div Biochem, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Carvalho, Cristina M. L.] Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci, P-1649003 Lisbon, Portugal	Karolinska Institutet; Universidade de Lisboa	Holmgren, A (corresponding author), Karolinska Inst, Div Biochem, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden.	cristina.carvalho@ff.ul.pt; arne.holmgren@ki.se	Lu, Jun/E-9701-2017; Carvalho, Cristina/E-3379-2014; Zhang, Xu/F-4324-2018; iMed.ULisboa, CBT/B-4215-2014; Arnér, Elias/K-6737-2019; Arnér, Elias S.J./J-5832-2012	Lu, Jun/0000-0002-1699-8835; Carvalho, Cristina/0000-0002-1097-7910; Arnér, Elias/0000-0002-4807-6114; Arnér, Elias S.J./0000-0002-4807-6114	Swedish Cancer Society [961]; Swedish Research Council Medicine [13x-3529]; K. A. Wallenberg Foundation; Karolinska Institutet	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council Medicine(Swedish Research Council); K. A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Karolinska Institutet(Karolinska Institutet)	The authors thank Mr. Sergio J. Montano (Division of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet) for his excellent assistance in measuring TrxR activity. This research was supported by grants from the Swedish Cancer Society (961), the Swedish Research Council Medicine (13x-3529), The K. A. Wallenberg Foundation, and the Karolinska Institutet.	Agarwal R, 2007, IND HEALTH, V45, P388, DOI 10.2486/indhealth.45.388; Amer E. S. J., 2000, CURRENT PROTOCOLS S5, P741; [Anonymous], 2000, AIR QUAL GUID EUR; APOSHIAN HV, 1995, TOXICOLOGY, V97, P23, DOI 10.1016/0300-483X(95)02965-B; APOSHIAN HV, 1990, ANNU REV PHARMACOL, V30, P279; APOSHIAN HV, 1982, ADV ENZYME REGUL, V20, P301; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; BALLATORI N, 1985, FUND APPL TOXICOL, V5, P816, DOI 10.1016/0272-0590(85)90165-4; BJORKMAN L, 1995, ARCH TOXICOL, V69, P228, DOI 10.1007/s002040050163; Bjornstedt M., 1985, METHOD ENZYMOL, V252, P209; Boelsterli UA, 2003, MECH TOXICOLOGY; Carvalho CML, 2008, J BIOL CHEM, V283, P11913, DOI 10.1074/jbc.M710133200; Chapman L, 2000, ENVIRON HEALTH PERSP, V108, P29, DOI [10.2307/3454631, 10.2307/3454292]; Cherdwongcharoensuk D, 2010, BIOL TRACE ELEM RES, V136, P197, DOI 10.1007/s12011-009-8532-5; Choi AL, 2008, ENVIRON RES, V107, P45, DOI 10.1016/j.envres.2007.07.006; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Clarkson TW, 2002, ENVIRON HEALTH PERSP, V110, P11, DOI 10.1289/ehp.02110s111; Clarkson TW, 2003, J TRACE ELEM EXP MED, V16, P321, DOI 10.1002/jtra.10050; CUVINARALAR MLA, 1991, ECOTOX ENVIRON SAFE, V21, P348, DOI 10.1016/0147-6513(91)90074-Y; dos Santos APM, 2007, TOXICOL LETT, V169, P121, DOI 10.1016/j.toxlet.2006.12.007; Dumont E, 2006, ANAL BIOANAL CHEM, V385, P1304, DOI 10.1007/s00216-006-0529-8; Farina M, 2004, TOXICOL LETT, V146, P227, DOI 10.1016/j.toxlet.2003.10.001; FRIEDHEIM EAH, 1954, AM J TROP MED HYG, V3, P714, DOI 10.4269/ajtmh.1954.3.714; Gailer J, 2000, CHEM RES TOXICOL, V13, P1135, DOI 10.1021/tx000050h; Ganther HE, 1999, CARCINOGENESIS, V20, P1657, DOI 10.1093/carcin/20.9.1657; GANTHER HE, 1972, SCIENCE, V175, P1122, DOI 10.1126/science.175.4026.1122; GASIEWICZ TA, 1978, CHEM-BIOL INTERACT, V21, P299, DOI 10.1016/0009-2797(78)90028-5; GOYER R, 1995, METAL TOXICOLOGY, P35; GREGUS Z, 1992, TOXICOL APPL PHARM, V114, P88, DOI 10.1016/0041-008X(92)90100-7; Heinz GH, 1998, ENVIRON TOXICOL CHEM, V17, P139; Hoffman DJ, 1998, ENVIRON TOXICOL CHEM, V17, P161, DOI 10.1002/etc.5620170204; Hol PJ, 2001, ENVIRON RES, V87, P141, DOI 10.1006/enrs.2001.4308; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; KUMAR S, 1992, EUR J BIOCHEM, V207, P435, DOI 10.1111/j.1432-1033.1992.tb17068.x; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; MEDINA D, 1984, CANCER RES, V44, P4361; Melchart D, 2008, J DENT RES, V87, P349, DOI 10.1177/154405910808700410; PARIZEK J, 1967, EXPERIENTIA, V23, P142, DOI 10.1007/BF02135970; PETERS RA, 1945, NATURE, V156, P616, DOI 10.1038/156616a0; Petrunkin VE, 1956, UKR KHIM ZH, V22, P603; Ralston NVC, 2008, NEUROTOXICOLOGY, V29, P802, DOI 10.1016/j.neuro.2008.07.007; RIVERA M, 1989, TOXICOL APPL PHARM, V100, P96, DOI 10.1016/0041-008X(89)90094-X; Rooney JPK, 2007, TOXICOLOGY, V234, P145, DOI 10.1016/j.tox.2007.02.016; ROZELL B, 1985, EUR J CELL BIOL, V38, P79; Rush T, 2009, NEUROTOXICOLOGY, V30, P47, DOI 10.1016/j.neuro.2008.10.009; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121; World Health Organization, 2003, SUM CONCL 61 M FAO W; Yang DY, 2008, ENVIRON REV, V16, P71, DOI 10.1139/A08-001; Yoneda S, 1997, TOXICOL APPL PHARM, V143, P274, DOI 10.1006/taap.1996.8095; Zhon LW, 1998, J BIOL CHEM, V273, P8581, DOI 10.1074/jbc.273.15.8581; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897	52	85	88	1	36	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					370	381		10.1096/fj.10-157594	http://dx.doi.org/10.1096/fj.10-157594			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20810785				2022-12-25	WOS:000285869500033
J	Masino, L; Nicastro, G; Calder, L; Vendruscolo, M; Pastore, A				Masino, Laura; Nicastro, Giuseppe; Calder, Lesley; Vendruscolo, Michele; Pastore, Annalisa			Functional interactions as a survival strategy against abnormal aggregation	FASEB JOURNAL			English	Article						ataxin-3; fibrillogenesis; native-like aggregation; neurodegeneration; polyglutamine proteins; structure	JOSEPHIN DOMAIN; PROTEIN ATAXIN-3; POLYGLUTAMINE PROTEIN; UBIQUITIN-BINDING; DISEASE; FIBRILLOGENESIS; PREDICTION; FIBRILS; PATHWAY; PROTEOSTASIS	Protein aggregation is under intense scrutiny because of its role in human disease. Although increasing evidence indicates that protein native states are highly protected against aggregation, the specific protection mechanisms are poorly understood. Insight into such mechanisms can be gained through study of the relatively few proteins that aggregate under native conditions. Ataxin-3, the protein responsible for Spinocerebellar ataxia type 3, a polyglutamine expansion disease, represents one of such examples. Polyglutamine expansion is central for determining solubility and aggregation rates of ataxin-3, but these properties are profoundly modulated by its N-terminal Josephin domain. This work aims at identifying the regions that promote Josephin fibrillogenesis and rationalizing the mechanisms that protect Josephin and nonexpanded ataxin-3 from aberrant aggregation. Using different biophysical techniques, aggregation propensity predictions and rational design of amino acid substitutions, we show that Josephin has an intrinsic tendency to fibrillize under native conditions and that fibrillization is promoted by two solvent-exposed patches, which are also involved in recognition of natural substrates, such as ubiquitin. Indeed, designed mutations at these patches or substrate binding significantly reduce Josephin aggregation kinetics. Our results provide evidence that protein nonpathologic function can play an active role in preventing aberrant fibrillization and suggest the molecular mechanism whereby this occurs in ataxin-3.-Masino, L., Nicastro, G., Calder, L., Vendruscolo, M., Pastore, A. Functional interactions as a survival strategy against abnormal aggregation. FASEB J. 25, 45-54 (2011). www.fasebj.org	[Masino, Laura; Nicastro, Giuseppe; Calder, Lesley; Pastore, Annalisa] Natl Inst Med Res, MRC, London NW7 1AA, England; [Vendruscolo, Michele] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	MRC National Institute for Medical Research; University of Cambridge	Pastore, A (corresponding author), Natl Inst Med Res, MRC, Ridgeway,Mill Hill, London NW7 1AA, England.	apastor@nimr.mrc.ac.uk	Vendruscolo, Michele/F-5901-2012	Vendruscolo, Michele/0000-0002-3616-1610; Masino, Laura/0000-0002-5326-7003	MRC [U117584256]; MRC [MC_U117533887, MC_U117584256] Funding Source: UKRI; Medical Research Council [MC_U117584256, MC_U117533887] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors are very thankful to Xavier Daura and Oscar Conchillo Sole for help with the Aggrescan Web server and to the Medical Research Council (MRC) Biomedical NMR Centre for technical support. The authors acknowledge support from the MRC (grant U117584256).	Albrecht M, 2004, EUR J BIOCHEM, V271, P3155, DOI 10.1111/j.1432-1033.2004.04245.x; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bevivino AE, 2001, P NATL ACAD SCI USA, V98, P11955, DOI 10.1073/pnas.211305198; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Chow M. K., 2004, J BIOL CHEM, V1, P1; Chow MKM, 2004, J MOL BIOL, V335, P333, DOI 10.1016/j.jmb.2003.08.064; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Cummings CJ, 2000, ANNU REV GENOM HUM G, V1, P281, DOI 10.1146/annurev.genom.1.1.281; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; de Chiara C, 2003, FEBS LETT, V551, P107, DOI 10.1016/S0014-5793(03)00818-4; de Chiara C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008372; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ellisdon AM, 2007, J MOL BIOL, V368, P595, DOI 10.1016/j.jmb.2007.02.058; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Evert BO, 2006, J NEUROSCI, V26, P11474, DOI 10.1523/JNEUROSCI.2053-06.2006; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Gales L., 2005, J MOL BIOL, V26, P26; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Li FS, 2002, J BIOL CHEM, V277, P45004, DOI 10.1074/jbc.M205259200; Marchal S, 2003, J BIOL CHEM, V278, P31554, DOI 10.1074/jbc.M304205200; Marshall KE, 2009, BIOCHEM SOC T, V37, P671, DOI 10.1042/BST0370671; Masino L, 2004, J MOL BIOL, V344, P1021, DOI 10.1016/j.jmb.2004.09.065; Masino L, 2003, FEBS LETT, V549, P21, DOI 10.1016/S0014-5793(03)00748-8; Nelson R, 2006, ADV PROTEIN CHEM, V73, P235, DOI 10.1016/S0065-3233(06)73008-X; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Nicastro G, 2004, J BIOMOL NMR, V30, P457, DOI 10.1007/s10858-004-4343-3; Nicastro G, 2006, J BIOMOL NMR, V36, P267, DOI 10.1007/s10858-006-9092-z; Nicastro G, 2009, BIOPOLYMERS, V91, P1203, DOI 10.1002/bip.21210; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Pechmann S, 2009, P NATL ACAD SCI USA, V106, P10159, DOI 10.1073/pnas.0812414106; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Reumers J, 2008, NUCLEIC ACIDS RES, V36, pD825, DOI 10.1093/nar/gkm979; Riess O, 2008, CEREBELLUM, V7, P125, DOI 10.1007/s12311-008-0013-4; Saunders HM, 2009, PROTEIN ENG DES SEL, V22, P447, DOI 10.1093/protein/gzp033; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Shehi E, 2003, BIOCHEMISTRY-US, V42, P14626, DOI 10.1021/bi0352825; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Uversky VN, 2009, FRONT BIOSCI-LANDMRK, V14, P5188, DOI 10.2741/3594; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	51	64	64	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2011	25	1					45	54		10.1096/fj.10-161208	http://dx.doi.org/10.1096/fj.10-161208			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	702BL	20810784	Green Published			2022-12-25	WOS:000285869500005
J	Arechaga, I; Martinez-Costa, OH; Ferreras, C; Carrascosa, JL; Aragon, JJ				Arechaga, Ignacio; Martinez-Costa, Oscar H.; Ferreras, Cristina; Carrascosa, Jose L.; Aragon, Juan J.			Electron microscopy analysis of mammalian phosphofructokinase reveals an unusual 3-dimensional structure with significant implications for enzyme function	FASEB JOURNAL			English	Article						glycolysis; enzyme regulation; allostery; 3-D reconstruction; structure/function relationships	FRUCTOSE 2,6-BISPHOSPHATE; LIVER PHOSPHOFRUCTOKINASE; ALLOSTERIC TRANSITIONS; ACTIVE FORM; BINDING; IMAGE; 6-PHOSPHATE; ATP; CRYSTALLIZATION; CLASSIFICATION	Phosphofructokinase is a sophisticated allosteric enzyme that is fundamental for the control of glycolysis. The structure of the bacterial enzyme is well characterized. However, little is known about the structural organization of the more complex enzyme from mammals. We have obtained the structure of human muscle phosphofructokinase in the presence of fructose 6-phosphate at a resolution of 1.8 nm by electron microscopy (EM). Particles of the tetrameric enzyme corresponded to an elongated molecule (14.5x9 nm) arranged into 2 dimeric subdomains. Image analysis and 3-dimensional reconstruction showed the presence of a prominent channel in one of the dimers but not in the opposite one, revealing that they are in greatly different conformations. Fitting of bacterial structures into the EM model suggested disruption of the fructose 6-phosphate catalytic and the fructose 2,6-bisphophate allosteric sites in the cavity-containing dimer. Therefore, the reported structure might have major implications for the function of mammalian phosphofructokinase.-Arechaga, I., Martinez-Costa, O. H., Ferreras, C., Carrascosa, J. L., Aragon, J. J. Electron microscopy analysis of mammalian phosphofructokinase reveals an unusual 3-dimensional structure with significant implications for enzyme function. FASEB J. 24, 4960-4968 (2010). www.fasebj.org	[Martinez-Costa, Oscar H.; Ferreras, Cristina; Aragon, Juan J.] UAM, Dept Bioquim, Madrid 28029, Spain; [Martinez-Costa, Oscar H.; Ferreras, Cristina; Aragon, Juan J.] Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, CSIC, Fac Med, Madrid 28029, Spain; [Arechaga, Ignacio; Carrascosa, Jose L.] Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Aragon, JJ (corresponding author), UAM, Dept Bioquim, Madrid 28029, Spain.	jlcarrascosa@cnb.csic.es; juanjose.aragon@uam.es	Martinez-Costa, Oscar/B-7275-2014; Arechaga, Ignacio/K-2198-2014	Martinez-Costa, Oscar/0000-0003-4893-2205; Arechaga, Ignacio/0000-0002-1342-9370	Ministerio de Ciencia e Innovacion (MICINN) [BFU2008-02328/BMG, CSD2007-00010, BFU2005-09071, BFU2008-02364, BFU2009-13114]; Direccion General de Universidades of the Comunidad de Madrid [S2009/MAT-1507]	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Direccion General de Universidades of the Comunidad de Madrid	The authors thank Valentina Sanchez for help with protein purification and Jaime Martin-Benito for help with the 3-D image reconstruction analysis. This work was supported by grants BFU2008-02328/BMG and Consolider CSD2007-00010 from the Ministerio de Ciencia e Innovacion (MICINN) and S2009/MAT-1507 from the Direccion General de Universidades of the Comunidad de Madrid to J.LC., and BFU2005-09071, BFU2008-02364 and BFU2009-13114 from MICINN to J.J.A.	ARAGON JJ, 1991, FASEB J, V5, P2945, DOI 10.1096/fasebj.5.14.1752361; AUZAT I, 1995, BIOCHEMISTRY-US, V34, P7062, DOI 10.1021/bi00021a018; Auzat I, 1997, J MOL BIOL, V267, P476, DOI 10.1006/jmbi.1997.0883; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANUELOS M, 1977, J BIOL CHEM, V252, P6394; Barcena M, 2007, J STRUCT BIOL, V159, P135, DOI 10.1016/j.jsb.2007.03.004; Benjamin S, 2007, J STRUCT BIOL, V159, P498, DOI 10.1016/j.jsb.2007.06.001; Benjamin S, 2009, J STRUCT BIOL, V168, P345, DOI 10.1016/j.jsb.2009.06.014; BLANGY D, 1968, J MOL BIOL, V31, P13, DOI 10.1016/0022-2836(68)90051-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COLOMBO G, 1975, J BIOL CHEM, V250, P9404; DUNAWAY GA, 1988, BIOCHEM J, V251, P677, DOI 10.1042/bj2510677; EVANS PR, 1981, PHILOS T ROY SOC B, V293, P53, DOI 10.1098/rstb.1981.0059; Ferreras C, 2009, J BIOL CHEM, V284, P9124, DOI 10.1074/jbc.M807737200; FOE LG, 1980, J BIOL CHEM, V255, P537; FOE LG, 1985, J BIOL CHEM, V260, P726; FRIEDEN C, 1976, J BIOL CHEM, V251, P5644; Heinisch JJ, 1996, J BIOL CHEM, V271, P15928, DOI 10.1074/jbc.271.27.15928; HESTERBERG LK, 1980, BIOCHEMISTRY-US, V19, P2030, DOI 10.1021/bi00551a004; HESTERBERG LK, 1981, J BIOL CHEM, V256, P9724; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; HILL DE, 1975, BIOCHEMISTRY-US, V14, P203, DOI 10.1021/bi00673a003; KARADSHEH NS, 1977, J BIOL CHEM, V252, P3515; KEMP RG, 1983, MOL CELL BIOCHEM, V57, P147, DOI 10.1007/BF00849191; Kemp RG, 2002, BIOCHEMISTRY-US, V41, P9426, DOI 10.1021/bi020110d; KEMP RG, 1967, BIOCHEMISTRY-US, V6, P423, DOI 10.1021/bi00854a009; KITAJIMA S, 1983, J BIOL CHEM, V258, P7352; KONO N, 1973, J BIOL CHEM, V248, P8592; KOPPERSCHLAGER G, 1968, Febs Letters, V1, P137, DOI 10.1016/0014-5793(68)80041-9; Li YL, 1999, BIOCHEMISTRY-US, V38, P16407, DOI 10.1021/bi991761l; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Martinez-Costa OH, 2004, BIOCHEM J, V377, P77, DOI 10.1042/BJ20031032; Martinez-Costa OH, 2007, FEBS LETT, V581, P3033, DOI 10.1016/j.febslet.2007.05.059; Martinez-Oyanedel J, 2007, J MOL BIOL, V366, P1185, DOI 10.1016/j.jmb.2006.10.019; MARTINEZCOSTA OH, 1994, EUR J BIOCHEM, V226, P1007, DOI 10.1111/j.1432-1033.1994.01007.x; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Ortigosa AD, 2004, BIOCHEMISTRY-US, V43, P577, DOI 10.1021/bi035077p; PARMEGGIANI A, 1966, J BIOL CHEM, V241, P4625; Pascual-Montano A, 2001, J STRUCT BIOL, V133, P233, DOI 10.1006/jsbi.2001.4369; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POORMAN RA, 1984, NATURE, V309, P467, DOI 10.1038/309467a0; REINHART GD, 1980, BIOCHEMISTRY-US, V19, P1477, DOI 10.1021/bi00548a034; Ruiz T, 2003, J STRUCT BIOL, V143, P124, DOI 10.1016/S1047-8477(03)00140-0; Ruiz T, 2001, J STRUCT BIOL, V136, P167, DOI 10.1006/jsbi.2002.4440; Sanchez-Martinez C, 2000, BIOCHEM BIOPH RES CO, V271, P635, DOI 10.1006/bbrc.2000.2681; Santamaria B, 2002, J BIOL CHEM, V277, P1210, DOI 10.1074/jbc.M109480200; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Scheres SHW, 2007, STRUCTURE, V15, P1167, DOI 10.1016/j.str.2007.09.003; SCHIRMER T, 1990, NATURE, V343, P140, DOI 10.1038/343140a0; SOLS A, 1981, CURR TOP CELL REGUL, V19, P77; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; TELFORD JN, 1975, P NATL ACAD SCI USA, V72, P3054, DOI 10.1073/pnas.72.8.3054; Uyeda K, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P193; VANSCHAFTINGEN E, 1987, ADV ENZYMOL RAMB, V59, P315; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080	57	6	6	4	32	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4960	4968		10.1096/fj.10-165845	http://dx.doi.org/10.1096/fj.10-165845			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20732951				2022-12-25	WOS:000284824400034
J	Luo, J; Yang, J; Yu, BY; Liu, W; Li, M; Zhuang, SM				Luo, J.; Yang, J.; Yu, B-Y; Liu, W.; Li, M.; Zhuang, S-M			Identification of Siah-interacting protein as a potential regulator of apoptosis and curcumin resistance	ONCOGENE			English	Article						Siah-interacting protein; SIP; curcumin; apoptosis	CALCYCLIN-BINDING-PROTEIN; KINASE-C; ACQUIRED-RESISTANCE; CANCER-THERAPY; UP-REGULATION; BETA-CATENIN; CELLS; PHOSPHORYLATION; TRANSLOCATION; S100A6	The mechanism underlying curcumin (diferuloylmethane) resistance is still largely unknown. Here we employed proteomic approach to identify the Siah-interacting protein (SIP) as a candidate for detailed study, because the spot intensity of SIP on a two-dimensional gel displayed 70-90% reduction in curcumin-sensitive cells, but remained unchanged in curcumin-resistant sublines, after curcumin treatment. Both gain-and loss-of-function studies revealed that SIP promoted curcumin-induced apoptosis. Moreover, SIP underwent phosphorylation and nuclear translocation in curcumin-sensitive but not resistant cells, upon curcumin exposure. The nuclear translocation of SIP was remarkably impaired when a putative nuclear localization sequence (NLS, amino acid (aa) 143-159) was deleted or the serine 141 was mutated into alanine, whereas truncation of the N-terminal region (aa 1-43) obviously increased the nuclear import of SIP. In accordance with their nuclear localization, N-terminal truncation significantly enhanced the proapoptotic effect of SIP, whereas NLS deletion or Ser141Ala mutation attenuated the apoptosis-promoting activity of both wild-type- and N-terminal truncated-SIP. These data suggest that SIP plays a role in apoptosis and curcumin resistance, and the function of SIP may be regulated by different motifs, such as the NLS, N-terminal region and serine 141. Our findings provide new insights into the biological significance of SIP and the mechanisms of drug resistance. Oncogene (2010) 29, 6357-6366; doi:10.1038/onc.2010.358; published online 23 August 2010	[Luo, J.; Yang, J.; Yu, B-Y; Zhuang, S-M] Sun Yat Sen Univ, Sch Life Sci, Minist Educ, Key Lab Gene Engn,State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, W.; Li, M.] Sun Yat Sen Univ, Zhongshan Sch Med, Prote Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhuang, SM (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Minist Educ, Key Lab Gene Engn,State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	zhuangshimei@163.com		Yang, Jin-E/0000-0002-7511-1042; Zhuang, Shi-Mei/0000-0002-2512-3942	National Natural Science Foundation of China [30470664]; Ministry of Science and Technology of China [2010CB912803, 2005CB724600]; Ministry of Education of China [105136]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education of China(Ministry of Education, China)	This study was supported by grants from the National Natural Science Foundation of China (30470664), Ministry of Science and Technology of China (2010CB912803, 2005CB724600) and Ministry of Education of China (105136).	Aggarwal BB, 2005, CLIN CANCER RES, V11, P7490, DOI 10.1158/1078-0432.CCR-05-1192; Bhandarkar SS, 2007, ADV EXP MED BIOL, V595, P185; Bhattacharya S, 2005, BIOCHEMISTRY-US, V44, P9462, DOI 10.1021/bi0502689; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Daouti S, 2009, CANCER RES, V69, P1924, DOI 10.1158/0008-5472.CAN-08-2627; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Filipek A, 1996, BIOCHEM J, V320, P585, DOI 10.1042/bj3200585; Filipek A, 2002, J BIOL CHEM, V277, P21103, DOI 10.1074/jbc.M111010200; Filipek A, 2002, J BIOL CHEM, V277, P28848, DOI 10.1074/jbc.M203602200; Gutcher I, 2003, CELL MOL LIFE SCI, V60, P1061, DOI 10.1007/s00018-003-2281-y; Hsieh HL, 2002, J CELL SCI, V115, P3149; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pD80; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Joo JH, 2008, J CELL BIOCHEM, V103, P1183, DOI 10.1002/jcb.21496; Karunagaran D, 2005, CURR CANCER DRUG TAR, V5, P117, DOI 10.2174/1568009053202081; Kawamori T, 1999, CANCER RES, V59, P597; Kilanczyk E, 2009, BIOCHEM BIOPH RES CO, V380, P54, DOI 10.1016/j.bbrc.2009.01.026; Knauf JA, 1999, J BIOL CHEM, V274, P23414, DOI 10.1074/jbc.274.33.23414; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Li N, 2002, CARCINOGENESIS, V23, P1307, DOI 10.1093/carcin/23.8.1307; Lotfi K, 2002, BIOCHEM BIOPH RES CO, V293, P1489, DOI 10.1016/S0006-291X(02)00415-1; Mahmmoud YA, 2007, BRIT J PHARMACOL, V150, P200, DOI 10.1038/sj.bjp.0706970; Mansson E, 2002, BIOCHEM BIOPH RES CO, V298, P338, DOI 10.1016/S0006-291X(02)02471-3; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Ning XX, 2007, MOL CANCER RES, V5, P1254, DOI 10.1158/1541-7786.MCR-06-0426; O'Connor R, 2009, CURR CANCER DRUG TAR, V9, P273, DOI 10.2174/156800909788166583; Orre LM, 2007, MOL CELL PROTEOMICS, V6, P2122, DOI 10.1074/mcp.M700202-MCP200; Santelli E, 2005, J BIOL CHEM, V280, P34278, DOI 10.1074/jbc.M506707200; Shankar E, 2008, ONCOGENE, V27, P3957, DOI 10.1038/onc.2008.39; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Sun SR, 2007, BIOCHEM BIOPH RES CO, V356, P864, DOI 10.1016/j.bbrc.2007.03.080; Takigawa Y, 2008, CURR DRUG TARGETS, V9, P1013, DOI 10.2174/138945008786786127; Tran SEF, 2001, J BIOL CHEM, V276, P16484, DOI 10.1074/jbc.M010384200; Wang WZ, 2008, FEBS LETT, V582, P2689, DOI 10.1016/j.febslet.2008.06.048; Wu J, 2003, J BIOCHEM MOL BIOL, V36, P354; Wu JH, 2004, CANCER RES, V64, P6461, DOI 10.1158/0008-5472.CAN-04-0866; Yang YJ, 2006, LIFE SCI, V78, P753, DOI 10.1016/j.lfs.2005.05.100	41	4	4	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2010	29	48					6357	6366		10.1038/onc.2010.358	http://dx.doi.org/10.1038/onc.2010.358			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	688SW	20729913				2022-12-25	WOS:000284874700006
J	Wuertz, CM; Lorincz, A; Vettel, C; Thomas, MA; Wieland, T; Lutz, S				Wuertz, Christina M.; Lorincz, Akos; Vettel, Christiane; Thomas, Martin A.; Wieland, Thomas; Lutz, Susanne			p63RhoGEF-a key mediator of angiotensin II-dependent signaling and processes in vascular smooth muscle cells	FASEB JOURNAL			English	Article						G-protein-coupled receptors; RhoA; guanine nucleotide exchange factor; contraction; proliferation	NUCLEOTIDE-EXCHANGE FACTORS; STRESS FIBER FORMATION; RAT UTERINE MYOCYTES; LIGHT-CHAIN KINASE; TYPE-1 RECEPTOR; RHOA ACTIVATION; G-PROTEINS; INDUCED MIGRATION; INVOLVEMENT; TRANSFORMATION	The purpose of our study was to investigate the role of endogenous p63RhoGEF in G(q/11)-dependent RhoA activation and signaling in rat aortic smooth muscle cells (RASMCs). Therefore, we studied the expression and subcellular localization in freshly isolated RASMCs and performed loss of function experiments to analyze its contribution to RhoGTPase activation and functional responses such as proliferation and contraction. By this, we could show that p63RhoGEF is endogenously expressed in RASMCs and acts there as the dominant mediator of the fast angiotensin II (ANG II)-dependent but not of the sphingosine-1-phosphate (S1P)-dependent RhoA activation. p63RhoGEF is not an activator of the concomitant Rac1 activation and functions independently of caveolae. The knockdown of endogenous p63RhoGEF significantly reduced the mitogenic response of ANG II, abolished ANG II-induced stress fiber formation and cell elongation in 2-D culture, and impaired the ANG II-driven contraction in a collagen-based 3-D model. In conclusion, our data provide for the first time evidence that p63RhoGEF is an important mediator of ANG II-dependent RhoA activation in RASMCs and therewith a leading actor in the subsequently triggered cellular processes, such as proliferation and contraction.-Wuertz, C. M., Lorincz, A., Vettel, C., Thomas, M. A., Wieland, T., Lutz, S. p63RhoGEF-a key mediator of angiotensin II-dependent signaling and processes in vascular smooth muscle cells. FASEB J. 24, 4865-4876 (2010). www.fasebj.org	[Lutz, Susanne] Univ Gottingen, Dept Pharmacol, Med Fac Goettingen, D-37075 Gottingen, Germany; [Wuertz, Christina M.; Lorincz, Akos; Vettel, Christiane; Thomas, Martin A.; Wieland, Thomas] Heidelberg Univ, Inst Expt & Clin Pharmacol & Toxicol, Med Fac Mannheim, Heidelberg, Germany	University of Gottingen; Ruprecht Karls University Heidelberg	Lutz, S (corresponding author), Univ Gottingen, Dept Pharmacol, Med Fac Goettingen, Robert Koch Str 40, D-37075 Gottingen, Germany.	susanne.lutz@med.uni-goettingen.de	Lőrincz, Ákos M./N-9929-2017; Wieland, Thomas/Q-1506-2019; Wieland, Thomas/G-1772-2012	Lőrincz, Ákos M./0000-0002-2819-5116; Wieland, Thomas/0000-0001-8262-8261; Wieland, Thomas/0000-0001-8262-8261	Deutsche Forschungsgemeinschaft [Lu1486/1-1, SFB TR 23 TP B6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank S. Gorbey for the coordination of the animal facility, Z. Baraniak and H. Scheffel for the help with the animal work, and W. Greffrath for the help with the calcium assay. This work was supported by Deutsche Forschungsgemeinschaft grants Lu1486/1-1 and SFB TR 23 TP B6 (to S.L. and T.W).	Allen CL, 2008, J MOL CELL CARDIOL, V45, P198, DOI 10.1016/j.yjmcc.2008.05.021; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Bregeon J, 2009, AM J PHYSIOL-CELL PH, V297, pC1062, DOI 10.1152/ajpcell.00174.2009; Bryan B, 2004, J BIOL CHEM, V279, P45824, DOI 10.1074/jbc.M406216200; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; Coussin F, 2002, CIRC RES, V91, P151, DOI 10.1161/01.RES.0000028150.51130.36; Cuello F, 2007, CIRC RES, V100, P864, DOI 10.1161/01.RES.0000260809.15393.fa; Friedrich EB, 2006, BIOCHEM BIOPH RES CO, V349, P883, DOI 10.1016/j.bbrc.2006.07.217; Gohla A, 1999, J BIOL CHEM, V274, P17901, DOI 10.1074/jbc.274.25.17901; Guilluy C, 2010, NAT MED, V16, P183, DOI 10.1038/nm.2079; Guo XG, 2003, J BIOL CHEM, V278, P13207, DOI 10.1074/jbc.M208896200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Horiuchi M, 2003, CIRCULATION, V107, P106, DOI 10.1161/01.CIR.0000043244.13596.20; Ishizaka N, 1998, HYPERTENSION, V32, P459, DOI 10.1161/01.HYP.32.3.459; Jia GH, 2008, J MOL CELL CARDIOL, V44, P882, DOI 10.1016/j.yjmcc.2008.03.002; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; Ladwein M, 2008, FEBS LETT, V582, P2066, DOI 10.1016/j.febslet.2008.04.033; Liu HW, 2002, HYPERTENSION, V40, P451, DOI 10.1161/01.HYP.0000033466.05496.89; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Lutz S, 2004, N-S ARCH PHARMACOL, V369, pR52; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Mao JH, 1998, J BIOL CHEM, V273, P27118, DOI 10.1074/jbc.273.42.27118; Mendez-Bolaina E, 2007, AM J PHYSIOL-CELL PH, V293, pC1953, DOI 10.1152/ajpcell.00519.2006; Min LJ, 2005, CIRC RES, V97, P434, DOI 10.1161/01.RES.0000180753.63183.95; Mizuno Y, 2008, AM J PHYSIOL-CELL PH, V295, pC358, DOI 10.1152/ajpcell.90645.2007; Moepps B, 2008, CELL SIGNAL, V20, P1528, DOI 10.1016/j.cellsig.2008.04.010; Murthy KS, 2003, BIOCHEM J, V374, P145, DOI 10.1042/BJ20021274; Naito H, 2006, CIRCULATION, V114, pI72, DOI 10.1161/CIRCULATIONAHA.105.001560; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Ohtsu H, 2005, ARTERIOSCL THROM VAS, V25, P1831, DOI 10.1161/01.ATV.0000175749.41799.9b; Ohtsu H, 2008, ENDOCRINOLOGY, V149, P3569, DOI 10.1210/en.2007-1694; PAN P, BMC CELL BIOL, V11, P36; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Peifley KA, 1998, BIOCHEM BIOPH RES CO, V242, P202, DOI 10.1006/bbrc.1997.7940; Ridley AJ, 1997, INT J BIOCHEM CELL B, V29, P1225, DOI 10.1016/S1357-2725(97)00052-6; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sah VP, 1996, J BIOL CHEM, V271, P31185, DOI 10.1074/jbc.271.49.31185; Shin EY, 2009, EXP MOL MED, V41, P387, DOI 10.3858/emm.2009.41.6.044; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Souchet M, 2002, J CELL SCI, V115, P629; Sriwai W, 2008, BIOCHEM J, V411, P543, DOI [10.1042/BJ20071299, 10.1042/bj20071299]; Steffens F, 2003, MOL ENDOCRINOL, V17, P2103, DOI 10.1210/me.2003-0047; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; Suzuki H, 2009, ARTERIOSCL THROM VAS, V29, P217, DOI 10.1161/ATVBAHA.108.181024; Takashima S, 2008, CARDIOVASC RES, V79, P689, DOI 10.1093/cvr/cvn118; Taylor DS, 1999, P NATL ACAD SCI USA, V96, P1633, DOI 10.1073/pnas.96.4.1633; Thomas CM, 2008, J CELL MOL MED, V12, P796, DOI 10.1111/j.1582-4934.2008.00295.x; Ueda H, 2004, EXP CELL RES, V298, P207, DOI 10.1016/j.yexcr.2004.04.015; Vogt A, 2007, CELL SIGNAL, V19, P1229, DOI 10.1016/j.cellsig.2007.01.003; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; VOYNOYASENETSKAYA TA, 1994, ONCOGENE, V9, P2559; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; White CD, 2008, NEUROENDOCRINOLOGY, V88, P67, DOI 10.1159/000119093; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Ying ZK, 2009, ARTERIOSCL THROM VAS, V29, pE48; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Zhou XB, 2007, MOL ENDOCRINOL, V21, P740, DOI 10.1210/me.2006-0220; Zohn IM, 1998, ONCOGENE, V17, P1415, DOI 10.1038/sj.onc.1202181; Zuo L, 2005, ARTERIOSCL THROM VAS, V25, P1824, DOI 10.1161/01.ATV.0000175295.09607.18	61	49	49	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					4865	4876		10.1096/fj.10-155499	http://dx.doi.org/10.1096/fj.10-155499			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20739613				2022-12-25	WOS:000284824400026
J	Gloor, JW; Balakrishnan, L; Bambara, RA				Gloor, Jason W.; Balakrishnan, Lata; Bambara, Robert A.			Flap Endonuclease 1 Mechanism Analysis Indicates Flap Base Binding Prior to Threading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; DNA-POLYMERASE-I; SUBSTRATE-SPECIFICITY; STRUCTURAL BASIS; BLOOM PROTEIN; REPAIR; FEN-1; PCNA; REPLICATION; CLEAVAGE	FEN1 cleaves 5' flaps at their base to create a nicked product for ligation. FEN1 has been reported to enter the flap from the 5'-end and track to the base. Current binding analyses support a very different mechanism of interaction with the flap substrate. Measurements of FEN1 binding to a flap substrate show that the nuclease binds with similar high affinity to the base of a long flap even when the 5'-end is blocked with biotin/streptavidin. However, FEN1 bound to a blocked flap is more sensitive to sequestration by a competing substrate. These results are consistent with a substrate interaction mechanism in which FEN1 first binds the flap base and then threads the flap through an opening in the protein from the 5'-end to the base for cleavage. Significantly, when the unblocked flap length is reduced from five to two nucleotides, FEN1 can be sequestered from the substrate to a similar extent as a blocked, long flap substrate. Apparently, interactions related to threading occur only when the flap is greater than two to four nucleotides long, implying that short flaps are cleaved without a threading requirement.	[Gloor, Jason W.; Balakrishnan, Lata; Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu			National Institutes of Health [GM024441, GM068411]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411, R01GM024441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM024441 (to R. A. B.).; Supported by National Institutes of Health T32 Fellowship GM068411.	Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Balakrishnan L, 2009, J BIOL CHEM, V284, P15158, DOI 10.1074/jbc.M109.000505; Barnes CJ, 1996, J BIOL CHEM, V271, P29624, DOI 10.1074/jbc.271.47.29624; Bartos JD, 2006, J BIOL CHEM, V281, P32227, DOI 10.1074/jbc.M606310200; Bornarth CJ, 1999, BIOCHEMISTRY-US, V38, P13347, DOI 10.1021/bi991321u; Brosh RM, 2002, BIOCHEMISTRY-US, V41, P12204, DOI 10.1021/bi026031j; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; Finger LD, 2009, J BIOL CHEM, V284, P22184, DOI 10.1074/jbc.M109.015065; HARRINGTON JJ, 1995, J BIOL CHEM, V270, P4503, DOI 10.1074/jbc.270.9.4503; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hohl M, 2007, NUCLEIC ACIDS RES, V35, P3053, DOI 10.1093/nar/gkm092; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Hwang KY, 1998, NAT STRUCT BIOL, V5, P707, DOI 10.1038/1406; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Kim CY, 2001, BIOCHEMISTRY-US, V40, P3208, DOI 10.1021/bi002100n; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; ROBINS P, 1994, J BIOL CHEM, V269, P28535; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Sharma S, 2005, NUCLEIC ACIDS RES, V33, P6769, DOI 10.1093/nar/gki1002; Tom S, 2000, J BIOL CHEM, V275, P10498, DOI 10.1074/jbc.275.14.10498; Wang WS, 2005, J BIOL CHEM, V280, P5391, DOI 10.1074/jbc.M412359200; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; Xu Y, 2001, J BIOL CHEM, V276, P30167, DOI 10.1074/jbc.M100985200	31	29	29	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34922	34931		10.1074/jbc.M110.165902	http://dx.doi.org/10.1074/jbc.M110.165902			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739288	Green Published, hybrid			2022-12-25	WOS:000283659100066
J	Lv, P; Wei, DG; Yamoah, EN				Lv, Ping; Wei, Dongguang; Yamoah, Ebenezer N.			K(v)7-type Channel Currents in Spiral Ganglion Neurons INVOLVEMENT IN SENSORINEURAL HEARING LOSS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER HAIR-CELLS; INNER-EAR; POTASSIUM CHANNELS; K+ CURRENTS; ELECTRICAL-STIMULATION; DOMINANT DEAFNESS; AUDITORY NEURONS; EXPRESSION; CALCIUM; KCNQ4	Alterations in K(v)7-mediated currents in excitable cells result in several diseased conditions. A case in DFNA2, an autosomal dominant version of progressive hearing loss, involves degeneration of hair cells and spiral ganglion neurons (SGNs) from basal to apical cochlea, manifesting as high-to-low frequency hearing loss, and has been ascribed to mutations in K(v)7.4 channels. Analyses of the cellular mechanisms of K(v)7.4 mutations and progressive degeneration of SGNs have been hampered by the paucity of functional data on the role K(v)7 channels play in young and adult neurons. To understand the cellular mechanisms of the disease in SGNs, we examined temporal (young, 0.5 months old, and senescent, 17 months old) and spatial (apical and basal) roles of K(v)7-mediated currents. We report that differential contribution of K(v)7 currents in mice SGNs results in distinct and profound variations of the membrane properties of basal versus apical neurons. The current produces a major impact on the resting membrane potential of basal neurons. Inhibition of the current promotes membrane depolarization, resulting in activation of Ca2+ currents and a sustained rise in intracellular Ca2+. Using TUNEL assay, we demonstrate that a sustained increase in intracellular Ca2+ mediated by inhibition of K(v)7 current results in significant SGN apoptotic death. Thus, this study provides evidence of the cellular etiology and mechanisms of SGN degeneration in DFNA2.	[Lv, Ping; Wei, Dongguang; Yamoah, Ebenezer N.] Univ Calif Davis, Dept Anesthesiol & Pain Med, Program Commun Sci, Sch Med, Davis, CA 95618 USA	University of California System; University of California Davis	Yamoah, EN (corresponding author), Univ Calif Davis, Dept Anesthesiol & Pain Med, Program Commun Sci, Sch Med, 1515 Newton Ct, Davis, CA 95618 USA.	enyamoah@ucdavis.edu			National Institutes of Health [DC010386]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DC010386 (to E. N. Y.).	Abbott GW, 2002, FASEB J, V16, DOI 10.1096/fj.01-0520hyp; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Adamson CL, 2002, J COMP NEUROL, V447, P331, DOI 10.1002/cne.10244; Beisel KW, 2005, J NEUROSCI, V25, P9285, DOI 10.1523/JNEUROSCI.2110-05.2005; Beisel KW, 2004, GENOMICS, V83, P1012, DOI 10.1016/j.ygeno.2004.01.006; Beisel KW, 2000, MOL BRAIN RES, V82, P137; Bok J, 2007, MOL CELL NEUROSCI, V36, P13, DOI 10.1016/j.mcn.2007.05.008; CHOI DW, 1989, ANN NY ACAD SCI, V568, P219; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; Chung HJ, 2006, P NATL ACAD SCI USA, V103, P8870, DOI 10.1073/pnas.0603376103; Eatock RA, 2003, CURR TOP DEV BIOL, V57, P389, DOI 10.1016/S0070-2153(03)57013-2; Hegarty JL, 1997, J NEUROSCI, V17, P1959; Hisashi K, 1995, HEARING RES, V91, P196, DOI 10.1016/0378-5955(95)00191-3; Holt JR, 2007, J NEUROSCI, V27, P8940, DOI 10.1523/JNEUROSCI.2085-07.2007; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; HU B, 2002, HUM MOL GENET */* T, V11, P2435; Hurley KM, 2006, J NEUROSCI, V26, P10253, DOI 10.1523/JNEUROSCI.2596-06.2006; Jagger DJ, 2002, NEUROSCIENCE, V109, P169, DOI 10.1016/S0306-4522(01)00454-7; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jin Z, 2009, AUDIOL NEURO-OTOL, V14, P98, DOI 10.1159/000158538; Jung DK, 2005, NEUROL RES, V27, P436, DOI 10.1179/016164105X22011; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Leake PA, 1999, J COMP NEUROL, V412, P543, DOI 10.1002/(SICI)1096-9861(19991004)412:4<543::AID-CNE1>3.0.CO;2-3; Levic S, 2007, P NATL ACAD SCI USA, V104, P19108, DOI 10.1073/pnas.0705927104; Lin X, 1998, J NEUROPHYSIOL, V79, P2503, DOI 10.1152/jn.1998.79.5.2503; Martinez-Monedero R, 2006, J NEUROBIOL, V66, P319, DOI 10.1002/neu.20232; Mo ZL, 2002, J PHYSIOL-LONDON, V542, P763, DOI 10.1113/jphysiol.2002.017202; Nie LP, 2005, J NEUROSCI, V25, P8671, DOI 10.1523/JNEUROSCI.1422-05.2005; Ohyama H, 2001, PFLUG ARCH EUR J PHY, V442, P329, DOI 10.1007/s004240100547; Oliver D, 2003, J NEUROSCI, V23, P2141; Pirvola U, 1997, J NEUROBIOL, V33, P1019, DOI 10.1002/(SICI)1097-4695(199712)33:7<1019::AID-NEU11>3.0.CO;2-A; Rodriguez-Contreras A, 2001, J PHYSIOL-LONDON, V534, P669, DOI 10.1111/j.1469-7793.2001.00669.x; Roehm PC, 2008, MOL CELL NEUROSCI, V37, P376, DOI 10.1016/j.mcn.2007.10.014; SANTOS-SACCHI J, 1993, J NEUROSCI, V13, P3599; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Semenova MM, 2007, NAT NEUROSCI, V10, P436, DOI 10.1038/nn1869; Shen HY, 2007, HEARING RES, V226, P52, DOI 10.1016/j.heares.2006.12.011; Vollmer M, 1999, J NEUROPHYSIOL, V82, P2883, DOI 10.1152/jn.1999.82.6.2883; Wei D, 2007, DEV NEUROBIOL, V67, P108, DOI 10.1002/dneu.20336; Wildburger NC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-44; Xu TH, 2007, J BIOL CHEM, V282, P23899, DOI 10.1074/jbc.M702108200; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	44	44	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34699	34707		10.1074/jbc.M110.136192	http://dx.doi.org/10.1074/jbc.M110.136192			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20739290	hybrid, Green Published			2022-12-25	WOS:000283659100045
J	Zhang, LP; Ten Hagen, KG				Zhang, Liping; Ten Hagen, Kelly G.			Dissecting the Biological Role of Mucin-type O-Glycosylation Using RNA Interference in Drosophila Cell Culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; UDP-GALNAC; CAENORHABDITIS-ELEGANS; EXPRESSION; FAMILY; GOLGI; CYTOKINESIS; SECRETION; ADHESION; HT-29	Mucin type O-glycosylation is a highly conserved form of post-translational modification initiated by the family of enzymes known as the polypeptide alpha-N-acetylgalactosaminyltransferases (ppGalNAcTs in mammals and PGANTs in Drosophila). To address the cellular functions of the many PGANT family members, RNA interference (RNAi) to each pgant gene was performed in two independent Drosophila cell culture lines. We demonstrate that RNAi to individual pgant genes results in specific reduction in gene expression without affecting the expression of other family members. Cells with reduced expression of individual pgant genes were then examined for changes in viability, morphology, adhesion, and secretion to assess the contribution of each family member to these cellular functions. Here we find that RNAi to pgant3, pgant6, or pgant7 resulted in reduced secretion, further supporting a role for O-glycosylation in proper secretion. Additionally, RNAi to pgant3 or pgant6 resulted in altered Golgi organization, suggesting a role for each in establishing or maintaining proper secretory apparatus structure. Other subcellular effects observed included multinucleated cells seen after RNAi to either pgant2 or pgant35A, suggesting a role for these genes in the completion of cytokinesis. These studies demonstrate the efficient and specific knockdown of pgant gene expression in two Drosophila cell culture systems, resulting in specific morphological and functional effects. Our work provides new information regarding the biological roles of O-glycosylation and illustrates a new platform for interrogating the cellular and subcellular effects of this form of post-translational modification.	[Zhang, Liping; Ten Hagen, Kelly G.] NIDCR, Dev Glycobiol Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ten Hagen, KG (corresponding author), Bldg 30,Rm 426,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	Kelly.Tenhagen@nih.gov			National Institutes of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health (Intramural Research Program of the NIDCR).	Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Barr FA, 2009, SEMIN CELL DEV BIOL, V20, P780, DOI 10.1016/j.semcdb.2009.03.007; Behr M, 2007, NAT CELL BIOL, V9, P847, DOI 10.1038/ncb1611; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Delannoy P, 1996, GLYCOCONJUGATE J, V13, P717, DOI 10.1007/BF00702335; Derby MC, 2007, TRAFFIC, V8, P758, DOI 10.1111/j.1600-0854.2007.00563.x; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Farkas RM, 2003, MOL BIOL CELL, V14, P190, DOI 10.1091/mbc.E02-06-0343; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Gouyer V, 2001, J CELL SCI, V114, P1455; Hagen FK, 1998, J BIOL CHEM, V273, P8268, DOI 10.1074/jbc.273.14.8268; Hagen KGT, 2009, GLYCOBIOLOGY, V19, P102, DOI 10.1093/glycob/cwn096; Hang HC, 2005, BIOORGAN MED CHEM, V13, P5021, DOI 10.1016/j.bmc.2005.04.085; Huet G, 1998, J CELL BIOL, V141, P1311, DOI 10.1083/jcb.141.6.1311; Ichikawa S, 2009, ENDOCRINOLOGY, V150, P2543, DOI 10.1210/en.2008-0877; Jani K, 2007, J CELL BIOL, V179, P1583, DOI 10.1083/jcb.200707045; KIGER AA, 2003, J Biol */* N J BIOL, V27, P1; Kingsley PD, 2000, GLYCOBIOLOGY, V10, P1317, DOI 10.1093/glycob/10.12.1317; Korolchuk VI, 2007, J CELL SCI, V120, P4367, DOI 10.1242/jcs.012336; Lowe M, 2000, J CELL BIOL, V149, P341, DOI 10.1083/jcb.149.2.341; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Mellen MA, 2008, CELL DEATH DIFFER, V15, P1279, DOI 10.1038/cdd.2008.40; Polevoy G, 2009, J CELL BIOL, V187, P847, DOI 10.1083/jcb.200908107; Potter BA, 2006, AM J PHYSIOL-CELL PH, V290, pC1, DOI 10.1152/ajpcell.00333.2005; Ramirez IBR, 2009, SEMIN CELL DEV BIOL, V20, P770, DOI 10.1016/j.semcdb.2009.03.011; Robinett CC, 2009, J CELL SCI, V122, P4526, DOI 10.1242/jcs.054536; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7; Ten Hagen KG, 2002, J BIOL CHEM, V277, P22616, DOI 10.1074/jbc.M201807200; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tian E, 2007, J BIOL CHEM, V282, P606, DOI 10.1074/jbc.M606268200; Tian E, 2006, GLYCOBIOLOGY, V16, P83, DOI 10.1093/glycob/cwj051; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Weber Y, 2004, EUKARYOT CELL, V3, P1164, DOI 10.1128/EC.3.5.1164-1168.2004; Wei JH, 2009, SEMIN CELL DEV BIOL, V20, P810, DOI 10.1016/j.semcdb.2009.03.010; Xu H, 2002, J CELL SCI, V115, P4447, DOI 10.1242/jcs.00139; Xu H, 2002, DEV BIOL, V251, P294, DOI 10.1006/dbio.2002.0830; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; Young WW, 2003, GLYCOBIOLOGY, V13, P549, DOI 10.1093/glycob/cwg062; Zhang LP, 2010, J BIOL CHEM, V285, P19491, DOI 10.1074/jbc.M109.098145; Zhang LP, 2008, J BIOL CHEM, V283, P34076, DOI 10.1074/jbc.M804267200	44	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					34477	34484		10.1074/jbc.M110.133561	http://dx.doi.org/10.1074/jbc.M110.133561			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20807760	Green Published, hybrid			2022-12-25	WOS:000283659100022
J	Liu, RP; Xu, YM; Chen, MA; Weiwer, M; Zhou, XX; Bridges, AS; DeAngelis, PL; Zhang, QS; Linhardt, RJ; Liu, JA				Liu, Renpeng; Xu, Yongmei; Chen, Miao; Weiwer, Michel; Zhou, Xianxuan; Bridges, Arlene S.; DeAngelis, Paul L.; Zhang, Qisheng; Linhardt, Robert J.; Liu, Jian			Chemoenzymatic Design of Heparan Sulfate Oligosaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; SUBSTRATE SPECIFICITIES; ANTITHROMBIN-III; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; BINDING; GLYCOSAMINOGLYCANS; PENTASACCHARIDE; TYPE-1; ENTRY	Heparan sulfate is a sulfated glycan that exhibits essential physiological functions. Interrogation of the specificity of heparan sulfate-mediated activities demands a library of structurally defined oligosaccharides. Chemical synthesis of large heparan sulfate oligosaccharides remains challenging. We report the synthesis of oligosaccharides with different sulfation patterns and sizes from a disaccharide building block using glycosyl-transferases, heparan sulfate C-5-epimerase, and sulfotransferases. This method offers a generic approach to prepare heparan sulfate oligosaccharides possessing predictable structures.	[Zhang, Qisheng; Liu, Jian] Univ N Carolina, Div Med Chem & Nat Prod, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Bridges, Arlene S.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Weiwer, Michel; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA; [DeAngelis, Paul L.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Rensselaer Polytechnic Institute; University of Oklahoma System; University of Oklahoma Health Sciences Center	Liu, JA (corresponding author), Univ N Carolina, Div Med Chem & Nat Prod, Eshelman Sch Pharm, Rm 303,Beard Hall, Chapel Hill, NC 27599 USA.	jian_liu@unc.edu	Liu, Renpeng/G-1625-2011; BRIDGES, ARLENE/N-4534-2013	ZHOU, XIANXUAN/0000-0003-0105-5161; Zhang, Qisheng/0000-0001-9808-5038	National Institutes of Health [AI50050, HL094463, HL62244, HL096972, GM38060]; American Heart Association, MidAtlantic Affiliate [0855424E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062244, R01HL096972, R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, MidAtlantic Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported, in whole or in part, by National Institutes of Health Grants AI50050, HL094463, HL62244, HL096972, and GM38060. This work was also supported by Grant-in-aid 0855424E from American Heart Association, MidAtlantic Affiliate.	Arungundram S, 2009, J AM CHEM SOC, V131, P17394, DOI 10.1021/ja907358k; ATHA DH, 1985, BIOCHEMISTRY-US, V24, P6723, DOI 10.1021/bi00344a063; Baleux F, 2009, NAT CHEM BIOL, V5, P743, DOI 10.1038/nchembio.207; Boltje TJ, 2009, NAT CHEM, V1, P611, DOI [10.1038/nchem.399, 10.1038/NCHEM.399]; Chen JH, 2005, J BIOL CHEM, V280, P42817, DOI 10.1074/jbc.M504338200; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Chen M, 2006, BIOCHEMISTRY-US, V45, P12358, DOI 10.1021/bi060844g; CONRAD HE, 1998, HEPARIN BINDING PROT, P34; Copeland R, 2008, BIOCHEMISTRY-US, V47, P5774, DOI 10.1021/bi800205t; de Agostini AI, 2008, J BIOL CHEM, V283, P28115, DOI 10.1074/jbc.M805338200; de Paz JL, 2008, MOL BIOSYST, V4, P707, DOI 10.1039/b802217h; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Edavettal SC, 2004, J BIOL CHEM, V279, P25789, DOI 10.1074/jbc.M401089200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Jaipuri FA, 2008, ANGEW CHEM INT EDIT, V47, P1707, DOI 10.1002/anie.200704262; Kakuta Y, 1999, J BIOL CHEM, V274, P10673, DOI 10.1074/jbc.274.16.10673; Kuberan B, 2003, NAT BIOTECHNOL, V21, P1343, DOI 10.1038/nbt885; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; LEE MK, 1991, P NATL ACAD SCI USA, V88, P2768, DOI 10.1073/pnas.88.7.2768; Liu HY, 2009, NAT PROD REP, V26, P313, DOI 10.1039/b819896a; Liu JA, 1999, J BIOL CHEM, V274, P5185, DOI 10.1074/jbc.274.8.5185; Liu J, 2007, APPL MICROBIOL BIOT, V74, P263, DOI 10.1007/s00253-006-0722-x; Peterson S, 2009, NAT PROD REP, V26, P610, DOI 10.1039/b803795g; Petitou M, 2004, ANGEW CHEM INT EDIT, V43, P3118, DOI 10.1002/anie.200300640; Pope RM, 2001, GLYCOBIOLOGY, V11, P505, DOI 10.1093/glycob/11.6.505; Przybylski C, 2010, GLYCOBIOLOGY, V20, P224, DOI 10.1093/glycob/cwp169; Sala RF, 1998, CARBOHYD RES, V306, P127, DOI 10.1016/S0008-6215(97)10033-7; Sigulinsky C, 2010, CARBOHYD RES, V345, P250, DOI 10.1016/j.carres.2009.10.024; Sismey-Ragatz AE, 2007, J BIOL CHEM, V282, P28321, DOI 10.1074/jbc.M701599200; Smeds E, 2003, BIOCHEM J, V372, P371, DOI 10.1042/BJ20021665; Venkataraman G, 1999, SCIENCE, V286, P537, DOI 10.1126/science.286.5439.537; Xia GQ, 2002, J BIOL CHEM, V277, P37912, DOI 10.1074/jbc.M204209200; Xu D, 2008, NAT CHEM BIOL, V4, P200, DOI 10.1038/nchembio.66; Zaia J, 2003, ANAL CHEM, V75, P2445, DOI 10.1021/ac0263418; Zhang ZQ, 2008, J AM CHEM SOC, V130, P12998, DOI 10.1021/ja8026345	36	121	126	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					34240	34249		10.1074/jbc.M110.159152	http://dx.doi.org/10.1074/jbc.M110.159152			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20729556	hybrid, Green Published			2022-12-25	WOS:000283354000069
J	Antczak, P; Ortega, F; Chipman, JK; Falciani, F				Antczak, Philipp; Ortega, Fernando; Chipman, J. Kevin; Falciani, Francesco			Mapping Drug Physico-Chemical Features to Pathway Activity Reveals Molecular Networks Linked to Toxicity Outcome	PLOS ONE			English	Article							EXPRESSION; SELECTION	The identification of predictive biomarkers is at the core of modern toxicology. So far, a number of approaches have been proposed. These rely on statistical inference of toxicity response from either compound features (i.e., QSAR), in vitro cell based assays or molecular profiling of target tissues (i.e., expression profiling). Although these approaches have already shown the potential of predictive toxicology, we still do not have a systematic approach to model the interaction between chemical features, molecular networks and toxicity outcome. Here, we describe a computational strategy designed to address this important need. Its application to a model of renal tubular degeneration has revealed a link between physicochemical features and signalling components controlling cell communication pathways, which in turn are differentially modulated in response to toxic chemicals. Overall, our findings are consistent with the existence of a general toxicity mechanism operating in synergy with more specific single-target based mode of actions (MOAs) and provide a general framework for the development of an integrative approach to predictive toxicology.	[Antczak, Philipp; Ortega, Fernando; Chipman, J. Kevin; Falciani, Francesco] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham	Falciani, F (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	f.falciani@bham.ac.uk	Ortega, Fernando/G-2129-2015; Falciani, Francesco/F-3490-2010; Antczak, Philipp/L-5879-2019	Ortega, Fernando/0000-0002-3172-2095; Antczak, Philipp/0000-0001-9600-7757	Biotechnology and Biological Sciences Research Council (BBSRC); United Kingdom Natural Environment Research Council (NERC) [NE/C507661/1]; NERC [NE/D000793/1] Funding Source: UKRI; Natural Environment Research Council [NE/D000793/1, NE/C507661/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United Kingdom Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work has been partially supported by a Biotechnology and Biological Sciences Research Council (BBSRC) PhD studentship to PA and by the United Kingdom Natural Environment Research Council (NERC) Post-Genomic and Proteomic Programme grant NE/C507661/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin RP, 2002, TOXICOLOGY, V181, P555, DOI 10.1016/S0300-483X(02)00481-X; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bushel PR, 2002, J BIOMED INFORM, V35, P160, DOI 10.1016/S1532-0464(02)00525-7; Cariello NF, 2002, MUTAGENESIS, V17, P321, DOI 10.1093/mutage/17.4.321; Chipman JK, 2003, TOXICOL SCI, V71, P146, DOI 10.1093/toxsci/71.2.146; Conesa A, 2008, GENOMICS, V92, P373, DOI 10.1016/j.ygeno.2008.05.015; Dieterle F, 2008, CURR OPIN DRUG DISC, V11, P60; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Doi AM, 2007, TOXICOL PATHOL, V35, P533, DOI 10.1080/01926230701338941; Fielden MR, 2005, TOXICOL PATHOL, V33, P675, DOI 10.1080/01926230500321213; Freeman JW, 2004, FRONT BIOSCI-LANDMRK, V9, P1889, DOI 10.2741/1388; Geng H, 2009, AM J PATHOL, V174, P1291, DOI 10.2353/ajpath.2009.080295; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.2307/2333639; Judson R, 2009, ENVIRON HEALTH PERSP, V117, P685, DOI 10.1289/ehp.0800168; KLAASSEN C, 1993, J OCCUPATIONAL ENV M, V35, P76; Kong SW, 2006, BIOINFORMATICS, V22, P2373, DOI 10.1093/bioinformatics/btl401; Lobenhofer EK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r100; Mayr LM, 2009, CURR OPIN PHARMACOL, V9, P580, DOI 10.1016/j.coph.2009.08.004; Merlot C, 2010, DRUG DISCOV TODAY, V15, P16, DOI 10.1016/j.drudis.2009.09.010; Pereira CV, 2009, CURR DRUG SAF, V4, P34, DOI 10.2174/157488609787354440; RAYCHAUDHURI S, 2000, PAC S BIOC PAC S BIO; Sameith K, 2008, BIOINFORMATICS, V24, P2602, DOI 10.1093/bioinformatics/btn489; SCHOEPPE W, 1977, P ROY SOC MED, V70, P36, DOI 10.1177/00359157770700S207; SONG S, 2006, PRINCIPAL COORDINATE; Song S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-502; Steiner G, 2004, ENVIRON HEALTH PERSP, V112, P1236, DOI 10.1289/txg.7036; TEAM RDC, 2005, R LANGUAGE ENV STAT; Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y; Thomas RS, 2001, MOL PHARMACOL, V60, P1189, DOI 10.1124/mol.60.6.1189; Trevino V, 2006, BIOINFORMATICS, V22, P1154, DOI 10.1093/bioinformatics/btl074; Vayer P, 2009, M S-MED SCI, V25, P871, DOI 10.1051/medsci/20092510871; Vedani A, 2006, BASIC CLIN PHARMACOL, V99, P195, DOI 10.1111/j.1742-7843.2006.pto_471.x; Waring JF, 2002, TOXICOLOGY, V181, P537, DOI 10.1016/S0300-483X(02)00477-8	33	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12385	10.1371/journal.pone.0012385	http://dx.doi.org/10.1371/journal.pone.0012385			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20811577	Green Submitted, Green Published, gold			2022-12-25	WOS:000281301500004
J	Murray, SA; Morgan, JL; Kane, C; Sharma, Y; Heffner, CS; Lake, J; Donahue, LR				Murray, Stephen A.; Morgan, Judith L.; Kane, Coleen; Sharma, Yashoda; Heffner, Caleb S.; Lake, Jeffrey; Donahue, Leah Rae			Mouse Gestation Length Is Genetically Determined	PLOS ONE			English	Article							PRETERM BIRTH; MICE; PARTURITION; INSIGHTS; BIOLOGY	Background: Preterm birth is an enormous public health problem, affecting over 12% of live births and costing over $26 billion in the United States alone. The causes are complex, but twin studies support the role of genetics in determining gestation length. Despite widespread use of the mouse in studies of the genetics of preterm birth, there have been few studies that actually address the precise natural gestation length of the mouse, and to what degree the timing of labor and birth is genetically determined. Methodology/Principal Findings: To further develop the mouse as a genetic model of preterm birth, we developed a high-throughput monitoring system and measured the gestation length in 15 inbred strains. Our results show an unexpectedly wide variation in overall gestation length between strains that approaches two full days, while intra-strain variation is quite low. Although litter size shows a strong inverse correlation with gestation length, genetic difference alone accounts for a significant portion of the variation. In addition, ovarian transplant experiments support a primary role of maternal genetics in the determination of gestation length. Preliminary analysis of gestation length in the C57BL/6J-Chr#(A/J)/NaJ chromosome substitution strain (B.A CSS) panel suggests complex genetic control of gestation length. Conclusions/Significance: Together, these data support the role of genetics in regulating gestation length and present the mouse as an important tool for the discovery of genes governing preterm birth.	[Murray, Stephen A.; Morgan, Judith L.; Kane, Coleen; Sharma, Yashoda; Heffner, Caleb S.; Lake, Jeffrey; Donahue, Leah Rae] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Murray, SA (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	leahrae.donahue@jax.org		Heffner, Caleb/0000-0002-2631-6201	March of Dimes [MOD154LRD]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD011102] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by the March of Dimes (www.marchofdimes.com) Grant #MOD154LRD. The funders, as part of a panel of independent scientists who have an interest in this work, helped conceive and design the study, and have served as advisers during the work. The data collection, analysis, decision to publish and preparation of the manuscript was entirely the work of the authors.	BEHRMAN RE, 2007, PRETERM BIRTH CAUSES, pR16; Chaudhari BP, 2008, CLIN GENET, V74, P493, DOI 10.1111/j.1399-0004.2008.01124.x; DeFranco E, 2007, SEMIN REPROD MED, V25, P40, DOI 10.1055/s-2006-956774; Delahunty KM, 2009, J CLIN DENSITOM, V12, P89, DOI 10.1016/j.jocd.2008.10.008; Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Kimura T, 1999, REV REPROD, V4, P73, DOI 10.1530/ror.0.0040073; KISTKA ZA, 2008, AM J OBSTET GYNECOL, V43, pE41; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Ratajczak CK, 2008, PEDIATR RES, V64, P581, DOI 10.1203/PDR.0b013e31818718d2; Romero R, 2010, AM J OBSTET GYNECOL, V202; Sztein J, 1998, BIOL REPROD, V58, P1071, DOI 10.1095/biolreprod58.4.1071; Wilcox AJ, 2008, AM J EPIDEMIOL, V167, P474, DOI 10.1093/aje/kwm319	13	82	82	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2010	5	8							e12418	10.1371/journal.pone.0012418	http://dx.doi.org/10.1371/journal.pone.0012418			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642RO	20811634	Green Published, Green Submitted, gold			2022-12-25	WOS:000281234700032
J	Mat, WK; Xue, H; Wong, JTF				Mat, Wai-Kin; Xue, Hong; Wong, J. Tze-Fei			Genetic Code Mutations: The Breaking of a Three Billion Year Invariance	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; UNNATURAL AMINO-ACID; ESCHERICHIA-COLI; COEVOLUTION THEORY; MAMMALIAN-CELLS; PROTEINS; TRYPTOPHAN; SUPPRESSION; EVOLUTION; GROWTH	The genetic code has been unchanging for some three billion years in its canonical ensemble of encoded amino acids, as indicated by the universal adoption of this ensemble by all known organisms. Code mutations beginning with the encoding of 4-fluoro-Trp by Bacillus subtilis, initially replacing and eventually displacing Trp from the ensemble, first revealed the intrinsic mutability of the code. This has since been confirmed by a spectrum of other experimental code alterations in both prokaryotes and eukaryotes. To shed light on the experimental conversion of a rigidly invariant code to a mutating code, the present study examined code mutations determining the propagation of Bacillus subtilis on Trp and 4-, 5- and 6-fluorotryptophans. The results obtained with the mutants with respect to cross-inhibitions between the different indole amino acids, and the growth effects of individual nutrient withdrawals rendering essential their biosynthetic pathways, suggested that oligogenic barriers comprising sensitive proteins which malfunction with amino acid analogues provide effective mechanisms for preserving the invariance of the code through immemorial time, and mutations of these barriers open up the code to continuous change.	[Mat, Wai-Kin] Hong Kong Univ Sci & Technol, Fok Ying Tung Grad Sch, Appl Genom Ctr, Hong Kong, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Mat, WK (corresponding author), Hong Kong Univ Sci & Technol, Fok Ying Tung Grad Sch, Appl Genom Ctr, Hong Kong, Hong Kong, Peoples R China.	bcjtw@ust.hk		Xue, Hong/0000-0002-8133-9828; Wong, J. Tze-Fei/0000-0001-8539-8537	Research Grants Council of Hong Kong [HKUST6437/06M]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by The Research Grants Council of Hong Kong (Grant No. HKUST6437/06M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacher JM, 2007, METH MOL B, V352, P23; Bacher JM, 2004, TRENDS ECOL EVOL, V19, P69, DOI 10.1016/j.tree.2003.11.007; Bacher JM, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-24; Bacher JM, 2001, J BACTERIOL, V183, P5414, DOI 10.1128/JB.183.18.5414-5425.2001; Bock A, 2001, SCIENCE, V292, P453, DOI 10.1126/science.1060637; BRONSKILL PM, 1988, BIOCHEM J, V249, P305, DOI 10.1042/bj2490305; Budisa N., 2006, ENG GENETIC CODE, P90; COHEN P, 2000, NEW SCI, V167, P32; Cropp TA, 2007, NAT PROTOC, V2, P2590, DOI 10.1038/nprot.2007.378; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; Gibson DG, 2010, CREATION BACTERIAL C; HESMAN T, 2000, SCI NEWS, V157, P360, DOI DOI 10.2307/4012452; Kohrer C, 2004, NUCLEIC ACIDS RES, V32, P6200, DOI 10.1093/nar/gkh959; KWOK Y, 1980, CAN J BIOCHEM CELL B, V58, P213, DOI 10.1139/o80-029; Lee HS, 2009, J AM CHEM SOC, V131, P12921, DOI 10.1021/ja904896s; LEMEIGNAN B, 1993, J MOL BIOL, V231, P161, DOI 10.1006/jmbi.1993.1269; MAT WK, 2004, AM SOC MICR 104 M; Mehl RA, 2003, J AM CHEM SOC, V125, P935, DOI 10.1021/ja0284153; PENKE B, 1974, ANAL BIOCHEM, V60, P45, DOI 10.1016/0003-2697(74)90129-8; Pezo V, 2004, P NATL ACAD SCI USA, V101, P8593, DOI 10.1073/pnas.0402893101; Sakamoto K, 2002, NUCLEIC ACIDS RES, V30, P4692, DOI 10.1093/nar/gkf589; Santoro SW, 2003, NUCLEIC ACIDS RES, V31, P6700, DOI 10.1093/nar/gkg903; Tang Y, 2002, BIOCHEMISTRY-US, V41, P10635, DOI 10.1021/bi026130x; Tze-Fei J Wong, 2009, PREBIOTIC EVOLUTION, P110; Wong JTF, 2007, ORIGINS LIFE EVOL B, V37, P403, DOI 10.1007/s11084-007-9094-1; WONG JT, 1984, DYNAMICS BIOCH SYSTE, P247; WONG JT, 2002, FUNDAMENTALS LIFE, P473; WONG JT, 2010, CHEM SYNTHE IN PRESS; WONG JTF, 1976, P NATL ACAD SCI USA, V73, P2336, DOI 10.1073/pnas.73.7.2336; Wong JTF, 2005, BIOESSAYS, V27, P416, DOI 10.1002/bies.20208; WONG JTF, 1975, P NATL ACAD SCI USA, V72, P1909, DOI 10.1073/pnas.72.5.1909; WONG JTF, 1983, P NATL ACAD SCI-BIOL, V80, P6303, DOI 10.1073/pnas.80.20.6303	32	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2010	5	8							e12206	10.1371/journal.pone.0012206	http://dx.doi.org/10.1371/journal.pone.0012206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TW	20808824	Green Published, gold, Green Submitted			2022-12-25	WOS:000281077000002
J	Jacox, E; Gotea, V; Ovcharenko, I; Elnitski, L				Jacox, Edwin; Gotea, Valer; Ovcharenko, Ivan; Elnitski, Laura			Tissue-Specific and Ubiquitous Expression Patterns from Alternative Promoters of Human Genes	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; MAMMALIAN GENOMES; P1 PROMOTER; DNA; IDENTIFICATION; LIVER; RNA; CONSERVATION; EVOLUTION; SELECTION	Background: Transcriptome diversity provides the key to cellular identity. One important contribution to expression diversity is the use of alternative promoters, which creates mRNA isoforms by expanding the choice of transcription initiation sites of a gene. The proximity of the basal promoter to the transcription initiation site enables prediction of a promoter's location based on the gene annotations. We show that annotation of alternative promoters regulating expression of transcripts with distinct first exons enables a novel methodology to quantify expression levels and tissue specificity of mRNA isoforms. Principal Findings: The use of distinct alternative first exons in 3,296 genes was examined using exon-microarray data from 11 human tissues. Comparing two transcripts from each gene we found that the activity of alternative promoters (i.e., P1 and P2) was not correlated through tissue specificity or level of expression. Furthermore neither P1 nor P2 conferred any bias for tissue-specific or ubiquitous expression. Genes associated with specific diseases produced transcripts whose limited expression patterns were consistent with the tissue affected in disease. Notably, genes that were historically designated as tissue-specific or housekeeping had alternative isoforms that showed differential expression. Furthermore, only a small number of alternative promoters showed expression exclusive to a single tissue indicating that "tissue preference" provides a better description of promoter activity than tissue specificity. When compared to gene expression data in public databases, as few as 22% of the genes had detailed information for more than one isoform, whereas the remainder collapsed the expression patterns from individual transcripts into one profile. Conclusions: We describe a computational pipeline that uses microarray data to assess the level of expression and breadth of tissue profiles for transcripts with distinct first exons regulated by alternative promoters. We conclude that alternative promoters provide individualized regulation that is confirmed through expression levels, tissue preference and chromatin modifications. Although the selective use of alternative promoters often goes uncharacterized in gene expression analyses, transcripts produced in this manner make unique contributions to the cell that requires further exploration.	[Jacox, Edwin; Gotea, Valer; Elnitski, Laura] NHGRI, NIH, Rockville, MD USA; [Gotea, Valer; Ovcharenko, Ivan] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA	Jacox, E (corresponding author), NHGRI, NIH, Rockville, MD USA.	Elnitski@mail.nih.gov	Elnitski, Laura/AAD-3595-2021	Elnitski, Laura/0000-0003-1065-019X; Gotea, Valer/0000-0001-7857-3309	National Human Genome Research Institute, National Institutes of Health; National Center for Biotechnology Information, National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200323] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM200881] Funding Source: NIH RePORTER	National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Center for Biotechnology Information, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	LE is supported by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. IO is supported by the Intramural Research Program of the National Center for Biotechnology Information, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Briancon N, 2006, EMBO J, V25, P1253, DOI 10.1038/sj.emboj.7601021; Briancon N, 2004, J BIOL CHEM, V279, P33398, DOI 10.1074/jbc.M405312200; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Eeckhoute J, 2003, ENDOCRINOLOGY, V144, P1686, DOI 10.1210/en.2002-0024; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Faulkner GJ, 2009, CELL CYCLE, V8, P2895, DOI 10.4161/cc.8.18.9536; Garaud S, 2008, J IMMUNOL, V181, P2010, DOI 10.4049/jimmunol.181.3.2010; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Gopal E, 2007, BBA-BIOMEMBRANES, V1768, P2690, DOI 10.1016/j.bbamem.2007.06.031; Harries LW, 2008, DIABETES, V57, P1745, DOI 10.2337/db07-1742; HOBART MJ, 1977, J EXP MED, V146, P629, DOI 10.1084/jem.146.2.629; Huh JW, 2009, MOL CELLS, V28, P111, DOI 10.1007/s10059-009-0106-z; Jiang JT, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-25; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li X, 2007, DRUG METAB PHARMACOK, V22, P152, DOI 10.2133/dmpk.22.152; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Luzzi V, 2003, J MOL DIAGN, V5, P9, DOI 10.1016/S1525-1578(10)60445-X; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Murphy R, 2008, DIABETES RES CLIN PR, V79, pS30, DOI 10.1016/S0168-8227(08)70721-6; Nagayama S, 2004, ONCOGENE, V23, P5551, DOI 10.1038/sj.onc.1207710; Nemeth E, 2009, SEMIN IMMUNOPATHOL, V31, P333, DOI 10.1007/s00281-009-0173-4; Niu NF, 2007, DIABETES-METAB RES, V23, P21, DOI 10.1002/dmrr.641; Okamoto R, 2006, CELL SIGNAL, V18, P1408, DOI 10.1016/j.cellsig.2005.11.001; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; REID RA, 1994, MOL BRAIN RES, V21, P1, DOI 10.1016/0169-328X(94)90372-7; Riggins GJ, 2001, HUM MOL GENET, V10, P663, DOI 10.1093/hmg/10.7.663; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Severin J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r39; Shields DJ, 2001, BBA-MOL CELL BIOL L, V1532, P105, DOI 10.1016/S1388-1981(01)00122-6; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tsuritani K, 2007, GENOME RES, V17, P1005, DOI 10.1101/gr.6030107; WAYE MMY, 1995, MIAM WINT BIOT S P, V6; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yasojima K, 1998, CIRC RES, V83, P860, DOI 10.1161/01.RES.83.8.860; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	48	25	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12274	10.1371/journal.pone.0012274	http://dx.doi.org/10.1371/journal.pone.0012274			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20806066	Green Submitted, Green Published, gold			2022-12-25	WOS:000281011600032
J	Rivero, O; Reif, A; Sanjuan, J; Molto, MD; Kittel-Schneider, S; Najera, C; Topner, T; Lesch, KP				Rivero, Olga; Reif, Andreas; Sanjuan, Julio; Molto, Maria D.; Kittel-Schneider, Sarah; Najera, Carmen; Toepner, Theresia; Lesch, Klaus-Peter			Impact of the AHI1 Gene on the Vulnerability to Schizophrenia: A Case-Control Association Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; JOUBERT-SYNDROME; CEREBELLAR DEVELOPMENT; BIPOLAR-DISORDER; CHROMOSOME 6Q23; SUSCEPTIBILITY; LOCUS; METAANALYSIS; EXPRESSION; MUTATIONS	Background: The Abelson helper integration-1 (AHI1) gene is required for both cerebellar and cortical development in humans. While the accelerated evolution of AHI1 in the human lineage indicates a role in cognitive (dys) function, a linkage scan in large pedigrees identified AHI1 as a positional candidate for schizophrenia. To further investigate the contribution of AHI1 to the susceptibility of schizophrenia, we evaluated the effect of AHI1 variation on the vulnerability to psychosis in two samples from Spain and Germany. Methodology/Principal Findings: 29 single-nucleotide polymorphisms (SNPs) located in a genomic region including the AHI1 gene were genotyped in two samples from Spain (280 patients with psychotic disorders; 348 controls) and Germany (247 patients with schizophrenic disorders; 360 controls). Allelic, genotypic and haplotype frequencies were compared between cases and controls in both samples separately, as well as in the combined sample. The effect of genotype on several psychopathological measures (BPRS, KGV, PANSS) assessed in a Spanish subsample was also evaluated. We found several significant associations in the Spanish sample. Particularly, rs7750586 and rs911507, both located upstream of the AHI1 coding region, were found to be associated with schizophrenia in the analysis of genotypic (p = 0.0033, and 0.031, respectively) and allelic frequencies (p = 0.001 in both cases). Moreover, several other risk and protective haplotypes were detected (0.006<p<0.036). Joint analysis also supported the association of rs7750586 and rs911507 with the risk for schizophrenia. The analysis of clinical measures also revealed an effect on symptom severity (minimum P value = 0.0037). Conclusions/Significance: Our data support, in agreement with previous reports, an effect of AHI1 variation on the susceptibility to schizophrenia in central and southern European populations.	[Rivero, Olga; Reif, Andreas; Kittel-Schneider, Sarah; Toepner, Theresia; Lesch, Klaus-Peter] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Unit Mol Psychiat, Wurzburg, Germany; [Rivero, Olga; Molto, Maria D.; Najera, Carmen] Univ Valencia, Dept Genet, Valencia, Spain; [Rivero, Olga; Sanjuan, Julio; Molto, Maria D.; Najera, Carmen] Ctr Biomed Res Network Mental Hlth CIBERSAM, Valencia, Spain; [Sanjuan, Julio] Univ Valencia, Dept Med, Teaching Unit Psychiat, Valencia, Spain	University of Wurzburg; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Valencia	Rivero, O (corresponding author), Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Unit Mol Psychiat, Wurzburg, Germany.	RiveroMar_O@klinik.uni-wuerzburg.de	Lesch, Klaus-Peter/J-4906-2013; Rivero, Olga/AAA-8059-2020	Lesch, Klaus-Peter/0000-0001-8348-153X; Molto, Maria Dolores/0000-0001-5219-2022; Rivero, Olga/0000-0002-2664-4053; Kittel-Schneider, Sarah/0000-0003-3057-6150	Spanish Ministry of Health: Instituto de Salud Carlos III [FIS02/0018]; Red de Genotipacion y Psiquiatria Genetica-ISCIII [G03/184]; Red de Enfermedades Mentales (REM-TAP Network); CIBER de Salud Mental (CIBERSAM); Deutsche Forschungsgemeinschaft [RE1632/1-5]; Bundesministerium fur Bildung und Forschung (IZKF Wurzburg) [01KS9603]; European Comission [LSHM-CT-2003-503474]	Spanish Ministry of Health: Instituto de Salud Carlos III(Instituto de Salud Carlos IIISpanish Government); Red de Genotipacion y Psiquiatria Genetica-ISCIII; Red de Enfermedades Mentales (REM-TAP Network); CIBER de Salud Mental (CIBERSAM); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (IZKF Wurzburg)(Federal Ministry of Education & Research (BMBF)); European Comission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by the Spanish Ministry of Health: Instituto de Salud Carlos III, FIS02/0018 (to OR, JS, and CN), Red de Genotipacion y Psiquiatria Genetica-ISCIII G03/184 (to OR, JS, MDM and CN), Red de Enfermedades Mentales (REM-TAP Network) and CIBER de Salud Mental (CIBERSAM) (to OR, JS, MDM and CN). Furthermore, this work was supported by the Deutsche Forschungsgemeinschaft (Grant RE1632/1-5 to AR, Clinical Research Unit - KFO 125 to AR and KPL; SFB 581 to KPL, SFB TRR 58 to AR and KPL), Bundesministerium fur Bildung und Forschung (IZKF Wurzburg, 01KS9603, to KPL; IZKF N-27-N, to AR) and the European Comission (NEWMOOD LSHM-CT-2003-503474, to KPL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Retuerto AI, 2008, HUM MOL GENET, V17, P3887, DOI 10.1093/hmg/ddn291; Amann-Zalcenstein D, 2006, EUR J HUM GENET, V14, P1111, DOI 10.1038/sj.ejhg.5201675; Andreasen NC, 1998, SCHIZOPHRENIA BULL, V24, P203, DOI 10.1093/oxfordjournals.schbul.a033321; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Burmeister M, 2008, NAT REV GENET, V9, P527, DOI 10.1038/nrg2381; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Crow TJ, 1997, SCHIZOPHR RES, V28, P127, DOI 10.1016/S0920-9964(97)00110-2; Dean B, 2009, AUST NZ J PSYCHIAT, V43, P13, DOI 10.1080/00048670802534416; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Doering JE, 2008, J COMP NEUROL, V511, P238, DOI 10.1002/cne.21824; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Dudbridge F, 2006, 20065 MRC BIOST UN; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Glahn DC, 2005, HUM BRAIN MAPP, V25, P60, DOI 10.1002/hbm.20138; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Hirayasu Y, 2007, NEUROPATHOLOGY, V27, P601, DOI 10.1111/j.1440-1789.2007.00827.x; Horrobin DF, 1998, MED HYPOTHESES, V50, P269, DOI 10.1016/S0306-9877(98)90000-7; Ingason A, 2007, EUR J HUM GENET, V15, P988, DOI 10.1038/sj.ejhg.5201848; Ingason A, 2010, HUM MOL GENET, V19, P1379, DOI 10.1093/hmg/ddq009; Jablensky A, 1992, Psychol Med Monogr Suppl, V20, P1; JABLENSKY A, 2003, SCHIZOPHRENIA; Kirov G, 2009, MOL PSYCHIATR, V14, P796, DOI 10.1038/mp.2008.33; Kohn Y, 2005, MOL PSYCHIATR, V10, P1062, DOI 10.1038/sj.mp.4001738; Lang UE, 2007, CELL PHYSIOL BIOCHEM, V20, P687, DOI 10.1159/000110430; Langefeld Carl D., 2007, V404, P431, DOI 10.1007/978-1-59745-530-5_21; Lerer B, 2003, MOL PSYCHIATR, V8, P488, DOI 10.1038/sj.mp.4001322; Levi A, 2005, EUR J HUM GENET, V13, P763, DOI 10.1038/sj.ejhg.5201406; Louie CM, 2005, HUM MOL GENET, V14, pR235, DOI 10.1093/hmg/ddi264; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Mutsuddi M, 2006, AM J HUM GENET, V79, P903, DOI 10.1086/508942; Peltonen L, 2006, HUM MOL GENET, V15, pR67, DOI 10.1093/hmg/ddl060; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reif A, 2006, MOL PSYCHIATR, V11, P286, DOI 10.1038/sj.mp.4001779; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Selch S, 2007, BIOL PSYCHIAT, V61, P1211, DOI 10.1016/j.biopsych.2006.08.030; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Sheng G, 2008, J CLIN INVEST, V118, P2785, DOI 10.1172/JCI35339; Shergill SS, 2000, ARCH GEN PSYCHIAT, V57, P1033, DOI 10.1001/archpsyc.57.11.1033; Shih RA, 2004, INT REV PSYCHIATR, V16, P260, DOI 10.1080/09540260400014401; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; TORRI F, 2010, FASEB J IN PRESS; White T, 2008, SCHIZOPHRENIA BULL, V34, P18, DOI 10.1093/schbul/sbm110; Yu FL, 2009, HUM MOL GENET, V18, P4853, DOI 10.1093/hmg/ddp457	49	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12254	10.1371/journal.pone.0012254	http://dx.doi.org/10.1371/journal.pone.0012254			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805890	Green Published, gold, Green Submitted			2022-12-25	WOS:000281011600023
J	Gangaiah, D; Liu, Z; Arcos, J; Kassem, II; Sanad, Y; Torrelles, JB; Rajashekara, G				Gangaiah, Dharanesh; Liu, Zhe; Arcos, Jesus; Kassem, Issmat I.; Sanad, Yasser; Torrelles, Jordi B.; Rajashekara, Gireesh			Polyphosphate Kinase 2: A Novel Determinant of Stress Responses and Pathogenesis in Campylobacter jejuni	PLOS ONE			English	Article							INORGANIC POLYPHOSPHATE; BIOFILM FORMATION; PSEUDOMONAS-AERUGINOSA; VIBRIO-CHOLERAE; SURVIVAL; VIRULENCE; IDENTIFICATION; ADAPTATION; ENTERITIS; ALGINATE	Background: Inorganic polyphosphate (poly P) plays an important role in stress tolerance and virulence in many bacteria. PPK1 is the principal enzyme involved in poly P synthesis, while PPK2 uses poly P to generate GTP, a signaling molecule that serves as an alternative energy source and a precursor for various physiological processes. Campylobacter jejuni, an important cause of foodborne gastroenteritis in humans, possesses homologs of both ppk1 and ppk2. ppk1 has been previously shown to impact the pathobiology of C. jejuni. Methodology/Principal Findings: Here, we demonstrate for the first time that the deletion of ppk2 in C. jejuni resulted in a significant decrease in poly P-dependent GTP synthesis, while displaying an increased intracellular ATP: GTP ratio. The Delta ppk2 mutant exhibited a significant survival defect under osmotic, nutrient, aerobic, and antimicrobial stresses and displayed an enhanced ability to form static biofilms. However, the Delta ppk2 mutant was not defective in poly P and ppGpp synthesis suggesting that PPK2-mediated stress tolerance is not ppGpp-mediated. Importantly, the Delta ppk2 mutant was significantly attenuated in invasion and intracellular survival within human intestinal epithelial cells as well as in chicken colonization. Conclusions/Significance: Taken together, we have highlighted the role of PPK2 as a novel pathogenicity determinant that is critical for C. jejuni survival, adaptation, and persistence in the host environments. PPK2 is absent in humans and animals; therefore, can serve as a novel target for therapeutic intervention of C. jejuni infections.	[Gangaiah, Dharanesh; Liu, Zhe; Kassem, Issmat I.; Sanad, Yasser; Rajashekara, Gireesh] Ohio State Univ, Food Anim Hlth Res Program, Ohio Agr Res Dev Ctr, Dept Vet Prevent Med, Wooster, OH USA; [Arcos, Jesus; Torrelles, Jordi B.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gangaiah, D (corresponding author), Ohio State Univ, Food Anim Hlth Res Program, Ohio Agr Res Dev Ctr, Dept Vet Prevent Med, Wooster, OH USA.	rajashekara.2@osu.edu	Rajashekara, Gireesh/E-3913-2011; Torrelles, Jordi/E-4204-2011	Sanad, Yasser/0000-0001-6008-5630; KASSEM, ISSMAT/0000-0002-2978-9573	USDA [2007-35201-18414]; Ohio Agricultural Research and Development Center; Ohio State University	USDA(United States Department of Agriculture (USDA)); Ohio Agricultural Research and Development Center; Ohio State University(Ohio State University)	Research in Dr. Rajashekara's lab is supported by the USDA grant 2007-35201-18414 and by the Ohio Agricultural Research and Development Center, The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Altekruse SF, 1999, EMERG INFECT DIS, V5, P28, DOI 10.3201/eid0501.990104; Bacon DJ, 2000, INFECT IMMUN, V68, P4384, DOI 10.1128/IAI.68.8.4384-4390.2000; BEERY JT, 1988, APPL ENVIRON MICROB, V54, P2365, DOI 10.1128/AEM.54.10.2365-2370.1988; Candon HL, 2007, J BACTERIOL, V189, P8099, DOI 10.1128/JB.01037-07; Chakrabarty AM, 1998, MOL MICROBIOL, V28, P875, DOI 10.1046/j.1365-2958.1998.00846.x; Chaveerach P, 2003, APPL ENVIRON MICROB, V69, P711, DOI 10.1128/AEM.69.1.711-714.2003; Day WA, 2000, INFECT IMMUN, V68, P6337, DOI 10.1128/IAI.68.11.6337-6345.2000; DEMELO MA, 1989, INFECT IMMUN, V57, P2214, DOI 10.1128/IAI.57.7.2214-2222.1989; Fields JA, 2008, J BACTERIOL, V190, P3411, DOI 10.1128/JB.01928-07; Gangaiah D, 2009, APPL ENVIRON MICROB, V75, P7838, DOI 10.1128/AEM.01603-09; Gaynor EC, 2005, MOL MICROBIOL, V56, P8, DOI 10.1111/j.1365-2958.2005.04525.x; Hughes R, 2004, LANCET NEUROL, V3, P644, DOI 10.1016/S1474-4422(04)00902-0; Ishige K, 2002, P NATL ACAD SCI USA, V99, P16684, DOI 10.1073/pnas.262655299; Jahid IK, 2006, APPL ENVIRON MICROB, V72, P7043, DOI 10.1128/AEM.00924-06; Joshua GWP, 2006, MICROBIOL-SGM, V152, P387, DOI 10.1099/mic.0.28358-0; Kalischuk LD, 2010, AM J PHYSIOL-GASTR L, V298, pG1, DOI 10.1152/ajpgi.00193.2009; Kim HY, 1998, MOL MICROBIOL, V27, P717, DOI 10.1046/j.1365-2958.1998.00702.x; Kim KS, 2002, P NATL ACAD SCI USA, V99, P7675, DOI 10.1073/pnas.112210499; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; KORNBERG A, 1995, J BACTERIOL, V177, P491, DOI 10.1128/jb.177.3.491-496.1995; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Lecuit M, 2004, NEW ENGL J MED, V350, P239, DOI 10.1056/NEJMoa031887; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Lindner SN, 2007, APPL ENVIRON MICROB, V73, P5026, DOI 10.1128/AEM.00600-07; Malik-Kale P, 2008, J BACTERIOL, V190, P2286, DOI 10.1128/JB.01736-07; McLennan MK, 2008, J BACTERIOL, V190, P1097, DOI 10.1128/JB.00516-07; Mendrygal KE, 2000, J BACTERIOL, V182, P599, DOI 10.1128/JB.182.3.599-606.2000; Miller WG, 2000, APPL ENVIRON MICROB, V66, P5426, DOI 10.1128/AEM.66.12.5426-5436.2000; Nocek B, 2008, P NATL ACAD SCI USA, V105, P17730, DOI 10.1073/pnas.0807563105; Ogawa N, 2000, J BACTERIOL, V182, P6687, DOI 10.1128/JB.182.23.6687-6693.2000; Pandit SB, 2003, PROTEINS, V52, P585, DOI 10.1002/prot.10420; Pogacar MS, 2009, INT J FOOD MICROBIOL, V129, P68, DOI 10.1016/j.ijfoodmicro.2008.11.010; PONKA A, 1981, ANN RHEUM DIS, V40, P414, DOI 10.1136/ard.40.4.414; Price-Carter M, 2005, J BACTERIOL, V187, P3088, DOI 10.1128/JB.187.9.3088-3099.2005; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Raskin DM, 2007, P NATL ACAD SCI USA, V104, P4636, DOI 10.1073/pnas.0611650104; Reid AN, 2008, APPL ENVIRON MICROB, V74, P1583, DOI 10.1128/AEM.01507-07; Reid AN, 2008, APPL ENVIRON MICROB, V74, P1598, DOI 10.1128/AEM.01508-07; Ritz M, 2009, J MICROBIOL METH, V76, P196, DOI 10.1016/j.mimet.2008.10.014; ROLLINS DM, 1986, APPL ENVIRON MICROB, V52, P531, DOI 10.1128/AEM.52.3.531-538.1986; RUSSELL RG, 1993, J INFECT DIS, V168, P210, DOI 10.1093/infdis/168.1.210; Sambrook J., 2001, MOL CLONING LAB MANU; Seufferheld MJ, 2008, APPL ENVIRON MICROB, V74, P5867, DOI 10.1128/AEM.00501-08; Sundin GW, 1996, J BACTERIOL, V178, P7120, DOI 10.1128/jb.178.24.7120-7128.1996; Sureka K, 2009, MOL MICROBIOL, V74, P1187, DOI 10.1111/j.1365-2958.2009.06925.x; Svensson SL, 2009, MOL MICROBIOL, V71, P253, DOI 10.1111/j.1365-2958.2008.06534.x; Tan SM, 2005, J BACTERIOL, V187, P7687, DOI 10.1128/JB.187.22.7687-7695.2005; Tholozan JL, 1999, APPL ENVIRON MICROB, V65, P1110; Wilson DL, 2003, MICROBIOL-SGM, V149, P3603, DOI 10.1099/mic.0.26531-0; Wosten MMSM, 2006, MOL MICROBIOL, V62, P278, DOI 10.1111/j.1365-2958.2006.05372.x; YAO RJ, 1993, GENE, V130, P127, DOI 10.1016/0378-1119(93)90355-7; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718	57	48	53	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12142	10.1371/journal.pone.0012142	http://dx.doi.org/10.1371/journal.pone.0012142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808906	Green Published, gold, Green Submitted			2022-12-25	WOS:000280968100004
J	Heron, SF; Willis, BL; Skirving, WJ; Eakin, CM; Page, CA; Miller, IR				Heron, Scott F.; Willis, Bette L.; Skirving, William J.; Eakin, C. Mark; Page, Cathie A.; Miller, Ian R.			Summer Hot Snaps and Winter Conditions: Modelling White Syndrome Outbreaks on Great Barrier Reef Corals	PLOS ONE			English	Article							DYNAMICS; DISEASE; TEMPERATURE; PATTERNS; ECOLOGY; SHIFTS	Coral reefs are under increasing pressure in a changing climate, one such threat being more frequent and destructive outbreaks of coral diseases. Thermal stress from rising temperatures has been implicated as a causal factor in disease outbreaks observed on the Great Barrier Reef, Australia, and elsewhere in the world. Here, we examine seasonal effects of satellite-derived temperature on the abundance of coral diseases known as white syndromes on the Great Barrier Reef, considering both warm stress during summer and deviations from mean temperatures during the preceding winter. We found a high correlation (r(2) = 0.953) between summer warm thermal anomalies (Hot Snap) and disease abundance during outbreak events. Inclusion of thermal conditions during the preceding winter revealed that a significant reduction in disease outbreaks occurred following especially cold winters (Cold Snap), potentially related to a reduction in pathogen loading. Furthermore, mild winters (i.e., neither excessively cool nor warm) frequently preceded disease outbreaks. In contrast, disease outbreaks did not typically occur following warm winters, potentially because of increased disease resistance of the coral host. Understanding the balance between the effects of warm and cold winters on disease outbreak will be important in a warming climate. Combining the influence of winter and summer thermal effects resulted in an algorithm that yields both a Seasonal Outlook of disease risk at the conclusion of winter and near real-time monitoring of Outbreak Risk during summer. This satellite-derived system can provide coral reef managers with an assessment of risk three-to-six months in advance of the summer season that can then be refined using near-real-time summer observations. This system can enhance the capacity of managers to prepare for and respond to possible disease outbreaks and focus research efforts to increase understanding of environmental impacts on coral disease in this era of rapidly changing climate.	[Heron, Scott F.] Natl Ocean & Atmospher Adm, Townsville, Qld, Australia; [Heron, Scott F.; Skirving, William J.] James Cook Univ, Dept Phys, Sch Engn & Phys Sci, Townsville, Qld 4811, Australia; [Heron, Scott F.; Skirving, William J.] James Cook Univ, Marine Geophys Lab, Sch Engn & Phys Sci, Townsville, Qld 4811, Australia; [Willis, Bette L.; Page, Cathie A.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Willis, Bette L.; Page, Cathie A.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Eakin, C. Mark] Natl Ocean & Atmospher Adm, Silver Spring, MD USA; [Miller, Ian R.] Australian Inst Marine Sci, Long Term Monitoring Program, Townsville, Qld 4810, Australia	National Oceanic Atmospheric Admin (NOAA) - USA; James Cook University; James Cook University; James Cook University; James Cook University; National Oceanic Atmospheric Admin (NOAA) - USA; Australian Institute of Marine Science	Heron, SF (corresponding author), Natl Ocean & Atmospher Adm, Townsville, Qld, Australia.	scott.heron@noaa.gov	Heron, Scott F/E-7928-2011; Eakin, C. Mark/F-5585-2010; Skirving, William/E-7927-2011	Eakin, C. Mark/0000-0002-5987-0858; Heron, Scott/0000-0001-5262-6978; Skirving, William/0000-0003-0167-6427	NOAA; World Bank/Global Environment Facility Coral Reef Targeted Research Remote Sensing and Coral Disease Working Groups; Marine and Tropical Sciences	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); World Bank/Global Environment Facility Coral Reef Targeted Research Remote Sensing and Coral Disease Working Groups; Marine and Tropical Sciences	This work was supported by the NOAA Coral Reef Conservation Program; the World Bank/Global Environment Facility Coral Reef Targeted Research Remote Sensing and Coral Disease Working Groups; and the Marine and Tropical Sciences Research Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandt ME, 2009, DIS AQUAT ORGAN, V87, P117, DOI 10.3354/dao02137; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Eakin C. M., 2009, V205, P41; Harvell C. D., 2007, OCEANOGRAPHY, V20, P58; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hoegh-Guldberg O, 2005, LIMNOL OCEANOGR, V50, P265, DOI 10.4319/lo.2005.50.1.0265; Hoegh-Guldberg O, 2004, CORAL REEFS, V23, P444, DOI 10.1007/s00338-004-0401-2; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jones RJ, 2004, MAR ECOL PROG SER, V281, P63, DOI 10.3354/meps281063; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; KIRKWOOD CW, DECISION TREE PRIMER; Lafferty KD, 2004, ANNU REV ECOL EVOL S, V35, P31, DOI 10.1146/annurev.ecolsys.35.021103.105704; Liu G., 2003, EOS, V84, P137, DOI [10.1029/2003EO150001, DOI 10.1029/2003E0150001]; Mao-Jones J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000345; Maynard JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032175; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Ninio R, 2002, CORAL REEFS, V21, P95, DOI 10.1007/s00338-001-0202-9; Ninio R, 2000, MAR ECOL PROG SER, V194, P65, DOI 10.3354/meps194065; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Sato Y, 2009, P R SOC B, V276, P2795, DOI 10.1098/rspb.2009.0481; Skirving W, 2006, RE S D I PR, V9, P11, DOI 10.1007/1-4020-3968-9_2; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sweatman H.H., 2008, 8 AUSTR I MAR SCI; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Wobeser G.A, 2006, ESSENTIALS DIS WILD	28	81	81	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12210	10.1371/journal.pone.0012210	http://dx.doi.org/10.1371/journal.pone.0012210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808912	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000280968100014
J	Kanazawa, S; Fujiwara, T; Matsuzaki, S; Shingaki, K; Taniguchi, M; Miyata, S; Tohyama, M; Sakai, Y; Yano, K; Hosokawa, K; Kubo, T				Kanazawa, Shigeyuki; Fujiwara, Toshihiro; Matsuzaki, Shinsuke; Shingaki, Kenta; Taniguchi, Manabu; Miyata, Shingo; Tohyama, Masaya; Sakai, Yasuo; Yano, Kenji; Hosokawa, Ko; Kubo, Tateki			bFGF Regulates PI3-Kinase-Rac1-JNK Pathway and Promotes Fibroblast Migration in Wound Healing	PLOS ONE			English	Article							ENDOTHELIAL-CELL-MIGRATION; RHO-ASSOCIATED KINASE; GROWTH-FACTOR; ALPHA(V)BETA(3) INTEGRIN; SIGNALING PATHWAYS; ACTIVATION; GTPASES; RECEPTOR; MOTILITY; POLARITY	Fibroblast proliferation and migration play important roles in wound healing. bFGF is known to promote both fibroblast proliferation and migration during the process of wound healing. However, the signal transduction of bFGF-induced fibroblast migration is still unclear, because bFGF can affect both proliferation and migration. Herein, we investigated the effect of bFGF on fibroblast migration regardless of its effect on fibroblast proliferation. We noticed involvement of the small GTPases of the Rho family, PI3-kinase, and JNK. bFGF activated RhoA, Rac1, PI3-kinase, and JNK in cultured fibroblasts. Inhibition of RhoA did not block bFGF-induced fibroblast migration, whereas inhibition of Rac1, PI3-kinase, or JNK blocked the fibroblastmigration significantly. PI3-kinase- inhibited cells down-regulated the activities of Rac1 and JNK, and Rac1-inhibited cells down-regulated JNK activity, suggesting that PI3-kinase is upstream of Rac1 and that JNK is downstream of Rac1. Thus, we concluded that PI3-kinase, Rac1, and JNK were essential for bFGF-induced fibroblast migration, which is a novel pathway of bFGF-induced cell migration.	[Kanazawa, Shigeyuki; Fujiwara, Toshihiro; Sakai, Yasuo; Yano, Kenji; Hosokawa, Ko; Kubo, Tateki] Osaka Univ, Grad Sch Med, Dept Plast Surg, Osaka, Japan; [Matsuzaki, Shinsuke; Shingaki, Kenta; Taniguchi, Manabu; Miyata, Shingo; Tohyama, Masaya] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Osaka, Japan	Osaka University; Osaka University	Kanazawa, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Plast Surg, Osaka, Japan.	tateki@psurg.med.osaka-u.ac.jp			Osaka University	Osaka University	This work was supported in part by Osaka University operating budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; BILATO C, 1995, J CLIN INVEST, V96, P1905, DOI 10.1172/JCI118236; Chang YZ, 2002, CIRC RES, V91, P390, DOI 10.1161/01.RES.0000033524.92083.64; Chen BH, 2002, J BIOL CHEM, V277, P33857, DOI 10.1074/jbc.M204429200; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jones PL, 1997, J CELL BIOL, V139, P279, DOI 10.1083/jcb.139.1.279; Kavurma MM, 2003, J CELL BIOCHEM, V89, P289, DOI 10.1002/jcb.10497; Kim S, 2000, J BIOL CHEM, V275, P33920, DOI 10.1074/jbc.M003668200; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kondo H, 2000, BIOCHEM BIOPH RES CO, V272, P648, DOI 10.1006/bbrc.2000.2790; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Kurokawa K, 2005, BIOCHEM SOC T, V33, P631, DOI 10.1042/BST0330631; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Liu GZ, 2001, J CELL BIOCHEM, V83, P129, DOI 10.1002/jcb.1208; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Ohgoda O, 1998, J DERMATOL SCI, V17, P123, DOI 10.1016/S0923-1811(98)00003-6; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Ridley A, 2000, J CELL BIOL, V150, pF107, DOI 10.1083/jcb.150.4.F107; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Royal I, 2000, MOL BIOL CELL, V11, P1709, DOI 10.1091/mbc.11.5.1709; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; SATO Y, 1988, J CELL BIOL, V107, P1199, DOI 10.1083/jcb.107.3.1199; SCHLEEF RR, 1982, TISSUE CELL, V14, P629, DOI 10.1016/0040-8166(82)90053-2; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; SCHREIER T, 1993, RES EXP MED, V193, P195, DOI 10.1007/BF02576227; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Smith LG, 2004, CURR BIOL, V14, pR109, DOI 10.1016/j.cub.2004.01.016; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; TSUBOI R, 1990, J CELL BIOL, V110, P511, DOI 10.1083/jcb.110.2.511; Tsuboi Ryoji, 1992, Journal of Dermatology (Tokyo), V19, P652; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; van Horssen R, 2006, J CELL BIOCHEM, V99, P1536, DOI 10.1002/jcb.20994; Verma S, 2004, J BIOL CHEM, V279, P34062, DOI 10.1074/jbc.M404814200; Wagner W, 2007, J CELL MOL MED, V11, P1342, DOI 10.1111/j.1582-4934.2007.00037.x; Wang DI, 1999, EXP MOL PATHOL, V66, P179, DOI 10.1006/exmp.1999.2265; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Woodard AS, 1998, J CELL SCI, V111, P469; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; Zhang L, 2003, EMBO J, V22, P4443, DOI 10.1093/emboj/cdg440	69	110	114	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12228	10.1371/journal.pone.0012228	http://dx.doi.org/10.1371/journal.pone.0012228			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808927	Green Published, gold, Green Submitted			2022-12-25	WOS:000280968100025
J	Sangeetha, VM; Kale, VP; Limaye, LS				Sangeetha, V. M.; Kale, Vaijayanti P.; Limaye, Lalita S.			Expansion of Cord Blood CD34(+) Cells in Presence of zVADfmk and zLLYfmk Improved Their In Vitro Functionality and In Vivo Engraftment in NOD/SCID Mouse	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; SELF-RENEWAL; LONG-TERM; BCL-2 EXPRESSION; PROGENITOR CELLS; TRANSPLANTATION; APOPTOSIS; SERUM; DIFFERENTIATION; THROMBOPOIETIN	Background: Cord blood (CB) is a promising source for hematopoietic stem cell transplantations. The limitation of cell dose associated with this source has prompted the ex vivo expansion of hematopoietic stem and progenitor cells (HSPCs). However, the expansion procedure is known to exhaust the stem cell pool causing cellular defects that promote apoptosis and disrupt homing to the bone marrow. The role of apoptotic machinery in the regulation of stem cell compartment has been speculated in mouse hematopoietic and embryonic systems. We have consistently observed an increase in apoptosis in the cord blood derived CD34(+) cells cultured with cytokines compared to their freshly isolated counterpart. The present study was undertaken to assess whether pharmacological inhibition of apoptosis could improve the outcome of expansion. Methodology/Principal Findings: CB CD34(+) cells were expanded with cytokines in the presence or absence of cell permeable inhibitors of caspases and calpains; zVADfmk and zLLYfmk respectively. A novel role of apoptotic protease inhibitors was observed in increasing the CD34(+) cell content of the graft during ex vivo expansion. This was further reflected in improved in vitro functional aspects of the HSPCs; a higher clonogenicity and long term culture initiating potential. These cells sustained superior long term engraftment and an efficient regeneration of major lympho-myeloid lineages in the bone marrow of NOD/SCID mouse compared to the cells expanded with growth factors alone. Conclusion/Significance: Our data show that, use of either zVADfmk or zLLYfmk in the culture medium improves expansion of CD34(+) cells. The strategy protects stem cell pool and committed progenitors, and improves their in vitro functionality and in vivo engraftment. This observation may complement the existing protocols used in the manipulation of hematopoietic cells for therapeutic purposes. These findings may have an impact in the CB transplant procedures involving a combined infusion of unmanipulated and expanded grafts.	[Sangeetha, V. M.; Kale, Vaijayanti P.; Limaye, Lalita S.] Natl Ctr Cell Sci, Stem Cell Biol Lab, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Sangeetha, VM (corresponding author), Natl Ctr Cell Sci, Stem Cell Biol Lab, Pune, Maharashtra, India.	lslimaye@nccs.res.in	Vadakke-Madathil, Sangeetha/B-5340-2011; Kale, Vaijayanti/R-9342-2019	Vadakke-Madathil, Sangeetha/0000-0002-4948-9412; Kale, Vaijayanti/0000-0001-7498-7563	Defence research development organization (DRDO) (Life Science Research Board), Government of India, New Delhi; Lady Tata Trust, Mumbai, India	Defence research development organization (DRDO) (Life Science Research Board), Government of India, New Delhi(Defence Research & Development Organisation (DRDO)); Lady Tata Trust, Mumbai, India	The present work received financial support from DRDO (LSRB) Defence research development organization (Life Science Research Board), Government of India, New Delhi. SVM is a recipient of the Lady Tata Trust's Senior research scholarship, Mumbai, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenzi Faris Q., 2009, Yale Journal of Biology and Medicine, V82, P7; Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059; Ballen KK, 2005, BLOOD, V105, P3786, DOI 10.1182/blood-2004-10-4125; Barker JN, 2003, NAT REV CANCER, V3, P526, DOI 10.1038/nrc1125; BROXMEYER HE, 2009, BONE MARROW TRANSPL, P1; Bryder D, 2001, J EXP MED, V194, P941, DOI 10.1084/jem.194.7.941; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; DALEY JP, FOCUS; Danet GH, 2001, EXP HEMATOL, V29, P1465, DOI 10.1016/S0301-472X(01)00750-0; de Lima M, 2008, BONE MARROW TRANSPL, V41, P771, DOI 10.1038/sj.bmt.1705979; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gluckman E, 2001, TRANSFUS CLIN BIOL, V8, P146, DOI 10.1016/S1246-7820(01)00132-X; Hatzold J, 2008, PLOS BIOL, V6, P771, DOI 10.1371/journal.pbio.0060084; Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538; Hogan CJ, 2002, P NATL ACAD SCI USA, V99, P413, DOI 10.1073/pnas.012336799; IMAI Y, 2009, STEM CELLS DEV; Janzen V, 2008, CELL STEM CELL, V2, P584, DOI 10.1016/j.stem.2008.03.012; Jaroscak J, 2003, BLOOD, V101, P5061, DOI 10.1182/blood-2001-12-0290; KANG HJ, 2009, BONE MARROW TRANSPLA; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; KELLY SS, 2009, BONE MARROW TRANSPL, P1; Kogler G, 1999, BONE MARROW TRANSPL, V24, P397, DOI 10.1038/sj.bmt.1701916; Limaye LS, 2001, J HEMATOTH STEM CELL, V10, P709, DOI 10.1089/152581601753193931; Liu BL, 2003, EXP HEMATOL, V31, P824, DOI 10.1016/S0301-472X(03)00161-9; MacMillan ML, 2009, BONE MARROW TRANSPL, V43, P447, DOI 10.1038/bmt.2008.348; Majhail NS, 2006, CURR OPIN IMMUNOL, V18, P571, DOI 10.1016/j.coi.2006.07.015; Mattia G, 2008, EXP HEMATOL, V36, P244, DOI 10.1016/j.exphem.2007.09.006; Moore MAS, 2007, EXP HEMATOL, V35, P105, DOI 10.1016/j.exphem.2007.01.018; Neumar RW, 2003, J BIOL CHEM, V278, P14162, DOI 10.1074/jbc.M212255200; Nishino T, 2009, EXP HEMATOL, V37, P1364, DOI 10.1016/j.exphem.2009.09.001; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Piacibello W, 1999, BLOOD, V93, P3736, DOI 10.1182/blood.V93.11.3736.411k01_3736_3749; Piacibello W, 1997, BLOOD, V89, P2644, DOI 10.1182/blood.V89.8.2644; Sasnoor LM, 2005, TRANSPLANTATION, V80, P1251, DOI 10.1097/01.tp.0000169028.01327.90; Sasnoor LM, 2003, J HEMATOTH STEM CELL, V12, P553, DOI 10.1089/152581603322448268; Seet LF, 2009, EUR J HAEMATOL, V82, P124, DOI 10.1111/j.1600-0609.2008.01169.x; Stroh C, 2002, FASEB J, V16, P1651, DOI 10.1096/fj.02-0034fje; Tanaka H, 2006, STEM CELLS, V24, P2592, DOI 10.1634/stemcells.2005-0434; Ueda T, 2000, J CLIN INVEST, V105, P1013, DOI 10.1172/JCI8583; Yamane T, 2005, P NATL ACAD SCI USA, V102, P3312, DOI 10.1073/pnas.0500167102	42	24	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12221	10.1371/journal.pone.0012221	http://dx.doi.org/10.1371/journal.pone.0012221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808921	Green Submitted, gold, Green Published			2022-12-25	WOS:000280968100020
J	Dong, HY; Paquette, M; Williams, A; Zoeller, RT; Wade, M; Yauk, C				Dong, Hongyan; Paquette, Martin; Williams, Andrew; Zoeller, R. Thomas; Wade, Mike; Yauk, Carole			Thyroid Hormone May Regulate mRNA Abundance in Liver by Acting on MicroRNAs	PLOS ONE			English	Article							MUSCLE-SPECIFIC MICRORNAS; GENES; TARGETS; SPECIFICITY; EXPRESSION; MIR-133; MIRNAS; FAMILY; MICE	MicroRNAs (miRNAs) are extensively involved in diverse biological processes. However, very little is known about the role of miRNAs in mediating the action of thyroid hormones (TH). Appropriate TH levels are known to be critically important for development, differentiation and maintenance of metabolic balance in mammals. We induced transient hypothyroidism in juvenile mice by short-term exposure to methimazole and perchlorate from post natal day (PND) 12 to 15. The expression of miRNAs in the liver was analyzed using Taqman Low Density Arrays (containing up to 600 rodent miRNAs). We found the expression of 40 miRNAs was significantly altered in the livers of hypothyroid mice compared to euthyroid controls. Among the miRNAs, miRs-1, 206, 133a and 133b exhibited a massive increase in expression (50- to 500-fold). The regulation of TH on the expression of miRs-1, 206, 133a and 133b was confirmed in various mouse models including: chronic hypothyroid, short-term hyperthyroid and short-term hypothyroid followed by TH supplementation. TH regulation of these miRNAs was also confirmed in mouse hepatocyte AML 12 cells. The expression of precursors of miRs-1, 206, 133a and 133b were examined in AML 12 cells and shown to decrease after TH treatment, only pre-mir-206 and pre-mir-133b reached statistical significance. To identify the targets of these miRNAs, DNA microarrays were used to examine hepatic mRNA levels in the short-term hypothyroid mouse model relative to controls. We found transcripts from 92 known genes were significantly altered in these hypothyroid mice. Web-based target predication software (TargetScan and Microcosm) identified 14 of these transcripts as targets of miRs-1, 206, 133a and 133b. The vast majority of these mRNA targets were significantly down-regulated in hypothyroid mice, corresponding with the up-regulation of miRs-1, 206, 133a and 133b in hypothyroid mouse liver. To further investigate target genes, miR-206 was over-expressed in AML 12 cells. TH treatment of cells over-expressing miR-206 resulted in decreased miR-206 expression, and a significant increase in two predicted target genes, Mup1 and Gpd2. The results suggest that TH regulation of these genes may occur secondarily via miR-206. These studies provide new insight into the role of miRNAs in mediating TH regulation of gene expression.	[Dong, Hongyan; Paquette, Martin; Williams, Andrew; Wade, Mike; Yauk, Carole] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada; [Zoeller, R. Thomas] Univ Massachusetts, Mol & Cellular Biol Program, Amherst, MA 01003 USA	Health Canada; University of Massachusetts System; University of Massachusetts Amherst	Dong, HY (corresponding author), Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada.	hongyan_dong@hc-sc.gc.ca		Wade, Michael/0000-0002-7331-3839; Yauk, Carole/0000-0002-6725-3454; Williams, Andrew/0000-0002-7637-7686; Yauk, Carole/0000-0003-4919-876X	Canada Genomics Research and Development Initiative; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010026] Funding Source: NIH RePORTER	Canada Genomics Research and Development Initiative; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was founded by the Health Canada Genomics Research and Development Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boelaert K, 2005, J ENDOCRINOL, V187, P1, DOI 10.1677/joe.1.06131; Bryzgalova G, 2008, J STEROID BIOCHEM, V111, P262, DOI 10.1016/j.jsbmb.2008.06.010; Chen XM, 2009, WORLD J GASTROENTERO, V15, P1665, DOI 10.3748/wjg.15.1665; Dong H, 2007, ENDOCRINOLOGY, V148, P3932, DOI 10.1210/en.2007-0452; Dong HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004610; Dossantos RA, 2003, ENDOCRINOLOGY, V144, P5469, DOI 10.1210/en.2003-0687; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Higgins JJ., 2003, INTRO MODERN NONPARA; Kato Y, 2009, INT J BIOCHEM CELL B, V41, P2225, DOI 10.1016/j.biocel.2009.04.018; Kerr MK, 2001, P NATL ACAD SCI USA, V98, P8961, DOI 10.1073/pnas.161273698; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Lynn FC, 2009, TRENDS ENDOCRIN MET, V20, P452, DOI 10.1016/j.tem.2009.05.007; MEES ST, 2009, J SURG RES; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Nitto T, 2008, GENE, V426, P57, DOI 10.1016/j.gene.2008.08.019; Stahlberg Nina, 2005, BMC Physiol, V5, P8, DOI 10.1186/1472-6793-5-8; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Visser WE, 2009, J CLIN ENDOCR METAB, V94, P3487, DOI 10.1210/jc.2009-0782; Wu H., 2003, MAANOVA SOFTWARE PAC; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200; [No title captured]; [No title captured]; [No title captured]; [No title captured]	32	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12136	10.1371/journal.pone.0012136	http://dx.doi.org/10.1371/journal.pone.0012136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20808432	Green Published, gold			2022-12-25	WOS:000280862200005
J	Gasparini, C; Simmons, LW; Beveridge, M; Evans, JP				Gasparini, Clelia; Simmons, Leigh W.; Beveridge, Maxine; Evans, Jonathan P.			Sperm Swimming Velocity Predicts Competitive Fertilization Success in the Green Swordtail Xiphophorus helleri	PLOS ONE			English	Article							POSTCOPULATORY SEXUAL SELECTION; GUPPY POECILIA-RETICULATA; CRYPTIC FEMALE CHOICE; INBREEDING AVOIDANCE; MULTIPLE PATERNITY; TRINIDADIAN GUPPY; EVOLUTION; TRAITS; SIZE; PREFERENCE	Sperm competition is expected to favour the evolution of traits that influence the performance of sperm when they compete to fertilize a female's eggs. While there is considerable evidence that selection favours increases in sperm numbers, much less is known about how sperm quality contributes towards competitive fertilization success. Here, we determine whether variation in sperm quality influences competitive fertilization success in the green swordtail Xiphophorus helleri, a highly promiscuous livebearing fish. We use artificial insemination as a method of controlled sperm delivery and show that sperm swimming velocity is the primary determinant of fertilization success when ejaculates from two males compete to fertilize a female's eggs. By contrast, we found no evidence that sperm length had any effect on siring success. We also found no evidence that pre- and postcopulatory sexual traits were phenotypically integrated in this species, suggesting that the previous observation that reproductive skew favours males with high mating rates is unlikely to be due to any direct association between sperm quality and male sexual ornamentation.	[Gasparini, Clelia] Univ Padua, Dipartimento Biol, Padua, Italy; [Simmons, Leigh W.; Beveridge, Maxine; Evans, Jonathan P.] Univ Western Australia, Ctr Evolutionary Biol, Nedlands, WA 6009, Australia	University of Padua; University of Western Australia	Gasparini, C (corresponding author), Univ Padua, Dipartimento Biol, Padua, Italy.	jonevans@cyllene.uwa.edu.au	Evans, Jonathan/A-1992-2011; Gasparini, Clelia/F-2159-2011; Simmons, Leigh W/B-1815-2011	Simmons, Leigh W/0000-0003-0562-1474	Australian Research Council [DP0663574]; University of Padova	Australian Research Council(Australian Research Council); University of Padova	Funded by the Australian Research Council (DP0663574) and an institutional grant from the University of Padova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2005, J ZOOL, V267, P135, DOI 10.1017/S0952836905007284; [Anonymous], ECOLOGY EVOLUTION PO; Arnqvist Goran, 2005, pUnpaginated; BASOLO A L, 1990, Animal Behaviour, V40, P332, DOI 10.1016/S0003-3472(05)80928-5; Benson KE, 2006, ANIM BEHAV, V71, P129, DOI 10.1016/j.anbehav.2005.05.004; BILLARD R, 1990, CONTROLS SPERM MOTIL; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Birkhead TR, 1998, SPERM COMPETITION SE; Byrne PG, 2003, P ROY SOC B-BIOL SCI, V270, P2079, DOI 10.1098/rspb.2003.2433; CLARK E, 1950, SCIENCE, V112, P722, DOI 10.1126/science.112.2920.722; Crawley M.J., 1993, GLIM ECOLOGISTS; Danielsson I, 2001, P ROY SOC B-BIOL SCI, V268, P77, DOI 10.1098/rspb.2000.1332; Denk AG, 2005, BEHAV ECOL, V16, P825, DOI 10.1093/beheco/ari065; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Edvardsson M, 2000, P ROY SOC B-BIOL SCI, V267, P559, DOI 10.1098/rspb.2000.1037; Elgee KE, 2010, J EVOLUTION BIOL, V23, P1331, DOI 10.1111/j.1420-9101.2010.01996.x; Evans JP, 2008, BEHAV ECOL SOCIOBIOL, V62, P1167, DOI 10.1007/s00265-008-0545-0; Evans JP, 2003, NATURE, V421, P360, DOI 10.1038/nature01367; Evans JP, 2001, P ROY SOC B-BIOL SCI, V268, P719, DOI 10.1098/rspb.2000.1577; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Garcia-Gonzalez F, 2007, EVOLUTION, V61, P816, DOI 10.1111/j.1558-5646.2007.00084.x; GOMENDIO M, 1991, P ROY SOC B-BIOL SCI, V243, P181, DOI 10.1098/rspb.1991.0029; Gomendio M, 2008, INT J DEV BIOL, V52, P439, DOI 10.1387/ijdb.082595mg; Hosken DJ, 2008, CURR BIOL, V18, pR553, DOI 10.1016/j.cub.2008.04.028; Hunter FM, 2002, CURR BIOL, V12, P121, DOI 10.1016/S0960-9822(01)00647-9; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kleven O, 2009, EVOLUTION, V63, P2466, DOI 10.1111/j.1558-5646.2009.00725.x; Liljedal S, 2008, BEHAV ECOL SOCIOBIOL, V62, P1805, DOI 10.1007/s00265-008-0609-1; Matthews IM, 1997, P ROY SOC B-BIOL SCI, V264, P695, DOI 10.1098/rspb.1997.0099; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pilastro A, 2004, EVOLUTION, V58, P665, DOI 10.1111/j.0014-3820.2004.tb01690.x; Preston BT, 2001, NATURE, V409, P681, DOI 10.1038/35055617; Rios-Cardenas O, 2010, ECOLOGY EVOLUTION PO; Rosenthal GG, 1996, ANIM BEHAV, V51, P811, DOI 10.1006/anbe.1996.0085; Rosenthal GG, 1998, P NATL ACAD SCI USA, V95, P4431, DOI 10.1073/pnas.95.8.4431; Seckinger J, 2002, MOL ECOL NOTES, V2, P4, DOI 10.1046/j.1471-8286.2002.00124.x; Simmons LW, 2008, J HERED, V99, P610, DOI 10.1093/jhered/esn053; Simmons LW, 2006, P NATL ACAD SCI USA, V103, P16346, DOI 10.1073/pnas.0603474103; Simmons LW, 2006, MOL ECOL, V15, P3817, DOI 10.1111/j.1365-294X.2006.03035.x; Simmons LW, 2002, EVOLUTION, V56, P1622, DOI 10.1111/j.0014-3820.2002.tb01474.x; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Tatarenkov A, 2008, MOL ECOL, V17, P4522, DOI 10.1111/j.1365-294X.2008.03936.x; THORNHILL R, 1983, AM NAT, V122, P765, DOI 10.1086/284170; Vladic TV, 2002, BIOL REPROD, V66, P98, DOI 10.1095/biolreprod66.1.98; Walling CA, 2010, BEHAV ECOL SOCIOBIOL, V64, P541, DOI 10.1007/s00265-009-0869-4; Wilson-Leedy JG, 2007, THERIOGENOLOGY, V67, P661, DOI 10.1016/j.theriogenology.2006.10.003; Yue GH, 2004, MOL ECOL NOTES, V4, P474, DOI 10.1111/j.1471-8286.2004.00675.x	48	103	104	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12146	10.1371/journal.pone.0012146	http://dx.doi.org/10.1371/journal.pone.0012146			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730092	Green Published, gold, Green Submitted			2022-12-25	WOS:000280862200007
J	Paskaleva, EE; Xue, J; Lee, DYW; Shekhtman, A; Canki, M				Paskaleva, Elena E.; Xue, Jing; Lee, David Y-W.; Shekhtman, Alexander; Canki, Mario			Palmitic Acid Analogs Exhibit Nanomolar Binding Affinity for the HIV-1 CD4 Receptor and Nanomolar Inhibition of gp120-to-CD4 Fusion	PLOS ONE			English	Article							PROTEINS; DOCKING	Background: We recently reported that palmitic acid (PA) is a novel and efficient CD4 fusion inhibitor to HIV-1 entry and infection. In the present report, based on in silico modeling of the novel CD4 pocket that binds PA, we describe discovery of highly potent PA analogs with increased CD4 receptor binding affinities (K-d) and gp120-to-CD4 inhibition constants (K-i). The PA analogs were selected to satisfy Lipinski's rule of drug-likeness, increased solubility, and to avoid potential cytotoxicity. Principal Findings: PA analog 2-bromopalmitate (2-BP) was most efficacious with K-d similar to 74 nM and K-i similar to 122 nM, ascorbyl palmitate (6-AP) exhibited slightly higher K-d similar to 140 nM and K-i similar to 354 nM, and sucrose palmitate (SP) was least efficacious binding to CD4 with K-d similar to 364 nM and inhibiting gp120-to-CD4 binding with K-i similar to 1486 nM. Importantly, PA and its analogs specifically bound to the CD4 receptor with the one to one stoichiometry. Significance: Considering observed differences between K-i and K-d values indicates clear and rational direction for improving inhibition efficacy to HIV-1 entry and infection. Taken together this report introduces a novel class of natural small molecules fusion inhibitors with nanomolar efficacy of CD4 receptor binding and inhibition of HIV-1 entry.	[Paskaleva, Elena E.; Canki, Mario] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Xue, Jing; Shekhtman, Alexander] SUNY Albany, Dept Chem, Albany, NY 12222 USA; [Lee, David Y-W.] Harvard Univ, Sch Med, McLean Hosp, Mailman Res Ctr, Belmont, MA 02178 USA	Albany Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Harvard University; McLean Hospital	Paskaleva, EE (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.	cankim@mail.amc.edu		Paskaleva, Elena/0000-0002-4291-9969; Shekhtman, Alexander/0000-0003-2649-2675	NIH [AT003371]; American Diabetes Association [1-06-CD-23, 1R01GM085006]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT003371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085006] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant number AT003371 to MC and American Diabetes Association Career Development Award number 1-06-CD-23 and 1R01GM085006 to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILARCORDOVA E, 1994, AIDS RES HUM RETROV, V10, P295, DOI 10.1089/aid.1994.10.295; Bhal SK, 2007, MOL PHARMACEUT, V4, P556, DOI 10.1021/mp0700209; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dong SL, 2008, J PHYS CHEM B, V112, P9371, DOI 10.1021/jp801216e; Eftink MR, 1997, METHOD ENZYMOL, V278, P221; Goodsell D.S, 2009, CSH PROTOC; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Hetenyi C, 2006, FEBS LETT, V580, P1447, DOI 10.1016/j.febslet.2006.01.074; Lee DYW, 2009, AIDS RES HUM RETROV, V25, P1231, DOI 10.1089/aid.2009.0019; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Paskaleva Elena E, 2006, AIDS Res Ther, V3, P15, DOI 10.1186/1742-6405-3-15; Paskaleva EE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-8; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14	15	39	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12168	10.1371/journal.pone.0012168	http://dx.doi.org/10.1371/journal.pone.0012168			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730055	Green Published, Green Submitted, gold			2022-12-25	WOS:000280862200022
J	Acin-Perez, R; Hoyos, B; Gong, JL; Vinogradov, V; Fischman, DA; Leitges, M; Borhan, B; Starkov, A; Manfredi, G; Hammerling, U				Acin-Perez, Rebeca; Hoyos, Beatrice; Gong, Jianli; Vinogradov, Valerie; Fischman, Donald A.; Leitges, Michael; Borhan, Babak; Starkov, Anatoly; Manfredi, Giovanni; Hammerling, Ulrich			Regulation of intermediary metabolism by the PKC delta signalosome in mitochondria	FASEB JOURNAL			English	Article						energy homeostasis; pyruvate dehydrogenase complex; Krebs cycle control; cytochrome c; vitamin A	PROTEIN-KINASE-C; OXIDATIVE-PHOSPHORYLATION; REPERFUSION INJURY; REACTIVE OXYGEN; CYTOCHROME-C; ACTIVATION; MECHANISMS; CELLS; CARDIOPROTECTION; DYSFUNCTION	PKC delta has emerged as a novel regulatory molecule of oxidative phosphorylation by targeting the pyruvate dehydrogenase complex (PDHC). We showed that activation of PKC delta leads to the dephosphorylation of pyruvate dehydrogenase kinase 2 (PDK2), thereby decreasing PDK2 activity and increasing PDH activity, accelerating oxygen consumption, and augmenting ATP synthesis. However, the molecular components that mediate PKC delta signaling in mitochondria have remained elusive so far. Here, we identify for the first time a functional complex, which includes cytochrome c as the upstream driver of PKC delta, and uses the adapter protein p66Shc as a platform with vitamin A (retinol) as a fourth partner. All four components are necessary for the activation of the PKC delta signal chain. Genetic ablation of any one of the three proteins, or retinol depletion, silences signaling. Furthermore, mutations that disrupt the interaction of cytochrome c with p66Shc, of p66Shc with PKC delta, or the deletion of the retinol-binding pocket on PKC delta, attenuate signaling. In cytochrome c-deficient cells, reintroduction of cytochrome c Fe3+ protein restores PKC delta signaling. Taken together, these results indicate that oxidation of PKC delta is key to the activation of the pathway. The PKC delta/p66Shc/cytochrome c signalosome might have evolved to effect site-directed oxidation of zinc-finger structures of PKC delta, which harbor the activation centers and the vitamin A binding sites. Our findings define the molecular mechanisms underlying the signaling function of PKC delta in mitochondria.- Acin-Perez, R., Hoyos, B., Gong, J., Vinogradov, V., Fischman, D. A., Leitges, M., Borhan, B., Starkov, A., Manfredi, G., Hammerling, U. Regulation of intermediary metabolism by the PKC delta signalosome in mitochondria. FASEB J. 24, 5033-5042 (2010). www.fasebj.org	[Acin-Perez, Rebeca; Starkov, Anatoly; Manfredi, Giovanni] Weill Cornell Med Sch, Dept Neurol & Neurobiol, New York, NY USA; [Fischman, Donald A.] Weill Cornell Med Sch, Dept Cell & Dev Biol, New York, NY USA; [Hoyos, Beatrice; Gong, Jianli; Vinogradov, Valerie; Hammerling, Ulrich] Sloan Kettering Inst Canc Res, Program Immunol, New York, NY USA; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway; [Borhan, Babak] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; University of Oslo; Michigan State University	Acin-Perez, R (corresponding author), Weill Cornell Med Sch, Dept Neurol & Neurobiol, New York, NY USA.	u-hammerling@ski.mskcc.org	Acin-Perez, Rebeca/H-6160-2015; Leitges, Michael/AAN-1953-2021; Acin-Perez, Rebeca/AAU-4913-2020; Starkov, Anatoly/B-2688-2012; Gong, Jianli/G-1212-2011	Acin-Perez, Rebeca/0000-0001-9553-8337; Acin-Perez, Rebeca/0000-0001-9553-8337; Starkov, Anatoly/0000-0002-1334-4828; Leitges, Michael/0000-0003-4203-6995	U.S. National Institutes of Health [NIH R01 GM088999, NIH R01 DK 069348, NIH RO1 CA089362]; Muscular Dystrophy Association; United Mitochondrial Disease Foundation; NATIONAL CANCER INSTITUTE [R01CA089362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088999] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); United Mitochondrial Disease Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Drs. Pier Paolo Pandolfi (Harvard University, Boston, MA, USA) and Guiseppe Pelicci (University of Milan, Milan, Italy) for donating p66Shc<SUP>-/-</SUP> mice to Sloan-Kettering Institute. The authors also thank Dr. Ushio Kikkawa (Kobe University, Kobe, Japan) for his generous gift of mutant PKC delta expression vectors, and K. Nakanishi for his valuable suggestions regarding the synthesis and use of retinoids. Special thanks go to Dr. Silke Vogel (Columbia University, New York, NY, USA) for RBP and CRPB expression vectors and to Tony Riley (Sloan-Kettering Institute, New York, NY, USA) for expert medical illustration. This work was supported by U.S. National Institutes of Health grants NIH R01 GM088999 (G. M.), NIH R01 DK 069348 (U. H.), and NIH RO1 CA089362 (U. H.); the Muscular Dystrophy Association (G. M.); and the United Mitochondrial Disease Foundation (R.A.-P.).	Acin-Perez R, 2010, FASEB J, V24, P627, DOI 10.1096/fj.09-142281; Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Arany I, 2010, AM J PHYSIOL-RENAL, V298, pF1214, DOI 10.1152/ajprenal.00639.2009; Bright R, 2005, STROKE, V36, P2781, DOI 10.1161/01.STR.0000189996.71237.f7; Budas GR, 2007, PHARMACOL RES, V55, P523, DOI 10.1016/j.phrs.2007.04.005; Chiu HJ, 2008, FASEB J, V22, P3878, DOI 10.1096/fj.08-112375; Churchill EN, 2005, CIRC RES, V97, P78, DOI 10.1161/01.RES.0000173896.32522.6e; D'Aurelio M, 2001, J BIOL CHEM, V276, P46925, DOI 10.1074/jbc.M106429200; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gopalakrishna R, 2008, J BIOL CHEM, V283, P14430, DOI 10.1074/jbc.M801519200; Graumann J, 2001, STRUCTURE, V9, P377, DOI 10.1016/S0969-2126(01)00599-8; Gray MO, 2004, J BIOL CHEM, V279, P3596, DOI 10.1074/jbc.M311459200; Hanlon PR, 2005, FASEB J, V19, P1323, DOI 10.1096/fj.04-3545fje; Hofhaus G, 1996, J BIOL CHEM, V271, P13155, DOI 10.1074/jbc.271.22.13155; Hoyos B, 2005, J BIOL CHEM, V280, P6872, DOI 10.1074/jbc.M412695200; Hoyos B, 2002, J BIOL CHEM, V277, P23949, DOI 10.1074/jbc.M110750200; Hurley JH, 1997, CURR OPIN STRUC BIOL, V7, P557, DOI 10.1016/S0959-440X(97)80122-4; Imam A., 2000, FASEB J, V2000, DOI [10.1096/0E1000-13290e, DOI 10.1096/FJF.1000-1329FJE]; Inagaki K, 2003, CIRCULATION, V108, P2304, DOI 10.1161/01.CIR.0000101682.24138.36; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Knapp LT, 2000, J BIOL CHEM, V275, P24136, DOI 10.1074/jbc.M002043200; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Korichneva I, 2002, J BIOL CHEM, V277, P44327, DOI 10.1074/jbc.M205634200; Majumder PK, 2001, CELL GROWTH DIFFER, V12, P465; Mayr M, 2004, AM J PHYSIOL-HEART C, V287, pH937, DOI 10.1152/ajpheart.00877.2003; Morita M, 2008, J BIOCHEM, V143, P31, DOI 10.1093/jb/mvm190; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Tan Q, 1997, ANGEW CHEM INT EDIT, V36, P2089, DOI 10.1002/anie.199720891; Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5; Vogel S, 2002, BIOCHEMISTRY-US, V41, P15360, DOI 10.1021/bi0268551; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	36	33	34	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2010	24	12					5033	5042		10.1096/fj.10-166934	http://dx.doi.org/10.1096/fj.10-166934			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20798245	Green Published			2022-12-25	WOS:000284824400041
J	Jenkins, RW; Canals, D; Idkowiak-Baldys, J; Simbari, F; Roddy, P; Perry, DM; Kitatani, K; Luberto, C; Hannun, YA				Jenkins, Russell W.; Canals, Daniel; Idkowiak-Baldys, Jolanta; Simbari, Fabio; Roddy, Patrick; Perry, David M.; Kitatani, Kazuyuki; Luberto, Chiara; Hannun, Yusuf A.			Regulated Secretion of Acid Sphingomyelinase IMPLICATIONS FOR SELECTIVITY OF CERAMIDE FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIEMANN-PICK-DISEASE; TRICYCLIC ANTIDEPRESSANT DESIPRAMINE; DELTA-MEDIATED PHOSPHORYLATION; TANDEM MASS-SPECTROMETRY; BETA-GLUCOSIDASE 1; LYSOSOMAL SPHINGOMYELINASE; ZN2+-STIMULATED SPHINGOMYELINASE; ELEVATED SPHINGOMYELINASE; BIOACTIVE SPHINGOLIPIDS; ENDOTHELIAL APOPTOSIS	The acid sphingomyelinase (aSMase) gene gives rise to two distinct enzymes, lysosomal sphingomyelinase (L-SMase) and secretory sphingomyelinase (S-SMase), via differential trafficking of a common protein precursor. However, the regulation of S-SMase and its role in cytokine-induced ceramide formation remain ill defined. To determine the role of S-SMase in cellular sphingolipid metabolism, MCF7 breast carcinoma cells stably transfected with V5-aSMase(WT) were treated with inflammatory cytokines. Interleukin-1 beta and tumor necrosis factor-alpha induced a time-and dose-dependent increase in S-SMase secretion and activity, coincident with selective elevations in cellular C-16-ceramide. To establish a role for S-SMase, we utilized a mutant of aSMase (S508A) that is shown to retain L-SMase activity, but is defective in secretion. MCF7 expressing V5-aSMaseWT exhibited increased S-SMase and L-SMase activity, as well as elevated cellular levels of specific long-chain and very long-chain ceramide species relative to vector control MCF7. Interestingly, elevated levels of only certain very long-chain ceramides were evident in V5-aSMase(S508A) MCF7. Secretion of the S508A mutant was also defective in response to IL-1 beta, as was the regulated generation of C-16-ceramide. Taken together, these data support a crucial role for Ser(508) in the regulation of S-SMase secretion, and they suggest distinct metabolic roles for S-SMase and L-SMase.	[Jenkins, Russell W.; Canals, Daniel; Idkowiak-Baldys, Jolanta; Roddy, Patrick; Perry, David M.; Kitatani, Kazuyuki; Luberto, Chiara; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Simbari, Fabio] CSIC, Dept Biomed Chem, Inst Adv Chem Catalonia, Barcelona, Spain; [Kitatani, Kazuyuki] Tottori Univ Hosp, Dept Clin Lab, Yonago, Tottori 6838504, Japan	Medical University of South Carolina; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Tottori University	Hannun, YA (corresponding author), 173 Ashley Ave,POB 250509, Charleston, SC 29425 USA.	hannun@musc.edu	Canals, Daniel/AAW-1998-2021; Canals, Daniel/AAJ-8176-2021; Kitatani, Kazuyuki/H-7100-2019	Canals, Daniel/0000-0002-9293-5123; Kitatani, Kazuyuki/0000-0002-8516-6135	NCI [GM08716, P01 CA97132, 1P30 CA138313-01]; MUSC Hollings Cancer Center Abney Foundation; American Heart Association [081509E]; Ministerio de Educacion y Ciencia (Spain) [AP2006-02190]; Japan Society for the Promotion of Science [21890144]; NATIONAL CANCER INSTITUTE [P30CA138313, P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008716] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MUSC Hollings Cancer Center Abney Foundation; American Heart Association(American Heart Association); Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM08716 (MSTP to R. W. J.) and P01 CA97132 from the NCI (to Y. A. H.), MUSC Hollings Cancer Center Abney Foundation scholarship (to R. W. J.), American Heart Association Grant 081509E (to R. W. J.), Ministerio de Educacion y Ciencia (Spain) Predoctoral Fellowship AP2006-02190 (to F. S.) and Japan Society for the Promotion of Science Grant-in-aid for Young Scientists (Start-up) Grant 21890144 (to K. K.).; Special thanks to the Medical University of South Carolina (MUSC) Analytical Lipidomics Core (Dr. Jacek Bielawski, Barbara Rembiesa, Justin Snider, and Jason Pierce), the MUSC Synthetic Lipidomics Core (Dr. Alicja Bielawska and Nalini Mayroo), and the MUSC Hollings Cancer Center Imaging Core supported by National Institutes of Health Grant 1P30 CA138313-01 from the NCI to Dr. Andrew Kraft. Additional thanks to Dr. Christopher J. Clarke (MUSC) for careful reading of this manuscript. We also thank Dr. Elizabeth Garrett-Mayer (MUSC) for assistance with statistical analyses.	Abe T, 1999, EUR J PEDIATR, V158, P953, DOI 10.1007/s004310051254; BARENHOLZ Y, 1980, BIOCHIM BIOPHYS ACTA, V604, P129, DOI 10.1016/0005-2736(80)90572-6; Bartelsen O, 1998, J BIOTECHNOL, V63, P29, DOI 10.1016/S0168-1656(98)00070-4; Bezombes C, 2001, FASEB J, V15, P297; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bielawski J, 2009, METHODS MOL BIOL, V579, P443, DOI 10.1007/978-1-60761-322-0_22; CALLAHAN JW, 1983, J NEUROSCI RES, V10, P151, DOI 10.1002/jnr.490100205; Claus RA, 2005, FASEB J, V19, P1719, DOI 10.1096/fj.04-2842fje; Devlin CM, 2008, ARTERIOSCL THROM VAS, V28, P1723, DOI 10.1161/ATVBAHA.108.173344; Doehner W, 2007, EUR HEART J, V28, P821, DOI 10.1093/eurheartj/ehl541; Ferlinz K, 1997, EUR J BIOCHEM, V243, P511, DOI 10.1111/j.1432-1033.1997.511_1a.x; Goni FM, 2002, FEBS LETT, V531, P38, DOI 10.1016/S0014-5793(02)03482-8; Gorska M, 2003, HORM METAB RES, V35, P506; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Gulbins E, 2006, AM J PHYSIOL-REG I, V290, pR11, DOI 10.1152/ajpregu.00416.2005; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Herz J, 2009, NAT IMMUNOL, V10, P761, DOI 10.1038/ni.1757; HURWITZ R, 1994, J BIOL CHEM, V269, P5440; HURWITZ R, 1994, BIOL CHEM H-S, V375, P447, DOI 10.1515/bchm3.1994.375.7.447; Idkowiak-Baldys J, 2009, J BIOL CHEM, V284, P22322, DOI 10.1074/jbc.M109.026765; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Jones I, 2008, MOL GENET METAB, V95, P152, DOI 10.1016/j.ymgme.2008.08.004; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; Kitatani K, 2009, J BIOL CHEM, V284, P12972, DOI 10.1074/jbc.M802790200; Kolzer M, 2004, FEBS LETT, V559, P96, DOI 10.1016/S0014-5793(04)00033-X; Lee CY, 2007, BIOCHEMISTRY-US, V46, P14969, DOI 10.1021/bi700817g; Lee CY, 2006, J LIPID RES, V47, P622, DOI 10.1194/jlr.M500487-JLR200; Lemaire R, 1997, BRIT J RHEUMATOL, V36, P735; LIPPINCOTTSCHWA.J, 1989, R D CELL, V56, P801; Liu B, 2000, METHOD ENZYMOL, V311, P164; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Marathe S, 2000, HUM MOL GENET, V9, P1967, DOI 10.1093/hmg/9.13.1967; Marathe S, 1999, ARTERIOSCL THROM VAS, V19, P2648, DOI 10.1161/01.ATV.19.11.2648; Marathe S, 1998, J BIOL CHEM, V273, P4081, DOI 10.1074/jbc.273.7.4081; Marathe S, 2000, ARTERIOSCL THROM VAS, V20, P2607, DOI 10.1161/01.ATV.20.12.2607; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; McCollister BD, 2007, INFECT IMMUN, V75, P5346, DOI 10.1128/IAI.00689-07; Milhas D, 2010, FEBS LETT, V584, P1887, DOI 10.1016/j.febslet.2009.10.058; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Paris F, 2001, J BIOL CHEM, V276, P8297, DOI 10.1074/jbc.M008732200; Pettus BJ, 2004, CURR MOL MED, V4, P405, DOI 10.2174/1566524043360573; Radisky DC, 2009, NAT REV MOL CELL BIO, V10, P228, DOI 10.1038/nrm2633; Romiti E, 2000, MOL CELL BIOCHEM, V205, P75, DOI 10.1023/A:1007041329052; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Sathishkumar S, 2005, CANCER BIOL THER, V4, P979, DOI 10.4161/cbt.4.9.1915; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; Schissel SL, 1998, J BIOL CHEM, V273, P2738, DOI 10.1074/jbc.273.5.2738; Schissel SL, 1996, J BIOL CHEM, V271, P18431, DOI 10.1074/jbc.271.31.18431; Schuchman EH, 2007, J INHERIT METAB DIS, V30, P654, DOI 10.1007/s10545-007-0632-9; Segui B, 2000, FASEB J, V14, P36, DOI 10.1096/fasebj.14.1.36; Seto M, 2004, PROTEIN SCI, V13, P3172, DOI 10.1110/ps.04966204; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; SPENCE MW, 1989, J BIOL CHEM, V264, P5358; Tabas I, 1999, CHEM PHYS LIPIDS, V102, P123, DOI 10.1016/S0009-3084(99)00080-8; Takahashi T, 2002, J PEDIAT HEMATOL ONC, V24, P401, DOI 10.1097/00043426-200206000-00016; Tardy C, 2006, BBA-REV CANCER, V1765, P101, DOI 10.1016/j.bbcan.2005.11.003; WEITZ G, 1983, H-S Z PHYSIOL CHEM, V364, P863, DOI 10.1515/bchm2.1983.364.2.863; Wong ML, 2000, P NATL ACAD SCI USA, V97, P8681, DOI 10.1073/pnas.150098097; Zeidan YH, 2008, J CELL BIOL, V181, P335, DOI 10.1083/jcb.200705060; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200	64	82	85	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					35706	35718		10.1074/jbc.M110.125609	http://dx.doi.org/10.1074/jbc.M110.125609			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20807762	Green Published, hybrid			2022-12-25	WOS:000283845300049
J	Sala-Rabanal, M; Kucheryavykh, LY; Skatchkov, SN; Eaton, MJ; Nichols, CG				Sala-Rabanal, Monica; Kucheryavykh, Lilia Y.; Skatchkov, Serguei N.; Eaton, Misty J.; Nichols, Colin G.			Molecular Mechanisms of EAST/SeSAME Syndrome Mutations in Kir4.1 (KCNJ10)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING POTASSIUM CHANNEL; ANTENATAL BARTTER-SYNDROME; ROMK K(IR)1.1 CHANNELS; RECTIFIER K+ CHANNELS; RETINAL GLIAL-CELLS; SEIZURE SUSCEPTIBILITY; SENSORINEURAL DEAFNESS; GLUTAMATE UPTAKE; BASOLATERAL MEMBRANE; CORTICAL ASTROCYTES	Inwardly rectifying potassium channel Kir4.1 is critical for glial function, control of neuronal excitability, and systemic K+ homeostasis. Novel mutations in Kir4.1 have been associated with EAST/SeSAME syndrome, characterized by mental retardation, ataxia, seizures, hearing loss, and renal salt waste. Patients are homozygous for R65P, G77R, C140R or T164I; or compound heterozygous for A167V/R297C or R65P/R199Stop, a deletion of the C-terminal half of the protein. We investigated the functional significance of these mutations by radiotracer efflux and inside-out membrane patch clamping in COSm6 cells expressing homomeric Kir4.1 or heteromeric Kir4.1/Kir5.1 channels. All of the mutations compromised channel function, but the underlying mechanisms were different. R65P, T164I, and R297C caused an alkaline shift in pH sensitivity, indicating that these positions are crucial for pH sensing and pore gating. In R297C, this was due to disruption of intersubunit salt bridge Glu(288)-Arg(297). C140R breaks the Cys(108)-Cys(140) disulfide bond essential for protein folding and function. A167V did not affect channel properties but may contribute to decreased surface expression in A167V/R297C. In G77R, introduction of a positive charge within the bilayer may affect channel structure or gating. R199 Stop led to a dramatic decrease in surface expression, but channel activity was restored by co-expression with intact subunits, suggesting remarkable tolerance for truncation of the cytoplasmic domain. These results provide an explanation for the molecular defects that underlie the EAST/SeSAME syndrome.	[Sala-Rabanal, Monica] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Sala-Rabanal, Monica; Nichols, Colin G.] Washington Univ, EXCITE Ctr, Ctr Invest Membrane Excitabil Diseases, St Louis, MO 63110 USA; [Kucheryavykh, Lilia Y.; Skatchkov, Serguei N.; Eaton, Misty J.] Univ Cent Caribe, Dept Biochem, Bayamon, PR 00960 USA; [Skatchkov, Serguei N.] Univ Cent Caribe, Dept Physiol, Bayamon, PR 00960 USA	Washington University (WUSTL); Washington University (WUSTL)	Sala-Rabanal, M (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	msala@wustl.edu	Nichols, Colin/D-6336-2012; Sala-Rabanal, Monica/AAU-2383-2021	Ghisays, Valentina/0000-0002-8434-9407	National Institutes of Health [HL54171, S11-NS48201, U54-NS039408, G12-RR03035]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003035] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS039408, R01NS065201, S11NS048201] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants HL54171( to C. G. N.), S11-NS48201( to M. J. E.), U54-NS039408( to S. N. S.), and G12-RR03035.	Benfenati V, 2006, J NEUROCHEM, V98, P430, DOI 10.1111/j.1471-4159.2006.03877.x; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Bolton S, 2006, EXP NEUROL, V202, P36, DOI 10.1016/j.expneurol.2006.05.009; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Buono RJ, 2004, EPILEPSY RES, V58, P175, DOI 10.1016/j.eplepsyres.2004.02.003; Butt AM, 2006, J CELL MOL MED, V10, P33, DOI 10.1111/j.1582-4934.2006.tb00289.x; Cho HC, 2000, BIOCHEMISTRY-US, V39, P4649, DOI 10.1021/bi992469g; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Ferraro TN, 2004, MAMM GENOME, V15, P239, DOI 10.1007/s00335-003-2270-3; Heuser K, 2010, EPILEPSY RES, V88, P55, DOI 10.1016/j.eplepsyres.2009.09.023; Hibino H, 2004, J BIOL CHEM, V279, P44065, DOI 10.1074/jbc.M405985200; Hibino H, 2010, PFLUG ARCH EUR J PHY, V459, P521, DOI 10.1007/s00424-009-0754-z; Inyushin M, 2010, EPILEPSIA, V51, P1707, DOI 10.1111/j.1528-1167.2010.02592.x; Ishii M, 2003, AM J PHYSIOL-CELL PH, V285, pC260, DOI 10.1152/ajpcell.00560.2002; Jagger DJ, 2010, JARO-J ASSOC RES OTO, V11, P435, DOI 10.1007/s10162-010-0218-3; Kofuji P, 2002, GLIA, V39, P292, DOI 10.1002/glia.10112; Kucheryavykh Lilia Y, 2009, Open Neurosci J, V3, P40; Kucheryavykh YV, 2007, GLIA, V55, P274, DOI 10.1002/glia.20455; Kucheryavykh YV, 2007, CHANNELS, V1, P172, DOI 10.4161/chan.4389; Kurata HT, 2006, J GEN PHYSIOL, V127, P467, DOI 10.1085/jgp.200509467; Lachheb S, 2008, AM J PHYSIOL-RENAL, V294, pF1398, DOI 10.1152/ajprenal.00288.2007; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; Lenzen KP, 2005, EPILEPSY RES, V63, P113, DOI 10.1016/j.eplepsyres.2005.01.002; Leyland ML, 1999, PFLUG ARCH EUR J PHY, V438, P778, DOI 10.1007/s004240051106; Lin YW, 2003, J GEN PHYSIOL, V122, P225, DOI 10.1085/jgp.200308822; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lourdel S, 2002, J PHYSIOL-LONDON, V538, P391, DOI 10.1113/jphysiol.2001.012961; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Neusch C, 2001, J NEUROSCI, V21, P5429, DOI 10.1523/JNEUROSCI.21-15-05429.2001; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Olsen ML, 2007, J NEUROPHYSIOL, V98, P786, DOI 10.1152/jn.00340.2007; Peters M, 2003, KIDNEY INT, V64, P923, DOI 10.1046/j.1523-1755.2003.00153.x; Raap M, 2002, NEUROREPORT, V13, P1037, DOI 10.1097/00001756-200206120-00012; Rapedius M, 2007, CHANNELS, V1, P327, DOI 10.4161/chan.5176; Rapedius M, 2007, NEURON, V55, P602, DOI 10.1016/j.neuron.2007.07.026; Rapedius M, 2006, EMBO REP, V7, P611, DOI 10.1038/sj.embor.7400678; Reichold M, 2010, P NATL ACAD SCI USA, V107, P14490, DOI 10.1073/pnas.1003072107; Rozengurt N, 2003, HEARING RES, V177, P71, DOI 10.1016/S0378-5955(02)00799-2; Satz JS, 2009, J NEUROSCI, V29, P13136, DOI 10.1523/JNEUROSCI.0474-09.2009; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Schulte U, 1999, P NATL ACAD SCI USA, V96, P15298, DOI 10.1073/pnas.96.26.15298; Schulte U, 1998, J BIOL CHEM, V273, P34575, DOI 10.1074/jbc.273.51.34575; Schulte U, 2000, EUR J BIOCHEM, V267, P5837, DOI 10.1046/j.1432-1327.2000.01671.x; Shang LJ, 2005, MOL BRAIN RES, V139, P178, DOI 10.1016/j.molbrainres.2005.05.003; Skatchkov SN, 2001, NEUROREPORT, V12, P1437, DOI 10.1097/00001756-200105250-00028; Tanemoto M, 2005, J AM SOC NEPHROL, V16, P2608, DOI 10.1681/ASN.2005030266; Tanemoto M, 2004, AM J PHYSIOL-RENAL, V287, pF1148, DOI 10.1152/ajprenal.00203.2004; Tanemoto M, 2000, J PHYSIOL-LONDON, V525, P587, DOI 10.1111/j.1469-7793.2000.00587.x; Tang X, 2010, NEUROSCIENCE, V166, P397, DOI 10.1016/j.neuroscience.2010.01.005; Tang XF, 2010, BIOCHEM BIOPH RES CO, V399, P537, DOI 10.1016/j.bbrc.2010.07.105; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tucker SJ, 2000, J BIOL CHEM, V275, P16404, DOI 10.1074/jbc.C000127200; Wagner CA, 2010, J NEPHROL, V23, P5; Wu J, 2004, MOL VIS, V10, P650; Yang T, 2009, AM J HUM GENET, V84, P651, DOI 10.1016/j.ajhg.2009.04.014	55	82	83	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 12	2010	285	46					36040	36048		10.1074/jbc.M110.163170	http://dx.doi.org/10.1074/jbc.M110.163170			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	675QK	20807765	Green Published, hybrid			2022-12-25	WOS:000283845300080
J	Jutabha, P; Anzai, N; Kitamura, K; Taniguchi, A; Kaneko, S; Yan, K; Yamada, H; Shimada, H; Kimura, T; Katada, T; Fukutomi, T; Tomita, K; Urano, W; Yamanaka, H; Seki, G; Fujita, T; Moriyama, Y; Yamada, A; Uchida, S; Wempe, MF; Endou, H; Sakurai, H				Jutabha, Promsuk; Anzai, Naohiko; Kitamura, Kenichiro; Taniguchi, Atsuo; Kaneko, Shuji; Yan, Kunimasa; Yamada, Hideomi; Shimada, Hidetaka; Kimura, Toru; Katada, Tomohisa; Fukutomi, Toshiyuki; Tomita, Kimio; Urano, Wako; Yamanaka, Hisashi; Seki, George; Fujita, Toshiro; Moriyama, Yoshinori; Yamada, Akira; Uchida, Shunya; Wempe, Michael F.; Endou, Hitoshi; Sakurai, Hiroyuki			Human Sodium Phosphate Transporter 4 (hNPT4/SLC17A3) as a Common Renal Secretory Pathway for Drugs and Urate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC ANION TRANSPORT; URIC-ACID; HOMINOID EVOLUTION; APICAL MEMBRANE; IDENTIFICATION; GOUT; FAMILY; HYPERURICEMIA; EXCRETION; EXCHANGER	The evolutionary loss of hepatic urate oxidase (uricase) has resulted in humans with elevated serum uric acid (urate). Uricase loss may have been beneficial to early primate survival. However, an elevated serum urate has predisposed man to hyperuricemia, a metabolic disturbance leading to gout, hypertension, and various cardiovascular diseases. Human serum urate levels are largely determined by urate reabsorption and secretion in the kidney. Renal urate reabsorption is controlled via two proximal tubular urate transporters: apical URAT1 (SLC22A12) and basolateral URATv1/GLUT9 (SLC2A9). In contrast, the molecular mechanism(s) for renal urate secretion remain unknown. In this report, we demonstrate that an orphan transporter hNPT4 (human sodium phosphate transporter 4; SLC17A3) was a multispecific organic anion efflux transporter expressed in the kidneys and liver. hNPT4 was localized at the apical side of renal tubules and functioned as a voltage-driven urate transporter. Furthermore, loop diuretics, such as furosemide and bumetanide, substantially interacted with hNPT4. Thus, this protein is likely to act as a common secretion route for both drugs and may play an important role in diuretics-induced hyperuricemia. The in vivo role of hNPT4 was suggested by two hyperuricemia patients with missense mutations in SLC17A3. These mutated versions of hNPT4 exhibited reduced urate efflux when they were expressed in Xenopus oocytes. Our findings will complete a model of urate secretion in the renal tubular cell, where intracellular urate taken up via OAT1 and/or OAT3 from the blood exits from the cell into the lumen via hNPT4.	[Jutabha, Promsuk; Anzai, Naohiko; Kimura, Toru; Katada, Tomohisa; Fukutomi, Toshiyuki; Endou, Hitoshi; Sakurai, Hiroyuki] Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Tokyo 1818611, Japan; [Yan, Kunimasa] Kyorin Univ, Sch Med, Dept Pediat, Tokyo 1818611, Japan; [Yamada, Akira] Kyorin Univ, Sch Med, Dept Nephrol, Tokyo 1818611, Japan; [Kitamura, Kenichiro; Tomita, Kimio] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Dept Nephrol, Kumamoto 8608556, Japan; [Taniguchi, Atsuo; Urano, Wako; Yamanaka, Hisashi] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo 1620054, Japan; [Kaneko, Shuji] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Pharmacol, Kyoto 6068501, Japan; [Yamada, Hideomi; Seki, George; Fujita, Toshiro] Univ Tokyo, Fac Med, Dept Internal Med, Tokyo 1130033, Japan; [Shimada, Hidetaka] Shimada Hosp, Kumamoto 8600017, Japan; [Moriyama, Yoshinori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Membrane Biochem, Okayama 7008530, Japan; [Uchida, Shunya; Endou, Hitoshi] Teikyo Univ, Sch Med, Dept Internal Med, Div Nephrol, Tokyo 1738605, Japan; [Wempe, Michael F.] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Denver, CO 80045 USA; [Yamada, Akira] J Pharma Co Ltd, Tokyo 1600022, Japan	Kyorin University; Kyorin University; Kyorin University; Kumamoto University; Tokyo Women's Medical University; Kyoto University; University of Tokyo; Okayama University; Teikyo University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Anzai, N (corresponding author), 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	anzai-path@umin.ac.jp	Jutabha, Promsuk/AFF-4363-2022; Kaneko, Shuji/AAR-1005-2021; Jutabha, Promsuk/AAE-9872-2022; ANZAI, NAOHIKO/K-9492-2017	ANZAI, NAOHIKO/0000-0003-0605-0458; Kaneko, Shuji/0000-0001-5152-5809	Japan Society for the Promotion; KAKENHI [21390073, 21659216, 21890245]; Nakatomi Foundation; Gout Research Foundation of Japan; Kyorin University School of Medicine	Japan Society for the Promotion(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nakatomi Foundation; Gout Research Foundation of Japan(Gout Research Foundation of Japan); Kyorin University School of Medicine	This work was supported in part by Japan Society for the Promotion of urate to the luminal (urine) space, is elusive. Science Grants KAKENHI 21390073, 21659216, and 21890245 and by the Nakatomi Foundation, the Gout Research Foundation of Japan, and Kyorin University School of Medicine Collaborative Project 2009.	Anzai N, 2004, J BIOL CHEM, V279, P45942, DOI 10.1074/jbc.M406724200; ANZAI N, 2010, CURR RHEUMA IN PRESS, V6; Anzai N, 2008, J BIOL CHEM, V283, P26834, DOI 10.1074/jbc.C800156200; Anzai N, 2007, CURR OPIN RHEUMATOL, V19, P151, DOI 10.1097/BOR.0b013e328032781a; Anzai N, 2006, J PHARMACOL SCI, V100, P411, DOI 10.1254/jphs.CRJ06006X; Anzai N, 2010, CURR HYPERTENS REV, V6, P148, DOI 10.2174/157340210791936732; Anzai N, 2007, EXPERT OPIN DRUG DIS, V2, P1251, DOI 10.1517/17460441.2.9.1251; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; AVNER ED, 1990, PEDIATR NEPHROL, V4, P372, DOI 10.1007/BF00862522; BURCKHARDT G, 2000, KIDNEY PHYSL PATHOPH, P193; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Dantzler WH, 2002, BBA-BIOMEMBRANES, V1566, P169, DOI 10.1016/S0005-2736(02)00599-0; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Ellison DH, 2008, BRENNER RECTORS KIDN, P1646; Emmerson BT, 1996, NEW ENGL J MED, V334, P445, DOI 10.1056/NEJM199602153340707; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Eraly SA, 2008, PHYSIOL GENOMICS, V33, P180, DOI 10.1152/physiolgenomics.00207.2007; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Horita S, 2005, J AM SOC NEPHROL, V16, P2270, DOI 10.1681/ASN.2004080667; Jutabha P, 2003, J BIOL CHEM, V278, P27930, DOI 10.1074/jbc.M303210200; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; KUSANO K, 1982, J PHYSIOL-LONDON, V328, P143, DOI 10.1113/jphysiol.1982.sp014257; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Melis D, 2004, J INHERIT METAB DIS, V27, P725, DOI 10.1023/B:BOLI.0000045755.89308.2f; MOLLER JV, 1982, PHARMACOL REV, V34, P315; Mount DB, 2006, RHEUM DIS CLIN N AM, V32, P313, DOI 10.1016/j.rdc.2006.02.006; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; Pascual E, 2006, ANN RHEUM DIS, V65, P981, DOI 10.1136/ard.2005.049023; PRITCHARD JB, 1993, PHYSIOL REV, V73, P765, DOI 10.1152/physrev.1993.73.4.765; Rafey MA, 2003, CURR OPIN NEPHROL HY, V12, P511, DOI 10.1097/00041552-200309000-00005; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; Roch-Ramel F, 1999, NEWS PHYSIOL SCI, V14, P80; Ruddy DA, 1997, GENOME RES, V7, P441, DOI 10.1101/gr.7.5.441; Russel FGM, 2002, ANNU REV PHYSIOL, V64, P563, DOI 10.1146/annurev.physiol.64.081501.155913; Tsuchida H, 2010, CELL PHYSIOL BIOCHEM, V25, P511, DOI 10.1159/000303060; Uchino H, 2000, BIOCHEM BIOPH RES CO, V270, P254, DOI 10.1006/bbrc.2000.2407; Van Aubel RAMH, 2005, AM J PHYSIOL-RENAL, V288, pF327, DOI 10.1152/ajprenal.00133.2004; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Watanabe S, 2002, HYPERTENSION, V40, P355, DOI 10.1161/01.HYP.0000028589.66335.AA; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854; WU XW, 1994, P NATL ACAD SCI USA, V91, P742, DOI 10.1073/pnas.91.2.742; Yamauchi Y, 2007, NEUROSCI LETT, V428, P72, DOI 10.1016/j.neulet.2007.09.037	43	101	112	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	2010	285	45					35123	35132		10.1074/jbc.M110.121301	http://dx.doi.org/10.1074/jbc.M110.121301			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	673KL	20810651	hybrid, Green Published			2022-12-25	WOS:000283659100086
J	Erat, MC; Schwarz-Linek, U; Pickford, AR; Farndale, RW; Campbell, ID; Vakonakis, I				Erat, Michele C.; Schwarz-Linek, Ulrich; Pickford, Andrew R.; Farndale, Richard W.; Campbell, Iain D.; Vakonakis, Ioannis			Implications for Collagen Binding from the Crystallographic Structure of Fibronectin (6)FnI(1-2)FnII(7)FnI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA FIBRONECTIN; GELATIN-BINDING; I COLLAGEN; (6)F1(1)F2(2)F2 FRAGMENT; CRYSTAL-STRUCTURES; TRACE-ELEMENTS; BURN INJURY; PROTEIN; SITES; DOMAIN	Collagen and fibronectin (FN) are two abundant and essential components of the vertebrate extracellular matrix; they interact directly with cellular receptors and affect cell adhesion and migration. Past studies identified a FN fragment comprising six modules, (6)FnI(1-2)FnII(7-9)FnI, and termed the gelatin binding domain (GBD) as responsible for collagen interaction. Recently, we showed that the GBD binds tightly to a specific site within type I collagen and determined the structure of domains (8-9)FnI in complex with a peptide from that site. Here, we present the crystallographic structure of domains (6)FnI(1-2)FnII(7)FnI, which form a compact, globular unit through interdomain interactions. Analysis of NMR titrations with single-stranded collagen peptides reveals a dominant collagen interaction surface on domains (2)FnII and (7)FnI; a similar surface appears involved in interactions with triple-helical peptides. Models of the complete GBD, based on the new structure and the (8-9)FnI.collagen complex show a continuous putative collagen binding surface. We explore the implications of this model using long collagen peptides and discuss our findings in the context of FN interactions with collagen fibrils.	[Vakonakis, Ioannis] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Schwarz-Linek, Ulrich] Univ St Andrews, St Andrews KY16 9ST, Fife, Scotland; [Pickford, Andrew R.] Univ Portsmouth, Sch Biol Sci, Portsmouth PO1 2DY, Hants, England; [Farndale, Richard W.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Oxford; University of St Andrews; University of Portsmouth; University of Cambridge	Vakonakis, I (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	ioannis.vakonakis@bioch.ox.ac.uk	Pickford, Andy/AGB-6901-2022	Schwarz-Linek, Ulrich/0000-0003-0526-223X; Pickford, Andy/0000-0002-7237-0030	EC; Biotechnology and Biological Sciences Research Council; Medical Research Council; Wellcome Trust; Medical Research Council [G0500707] Funding Source: researchfish; MRC [G0500707] Funding Source: UKRI	EC(European CommissionEuropean Commission Joint Research Centre); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by EC Marie Curie Fellowship FP7.; Supported by the Biotechnology and Biological Sciences Research Council.; Supported by the Medical Research Council.; Supported by the Wellcome Trust Career Development fellowship program.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; BLUMENSTOCK FA, 1978, J BIOL CHEM, V253, P4287; BLUMENSTOCK FA, 1993, J LEUKOCYTE BIOL, V54, P56, DOI 10.1002/jlb.54.1.56; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DENO DC, 1984, J CLIN INVEST, V73, P20, DOI 10.1172/JCI111191; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; ERIKSEN HO, 1984, BURNS, V10, P422, DOI 10.1016/0305-4179(84)90083-4; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fallah S, 2009, CONTRACEPTION, V80, P40, DOI 10.1016/j.contraception.2009.01.010; Fawzi NL, 2010, P NATL ACAD SCI USA, V107, P1379, DOI 10.1073/pnas.0909370107; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Fiori S, 2002, J MOL BIOL, V319, P1235, DOI 10.1016/S0022-2836(02)00365-0; Gehrmann ML, 2004, J BIOL CHEM, V279, P46921, DOI 10.1074/jbc.M408859200; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; Holmes DF, 2006, P NATL ACAD SCI USA, V103, P17249, DOI 10.1073/pnas.0608417103; Hornebeck W, 2005, PATHOL BIOL, V53, P405, DOI 10.1016/j.patbio.2004.12.015; INGHAM KC, 1985, EUR J BIOCHEM, V148, P219, DOI 10.1111/j.1432-1033.1985.tb08828.x; INGHAM KC, 1988, J BIOL CHEM, V263, P4624; IYENGAR V, 1988, CLIN CHEM, V34, P474; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; KAPLAN JE, 1976, J RETICULOENDOTH SOC, V20, P375; Katagiri Y, 2003, J BIOL CHEM, V278, P11897, DOI 10.1074/jbc.M212512200; KLEINMAN HK, 1981, BIOCHEMISTRY-US, V20, P2325, DOI 10.1021/bi00511a039; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LACELLE P, 1990, BLOOD, V75, P470; LANSER ME, 1980, ANN SURG, V192, P776, DOI 10.1097/00000658-198012000-00014; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; LiWang AC, 1999, BIOCHEMISTRY-US, V38, P442, DOI 10.1021/bi9812726; Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179; Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Pagett A, 2005, BIOCHEMISTRY-US, V44, P14682, DOI 10.1021/bi050937i; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Pickford AR, 2001, EMBO J, V20, P1519, DOI 10.1093/emboj/20.7.1519; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Rudino-Pinera E, 2007, J MOL BIOL, V368, P833, DOI 10.1016/j.jmb.2007.02.061; Sauter NK, 2004, J APPL CRYSTALLOGR, V37, P399, DOI 10.1107/S0021889804005874; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; Tang C, 2008, J AM CHEM SOC, V130, P4048, DOI 10.1021/ja710493m; Trexler M, 2003, J BIOL CHEM, V278, P12241, DOI 10.1074/jbc.M210116200; Vakonakis I, 2008, STRUCTURE, V16, P944, DOI 10.1016/j.str.2008.02.020; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005; van den Dolder J, 2003, TISSUE ENG, V9, P505, DOI 10.1089/107632703322066688; VERSIECK J, 1985, CRC CR REV CL LAB SC, V22, P97, DOI 10.3109/10408368509165788; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Xu XP, 2009, BIOCHEMISTRY-US, V48, P5822, DOI 10.1021/bi900513h; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	59	27	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33764	33770		10.1074/jbc.M110.139394	http://dx.doi.org/10.1074/jbc.M110.139394			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20739283	hybrid, Green Published			2022-12-25	WOS:000283354000022
J	Wallach, I; Jaitly, N; Lilien, R				Wallach, Izhar; Jaitly, Navdeep; Lilien, Ryan			A Structure-Based Approach for Mapping Adverse Drug Reactions to the Perturbation of Underlying Biological Pathways	PLOS ONE			English	Article							GENE-EXPRESSION; PARKINSONS-DISEASE; HEPARAN-SULFATE; INGUINAL-HERNIA; CANCER RISK; PROTEIN; GLYCOSAMINOGLYCANS; PHARMACOLOGY; METABOLISM; MECHANISMS	Adverse drug reactions (ADR), also known as side-effects, are complex undesired physiologic phenomena observed secondary to the administration of pharmaceuticals. Several phenomena underlie the emergence of each ADR; however, a dominant factor is the drug's ability to modulate one or more biological pathways. Understanding the biological processes behind the occurrence of ADRs would lead to the development of safer and more effective drugs. At present, no method exists to discover these ADR-pathway associations. In this paper we introduce a computational framework for identifying a subset of these associations based on the assumption that drugs capable of modulating the same pathway may induce similar ADRs. Our model exploits multiple information resources. First, we utilize a publicly available dataset pairing drugs with their observed ADRs. Second, we identify putative protein targets for each drug using the protein structure database and in-silico virtual docking. Third, we label each protein target with its known involvement in one or more biological pathways. Finally, the relationships among these information sources are mined using multiple stages of logistic-regression while controlling for over-fitting and multiple-hypothesis testing. As proof-of-concept, we examined a dataset of 506 ADRs, 730 drugs, and 830 human protein targets. Our method yielded 185 ADR-pathway associations of which 45 were selected to undergo a manual literature review. We found 32 associations to be supported by the scientific literature.	[Wallach, Izhar; Jaitly, Navdeep; Lilien, Ryan] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Lilien, Ryan] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada; [Wallach, Izhar; Lilien, Ryan] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Wallach, I (corresponding author), Univ Toronto, Dept Comp Sci, Toronto, ON, Canada.	izharw@cs.toronto.edu; lilien@cs.toronto.edu			Bill and Melinda Gates Foundation; Natural Sciences and Engineering Research Council of Canada	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work is supported by grants to R. H. L. from the Bill and Melinda Gates Foundation (Grand Challenges Explorations) and the Natural Sciences and Engineering Research Council of Canada (Discovery). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SSSJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-63; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; An Jianghong, 2004, Genome Inform, V15, P31; Aoki K, 2004, J BIOL CHEM, V279, P39798, DOI 10.1074/jbc.M402677200; Banks PA, 2006, AM J GASTROENTEROL, V101, P2379, DOI 10.1111/j.1572-0241.2006.00856.x; Basaria S, 2000, DIABETES CARE, V23, P564, DOI 10.2337/diacare.23.4.564; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bau DT, 2006, CANCER LETT, V240, P1, DOI 10.1016/j.canlet.2005.08.003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Das S, 2009, J BIOL CHEM, V284, P22888, DOI 10.1074/jbc.M109.021949; DiGiovanni CW, 2007, J AM ACAD ORTHOP SUR, V15, P208, DOI 10.5435/00124635-200704000-00004; Durrant JD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000648; Ericson E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000151; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Finnen RL, 2006, J VIROL, V80, P10325, DOI 10.1128/JVI.00939-06; FLINT MH, 1982, CONNECT TISSUE RES, V9, P173, DOI 10.3109/03008208209160258; Fliri AF, 2005, NAT CHEM BIOL, V1, P389, DOI 10.1038/nchembio747; Fliri AF, 2007, CHEMMEDCHEM, V2, P1774, DOI 10.1002/cmdc.200700153; FRIEDLAND IM, 1962, J BIOL CHEM, V237, P3829; Fu YP, 2003, CANCER RES, V63, P2440; Guha R, 2006, J CHEM INF MODEL, V46, P991, DOI 10.1021/ci050400b; Gurujeyalakshmi G, 1996, J PHARMACOL EXP THER, V277, P1152; Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; IMURA H, 2000, NEW ENGL J MED, V342, P1533; International Union of Biochemistry and Molecular Biology. Nomenclature Committee. Webb EC, 1992, ENZ NOM 1992 REC NOM; Irwin JJ, 2009, J MED CHEM, V52, P5712, DOI 10.1021/jm9006966; Isaia GC, 1999, ACTA DIABETOL, V36, P35, DOI 10.1007/s005920050142; James M C, 2000, Prog Cell Cycle Res, V4, P71; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Joyce JG, 1999, J BIOL CHEM, V274, P5810, DOI 10.1074/jbc.274.9.5810; KANEHISA M, 2009, NUCLEIC ACIDS RES; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; KEISER MJ, 2009, NATURE; Kim SJ, 2007, IEEE J-STSP, V1, P606, DOI 10.1109/JSTSP.2007.910971; Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Kuschel B, 2002, HUM MOL GENET, V11, P1399, DOI 10.1093/hmg/11.12.1399; Levenshtein V. I., 1966, BINARY CODES CAPABLE; Liebler DC, 2005, NAT REV DRUG DISCOV, V4, P410, DOI 10.1038/nrd1720; Liu HX, 2009, SCAND J GASTROENTERO, V44, P626, DOI 10.1080/00365520902745047; Menozzi FD, 2002, MOL MICROBIOL, V43, P1379, DOI 10.1046/j.1365-2958.2002.02841.x; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Sakai Y, 2009, INT J UROL, V16, P848, DOI 10.1111/j.1442-2042.2009.02370.x; Sambrook P, 2001, BEST PRACT RES CL RH, V15, P401, DOI 10.1053/berh.2001.0157; Scheiber J, 2009, J MED CHEM, V52, P3103, DOI 10.1021/jm801546k; Srinivasan P, 2004, J AM SOC INF SCI TEC, V55, P396, DOI 10.1002/asi.10389; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Thomas AA, 2009, J AM COLL SURGEONS, V209, P371, DOI 10.1016/j.jamcollsurg.2009.05.015; Wadstrom T, 1999, J MED MICROBIOL, V48, P223, DOI 10.1099/00222615-48-3-223; Warner TF, 2002, PATHOL RES PRACT, V198, P701, DOI 10.1078/0344-0338-00324; Whitebread S, 2005, DRUG DISCOV TODAY, V10, P1421, DOI 10.1016/S1359-6446(05)03632-9; *WHO COLL CTR DRUG, 2009, WHO COLL CTR DRUG ST; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wong F, 1997, J GASTROEN HEPATOL, V12, P437, DOI 10.1111/j.1440-1746.1997.tb00463.x; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387; Yang L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000441; Zsoldos Z, 2007, J MOL GRAPH MODEL, V26, P198, DOI 10.1016/j.jmgm.2006.06.002	67	45	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2010	5	8							e12063	10.1371/journal.pone.0012063	http://dx.doi.org/10.1371/journal.pone.0012063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641TV	20808786	Green Published, Green Submitted, gold			2022-12-25	WOS:000281153500001
J	Villa, CE; Caccia, M; Sironi, L; D'Alfonso, L; Collini, M; Rivolta, I; Miserocchi, G; Gorletta, T; Zanoni, I; Granucci, F; Chirico, G				Villa, Carlo E.; Caccia, Michele; Sironi, Laura; D'Alfonso, Laura; Collini, Maddalena; Rivolta, Ilaria; Miserocchi, Giuseppe; Gorletta, Tatiana; Zanoni, Ivan; Granucci, Francesca; Chirico, Giuseppe			Accumulative Difference Image Protocol for Particle Tracking in Fluorescence Microscopy Tested in Mouse Lymphonodes	PLOS ONE			English	Article							IN-VIVO; DYNAMICS; SPECTROSCOPY; EXCITATION; CELLS	The basic research in cell biology and in medical sciences makes large use of imaging tools mainly based on confocal fluorescence and, more recently, on non-linear excitation microscopy. Substantially the aim is the recognition of selected targets in the image and their tracking in time. We have developed a particle tracking algorithm optimized for low signal/noise images with a minimum set of requirements on the target size and with no a priori knowledge of the type of motion. The image segmentation, based on a combination of size sensitive filters, does not rely on edge detection and is tailored for targets acquired at low resolution as in most of the in-vivo studies. The particle tracking is performed by building, from a stack of Accumulative Difference Images, a single 2D image in which the motion of the whole set of the particles is coded in time by a color level. This algorithm, tested here on solid-lipid nanoparticles diffusing within cells and on lymphocytes diffusing in lymphonodes, appears to be particularly useful for the cellular and the in-vivo microscopy image processing in which few a priori assumption on the type, the extent and the variability of particle motions, can be done.	[Villa, Carlo E.; Caccia, Michele; Sironi, Laura; D'Alfonso, Laura; Collini, Maddalena; Chirico, Giuseppe] Univ Milano Bicocca, Dipartimento Fis, Milan, Italy; [Rivolta, Ilaria; Miserocchi, Giuseppe] Univ Milano Bicocca, Dipartimento Med Sperimentale, Monza, Italy; [Gorletta, Tatiana; Zanoni, Ivan; Granucci, Francesca] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy	University of Milano-Bicocca; University of Milano-Bicocca; University of Milano-Bicocca	Villa, CE (corresponding author), Univ Milano Bicocca, Dipartimento Fis, Milan, Italy.	giuseppe.chirico@mib.infn.it	Caccia, Michele/AAW-2808-2021; Caccia, Michele/Q-5623-2018; Villa, Carlo Emanuele/AAT-6978-2020; GRANUCCI, Francesca/K-6150-2019; D'Alfonso, Laura/J-4193-2012; Sironi, Laura/AAA-5384-2022	Caccia, Michele/0000-0002-2968-5635; D'Alfonso, Laura/0000-0002-7378-4462; CHIRICO, Giuseppe/0000-0001-6578-6460; Villa, Carlo Emanuele/0000-0002-1208-3160; Zanoni, Ivan/0000-0002-3423-7474; SIRONI, LAURA/0000-0002-6638-7709; granucci, francesca/0000-0002-7046-4914	EU [201842]; European Commission	EU(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	We acknowledge the EU contract ENCITE (n. 201842) funding to G.C and F.G. ENCITE is co-funded by the European Commission under the 7th Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Shalom Y., 2004, ESTIMATION APPL TRAC; Caccia M, 2008, EUR BIOPHYS J BIOPHY, V37, P979, DOI 10.1007/s00249-008-0323-y; Cavanagh LL, 2008, IMMUNOL CELL BIOL, V86, P428, DOI 10.1038/icb.2008.25; Celli S, 2008, IMMUNOL REV, V221, P182, DOI 10.1111/j.1600-065X.2008.00588.x; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; Degerman J, 2009, J MICROSC-OXFORD, V233, P178, DOI 10.1111/j.1365-2818.2008.03108.x; DIASPRO A, 2005, Q REV BIOPHYS, V97, P166; DOI M, 1999, THEORY POLYM DYNAMIC, pCH1; Gonzalez R. C., 2002, DIGITAL IMAGE PROCES; Hand AJ, 2009, J MICROSC-OXFORD, V234, P62, DOI 10.1111/j.1365-2818.2009.03144.x; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; *IMPR, VOL; Kalaidzidis Y, 2009, J MATH BIOL, V58, P57, DOI 10.1007/s00285-008-0180-4; Khandoga AG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004693; Li D, 2009, OPT LETT, V34, P202, DOI 10.1364/OL.34.000202; Moerner WE, 2003, REV SCI INSTRUM, V74, P3597, DOI 10.1063/1.1589587; PAL NR, 1993, PATTERN RECOGN, V26, P1277, DOI 10.1016/0031-3203(93)90135-J; Parikesit GOF, 2009, BIOMICROFLUIDICS, V3, DOI 10.1063/1.3270523; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Verestoy J., 1999, Machine Graphics & Vision, V8, P553; Wang F, 2006, NANOTECHNOLOGY, V17, pR1, DOI 10.1088/0957-4484/17/1/R01	24	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e12216	10.1371/journal.pone.0012216	http://dx.doi.org/10.1371/journal.pone.0012216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808918	Green Submitted, gold, Green Published			2022-12-25	WOS:000280968100017
J	Azam, L; Maskos, U; Changeux, JP; Dowell, CD; Christensen, S; De Biasi, M; McIntosh, JM				Azam, Layla; Maskos, Uwe; Changeux, Jean-Pierre; Dowell, Cheryl D.; Christensen, Sean; De Biasi, Mariella; McIntosh, J. Michael			alpha-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between alpha 6 beta 4 and alpha 6 beta 2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release	FASEB JOURNAL			English	Article						nicotinic; alpha 6; Conus; hydroxyproline; hippocampus	VENTRAL TEGMENTAL AREA; SUBUNIT MESSENGER-RNAS; RAT STRIATAL SYNAPTOSOMES; DOPAMINE RELEASE; PARKINSONS-DISEASE; HIPPOCAMPAL SYNAPTOSOMES; CHOLINERGIC-RECEPTORS; ALZHEIMERS-DISEASE; LOCUS-COERULEUS; MUTANT MICE	alpha 6* (asterisk indicates the presence of additional subunits) nicotinic acetylcholine receptors (nAChRs) are broadly implicated in catecholamine-dependent disorders that involve attention, motor movement, and nicotine self-administration. Different molecular forms of alpha 6 nAChRs mediate catecholamine release, but receptor differentiation is greatly hampered by a paucity of subtype selective ligands. alpha-Conotoxins are nAChR-targeted peptides used by Conus species to incapacitate prey. We hypothesized that distinct conotoxin-binding kinetics could be exploited to develop a series of selective probes to enable study of native receptor subtypes. Proline6 of alpha-conotoxin BuIA was found to be critical for nAChR selectivity; substitution of proline6 with 4-hydroyx-proline increased the IC(50) by 2800-fold at alpha 6/alpha 3 beta 2 beta 3 but only by 6-fold at alpha 6/alpha 3 beta 4 nAChRs (to 1300 and 12 nM, respectively). We used conotoxin probes together with subunit-null mice to interrogate nAChR subtypes that modulate hippocampal norepinephrine release. Release was abolished in alpha 6-null mutant mice. alpha-Conotoxin BuIA[T5A;P6O] partially blocked norepinephrine release in wild-type controls but failed to block release in beta 4(-/-) mice. In contrast, BuIA[T5A;P6O] failed to block dopamine release in the wild-type striatum known to contain alpha 6 beta 2* nAChRs. BuIA[T5A;P6O] is a novel ligand for distinguishing between closely related alpha 6* nAChRs; alpha 6 beta 4* nAChRs modulate norepinephrine release in hippocampus but not dopamine release in striatum.-Azam, L., Maskos, U., Changeux, J.-P., Dowell, C. D., Christensen, S., De Biasi, M., McIntosh, J. M. alpha-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between alpha 6 beta 4 and alpha 6 beta 2 nAChRs and blocks nicotine-stimulated norepinephrine release. FASEB J. 24, 5113-5123 (2010). www.fasebj.org	[Azam, Layla; Dowell, Cheryl D.; Christensen, Sean; McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA; [Maskos, Uwe; Changeux, Jean-Pierre] Inst Pasteur, Unite Neurobiol Integrat Syst Cholinerg, Paris, France; [De Biasi, Mariella] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [De Biasi, Mariella] Baylor Coll Med, Grad Program Translat Biol & Mol Med, Houston, TX 77030 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Baylor College of Medicine; Baylor College of Medicine	Azam, L (corresponding author), Univ Utah, Dept Biol, 257 S 1400 East, Salt Lake City, UT 84112 USA.	layla.azam@utah.edu	De Biasi, Mariella/M-7646-2017	De Biasi, Mariella/0000-0002-0687-8872	Kirschstein-National Research Service Award [DA 016835]; National Institutes of Health [DA017173, MH53631, GM48677]; Institut Pasteur; ANR; European Union [HEALTH-F2-2008-202088]; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche Neurologie; European Commission; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH053631, R01MH053631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017173, F32DA016835] Funding Source: NIH RePORTER	Kirschstein-National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut Pasteur(European Commission); ANR(French National Research Agency (ANR)); European Union(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche Neurologie(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Kirschstein-National Research Service Award Postdoctoral Fellowship DA 016835 (to L. A.), National Institutes of Health grants DA017173 (to M. D. B.) and MH53631 and GM48677 (to J.M.M.), and Institut Pasteur, Centre National de la Recherche Scientifique, Agence Nationale de la Recherche Neurologie 2005, European Commission European Research and Technological Development NeuroCypres, and ANR Blanc 2008 (to U. M. and J.P.C.). The research leading to these results received funding from the European Union Seventh Framework program under grant agreement HEALTH-F2-2008-202088 (NeuroCypres project).	Azam L, 2005, J BIOL CHEM, V280, P80, DOI 10.1074/jbc.M406281200; Azam L, 2005, J PHARMACOL EXP THER, V312, P231, DOI 10.1124/jpet.104.071456; Azam L, 2003, NEUROSCIENCE, V119, P965, DOI 10.1016/S0306-4522(03)00220-3; Azam L, 2002, J COMP NEUROL, V444, P260, DOI 10.1002/cne.10138; Azam L, 2008, J BIOL CHEM, V283, P11625, DOI 10.1074/jbc.M710288200; Azam L, 2006, MOL PHARMACOL, V70, P967, DOI 10.1124/mol.106.024513; Azam L, 2009, ACTA PHARMACOL SIN, V30, P771, DOI 10.1038/aps.2009.47; Berisio R, 2004, J AM CHEM SOC, V126, P11402, DOI 10.1021/ja047069h; Bordia T, 2007, MOL PHARMACOL, V72, P52, DOI 10.1124/mol.107.035998; Brunzell DH, 2010, NEUROPSYCHOPHARMACOL, V35, P665, DOI 10.1038/npp.2009.171; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Champtiaux N, 2003, J NEUROSCI, V23, P7820; Champtiaux N, 2002, J NEUROSCI, V22, P1208, DOI 10.1523/JNEUROSCI.22-04-01208.2002; Chi SW, 2006, BIOCHEM BIOPH RES CO, V349, P1228, DOI 10.1016/j.bbrc.2006.08.164; Clarke PBS, 1996, BRIT J PHARMACOL, V117, P595, DOI 10.1111/j.1476-5381.1996.tb15232.x; Cui CH, 2003, J NEUROSCI, V23, P11045; Ellison M, 2006, BIOCHEMISTRY-US, V45, P1511, DOI 10.1021/bi0520129; Goldner FM, 1997, NEUROREPORT, V8, P2739; Gotti C, 2007, BIOCHEM PHARMACOL, V74, P1102, DOI 10.1016/j.bcp.2007.05.023; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Gotti C, 2006, NEUROBIOL DIS, V23, P481, DOI 10.1016/j.nbd.2006.04.005; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Grady SR, 2007, BIOCHEM PHARMACOL, V74, P1235, DOI 10.1016/j.bcp.2007.07.032; Grady SR, 2010, J MOL NEUROSCI, V40, P91, DOI 10.1007/s12031-009-9263-y; Grady SR, 2002, J PHARMACOL EXP THER, V301, P651, DOI 10.1124/jpet.301.2.651; Innocent N, 2008, J PHARMACOL EXP THER, V327, P529, DOI 10.1124/jpet.108.142943; Jackson KJ, 2009, J PHARMACOL EXP THER, V331, P547, DOI 10.1124/jpet.109.155457; Kulak JM, 1997, J NEUROSCI, V17, P5263; LEE EHY, 1995, BRAIN RES BULL, V37, P411, DOI 10.1016/0361-9230(95)00039-9; LEE EHY, 1993, SYNAPSE, V14, P144, DOI 10.1002/syn.890140207; Lena C, 1999, P NATL ACAD SCI USA, V96, P12126, DOI 10.1073/pnas.96.21.12126; LeNovere N, 1996, EUR J NEUROSCI, V8, P2428; Lof E, 2007, PSYCHOPHARMACOLOGY, V195, P333, DOI 10.1007/s00213-007-0899-4; Lopez-Vera E, 2008, BIOCHEMISTRY-US, V47, P1741, DOI 10.1021/bi701934m; Luo SQ, 1998, J NEUROSCI, V18, P8571; Marritt AM, 2005, MOL PHARMACOL, V68, P1656, DOI 10.1124/mol.105.012380; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Moretti M, 2004, MOL PHARMACOL, V66, P85, DOI 10.1124/mol.66.1.85; Moroni M, 2006, J MOL NEUROSCI, V30, P95, DOI 10.1385/JMN:30:1:95; Nicke A, 2004, EUR J BIOCHEM, V271, P2305, DOI 10.1111/j.1432-1033.2004.04145.x; Perez XA, 2008, MOL PHARMACOL, V74, P844, DOI 10.1124/mol.108.048843; Perry DC, 2007, J PHARMACOL EXP THER, V322, P306, DOI 10.1124/jpet.107.121228; PETERKOFSKY B, 1991, AM J CLIN NUTR, V54, pS1135, DOI 10.1093/ajcn/54.6.1135s; Pimentel L, 2003, AM J EMERG MED, V21, P328, DOI 10.1016/S0735-6757(03)00083-4; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Quik M, 2006, J PHARMACOL EXP THER, V316, P481, DOI 10.1124/jpet.105.094375; Quik M, 2000, J COMP NEUROL, V425, P58, DOI 10.1002/1096-9861(20000911)425:1<58::AID-CNE6>3.0.CO;2-X; Quiram PA, 2000, J BIOL CHEM, V275, P4889, DOI 10.1074/jbc.275.7.4889; RAPIER C, 1988, J NEUROCHEM, V50, P1123, DOI 10.1111/j.1471-4159.1988.tb10582.x; Salminen O, 2004, MOL PHARMACOL, V65, P1526, DOI 10.1124/mol.65.6.1526; Salminen O, 2007, MOL PHARMACOL, V71, P1563, DOI 10.1124/mol.106.031492; Scholze P, 2007, BRIT J PHARMACOL, V151, P414, DOI 10.1038/sj.bjp.0707236; Shiembob DL, 2006, BIOCHEMISTRY-US, V45, P11200, DOI 10.1021/bi0611715; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Vailati S, 1999, MOL PHARMACOL, V56, P11, DOI 10.1124/mol.56.1.11; Vincler MA, 2003, BRAIN RES, V974, P25, DOI 10.1016/S0006-8993(03)02546-0; Walsh H, 2008, J BIOL CHEM, V283, P6022, DOI 10.1074/jbc.M703432200; Weinshenker D, 2008, CURR ALZHEIMER RES, V5, P342, DOI 10.2174/156720508784533286; Whiteaker P, 2007, BIOCHEMISTRY-US, V46, P6628, DOI 10.1021/bi7004202; Xu W, 1999, J NEUROSCI, V19, P9298; Zoli M, 2002, J NEUROSCI, V22, P8785	64	57	59	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2010	24	12					5113	5123		10.1096/fj.10-166272	http://dx.doi.org/10.1096/fj.10-166272			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20739611	Green Published			2022-12-25	WOS:000284824400049
J	Sriram, K; Lin, GX; Jefferson, AM; Roberts, JR; Wirth, O; Hayashi, Y; Krajnak, KM; Soukup, JM; Ghio, AJ; Reynolds, SH; Castranova, V; Munson, AE; Antonini, JM				Sriram, Krishnan; Lin, Gary X.; Jefferson, Amy M.; Roberts, Jenny R.; Wirth, Oliver; Hayashi, Yusuke; Krajnak, Kristine M.; Soukup, Joleen M.; Ghio, Andrew J.; Reynolds, Steven H.; Castranova, Vincent; Munson, Albert E.; Antonini, James M.			Mitochondrial dysfunction and loss of Parkinson's disease-linked proteins contribute to neurotoxicity of manganese-containing welding fumes	FASEB JOURNAL			English	Article						brain; DJ-1; neurodegeneration; Park genes; proteasome; ubiquitin-proteasome pathway	EARLY-ONSET PARKINSONISM; OXIDATIVE STRESS; CELL-DEATH; NEURODEGENERATIVE DISEASES; PERMEABILITY TRANSITION; JUVENILE PARKINSONISM; NEUROLOGICAL DISEASE; CEREBROSPINAL-FLUID; S18Y POLYMORPHISM; ALPHA-SYNUCLEIN	Welding generates complex metal aerosols, inhalation of which is linked to adverse health effects among welders. An important health concern of welding fume (WF) exposure is neurological dysfunction akin to Parkinson's disease (PD), thought to be mediated by manganese (Mn) in the fumes. Also, there is a proposition that welding might accelerate the onset of PD. Our recent findings link the presence of Mn in the WF with dopaminergic neurotoxicity seen in rats exposed to manual metal arc-hard surfacing (MMA-HS) or gas metal arc-mild steel (GMA-MS) fumes. To elucidate the molecular mechanisms further, we investigated the association of PD-linked (Park) genes and mitochondrial function in causing dopaminergic abnormality. Repeated instillations of the two fumes at doses that mimic similar to 1 to 5 yr of worker exposure resulted in selective brain accumulation of Mn. This accumulation caused impairment of mitochondrial function and loss of tyrosine hydroxylase (TH) protein, indicative of dopaminergic injury. A fascinating finding was the altered expression of Parkin (Park2), Uchl1 (Park5), and Dj1 (Park7) proteins in dopaminergic brain areas. A similar regimen of manganese chloride (MnCl(2)) also caused extensive loss of striatal TH, mitochondrial electron transport components, and Park proteins. As mutations in PARK genes have been linked to early-onset PD in humans, and because welding is implicated as a risk factor for parkinsonism, PARK genes might play a critical role in WF-mediated dopaminergic dysfunction. Whether these molecular alterations culminate in neurobehavioral and neuropathological deficits reminiscent of PD remains to be ascertained.-Sriram, K., Lin, G. X., Jefferson, A. M., Roberts, J. R., Wirth, O., Hayashi, Y., Krajnak, K. M., Soukup, J. M., Ghio, A. J., Reynolds, S. H., Castranova, V., Munson, A. E., Antonini, J. M. Mitochondrial dysfunction and loss of Parkinson's disease-linked proteins contribute to neurotoxicity of manganese-containing welding fumes. FASEB J. 24, 4989-5002 (2010). www.fasebj.org	[Sriram, Krishnan] NIOSH, Toxicol & Mol Biol Branch, CDC, Hlth Effects Lab, Morgantown, WV 26505 USA; [Soukup, Joleen M.; Ghio, Andrew J.] US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); United States Environmental Protection Agency	Sriram, K (corresponding author), NIOSH, Toxicol & Mol Biol Branch, CDC, Hlth Effects Lab, Mailstop L-3014,1095 Willowdale Rd, Morgantown, WV 26505 USA.	kos4@cdc.gov	Sriram, Krishnan/F-1039-2014	Sriram, Krishnan/0000-0001-7005-1872				Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Antonini JM, 2010, INHAL TOXICOL, V22, P805, DOI 10.3109/08958371003621641; Antonini JM, 2006, J OCCUP ENVIRON HYG, V3, P194, DOI 10.1080/15459620600584352; Berlinger B, 2009, ANN OCCUP HYG, V53, P333, DOI 10.1093/annhyg/mep013; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bowler RM, 2007, OCCUP ENVIRON MED, V64, P167, DOI 10.1136/oem.2006.028761; Bowler RM, 2007, NEUROTOXICOLOGY, V28, P298, DOI 10.1016/j.neuro.2006.11.001; Bowler RM, 2006, NEUROTOXICOLOGY, V27, P315, DOI 10.1016/j.neuro.2005.10.007; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Couper J., 1837, BR ANN MED PHARM, V1, P41, DOI DOI 10.1002/JCP.22692; DAY INM, 1987, FEBS LETT, V210, P157, DOI 10.1016/0014-5793(87)81327-3; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; GALVANI P, 1995, EUR J PHARM-ENVIRON, V293, P377, DOI 10.1016/S0014-2999(95)80096-4; GAVIN CE, 1992, TOXICOL APPL PHARM, V115, P1, DOI 10.1016/0041-008X(92)90360-5; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Goldman SM, 2005, NEUROLOGY, V65, P1430, DOI 10.1212/01.wnl.0000180361.74060.70; Greenamyre JT, 2003, PARKINSONISM RELAT D, V9, pS59, DOI 10.1016/S1353-8020(03)00023-3; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; HaMai D, 2001, FREE RADICAL BIO MED, V31, P763, DOI 10.1016/S0891-5849(01)00639-6; Harris MK, 2005, J OCCUP ENVIRON HYG, V2, P375, DOI 10.1080/15459620591007736; HASEGAWA E, 1990, BIOCHEM BIOPH RES CO, V170, P1049, DOI 10.1016/0006-291X(90)90498-C; Heales SJR, 1999, BBA-BIOENERGETICS, V1410, P215, DOI 10.1016/S0005-2728(98)00168-6; Hedrich K, 2004, NEUROLOGY, V62, P389, DOI 10.1212/01.WNL.0000113022.51739.88; Higashi Y, 2004, J NEUROCHEM, V89, P1490, DOI 10.1111/j.1471-4159.2004.02445.x; Hunot S, 2001, CLIN NEUROSCI RES, V1, P434, DOI 10.1016/S1566-2772(01)00022-6; HUSAIN R, 1976, B ENVIRON CONTAM TOX, V16, P118, DOI 10.1007/BF01753116; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; IWAMOTO N, 1984, T JWRI, V13, P21; Jenkins NT, 2005, WELD J, V84, p87S; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Josephs KA, 2005, NEUROLOGY, V64, pA419; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kim YH, 1999, NEUROTOXICOLOGY, V20, P249; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitazawa M, 2002, J PHARMACOL EXP THER, V302, P26, DOI 10.1124/jpet.302.1.26; Korczynski R E, 2000, Appl Occup Environ Hyg, V15, P936, DOI 10.1080/104732200750051175; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Lucchini R, 1999, NEUROTOXICOLOGY, V20, P287; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; McGeer PL, 2004, PARKINSONISM RELAT D, V10, pS3, DOI 10.1016/j.parkreldis.2004.01.005; Mellick GD, 2000, NEUROSCI LETT, V293, P127, DOI 10.1016/S0304-3940(00)01510-X; Mergler D, 1997, ENVIRON RES, V73, P92, DOI 10.1006/enrs.1997.3710; MIZUNO Y, 1995, BBA-MOL BASIS DIS, V1271, P265, DOI 10.1016/0925-4439(95)00038-6; Mogi M, 1996, NEUROSCI LETT, V211, P13, DOI 10.1016/0304-3940(96)12706-3; MOGI M, 1994, NEUROSCI LETT, V165, P208, DOI 10.1016/0304-3940(94)90746-3; MUKOYAMA M, 1989, ACTA NEUROPATHOL, V79, P294, DOI 10.1007/BF00294664; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; NELSON K, 1993, BRIT J IND MED, V50, P510; Neumann M, 2004, ACTA NEUROPATHOL, V107, P489, DOI 10.1007/s00401-004-0834-2; Olzmann JA, 2007, J COMP NEUROL, V500, P585, DOI 10.1002/cne.21191; Panov A, 2005, J BIOL CHEM, V280, P42026, DOI 10.1074/jbc.M508628200; Park J, 2006, NEUROTOXICOLOGY, V27, P445, DOI 10.1016/j.neuro.2006.01.005; Park RM, 2005, AM J IND MED, V48, P63, DOI 10.1002/ajim.20178; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Periquet M, 2003, BRAIN, V126, P1271, DOI 10.1093/brain/awg136; Prabhakaran K, 2009, NEUROTOXICOLOGY, V30, P414, DOI 10.1016/j.neuro.2009.02.012; Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5; Racette BA, 2005, NEUROLOGY, V64, P230, DOI 10.1212/01.WNL.0000149511.19487.44; Racette BA, 2001, NEUROLOGY, V56, P8, DOI 10.1212/WNL.56.1.8; Rao KVR, 2004, J BIOL CHEM, V279, P32333, DOI 10.1074/jbc.M402096200; Reaney SH, 2005, TOXICOL APPL PHARM, V205, P271, DOI 10.1016/j.taap.2004.10.013; Reaney SH, 2006, TOXICOL SCI, V93, P114, DOI 10.1093/toxsci/kfl028; Reasor MJ, 2000, J TOXICOL ENV HEAL A, V62, P9, DOI 10.1080/00984100050201631; Rizzu P, 2004, ANN NEUROL, V55, P113, DOI 10.1002/ana.10782; Roels H, 1997, ARCH TOXICOL, V71, P223, DOI 10.1007/s002040050380; ROELS HA, 1992, BRIT J IND MED, V49, P25; Roth JA, 2010, J NEUROCHEM, V113, P454, DOI 10.1111/j.1471-4159.2010.06607.x; Roth JA, 2009, NEUROMOL MED, V11, P281, DOI 10.1007/s12017-009-8088-8; Sadek AH, 2003, INT J TOXICOL, V22, P393, DOI 10.1080/713936672; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Sriram K, 2002, FASEB J, V16, P1474, DOI 10.1096/fj.02-0216fje; Sriram K, 1997, BRAIN RES, V749, P44, DOI 10.1016/S0006-8993(96)01271-1; SRIRAM K, ARCH TOXICOL, V84, P521; SRIRAM K, 2005, ROLE GLIA NEUROTOXIC, P141; Sriram K, 2006, FASEB J, V20, P670, DOI 10.1096/fj.05-5106com; Stampfer MJ, 2009, J OCCUP ENVIRON HYG, V6, P267, DOI 10.1080/15459620902754703; STONE KC, 1992, AM J RESP CELL MOL, V6, P235, DOI 10.1165/ajrcmb/6.2.235; Susi P, 2000, Appl Occup Environ Hyg, V15, P26; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Tanner CM, 2009, ARCH NEUROL-CHICAGO, V66, P1106, DOI 10.1001/archneurol.2009.195; Ved R, 2005, J BIOL CHEM, V280, P42655, DOI 10.1074/jbc.M505910200; WENNBERG A, 1991, SCAND J WORK ENV HEA, V17, P255, DOI 10.5271/sjweh.1705; Yin ZB, 2008, BRAIN RES, V1203, P1, DOI 10.1016/j.brainres.2008.01.079; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Zhang J, 2003, J NEUROCHEM, V84, P336, DOI 10.1046/j.1471-4159.2003.01525.x; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zhang SR, 2004, TOXICOL IN VITRO, V18, P71, DOI 10.1016/j.tiv.2003.09.002; Zhang ZJ, 2008, NEUROSCI LETT, V442, P200, DOI 10.1016/j.neulet.2008.07.012; Zimmer AT, 2001, J AEROSOL SCI, V32, P993, DOI 10.1016/S0021-8502(01)00035-0	96	56	59	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2010	24	12					4989	5002		10.1096/fj.10-163964	http://dx.doi.org/10.1096/fj.10-163964			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	688BO	20798247				2022-12-25	WOS:000284824400037
J	Bernhardt, A; Kuester, D; Roessner, A; Reinheckel, T; Krueger, S				Bernhardt, Anja; Kuester, Doerthe; Roessner, Albert; Reinheckel, Thomas; Krueger, Sabine			Cathepsin X-deficient Gastric Epithelial Cells in Co-culture with Macrophages CHARACTERIZATION OF CYTOKINE RESPONSE AND MIGRATION CAPABILITY AFTER HELICOBACTER PYLORI INFECTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYLORI INFECTION; PROCATHEPSIN-X; CANCER; DISEASE; CARCINOGENESIS; OSTEOPONTIN; PROGRESSION; METASTASIS; ACTIVATION; EXPRESSION	Our previous studies have shown an association between Helicobacter pylori infection, the strong up-regulation of cathepsin X (CTSX, also called cathepsin Z/P), and the development of gastric cancer. In the present study, we analyzed primary and conventional gastric epithelial cell lines to establish an optimal in vitro mouse model system for the examination of H. pylori-induced overexpression of Ctsx in a functional way. Gastric epithelial cells were isolated from stomachs of wild-type C57BL6/N and Ctsx(-/-) mice and compared with the gastric cancer cell line CLS103. Indirect co-cultures of epithelial cells and macrophages were infected with H. pylori strain SS1 and analyzed for the expression of cathepsins, cytokines, and adhesion factors. Cellular interactions, migration capability, and adherence of H. pylori were assessed using time-lapse video microscopy and colony-forming assays. Isolated primary cells from wild-type and transgenic mice revealed qualities and expression profiles similar to those of corresponding tissue samples. Adherence of H. pylori was significantly higher in primary compared with commercially cells. Thus, induction of cathepsins, cytokines, and adhesion proteins was detected solely in primary cells and co-cultured macrophages. Microarray and migration experiments indicated that Ctsx is involved in B/T-cell proliferation/migration and adhesion of macrophages. Primary epithelial cells from stomach of Ctsx(-/-) mice represent an excellent model of H. pylori gastritis to elaborate the special functions of Ctsx in regulating the immune response to H. pylori.	[Bernhardt, Anja; Kuester, Doerthe; Roessner, Albert; Krueger, Sabine] Otto Von Guericke Univ, Inst Pathol, D-39120 Magdeburg, Germany; [Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany	Otto von Guericke University; University of Freiburg	Krueger, S (corresponding author), Leipziger St 44, D-39120 Magdeburg, Germany.	sabine.krueger@med.ovgu.de	Jechorek, Doerthe/J-4716-2014; Reinheckel, Thomas/AAL-9761-2021	Jechorek, Doerthe/0000-0002-1480-5200; Reinheckel, Thomas/0000-0001-9866-9105	Deutsche Forschungsgemeinschaft [KR 1901/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant KR 1901/4-1 from the Deutsche Forschungsgemeinschaft.	Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Buhling F, 2004, BIOL CHEM, V385, P439, DOI 10.1515/BC.2004.051; DOOLEY CP, 1989, NEW ENGL J MED, V321, P1562, DOI 10.1056/NEJM198912073212302; El-Tanani MK, 2008, FRONT BIOSCI, V13, P4276, DOI 10.2741/3004; FORMAN D, 1991, BRIT MED J, V302, P1302, DOI 10.1136/bmj.302.6788.1302; Gerber A, 2001, J INTERF CYTOK RES, V21, P11, DOI 10.1089/107999001459114; Goll R, 2005, SCAND J IMMUNOL, V61, P92, DOI 10.1111/j.0300-9475.2005.01537.x; GRAHAM DY, 1991, DIGEST DIS SCI, V36, P1084, DOI 10.1007/BF01297451; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Junnila S, 2010, GENE CHROMOSOME CANC, V49, P28, DOI 10.1002/gcc.20715; Krueger S, 2005, J PATHOL, V207, P32, DOI 10.1002/path.1820; Krueger S, 2007, PATHOL RES PRACT, V203, P433, DOI 10.1016/j.prp.2007.04.003; Krueger S, 2009, J PATHOL, V217, P581, DOI 10.1002/path.2485; Lechner AM, 2006, J BIOL CHEM, V281, P39588, DOI 10.1074/jbc.M513439200; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; MARCHETTI M, 1995, SCIENCE, V267, P1655, DOI 10.1126/science.7886456; MARSHALL BJ, 1984, LANCET, V1, P1311; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; Nascimento FD, 2005, ARCH BIOCHEM BIOPHYS, V436, P323, DOI 10.1016/j.abb.2005.01.013; Naumann M, 2004, TRENDS MICROBIOL, V12, P29, DOI 10.1016/j.tim.2003.11.005; Obermajer N, 2008, IMMUNOLOGY, V124, P76, DOI 10.1111/j.1365-2567.2007.02740.x; Obermajer N, 2009, EUR J CELL BIOL, V88, P461, DOI 10.1016/j.ejcb.2009.03.003; Peek RM, 2000, GASTROENTEROLOGY, V118, P48, DOI 10.1016/S0016-5085(00)70413-6; Schmausser B, 2000, CANCER LETT, V152, P145, DOI 10.1016/S0304-3835(99)00442-5; Sevenich L, 2010, P NATL ACAD SCI USA, V107, P2497, DOI 10.1073/pnas.0907240107; Sivaraman J, 2000, J MOL BIOL, V295, P939, DOI 10.1006/jmbi.1999.3410; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Wong BLW, 2009, AM J PATHOL, V174, P1319, DOI 10.2353/ajpath.2009.080708; WOTHERSPOON AC, 1991, LANCET, V338, P1175, DOI 10.1016/0140-6736(91)92035-Z; Xia HHX, 2001, AM J GASTROENTEROL, V96, P16, DOI 10.1111/j.1572-0241.2001.03447.x	32	24	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33691	33700		10.1074/jbc.M110.146183	http://dx.doi.org/10.1074/jbc.M110.146183			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20736174	Green Published, hybrid			2022-12-25	WOS:000283354000014
J	Dermody, JL; Buratowski, S				Dermody, Jessica L.; Buratowski, Stephen			Leo1 Subunit of the Yeast Paf1 Complex Binds RNA and Contributes to Complex Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION ELONGATION-FACTORS; POLYMERASE-II COMPLEX; PRE-MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; HISTONE H2B; IN-VIVO; GENE-EXPRESSION; H3 METHYLATION; PROTEIN; RTF1	The Paf1 complex (Paf1C) affects RNA polymerase II transcription by coordinating co-transcriptional chromatin modifications and helping recruit mRNA 3' end processing factors. Paf1C cross-links to transcribed genes, but not downstream of the cleavage and polyadenylation site, suggesting that it may interact with the nascent mRNA. Paf1C purified from Saccharomyces cerevisiae binds RNA in vitro, as do the purified Leo1 and Rtf1 subunits of the complex. In vivo cross-linking and immunoprecipitation of RNA associated with Paf1C (RNA-IP) show that Leo1, but not Rtf1, is necessary for the complex to bind RNA. Cells lacking Leo1 have reduced Paf1C recruitment as well as decreased levels of histone H3 and trimethylated H3 Lys(4) within transcribed chromatin. Together, these results suggest that association of Paf1C with RNA stabilizes its localization at actively transcribed regions where it influences chromatin structure.	[Dermody, Jessica L.; Buratowski, Stephen] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Buratowski, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	SteveB@hms.harvard.edu			National Institutes of Health [GM075383, GM46498, GM56663]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM046498, R01GM056663, R01GM046498, F31GM075383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Fellowship GM075383 (to J. L. D.) and Grants GM46498 and GM56663 (to S. B.).	Abruzzi KC, 2004, EMBO J, V23, P2620, DOI 10.1038/sj.emboj.7600261; Ardehali MB, 2009, EMBO J, V28, P1067, DOI 10.1038/emboj.2009.56; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; CHEN J, 1992, MOL CELL BIOL, V12, P3470, DOI 10.1128/MCB.12.8.3470; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costa PJ, 2000, GENETICS, V156, P535; de Jong RN, 2008, STRUCTURE, V16, P149, DOI 10.1016/j.str.2007.10.018; Desmoucelles C, 2002, J BIOL CHEM, V277, P27036, DOI 10.1074/jbc.M111433200; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Ganem C, 2006, MOL GENET GENOMICS, V275, P136, DOI 10.1007/s00438-005-0071-y; Gilbert C., 2006, CURR PROTOC MOL BIOL; Imbeault D, 2008, J BIOL CHEM, V283, P27350, DOI 10.1074/jbc.C800147200; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Kaplan CD, 2005, J BIOL CHEM, V280, P913, DOI 10.1074/jbc.M411108200; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Keogh Michael-Christopher, 2004, Methods Mol Biol, V257, P1, DOI 10.1385/1-59259-750-5:001; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim T, 2007, J BIOL CHEM, V282, P20827, DOI 10.1074/jbc.M703034200; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; MAGDOLEN V, 1994, BBA-GENE STRUCT EXPR, V1218, P205, DOI 10.1016/0167-4781(94)90013-2; Marton HA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-4; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Musso M, 2000, NUCLEIC ACIDS RES, V28, P4090, DOI 10.1093/nar/28.21.4090; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Nordick K, 2008, EUKARYOT CELL, V7, P1158, DOI 10.1128/EC.00434-07; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Penheiter KL, 2005, MOL CELL, V20, P213, DOI 10.1016/j.molcel.2005.08.023; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Rani PG, 2004, MOL CELL BIOL, V24, P1709, DOI 10.1128/MCB.24.4.1709-1720.2004; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Rondon AG, 2004, EMBO REP, V5, P47, DOI 10.1038/sj.embor.7400045; Runner VM, 2008, MOL CELL BIOL, V28, P1883, DOI 10.1128/MCB.01714-07; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Sheldon KE, 2005, MOL CELL, V20, P225, DOI 10.1016/j.molcel.2005.08.026; Shi XM, 1996, MOL CELL BIOL, V16, P669; Shi XM, 1997, MOL CELL BIOL, V17, P1160, DOI 10.1128/MCB.17.3.1160; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Stolinski LA, 1997, MOL CELL BIOL, V17, P4490, DOI 10.1128/MCB.17.8.4490; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Wade PA, 1996, PROTEIN EXPRES PURIF, V8, P85, DOI 10.1006/prep.1996.0077; Warner MH, 2007, MOL CELL BIOL, V27, P6103, DOI 10.1128/MCB.00772-07; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Zhang M, 2001, GENE DEV, V15, P30, DOI 10.1101/gad.851701; Zhang YF, 2009, P NATL ACAD SCI USA, V106, P2153, DOI 10.1073/pnas.0812939106; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105	54	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33671	33679		10.1074/jbc.M110.140764	http://dx.doi.org/10.1074/jbc.M110.140764			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20732871	Green Published, hybrid			2022-12-25	WOS:000283354000012
J	Otaki, N; Chikazawa, M; Nagae, R; Shimozu, Y; Shibata, T; Ito, S; Takasaki, Y; Fujii, J; Uchida, K				Otaki, Natsuki; Chikazawa, Miho; Nagae, Ritsuko; Shimozu, Yuki; Shibata, Takahiro; Ito, Sohei; Takasaki, Yoshinari; Fujii, Junichi; Uchida, Koji			Identification of a Lipid Peroxidation Product as the Source of Oxidation-specific Epitopes Recognized by Anti-DNA Autoantibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CELL-SURFACE PROTEIN; MONOCLONAL-ANTIBODY; DSDNA ANTIBODIES; MICHAEL ADDUCTS; B-CELLS; BINDING; EXPRESSION; DISEASE; NEPHRITIS	Lipid peroxidation in tissue and in tissue fractions represents a degradative process, which is the consequence of the production and the propagation of free radical reactions primarily involving membrane polyunsaturated fatty acids, and has been implicated in the pathogenesis of numerous diseases, including systemic lupus erythematosus (SLE). We have found that bovine serum albumin incubated with peroxidized polyunsaturated fatty acids significantly cross-reacted with the sera from MRL-lpr mice, a representative murine model of SLE. To identify the active substances responsible for the generation of autoantigenic epitopes recognized by the SLE sera, we performed the activity-guiding separation of a principal source from 13-hydroperoxy-9Z, 11E-octadecadienoic acid and identified 4-oxo-2-nonenal ( ONE), a highly reactive aldehyde originating from the peroxidation of omega 6 polyunsaturated fatty acids, as the source of the autoantigenic epitopes. When the age-dependent change in the antibody titer against the ONE-modified protein was measured in the sera from MRL-lpr mice and control MRL-MpJ mice, all of the MRL-lpr mice developed an anti-ONE titer, which was comparable with the anti-DNA titer. Strikingly, a subset of the anti-DNA monoclonal antibodies generated from the SLE mice showing recognition specificity toward DNA cross-reacted with the ONE-specific epitopes. Furthermore, these dual-specific antibodies rapidly bound and internalized into living cells. These findings raised the possibility that the enhanced lipid peroxidation followed by the generation of ONE may be involved in the pathogenesis of autoimmune disorders.	[Otaki, Natsuki; Chikazawa, Miho; Nagae, Ritsuko; Shimozu, Yuki; Shibata, Takahiro; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Ito, Sohei] Univ Shizuoka, Sch Food & Nutr Sci, Shizuoka 4228526, Japan; [Takasaki, Yoshinari] Juntendo Univ, Dept Internal Med & Rheumatol, Sch Med, Tokyo 1138421, Japan; [Fujii, Junichi] Yamagata Univ, Grad Sch Med Sci, Yamagata 9909985, Japan	Nagoya University; University of Shizuoka; Juntendo University; Yamagata University	Uchida, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp	Ito, Sohei/M-5930-2019; Shibata, Takahiro/I-6872-2014	Ito, Sohei/0000-0002-9937-3100; Fujii, Junichi/0000-0003-2267-7357; Shibata, Takahiro/0000-0003-3194-607X; Uchida, Koji/0000-0003-3894-5299	Ministry of Education, Culture, Sports, Science, and Technology	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a research grant from the Ministry of Education, Culture, Sports, Science, and Technology.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antone SM, 1997, J IMMUNOL, V159, P5422; BALLARD DW, 1985, J IMMUNOL, V135, P3372; Binder CJ, 2005, SPRINGER SEMIN IMMUN, V26, P385, DOI 10.1007/s00281-004-0185-z; Brash AR, 1996, METHOD ENZYMOL, V272, P250, DOI 10.1016/S0076-6879(96)72030-X; Brown JM, 1999, CANCER RES, V59, P1391; Budhai L, 1996, J CLIN INVEST, V98, P1585, DOI 10.1172/JCI118952; CHAN TM, 1995, CLIN EXP IMMUNOL, V100, P506; Chan TM, 2002, J AM SOC NEPHROL, V13, P1219, DOI 10.1097/01.ASN.0000014223.71109.13; CHEN C, 1994, J IMMUNOL, V152, P1970; CHEN LJ, 1995, CHEM RES TOXICOL, V8, P903, DOI 10.1021/tx00049a001; Deshmukh US, 2006, AUTOIMMUN REV, V5, P414, DOI 10.1016/j.autrev.2005.10.010; Doorn JA, 2002, CHEM RES TOXICOL, V15, P1445, DOI 10.1021/tx025590o; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Foote J, 2003, SCIENCE, V299, P1327, DOI 10.1126/science.1082717; FRANKEL EN, 1983, PROG LIPID RES, V22, P1, DOI 10.1016/0163-7827(83)90002-4; GILKESON GS, 1995, J CLIN INVEST, V95, P1398, DOI 10.1172/JCI117793; HANSEN C, 1996, CLIN EXP RHEUMATOL, V15, P559; Higuchi T, 2002, J IMMUNOL, V168, P9, DOI 10.4049/jimmunol.168.1.9; Iuchi Y, 2009, BIOCHEM J, V422, P313, DOI 10.1042/BJ20090176; JACOB L, 1987, P NATL ACAD SCI USA, V84, P2956, DOI 10.1073/pnas.84.9.2956; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; KATZ JB, 1994, J EXP MED, V180, P925, DOI 10.1084/jem.180.3.925; Kawai Y, 2004, FREE RADICAL BIO MED, V36, P529, DOI 10.1016/j.freeradbiomed.2003.12.006; Kawai Y, 2002, CARCINOGENESIS, V23, P485, DOI 10.1093/carcin/23.3.485; KOFFLER D, 1971, J EXP MED, V134, P294, DOI 10.1084/jem.134.1.294; Kowal C, 1999, EUR J IMMUNOL, V29, P1901, DOI 10.1002/(SICI)1521-4141(199906)29:06<1901::AID-IMMU1901>3.0.CO;2-L; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lee SH, 2000, CHEM RES TOXICOL, V13, P698, DOI 10.1021/tx000101a; LIMPANASITHIKUL W, 1995, J IMMUNOL, V155, P967; Lin D, 2005, CHEM RES TOXICOL, V18, P1219, DOI 10.1021/tx050080q; Oe T, 2003, CHEM RES TOXICOL, V16, P1598, DOI 10.1021/tx034178l; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Pardridge WM, 1998, J PHARMACOL EXP THER, V286, P548; PISETSKY DS, 1990, ARTHRITIS RHEUM, V33, P153, DOI 10.1002/art.1780330202; Pollack M, 2003, CHEM RES TOXICOL, V16, P893, DOI 10.1021/tx030009p; RADIC MZ, 1993, J IMMUNOL, V150, P4966; Rindgen D, 1999, CHEM RES TOXICOL, V12, P1195, DOI 10.1021/tx990034o; Rindgen D, 2000, CHEM RES TOXICOL, V13, P846, DOI 10.1021/tx0000771; SCHWARTZ RS, 1985, J CLIN INVEST, V75, P321, DOI 10.1172/JCI111704; Shimozu Y, 2009, CHEM RES TOXICOL, V22, P957, DOI 10.1021/tx900059k; Song YC, 2008, EUR J IMMUNOL, V38, P3178, DOI 10.1002/eji.200838678; Spatz L, 1997, METHODS, V11, P70, DOI 10.1006/meth.1996.0389; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Toyoda K, 2007, J BIOL CHEM, V282, P25769, DOI 10.1074/jbc.M703039200; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Yocum AK, 2005, J MASS SPECTROM, V40, P754, DOI 10.1002/jms.847; Yung S, 2006, KIDNEY INT, V69, P272, DOI 10.1038/sj.ki.5000042; Yung S, 2005, J AM SOC NEPHROL, V16, P3281, DOI 10.1681/ASN.2004110917; Zhang WH, 2003, CHEM RES TOXICOL, V16, P512, DOI 10.1021/tx020105a; Zhu XC, 2007, CHEM RES TOXICOL, V20, P165, DOI 10.1021/tx600295j	53	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 29	2010	285	44					33834	33842		10.1074/jbc.M110.165175	http://dx.doi.org/10.1074/jbc.M110.165175			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	669MD	20736172	Green Published, hybrid			2022-12-25	WOS:000283354000030
J	Arnold, C; Markovic, M; Blossey, K; Wallukat, G; Fischer, R; Dechend, R; Konkel, A; von Schacky, C; Luft, FC; Muller, DN; Rothe, M; Schunck, WH				Arnold, Cosima; Markovic, Marija; Blossey, Katrin; Wallukat, Gerd; Fischer, Robert; Dechend, Ralf; Konkel, Anne; von Schacky, Clemens; Luft, Friedrich C.; Muller, Dominik N.; Rothe, Michael; Schunck, Wolf-Hagen			Arachidonic Acid-metabolizing Cytochrome P450 Enzymes Are Targets of omega-3 Fatty Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; CORONARY-HEART-DISEASE; SENSITIVE K+ CHANNELS; SUDDEN CARDIAC DEATH; 20-HYDROXYEICOSATETRAENOIC ACID; EICOSAPENTAENOIC-ACID; EPOXYEICOSATRIENOIC ACIDS; EPOXYGENASE METABOLITES; CARDIOVASCULAR-DISEASES; DOCOSAHEXAENOIC ACID	Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) protect against cardiovascular disease by largely unknown mechanisms. We tested the hypothesis that EPA and DHA may compete with arachidonic acid (AA) for the conversion by cytochrome P450 (CYP) enzymes, resulting in the formation of alternative, physiologically active, metabolites. Renal and hepatic microsomes, as well as various CYP isoforms, displayed equal or elevated activities when metabolizing EPA or DHA instead of AA. CYP2C/2J isoforms converting AA to epoxyeicosatrienoic acids (EETs) preferentially epoxidized the omega-3 double bond and thereby produced 17,18-epoxyeicosatetraenoic (17,18-EEQ) and 19,20-epoxydocosapentaenoic acid (19,20-EDP) from EPA and DHA. We found that these omega-3 epoxides are highly active as antiarrhythmic agents, suppressing the Ca2+-induced increased rate of spontaneous beating of neonatal rat cardiomyocytes, at low nanomolar concentrations. CYP4A/4F isoforms omega-hydroxylating AA were less regioselective toward EPA and DHA, catalyzing predominantly omega- and omega minus 1 hydroxylation. Rats given dietary EPA/DHA supplementation exhibited substantial replacement of AA by EPA and DHA in membrane phospholipids in plasma, heart, kidney, liver, lung, and pancreas, with less pronounced changes in the brain. The changes in fatty acids were accompanied by concomitant changes in endogenous CYP metabolite profiles (e. g. altering the EET/EEQ/EDP ratio from 87: 0: 13 to 27: 18: 55 in the heart). These results demonstrate that CYP enzymes efficiently convert EPA and DHA to novel epoxy and hydroxy metabolites that could mediate some of the beneficial cardiovascular effects of dietary omega-3 fatty acids.	[Luft, Friedrich C.; Muller, Dominik N.; Schunck, Wolf-Hagen] Max Delbrueck Ctr Mol Med, D-13125 Berlin, Germany; [Blossey, Katrin; Rothe, Michael] Lipidomix GmbH, D-13125 Berlin, Germany; [Fischer, Robert; Dechend, Ralf; Luft, Friedrich C.] Fac Med Charite, Expt & Clin Res Ctr, D-13125 Berlin, Germany; [von Schacky, Clemens] Omegametrix GmbH, D-82152 Martinsried, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schunck, WH (corresponding author), Max Delbrueck Ctr Mol Med, Robert Roessle Str 10, D-13125 Berlin, Germany.	schunck@mdc-berlin.de		Luft, Friedrich/0000-0002-8635-1199; Muller, Dominik N/0000-0003-3650-5644	Deutsche Forschungsgemeinschaft [SCHU822/5, FOR1054]; Solvay Arzneimittel GmbH	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Solvay Arzneimittel GmbH(Solvay SA)	This work was supported in part by grants SCHU822/5 and FOR1054 from the Deutsche Forschungsgemeinschaft (to D.N.M. and W.-H.S.). The animal studies were supported by Solvay Arzneimittel GmbH.	Barbosa-Sicard E, 2005, BIOCHEM BIOPH RES CO, V329, P1275, DOI 10.1016/j.bbrc.2005.02.103; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Campbell WB, 2007, HYPERTENSION, V49, P590, DOI 10.1161/01.HYP.0000255173.50317.fc; Capdevila JH, 2007, KIDNEY INT, V72, P683, DOI 10.1038/sj.ki.5002394; Capdevila JH, 2000, J LIPID RES, V41, P163; CAPDEVILA JH, 1990, METHOD ENZYMOL, V187, P385; Capdevila JH, 2002, PROSTAG OTH LIPID M, V68-9, P325, DOI 10.1016/S0090-6980(02)00038-2; Carroll MA, 1997, KIDNEY INT, V51, P1696, DOI 10.1038/ki.1997.234; Chapkin RS, 2008, BRIT J NUTR, V100, P1152, DOI 10.1017/S0007114508992576; Chen CT, 2009, PROSTAG LEUKOTR ESS, V80, P157, DOI 10.1016/j.plefa.2009.01.005; Cheng J, 2008, AM J PHYSIOL-HEART C, V294, pH1018, DOI 10.1152/ajpheart.01172.2007; Deckelbaum RJ, 2006, AM J CLIN NUTR, V83, p1520S, DOI 10.1093/ajcn/83.6.1520S; FALCK JR, 1990, METHOD ENZYMOL, V187, P357; Fer M, 2008, J LIPID RES, V49, P2379, DOI 10.1194/jlr.M800199-JLR200; Fer M, 2008, ARCH BIOCHEM BIOPHYS, V471, P116, DOI 10.1016/j.abb.2008.01.002; Fischer R, 2008, HYPERTENSION, V51, P540, DOI 10.1161/HYPERTENSIONAHA.107.103143; Fleming I, 2008, TRENDS CARDIOVAS MED, V18, P20, DOI 10.1016/j.tcm.2007.11.002; Gainer JV, 2005, CIRCULATION, V111, P63, DOI 10.1161/01.CIR.0000151309.82473.59; Gao F, 2009, J LIPID RES, V50, P749, DOI 10.1194/jlr.D800056-JLR200; Gross ER, 2004, J MOL CELL CARDIOL, V37, P1245, DOI 10.1016/j.yjmcc.2004.10.008; Harder DR, 1998, STROKE, V29, P229, DOI 10.1161/01.STR.29.1.229; Harmon SD, 2006, PROSTAG LEUKOTR ESS, V75, P169, DOI 10.1016/j.plefa.2006.05.005; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hercule HC, 2007, EXP PHYSIOL, V92, P1067, DOI 10.1113/expphysiol.2007.038166; Iliff JJ, 2009, FUTUR NEUROL, V4, P179, DOI 10.2217/14796708.4.2.179; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Jiang H, 2007, BRIT J PHARMACOL, V151, P1033, DOI 10.1038/sj.bjp.0707311; Jiang HL, 2007, PROSTAG OTH LIPID M, V82, P4, DOI 10.1016/j.prostaglandins.2006.05.013; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Kaduce TL, 2004, J BIOL CHEM, V279, P2648, DOI 10.1074/jbc.M306849200; Kaergel E, 2002, HYPERTENSION, V40, P273, DOI 10.1161/01.HYP.0000029240.44253.5E; KANG JX, 1994, P NATL ACAD SCI USA, V91, P9886, DOI 10.1073/pnas.91.21.9886; KARARA A, 1992, BIOCHEM BIOPH RES CO, V182, P1320, DOI 10.1016/0006-291X(92)91877-S; KARARA A, 1991, J BIOL CHEM, V266, P7561; Karlgren M, 2004, BIOCHEM BIOPH RES CO, V315, P679, DOI 10.1016/j.bbrc.2004.01.110; Kim HY, 2007, J BIOL CHEM, V282, P18661, DOI 10.1074/jbc.R700015200; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Kroetz DL, 2005, ANNU REV PHARMACOL, V45, P413, DOI 10.1146/annurev.pharmtox.45.120403.100045; Kulas J, 2008, ARCH BIOCHEM BIOPHYS, V472, P65, DOI 10.1016/j.abb.2008.02.002; Laffer CL, 2003, CIRCULATION, V107, P574, DOI 10.1161/01.CIR.0000046269.52392.14; Lauterbach B, 2002, HYPERTENSION, V39, P609, DOI 10.1161/hy0202.103293; Lavie CJ, 2009, J AM COLL CARDIOL, V54, P585, DOI 10.1016/j.jacc.2009.02.084; Leaf A, 2003, CIRCULATION, V107, P2646, DOI 10.1161/01.CIR.0000069566.78305.33; Lu T, 2002, MOL PHARMACOL, V62, P1076, DOI 10.1124/mol.62.5.1076; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; McGiff JC, 1999, AM J PHYSIOL-REG I, V277, pR607, DOI 10.1152/ajpregu.1999.277.3.R607; Minuz P, 2008, HYPERTENSION, V51, P1379, DOI 10.1161/HYPERTENSIONAHA.107.105395; Miyata Noriyuki, 2005, Journal of Smooth Muscle Research, V41, P175, DOI 10.1540/jsmr.41.175; MORIN C, 2009, AM J RESP CELL MOL B; Morin C, 2009, AM J PHYSIOL-LUNG C, V296, pL130, DOI 10.1152/ajplung.90436.2008; Mozaffarian D, 2008, AM J CLIN NUTR, V87, p1991S, DOI 10.1093/ajcn/87.6.1991S; Muller DN, 2007, BIOCHEM J, V403, P109, DOI 10.1042/BJ20061328; Nithipatikom K, 2004, CIRC RES, V95, pE65, DOI 10.1161/01.RES.0000146277.62128.6f; OMURA T, 1964, J BIOL CHEM, V239, P2370; Rapoport SI, 2008, PROSTAG LEUKOTR ESS, V79, P153, DOI 10.1016/j.plefa.2008.09.010; Rivera J, 2004, CLIN CHEM, V50, P224, DOI 10.1373/clinchem.2003.025775; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Schwarz D, 2005, BIOCHEM BIOPH RES CO, V336, P779, DOI 10.1016/j.bbrc.2005.08.172; Schwarz D, 2004, BIOCHEM PHARMACOL, V67, P1445, DOI 10.1016/j.bcp.2003.12.023; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Seubert J, 2004, CIRC RES, V95, P506, DOI 10.1161/01.RES.0000139436.89654.c8; Seubert JM, 2007, PROSTAG OTH LIPID M, V82, P50, DOI 10.1016/j.prostaglandins.2006.05.017; Shearer GC, 2009, CURR ATHEROSCLER REP, V11, P403, DOI 10.1007/s11883-009-0061-3; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Spiecker M, 2004, CIRCULATION, V110, P2132, DOI 10.1161/01.CIR.0000143832.91812.60; Stark K, 2005, ARCH BIOCHEM BIOPHYS, V441, P174, DOI 10.1016/j.abb.2005.07.003; VANROLLINS M, 1990, LIPIDS, V25, P481, DOI 10.1007/BF02538092; VANROLLINS M, 1988, BIOCHIM BIOPHYS ACTA, V966, P133, DOI 10.1016/0304-4165(88)90137-7; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Wallukat G, 2010, J AM COLL CARDIOL, V55, P463, DOI 10.1016/j.jacc.2009.06.064; Ward NC, 2005, FREE RADICAL BIO MED, V38, P1032, DOI 10.1016/j.freeradbiomed.2004.12.024; Wu S, 1996, J BIOL CHEM, V271, P3460; Xiao YF, 2005, J MEMBRANE BIOL, V206, P141, DOI 10.1007/S00232-005-0786-Z; Yang WQ, 2008, J PHARMACOL EXP THER, V324, P1019, DOI 10.1124/jpet.107.129577; Ye D, 2002, J PHARMACOL EXP THER, V303, P768, DOI 10.1124/jpet.303.2.768; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Zhang YD, 2001, AM J PHYSIOL-HEART C, V280, pH2430, DOI 10.1152/ajpheart.2001.280.6.H2430	79	283	291	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 22	2010	285	43					32720	32733		10.1074/jbc.M110.118406	http://dx.doi.org/10.1074/jbc.M110.118406			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	665PP	20732876	Green Published, hybrid			2022-12-25	WOS:000283048200007
J	Oesch, NW; Taylor, WR				Oesch, Nicholas W.; Taylor, W. Rowland			Tetrodotoxin-Resistant Sodium Channels Contribute to Directional Responses in Starburst Amacrine Cells	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; RECEPTIVE-FIELD PROPERTIES; DORSAL-ROOT GANGLIA; RABBIT RETINA; ACTION-POTENTIALS; NA+ CHANNELS; MOUSE RETINA; SELECTIVITY; INHIBITION; CURRENTS	The biophysical mechanisms that give rise to direction selectivity in the retina remain uncertain. Current evidence suggests that the directional signal first arises within the dendrites of starburst amacrine cells (SBACs). Two models have been proposed to explain this phenomenon, one based on mutual inhibitory interactions between SBACs, and the other positing an intrinsic dendritic mechanism requiring a voltage-gradient depolarizing towards the dendritic tips. We tested these models by recording current and voltage responses to visual stimuli in SBACs. In agreement with previous work, we found that the excitatory currents in the SBACs were directional, and remained directional when GABA receptors were blocked. Contrary to the mutual-inhibitory model, stimuli that produce strong directional signals in ganglion cells failed to reveal a significant inhibitory input to SBACs. Suppression of the tonic excitatory conductance, proposed to generate the dendritic voltage-gradient required for the dendrite autonomous model, failed to eliminate the directional signal in SBACs. However, selective block of tetrodotoxin-resistant sodium channels did reduce the strength of the directional excitatory signal in the SBACs. These results indicate that current models of direction-selectivity in the SBACs are inadequate, and suggest that voltage-gated excitatory channels, specifically tetrodotoxin-resistant sodium channels, are important elements in directional signaling. This is the first physiological evidence that tetrodotoxin-resistant sodium channels play a role in retinal information processing.	[Oesch, Nicholas W.] Oregon Hlth & Sci Univ, Grad Program Neurosci, Portland, OR 97201 USA; [Taylor, W. Rowland] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Oesch, NW (corresponding author), Oregon Hlth & Sci Univ, Grad Program Neurosci, Portland, OR 97201 USA.	oeschn@ninds.nih.gov		Oesch, Nicholas/0000-0001-6972-0741; Taylor, William/0000-0002-6806-3249	National Institutes of Health [EY014888]; NATIONAL EYE INSTITUTE [R01EY014888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grant EY014888 (WRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; Amthor FR, 2002, VISUAL NEUROSCI, V19, P495, DOI 10.1017/S0952523802194119; BLOOMFIELD SA, 1992, J NEUROPHYSIOL, V68, P711, DOI 10.1152/jn.1992.68.3.711; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P277, DOI 10.1113/jphysiol.1978.sp012233; Chiao CC, 2002, J NEUROSCI, V22, P10509; Cohen ED, 2001, VISUAL NEUROSCI, V18, P799, DOI 10.1017/S0952523801185135; COHEN ED, 1995, P NATL ACAD SCI USA, V92, P1127, DOI 10.1073/pnas.92.4.1127; Cook PB, 1998, J NEUROSCI, V18, P2301; Cummins TR, 1997, J NEUROSCI, V17, P3503; DODT HU, 2002, SCI STKE, pPL2; ELLIAS SA, 1980, BRAIN RES, V196, P365, DOI 10.1016/0006-8993(80)90401-1; ELLIOTT AA, 1993, J PHYSIOL-LONDON, V463, P39, DOI 10.1113/jphysiol.1993.sp019583; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gavrikov KE, 2003, P NATL ACAD SCI USA, V100, P16047, DOI 10.1073/pnas.2637041100; Gavrikov KE, 2006, P NATL ACAD SCI USA, V103, P18793, DOI 10.1073/pnas.0604551103; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; JENSEN RJ, 1995, VISUAL NEUROSCI, V12, P177, DOI 10.1017/S0952523800007409; JENSEN RJ, 1995, J NEUROPHYSIOL, V74, P12, DOI 10.1152/jn.1995.74.1.12; Kaneda M, 2007, J NEUROPHYSIOL, V97, P4225, DOI 10.1152/jn.01022.2006; Kittila CA, 1997, J NEUROPHYSIOL, V77, P675, DOI 10.1152/jn.1997.77.2.675; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; Leffler A, 2005, PFLUG ARCH EUR J PHY, V451, P454, DOI 10.1007/s00424-005-1463-x; MILLER RF, 1983, P NATL ACAD SCI-BIOL, V80, P3069, DOI 10.1073/pnas.80.10.3069; O'Brien BJ, 2008, J COMP NEUROL, V508, P940, DOI 10.1002/cne.21701; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; OGATA N, 1993, J PHYSIOL-LONDON, V466, P9; Ozaita A, 2004, J NEUROSCI, V24, P7335, DOI 10.1523/JNEUROSCI.1275-04.2004; Pan ZH, 2000, J NEUROPHYSIOL, V84, P2564, DOI 10.1152/jn.2000.84.5.2564; Peters BN, 1996, J NEUROPHYSIOL, V75, P469, DOI 10.1152/jn.1996.75.1.469; POZNANSKI RR, 1992, B MATH BIOL, V54, P905; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; Shields CR, 2003, J NEUROPHYSIOL, V89, P2449, DOI 10.1152/jn.00916.2002; SPRUSTON N, 1994, TRENDS NEUROSCI, V17, P161, DOI 10.1016/0166-2236(94)90094-9; Sunami A, 2000, P NATL ACAD SCI USA, V97, P2326, DOI 10.1073/pnas.030438797; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; TAYLOR WR, 1995, EUR J NEUROSCI, V7, P2308, DOI 10.1111/j.1460-9568.1995.tb00652.x; Taylor WR, 1999, VISUAL NEUROSCI, V16, P285, DOI 10.1017/S0952523899162096; Taylor WR, 2002, J NEUROSCI, V22, P7712; Tukker JJ, 2004, VISUAL NEUROSCI, V21, P611, DOI 10.1017/S0952523804214109; VANEY DI, 1994, J NEUROSCI, V14, P6301; Velte TJ, 1997, VISUAL NEUROSCI, V14, P1073, DOI 10.1017/S0952523800011780; Weiser T, 2002, MOL PHARMACOL, V62, P433, DOI 10.1124/mol.62.3.433; WYATT HJ, 1976, SCIENCE, V191, P204, DOI 10.1126/science.1857; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zenisek D, 2001, J NEUROSCI, V21, P4543, DOI 10.1523/JNEUROSCI.21-13-04543.2001; Zheng JJ, 2004, NEURON, V44, P851, DOI 10.1016/j.neuron.2004.11.015; Zhou ZJ, 1996, P NATL ACAD SCI USA, V93, P8057, DOI 10.1073/pnas.93.15.8057	50	40	40	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12447	10.1371/journal.pone.0012447	http://dx.doi.org/10.1371/journal.pone.0012447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805982	Green Published, gold, Green Submitted			2022-12-25	WOS:000281301500013
J	Pugach, P; Krarup, A; Gettie, A; Kuroda, M; Blanchard, J; Piatak, M; Lifson, JD; Trkola, A; Robbiani, M				Pugach, Pavel; Krarup, Anders; Gettie, Agegnehu; Kuroda, Marcelo; Blanchard, James; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Trkola, Alexandra; Robbiani, Melissa			In Vivo Binding and Retention of CD4-Specific DARPin 57.2 in Macaques	PLOS ONE			English	Article							ANKYRIN REPEAT PROTEINS; ANTI-CD4 MONOCLONAL-ANTIBODY; ANTIRETROVIRAL ACTIVITY; VIRUS; LYMPHOCYTES; SELECTION; EFFICACY; TNX-355; TYPE-1	Background: The recently described Designed Ankyrin Repeat Protein (DARPin) technology can produce highly selective ligands to a variety of biological targets at a low production cost. Methodology/Principal Findings: To investigate the in vivo use of DARPins for future application to novel anti-HIV strategies, we identified potent CD4-specific DARPins that recognize rhesus CD4 and followed the fate of intravenously injected CD4-specific DARPin 57.2 in rhesus macaques. The human CD4-specific DARPin 57.2 bound macaque CD4(+) cells and exhibited potent inhibitory activity against SIV infection in vitro. DARPin 57.2 or the control E3_5 DARPin was injected into rhesus macaques and the fate of cell-free and cell-bound CD4-specific DARPin was evaluated. DARPin-bound CD4(+) cells were detected in the peripheral blood as early as 30 minutes after the injection, decreasing within 6 hours and being almost undetectable within 24 hours. The amount of DARPin bound was dependent on the amount of DARPin injected. CD4-specific DARPin was also detected on CD4(+) cells in the lymph nodes within 30 minutes, which persisted with similar kinetics to blood. More extensive analysis using blood revealed that DARPin 57.2 bound to all CD4(+) cell types (T cells, monocytes, dendritic cells) in vivo and in vitro with the amount of binding directly proportional to the amount of CD4 on the cell surface. Cell-free DARPins were also detected in the plasma, but were rapidly cleared from circulation. Conclusions/Significance: We demonstrated that the CD4-specific DARPin can rapidly and selectively bind its target cells in vivo, warranting further studies on possible clinical use of the DARPin technology.	[Pugach, Pavel; Robbiani, Melissa] Populat Council, Ctr Biomed Res, New York, NY 10021 USA; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Krarup, Anders; Trkola, Alexandra] Univ Zurich Hosp, Div Infect Dis, CH-8091 Zurich, Switzerland; [Kuroda, Marcelo; Blanchard, James] Tulane Univ, Hlth Sci Ctr, Tulane Natl Primate Res Ctr, Covington, LA USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] SAIC Frederick Inc, AIDS & Canc Virus Program, Natl Canc Inst, Frederick, MD USA	Population Council; Rockefeller University; University of Zurich; University Zurich Hospital; Tulane University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Pugach, P (corresponding author), Populat Council, Ctr Biomed Res, 1230 York Ave, New York, NY 10021 USA.	mrobbiani@popcouncil.org	Trkola, Alexandra/K-2115-2012	Trkola, Alexandra/0000-0003-1013-876X	Campbell Foundation; National Institutes of Health (NIH) [AI040877, AI084133]; National Cancer Institute, NIH [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084133, R37AI040877, R01AI040877] Funding Source: NIH RePORTER	Campbell Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Campbell Foundation, by National Institutes of Health (NIH) grants AI040877 and AI084133 and in part with federal funds from the National Cancer Institute, NIH, under contract HHSN261200800001E. PP is an F.M. Kirby Foundation fellow. MR is a 2002 and AT is a 2006 Elizabeth Glaser Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Cline AN, 2005, J MED PRIMATOL, V34, P303; Crostarosa F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008060; Jacobson JM, 2009, ANTIMICROB AGENTS CH, V53, P450, DOI 10.1128/AAC.00942-08; Krzywda S, 2004, J BIOL CHEM, V279, P1541, DOI 10.1074/jbc.M310265200; Kuritzkes DR, 2004, J INFECT DIS, V189, P286, DOI 10.1086/380802; Milovnik P, 2009, PROTEIN ENG DES SEL, V22, P357, DOI 10.1093/protein/gzp011; MOREL P, 1993, MOL IMMUNOL, V30, P649, DOI 10.1016/0161-5890(93)90076-N; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Patterson S, 2001, J VIROL, V75, P6710, DOI 10.1128/JVI.75.14.6710-6713.2001; Pugach P, 2004, VIROLOGY, V321, P8, DOI 10.1016/j.virol.2003.12.012; Reimann KA, 1997, AIDS RES HUM RETROV, V13, P933, DOI 10.1089/aid.1997.13.933; Schweizer A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000109; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Stumpp MT, 2007, CURR OPIN DRUG DISC, V10, P153; Teleshova N, 2006, J IMMUNOL, V177, P8531, DOI 10.4049/jimmunol.177.12.8531; Turville SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003162; *UDOHAHS, 1985, GUID CAR US LAB AN, P1; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; Veesler D, 2009, J BIOL CHEM, V284, P30718, DOI 10.1074/jbc.M109.037812; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Zahnd C, 2006, J BIOL CHEM, V281, P35167, DOI 10.1074/jbc.M602547200; Zahnd C, 2010, CANCER RES, V70, P1595, DOI 10.1158/0008-5472.CAN-09-2724	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12455	10.1371/journal.pone.0012455	http://dx.doi.org/10.1371/journal.pone.0012455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805996	Green Published, gold, Green Submitted			2022-12-25	WOS:000281301500021
J	Raghu, H; Lakka, SS; Gondi, CS; Mohanam, S; Dinh, DH; Gujrati, M; Rao, JS				Raghu, Hari; Lakka, Sajani S.; Gondi, Christopher S.; Mohanam, Sanjeeva; Dinh, Dzung H.; Gujrati, Meena; Rao, Jasti S.			Suppression of uPA and uPAR Attenuates Angiogenin Mediated Angiogenesis in Endothelial and Glioblastoma Cell Lines	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; RIBOSOMAL-RNA TRANSCRIPTION; DOWN-REGULATION; SPARC EXPRESSION; GENE-EXPRESSION; TUMOR-GROWTH; INHIBITS ANGIOGENESIS; UROKINASE RECEPTOR; INDUCED MIGRATION; GASTRIC-CANCER	Background: In our earlier reports, we showed that downregulation of uPA and uPAR inhibited glioma tumor angiogenesis in SNB19 cells, and intraperitoneal injection of a hairpin shRNA expressing plasmid targeting uPA and uPAR inhibited angiogenesis in nude mice. The exact mechanism by which inhibition of angiogenesis takes place is not clearly understood. Methodology/Principal Findings: In the present study, we have attempted to investigate the mechanism by which uPA/uPAR downregulation by shRNA inhibits angiogenesis in endothelial and glioblastoma cell lines. uPA/uPAR downregulation by shRNA in U87 MG and U87 SPARC co-cultures with endothelial cells inhibited angiogenesis as assessed by in vitro angiogenesis assay and in vivo dorsal skin-fold chamber model in nude mice. Protein antibody array analysis of co-cultures of U87 and U87 SPARC cells with endothelial cells treated with pU2 (shRNA against uPA and uPAR) showed decreased angiogenin secretion and angiopoietin-1 as well as several other pro-angiogenic molecules. Therefore, we investigated the role of angiogenin and found that nuclear translocation, ribonucleolytic and 45S rRNA synthesis, which are all critical for angiogenic function of angiogenin, were significantly inhibited in endothelial cells transfected with uPA, uPAR and uPA/uPAR when compared with controls. Moreover, uPA and uPAR downregulation significantly inhibited the phosphorylation of Tie-2 receptor and also down regulated FKHR activation in the nucleus of endothelial cells via the GRB2/AKT/BAD pathway. Treatment of endothelial cells with ruPA increased angiogenin secretion and angiogenin expression as determined by ELISA and western blotting in a dose-dependent manner. The amino terminal fragment of uPA down regulated ruPA-induced angiogenin in endothelial cells, thereby suggesting that uPA plays a critical role in positively regulating angiogenin in glioblastoma cells. Conclusions/Significance: Taken together, our results suggest that uPA/uPAR downregulation suppresses angiogenesis in endothelial cells induced by glioblastoma cell lines partially by downregulation of angiogenin and by inhibition of the angiopoietin-1/AKT/FKHR pathway.	[Raghu, Hari; Lakka, Sajani S.; Gondi, Christopher S.; Mohanam, Sanjeeva; Rao, Jasti S.] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA; [Gujrati, Meena] Univ Illinois, Coll Med, Dept Pathol, Peoria, IL 61656 USA; [Dinh, Dzung H.; Rao, Jasti S.] Univ Illinois, Coll Med, Dept Neurosurg, Peoria, IL 61656 USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Raghu, H (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA.	jsrao@uic.edu		Gondi, Christopher/0000-0002-3036-9920	National Institutes of Health (NIH) [CA 75557]; NATIONAL CANCER INSTITUTE [R01CA075557] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a grant from National Institutes of Health (NIH), CA 75557 (to J.S.R.). The contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behzadian MA, 2003, FASEB J, V17, P752, DOI 10.1096/fj.02-0484fje; Birkenkamp KU, 2003, BIOCHEM SOC T, V31, P292, DOI 10.1042/bst0310292; Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082; Chandrasekar N, 2003, ONCOGENE, V22, P392, DOI 10.1038/sj.onc.1206164; Fryer BH, 2005, CANCER LETT, V229, P13, DOI 10.1016/j.canlet.2004.12.009; Gladson CL, 1999, J NEUROPATH EXP NEUR, V58, P1029, DOI 10.1097/00005072-199910000-00001; Golembieski WA, 2002, J NEURO-ONCOL, V60, P213, DOI 10.1023/A:1021167211131; Golembieski WA, 1999, INT J DEV NEUROSCI, V17, P463, DOI 10.1016/S0736-5748(99)00009-X; Gondi CS, 2007, CLIN CANCER RES, V13, P4051, DOI 10.1158/1078-0432.CCR-06-3032; Gondi CS, 2004, CANCER RES, V64, P4069, DOI 10.1158/0008-5472.CAN-04-1243; Gourse RL, 1996, ANNU REV MICROBIOL, V50, P645, DOI 10.1146/annurev.micro.50.1.645; Hanahan D, 1996, EUR J CANCER, V32A, P2386, DOI 10.1016/S0959-8049(96)00401-7; Hu GF, 1998, P NATL ACAD SCI USA, V95, P9791, DOI 10.1073/pnas.95.17.9791; Jo M, 2002, J BIOL CHEM, V277, P12479, DOI 10.1074/jbc.M111147200; Kaneko T, 2003, CANCER SCI, V94, P43, DOI 10.1111/j.1349-7006.2003.tb01350.x; Kargiotis O, 2008, INT J ONCOL, V33, P937, DOI 10.3892/ijo_00000081; Kim CK, 2007, CANCER SCI, V98, P253, DOI 10.1111/j.1349-7006.2006.00378.x; Kishimoto K, 2005, ONCOGENE, V24, P445, DOI 10.1038/sj.onc.1208223; Kunigal S, 2006, INT J ONCOL, V29, P1349; LEUNIG M, 1992, CANCER RES, V52, P6553; Liotta LA, 1996, J CLIN INVEST, V97, P273, DOI 10.1172/JCI118412; Marron MB, 2000, ADV EXP MED BIOL, V476, P35; Mohan PM, 1999, CLIN EXP METASTAS, V17, P617, DOI 10.1023/A:1006779902978; Mohanam S, 2002, ONCOGENE, V21, P7824, DOI 10.1038/sj.onc.1205893; Mohanam S, 2001, CLIN CANCER RES, V7, P2519; Mohanam Sanjeeva, 1999, Frontiers in Bioscience, V4, pD178, DOI 10.2741/Mohanam; MURPHY G, 1992, ANN NY ACAD SCI, V667, P1, DOI 10.1111/j.1749-6632.1992.tb51590.x; Ou XL, 2009, WORLD J GASTROENTERO, V15, P5432, DOI 10.3748/wjg.15.5432; Papapetropoulos A, 1999, LAB INVEST, V79, P213; PYKE C, 1991, AM J PATHOL, V138, P1059; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Sakai N, 2001, HUM PATHOL, V32, P1064, DOI 10.1053/hupa.2001.28244; Seno T, 2009, INT J ONCOL, V34, P707, DOI 10.3892/ijo_00000197; SHAPIRO R, 1987, P NATL ACAD SCI USA, V84, P8783, DOI 10.1073/pnas.84.24.8783; Shi Q, 2007, ONCOGENE, V26, P4084, DOI 10.1038/sj.onc.1210181; Shimoyama S, 1999, CLIN CANCER RES, V5, P1125; Subramanian R, 2006, INT J ONCOL, V28, P831; Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468; Tsuji T, 2005, CANCER RES, V65, P1352, DOI 10.1158/0008-5472.CAN-04-2058; Weber CC, 2005, J BIOL CHEM, V280, P22445, DOI 10.1074/jbc.M410367200; WEI Y, 1994, J BIOL CHEM, V269, P32380; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wiedlocha Antoni, 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P299; Xu ZP, 2003, BIOCHEMISTRY-US, V42, P121, DOI 10.1021/bi020465x; YAMAMOTO M, 1994, CANCER RES, V54, P5016; Yamanaka M, 2001, J UROLOGY, V166, P2495, DOI 10.1016/S0022-5347(05)65623-6; Yoshioka N, 2006, P NATL ACAD SCI USA, V103, P14519, DOI 10.1073/pnas.0606708103; Zhang JC, 2000, FASEB J, V14, P2589, DOI 10.1096/fj.99-1025com	50	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12458	10.1371/journal.pone.0012458	http://dx.doi.org/10.1371/journal.pone.0012458			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20805979	Green Submitted, Green Published, gold			2022-12-25	WOS:000281301500024
J	Shaffer, MH; Huang, YP; Corbo, E; Wu, GF; Velez, M; Choi, JK; Saotome, I; Cannon, JL; McClatchey, AI; Sperling, AI; Maltzman, JS; Oliver, PM; Bhandoola, A; Laufer, TM; Burkhardt, JK				Shaffer, Meredith H.; Huang, Yanping; Corbo, Evann; Wu, Gregory F.; Velez, Marielena; Choi, John K.; Saotome, Ichiko; Cannon, Judy L.; McClatchey, Andrea I.; Sperling, Anne I.; Maltzman, Jonathan S.; Oliver, Paula M.; Bhandoola, Avinash; Laufer, Terri M.; Burkhardt, Janis K.			Ezrin Is Highly Expressed in Early Thymocytes, but Dispensable for T Cell Development in Mice	PLOS ONE			English	Article							IMMUNOLOGICAL SYNAPSE; ERM PROTEINS; MOESIN; RADIXIN; CYTOSKELETON; LYMPHOCYTES; DEFECTS; CD43; MICROVILLI; KNOCKOUT	Background: Ezrin/radixin/moesin (ERM) proteins are highly homologous proteins that function to link cargo molecules to the actin cytoskeleton. Ezrin and moesin are both expressed in mature lymphocytes, where they play overlapping roles in cell signaling and polarity, but their role in lymphoid development has not been explored. Methodology/Principal Findings: We characterized ERM protein expression in lymphoid tissues and analyzed the requirement for ezrin expression in lymphoid development. In wildtype mice, we found that most cells in the spleen and thymus express both ezrin and moesin, but little radixin. ERM protein expression in the thymus was differentially regulated, such that ezrin expression was highest in immature thymocytes and diminished during T cell development. In contrast, moesin expression was low in early thymocytes and upregulated during T cell development. Mice bearing a germline deletion of ezrin exhibited profound defects in the size and cellularity of the spleen and thymus, abnormal thymic architecture, diminished hematopoiesis, and increased proportions of granulocytic precursors. Further analysis using fetal liver chimeras and thymic transplants showed that ezrin expression is dispensable in hematopoietic and stromal lineages, and that most of the defects in lymphoid development in ezrin(-/-) mice likely arise as a consequence of nutritional stress. Conclusions/Significance: We conclude that despite high expression in lymphoid precursor cells, ezrin is dispensable for lymphoid development, most likely due to redundancy with moesin.	[Shaffer, Meredith H.; Huang, Yanping; Choi, John K.; Oliver, Paula M.; Burkhardt, Janis K.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Shaffer, Meredith H.; Huang, Yanping; Choi, John K.; Oliver, Paula M.; Burkhardt, Janis K.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Shaffer, Meredith H.; Huang, Yanping; Velez, Marielena; Choi, John K.; Oliver, Paula M.; Bhandoola, Avinash; Burkhardt, Janis K.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Corbo, Evann; Maltzman, Jonathan S.; Laufer, Terri M.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Wu, Gregory F.] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Saotome, Ichiko; McClatchey, Andrea I.] Massachusetts Gen Hosp, Ctr Canc, Dept Pathol, Charlestown, MA USA; [Saotome, Ichiko; McClatchey, Andrea I.] Harvard Univ, Sch Med, Charlestown, MA USA; [Cannon, Judy L.; Sperling, Anne I.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Harvard University; Massachusetts General Hospital; Harvard University; University of Chicago	Shaffer, MH (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	jburkhar@mail.med.upenn.edu	Sperling, Anne/ACZ-2351-2022; Shaffer, Meredith/N-5984-2017; Choi, John Kim/N-7558-2018	Choi, John Kim/0000-0002-2861-0180; Burkhardt, Janis/0000-0002-8176-1375; Sperling, Anne I./0000-0002-4265-9212; Cannon, Judy/0000-0003-0069-8106; Shaffer, Meredith/0000-0002-6982-7968	National Institutes of Health (NIH) [R01 AI50098, P01 CA093615, T32-HD07516-09, T32-GM7229-29]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA093615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093566, R01AI050098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (http://www.nih.gov) grants R01 AI50098 and P01 CA093615 (to J.K.B.) and by NIH training grants T32-HD07516-09 and T32-GM7229-29 (to M. H. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenspach EJ, 2001, IMMUNITY, V15, P739, DOI 10.1016/S1074-7613(01)00224-2; Bonilha VL, 2006, EXP EYE RES, V82, P720, DOI 10.1016/j.exer.2005.09.013; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Brown MJ, 2003, BLOOD, V102, P3890, DOI 10.1182/blood-2002-12-3807; Cullinan P, 2002, IMMUNOL REV, V189, P111, DOI 10.1034/j.1600-065X.2002.18910.x; Delon J, 2001, IMMUNITY, V15, P691, DOI 10.1016/S1074-7613(01)00231-X; Doi Y, 1999, J BIOL CHEM, V274, P2315, DOI 10.1074/jbc.274.4.2315; Elmore SA, 2006, TOXICOL PATHOL, V34, P656, DOI 10.1080/01926230600865556; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Garcia GG, 2007, J IMMUNOL, V179, P6403, DOI 10.4049/jimmunol.179.10.6403; Ilani T, 2007, J CELL BIOL, V179, P733, DOI 10.1083/jcb.200707199; Ivetic A, 2002, J BIOL CHEM, V277, P2321, DOI 10.1074/jbc.M109460200; Kikuchi S, 2002, NAT GENET, V31, P320, DOI 10.1038/ng905; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Langbein L, 2003, EUR J CELL BIOL, V82, P385, DOI 10.1078/0171-9335-00330; Lozupone F, 2004, J BIOL CHEM, V279, P9199, DOI 10.1074/jbc.M305561200; LUNDBERG K, 1991, BIOCHEM BIOPH RES CO, V178, P16, DOI 10.1016/0006-291X(91)91773-6; MCPHEE SJ, 2006, PATHOPHYSIOLOGY DIS, pR9; MILLER JFA, 1959, NATURE, V184, P1809, DOI 10.1038/1841809a0; OKAYAMA T, 2008, BIOCH BIOPHYS ACTA; Parlato S, 2000, EMBO J, V19, P5123, DOI 10.1093/emboj/19.19.5123; Potter DA, 1998, J CELL BIOL, V141, P647, DOI 10.1083/jcb.141.3.647; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; SATO N, 1992, J CELL SCI, V103, P131; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Shaffer MH, 2009, J IMMUNOL, V182, P1021, DOI 10.4049/jimmunol.182.2.1021; Shcherbina A, 1999, FEBS LETT, V443, P31, DOI 10.1016/S0014-5793(98)01674-3; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295	30	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2010	5	8							e12404	10.1371/journal.pone.0012404	http://dx.doi.org/10.1371/journal.pone.0012404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	643MT	20806059	Green Published, Green Submitted, gold			2022-12-25	WOS:000281301500005
J	Gao, X; Wang, ZY; Martin, J; Abubucker, S; Zhang, X; Mitreva, M; Hawdon, JM				Gao, Xin; Wang, Zhengyuan; Martin, John; Abubucker, Sahar; Zhang, Xu; Mitreva, Makedonka; Hawdon, John M.			Identification of Hookworm DAF-16/FOXO Response Elements and Direct Gene Targets	PLOS ONE			English	Article							DNA-BINDING-SITES; AGE-1 PI3 KINASE; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; ANCYLOSTOMA-CANINUM; CRYSTAL-STRUCTURE; LIFE-SPAN; PROTEIN; LONGEVITY; DIAPAUSE	Background: The infective stage of the parasitic nematode hookworm is developmentally arrested in the environment and needs to infect a specific host to complete its life cycle. The canine hookworm (Ancylostoma caninum) is an excellent model for investigating human hookworm infections. The transcription factor of A. caninum, Ac-DAF-16, which has a characteristic fork head or "winged helix" DNA binding domain (DBD), has been implicated in the resumption of hookworm development in the host. However, the precise roles of Ac-DAF-16 in hookworm parasitism and its downstream targets are unknown. In the present study, we combined molecular techniques and bioinformatics to identify a group of Ac-DAF-16 binding sites and target genes. Methodology/Principal Findings: The DNA binding domain of Ac-DAF-16 was used to select genomic fragments by in vitro genomic selection. Twenty four bound genomic fragments were analyzed for the presence of the DAF-16 family binding element (DBE) and possible alternative Ac-DAF-16 bind motifs. The 22 genes linked to these genomic fragments were identified using bioinformatics tools and defined as candidate direct gene targets of Ac-DAF-16. Their developmental stage-specific expression patterns were examined. Also, a new putative DAF-16 binding element was identified. Conclusions/Significance: Our results show that Ac-DAF-16 is involved in diverse biological processes throughout hookworm development. Further investigation of these target genes will provide insights into the molecular basis by which Ac-DAF-16 regulates its downstream gene network in hookworm infection.	[Gao, Xin; Hawdon, John M.] George Washington Univ, Med Ctr, Dept Microbiol & Trop Med, Washington, DC 20037 USA; [Wang, Zhengyuan; Martin, John; Abubucker, Sahar; Zhang, Xu; Mitreva, Makedonka] Washington Univ, Sch Med, Dept Genet, Genome Ctr, St Louis, MO 63110 USA	George Washington University; Washington University (WUSTL)	Gao, X (corresponding author), George Washington Univ, Med Ctr, Dept Microbiol & Trop Med, Washington, DC 20037 USA.	mtmjmh@gwumc.edu	Wang, Zhengyuan/GWV-6069-2022; Gao, Cyan/O-9316-2014; Hawdon, John/I-1201-2019; wang, zhengyuan/HGA-0435-2022	Hawdon, John/0000-0002-6164-1413; wang, zhengyuan/0000-0002-8447-9674; Mitreva, Makedonka/0000-0001-9572-3436	National Institute of Allergy and Infectious Diseases [1R01AI069293, R01AI081803]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069293, R01AI081803] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants 1R01AI069293 and R01AI081803 from the National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubucker S, 2008, MOL BIOCHEM PARASIT, V157, P187, DOI 10.1016/j.molbiopara.2007.11.001; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brand A, 2004, INT J PARASITOL, V34, P909, DOI 10.1016/j.ijpara.2004.04.003; Brent MM, 2008, STRUCTURE, V16, P1407, DOI 10.1016/j.str.2008.06.013; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gao X, 2009, INT J PARASITOL, V39, P407, DOI 10.1016/j.ijpara.2008.09.005; GOTTLIEB S, 1994, GENETICS, V137, P107; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; HACKER U, 1992, P NATL ACAD SCI USA, V89, P8754, DOI 10.1073/pnas.89.18.8754; Hawdon J.M., 1991, P274; HAWDON JM, 1991, J HELMINTHOL SOC W, V58, P140; Hawdon JM, 2003, INT J PARASITOL, V33, P787, DOI 10.1016/S0020-7519(03)00088-2; HOTEZ P, 1993, PARASITOL TODAY, V9, P23, DOI 10.1016/0169-4758(93)90159-D; Hu M, 2010, INT J PARASITOL, V40, P405, DOI 10.1016/j.ijpara.2009.09.005; Jakobsen MR, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh064; KELLER EB, 1984, P NATL ACAD SCI-BIOL, V81, P7417, DOI 10.1073/pnas.81.23.7417; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kiss JE, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-21; Kojima T, 2006, J BIOSCI BIOENG, V101, P440, DOI 10.1263/jbb.101.440; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Liu JS, 1995, J AM STAT ASSOC, V90, P1156, DOI 10.2307/2291508; Liu Tao, 2004, BMC Developmental Biology, V4; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Martin J, 2009, NUCLEIC ACIDS RES, V37, pD571, DOI 10.1093/nar/gkn744; Massey HC, 2006, INT J PARASITOL, V36, P347, DOI 10.1016/j.ijpara.2005.11.007; Massey HC, 2003, INT J PARASITOL, V33, P1537, DOI 10.1016/S0020-7519(03)00205-4; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Mitreva M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-58; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; NEUWALD AF, 1995, PROTEIN SCI, V4, P1618, DOI 10.1002/pro.5560040820; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; ROGERS WP, 1963, ADV PARASIT, V1, P109, DOI 10.1016/S0065-308X(08)60503-5; Sapio MR, 2005, DEV BIOL, V282, P231, DOI 10.1016/j.ydbio.2005.03.011; Schad G.A., 1982, P361; Shostak Y, 2004, GENE DEV, V18, P2529, DOI 10.1101/gad.1218504; Sleumer MC, 2009, NUCLEIC ACIDS RES, V37, P1323, DOI 10.1093/nar/gkn1041; Staley JP, 2009, CURR OPIN CELL BIOL, V21, P109, DOI 10.1016/j.ceb.2009.01.003; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Tissenbaum HA, 2000, P NATL ACAD SCI USA, V97, P460, DOI 10.1073/pnas.97.1.460; Tissenbaum HA, 1998, GENETICS, V148, P703; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-307; WEBB DC, 1994, PHOSPHATE IN MICROORGANISMS, P37; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; Whittle CM, 2009, P NATL ACAD SCI USA, V106, P12049, DOI 10.1073/pnas.0812894106; Zhao ZY, 2007, GENETICS, V175, P1407, DOI 10.1534/genetics.106.066720	60	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12289	10.1371/journal.pone.0012289	http://dx.doi.org/10.1371/journal.pone.0012289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808816	Green Published, Green Submitted, gold			2022-12-25	WOS:000281075500021
J	Herrera, GM; Meredith, AL				Herrera, Gerald M.; Meredith, Andrea L.			Diurnal Variation in Urodynamics of Rat	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; NOCTURNAL POLYURIA; CIRCADIAN-RHYTHMS; RENAL-FUNCTION; OVERACTIVE BLADDER; FEMALE RATS; HEART-RATE; ANESTHETICS; KIDNEY; TEMPERATURE	In humans, the storage and voiding functions of the urinary bladder have a characteristic diurnal variation, with increased voiding during the day and urine storage during the night. However, in animal models, the daily functional differences in urodynamics have not been well-studied. The goal of this study was to identify key urodynamic parameters that vary between day and night. Rats were chronically instrumented with an intravesical catheter, and bladder pressure, voided volumes, and micturition frequency were measured by continuous filling cystometry during the light (inactive) or dark (active) phases of the circadian cycle. Cage activity was recorded by video during the experiment. We hypothesized that nocturnal rats entrained to a standard 12: 12 light: dark cycle would show greater ambulatory activity and more frequent, smaller volume micturitions in the dark compared to the light. Rats studied during the light phase had a bladder capacity of 1.44+/-0.21 mL and voided every 8.2+/-1.2 min. Ambulatory activity was lower in the light phase, and rats slept during the recording period, awakening only to urinate. In contrast, rats studied during the dark were more active, had a lower bladder capacities (0.65+/-0.18 mL), and urinated more often (every 3.7+/-0.9 min). Average bladder pressures were not significantly different between the light and dark (13.40+/-2.49 and 12.19+/-2.85 mmHg, respectively). These results identify a day-night difference in bladder capacity and micturition frequency in chronically-instrumented nocturnal rodents that is phase-locked to the normal circadian locomotor activity rhythm of the animal. Furthermore, since it has generally been assumed that the daily hormonal regulation of renal function is a major driver of the circadian rhythm in urination, and few studies have addressed the involvement of the lower urinary tract, these results establish the bladder itself as a target for circadian regulation.	[Herrera, Gerald M.] Catamount Res & Dev Co, St Albans, VT USA; [Herrera, Gerald M.] Med Associates Inc, St Albans, VT USA; [Meredith, Andrea L.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Herrera, GM (corresponding author), Catamount Res & Dev Co, St Albans, VT USA.	ameredith@som.umaryland.edu		Meredith, Andrea/0000-0003-1061-2302	University of Maryland Medical School; NIDDK [R21DK089337]; Catamount Research & Development, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK089337] Funding Source: NIH RePORTER	University of Maryland Medical School; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Catamount Research & Development, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	ALM was supported by University of Maryland Medical School startup funds and NIDDK (R21DK089337). This study was funded by Catamount Research & Development, Inc. GMH is a full-time employee and co-owner of Catamount Research & Development, Inc. and was involved in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartness TJ, 2001, J BIOL RHYTHM, V16, P196, DOI 10.1177/074873001129001908; BUIJSEN JGM, 1994, NEPHROL DIAL TRANSPL, V9, P1330; CHAMBERLAIN PF, 1984, OBSTET GYNECOL, V64, P657; COLWELL CS, 1993, J BIOL RHYTHM, V8, P179, DOI 10.1177/074873049300800301; De Guchtenaere A, 2007, J UROLOGY, V178, P2626, DOI 10.1016/j.juro.2007.08.028; Dispersyn G, 2009, ANESTHESIOLOGY, V110, P1305, DOI 10.1097/ALN.0b013e3181a10225; DORR W, 1992, J UROLOGY, V148, P183, DOI 10.1016/S0022-5347(17)36549-7; Dorr W, 1997, UROL INT, V58, P153; Drake NL, 2005, AM J OBSTET GYNECOL, V192, P1682, DOI 10.1016/j.ajog.2004.11.033; Ghoniem GM, 1996, J UROLOGY, V156, P233, DOI 10.1016/S0022-5347(01)66007-5; GOLDMAN R, 1951, J CLIN INVEST, V30, P1191, DOI 10.1172/JCI102538; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Kalsbeek A, 2006, CHRONOBIOL INT, V23, P201, DOI 10.1080/07420520500464528; Kalsbeek A, 2004, J NEUROSCI, V24, P7604, DOI 10.1523/JNEUROSCI.5328-03.2004; Kelada Ehab, 2007, Archives of Gynecology and Obstetrics, V275, P223, DOI 10.1007/s00404-006-0247-7; Kiddoo DA, 2006, AM J PHYSIOL-REG I, V290, pR1697, DOI 10.1152/ajpregu.00742.2005; KOOPMAN MG, 1985, NETH J MED, V28, P416; Ku JH, 2004, BJU INT, V93, P1005, DOI 10.1111/j.1464-410X.2004.04770.x; LONGHURST PA, 1992, J UROLOGY, V148, P1615, DOI 10.1016/S0022-5347(17)36981-1; Matsuura S, 2000, NEUROUROL URODYNAM, V19, P87, DOI 10.1002/(SICI)1520-6777(2000)19:1<87::AID-NAU9>3.0.CO;2-O; MILLS JN, 1951, J PHYSIOL-LONDON, V113, P528, DOI 10.1113/jphysiol.1951.sp004593; OLIVER JE, 1973, AM J VET RES, V34, P665; Oosting J, 1997, J HYPERTENS, V15, P401, DOI 10.1097/00004872-199715040-00011; Prudian F, 1997, N-S ARCH PHARMACOL, V355, P774, DOI 10.1007/PL00005012; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schmidt F, 2001, NEUROUROL URODYNAM, V20, P287, DOI 10.1002/nau.1006; SHIRLEY DG, 1989, J PHYSIOL-LONDON, V408, P67, DOI 10.1113/jphysiol.1989.sp017447; Sly DJ, 1999, J AUTONOM NERV SYST, V77, P73, DOI 10.1016/S0165-1838(99)00031-4; Smith PP, 2008, NEUROUROL URODYNAM, V27, P324, DOI 10.1002/nau.20512; STEWART FA, 1978, RADIAT RES, V75, P649, DOI 10.2307/3574851; Van Hoeck K, 2007, EUR J PEDIATR, V166, P579, DOI 10.1007/s00431-006-0286-x; VANACKER BAC, 1992, J LAB CLIN MED, V120, P400; Weiss JP, 2002, UROLOGY, V60, P28, DOI 10.1016/S0090-4295(02)01789-2; Weiss JP, 2003, CURR UROL REP, V4, P362, DOI DOI 10.1007/S11934-003-0007-1; WESSON LG, 1964, MEDICINE, V43, P547, DOI 10.1097/00005792-196409000-00002; Zuber AM, 2009, P NATL ACAD SCI USA, V106, P16523, DOI 10.1073/pnas.0904890106	36	38	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12298	10.1371/journal.pone.0012298	http://dx.doi.org/10.1371/journal.pone.0012298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20808873	Green Submitted, gold, Green Published			2022-12-25	WOS:000281075500025
J	Ceesay, SJ; Casals-Pascual, C; Nwakanma, DC; Walther, M; Gomez-Escobar, N; Fulford, AJC; Takem, EN; Nogaro, S; Bojang, KA; Corrah, T; Jaye, MC; Taal, MA; Sonko, AAJ; Conway, DJ				Ceesay, Serign J.; Casals-Pascual, Climent; Nwakanma, Davis C.; Walther, Michael; Gomez-Escobar, Natalia; Fulford, Anthony J. C.; Takem, Ebako N.; Nogaro, Sarah; Bojang, Kalifa A.; Corrah, Tumani; Jaye, Momodou Cherno; Taal, Makie Abdoulie; Sonko, Aja Adam Jagne; Conway, David J.			Continued Decline of Malaria in The Gambia with Implications for Elimination	PLOS ONE			English	Article							GUINEA-BISSAU; SOUTH-AFRICA; WEST-AFRICA; TRANSMISSION; MORBIDITY; MORTALITY; CHILDREN; ERADICATION; COMBINATION; PROSPECTS	Background: A substantial decline in malaria was reported to have occurred over several years until 2007 in the western part of The Gambia, encouraging consideration of future elimination in this previously highly endemic region. Scale up of interventions has since increased with support from the Global Fund and other donors. Methodology/Principal Findings: We continued to examine laboratory records at four health facilities previously studied and investigated six additional facilities for a 7 year period, adding data from 243,707 slide examinations, to determine trends throughout the country until the end of 2009. We actively detected infections in a community cohort of 800 children living in rural villages throughout the 2008 malaria season, and assayed serological changes in another rural population between 2006 and 2009. Proportions of malaria positive slides declined significantly at all of the 10 health facilities between 2003 (annual mean across all sites, 38.7%) and 2009 (annual mean, 7.9%). Statistical modelling of trends confirmed significant seasonality and decline over time at each facility. Slide positivity was lowest in 2009 at all sites, except two where lowest levels were observed in 2006. Mapping households of cases presenting at the latter sites in 2007-2009 indicated that these were not restricted to a few residual foci. Only 2.8% (22/800) of a rural cohort of children had a malaria episode in the 2008 season, and there was substantial serological decline between 2006 and 2009 in a separate rural area. Conclusions: Malaria has continued to decline in The Gambia, as indicated by a downward trend in slide positivity at health facilities, and unprecedented low incidence and seroprevalence in community surveys. We recommend intensification of control interventions for several years to further reduce incidence, prior to considering an elimination programme.	[Ceesay, Serign J.; Casals-Pascual, Climent; Nwakanma, Davis C.; Walther, Michael; Gomez-Escobar, Natalia; Fulford, Anthony J. C.; Takem, Ebako N.; Nogaro, Sarah; Bojang, Kalifa A.; Corrah, Tumani; Conway, David J.] MRC Labs, Banjul, Gambia; [Casals-Pascual, Climent] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Fulford, Anthony J. C.; Conway, David J.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Jaye, Momodou Cherno] Royal Victoria Teaching Hosp, Natl Hlth Lab Serv, Banjul, Gambia; [Taal, Makie Abdoulie] Natl Publ Hlth Labs, Banjul, Gambia; [Sonko, Aja Adam Jagne] Natl Malaria Control Programme, Banjul, Gambia	MRC Laboratory Molecular Biology; University of Oxford; Wellcome Centre for Human Genetics; University of London; London School of Hygiene & Tropical Medicine	Ceesay, SJ (corresponding author), MRC Labs, Banjul, Gambia.	dconway@mrc.gm	Casals-Pascual, Climent/N-7692-2018	Casals-Pascual, Climent/0000-0002-0867-8954; Conway, David/0000-0002-8711-3037; Nwakanma, Davis/0000-0002-6706-6069; Bojang, Kalifa/0000-0001-7506-0938	UK Medical Research Council (MRC); Medical Research Council [MC_U190097907, MC_U190074193, MC_U190088482, G0701885] Funding Source: researchfish; MRC [MC_U190097907, MC_U190088482, G0701885, MC_U190074193] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Financial support for the research was provided by the UK Medical Research Council (MRC) (http://www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767; Akpogheneta OJ, 2010, PARASITE IMMUNOL, V32, P296, DOI 10.1111/j.1365-3024.2009.01193.x; *ALL PART PARL GRO, 2010, 6 ALL PART PARL GROU; [Anonymous], 2009, WHO WORLD MAL REP 20; [Anonymous], 2008, GLOB MAL CONTR EL RE; Behrens RH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-235; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; BISOFFI Z, 2008, EURO SURVEILL, V13; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Finney OC, 2009, EUR J IMMUNOL, V39, P1288, DOI 10.1002/eji.200839112; Fulford AJC, 2006, PAEDIATR PERINAT EP, V20, P251, DOI 10.1111/j.1365-3016.2006.00714.x; Gerritsen AAM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-162; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kleinschmidt I, 2001, TROP MED INT HEALTH, V6, P779, DOI 10.1046/j.1365-3156.2001.00790.x; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Majambere S, 2010, AM J TROP MED HYG, V82, P176, DOI 10.4269/ajtmh.2010.09-0373; MCGREGOR IA, 1956, BRIT MED J, V2, P686, DOI 10.1136/bmj.2.4994.686; Mendis K, 2009, TROP MED INT HEALTH, V14, P802, DOI 10.1111/j.1365-3156.2009.02287.x; *MICS, 2007, GAMB MULT IND CLUST, P1; Mmbando BP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-216; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Okiro Emelda A, 2009, BMC Med, V7, P75, DOI 10.1186/1741-7015-7-75; PAMPANA E, 1963, TXB MALARIA ERADICAT, P508; RAMROTH H, 2009, GLOB HLTH ACTION, V2, DOI DOI 10.3402/GHA.V3402I3400.1909; Rodrigues A, 2008, TROP MED INT HEALTH, V13, P410, DOI 10.1111/j.1365-3156.2008.02016.x; Satoguina J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-274; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Smith DL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-87; Snow RW, 2010, LANCET, V376, P137, DOI 10.1016/S0140-6736(10)60577-6; Tatem AJ, 2010, P NATL ACAD SCI USA, V107, P12222, DOI 10.1073/pnas.1002971107; Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133, DOI 10.4269/ajtmh.2009.80.133	35	100	100	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2010	5	8							e12242	10.1371/journal.pone.0012242	http://dx.doi.org/10.1371/journal.pone.0012242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639XY	20805878	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000281011600016
J	Barton, MD; Delneri, D; Oliver, SG; Rattray, M; Bergman, CM				Barton, Michael D.; Delneri, Daniela; Oliver, Stephen G.; Rattray, Magnus; Bergman, Casey M.			Evolutionary Systems Biology of Amino Acid Biosynthetic Cost in Yeast	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEIN EVOLUTION; GENE-EXPRESSION; SELECTION; RECONSTRUCTION; MINIMIZATION; MODEL; RATES; USAGE	Every protein has a biosynthetic cost to the cell based on the synthesis of its constituent amino acids. In order to optimise growth and reproduction, natural selection is expected, where possible, to favour the use of proteins whose constituents are cheaper to produce, as reduced biosynthetic cost may confer a fitness advantage to the organism. Quantifying the cost of amino acid biosynthesis presents challenges, since energetic requirements may change across different cellular and environmental conditions. We developed a systems biology approach to estimate the cost of amino acid synthesis based on genome-scale metabolic models and investigated the effects of the cost of amino acid synthesis on Saccharomyces cerevisiae gene expression and protein evolution. First, we used our two new and six previously reported measures of amino acid cost in conjunction with codon usage bias, tRNA gene number and atomic composition to identify which of these factors best predict transcript and protein levels. Second, we compared amino acid cost with rates of amino acid substitution across four species in the genus Saccharomyces. Regardless of which cost measure is used, amino acid biosynthetic cost is weakly associated with transcript and protein levels. In contrast, we find that biosynthetic cost and amino acid substitution rates show a strong negative correlation, but for only a subset of cost measures. In the economy of the yeast cell, we find that the cost of amino acid synthesis plays a limited role in shaping transcript and protein expression levels compared to that of translational optimisation. Biosynthetic cost does, however, appear to affect rates of amino acid evolution in Saccharomyces, suggesting that expensive amino acids may only be used when they have specific structural or functional roles in protein sequences. However, as there appears to be no single currency to compute the cost of amino acid synthesis across all cellular and environmental conditions, we conclude that a systems approach is necessary to unravel the full effects of amino acid biosynthetic cost in complex biological systems.	[Barton, Michael D.; Delneri, Daniela; Oliver, Stephen G.; Bergman, Casey M.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Barton, Michael D.] No Kentucky Univ, Dept Biol Sci, Highland Hts, KY 41076 USA; [Oliver, Stephen G.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Rattray, Magnus] Univ Manchester, Sch Comp Sci, Manchester, Lancs, England	University of Manchester; Northern Kentucky University; University of Cambridge; University of Manchester	Barton, MD (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	mail@michaelbarton.me.uk	Bergman, Casey/F-7854-2010; Zeef, Leo/D-6922-2011; Rattray, Magnus/B-4393-2009; Rattray, Magnus/AAE-3297-2021; Oliver, Stephen/AAQ-5992-2021	Bergman, Casey/0000-0002-5462-9854; Rattray, Magnus/0000-0001-8196-5565; Rattray, Magnus/0000-0001-8196-5565; Oliver, Stephen/0000-0003-3410-6439; Barton, Michael/0000-0002-0064-2279; Delneri, Daniela/0000-0001-8070-411X	Natural Environment Research Council [NER/S/R/2005/13609, NE/B500190/1, NER/T/S/2001/00343]; Biotechnology and Biological Sciences Research Council [BB/C008219/1]; Biotechnology and Biological Sciences Research Council [BB/C505140/2, BB/C505140/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Natural Environment Research Council Ph. D. studentship NER/S/R/2005/13609 to MDB, Natural Environment Research Council advanced fellowship NE/B500190/1 to DD, NER/T/S/2001/00343 to SGO, and Biotechnology and Biological Sciences Research Council grant BB/C008219/1 to SGO, MR, and CMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 2003, AUTOMATIC CONTROL IE, V19, P716; Akashi H, 2003, GENETICS, V164, P1291; Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Berkelaar M., IP SOLVE OPEN SOURCE; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Carlson RP, 2007, BIOINFORMATICS, V23, P1258, DOI 10.1093/bioinformatics/btm082; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Craig CL, 1998, MOL BIOL EVOL, V15, P774, DOI 10.1093/oxfordjournals.molbev.a025981; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Heizer EM, 2006, MOL BIOL EVOL, V23, P1670, DOI 10.1093/molbev/msl029; Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909; Hurst LD, 2006, NATURE, V442, pE11, DOI 10.1038/nature05137; IKEMURA T, 1982, J MOL BIOL, V158, P573, DOI 10.1016/0022-2836(82)90250-9; Jansen R, 2003, NUCLEIC ACIDS RES, V31, P2242, DOI 10.1093/nar/gkg306; Lee JM, 2006, BRIEF BIOINFORM, V7, P140, DOI 10.1093/bib/bbl007; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; R Core Team, 2022, R LANG ENV STAT COMP; Raiford DW, 2008, J MOL EVOL, V67, P621, DOI 10.1007/s00239-008-9162-9; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Rocha EPC, 2004, MOL BIOL EVOL, V21, P108, DOI 10.1093/molbev/msh004; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Seligmann H, 2003, J MOL EVOL, V56, P151, DOI 10.1007/s00239-002-2388-z; Shlomi T, 2005, P NATL ACAD SCI USA, V102, P7695, DOI 10.1073/pnas.0406346102; Swire J, 2007, J MOL EVOL, V64, P558, DOI 10.1007/s00239-006-0206-8; VARMA A, 1993, APPL ENVIRON MICROB, V59, P2465, DOI 10.1128/AEM.59.8.2465-2473.1993; Wagner A, 2005, MOL BIOL EVOL, V22, P1365, DOI 10.1093/molbev/msi126; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	39	45	47	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2010	5	8							e11935	10.1371/journal.pone.0011935	http://dx.doi.org/10.1371/journal.pone.0011935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	639II	20808905	Green Published, gold			2022-12-25	WOS:000280968100002
J	Hall, CHT; Kassel, R; Tacke, RS; Hahn, YS				Hall, Caroline H. T.; Kassel, Rachel; Tacke, Robert S.; Hahn, Young S.			HCV+ Hepatocytes Induce Human Regulatory CD4(+) T Cells through the Production of TGF-beta	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; ANTIVIRAL THERAPY; LIVER-DISEASE; INFECTION; EXPRESSION; LYMPHOCYTES; TGF-BETA-1; EXPANSION; CORE; TRANSFORMING-GROWTH-FACTOR-BETA-1	Background: Hepatitis C Virus (HCV) is remarkably efficient at establishing persistent infection and is associated with the development of chronic liver disease. Impaired T cell responses facilitate and maintain persistent HCV infection. Importantly, CD4(+) regulatory T cells (Tregs) act by dampening antiviral T cell responses in HCV infection. The mechanism for induction and/or expansion of Tregs in HCV is unknown. Methodology/Principal Findings: HCV-expressing hepatocytes were used to determine if hepatocytes are able to induce Tregs. The infected liver environment was modeled by establishing the co-culture of the human hepatoma cell line, Huh7.5, containing the full-length genome of HCV genotype 1a (Huh7.5-FL) with activated CD4(+) T cells. The production of IFN-gamma was diminished following co-culture with Huh7.5-FL as compared to controls. Notably, CD4(+) T cells in contact with Huh7.5-FL expressed an increased level of the Treg markers, CD25, Foxp3, CTLA-4 and LAP, and were able to suppress the proliferation of effector T cells. Importantly, HCV+ hepatocytes upregulated the production of TGF-beta and blockade of TGF-beta abrogated Treg phenotype and function. Conclusions/Significance: These results demonstrate that HCV infected hepatocytes are capable of directly inducing Tregs development and may contribute to impaired host T cell responses.	[Hall, Caroline H. T.; Kassel, Rachel; Tacke, Robert S.; Hahn, Young S.] Univ Virginia, Dept Microbiol, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Hahn, Young S.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Hall, CHT (corresponding author), Univ Virginia, Dept Microbiol, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA.	ysh5e@virginia.edu		Hall, Caroline/0000-0002-7100-3423	National Institutes of Health [5-T32-AI007496, 5-T32-AI007046, 5-T32-GM007267, R01AI057591, U19AI066328]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007496, T32AI007046, R01AI057591, U19AI066328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following National Institutes of Health grants: 5-T32-AI007496 to CHTH and RST, 5-T32-AI007046 to CHTH and RK, 5-T32-GM007267 to RK, R01AI057591, U19AI066328 to YSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boettler T, 2005, J VIROL, V79, P7860, DOI 10.1128/JVI.79.12.7860-7867.2005; Boudreau HE, 2009, J VIROL, V83, P12934, DOI 10.1128/JVI.01059-09; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; Correia MP, 2009, J IMMUNOL, V182, P6149, DOI 10.4049/jimmunol.0802470; Cottrez F, 2001, J IMMUNOL, V167, P773, DOI 10.4049/jimmunol.167.2.773; Ebinuma H, 2008, J VIROL, V82, P5043, DOI 10.1128/JVI.01548-07; Erickson AL, 2001, IMMUNITY, V15, P883, DOI 10.1016/S1074-7613(01)00245-X; Fan TM, 2008, MOL IMMUNOL, V45, P2937, DOI 10.1016/j.molimm.2008.01.019; Fogel-Petrovic M, 2007, INT IMMUNOPHARMACOL, V7, P1924, DOI 10.1016/j.intimp.2007.07.003; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; KAKUMU S, 1992, J CLIN PATHOL, V45, P408, DOI 10.1136/jcp.45.5.408; Kimura T, 2006, J INFECT DIS, V193, P1371, DOI 10.1086/503436; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Leroy V, 2002, EUR J GASTROEN HEPAT, V14, P485, DOI 10.1097/00042737-200205000-00004; LIN W, GASTROENTEROLOGY, V138, P2509; MAEDA H, 1995, J IMMUNOL, V155, P4926; Marek B, 2005, J CLIN PHARM THER, V30, P271, DOI 10.1111/j.1365-2710.2005.00644.x; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Pavio N, 2005, ONCOGENE, V24, P6119, DOI 10.1038/sj.onc.1208749; Pellicano R, 2000, J HEPATOL, V33, P648, DOI 10.1034/j.1600-0641.2000.033004648.x; Perrella A, 2006, GUT, V55, P1370, DOI 10.1136/gut.2006.099887; ROWELL DL, 1997, AM J PHYSIOL, V273, P322; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Selvaraj RK, 2007, J IMMUNOL, V179, P1390, DOI 10.4049/jimmunol.179.2.1390-b; Smyk-Pearson S, 2008, J INFECT DIS, V197, P46, DOI 10.1086/523651; Taniguchi H, 2004, J MED VIROL, V72, P52, DOI 10.1002/jmv.10545; Tarantino G, 2008, INT J IMMUNOPATH PH, V21, P1007, DOI 10.1177/039463200802100426; Tester I, 2005, J EXP MED, V201, P1725, DOI 10.1084/jem.20042284; Tran DQ, 2009, BLOOD, V113, P5125, DOI 10.1182/blood-2009-01-199950; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Warren A, 2006, HEPATOLOGY, V44, P1182, DOI 10.1002/hep.21378; Weber SE, 2006, J IMMUNOL, V176, P4730, DOI 10.4049/jimmunol.176.8.4730; Wiedmann M, 2000, HEPATOLOGY, V31, P230, DOI 10.1002/hep.510310134; Yakoob J, 2003, EUR J GASTROEN HEPAT, V15, P701, DOI 10.1097/00042737-200306000-00019; Yamagiwa S, 2001, J IMMUNOL, V166, P7282, DOI 10.4049/jimmunol.166.12.7282; Yao ZQ, 2004, J VIROL, V78, P6409, DOI 10.1128/JVI.78.12.6409-6419.2004	44	46	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2010	5	8							e12154	10.1371/journal.pone.0012154	http://dx.doi.org/10.1371/journal.pone.0012154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	638AP	20730048	Green Submitted, Green Published, gold			2022-12-25	WOS:000280862200013
J	Zhang, Q; Yang, RY; Tang, JJ; Yang, HS; Hu, SJ; Chen, X				Zhang, Qian; Yang, Ruyi; Tang, Jianjun; Yang, Haishui; Hu, Shuijin; Chen, Xin			Positive Feedback between Mycorrhizal Fungi and Plants Influences Plant Invasion Success and Resistance to Invasion	PLOS ONE			English	Article							SOLIDAGO-CANADENSIS L.; SOIL BIOTA; COMMUNITY STRUCTURE; GROWTH; GRASS; NITROGEN; COLONIZATION; COEXISTENCE; SERPENTINE; DIVERSITY	Negative or positive feedback between arbuscular mycorrhizal fungi (AMF) and host plants can contribute to plant species interactions, but how this feedback affects plant invasion or resistance to invasion is not well known. Here we tested how alterations in AMF community induced by an invasive plant species generate feedback to the invasive plant itself and affect subsequent interactions between the invasive species and its native neighbors. We first examined the effects of the invasive forb Solidago canadensis L. on AMF communities comprising five different AMF species. We then examined the effects of the altered AMF community on mutualisms formed with the native legume forb species Kummerowia striata (Thunb.) Schindl. and on the interaction between the invasive and native plants. The host preferences of the five AMF were also assessed to test whether the AMF form preferred mutualistic relations with the invasive and/or the native species. We found that S. canadensis altered AMF spore composition by increasing one AMF species (Glomus geosporum) while reducing Glomus mosseae, which is the dominant species in the field. The host preference test showed that S. canadensis had promoted the abundance of AMF species (G. geosporum) that most promoted its own growth. As a consequence, the altered AMF community enhanced the competitiveness of invasive S. canadensis at the expense of K. striata. Our results demonstrate that the invasive S. canadensis alters soil AMF community composition because of fungal-host preference. This change in the composition of the AMF community generates positive feedback to the invasive S. canadensis itself and decreases AM associations with native K. striata, thereby making the native K. striata less dominant.	[Zhang, Qian; Yang, Ruyi; Tang, Jianjun; Yang, Haishui; Chen, Xin] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Ruyi] Anhui Normal Univ, Coll Environm Sci, Wuhu, Peoples R China; [Hu, Shuijin] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA	Zhejiang University; Anhui Normal University; University of North Carolina; North Carolina State University	Chen, X (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	chen-tang@zju.edu.cn	Schlyter, Fredrik/F-8567-2015	Schlyter, Fredrik/0000-0002-1244-0308; Hu, Shuijin/0000-0002-3225-5126; Yang, Haishui/0000-0001-7255-9653	Zhejiang Provincial Natural Science Foundation of China [Z5090089]; Research Fund for the Doctoral Program of Higher Education of China (RFDP) [20070335079]; Natural Science Foundation of China (NSFC) [3073020, 30870405]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Research Fund for the Doctoral Program of Higher Education of China (RFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the Zhejiang Provincial Natural Science Foundation of China (No. Z5090089), the Research Fund for the Doctoral Program of Higher Education of China (RFDP, No. 20070335079), and the Natural Science Foundation of China (NSFC, No. 3073020 and 30870405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batten KM, 2006, BIOL INVASIONS, V8, P217, DOI 10.1007/s10530-004-3856-8; Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; Bever JD, 2002, PLANT SOIL, V244, P281, DOI 10.1023/A:1020221609080; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Bever JD, 1996, J ECOL, V84, P71, DOI 10.2307/2261701; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Bever JD, 2002, P ROY SOC B-BIOL SCI, V269, P2595, DOI 10.1098/rspb.2002.2162; Bray SR, 2003, ECOL APPL, V13, P565, DOI 10.1890/1051-0761(2003)013[0565:MDAGPA]2.0.CO;2; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; Callaway RM, 2008, ECOLOGY, V89, P1043, DOI 10.1890/07-0370.1; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Carey EV, 2004, PLANT ECOL, V172, P133, DOI 10.1023/B:VEGE.0000026031.14086.f1; Chen X, 2005, APPL SOIL ECOL, V28, P259, DOI 10.1016/j.apsoil.2004.07.009; Chen X, 2004, AGR ECOSYST ENVIRON, V102, P377, DOI 10.1016/j.agee.2003.08.006; Cornejo P, 2004, FEMS MICROBIOL LETT, V241, P265, DOI 10.1016/j.femsle.2004.10.030; Eom AH, 2000, OECOLOGIA, V122, P435, DOI 10.1007/s004420050050; Fransen B, 2001, ECOLOGY, V82, P2534, DOI 10.1890/0012-9658(2001)082[2534:SNHACB]2.0.CO;2; GERDEMANN J. W., 1963, TRANS BRIT MYCOL SOC, V46, P235; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hausmann NT, 2009, NEW PHYTOL, V183, P1188, DOI 10.1111/j.1469-8137.2009.02882.x; Hawkes CV, 2006, PLANT SOIL, V281, P369, DOI 10.1007/s11104-005-4826-3; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; Jansa J, 2008, NEW PHYTOL, V177, P779, DOI 10.1111/j.1469-8137.2007.02294.x; Kiers ET, 2006, ECOLOGY, V87, P1627, DOI 10.1890/0012-9658(2006)87[1627:MSITAM]2.0.CO;2; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Kowalchuk GA, 2002, MOL ECOL, V11, P571, DOI 10.1046/j.0962-1083.2001.01457.x; Liang ZB, 2008, SOIL BIOL BIOCHEM, V40, P956, DOI 10.1016/j.soilbio.2007.11.016; Lu JZ, 2007, ACTA PHYTOTAXON SIN, V45, P670, DOI 10.1360/aps06200; Marler MJ, 1999, ECOLOGY, V80, P1180, DOI 10.1890/0012-9658(1999)080[1180:MIECEO]2.0.CO;2; Moora M, 2004, FUNCT ECOL, V18, P554, DOI 10.1111/j.0269-8463.2004.00876.x; Mummey DL, 2006, PLANT SOIL, V288, P81, DOI 10.1007/s11104-006-9091-6; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; PLENCHETTE C, 1983, PLANT SOIL, V70, P199, DOI 10.1007/BF02374780; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Schechter SP, 2008, MOL ECOL, V17, P3198, DOI 10.1111/j.1365-294X.2008.03828.x; SCHEUBLIN TR, 2007, J ECOL, V85, P2682; Seifert EK, 2009, ECOLOGY, V90, P1055, DOI 10.1890/08-0419.1; SEMPLE JC, 2006, FLORA N AM MAGNOLI 2; SEMPLE JC, 2006, FLORA N AM MAGNOLI 7; SIMON L, 1992, APPL ENVIRON MICROB, V58, P291, DOI 10.1128/AEM.58.1.291-295.1992; Stampe ED, 2003, OIKOS, V100, P362, DOI 10.1034/j.1600-0706.2003.12006.x; Stinson KA, 2006, PLOS BIOL, V4, P727, DOI 10.1371/journal.pbio.0040140; Sykorova Z, 2007, APPL ENVIRON MICROB, V73, P5426, DOI 10.1128/AEM.00987-07; Tanaka Y, 2005, PLANT CELL ENVIRON, V28, P1247, DOI 10.1111/j.1365-3040.2005.01360.x; Tang J.J., 2009, B SCI TECHNOLOGY, V25, P233; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van der Heijden MGA, 2003, NEW PHYTOL, V157, P569, DOI 10.1046/j.1469-8137.2003.00688.x; van der Putten WH, 2007, ECOLOGY, V88, P978, DOI 10.1890/06-1051; Vandenkoornhuyse P, 2003, MOL ECOL, V12, P3085, DOI 10.1046/j.1365-294X.2003.01967.x; Vogelsang KM, 2009, ECOLOGY, V90, P399, DOI 10.1890/07-2144.1; Weber E, 2001, CONSERV BIOL, V15, P122, DOI 10.1046/j.1523-1739.2001.99424.x; Yang RY, 2007, ALLELOPATHY J, V19, P241; ZANBINKI CA, 2002, FUNCT ECOL, V16, P758; Zhang Q, 2007, ALLELOPATHY J, V20, P71; Zhang SS, 2009, APPL SOIL ECOL, V41, P215, DOI 10.1016/j.apsoil.2008.11.002	60	126	144	8	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2010	5	8							e12380	10.1371/journal.pone.0012380	http://dx.doi.org/10.1371/journal.pone.0012380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	641UD	20548795	Green Submitted, gold, Green Published			2022-12-25	WOS:000281154300014
J	Burl, S; Adetifa, UJ; Cox, M; Touray, E; Whittle, H; McShane, H; Rowland-Jones, SL; Flanagan, KL				Burl, Sarah; Adetifa, Uche J.; Cox, Momodou; Touray, Ebrima; Whittle, Hilton; McShane, Helen; Rowland-Jones, Sarah L.; Flanagan, Katie L.			The Tuberculin Skin Test (TST) Is Affected by Recent BCG Vaccination but Not by Exposure to Non-Tuberculosis Mycobacteria (NTM) during Early Life	PLOS ONE			English	Article							CALMETTE-GUERIN VACCINATION; IMMUNE-RESPONSES; T-CELLS; REACTIVITY; HYPERSENSITIVITY; INTERLEUKIN-10; DEPRESSION; ANERGY	The tuberculin skin test (TST) is widely used in TB clinics to aid Mycobacterium tuberculosis (M.tb) diagnosis, but the definition and the significance of a positive test in very young children is still unclear. This study compared the TST in Gambian children at 41/2 months of age who either received BCG vaccination at birth (Group 1) or were BCG naive (Group 2) in order to examine the role of BCG vaccination and/or exposure to environmental mycobacteria in TST reactivity at this age. Nearly half of the BCG vaccinated children had a positive TST (>= 5 mm) whereas all the BCG naive children were non-reactive, confirming that recent BCG vaccination affects TST reactivity. The BCG naive children demonstrated in vitro PPD responses in peripheral blood in the absence of TST reactivity, supporting exposure to and priming by environmental mycobacterial antigens. Group 2 were then vaccinated at 41/2 months of age and a repeat TST was performed at 20-28 months of age. Positive reactivity (>= 5 mm) was evident in 11.1% and 12.5% infants from Group 1 and Group 2 respectively suggesting that the timing of BCG vaccination had little effect by this age. We further assessed for immune correlates in peripheral blood at 41/2 months of age. Mycobacterial specific IFN gamma responses were greater in TST responders than in non-responders, although the size of induration did not correlate with IFN gamma. However the IFN gamma: IL-10 ratio positively correlated with TST induration suggesting that the relationship between PPD induced IFN gamma and IL-10 in the peripheral blood may be important in controlling TST reactivity. Collectively these data provide further insights into how the TST is regulated in early life, and how a positive response might be interpreted.	[Burl, Sarah; Adetifa, Uche J.; Cox, Momodou; Touray, Ebrima; Whittle, Hilton; Flanagan, Katie L.] Med Res Council UK Gambia, Fajara, Gambia; [McShane, Helen] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [McShane, Helen] Univ Oxford, Jenner Inst, Oxford, England; [Rowland-Jones, Sarah L.] Univ Oxford, WIMM, Oxford, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of Oxford; Jenner Institute; University of Oxford	Burl, S (corresponding author), Med Res Council UK Gambia, Fajara, Gambia.	sburl0712@gmail.com		Levy, Ofer/0000-0002-5859-1945; Flanagan, Katie/0000-0002-1575-1953; McShane, Helen/0000-0002-2126-5142	Medical Research Council (MRC), The Gambia; MRC [MC_UP_A900_1115, MC_UP_A900_1122, MC_U190081990] Funding Source: UKRI; Medical Research Council [MC_U190081990, MC_U190085854] Funding Source: researchfish	Medical Research Council (MRC), The Gambia(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by The Medical Research Council (MRC), The Gambia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRODY JA, 1964, NEW ENGL J MED, V271, P1294, DOI 10.1056/NEJM196412172712505; BURL S, 2010, J IMMUNOLOG IN PRESS; Cavani A, 2003, J IMMUNOL, V171, P5760, DOI 10.4049/jimmunol.171.11.5760; Chan PC, 2008, INT J TUBERC LUNG D, V12, P1401; CORRAH PT, 1994, THESIS OPEN U FAJARA; Davids V, 2006, J INFECT DIS, V193, P531, DOI 10.1086/499825; Delgado JC, 2002, P NATL ACAD SCI USA, V99, P7576, DOI 10.1073/pnas.062056099; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; FINNEY O, 2009, THESIS U LONDON LOND; Floyd S, 2000, INT J TUBERC LUNG D, V4, P1133; Ildirim I, 1995, PEDIATR INFECT DIS J, V14, P1060, DOI 10.1097/00006454-199512000-00006; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Martins MVBS, 2007, TUBERCULOSIS, V87, P202, DOI 10.1016/j.tube.2006.07.006; Menzies D, 2000, CLIN INFECT DIS, V31, pS71, DOI 10.1086/314075; MENZIES R, 1992, AM REV RESPIR DIS, V145, P621, DOI 10.1164/ajrccm/145.3.621; Miles DJC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002905; MiretCuadras P, 1996, TUBERCLE LUNG DIS, V77, P52, DOI 10.1016/S0962-8479(96)90076-3; Mitchell AG, 1935, AM J DIS CHILD, V49, P695, DOI 10.1001/archpedi.1935.01970030141012; Nadler R, 2003, CLIN EXP IMMUNOL, V131, P206, DOI 10.1046/j.1365-2249.2003.02071.x; Newport MJ, 2004, GENES IMMUN, V5, P122, DOI 10.1038/sj.gene.6364051; Okan F, 2006, INT J TUBERC LUNG D, V10, P1337; Ota MOC, 2006, J TROP PEDIATRICS, V52, P136, DOI 10.1093/tropej/fmi087; PESANTI EL, 1994, AM J RESP CRIT CARE, V149, P1699, DOI 10.1164/ajrccm.149.6.7710481; RODYSILL KJ, 1989, J AM GERIATR SOC, V37, P435, DOI 10.1111/j.1532-5415.1989.tb02640.x; Santiago EM, 2003, PEDIATRICS, V112, pE298, DOI 10.1542/peds.112.4.e298; SEPULVEDA RL, 1994, TUBERCLE LUNG DIS, V75, P138, DOI 10.1016/0962-8479(94)90043-4; Shingadia D, 2003, LANCET INFECT DIS, V3, P624, DOI 10.1016/S1473-3099(03)00771-0; Sigmundsdottir H, 2004, CLIN IMMUNOL, V111, P119, DOI 10.1016/j.clim.2004.01.003; STARR S, 1964, PEDIATRICS, V33, P769; STARR S, 1964, NEW ENGL J MED, V270, P386, DOI 10.1056/NEJM196402202700802; Sterne JAC, 1996, TUBERCLE LUNG DIS, V77, P117, DOI 10.1016/S0962-8479(96)90025-8; *UNICEF, 2005, GLANC GAMB STAT; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; WEIR RE, 1994, J IMMUNOL METHODS, V176, P93, DOI 10.1016/0022-1759(94)90353-0	34	109	112	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12287	10.1371/journal.pone.0012287	http://dx.doi.org/10.1371/journal.pone.0012287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	21533209	Green Published, gold, Green Submitted			2022-12-25	WOS:000281075500019
J	Truman, JP; Garcia-Barros, M; Kaag, M; Hambardzumyan, D; Stancevic, B; Chan, M; Fuks, Z; Kolesnick, R; Haimovitz-Friedman, A				Truman, Jean-Philip; Garcia-Barros, Monica; Kaag, Matthew; Hambardzumyan, Dolores; Stancevic, Branka; Chan, Michael; Fuks, Zvi; Kolesnick, Richard; Haimovitz-Friedman, Adriana			Endothelial Membrane Remodeling Is Obligate for Anti-Angiogenic Radiosensitization during Tumor Radiosurgery	PLOS ONE			English	Article							RADIATION-INDUCED APOPTOSIS; FIBROBLAST-GROWTH-FACTOR; ACID SPHINGOMYELINASE; CERAMIDE SYNTHASE; LNCAP CELLS; MICE; RADIOTHERAPY; RAFTS; NORMALIZATION; INHIBITION	Background: While there is significant interest in combining anti-angiogenesis therapy with conventional anti-cancer treatment, clinical trials have as of yet yielded limited therapeutic gain, mainly because mechanisms of anti-angiogenic therapy remain to a large extent unknown. Currently, anti-angiogenic tumor therapy is conceptualized to either "normalize" dysfunctional tumor vasculature, or to prevent recruitment of circulating endothelial precursors into the tumor. An alternative biology, restricted to delivery of anti-angiogenics immediately prior to single dose radiotherapy (radiosurgery), is provided in the present study. Methodology/Principal Findings: Genetic data indicate an acute wave of ceramide-mediated endothelial apoptosis, initiated by acid sphingomyelinase (ASMase), regulates tumor stem cell response to single dose radiotherapy, obligatory for tumor cure. Here we show VEGF prevented radiation-induced ASMase activation in cultured endothelium, occurring within minutes after radiation exposure, consequently repressing apoptosis, an event reversible with exogenous C(16)-ceramide. Anti-VEGFR2 acts conversely, enhancing ceramide generation and apoptosis. In vivo, MCA/129 fibrosarcoma tumors were implanted in asmase(+/+) mice or asmase(-/-) littermates and irradiated in the presence or absence of anti-VEGFR2 DC101 or anti-VEGF G6-31 antibodies. These anti-angiogenic agents, only if delivered immediately prior to single dose radiotherapy, de-repressed radiation-induced ASMase activation, synergistically increasing the endothelial apoptotic component of tumor response and tumor cure. Anti-angiogenic radiosensitization was abrogated in tumors implanted in asmase(-/-) mice that provide apoptosis-resistant vasculature, or in wild-type littermates pre-treated with anti-ceramide antibody, indicating that ceramide is necessary for this effect. Conclusions/Significance: These studies show that angiogenic factors fail to suppress apoptosis if ceramide remains elevated while anti-angiogenic therapies fail without ceramide elevation, defining a ceramide rheostat that determines outcome of single dose radiotherapy. Understanding the temporal sequencing of anti-angiogenic drugs and radiation enables optimized radiosensitization and design of innovative radiosurgery clinical trials.	[Truman, Jean-Philip; Fuks, Zvi; Haimovitz-Friedman, Adriana] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [Garcia-Barros, Monica; Stancevic, Branka; Kolesnick, Richard] Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10021 USA; [Kaag, Matthew] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Hambardzumyan, Dolores] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Chan, Michael] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Wake Forest University	Truman, JP (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA.	a-haimovitz-friedman@ski.mskcc.org			National Institutes of Health [R01 CA105125, R01 CA085704]; D.K. Ludwig Fund for Cancer Research	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); D.K. Ludwig Fund for Cancer Research	This work was supported by National Institutes of Health R01 CA105125 to Adriana Haimovitz-Friedman, NIH R01 CA085704 to Richard Kolesnick, and a gift from the Virginia and D.K. Ludwig Fund for Cancer Research to Zvi Fuks. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bocci G, 2001, MOL HUM REPROD, V7, P771, DOI 10.1093/molehr/7.8.771; Cremesti A, 2001, J BIOL CHEM, V276, P23954, DOI 10.1074/jbc.M101866200; Ferrara N, 1999, CURR TOP MICROBIOL, V237, P1; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fuks Z, 2005, CANCER CELL, V8, P89, DOI 10.1016/j.ccr.2005.07.014; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Garzotto M, 1999, CANCER RES, V59, P5194; Garzotto M, 1998, CANCER RES, V58, P2260; Geng L, 2001, CANCER RES, V61, P2413; Goggel R, 2004, NAT MED, V10, P155, DOI 10.1038/nm977; Grassme H, 2003, ONCOGENE, V22, P5457, DOI 10.1038/sj.onc.1206540; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Gulbins E, 2004, J MOL MED, V82, P357, DOI 10.1007/s00109-004-0539-y; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; HAIMOVITZFRIEDMAN A, 1991, CANCER RES, V51, P2552; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; KIM JH, 1986, CANCER RES, V46, P1120; Kolesnick R, 2003, ONCOGENE, V22, P5897, DOI 10.1038/sj.onc.1206702; Korsisaari N, 2007, P NATL ACAD SCI USA, V104, P10625, DOI 10.1073/pnas.0704213104; Lacour S, 2004, CANCER RES, V64, P3593, DOI 10.1158/0008-5472.CAN-03-2787; MCCAMMON R, 2008, INT J RAD ONCOL BIOL; Nix M, 2000, CELL DEATH DIFFER, V7, P413, DOI 10.1038/sj.cdd.4400666; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pena LA, 2000, CANCER RES, V60, P321; Rotolo JA, 2005, J BIOL CHEM, V280, P26425, DOI 10.1074/jbc.M414569200; Rotolo JA, 2008, INT J RADIAT ONCOL, V70, P804, DOI 10.1016/j.ijrobp.2007.11.043; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Sessa C, 2008, NAT CLIN PRACT ONCOL, V5, P378, DOI 10.1038/ncponc1150; Siejka A, 2003, LIFE SCI, V72, P2473, DOI 10.1016/S0024-3205(03)00164-4; Tabas I, 1999, CHEM PHYS LIPIDS, V102, P123, DOI 10.1016/S0009-3084(99)00080-8; UCHIDA K, 1994, AM J PHYSIOL, V266, P81; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Witte L, 1998, CANCER METAST REV, V17, P155, DOI 10.1023/A:1006094117427; Yamada Y, 2008, INT J RADIAT ONCOL, V71, P484, DOI 10.1016/j.ijrobp.2007.11.046; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200	39	94	97	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12310	10.1371/journal.pone.0012310	http://dx.doi.org/10.1371/journal.pone.0012310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20941382	Green Published, gold, Green Submitted			2022-12-25	WOS:000281075500027
J	Li, K; Wang, R; Lozada, E; Fan, W; Orren, DK; Luo, JY				Li, Kai; Wang, Rui; Lozada, Enerlyn; Fan, Wei; Orren, David K.; Luo, Jianyuan			Acetylation of WRN Protein Regulates Its Stability by Inhibiting Ubiquitination	PLOS ONE			English	Article							WERNER-SYNDROME PROTEIN; DNA-REPAIR; RECQ HELICASES; SYNDROME GENE; TRANSCRIPTION; DAMAGE; DEACETYLATION; LOCALIZATION; COACTIVATOR; MUTATIONS	Background: WRN is a multi-functional protein involving DNA replication, recombination and repair. WRN acetylation has been demonstrated playing an important role in response to DNA damage. We previously found that WRN acetylation can regulate its enzymatic activities and nuclear distribution. Methodology/Principal Finding: Here, we investigated the factors involved in WRN acetylation and found that CBP and p300 are the only major acetyltransferases for WRN acetylation. We further identified 6 lysine residues in WRN that are subject to acetylation. Interestingly, WRN acetylation can increase its protein stability. SIRT1-mediated deacetylation of WRN reverses this effect. CBP dramatically increases the half-life of wild type WRN, while mutation of these 6 lysine residues (WRN-6KR) abrogates this increase. We further found that WRN stability is regulated by the ubiquitination pathway and WRN acetylation by CBP significantly reduces its ubiquitination. Importantly, we found that WRN is strongly acetylated and stabilized in response to mitomycin C (MMC) treatment. H1299 cells stably expressing WRN-6KR, which mimics unacetylated WRN, display significantly higher MMC sensitivity compared with the cells expressing wild-type WRN. Conclusion/Significance: Taken together, these data demonstrate that WRN acetylation regulates its stability and has significant implications regarding the role of acetylation on WRN function in response to DNA damage.	[Li, Kai; Wang, Rui; Fan, Wei; Luo, Jianyuan] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Li, Kai; Wang, Rui; Fan, Wei; Luo, Jianyuan] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA USA; [Lozada, Enerlyn; Orren, David K.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Kentucky	Li, K (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA.	Jianyuan.luo@umassmed.edu	Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914	National Institutes of Health National Institute on Aging (NIH/NIA) [R01AG026534, R01AG027258]; NATIONAL CANCER INSTITUTE [R01CA113371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026534, R01AG027258] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Aging (NIH/NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institutes of Health National Institute on Aging (NIH/NIA) grant R01AG026534 to J. Luo and R01AG027258 to D. Orren. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blander G, 2002, J BIOL CHEM, V277, P50934, DOI 10.1074/jbc.M210479200; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; Ge XJ, 2009, MOL BIOL CELL, V20, P419, DOI 10.1091/mbc.E08-08-0792; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Inari A, 2004, J BIOL CHEM, V279, P30830, DOI 10.1074/jbc.M402403200; Kahyo T, 2008, FEBS LETT, V582, P2479, DOI 10.1016/j.febslet.2008.06.031; Karmakar P, 2005, MECH AGEING DEV, V126, P1146, DOI 10.1016/j.mad.2005.06.004; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kusumoto R, 2007, MECH AGEING DEV, V128, P50, DOI 10.1016/j.mad.2006.11.010; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Lee JW, 2005, MECH AGEING DEV, V126, P79, DOI 10.1016/j.mad.2004.09.011; Li K, 2008, J BIOL CHEM, V283, P7590, DOI 10.1074/jbc.M709707200; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; MARTIN GM, 1970, LAB INVEST, V23, P86; Muftuoglu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001918; Mushegian AR, 1997, P NATL ACAD SCI USA, V94, P5831, DOI 10.1073/pnas.94.11.5831; Ogburn CE, 1997, HUM GENET, V101, P121, DOI 10.1007/s004390050599; Poot M, 2001, FASEB J, V15, P1224, DOI 10.1096/fj.00-0611fje; Rausa FM, 2004, J BIOL CHEM, V279, P43070, DOI 10.1074/jbc.M407472200; Singh DK, 2009, BIOGERONTOLOGY, V10, P235, DOI 10.1007/s10522-008-9205-z; STEFANINI M, 1989, MUTAT RES, V219, P179, DOI 10.1016/0921-8734(89)90013-1; Vaitiekunaite R, 2007, MECH AGEING DEV, V128, P650, DOI 10.1016/j.mad.2007.09.004; Wang R, 2005, J BIOL CHEM, V280, P11528, DOI 10.1074/jbc.M413930200; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	27	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2010	5	4							e10341	10.1371/journal.pone.0010341	http://dx.doi.org/10.1371/journal.pone.0010341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	588NU	20808827	Green Published, Green Submitted, gold			2022-12-25	WOS:000277079300021
